Citrus Sinensis ID: 037869

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380
Protein Sequence
MGSAFSCCGSEKVEEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGKVMQTRIETLAYKEELLAFDQTTDDDDRDPGNQELGVFGHTKVQKMRAPYNQFGDQKMH
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccEEEEcHHHHHHHHcccccccccccccccccEEEEEccccEEEEEEcccccccHHHHHHHHHHHHHHccccccccEEEEEcccccEEEEEEccccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHcccccccccccHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHcccccccccccccccHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccEEcHHHHHHHHccccHHcccccccccEEEEEEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHcccHEEEEEEEEccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHHcccccccccccHHHEEEEHHHEEEEccccHHHHcccHHHHccccccccHHHccHHHHHHccccHHHHHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHHcccHHHHccccHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHccccccc
Coil and Loop (DISEMBL)
mgsafsccgsekveeglttittpnnatwRIFTYKelhtatngfsddnklgeggfgsvywgrtsdGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRhknllglrgycagtdqrlivydympnlsllSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHhevtphiihrdikasnvlldsdfeplvadfgfaklipegvshmttrvkgtlgylapeyamwgkvsescdvySFGILLLEILtgrkpieklpggvkrtitewaeplivkgkfkelvdpklrgdfdenQLKQAINVAVLCVqsepekrpnmKEVVNTLtgydprgkVMQTRIETLAYKEELLAfdqttddddrdpgnqelgvfghtkvqkmrapynqfgdqkmh
Flexible Loop (DISEMBL)
mgsafsccgsekveeglttittpnnatWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILtgrkpieklpggvkrtitewaeplivkgkfkelVDPKLRGDFDENQLKQAINVAVLcvqsepekrpnmkevvntltgydprgkVMQTRIETLAYKEELLAFDQTTDDDDRDPGNQElgvfghtkvqkmrapynqfgdqkmh
Low Complexity Region (SEG)
MGSAFSCCGSEKVEEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGKVMQTRIETLAYKEELLAFdqttddddrdPGNQELGVFGHTKVQKMRAPYNQFGDQKMH
Disordered region (IsUnstruct)
******CCG**KVEEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQ***********VVNTLTGYDPRGKVMQTRIETLAYKEELLAF****************************************
Disordered Region (DISOPRED)
****************************RIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAM***AEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD**************************************************************
Disordered Region (DISEMBL)
***********KVEEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGKVMQTRIETLAYKEELLAFDQTTDDDDRDPGNQELGVFGHTKVQKMRAPYNQFGDQKMH
Disordered Region (DISPRO)
*************************ATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY*PR************************************************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGSAFSCCGSEKVEEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGKVMQTRIETLAYKEELLAFDQTTDDDDRDPGNQELGVFGHTKVQKMRAPYNQFGDQKMH
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	380	2.2.26 [Sep-21-2011]
Q9LSC2	361	PTI1-like tyrosine-protei	no	no	0.763	0.803	0.542	5e-93
Q9CAL8	710	Proline-rich receptor-lik	no	no	0.823	0.440	0.447	3e-79
Q9FFW5	681	Proline-rich receptor-lik	no	no	0.755	0.421	0.484	5e-77
Q9LV48	652	Proline-rich receptor-lik	no	no	0.747	0.435	0.472	6e-77
Q9LK03	717	Proline-rich receptor-lik	no	no	0.747	0.396	0.472	2e-76
Q8GX23	670	Proline-rich receptor-lik	no	no	0.784	0.444	0.459	5e-76
Q9C660	762	Proline-rich receptor-lik	no	no	0.736	0.367	0.479	1e-75
Q9SGY7	718	Putative proline-rich rec	no	no	0.85	0.449	0.432	2e-75
Q9ZUE0	720	Proline-rich receptor-lik	no	no	0.889	0.469	0.411	5e-75
Q1PEM5	513	Proline-rich receptor-lik	no	no	0.747	0.553	0.462	2e-74

>sp|Q9LSC2|Y3589_ARATH PTI1-like tyrosine-protein kinase At3g15890 OS=Arabidopsis thaliana GN=At3g15890 PE=1 SV=1

 Score =  341 bits (875), Expect = 5e-93,   Method: Compositional matrix adjust.
 Identities = 158/291 (54%), Positives = 212/291 (72%), Gaps = 1/291 (0%)

Query: 27  TWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAV 86
           +WR+F+ KELH ATN F+ DNKLGEG FGSVYWG+  DG QIAVK+LK  +++ E++FAV
Sbjct: 23  SWRVFSLKELHAATNSFNYDNKLGEGRFGSVYWGQLWDGSQIAVKRLKEWSNREEIDFAV 82

Query: 87  EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKI 146
           EVE+L R+RHKNLL +RGYCA   +RL+VY+YM NLSL+SHLHGQ++ E  LDW +RMKI
Sbjct: 83  EVEILARIRHKNLLSVRGYCAEGQERLLVYEYMQNLSLVSHLHGQHSAECLLDWTKRMKI 142

Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP-EGVSHMTTRV 205
           AI SA+ I YLH   TPHI+H D++ASNVLLDS+FE  V DFG+ KL+P +      T+ 
Sbjct: 143 AISSAQAIAYLHDHATPHIVHGDVRASNVLLDSEFEARVTDFGYGKLMPDDDTGDGATKA 202

Query: 206 KGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIV 265
           K   GY++PE    GK SE+ DVYSFGILL+ +++G++P+E+L     R ITEW  PL+ 
Sbjct: 203 KSNNGYISPECDASGKESETSDVYSFGILLMVLVSGKRPLERLNPTTTRCITEWVLPLVY 262

Query: 266 KGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
           +  F E+VD +L  +    +LK+ + V ++C Q++P+KRP M EVV  L  
Sbjct: 263 ERNFGEIVDKRLSEEHVAEKLKKVVLVGLMCAQTDPDKRPTMSEVVEMLVN 313

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 2

>sp|Q9CAL8|PEK13_ARATH Proline-rich receptor-like protein kinase PERK13 OS=Arabidopsis thaliana GN=PERK13 PE=2 SV=1

 Score =  295 bits (756), Expect = 3e-79,   Method: Compositional matrix adjust.
 Identities = 149/333 (44%), Positives = 212/333 (63%), Gaps = 20/333 (6%)

Query: 31  FTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEV 90
           FTY+EL   T GFS  N LGEGGFG VY G+ +DG  +AVK+LK  + + + EF  EVE+
Sbjct: 341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEI 400

Query: 91  LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
           + RV H++L+ L GYC    +RL++Y+Y+PN +L  HLHG+  G   L+W RR++IAIGS
Sbjct: 401 ISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGK--GRPVLEWARRVRIAIGS 458

Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG 210
           A+G+ YLH +  P IIHRDIK++N+LLD +FE  VADFG AKL     +H++TRV GT G
Sbjct: 459 AKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFG 518

Query: 211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVK---- 266
           YLAPEYA  GK+++  DV+SFG++LLE++TGRKP+++     + ++ EWA PL+ K    
Sbjct: 519 YLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLGEESLVEWARPLLHKAIET 578

Query: 267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGKVM-- 324
           G F ELVD +L   + EN++ + I  A  CV+    KRP M +VV  L      G +   
Sbjct: 579 GDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDMGDISNG 638

Query: 325 ------------QTRIETLAYKEELLAFDQTTD 345
                       Q   +T+ +++    FD ++D
Sbjct: 639 NKVGQSSAYDSGQYNNDTMKFRKMAFGFDDSSD 671

Regulates negatively root hairs elongation.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9FFW5|PERK8_ARATH Proline-rich receptor-like protein kinase PERK8 OS=Arabidopsis thaliana GN=PERK8 PE=1 SV=1

 Score =  288 bits (736), Expect = 5e-77,   Method: Compositional matrix adjust.
 Identities = 144/297 (48%), Positives = 196/297 (65%), Gaps = 10/297 (3%)

Query: 24  NNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEME 83
           N  +W  F+Y EL   T+GFS+ N LGEGGFG VY G  SDG ++AVK+LK   S+ E E
Sbjct: 322 NQRSW--FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGERE 379

Query: 84  FAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRR 143
           F  EVE++ RV H++L+ L GYC     RL+VYDY+PN +L  HLH    G   + W+ R
Sbjct: 380 FKAEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHA--PGRPVMTWETR 437

Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE--GVSHM 201
           +++A G+A GI YLH +  P IIHRDIK+SN+LLD+ FE LVADFG AK+  E    +H+
Sbjct: 438 VRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHV 497

Query: 202 TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE 261
           +TRV GT GY+APEYA  GK+SE  DVYS+G++LLE++TGRKP++        ++ EWA 
Sbjct: 498 STRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLGDESLVEWAR 557

Query: 262 PLIVKG----KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           PL+ +     +F ELVDP+L  +F   ++ + +  A  CV+    KRP M +VV  L
Sbjct: 558 PLLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRAL 614

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LV48|PERK1_ARATH Proline-rich receptor-like protein kinase PERK1 OS=Arabidopsis thaliana GN=PERK1 PE=1 SV=1

 Score =  288 bits (736), Expect = 6e-77,   Method: Compositional matrix adjust.
 Identities = 137/290 (47%), Positives = 198/290 (68%), Gaps = 6/290 (2%)

Query: 31  FTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEV 90
           FTY+EL  ATNGFS+ N LG+GGFG V+ G    G ++AVK+LKA + + E EF  EVE+
Sbjct: 268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327

Query: 91  LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
           + RV H++L+ L GYC    QRL+VY+++PN +L  HLHG+  G   ++W  R+KIA+GS
Sbjct: 328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGK--GRPTMEWSTRLKIALGS 385

Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG 210
           A+G+ YLH +  P IIHRDIKASN+L+D  FE  VADFG AK+  +  +H++TRV GT G
Sbjct: 386 AKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFG 445

Query: 211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVK---- 266
           YLAPEYA  GK++E  DV+SFG++LLE++TGR+P++     V  ++ +WA PL+ +    
Sbjct: 446 YLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASEE 505

Query: 267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
           G F+ L D K+  ++D  ++ + +  A  CV+    +RP M ++V  L G
Sbjct: 506 GDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEG 555

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LK03|PERK2_ARATH Proline-rich receptor-like protein kinase PERK2 OS=Arabidopsis thaliana GN=PERK2 PE=2 SV=3

 Score =  286 bits (733), Expect = 2e-76,   Method: Compositional matrix adjust.
 Identities = 137/290 (47%), Positives = 197/290 (67%), Gaps = 6/290 (2%)

Query: 31  FTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEV 90
           F Y+EL  ATNGFS+ N LG+GGFG V+ G   +G ++AVK+LK  +S+ E EF  EV +
Sbjct: 342 FNYEELSRATNGFSEANLLGQGGFGYVFKGMLRNGKEVAVKQLKEGSSQGEREFQAEVGI 401

Query: 91  LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
           + RV H++L+ L GYC    QRL+VY+++PN +L  HLHG+  G   ++W  R+KIA+GS
Sbjct: 402 ISRVHHRHLVALVGYCIADAQRLLVYEFVPNNTLEFHLHGK--GRPTMEWSSRLKIAVGS 459

Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG 210
           A+G+ YLH    P IIHRDIKASN+L+D  FE  VADFG AK+  +  +H++TRV GT G
Sbjct: 460 AKGLSYLHENCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFG 519

Query: 211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVK---- 266
           YLAPEYA  GK++E  DV+SFG++LLE++TGR+PI+        ++ +WA PL+ +    
Sbjct: 520 YLAPEYASSGKLTEKSDVFSFGVVLLELITGRRPIDVNNVHADNSLVDWARPLLNQVSEL 579

Query: 267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
           G F+ +VD KL  ++D+ ++ + +  A  CV+S   +RP M +V   L G
Sbjct: 580 GNFEVVVDKKLNNEYDKEEMARMVACAAACVRSTAPRRPRMDQVARVLEG 629

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GX23|PERK5_ARATH Proline-rich receptor-like protein kinase PERK5 OS=Arabidopsis thaliana GN=PERK5 PE=2 SV=1

 Score =  285 bits (728), Expect = 5e-76,   Method: Compositional matrix adjust.
 Identities = 142/309 (45%), Positives = 200/309 (64%), Gaps = 11/309 (3%)

Query: 16  GLTTITTPNNATW----RIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVK 71
           G T I +P  AT       FTY EL  AT GF+  N LG+GGFG V+ G    G ++AVK
Sbjct: 281 GRTAIPSPQAATLGHNQSTFTYDELSIATEGFAQSNLLGQGGFGYVHKGVLPSGKEVAVK 340

Query: 72  KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQ 131
            LK  + + E EF  EV+++ RV H++L+ L GYC    QRL+VY+++PN +L  HLHG+
Sbjct: 341 SLKLGSGQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNTLEFHLHGK 400

Query: 132 YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA 191
             G   LDW  R+KIA+GSA G+ YLH +  P IIHRDIKA+N+LLD  FE  VADFG A
Sbjct: 401 --GRPVLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLDFSFETKVADFGLA 458

Query: 192 KLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGG 251
           KL  +  +H++TRV GT GYLAPEYA  GK+S+  DV+SFG++LLE++TGR P++ L G 
Sbjct: 459 KLSQDNYTHVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPPLD-LTGE 517

Query: 252 VKRTITEWAEPLIVK----GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNM 307
           ++ ++ +WA PL +K    G + +L DP+L  ++   ++ Q  + A   ++    +RP M
Sbjct: 518 MEDSLVDWARPLCLKAAQDGDYNQLADPRLELNYSHQEMVQMASCAAAAIRHSARRRPKM 577

Query: 308 KEVVNTLTG 316
            ++V  L G
Sbjct: 578 SQIVRALEG 586

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C660|PEK10_ARATH Proline-rich receptor-like protein kinase PERK10 OS=Arabidopsis thaliana GN=PERK10 PE=1 SV=2

 Score =  283 bits (724), Expect = 1e-75,   Method: Compositional matrix adjust.
 Identities = 137/286 (47%), Positives = 191/286 (66%), Gaps = 6/286 (2%)

Query: 30  IFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVE 89
           +F+Y+EL  ATNGFSD+N LGEGGFG VY G   D   +AVK+LK    + + EF  EV+
Sbjct: 417 LFSYEELVIATNGFSDENLLGEGGFGRVYKGVLPDERVVAVKQLKIGGGQGDREFKAEVD 476

Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIG 149
            + RV H+NLL + GYC   ++RL++YDY+PN +L  HLH   AG   LDW  R+KIA G
Sbjct: 477 TISRVHHRNLLSMVGYCISENRRLLIYDYVPNNNLYFHLHA--AGTPGLDWATRVKIAAG 534

Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
           +A G+ YLH +  P IIHRDIK+SN+LL+++F  LV+DFG AKL  +  +H+TTRV GT 
Sbjct: 535 AARGLAYLHEDCHPRIIHRDIKSSNILLENNFHALVSDFGLAKLALDCNTHITTRVMGTF 594

Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKG-- 267
           GY+APEYA  GK++E  DV+SFG++LLE++TGRKP++        ++ EWA PL+     
Sbjct: 595 GYMAPEYASSGKLTEKSDVFSFGVVLLELITGRKPVDASQPLGDESLVEWARPLLSNATE 654

Query: 268 --KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
             +F  L DPKL  ++   ++ + I  A  C++    KRP M ++V
Sbjct: 655 TEEFTALADPKLGRNYVGVEMFRMIEAAAACIRHSATKRPRMSQIV 700

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SGY7|PEK11_ARATH Putative proline-rich receptor-like protein kinase PERK11 OS=Arabidopsis thaliana GN=PERK11 PE=2 SV=2

 Score =  282 bits (722), Expect = 2e-75,   Method: Compositional matrix adjust.
 Identities = 147/340 (43%), Positives = 218/340 (64%), Gaps = 17/340 (5%)

Query: 22  TPNNA---TWRI-FTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMN 77
           TP++A   T +I FTY+EL   T GF     +GEGGFG VY G   +G  +A+K+LK+++
Sbjct: 345 TPDSAVIGTSKIHFTYEELSQITEGFCKSFVVGEGGFGCVYKGILFEGKPVAIKQLKSVS 404

Query: 78  SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ 137
           ++   EF  EVE++ RV H++L+ L GYC     R ++Y+++PN +L  HLHG+      
Sbjct: 405 AEGYREFKAEVEIISRVHHRHLVSLVGYCISEQHRFLIYEFVPNNTLDYHLHGKNL--PV 462

Query: 138 LDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG 197
           L+W RR++IAIG+A+G+ YLH +  P IIHRDIK+SN+LLD +FE  VADFG A+L    
Sbjct: 463 LEWSRRVRIAIGAAKGLAYLHEDCHPKIIHRDIKSSNILLDDEFEAQVADFGLARLNDTA 522

Query: 198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTIT 257
            SH++TRV GT GYLAPEYA  GK+++  DV+SFG++LLE++TGRKP++      + ++ 
Sbjct: 523 QSHISTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLLELITGRKPVDTSQPLGEESLV 582

Query: 258 EWAEPLIV----KGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT 313
           EWA P ++    KG   E+VDP+L  D+ E+++ + I  A  CV+    KRP M +VV  
Sbjct: 583 EWARPRLIEAIEKGDISEVVDPRLENDYVESEVYKMIETAASCVRHSALKRPRMVQVVRA 642

Query: 314 LTGYDPRG------KVMQTRI-ETLAYKEELLAFDQTTDD 346
           L   D         KV Q+R+ ++  Y  E+  F + ++D
Sbjct: 643 LDTRDDLSDLTNGVKVGQSRVYDSGQYSNEIRIFRRASED 682

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZUE0|PEK12_ARATH Proline-rich receptor-like protein kinase PERK12 OS=Arabidopsis thaliana GN=PERK12 PE=2 SV=2

 Score =  281 bits (719), Expect = 5e-75,   Method: Compositional matrix adjust.
 Identities = 146/355 (41%), Positives = 219/355 (61%), Gaps = 17/355 (4%)

Query: 1   MGSAFSCCGSEKVEEGLTTITTPNNATW----RIFTYKELHTATNGFSDDNKLGEGGFGS 56
           MG+++   G       + +  TP++A        F+Y+EL   T GF+  N LGEGGFG 
Sbjct: 325 MGNSYGTAGGGYPHHQMQSSGTPDSAILGSGQTHFSYEELAEITQGFARKNILGEGGFGC 384

Query: 57  VYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY 116
           VY G   DG  +AVK+LKA + + + EF  EVE++ RV H++L+ L GYC     RL++Y
Sbjct: 385 VYKGTLQDGKVVAVKQLKAGSGQGDREFKAEVEIISRVHHRHLVSLVGYCISDQHRLLIY 444

Query: 117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVL 176
           +Y+ N +L  HLHG+  G   L+W +R++IAIGSA+G+ YLH +  P IIHRDIK++N+L
Sbjct: 445 EYVSNQTLEHHLHGK--GLPVLEWSKRVRIAIGSAKGLAYLHEDCHPKIIHRDIKSANIL 502

Query: 177 LDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLL 236
           LD ++E  VADFG A+L     +H++TRV GT GYLAPEYA  GK+++  DV+SFG++LL
Sbjct: 503 LDDEYEAQVADFGLARLNDTTQTHVSTRVMGTFGYLAPEYASSGKLTDRSDVFSFGVVLL 562

Query: 237 EILTGRKPIEKLPGGVKRTITEWAEPLIVK----GKFKELVDPKLRGDFDENQLKQAINV 292
           E++TGRKP+++     + ++ EWA PL++K    G   EL+D +L   + E+++ + I  
Sbjct: 563 ELVTGRKPVDQTQPLGEESLVEWARPLLLKAIETGDLSELIDTRLEKRYVEHEVFRMIET 622

Query: 293 AVLCVQSEPEKRPNMKEVVNTLTGYDPRGKV-------MQTRIETLAYKEELLAF 340
           A  CV+    KRP M +VV  L      G +         T  ++  Y E+++ F
Sbjct: 623 AAACVRHSGPKRPRMVQVVRALDCDGDSGDISNGIKIGQSTTYDSGQYNEDIMKF 677

Regulates the auxin-related MAX (More Axillary Growth) pathway during the shoot branching.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q1PEM5|PERK3_ARATH Proline-rich receptor-like protein kinase PERK3 OS=Arabidopsis thaliana GN=PERK3 PE=2 SV=2

 Score =  279 bits (714), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 134/290 (46%), Positives = 194/290 (66%), Gaps = 6/290 (2%)

Query: 31  FTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEV 90
           FTY EL  ATN FS+ N LGEGGFG VY G  ++G ++AVK+LK  +++ E EF  EV +
Sbjct: 171 FTYGELARATNKFSEANLLGEGGFGFVYKGILNNGNEVAVKQLKVGSAQGEKEFQAEVNI 230

Query: 91  LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
           + ++ H+NL+ L GYC    QRL+VY+++PN +L  HLHG+  G   ++W  R+KIA+ S
Sbjct: 231 ISQIHHRNLVSLVGYCIAGAQRLLVYEFVPNNTLEFHLHGK--GRPTMEWSLRLKIAVSS 288

Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG 210
           ++G+ YLH    P IIHRDIKA+N+L+D  FE  VADFG AK+  +  +H++TRV GT G
Sbjct: 289 SKGLSYLHENCNPKIIHRDIKAANILIDFKFEAKVADFGLAKIALDTNTHVSTRVMGTFG 348

Query: 211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKG--- 267
           YLAPEYA  GK++E  DVYSFG++LLE++TGR+P++        ++ +WA PL+V+    
Sbjct: 349 YLAPEYAASGKLTEKSDVYSFGVVLLELITGRRPVDANNVYADDSLVDWARPLLVQALEE 408

Query: 268 -KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
             F+ L D KL  ++D  ++ + +  A  CV+    +RP M +VV  L G
Sbjct: 409 SNFEGLADIKLNNEYDREEMARMVACAAACVRYTARRRPRMDQVVRVLEG 458

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	380
255587651	389	serine-threonine protein kinase, plant-t	0.992	0.969	0.814	0.0
357479817	373	Receptor-like kinase [Medicago truncatul	0.978	0.997	0.816	1e-180
224117558	378	predicted protein [Populus trichocarpa]	0.944	0.949	0.847	1e-179
225446180	383	PREDICTED: PTI1-like tyrosine-protein ki	0.992	0.984	0.794	1e-177
356550770	380	PREDICTED: PTI1-like tyrosine-protein ki	0.989	0.989	0.802	1e-174
356564872	379	PREDICTED: PTI1-like tyrosine-protein ki	0.992	0.994	0.797	1e-172
413955003	427	putative protein kinase superfamily prot	0.944	0.840	0.646	1e-150
242093800	437	hypothetical protein SORBIDRAFT_10g02605	0.878	0.764	0.701	1e-147
449457229	407	PREDICTED: PTI1-like tyrosine-protein ki	0.831	0.776	0.762	1e-145
297725141	401	Os06g0654500 [Oryza sativa Japonica Grou	0.960	0.910	0.636	1e-142

>gi|255587651|ref|XP_002534343.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis] gi|223525459|gb|EEF28041.1| serine-threonine protein kinase, plant-type, putative [Ricinus communis]

 Score =  650 bits (1676), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 311/382 (81%), Positives = 340/382 (89%), Gaps = 5/382 (1%)

Query: 1   MGSAFSCCGSEKVEEGLTTITTPNNA--TWRIFTYKELHTATNGFSDDNKLGEGGFGSVY 58
           MGS+ SCCG+EK+++G   I   NN   +WR+FTYKELH ATNGFSDDNKLGEGGFGSVY
Sbjct: 1   MGSSLSCCGNEKIDDGANLIGGGNNTATSWRLFTYKELHAATNGFSDDNKLGEGGFGSVY 60

Query: 59  WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY 118
           WG+T+DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRH+NLLGLRGYC GTDQRLIVYDY
Sbjct: 61  WGKTTDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHRNLLGLRGYCVGTDQRLIVYDY 120

Query: 119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLD 178
           MPNLSLLSHLHGQ+AGEVQLDW+RRMKI IGSAEG+LYLHHEVTPHIIHRDIKASNVLLD
Sbjct: 121 MPNLSLLSHLHGQFAGEVQLDWRRRMKIVIGSAEGLLYLHHEVTPHIIHRDIKASNVLLD 180

Query: 179 SDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEI 238
           SDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEI
Sbjct: 181 SDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEI 240

Query: 239 LTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQ 298
           +TGRKPIEKLP GVKRTITEWAEPLI+KG+ K+LVDP+LRG+FDE QLKQ INVA LCVQ
Sbjct: 241 ITGRKPIEKLPVGVKRTITEWAEPLIIKGRIKDLVDPRLRGNFDETQLKQTINVAALCVQ 300

Query: 299 SEPEKRPNMKEVVNTLTGYDPRGKVMQTRIETLAYKEELLAFDQTT---DDDDRDPGNQE 355
           +EPEKRP+MKEVV+ L GYD RG+VMQTRI++  YKEELLA DQT+        DP   E
Sbjct: 301 NEPEKRPSMKEVVSMLKGYDSRGRVMQTRIDSAKYKEELLALDQTSDDGGGGGGDPDESE 360

Query: 356 LGVFGHTKVQKMRAPYNQFGDQ 377
            GVFG  +VQKM+ PY + GD 
Sbjct: 361 YGVFGAMEVQKMQDPYRRLGDN 382

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357479817|ref|XP_003610194.1| Receptor-like kinase [Medicago truncatula] gi|355511249|gb|AES92391.1| Receptor-like kinase [Medicago truncatula]

 Score =  638 bits (1645), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 307/376 (81%), Positives = 336/376 (89%), Gaps = 4/376 (1%)

Query: 1   MGSAFSCCGSEKVEEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWG 60
           MGS+ SCCGSEKV+E  T+    NN +WRIFTYKELHTATNGFSDD KLGEGGFGSVYWG
Sbjct: 1   MGSSLSCCGSEKVDEVPTSYGVANN-SWRIFTYKELHTATNGFSDDYKLGEGGFGSVYWG 59

Query: 61  RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMP 120
           RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC G DQRLIVYDYMP
Sbjct: 60  RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCVGDDQRLIVYDYMP 119

Query: 121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD 180
           NLSLLSHLHGQYAGEVQL+W++RM IAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD
Sbjct: 120 NLSLLSHLHGQYAGEVQLNWQKRMSIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD 179

Query: 181 FEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT 240
           F PLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLE++T
Sbjct: 180 FVPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLELVT 239

Query: 241 GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSE 300
           GRKPIEKLPGG+KRTITEWAEPLI KG+F+++VDPKLRG+FDENQ+KQ +NVA LCVQSE
Sbjct: 240 GRKPIEKLPGGLKRTITEWAEPLITKGRFRDMVDPKLRGNFDENQVKQTVNVAALCVQSE 299

Query: 301 PEKRPNMKEVVNTLTGYDP-RGKVMQTRIETLAYKEELLAFDQTTDDDDRDPGNQELGVF 359
           PEKRPNMK+VV+ L G +P +GKV + RI+++ Y +ELLA DQ +DDD    GN   GVF
Sbjct: 300 PEKRPNMKQVVSLLKGQEPDQGKVTKMRIDSVKYNDELLALDQPSDDD--YDGNSSYGVF 357

Query: 360 GHTKVQKMRAPYNQFG 375
               VQKM+ PY + G
Sbjct: 358 SAIDVQKMKDPYKKIG 373

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224117558|ref|XP_002331666.1| predicted protein [Populus trichocarpa] gi|222874085|gb|EEF11216.1| predicted protein [Populus trichocarpa]

 Score =  635 bits (1638), Expect = e-179,   Method: Compositional matrix adjust.
 Identities = 306/361 (84%), Positives = 327/361 (90%), Gaps = 2/361 (0%)

Query: 20  ITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSK 79
           I    N TWRIFTYKELHTATNGFS+DNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSK
Sbjct: 12  IGGAGNNTWRIFTYKELHTATNGFSEDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSK 71

Query: 80  AEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLD 139
           AEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHG +AG+VQLD
Sbjct: 72  AEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGHFAGDVQLD 131

Query: 140 WKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS 199
           WK+RMKIAIGSAEG+LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS
Sbjct: 132 WKKRMKIAIGSAEGLLYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS 191

Query: 200 HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEW 259
           HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEI+TGRKPIEKLPGGVKRT+TEW
Sbjct: 192 HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIVTGRKPIEKLPGGVKRTVTEW 251

Query: 260 AEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP 319
           AEPLI KG+FK+L DPKLRG+FDENQ KQ+INVA LCVQSEPE RP MK VV+ L GYDP
Sbjct: 252 AEPLITKGRFKDLADPKLRGNFDENQFKQSINVAALCVQSEPENRPTMKVVVSMLKGYDP 311

Query: 320 RGKVMQTRIETLAYKEELLAFDQTTDDDDRDPG--NQELGVFGHTKVQKMRAPYNQFGDQ 377
           RGKVMQTRI+++ YKEELL  DQT+D ++   G    E GVFG  +VQ M+ PY + GD 
Sbjct: 312 RGKVMQTRIKSVKYKEELLELDQTSDGENDGGGLEESEYGVFGPMEVQNMQDPYKRHGDG 371

Query: 378 K 378
           K
Sbjct: 372 K 372

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225446180|ref|XP_002271881.1| PREDICTED: PTI1-like tyrosine-protein kinase At3g15890 [Vitis vinifera]

 Score =  626 bits (1615), Expect = e-177,   Method: Compositional matrix adjust.
 Identities = 305/384 (79%), Positives = 344/384 (89%), Gaps = 7/384 (1%)

Query: 1   MGSAFSCCGSEKVEEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWG 60
           MGS+ SCCG+EKV+EG+T +    N+ WRIF+YKEL+TATNGFS++NKLGEGGFGSVYWG
Sbjct: 1   MGSSLSCCGAEKVDEGVTLVGV--NSPWRIFSYKELYTATNGFSEENKLGEGGFGSVYWG 58

Query: 61  RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMP 120
           +T+DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC GTDQRLIVYDYMP
Sbjct: 59  KTTDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCVGTDQRLIVYDYMP 118

Query: 121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD 180
           NLSLLS+LHGQ++ +VQLDW+RRMKI IGSAEG+LYLHHEVTPHIIHRDIKASNVLLDSD
Sbjct: 119 NLSLLSYLHGQFSSQVQLDWRRRMKIIIGSAEGLLYLHHEVTPHIIHRDIKASNVLLDSD 178

Query: 181 FEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT 240
           FEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT
Sbjct: 179 FEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT 238

Query: 241 GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSE 300
           G+KPIEKLPGGVKRTITEWAEPLI+KG+FK+LVDP+LRG+FDENQL+QAINVA LCVQ+E
Sbjct: 239 GKKPIEKLPGGVKRTITEWAEPLIIKGRFKDLVDPRLRGNFDENQLRQAINVAALCVQNE 298

Query: 301 PEKRPNMKEVVNTLTGYDPRGKVMQTRIETLAYKEELLAFDQTTDDDDRDPG-----NQE 355
            EKRPNMKEVV+ L GY P+ KV Q R+E++ Y EELLA DQ + DDD D       ++ 
Sbjct: 299 CEKRPNMKEVVSLLKGYQPKDKVTQMRMESVKYGEELLALDQGSGDDDDDDDNDPDESKG 358

Query: 356 LGVFGHTKVQKMRAPYNQFGDQKM 379
            GVFG  +VQKM  P  + GD+++
Sbjct: 359 YGVFGAMEVQKMPEPRIRRGDRRI 382

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356550770|ref|XP_003543757.1| PREDICTED: PTI1-like tyrosine-protein kinase At3g15890-like [Glycine max]

 Score =  617 bits (1591), Expect = e-174,   Method: Compositional matrix adjust.
 Identities = 304/379 (80%), Positives = 333/379 (87%), Gaps = 3/379 (0%)

Query: 1   MGSAFSCCGSEKVEEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWG 60
           MGS+ SCCGSE+VEE  T+    +N +WRIFTYKELH ATNGF+DDNKLGEGGFGSVYWG
Sbjct: 1   MGSSISCCGSERVEEVPTSFGVVHN-SWRIFTYKELHAATNGFNDDNKLGEGGFGSVYWG 59

Query: 61  RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMP 120
           RT+DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC G DQRLIVYDYMP
Sbjct: 60  RTNDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCVGDDQRLIVYDYMP 119

Query: 121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD 180
           NLSLLSHLHGQ+A EVQL+W+RRMKIAIGSAEG+LYLH EV PHIIHRDIKASNVLL+SD
Sbjct: 120 NLSLLSHLHGQFAVEVQLNWQRRMKIAIGSAEGLLYLHREVAPHIIHRDIKASNVLLNSD 179

Query: 181 FEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT 240
           FEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLE++T
Sbjct: 180 FEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLELVT 239

Query: 241 GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSE 300
           GRKPIEKLPGG+KRTITEWAEPLI  G+ ++LVDPKLRG+FDENQ+KQ INVA LCVQSE
Sbjct: 240 GRKPIEKLPGGLKRTITEWAEPLITNGRLRDLVDPKLRGNFDENQVKQTINVAALCVQSE 299

Query: 301 PEKRPNMKEVVNTLTGYD-PRGKVMQTRIETLAYKEELLAFDQTTDDDDRDPGNQELGVF 359
           PEKRPNMK+VVN L GY+    KV   RI+++ Y EELLA DQ +DDDD D      GVF
Sbjct: 300 PEKRPNMKQVVNLLKGYEFEEKKVTAMRIDSIKYNEELLALDQPSDDDDHDDATASYGVF 359

Query: 360 GHTKVQKMRAPYNQFGDQK 378
              +VQKM+ PY + GD K
Sbjct: 360 SAIEVQKMKDPYMR-GDNK 377

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356564872|ref|XP_003550671.1| PREDICTED: PTI1-like tyrosine-protein kinase At3g15890-like [Glycine max]

 Score =  612 bits (1577), Expect = e-172,   Method: Compositional matrix adjust.
 Identities = 303/380 (79%), Positives = 334/380 (87%), Gaps = 3/380 (0%)

Query: 1   MGSAFSCCGSEKVEEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWG 60
           MGS+FSCCGSE+VEE  T+    +N +WRIFTYKELH ATNGFSDDNKLGEGGFGSVYWG
Sbjct: 1   MGSSFSCCGSERVEEVPTSFGVVHN-SWRIFTYKELHAATNGFSDDNKLGEGGFGSVYWG 59

Query: 61  RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMP 120
           RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRH NLLGLRGYC G DQRLIVYDYMP
Sbjct: 60  RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHNNLLGLRGYCVGDDQRLIVYDYMP 119

Query: 121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD 180
           NLSLLSHLHGQ+A +VQL+W+RRMKIAIGSAEG+LYLH EVTPHIIHRDIKASNVLL+SD
Sbjct: 120 NLSLLSHLHGQFAVDVQLNWQRRMKIAIGSAEGLLYLHREVTPHIIHRDIKASNVLLNSD 179

Query: 181 FEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT 240
           FEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLE++T
Sbjct: 180 FEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLELVT 239

Query: 241 GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSE 300
           GRKPIEKL GG+KRTITEWAEPLI  G+FK+LVDPKLRG+FDENQ+KQ +NVA LCVQSE
Sbjct: 240 GRKPIEKLTGGLKRTITEWAEPLITNGRFKDLVDPKLRGNFDENQVKQTVNVAALCVQSE 299

Query: 301 PEKRPNMKEVVNTLTGYDP-RGKVMQTRIETLAYKEELLAFDQTTDDDDRDPGNQELGVF 359
           PEKRPNMK+VVN L GY+    KV   RI+++ Y EELLA DQ++DDD  D      GVF
Sbjct: 300 PEKRPNMKQVVNLLKGYESEEKKVTTMRIDSVKYNEELLALDQSSDDDHDD-ATAIFGVF 358

Query: 360 GHTKVQKMRAPYNQFGDQKM 379
              ++QKM+ PY Q  ++ M
Sbjct: 359 SAIEIQKMKDPYKQSDNKIM 378

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|413955003|gb|AFW87652.1| putative protein kinase superfamily protein [Zea mays]

 Score =  536 bits (1382), Expect = e-150,   Method: Compositional matrix adjust.
 Identities = 262/405 (64%), Positives = 306/405 (75%), Gaps = 46/405 (11%)

Query: 11  EKVEEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAV 70
           EKVE+G  + +T  ++TWRIF+YKELH ATNGFS++NKLGEGGFGSVYWG+TSDGLQIAV
Sbjct: 12  EKVEQGCVSASTTMSSTWRIFSYKELHAATNGFSEENKLGEGGFGSVYWGKTSDGLQIAV 71

Query: 71  KKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLH 129
           KKLKA N SKAEMEFAVEVEVL RVRHKNLLGLRGYCAG DQR+IVYDYMPNLSLLSHLH
Sbjct: 72  KKLKATNNSKAEMEFAVEVEVLARVRHKNLLGLRGYCAGADQRMIVYDYMPNLSLLSHLH 131

Query: 130 GQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG 189
           GQ+AGEV+LDWKRR+ +A+GSAEG++YLHHEV PHIIHRDIKASNVLLDSDF PLVADFG
Sbjct: 132 GQFAGEVRLDWKRRVAVAVGSAEGLVYLHHEVAPHIIHRDIKASNVLLDSDFAPLVADFG 191

Query: 190 FAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLP 249
           FAKL+PEGVSHMTTRVKGTLGYLAPEYAMWGKVS +CDVYSFGILLLE+++GRKPIE+LP
Sbjct: 192 FAKLVPEGVSHMTTRVKGTLGYLAPEYAMWGKVSGACDVYSFGILLLELVSGRKPIERLP 251

Query: 250 GGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKE 309
            G KRTITEWAEPLI +G+  +LVDP+LRG FD  QL +A+  A LCVQ EP++RP+MK 
Sbjct: 252 SGAKRTITEWAEPLIARGRLGDLVDPRLRGAFDAAQLARAVECAALCVQGEPDRRPDMKT 311

Query: 310 VVNTLTGYDPRG----------------KVMQTRIETLAYKEELLAFDQTTD-------- 345
           VV  L G +  G                + +  R+E++ Y + L+  D++T         
Sbjct: 312 VVRILRGDNNAGAPAAAMVGRGGSKGDLQQLPVRMESVKYADRLMEMDKSTSYYGEPEDG 371

Query: 346 -------------------DDDRDPGNQELGVFGHTKVQKMRAPY 371
                               DD+   N   G FG   VQ M+ PY
Sbjct: 372 DEDEQEEEDDDDEVEEYSLIDDKSSMN--FGAFGAMPVQTMQDPY 414

Source: Zea mays

Species: Zea mays

Genus: Zea

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|242093800|ref|XP_002437390.1| hypothetical protein SORBIDRAFT_10g026050 [Sorghum bicolor] gi|241915613|gb|EER88757.1| hypothetical protein SORBIDRAFT_10g026050 [Sorghum bicolor]

 Score =  526 bits (1354), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 249/355 (70%), Positives = 293/355 (82%), Gaps = 21/355 (5%)

Query: 11  EKVEEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAV 70
           EKVE+G  + ++P ++TWRIF+YKELH ATNGFS++NKLGEGGFGSVYWG+TSDGLQIAV
Sbjct: 12  EKVEQGCVS-SSPMSSTWRIFSYKELHAATNGFSEENKLGEGGFGSVYWGKTSDGLQIAV 70

Query: 71  KKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLH 129
           KKLKA N SKAEMEFAVEVEVL RVRH+NLLGLRGYCAG DQR+IVYDYMPNLSLLSHLH
Sbjct: 71  KKLKATNNSKAEMEFAVEVEVLARVRHRNLLGLRGYCAGADQRMIVYDYMPNLSLLSHLH 130

Query: 130 GQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG 189
           GQ+AGEVQLDWKRR+ +A+GSAEG++YLHHE  PHIIHRDIKASNVLLDSDF PLVADFG
Sbjct: 131 GQFAGEVQLDWKRRVAVAVGSAEGLVYLHHEAAPHIIHRDIKASNVLLDSDFAPLVADFG 190

Query: 190 FAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLP 249
           FAKL+PEGVSHMTTRVKGTLGYLAPEYAMWGKVS +CDVYSFGILLLE+++GRKPIE+LP
Sbjct: 191 FAKLVPEGVSHMTTRVKGTLGYLAPEYAMWGKVSGACDVYSFGILLLELVSGRKPIERLP 250

Query: 250 GGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKE 309
            G KRTITEWAEPLI +G+  +LVDP+LRG FD  QL + +  A LCVQ EP++RP+M+ 
Sbjct: 251 SGAKRTITEWAEPLIARGRLGDLVDPRLRGAFDAAQLARVVECAALCVQGEPDRRPDMRT 310

Query: 310 VVNTLTGYD--------------PRG-----KVMQTRIETLAYKEELLAFDQTTD 345
           VV  L G +               RG     + +  RIE++ Y + L+  D+++ 
Sbjct: 311 VVRILRGENVAAAAAAAAAATVGARGGGKGEQKVPVRIESVKYADRLMEMDKSSS 365

Source: Sorghum bicolor

Species: Sorghum bicolor

Genus: Sorghum

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449457229|ref|XP_004146351.1| PREDICTED: PTI1-like tyrosine-protein kinase At3g15890-like [Cucumis sativus]

 Score =  520 bits (1338), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 241/316 (76%), Positives = 276/316 (87%)

Query: 1   MGSAFSCCGSEKVEEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWG 60
           MGS+FSCC SEKV+      +  N+++WR++TYKELH ATNGF DDNKLGEGGFGSVYWG
Sbjct: 1   MGSSFSCCDSEKVDRQRLGSSGFNSSSWRMYTYKELHAATNGFHDDNKLGEGGFGSVYWG 60

Query: 61  RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMP 120
           +T+DGLQIAVKKLKAMN KAEMEFAVEVEVL R+RHKNLLGLRGYC GTDQRLIVYDYMP
Sbjct: 61  KTTDGLQIAVKKLKAMNYKAEMEFAVEVEVLARLRHKNLLGLRGYCVGTDQRLIVYDYMP 120

Query: 121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD 180
           NLSLLSHLHG +A E  LDWKRR+KIA+GSA+GILYLH EV PHIIHRDIKASNVLLDSD
Sbjct: 121 NLSLLSHLHGHFASEALLDWKRRLKIALGSAQGILYLHQEVKPHIIHRDIKASNVLLDSD 180

Query: 181 FEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT 240
           FEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDV+S+GILLLE++T
Sbjct: 181 FEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVFSYGILLLELMT 240

Query: 241 GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSE 300
           GRKPIE+LPGG KRTI+EW    I K +FK+L D KL+G  +  + +Q +++A++CVQ+E
Sbjct: 241 GRKPIERLPGGAKRTISEWVNMTINKDRFKDLADKKLKGQLNWKEFEQVMHLAIMCVQTE 300

Query: 301 PEKRPNMKEVVNTLTG 316
            EKRP +K+VV  L G
Sbjct: 301 AEKRPTIKQVVEILKG 316

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297725141|ref|NP_001174934.1| Os06g0654500 [Oryza sativa Japonica Group] gi|255677286|dbj|BAH93662.1| Os06g0654500 [Oryza sativa Japonica Group]

 Score =  511 bits (1315), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 257/404 (63%), Positives = 304/404 (75%), Gaps = 39/404 (9%)

Query: 1   MGSAFSCC--GSEKVEEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY 58
           MGSA S C  GS+KVE+G  + +  +N TWRIF+YKELH ATNGFS++NKLGEGGFGSVY
Sbjct: 1   MGSAASSCCGGSKKVEQGCVSASMSSN-TWRIFSYKELHAATNGFSEENKLGEGGFGSVY 59

Query: 59  WGRTSDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT---DQRLI 114
           WG+TSDGLQIAVKKLKA N SKAEMEFAVEVEVL RVRHKNLLGLRGYCAG    DQR+I
Sbjct: 60  WGKTSDGLQIAVKKLKATNTSKAEMEFAVEVEVLARVRHKNLLGLRGYCAGGAAGDQRMI 119

Query: 115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASN 174
           VYDYMPNLSLLSHLHGQ+A +V+LDW RRM +A+G+AEG+++LHHE TPHIIHRDIKASN
Sbjct: 120 VYDYMPNLSLLSHLHGQFAADVRLDWARRMAVAVGAAEGLVHLHHEATPHIIHRDIKASN 179

Query: 175 VLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGIL 234
           VLLDS F PLVADFGFAKL+PEGV      VKGTLGYLAPEYAMWGKVS +CDVYSFGIL
Sbjct: 180 VLLDSGFAPLVADFGFAKLVPEGV------VKGTLGYLAPEYAMWGKVSGACDVYSFGIL 233

Query: 235 LLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAV 294
           LLE+++GRKPIE+LP G KRT+TEWAEPLI +G+  +LVDP+LRG FD  QL +A+  A 
Sbjct: 234 LLELVSGRKPIERLPSGAKRTVTEWAEPLIARGRLADLVDPRLRGAFDAAQLARAVEAAA 293

Query: 295 LCVQSEPEKRPNMKEVVNTLTGYDPRGKVMQTRIETLAYKEELLAFDQTTD--------- 345
           LCVQ+EPE+RP+M+ VV  L G D   K    R++++ Y + L+  D+++          
Sbjct: 294 LCVQAEPERRPDMRAVVRILRG-DADAK--PVRMKSIKYADHLMEMDKSSVYYGEDGGGD 350

Query: 346 -------------DDDRDPGNQELGVFGHTKVQKMRAPY-NQFG 375
                            D  +   GVFG   VQ M  PY  +FG
Sbjct: 351 GEEDMDDEEVEEYSLMEDKSSVNFGVFGAMPVQTMHDPYVRRFG 394

Source: Oryza sativa Japonica Group

Species: Oryza sativa

Genus: Oryza

Family: Poaceae

Order: Poales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	380
TAIR|locus:2035099	350	AT1G52540 [Arabidopsis thalian	0.847	0.92	0.539	5.1e-90
TAIR|locus:2093900	361	AT3G15890 [Arabidopsis thalian	0.844	0.889	0.507	3.3e-86
TAIR|locus:2026846	710	PERK13 "proline-rich extensin-	0.763	0.408	0.489	1.4e-73
TAIR|locus:2010282	699	PERK7 "proline-rich extensin-l	0.755	0.410	0.489	1.2e-72
TAIR|locus:2093999	700	PERK6 "proline-rich extensin-l	0.744	0.404	0.479	2e-72
TAIR|locus:2159873	681	PERK8 "proline-rich extensin-l	0.752	0.419	0.489	8.6e-72
TAIR|locus:2091722	652	PERK1 "proline-rich extensin-l	0.747	0.435	0.472	1.4e-71
TAIR|locus:2036636	632	NIK3 "NSP-interacting kinase 3	0.752	0.452	0.479	2.3e-71
TAIR|locus:2139474	670	PERK5 "proline-rich extensin-l	0.784	0.444	0.459	2.9e-71
UNIPROTKB|Q9ARH1	647	Q9ARH1 "Receptor protein kinas	0.747	0.438	0.465	9.9e-71

TAIR|locus:2035099 AT1G52540 [Arabidopsis thaliana (taxid:3702)]

 Score = 898 (321.2 bits), Expect = 5.1e-90, P = 5.1e-90
 Identities = 177/328 (53%), Positives = 231/328 (70%)

Query:     5 FSC-CGSEKVEEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTS 63
             FSC C  +  +      T P+   WRIF+ KELH ATN F+ DNKLGEG FGSVYWG+  
Sbjct:     4 FSCFCCGKGFDRQKKVKTEPS---WRIFSLKELHAATNSFNYDNKLGEGRFGSVYWGQLW 60

Query:    64 DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLS 123
             DG QIAVK+LKA +S+ E++FAVEVE+L R+RHKNLL +RGYCA   +RLIVYDYMPNLS
Sbjct:    61 DGSQIAVKRLKAWSSREEIDFAVEVEILARIRHKNLLSVRGYCAEGQERLIVYDYMPNLS 120

Query:   124 LLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEP 183
             L+SHLHGQ++ E  LDW RRM IA+ SA+ I YLHH  TP I+H D++ASNVLLDS+FE 
Sbjct:   121 LVSHLHGQHSSESLLDWTRRMNIAVSSAQAIAYLHHFATPRIVHGDVRASNVLLDSEFEA 180

Query:   184 LVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRK 243
              V DFG+ KL+P+  ++ +T+    +GYL+PE    GK S+  DVYSFG+LLLE++TG++
Sbjct:   181 RVTDFGYDKLMPDDGANKSTK-GNNIGYLSPECIESGKESDMGDVYSFGVLLLELVTGKR 239

Query:   244 PIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEK 303
             P E++    KR ITEW  PL+ + KF E+VD +L G + E +LK+ + V ++C Q E EK
Sbjct:   240 PTERVNLTTKRGITEWVLPLVYERKFGEIVDQRLNGKYVEEELKRIVLVGLMCAQRESEK 299

Query:   304 RPNMKEVVNTLTGYDPRGKVMQTRIETL 331
             RP M EVV  L   + + K+ Q     L
Sbjct:   300 RPTMSEVVEMLM-IESKEKMAQLEANPL 326

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2093900 AT3G15890 [Arabidopsis thaliana (taxid:3702)]

 Score = 862 (308.5 bits), Expect = 3.3e-86, P = 3.3e-86
 Identities = 166/327 (50%), Positives = 225/327 (68%)

Query:     6 SCCGSEKVEEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDG 65
             SCCG  K  +G          +WR+F+ KELH ATN F+ DNKLGEG FGSVYWG+  DG
Sbjct:     6 SCCG--KGFDGKKK--EKEEPSWRVFSLKELHAATNSFNYDNKLGEGRFGSVYWGQLWDG 61

Query:    66 LQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
              QIAVK+LK  +++ E++FAVEVE+L R+RHKNLL +RGYCA   +RL+VY+YM NLSL+
Sbjct:    62 SQIAVKRLKEWSNREEIDFAVEVEILARIRHKNLLSVRGYCAEGQERLLVYEYMQNLSLV 121

Query:   126 SHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV 185
             SHLHGQ++ E  LDW +RMKIAI SA+ I YLH   TPHI+H D++ASNVLLDS+FE  V
Sbjct:   122 SHLHGQHSAECLLDWTKRMKIAISSAQAIAYLHDHATPHIVHGDVRASNVLLDSEFEARV 181

Query:   186 ADFGFAKLIPEG-VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
              DFG+ KL+P+       T+ K   GY++PE    GK SE+ DVYSFGILL+ +++G++P
Sbjct:   182 TDFGYGKLMPDDDTGDGATKAKSNNGYISPECDASGKESETSDVYSFGILLMVLVSGKRP 241

Query:   245 IEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKR 304
             +E+L     R ITEW  PL+ +  F E+VD +L  +    +LK+ + V ++C Q++P+KR
Sbjct:   242 LERLNPTTTRCITEWVLPLVYERNFGEIVDKRLSEEHVAEKLKKVVLVGLMCAQTDPDKR 301

Query:   305 PNMKEVVNTLTGYDPRGKVMQTRIETL 331
             P M EVV  L   + + K+ +     L
Sbjct:   302 PTMSEVVEMLVN-ESKEKISELEANPL 327

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2026846 PERK13 "proline-rich extensin-like receptor kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 743 (266.6 bits), Expect = 1.4e-73, P = 1.4e-73
 Identities = 146/298 (48%), Positives = 202/298 (67%)

Query:    31 FTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEV 90
             FTY+EL   T GFS  N LGEGGFG VY G+ +DG  +AVK+LK  + + + EF  EVE+
Sbjct:   341 FTYEELTDITEGFSKHNILGEGGFGCVYKGKLNDGKLVAVKQLKVGSGQGDREFKAEVEI 400

Query:    91 LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
             + RV H++L+ L GYC    +RL++Y+Y+PN +L  HLHG+  G   L+W RR++IAIGS
Sbjct:   401 ISRVHHRHLVSLVGYCIADSERLLIYEYVPNQTLEHHLHGK--GRPVLEWARRVRIAIGS 458

Query:   151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG 210
             A+G+ YLH +  P IIHRDIK++N+LLD +FE  VADFG AKL     +H++TRV GT G
Sbjct:   459 AKGLAYLHEDCHPKIIHRDIKSANILLDDEFEAQVADFGLAKLNDSTQTHVSTRVMGTFG 518

Query:   211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKL-PGGVKRTITEWAEPLIVK--- 266
             YLAPEYA  GK+++  DV+SFG++LLE++TGRKP+++  P G + ++ EWA PL+ K   
Sbjct:   519 YLAPEYAQSGKLTDRSDVFSFGVVLLELITGRKPVDQYQPLG-EESLVEWARPLLHKAIE 577

Query:   267 -GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGKV 323
              G F ELVD +L   + EN++ + I  A  CV+    KRP M +VV  L      G +
Sbjct:   578 TGDFSELVDRRLEKHYVENEVFRMIETAAACVRHSGPKRPRMVQVVRALDSEGDMGDI 635

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=ISS

GO:0048765 "root hair cell differentiation" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2010282 PERK7 "proline-rich extensin-like receptor kinase 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 734 (263.4 bits), Expect = 1.2e-72, P = 1.2e-72
 Identities = 146/298 (48%), Positives = 208/298 (69%)

Query:    24 NNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEME 83
             NN+T   FTY+EL +AT GFS D  LG+GGFG V+ G   +G +IAVK LKA + + E E
Sbjct:   320 NNST---FTYEELASATQGFSKDRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGERE 376

Query:    84 FAVEVEVLGRVRHKNLLGLRGYCAGTD-QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKR 142
             F  EVE++ RV H++L+ L GYC+    QRL+VY+++PN +L  HLHG+ +G V +DW  
Sbjct:   377 FQAEVEIISRVHHRHLVSLVGYCSNAGGQRLLVYEFLPNDTLEFHLHGK-SGTV-MDWPT 434

Query:   143 RMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMT 202
             R+KIA+GSA+G+ YLH +  P IIHRDIKASN+LLD +FE  VADFG AKL  +  +H++
Sbjct:   435 RLKIALGSAKGLAYLHEDCHPKIIHRDIKASNILLDHNFEAKVADFGLAKLSQDNNTHVS 494

Query:   203 TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEP 262
             TRV GT GYLAPEYA  GK++E  DV+SFG++LLE++TGR P++ L G ++ ++ +WA P
Sbjct:   495 TRVMGTFGYLAPEYASSGKLTEKSDVFSFGVMLLELITGRGPVD-LSGDMEDSLVDWARP 553

Query:   263 LIVK----GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
             L ++    G++ ELVDP L   ++  ++ + +  A   V+    +RP M ++V TL G
Sbjct:   554 LCMRVAQDGEYGELVDPFLEHQYEPYEMARMVACAAAAVRHSGRRRPKMSQIVRTLEG 611

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2093999 PERK6 "proline-rich extensin-like receptor kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 732 (262.7 bits), Expect = 2.0e-72, P = 2.0e-72
 Identities = 139/290 (47%), Positives = 200/290 (68%)

Query:    31 FTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEV 90
             FTY EL  AT GFS    LG+GGFG V+ G   +G +IAVK LKA + + E EF  EV++
Sbjct:   325 FTYDELAAATQGFSQSRLLGQGGFGYVHKGILPNGKEIAVKSLKAGSGQGEREFQAEVDI 384

Query:    91 LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
             + RV H+ L+ L GYC    QR++VY+++PN +L  HLHG+ +G+V LDW  R+KIA+GS
Sbjct:   385 ISRVHHRFLVSLVGYCIAGGQRMLVYEFLPNDTLEFHLHGK-SGKV-LDWPTRLKIALGS 442

Query:   151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG 210
             A+G+ YLH +  P IIHRDIKASN+LLD  FE  VADFG AKL  + V+H++TR+ GT G
Sbjct:   443 AKGLAYLHEDCHPRIIHRDIKASNILLDESFEAKVADFGLAKLSQDNVTHVSTRIMGTFG 502

Query:   211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVK---- 266
             YLAPEYA  GK+++  DV+SFG++LLE++TGR+P++ L G ++ ++ +WA P+ +     
Sbjct:   503 YLAPEYASSGKLTDRSDVFSFGVMLLELVTGRRPVD-LTGEMEDSLVDWARPICLNAAQD 561

Query:   267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
             G + ELVDP+L   ++ +++ Q +  A   V+    +RP M ++V  L G
Sbjct:   562 GDYSELVDPRLENQYEPHEMAQMVACAAAAVRHSARRRPKMSQIVRALEG 611

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2159873 PERK8 "proline-rich extensin-like receptor kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 726 (260.6 bits), Expect = 8.6e-72, P = 8.6e-72
 Identities = 146/298 (48%), Positives = 198/298 (66%)

Query:    24 NNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEME 83
             N  +W  F+Y EL   T+GFS+ N LGEGGFG VY G  SDG ++AVK+LK   S+ E E
Sbjct:   322 NQRSW--FSYDELSQVTSGFSEKNLLGEGGFGCVYKGVLSDGREVAVKQLKIGGSQGERE 379

Query:    84 FAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRR 143
             F  EVE++ RV H++L+ L GYC     RL+VYDY+PN +L  HLH    G   + W+ R
Sbjct:   380 FKAEVEIISRVHHRHLVTLVGYCISEQHRLLVYDYVPNNTLHYHLHAP--GRPVMTWETR 437

Query:   144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV--SHM 201
             +++A G+A GI YLH +  P IIHRDIK+SN+LLD+ FE LVADFG AK+  E    +H+
Sbjct:   438 VRVAAGAARGIAYLHEDCHPRIIHRDIKSSNILLDNSFEALVADFGLAKIAQELDLNTHV 497

Query:   202 TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE-KLPGGVKRTITEWA 260
             +TRV GT GY+APEYA  GK+SE  DVYS+G++LLE++TGRKP++   P G   ++ EWA
Sbjct:   498 STRVMGTFGYMAPEYATSGKLSEKADVYSYGVILLELITGRKPVDTSQPLG-DESLVEWA 556

Query:   261 EPLIVKG----KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
              PL+ +     +F ELVDP+L  +F   ++ + +  A  CV+    KRP M +VV  L
Sbjct:   557 RPLLGQAIENEEFDELVDPRLGKNFIPGEMFRMVEAAAACVRHSAAKRPKMSQVVRAL 614

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005199 "structural constituent of cell wall" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

TAIR|locus:2091722 PERK1 "proline-rich extensin-like receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 724 (259.9 bits), Expect = 1.4e-71, P = 1.4e-71
 Identities = 137/290 (47%), Positives = 198/290 (68%)

Query:    31 FTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEV 90
             FTY+EL  ATNGFS+ N LG+GGFG V+ G    G ++AVK+LKA + + E EF  EVE+
Sbjct:   268 FTYEELSRATNGFSEANLLGQGGFGYVHKGILPSGKEVAVKQLKAGSGQGEREFQAEVEI 327

Query:    91 LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
             + RV H++L+ L GYC    QRL+VY+++PN +L  HLHG+  G   ++W  R+KIA+GS
Sbjct:   328 ISRVHHRHLVSLIGYCMAGVQRLLVYEFVPNNNLEFHLHGK--GRPTMEWSTRLKIALGS 385

Query:   151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG 210
             A+G+ YLH +  P IIHRDIKASN+L+D  FE  VADFG AK+  +  +H++TRV GT G
Sbjct:   386 AKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFG 445

Query:   211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVK---- 266
             YLAPEYA  GK++E  DV+SFG++LLE++TGR+P++     V  ++ +WA PL+ +    
Sbjct:   446 YLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASEE 505

Query:   267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
             G F+ L D K+  ++D  ++ + +  A  CV+    +RP M ++V  L G
Sbjct:   506 GDFEGLADSKMGNEYDREEMARMVACAAACVRHSARRRPRMSQIVRALEG 555

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;ISS;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009611 "response to wounding" evidence=ISS

GO:0009620 "response to fungus" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

GO:0052541 "plant-type cell wall cellulose metabolic process" evidence=RCA

GO:0052546 "cell wall pectin metabolic process" evidence=RCA

TAIR|locus:2036636 NIK3 "NSP-interacting kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 722 (259.2 bits), Expect = 2.3e-71, P = 2.3e-71
 Identities = 138/288 (47%), Positives = 191/288 (66%)

Query:    31 FTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMN-SKAEMEFAVEVE 89
             +T+KEL +ATN F+  N LG GG+G VY G  +DG  +AVK+LK  N +  E++F  EVE
Sbjct:   289 YTFKELRSATNHFNSKNILGRGGYGIVYKGHLNDGTLVAVKRLKDCNIAGGEVQFQTEVE 348

Query:    90 VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIG 149
              +    H+NLL LRG+C+   +R++VY YMPN S+ S L     GE  LDW RR KIA+G
Sbjct:   349 TISLALHRNLLRLRGFCSSNQERILVYPYMPNGSVASRLKDNIRGEPALDWSRRKKIAVG 408

Query:   150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
             +A G++YLH +  P IIHRD+KA+N+LLD DFE +V DFG AKL+    SH+TT V+GT+
Sbjct:   409 TARGLVYLHEQCDPKIIHRDVKAANILLDEDFEAVVGDFGLAKLLDHRDSHVTTAVRGTV 468

Query:   210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE-KLPGGVKRTITEWAEPLIVKGK 268
             G++APEY   G+ SE  DV+ FGILLLE++TG+K ++       K  + +W + L  +GK
Sbjct:   469 GHIAPEYLSTGQSSEKTDVFGFGILLLELITGQKALDFGRSAHQKGVMLDWVKKLHQEGK 528

Query:   269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
              K+L+D  L   FD  +L++ + VA+LC Q  P  RP M EV+  L G
Sbjct:   529 LKQLIDKDLNDKFDRVELEEIVQVALLCTQFNPSHRPKMSEVMKMLEG 576

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0048653 "anther development" evidence=RCA

TAIR|locus:2139474 PERK5 "proline-rich extensin-like receptor kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 721 (258.9 bits), Expect = 2.9e-71, P = 2.9e-71
 Identities = 142/309 (45%), Positives = 200/309 (64%)

Query:    16 GLTTITTPNNATW----RIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVK 71
             G T I +P  AT       FTY EL  AT GF+  N LG+GGFG V+ G    G ++AVK
Sbjct:   281 GRTAIPSPQAATLGHNQSTFTYDELSIATEGFAQSNLLGQGGFGYVHKGVLPSGKEVAVK 340

Query:    72 KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQ 131
              LK  + + E EF  EV+++ RV H++L+ L GYC    QRL+VY+++PN +L  HLHG+
Sbjct:   341 SLKLGSGQGEREFQAEVDIISRVHHRHLVSLVGYCISGGQRLLVYEFIPNNTLEFHLHGK 400

Query:   132 YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA 191
               G   LDW  R+KIA+GSA G+ YLH +  P IIHRDIKA+N+LLD  FE  VADFG A
Sbjct:   401 --GRPVLDWPTRVKIALGSARGLAYLHEDCHPRIIHRDIKAANILLDFSFETKVADFGLA 458

Query:   192 KLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGG 251
             KL  +  +H++TRV GT GYLAPEYA  GK+S+  DV+SFG++LLE++TGR P++ L G 
Sbjct:   459 KLSQDNYTHVSTRVMGTFGYLAPEYASSGKLSDKSDVFSFGVMLLELITGRPPLD-LTGE 517

Query:   252 VKRTITEWAEPLIVK----GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNM 307
             ++ ++ +WA PL +K    G + +L DP+L  ++   ++ Q  + A   ++    +RP M
Sbjct:   518 MEDSLVDWARPLCLKAAQDGDYNQLADPRLELNYSHQEMVQMASCAAAAIRHSARRRPKM 577

Query:   308 KEVVNTLTG 316
              ++V  L G
Sbjct:   578 SQIVRALEG 586

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

GO:0048610 "cellular process involved in reproduction" evidence=RCA

GO:0048868 "pollen tube development" evidence=RCA

GO:0051510 "regulation of unidimensional cell growth" evidence=RCA

UNIPROTKB|Q9ARH1 Q9ARH1 "Receptor protein kinase PERK1" [Brassica napus (taxid:3708)]

 Score = 716 (257.1 bits), Expect = 9.9e-71, P = 9.9e-71
 Identities = 135/290 (46%), Positives = 196/290 (67%)

Query:    31 FTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEV 90
             FTY+EL  ATNGFS+ N LG+GGFG V+ G    G ++AVK+LK  + + E EF  EVE+
Sbjct:   263 FTYEELARATNGFSEANLLGQGGFGYVHKGVLPSGKEVAVKQLKVGSGQGEREFQAEVEI 322

Query:    91 LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
             + RV H++L+ L GYC    +RL+VY+++PN +L  HLHG+  G   ++W  R+KIA+GS
Sbjct:   323 ISRVHHRHLVSLVGYCIAGAKRLLVYEFVPNNNLELHLHGE--GRPTMEWSTRLKIALGS 380

Query:   151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG 210
             A+G+ YLH +  P IIHRDIKASN+L+D  FE  VADFG AK+  +  +H++TRV GT G
Sbjct:   381 AKGLSYLHEDCNPKIIHRDIKASNILIDFKFEAKVADFGLAKIASDTNTHVSTRVMGTFG 440

Query:   211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVK---- 266
             YLAPEYA  GK++E  DV+SFG++LLE++TGR+P++     V  ++ +WA PL+ +    
Sbjct:   441 YLAPEYAASGKLTEKSDVFSFGVVLLELITGRRPVDANNVYVDDSLVDWARPLLNRASEQ 500

Query:   267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
             G F+ L D K+   +D  ++ + +  A  CV+    +RP M ++V  L G
Sbjct:   501 GDFEGLADAKMNNGYDREEMARMVACAAACVRHSARRRPRMSQIVRALEG 550

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0005887 "integral to plasma membrane" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00031466001 SubName- Full=Chromosome chr11 scaffold_56, whole genome shotgun sequence; (383 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	380
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-49
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	5e-47
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-47
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	5e-45
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-44
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	7e-43
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-38
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-35
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-34
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-34
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-33
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-32
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-32
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-31
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-30
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	5e-28
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	9e-28
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-27
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-26
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	4e-26
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-26
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-25
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	4e-25
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	6e-25
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	6e-25
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-24
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	7e-24
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	8e-24
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-23
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	3e-23
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-23
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-23
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-22
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-22
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-22
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-22
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-22
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-22
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-21
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-21
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-21
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	2e-21
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-21
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-21
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-20
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	9e-20
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	1e-19
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-19
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-19
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-19
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-19
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-19
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-19
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	3e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-19
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-19
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	8e-19
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	8e-19
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-18
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	3e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-18
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	5e-18
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	6e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	7e-18
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-17
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-17
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-17
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-17
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-17
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-17
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	4e-17
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	5e-17
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	5e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-17
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	8e-17
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-16
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-16
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-16
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-16
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-16
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-16
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-16
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	5e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	8e-16
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	8e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	9e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	9e-16
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	1e-15
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-15
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-15
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-15
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-15
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-15
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-15
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	5e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-15
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	6e-15
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-15
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	8e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-15
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-14
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	1e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-14
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-14
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-14
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	2e-14
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	3e-14
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	4e-14
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-14
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-14
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	7e-14
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-14
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	8e-14
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	9e-14
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	9e-14
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-13
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-13
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-13
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-13
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	3e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-13
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-13
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	4e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	6e-13
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	7e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-13
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-13
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	9e-13
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-12
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-12
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-12
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-12
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-12
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-12
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-12
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-12
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-12
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	7e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	8e-12
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-12
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	9e-12
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-11
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-11
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-11
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-11
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-11
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-11
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-11
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-11
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	4e-11
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-11
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-11
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	7e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	8e-11
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	9e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-10
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-10
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-10
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	2e-10
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-10
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-10
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-10
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-10
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	3e-10
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-10
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-10
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	5e-10
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-10
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	5e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	5e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-10
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	6e-10
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	6e-10
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-10
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	7e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-10
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	8e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	8e-10
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	8e-10
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-09
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-09
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	1e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-09
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	4e-09
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-09
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	4e-09
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	5e-09
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	6e-09
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-09
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-09
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-08
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-08
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-08
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-08
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	3e-08
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	3e-08
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	4e-08
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-08
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-08
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	6e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	6e-08
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	7e-08
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	8e-08
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-07
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	5e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	5e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-07
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	1e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-06
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-06
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-06
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-06
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	4e-06
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-06
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	5e-06
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	9e-06
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-05
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	3e-05
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	7e-05
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	2e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	2e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	5e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	5e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	0.002
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	0.002

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  164 bits (418), Expect = 3e-49
 Identities = 82/270 (30%), Positives = 125/270 (46%), Gaps = 59/270 (21%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGLRGYC 106
           LGEGGFG+VY  R    G ++A+K +K  +S + +E    E+E+L ++ H N++ L G  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
              +   +V +Y    SL   L      E +L     ++I +   EG+ YLH      II
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN---GII 114

Query: 167 HRDIKASNVLLDSD-FEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPE-YAMWGKVSE 224
           HRD+K  N+LLDSD  +  +ADFG +KL+    S + T V GT  Y+APE     G  SE
Sbjct: 115 HRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIV-GTPAYMAPEVLLGKGYYSE 173

Query: 225 SCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN 284
             D++S G++L E+                             + K+L+           
Sbjct: 174 KSDIWSLGVILYEL----------------------------PELKDLIR---------- 195

Query: 285 QLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                       +Q +PEKRP+ KE++  L
Sbjct: 196 ----------KMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  160 bits (407), Expect = 5e-47
 Identities = 76/279 (27%), Positives = 122/279 (43%), Gaps = 35/279 (12%)

Query: 46  DNKLGEGGFGSVY---WGRTSDGLQI--AVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNL 99
             KLGEG FG VY           ++  AVK LK   + +   EF  E  ++ ++ H N+
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           + L G C   +   IV +YM    LLS+L        +L     +  A+  A G+ YL  
Sbjct: 64  VKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKN---RPKLSLSDLLSFALQIARGMEYLES 120

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
           +   + IHRD+ A N L+  +    ++DFG ++ + +   +     K  + ++APE    
Sbjct: 121 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177

Query: 220 GKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD---P 275
           GK +   DV+SFG+LL EI T G +P   +       + E+    +  G          P
Sbjct: 178 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN---EEVLEY----LKNGYRLPQPPNCPP 230

Query: 276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           +L             ++ + C   +PE RP   E+V  L
Sbjct: 231 ELY------------DLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  160 bits (407), Expect = 6e-47
 Identities = 78/279 (27%), Positives = 126/279 (45%), Gaps = 34/279 (12%)

Query: 46  DNKLGEGGFGSVYWGR-----TSDGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNL 99
             KLGEG FG VY G          +++AVK LK   + +   EF  E  ++ ++ H N+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           + L G C   +  +IV +YMP   LL +L  +     +L     +  A+  A G+ YL  
Sbjct: 64  VKLLGVCTEEEPLMIVMEYMPGGDLLDYL--RKNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
           +   + IHRD+ A N L+  +    ++DFG ++ + +   +     K  + ++APE    
Sbjct: 122 K---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178

Query: 220 GKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD---P 275
           GK +   DV+SFG+LL EI T G +P   +       + E+    + KG          P
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSN---AEVLEY----LKKGYRLPKPPNCPP 231

Query: 276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           +L              + + C   +PE RP   E+V  L
Sbjct: 232 ELY------------KLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  155 bits (394), Expect = 5e-45
 Identities = 83/271 (30%), Positives = 125/271 (46%), Gaps = 26/271 (9%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKA--MNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           KLG G FG+VY  +    G  +AVK LK     SK +     E+ +L R+ H N++ L  
Sbjct: 6   KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                D   +V +Y     L  +L         L      KIA+    G+ YLH      
Sbjct: 66  AFEDKDHLYLVMEYCEGGDLFDYLSR----GGPLSEDEAKKIALQILRGLEYLHSN---G 118

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK-VS 223
           IIHRD+K  N+LLD +    +ADFG AK + +  S +TT V GT  Y+APE  + G    
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFV-GTPWYMAPEVLLGGNGYG 177

Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDE 283
              DV+S G++L E+LTG+ P     G                   + ++ P L  D  +
Sbjct: 178 PKVDVWSLGVILYELLTGKPP---FSGENILD---------QLQLIRRILGPPLEFDEPK 225

Query: 284 --NQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
             +  ++A ++   C+  +P KRP  +E++ 
Sbjct: 226 WSSGSEEAKDLIKKCLNKDPSKRPTAEEILQ 256

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  154 bits (391), Expect = 1e-44
 Identities = 77/273 (28%), Positives = 127/273 (46%), Gaps = 26/273 (9%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +    KLGEG FG VY  R    G  +A+K +K    K + E  + E+++L +++H N++
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L       D+  +V +Y     L   L  +  G +  D  R           + YLH +
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEAR--FYLRQILSALEYLHSK 116

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
               I+HRD+K  N+LLD D    +ADFG A+ +  G   +TT V GT  Y+APE  +  
Sbjct: 117 ---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPG-EKLTTFV-GTPEYMAPEVLLGK 171

Query: 221 KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGD 280
              ++ D++S G++L E+LTG+ P              +     +   FK++  PK    
Sbjct: 172 GYGKAVDIWSLGVILYELLTGKPP--------------FPGDDQLLELFKKIGKPKPPFP 217

Query: 281 FDENQL-KQAINVAVLCVQSEPEKRPNMKEVVN 312
             E  +  +A ++    +  +PEKR   +E + 
Sbjct: 218 PPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQ 250

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  149 bits (379), Expect = 7e-43
 Identities = 81/288 (28%), Positives = 125/288 (43%), Gaps = 45/288 (15%)

Query: 47  NKLGEGGFGSVYWGRTSDG----LQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLG 101
            KLGEG FG VY G+         ++AVK LK   S+ E  +F  E  V+ ++ H N++ 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQ---LDWKRRMKIAIGSAEGILY 156
           L G C   +   +V +YM    LL +L          +   L  K  +  AI  A+G+ Y
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR-----VKGTLGY 211
           L  +     +HRD+ A N L+  D    ++DFG ++ + +   +         ++    +
Sbjct: 121 LASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR----W 173

Query: 212 LAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKG--- 267
           +APE    G  +   DV+SFG+LL EI T G  P    PG     + E+    + KG   
Sbjct: 174 MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP---YPGLSNEEVLEY----LRKGYRL 226

Query: 268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
              E    +L              + + C Q +PE RP   E+V  L 
Sbjct: 227 PKPEYCPDELY------------ELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  138 bits (349), Expect = 2e-38
 Identities = 85/283 (30%), Positives = 129/283 (45%), Gaps = 46/283 (16%)

Query: 48  KLGEGGFGSVYWGR-----TSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLG 101
           KLGEG FG VY G           ++AVK LK   S+ E  EF  E  ++ ++ H N++ 
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65

Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
           L G C   +   IV +YMP   LL  L        +L  K  +++A+  A+G+ YL  + 
Sbjct: 66  LLGVCTQGEPLYIVTEYMPGGDLLDFLRKH---GEKLTLKDLLQMALQIAKGMEYLESK- 121

Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL--GYLAPEYAMW 219
             + +HRD+ A N L+  +    ++DFG ++ I E   +   R  G L   ++APE    
Sbjct: 122 --NFVHRDLAARNCLVTENLVVKISDFGLSRDIYED-DYYRKRGGGKLPIKWMAPESLKD 178

Query: 220 GKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR 278
           GK +   DV+SFG+LL EI T G +P   +            E         EL++    
Sbjct: 179 GKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSN---------EE-------VLELLE---- 218

Query: 279 GDFDENQLKQAIN-------VAVLCVQSEPEKRPNMKEVVNTL 314
              D  +L +  N       + + C   +PE RP   E+V  L
Sbjct: 219 ---DGYRLPRPENCPDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  131 bits (330), Expect = 1e-35
 Identities = 76/205 (37%), Positives = 115/205 (56%), Gaps = 7/205 (3%)

Query: 43  FSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
           F+ + KLG G FG V+ G   + +++A+K LK+ +   + +F  EV+ L R+RHK+L+ L
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
              C+  +   I+ + M   SLL+ L     G+V L     + +A   AEG+ YL  +  
Sbjct: 68  FAVCSVGEPVYIITELMEKGSLLAFL-RSPEGQV-LPVASLIDMACQVAEGMAYLEEQ-- 123

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
            + IHRD+ A N+L+  D    VADFG A+LI E V ++++  K    + APE A  G  
Sbjct: 124 -NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV-YLSSDKKIPYKWTAPEAASHGTF 181

Query: 223 SESCDVYSFGILLLEILT-GRKPIE 246
           S   DV+SFGILL E+ T G+ P  
Sbjct: 182 STKSDVWSFGILLYEMFTYGQVPYP 206

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  128 bits (323), Expect = 1e-34
 Identities = 73/281 (25%), Positives = 121/281 (43%), Gaps = 57/281 (20%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLK-AMNSKAEME-FAVEVEVLGRVRHKNLLGLR 103
             LG G FGSVY       G  +AVK ++ + +S+ E+E    E+ +L  ++H N++   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 104 GYC--AGTDQRLIVYDYMPNLSLLSHLHG----------QYAGEVQLDWKRRMKIAIGSA 151
           G       +   I  +Y+   SL S L            +Y  ++               
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQI--------------L 111

Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG-VSHMTTRVKGTLG 210
           EG+ YLH      I+HRDIK +N+L+DSD    +ADFG AK + +      T  V+GT  
Sbjct: 112 EGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY 168

Query: 211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE-----PLIV 265
           ++APE     +   + D++S G  ++E+ TG+ P              W+E       + 
Sbjct: 169 WMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP--------------WSELGNPMAALY 214

Query: 266 KGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPN 306
           K                E+  ++A +    C++ +P+KRP 
Sbjct: 215 KIGSSGEPPE-----IPEHLSEEAKDFLRKCLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  132 bits (334), Expect = 8e-34
 Identities = 77/273 (28%), Positives = 142/273 (52%), Gaps = 21/273 (7%)

Query: 45  DDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           ++N +  G  G+ Y G++  +G+Q  VK++  +NS    E A     +G+++H N++ L 
Sbjct: 694 EENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVKLI 749

Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G C       ++++Y+   +L   L         L W+RR KIAIG A+ + +LH   +P
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSP 802

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
            ++  ++    +++D   EP +      +L   G+    T+   +  Y+APE      ++
Sbjct: 803 AVVVGNLSPEKIIIDGKDEPHL------RLSLPGLLCTDTKCFISSAYVAPETRETKDIT 856

Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGD--F 281
           E  D+Y FG++L+E+LTG+ P +    GV  +I EWA            +DP +RGD   
Sbjct: 857 EKSDIYGFGLILIELLTGKSPAD-AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSV 915

Query: 282 DENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           ++N++ + +N+A+ C  ++P  RP   +V+ TL
Sbjct: 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  125 bits (316), Expect = 1e-33
 Identities = 77/268 (28%), Positives = 122/268 (45%), Gaps = 31/268 (11%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           F    K+G+GGFG VY  R    G ++A+K +K  + + + +   E+++L + +H N++ 
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61

Query: 102 LRG--YCAGTDQRLIVYDYMPNLSL--LSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
             G       D+  IV ++    SL  L     Q   E Q+       +     +G+ YL
Sbjct: 62  YYGSYLKK--DELWIVMEFCSGGSLKDLLKSTNQTLTESQI-----AYVCKELLKGLEYL 114

Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           H      IIHRDIKA+N+LL SD E  + DFG +  + +  +  T    GT  ++APE  
Sbjct: 115 HSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM--VGTPYWMAPEVI 169

Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL 277
                    D++S GI  +E+  G+ P  +LP  +K          I       L +P+ 
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKPPYSELP-PMKALF------KIATNGPPGLRNPEK 222

Query: 278 RGDFDENQLKQAINVAVLCVQSEPEKRP 305
             D    + K  +     C+Q  PEKRP
Sbjct: 223 WSD----EFKDFLK---KCLQKNPEKRP 243

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  121 bits (306), Expect = 3e-32
 Identities = 82/271 (30%), Positives = 130/271 (47%), Gaps = 23/271 (8%)

Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           KLG G FG V+ G  ++   +AVK LK   +    +F  E +++ ++RH  L+ L   C 
Sbjct: 13  KLGAGQFGEVWEGLWNNTTPVAVKTLKP-GTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT 71

Query: 108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH 167
             +   IV + M   SLL +L G     ++L   + + +A   A G+ YL  +   + IH
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRALKL--PQLIDMAAQVASGMAYLEAQ---NYIH 126

Query: 168 RDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCD 227
           RD+ A NVL+  +    VADFG A++I E +       K  + + APE A++ + S   D
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186

Query: 228 VYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQL 286
           V+SFGILL EI+T GR P   +           AE L       + VD   R        
Sbjct: 187 VWSFGILLTEIVTYGRMPYPGMTN---------AEVL-------QQVDQGYRMPCPPGCP 230

Query: 287 KQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
           K+  ++ + C + +P+ RP  + +   L  +
Sbjct: 231 KELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  122 bits (307), Expect = 4e-32
 Identities = 79/279 (28%), Positives = 135/279 (48%), Gaps = 17/279 (6%)

Query: 47  NKLGEGGFGSVYWGR---TSD--GLQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLL 100
            +LGEG FG V   R     D  G Q+AVK L     +    +F  E+E+L  + H+N++
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 101 GLRGYCAGTDQR--LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
             +G C     R   ++ +Y+P+ SL  +L        Q++ KR +  +    +G+ YL 
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD---QINLKRLLLFSSQICKGMDYLG 126

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG--YLAPEY 216
              +   IHRD+ A N+L++S+    ++DFG AK++PE   +   +  G     + APE 
Sbjct: 127 ---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPEC 183

Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
               K S + DV+SFG+ L E+ T   P +  P    R I      +IV  +  EL+   
Sbjct: 184 LRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT-RLLELLKEG 242

Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
            R     +   +  ++  LC ++EP+ RP+  +++  + 
Sbjct: 243 ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVD 281

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  121 bits (304), Expect = 4e-31
 Identities = 79/284 (27%), Positives = 119/284 (41%), Gaps = 23/284 (8%)

Query: 42  GFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRH-K 97
            +    KLGEG FG VY     D   +A+K L       SK    F  E+++L  + H  
Sbjct: 1   SYRILRKLGEGSFGEVY--LARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
           N++ L  +        +V +Y+   SL   L  +   +  L     + I       + YL
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYL 117

Query: 158 HHEVTPHIIHRDIKASNVLLDSD-FEPLVADFGFAKLIPEGVSH-----MTTRVKGTLGY 211
           H +    IIHRDIK  N+LLD D     + DFG AKL+P+  S      + +   GT GY
Sbjct: 118 HSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGY 174

Query: 212 LAPEYAM---WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGK 268
           +APE  +       S S D++S GI L E+LTG  P E        + T      I+   
Sbjct: 175 MAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL----KIILEL 230

Query: 269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
               +   L     E   K A ++    +  +P+ R +    ++
Sbjct: 231 PTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  117 bits (295), Expect = 1e-30
 Identities = 86/266 (32%), Positives = 127/266 (47%), Gaps = 37/266 (13%)

Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           KLG G FG V+ G  +   ++AVK LK      E  F  E +++ ++RH  L+ L   C+
Sbjct: 13  KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 108 GTDQRLIVYDYMPNLSLLSHLH---GQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
             +   IV +YM   SLL  L    G+     QL     + +A   AEG+ YL      +
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQL-----VDMAAQIAEGMAYLESR---N 123

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIP--EGVSHMTTR--VKGTLGYLAPEYAMWG 220
            IHRD+ A N+L+  +    +ADFG A+LI   E  +    +  +K T    APE A +G
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWT----APEAANYG 179

Query: 221 KVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
           + +   DV+SFGILL EI+T GR P    PG   R +              E V+   R 
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRVP---YPGMTNREVL-------------EQVERGYRM 223

Query: 280 DFDENQLKQAINVAVLCVQSEPEKRP 305
               N  ++  ++ + C   +PE+RP
Sbjct: 224 PRPPNCPEELYDLMLQCWDKDPEERP 249

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  110 bits (276), Expect = 5e-28
 Identities = 86/268 (32%), Positives = 125/268 (46%), Gaps = 28/268 (10%)

Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG 108
           +G+G FG V  G    G ++AVK LK  +S A   F  E  V+  +RH NL+ L G    
Sbjct: 14  IGKGEFGDVMLG-DYRGQKVAVKCLKD-DSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 109 TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHR 168
            +   IV +YM   SL+ +L  +  G   +   +++  A+   EG+ YL  +   + +HR
Sbjct: 72  GNPLYIVTEYMAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHR 126

Query: 169 DIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDV 228
           D+ A NVL+  D    V+DFG AK   +G       VK T    APE     K S   DV
Sbjct: 127 DLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWT----APEALREKKFSTKSDV 182

Query: 229 YSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLK 287
           +SFGILL EI + GR P  ++P  +K  +       + KG          R +  E    
Sbjct: 183 WSFGILLWEIYSFGRVPYPRIP--LKDVVPH-----VEKG---------YRMEAPEGCPP 226

Query: 288 QAINVAVLCVQSEPEKRPNMKEVVNTLT 315
           +   V   C + +P KRP  K++   L 
Sbjct: 227 EVYKVMKDCWELDPAKRPTFKQLREQLA 254

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  109 bits (275), Expect = 9e-28
 Identities = 72/275 (26%), Positives = 125/275 (45%), Gaps = 35/275 (12%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKK--LKAMNSKAEMEFAV-EVEVLGRVRHKNLLGL 102
            ++G+G FG VY  R  SDG    +K+  L  M+ K E E A+ EV++L ++ H N++  
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK-EREDALNEVKILKKLNHPNIIKY 64

Query: 103 RGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
                    +L IV +Y     L   +  Q         ++ +   +     + YLH   
Sbjct: 65  YE-SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR- 122

Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK 221
              I+HRDIK  N+ L S+    + DFG +K++   V    T V GT  YL+PE  +   
Sbjct: 123 --KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVV-GTPYYLSPE--LCQN 177

Query: 222 V--SESCDVYSFGILLLEILTGRKPIE--KLPGGVKRTITEWAEPLIVKGKFKELVDPKL 277
              +   D++S G +L E+ T + P E   L     +         I+KG++     P +
Sbjct: 178 KPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALK---------ILKGQY-----PPI 223

Query: 278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
              +    L+  ++     +Q +PE+RP++ +++ 
Sbjct: 224 PSQYSSE-LRNLVS---SLLQKDPEERPSIAQILQ 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  108 bits (271), Expect = 2e-27
 Identities = 83/272 (30%), Positives = 138/272 (50%), Gaps = 26/272 (9%)

Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           KLG+G FG V+ G  +   ++A+K LK      E  F  E +V+ ++RH+ L+ L  Y  
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQL--YAV 69

Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            +++ + IV +YM   SLL  L G+    ++L   + + +A   A G+ Y+      + +
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVERM---NYV 124

Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+  +    VADFG A+LI +         K  + + APE A++G+ +   
Sbjct: 125 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL E+ T GR P    PG V R + +  E    +G ++    P+      +  
Sbjct: 185 DVWSFGILLTELTTKGRVP---YPGMVNREVLDQVE----RG-YRMPCPPECPESLHDLM 236

Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
            +        C + EPE+RP  + +   L  Y
Sbjct: 237 CQ--------CWRKEPEERPTFEYLQAFLEDY 260

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 1e-26
 Identities = 72/271 (26%), Positives = 128/271 (47%), Gaps = 25/271 (9%)

Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
           K+G+G FG VY G      ++AVK  ++ +    + +F  E E+L +  H N++ L G C
Sbjct: 2   KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61

Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
                  IV + +P  SLL+ L  +     +L  K+ +++++ +A G+ YL  +   + I
Sbjct: 62  VQKQPIYIVMELVPGGSLLTFLRKKKN---RLTVKKLLQMSLDAAAGMEYLESK---NCI 115

Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT-LGYLAPEYAMWGKVSES 225
           HRD+ A N L+  +    ++DFG ++    G+  ++  +K   + + APE   +G+ +  
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175

Query: 226 CDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN 284
            DV+S+GILL E  + G  P   +     R   E             +  P+L  + +  
Sbjct: 176 SDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE---------SGYRMPAPQLCPE-EIY 225

Query: 285 QLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
           +L         C   +PE RP+  E+ N L 
Sbjct: 226 RLML------QCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  105 bits (264), Expect = 4e-26
 Identities = 80/279 (28%), Positives = 129/279 (46%), Gaps = 19/279 (6%)

Query: 49  LGEGGFGSVYWGR---TSDGL--QIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGL 102
           LGEG FG V        +DG    +AVK LK    +     +  E+ +L  + H+N++  
Sbjct: 12  LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71

Query: 103 RGYCA--GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           +G C+  G     ++ +Y+P  SL  +L        QL     +  A    EG+ YLH +
Sbjct: 72  KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEGMAYLHSQ 126

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGYLAPEYAM 218
              H IHRD+ A NVLLD+D    + DFG AK +PEG  +   R  G   + + A E   
Sbjct: 127 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK 183

Query: 219 WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR 278
             K S + DV+SFG+ L E+LT     +  P   +  I    +  +   +  EL++  +R
Sbjct: 184 ENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMI-GPKQGQMTVVRLIELLERGMR 242

Query: 279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
               +N  ++   +   C ++E + RP  + ++  L   
Sbjct: 243 LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM 281

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  104 bits (263), Expect = 6e-26
 Identities = 70/215 (32%), Positives = 108/215 (50%), Gaps = 26/215 (12%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV----EVEVLGRVRHKNLLG 101
            ++GEG +G VY  R    G  +A+KK++  N K    F +    E+++L ++RH N++ 
Sbjct: 5   AQIGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHPNIVR 62

Query: 102 LRGYCAGTDQRLI--VYDYMPN-LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           L+       +  I  V++YM + L+ L         E Q+  K  MK  +   EG+ YLH
Sbjct: 63  LKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQI--KCYMKQLL---EGLQYLH 117

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYA 217
                 I+HRDIK SN+L+++D    +ADFG A+       +  T RV  TL Y  PE  
Sbjct: 118 SN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELL 173

Query: 218 MWG--KVSESCDVYSFGILLLEILTGRKPIEKLPG 250
           + G  +     D++S G +L E+  G KPI    G
Sbjct: 174 L-GATRYGPEVDMWSVGCILAELFLG-KPI--FQG 204

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  104 bits (260), Expect = 1e-25
 Identities = 70/221 (31%), Positives = 111/221 (50%), Gaps = 34/221 (15%)

Query: 49  LGEGGFGSVYWGR------TSDGLQIAVKKLKAMNSK-AEMEFAVEVEVLGRVRHKNLLG 101
           LGEG FG V+ G        +D   +AVK LK   S  A  +F  E E+L   +H+N++ 
Sbjct: 13  LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72

Query: 102 LRGYCAGTDQRLIVYDYMPN--LS--LLSH------LHGQYAGEVQLDWKRRMKIAIGSA 151
             G C   D  ++V++YM +  L+  L SH      L    +   +L   + ++IA+  A
Sbjct: 73  FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132

Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT---RVKGT 208
            G++YL  +   H +HRD+   N L+  D    + DFG ++ +       TT   RV G 
Sbjct: 133 SGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDV------YTTDYYRVGGH 183

Query: 209 ----LGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
               + ++ PE  M+ K +   DV+SFG++L EI T G++P
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 4e-25
 Identities = 68/216 (31%), Positives = 96/216 (44%), Gaps = 44/216 (20%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVE-------VLGRVRHKNLL 100
           LG+G FG V   R    G   A+K LK    K ++    EVE       +L R+ H  ++
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLK----KKKIIKRKEVEHTLTERNILSRINHPFIV 56

Query: 101 GLRGYCAGTDQRLI--VYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAI 148
            L  + A   +  +  V +Y P   L SHL  +          YA E+            
Sbjct: 57  KL--HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEI------------ 102

Query: 149 GSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT 208
                + YLH      II+RD+K  N+LLD+D    + DFG AK +    S   T   GT
Sbjct: 103 --VLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFC-GT 156

Query: 209 LGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
             YLAPE  +     ++ D +S G+LL E+LTG+ P
Sbjct: 157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  102 bits (256), Expect = 6e-25
 Identities = 85/293 (29%), Positives = 140/293 (47%), Gaps = 51/293 (17%)

Query: 48  KLGEGGFGSVYWGR------TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +LGEG FG V+         T D + +AVK LK     A  +F  E E+L  ++H++++ 
Sbjct: 12  ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71

Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHL--HG------------QYAGEVQLDWKRRMKIA 147
             G C   D  ++V++YM +  L   L  HG            Q  GE+ L   + + IA
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL--SQMLHIA 129

Query: 148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG 207
              A G++YL    + H +HRD+   N L+ ++    + DFG ++ +    S    RV G
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV---YSTDYYRVGG 183

Query: 208 ----TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKL-PGGVKRTITEWAE 261
                + ++ PE  M+ K +   DV+SFG++L EI T G++P  +L    V   IT+   
Sbjct: 184 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ--- 240

Query: 262 PLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                G+  E   P++         K+  ++ + C Q EP++R N+KE+   L
Sbjct: 241 -----GRVLE--RPRVCP-------KEVYDIMLGCWQREPQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  102 bits (255), Expect = 6e-25
 Identities = 76/288 (26%), Positives = 130/288 (45%), Gaps = 57/288 (19%)

Query: 49  LGEGGFGSVY---WGRTSDGLQI--AVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLLGL 102
           LG G FG+VY   W    + ++I  A+K L+   S KA  E   E  V+  V H +++ L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ----LDWKRRMKIAIGSAEGILYLH 158
            G C  +  +LI    MP   LL ++   +   +     L+W  ++      A+G+ YL 
Sbjct: 75  LGICLSSQVQLIT-QLMPLGCLLDYVR-NHKDNIGSQYLLNWCVQI------AKGMSYLE 126

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG---TLGYLAPE 215
            +    ++HRD+ A NVL+ +     + DFG AKL+           +G    + ++A E
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEY--HAEGGKVPIKWMALE 181

Query: 216 YAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD 274
             +    +   DV+S+G+ + E++T G KP E +P                     E+ D
Sbjct: 182 SILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA-------------------VEIPD 222

Query: 275 PKLRGDFDENQLKQ----AINVAVLCVQS---EPEKRPNMKEVVNTLT 315
              +G+    +L Q     I+V ++ V+    + E RP  KE++N  +
Sbjct: 223 LLEKGE----RLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFS 266

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  100 bits (252), Expect = 1e-24
 Identities = 79/280 (28%), Positives = 123/280 (43%), Gaps = 49/280 (17%)

Query: 47  NKLGEGGFGSVYWG-RTSDGLQIAVKKLKAMNSKAE--MEFAVEVEVLGRVRHKNLLGLR 103
           + +G G FG VY G     G  +A+K++     K E       E+++L  ++H N++   
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 104 GYCAGTDQRLIVYDYMPNLSLLS----------HLHGQYAGEVQLDWKRRMKIAIGSAEG 153
           G    +D   I+ +Y  N SL             L   Y  +V               +G
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQV--------------LQG 111

Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLA 213
           + YLH +    +IHRDIKA+N+L   D    +ADFG A  + + VS     V GT  ++A
Sbjct: 112 LAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLND-VSKDDASVVGTPYWMA 167

Query: 214 PEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKL-PGGVKRTITEWAEPLIVKGKFKEL 272
           PE       S + D++S G  ++E+LTG  P   L P      I +   P + +G     
Sbjct: 168 PEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEG----- 222

Query: 273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
           + P+L+ DF    L Q       C Q +P  RP  K+++ 
Sbjct: 223 ISPELK-DF----LMQ-------CFQKDPNLRPTAKQLLK 250

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  100 bits (251), Expect = 2e-24
 Identities = 78/270 (28%), Positives = 119/270 (44%), Gaps = 33/270 (12%)

Query: 48  KLGEGGFGSVYWGRTS-DGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRG- 104
            LG+G  G VY  R    G   A+KK+    + +   +   E++ L       ++   G 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 105 -YCAGTDQRLIVYDYMPNLSLLSHLHGQYAG--EVQLDWKRRMKIAIGSAEGILYLHHEV 161
            Y  G     IV +YM   SL + L  +     E  L       IA    +G+ YLH   
Sbjct: 68  FYKEGEIS--IVLEYMDGGSL-ADLLKKVGKIPEPVL-----AYIARQILKGLDYLHT-- 117

Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK 221
             HIIHRDIK SN+L++S  E  +ADFG +K++   +    T V GT+ Y++PE      
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFV-GTVTYMSPERIQGES 176

Query: 222 VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL--IVKGKFKELVDPKLRG 279
            S + D++S G+ LLE   G+ P              + E +  I  G       P L  
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQPS------FFELMQAICDGP-----PPSLPA 225

Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKE 309
           +    + +  I+    C+Q +P+KRP+  E
Sbjct: 226 EEFSPEFRDFIS---ACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 99.0 bits (246), Expect = 7e-24
 Identities = 83/277 (29%), Positives = 138/277 (49%), Gaps = 32/277 (11%)

Query: 46  DNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           D KLG+G FG V+ G  +   ++A+K LK      E  F  E +++ ++RH  L+ L  Y
Sbjct: 11  DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPL--Y 67

Query: 106 CAGTDQRL-IVYDYMPNLSLLSHLH---GQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
              +++ + IV ++M   SLL  L    G+Y    QL     + +A   A+G+ Y+    
Sbjct: 68  AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQL-----VDMAAQIADGMAYIERM- 121

Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK 221
             + IHRD++A+N+L+  +    +ADFG A+LI +         K  + + APE A++G+
Sbjct: 122 --NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179

Query: 222 VSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGD 280
            +   DV+SFGILL E++T GR P    PG V R + E              V+   R  
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVP---YPGMVNREVLEQ-------------VERGYRMP 223

Query: 281 FDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
             +   +    +  LC + +P++RP  + + + L  Y
Sbjct: 224 CPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY 260

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 98.8 bits (246), Expect = 8e-24
 Identities = 61/197 (30%), Positives = 97/197 (49%), Gaps = 11/197 (5%)

Query: 47  NKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +KLG G +G VY   W +    L +AVK LK    + E EF  E  V+  ++H NL+ L 
Sbjct: 12  HKLGGGQYGEVYEGVWKKY--SLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 68

Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G C       I+ ++M   +LL +L  +     +++    + +A   +  + YL  +   
Sbjct: 69  GVCTREPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKK--- 123

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + IHRD+ A N L+  +    VADFG ++L+           K  + + APE   + K S
Sbjct: 124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 183

Query: 224 ESCDVYSFGILLLEILT 240
              DV++FG+LL EI T
Sbjct: 184 IKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 97.4 bits (242), Expect = 3e-23
 Identities = 66/200 (33%), Positives = 105/200 (52%), Gaps = 11/200 (5%)

Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           KLG G FG V+ G  ++  ++AVK LK   M+ +A +E   E  ++  ++H  L+ L   
Sbjct: 13  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE---EANLMKTLQHDKLVRLYAV 69

Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               +   I+ +YM   SLL  L     G+V L   + +  +   AEG+ Y+  +   + 
Sbjct: 70  VTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERK---NY 124

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSES 225
           IHRD++A+NVL+       +ADFG A++I +         K  + + APE   +G  +  
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 184

Query: 226 CDVYSFGILLLEILT-GRKP 244
            DV+SFGILL EI+T G+ P
Sbjct: 185 SDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 97.1 bits (242), Expect = 3e-23
 Identities = 78/270 (28%), Positives = 130/270 (48%), Gaps = 28/270 (10%)

Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG 108
           LG G FG V+ G+    + +A+K ++   + +E +F  E +V+ ++ H NL+ L G C  
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIRE-GAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-- 68

Query: 109 TDQR--LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
           T QR   IV +YM N  LL++L  +  G++  +W   M   +   E + YL        I
Sbjct: 69  TKQRPIFIVTEYMANGCLLNYLR-ERKGKLGTEWLLDMCSDV--CEAMEYLESN---GFI 122

Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD+ A N L+  D    V+DFG A+ + +     +   K  + +  PE   + + S   
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKS 182

Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFG+L+ E+ + G+ P E      + + +E  E  +  G    L  PKL        
Sbjct: 183 DVWSFGVLMWEVFSEGKMPYE------RFSNSEVVES-VSAG--YRLYRPKLAP------ 227

Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
             +   +   C   +PE RP  K++++ LT
Sbjct: 228 -TEVYTIMYSCWHEKPEDRPAFKKLLSQLT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 96.8 bits (241), Expect = 4e-23
 Identities = 78/272 (28%), Positives = 123/272 (45%), Gaps = 35/272 (12%)

Query: 43  FSDDNKLGEGGFGSVYWG-RTSDGLQIAVKK--LKAMNSKAEMEFAVEVEVLGRVRHKNL 99
           F   NK+G+G FG V+   R +D    A+K+  L  MN +   E   E  VL ++    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 100 LGLRGY-CAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLD--WKRRMKIAIGSAEGIL 155
           +  R Y       +L IV +Y  N  L   L  Q    +  D  W+  ++I +G A    
Sbjct: 62  I--RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLA---- 115

Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPE 215
           +LH   +  I+HRDIK+ N+ LD+     + D G AKL+ +  +   T V GT  YL+PE
Sbjct: 116 HLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIV-GTPYYLSPE 171

Query: 216 YAMWGKVSESCDVYSFGILLLEILTGRKPIE-KLPGGVKRTITEWAEPLIVKGKFKELVD 274
                  +E  DV++ G++L E  TG+ P +    G +           I++G F  +  
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILK--------IIRGVFPPVSQ 223

Query: 275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPN 306
                     QL Q I+    C+  +  +RP+
Sbjct: 224 MY------SQQLAQLID---QCLTKDYRQRPD 246

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 96.6 bits (241), Expect = 5e-23
 Identities = 60/212 (28%), Positives = 109/212 (51%), Gaps = 13/212 (6%)

Query: 46  DNKLGEGGFGSVYWGRTS----DGLQIAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLL 100
           +  +G G FG V  GR        + +A+K LKA +S K  ++F  E  ++G+  H N++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L G    +   +I+ +YM N SL   L      + +    + + +  G A G+ YL   
Sbjct: 69  RLEGVVTKSRPVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM 125

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRV-KGTLGYLAPEYAMW 219
                +HRD+ A N+L++S+    V+DFG ++ + +  +  TT+  K  + + APE   +
Sbjct: 126 NY---VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY 182

Query: 220 GKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
            K + + DV+SFGI++ E+++ G +P   +  
Sbjct: 183 RKFTSASDVWSFGIVMWEVMSYGERPYWDMSN 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 95.4 bits (237), Expect = 1e-22
 Identities = 79/269 (29%), Positives = 132/269 (49%), Gaps = 32/269 (11%)

Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            +GEG FG+V  G  + G ++AVK +K  + ++A   F  E  V+ ++ HKNL+ L G  
Sbjct: 13  IIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLLGVI 68

Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
              +   IV + M   +L++ L  +  G   +   + ++ ++  AEG+ YL    +  ++
Sbjct: 69  L-HNGLYIVMELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLE---SKKLV 122

Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD+ A N+L+  D    V+DFG A++   GV +    VK T    APE     K S   
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWT----APEALKHKKFSSKS 178

Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+S+G+LL E+ + GR P  K+      ++ E           KE V+   R +  E  
Sbjct: 179 DVWSYGVLLWEVFSYGRAPYPKM------SLKE----------VKECVEKGYRMEPPEGC 222

Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                 +   C ++EP+KRP+  ++   L
Sbjct: 223 PADVYVLMTSCWETEPKKRPSFHKLREKL 251

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 95.5 bits (237), Expect = 1e-22
 Identities = 72/219 (32%), Positives = 112/219 (51%), Gaps = 19/219 (8%)

Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           KLG G FG V+ G  +   ++AVK LK      E  F  E +++ ++RH  L+ L  Y  
Sbjct: 13  KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQL--YAV 69

Query: 108 GTDQRL-IVYDYMPNLSLLSHL---HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
            +++ + IV +YM   SLL  L    G+      L     + +A   A G+ Y+      
Sbjct: 70  VSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNL-----VDMAAQVAAGMAYIERM--- 121

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + IHRD++++N+L+       +ADFG A+LI +         K  + + APE A++G+ +
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 181

Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAE 261
              DV+SFGILL E++T GR P    PG   R + E  E
Sbjct: 182 IKSDVWSFGILLTELVTKGRVP---YPGMNNREVLEQVE 217

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 95.4 bits (237), Expect = 2e-22
 Identities = 78/287 (27%), Positives = 131/287 (45%), Gaps = 48/287 (16%)

Query: 48  KLGEGGFGSVYWGRTS------DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +LGEG FG V+           D + +AVK LK  +  A  +F  E E+L  ++H++++ 
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 102 LRGYCAGTDQRLIVYDYM-------------PNLSLLSHLHGQYAGEVQLDWKRRMKIAI 148
             G C      L+V++YM             P+  +L+       G  QL   + + IA 
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPG--QLTLGQMLAIAS 129

Query: 149 GSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG- 207
             A G++YL    + H +HRD+   N L+       + DFG ++ I    S    RV G 
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI---YSTDYYRVGGR 183

Query: 208 ---TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPL 263
               + ++ PE  ++ K +   D++SFG++L EI T G++P  +L        TE  E  
Sbjct: 184 TMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSN------TEAIE-C 236

Query: 264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           I +G  +EL  P+           +   +   C Q EP++R  +K++
Sbjct: 237 ITQG--RELERPR-------TCPPEVYAIMQGCWQREPQQRMVIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 95.1 bits (237), Expect = 2e-22
 Identities = 79/277 (28%), Positives = 128/277 (46%), Gaps = 31/277 (11%)

Query: 47  NKLGEGGFGSVYWGRTSD-GLQIAVKKLKAMNSKAEM--EFAVEVEVLGRVRHKNLLGLR 103
           NK+G G FG VY     D G  +AVK+++  ++  +   E A E++VL  ++H NL+   
Sbjct: 6   NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G     ++  I  +Y    +L   L     G + LD        +   EG+ YLH   + 
Sbjct: 66  GVEVHREKVYIFMEYCSGGTLEELLEH---GRI-LDEHVIRVYTLQLLEGLAYLH---SH 118

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG---YLAPEYAMWG 220
            I+HRDIK +N+ LD +    + DFG A  +    + M   V+   G   Y+APE    G
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 221 KVSE---SCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL 277
           K      + D++S G ++LE+ TG++P  +L         E+     V    K    P +
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELD-------NEFQIMFHVGAGHK----PPI 227

Query: 278 RGDFDENQLK-QAINVAVLCVQSEPEKRPNMKEVVNT 313
               D  QL  +  +    C++S+P+KRP   E++  
Sbjct: 228 P---DSLQLSPEGKDFLDRCLESDPKKRPTASELLQH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 94.6 bits (235), Expect = 2e-22
 Identities = 78/274 (28%), Positives = 134/274 (48%), Gaps = 36/274 (13%)

Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G FG V +G+      +A+K +K   S +E EF  E +V+ ++ H+ L+ L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMKLSHEKLVQLYGVC- 68

Query: 108 GTDQR--LIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
            T QR   IV +YM N  LL++L  HG+     QL     +++     EG+ YL    + 
Sbjct: 69  -TKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-----LEMCKDVCEGMAYLE---SK 119

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAK--LIPEGVSHMTTRVKGTLGYLAPEYAMWGK 221
             IHRD+ A N L+D      V+DFG ++  L  E  S + +  K  + +  PE  ++ K
Sbjct: 120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS--KFPVRWSPPEVLLYSK 177

Query: 222 VSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGD 280
            S   DV++FG+L+ E+ + G+ P E+         +E  E +    +   L  P L  +
Sbjct: 178 FSSKSDVWAFGVLMWEVYSLGKMPYERF------NNSETVEKVS---QGLRLYRPHLASE 228

Query: 281 FDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                  +   +   C   + E+RP  +++++++
Sbjct: 229 -------KVYAIMYSCWHEKAEERPTFQQLLSSI 255

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 94.8 bits (236), Expect = 2e-22
 Identities = 74/274 (27%), Positives = 126/274 (45%), Gaps = 37/274 (13%)

Query: 49  LGEGGFGSVYWGRTSD-GLQIAVKKLKAMNSKAEMEFAV-----EVEVLGRVRHKNLLGL 102
           LG G FGSVY G   D G   AVK++   +     + AV     E+ +L +++H N++  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 103 RGYCAGTDQRLIVY-DYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            G     +  L ++ + +P  SL   L  +G +   V   + R++        G+ YLH 
Sbjct: 68  LG-TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQI------LLGLEYLHD 120

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM- 218
               + +HRDIK +N+L+D++    +ADFG AK + E         KG+  ++APE    
Sbjct: 121 R---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS--FAKSFKGSPYWMAPEVIAQ 175

Query: 219 WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR 278
            G    + D++S G  +LE+ TG+ P              W++   V   FK +   K  
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPP--------------WSQLEGVAAVFK-IGRSKEL 220

Query: 279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
               ++   +A +  + C+Q +P  RP   E++ 
Sbjct: 221 PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 94.5 bits (235), Expect = 2e-22
 Identities = 80/271 (29%), Positives = 135/271 (49%), Gaps = 30/271 (11%)

Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           KLG G FG V+ G  +   ++A+K LK  +M+ +A   F  E  ++ +++H  L+ L  Y
Sbjct: 13  KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEA---FLAEANLMKQLQHPRLVRL--Y 67

Query: 106 CAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
              T + + I+ +YM N SL+  L       ++L   + + +A   AEG+ ++  +   +
Sbjct: 68  AVVTQEPIYIITEYMENGSLVDFLKTPEG--IKLTINKLIDMAAQIAEGMAFIERK---N 122

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
            IHRD++A+N+L+       +ADFG A+LI +         K  + + APE   +G  + 
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 182

Query: 225 SCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDE 283
             DV+SFGILL EI+T GR P    PG    T  E  + L          +   R    +
Sbjct: 183 KSDVWSFGILLTEIVTYGRIP---YPG---MTNPEVIQNL----------ERGYRMPRPD 226

Query: 284 NQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           N  ++   +  LC + +PE+RP  + + + L
Sbjct: 227 NCPEELYELMRLCWKEKPEERPTFEYLRSVL 257

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 93.8 bits (234), Expect = 8e-22
 Identities = 75/278 (26%), Positives = 124/278 (44%), Gaps = 43/278 (15%)

Query: 43  FSDDNKLGEGGFGSVYWG-RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           + +  K+GEG  G VY     + G ++A+KK++ +  + +     E+ ++   +H N++ 
Sbjct: 21  YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR-LRKQNKELIINEILIMKDCKHPNIVD 79

Query: 102 LRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKR-RMK---IAIGSAE---G 153
                      L +V +YM   SL          ++ +     RM    IA    E   G
Sbjct: 80  YYD-SYLVGDELWVVMEYMDGGSLT---------DI-ITQNFVRMNEPQIAYVCREVLQG 128

Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLA 213
           + YLH   + ++IHRDIK+ N+LL  D    +ADFGFA  + +  S   + V GT  ++A
Sbjct: 129 LEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-GTPYWMA 184

Query: 214 PEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPG--GVKRTITEWAEPLIVKGKFKE 271
           PE           D++S GI+ +E+  G  P  + P    +    T+   PL    K  E
Sbjct: 185 PEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPL----KNPE 240

Query: 272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKE 309
              P+ + DF              C+  +PEKRP+ +E
Sbjct: 241 KWSPEFK-DFLN-----------KCLVKDPEKRPSAEE 266

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 92.9 bits (231), Expect = 1e-21
 Identities = 74/274 (27%), Positives = 129/274 (47%), Gaps = 29/274 (10%)

Query: 42  GFSDDNKLGEGGFGSVYW-GRTSDGLQIAVKKLKAMN-SKAEMEFAV-EVEVLGRVRHKN 98
            F    KLG+G +GSVY   R SD    A+K++   + S+ E E AV E+ +L  V H N
Sbjct: 1   DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60

Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           ++  +      ++  IV +Y P   L   +  +      +  +   +I I    G+  LH
Sbjct: 61  IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM 218
            +    I+HRD+K++N+LL ++    + D G +K++ +    M     GT  Y+APE  +
Sbjct: 121 EQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN---MAKTQIGTPHYMAPE--V 172

Query: 219 WGK--VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
           W     S   D++S G LL E+ T   P E       R++ +     + +GK+     P 
Sbjct: 173 WKGRPYSYKSDIWSLGCLLYEMATFAPPFE------ARSMQDLRYK-VQRGKY-----PP 220

Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           +   + ++ L+  I      +Q +P+ RPN  ++
Sbjct: 221 IPPIYSQD-LQNFIR---SMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 92.6 bits (230), Expect = 1e-21
 Identities = 76/272 (27%), Positives = 126/272 (46%), Gaps = 30/272 (11%)

Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G FG V+ G+    +++A+K +    + +E +F  E +V+ ++ H  L+ L G C 
Sbjct: 11  ELGSGQFGVVHLGKWRAQIKVAIKAINE-GAMSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69

Query: 108 GTDQRLIVYDYMPNLSLLSHL---HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                 IV ++M N  LL++L    G+ + ++ L       +     EG+ YL       
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLL------SMCQDVCEGMEYLERN---S 120

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
            IHRD+ A N L+ S     V+DFG  + + +     ++  K  + +  PE   + K S 
Sbjct: 121 FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSS 180

Query: 225 SCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDE 283
             DV+SFG+L+ E+ T G+ P E      K++  E  E +I +G    L  PKL      
Sbjct: 181 KSDVWSFGVLMWEVFTEGKMPFE------KKSNYEVVE-MISRG--FRLYRPKLAS---- 227

Query: 284 NQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
                   V   C   +PE RP   E++  +T
Sbjct: 228 ---MTVYEVMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 92.4 bits (229), Expect = 2e-21
 Identities = 72/269 (26%), Positives = 121/269 (44%), Gaps = 24/269 (8%)

Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           LG+G FG V+ G   D   +AVK  K  +  + +++F  E  +L +  H N++ L G C 
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH 167
                 IV + +P    LS L  +   + +L  K+ +K A+ +A G+ YL    + + IH
Sbjct: 63  QRQPIYIVMELVPGGDFLSFLRKK---KDELKTKQLVKFALDAAAGMAYLE---SKNCIH 116

Query: 168 RDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCD 227
           RD+ A N L+  +    ++DFG ++   +G+   +   +  + + APE   +G+ S   D
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESD 176

Query: 228 VYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQL 286
           V+S+GILL E  + G  P                 P +   + +E V+   R    +   
Sbjct: 177 VWSYGILLWETFSLGVCPY----------------PGMTNQQAREQVEKGYRMSCPQKCP 220

Query: 287 KQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
                V   C   +PE RP   E+   L 
Sbjct: 221 DDVYKVMQRCWDYKPENRPKFSELQKELA 249

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 92.2 bits (229), Expect = 2e-21
 Identities = 70/215 (32%), Positives = 105/215 (48%), Gaps = 23/215 (10%)

Query: 49  LGEGGFGSVYWGRTSDGL-------QIAVKKLKAMNSKAE-MEFAVEVEVLGRVRHKNLL 100
           LG G FG VY G  +D L       ++AVK L+   +  E  EF  E  ++    H N++
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ---LDWKRRMKIAIGSAEGILYL 157
            L G C   + + I+ + M    LLS+L            L  K  + I +  A+G +YL
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 158 HHEVTPHIIHRDIKASNVLL-----DSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG-- 210
                 H IHRD+ A N L+     D+D    + DFG A+ I +   +     +G L   
Sbjct: 123 EQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKS-DYYRKEGEGLLPVR 178

Query: 211 YLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
           ++APE  + GK +   DV+SFG+L+ EILT G++P
Sbjct: 179 WMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 92.5 bits (230), Expect = 2e-21
 Identities = 64/202 (31%), Positives = 106/202 (52%), Gaps = 17/202 (8%)

Query: 49  LGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
           LG+G FGSV   R  D LQ      +AVKKL+   ++   +F  E+E+L  ++H N++  
Sbjct: 12  LGKGNFGSVELCRY-DPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKY 70

Query: 103 RGYC--AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           +G C  AG     +V +Y+P  SL  +L        +LD ++ +  A    +G+ YL   
Sbjct: 71  KGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE---RLDHRKLLLYASQICKGMEYLG-- 125

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGYLAPEYAM 218
            +   +HRD+   N+L++S+    + DFG  K++P+   +   R  G   + + APE   
Sbjct: 126 -SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184

Query: 219 WGKVSESCDVYSFGILLLEILT 240
             K S + DV+SFG++L E+ T
Sbjct: 185 ESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 91.3 bits (227), Expect = 3e-21
 Identities = 64/207 (30%), Positives = 96/207 (46%), Gaps = 18/207 (8%)

Query: 48  KLGEGGFGSVYWGR----TSDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGL 102
           KLG+G FG V  G         + +AVK LK+   S    +F  E  ++  + H+NL+ L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLD--WKRRMKIAIGSAEGILYLHHE 160
            G    T   ++V +  P  SLL  L     G   +       ++IA     G+ YL  +
Sbjct: 62  YGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA----NGMRYLESK 116

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLGYLAPEYAM 218
                IHRD+ A N+LL SD +  + DFG  + +P+   H  M   +K    + APE   
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLR 173

Query: 219 WGKVSESCDVYSFGILLLEILT-GRKP 244
               S + DV+ FG+ L E+ T G +P
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 88.9 bits (220), Expect = 2e-20
 Identities = 69/203 (33%), Positives = 97/203 (47%), Gaps = 14/203 (6%)

Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG 108
           +G+G FG V  G    G ++AVK +K  N      F  E  V+ ++RH NL+ L G    
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 109 TDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH 167
               L IV +YM   SL+ +L  +  G   L     +K ++   E + YL      + +H
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVH 125

Query: 168 RDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCD 227
           RD+ A NVL+  D    V+DFG  K      S      K  + + APE     K S   D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSD 181

Query: 228 VYSFGILLLEILT-GRKPIEKLP 249
           V+SFGILL EI + GR P  ++P
Sbjct: 182 VWSFGILLWEIYSFGRVPYPRIP 204

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 89.2 bits (222), Expect = 4e-20
 Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 40/223 (17%)

Query: 46  DNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEME---FAV--EVEVLGRVRHKNL 99
             KLGEG +  VY  R    G  +A+KK+K    K   +   F    E+++L  ++H N+
Sbjct: 5   GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI 64

Query: 100 LGLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE------ 152
           +GL     G    + +V+++M   + L  +            K +  I +  A+      
Sbjct: 65  IGLLD-VFGHKSNINLVFEFME--TDLEKV-----------IKDK-SIVLTPADIKSYML 109

Query: 153 ----GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT 208
               G+ YLH      I+HRD+K +N+L+ SD    +ADFG A+        MT +V  T
Sbjct: 110 MTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV-T 165

Query: 209 LGYLAPEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEKLPG 250
             Y APE     +      D++S G +  E+L  R P   LPG
Sbjct: 166 RWYRAPELLFGARHYGVGVDMWSVGCIFAELLL-RVPF--LPG 205

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 87.6 bits (217), Expect = 9e-20
 Identities = 76/283 (26%), Positives = 130/283 (45%), Gaps = 48/283 (16%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLK-AMNSKAEMEFAV-----EVEVLGRVRHKNLLG 101
           LG G F S Y  R    G  +AVK++    N+ +E E  V     E+ ++ R+ H +++ 
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLH--GQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           + G         +  ++M   S+   L   G +   V +++  ++        G+ YLH 
Sbjct: 68  MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL------LRGLSYLHE 121

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPL-VADFGFA-KLIPE--GVSHMTTRVKGTLGYLAPE 215
                IIHRD+K +N+L+DS  + L +ADFG A +L  +  G      ++ GT+ ++APE
Sbjct: 122 N---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPE 178

Query: 216 YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVK-------GK 268
                +   SCDV+S G +++E+ T      K P   ++     A  LI K         
Sbjct: 179 VLRGEQYGRSCDVWSVGCVIIEMATA-----KPPWNAEKHSNHLA--LIFKIASATTAPS 231

Query: 269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
             E + P LR            +V + C++ +PE RP  +E++
Sbjct: 232 IPEHLSPGLR------------DVTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 87.4 bits (217), Expect = 1e-19
 Identities = 74/268 (27%), Positives = 117/268 (43%), Gaps = 26/268 (9%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
            +LG G  G V        G  +AVK ++  +N   + +   E+++L +     ++G  G
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 105 YCAGTDQRLIVYDYMPNLSL---LSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
                    I  +YM   SL   L  + G+   E  L      KIA+   +G+ YLH   
Sbjct: 67  AFYNNGDISICMEYMDGGSLDKILKEVQGRI-PERILG-----KIAVAVLKGLTYLHE-- 118

Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK 221
              IIHRD+K SN+L++S  +  + DFG +    + V+ +     GT  Y+APE      
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSG---QLVNSLAKTFVGTSSYMAPERIQGND 175

Query: 222 VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF 281
            S   D++S G+ L+E+ TGR P           I E  +  IV         P+L    
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYPP-ENDPPDGIFELLQ-YIVNEP-----PPRLPSGK 228

Query: 282 DENQLKQAINVAVLCVQSEPEKRPNMKE 309
                +  +N   LC+  +P +RP+ KE
Sbjct: 229 FSPDFQDFVN---LCLIKDPRERPSYKE 253

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 88.2 bits (219), Expect = 1e-19
 Identities = 67/212 (31%), Positives = 108/212 (50%), Gaps = 21/212 (9%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKNLLGLR 103
           N++GEG +G VY  R T+ G  +A+KK++  N +  +  +   E+ +L  +RH N++ L+
Sbjct: 13  NRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELK 72

Query: 104 GYCAGT--DQRLIVYDYMPN--LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
               G   D   +V +Y      SLL ++   ++ E Q+       + +    G+ YLH 
Sbjct: 73  EVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFS-ESQVK-----CLMLQLLRGLQYLHE 126

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
                IIHRD+K SN+LL       +ADFG A+        MT +V  TL Y APE  + 
Sbjct: 127 NF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV-TLWYRAPELLLG 182

Query: 220 GKV-SESCDVYSFGILLLEILTGRKPIEKLPG 250
               + + D+++ G +L E+L   KP+  LPG
Sbjct: 183 CTTYTTAIDMWAVGCILAELLAH-KPL--LPG 211

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 87.4 bits (216), Expect = 1e-19
 Identities = 73/273 (26%), Positives = 130/273 (47%), Gaps = 24/273 (8%)

Query: 46  DNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           + KLG G FG V+    +   ++AVK +K  +   E  F  E  V+  ++H  L+ L   
Sbjct: 11  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAV 69

Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               +   I+ ++M   SLL  L      +  L   + +  +   AEG+ ++      + 
Sbjct: 70  VT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NY 123

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSES 225
           IHRD++A+N+L+ +     +ADFG A++I +         K  + + APE   +G  +  
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 183

Query: 226 CDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN 284
            DV+SFGILL+EI+T GR P    PG         + P +++      ++   R    EN
Sbjct: 184 SDVWSFGILLMEIVTYGRIP---YPG--------MSNPEVIRA-----LERGYRMPRPEN 227

Query: 285 QLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
             ++  N+ + C ++ PE+RP  + + + L  +
Sbjct: 228 CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 86.7 bits (215), Expect = 2e-19
 Identities = 84/285 (29%), Positives = 117/285 (41%), Gaps = 36/285 (12%)

Query: 47  NKLGEGGFGSVYWG--RTSDG----LQIAVKKLKAMNSKA-EMEFAVEVEVLGRVRHKNL 99
             LG G FG VY G  R  DG    LQ+AVK L    S+  E +F +E  ++ +  H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ---LDWKRRMKIAIGSAEGILY 156
           + L G       R I+ + M    L S L        +   L  K  +  A   A+G  Y
Sbjct: 72  VRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKY 131

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVA---DFGFAKLIPEGVSHMTTRVKGTL--GY 211
           L      H IHRDI A N LL       VA   DFG A+ I    S+     +  L   +
Sbjct: 132 LE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI-YRASYYRKGGRAMLPIKW 187

Query: 212 LAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFK 270
           + PE  + G  +   DV+SFG+LL EI + G  P    PG   + + E     +  G   
Sbjct: 188 MPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP---YPGRTNQEVME----FVTGGG-- 238

Query: 271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
                  R D  +        +   C Q  PE RPN   ++  + 
Sbjct: 239 -------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 86.7 bits (214), Expect = 3e-19
 Identities = 65/221 (29%), Positives = 108/221 (48%), Gaps = 26/221 (11%)

Query: 48  KLGEGGFGSVYWGRT------SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +LGEG FG V+           D + +AVK LK  +  A  +F  E E+L  ++H++++ 
Sbjct: 12  ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71

Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYA-------GEVQLDWKRRMKIAIGSAE 152
             G C   D  ++V++YM +  L   L  HG  A          +L   + + IA   A 
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG----T 208
           G++YL    + H +HRD+   N L+  +    + DFG ++ +    S    RV G     
Sbjct: 132 GMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV---YSTDYYRVGGHTMLP 185

Query: 209 LGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKL 248
           + ++ PE  M+ K +   DV+S G++L EI T G++P  +L
Sbjct: 186 IRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL 226

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 86.2 bits (213), Expect = 3e-19
 Identities = 63/208 (30%), Positives = 110/208 (52%), Gaps = 22/208 (10%)

Query: 49  LGEGGFGSVYWGRTS----DGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +G G FG V+ G         + +A+K LK     K   +F  E  ++G+  H N++ L 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLH---GQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G        +I+ +YM N +L  +L    G+++   QL    R     G A G+ YL   
Sbjct: 73  GVVTKFKPAMIITEYMENGALDKYLRDHDGEFS-SYQLVGMLR-----GIAAGMKYLSDM 126

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTRVKGTLGYLAPEYA 217
              + +HRD+ A N+L++S+ E  V+DFG ++++   PEG ++ T+  K  + + APE  
Sbjct: 127 ---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG-TYTTSGGKIPIRWTAPEAI 182

Query: 218 MWGKVSESCDVYSFGILLLEILT-GRKP 244
            + K + + DV+SFGI++ E+++ G +P
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 86.4 bits (214), Expect = 3e-19
 Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 30/220 (13%)

Query: 49  LGEGGFGSVYWGR------TSDGLQIAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLLG 101
           LGEG FG VY G             +A+K LK     K + EF  E E++  ++H N++ 
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVC 72

Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHL----------HGQYAGEVQ--LDWKRRMKIAIG 149
           L G C       ++++Y+ +  L   L                 V+  LD    + IAI 
Sbjct: 73  LLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132

Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT- 208
            A G+ YL    + H +HRD+ A N L+       ++DFG ++   +  S    RV+   
Sbjct: 133 IAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSR---DIYSADYYRVQSKS 186

Query: 209 ---LGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
              + ++ PE  ++GK +   D++SFG++L EI + G +P
Sbjct: 187 LLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 85.8 bits (212), Expect = 3e-19
 Identities = 66/269 (24%), Positives = 127/269 (47%), Gaps = 24/269 (8%)

Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           ++G G FG V+ G   +  ++A+K ++   + +E +F  E +V+ ++ H  L+ L G C 
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTIRE-GAMSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH 167
                 +V+++M +  L  +L  Q     +   +  + + +   EG+ YL      ++IH
Sbjct: 70  ERSPICLVFEFMEHGCLSDYLRAQRG---KFSQETLLGMCLDVCEGMAYLESS---NVIH 123

Query: 168 RDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCD 227
           RD+ A N L+  +    V+DFG  + + +     +T  K  + + +PE   + K S   D
Sbjct: 124 RDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSD 183

Query: 228 VYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQL 286
           V+SFG+L+ E+ + G+ P E       R+ +E  E +     F+ L  P+L         
Sbjct: 184 VWSFGVLMWEVFSEGKTPYE------NRSNSEVVETI--NAGFR-LYKPRLAS------- 227

Query: 287 KQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
           +    +   C +  PE RP+   +++ L 
Sbjct: 228 QSVYELMQHCWKERPEDRPSFSLLLHQLA 256

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 86.0 bits (213), Expect = 3e-19
 Identities = 71/272 (26%), Positives = 126/272 (46%), Gaps = 33/272 (12%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           LG+G +G VY  R  S  ++IA+K++   +S+       E+ +   ++H+N++   G  +
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA--EGILYLHHEVTPHI 165
                 I  + +P  SL + L  ++     L    +  I       EG+ YLH      I
Sbjct: 76  ENGFFKIFMEQVPGGSLSALLRSKWG---PLKDNEQTIIFYTKQILEGLKYLHDN---QI 129

Query: 166 IHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK--V 222
           +HRDIK  NVL+++    + ++DFG +K +  G++  T    GTL Y+APE    G    
Sbjct: 130 VHRDIKGDNVLVNTYSGVVKISDFGTSKRLA-GINPCTETFTGTLQYMAPEVIDKGPRGY 188

Query: 223 SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEP---LIVKGKFKELVDPKLRG 279
               D++S G  ++E+ TG+ P  +L            EP   +   G FK  + P++  
Sbjct: 189 GAPADIWSLGCTIVEMATGKPPFIEL-----------GEPQAAMFKVGMFK--IHPEIPE 235

Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
                    A N  + C + +P+KR +  +++
Sbjct: 236 SLSAE----AKNFILRCFEPDPDKRASAHDLL 263

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.2 bits (211), Expect = 6e-19
 Identities = 64/207 (30%), Positives = 101/207 (48%), Gaps = 21/207 (10%)

Query: 49  LGEGGFGSVYWGRTSD-GLQIAVKKLKAMNSKAEMEFAV-----EVEVLGRVRHKNLLGL 102
           LG+G FG VY     D G ++AVK++       E +  V     E+++L  ++H+ ++  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 103 RGYCAGTDQRL-IVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            G C   D+ L I  +YMP  S+   L  +G     V   + R++       EG+ YLH 
Sbjct: 70  YG-CLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQI------LEGVEYLH- 121

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMT--TRVKGTLGYLAPEYA 217
             +  I+HRDIK +N+L DS     + DFG +K +    S  T    V GT  +++PE  
Sbjct: 122 --SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVI 179

Query: 218 MWGKVSESCDVYSFGILLLEILTGRKP 244
                    DV+S G  ++E+LT + P
Sbjct: 180 SGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 84.7 bits (210), Expect = 7e-19
 Identities = 75/283 (26%), Positives = 127/283 (44%), Gaps = 40/283 (14%)

Query: 47  NKLGEGGFGSVYWG--RTSDG--LQIAVKKLKAMNSKA-EMEFAVEVEVLGRVRHKNLLG 101
            +LG G FGSV  G      G  +++AVK LK  +  A + EF  E  V+ ++ H  ++ 
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ----LDWKRRMKIAIGSAEGILYL 157
           L G C G +  ++V +  P   LL +L  +   E+      +       A   A G+ YL
Sbjct: 61  LIGVCKG-EPLMLVMELAPLGPLLKYLKKR--REIPVSDLKEL------AHQVAMGMAYL 111

Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGYLAPE 215
             +   H +HRD+ A NVLL +  +  ++DFG ++ +  G  +      G   L + APE
Sbjct: 112 ESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPE 168

Query: 216 YAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD 274
              +GK S   DV+S+G+ L E  + G KP  ++ G             ++      +++
Sbjct: 169 CINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG-----------AEVIA-----MLE 212

Query: 275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
              R    E   ++  ++ + C +  PE RP   E+ +T    
Sbjct: 213 SGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD 255

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 85.4 bits (212), Expect = 8e-19
 Identities = 60/203 (29%), Positives = 94/203 (46%), Gaps = 19/203 (9%)

Query: 48  KLGEGGFGSVYWGRTSDGLQI-AVKKLKAMNS-KAEMEFAV-EVEVLGRVRHKNLLGLRG 104
            +GEG +G V   R     +I A+KK K     +   + A+ EV+VL ++RH+N++ L+ 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                 +  +V++Y+   +LL  L     G   L             + I Y H     +
Sbjct: 68  AFRRKGRLYLVFEYVER-TLLELLEASPGG---LPPDAVRSYIWQLLQAIAYCHSH---N 120

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG-VSHMTTRVKGTLGYLAPE----YAMW 219
           IIHRDIK  N+L+       + DFGFA+ +     S +T  V  T  Y APE       +
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYV-ATRWYRAPELLVGDTNY 179

Query: 220 GKVSESCDVYSFGILLLEILTGR 242
           GK     DV++ G ++ E+L G 
Sbjct: 180 GK---PVDVWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 87.6 bits (217), Expect = 8e-19
 Identities = 78/294 (26%), Positives = 129/294 (43%), Gaps = 59/294 (20%)

Query: 46  DNKLGEGGFGSV-YWGRTSDGLQIAVK--KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
              LG G  G+V    R SDG   AVK   ++ M+   +     EV  L      +++  
Sbjct: 37  SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKC 96

Query: 103 RGYCAGTDQR--------LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE-- 152
               A  D R         +V DY              AG+++ + K R K      E  
Sbjct: 97  HEDFAKKDPRNPENVLMIALVLDY------------ANAGDLRQEIKSRAKTNRTFREHE 144

Query: 153 -GILYL------HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRV 205
            G+L++      HH  + H+IHRDIK++N+LL S+    + DFGF+K+    VS    R 
Sbjct: 145 AGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRT 204

Query: 206 -KGTLGYLAPEYAMWGK--VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEP 262
             GT  Y+APE  +W +   S+  D++S G+LL E+LT ++P +    G           
Sbjct: 205 FCGTPYYVAPE--IWRRKPYSKKADMFSLGVLLYELLTLKRPFD----GE---------- 248

Query: 263 LIVKGKFKELVDPKLRGDFD---ENQLKQAINVAVLCVQSEPEKRPNMKEVVNT 313
                  +E++   L G +D    +   +   +    + S+P++RP+  +++N 
Sbjct: 249 -----NMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297

Length = 496

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 83.1 bits (205), Expect = 3e-18
 Identities = 71/271 (26%), Positives = 117/271 (43%), Gaps = 26/271 (9%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLK-AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           ++G G FG V+ GR  +D   +AVK  +  +    + +F  E  +L +  H N++ L G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
           C       IV + +     L+ L  +     +L  K  +++   +A G+ YL    + H 
Sbjct: 62  CTQKQPIYIVMELVQGGDFLTFLRTEGP---RLKVKELIQMVENAAAGMEYLE---SKHC 115

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT-LGYLAPEYAMWGKVSE 224
           IHRD+ A N L+       ++DFG ++   +GV   T  +K   + + APE   +G+ S 
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175

Query: 225 SCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDE 283
             DV+SFGILL E  + G  P   L     R                E ++  +R    E
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTR----------------EAIEQGVRLPCPE 219

Query: 284 NQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                   +   C + +P +RP+   V   L
Sbjct: 220 LCPDAVYRLMERCWEYDPGQRPSFSTVHQEL 250

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 83.4 bits (206), Expect = 3e-18
 Identities = 70/276 (25%), Positives = 130/276 (47%), Gaps = 32/276 (11%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSK---AEMEFAV---EVEVLGRVRHKNLL 100
             LG+G +G+VY G T+ G  IAVK+++   S    AE E+     EV++L  ++H N++
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
              G C   +   I  +++P  S+ S L+ ++    +  + +  K  +   +G+ YLH+ 
Sbjct: 66  QYLGTCLDDNTISIFMEFVPGGSISSILN-RFGPLPEPVFCKYTKQIL---DGVAYLHNN 121

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAK---LIPEGVSH--MTTRVKGTLGYLAPE 215
               ++HRDIK +NV+L  +    + DFG A+    +    +H  M   + GT  ++APE
Sbjct: 122 ---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPE 178

Query: 216 YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP 275
                      D++S G  + E+ TG+ P+  +              +   G  + L+ P
Sbjct: 179 VINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR---------LAAMFYIGAHRGLM-P 228

Query: 276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
           +L   F       AI+    C+  +  +RP+  +++
Sbjct: 229 RLPDSFSAA----AIDFVTSCLTRDQHERPSALQLL 260

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 83.0 bits (205), Expect = 4e-18
 Identities = 64/208 (30%), Positives = 108/208 (51%), Gaps = 22/208 (10%)

Query: 49  LGEGGFGSVYWGR----TSDGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +G G FG V  GR        + +A+K LKA    K   +F  E  ++G+  H N++ L 
Sbjct: 12  IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLH---GQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G    +   +IV +YM N SL + L    GQ+   +QL     + +  G A G+ YL   
Sbjct: 72  GVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFT-VIQL-----VGMLRGIASGMKYLSDM 125

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTRVKGTLGYLAPEYA 217
                +HRD+ A N+L++S+    V+DFG ++++   PE   + T   K  + + APE  
Sbjct: 126 ---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA-YTTRGGKIPIRWTAPEAI 181

Query: 218 MWGKVSESCDVYSFGILLLEILT-GRKP 244
            + K + + DV+S+GI++ E+++ G +P
Sbjct: 182 AYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 82.8 bits (205), Expect = 5e-18
 Identities = 71/273 (26%), Positives = 116/273 (42%), Gaps = 29/273 (10%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
             +G G    VY      +  ++A+K++     +  ++    EV+ + +  H N++    
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-- 64

Query: 105 YCAGT--DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           Y +    D+  +V  Y+   SLL  +   Y     LD      +     +G+ YLH    
Sbjct: 65  YTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGG-LDEAIIATVLKEVLKGLEYLHSN-- 121

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK----GTLGYLAPEYAM 218
              IHRDIKA N+LL  D    +ADFG +  + +G    T +V+    GT  ++APE   
Sbjct: 122 -GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD-RTRKVRKTFVGTPCWMAPEVME 179

Query: 219 WGK-VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL 277
                    D++SFGI  +E+ TG  P  K P            P+ V     +   P L
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYSKYP------------PMKVLMLTLQNDPPSL 227

Query: 278 RGDFDENQLKQAI-NVAVLCVQSEPEKRPNMKE 309
               D  +  ++   +  LC+Q +P KRP  +E
Sbjct: 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEE 260

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 82.3 bits (204), Expect = 6e-18
 Identities = 67/270 (24%), Positives = 110/270 (40%), Gaps = 28/270 (10%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           F    KLGEG +GSVY       G  +A+K +       E+    E+ +L +     ++ 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEII--KEISILKQCDSPYIVK 62

Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
             G         IV +Y    S+   +         L  +    I   + +G+ YLH   
Sbjct: 63  YYGSYFKNTDLWIVMEYCGAGSVSDIMK---ITNKTLTEEEIAAILYQTLKGLEYLHSN- 118

Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK 221
               IHRDIKA N+LL+ + +  +ADFG +  + + ++   T V GT  ++APE      
Sbjct: 119 --KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT-VIGTPFWMAPEVIQEIG 175

Query: 222 VSESCDVYSFGILLLEILTGRKPIEKL-PGGVKRTITEWAEPLIVKGKFKELVDPKLRGD 280
            +   D++S GI  +E+  G+ P   + P      I     P           DP+    
Sbjct: 176 YNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPP-----TLS---DPE---- 223

Query: 281 FDENQLKQAINVAV-LCVQSEPEKRPNMKE 309
               +     N  V  C+  +PE+RP+  +
Sbjct: 224 ----KWSPEFNDFVKKCLVKDPEERPSAIQ 249

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 82.1 bits (203), Expect = 6e-18
 Identities = 73/274 (26%), Positives = 119/274 (43%), Gaps = 41/274 (14%)

Query: 49  LGEGGFGS-VYWGRTSDGLQIAVKK--LKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           LG+G FG    + RT D   +  K+  L  ++ K   +   E+ +L  ++H N++    +
Sbjct: 8   LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67

Query: 106 CAGTDQRLIVYDYMPNLSL---LSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
               +  LI  +Y    +L   +    GQ   E  + W       I SA  + Y+H    
Sbjct: 68  FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW---YLFQIVSA--VSYIHKA-- 120

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
             I+HRDIK  N+ L       + DFG +K++    S   T V GT  Y++PE     K 
Sbjct: 121 -GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVV-GTPYYMSPELCQGVKY 178

Query: 223 SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL-----IVKGKFKELVDPKL 277
           +   D+++ G +L E+LT           +KRT  +   PL     IV+G +  +V    
Sbjct: 179 NFKSDIWALGCVLYELLT-----------LKRTF-DATNPLNLVVKIVQGNYTPVVSV-- 224

Query: 278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
                     + I++    +Q +PEKRP   EV+
Sbjct: 225 -------YSSELISLVHSLLQQDPEKRPTADEVL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 82.9 bits (205), Expect = 7e-18
 Identities = 75/279 (26%), Positives = 127/279 (45%), Gaps = 36/279 (12%)

Query: 49  LGEGGFGSVY------WGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRV-RHKNLL 100
           LG G FG V         ++   +++AVK LK     +E E    E++++  +  H+N++
Sbjct: 43  LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L G C      L++ +Y     LL+ L  +   E  L  +  +  +   A+G+ +L   
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFL--- 157

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT----LGYLAPEY 216
            + + IHRD+ A NVLL       + DFG A+ I    +++   VKG     + ++APE 
Sbjct: 158 ASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV---VKGNARLPVKWMAPES 214

Query: 217 AMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP 275
                 +   DV+S+GILL EI + G  P    PG            + V  KF +L+  
Sbjct: 215 IFNCVYTFESDVWSYGILLWEIFSLGSNP---YPG------------MPVDSKFYKLIKE 259

Query: 276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
             R    E+   +  ++   C  ++P KRP  K++V  +
Sbjct: 260 GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 82.2 bits (203), Expect = 7e-18
 Identities = 62/211 (29%), Positives = 107/211 (50%), Gaps = 26/211 (12%)

Query: 49  LGEGGFGSVYWGRTS----DGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +G G FG V  GR        + +A+K LK+    K   +F  E  ++G+  H N++ L 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71

Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLH---GQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G    +   +I+ ++M N +L S L    GQ+   +QL    R     G A G+ YL   
Sbjct: 72  GVVTKSRPVMIITEFMENGALDSFLRQNDGQFT-VIQLVGMLR-----GIAAGMKYLSEM 125

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG------YLAP 214
              + +HRD+ A N+L++S+    V+DFG ++ + +  S  T     +LG      + AP
Sbjct: 126 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT--YTSSLGGKIPIRWTAP 180

Query: 215 EYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
           E   + K + + DV+S+GI++ E+++ G +P
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 81.8 bits (203), Expect = 1e-17
 Identities = 68/217 (31%), Positives = 95/217 (43%), Gaps = 49/217 (22%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   R     +  A+K   K K +  K       E  +L  +RH  L+    
Sbjct: 9   LGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLV---- 64

Query: 105 YCAGTDQ---RL-IVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGS 150
              G+ Q    L +V +Y+P   L SHL           + YA +V L            
Sbjct: 65  NLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVL------------ 112

Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG 210
              + YLH      I++RD+K  N+LLDSD    + DFGFAK +       T  + GT  
Sbjct: 113 --ALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----TYTLCGTPE 163

Query: 211 YLAPEYAM---WGKVSESCDVYSFGILLLEILTGRKP 244
           YLAPE  +   +GK   + D ++ GIL+ E+L G  P
Sbjct: 164 YLAPEIILSKGYGK---AVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 81.5 bits (201), Expect = 1e-17
 Identities = 58/205 (28%), Positives = 106/205 (51%), Gaps = 17/205 (8%)

Query: 49  LGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVE----VLGRVRHKNLLG 101
           LG G FG+V+   W    D ++I V  +K +  ++  +   E+      +G + H  ++ 
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVA-IKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVR 73

Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
           L G C G   +L+     P  SLL H+  Q+     LD +R +   +  A+G+ YL    
Sbjct: 74  LLGICPGASLQLVT-QLSPLGSLLDHVR-QHRD--SLDPQRLLNWCVQIAKGMYYLEEH- 128

Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWG 220
              ++HR++ A N+LL SD    +ADFG A L+ P+   +  +  K  + ++A E  ++G
Sbjct: 129 --RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186

Query: 221 KVSESCDVYSFGILLLEILT-GRKP 244
           + +   DV+S+G+ + E+++ G +P
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEP 211

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 81.6 bits (202), Expect = 1e-17
 Identities = 69/287 (24%), Positives = 120/287 (41%), Gaps = 46/287 (16%)

Query: 49  LGEGGFGSVYWG------RTSDGLQIAVKKLKAMNSKAE-MEFAVEVEVLGRVRHKNLLG 101
           LG+G FG VY G      +     ++A+K +    S  E +EF  E  V+      +++ 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ------LDWKRRMKIAIGSAEGIL 155
           L G  +     L+V + M    L S+L  +               ++ +++A   A+G+ 
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI-------PEGVSHMTTRVKGT 208
           YL  +     +HRD+ A N ++  D    + DFG  + I         G   +  R    
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 186

Query: 209 LGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKG 267
             ++APE    G  +   DV+SFG++L E+ T   +P + L         E     ++ G
Sbjct: 187 --WMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS-------NEEVLKFVIDG 237

Query: 268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
              +L  P       EN   + + +  +C Q  P+ RP   E+V++L
Sbjct: 238 GHLDL--P-------ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 76/275 (27%), Positives = 121/275 (44%), Gaps = 52/275 (18%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQI-AVKKLKAMNSKAEMEFAV----EVEVLGRVRHKNLLG 101
           N++ EG +G VY  R     +I A+KKLK M  + E  F +    E+ +L +++H N++ 
Sbjct: 11  NRIEEGTYGVVYRARDKKTGEIVALKKLK-MEKEKE-GFPITSLREINILLKLQHPNIVT 68

Query: 102 LRGYCAGT--DQRLIVYDYMPN--LSLLSHLHGQYA-GEV-----QLDWKRRMKIAIGSA 151
           ++    G+  D+  +V +Y+ +   SL+  +   +   EV     QL             
Sbjct: 69  VKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQL------------L 116

Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGY 211
            G+ +LH      I+HRD+K SN+LL++     + DFG A+     +   T  V  TL Y
Sbjct: 117 SGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVV-TLWY 172

Query: 212 LAPEYAMWGKV-SESCDVYSFGILLLEILT------GRKPIE------KLPGGVKRTITE 258
            APE  +  K  S + D++S G +  E+LT      G+  I+      KL G     I  
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKI-- 230

Query: 259 WAE----PLIVKGKFKELVDPKLRGDFDENQLKQA 289
           W      P   K  F +    +LR  F    L   
Sbjct: 231 WPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDN 265

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 81.0 bits (200), Expect = 2e-17
 Identities = 66/212 (31%), Positives = 101/212 (47%), Gaps = 19/212 (8%)

Query: 49  LGEGGFGSVYWGRTS--DG--LQIAVKKLKAMN-SKAEME-FAVEVEVLGRVRHKNLLGL 102
           LGEG FGSV  G+ S  DG  L++AVK +K    + +E+E F  E   +    H N++ L
Sbjct: 7   LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66

Query: 103 RGYCAGTDQR------LIVYDYMPNLSLLSHLHGQYAGE--VQLDWKRRMKIAIGSAEGI 154
            G C            +++  +M +  L S L     G    +L  +  +K  +  A G+
Sbjct: 67  IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126

Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRV-KGTLGYLA 213
            YL      + IHRD+ A N +L  D    VADFG +K I  G  +   R+ K  + ++A
Sbjct: 127 EYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA 183

Query: 214 PEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
            E       +   DV++FG+ + EI T G+ P
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 80.7 bits (199), Expect = 3e-17
 Identities = 63/217 (29%), Positives = 110/217 (50%), Gaps = 26/217 (11%)

Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-------KAMNSKAEMEFAV--EVEVLGRVRHKN 98
           +G G FGSVY G   S G  +AVK++        + + K  M  A+  E+ +L  ++H+N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQL--DWKRRMKIAIGSAEGILY 156
           ++   G     D   I  +Y+P  S+ + L+   A E  L  ++ R++       +G+ Y
Sbjct: 68  IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQI------LKGLNY 121

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR-----VKGTLGY 211
           LH+     IIHRDIK +N+L+D+     ++DFG +K +        T      ++G++ +
Sbjct: 122 LHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFW 178

Query: 212 LAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKL 248
           +APE       +   D++S G L++E+LTG+ P    
Sbjct: 179 MAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 80.6 bits (199), Expect = 4e-17
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 29/210 (13%)

Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGLRGYCA 107
           LG+G FG VY  +  +    A  K+  + S+ E+E F VE+++L   +H N++GL     
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYE--- 69

Query: 108 GTDQRLIVYDYMPNLSLLSHLHGQYA-GEVQLDWKRRMK------IAIGSAEGILYLHHE 160
                   Y Y   L +L       A   + L+ +R +       +     E + +LH  
Sbjct: 70  -------AYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGF-AKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
               +IHRD+KA N+LL  D +  +ADFG  AK         T    GT  ++APE    
Sbjct: 123 ---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT--FIGTPYWMAPEVVAC 177

Query: 220 GKVSES-----CDVYSFGILLLEILTGRKP 244
               ++      D++S GI L+E+     P
Sbjct: 178 ETFKDNPYDYKADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 80.8 bits (200), Expect = 4e-17
 Identities = 70/237 (29%), Positives = 105/237 (44%), Gaps = 34/237 (14%)

Query: 38  TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRV 94
           +    +    KLGEG FG VY  R    G  +A+KK+   N K         E+++L ++
Sbjct: 5   SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL 64

Query: 95  RHKNLLGL-----RGYCAGTDQRLIVYDYMP----NLSLLSHLHGQYAGEVQLDWKRRMK 145
           +H N++ L             +R  VY   P    +LS L  L        +   K  M 
Sbjct: 65  KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGL--LENPSVKLTESQIKCYML 122

Query: 146 IAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI------PEGVS 199
             +   EGI YLH     HI+HRDIKA+N+L+D+     +ADFG A+        P+G  
Sbjct: 123 QLL---EGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGG 176

Query: 200 HMTTR----VKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPIEKLPGG 251
              TR    +  T  Y  PE  +   + + + D++  G +  E+ T R+PI  L G 
Sbjct: 177 GGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT-RRPI--LQGK 230

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 80.5 bits (199), Expect = 5e-17
 Identities = 84/293 (28%), Positives = 131/293 (44%), Gaps = 51/293 (17%)

Query: 49  LGEGGFGSVYWGRTSDGLQ-------IAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKNL 99
           LGEG FG V     + GL        +AVK LK   ++ ++ +   E+E++  + +HKN+
Sbjct: 20  LGEGAFGQV-VKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLH-----GQYAG-------EVQLDWKRRMKIA 147
           + L G C       +V +Y  + +L   L      G+YA        E  L  K  +  A
Sbjct: 79  INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG 207
              A G+ +L    +   IHRD+ A NVL+  D    +ADFG A+     + H+    K 
Sbjct: 139 YQVARGMEFL---ASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYRKT 191

Query: 208 TLGYL-----APEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE 261
           T G L     APE A++ +V +   DV+SFG+LL EI T         GG          
Sbjct: 192 TNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFT--------LGGSPY------- 235

Query: 262 PLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           P I   +  +L+    R +  +N  ++  ++   C    P +RP  K++V  L
Sbjct: 236 PGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDL 288

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 80.0 bits (197), Expect = 5e-17
 Identities = 62/203 (30%), Positives = 108/203 (53%), Gaps = 18/203 (8%)

Query: 49  LGEGGFGSVYWGR-----TSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLGL 102
           LGEG FG V   R      + G Q+AVK LK  +    + +   E+E+L  + H+N++  
Sbjct: 12  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71

Query: 103 RGYC---AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           +G C    G   +LI+ +++P+ SL  +L        +++ K+++K A+   +G+ YL  
Sbjct: 72  KGICTEDGGNGIKLIM-EFLPSGSLKEYLPRNKN---KINLKQQLKYAVQICKGMDYLG- 126

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR--VKGTLGYLAPEYA 217
             +   +HRD+ A NVL++S+ +  + DFG  K I     + T +  +   + + APE  
Sbjct: 127 --SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184

Query: 218 MWGKVSESCDVYSFGILLLEILT 240
           +  K   + DV+SFG+ L E+LT
Sbjct: 185 IQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 80.4 bits (198), Expect = 5e-17
 Identities = 70/237 (29%), Positives = 112/237 (47%), Gaps = 42/237 (17%)

Query: 49  LGEGGFGSVYWGRT-SDGLQI--AVKKLKAMNSKAE-MEFAVEVEVLGRV-RHKNLLGLR 103
           +GEG FG V   R   DGL++  A+K++K   SK +  +FA E+EVL ++  H N++ L 
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ------------LDWKRRMKIAIGSA 151
           G C       +  +Y P+ +LL  L      E              L  ++ +  A   A
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134

Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG- 210
            G+ YL  +     IHRD+ A N+L+  ++   +ADFG ++            VK T+G 
Sbjct: 135 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGR 184

Query: 211 ----YLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP---------IEKLPGGVK 253
               ++A E   +   + + DV+S+G+LL EI++ G  P          EKLP G +
Sbjct: 185 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 241

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 79.6 bits (197), Expect = 7e-17
 Identities = 76/274 (27%), Positives = 116/274 (42%), Gaps = 36/274 (13%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEF-AVEVEVLGRVRHKNLL 100
           F+    +G+G FG VY          +A+K +    ++ E+E    E++ L + R   + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 101 GLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE---GILY 156
              G       +L I+ +Y    S L  L      E          IA    E   G+ Y
Sbjct: 63  KYYG-SFLKGSKLWIIMEYCGGGSCLDLLKPGKLDE--------TYIAFILREVLLGLEY 113

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
           LH E     IHRDIKA+N+LL  + +  +ADFG +  +   +S   T V GT  ++APE 
Sbjct: 114 LHEEGK---IHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-GTPFWMAPEV 169

Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPIEKL-PGGVKRTITEWAEPLIVKGKFKELVDP 275
                  E  D++S GI  +E+  G  P+  L P  V   I +   P +   KF +    
Sbjct: 170 IKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFK- 228

Query: 276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKE 309
               DF             LC+  +P++RP+ KE
Sbjct: 229 ----DFVS-----------LCLNKDPKERPSAKE 247

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 79.6 bits (196), Expect = 8e-17
 Identities = 57/222 (25%), Positives = 107/222 (48%), Gaps = 36/222 (16%)

Query: 48  KLGEGGFGSVYWGRTSDGLQ----------------IAVKKLKA-MNSKAEMEFAVEVEV 90
           KLGEG FG V+    ++GL                 +AVK L+A +   A  +F  E+++
Sbjct: 12  KLGEGQFGEVHLCE-AEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI 70

Query: 91  LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
           + R+++ N++ L G C   D   ++ +YM N  L   L  +   E++  +     I   S
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQR---EIESTFTHANNIPSVS 127

Query: 151 AEGILYLHHEVTP--------HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMT 202
              +LY+  ++          + +HRD+   N L+ + +   +ADFG ++ +  G  +  
Sbjct: 128 IANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYY-- 185

Query: 203 TRVKG----TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT 240
            R++G     + ++A E  + GK + + DV++FG+ L E+ T
Sbjct: 186 -RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 63/207 (30%), Positives = 94/207 (45%), Gaps = 19/207 (9%)

Query: 49  LGEGGFGSVYWGRTSDG--------LQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLL 100
           LG G +G V+  R   G        +++  K      +K       E  VL  VR    L
Sbjct: 8   LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67

Query: 101 GLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
               Y   T+ +L ++ DY+    + +HL+       Q D     ++   S E IL L H
Sbjct: 68  VTLHYAFQTEAKLHLILDYVSGGEMFTHLY-------QRDNFSEDEVRFYSGEIILALEH 120

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
                I++RDIK  N+LLDS+   ++ DFG +K         T    GT+ Y+APE  + 
Sbjct: 121 LHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE-IIR 179

Query: 220 GKV--SESCDVYSFGILLLEILTGRKP 244
           GK    ++ D +S GIL+ E+LTG  P
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTGASP 206

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 78.7 bits (195), Expect = 2e-16
 Identities = 58/213 (27%), Positives = 97/213 (45%), Gaps = 30/213 (14%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV----EVEVLGRVRHK 97
           +    KLGEG +G VY  R    G  +A+KK++      E         E+ +L  ++H 
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR--LDNEEEGIPSTALREISLLKELKHP 58

Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDW-KRRMKIAIGSAEGILY 156
           N++ L        +  +V++Y  ++ L  +L  +  G +  +  K  M   +    G+ Y
Sbjct: 59  NIVKLLDVIHTERKLYLVFEYC-DMDLKKYLD-KRPGPLSPNLIKSIMYQLL---RGLAY 113

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPE- 215
            H      I+HRD+K  N+L++ D    +ADFG A+     +   T  V  TL Y APE 
Sbjct: 114 CHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVV-TLWYRAPEI 169

Query: 216 ------YAMWGKVSESCDVYSFGILLLEILTGR 242
                 Y      S + D++S G +  E++TG+
Sbjct: 170 LLGSKHY------STAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 68/241 (28%), Positives = 99/241 (41%), Gaps = 34/241 (14%)

Query: 50  GEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAV------EVEVLGRVRHKNLLGLR 103
           G+G FG V   +  D  +  +  +K MN +  +E         E  +L  + H  L+ L 
Sbjct: 9   GKGAFGKVCIVQKRDTKK--MFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLW 66

Query: 104 -GYCAGTDQRLIVYDYMPNLSLLSHL-HGQYAGEVQLDWKRRMKIA-IGSAEGILYLHHE 160
             +    +  L+V D +    L  HL       E Q+    +  I  I  A  + YLH  
Sbjct: 67  YSFQDEENMYLVV-DLLLGGDLRYHLSQKVKFSEEQV----KFWICEIVLA--LEYLH-- 117

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
            +  IIHRDIK  N+LLD      + DF  A  +      +TT   GT GY+APE     
Sbjct: 118 -SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--LTTSTSGTPGYMAPEVLCRQ 174

Query: 221 KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEW-------AEPLIVKGKFKELV 273
             S + D +S G+   E L G++P      G  RTI +        A+ L       E +
Sbjct: 175 GYSVAVDWWSLGVTAYECLRGKRPYR----GHSRTIRDQIRAKQETADVLYPATWSTEAI 230

Query: 274 D 274
           D
Sbjct: 231 D 231

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 72/291 (24%), Positives = 135/291 (46%), Gaps = 58/291 (19%)

Query: 49  LGEGGFGSVYWGRTSD-GLQIAVKKLK-----AMNSKAEMEFAV-----EVEVLGRVRHK 97
           +G+G +G VY       G  +AVK+++     A    +  +  V     E+E L  + H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGIL 155
           N++   G+    +   I  +Y+P  S+ S L  +G++  ++   +  ++       EG+ 
Sbjct: 69  NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV------LEGLA 122

Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL---IPEGVSHMTTRVKGTLGYL 212
           YLH +    I+HRD+KA N+L+D+D    ++DFG +K    I +   +M+  ++G++ ++
Sbjct: 123 YLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS--MQGSVFWM 177

Query: 213 APE--------YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI 264
           APE        Y+   KV    D++S G ++LE+  GR+P              W++   
Sbjct: 178 APEVIHSYSQGYS--AKV----DIWSLGCVVLEMFAGRRP--------------WSDEEA 217

Query: 265 VKGKFK---ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
           +   FK   +   P +  D   N    A++    C    P+ RP  +E++ 
Sbjct: 218 IAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 78.6 bits (193), Expect = 2e-16
 Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 25/214 (11%)

Query: 49  LGEGGFGSVY---WGRTSDGLQIAVKKLKAMNS----KAEMEFAVEVEVLGRVRHKNLLG 101
           LG G FG+VY   W    + ++I V  +K +N     KA +EF  E  ++  + H +L+ 
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVA-IKILNETTGPKANVEFMDEALIMASMDHPHLVR 73

Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLH---GQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           L G C     +L+    MP+  LL ++H        ++ L+W       +  A+G++YL 
Sbjct: 74  LLGVCLSPTIQLVT-QLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 126

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL--GYLAPEY 216
                 ++HRD+ A NVL+ S     + DFG A+L+ EG         G +   ++A E 
Sbjct: 127 ER---RLVHRDLAARNVLVKSPNHVKITDFGLARLL-EGDEKEYNADGGKMPIKWMALEC 182

Query: 217 AMWGKVSESCDVYSFGILLLEILT-GRKPIEKLP 249
             + K +   DV+S+G+ + E++T G KP + +P
Sbjct: 183 IHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP 216

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 18/207 (8%)

Query: 49  LGEGGFGSVYWGRTSDG--------LQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLL 100
           LG G +G V+  R   G        +++  K      +K       E +VL  +R    L
Sbjct: 8   LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67

Query: 101 GLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
               Y   TD +L ++ DY+    L +HL        Q +  +  ++ I S E +L L H
Sbjct: 68  VTLHYAFQTDTKLHLILDYINGGELFTHL-------SQRERFKEQEVQIYSGEIVLALEH 120

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
                II+RDIK  N+LLDS+   ++ DFG +K   E          GT+ Y+AP+    
Sbjct: 121 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRG 180

Query: 220 GKV--SESCDVYSFGILLLEILTGRKP 244
           G     ++ D +S G+L+ E+LTG  P
Sbjct: 181 GDGGHDKAVDWWSMGVLMYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 70/274 (25%), Positives = 118/274 (43%), Gaps = 54/274 (19%)

Query: 49  LGEGGFGSVYWGRTSDGLQIAVKK---LKAMNSKAEMEFAV-----EVEVLGRVRH---K 97
           +G G +G+VY      G  +   +   LK +N     +  V     EV +L ++R     
Sbjct: 9   IGRGAYGAVY-----RGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPP 62

Query: 98  NLLGLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQ-----YAGEVQLDWKRRMKIAIGSA 151
           N+    G       RL I+ +Y    S+ + +        Y   +     R + +A+   
Sbjct: 63  NITKYYG-SYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVII----REVLVALK-- 115

Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGY 211
               Y+H      +IHRDIKA+N+L+ +     + DFG A L+ +  S  +T V GT  +
Sbjct: 116 ----YIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFV-GTPYW 167

Query: 212 LAPEYAMWGKVSES-CDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK 270
           +APE    GK  ++  D++S GI + E+ TG  P   +     R +      LI K K  
Sbjct: 168 MAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD--AFRAMM-----LIPKSK-- 218

Query: 271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKR 304
               P+L  +     L++ +     C+  EP++R
Sbjct: 219 ---PPRLEDNGYSKLLREFV---AACLDEEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 56/207 (27%), Positives = 92/207 (44%), Gaps = 21/207 (10%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
            ++G G +G VY  R     ++   K+  +    + E    E+ +L   RH N++   G 
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGS 68

Query: 106 CAGTDQRLIVYDYMPNLSL--LSHLHGQYAGEVQLDWKRRMKIAIGSAE---GILYLHHE 160
               D+  IV +Y    SL  +  +      E+Q        IA    E   G+ YLH  
Sbjct: 69  YLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQ--------IAYVCRETLKGLAYLHET 120

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA--- 217
                IHRDIK +N+LL  D +  +ADFG +  +   ++   + + GT  ++APE A   
Sbjct: 121 ---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFI-GTPYWMAPEVAAVE 176

Query: 218 MWGKVSESCDVYSFGILLLEILTGRKP 244
             G     CD+++ GI  +E+   + P
Sbjct: 177 RKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 77.8 bits (191), Expect = 4e-16
 Identities = 65/214 (30%), Positives = 103/214 (48%), Gaps = 11/214 (5%)

Query: 49  LGEGGFGSVYWGRT-SDGLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG+GGFG V   +  + G   A KKL   +    K E     E ++L +V  + ++ L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAY 67

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                D   +V   M    L  H++  + GE   +  R +  A     G+  LH E    
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIY--HMGEAGFEEGRAVFYAAEICCGLEDLHQE---R 122

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
           I++RD+K  N+LLD      ++D G A  +PEG + +  RV GT+GY+APE     + + 
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEVVKNERYTF 180

Query: 225 SCDVYSFGILLLEILTGRKPIEKLPGGVKRTITE 258
           S D ++ G LL E++ G+ P ++    +KR   E
Sbjct: 181 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 214

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 77.8 bits (191), Expect = 5e-16
 Identities = 67/211 (31%), Positives = 108/211 (51%), Gaps = 24/211 (11%)

Query: 43  FSDDNKLGEGGFGSVYWGRTSDGLQI-AVKKL----KAMNSKAEMEFAVEVEVLGRVRHK 97
           F+D  ++G G FG+VY+ R     ++ A+KK+    K  N K + +   EV+ L R++H 
Sbjct: 27  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ-DIIKEVKFLQRIKHP 85

Query: 98  NLLGLRGYCAGTDQRLIVYDY-MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
           N +  +G         +V +Y + + S L  +H +   EV++       I  G+ +G+ Y
Sbjct: 86  NSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAITHGALQGLAY 140

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
           LH   + ++IHRDIKA N+LL    +  +ADFG A +     S +     GT  ++APE 
Sbjct: 141 LH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPYWMAPEV 192

Query: 217 AMW---GKVSESCDVYSFGILLLEILTGRKP 244
            +    G+     DV+S GI  +E L  RKP
Sbjct: 193 ILAMDEGQYDGKVDVWSLGITCIE-LAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 76.1 bits (188), Expect = 8e-16
 Identities = 65/204 (31%), Positives = 93/204 (45%), Gaps = 21/204 (10%)

Query: 49  LGEGGFGSVYWGRT-SDGLQIAVKKLKA---MNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG GGFG V   +  S     A+K +K    + +  +     E E+L    H  ++ L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-- 58

Query: 105 YCAGTDQRLI--VYDYMPNLSLLSHLH--GQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           Y    D++ I  + +Y     L + L   G +      ++  R  IA        YLH+ 
Sbjct: 59  YRTFKDKKYIYMLMEYCLGGELWTILRDRGLFD-----EYTARFYIA-CVVLAFEYLHNR 112

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
               II+RD+K  N+LLDS+    + DFGFAK +       T    GT  Y+APE  +  
Sbjct: 113 ---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKL--KSGQKTWTFCGTPEYVAPEIILNK 167

Query: 221 KVSESCDVYSFGILLLEILTGRKP 244
               S D +S GILL E+LTGR P
Sbjct: 168 GYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 76.6 bits (188), Expect = 8e-16
 Identities = 67/232 (28%), Positives = 112/232 (48%), Gaps = 32/232 (13%)

Query: 49  LGEGGFGSVYWGR-TSDGLQI--AVKKLKAMNSKAE-MEFAVEVEVLGRV-RHKNLLGLR 103
           +GEG FG V   R   DGL++  A+K++K   SK +  +FA E+EVL ++  H N++ L 
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62

Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHG------------QYAGEVQLDWKRRMKIAIGSA 151
           G C       +  +Y P+ +LL  L                +    L  ++ +  A   A
Sbjct: 63  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 122

Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGY 211
            G+ YL  +     IHRD+ A N+L+  ++   +ADFG ++   + V    T  +  + +
Sbjct: 123 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRW 177

Query: 212 LAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP---------IEKLPGGVK 253
           +A E   +   + + DV+S+G+LL EI++ G  P          EKLP G +
Sbjct: 178 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 229

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 76.2 bits (187), Expect = 9e-16
 Identities = 66/211 (31%), Positives = 103/211 (48%), Gaps = 18/211 (8%)

Query: 49  LGEGGFGSVYWGRTSDG---LQIAVKKLK-AMNSKAEME-FAVEVEVLGRVRHKNLLGLR 103
           LGEG FGSV  G+ +     L++AVK +K A+ +++EME F  E   +    H N++ L 
Sbjct: 7   LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66

Query: 104 GYCAGTDQR------LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRM--KIAIGSAEGIL 155
           G C  T +       +++  +M +  L S L     G+       +M  K     A G+ 
Sbjct: 67  GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126

Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRV-KGTLGYLAP 214
           YL    +   IHRD+ A N +L+ +    VADFG +K I  G  +   R+ K  + ++A 
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 215 EYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
           E       +   DV+SFG+ + EI T G+ P
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 76.3 bits (188), Expect = 9e-16
 Identities = 78/277 (28%), Positives = 111/277 (40%), Gaps = 29/277 (10%)

Query: 41  NGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKK--LKAMNSKAEMEFAVEVEVLGRVRHKN 98
               + ++LGEG  GSV   R  +   I   K      N   + +   E+E+    +   
Sbjct: 1   EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60

Query: 99  LLGLRGYCAGTDQR----LIVYDYMPNLSLLSHL-----HGQYAGEVQLDWKRRMKIAIG 149
           ++  + Y A  D+      I  +Y    SL S        G   GE     K   KIA  
Sbjct: 61  IV--KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGE-----KVLGKIAES 113

Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
             +G+ YLH   +  IIHRDIK SN+LL    +  + DFG +    E V+ +     GT 
Sbjct: 114 VLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG---ELVNSLAGTFTGTS 167

Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKF 269
            Y+APE       S + DV+S G+ LLE+   R P    P G            IV    
Sbjct: 168 FYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP--PEGEPPLGPIELLSYIVNMPN 225

Query: 270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPN 306
            EL D    G     + K  I     C++ +P +RP 
Sbjct: 226 PELKDEPGNGIKWSEEFKDFIKQ---CLEKDPTRRPT 259

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 76.1 bits (188), Expect = 1e-15
 Identities = 71/291 (24%), Positives = 121/291 (41%), Gaps = 58/291 (19%)

Query: 47  NKLGEGGFGSVY-WGRTSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
             +G+G FG+V    R SDG  +  K++    M  K + +   EV +L  ++H N++   
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYY 65

Query: 104 G---------------YCAGTD-QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWK--RRMK 145
                           YC G D  +LI                +Y  E  + W+   ++ 
Sbjct: 66  DRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKER---------KYIEEEFI-WRILTQLL 115

Query: 146 IAIGSAEGILYLHH---EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMT 202
           +A       LY  H   +    ++HRD+K +N+ LD++    + DFG AK++    S   
Sbjct: 116 LA-------LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAK 168

Query: 203 TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEP 262
           T V GT  Y++PE        E  D++S G L+ E+     P         R   + A  
Sbjct: 169 TYV-GTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT------ARNQLQLAS- 220

Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT 313
            I +GKF+ +  P         +L + I      +  +P+KRP+ +E++  
Sbjct: 221 KIKEGKFRRI--PYRYSS----ELNEVIK---SMLNVDPDKRPSTEELLQL 262

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 76/278 (27%), Positives = 124/278 (44%), Gaps = 37/278 (13%)

Query: 49  LGEGGFGSVYWG-RTSDG----LQIAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLLGL 102
           LG G FG+VY G    DG    + +A+K L+   S KA  E   E  V+  V    +  L
Sbjct: 15  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74

Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHLH---GQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            G C  +  +L V   MP   LL ++     +   +  L+W       +  A+G+ YL  
Sbjct: 75  LGICLTSTVQL-VTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMSYLE- 126

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP-EGVSHMTTRVKGTLGYLAPEYAM 218
           EV   ++HRD+ A NVL+ S     + DFG A+L+  +   +     K  + ++A E  +
Sbjct: 127 EV--RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184

Query: 219 WGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL 277
             + +   DV+S+G+ + E++T G KP + +P    R I +  E      K + L  P  
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPA---REIPDLLE------KGERLPQPP- 234

Query: 278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
                         + V C   + E RP  +E+V+  +
Sbjct: 235 ------ICTIDVYMIMVKCWMIDSECRPRFRELVDEFS 266

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 65/232 (28%), Positives = 109/232 (46%), Gaps = 21/232 (9%)

Query: 43  FSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-AMNSKAEMEFAVEVEVLGRVRH 96
           F     LG G FG+VY   W    + ++I  A+K+L+ A + KA  E   E  V+  V +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLH---GQYAGEVQLDWKRRMKIAIGSAEG 153
            ++  L G C  +  +LI    MP   LL ++         +  L+W       +  A+G
Sbjct: 69  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 121

Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYL 212
           + YL       ++HRD+ A NVL+ +     + DFG AKL+  +   +     K  + ++
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178

Query: 213 APEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPL 263
           A E  +    +   DV+S+G+ + E++T G KP + +P     +I E  E L
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 230

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 76.5 bits (188), Expect = 1e-15
 Identities = 62/229 (27%), Positives = 104/229 (45%), Gaps = 43/229 (18%)

Query: 48  KLGEGGFGSVYWG-----------------RTSDGLQIAVKKLKAMNSK-AEMEFAVEVE 89
           KLGEG FG V+                   R    L +AVK L+   +K A  +F  EV+
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSL---LSHLH------------GQYAG 134
           +L R++  N++ L G C   D   ++ +YM N  L   LS  H                 
Sbjct: 72  ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131

Query: 135 EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI 194
              + +   + +A+  A G+ YL    + + +HRD+   N L+  +    +ADFG ++ +
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSRNL 188

Query: 195 PEGVSHMTTRVKG----TLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
             G  +   R++G     + ++A E  + GK + + DV++FG+ L EIL
Sbjct: 189 YAGDYY---RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 71/235 (30%), Positives = 110/235 (46%), Gaps = 32/235 (13%)

Query: 46  DNKLGEGGFGSVYWGRTS-DGLQI--AVKKLKAMNSKAE-MEFAVEVEVLGRV-RHKNLL 100
           ++ +GEG FG V       DGL++  A+K LK   S+ +  +FA E+EVL ++  H N++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ------------LDWKRRMKIAI 148
            L G C       I  +Y P  +LL  L      E              L  ++ ++ A 
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126

Query: 149 GSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT 208
             A G+ YL  +     IHRD+ A NVL+  +    +ADFG ++   E V    T  +  
Sbjct: 127 DVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMGRLP 181

Query: 209 LGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP---------IEKLPGGVK 253
           + ++A E   +   +   DV+SFG+LL EI++ G  P          EKLP G +
Sbjct: 182 VRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 236

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 24/211 (11%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKL----KAMNSKAEMEFAVEVEVLGRVRHK 97
           FSD  ++G G FG+VY+ R   +   +A+KK+    K  N K + +   EV  L ++RH 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ-DIIKEVRFLQKLRHP 75

Query: 98  NLLGLRGYCAGTDQRLIVYDY-MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
           N +  RG         +V +Y + + S L  +H +   EV++       +  G+ +G+ Y
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAVTHGALQGLAY 130

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
           LH     ++IHRD+KA N+LL       + DFG A ++      +     GT  ++APE 
Sbjct: 131 LHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEV 182

Query: 217 AMW---GKVSESCDVYSFGILLLEILTGRKP 244
            +    G+     DV+S GI  +E L  RKP
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 75.7 bits (186), Expect = 1e-15
 Identities = 72/285 (25%), Positives = 120/285 (42%), Gaps = 33/285 (11%)

Query: 47  NKLGEGGFGSVYWGRTSDGL---QIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGL 102
           +++G G FG V  G    G+   ++ VK+L+A      ++ F  EV+    + H N+L  
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHL---HGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            G C  +   L+V ++ P   L ++L    G  A   Q D  +RM   +  A G+L+LH 
Sbjct: 61  LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV--ASGLLWLHQ 118

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFA-KLIPEGVSHMTTRVKGTLGYLAPEYA- 217
                 IH D+   N  L +D    + D+G A +  PE            L +LAPE   
Sbjct: 119 A---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVE 175

Query: 218 ------MWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFK 270
                 +    ++  +++S G+ + E+ T   +P   L         E     +V+ +  
Sbjct: 176 IRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLS-------DEQVLKQVVREQDI 228

Query: 271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
           +L  P+L   + +   +    V   C    PE RP  +EV   LT
Sbjct: 229 KLPKPQLDLKYSDRWYE----VMQFCWLD-PETRPTAEEVHELLT 268

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 74.9 bits (185), Expect = 2e-15
 Identities = 58/232 (25%), Positives = 100/232 (43%), Gaps = 55/232 (23%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKL--KAMNSKAEMEFA-VEVEVLGRV-RHKNLLGLR 103
           +GEG F +V   +      + A+K L  + +  + ++++  +E EVL R+  H  ++ L 
Sbjct: 9   IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKL- 67

Query: 104 GYCAGTDQRLI--VYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAIGSA 151
            Y    D+  +  V +Y PN  LL ++             YA E+               
Sbjct: 68  -YYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEI--------------L 112

Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK----- 206
             + YLH   +  IIHRD+K  N+LLD D    + DFG AK++    S  + +       
Sbjct: 113 LALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169

Query: 207 --------------GTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
                         GT  Y++PE        +S D+++ G ++ ++LTG+ P
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 69/211 (32%), Positives = 105/211 (49%), Gaps = 24/211 (11%)

Query: 43  FSDDNKLGEGGFGSVYWGRTSDGLQI-AVKKL----KAMNSKAEMEFAVEVEVLGRVRHK 97
           F+D  ++G G FG+VY+ R     ++ A+KK+    K  N K + +   EV  L ++RH 
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQ-DIIKEVRFLQQLRHP 75

Query: 98  NLLGLRGYCAGTDQRLIVYDY-MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
           N +  +G         +V +Y + + S +  +H +   EV++       I  G+ +G+ Y
Sbjct: 76  NTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEI-----AAICHGALQGLAY 130

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPE- 215
           LH       IHRDIKA N+LL       +ADFG A L+    S +     GT  ++APE 
Sbjct: 131 LHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEV 182

Query: 216 -YAM-WGKVSESCDVYSFGILLLEILTGRKP 244
             AM  G+     DV+S GI  +E L  RKP
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIE-LAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 74.8 bits (184), Expect = 3e-15
 Identities = 61/201 (30%), Positives = 86/201 (42%), Gaps = 13/201 (6%)

Query: 49  LGEGGFGSVYWGRTSD-GLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG+GGFG V   +    G   A KKL   +    K E     E ++L +V  + ++ L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59

Query: 105 YCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           Y   T   L +V   M    L    H    GE      R +  A     G+ +LH     
Sbjct: 60  YAFETKDDLCLVMTLMNGGDL--KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR--- 114

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
            I++RD+K  NVLLD      ++D G A  +  G   +  R  GT GY+APE        
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-KKIKGRA-GTPGYMAPEVLQGEVYD 172

Query: 224 ESCDVYSFGILLLEILTGRKP 244
            S D ++ G  L E++ GR P
Sbjct: 173 FSVDWFALGCTLYEMIAGRSP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 74.8 bits (184), Expect = 3e-15
 Identities = 64/208 (30%), Positives = 93/208 (44%), Gaps = 20/208 (9%)

Query: 49  LGEGGFGSVYW----GRTSDGLQIAVKKLK----AMNSKAEMEFAVEVEVLGRVRHKNLL 100
           LG G +G V+     G    G   A+K LK       +K       E +VL  VR    L
Sbjct: 8   LGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFL 67

Query: 101 GLRGYCAGTDQRL-IVYDYMPNLSLLSHL-HGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
               Y   TD +L ++ DY+    L +HL   ++  E        +++ I   E +L L 
Sbjct: 68  VTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTE------SEVRVYIA--EIVLALD 119

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM 218
           H     II+RDIK  N+LLDS+   ++ DFG +K              GT+ Y+APE   
Sbjct: 120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR 179

Query: 219 WGKV--SESCDVYSFGILLLEILTGRKP 244
            G     ++ D +S G+L  E+LTG  P
Sbjct: 180 GGSGGHDKAVDWWSLGVLTFELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 75.1 bits (185), Expect = 4e-15
 Identities = 67/216 (31%), Positives = 95/216 (43%), Gaps = 39/216 (18%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLK--AMNSKAEMEFA-VEVEVLGRV-RHKNLLGLR 103
           LG+G FG V         ++ AVK LK   +    ++E    E  VL    +H  L  L 
Sbjct: 3   LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62

Query: 104 GYCAGTDQRL-IVYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAIGSAE 152
             C  T  RL  V +Y+    L+ H+             YA E+ L              
Sbjct: 63  S-CFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVL-------------- 107

Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           G+ +LH      II+RD+K  NVLLDS+    +ADFG  K   EG+     T+   GT  
Sbjct: 108 GLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILGGVTTSTFCGTPD 161

Query: 211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
           Y+APE   +     + D ++ G+LL E+L G+ P E
Sbjct: 162 YIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFE 197

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 74.2 bits (182), Expect = 5e-15
 Identities = 63/201 (31%), Positives = 99/201 (49%), Gaps = 13/201 (6%)

Query: 49  LGEGGFGSVYWGRTSD-GLQIAVKKL--KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           LG+GGFG V   +  + G   A KKL  K +  K+  + A+ E E+L +V    ++ L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNL-A 59

Query: 105 YCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           Y   +   L +V   M    L  H++    GE  L+ +R +  +     GIL+LH   + 
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIY--NVGERGLEMERVIHYSAQITCGILHLH---SM 114

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
            I++RD+K  NVLLD      ++D G A  + +G +   T+  GT GY+APE       S
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYS 172

Query: 224 ESCDVYSFGILLLEILTGRKP 244
              D ++ G  + E++ GR P
Sbjct: 173 YPVDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 75.1 bits (184), Expect = 5e-15
 Identities = 81/292 (27%), Positives = 131/292 (44%), Gaps = 47/292 (16%)

Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           + +  + +AVK LK   +  ++ +   E+E++  + +HKN
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQ------YA------GEVQLDWKRRMKI 146
           ++ L G C       ++ +Y    +L  +L  +      Y+       E QL +K  +  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
           A   A G+ YL    +   IHRD+ A NVL+  D    +ADFG A+ +   + +      
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV-HNIDYYKKTTN 195

Query: 207 GTL--GYLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP 262
           G L   ++APE A++ +V +   DV+SFG+LL EI T G  P   +P             
Sbjct: 196 GRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP------------- 241

Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
             V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L
Sbjct: 242 --VEELFK-LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 73.7 bits (181), Expect = 5e-15
 Identities = 69/274 (25%), Positives = 112/274 (40%), Gaps = 39/274 (14%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKL--KAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           K+GEG FG     +   DG Q  +K++    M+ K   E   EV VL  ++H N++  + 
Sbjct: 7   KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQ----YAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
                    IV DY     L   ++ Q    +  +  LDW  ++ +A         L H 
Sbjct: 67  SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLA---------LKHV 117

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
               I+HRDIK+ N+ L  D    + DFG A+++   V    T + GT  YL+PE     
Sbjct: 118 HDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENR 176

Query: 221 KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGD 280
             +   D+++ G +L E+ T +   E                    G  K LV   +RG 
Sbjct: 177 PYNNKSDIWALGCVLYEMCTLKHAFE-------------------AGNMKNLVLKIIRGS 217

Query: 281 FDENQLKQAINVAVLCVQ---SEPEKRPNMKEVV 311
           +       + ++  L  Q     P  RP++  ++
Sbjct: 218 YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 74.7 bits (183), Expect = 5e-15
 Identities = 66/211 (31%), Positives = 106/211 (50%), Gaps = 24/211 (11%)

Query: 43  FSDDNKLGEGGFGSVYWGRTSDGLQI-AVKKL----KAMNSKAEMEFAVEVEVLGRVRHK 97
           F   +++G G FG+VY+   S   ++ AVKK+    K  N K + +   EV+ L +++H 
Sbjct: 23  FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQ-DIIKEVKFLQQLKHP 81

Query: 98  NLLGLRGYCAGTDQRLIVYDY-MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
           N +  +G         +V +Y + + S L  +H +   EV++       I  G+ +G+ Y
Sbjct: 82  NTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAITHGALQGLAY 136

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
           LH   + ++IHRDIKA N+LL    +  +ADFG A       S +     GT  ++APE 
Sbjct: 137 LH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFV-----GTPYWMAPEV 188

Query: 217 AMW---GKVSESCDVYSFGILLLEILTGRKP 244
            +    G+     DV+S GI  +E L  RKP
Sbjct: 189 ILAMDEGQYDGKVDVWSLGITCIE-LAERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 74.3 bits (183), Expect = 6e-15
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 15/207 (7%)

Query: 48  KLGEGGFGSVYWGRTSDGLQI-AVKKLK-AMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           K+GEG +G VY  R     +I A+KK+K    S+   + A+ E+++L  + H N++ L  
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                    +V+++M   + L  L         L             +G+ + H      
Sbjct: 66  VFRHKGDLYLVFEFM--DTDLYKLIKDRQRG--LPESLIKSYLYQLLQGLAFCHSH---G 118

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
           I+HRD+K  N+L++++    +ADFG A+     V   T  V  T  Y APE  +  K  S
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV-VTRWYRAPELLLGDKGYS 177

Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPG 250
              D++S G +  E+L+ R P+   PG
Sbjct: 178 TPVDIWSVGCIFAELLSRR-PL--FPG 201

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 73.8 bits (181), Expect = 7e-15
 Identities = 77/299 (25%), Positives = 122/299 (40%), Gaps = 50/299 (16%)

Query: 46  DNKLGEGGFGSVYWGRTSD--GL----QIAVKKLKAMNSKAE-MEFAVEVEVLGRVRHKN 98
              LGEG FG V         G      +AVK LK   S +E  +   E  +L +V H +
Sbjct: 5   GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPH 64

Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQ--------------------YAGEVQL 138
           ++ L G C+     L++ +Y    SL S L                          E  L
Sbjct: 65  VIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 139 DWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV 198
                +  A   + G+ YL       ++HRD+ A NVL+    +  ++DFG ++ + E  
Sbjct: 125 TMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEED 181

Query: 199 SHMTTRVKGTL--GYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRT 255
           S++  R KG +   ++A E       +   DV+SFG+LL EI+T G  P           
Sbjct: 182 SYV-KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY---------- 230

Query: 256 ITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                 P I   +   L+    R +  EN  ++  N+ + C + EP+KRP   ++   L
Sbjct: 231 ------PGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 74.3 bits (183), Expect = 8e-15
 Identities = 64/219 (29%), Positives = 90/219 (41%), Gaps = 48/219 (21%)

Query: 49  LGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVL----------GRVRHK 97
           LG G FG V        G   A+K LK    K ++    EVE L             RH 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALK----KGDIIARDEVESLMCEKRIFETANSERHP 62

Query: 98  NLLGLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQ---------YAGEVQLDWKRRMKIA 147
            L+ L   C  T+  +  V +Y     L+ H+H           YA  V L         
Sbjct: 63  FLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVL--------- 112

Query: 148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRV 205
                G+ YLH      I++RD+K  N+LLD++    +ADFG  K   EG+     T+  
Sbjct: 113 -----GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGFGDRTSTF 161

Query: 206 KGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
            GT  +LAPE       + + D +  G+L+ E+L G  P
Sbjct: 162 CGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 73.8 bits (181), Expect = 8e-15
 Identities = 57/200 (28%), Positives = 98/200 (49%), Gaps = 14/200 (7%)

Query: 48  KLGEGGFGSVYWG-RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG-LRGY 105
           K+G+G  G+VY     + G ++A+K++       +     E+ V+   +H N++  L  Y
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85

Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
             G D+  +V +Y+   SL          E  +D  +   +     + + +LH   +  +
Sbjct: 86  LVG-DELWVVMEYLAGGSLTD-----VVTETCMDEGQIAAVCRECLQALEFLH---SNQV 136

Query: 166 IHRDIKASNVLLDSDFEPLVADFGF-AKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
           IHRDIK+ N+LL  D    + DFGF A++ PE  S  +T V GT  ++APE         
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-SKRSTMV-GTPYWMAPEVVTRKAYGP 194

Query: 225 SCDVYSFGILLLEILTGRKP 244
             D++S GI+ +E++ G  P
Sbjct: 195 KVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 79/269 (29%), Positives = 111/269 (41%), Gaps = 58/269 (21%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLKA---MNSKAEMEFAVEVEVL-GRVRHKNLLGLR 103
           +G+G FG V   +  +DG   AVK L+    +  K +     E  VL   V+H  L+GL 
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAIGSAEG 153
                 D+   V DY+    L  HL  +          YA E            I SA G
Sbjct: 63  YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAE------------IASALG 110

Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLGY 211
             YLH   + +II+RD+K  N+LLDS    ++ DFG  K   EG+ H   T+   GT  Y
Sbjct: 111 --YLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCK---EGIEHSKTTSTFCGTPEY 162

Query: 212 LAPEYAMWGKVSESCDVYSFGILLLEILTG-----------------RKPIEKLPGGVKR 254
           LAPE         + D +  G +L E+L G                  KP+ +L   +  
Sbjct: 163 LAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL-RLKPNISV 221

Query: 255 TITEWAEPLIVKGKFKELVDPKLRGDFDE 283
           +     E L+ K + K L     + DF E
Sbjct: 222 SARHLLEGLLQKDRTKRL---GAKDDFLE 247

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 55/202 (27%), Positives = 98/202 (48%), Gaps = 17/202 (8%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKK--LKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           ++GEG  G V+  +    G  +A+KK  L+ +      +   E++ L   +H  ++ L  
Sbjct: 7   RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66

Query: 105 -YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
            +  G+   L V +YMP+  L   L  +     +   K  M++ +   +G+ Y+H     
Sbjct: 67  VFPHGSGFVL-VMEYMPS-DLSEVLRDEERPLPEAQVKSYMRMLL---KGVAYMHAN--- 118

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWG-- 220
            I+HRD+K +N+L+ +D    +ADFG A+L   E     + +V  T  Y APE  ++G  
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQV-ATRWYRAPEL-LYGAR 176

Query: 221 KVSESCDVYSFGILLLEILTGR 242
           K     D+++ G +  E+L G 
Sbjct: 177 KYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 68/265 (25%), Positives = 114/265 (43%), Gaps = 43/265 (16%)

Query: 49  LGEGGFGSVYWGRTSD-GLQIAVKKLK-----AMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
           LG+G FG VY    +D G ++AVK+++        SK       E+++L  + H+ ++  
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 103 RGYCAGTDQRL--IVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
            G      +R   I  ++MP  S+   L  +G     V   + R++       EG+ YLH
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQI------LEGVSYLH 123

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP----EGVSHMTTRVKGTLGYLAP 214
              +  I+HRDIK +N+L DS     + DFG +K +      G    +  V GT  +++P
Sbjct: 124 ---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKS--VTGTPYWMSP 178

Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPIE------------------KLPGGVKRTI 256
           E           D++S G  ++E+LT + P                     LP  V    
Sbjct: 179 EVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHC 238

Query: 257 TEWAEPLIVKGKFKELVDPKLRGDF 281
            ++ + + V+ K +   D  LR  F
Sbjct: 239 RDFLKRIFVEAKLRPSADELLRHTF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 72.6 bits (178), Expect = 1e-14
 Identities = 62/273 (22%), Positives = 115/273 (42%), Gaps = 39/273 (14%)

Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           +G G FG V+  R     ++ + K    + M     +    E +VL  + H N++     
Sbjct: 8   VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67

Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQ----YAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
                  +IV +Y P  +L  ++  +       +  L +  ++ +A         LHH  
Sbjct: 68  FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLA---------LHHVH 118

Query: 162 TPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
           T  I+HRD+K  N+LLD     + + DFG +K++          V GT  Y++PE     
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL--SSKSKAYTVVGTPCYISPELCEGK 176

Query: 221 KVSESCDVYSFGILLLEILTGRKPIE--KLPGGVKRTITEWAEPLIVKGKFKELVDPKLR 278
             ++  D+++ G +L E+ + ++  E   LP  V +         I+ G F  +      
Sbjct: 177 PYNQKSDIWALGCVLYELASLKRAFEAANLPALVLK---------IMSGTFAPI------ 221

Query: 279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
            D     L+Q I   +  +  +P KRP + +++
Sbjct: 222 SDRYSPDLRQLI---LSMLNLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 82/314 (26%), Positives = 137/314 (43%), Gaps = 58/314 (18%)

Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           +  + + +AVK LK   ++ ++ +   E+E++  + +HKN
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHG------QYAGEV------QLDWKRRMKI 146
           ++ L G C       ++ +Y    +L  +L        +Y+ ++      Q+ +K  +  
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
               A G+ YL    +   IHRD+ A NVL+  +    +ADFG A+ +   + +      
Sbjct: 143 TYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDV-NNIDYYKKTTN 198

Query: 207 GTL--GYLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP 262
           G L   ++APE A++ +V +   DV+SFG+L+ EI T G  P   +P             
Sbjct: 199 GRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------------- 244

Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGK 322
             V+  FK L+    R D   N   +   +   C  + P  RP  K++V  L        
Sbjct: 245 --VEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL-------- 293

Query: 323 VMQTRIETLAYKEE 336
               RI TL   EE
Sbjct: 294 ---DRILTLTTNEE 304

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 73.5 bits (180), Expect = 2e-14
 Identities = 84/295 (28%), Positives = 129/295 (43%), Gaps = 53/295 (17%)

Query: 49  LGEGGFGSVY----WG----RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V     +G    R    + +AVK LK   +  ++ +   E+E++  + +HKN
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLH------------GQYAGEVQLDWKRRMKI 146
           ++ L G C       ++ +Y    +L   L                  E QL +K  +  
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
           A   A G+ YL    +   IHRD+ A NVL+  D    +ADFG A+    GV  +    K
Sbjct: 140 AYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLAR----GVHDIDYYKK 192

Query: 207 GTLG-----YLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEW 259
            + G     ++APE A++ +V +   DV+SFGIL+ EI T G  P   +P          
Sbjct: 193 TSNGRLPVKWMAPE-ALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP---------- 241

Query: 260 AEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L
Sbjct: 242 -----VEELFK-LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEAL 290

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 68/282 (24%), Positives = 123/282 (43%), Gaps = 31/282 (10%)

Query: 40  TNGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLK---AMNSKAEMEFAVEVEVLGRVR 95
              F  + K+G+G F  VY      DG  +A+KK++    M++KA  +   E+++L ++ 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 96  HKNLLGLRGYCAGTDQRLIVYDYMP--NLS-LLSHLHGQ--YAGEVQLDWKRRMKIAIGS 150
           H N++         ++  IV +     +LS ++ H   Q     E  + WK  +++    
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTI-WKYFVQLCSA- 118

Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG 210
                 L H  +  I+HRDIK +NV + +     + D G  +      +   + V GT  
Sbjct: 119 ------LEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPY 171

Query: 211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK 270
           Y++PE       +   D++S G LL E+   + P      G K  +    +  I K  + 
Sbjct: 172 YMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLYSLCKK-IEKCDY- 225

Query: 271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
               P L  D    +L+  ++    C+  +PEKRP++  V+ 
Sbjct: 226 ----PPLPADHYSEELRDLVSR---CINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 48/173 (27%), Positives = 87/173 (50%), Gaps = 17/173 (9%)

Query: 145 KIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR 204
           KIA+   EG+ YL++     I+HRDIK SN+L++S  +  + DFG +    E ++ +   
Sbjct: 107 KIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSG---ELINSIADT 161

Query: 205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI 264
             GT  Y++PE    GK +   DV+S GI ++E+  G+ P                +P+ 
Sbjct: 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ----DDPMG 217

Query: 265 VKGKFKELVD---PKL-RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT 313
           +    +++V    P+L   DF E+ L+  ++    C+  +P +RP  +++   
Sbjct: 218 ILDLLQQIVQEPPPRLPSSDFPED-LRDFVD---ACLLKDPTERPTPQQLCAM 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 75/272 (27%), Positives = 121/272 (44%), Gaps = 29/272 (10%)

Query: 43  FSDDNKLGEGGFGSVYWGRTSDGLQI-AVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLL 100
           F+   ++G+G FG V+ G  +   Q+ A+K +    ++ E+E    E+ VL +     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 101 GLRG-YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
              G Y  GT +  I+ +Y+   S L  L      E Q+    +  +     +G+ YLH 
Sbjct: 66  KYYGSYLKGT-KLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL-----KGLDYLHS 119

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
           E     IHRDIKA+NVLL    +  +ADFG A  + +      T V GT  ++APE    
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQ 175

Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
                  D++S GI  +E+  G  P   +             P+ V     +   P L G
Sbjct: 176 SAYDSKADIWSLGITAIELAKGEPPNSDM------------HPMRVLFLIPKNNPPTLTG 223

Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
           +F +   K+ I+    C+  +P  RP  KE++
Sbjct: 224 EFSKP-FKEFIDA---CLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 68/204 (33%), Positives = 98/204 (48%), Gaps = 19/204 (9%)

Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLK---AMNSKAEMEFAVEVEVLGR-VRHKNLLGLR 103
           +G+G FG V    R  DG   AVK L+    +N K +     E  VL + V+H  L+GL 
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIA-IGSAEGILYLHHEVT 162
                T++   V D++    L  HL  + +     + + R   A I SA G  YLH   +
Sbjct: 63  YSFQTTEKLYFVLDFVNGGELFFHLQRERSFP---EPRARFYAAEIASALG--YLH---S 114

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLGYLAPEYAMWG 220
            +I++RD+K  N+LLDS    ++ DFG  K   EG++    TT   GT  YLAPE     
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCK---EGIAQSDTTTTFCGTPEYLAPEVIRKQ 171

Query: 221 KVSESCDVYSFGILLLEILTGRKP 244
               + D +  G +L E+L G  P
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 72.6 bits (179), Expect = 3e-14
 Identities = 61/234 (26%), Positives = 106/234 (45%), Gaps = 52/234 (22%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV----EVEVLGRVRHK 97
           +     +G G +G V        G ++A+KK+   N   ++  A     E+++L  +RH+
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHLRHE 59

Query: 98  NLLGLR---GYCAGTDQR--LIVYDYMP-NL-------SLLSHLHGQYAGEVQLDWKRRM 144
           N++GL       +  D     IV + M  +L         L+  H QY            
Sbjct: 60  NIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQY------------ 107

Query: 145 KIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHM 201
                   G+ YLH   + ++IHRD+K SN+L++S+ +  + DFG A+ +    +    +
Sbjct: 108 -FLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL 163

Query: 202 T----TRVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPIEKLPG 250
           T    TR      Y APE  +   + +++ D++S G +  E+LT RKP+   PG
Sbjct: 164 TEYVVTRW-----YRAPELLLSSSRYTKAIDIWSVGCIFAELLT-RKPL--FPG 209

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 71.5 bits (175), Expect = 4e-14
 Identities = 75/273 (27%), Positives = 125/273 (45%), Gaps = 38/273 (13%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVE--VLGRVRHKNLLGLRGY 105
           +G+G +G V   R  +DG Q  +KKL   N+      A E E  +L +++H N++  R  
Sbjct: 8   VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67

Query: 106 CAGTDQRL-IVYDYMPNLSL---LSHLHGQYAGEVQ-LDWKRRMKIAIGSAEGILYLHHE 160
             G D  L IV  +     L   L    G+   E Q ++W  ++ +A+       YLH +
Sbjct: 68  WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ------YLHEK 121

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
              HI+HRD+K  NV L       V D G A+++ E    M + + GT  Y++PE     
Sbjct: 122 ---HILHRDLKTQNVFLTRTNIIKVGDLGIARVL-ENQCDMASTLIGTPYYMSPELFSNK 177

Query: 221 KVSESCDVYSFGILLLEILTGRKPI--EKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR 278
             +   DV++ G  + E+ T +     + +   V R         I++GK      P + 
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYR---------IIEGKL-----PPMP 223

Query: 279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
            D+   +L + I   +L  +  PEKRP++K ++
Sbjct: 224 KDYSP-ELGELIA-TMLSKR--PEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 71.9 bits (176), Expect = 4e-14
 Identities = 61/223 (27%), Positives = 110/223 (49%), Gaps = 37/223 (16%)

Query: 48  KLGEGGFGSVYWGRTSDGLQ------------------IAVKKLKA-MNSKAEMEFAVEV 88
           KLGEG FG V+    ++G++                  +AVK L+   N  A  +F  E+
Sbjct: 12  KLGEGQFGEVHLCE-AEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70

Query: 89  EVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSL---LSHLHGQYAGE----VQLDWK 141
           +++ R++  N++ L   C  +D   ++ +YM N  L   LS    Q A E    V + + 
Sbjct: 71  KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130

Query: 142 RRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM 201
             + +A   A G+ YL    + + +HRD+   N L+  ++   +ADFG ++ +  G  + 
Sbjct: 131 TLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY- 186

Query: 202 TTRVKG----TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT 240
             R++G     + +++ E  + GK + + DV++FG+ L EILT
Sbjct: 187 --RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 72.0 bits (176), Expect = 4e-14
 Identities = 81/295 (27%), Positives = 132/295 (44%), Gaps = 53/295 (17%)

Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           + +   ++AVK LK+  ++ ++ +   E+E++  + +HKN
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQ------------YAGEVQLDWKRRMKI 146
           ++ L G C       ++ +Y    +L  +L  +               E QL +K  +  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
           A   A G+ YL    +   IHRD+ A NVL+  D    +ADFG A+     + H+    K
Sbjct: 146 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKK 198

Query: 207 GTLG-----YLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEW 259
            T G     ++APE A++ ++ +   DV+SFG+LL EI T G  P   +P          
Sbjct: 199 TTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---------- 247

Query: 260 AEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L
Sbjct: 248 -----VEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 71.6 bits (175), Expect = 6e-14
 Identities = 67/204 (32%), Positives = 95/204 (46%), Gaps = 19/204 (9%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLKA---MNSKAEMEFAVEVEVLGR-VRHKNLLGLR 103
           +G+G FG V   R  ++    AVK L+    +  K E     E  VL + V+H  L+GL 
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIA-IGSAEGILYLHHEVT 162
                 D+   V DY+    L  HL  +      L+ + R   A I SA G  YLH   +
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIASALG--YLH---S 114

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLGYLAPEYAMWG 220
            +I++RD+K  N+LLDS    ++ DFG  K   E + H   T+   GT  YLAPE     
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNGTTSTFCGTPEYLAPEVLHKQ 171

Query: 221 KVSESCDVYSFGILLLEILTGRKP 244
               + D +  G +L E+L G  P
Sbjct: 172 PYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 71.2 bits (175), Expect = 6e-14
 Identities = 72/296 (24%), Positives = 121/296 (40%), Gaps = 63/296 (21%)

Query: 45  DDNKLGEGGFGSVY--WGRTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGR-------V 94
           D  ++G G FG+V     + S  + +AVK++++   + E     ++++V+ R       V
Sbjct: 8   DLGEIGRGAFGTVNKMLHKPSGTI-MAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIV 66

Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMP----NLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
           +    L   G C       I  + M           +   +      +  +   KIA+ +
Sbjct: 67  KFYGALFREGDC------WICMELMDISLDKFYKYVYEVLK----SVIPEEILGKIAVAT 116

Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG 210
            + + YL  E+   IIHRD+K SN+LLD +    + DFG +  + + ++   TR  G   
Sbjct: 117 VKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK--TRDAGCRP 172

Query: 211 YLAPEYAMWGKVSESC--------DVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEP 262
           Y+APE     ++  S         DV+S GI L E+ TG+ P  K           W   
Sbjct: 173 YMAPE-----RIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK-----------WNSV 216

Query: 263 L-----IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT 313
                 +VKG       P L    +       +N   LC+  +  KRP  KE++  
Sbjct: 217 FDQLTQVVKGD-----PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 71.8 bits (176), Expect = 7e-14
 Identities = 72/288 (25%), Positives = 114/288 (39%), Gaps = 76/288 (26%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKA-EMEFAVEVEVLGRVRHKNLLGLRG 104
           N++G G  G+VY       G   A+K +   +      +   E+E+L  V H N++    
Sbjct: 80  NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD 139

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQL-DWKRRMKIAIGSAEGILYLHHEVTP 163
                 +  ++ ++M   SL        A E  L D  R++        GI YLH     
Sbjct: 140 MFDHNGEIQVLLEFMDGGSLEGT---HIADEQFLADVARQI------LSGIAYLHRR--- 187

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPE-------- 215
           HI+HRDIK SN+L++S     +ADFG ++++ + +    + V GT+ Y++PE        
Sbjct: 188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSV-GTIAYMSPERINTDLNH 246

Query: 216 -----YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE--------- 261
                YA         D++S G+ +LE   GR P      GV R   +WA          
Sbjct: 247 GAYDGYA--------GDIWSLGVSILEFYLGRFPF-----GVGRQ-GDWASLMCAICMSQ 292

Query: 262 ----PLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRP 305
               P     +F+  +                      C+Q EP KR 
Sbjct: 293 PPEAPATASREFRHFIS--------------------CCLQREPAKRW 320

Length = 353

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 71.0 bits (174), Expect = 7e-14
 Identities = 64/215 (29%), Positives = 104/215 (48%), Gaps = 26/215 (12%)

Query: 47  NKLGEGGFGSVYWGRTSD-GLQIAVKKLKAMNSKAEMEF-AV-EVEVLGRVRHKNLLGLR 103
            ++GEG +G VY  R  D G  +A+KK++  N K      A+ E+++L ++ H+N++ L+
Sbjct: 13  GQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK 72

Query: 104 GYCAGTDQRL----------IVYDYMPN--LSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
                    L          +V++YM +  + LL       +G V               
Sbjct: 73  EIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLE------SGLVHFSEDHIKSFMKQLL 126

Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGY 211
           EG+ Y H +   + +HRDIK SN+LL++  +  +ADFG A+L     S   T    TL Y
Sbjct: 127 EGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWY 183

Query: 212 LAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPI 245
             PE  +   +   + DV+S G +L E+ T +KPI
Sbjct: 184 RPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 71.0 bits (174), Expect = 8e-14
 Identities = 56/199 (28%), Positives = 100/199 (50%), Gaps = 11/199 (5%)

Query: 48  KLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           KLGEG + +VY GR  + G  +A+K++     +     A+ E+ ++  ++H+N++ L   
Sbjct: 7   KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDV 66

Query: 106 CAGTDQRLIVYDYMPN-LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
               ++ ++V++YM   L      HG       LD            +GI + H      
Sbjct: 67  IHTENKLMLVFEYMDKDLKKYMDTHGVRGA---LDPNTVKSFTYQLLKGIAFCHEN---R 120

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
           ++HRD+K  N+L++   E  +ADFG A+     V+  +  V  TL Y AP+  +  +  S
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVLLGSRTYS 179

Query: 224 ESCDVYSFGILLLEILTGR 242
            S D++S G ++ E++TGR
Sbjct: 180 TSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 71.2 bits (174), Expect = 8e-14
 Identities = 85/285 (29%), Positives = 132/285 (46%), Gaps = 39/285 (13%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLKA----MNSKAEMEFAVEVEVLGRV-RHKNLLGL 102
           LG+G FG V+        Q  A+K LK     M+   E    VE  VL     H  L  L
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTM-VEKRVLSLAWEHPFLTHL 61

Query: 103 RGYCA-GTDQRLI-VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
             YC   T + L  V +Y+    L+ H+   +    + D  R    A     G+ +LH  
Sbjct: 62  --YCTFQTKENLFFVMEYLNGGDLMFHIQSCH----KFDLPRATFYAAEIICGLQFLH-- 113

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
            +  I++RD+K  N+LLD+D    +ADFG  K    G +  T    GT  Y+APE  +  
Sbjct: 114 -SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILLGQ 171

Query: 221 KVSESCDVYSFGILLLEILTGRKPI-----EKLPGGVK-------RTITEWAEPLIVKGK 268
           K + S D +SFG+LL E+L G+ P      E+L   ++       R +T  A+ ++VK  
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLF 231

Query: 269 FKELVDPK----LRGDFDENQLKQAINVAVL-CVQSEPEKRPNMK 308
            +E   P+    ++GD  ++   + I+ + L   + EP  +P +K
Sbjct: 232 VRE---PERRLGVKGDIRQHPFFREIDWSALEEREIEPPFKPKVK 273

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 70.5 bits (172), Expect = 9e-14
 Identities = 76/277 (27%), Positives = 119/277 (42%), Gaps = 39/277 (14%)

Query: 43  FSDDNKLGEGGFGSVYWG---RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL 99
           F+   K+G+G FG V+ G   RT   + I +  L+    + E +   E+ VL +     +
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYV 64

Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
               G      +  I+ +Y+   S L  L      E Q+    R  +     +G+ YLH 
Sbjct: 65  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL-----KGLDYLHS 119

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK-----GTLGYLAP 214
           E     IHRDIKA+NVLL    E  +ADFG A  + +      T++K     GT  ++AP
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTD------TQIKRNTFVGTPFWMAP 170

Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD 274
           E           D++S GI  +E+  G  P  +L             P+ V     +   
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL------------HPMKVLFLIPKNNP 218

Query: 275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
           P L G++ +  LK+ +     C+  EP  RP  KE++
Sbjct: 219 PTLEGNYSK-PLKEFVEA---CLNKEPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 71.1 bits (174), Expect = 9e-14
 Identities = 69/206 (33%), Positives = 100/206 (48%), Gaps = 20/206 (9%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKL--KAMNSKAEMEFAV-EVEVLGRVRHKN---LLG 101
           +G+G FG VY  R  D  +I A+K L  K + +K E+   + E  +L R        ++G
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 102 LRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           L+ +   TD  L +V DYM    L  HL  Q  G      + R K  I  AE +L L H 
Sbjct: 61  LK-FSFQTDSDLYLVTDYMSGGELFWHL--QKEGRFS---EDRAKFYI--AELVLALEHL 112

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRV-KGTLGYLAPEYAMW 219
               I++RD+K  N+LLD+     + DFG +K       + TT    GT  YLAPE  + 
Sbjct: 113 HKYDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLD 170

Query: 220 GK-VSESCDVYSFGILLLEILTGRKP 244
            K  ++  D +S G+L+ E+  G  P
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCGWSP 196

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 70/214 (32%), Positives = 96/214 (44%), Gaps = 39/214 (18%)

Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA---MNSKAEMEFAVEVEVLGR-VRHKNLLGLR 103
           +G+G FG V    R SDG   AVK L+    +  K +     E  VL + ++H  L+GL 
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 104 GYCAGTDQRL-IVYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAIGSAE 152
            Y   T ++L  V DY+    L  HL  +          YA EV              A 
Sbjct: 63  -YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEV--------------AS 107

Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK--LIPEGVSHMTTRVKGTLG 210
            I YLH   + +II+RD+K  N+LLDS    ++ DFG  K  + PE     T+   GT  
Sbjct: 108 AIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEET---TSTFCGTPE 161

Query: 211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           YLAPE         + D +  G +L E+L G  P
Sbjct: 162 YLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 70.3 bits (172), Expect = 1e-13
 Identities = 59/202 (29%), Positives = 94/202 (46%), Gaps = 12/202 (5%)

Query: 49  LGEGGFGSVYWG----RTSDGLQIAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLLGLR 103
           LG G FG +  G     +   L +A+  L+A  S K    F  E   LG+  H N++ L 
Sbjct: 13  LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72

Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G     +  +IV +YM N +L S L      E QL   + M +  G A G+ YL      
Sbjct: 73  GVITRGNTMMIVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM--- 126

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
             +H+ + A  VL++SD    ++ F   +       + T   K  + + APE   +   S
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS 186

Query: 224 ESCDVYSFGILLLEILT-GRKP 244
            + DV+SFGI++ E+++ G +P
Sbjct: 187 SASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 71/282 (25%), Positives = 116/282 (41%), Gaps = 57/282 (20%)

Query: 52  GGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFA---VEVEVLGRVRHKNLLGLRGYCA 107
           G +G V+  +  S G   A+K +K  +   + +      E ++L + +   ++ L  Y  
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62

Query: 108 GTDQRL-IVYDYMPN---LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGIL---YLHHE 160
              + L +V +Y+P     SLL ++     G +  D  R     I  AE +L   YLH  
Sbjct: 63  QGKKNLYLVMEYLPGGDLASLLENV-----GSLDEDVAR-----IYIAEIVLALEYLHSN 112

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM-------TTRVKGTLGYLA 213
               IIHRD+K  N+L+DS+    + DFG +K+                 R+ GT  Y+A
Sbjct: 113 ---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169

Query: 214 PEYAMWGKVSESCDVYSFGILLLEILTGRKPI-----EKLPGGVKRTITEWAEPLIVKGK 268
           PE  +    S++ D +S G +L E L G  P      E++   +     EW E       
Sbjct: 170 PEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPE------- 222

Query: 269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEV 310
                        D     +AI++    +  +PEKR   K +
Sbjct: 223 -------------DVEVSDEAIDLISKLLVPDPEKRLGAKSI 251

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 69.8 bits (171), Expect = 1e-13
 Identities = 67/201 (33%), Positives = 99/201 (49%), Gaps = 15/201 (7%)

Query: 49  LGEGGFGSVYWGR--TSDGLQI--AVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGLR 103
           +G+G FG VY G    SDG +I  AVK L  +    E+E F  E  ++    H N+L L 
Sbjct: 3   IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62

Query: 104 GYCAGTD-QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G C  ++   L+V  YM +  L + +  +       D    +   +  A+G+ YL    +
Sbjct: 63  GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDL---IGFGLQVAKGMEYL---AS 116

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLI--PEGVS-HMTTRVKGTLGYLAPEYAMW 219
              +HRD+ A N +LD  F   VADFG A+ I   E  S H  T  K  + ++A E    
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQT 176

Query: 220 GKVSESCDVYSFGILLLEILT 240
            K +   DV+SFG+LL E++T
Sbjct: 177 QKFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 65/238 (27%), Positives = 105/238 (44%), Gaps = 39/238 (16%)

Query: 18  TTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKA- 75
              T P+ ++W++          + F     LG G FG V   +    G   A+K LK  
Sbjct: 5   YMFTKPDTSSWKL----------SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKR 54

Query: 76  --MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQR--LIVYDYMPNLSLLSHLH-- 129
             +  K     A E  +L  + H  ++ +   C+  D+     + +++    L +HL   
Sbjct: 55  EILKMKQVQHVAQEKSILMELSHPFIVNM--MCSFQDENRVYFLLEFVVGGELFTHLRKA 112

Query: 130 GQYAGEVQLDWKRRMKIAIGSAEGIL---YLHHEVTPHIIHRDIKASNVLLDSDFEPLVA 186
           G++  +V   +          AE +L   YLH +    II+RD+K  N+LLD+     V 
Sbjct: 113 GRFPNDVAKFY---------HAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVT 160

Query: 187 DFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           DFGFAK +P+     T  + GT  YLAPE        ++ D ++ G+LL E + G  P
Sbjct: 161 DFGFAKKVPD----RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 69/217 (31%), Positives = 98/217 (45%), Gaps = 41/217 (18%)

Query: 49  LGEGGFGSVYWG--RTSDGLQIAVKKLKA----MNSKAEMEFAVEVEVLGRVRHKNLLGL 102
           LG+G FG V     + +D L  A+K LK      +   E    VE  VL        L  
Sbjct: 8   LGKGSFGKVMLAERKGTDEL-YAIKILKKDVIIQDDDVECTM-VEKRVLALPGKPPFLTQ 65

Query: 103 RGYCAGTDQRL-IVYDYMPNLSLLSHLH--GQ--------YAGEVQLDWKRRMKIAIGSA 151
              C  T  RL  V +Y+    L+ H+   G+        YA E+              A
Sbjct: 66  LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEI--------------A 111

Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL-IPEGVSHMTTRV-KGTL 209
            G+ +LH   +  II+RD+K  NV+LD++    +ADFG  K  I  G    TTR   GT 
Sbjct: 112 IGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK---TTRTFCGTP 165

Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
            Y+APE   +    +S D ++FG+LL E+L G+ P +
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 69.3 bits (169), Expect = 2e-13
 Identities = 72/278 (25%), Positives = 121/278 (43%), Gaps = 43/278 (15%)

Query: 49  LGEGGFGSVYWGRTSD-GLQIAVKKLK-----AMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
           LG+G FG VY     D G ++A K+++        SK       E+++L  ++H+ ++  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 103 RGYCAGTDQRL--IVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
            G      ++   I  +YMP  S+   L  +G     V   + R++       EG+ YLH
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQI------LEGMSYLH 123

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMT--TRVKGTLGYLAPEY 216
             +   I+HRDIK +N+L DS     + DFG +K +       T    V GT  +++PE 
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEV 180

Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK---ELV 273
                     DV+S G  ++E+LT + P              WAE   +   FK   +  
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP--------------WAEYEAMAAIFKIATQPT 226

Query: 274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
           +P+L     E+         + C+  E   RP+ +E++
Sbjct: 227 NPQLPSHISEHARD-----FLGCIFVEARHRPSAEELL 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 66/210 (31%), Positives = 96/210 (45%), Gaps = 11/210 (5%)

Query: 49  LGEGGFGSVYWGRT-SDGLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG+GGFG V   +  + G   A KKL   +    K E     E  +L +V  + ++ L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                D   +V   M    L  H++    G    D +R +  A     G+  L  E    
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---R 122

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
           I++RD+K  N+LLD      ++D G A  IPEG   +  RV GT+GY+APE     K + 
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG-ETVRGRV-GTVGYMAPEVINNEKYTF 180

Query: 225 SCDVYSFGILLLEILTGRKPIEKLPGGVKR 254
           S D +  G L+ E++ G+ P  K    VKR
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFRKRKERVKR 210

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 69.6 bits (170), Expect = 2e-13
 Identities = 74/283 (26%), Positives = 126/283 (44%), Gaps = 36/283 (12%)

Query: 48  KLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNSKAE-MEFAVEVEVLGRVRHKNLL 100
           +LG+G FG VY G   D ++      +AVK +    S  E +EF  E  V+      +++
Sbjct: 13  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHG------QYAGEVQLDWKRRMKIAIGSAEGI 154
            L G  +     L+V + M +  L S+L           G      +  +++A   A+G+
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL--GYL 212
            YL+ +     +HRD+ A N ++  DF   + DFG  + I E   +     KG L   ++
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVRWM 188

Query: 213 APEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKE 271
           APE    G  + S D++SFG++L EI +   +P + L         E     ++ G +  
Sbjct: 189 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-------NEQVLKFVMDGGYL- 240

Query: 272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                   D  +N  ++  ++  +C Q  P+ RP   E+VN L
Sbjct: 241 --------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 69.2 bits (169), Expect = 3e-13
 Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 11/210 (5%)

Query: 49  LGEGGFGSVYWGRT-SDGLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG+GGFG V   +  + G   A K+L   +    K E     E ++L +V  + ++ L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAY 67

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                D   +V   M    L  H++    G    + +R +  A     G+  LH E   +
Sbjct: 68  AYETKDALCLVLTIMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---N 122

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
            ++RD+K  N+LLD      ++D G A  IPEG S +  RV GT+GY+APE     + + 
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-IRGRV-GTVGYMAPEVLNNQRYTL 180

Query: 225 SCDVYSFGILLLEILTGRKPIEKLPGGVKR 254
           S D +  G L+ E++ G+ P       VKR
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKR 210

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 62/244 (25%), Positives = 105/244 (43%), Gaps = 60/244 (24%)

Query: 46  DNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAE------------MEFAV--EVEV 90
              LGEG +G V     T  G  +A+KK+K +    +            + F    E+++
Sbjct: 14  GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKI 73

Query: 91  LGRVRHKNLLGLRG-YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIG 149
           +  ++H+N++GL   Y  G D   +V D M             A +++    R++++   
Sbjct: 74  MNEIKHENIMGLVDVYVEG-DFINLVMDIM-------------ASDLKKVVDRKIRLTES 119

Query: 150 SAEGILY--------LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK--------- 192
             + IL         LH     + +HRD+  +N+ ++S     +ADFG A+         
Sbjct: 120 QVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176

Query: 193 -----LIPEGVSHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIE 246
                   +    MT++V  TL Y APE  M   K   + D++S G +  E+LTG KP+ 
Sbjct: 177 TLSKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG-KPL- 233

Query: 247 KLPG 250
             PG
Sbjct: 234 -FPG 236

Length = 335

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 51/197 (25%), Positives = 87/197 (44%), Gaps = 42/197 (21%)

Query: 145 KIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA-KLIPEGVSHMTT 203
           KI+I    G+ YL  +    I+HRD+K SN+L++S  E  + DFG + +LI      M  
Sbjct: 103 KISIAVLRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMAN 156

Query: 204 RVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI--------------EKLP 249
              GT  Y++PE       +   D++S G+ L+E+  GR PI                  
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSE 216

Query: 250 GGVKRTITEWA-------EPLIVKGKFKELVD-------PKLRGDFDENQLKQAINVAVL 295
           G  K +    +        P+ +   F EL+D       PKL      ++ +  ++    
Sbjct: 217 GEAKESHRPVSGHPPDSPRPMAI---F-ELLDYIVNEPPPKLPSGAFSDEFQDFVDK--- 269

Query: 296 CVQSEPEKRPNMKEVVN 312
           C++  P++R ++KE+  
Sbjct: 270 CLKKNPKERADLKELTK 286

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 68.7 bits (168), Expect = 4e-13
 Identities = 73/263 (27%), Positives = 115/263 (43%), Gaps = 30/263 (11%)

Query: 49  LGEGGFGSVYWGRT-SDGLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG+GGFG V   +  + G   A KKL   +    K E     E ++L +V  + ++ L  
Sbjct: 8   LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                D   +V   M    L  H++    G    D +R +  A     G+  LH E    
Sbjct: 68  AYETKDALCLVLTLMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---R 122

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
           I++RD+K  N+LLD      ++D G A  IPEG   +  RV GT+GY+APE     + + 
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG-ETIRGRV-GTVGYMAPEVVKNERYTF 180

Query: 225 SCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN 284
           S D +  G L+ E++ G+ P  +    VKR                E V+ +++ D +E 
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFRQRKEKVKR----------------EEVERRVKEDQEEY 224

Query: 285 QLK---QAINVAVLCVQSEPEKR 304
             K    A ++    +  +P  R
Sbjct: 225 SEKFSEAARSICRQLLTKDPGFR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 69.0 bits (169), Expect = 4e-13
 Identities = 63/217 (29%), Positives = 100/217 (46%), Gaps = 24/217 (11%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLK---AMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           +G G FG V+  R        A+K +     +  K E     E  VL  V H  ++ L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66

Query: 105 YCAGTDQRLI--VYDYMPNLSLLSHLH--GQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           +    DQR +  + +Y+P   L S+L   G+++    L +   +  A+       YLH  
Sbjct: 67  FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALE------YLH-- 118

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
            +  I++RD+K  N+LLD +    + DFGFAK     +   T  + GT  YLAPE     
Sbjct: 119 -SKEIVYRDLKPENILLDKEGHIKLTDFGFAK----KLRDRTWTLCGTPEYLAPEVIQSK 173

Query: 221 KVSESCDVYSFGILLLEILTGRKPI-EKLPGGVKRTI 256
             +++ D ++ GIL+ E+L G  P  +  P G+   I
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI 210

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 68.9 bits (169), Expect = 4e-13
 Identities = 66/234 (28%), Positives = 104/234 (44%), Gaps = 39/234 (16%)

Query: 48  KLGEGGFGSVYWGRTSDGLQ------------------IAVKKLKA-MNSKAEMEFAVEV 88
           KLGEG FG V+     DGLQ                  +AVK L+   +  A  +F  EV
Sbjct: 12  KLGEGQFGEVHLCEA-DGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70

Query: 89  EVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLH-------GQYAGEVQLDWK 141
           ++L R+   N+  L G C       ++ +YM N  L   L        G       L + 
Sbjct: 71  KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFS 130

Query: 142 RRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM 201
             + +A   A G+ YL    + + +HRD+   N L+  ++   +ADFG ++ +     + 
Sbjct: 131 TLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY- 186

Query: 202 TTRVKGT----LGYLAPEYAMWGKVSESCDVYSFGILLLEILT--GRKPIEKLP 249
             RV+G     + ++A E  + GK +   DV++FG+ L EILT    +P E L 
Sbjct: 187 --RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT 238

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 68.5 bits (167), Expect = 4e-13
 Identities = 60/208 (28%), Positives = 96/208 (46%), Gaps = 21/208 (10%)

Query: 49  LGEGGFGSVYWGRTSD-GLQIAVKKL-----KAMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
           LG G FG VY    +D G ++AVK++         SK       E+++L  +RH  ++  
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 103 RGYCAGTDQR--LIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
            G     +++   I  +YMP  S+   L  +G     V   + R++       +G+ YLH
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQI------LQGVSYLH 123

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMT--TRVKGTLGYLAPEY 216
             +   I+HRDIK +N+L DS     + DFG +K I       T    V GT  +++PE 
Sbjct: 124 SNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEV 180

Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKP 244
                     DV+S    ++E+LT + P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 68.5 bits (167), Expect = 6e-13
 Identities = 60/213 (28%), Positives = 103/213 (48%), Gaps = 25/213 (11%)

Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGLRGYC 106
           +LG+G FG VY  +  +   +A  K+    S+ E+E + VE+E+L    H  ++ L G  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 107 AGTDQRLIVYDYMP----NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
               +  I+ ++ P    +  +L    G    ++Q+  ++ +       E + YLH   +
Sbjct: 79  YWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML-------EALQYLH---S 128

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK--GTLGYLAPEYAMWG 220
             IIHRD+KA NVLL  D +  +ADFG +    + V  +  R    GT  ++APE  M  
Sbjct: 129 MKIIHRDLKAGNVLLTLDGDIKLADFGVSA---KNVKTLQRRDSFIGTPYWMAPEVVMCE 185

Query: 221 KVSES-----CDVYSFGILLLEILTGRKPIEKL 248
            + ++      D++S GI L+E+     P  +L
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 67.7 bits (165), Expect = 7e-13
 Identities = 66/275 (24%), Positives = 126/275 (45%), Gaps = 27/275 (9%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKA---MNSKAEMEFAVEVEVLGRVRHKN 98
           F  + K+G G F  VY      DG+ +A+KK++    M++KA  +   E+++L ++ H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKR---RMKIAIGSAEGIL 155
           ++         ++  IV + + +   LS +   +  + +L  ++   +  + + SA    
Sbjct: 64  VIKYYASFIEDNELNIVLE-LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA---- 118

Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPE 215
            L H  +  ++HRDIK +NV + +     + D G  +      +   + V GT  Y++PE
Sbjct: 119 -LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPE 176

Query: 216 YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP 275
                  +   D++S G LL E+   + P      G K  +    +      K ++   P
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLYSLCK------KIEQCDYP 226

Query: 276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEV 310
            L  D    +L+Q +N   +C+  +PEKRP++  V
Sbjct: 227 PLPSDHYSEELRQLVN---MCINPDPEKRPDITYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 68.2 bits (166), Expect = 7e-13
 Identities = 54/199 (27%), Positives = 94/199 (47%), Gaps = 12/199 (6%)

Query: 48  KLGEGGFGSVYWG-RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG-LRGY 105
           K+G+G  G+VY     + G ++A+K++       +     E+ V+   ++ N++  L  Y
Sbjct: 26  KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85

Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
             G D+  +V +Y+   SL          E  +D  +   +     + + +LH   +  +
Sbjct: 86  LVG-DELWVVMEYLAGGSLTD-----VVTETCMDEGQIAAVCRECLQALDFLH---SNQV 136

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSES 225
           IHRDIK+ N+LL  D    + DFGF   I    S  +T V GT  ++APE          
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195

Query: 226 CDVYSFGILLLEILTGRKP 244
            D++S GI+ +E++ G  P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 67.8 bits (166), Expect = 8e-13
 Identities = 68/276 (24%), Positives = 116/276 (42%), Gaps = 31/276 (11%)

Query: 46  DNKLGEGGFGSVYWG----RTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLL 100
              +GEG FG VY G      ++ + +AVK  K   S +  E F  E  ++ +  H +++
Sbjct: 11  GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70

Query: 101 GLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            L G    T+  + IV +  P   L S+L      +  LD    +  +   +  + YL  
Sbjct: 71  KLIGVI--TENPVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLE- 124

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
             +   +HRDI A NVL+ S     + DFG ++ + +   +  ++ K  + ++APE   +
Sbjct: 125 --SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF 182

Query: 220 GKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR 278
            + + + DV+ FG+ + EIL  G KP + +         E  E L           P L 
Sbjct: 183 RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL----PMPPNCPPTL- 237

Query: 279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                       ++   C   +P KRP   E+   L
Sbjct: 238 -----------YSLMTKCWAYDPSKRPRFTELKAQL 262

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 68.3 bits (167), Expect = 8e-13
 Identities = 69/204 (33%), Positives = 93/204 (45%), Gaps = 19/204 (9%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLKA----MNSKAEMEFAVEVEVLGRV-RHKNLLGL 102
           LG+G FG V         +  A+K LK      +   E    VE  VL     H  L  L
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTM-VERRVLALAWEHPFLTHL 61

Query: 103 RGYCA-GTDQRLI-VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
             +C   T + L  V +Y+    L+ H+  Q +G  + D  R    A     G+ +LH  
Sbjct: 62  --FCTFQTKEHLFFVMEYLNGGDLMFHI--QSSG--RFDEARARFYAAEIICGLQFLH-- 113

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
               II+RD+K  NVLLD D    +ADFG  K    G     +   GT  Y+APE     
Sbjct: 114 -KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG-EGKASTFCGTPDYIAPEILKGQ 171

Query: 221 KVSESCDVYSFGILLLEILTGRKP 244
           K +ES D +SFG+LL E+L G+ P
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 67.4 bits (164), Expect = 9e-13
 Identities = 66/283 (23%), Positives = 124/283 (43%), Gaps = 36/283 (12%)

Query: 48  KLGEGGFGSVYWG------RTSDGLQIAVKKL-KAMNSKAEMEFAVEVEVLGRVRHKNLL 100
           +LG+G FG VY G      +     ++A+K + +A + +  +EF  E  V+      +++
Sbjct: 13  ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHG------QYAGEVQLDWKRRMKIAIGSAEGI 154
            L G  +     L++ + M    L S+L            +     K+ +++A   A+G+
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG--YL 212
            YL+       +HRD+ A N ++  DF   + DFG  + I E   +     KG L   ++
Sbjct: 133 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVRWM 188

Query: 213 APEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKE 271
           +PE    G  +   DV+SFG++L EI T   +P + +         E     +++G   +
Sbjct: 189 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMS-------NEQVLRFVMEGGLLD 241

Query: 272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
             D         N       +  +C Q  P+ RP+  E+++++
Sbjct: 242 KPD---------NCPDMLFELMRMCWQYNPKMRPSFLEIISSI 275

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 67.4 bits (165), Expect = 1e-12
 Identities = 60/198 (30%), Positives = 99/198 (50%), Gaps = 12/198 (6%)

Query: 48  KLGEGGFGSVYWGRTSDGLQI-AVKK-LKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
            +GEG +G V   +  +  QI A+KK L++ + K   + A+ E+ +L ++RH+NL+ L  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                 +  +V++++ + ++L  L     G   LD  R  K       GI + H     +
Sbjct: 68  VFRRKKRLYLVFEFVDH-TVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHSH---N 120

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG-KVS 223
           IIHRDIK  N+L+       + DFGFA+ +       T  V  T  Y APE  +   K  
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-ATRWYRAPELLVGDTKYG 179

Query: 224 ESCDVYSFGILLLEILTG 241
            + D+++ G L+ E+LTG
Sbjct: 180 RAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 61/221 (27%), Positives = 103/221 (46%), Gaps = 30/221 (13%)

Query: 48  KLGEGGFGSVYWGRTS-DGLQ----IAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLG 101
           +LGE  FG +Y G     G+     +A+K LK +N+  +  EF  E  ++  + H N++ 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHL-----HGQYA------GEVQ--LDWKRRMKIAI 148
           L G         ++++Y+    L   L     H          G V+  LD    + IAI
Sbjct: 72  LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131

Query: 149 GSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT 208
             A G+ YL    +   +H+D+ A N+L+       ++D G ++ I    S    RV+  
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREI---YSADYYRVQPK 185

Query: 209 ----LGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
               + ++ PE  M+GK S   D++SFG++L EI + G +P
Sbjct: 186 SLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 66.9 bits (163), Expect = 1e-12
 Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 22/209 (10%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKK--LKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           K+GEG FG +Y  +  SD     +K+  L  M  K +     EV +L +++H N++    
Sbjct: 7   KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---HGQYAGEVQ-LDWKRRMKIAIGSAEGILYLHHE 160
                 +  IV +Y     L+  +    G    E Q L W   ++I++G       L H 
Sbjct: 67  SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISLG-------LKHI 117

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVA---DFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
               I+HRDIK+ N+ L  +   +VA   DFG A+ + + +    T V GT  YL+PE  
Sbjct: 118 HDRKILHRDIKSQNIFLSKN--GMVAKLGDFGIARQLNDSMELAYTCV-GTPYYLSPEIC 174

Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPIE 246
                +   D++S G +L E+ T + P E
Sbjct: 175 QNRPYNNKTDIWSLGCVLYELCTLKHPFE 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 66/278 (23%), Positives = 108/278 (38%), Gaps = 34/278 (12%)

Query: 30  IFTYKELHTATNGFSDDNKLGEGGFGSVYWGR------TSDGLQIAVKKL-KAMNSKAEM 82
            F    L   T        LG G FG V+  +            + VK L K  +   + 
Sbjct: 1   AFPRSNLQEIT-------TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS 53

Query: 83  EFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ----- 137
           EF  E+++  ++ HKN++ L G C   +   ++ +Y     L   L    + + +     
Sbjct: 54  EFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP 113

Query: 138 LDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG 197
           L  K+++ +    A G+ +L        +HRD+ A N L+ S  E  V+    +K +   
Sbjct: 114 LSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNS 170

Query: 198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLP-----GG 251
             +        L +LAPE       S   DV+SFG+L+ E+ T G  P   L        
Sbjct: 171 EYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR 230

Query: 252 VKRTITEWAEPLIVKGKFKEL------VDPKLRGDFDE 283
           ++    E   P     +  +L      V+PK R  F E
Sbjct: 231 LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSE 268

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 66/268 (24%), Positives = 123/268 (45%), Gaps = 28/268 (10%)

Query: 48  KLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGL-RGY 105
           K+GEG  G V   R    G Q+AVK +     +       EV ++   +H+N++ + + Y
Sbjct: 28  KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87

Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
             G ++  ++ +++   +L          + +L+ ++   +     + + YLH +    +
Sbjct: 88  LVG-EELWVLMEFLQGGALTD-----IVSQTRLNEEQIATVCESVLQALCYLHSQ---GV 138

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSES 225
           IHRDIK+ ++LL  D    ++DFGF   I + V    + V GT  ++APE          
Sbjct: 139 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVISRTPYGTE 197

Query: 226 CDVYSFGILLLEILTGRKP-IEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN 284
            D++S GI+++E++ G  P     P    + + +   P   K K    + P LR DF E 
Sbjct: 198 VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP---KLKNAHKISPVLR-DFLER 253

Query: 285 QLKQAINVAVLCVQSEPEKRPNMKEVVN 312
            L +           EP++R   +E+++
Sbjct: 254 MLTR-----------EPQERATAQELLD 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 64/267 (23%), Positives = 120/267 (44%), Gaps = 28/267 (10%)

Query: 48  KLGEGGFGSVYWG-RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGL-RGY 105
           K+GEG  G V        G Q+AVKK+     +       EV ++    H+N++ +   Y
Sbjct: 29  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88

Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
             G D+  +V +++   +L   +      E Q+       + +     + YLH      +
Sbjct: 89  LVG-DELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLH---NQGV 139

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSES 225
           IHRDIK+ ++LL SD    ++DFGF   + + V    + V GT  ++APE          
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-GTPYWMAPEVISRLPYGTE 198

Query: 226 CDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
            D++S GI+++E++ G  P    P            PL    + ++ + P+++   D ++
Sbjct: 199 VDIWSLGIMVIEMIDGEPPYFNEP------------PLQAMRRIRDNLPPRVK---DSHK 243

Query: 286 LKQAINVAV-LCVQSEPEKRPNMKEVV 311
           +   +   + L +  EP +R   +E++
Sbjct: 244 VSSVLRGFLDLMLVREPSQRATAQELL 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 67.1 bits (163), Expect = 2e-12
 Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 14/200 (7%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG-LRGY 105
           K+G+G  G+VY     + G ++A++++       +     E+ V+   ++ N++  L  Y
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86

Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
             G D+  +V +Y+   SL          E  +D  +   +     + + +LH   +  +
Sbjct: 87  LVG-DELWVVMEYLAGGSLTD-----VVTETCMDEGQIAAVCRECLQALEFLH---SNQV 137

Query: 166 IHRDIKASNVLLDSDFEPLVADFGF-AKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
           IHRDIK+ N+LL  D    + DFGF A++ PE      + + GT  ++APE         
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 225 SCDVYSFGILLLEILTGRKP 244
             D++S GI+ +E++ G  P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 67.1 bits (163), Expect = 2e-12
 Identities = 53/199 (26%), Positives = 94/199 (47%), Gaps = 12/199 (6%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG-LRGY 105
           K+G+G  G+V+     + G ++A+K++       +     E+ V+  +++ N++  L  +
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85

Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
             G D+  +V +Y+   SL          E  +D  +   +     + + +LH      +
Sbjct: 86  LVG-DELFVVMEYLAGGSLTD-----VVTETCMDEAQIAAVCRECLQALEFLHAN---QV 136

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSES 225
           IHRDIK+ NVLL  D    + DFGF   I    S  +T V GT  ++APE          
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 195

Query: 226 CDVYSFGILLLEILTGRKP 244
            D++S GI+ +E++ G  P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 58/218 (26%), Positives = 101/218 (46%), Gaps = 30/218 (13%)

Query: 48  KLGEGGFGSVYWG---RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLGLR 103
           +LG G FG V  G        + +A+K LK  N K+   E   E E++ ++ +  ++ + 
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT- 162
           G C   +  ++V +      L   L G           ++ +I +     ++ L H+V+ 
Sbjct: 62  GVCEA-EALMLVMEMASGGPLNKFLSG-----------KKDEITV---SNVVELMHQVSM 106

Query: 163 -------PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGYLA 213
                   + +HRD+ A NVLL +     ++DFG +K +    S+   R  G   L + A
Sbjct: 107 GMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYA 166

Query: 214 PEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
           PE   + K S   DV+S+GI + E  + G+KP +K+ G
Sbjct: 167 PECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG 204

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 27/214 (12%)

Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGLRGYC 106
           +LG+G FG VY  +  +   +A  K+    S+ E+E + VE+++L    H N++ L    
Sbjct: 12  ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL---- 67

Query: 107 AGTDQRLIVYDYMPNLSLLSHL-HGQYAGEVQLDWKRRMK------IAIGSAEGILYLHH 159
                 L  + Y  NL +L     G     V L+ +R +       +   + E + YLH 
Sbjct: 68  ------LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHE 121

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
                IIHRD+KA N+L   D +  +ADFG +      +    + + GT  ++APE  M 
Sbjct: 122 N---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMC 177

Query: 220 GKVSE-----SCDVYSFGILLLEILTGRKPIEKL 248
               +       DV+S GI L+E+     P  +L
Sbjct: 178 ETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.4 bits (162), Expect = 3e-12
 Identities = 65/207 (31%), Positives = 103/207 (49%), Gaps = 20/207 (9%)

Query: 49  LGEGGFGSVYWGRT---SDGLQI-AVKKLKAMNSKAE--MEFAVEVEVLGRVRHKNLLGL 102
           LG+G FG V+  R     D  Q+ A+K LK    K    +   +E ++L  V H  ++ L
Sbjct: 4   LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63

Query: 103 RGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
             Y   T+ +L ++ D++    L + L    + EV    +  +K  +  AE  L L H  
Sbjct: 64  H-YAFQTEGKLYLILDFLRGGDLFTRL----SKEVMFT-EEDVKFYL--AELALALDHLH 115

Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM--TTRVKGTLGYLAPEYAMW 219
           +  II+RD+K  N+LLD +    + DFG +K   E + H        GT+ Y+APE    
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNR 172

Query: 220 GKVSESCDVYSFGILLLEILTGRKPIE 246
              ++S D +SFG+L+ E+LTG  P +
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQ 199

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 66.1 bits (161), Expect = 5e-12
 Identities = 64/204 (31%), Positives = 92/204 (45%), Gaps = 15/204 (7%)

Query: 49  LGEGGFGSVYWGRT-SDGLQIAVKKLK--AMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           LG+G FG V   R    G   AVK LK   +    ++E  + E  +L   R+   L    
Sbjct: 3   LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62

Query: 105 YCAGTDQRLI-VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
            C  T  RL  V +++    L+ H+        + D  R    A      +++LH +   
Sbjct: 63  CCFQTPDRLFFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEITSALMFLHDK--- 115

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKL-IPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
            II+RD+K  NVLLD +    +ADFG  K  I  G +  T+   GT  Y+APE       
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKT--TSTFCGTPDYIAPEILQEMLY 173

Query: 223 SESCDVYSFGILLLEILTGRKPIE 246
             S D ++ G+LL E+L G  P E
Sbjct: 174 GPSVDWWAMGVLLYEMLCGHAPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 65.6 bits (160), Expect = 5e-12
 Identities = 53/228 (23%), Positives = 93/228 (40%), Gaps = 40/228 (17%)

Query: 49  LGEGGFGSVYWGR------TSDGLQIAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLLG 101
           +G+G FG V+  R            +AVK LK   S   + +F  E  ++    H N++ 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 102 LRGYCAGTDQRLIVYDYMP--------------NLSLLSHLHGQYA----GEVQLDWKRR 143
           L G CA      ++++YM                   LSH            + L    +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT 203
           + IA   A G+ YL        +HRD+   N L+  +    +ADFG ++ I     +   
Sbjct: 133 LCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI-----YSAD 184

Query: 204 RVKGT------LGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
             K +      + ++ PE   + + +   DV+++G++L EI + G +P
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 66.3 bits (162), Expect = 5e-12
 Identities = 64/211 (30%), Positives = 94/211 (44%), Gaps = 30/211 (14%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLKAMNSKAEME-------FAVEVEVLGRVRHKNLL 100
           +G G FG V   R     Q+ A+K L    SK EM        F  E +++     + ++
Sbjct: 51  IGRGAFGEVQLVRHKSSKQVYAMKLL----SKFEMIKRSDSAFFWEERDIMAHANSEWIV 106

Query: 101 GLRGYCAGTDQRLI--VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
            L  + A  D + +  V +YMP   L++ L   Y  ++   W R       +AE +L L 
Sbjct: 107 QL--HYAFQDDKYLYMVMEYMPGGDLVN-LMSNY--DIPEKWAR-----FYTAEVVLALD 156

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA-KLIPEGVSHMTTRVKGTLGYLAPEYA 217
              +   IHRD+K  N+LLD      +ADFG   K+   G+    T V GT  Y++PE  
Sbjct: 157 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAV-GTPDYISPEVL 215

Query: 218 MW----GKVSESCDVYSFGILLLEILTGRKP 244
                 G     CD +S G+ L E+L G  P
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 18/209 (8%)

Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYC- 106
           +G G +G VY GR     Q+A  K+  +    E E  +E+ +L +   H+N+    G   
Sbjct: 24  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFI 83

Query: 107 ----AGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
                G D +L +V ++    S+   +       ++ DW     IA    E +  L H  
Sbjct: 84  KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDW-----IAYICREILRGLAHLH 138

Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK 221
              +IHRDIK  NVLL  + E  + DFG +  +   V    T + GT  ++APE     +
Sbjct: 139 AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDE 197

Query: 222 VSESC-----DVYSFGILLLEILTGRKPI 245
             ++      D++S GI  +E+  G  P+
Sbjct: 198 NPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 65.4 bits (159), Expect = 7e-12
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 25/205 (12%)

Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLK-----AMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
           +G G +GSV     T  GL++AVKKL       +++K       E+ +L  ++H+N++GL
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR---ELRLLKHMKHENVIGL 81

Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLH 158
                         +   ++ L++HL G     +    +L       +      G+ Y+H
Sbjct: 82  LDVFTPARS----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH 137

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM 218
              +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  +
Sbjct: 138 ---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIML 190

Query: 219 -WGKVSESCDVYSFGILLLEILTGR 242
            W   +++ D++S G ++ E+LTGR
Sbjct: 191 NWMHYNQTVDIWSVGCIMAELLTGR 215

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 65.4 bits (159), Expect = 8e-12
 Identities = 66/203 (32%), Positives = 93/203 (45%), Gaps = 17/203 (8%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLKA----MNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           LG+G FG V        G   AVK LK     ++   E    VE  VL  +  +N     
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTM-VEKRVLA-LAWENPFLTH 60

Query: 104 GYCA--GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
            YC     +    V +++    L+ H+  Q  G  + D  R    A     G+ +LH   
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHI--QDKG--RFDLYRATFYAAEIVCGLQFLH--- 113

Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK 221
           +  II+RD+K  NV+LD D    +ADFG  K    G +  +T   GT  Y+APE     K
Sbjct: 114 SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFC-GTPDYIAPEILQGLK 172

Query: 222 VSESCDVYSFGILLLEILTGRKP 244
            + S D +SFG+LL E+L G+ P
Sbjct: 173 YTFSVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 64.7 bits (158), Expect = 8e-12
 Identities = 60/209 (28%), Positives = 107/209 (51%), Gaps = 15/209 (7%)

Query: 43  FSDDNKLGEGGFGSVYWGRTSDGLQI-AVKKLKAMNSKAE--MEFAV-EVEVLGRVRHKN 98
           ++   K+GEG +G VY GR     QI A+KK++ + S+ E     A+ E+ +L  ++H N
Sbjct: 2   YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIR-LESEEEGVPSTAIREISLLKELQHPN 60

Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           ++ L+       +  ++++++ ++ L  +L     G+  +D +          +GIL+ H
Sbjct: 61  IVCLQDVLMQESRLYLIFEFL-SMDLKKYLDSLPKGQ-YMDAELVKSYLYQILQGILFCH 118

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM 218
                 ++HRD+K  N+L+D+     +ADFG A+     V   T  V  TL Y APE  +
Sbjct: 119 SR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVV-TLWYRAPEVLL 174

Query: 219 WGKVSESC--DVYSFGILLLEILTGRKPI 245
            G    S   D++S G +  E+ T +KP+
Sbjct: 175 -GSPRYSTPVDIWSIGTIFAEMAT-KKPL 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 65.2 bits (159), Expect = 9e-12
 Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 24/208 (11%)

Query: 49  LGEGGFGSVYWGRTSDGLQ----IAVKKLK----AMNSKAEMEFAVEVEVLGRVRHKNLL 100
           LG+GG+G V+  R   G       A+K LK      N K       E  +L  V+H  ++
Sbjct: 4   LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63

Query: 101 GLRGYCAGTDQRL-IVYDYMPNLSLLSHLH--GQYAGEVQLDWKRRMKIAIGSAEGILYL 157
            L  Y   T  +L ++ +Y+    L  HL   G +  +    +   + +A+       +L
Sbjct: 64  DLI-YAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALE------HL 116

Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK-LIPEGVSHMTTRVKGTLGYLAPEY 216
           H +    II+RD+K  N+LLD+     + DFG  K  I EG   +T    GT+ Y+APE 
Sbjct: 117 HQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEYMAPEI 171

Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKP 244
            M     ++ D +S G L+ ++LTG  P
Sbjct: 172 LMRSGHGKAVDWWSLGALMYDMLTGAPP 199

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 71/278 (25%), Positives = 119/278 (42%), Gaps = 38/278 (13%)

Query: 49  LGEGGFGSVYWGRTSDGLQ--IAVKKLKAMN----------SKAEMEFAVEVEVLG-RVR 95
           LG G FG VY  R  +  Q  +A+K++   N           K+  +   EV ++  ++R
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 96  HKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGIL 155
           H N++         D+  IV D +    L  H +     + +   +R   I +     + 
Sbjct: 68  HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127

Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPE 215
           YLH E    I+HRD+  +N++L  D +  + DFG AK      S +T+ V GT+ Y  PE
Sbjct: 128 YLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE-SKLTSVV-GTILYSCPE 183

Query: 216 YAMWGKVSESCDVYSFGILLLEILTGRKPI---EKLPGGVKRTITEWAEPLIVKGKFKEL 272
                   E  DV++FG +L ++ T + P      L    K          IV+  ++ L
Sbjct: 184 IVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATK----------IVEAVYEPL 233

Query: 273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEV 310
            +    G + E       +V   C+  + E RP++ +V
Sbjct: 234 PE----GMYSE----DVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 39/97 (40%), Positives = 58/97 (59%), Gaps = 6/97 (6%)

Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL-IPEGVSHMTTRVKGTL 209
           A G+ +LH   +  II+RD+K  NV+LDS+    +ADFG  K  + +GV+  T    GT 
Sbjct: 111 AIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVT--TKTFCGTP 165

Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
            Y+APE   +    +S D ++FG+LL E+L G+ P E
Sbjct: 166 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 65/205 (31%), Positives = 95/205 (46%), Gaps = 17/205 (8%)

Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA----MNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           LG+G FG V    R       A+K LK      +   E    VE  VL        L   
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTM-VEKRVLALQDKPPFLTQL 66

Query: 104 GYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
             C  T  RL  V +Y+    L+ H+  Q  G+ +    + +  A   + G+ +LH    
Sbjct: 67  HSCFQTVDRLYFVMEYVNGGDLMYHI--QQVGKFK--EPQAVFYAAEISVGLFFLHRR-- 120

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRV-KGTLGYLAPEYAMWGK 221
             II+RD+K  NV+LDS+    +ADFG  K     V  +TTR   GT  Y+APE   +  
Sbjct: 121 -GIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQP 177

Query: 222 VSESCDVYSFGILLLEILTGRKPIE 246
             +S D +++G+LL E+L G+ P +
Sbjct: 178 YGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 72/272 (26%), Positives = 114/272 (41%), Gaps = 29/272 (10%)

Query: 43  FSDDNKLGEGGFGSVYWG---RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL 99
           F+   ++G+G FG VY G   RT + + I +  L+    + E +   E+ VL +     +
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIE-DIQQEITVLSQCDSPYI 64

Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
               G      +  I+ +Y+   S L  L      E  +    R  +     +G+ YLH 
Sbjct: 65  TRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREIL-----KGLDYLHS 119

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
           E     IHRDIKA+NVLL    +  +ADFG A  + +      T V GT  ++APE    
Sbjct: 120 E---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQ 175

Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
                  D++S GI  +E+  G  P   L             P+ V     +   P L G
Sbjct: 176 SAYDFKADIWSLGITAIELAKGEPPNSDL------------HPMRVLFLIPKNSPPTLEG 223

Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
            + +   K+ +     C+  +P  RP  KE++
Sbjct: 224 QYSK-PFKEFVEA---CLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 63/229 (27%), Positives = 105/229 (45%), Gaps = 17/229 (7%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLKAMN--SKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           +G+G FG V   R  D  +I A+K ++  +  S++E+   + E  VL +V    ++ L+ 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                ++  +V  ++    L  HL  Q  G   L   R       +AE +  L +    +
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHL--QREGRFDLSRAR-----FYTAELLCALENLHKFN 113

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
           +I+RD+K  N+LLD      + DFG  KL  +     T    GT  YLAPE  +    ++
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKD-DDKTNTFCGTPEYLAPELLLGHGYTK 172

Query: 225 SCDVYSFGILLLEILTGRKPI--EKLPGGVKRTITEWAEPLIVKGKFKE 271
           + D ++ G+LL E+LTG  P   E +    ++ +    EPL     F  
Sbjct: 173 AVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ---EPLRFPDGFDR 218

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 53/206 (25%), Positives = 85/206 (41%), Gaps = 29/206 (14%)

Query: 52  GGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT- 109
           G FGSVY  +  S G   A+K LK    K++M    + +V      + ++ ++G      
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLK----KSDMI--AKNQVTNVKAERAIMMIQGESPYVA 60

Query: 110 ---------DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
                    D   +V +Y+      S +  +  G +  DW ++       AE +L +   
Sbjct: 61  KLYYSFQSKDYLYLVMEYLNGGDCASLI--KTLGGLPEDWAKQY-----IAEVVLGVEDL 113

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
               IIHRDIK  N+L+D      + DFG ++           +  GT  YLAPE  +  
Sbjct: 114 HQRGIIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPETILGV 168

Query: 221 KVSESCDVYSFGILLLEILTGRKPIE 246
              +  D +S G ++ E L G  P  
Sbjct: 169 GDDKMSDWWSLGCVIFEFLFGYPPFH 194

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 63.4 bits (155), Expect = 2e-11
 Identities = 60/212 (28%), Positives = 109/212 (51%), Gaps = 24/212 (11%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVR---HKNLL 100
            ++GEG +G+VY  R  + G  +A+KK++   S+  +  +   E+ +L ++    H N++
Sbjct: 5   AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIV 64

Query: 101 GLRGYCAG--TDQRL---IVYDYMP-NLS-LLSHLHGQYAGEVQLDWKRRMKIAIGSAEG 153
            L   C G  TD+ L   +V++++  +L+  LS           +  K  M+  +    G
Sbjct: 65  RLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETI--KDLMRQLLR---G 119

Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLA 213
           + +LH   +  I+HRD+K  N+L+ SD +  +ADFG A++    ++   T V  TL Y A
Sbjct: 120 VDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMA--LTSVVVTLWYRA 174

Query: 214 PEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           PE  +    +   D++S G +  E L  R+P+
Sbjct: 175 PEVLLQSSYATPVDMWSVGCIFAE-LFRRRPL 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 29/277 (10%)

Query: 48  KLGEGGFGSVYWGRTSDGL---QIAVKKLKAMNSKAE-MEFAVEVEVLGRVRHKNLLGLR 103
           ++G G FG V  G  + G    Q+ VK+L+   S  E M+F  E +    ++H NLL   
Sbjct: 2   EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGE-VQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G C      L+V ++ P   L  +L      E +  D     ++A   A G+L+LH    
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-- 119

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT-RVKGTLGYLAPEYA---- 217
            + IH D+   N LL +D    + D+G +    +   ++T  ++   L ++APE      
Sbjct: 120 -NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 218 ---MWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV 273
              +    ++  +V+S G+ + E+   G +P   L      T T       V+ +  +L 
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT-------VREQQLKLP 231

Query: 274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEV 310
            P+L+    +   +    V   C   +PE+RP+ +EV
Sbjct: 232 KPRLKLPLSDRWYE----VMQFC-WLQPEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 50/206 (24%), Positives = 101/206 (49%), Gaps = 20/206 (9%)

Query: 49  LGEGGFG-SVYWGRTSDGLQIAVKKLKAMNSKAEMEFA-VEVEVLGRVRHKNLLGLRGYC 106
           +GEG FG ++     +   + A+K+++   S + +E +  E  +L +++H N++  +   
Sbjct: 8   VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF 67

Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQ----YAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
                  IV +Y     L+  +  Q    +  +  L W  +M +      G+ ++H +  
Sbjct: 68  EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHEK-- 119

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
             ++HRDIK+ N+ L  + +  + DFG A+L+    ++  T V GT  Y+ PE  +W  +
Sbjct: 120 -RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYV-GTPYYVPPE--IWENM 175

Query: 223 --SESCDVYSFGILLLEILTGRKPIE 246
             +   D++S G +L E+ T + P +
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPFQ 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 63.3 bits (154), Expect = 3e-11
 Identities = 56/208 (26%), Positives = 99/208 (47%), Gaps = 19/208 (9%)

Query: 43  FSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKLKAMNSKAEME----FAV-EVEVLGRVRH 96
           F    K+GEG +G VY  R    G  +A+KK++      E E     A+ E+ +L  + H
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRL---DTETEGVPSTAIREISLLKELNH 58

Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
            N++ L       ++  +V++++ +  L   +       + L   +     +   +G+ +
Sbjct: 59  PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQL--LQGLAF 115

Query: 157 LH-HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPE 215
            H H V    +HRD+K  N+L++++    +ADFG A+     V   T  V  TL Y APE
Sbjct: 116 CHSHRV----LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPE 170

Query: 216 YAMWGKV-SESCDVYSFGILLLEILTGR 242
             +  K  S + D++S G +  E++T R
Sbjct: 171 ILLGCKYYSTAVDIWSLGCIFAEMVTRR 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 63.1 bits (153), Expect = 3e-11
 Identities = 68/273 (24%), Positives = 128/273 (46%), Gaps = 34/273 (12%)

Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRVRHKNLLGLRG 104
           ++G G +G VY  R  +  ++A   +K +  +   +FAV   E+ ++   +H N++   G
Sbjct: 16  RIGSGTYGDVYKARNVNTGELAA--IKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFG 73

Query: 105 YCAGTDQRLIVYDYMPNLSL--LSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
                D+  I  ++    SL  + H+ G  + E Q+ +  R  +     +G+ YLH +  
Sbjct: 74  SYLRRDKLWICMEFCGGGSLQDIYHVTGPLS-ESQIAYVSRETL-----QGLYYLHSKGK 127

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW--- 219
              +HRDIK +N+LL  +    +ADFG +  I   ++   + + GT  ++APE A     
Sbjct: 128 ---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERK 183

Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
           G  ++ CD+++ GI  +E+   + P+  L           A  L+ K  F+    PKL+ 
Sbjct: 184 GGYNQLCDIWAVGITAIELAELQPPMFDLH-------PMRALFLMTKSNFQP---PKLKD 233

Query: 280 DFD-ENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
                N     + +A   +   P+KRP  ++++
Sbjct: 234 KMKWSNSFHHFVKMA---LTKNPKKRPTAEKLL 263

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 63.2 bits (153), Expect = 4e-11
 Identities = 64/202 (31%), Positives = 90/202 (44%), Gaps = 16/202 (7%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFA---VEVEVLGRVRHKNLLGLRG 104
           LG+G FG V   R  + G   A+K LK     A+ E A    E  VL   RH  L  L+ 
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                D+   V +Y+    L  HL  +       D  R     I SA  + YLH   +  
Sbjct: 63  SFQTKDRLCFVMEYVNGGELFFHLSRERV--FSEDRTRFYGAEIVSA--LDYLH---SGK 115

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK--GTLGYLAPEYAMWGKV 222
           I++RD+K  N++LD D    + DFG  K   EG++   T     GT  YLAPE       
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLEDNDY 172

Query: 223 SESCDVYSFGILLLEILTGRKP 244
             + D +  G+++ E++ GR P
Sbjct: 173 GRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 63.3 bits (154), Expect = 4e-11
 Identities = 67/203 (33%), Positives = 88/203 (43%), Gaps = 18/203 (8%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFA---VEVEVLGRVRHKNLLGLRG 104
           LG+G FG V   R  + G   A+K LK     A+ E A    E  VL   RH  L  L+ 
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALK- 61

Query: 105 YCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           Y   T  RL  V +Y     L  HL          D  R     I SA G  YLH     
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHL--SRERVFSEDRARFYGAEIVSALG--YLHSC--- 114

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLGYLAPEYAMWGK 221
            +++RD+K  N++LD D    + DFG  K   EG+S         GT  YLAPE      
Sbjct: 115 DVVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDND 171

Query: 222 VSESCDVYSFGILLLEILTGRKP 244
              + D +  G+++ E++ GR P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 62.3 bits (152), Expect = 5e-11
 Identities = 68/296 (22%), Positives = 111/296 (37%), Gaps = 72/296 (24%)

Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEM--EFAVEVEVLGRV-RHKNLLGLRG- 104
           +GEG +G VY  R     Q+    +K M+   +   E   E  +L +   H N+    G 
Sbjct: 14  IGEGTYGKVYKARHKKTGQLVA--IKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGA 71

Query: 105 ------------------YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMK- 145
                              C G      V D +  L                   +R+K 
Sbjct: 72  FIKKNPPGNDDQLWLVMELCGGGS----VTDLVKGL---------------RKKGKRLKE 112

Query: 146 -----IAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH 200
                I   +  G+ YLH      +IHRDIK  N+LL  + E  + DFG +  +   +  
Sbjct: 113 EWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGR 169

Query: 201 MTTRVKGTLGYLAPEYAMWGKVSES-----CDVYSFGILLLEILTGRKPIEKLPGGVKRT 255
             T + GT  ++APE     +  ++      DV+S GI  +E+  G+ P+  +     R 
Sbjct: 170 RNTFI-GTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHP--MRA 226

Query: 256 ITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
           +       I +        P L+    EN  K+  +    C+    E+RP M+E++
Sbjct: 227 LF-----KIPRNP-----PPTLKS--PENWSKKFNDFISECLIKNYEQRPFMEELL 270

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 62.6 bits (152), Expect = 5e-11
 Identities = 61/201 (30%), Positives = 90/201 (44%), Gaps = 10/201 (4%)

Query: 49  LGEGGFGSVY-WGRTSDGLQIAVKKL--KAMNSKAEMEFA-VEVEVLGRVRHKNLLGLRG 104
           LG+GGFG V      + G   A KKL  K +  +   E A VE  +L +V  + ++ L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59

Query: 105 YCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           Y   T   L +V   M    L  H++            R          G+ +LH     
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR--- 116

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
            II+RD+K  NVLLD+D    ++D G A  + +G S  T    GT G++APE     +  
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEYD 175

Query: 224 ESCDVYSFGILLLEILTGRKP 244
            S D ++ G+ L E++  R P
Sbjct: 176 FSVDYFALGVTLYEMIAARGP 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 62.7 bits (152), Expect = 5e-11
 Identities = 66/203 (32%), Positives = 90/203 (44%), Gaps = 18/203 (8%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFA---VEVEVLGRVRHKNLLGLRG 104
           LG+G FG V   R  + G   A+K L+     A+ E A    E  VL   RH  L  L+ 
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 61

Query: 105 YCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           Y   T  RL  V +Y     L  HL  +       +  R     I SA  + YLH     
Sbjct: 62  YAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSA--LEYLHSR--- 114

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK--GTLGYLAPEYAMWGK 221
            +++RDIK  N++LD D    + DFG  K   EG+S   T     GT  YLAPE      
Sbjct: 115 DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDND 171

Query: 222 VSESCDVYSFGILLLEILTGRKP 244
              + D +  G+++ E++ GR P
Sbjct: 172 YGRAVDWWGLGVVMYEMMCGRLP 194

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 62.5 bits (152), Expect = 6e-11
 Identities = 59/224 (26%), Positives = 104/224 (46%), Gaps = 37/224 (16%)

Query: 40  TNGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKL-----KAMNSKAEMEFAVEVEVLGR 93
           TN + D   +G G FG V   R    G  +A+KK+       + +K       E+++L  
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYR---ELKLLKH 65

Query: 94  VRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQ------YAGEVQLDWKRRMKIA 147
           +RH+N++ L      +D   I    + ++  ++ L G        +  ++  + +     
Sbjct: 66  LRHENIISL------SD---IFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQ 116

Query: 148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG 207
           I    G+ Y+H   +  ++HRD+K SN+L++ + +  + DFG A++       MT  V  
Sbjct: 117 I--LRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQD---PQMTGYVS- 167

Query: 208 TLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPIEKLPG 250
           T  Y APE  + W K     D++S G +  E+L G KP+   PG
Sbjct: 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEG-KPL--FPG 208

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 62.3 bits (151), Expect = 7e-11
 Identities = 56/203 (27%), Positives = 100/203 (49%), Gaps = 21/203 (10%)

Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKNLLGLRGY 105
           KLGEG + +VY G +    Q+   K+ +M ++  + F    E  +L  ++H N++ L   
Sbjct: 12  KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71

Query: 106 CAGTDQRLIVYDYM-PNLS--LLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
               +    V++YM  +L+  ++ H  G +   V+L   + ++       G+ Y+H +  
Sbjct: 72  IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR-------GLAYIHGQ-- 122

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFA--KLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
            HI+HRD+K  N+L+    E  +ADFG A  K IP   S   +    TL Y  P+  +  
Sbjct: 123 -HILHRDLKPQNLLISYLGELKLADFGLARAKSIP---SQTYSSEVVTLWYRPPDVLLGA 178

Query: 221 -KVSESCDVYSFGILLLEILTGR 242
              S + D++  G + +E+L G+
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 62.0 bits (150), Expect = 8e-11
 Identities = 62/238 (26%), Positives = 108/238 (45%), Gaps = 16/238 (6%)

Query: 48  KLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGL-RGY 105
           K+GEG  G V      S G  +AVKK+     +       EV ++   +H+N++ +   Y
Sbjct: 27  KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86

Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
             G D+  +V +++   +L   +      E Q+       + +   + +  LH +    +
Sbjct: 87  LVG-DELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLKALSVLHAQ---GV 137

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSES 225
           IHRDIK+ ++LL  D    ++DFGF   + + V    + V GT  ++APE          
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMAPELISRLPYGPE 196

Query: 226 CDVYSFGILLLEILTGRKP-IEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
            D++S GI+++E++ G  P   + P    + I +   P   K K    V P L+G  D
Sbjct: 197 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP---KLKNLHKVSPSLKGFLD 251

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 61.5 bits (149), Expect = 9e-11
 Identities = 78/282 (27%), Positives = 128/282 (45%), Gaps = 35/282 (12%)

Query: 49  LGEGGFGSVYWG--RTSDG--LQIAVKKLKA-MNSKAEME-FAVEVEVLGRVRHKNLLGL 102
           LG+G FGSV     ++ DG   ++AVK LKA + S +++E F  E   +    H N++ L
Sbjct: 7   LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66

Query: 103 RGYC--AGTDQRL----IVYDYMPNLSLLSHLHGQYAGE--VQLDWKRRMKIAIGSAEGI 154
            G    +    RL    ++  +M +  L + L     GE    L  +  ++  I  A G+
Sbjct: 67  IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126

Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRV-KGTLGYLA 213
            YL  +   + IHRD+ A N +L+ +    VADFG +K I  G  +      K  + +LA
Sbjct: 127 EYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLA 183

Query: 214 PEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL 272
            E       +   DV++FG+ + EI+T G+ P      GV+   +E    LI   + K+ 
Sbjct: 184 LESLADNVYTTHSDVWAFGVTMWEIMTRGQTPY----AGVEN--SEIYNYLIKGNRLKQP 237

Query: 273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            D           L+    +   C   EP+ RP+ + + + L
Sbjct: 238 PDC----------LEDVYELMCQCWSPEPKCRPSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 16/212 (7%)

Query: 48  KLGEGGFGSVYWG--RTSDGLQ-IAVKKLKAMNSKAEM--EFAVEVEVLGRVRHKNLLGL 102
           +LG G FG+V  G  +     + +AVK LK  N+   +  E   E  V+ ++ +  ++ +
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
            G C      L++      L+ L  L+        +  K   ++    + G+ YL     
Sbjct: 62  IGICEAESWMLVM-----ELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEET-- 114

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGYLAPEYAMWG 220
            + +HRD+ A NVLL +     ++DFG +K +    ++   +  G   + + APE   + 
Sbjct: 115 -NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY 173

Query: 221 KVSESCDVYSFGILLLEILT-GRKPIEKLPGG 251
           K S   DV+SFG+L+ E  + G+KP + + G 
Sbjct: 174 KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN 205

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 55/228 (24%), Positives = 95/228 (41%), Gaps = 37/228 (16%)

Query: 48  KLGEGGFGSVYWGRTSD-GLQIAVKKLK---AMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
            +G+GG G VY         ++A+KK++   + N   +  F  E ++   + H  ++ + 
Sbjct: 9   LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68

Query: 104 GYCAGTDQRLIVYDYMPNL---SLLSHLHGQYAGEV-------QLDWKRRMKIAIGSAEG 153
             C+  D    VY  MP +   +L S L   +  E        +      + I       
Sbjct: 69  SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125

Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI--------------PEGVS 199
           I Y+H   +  ++HRD+K  N+LL    E ++ D+G A                      
Sbjct: 126 IEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICY 182

Query: 200 HMTT---RVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
              T   ++ GT  Y+APE  +    SES D+Y+ G++L ++LT   P
Sbjct: 183 SSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230

Length = 932

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 58/234 (24%), Positives = 107/234 (45%), Gaps = 32/234 (13%)

Query: 35  ELHTATNGFSDDNKLGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEM----EFAVE 87
           E++ +T  F ++  LGE  FG VY G    T+ G Q     +K +  KAE     EF  E
Sbjct: 1   EINLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58

Query: 88  VEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMK 145
             +  R++H N++ L G         +++ Y  +  L   L     ++     D  + +K
Sbjct: 59  AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118

Query: 146 IAIGSAE----------GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP 195
             +  A+          G+ +L    + H++H+D+   NVL+       ++D G   L  
Sbjct: 119 STLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLG---LFR 172

Query: 196 EGVSHMTTRVKGT----LGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
           E  +    ++ G     + +++PE  M+GK S   D++S+G++L E+ + G +P
Sbjct: 173 EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 226

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 48/157 (30%), Positives = 74/157 (47%), Gaps = 20/157 (12%)

Query: 96  HKNLLGLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRM---KIAIGSA 151
           H  L+GL   C  T+ RL  V +++    L+ H+  Q          R++        SA
Sbjct: 55  HPFLVGLHS-CFQTESRLFFVIEFVSGGDLMFHMQRQ----------RKLPEEHARFYSA 103

Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV--SHMTTRVKGTL 209
           E  L L+      II+RD+K  NVLLD++    + D+G  K   EG+     T+   GT 
Sbjct: 104 EISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK---EGIRPGDTTSTFCGTP 160

Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
            Y+APE         S D ++ G+L+ E++ GR P +
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 60.9 bits (148), Expect = 2e-10
 Identities = 71/282 (25%), Positives = 128/282 (45%), Gaps = 46/282 (16%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMN----SKAEMEFAVEVEVLGRVRHK 97
             +  K+GEG  G V      S G Q+AVKK   M+     + E+ F  EV ++   +H 
Sbjct: 21  LDNFVKIGEGSTGIVCIATDKSTGRQVAVKK---MDLRKQQRRELLFN-EVVIMRDYQHP 76

Query: 98  NLLGLRG-YCAGTDQRLIVYDYMPNLSL---LSHLHGQYAGEVQLDWKRRMKIAIGSAEG 153
           N++ +   Y  G D+  +V +++   +L   ++H         +++ ++   + +   + 
Sbjct: 77  NIVEMYSSYLVG-DELWVVMEFLEGGALTDIVTH--------TRMNEEQIATVCLAVLKA 127

Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLA 213
           + +LH      +IHRDIK+ ++LL SD    ++DFGF   + + V    + V GT  ++A
Sbjct: 128 LSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-GTPYWMA 183

Query: 214 PEYAMWGKVSESCDVYSFGILLLEILTGRKP-IEKLPGGVKRTITEWAEPLIVKGKFKEL 272
           PE           D++S GI+++E++ G  P   + P    + I +   P     K K L
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPP-----KLKNL 238

Query: 273 --VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
             V P+LR   D              +  +P +R    E++N
Sbjct: 239 HKVSPRLRSFLD------------RMLVRDPAQRATAAELLN 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 60/228 (26%), Positives = 100/228 (43%), Gaps = 40/228 (17%)

Query: 43  FSDDNKLGEGGFGSVYWG-RTSDGLQIAVKKLKAMNSKAEMEFAV---------EVEVLG 92
           +     +G G +G V     T  G ++A+KK+      A   F V         E+++L 
Sbjct: 7   YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKI----PHA---FDVPTLAKRTLRELKILR 59

Query: 93  RVRHKNLLGLRGYCAGTDQRLI----VYDYMPNLSLLSHL-HGQYAGEVQLDWKRRMKIA 147
             +H N++ +R               V D M   S L H+ H      +  +  R     
Sbjct: 60  HFKHDNIIAIRDILRPPGADFKDVYVVMDLME--SDLHHIIHSD--QPLTEEHIRYFLYQ 115

Query: 148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVS-HMTT 203
           +    G+ Y+H   + ++IHRD+K SN+L++ D E  + DFG A+ +   P      MT 
Sbjct: 116 L--LRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTE 170

Query: 204 RVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPIEKLPG 250
            V  T  Y APE  +   + + + D++S G +  E+L GR+ +   PG
Sbjct: 171 YV-ATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL--FPG 214

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 61.5 bits (150), Expect = 2e-10
 Identities = 60/233 (25%), Positives = 90/233 (38%), Gaps = 49/233 (21%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLK---AMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           +G G FG V+  R  D  Q+ A+K L+    +          E ++L       ++ L  
Sbjct: 9   IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL-- 66

Query: 105 YCAGTDQR--LIVYDYMPN---LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           Y +  D+    +V +YMP    ++LL             +  R        AE +L L  
Sbjct: 67  YYSFQDEEHLYLVMEYMPGGDLMNLLIRK-----DVFPEETARFY-----IAELVLALDS 116

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG---------------------- 197
                 IHRDIK  N+L+D+D    +ADFG  K + +                       
Sbjct: 117 VHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVR 176

Query: 198 -VSHMTTRVK-----GTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
              H   RV+     GT  Y+APE          CD +S G++L E+L G  P
Sbjct: 177 RRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 61.2 bits (149), Expect = 2e-10
 Identities = 33/91 (36%), Positives = 53/91 (58%), Gaps = 8/91 (8%)

Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYL 212
           G+ Y+H   +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y 
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYR 182

Query: 213 APEYAM-WGKVSESCDVYSFGILLLEILTGR 242
           APE  + W   +++ D++S G ++ E+LTG+
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 37/104 (35%), Positives = 57/104 (54%), Gaps = 12/104 (11%)

Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGY 211
           G+ YLH   +  I+HRDIK  N+L++S+    + DFG A++  P+   HMT  V  T  Y
Sbjct: 115 GLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYY 170

Query: 212 LAPEYAMWGK-VSESCDVYSFGILLLEILTGR------KPIEKL 248
            APE  M  +  + + D++S G +  E+L  R       PI++L
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQL 214

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 34/101 (33%), Positives = 54/101 (53%), Gaps = 5/101 (4%)

Query: 145 KIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR 204
           K++I    G+ YL  +    I+HRD+K SN+L++S  E  + DFG +  +   +  M   
Sbjct: 107 KVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANS 161

Query: 205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
             GT  Y++PE       S   D++S G+ L+E+  GR PI
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 69/272 (25%), Positives = 124/272 (45%), Gaps = 30/272 (11%)

Query: 48  KLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
           ++G G +G VY  R    G   AVK +K            E+ ++   +H N++   G  
Sbjct: 16  RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75

Query: 107 AGTDQRLIVYDYMPNLSL--LSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
              ++  I  +Y    SL  + H+ G  + E+Q+ +  R  +     +G+ YLH   +  
Sbjct: 76  LSREKLWICMEYCGGGSLQDIYHVTGPLS-ELQIAYVCRETL-----QGLAYLH---SKG 126

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW---GK 221
            +HRDIK +N+LL  + +  +ADFG A  I   ++   + + GT  ++APE A     G 
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAVEKNGG 185

Query: 222 VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF 281
            ++ CD+++ GI  +E+   + P+  L           A  L+ K  F+    PKL+   
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLH-------PMRALFLMSKSNFQP---PKLK--- 232

Query: 282 DENQLKQAI-NVAVLCVQSEPEKRPNMKEVVN 312
           D+ +      N   + +   P+KRP  + ++ 
Sbjct: 233 DKTKWSSTFHNFVKISLTKNPKKRPTAERLLT 264

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 37/221 (16%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQI-AVKKLKAMNSKAEMEFAV--EVEVLGRVRHKNLLGLR 103
            K+G+G FG V+  R     QI A+KK+   N K         E+++L  ++H+N++ L 
Sbjct: 18  AKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 77

Query: 104 GYC-----AGTDQRLIVYDYMP----NLS-LLSHLHGQYA-GEVQLDWKRRMKIAIGSAE 152
             C          +   Y        +L+ LLS+ + ++   E+    K+ MK+ +    
Sbjct: 78  EICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEI----KKVMKMLL---N 130

Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK--LIPEGVSH--MTTRVKGT 208
           G+ Y+H      I+HRD+KA+N+L+  D    +ADFG A+   + +       T RV  T
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVV-T 186

Query: 209 LGYLAPEYAM----WGKVSESCDVYSFGILLLEILTGRKPI 245
           L Y  PE  +    +G      D++  G ++ E+ T R PI
Sbjct: 187 LWYRPPELLLGERDYGP---PIDMWGAGCIMAEMWT-RSPI 223

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 60.5 bits (147), Expect = 3e-10
 Identities = 36/99 (36%), Positives = 58/99 (58%), Gaps = 8/99 (8%)

Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYL 212
           G+ Y+H   + +++HRD+K SN+LL+++ +  + DFG A+   E    MT  V  T  Y 
Sbjct: 120 GLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV-TRWYR 175

Query: 213 APEYAM-WGKVSESCDVYSFGILLLEILTGRKPIEKLPG 250
           APE  +   + + + DV+S G +  E+L GRKP+   PG
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELL-GRKPL--FPG 211

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 60.7 bits (147), Expect = 3e-10
 Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 15/206 (7%)

Query: 43  FSDDNKLGEGGFGSVYW---GRTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHK 97
           + D  ++G G +G+V      RT  G ++A+KKL +   S+   + A  E+ +L  ++H+
Sbjct: 17  YRDLKQVGSGAYGTVCSALDRRT--GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74

Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
           N++GL             +D+   +  +    G+     +L   R   +     +G+ Y+
Sbjct: 75  NVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYI 134

Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           H      IIHRD+K  N+ ++ D E  + DFG A+   +  S MT  V  T  Y APE  
Sbjct: 135 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QTDSEMTGYVV-TRWYRAPEVI 187

Query: 218 M-WGKVSESCDVYSFGILLLEILTGR 242
           + W   +++ D++S G ++ E+LTG+
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 51/219 (23%), Positives = 96/219 (43%), Gaps = 31/219 (14%)

Query: 48  KLGEGGFGSVYWGRTSDGLQ---IAVKKLKAMNSKAE---MEFAVEVEVLGRVRHKNLLG 101
            +G G +G VY  +  +G      A+KK K    +          E+ +L  ++H+N++ 
Sbjct: 7   CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66

Query: 102 LRGYCAGTDQRLI--VYDYMP-NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA-----EG 153
           L         + +  ++DY   +L  +   H Q A  V +     M   + S       G
Sbjct: 67  LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQ-AKRVSIP--PSM---VKSLLWQILNG 120

Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTT--RVKG 207
           + YLH   +  ++HRD+K +N+L+  +        + D G A+L    +  +     V  
Sbjct: 121 VHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVV 177

Query: 208 TLGYLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPI 245
           T+ Y APE  +  +  +++ D+++ G +  E+LT   PI
Sbjct: 178 TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLE-PI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 22/218 (10%)

Query: 49  LGEGGFGSVYWGRTSD-GLQIAVKKL--KAMNSKAEMEFAV-EVEVLGRVRHKN--LLGL 102
           +G GGFG VY  R +D G   A+K L  K +  K     A+ E  +L  V   +   +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 103 RGYCAGTDQRL-IVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
             Y   T  +L  + D M    L  HL  HG ++       +  M+    +AE IL L H
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS-------EAEMRFY--AAEIILGLEH 112

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
                +++RD+K +N+LLD      ++D G A    +   H +    GT GY+APE    
Sbjct: 113 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 169

Query: 220 GKVSE-SCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
           G   + S D +S G +L ++L G  P  +     K  I
Sbjct: 170 GVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 59.7 bits (145), Expect = 5e-10
 Identities = 38/107 (35%), Positives = 55/107 (51%), Gaps = 12/107 (11%)

Query: 143 RMKIAIGSAEGILYLHHEVTPH-IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM 201
           +M +AI  A     LH+    H +IHRD+K SN+LLD+     + DFG +  + +  +  
Sbjct: 118 KMTVAIVKA-----LHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK- 171

Query: 202 TTRVKGTLGYLAPEY----AMWGKVSESCDVYSFGILLLEILTGRKP 244
            TR  G   Y+APE         K     DV+S GI L+E+ TG+ P
Sbjct: 172 -TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 59.4 bits (144), Expect = 5e-10
 Identities = 49/174 (28%), Positives = 86/174 (49%), Gaps = 30/174 (17%)

Query: 145 KIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR 204
           KIA+   + + YLH ++   +IHRD+K SNVL++ + +  + DFG +  + + V+   T 
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA--KTI 162

Query: 205 VKGTLGYLAPE-----YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEW 259
             G   Y+APE         G   +S DV+S GI ++E+ TGR P +            W
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKS-DVWSLGITMIELATGRFPYDS-----------W 210

Query: 260 AEPLIVKGKFKELVD---PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEV 310
             P     + K++V+   P+L  +    + +  +N    C++   ++RPN  E+
Sbjct: 211 KTPF---QQLKQVVEEPSPQLPAEKFSPEFQDFVNK---CLKKNYKERPNYPEL 258

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 59.6 bits (144), Expect = 5e-10
 Identities = 55/210 (26%), Positives = 102/210 (48%), Gaps = 21/210 (10%)

Query: 48  KLGEGGFGSVYWGR--TSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVR---HKNLL 100
           ++GEG +G V+  R   + G  +A+K+++    +  M  +   EV VL  +    H N++
Sbjct: 8   EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67

Query: 101 GLRGYC--AGTDQRL---IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGIL 155
            L   C  + TD+     +V++++ +  L ++L       V  +  + M   +    G+ 
Sbjct: 68  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQL--LRGLD 124

Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPE 215
           +LH   +  ++HRD+K  N+L+ S  +  +ADFG A++         T V  TL Y APE
Sbjct: 125 FLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPE 179

Query: 216 YAMWGKVSESCDVYSFGILLLEILTGRKPI 245
             +    +   D++S G +  E+   RKP+
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMFR-RKPL 208

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 59.2 bits (143), Expect = 5e-10
 Identities = 59/209 (28%), Positives = 93/209 (44%), Gaps = 22/209 (10%)

Query: 49  LGEGGFGSVYWGRTSD-GLQIAVKKL--KAMNSKAEMEFAVEVEVLGRVRHKN---LLGL 102
           +G GGFG VY  R +D G   A+K L  K +  K     A+   ++  +        +  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 103 RGYCAGTDQRL-IVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
             Y   T  +L  + D M    L  HL  HG ++       ++ M+    + E IL L H
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFS-------EKEMRFY--ATEIILGLEH 112

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
                +++RD+K +N+LLD      ++D G A    +   H +    GT GY+APE    
Sbjct: 113 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQK 169

Query: 220 GKVSE-SCDVYSFGILLLEILTGRKPIEK 247
           G   + S D +S G +L ++L G  P  +
Sbjct: 170 GTAYDSSADWFSLGCMLFKLLRGHSPFRQ 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 59.2 bits (143), Expect = 6e-10
 Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 22/210 (10%)

Query: 48  KLGEGGFGSVYWGRTSD-GLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVR---HKNLLG 101
           ++G G +G+VY  R    G  +A+K ++   ++  +  +   EV +L R+    H N++ 
Sbjct: 7   EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66

Query: 102 LRGYCAG--TDQRL---IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
           L   CA   TD+     +V++++ +  L ++L       +  +  + +        G+ +
Sbjct: 67  LMDVCATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLR--GLDF 123

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMT-TRVKGTLGYLAPE 215
           LH      I+HRD+K  N+L+ S  +  +ADFG A++       M  T V  TL Y APE
Sbjct: 124 LH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLWYRAPE 177

Query: 216 YAMWGKVSESCDVYSFGILLLEILTGRKPI 245
             +    +   D++S G +  E+   RKP+
Sbjct: 178 VLLQSTYATPVDMWSVGCIFAEMFR-RKPL 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 59.7 bits (145), Expect = 6e-10
 Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 46/236 (19%)

Query: 48  KLGEGGFGSVYWGRTSDGLQI-AVKKLKAMNSKAEMEFAVEV-------EVLGRVRHKNL 99
           ++G+GG+G V+  +  D  +I A+K++K    K+ +    EV       ++L   + + L
Sbjct: 8   QVGQGGYGQVFLAKKKDTGEIVALKRMK----KSLLFKLNEVRHVLTERDILTTTKSEWL 63

Query: 100 LGLRGYCAGTDQRL-IVYDYMP---------NLSLLSHLHGQ-YAGEVQLDWKRRMKIAI 148
           + L  Y    D+ L +  +Y+P         NL +LS  H + Y  E        M  A+
Sbjct: 64  VKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAE--------MFEAV 114

Query: 149 GSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT 208
            +        HE+    IHRD+K  N L+D+     + DFG +K     V++  + V G+
Sbjct: 115 DAL-------HELG--YIHRDLKPENFLIDASGHIKLTDFGLSK---GIVTYANSVV-GS 161

Query: 209 LGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE-KLPGGVKRTITEWAEPL 263
             Y+APE         + D +S G +L E L G  P     P      +  W E L
Sbjct: 162 PDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL 217

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 59.7 bits (144), Expect = 6e-10
 Identities = 34/101 (33%), Positives = 55/101 (54%), Gaps = 5/101 (4%)

Query: 145 KIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR 204
           K++I   +G+ YL  +    I+HRD+K SN+L++S  E  + DFG +  +   +  M   
Sbjct: 107 KVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANS 161

Query: 205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
             GT  Y++PE       S   D++S G+ L+E+  GR PI
Sbjct: 162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 59.3 bits (143), Expect = 7e-10
 Identities = 54/211 (25%), Positives = 101/211 (47%), Gaps = 24/211 (11%)

Query: 48  KLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           KLGEG + +VY G++  +G  +A+K ++    +     A+ E  +L  ++H N++ L   
Sbjct: 12  KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71

Query: 106 CAGTDQRLIVYDYMPN---LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
               +   +V++Y+       +  H  G +   V+L   + ++       G+ Y+H    
Sbjct: 72  IHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR-------GLSYIHQR-- 122

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGF--AKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
            +I+HRD+K  N+L+    E  +ADFG   AK +P   SH  +    TL Y  P+  +  
Sbjct: 123 -YILHRDLKPQNLLISDTGELKLADFGLARAKSVP---SHTYSNEVVTLWYRPPDVLLGS 178

Query: 221 KVSESC-DVYSFGILLLEILTGRKPIEKLPG 250
               +C D++  G + +E++ G   +   PG
Sbjct: 179 TEYSTCLDMWGVGCIFVEMIQG---VAAFPG 206

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 59.3 bits (143), Expect = 8e-10
 Identities = 66/203 (32%), Positives = 91/203 (44%), Gaps = 17/203 (8%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFA---VEVEVLGRVRHKNLLGLRG 104
           LG+G FG V   +  + G   A+K LK     A+ E A    E  VL   RH  L  L+ 
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 61

Query: 105 YCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           Y   T  RL  V +Y     L  HL  +       D  R     I SA  + YLH E   
Sbjct: 62  YSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSA--LDYLHSE--K 115

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK--GTLGYLAPEYAMWGK 221
           ++++RD+K  N++LD D    + DFG  K   EG+    T     GT  YLAPE      
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEYLAPEVLEDND 172

Query: 222 VSESCDVYSFGILLLEILTGRKP 244
              + D +  G+++ E++ GR P
Sbjct: 173 YGRAVDWWGLGVVMYEMMCGRLP 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 58.7 bits (142), Expect = 8e-10
 Identities = 44/176 (25%), Positives = 85/176 (48%), Gaps = 30/176 (17%)

Query: 145 KIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR 204
           +IA+   +G+ YL    +  I+HRD+K SN+L+++  +  + DFG +  +   V+ +   
Sbjct: 99  RIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL---VNSIAKT 152

Query: 205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP---IEK-----LPGGVKRTI 256
             GT  Y+APE     +     DV+S GI  +E+  GR P   I+K     +P  + + I
Sbjct: 153 YVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCI 212

Query: 257 TEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
            +   P++  G+F E                  ++    C++ +P++RP  + +++
Sbjct: 213 VDEDPPVLPVGQFSEKF----------------VHFITQCMRKQPKERPAPENLMD 252

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 59.6 bits (144), Expect = 8e-10
 Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 28/210 (13%)

Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEME-------FAVEVEVLGRVRHKNLLG 101
           +G G FG V   R     ++   KL    SK EM        F  E +++       ++ 
Sbjct: 51  IGRGAFGEVQLVRHKSSQKVYAMKLL---SKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107

Query: 102 LRGYCAGTDQR--LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           L  +CA  D +   +V +YMP   L++ L   Y  +V   W +       +AE +L L  
Sbjct: 108 L--FCAFQDDKYLYMVMEYMPGGDLVN-LMSNY--DVPEKWAK-----FYTAEVVLALDA 157

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFA-KLIPEGVSHMTTRVKGTLGYLAPEYAM 218
             +  +IHRD+K  N+LLD      +ADFG   K+   G+    T V GT  Y++PE   
Sbjct: 158 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAV-GTPDYISPEVLK 216

Query: 219 W----GKVSESCDVYSFGILLLEILTGRKP 244
                G     CD +S G+ L E+L G  P
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 59.2 bits (144), Expect = 8e-10
 Identities = 61/229 (26%), Positives = 108/229 (47%), Gaps = 44/229 (19%)

Query: 43  FSDDNKLGEGGFGSVYWG-RTSDGLQIAVKKLKAMNSKAEMEFAV----EVEVLGRVRHK 97
           + + + +GEG +G V        G+++A+KK+     +    F      E+++L R +H+
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQT---FCQRTLREIKILRRFKHE 63

Query: 98  NLLGLRG-YCAGTDQRL----IVYDYMPN-------LSLLSHLHGQYAGEVQLDWKRRMK 145
           N++G+       + +      IV + M            LS+ H QY     L   R +K
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQIL---RGLK 120

Query: 146 IAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH---MT 202
             I SA            +++HRD+K SN+LL+++ +  + DFG A++      H   +T
Sbjct: 121 -YIHSA------------NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLT 167

Query: 203 TRVKGTLGYLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
             V  T  Y APE  +  K  +++ D++S G +L E+L+ R P+   PG
Sbjct: 168 EYV-ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL--FPG 212

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 50/164 (30%), Positives = 74/164 (45%), Gaps = 34/164 (20%)

Query: 96  HKNLLGLRGYCAGTDQRLI-VYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRM 144
           H  L+GL   C  T+ RL  V +Y+    L+ H+  Q          Y+ E+ L      
Sbjct: 55  HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------ 107

Query: 145 KIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV--SHMT 202
                    + YLH      II+RD+K  NVLLDS+    + D+G  K   EG+     T
Sbjct: 108 --------ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTT 153

Query: 203 TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
           +   GT  Y+APE         S D ++ G+L+ E++ GR P +
Sbjct: 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 69/259 (26%), Positives = 106/259 (40%), Gaps = 37/259 (14%)

Query: 41  NGFSDDNKLGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEF-AVEVEVLGRVRH 96
             F   + +G G FG V   R   T D   + V K   + ++  + F   E ++L     
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60

Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
             +  L+      D   +V +Y P   LLS L  +Y  +   D  +        AE +L 
Sbjct: 61  PWIPQLQYAFQDKDNLYLVMEYQPGGDLLS-LLNRYEDQFDEDMAQ-----FYLAELVLA 114

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG-FAKLIPEGVSHMTTRVKGTLGYLAPE 215
           +H       +HRDIK  NVL+D      +ADFG  A+L    + +    V GT  Y+APE
Sbjct: 115 IHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPV-GTPDYIAPE 173

Query: 216 Y---------AMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVK 266
                       +G     CD +S G++  E++ GR P  +  G   +T        I+ 
Sbjct: 174 VLTTMNGDGKGTYGV---ECDWWSLGVIAYEMIYGRSPFHE--GTSAKTYNN-----IM- 222

Query: 267 GKFKELV----DPKLRGDF 281
             F+  +    DPK+  DF
Sbjct: 223 -NFQRFLKFPEDPKVSSDF 240

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 58.2 bits (140), Expect = 1e-09
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 18/209 (8%)

Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYC- 106
           +G G +G VY GR     Q+A  K+  +    E E   E+ +L +   H+N+    G   
Sbjct: 14  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73

Query: 107 ----AGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
                G D +L +V ++    S+   +       ++ +W     IA    E +  L H  
Sbjct: 74  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICREILRGLSHLH 128

Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK 221
              +IHRDIK  NVLL  + E  + DFG +  +   V    T + GT  ++APE     +
Sbjct: 129 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDE 187

Query: 222 VSESC-----DVYSFGILLLEILTGRKPI 245
             ++      D++S GI  +E+  G  P+
Sbjct: 188 NPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 50/207 (24%), Positives = 97/207 (46%), Gaps = 14/207 (6%)

Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAE--MEFAV-EVEVLGRVRHKNLLGLRG 104
           K+GEG +G+V+  +  +  +I   K   ++   E     A+ E+ +L  ++HKN++ L  
Sbjct: 7   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                 +  +V++Y      L        G++  +  +     +   +G+ + H     +
Sbjct: 67  VLHSDKKLTLVFEYCDQD--LKKYFDSCNGDIDPEIVKSFMFQL--LKGLAFCHSH---N 119

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
           ++HRD+K  N+L++ + E  +ADFG A+     V   +  V  TL Y  P+     K+ S
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYS 178

Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPG 250
            S D++S G +  E+    +P+   PG
Sbjct: 179 TSIDMWSAGCIFAELANAGRPL--FPG 203

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 38/117 (32%), Positives = 59/117 (50%), Gaps = 22/117 (18%)

Query: 132 YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA 191
           YA EV L               +++LH      +I+RD+K  N+LLD++    +ADFG  
Sbjct: 101 YAAEVTL--------------ALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMC 143

Query: 192 KLIPEGVSH--MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
           K   EG+ +   TT   GT  Y+APE     +   S D ++ G+L+ E++ G+ P E
Sbjct: 144 K---EGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFE 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 25/210 (11%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLKA--MNSKAEME-FAVEVEVLGRVRHKNLLGLRG 104
           +G G FG V   +  +  ++ A+K L    M  +AE   F  E +VL    ++ +  L  
Sbjct: 9   IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLH- 67

Query: 105 YCAGTDQRL-IVYDYMPN---LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           Y    +  L +V DY      L+LLS    +   ++   +   M IAI S        H+
Sbjct: 68  YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV-------HQ 120

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFA-KLIPEGVSHMTTRVKGTLGYLAPEY--A 217
           +  H +HRDIK  N+L+D +    +ADFG   KL+ +G    +  V GT  Y++PE   A
Sbjct: 121 L--HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQA 177

Query: 218 MW---GKVSESCDVYSFGILLLEILTGRKP 244
           M    GK    CD +S G+ + E+L G  P
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 39/100 (39%), Positives = 53/100 (53%), Gaps = 7/100 (7%)

Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA-KLIPEGVSHMTTRVKGTL 209
           AE +L +H     H +HRDIK  NVLLD +    +ADFG   K+  +G    +  V GT 
Sbjct: 109 AEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAV-GTP 167

Query: 210 GYLAPEY--AM---WGKVSESCDVYSFGILLLEILTGRKP 244
            Y++PE   AM    GK    CD +S G+ + E+L G  P
Sbjct: 168 DYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 60/274 (21%), Positives = 124/274 (45%), Gaps = 25/274 (9%)

Query: 43  FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLK---AMNSKAEMEFAVEVEVLGRVRHKN 98
           F  + K+G G F  VY      D   +A+KK++    M++KA  +   E+++L ++ H N
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 99  LLG-LRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRM-KIAIGSAEGILY 156
           ++  L  +    D  L +   + +   LS +   +  + +L  +R + K  +     + +
Sbjct: 64  VIKYLDSFIE--DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEH 121

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
           +H   +  ++HRDIK +NV + +     + D G  +      +   + V GT  Y++PE 
Sbjct: 122 MH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSPER 177

Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
                 +   D++S G LL E+   + P      G K  +    +      K ++   P 
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLFSLCQ------KIEQCDYPP 227

Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           L  +    +L++ ++   +C+  +P++RP++  V
Sbjct: 228 LPTEHYSEKLRELVS---MCIYPDPDQRPDIGYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 57.2 bits (139), Expect = 4e-09
 Identities = 37/107 (34%), Positives = 55/107 (51%), Gaps = 25/107 (23%)

Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI-----PEGVSHMTTRVKGTLG 210
           Y+H   + ++IHRD+K SN+LL+SD    +ADFG A+ +           +T  V  T  
Sbjct: 122 YIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYV-ATRW 177

Query: 211 YLAPE-------YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE       Y      ++  D++S G +L E+L G KP+   PG
Sbjct: 178 YRAPEILLGSTRY------TKGVDMWSVGCILGEMLLG-KPL--FPG 215

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 63/221 (28%), Positives = 102/221 (46%), Gaps = 37/221 (16%)

Query: 48  KLGEGGFG---SVYWGRTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVR-HKNLLG 101
           +LG+G +G   S     TS+   +A+KK+    + K   + A+ E+++L   R HKN+  
Sbjct: 7   ELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITC 66

Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE--------- 152
           L       D  ++       L L   L      E  L    R    +  A          
Sbjct: 67  L------YDMDIVFPGNFNELYLYEELM-----EADLHQIIRSGQPLTDAHFQSFIYQIL 115

Query: 153 -GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG----VSHMTTRVKG 207
            G+ Y+H   + +++HRD+K  N+L+++D E  + DFG A+   E        MT  V  
Sbjct: 116 CGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV-A 171

Query: 208 TLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPIEK 247
           T  Y APE  + +   +++ DV+S G +L E+L GRKP+ K
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELL-GRKPVFK 211

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 56.6 bits (137), Expect = 4e-09
 Identities = 60/214 (28%), Positives = 106/214 (49%), Gaps = 28/214 (13%)

Query: 48  KLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAV------EVEVLGRVRHKNLL 100
           K+GEG +G VY  R    G  +A+KK++ + ++ E    V      E+ +L  + H N++
Sbjct: 6   KIGEGTYGVVYKARDKLTGEIVALKKIR-LETEDE---GVPSTAIREISLLKELNHPNIV 61

Query: 101 GLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            L      ++ +L +V++++ +L L  ++    +    LD            +GI Y H 
Sbjct: 62  RLLDVVH-SENKLYLVFEFL-DLDLKKYMDS--SPLTGLDPPLIKSYLYQLLQGIAYCH- 116

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL--IPEGVSHMTTRVKGTLGYLAPEYA 217
             +  ++HRD+K  N+L+D +    +ADFG A+   +P  V   T  V  TL Y APE  
Sbjct: 117 --SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTYTHEVV-TLWYRAPEIL 171

Query: 218 MWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
           +  +  S   D++S G +  E++  R+P+   PG
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVN-RRPL--FPG 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 22/204 (10%)

Query: 49  LGEGGFGSVYWGRTSDG--LQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           LG G FG V      +     +A+K   K K +  K       E ++L  + H   + L 
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97

Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIG---SAEGILYLHHE 160
           G         +V +++      + L             +R    +G   +A+ +L   + 
Sbjct: 98  GSFKDESYLYLVLEFVIGGEFFTFLRRN----------KRFPNDVGCFYAAQIVLIFEYL 147

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
            + +I++RD+K  N+LLD D    + DFGFAK+    V   T  + GT  Y+APE  +  
Sbjct: 148 QSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV----VDTRTYTLCGTPEYIAPEILLNV 203

Query: 221 KVSESCDVYSFGILLLEILTGRKP 244
              ++ D ++ GI + EIL G  P
Sbjct: 204 GHGKAADWWTLGIFIYEILVGCPP 227

Length = 340

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 57.5 bits (139), Expect = 6e-09
 Identities = 52/196 (26%), Positives = 88/196 (44%), Gaps = 22/196 (11%)

Query: 65  GLQIAVKKLKAMNSKAEMEFA---VEVEVLGRVRHKNLLGL--RGYCAGTDQRLIVYDYM 119
           G ++A+K L+    + E + A    E  +  R+ H N++ L   G          V++Y+
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEA-PPGLLFAVFEYV 61

Query: 120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLD- 178
           P  +L   L     G +      R+ + +  A     L       I+HRD+K  N+++  
Sbjct: 62  PGRTLREVLAAD--GALPAGETGRLMLQVLDA-----LACAHNQGIVHRDLKPQNIMVSQ 114

Query: 179 SDFEP--LVADFGFAKLIP------EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYS 230
           +   P   V DFG   L+P            TT V GT  Y APE      V+ + D+Y+
Sbjct: 115 TGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYA 174

Query: 231 FGILLLEILTGRKPIE 246
           +G++ LE LTG++ ++
Sbjct: 175 WGLIFLECLTGQRVVQ 190

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 56.8 bits (137), Expect = 6e-09
 Identities = 62/230 (26%), Positives = 106/230 (46%), Gaps = 35/230 (15%)

Query: 24  NNATWRI-FTYKELHTATNGFSDDNKLGEGGFGSVYWG---RTSDGLQIAVKKL-KAMNS 78
           N   W +   Y  L           ++G G +GSV      RT  G ++A+KKL +   S
Sbjct: 7   NKTVWELPERYTSLK----------QVGSGAYGSVCSAIDKRT--GEKVAIKKLSRPFQS 54

Query: 79  KAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY---MPNLSL-LSHLHGQYA 133
           +   + A  E+ +L  ++H+N++GL              D+   MP +   L  + G   
Sbjct: 55  EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPL 114

Query: 134 GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL 193
            E ++ +     +      G+ Y+H   +  IIHRD+K  N+ ++ D E  + DFG A+ 
Sbjct: 115 SEDKVQY-----LVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR- 165

Query: 194 IPEGVSHMTTRVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGR 242
                + MT  V  T  Y APE  + W   +++ D++S G ++ E+LTG+
Sbjct: 166 --HADAEMTGYVV-TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 56.2 bits (135), Expect = 8e-09
 Identities = 48/161 (29%), Positives = 74/161 (45%), Gaps = 34/161 (21%)

Query: 99  LLGLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIA 147
           L+GL   C  T  RL +V +Y+    L+ H+  Q          YA E+ +         
Sbjct: 58  LVGLHS-CFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICI--------- 107

Query: 148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV--SHMTTRV 205
                 + +LH      II+RD+K  NVLLD+D    + D+G  K   EG+     T+  
Sbjct: 108 -----ALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCK---EGLGPGDTTSTF 156

Query: 206 KGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
            GT  Y+APE     +   S D ++ G+L+ E++ GR P +
Sbjct: 157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 55.7 bits (134), Expect = 2e-08
 Identities = 49/182 (26%), Positives = 83/182 (45%), Gaps = 26/182 (14%)

Query: 135 EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI 194
           E+ LD +  +  +   A+G+ +L    + + IHRD+ A N+LL       + DFG A+ I
Sbjct: 208 ELALDTEDLLSFSYQVAKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDI 264

Query: 195 PEGVSHMTTRVKGT----LGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLP 249
               +++   VKG     + ++APE       +   DV+S+GILL EI + G  P   +P
Sbjct: 265 RNDSNYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP 321

Query: 250 GGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKE 309
                          V  KF +++    R    E    +  ++   C  ++P KRP  K+
Sbjct: 322 ---------------VDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQ 366

Query: 310 VV 311
           +V
Sbjct: 367 IV 368

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 70/285 (24%), Positives = 126/285 (44%), Gaps = 46/285 (16%)

Query: 51  EGGFGSVYWGRTSDGL-----QIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           EG FG +++G   D       ++ VK +K   S+ ++   + E  +L  + H+N+L +  
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 105 YCA-GTDQRLIVYDYMPNLSLLSHL----HGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            C    +   ++Y YM   +L   L     G+      L  ++ + +AI  A G+ YLH 
Sbjct: 76  VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK-LIPEGVSHMTTRVKGTLGYLAPEYAM 218
                +IH+DI A N ++D + +  + D   ++ L P     +       + ++A E  +
Sbjct: 136 R---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLV 192

Query: 219 WGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL 277
             + S + DV+SFG+LL E++T G+ P  ++            +P  +    K       
Sbjct: 193 NKEYSSASDVWSFGVLLWELMTLGQTPYVEI------------DPFEMAAYLK------- 233

Query: 278 RGDFDENQLKQAIN-------VAVLCVQSEPEKRPNMKEVVNTLT 315
               D  +L Q IN       V   C   +PE+RP+  ++V  LT
Sbjct: 234 ----DGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLT 274

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 17/209 (8%)

Query: 49  LGEGGFGSVY-WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYC 106
           +G+G +G VY      DG   AVK L  + S  + E   E  +L  +  H N++   G  
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 107 AGTD-----QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
              D     Q  +V +     S+   + G      +LD      I  G+  G+ +LH+  
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN- 147

Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK 221
              IIHRD+K +N+LL ++    + DFG +  +        T V GT  ++APE     +
Sbjct: 148 --RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIACEQ 204

Query: 222 VSES-----CDVYSFGILLLEILTGRKPI 245
             +      CDV+S GI  +E+  G  P+
Sbjct: 205 QYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 54/208 (25%), Positives = 99/208 (47%), Gaps = 16/208 (7%)

Query: 41  NGFSDDNKLGEGGFGSVYWGRTSDGLQI-AVKKLKAMNSKAEMEFAV--EVEVLGRVRHK 97
           N F     +GEG +G V   R  +  +I A+KK K      E++     E+++L  ++ +
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 98  NLLGLRGYCAGTDQRLIVYDYMPN--LSLLSHL-HGQYAGEVQLDWKRRMKIAIGSAEGI 154
           N++ L+       +  +V++Y+    L LL  + +G    +V+    + +K        I
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIK-------AI 113

Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            + H      I+HRDIK  N+L+  +    + DFGFA+ + EG +   T    T  Y +P
Sbjct: 114 HWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSP 170

Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGR 242
           E  +     ++ D++S G +L E+  G+
Sbjct: 171 ELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 55.4 bits (133), Expect = 2e-08
 Identities = 53/186 (28%), Positives = 88/186 (47%), Gaps = 22/186 (11%)

Query: 65  GLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGL-------RGYCAGTDQRLIV 115
           G+ +AVKKL +   ++   + A  E+ +L  V HKN++ L       +      D  L++
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105

Query: 116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNV 175
                NL  + H+        +LD +R   +      GI +LH   +  IIHRD+K SN+
Sbjct: 106 ELMDANLCQVIHM--------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNI 154

Query: 176 LLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILL 235
           ++ SD    + DFG A+      + M T    T  Y APE  +     E+ D++S G ++
Sbjct: 155 VVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 212

Query: 236 LEILTG 241
            E++ G
Sbjct: 213 GELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 53/201 (26%), Positives = 93/201 (46%), Gaps = 18/201 (8%)

Query: 48  KLGEGGFGSVYWGRTSDGLQI-AVKKLKAMNS-----KAEMEFAVEVEVLGRVRHKNLLG 101
           K+GEG +G V+  R  +  QI A+KK           K  +    E+ +L +++H NL+ 
Sbjct: 8   KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALR---EIRMLKQLKHPNLVN 64

Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
           L        +  +V++Y  + ++L+ L     G   +      KI   + + + + H   
Sbjct: 65  LIEVFRRKRKLHLVFEYC-DHTVLNELEKNPRG---VPEHLIKKIIWQTLQAVNFCHKH- 119

Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG- 220
             + IHRD+K  N+L+    +  + DFGFA+++       T  V  T  Y APE  +   
Sbjct: 120 --NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYV-ATRWYRAPELLVGDT 176

Query: 221 KVSESCDVYSFGILLLEILTG 241
           +     DV++ G +  E+LTG
Sbjct: 177 QYGPPVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 52/212 (24%), Positives = 101/212 (47%), Gaps = 18/212 (8%)

Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKA-EMEFAVEVEVLGRVRHKNLLGLRG-Y 105
           K+G G +G VY  +  DG       LK +      M    E+ +L  ++H N++ L+  +
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67

Query: 106 CAGTDQRL-IVYDYMPN--LSLLSHLHGQYAGEVQLDWKRRM--KIAIGSAEGILYLHHE 160
            + +D+++ +++DY  +    ++       A +  +   R M   +     +GI YLH  
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN 127

Query: 161 VTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMT--TRVKGTLGYLAP 214
               ++HRD+K +N+L+  +        +AD GFA+L    +  +     V  T  Y AP
Sbjct: 128 ---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAP 184

Query: 215 EYAMWGK-VSESCDVYSFGILLLEILTGRKPI 245
           E  +  +  +++ D+++ G +  E+LT  +PI
Sbjct: 185 ELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 215

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 52/178 (29%), Positives = 84/178 (47%), Gaps = 8/178 (4%)

Query: 67  QIAVKKL-KAMNSKAEMEFAVEVEVLGR-VRHKNLLGLRGYCAGTDQRLIVYDYMPNLSL 124
            +A+KKL +   ++   + A    VL + V HKN++GL              D    + L
Sbjct: 51  NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110

Query: 125 LSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL 184
           +     Q   +++LD +R   +      GI +LH   +  IIHRD+K SN+++ SD    
Sbjct: 111 MDANLCQVI-QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLK 166

Query: 185 VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGR 242
           + DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++ G 
Sbjct: 167 ILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 55.0 bits (132), Expect = 3e-08
 Identities = 48/174 (27%), Positives = 80/174 (45%), Gaps = 26/174 (14%)

Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT-- 208
           A G+ +L    + + +HRD+ A NVLL       + DFG A+ I    ++++   KG+  
Sbjct: 247 ARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS---KGSTF 300

Query: 209 --LGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIV 265
             + ++APE       +   DV+S+GILL EI + G  P    PG            +IV
Sbjct: 301 LPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTP---YPG------------MIV 345

Query: 266 KGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP 319
              F   +    R    ++  ++  ++ V C  SEPEKRP+   + + +    P
Sbjct: 346 DSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 65/210 (30%), Positives = 92/210 (43%), Gaps = 28/210 (13%)

Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEME-------FAVEVEVLGRVRHKNLLG 101
           +G G FG V   R     ++   KL    SK EM        F  E +++       ++ 
Sbjct: 51  IGRGAFGEVQLVRHKSTRKVYAMKLL---SKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 107

Query: 102 LRGYCAGTDQRLI--VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           L  + A  D R +  V +YMP   L++ L   Y  +V   W R       +AE +L L  
Sbjct: 108 L--FYAFQDDRYLYMVMEYMPGGDLVN-LMSNY--DVPEKWAR-----FYTAEVVLALDA 157

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFA-KLIPEGVSHMTTRVKGTLGYLAPEYAM 218
             +   IHRD+K  N+LLD      +ADFG   K+  EG+    T V GT  Y++PE   
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLK 216

Query: 219 W----GKVSESCDVYSFGILLLEILTGRKP 244
                G     CD +S G+ L E+L G  P
Sbjct: 217 SQGGDGYYGRECDWWSVGVFLYEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 62/216 (28%), Positives = 109/216 (50%), Gaps = 31/216 (14%)

Query: 48  KLGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKNLLGL 102
           K+GEG +G VY  R   T++   IA+KK++       +      E+ +L  ++H N++ L
Sbjct: 9   KIGEGTYGVVYKARDRVTNE--TIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66

Query: 103 RGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS-----AEGILY 156
           +     +++RL +V++Y+ +L L  H+      +   D+ +  ++ I +       GI Y
Sbjct: 67  QD-VVHSEKRLYLVFEYL-DLDLKKHM------DSSPDFAKNPRL-IKTYLYQILRGIAY 117

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPE 215
            H   +  ++HRD+K  N+L+D     L +ADFG A+     V   T  V  TL Y APE
Sbjct: 118 CH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVV-TLWYRAPE 173

Query: 216 YAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
             +  +  S   D++S G +  E++  +KP+   PG
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVN-QKPL--FPG 206

Length = 294

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 54.0 bits (130), Expect = 3e-08
 Identities = 55/251 (21%), Positives = 108/251 (43%), Gaps = 38/251 (15%)

Query: 77  NSKAEME-FAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSL-LSHLHGQYAG 134
             K  ++    E++ L R+   N+L + G+       + + D +P LSL L +    Y  
Sbjct: 57  GHKVLIDITENEIKNLRRIDSNNILKIYGFI------IDIVDDLPRLSLILEYCTRGYLR 110

Query: 135 EV-----QLDWKRRMKIAIGSAEGILYLHHEV-TPHIIHRDIKASNVLLDSDFEPLVADF 188
           EV      L +K ++ +AI   +G+  L+     P+   +++ + + L+  +++  +   
Sbjct: 111 EVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPY---KNLTSVSFLVTENYKLKIICH 167

Query: 189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYA--MWGKVSESCDVYSFGILLLEILTGRKPIE 246
           G  K++          V   + Y + +    ++ + +   D+YS G++L EI TG+ P E
Sbjct: 168 GLEKILSSPPFK---NVN-FMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223

Query: 247 KLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPN 306
            L      T  E  + +I K          L+   D     +   +   C   +  KRPN
Sbjct: 224 NL------TTKEIYDLIINKNN-------SLKLPLDCPLEIK--CIVEACTSHDSIKRPN 268

Query: 307 MKEVVNTLTGY 317
           +KE++  L+ Y
Sbjct: 269 IKEILYNLSLY 279

Length = 283

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 61/238 (25%), Positives = 105/238 (44%), Gaps = 33/238 (13%)

Query: 61  RTSDGLQIAVKKLKAMNSKAEMEFA-VEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYM 119
           R SD  +  V K   +N + +  +A  E+  L    H  ++         D+ L++ +Y 
Sbjct: 88  RGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY- 146

Query: 120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE---GILYLH-----HEV-TPHIIHRDI 170
                         G++    K+R+K  +   E   G+L+        EV +  ++HRD+
Sbjct: 147 -----------GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDL 195

Query: 171 KASNVLLDSDFEPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVY 229
           K++N+ L       + DFGF+K   + VS  + +   GT  YLAPE     + S+  D++
Sbjct: 196 KSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMW 255

Query: 230 SFGILLLEILTGRKPIEKLPGGVKRTITEWAE-------PLIVKGKFKELVDPKLRGD 280
           S G++L E+LT  +P +   G  +R I +          P  V    K L+DP L  +
Sbjct: 256 SLGVILYELLTLHRPFK---GPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKN 310

Length = 478

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 54.1 bits (130), Expect = 4e-08
 Identities = 61/274 (22%), Positives = 118/274 (43%), Gaps = 27/274 (9%)

Query: 47  NKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLGLRG 104
           ++LG+G +GSVY       G+ +A+K+++    +++  +  +E+++L +     ++   G
Sbjct: 7   DELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYG 66

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                    +  +YM   SL   L+        +      +I     +G+ +L  E   +
Sbjct: 67  AFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--N 123

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
           IIHRD+K +NVL++ + +  + DFG +  +   ++       G   Y+APE    G  ++
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI---GCQSYMAPERIKSGGPNQ 180

Query: 225 ------SCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR 278
                   DV+S G+ +LE+  GR P    P      I       IV G       P L 
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYP---YPPETYANIFAQLSA-IVDGD-----PPTLP 231

Query: 279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
             + ++    A +    C+   P +RP   +++ 
Sbjct: 232 SGYSDD----AQDFVAKCLNKIPNRRPTYAQLLE 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 54.0 bits (130), Expect = 4e-08
 Identities = 36/100 (36%), Positives = 51/100 (51%), Gaps = 7/100 (7%)

Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA-KLIPEGVSHMTTRVKGTL 209
           AE +L +        +HRDIK  NVLLD +    +ADFG   +L+ +G       V GT 
Sbjct: 109 AEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAV-GTP 167

Query: 210 GYLAPEY--AM---WGKVSESCDVYSFGILLLEILTGRKP 244
            Y++PE   AM    G+    CD +S G+ + E+L G  P
Sbjct: 168 DYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 53.3 bits (129), Expect = 5e-08
 Identities = 61/221 (27%), Positives = 93/221 (42%), Gaps = 56/221 (25%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKA--------MNSKAEMEFAVEVEVLGRV-RHK 97
           +LG+G FGSVY  R    G  +A+KK+K         MN +       EV+ L ++  H 
Sbjct: 6   QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR-------EVKSLRKLNEHP 58

Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMK----IAIGS--- 150
           N++ L+      D+   V++YM   +L            QL   R+ K      I S   
Sbjct: 59  NIVKLKEVFRENDELYFVFEYM-EGNLY-----------QLMKDRKGKPFSESVIRSIIY 106

Query: 151 --AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT 208
              +G+ ++H        HRD+K  N+L+       +ADFG A+ I       T  V  T
Sbjct: 107 QILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREI-RSRPPYTDYV-ST 161

Query: 209 LGYLAPE-------YAMWGKVSESCDVYSFGILLLEILTGR 242
             Y APE       Y      S   D+++ G ++ E+ T R
Sbjct: 162 RWYRAPEILLRSTSY------SSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 49/159 (30%), Positives = 81/159 (50%), Gaps = 15/159 (9%)

Query: 135 EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI 194
           +++LD +R   +      GI +LH   +  IIHRD+K SN+++ SD    + DFG A+  
Sbjct: 113 QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-- 167

Query: 195 PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKR 254
             G S M T    T  Y APE  +     E+ D++S G ++ E++  R  I   PG  + 
Sbjct: 168 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV--RHKI-LFPG--RD 222

Query: 255 TITEWAEPLIVKG----KFKELVDPKLRGDFDENQLKQA 289
            I +W + +   G    +F + + P +R ++ EN+ K A
Sbjct: 223 YIDQWNKVIEQLGTPCPEFMKKLQPTVR-NYVENRPKYA 260

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 33/91 (36%), Positives = 52/91 (57%), Gaps = 8/91 (8%)

Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYL 212
           G+ Y+H   +  IIHRD+K SNV ++ D E  + DFG A+   +    MT  V  T  Y 
Sbjct: 130 GLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD---EMTGYV-ATRWYR 182

Query: 213 APEYAM-WGKVSESCDVYSFGILLLEILTGR 242
           APE  + W   +++ D++S G ++ E+L G+
Sbjct: 183 APEIMLNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 53.7 bits (129), Expect = 6e-08
 Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 5/88 (5%)

Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGY 211
           EG+ YLH +    IIHRD+K  N+ ++   +  + D G A+     V+     + GT+  
Sbjct: 168 EGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQF--PVVAPAFLGLAGTVET 222

Query: 212 LAPEYAMWGKVSESCDVYSFGILLLEIL 239
            APE     K +   D++S GI+L E+L
Sbjct: 223 NAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 53.5 bits (128), Expect = 6e-08
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 23/154 (14%)

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
           IHRD+ A N+LL  +    + DFG A+ I   P+ V   + R+   L ++APE +++ KV
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP--LKWMAPE-SIFDKV 252

Query: 223 -SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGD 280
            +   DV+SFG+LL EI + G  P    PG            + +  +F + +    R  
Sbjct: 253 YTTQSDVWSFGVLLWEIFSLGASP---YPG------------VQINEEFCQRLKDGTRMR 297

Query: 281 FDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
             EN   +   + + C Q +P++RP    +V  L
Sbjct: 298 APENATPEIYRIMLACWQGDPKERPTFSALVEIL 331

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 53.6 bits (129), Expect = 6e-08
 Identities = 56/190 (29%), Positives = 88/190 (46%), Gaps = 28/190 (14%)

Query: 65  GLQIAVKKLK---AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI-----VY 116
           G  +A+KKL       + A+  +  E+ ++  V HKN++GL      T Q+ +     VY
Sbjct: 41  GQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLN--VFTPQKSLEEFQDVY 97

Query: 117 DYM----PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKA 172
             M     NL  +  +         LD +R   +      GI +LH   +  IIHRD+K 
Sbjct: 98  LVMELMDANLCQVIQM--------DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKP 146

Query: 173 SNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFG 232
           SN+++ SD    + DFG A+    G S M T    T  Y APE  +     E+ D++S G
Sbjct: 147 SNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVG 204

Query: 233 ILLLEILTGR 242
            ++ E++ G 
Sbjct: 205 CIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 53.2 bits (128), Expect = 7e-08
 Identities = 51/224 (22%), Positives = 105/224 (46%), Gaps = 38/224 (16%)

Query: 43  FSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           + D   LG G  G V+    SD   ++AVKK+  +     ++ A+ E++++ R+ H N++
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKI-VLTDPQSVKHALREIKIIRRLDHDNIV 65

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGE--VQLDWKRRMKIAIGSAE------ 152
            +      +   L       ++  L+ L+  Y  +  ++ D    ++    S E      
Sbjct: 66  KVYEVLGPSGSDL-----TEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFM 120

Query: 153 -----GILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVK 206
                G+ Y+H   + +++HRD+K +NV ++++   L + DFG A+++    SH     K
Sbjct: 121 YQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH-----K 172

Query: 207 GTLG-------YLAPEYAMW-GKVSESCDVYSFGILLLEILTGR 242
           G L        Y +P   +     +++ D+++ G +  E+LTG+
Sbjct: 173 GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 52.7 bits (126), Expect = 8e-08
 Identities = 53/207 (25%), Positives = 92/207 (44%), Gaps = 27/207 (13%)

Query: 47  NKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           +KLGEG + +V+ GR+      +A+K+++  + +     A+ EV +L  ++H N++ L  
Sbjct: 11  DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 105 YCAGTDQRLIVYDYMP--------NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
                    +V++Y+         N   L  +H       QL              G+ Y
Sbjct: 71  IIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQL------------LRGLSY 118

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
            H      I+HRD+K  N+L++   E  +ADFG A+         +  V  TL Y  P+ 
Sbjct: 119 CHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDV 174

Query: 217 AMWG-KVSESCDVYSFGILLLEILTGR 242
            +   + S   D++  G +L E+ TGR
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 51/205 (24%), Positives = 92/205 (44%), Gaps = 27/205 (13%)

Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAM--------NSKAEMEFAVEVEVLGRVRHKNL 99
           +LG+G FG+VY     D   +A ++LK +        N    ++   E ++L ++ H  +
Sbjct: 7   RLGKGSFGTVYL--VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64

Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLH-----GQYAGEVQL-DWKRRMKIAIGSAEG 153
           +         D   I+ +Y     L   L      G+   E Q+ +W  ++ +      G
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLL------G 118

Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLA 213
           + Y+H      I+HRD+KA N+ L ++    + DFG ++L+  G   + T   GT  Y++
Sbjct: 119 VHYMHQR---RILHRDLKAKNIFLKNNLLK-IGDFGVSRLL-MGSCDLATTFTGTPYYMS 173

Query: 214 PEYAMWGKVSESCDVYSFGILLLEI 238
           PE           D++S G +L E+
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 52.3 bits (125), Expect = 1e-07
 Identities = 54/210 (25%), Positives = 95/210 (45%), Gaps = 33/210 (15%)

Query: 47  NKLGEGGFGSVYWGRT--SDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLR 103
           +KLGEG + +VY GR+  +D L +A+K+++  + +     A+ EV +L  ++H N++ L 
Sbjct: 12  DKLGEGTYATVYKGRSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 104 GYCAGTDQRLIVYDYMP--------NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGIL 155
                     +V++Y+         +     ++H       QL              G+ 
Sbjct: 71  DIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQL------------LRGLN 118

Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGF--AKLIPEGVSHMTTRVKGTLGYLA 213
           Y H      ++HRD+K  N+L++   E  +ADFG   AK IP   +   +    TL Y  
Sbjct: 119 YCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP---TKTYSNEVVTLWYRP 172

Query: 214 PEYAMWG-KVSESCDVYSFGILLLEILTGR 242
           P+  +     S   D++  G +  E+ TGR
Sbjct: 173 PDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 51/213 (23%), Positives = 103/213 (48%), Gaps = 20/213 (9%)

Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKA-EMEFAVEVEVLGRVRHKNLLGLRG-Y 105
           K+G G +G VY  +  DG       LK +      M    E+ +L  ++H N++ L+  +
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67

Query: 106 CAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY-----LHH 159
            +  D+++ +++DY  +  L   +    A +     K+ +++  G  + +LY     +H+
Sbjct: 68  LSHADRKVWLLFDYAEH-DLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHY 123

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMT--TRVKGTLGYLA 213
                ++HRD+K +N+L+  +        +AD GFA+L    +  +     V  T  Y A
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 214 PEYAMWGK-VSESCDVYSFGILLLEILTGRKPI 245
           PE  +  +  +++ D+++ G +  E+LT  +PI
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 42/150 (28%), Positives = 69/150 (46%), Gaps = 23/150 (15%)

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT----LGYLAPEYAMWGK 221
           IHRD+ A NVLL       + DFG A+ I    +++   VKG     + ++APE      
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYV---VKGNARLPVKWMAPESIFDCV 290

Query: 222 VSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGD 280
            +   DV+S+GILL EI + G+ P    PG            ++V  KF ++V    +  
Sbjct: 291 YTVQSDVWSYGILLWEIFSLGKSP---YPG------------ILVNSKFYKMVKRGYQMS 335

Query: 281 FDENQLKQAINVAVLCVQSEPEKRPNMKEV 310
             +    +  ++  +C   EP +RP   ++
Sbjct: 336 RPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 51.3 bits (122), Expect = 5e-07
 Identities = 61/276 (22%), Positives = 116/276 (42%), Gaps = 45/276 (16%)

Query: 33  YKELHTATNGFSDDNKLGEGGFGSVYW---GRTSDGLQIAVKKLKAMNSKAEMEFAVEVE 89
           Y +  +  N +    K+G G FG V+     RT +         + +  + + +  +EV 
Sbjct: 5   YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVN 64

Query: 90  VLGRVRHKNLLG-LRGYCAGTDQRLIVY-------DYMPNLSLLSHLHGQYAGEVQLDWK 141
           V+  ++HKN++  +  +    +Q+L +        D   N+     + G+      +D  
Sbjct: 65  VMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDIT 124

Query: 142 RRMKIAIGSAEGILYLHH-EVTPH---IIHRDIKASNVLLDSDFEPL------------- 184
           R++  A+       Y H+ +  P+   ++HRD+K  N+ L +    +             
Sbjct: 125 RQLLHALA------YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGR 178

Query: 185 ----VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS--ESCDVYSFGILLLEI 238
               + DFG +K I  G+  M     GT  Y +PE  +    S  +  D+++ G ++ E+
Sbjct: 179 PIAKIGDFGLSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYEL 236

Query: 239 LTGRKPIEKLPGGVKRTITEWAE--PLIVKGKFKEL 272
            +G+ P  K      + I+E      L +KGK KEL
Sbjct: 237 CSGKTPFHK-ANNFSQLISELKRGPDLPIKGKSKEL 271

Length = 1021

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 49.8 bits (119), Expect = 6e-07
 Identities = 46/175 (26%), Positives = 76/175 (43%), Gaps = 33/175 (18%)

Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYA----GEVQLDWKRRMKIAIGSAEG 153
           N++ L  Y    D   +V  +     L SH+  ++       V+  W   M +A+ +   
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI-SKFLNIPEECVK-RWAAEMVVALDA--- 100

Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG-FAKLIP----EGVSHMTTRVKGT 208
              LH E    I+ RD+  +N+LLD      +  F  ++++      E V +M       
Sbjct: 101 ---LHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM------- 147

Query: 209 LGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKR----TITEW 259
             Y APE     + +E+CD +S G +L E+LTG+  +E  P G+       I EW
Sbjct: 148 --YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHTTLNIPEW 200

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 50.2 bits (120), Expect = 7e-07
 Identities = 43/136 (31%), Positives = 61/136 (44%), Gaps = 31/136 (22%)

Query: 151 AEGIL---YLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR--- 204
           AE +L   YLH+     I+HRD+K  N+L+ S     + DFG +K+   G+  +TT    
Sbjct: 108 AETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKI---GLMSLTTNLYE 161

Query: 205 --------------VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI----- 245
                         V GT  Y+APE  +     +  D ++ GI+L E L G  P      
Sbjct: 162 GHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 221

Query: 246 EKLPGGVKRTITEWAE 261
           E+L G V     EW E
Sbjct: 222 EELFGQVISDDIEWPE 237

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 50.5 bits (120), Expect = 7e-07
 Identities = 49/182 (26%), Positives = 85/182 (46%), Gaps = 28/182 (15%)

Query: 71  KKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV---YDYMPNLSLLSH 127
           K++KA  S+A ++   E+  LGR+ H+N+L +           ++   YD+     L S 
Sbjct: 198 KRVKA-GSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSF 252

Query: 128 LHGQYAGEVQLDWKRR---------MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLD 178
           ++ +       DWK R         MK  + + E   Y+H +    +IHRDIK  N+ L+
Sbjct: 253 MYDE-----AFDWKDRPLLKQTRAIMKQLLCAVE---YIHDKK---LIHRDIKLENIFLN 301

Query: 179 SDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEI 238
            D + ++ DFG A    +          GT+   +PE        E  D++S G++LL++
Sbjct: 302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361

Query: 239 LT 240
           L+
Sbjct: 362 LS 363

Length = 501

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 70/288 (24%), Positives = 117/288 (40%), Gaps = 42/288 (14%)

Query: 48  KLGEGGFGSVYWGRT---SDGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           ++G G FG V        +   ++ VK+LKA  +SK + EF  + +    ++H N+L   
Sbjct: 2   EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRR-------MKIAIGSAEGILY 156
           G C      L+V++Y     L S+L  +        W RR        ++A   A G+ +
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQE-------QWHRRNSQLLLLQRMACEIAAGVTH 114

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA-KLIPEGVSHMTTRVKGTLGYLAPE 215
           +H     + +H D+   N  L SD    V D+G       E            L +LAPE
Sbjct: 115 MHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPE 171

Query: 216 Y--AMWGKV-----SESCDVYSFGILLLEIL-TGRKPIEKLPGGVKRTITEWAEPLIVKG 267
                 G +     ++  +V++ G+ L E+     +P   L    +  +       ++K 
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSD--REVLNH-----VIKD 224

Query: 268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
           +  +L  P+L   + E   +    V   C  S PEKR   +EV   LT
Sbjct: 225 QQVKLFKPQLELPYSERWYE----VLQFCWLS-PEKRATAEEVHRLLT 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 49.3 bits (118), Expect = 1e-06
 Identities = 58/218 (26%), Positives = 97/218 (44%), Gaps = 29/218 (13%)

Query: 32  TYKELHTATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV--EV 88
           TYK+L           KLGEG + +VY GR+   G  +A+K+++ +  +    F    E 
Sbjct: 6   TYKKLD----------KLGEGSYATVYKGRSKLTGQLVALKEIR-LEHEEGAPFTAIREA 54

Query: 89  EVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAI 148
            +L  ++H N++ L           +V++Y+   + L        G + +   R     +
Sbjct: 55  SLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD--TDLKQYMDDCGGGLSMHNVRLFLFQL 112

Query: 149 GSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGF--AKLIPEGVSHMTTRVK 206
               G+ Y H      ++HRD+K  N+L+    E  +ADFG   AK +P   S   +   
Sbjct: 113 --LRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP---SKTYSNEV 164

Query: 207 GTLGYLAPEYAMWGKV--SESCDVYSFGILLLEILTGR 242
            TL Y  P+  + G    S S D++  G +  E+ TGR
Sbjct: 165 VTLWYRPPD-VLLGSTEYSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 50/176 (28%), Positives = 76/176 (43%), Gaps = 49/176 (27%)

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
           IHRD+ A N+LL  +    + DFG A+ I   P+ V     R+   L ++APE +++ KV
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP--LKWMAPE-SIFDKV 251

Query: 223 -SESCDVYSFGILLLEILT-GRKP----------IEKLPGGVKRTITEWAEPLIVKGKFK 270
            +   DV+SFG+LL EI + G  P            +L  G +    E+A P I    + 
Sbjct: 252 YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEI----YS 307

Query: 271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGKVMQT 326
            ++D                     C  + PE RP   E+V  L      G ++Q 
Sbjct: 308 IMLD---------------------CWHNNPEDRPTFSELVEIL------GDLLQE 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 54/203 (26%), Positives = 99/203 (48%), Gaps = 19/203 (9%)

Query: 47  NKLGEGGFGSVYWGRT--SDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLR 103
            KLGEG + +V+ GR+  ++ L +A+K+++  + +     A+ EV +L  ++H N++ L 
Sbjct: 12  EKLGEGTYATVFKGRSKLTENL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 70

Query: 104 GYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEV-QLDWKRRMKIAIGSA-EGILYLHHE 160
                TD+ L +V++Y      L     QY  +   +     +KI +     G+ Y H  
Sbjct: 71  D-IVHTDKSLTLVFEY------LDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR 123

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW- 219
               ++HRD+K  N+L++   E  +ADFG A+         +  V  TL Y  P+  +  
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV-TLWYRPPDVLLGS 179

Query: 220 GKVSESCDVYSFGILLLEILTGR 242
            + S   D++  G +  E+ +GR
Sbjct: 180 SEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 49.0 bits (117), Expect = 2e-06
 Identities = 32/102 (31%), Positives = 53/102 (51%), Gaps = 10/102 (9%)

Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK--LIPEGVSHMTTRVKGTLG 210
            + Y+H   T ++ HRD+K  N+L ++D +  + DFG A+        +   T    T  
Sbjct: 115 ALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRW 171

Query: 211 YLAPEY--AMWGKVSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE   + + K + + D++S G +  E+LTG KP+   PG
Sbjct: 172 YRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTG-KPL--FPG 210

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 36/134 (26%), Positives = 55/134 (41%), Gaps = 35/134 (26%)

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEG------------------VSHMTTRVK- 206
           IHRDIK  N+LLDS     ++DFG    + +                     +M ++ K 
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 207 ---------------GTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI-EKLPG 250
                          GT  Y+APE  M    ++ CD +S G+++ E+L G  P   + P 
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242

Query: 251 GVKRTITEWAEPLI 264
              + +  W E LI
Sbjct: 243 ETYKKVMNWKETLI 256

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 40/149 (26%), Positives = 62/149 (41%), Gaps = 41/149 (27%)

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLI----------------PEGVS--HMTTRVK- 206
           IHRDIK  N+LLD+     ++DFG    +                P   S  +M ++ K 
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 207 ---------------GTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI-EKLPG 250
                          GT  Y+APE  M    ++ CD +S G+++ E+L G  P   + P 
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242

Query: 251 GVKRTITEWAEPLI------VKGKFKELV 273
              R +  W E L+      +  K K+L+
Sbjct: 243 ETYRKVMNWKETLVFPPEVPISEKAKDLI 271

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 68/279 (24%), Positives = 111/279 (39%), Gaps = 39/279 (13%)

Query: 49  LGEGGFGSVY-WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR-HKNLLGLRGY- 105
           +G+G +G V+      +G + AVK L  ++   E E   E  +L  +  H N++   G  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE-EIEAEYNILKALSDHPNVVKFYGMY 84

Query: 106 ----CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMK---IAIGSAEGILYLH 158
                   DQ  +V +     S+   + G       L    RM+   IA    E ++ L 
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGF------LKRGERMEEPIIAYILHEALMGLQ 138

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY-- 216
           H      IHRD+K +N+LL ++    + DFG +  +        T V GT  ++APE   
Sbjct: 139 HLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSV-GTPFWMAPEVIA 197

Query: 217 ---AMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV 273
               +       CDV+S GI  +E+  G  P+  L             P+    K     
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL------------HPMRALFKIPRNP 245

Query: 274 DPKLRG-DFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
            P L   +   N+    I     C+  + EKRP + +++
Sbjct: 246 PPTLHQPELWSNEFNDFIRK---CLTKDYEKRPTVSDLL 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 47.9 bits (114), Expect = 4e-06
 Identities = 31/141 (21%), Positives = 48/141 (34%), Gaps = 43/141 (30%)

Query: 166 IHRDIKASNVLLDSD-----------------------------------FEPLVADFGF 190
           IHRDIK  N+L+D D                                        ++   
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 191 AKLIPEGVSHMT--TRVK-----GTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRK 243
            +L P          R       GT  Y+APE  +    ++ CD +S G++L E+L G+ 
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Query: 244 P-IEKLPGGVKRTITEWAEPL 263
           P +   P   +  +  W   L
Sbjct: 243 PFLADTPAETQLKVINWETTL 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 44/154 (28%), Positives = 69/154 (44%), Gaps = 23/154 (14%)

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
           IHRD+ A N+LL  +    + DFG A+ I   P+ V     R+   L ++APE  ++ +V
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP--LKWMAPE-TIFDRV 257

Query: 223 -SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGD 280
            +   DV+SFG+LL EI + G  P    PG            + +  +F   +    R  
Sbjct: 258 YTIQSDVWSFGVLLWEIFSLGASP---YPG------------VKIDEEFCRRLKEGTRMR 302

Query: 281 FDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
             +    +     + C   EP +RP   E+V  L
Sbjct: 303 APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 47.3 bits (113), Expect = 4e-06
 Identities = 55/221 (24%), Positives = 88/221 (39%), Gaps = 58/221 (26%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVR-HKNLLGLR 103
            K+GEG F  V   +    G   A+K +K    S  ++    E++ L R+  H N+L L 
Sbjct: 5   GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLI 64

Query: 104 GYCAGTDQRLIVYDYMPN-LSLLSHL-----------HGQYAGEVQLDWKRRMKIAIGSA 151
                     +++D     L+L+  L             +   E ++  K  M   + S 
Sbjct: 65  E---------VLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRV--KSYMYQLLKSL 113

Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTRVKGT 208
           +   ++H      I HRDIK  N+L+  D   L ADFG  + I   P    +++TR    
Sbjct: 114 D---HMHRN---GIFHRDIKPENILIKDDILKL-ADFGSCRGIYSKPPYTEYISTR---- 162

Query: 209 LGYLAPE---------YAMWGKVSESCDVYSFGILLLEILT 240
             Y APE           M        D+++ G +  EIL+
Sbjct: 163 -WYRAPECLLTDGYYGPKM--------DIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 48.1 bits (114), Expect = 5e-06
 Identities = 36/104 (34%), Positives = 55/104 (52%), Gaps = 11/104 (10%)

Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT-- 208
           A G+ +L    + + +HRD+ A NVL+       + DFG A+ I    ++++   KG+  
Sbjct: 249 ANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYIS---KGSTF 302

Query: 209 --LGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLP 249
             L ++APE       +   DV+SFGILL EI T G  P  +LP
Sbjct: 303 LPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELP 346

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 47.1 bits (112), Expect = 5e-06
 Identities = 67/280 (23%), Positives = 117/280 (41%), Gaps = 39/280 (13%)

Query: 49  LGEGGFGSVYWG---RTSDGLQIAVKK--LKAMNSKAE--ME-FAVEVEVLGRVRHKNLL 100
           LG+G F  ++ G      D  ++   +  LK ++       E F     ++ ++ HK+L+
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
              G C   D+ ++V +Y+   SL ++L  +    + + WK  +   +  A     LH  
Sbjct: 63  LNYGVCVCGDESIMVQEYVKFGSLDTYLK-KNKNLINISWKLEVAKQLAWA-----LHFL 116

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL----GYLAPEY 216
               + H ++ A NVLL  + +    +  F KL   G+S +T   K  L     ++ PE 
Sbjct: 117 EDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS-ITVLPKEILLERIPWVPPEC 175

Query: 217 AMWGK-VSESCDVYSFGILLLEILTG-RKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD 274
               + +S + D +SFG  L EI +G  KP+  L    K    E    L    K+ EL  
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRHQLPAP-KWTELA- 233

Query: 275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                           N+   C+  EP+ RP+ + ++  L
Sbjct: 234 ----------------NLINQCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 62/276 (22%), Positives = 102/276 (36%), Gaps = 64/276 (23%)

Query: 49  LGEGGFGSVYWGRTSD-GLQIAVKKLK---AMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V      D     A+K L+    +N         E ++L    ++ ++ L  
Sbjct: 9   LGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYY 68

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
                D    V DY+P   ++S L     +   +   +   + +AI S   + +      
Sbjct: 69  SFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGF------ 122

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGF---------AKLIPEGVSHMTT---------- 203
              IHRDIK  N+L+D D    + DFG          +K   +G SH+            
Sbjct: 123 ---IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKG-SHIRQDSMEPSDLWD 178

Query: 204 ---------RVK-------------------GTLGYLAPEYAMWGKVSESCDVYSFGILL 235
                    R+K                   GT  Y+APE  +    ++ CD +S G++L
Sbjct: 179 DVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL 238

Query: 236 LEILTGRKP-IEKLPGGVKRTITEWAEPLIVKGKFK 270
            E+L G+ P +   P   +  +  W   L +  + K
Sbjct: 239 FEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVK 274

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 46.4 bits (111), Expect = 9e-06
 Identities = 36/111 (32%), Positives = 52/111 (46%), Gaps = 23/111 (20%)

Query: 145 KIAIGSAEGILYLH-HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMT 202
           KI     E +  LH H    +IIH DIK  NVL D   + + + D+G  K+I        
Sbjct: 113 KIIRQLVEALNDLHKH----NIIHNDIKLENVLYDRAKDRIYLCDYGLCKII-----GTP 163

Query: 203 TRVKGTLGYLAPE------YAMWGKVSESCDVYSFGILLLEILTGRKPIEK 247
           +   GTL Y +PE      Y        S D ++ G+L  E+LTG+ P ++
Sbjct: 164 SCYDGTLDYFSPEKIKGHNYD------VSFDWWAVGVLTYELLTGKHPFKE 208

Length = 267

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 56/213 (26%), Positives = 85/213 (39%), Gaps = 69/213 (32%)

Query: 146 IAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRV 205
           I  G+  G+ YLH       IHR+IKAS++L+  D        G   L   G+SH+ + V
Sbjct: 106 ILFGALRGLNYLHQN---GYIHRNIKASHILISGD--------GLVSL--SGLSHLYSLV 152

Query: 206 K----------------GTLGYLAPEYA---MWGKVSESCDVYSFGILLLEILTGRKP-- 244
           +                  L +L+PE     ++G   +S D+YS GI   E+ TGR P  
Sbjct: 153 RNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKS-DIYSVGITACELATGRVPFQ 211

Query: 245 --------IEKLPG-----------------------GVKRTITEWAEPLIVKGKFKELV 273
                   ++KL G                       GV   I    E ++  G  + + 
Sbjct: 212 DMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGI---GESVVAAGMTQTMT 268

Query: 274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPN 306
             +LR    +       N+  LC+Q +PEKRP+
Sbjct: 269 SERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS 301

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 68/277 (24%), Positives = 105/277 (37%), Gaps = 87/277 (31%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLKAMNSKAEMEFAVEVEVLGRVR-HKNLLG----- 101
           +G G FG V   +  D   I A+KKL+    K+EM   +E E +  VR  +++L      
Sbjct: 9   IGRGAFGEVRLVQKKDTGHIYAMKKLR----KSEM---LEKEQVAHVRAERDILAEADNP 61

Query: 102 --LRGYCAGTDQR--LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS------- 150
             ++ Y +  D+    ++ +Y+P   +++ L               MK    +       
Sbjct: 62  WVVKLYYSFQDENYLYLIMEYLPGGDMMTLL---------------MKKDTFTEEETRFY 106

Query: 151 -AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV--SHMTT---- 203
            AE IL +        IHRDIK  N+LLD+     ++DFG       G+  SH T     
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT----GLKKSHRTEFYRI 162

Query: 204 ------------------------------RVK-----GTLGYLAPEYAMWGKVSESCDV 228
                                         R       GT  Y+APE  +    ++ CD 
Sbjct: 163 LSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW 222

Query: 229 YSFGILLLEILTGRKP-IEKLPGGVKRTITEWAEPLI 264
           +S G+++ E+L G  P     P    R I  W E L 
Sbjct: 223 WSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQ 259

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 45/164 (27%), Positives = 69/164 (42%), Gaps = 20/164 (12%)

Query: 85  AVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRM 144
           A E  +L  + H +++ L+G           Y+    L L  +    Y     L  KR +
Sbjct: 131 ATEAHILRAINHPSIIQLKG--------TFTYNKFTCLILPRYKTDLYC---YLAAKRNI 179

Query: 145 KI----AIGSA--EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV 198
            I    AI  +    I YLH      IIHRDIKA N+ ++   +  + DFG A    +  
Sbjct: 180 AICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN 236

Query: 199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGR 242
           ++      GT+   APE         + D++S GI+L E+ T  
Sbjct: 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 45.2 bits (107), Expect = 3e-05
 Identities = 50/212 (23%), Positives = 86/212 (40%), Gaps = 29/212 (13%)

Query: 48  KLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEME-------FAVEVEVLGRVRHKNL 99
           K+GEG +G VY  R  + G  +A+KK     ++ EM+          E+ +L  +     
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKK-----TRLEMDEEGIPPTALREISLLQMLSESIY 62

Query: 100 LGLRGYC-------AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ-LDWKRRMKIAIGSA 151
           + +R           G     +V++Y+ +  L   +     G  + L  K          
Sbjct: 63  I-VRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120

Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLG 210
           +G+ + H      ++HRD+K  N+L+D     L +AD G  +     V   T  +  TL 
Sbjct: 121 KGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIV-TLW 176

Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTG 241
           Y APE  +     S   D++S G +  E+   
Sbjct: 177 YRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 45.4 bits (107), Expect = 3e-05
 Identities = 72/289 (24%), Positives = 126/289 (43%), Gaps = 45/289 (15%)

Query: 47  NKLGEGGFGSVYWGRTSD-GLQIAVKK-LKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           N +G G FG VY     D   ++A+KK L+    K       E+ ++  + H N++ L+ 
Sbjct: 72  NIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNR-----ELLIMKNLNHINIIFLKD 126

Query: 105 Y----CAGTDQRLI----VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKI-AIGSAEGIL 155
           Y    C   +++ I    V +++P    +      YA          +K+ +      + 
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQT--VHKYMKHYARNNHALPLFLVKLYSYQLCRALA 184

Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEG---VSHMTTRVKGTLGY 211
           Y+H   +  I HRD+K  N+L+D +   L + DFG AK +  G   VS++ +R      Y
Sbjct: 185 YIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF-----Y 236

Query: 212 LAPEYAMWGKVSESC--DVYSFGILLLE------ILTGRKPIEKLPGGVKRTITEWAEPL 263
            APE  M G  + +   D++S G ++ E      I +G+  +++L   ++   T   + L
Sbjct: 237 RAPEL-MLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQL 295

Query: 264 IVKG------KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPN 306
                     KF ++    L+  F +     AIN     ++ EP KR N
Sbjct: 296 KEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN 344

Length = 440

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 43.8 bits (104), Expect = 7e-05
 Identities = 60/245 (24%), Positives = 83/245 (33%), Gaps = 69/245 (28%)

Query: 48  KLGEGGFGSVYWGRTSD-GLQIAVKKLKAMNSKAEME-------FAVEVEVLGRVRHKNL 99
            LG+G  G V+  R    G   A+K L     K EM           E E+L  + H  L
Sbjct: 8   LLGKGDVGRVFLVRLKGTGKLFALKVL----DKKEMIKRNKVKRVLTEQEILATLDHPFL 63

Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQ------------YAGEVQLDWKRRMKIA 147
             L           +V DY P   L   L  Q            YA EV L         
Sbjct: 64  PTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL--------- 114

Query: 148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG---------- 197
                 + YLH      I++RD+K  N+LL      +++DF  +K               
Sbjct: 115 -----ALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRK 166

Query: 198 ------VSHMTTRVK------------GTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
                 V+ + +               GT  Y+APE         + D ++ GILL E+L
Sbjct: 167 GSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226

Query: 240 TGRKP 244
            G  P
Sbjct: 227 YGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 67/263 (25%), Positives = 116/263 (44%), Gaps = 46/263 (17%)

Query: 66  LQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           L++ +K L   +    + F     ++ +V H +L  + G C    + ++V +++ +  L 
Sbjct: 45  LRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104

Query: 126 SHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV 185
             L  +  G V + WK  + +A   A  + YL  +   +++H ++ A N+LL        
Sbjct: 105 VCLRKE-KGRVPVAWK--ITVAQQLASALSYLEDK---NLVHGNVCAKNILL-------- 150

Query: 186 ADFG-------FAKLIPEGVSHMT----TRVKGTLGYLAPEYAMWG-KVSESCDVYSFGI 233
           A  G       F KL   GVS        RV+  + ++APE    G  +S + D +SFG 
Sbjct: 151 ARLGLAEGTSPFIKLSDPGVSFTALSREERVE-RIPWIAPECVPGGNSLSTAADKWSFGT 209

Query: 234 LLLEI-LTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINV 292
            LLEI   G  P+++      RT +E       K +F E    K R    E   K+   +
Sbjct: 210 TLLEICFDGEVPLKE------RTPSE-------KERFYE---KKHR--LPEPSCKELATL 251

Query: 293 AVLCVQSEPEKRPNMKEVVNTLT 315
              C+  EP +RP+ + ++  LT
Sbjct: 252 ISQCLTYEPTQRPSFRTILRDLT 274

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 64/282 (22%), Positives = 106/282 (37%), Gaps = 64/282 (22%)

Query: 43  FSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKLKAMNSKAEMEFA---VEVEVLGRVRHKN 98
           F     LG G FG V   R  D     A+K L+  +     + A    E ++L    ++ 
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILY 156
           ++ L       D    V DY+P   ++S L   G +  ++   +   +  A+ S   + +
Sbjct: 63  VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGF 122

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADF----GF-----AKLIPEGVSHMTT---- 203
                    IHRDIK  N+L+D D    + DF    GF     +K    G  H+      
Sbjct: 123 ---------IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSG-DHVRQDSMD 172

Query: 204 ---------------RVK-------------------GTLGYLAPEYAMWGKVSESCDVY 229
                          R+K                   GT  Y+APE  +    ++ CD +
Sbjct: 173 FSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWW 232

Query: 230 SFGILLLEILTGRKP-IEKLPGGVKRTITEWAEPLIVKGKFK 270
           S G++L E+L G+ P + + P   +  +  W   L +  + K
Sbjct: 233 SVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAK 274

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 41.2 bits (97), Expect = 5e-04
 Identities = 45/205 (21%), Positives = 75/205 (36%), Gaps = 68/205 (33%)

Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG----- 207
            + Y+H +     IHR +KAS++LL  D        G   L   G+ +  + +K      
Sbjct: 113 ALDYIHSK---GFIHRSVKASHILLSGD--------GKVVL--SGLRYSVSMIKHGKRQR 159

Query: 208 -----------TLGYLAPEY---AMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVK 253
                       L +L+PE     + G   +S D+YS GI   E+  G  P + +P    
Sbjct: 160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKS-DIYSVGITACELANGHVPFKDMP---- 214

Query: 254 RT--ITEWAEPLIVKGKFKELVD----PKLRGDFDENQLKQAINVAV------------- 294
            T  + E      V+G    L+D    P       +++                      
Sbjct: 215 ATQMLLE-----KVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSE 269

Query: 295 -------LCVQSEPEKRPNMKEVVN 312
                  LC+Q +PE RP+  +++N
Sbjct: 270 HFHQFVELCLQRDPESRPSASQLLN 294

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 41.4 bits (97), Expect = 5e-04
 Identities = 29/95 (30%), Positives = 42/95 (44%), Gaps = 4/95 (4%)

Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA-KLIPEGVSHMTTRVKGTLG 210
           E + YLH      IIHRD+K  N+ LD     ++ DFG A KL     +       GTL 
Sbjct: 196 EALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLE 252

Query: 211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
             +PE           D++S G++L E+      +
Sbjct: 253 TNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 40.2 bits (94), Expect = 0.002
 Identities = 40/153 (26%), Positives = 73/153 (47%), Gaps = 25/153 (16%)

Query: 52  GGFGSVYWGRTSDGLQI-AVKKLKAMNSKAEM-------EFAVEVEVLGRVRHKNLLGLR 103
           G FG VY GR  +  ++ AVK +K    KA+M       +   E + L   +   ++ L 
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVK----KADMINKNMVHQVQAERDALALSKSPFIVHLY 70

Query: 104 GYCAGTDQRLIVYDYM--PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
                 +   +V +Y+   ++  L H++G +  E+ + +   + +A+       YLH   
Sbjct: 71  YSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALD------YLHR-- 122

Query: 162 TPH-IIHRDIKASNVLLDSDFEPLVADFGFAKL 193
             H IIHRD+K  N+L+ ++    + DFG +K+
Sbjct: 123 --HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 29/85 (34%), Positives = 42/85 (49%), Gaps = 4/85 (4%)

Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH-MTTRVKGTLGYL 212
           I Y+H E    IIHRDIK  NVL++   +  + DFG A       S      + GT+   
Sbjct: 273 IDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTN 329

Query: 213 APEYAMWGKVSESCDVYSFGILLLE 237
           APE       + S D++S G+++ E
Sbjct: 330 APEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	380
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.94
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.92
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.89
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.89
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.87
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.86
PRK10345	210	hypothetical protein; Provisional	99.86
smart00090	237	RIO RIO-like kinase.	99.83
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.82
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.82
PRK14879	211	serine/threonine protein kinase; Provisional	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.8
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.79
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.74
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.73
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.73
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.63
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.61
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.55
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.5
KOG1243	690	consensus Protein kinase [General function predict	99.49
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.47
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.42
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.39
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.3
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.29
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.29
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.24
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.15
KOG3087	229	consensus Serine/threonine protein kinase [General	99.13
COG4248	637	Uncharacterized protein with protein kinase and he	99.11
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.11
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.03
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.92
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.78
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.77
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.77
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.73
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.69
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.64
PRK09902	216	hypothetical protein; Provisional	98.61
PF01636	239	APH: Phosphotransferase enzyme family This family	98.56
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.48
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.47
PLN02876	822	acyl-CoA dehydrogenase	98.31
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.3
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.23
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.19
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.16
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.14
PRK10593	297	hypothetical protein; Provisional	98.14
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.13
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.11
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.11
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.01
PRK05231	319	homoserine kinase; Provisional	98.01
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.98
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.81
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.8
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.76
KOG2270	520	consensus Serine/threonine protein kinase involved	97.68
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.67
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.46
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.46
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.34
PLN02236	344	choline kinase	97.13
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.13
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.12
PLN02756	418	S-methyl-5-thioribose kinase	96.82
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.79
PRK11768	325	serine/threonine protein kinase; Provisional	96.68
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.68
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.62
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.62
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.56
COG2334	331	Putative homoserine kinase type II (protein kinase	96.41
PRK06148	1013	hypothetical protein; Provisional	96.39
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.2
PRK12396	409	5-methylribose kinase; Reviewed	96.18
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.73
PTZ00384	383	choline kinase; Provisional	95.39
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	95.0

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-54  Score=383.65  Aligned_cols=261  Identities=25%  Similarity=0.383  Sum_probs=215.4

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChh-------hHHHHHHHHHHHhcCCCCcceeEeeEEecC
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSK-------AEMEFAVEVEVLGRVRHKNLLGLRGYCAGT  109 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  109 (380)
                      ...+.|.+.+.||+|+||.|-+|.. ++|+.||||++++....       ......+|+++|.+|+|||||+++++|+.+
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~  248 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP  248 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC
Confidence            3667899999999999999999976 68999999999752211       122356899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC---CceEEe
Q 037869          110 DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD---FEPLVA  186 (380)
Q Consensus       110 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~---~~vkl~  186 (380)
                      +..|+||||++||+|.+++...    ..+.+..-.-++.|++.|+.|||++   ||+||||||+|||++.+   ..+||+
T Consensus       249 ds~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKIt  321 (475)
T KOG0615|consen  249 DSSYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKIT  321 (475)
T ss_pred             CceEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEec
Confidence            9999999999999999999654    5678888889999999999999999   99999999999999876   789999


Q ss_pred             eccCccccCCCCccceeccccccCccCccccccCC---CCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhh
Q 037869          187 DFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK---VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL  263 (380)
Q Consensus       187 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  263 (380)
                      |||+++....  .....++|||+.|.|||++.+..   +..++|+||+||+||.+++|.+||.+......  +    ...
T Consensus       322 DFGlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~s--l----~eQ  393 (475)
T KOG0615|consen  322 DFGLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPS--L----KEQ  393 (475)
T ss_pred             ccchhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCcc--H----HHH
Confidence            9999998753  45677889999999999998654   34588999999999999999999986543210  0    001


Q ss_pred             hhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCC
Q 037869          264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP  319 (380)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~  319 (380)
                      ...+.+.      .........+.+..+||.+||..||++|||+.|+|+|.|..+.
T Consensus       394 I~~G~y~------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  394 ILKGRYA------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             HhcCccc------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence            1111111      1123345678899999999999999999999999999997653

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-53  Score=373.52  Aligned_cols=256  Identities=26%  Similarity=0.353  Sum_probs=214.7

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEecc-cChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCe-EEEEEEe
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQ-RLIVYDY  118 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv~e~  118 (380)
                      ..+.+..||+|..|+||++++ .+++.+|+|++.. ..+....++.+|+++++..+||+||.++|+|..... ++|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            566688999999999999987 5788999999953 455566789999999999999999999999999884 9999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH-EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~-~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |.+|+|.+++...    +.+++.....++.++++||.|||+ +   +|+||||||+||||+..|.|||||||.+..+...
T Consensus       160 MDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS  232 (364)
T ss_pred             cCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhh
Confidence            9999999999653    579999999999999999999996 6   9999999999999999999999999999987543


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                         ...++.||..|||||.+.+..|+.++||||||++++|+.+|+.||.........       +...   +..+.. ..
T Consensus       233 ---~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~-------~~~L---l~~Iv~-~p  298 (364)
T KOG0581|consen  233 ---IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLD-------IFEL---LCAIVD-EP  298 (364)
T ss_pred             ---hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCC-------HHHH---HHHHhc-CC
Confidence               567788999999999999999999999999999999999999999754111000       0000   001111 11


Q ss_pred             cCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          278 RGDFDEN-QLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       278 ~~~~~~~-~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      ...++.. ++.++.+|+..||++||.+|||+.++++|.+-..
T Consensus       299 pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~  340 (364)
T KOG0581|consen  299 PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKK  340 (364)
T ss_pred             CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhh
Confidence            1233443 7789999999999999999999999999976543

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-54  Score=365.91  Aligned_cols=258  Identities=21%  Similarity=0.326  Sum_probs=214.9

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEec--ccChhhHHHHHHHHHHHhcCCCCcceeEee-EEecCCe-EE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLRG-YCAGTDQ-RL  113 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~-~~~~~~~-~~  113 (380)
                      .-..|.|+++||.|+||+||++.+ .+|..||.|.+.  ....+....+..|+.+|++|+|||||++++ .+.+++. ++
T Consensus        17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence            345688899999999999999986 689999999987  345566678999999999999999999998 5655555 89


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCC-CeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP-HIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~-~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      ||||||.+|+|...|+.....+..+++..+|.++.|++.||..+|+.... -|+||||||.|||++.+|.|||+|||+++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence            99999999999999987777778999999999999999999999993222 28999999999999999999999999999


Q ss_pred             ccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      .+... ......++|||.||+||.+.+.+|+.+|||||+||++|||+...+||.+..      ..      ....++.  
T Consensus       177 ~l~s~-~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n------~~------~L~~KI~--  241 (375)
T KOG0591|consen  177 FLSSK-TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN------LL------SLCKKIE--  241 (375)
T ss_pred             Hhcch-hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc------HH------HHHHHHH--
Confidence            88654 344566789999999999999999999999999999999999999998631      11      1111111  


Q ss_pred             cCCcccCCCC-HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 037869          273 VDPKLRGDFD-ENQLKQAINVAVLCVQSEPEKRPNMKEVVNT  313 (380)
Q Consensus       273 ~~~~~~~~~~-~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~  313 (380)
                        ..-..+.| ..++.++..||..|+..||+.||+.-.++..
T Consensus       242 --qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d  281 (375)
T KOG0591|consen  242 --QGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQD  281 (375)
T ss_pred             --cCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence              22223344 5678899999999999999999995555444

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-52  Score=389.07  Aligned_cols=251  Identities=25%  Similarity=0.389  Sum_probs=217.9

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecc---cChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKA---MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      .+|...+.||+|+|+.||.+++ .+|+.||+|++.+   ..+...+.+.+|+++.+.|+|||||+++++|++.++.|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            6799999999999999999998 7899999999975   34556678899999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      |+|+.++|..++++.    ..+++.+++.++.||+.||.|||++   +|+|||||..|+|++++.+|||+|||||..+..
T Consensus        98 ELC~~~sL~el~Krr----k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~  170 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRR----KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY  170 (592)
T ss_pred             EecCCccHHHHHHhc----CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecC
Confidence            999999999999753    6899999999999999999999999   999999999999999999999999999999865


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      .. ....+.||||-|+|||++.....+..+||||+|||||.||+|.+||+...  ....             +..+... 
T Consensus       171 ~~-Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~--vket-------------y~~Ik~~-  233 (592)
T KOG0575|consen  171 DG-ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKT--VKET-------------YNKIKLN-  233 (592)
T ss_pred             cc-cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccch--HHHH-------------HHHHHhc-
Confidence            43 34556789999999999999999999999999999999999999997531  1111             1111111 


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                       .-..|...+.++.+||.++|+.||.+|||+++|+.|-+.
T Consensus       234 -~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  234 -EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF  272 (592)
T ss_pred             -CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence             112345667899999999999999999999999999554

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-51  Score=377.67  Aligned_cols=287  Identities=51%  Similarity=0.912  Sum_probs=250.7

Q ss_pred             cceeccHHHHHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEE
Q 037869           27 TWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC  106 (380)
Q Consensus        27 ~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  106 (380)
                      ..+.|++.|+..+++.|.-...||+|+||+||+|...++..||||++.........+|.+|+.++.+++|||+|+++|+|
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            78899999999999999999999999999999999888899999988765433134599999999999999999999999


Q ss_pred             ecCC-eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEE
Q 037869          107 AGTD-QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV  185 (380)
Q Consensus       107 ~~~~-~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl  185 (380)
                      .+.+ ..++|+||+++|+|.+.+......  .++|..++.|+.++|+||+|||..+.+.|+||||||+|||++.+++.||
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            9988 599999999999999999875322  8899999999999999999999987778999999999999999999999


Q ss_pred             eeccCccccCC-CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh
Q 037869          186 ADFGFAKLIPE-GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI  264 (380)
Q Consensus       186 ~Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  264 (380)
                      +|||+++..+. ........ .||.+|+|||.+..+..+.++||||||++|.||++|+.|...........+..|..+..
T Consensus       219 sDFGLa~~~~~~~~~~~~~~-~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~  297 (361)
T KOG1187|consen  219 SDFGLAKLGPEGDTSVSTTV-MGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLL  297 (361)
T ss_pred             cCccCcccCCccccceeeec-CCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHH
Confidence            99999976543 22111111 69999999999999999999999999999999999998887655444555788888888


Q ss_pred             hccccccccCCccc-CCCCH-HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          265 VKGKFKELVDPKLR-GDFDE-NQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       265 ~~~~~~~~~~~~~~-~~~~~-~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ..+.+.+++++.+. ..++. .....+..+..+|++.+|..||++.++++.|+.
T Consensus       298 ~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~  351 (361)
T KOG1187|consen  298 EEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEG  351 (361)
T ss_pred             HCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHh
Confidence            88899999999987 55554 567779999999999999999999999988843

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-52  Score=368.12  Aligned_cols=253  Identities=23%  Similarity=0.377  Sum_probs=212.0

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ....|.+.++||.|+||+||+|+. .++..||||.+...  ..+..+.+..|+.+|+.++|||||.+++++..++.+|+|
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV   87 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV   87 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence            456899999999999999999987 56899999999764  667777889999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC------CceEEeecc
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD------FEPLVADFG  189 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~------~~vkl~Dfg  189 (380)
                      ||||.||+|.++|++.    +.+++..+..++.||+.||++||++   +||||||||+|||++..      -.+||+|||
T Consensus        88 MEyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG  160 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFG  160 (429)
T ss_pred             EEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence            9999999999999865    5899999999999999999999999   99999999999999764      468999999


Q ss_pred             CccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccc
Q 037869          190 FAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKF  269 (380)
Q Consensus       190 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  269 (380)
                      +++.+..  .....+.+|++.|||||++....|+.|+|+||+|+|+|++++|.+||...........            +
T Consensus       161 fAR~L~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~------------~  226 (429)
T KOG0595|consen  161 FARFLQP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLY------------I  226 (429)
T ss_pred             hhhhCCc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH------------H
Confidence            9999875  3456678999999999999999999999999999999999999999975432111110            0


Q ss_pred             ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 037869          270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL  314 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l  314 (380)
                      .  .........+...+....+|+...++.+|.+|.++.+-..+.
T Consensus       227 ~--k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~  269 (429)
T KOG0595|consen  227 K--KGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHP  269 (429)
T ss_pred             h--ccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhh
Confidence            0  011112223334445566888888889999998888877763

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-51  Score=376.02  Aligned_cols=261  Identities=33%  Similarity=0.501  Sum_probs=216.9

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC-eEE
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD-QRL  113 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~  113 (380)
                      ........+.+.||.|+||+||+|.+.....||||++....  ......|.+|+.+|++++|||||+++|++.+.. .+.
T Consensus        37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~  116 (362)
T KOG0192|consen   37 EIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC  116 (362)
T ss_pred             ecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence            33445566677799999999999998744449999998643  223558999999999999999999999999877 799


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC-eEecCCCCCCeeeCCCC-ceEEeeccCc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH-IIHRDIKASNVLLDSDF-EPLVADFGFA  191 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~-ivHrdlkp~Nill~~~~-~vkl~Dfgl~  191 (380)
                      |||||+++|+|.+++...  ....+++..++.++.||++||.|||+.   + ||||||||+|||++.++ ++||+|||++
T Consensus       117 iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGls  191 (362)
T KOG0192|consen  117 IVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLS  191 (362)
T ss_pred             EEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccc
Confidence            999999999999999763  356899999999999999999999999   7 99999999999999998 9999999999


Q ss_pred             cccCCCCccceeccccccCccCccccc--cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccc
Q 037869          192 KLIPEGVSHMTTRVKGTLGYLAPEYAM--WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKF  269 (380)
Q Consensus       192 ~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  269 (380)
                      +...... .......||..|||||++.  ...|+.|+||||||+++|||+||..||..... .              ...
T Consensus       192 r~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~--------------~~~  255 (362)
T KOG0192|consen  192 REKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-V--------------QVA  255 (362)
T ss_pred             eeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-H--------------HHH
Confidence            8765422 2233357999999999999  56999999999999999999999999987543 0              011


Q ss_pred             ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      ........+...+..++..+..|+.+||+.||..||++.+++..|..+.
T Consensus       256 ~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~  304 (362)
T KOG0192|consen  256 SAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIM  304 (362)
T ss_pred             HHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHH
Confidence            1122234444555567789999999999999999999999999887553

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-51  Score=377.78  Aligned_cols=263  Identities=30%  Similarity=0.497  Sum_probs=230.9

Q ss_pred             HHHHHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeE
Q 037869           33 YKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        33 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  112 (380)
                      .+.+......++.++.||+|.||.||.|.+....+||+|.++... .....|.+|+++|++|+|++||+++++|..+..+
T Consensus       198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~-m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~pi  276 (468)
T KOG0197|consen  198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGS-MSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPI  276 (468)
T ss_pred             cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccc-cChhHHHHHHHHHHhCcccCeEEEEEEEecCCce
Confidence            444555667778899999999999999999877899999998753 3345888999999999999999999999998899


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      ||||||++.|+|.++++.  ..+..+.....+.++.||++|++||+++   ++|||||..+||||+++..+||+|||+++
T Consensus       277 yIVtE~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr  351 (468)
T KOG0197|consen  277 YIVTEYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLAR  351 (468)
T ss_pred             EEEEEecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccccccc
Confidence            999999999999999986  2456799999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      ...+..........-...|.|||.+..+.++.+||||||||+||||+| |+.||.+.+                ...+.+
T Consensus       352 ~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms----------------n~ev~~  415 (468)
T KOG0197|consen  352 LIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMS----------------NEEVLE  415 (468)
T ss_pred             ccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCC----------------HHHHHH
Confidence            665554444444445889999999999999999999999999999999 999987654                233455


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .++.+.+-+.|..++.++.+++..||+.+|++|||++.+...+..+
T Consensus       416 ~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~  461 (468)
T KOG0197|consen  416 LLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDF  461 (468)
T ss_pred             HHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHh
Confidence            6778888899999999999999999999999999999998888765

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=4.1e-51  Score=348.96  Aligned_cols=267  Identities=20%  Similarity=0.286  Sum_probs=212.3

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      +.|+.+.++|+|+||+||++++ .+|+.||||++....  +.-..-..+|+++|++|+|+|+|.++++|.....+++|+|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            5788999999999999999998 469999999997533  3334567789999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      ||+. ++.+.+....   ..++.+.+.++++|++.|+.|+|++   +++||||||+||||+.+|.+||||||+|+.+...
T Consensus        82 ~~dh-TvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   82 YCDH-TVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             ecch-HHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            9976 7777776542   4688999999999999999999999   9999999999999999999999999999998753


Q ss_pred             CccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchh---------ccchhhhhcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTIT---------EWAEPLIVKG  267 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~---------~~~~~~~~~~  267 (380)
                       ....+.++.|.||+|||.+.| .+|...+||||+||++.||++|.+-|.+.++-.+....         +....+..+.
T Consensus       155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~  233 (396)
T KOG0593|consen  155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNP  233 (396)
T ss_pred             -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCC
Confidence             334556678999999999997 78999999999999999999999999876542221111         1111111111


Q ss_pred             ccccccCCcc--c---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          268 KFKELVDPKL--R---GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       268 ~~~~~~~~~~--~---~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .+.-+.-|..  .   ....+..+..+.+|++.||..||.+|++-++++.|..
T Consensus       234 ~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~y  286 (396)
T KOG0593|consen  234 FFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPY  286 (396)
T ss_pred             ceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChH
Confidence            1111111111  1   1122344567899999999999999999999999844

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-50  Score=355.13  Aligned_cols=253  Identities=25%  Similarity=0.332  Sum_probs=213.0

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      ..+.|++++.||+|+||.||.++. .+++.||+|++++.   ...+.....+|..+|..++||.||+++-.|++...+|+
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence            457899999999999999999986 56899999999863   23455678889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      |+||+.||.|...++++    +.+++..+..++..|+.||.|||+.   |||||||||+|||++.+|+++|+|||+++..
T Consensus       103 Vld~~~GGeLf~hL~~e----g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~  175 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQRE----GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKED  175 (357)
T ss_pred             EEeccCCccHHHHHHhc----CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhc
Confidence            99999999999999754    6899999999999999999999999   9999999999999999999999999999864


Q ss_pred             CCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      -.. ...+.+++||+.|+|||++.+..|+..+|.||||+++|||++|.+||......      .         .+..+..
T Consensus       176 ~~~-~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~------~---------~~~~I~~  239 (357)
T KOG0598|consen  176 LKD-GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK------K---------MYDKILK  239 (357)
T ss_pred             ccC-CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH------H---------HHHHHhc
Confidence            332 23455689999999999999999999999999999999999999999764310      0         0111111


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCC----CHHHHHHHhc
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRP----NMKEVVNTLT  315 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp----s~~~ll~~l~  315 (380)
                      .. ....+.-.+.++++++.++|..||++|.    ++.+|-+|..
T Consensus       240 ~k-~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~Hpf  283 (357)
T KOG0598|consen  240 GK-LPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPF  283 (357)
T ss_pred             Cc-CCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcc
Confidence            11 1122333557899999999999999994    7888888743

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-51  Score=365.97  Aligned_cols=266  Identities=24%  Similarity=0.327  Sum_probs=217.0

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecc-cChhhHHHHHHHHHHHhcCC-CCcceeEeeEEecCC-eE
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVR-HKNLLGLRGYCAGTD-QR  112 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~-~~  112 (380)
                      ....++|++.++||.|.||.||+|+. .+|+.||||+++. ....+...-++|++.|++++ ||||+++.+++.+.+ .+
T Consensus         6 ~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L   85 (538)
T KOG0661|consen    6 VIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRIL   85 (538)
T ss_pred             hhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence            34668999999999999999999986 5789999999985 33455556677999999998 999999999998877 89


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      |+|||||+ .+|..+++.+   +..+++..+..|++||++||+|+|.+   |+.|||+||+|||+.....|||+|||+|+
T Consensus        86 ~fVfE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLAR  158 (538)
T KOG0661|consen   86 YFVFEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAR  158 (538)
T ss_pred             eeeHHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEeccccccc
Confidence            99999995 5999999865   57899999999999999999999999   99999999999999988899999999999


Q ss_pred             ccCCCCccceeccccccCccCccccc-cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccc---
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGK---  268 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---  268 (380)
                      .+...  ...+.++.|.||+|||++. .+.|+.+.|+|++|||++|+.+.++-|.+..+..     ++.....+.|.   
T Consensus       159 ev~Sk--pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D-----qi~KIc~VLGtP~~  231 (538)
T KOG0661|consen  159 EVRSK--PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID-----QIYKICEVLGTPDK  231 (538)
T ss_pred             ccccC--CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH-----HHHHHHHHhCCCcc
Confidence            87653  3345667899999999987 5679999999999999999999999998755422     21111111111   


Q ss_pred             ----------------cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          269 ----------------FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       269 ----------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                                      +.+.....+. .+-++.+.++.++|.+|++.||.+||||.++++|...-
T Consensus       232 ~~~~eg~~La~~mnf~~P~~~~~~l~-~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq  295 (538)
T KOG0661|consen  232 DSWPEGYNLASAMNFRFPQVKPSPLK-DLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQ  295 (538)
T ss_pred             ccchhHHHHHHHhccCCCcCCCCChH-HhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccc
Confidence                            1111111111 22234778999999999999999999999999996644

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-49  Score=362.64  Aligned_cols=266  Identities=26%  Similarity=0.346  Sum_probs=218.6

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCe
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQ  111 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  111 (380)
                      +...+.|.+.+.||.|+|++|++|+. .+++.||||++.+.   ..........|-.+|..| .||.|++++-.|+++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            34567899999999999999999986 57999999998652   222233455688888888 89999999999999999


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA  191 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~  191 (380)
                      +|+|+||+++|+|.++|.+.    +.+++..++.++.+|+.||+|||++   |||||||||+|||++.+++++|+|||.+
T Consensus       149 LYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsA  221 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSA  221 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeecccc
Confidence            99999999999999999865    6899999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc------------ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhcc
Q 037869          192 KLIPEGVSH------------MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEW  259 (380)
Q Consensus       192 ~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~  259 (380)
                      ..++.....            ....++||..|.+||++.....+..+|||+||||+|+|++|.+||.+..+  ....   
T Consensus       222 K~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ne--yliF---  296 (604)
T KOG0592|consen  222 KILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANE--YLIF---  296 (604)
T ss_pred             ccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccH--HHHH---
Confidence            887532111            12458899999999999999999999999999999999999999986432  1111   


Q ss_pred             chhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc--CCCCCCccccc
Q 037869          260 AEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT--GYDPRGKVMQT  326 (380)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~--~~~~~~~~~~~  326 (380)
                             .++..     +.-.+++..++.+.+||.+.|..||++|+|+++|.+|..  ..++...+.++
T Consensus       297 -------qkI~~-----l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~  353 (604)
T KOG0592|consen  297 -------QKIQA-----LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQT  353 (604)
T ss_pred             -------HHHHH-----hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcC
Confidence                   01111     122455556688999999999999999999999999944  44454444333

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4.3e-49  Score=331.01  Aligned_cols=264  Identities=22%  Similarity=0.313  Sum_probs=213.3

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChh--hHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSK--AEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      .+|...++||+|.||.||+|++ .+|+.||||+++....+  ......+|++.|+.++|+||+.++++|...+.+.+|+|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            5788999999999999999987 68999999999864433  24578889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |++. +|+..|+..   ...++...+..++.++++||+|||++   .|+||||||.|+|++++|.+||+|||+++.+...
T Consensus        82 fm~t-dLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   82 FMPT-DLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             eccc-cHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9975 999999754   56899999999999999999999999   9999999999999999999999999999998765


Q ss_pred             CccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccc-----
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE-----  271 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  271 (380)
                      ....... +.|.||+|||.+.| ..|+..+|+||.|||+.||+-|.+-|.+.++-     ++....+..-|....     
T Consensus       155 ~~~~~~~-V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDi-----dQL~~If~~LGTP~~~~WP~  228 (318)
T KOG0659|consen  155 NRIQTHQ-VVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDI-----DQLSKIFRALGTPTPDQWPE  228 (318)
T ss_pred             Ccccccc-eeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchH-----HHHHHHHHHcCCCCcccCcc
Confidence            4443333 57999999999986 46999999999999999999888777654431     111111111111110     


Q ss_pred             -----------ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          272 -----------LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       272 -----------~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                                 .........+.+..+.++.+|+..||..||.+|+|+.|+++|-...
T Consensus       229 ~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~  285 (318)
T KOG0659|consen  229 MTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFK  285 (318)
T ss_pred             ccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhh
Confidence                       0111111224445667889999999999999999999999995543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-49  Score=365.38  Aligned_cols=256  Identities=24%  Similarity=0.352  Sum_probs=219.7

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      .+...|+..++||+|+.|.||.|+. .+++.||||++........+-+.+|+.+|+..+|+|||++++.|...+.+|+||
T Consensus       270 dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM  349 (550)
T KOG0578|consen  270 DPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM  349 (550)
T ss_pred             ChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence            4557899999999999999999975 678899999998766666778999999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||++||+|.+.+...     .+++.++..++..++.||+|||.+   ||+|||||.+|||++.+|.+||+|||++..+..
T Consensus       350 Eym~ggsLTDvVt~~-----~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~  421 (550)
T KOG0578|consen  350 EYMEGGSLTDVVTKT-----RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE  421 (550)
T ss_pred             eecCCCchhhhhhcc-----cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence            999999999999654     599999999999999999999999   999999999999999999999999999998876


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      ... .....+||+.|||||+.....|.+++||||||++++||+-|++||-...+  ...+.          .+..  ...
T Consensus       422 ~~~-KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P--lrAly----------LIa~--ng~  486 (550)
T KOG0578|consen  422 EQS-KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP--LRALY----------LIAT--NGT  486 (550)
T ss_pred             ccC-ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh--HHHHH----------HHhh--cCC
Confidence            543 45556799999999999999999999999999999999999999964221  11111          0111  111


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .....+...+..+.+|+.+||..||.+||++.|||+|..-
T Consensus       487 P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl  526 (550)
T KOG0578|consen  487 PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFL  526 (550)
T ss_pred             CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhh
Confidence            2223455667899999999999999999999999999653

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-48  Score=349.28  Aligned_cols=271  Identities=24%  Similarity=0.334  Sum_probs=221.2

Q ss_pred             HHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeE
Q 037869           35 ELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        35 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  112 (380)
                      ++....+.|++.+.||.|..++||+|++ ..++.||||++.... ..+...+.+|+..|+.++||||++++.+|..+..+
T Consensus        20 ~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~L   99 (516)
T KOG0582|consen   20 EFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSEL   99 (516)
T ss_pred             cCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEeccee
Confidence            3445788999999999999999999987 678999999998533 33457899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      |+||+||.+|++.+.+...+..  .+++..+..++.++++||.|||.+   |.+|||||+.||||+.+|.|||+|||.+.
T Consensus       100 WvVmpfMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa  174 (516)
T KOG0582|consen  100 WVVMPFMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSA  174 (516)
T ss_pred             EEeehhhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeee
Confidence            9999999999999999876543  499999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCccc---eeccccccCccCccccc--cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcc
Q 037869          193 LIPEGVSHM---TTRVKGTLGYLAPEYAM--WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKG  267 (380)
Q Consensus       193 ~~~~~~~~~---~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  267 (380)
                      .+.......   ...+.||++|+|||++.  ...|+.|+|||||||+..||.+|..||...++..-...       ...+
T Consensus       175 ~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~-------tLqn  247 (516)
T KOG0582|consen  175 SLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLL-------TLQN  247 (516)
T ss_pred             eecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHH-------HhcC
Confidence            764432221   15568999999999965  35699999999999999999999999987654211111       1111


Q ss_pred             ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ....+....+..+.....+..+.++|..||.+||.+|||++++++|-+..
T Consensus       248 ~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk  297 (516)
T KOG0582|consen  248 DPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFK  297 (516)
T ss_pred             CCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHh
Confidence            11111122223333345567899999999999999999999999985543

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-49  Score=351.77  Aligned_cols=259  Identities=28%  Similarity=0.425  Sum_probs=210.8

Q ss_pred             hCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC--eEEEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD--QRLIVY  116 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~lv~  116 (380)
                      ..+|...+.||+|+||+||++.+. +|...|||.+..........+.+|+.+|++++|||||+++|......  .++++|
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m   95 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM   95 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence            456888999999999999999874 58999999987653333567899999999999999999999754444  689999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-CCceEEeeccCccccC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS-DFEPLVADFGFAKLIP  195 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~-~~~vkl~Dfgl~~~~~  195 (380)
                      ||+++|+|.+++.+.   +..+++..+..+..|+++||+|||++   ||+||||||+|||++. ++.+||+|||++....
T Consensus        96 Ey~~~GsL~~~~~~~---g~~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   96 EYAPGGSLSDLIKRY---GGKLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             eccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            999999999999865   12799999999999999999999999   9999999999999999 7999999999998776


Q ss_pred             C--CCccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          196 E--GVSHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       196 ~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      .  ..........||+.|+|||++..+ ....++|||||||++.||+||.+||.......        .      .+..+
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~--------~------~~~~i  235 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEA--------E------ALLLI  235 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchH--------H------HHHHH
Confidence            3  222334457799999999999953 34459999999999999999999997631000        0      00011


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      ......+.++...+.++.+++.+|+..+|+.||||.++|+|.+...
T Consensus       236 g~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  236 GREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             hccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence            1111222566667789999999999999999999999999987544

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.1e-49  Score=355.38  Aligned_cols=266  Identities=25%  Similarity=0.351  Sum_probs=215.3

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecC--CeEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT--DQRL  113 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~  113 (380)
                      -...|+.+++||+|.||.||+|++ .+|+.||+|+++...  +.......+|+.+|++|+||||+++.+...+.  ..+|
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY  194 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY  194 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence            345788899999999999999987 679999999998543  55566788899999999999999999998776  6899


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +|+|||+. +|..++..   ....|++.++..++.||+.||.|+|++   ||+|||||.+||||+.+|.+||+|||||+.
T Consensus       195 lVFeYMdh-DL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~  267 (560)
T KOG0600|consen  195 LVFEYMDH-DLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARF  267 (560)
T ss_pred             EEEecccc-hhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceee
Confidence            99999976 88888864   356899999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      +........+..+-|.||+|||++.|. .|+.++|+||+||||.||++|.+.|.+..+..+     +...+...+...+.
T Consensus       268 y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ-----l~kIfklcGSP~e~  342 (560)
T KOG0600|consen  268 YTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ-----LHKIFKLCGSPTED  342 (560)
T ss_pred             ccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH-----HHHHHHHhCCCChh
Confidence            876555555666789999999999874 699999999999999999999999987654222     22222222221111


Q ss_pred             cCC--cc--------cCCC-------CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          273 VDP--KL--------RGDF-------DENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       273 ~~~--~~--------~~~~-------~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ..+  .+        ...+       ....++...+|+..+|..||.+|.|+.++|++-..
T Consensus       343 ~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF  403 (560)
T KOG0600|consen  343 YWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF  403 (560)
T ss_pred             ccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence            111  00        0011       12345678999999999999999999999987443

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=1.8e-48  Score=356.33  Aligned_cols=287  Identities=22%  Similarity=0.303  Sum_probs=224.4

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      -.+.|++++.||+|+||.||+|+. .+|+.||+|++++..   .......+.|-.+|....+|+||+++-+|++.+++||
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL  218 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL  218 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence            447899999999999999999986 579999999998643   2334567789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ||||++||++..++.+.    ..+++..+..++.+++.|+..||+.   |++||||||+|+||+..|++||+||||+.-+
T Consensus       219 iMEylPGGD~mTLL~~~----~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl  291 (550)
T KOG0605|consen  219 IMEYLPGGDMMTLLMRK----DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGL  291 (550)
T ss_pred             EEEecCCccHHHHHHhc----CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchh
Confidence            99999999999999653    6899999999999999999999999   9999999999999999999999999998432


Q ss_pred             CC-----------------------CCc-----------------------cceeccccccCccCccccccCCCCccchh
Q 037869          195 PE-----------------------GVS-----------------------HMTTRVKGTLGYLAPEYAMWGKVSESCDV  228 (380)
Q Consensus       195 ~~-----------------------~~~-----------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  228 (380)
                      ..                       ...                       ......+|||.|+|||++.+..|+..+|.
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDw  371 (550)
T KOG0605|consen  292 DKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDW  371 (550)
T ss_pred             hhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccH
Confidence            10                       000                       00112459999999999999999999999


Q ss_pred             hhhhHHHHHHHhCCCCCCCCCCCc-ccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC--
Q 037869          229 YSFGILLLEILTGRKPIEKLPGGV-KRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRP--  305 (380)
Q Consensus       229 wslG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp--  305 (380)
                      ||||||+||||.|.+||....... ...+..|..              .+..+-....+.++.+||.+||. ||+.|.  
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~--------------~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~  436 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRE--------------TLKFPEEVDLSDEAKDLITRLLC-DPENRLGS  436 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhh--------------hccCCCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence            999999999999999998754311 111111111              11222223344899999999999 999994  


Q ss_pred             -CHHHHHHHhcCC--CCCC--cccccchhhccchhhhhcccCcCCCC
Q 037869          306 -NMKEVVNTLTGY--DPRG--KVMQTRIETLAYKEELLAFDQTTDDD  347 (380)
Q Consensus       306 -s~~~ll~~l~~~--~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~  347 (380)
                       +++||.+|.+..  ++..  .......++....++...|+...+.+
T Consensus       437 ~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~~~~DT~yFddF~e~~  483 (550)
T KOG0605|consen  437 KGAEEIKKHPFFKGVDWDHLREMPAPFVPQVNSELDTQYFDDFPEED  483 (550)
T ss_pred             ccHHHHhcCCccccCCcchhhcCCCCCCCCCCCcccccccccCcccc
Confidence             799999996643  3332  22334455555566666666554433

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-48  Score=358.52  Aligned_cols=256  Identities=23%  Similarity=0.353  Sum_probs=214.3

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc----Ch-hhHHHHHHHHHHHhcCC-CCcceeEeeEEecCC
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM----NS-KAEMEFAVEVEVLGRVR-HKNLLGLRGYCAGTD  110 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~----~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  110 (380)
                      ...+.|.+.+.||+|+||+|++|.+ .+++.||+|++...    .. .....+.+|+.+++.++ ||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4567999999999999999999976 57899999977653    11 23446668999999998 999999999999999


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-CceEEeecc
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD-FEPLVADFG  189 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~-~~vkl~Dfg  189 (380)
                      .+|+|||||.||+|.+++..    .+++.+..+..+|.|++.|++|||++   ||+||||||+|||++.+ +++||+|||
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG  166 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFG  166 (370)
T ss_pred             eEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccc
Confidence            99999999999999999975    36899999999999999999999999   99999999999999999 999999999


Q ss_pred             CccccCCCCccceeccccccCccCccccccCC-CC-ccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcc
Q 037869          190 FAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK-VS-ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKG  267 (380)
Q Consensus       190 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  267 (380)
                      ++.... .........+||+.|+|||++.+.. |+ .++||||+|++||.|++|..||......  ..            
T Consensus       167 ~s~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~--~l------------  231 (370)
T KOG0583|consen  167 LSAISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP--NL------------  231 (370)
T ss_pred             cccccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH--HH------------
Confidence            999874 2234566778999999999999877 85 8899999999999999999999862210  00            


Q ss_pred             ccccccCCcccCCCCHHH-HHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          268 KFKELVDPKLRGDFDENQ-LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~-~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                       +..+...  .-.++... +.++.+|+.+||..||..|+|+.+|+.|.|...
T Consensus       232 -~~ki~~~--~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  232 -YRKIRKG--EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             -HHHHhcC--CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence             0001111  11223333 689999999999999999999999999987653

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-48  Score=349.43  Aligned_cols=254  Identities=26%  Similarity=0.327  Sum_probs=216.9

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh-hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      .....|+..++||+|+||.||+|.+ .+++.||+|++..... .+.+.+..|+.+|.+++++||.++++.+..+..++++
T Consensus        10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii   89 (467)
T KOG0201|consen   10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII   89 (467)
T ss_pred             CcccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence            3567899999999999999999987 6789999999986443 3456788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      ||||.||++.+.+...    ..+++..+..++.+++.||.|||.+   +.+|||||+.|||+..+|.+||+|||.+-++.
T Consensus        90 Mey~~gGsv~~lL~~~----~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~  162 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKSG----NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLT  162 (467)
T ss_pred             HHHhcCcchhhhhccC----CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeee
Confidence            9999999999999754    3447888888999999999999999   99999999999999999999999999999887


Q ss_pred             CCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      ...... .+++||+.|||||++.+..|+.++||||||++.+||++|.+|+....+....                .++..
T Consensus       163 ~~~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvl----------------flIpk  225 (467)
T KOG0201|consen  163 NTVKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVL----------------FLIPK  225 (467)
T ss_pred             chhhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEE----------------EeccC
Confidence            654443 7788999999999999999999999999999999999999999876542111                11222


Q ss_pred             cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .....+...++..+.+|+..||++||+.||||.+||+|-.
T Consensus       226 ~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~F  265 (467)
T KOG0201|consen  226 SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKF  265 (467)
T ss_pred             CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHH
Confidence            2222333356678999999999999999999999999844

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=5e-47  Score=327.90  Aligned_cols=265  Identities=25%  Similarity=0.333  Sum_probs=213.1

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh--hhHHHHHHHHHHHhcCCCCcceeEeeEEecC--CeEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS--KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT--DQRLIV  115 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv  115 (380)
                      +.|..+.+|++|+||.||+|++ ++++.||+|+++....  .....-++|+.+|.+.+|||||.+-.+....  +.+|||
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            5688899999999999999997 6799999999985432  2334677899999999999999999887543  569999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      ||||+. +|..++...   ..++...++.-++.|+++|++|||.+   .|+||||||+|+|++..|.+||+|||+|+.+.
T Consensus       156 Me~~Eh-DLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg  228 (419)
T KOG0663|consen  156 MEYVEH-DLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYG  228 (419)
T ss_pred             HHHHHh-hHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhc
Confidence            999976 899998765   35899999999999999999999999   89999999999999999999999999999987


Q ss_pred             CCCccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      .... ..+..+-|.||+|||++.|. .|+.+.|+||+|||+.||+++.+-|.+.++     +.++...+...+...+...
T Consensus       229 sp~k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE-----~dQl~~If~llGtPte~iw  302 (419)
T KOG0663|consen  229 SPLK-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE-----IDQLDKIFKLLGTPSEAIW  302 (419)
T ss_pred             CCcc-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch-----HHHHHHHHHHhCCCccccC
Confidence            6533 34455679999999999875 599999999999999999999999977543     2222222222222222222


Q ss_pred             Cc-------------------ccCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          275 PK-------------------LRGDFDEN-QLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       275 ~~-------------------~~~~~~~~-~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      ++                   ++..+... .+....+|+..+|..||.+|.|+++.|+|-+...
T Consensus       303 pg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e  366 (419)
T KOG0663|consen  303 PGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRE  366 (419)
T ss_pred             CCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhccccccc
Confidence            21                   12222222 4577899999999999999999999999977654

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-47  Score=324.34  Aligned_cols=249  Identities=27%  Similarity=0.334  Sum_probs=213.8

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      .+|++.+.||.|+||+|.+++. .++.-||+|++....   .+..+...+|..+|+.+.||.++++++.+.+.+.+|+||
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm  123 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM  123 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence            4788899999999999999987 468889999998643   233445677999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||++||.|+.++++.    .++++..++.++.||+.||+|||+.   +|++|||||+|||++.+|.+||+|||.+..+..
T Consensus       124 eyv~GGElFS~Lrk~----~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  124 EYVPGGELFSYLRKS----GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             eccCCccHHHHHHhc----CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            999999999999765    5899999999999999999999999   999999999999999999999999999998753


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                          .+.+.||||.|+|||++....|..++|.||||+++|||+.|.+||.....               ...+..++...
T Consensus       197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~---------------~~iY~KI~~~~  257 (355)
T KOG0616|consen  197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNP---------------IQIYEKILEGK  257 (355)
T ss_pred             ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCCh---------------HHHHHHHHhCc
Confidence                46778999999999999999999999999999999999999999976432               11112222222


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCC-----CCHHHHHHHhcCC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKR-----PNMKEVVNTLTGY  317 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~R-----ps~~~ll~~l~~~  317 (380)
                      +  .+|+..+.++.+|+..+|+.|-.+|     ....+|.+|.|..
T Consensus       258 v--~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~  301 (355)
T KOG0616|consen  258 V--KFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFK  301 (355)
T ss_pred             c--cCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccc
Confidence            2  3566667899999999999999999     4667888886643

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8.5e-48  Score=352.64  Aligned_cols=249  Identities=24%  Similarity=0.381  Sum_probs=214.0

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecc--cChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKA--MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ++|.+.+.||+|+||.||+|+. .+.+.||+|.+.+  ...++...+.+|+++++.++||||+.++++|+...++|+|+|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            6799999999999999999986 5688899999875  345566789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      ||.| +|..++..    +..++++.+..++.|++.||.|||++   +|+|||+||+|||+...|.+|+||||+++.+...
T Consensus        82 ~a~g-~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   82 YAVG-DLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             hhhh-hHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            9977 99999964    46899999999999999999999999   9999999999999999999999999999988654


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      . .......|||.|||||+..+.+|+..+|+||+|||+||+.+|++||...+      +.+...         .+.... 
T Consensus       154 t-~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s------i~~Lv~---------~I~~d~-  216 (808)
T KOG0597|consen  154 T-SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS------ITQLVK---------SILKDP-  216 (808)
T ss_pred             c-eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH------HHHHHH---------HHhcCC-
Confidence            3 34455679999999999999999999999999999999999999996422      111111         111111 


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                       ...+...+..+.+++...|.+||..|.|..+++.|..
T Consensus       217 -v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF  253 (808)
T KOG0597|consen  217 -VKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPF  253 (808)
T ss_pred             -CCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChH
Confidence             1234467789999999999999999999999999854

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2e-47  Score=356.37  Aligned_cols=250  Identities=23%  Similarity=0.325  Sum_probs=216.3

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      -+-|++.+.||.|+.|.|-+|++ .+|+.+|||++...   .......+.+|+-+|+.+.|||++++++++++..++|+|
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv   90 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV   90 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence            35688899999999999999987 68999999999754   223344688899999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      .||++||.|++++..    ++++++.++.+++.||+.|+.|+|..   +|+||||||+|+|++..++|||+|||+|..-.
T Consensus        91 lEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~  163 (786)
T KOG0588|consen   91 LEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEV  163 (786)
T ss_pred             EEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeeccc
Confidence            999999999999965    47899999999999999999999999   99999999999999999999999999998754


Q ss_pred             CCCccceeccccccCccCccccccCCC-CccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      .  .....+.||++.|.|||++.|.+| ..++||||+|||||.||||..||.+..                   +..++.
T Consensus       164 ~--gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-------------------ir~LLl  222 (786)
T KOG0588|consen  164 P--GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-------------------IRVLLL  222 (786)
T ss_pred             C--CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-------------------HHHHHH
Confidence            3  344566799999999999999998 689999999999999999999997421                   112222


Q ss_pred             Ccc--cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          275 PKL--RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       275 ~~~--~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      +-.  .-.+|.+++.++++||.+||..||+.|.|.++|++|++-.
T Consensus       223 KV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~  267 (786)
T KOG0588|consen  223 KVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLS  267 (786)
T ss_pred             HHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhh
Confidence            111  1245677889999999999999999999999999997644

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.2e-47  Score=336.61  Aligned_cols=252  Identities=20%  Similarity=0.371  Sum_probs=216.5

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeE
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  112 (380)
                      +....+|++.+.||+|.||.|-+|+. ..|+.||||.+++.   ...+...+++|+++|+.|+||||+.++++|+..+.+
T Consensus        49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI  128 (668)
T KOG0611|consen   49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI  128 (668)
T ss_pred             cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence            34668999999999999999999986 78999999999863   344555788899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      .|||||..+|.|.+++..+    ..+++.+++.+|.||+.|+.|+|.+   +++|||||.+|||++.++++||+|||++.
T Consensus       129 vivMEYaS~GeLYDYiSer----~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSN  201 (668)
T KOG0611|consen  129 VIVMEYASGGELYDYISER----GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSN  201 (668)
T ss_pred             EEEEEecCCccHHHHHHHh----ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhh
Confidence            9999999999999999654    6899999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCccceeccccccCccCccccccCCC-CccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      .+..  .....++||++.|.+||++.|.+| .+.+|-||||++||.|+.|..||++.+-               ..-+.+
T Consensus       202 ly~~--~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---------------k~lvrQ  264 (668)
T KOG0611|consen  202 LYAD--KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---------------KRLVRQ  264 (668)
T ss_pred             hhcc--ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---------------HHHHHH
Confidence            8755  456677899999999999999998 6789999999999999999999987431               111112


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      +.....+.   +..+.++.-||.+||..||++|.|+.+|..|-|
T Consensus       265 Is~GaYrE---P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  265 ISRGAYRE---PETPSDASGLIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             hhcccccC---CCCCchHHHHHHHHHhcCcccchhHHHHhhhhe
Confidence            22222221   122356778999999999999999999999965

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-47  Score=333.52  Aligned_cols=268  Identities=24%  Similarity=0.330  Sum_probs=211.8

Q ss_pred             HHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEec--ccChhhHHHHHHHHHHHhcCCCCcceeEeeEEec---
Q 037869           35 ELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG---  108 (380)
Q Consensus        35 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---  108 (380)
                      +.......|...+.||.|+||.|+.|.+ .+|+.||||++.  -.......+..+|+++|+.++|+||+.+.+++..   
T Consensus        16 ~~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   16 ELFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR   95 (359)
T ss_pred             eEEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence            3445677888899999999999999987 679999999997  3455566788899999999999999999999865   


Q ss_pred             --CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEe
Q 037869          109 --TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVA  186 (380)
Q Consensus       109 --~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~  186 (380)
                        -+.+|+|+|++ +-+|...|+.+    ..++...+..+++|+++||.|+|+.   +|+||||||.|++++.+..+||+
T Consensus        96 ~~f~DvYiV~elM-etDL~~iik~~----~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~  167 (359)
T KOG0660|consen   96 DKFNDVYLVFELM-ETDLHQIIKSQ----QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKIC  167 (359)
T ss_pred             cccceeEEehhHH-hhHHHHHHHcC----ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEec
Confidence              35689999999 45899998754    3599999999999999999999998   99999999999999999999999


Q ss_pred             eccCccccCCC-CccceeccccccCccCccccc-cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh
Q 037869          187 DFGFAKLIPEG-VSHMTTRVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI  264 (380)
Q Consensus       187 Dfgl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  264 (380)
                      |||+|+..... .....+.++.|.||+|||++. ...|+.+.||||+|||+.||++|++-|.+.+...+.     .....
T Consensus       168 DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql-----~lI~~  242 (359)
T KOG0660|consen  168 DFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQL-----QLILE  242 (359)
T ss_pred             cccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHH-----HHHHH
Confidence            99999987543 122335567899999999887 567999999999999999999999999875431111     11110


Q ss_pred             hccc----------------cccccCCccc---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          265 VKGK----------------FKELVDPKLR---GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       265 ~~~~----------------~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ..+.                +........+   ....++..+.+.+|+.+||..||.+|+|++|.|.|..
T Consensus       243 ~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPY  312 (359)
T KOG0660|consen  243 LLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPY  312 (359)
T ss_pred             hcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChh
Confidence            0000                0000000001   1112255678999999999999999999999999954

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7e-47  Score=346.17  Aligned_cols=253  Identities=23%  Similarity=0.320  Sum_probs=218.9

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCe-EEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQ-RLIV  115 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-~~lv  115 (380)
                      -++|..++.+|+|+||.+++++. .++..|++|.+...  ....+....+|+.++++++|||||.+.+.|++++. ++||
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            36799999999999999999976 46889999999743  33344477889999999999999999999998888 9999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |+||+||++.+.|..+.  +..++++.+..|+.|++.|+.|||+.   .|+|||||+.|||++.++.|+|+|||+++.+.
T Consensus        83 m~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~  157 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILN  157 (426)
T ss_pred             EeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcC
Confidence            99999999999998764  57899999999999999999999988   99999999999999999999999999999987


Q ss_pred             CCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      ... .....+.||+.|+.||++.+.+|..|+|||||||++|||++-+++|...+...                +..-...
T Consensus       158 ~~~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~----------------Li~ki~~  220 (426)
T KOG0589|consen  158 PED-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE----------------LILKINR  220 (426)
T ss_pred             Cch-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHH----------------HHHHHhh
Confidence            643 24566789999999999999999999999999999999999999998644210                0011112


Q ss_pred             cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 037869          276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL  314 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l  314 (380)
                      ....+.+..++.++..+|..||+.+|..||++.+||.++
T Consensus       221 ~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P  259 (426)
T KOG0589|consen  221 GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP  259 (426)
T ss_pred             ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence            234566778889999999999999999999999999873

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7e-46  Score=349.29  Aligned_cols=257  Identities=23%  Similarity=0.260  Sum_probs=207.0

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ...++|++.+.||+|+||.||+|++ .++..||+|++...   .......+.+|+.+++.++||||+++++++..++..|
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence            3456899999999999999999987 46889999999642   2223345778999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||+++|+|.+++...     .+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++..
T Consensus       120 lv~Ey~~gg~L~~~l~~~-----~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~  191 (370)
T cd05596         120 MVMEYMPGGDLVNLMSNY-----DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMK  191 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceee
Confidence            999999999999998643     578889999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCccceeccccccCccCccccccC----CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWG----KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKF  269 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  269 (380)
                      .............||+.|+|||++.+.    .++.++|||||||++|||++|..||.......  .             +
T Consensus       192 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~-------------~  256 (370)
T cd05596         192 MDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG--T-------------Y  256 (370)
T ss_pred             ccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH--H-------------H
Confidence            643322223345699999999998753    47899999999999999999999997533210  0             0


Q ss_pred             ccccCCc--ccCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHHhcCC
Q 037869          270 KELVDPK--LRGDFDENQLKQAINVAVLCVQSEPEK--RPNMKEVVNTLTGY  317 (380)
Q Consensus       270 ~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~P~~--Rps~~~ll~~l~~~  317 (380)
                      ..+....  +..+.....+.++.+||.+||+.+|.+  |+|+.++++|.+..
T Consensus       257 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~  308 (370)
T cd05596         257 SKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFK  308 (370)
T ss_pred             HHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccC
Confidence            1111110  111111234578999999999999988  99999999997654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=7e-46  Score=345.70  Aligned_cols=262  Identities=24%  Similarity=0.369  Sum_probs=205.1

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe------CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcC-CCCcceeEeeEEecC
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT------SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGT  109 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  109 (380)
                      ...++|++.+.||+|+||.||+|.+      .++..||+|+++... ......+.+|+.++..+ +||||+++++++...
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            3567899999999999999999963      235679999997533 33445788899999999 899999999988764


Q ss_pred             -CeEEEEEEecCCCCHHHhhccCCC-------------------------------------------------------
Q 037869          110 -DQRLIVYDYMPNLSLLSHLHGQYA-------------------------------------------------------  133 (380)
Q Consensus       110 -~~~~lv~e~~~~g~L~~~i~~~~~-------------------------------------------------------  133 (380)
                       ..+++||||+++|+|.+++.....                                                       
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             458999999999999999864311                                                       


Q ss_pred             ---CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCcc-ceecccccc
Q 037869          134 ---GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH-MTTRVKGTL  209 (380)
Q Consensus       134 ---~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~-~~~~~~gt~  209 (380)
                         ....+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+|||+++........ ......++.
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence               013478889999999999999999999   9999999999999999999999999999865332211 122234567


Q ss_pred             CccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHH
Q 037869          210 GYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQ  288 (380)
Q Consensus       210 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (380)
                      .|+|||++.+..++.++|||||||++|||++ |..||........  .   .. ....         ......+...+..
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~--~---~~-~~~~---------~~~~~~~~~~~~~  305 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEE--F---CQ-RLKD---------GTRMRAPENATPE  305 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHH--H---HH-HHhc---------CCCCCCCCCCCHH
Confidence            8999999999999999999999999999997 9999975432110  0   00 0000         1111123344578


Q ss_pred             HHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          289 AINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       289 ~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      +.+++.+||+.||.+|||+.+|++.|...
T Consensus       306 l~~li~~cl~~dp~~RPs~~el~~~l~~~  334 (338)
T cd05102         306 IYRIMLACWQGDPKERPTFSALVEILGDL  334 (338)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            99999999999999999999999988743

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-46  Score=311.06  Aligned_cols=270  Identities=22%  Similarity=0.297  Sum_probs=218.4

Q ss_pred             HHHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecC---
Q 037869           34 KELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT---  109 (380)
Q Consensus        34 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---  109 (380)
                      +.+....++|+|.++||+|||+-||++.. .++..||+|++...+.++.+...+|+...+.++|||+++++++...+   
T Consensus        14 ~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D   93 (302)
T KOG2345|consen   14 GTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD   93 (302)
T ss_pred             CcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence            34456778999999999999999999985 67889999999988778888899999999999999999999876443   


Q ss_pred             --CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEee
Q 037869          110 --DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD  187 (380)
Q Consensus       110 --~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~D  187 (380)
                        ...||+++|+..|+|.+.+.....++..+++..++.|+.++++||.+||.. .+.+.||||||.||++++++.++|.|
T Consensus        94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D  172 (302)
T KOG2345|consen   94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMD  172 (302)
T ss_pred             CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEe
Confidence              348999999999999999998877777899999999999999999999998 33499999999999999999999999


Q ss_pred             ccCccccCCCCcccee--------ccccccCccCccccc---cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccch
Q 037869          188 FGFAKLIPEGVSHMTT--------RVKGTLGYLAPEYAM---WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI  256 (380)
Q Consensus       188 fgl~~~~~~~~~~~~~--------~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  256 (380)
                      ||.++...-.......        ....|..|+|||.+.   +...++++|||||||+||.|+.|..||+..........
T Consensus       173 ~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSla  252 (302)
T KOG2345|consen  173 LGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLA  252 (302)
T ss_pred             ccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEE
Confidence            9999865322211111        123589999999887   34578999999999999999999999975432111110


Q ss_pred             hccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          257 TEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .             ....+....+.....++.+.++|+.||+.||.+||++.+++.++...
T Consensus       253 L-------------Av~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  253 L-------------AVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             E-------------eeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            0             01111222222334678999999999999999999999999987643

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.6e-45  Score=335.43  Aligned_cols=268  Identities=21%  Similarity=0.262  Sum_probs=206.2

Q ss_pred             CCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ++|++.+.||+|+||+||+|++. +++.||+|+++...  ......+.+|+.+++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            47999999999999999999874 68899999987532  2334567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |++++.+..+...    ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  153 (287)
T cd07848          81 YVEKNMLELLEEM----PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEG  153 (287)
T ss_pred             cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCccccccc
Confidence            9998766655432    24689999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccc-hhccchh--------hhhccc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRT-ITEWAEP--------LIVKGK  268 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-~~~~~~~--------~~~~~~  268 (380)
                      .........|++.|+|||++.+..++.++||||+||++|+|++|.+||.......... ......+        ......
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07848         154 SNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPR  233 (287)
T ss_pred             ccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccch
Confidence            3333334568999999999998889999999999999999999999997643211100 0000000        000000


Q ss_pred             cccccCCccc------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          269 FKELVDPKLR------GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       269 ~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      +.....+...      .......+.++.+|+.+||+.||++|||++++++|.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~  286 (287)
T cd07848         234 FHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPA  286 (287)
T ss_pred             hcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence            0000001000      0111234567999999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-45  Score=341.09  Aligned_cols=258  Identities=21%  Similarity=0.267  Sum_probs=208.7

Q ss_pred             CCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ++|++.+.||+|+||.||+|++. +++.||+|+++...   ......+.+|+.++..++||||+++++++...+..|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            47999999999999999999874 68899999997532   223456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++|+|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~  153 (333)
T cd05600          81 EYVPGGDFRTLLNNL----GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT  153 (333)
T ss_pred             eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc
Confidence            999999999999643    4689999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                          ......||+.|+|||++.+..++.++|||||||++|||++|..||........  ...       ...+.......
T Consensus       154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~-------i~~~~~~~~~~  220 (333)
T cd05600         154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET--WEN-------LKYWKETLQRP  220 (333)
T ss_pred             ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH--HHH-------HHhccccccCC
Confidence                23345689999999999999999999999999999999999999975432110  000       00000000000


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      .........+.++.++|.+||..+|.+||++.++++|.+...
T Consensus       221 ~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~  262 (333)
T cd05600         221 VYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKE  262 (333)
T ss_pred             CCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence            000111234578899999999999999999999999976543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.9e-45  Score=332.56  Aligned_cols=256  Identities=28%  Similarity=0.357  Sum_probs=206.9

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      .|++.+.||+|+||+||+|.+ .+++.||+|.+....   ......+.+|+.+++.++|+||+++++++..++..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            478889999999999999986 578999999986432   2223457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+++|+|.+.+...  ....+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05631          81 IMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG  155 (285)
T ss_pred             ecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC
Confidence            99999998887543  234689999999999999999999999   9999999999999999999999999999875432


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      .  ......|+..|+|||++.+..++.++|||||||++|+|++|..||..........  ....          .. ...
T Consensus       156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~--~~~~----------~~-~~~  220 (285)
T cd05631         156 E--TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKRE--EVDR----------RV-KED  220 (285)
T ss_pred             C--eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHH--HHHH----------Hh-hcc
Confidence            2  2234468999999999999999999999999999999999999997643211100  0000          00 001


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHhcCC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPN-----MKEVVNTLTGY  317 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps-----~~~ll~~l~~~  317 (380)
                      ...++...+..+.+|+.+||+.||.+||+     ++++++|.+..
T Consensus       221 ~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~  265 (285)
T cd05631         221 QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFK  265 (285)
T ss_pred             cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhc
Confidence            11233345578999999999999999997     89999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-46  Score=343.21  Aligned_cols=269  Identities=30%  Similarity=0.461  Sum_probs=218.0

Q ss_pred             eccHHHHHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecc--cChhhHHHHHHHHHHHhcCCCCcceeEeeEEe
Q 037869           30 IFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKA--MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA  107 (380)
Q Consensus        30 ~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  107 (380)
                      +...+++....+...+.++||+|.||+||+|++..  .||||+++.  ..+...+.|++|+..+++-+|.||+-+.|++.
T Consensus       381 s~s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~  458 (678)
T KOG0193|consen  381 SDSLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACM  458 (678)
T ss_pred             CccccccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhc
Confidence            33447788889999999999999999999999853  599999984  44556778999999999999999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEee
Q 037869          108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD  187 (380)
Q Consensus       108 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~D  187 (380)
                      .+.. .||+.+|+|-+|+.+++..   +..++....+.|+.|+++|+.|||.+   +|||||||..|||+.+++.|||+|
T Consensus       459 ~p~~-AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgD  531 (678)
T KOG0193|consen  459 NPPL-AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGD  531 (678)
T ss_pred             CCce-eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEec
Confidence            8776 9999999999999999865   46799999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccCCCC-ccceeccccccCccCccccc---cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhh
Q 037869          188 FGFAKLIPEGV-SHMTTRVKGTLGYLAPEYAM---WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL  263 (380)
Q Consensus       188 fgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  263 (380)
                      |||+....... ........|...|+|||++.   ..+|++.+||||||||+|||++|..||.....  ...+-      
T Consensus       532 FGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~--dqIif------  603 (678)
T KOG0193|consen  532 FGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR--DQIIF------  603 (678)
T ss_pred             ccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh--hheEE------
Confidence            99997653321 11233345889999999997   35799999999999999999999999973211  00000      


Q ss_pred             hhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCC
Q 037869          264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP  319 (380)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~  319 (380)
                      .+..-   .+.+. ......+++.++.+|+..||..++++||.+.+|+..|+.+.+
T Consensus       604 mVGrG---~l~pd-~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  604 MVGRG---YLMPD-LSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             Eeccc---ccCcc-chhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            00000   00000 012234567899999999999999999999999998877655

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-45  Score=331.53  Aligned_cols=261  Identities=24%  Similarity=0.324  Sum_probs=209.3

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--------------hhhHHHHHHHHHHHhcCCCCccee
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--------------SKAEMEFAVEVEVLGRVRHKNLLG  101 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------------~~~~~~~~~E~~~l~~l~h~niv~  101 (380)
                      ...-++|++.+.||+|.||.|-+|++ .+++.||||++.+..              -...+..++|+.+|+++.|||||+
T Consensus        93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~  172 (576)
T KOG0585|consen   93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK  172 (576)
T ss_pred             ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence            34558999999999999999999997 579999999986421              112346788999999999999999


Q ss_pred             EeeEEec--CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC
Q 037869          102 LRGYCAG--TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS  179 (380)
Q Consensus       102 ~~~~~~~--~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~  179 (380)
                      ++++..+  .+.+|||+|||..|.+...-.    ....+++.+++.++.+++.||+|||.+   ||+||||||+|+||++
T Consensus       173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSS  245 (576)
T ss_pred             EEEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcC
Confidence            9999865  467999999999887654432    222399999999999999999999999   9999999999999999


Q ss_pred             CCceEEeeccCccccCCCC----ccceeccccccCccCccccccCC----CCccchhhhhhHHHHHHHhCCCCCCCCCCC
Q 037869          180 DFEPLVADFGFAKLIPEGV----SHMTTRVKGTLGYLAPEYAMWGK----VSESCDVYSFGILLLEILTGRKPIEKLPGG  251 (380)
Q Consensus       180 ~~~vkl~Dfgl~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~p~~~~~~~  251 (380)
                      +|+|||+|||.+..++.+.    ........|||.|+|||.+.++.    .+.+.||||+|++||.|+.|+.||.+... 
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~-  324 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE-  324 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH-
Confidence            9999999999998763321    12223357999999999988632    36789999999999999999999965321 


Q ss_pred             cccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCC
Q 037869          252 VKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP  319 (380)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~  319 (380)
                                    ...+..+....+.-+-.++..+.+.+||.++|.+||+.|.+..+|..|+|....
T Consensus       325 --------------~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  325 --------------LELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             --------------HHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence                          111222333334333344566889999999999999999999999999987655

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-45  Score=335.83  Aligned_cols=249  Identities=24%  Similarity=0.274  Sum_probs=206.5

Q ss_pred             CCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++....   ......+.+|+.+++.++||||+++++++.++...++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47899999999999999999874 68999999986432   233456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   |++||||||+|||++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~  153 (291)
T cd05612          81 EYVPGGELFSYLRNS----GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD  153 (291)
T ss_pred             eCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence            999999999999643    4689999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      .    .....|++.|+|||++.+..++.++|||||||++|+|++|..||.......  .    ..         .+... 
T Consensus       154 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--~----~~---------~i~~~-  213 (291)
T cd05612         154 R----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--I----YE---------KILAG-  213 (291)
T ss_pred             C----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--H----HH---------HHHhC-
Confidence            2    223468999999999999899999999999999999999999997532110  0    00         00000 


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHhcCC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPN-----MKEVVNTLTGY  317 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps-----~~~ll~~l~~~  317 (380)
                       ...++...+..+.+||.+||+.||.+||+     ++++++|.+..
T Consensus       214 -~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~  258 (291)
T cd05612         214 -KLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK  258 (291)
T ss_pred             -CcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCcccc
Confidence             01223334568899999999999999995     99999997653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.8e-46  Score=328.15  Aligned_cols=264  Identities=23%  Similarity=0.321  Sum_probs=205.9

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC-----eEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD-----QRL  113 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~  113 (380)
                      .-+|.-.+++|.|+||.||.|.. .+++.||||+.-+....    -.+|+++|+.++|||||+++-+|....     .+.
T Consensus        23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln   98 (364)
T KOG0658|consen   23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN   98 (364)
T ss_pred             EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence            34677789999999999999986 45799999998764322    225999999999999999998885432     245


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-CceEEeeccCcc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD-FEPLVADFGFAK  192 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~-~~vkl~Dfgl~~  192 (380)
                      +||||++. +|.++++.....+..++...+.-+.+||++||+|||+.   ||+||||||+|+|++.+ |.+||||||.|+
T Consensus        99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK  174 (364)
T KOG0658|consen   99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAK  174 (364)
T ss_pred             HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcce
Confidence            99999976 99999985444456788889999999999999999998   99999999999999987 999999999999


Q ss_pred             ccCCCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccch----------
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE----------  261 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~----------  261 (380)
                      .+..+.+..+  +..|..|+|||.+.| ..|+.+.||||.|||+.||+-|++-|.+.+..  ..+..+..          
T Consensus       175 ~L~~~epniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~--dQL~eIik~lG~Pt~e~I  250 (364)
T KOG0658|consen  175 VLVKGEPNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV--DQLVEIIKVLGTPTREDI  250 (364)
T ss_pred             eeccCCCcee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH--HHHHHHHHHhCCCCHHHH
Confidence            9877665543  346999999999986 47999999999999999999999999874432  11111111          


Q ss_pred             ----hhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          262 ----PLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       262 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                          +........++....+........+.++.+|+.++|..+|.+|.++.+++.|..
T Consensus       251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~f  308 (364)
T KOG0658|consen  251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPF  308 (364)
T ss_pred             hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchh
Confidence                000111112222222222244456689999999999999999999999999843

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.9e-45  Score=340.09  Aligned_cols=250  Identities=26%  Similarity=0.319  Sum_probs=207.3

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      +.|++.+.||+|+||.||+|++ .+++.||+|+++...   ......+.+|+.++++++||||+++++++..++..|+||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            6789999999999999999987 468999999987532   233456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+.+|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        98 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  170 (329)
T PTZ00263         98 EFVVGGELFTHLRKA----GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD  170 (329)
T ss_pred             cCCCCChHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence            999999999999653    4688999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      .    .....|++.|+|||++.+..++.++|||||||++|+|++|..||......  ...             ..+... 
T Consensus       171 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~-------------~~i~~~-  230 (329)
T PTZ00263        171 R----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--RIY-------------EKILAG-  230 (329)
T ss_pred             C----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--HHH-------------HHHhcC-
Confidence            2    22346899999999999999999999999999999999999999653210  000             001111 


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHhcCCC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPN-----MKEVVNTLTGYD  318 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps-----~~~ll~~l~~~~  318 (380)
                       ...++...+..+.+||.+||+.||.+||+     ++++++|.+...
T Consensus       231 -~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        231 -RLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             -CcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence             01122334467899999999999999986     799999977543

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=9.2e-45  Score=330.63  Aligned_cols=265  Identities=21%  Similarity=0.302  Sum_probs=203.0

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ++|++.++||.|+||+||+|++ .++..||+|+++... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   84 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY   84 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence            5799999999999999999987 468899999987432 22334677899999999999999999999998999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +.+ +|.+++...   ...+++..+..++.|++.||+|||++   ||+||||||+|||++.++.+||+|||++.......
T Consensus        85 ~~~-~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~  157 (288)
T cd07871          85 LDS-DLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPT  157 (288)
T ss_pred             CCc-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence            975 899888643   23578999999999999999999999   99999999999999999999999999997653322


Q ss_pred             ccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchh-----------hhhc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEP-----------LIVK  266 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-----------~~~~  266 (380)
                      . ......+++.|+|||++.+ ..++.++||||+||++|+|++|..||........  .......           ....
T Consensus       158 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07871         158 K-TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEE--LHLIFRLLGTPTEETWPGITSN  234 (288)
T ss_pred             c-cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHHhhccccc
Confidence            1 1223457999999999875 5689999999999999999999999975432110  0000000           0000


Q ss_pred             cccccccCCcccC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          267 GKFKELVDPKLRG----DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       267 ~~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ..+.....+....    ......+.++.+||.+||+.||.+|||++++++|.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~  287 (288)
T cd07871         235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY  287 (288)
T ss_pred             hhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCC
Confidence            0011111111100    001123467899999999999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.4e-44  Score=334.62  Aligned_cols=245  Identities=25%  Similarity=0.304  Sum_probs=201.5

Q ss_pred             ceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCC
Q 037869           47 NKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNL  122 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  122 (380)
                      +.||+|+||.||+|++ .+++.||+|+++..   .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999987 57899999999753   2233456778999999999999999999999999999999999999


Q ss_pred             CHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccce
Q 037869          123 SLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMT  202 (380)
Q Consensus       123 ~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~  202 (380)
                      +|.+++...    ..+++..+..++.||+.||+|||+.   ||+||||||+||+++.++.+||+|||+++..... ....
T Consensus        81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~  152 (323)
T cd05571          81 ELFFHLSRE----RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATM  152 (323)
T ss_pred             cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCcc
Confidence            999998643    4689999999999999999999999   9999999999999999999999999998753221 1223


Q ss_pred             eccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCC
Q 037869          203 TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD  282 (380)
Q Consensus       203 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      ....||+.|+|||++.+..++.++|||||||++|||++|..||.......  ..    .. ....          ...++
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~--~~----~~-~~~~----------~~~~p  215 (323)
T cd05571         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LF----EL-ILME----------EIRFP  215 (323)
T ss_pred             cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH--HH----HH-HHcC----------CCCCC
Confidence            34568999999999999999999999999999999999999996532100  00    00 0000          01223


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhcC
Q 037869          283 ENQLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLTG  316 (380)
Q Consensus       283 ~~~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~~  316 (380)
                      ...+.++.++|.+||+.||++||     ++.++++|.+.
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f  254 (323)
T cd05571         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFF  254 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCc
Confidence            34557899999999999999999     89999999664

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.5e-45  Score=319.49  Aligned_cols=266  Identities=24%  Similarity=0.313  Sum_probs=207.8

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh--hhHHHHHHHHHHHhcCCCCc-ceeEeeEEecCC-----
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS--KAEMEFAVEVEVLGRVRHKN-LLGLRGYCAGTD-----  110 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~-----  110 (380)
                      ...|..+++||+|+||+||+|+. .+|+.||+|+++....  .-.....+|+.+|++++|+| |+++++++...+     
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~   89 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI   89 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence            34577788999999999999986 5789999999986443  23446788999999999999 999999998877     


Q ss_pred             -eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeecc
Q 037869          111 -QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG  189 (380)
Q Consensus       111 -~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfg  189 (380)
                       .+++||||+.. +|..++.........++...+..++.||+.||+|||++   +|+||||||+||+|+++|.+||+|||
T Consensus        90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFG  165 (323)
T KOG0594|consen   90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFG  165 (323)
T ss_pred             ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccc
Confidence             89999999965 99999976533224577789999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccc
Q 037869          190 FAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGK  268 (380)
Q Consensus       190 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (380)
                      +++.+.-+.. .....++|.||+|||++.|. .|+...||||+|||++||+++.+-|.+..+     ..+........+.
T Consensus       166 lAra~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se-----~~ql~~If~~lGt  239 (323)
T KOG0594|consen  166 LARAFSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE-----IDQLFRIFRLLGT  239 (323)
T ss_pred             hHHHhcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH-----HHHHHHHHHHcCC
Confidence            9997653322 24455689999999999976 799999999999999999999999987654     1111111111111


Q ss_pred             cccccCCc----------cc-----CCCCH---HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          269 FKELVDPK----------LR-----GDFDE---NQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       269 ~~~~~~~~----------~~-----~~~~~---~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ..+...+.          ..     ..+..   ....+..+++.+||+.+|.+|.|++.++.|..
T Consensus       240 P~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~y  304 (323)
T KOG0594|consen  240 PNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPY  304 (323)
T ss_pred             CCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChh
Confidence            11111110          00     01111   11247899999999999999999999999944

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.1e-44  Score=340.87  Aligned_cols=257  Identities=22%  Similarity=0.263  Sum_probs=205.8

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ...++|++.+.||+|+||.||++++ .+++.||+|++...   .......+.+|+.+++.++||||+++++++..++..|
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~  119 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY  119 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence            4457899999999999999999987 46889999998642   2233445778999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||+++|+|.+++...     .+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++..
T Consensus       120 lv~Ey~~gg~L~~~l~~~-----~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~  191 (370)
T cd05621         120 MVMEYMPGGDLVNLMSNY-----DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMK  191 (370)
T ss_pred             EEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEeccccee
Confidence            999999999999999643     578899999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCccceeccccccCccCccccccC----CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWG----KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKF  269 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  269 (380)
                      .............||+.|+|||++.+.    .++.++||||+||++|+|++|..||......  ..             +
T Consensus       192 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~--~~-------------~  256 (370)
T cd05621         192 MDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV--GT-------------Y  256 (370)
T ss_pred             cccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH--HH-------------H
Confidence            643322233455799999999998754    3789999999999999999999999753310  00             0


Q ss_pred             ccccCCcccCCCC--HHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHHhcCC
Q 037869          270 KELVDPKLRGDFD--ENQLKQAINVAVLCVQSEPEK--RPNMKEVVNTLTGY  317 (380)
Q Consensus       270 ~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~P~~--Rps~~~ll~~l~~~  317 (380)
                      ..+.........+  ...+..+.+++.+||..++.+  |+++.++++|.+..
T Consensus       257 ~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~  308 (370)
T cd05621         257 SKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFK  308 (370)
T ss_pred             HHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccC
Confidence            1111111011111  234577889999999866654  89999999997754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-45  Score=341.80  Aligned_cols=254  Identities=24%  Similarity=0.309  Sum_probs=208.1

Q ss_pred             CCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ++|++.+.||+|+||+||+|++. +++.||+|+++...   ......+..|+.++..++||||+++++++.+++..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            47999999999999999999874 78999999997532   233456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++++|.+++...    ..+++..++.++.|++.||+|||+.   ||+||||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~  153 (350)
T cd05573          81 EYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNK  153 (350)
T ss_pred             cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcc
Confidence            999999999999654    4789999999999999999999998   999999999999999999999999999987644


Q ss_pred             CC----------------------------ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCC
Q 037869          197 GV----------------------------SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKL  248 (380)
Q Consensus       197 ~~----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  248 (380)
                      ..                            ........||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~  233 (350)
T cd05573         154 AKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSD  233 (350)
T ss_pred             cCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCC
Confidence            32                            11223346899999999999999999999999999999999999999764


Q ss_pred             CCCcccchhccchhhhhccccccccC--CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHHHhcCC
Q 037869          249 PGGVKRTITEWAEPLIVKGKFKELVD--PKLRGDFDENQLKQAINVAVLCVQSEPEKRPN-MKEVVNTLTGY  317 (380)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps-~~~ll~~l~~~  317 (380)
                      ....  ..             ..+..  ..+..+.....+..+.++|.+||. ||.+||+ +.++++|.+..
T Consensus       234 ~~~~--~~-------------~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~  289 (350)
T cd05573         234 TLQE--TY-------------NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFK  289 (350)
T ss_pred             CHHH--HH-------------HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcC
Confidence            3210  00             00000  011111111245789999999998 9999999 99999997643

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.8e-44  Score=333.81  Aligned_cols=267  Identities=23%  Similarity=0.299  Sum_probs=209.0

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ..++|++.+.||+|+||.||++++ .++..||+|.+... .......+.+|+++++.++||||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEe
Confidence            357899999999999999999987 46888999998753 3344557889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++|+|.+++...    ..+++..+..++.|++.||.|||+..  +|+||||||+||+++.++.++|+|||++.....
T Consensus        83 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  156 (331)
T cd06649          83 EHMDGGSLDQVLKEA----KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (331)
T ss_pred             ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence            999999999999653    46899999999999999999999851  599999999999999999999999999976543


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcc---------
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKG---------  267 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~---------  267 (380)
                      .   ......|+..|+|||++.+..++.++|||||||++|+|++|..||........   ..........+         
T Consensus       157 ~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  230 (331)
T cd06649         157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL---EAIFGRPVVDGEEGEPHSIS  230 (331)
T ss_pred             c---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHhcccccccccCCccccC
Confidence            2   22334689999999999999999999999999999999999999964322100   00000000000         


Q ss_pred             ------------------------c-cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          268 ------------------------K-FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       268 ------------------------~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                                              . ...+.............+.++.+||.+||+.||++|||+.+|++|.+..
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~  305 (331)
T cd06649         231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIK  305 (331)
T ss_pred             cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHh
Confidence                                    0 0000000000001113457899999999999999999999999997643

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=335.39  Aligned_cols=258  Identities=23%  Similarity=0.329  Sum_probs=220.4

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccCh---hhHHHHHHHHHHHhcCC-CCcceeEeeEEecCCeE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNS---KAEMEFAVEVEVLGRVR-HKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  112 (380)
                      .....|++.+.||.|.||.||.+... +|+.||+|.+.+...   .+...+.+|+.+|+++. |||||.++++|++....
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~  111 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV  111 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence            46678999999999999999999874 599999999976433   24468899999999998 99999999999999999


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC----CceEEeec
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD----FEPLVADF  188 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~----~~vkl~Df  188 (380)
                      ++|||+|.||.|++.+...     .+++..+..++.|++.|+.|||+.   ||+||||||+|+|+...    +.++++||
T Consensus       112 ~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DF  183 (382)
T KOG0032|consen  112 YLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDF  183 (382)
T ss_pred             EEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeC
Confidence            9999999999999999754     399999999999999999999999   99999999999999643    57999999


Q ss_pred             cCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccc
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGK  268 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (380)
                      |++.....  .......+||+.|+|||++.+..|+..+||||+|+++|.|++|.+||.+........       ....+.
T Consensus       184 Gla~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~-------~i~~~~  254 (382)
T KOG0032|consen  184 GLAKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFL-------AILRGD  254 (382)
T ss_pred             CCceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHH-------HHHcCC
Confidence            99998766  445667789999999999999999999999999999999999999998755322111       111111


Q ss_pred             cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      +      ..........+..+.++|..|+..||..|+|+.++|+|+|-..
T Consensus       255 ~------~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~  298 (382)
T KOG0032|consen  255 F------DFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKS  298 (382)
T ss_pred             C------CCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccC
Confidence            1      2333445566789999999999999999999999999988554

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-45  Score=342.85  Aligned_cols=281  Identities=25%  Similarity=0.336  Sum_probs=222.9

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecc---cChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKA---MNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  112 (380)
                      ..-++|++++.||+|+||+|+++.. .+++.||||++++   ....+.+....|-.++... +||.+++++.+|++.+++
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            3457899999999999999999986 5688999999986   3345566777788887776 599999999999999999


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      |+||||+.||++....+     ...+++..+..++..++.||.|||++   ||++||||.+|||++.+|.+||+|||+++
T Consensus       445 ~fvmey~~Ggdm~~~~~-----~~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcK  516 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMHHIH-----TDVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCK  516 (694)
T ss_pred             EEEEEecCCCcEEEEEe-----cccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEeccccccc
Confidence            99999999999544443     34799999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      .--. ....+.+++||+.|+|||++.+..|+.++|.|||||+||||++|+.||.+.++...               +..+
T Consensus       517 e~m~-~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~---------------FdsI  580 (694)
T KOG0694|consen  517 EGMG-QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV---------------FDSI  580 (694)
T ss_pred             ccCC-CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH---------------HHHH
Confidence            6432 23467789999999999999999999999999999999999999999987543111               1111


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHhc--CCCCC----Ccccccchhhccchhhhhccc
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPN-----MKEVVNTLT--GYDPR----GKVMQTRIETLAYKEELLAFD  341 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps-----~~~ll~~l~--~~~~~----~~~~~~~~~~~~~~~~~~~~~  341 (380)
                      +..  ...+|...+.++.+++.++|.++|++|.-     +.+|..|..  .+++.    ++......++....++...|+
T Consensus       581 ~~d--~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~~~~D~snFd  658 (694)
T KOG0694|consen  581 VND--EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIKGPEDVSNFD  658 (694)
T ss_pred             hcC--CCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCcccCChhhhcccc
Confidence            111  11345566789999999999999999963     678888743  23322    122233344555566666665


Q ss_pred             CcC
Q 037869          342 QTT  344 (380)
Q Consensus       342 ~~~  344 (380)
                      +..
T Consensus       659 ~eF  661 (694)
T KOG0694|consen  659 EEF  661 (694)
T ss_pred             hhh
Confidence            543

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.8e-44  Score=329.94  Aligned_cols=265  Identities=25%  Similarity=0.399  Sum_probs=203.9

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCC-----------------CcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcce
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSD-----------------GLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLL  100 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv  100 (380)
                      ..++|++.++||+|+||.||+|.+.+                 +..||+|.+.... ......+.+|+.++..++||||+
T Consensus         3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv   82 (304)
T cd05096           3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNII   82 (304)
T ss_pred             chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCee
Confidence            45789999999999999999997532                 3469999987643 33345788999999999999999


Q ss_pred             eEeeEEecCCeEEEEEEecCCCCHHHhhccCCC---------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 037869          101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYA---------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI  165 (380)
Q Consensus       101 ~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~---------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~i  165 (380)
                      ++++++...+..++||||+++|+|.+++.....               ....+++..++.++.|++.||.|||+.   +|
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i  159 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NF  159 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---Cc
Confidence            999999999999999999999999998854311               113478889999999999999999999   99


Q ss_pred             EecCCCCCCeeeCCCCceEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh--CC
Q 037869          166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT--GR  242 (380)
Q Consensus       166 vHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~  242 (380)
                      +||||||+|||++.++.+||+|||+++....... .......++..|+|||++.+..++.++|||||||++|+|++  +.
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~  239 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKE  239 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCC
Confidence            9999999999999999999999999986543221 11223345788999999998899999999999999999987  55


Q ss_pred             CCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          243 KPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .||......  ..... .......      .........+..++..+.+|+.+||+.||.+|||+.+|.+.|+
T Consensus       240 ~p~~~~~~~--~~~~~-~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         240 QPYGELTDE--QVIEN-AGEFFRD------QGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCcCCHH--HHHHH-HHHHhhh------ccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            677653221  00000 0000000      0000111122344578999999999999999999999988875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-45  Score=350.92  Aligned_cols=270  Identities=22%  Similarity=0.307  Sum_probs=219.5

Q ss_pred             eccHHHHHHhhCCCCCcceeccCCceEEEEEEeCCC-cEEEEEEecccChhhHHHHHHHHHHHhcCC-CCcceeEeeEE-
Q 037869           30 IFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKLKAMNSKAEMEFAVEVEVLGRVR-HKNLLGLRGYC-  106 (380)
Q Consensus        30 ~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~-  106 (380)
                      .|....+.....+++|.+.|.+|||+.||+|.+..+ .+||+|++..........+.+|+.+|+.|+ |+|||.+++.. 
T Consensus        26 ~~~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~  105 (738)
T KOG1989|consen   26 YFVGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSA  105 (738)
T ss_pred             CCCceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Confidence            333344556778999999999999999999998554 999999998878888888999999999996 99999999942 


Q ss_pred             ec------CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC
Q 037869          107 AG------TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD  180 (380)
Q Consensus       107 ~~------~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~  180 (380)
                      ..      .-..+|+||||.||.|.+++..+...  .|++.++++|++|+++|+++||.. .+.|+|||||-+||||+.+
T Consensus       106 ~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~--~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~  182 (738)
T KOG1989|consen  106 INRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQT--RLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSAD  182 (738)
T ss_pred             ccccCCCceeEEEeehhhccCCcHHHHHHHHHhc--cCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCC
Confidence            11      12467999999999999999865433  499999999999999999999998 5669999999999999999


Q ss_pred             CceEEeeccCccccCCCCccc--------eeccccccCccCccccc---cCCCCccchhhhhhHHHHHHHhCCCCCCCCC
Q 037869          181 FEPLVADFGFAKLIPEGVSHM--------TTRVKGTLGYLAPEYAM---WGKVSESCDVYSFGILLLEILTGRKPIEKLP  249 (380)
Q Consensus       181 ~~vkl~Dfgl~~~~~~~~~~~--------~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~  249 (380)
                      |..||||||.+.-.-......        .....-|+.|+|||++.   +...++|+|||+|||+||-|+....||+...
T Consensus       183 g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg  262 (738)
T KOG1989|consen  183 GNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG  262 (738)
T ss_pred             CCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc
Confidence            999999999986432211000        11123699999999875   7789999999999999999999999998642


Q ss_pred             CCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCCCC
Q 037869          250 GGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRG  321 (380)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~~~  321 (380)
                      .                   ..++...+.-+-.+.++..+.+||..||+.||.+||++.+++.++..+....
T Consensus       263 ~-------------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~  315 (738)
T KOG1989|consen  263 K-------------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKP  315 (738)
T ss_pred             c-------------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCC
Confidence            2                   1123333333344678899999999999999999999999999987765543

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=6.6e-46  Score=356.96  Aligned_cols=262  Identities=27%  Similarity=0.468  Sum_probs=219.2

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeC------CCcEEEEEEecccChh-hHHHHHHHHHHHhcCCCCcceeEeeEEecCC
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTS------DGLQIAVKKLKAMNSK-AEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD  110 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  110 (380)
                      ....+....+.||+|+||+||+|+..      +...||||.++..... ...+|++|+++++.|+|||||+++|+|.+++
T Consensus       483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD  562 (774)
T ss_pred             echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence            35566677899999999999999742      2457999999976555 6778999999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHhhccCCC------C----CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYA------G----EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD  180 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~------~----~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~  180 (380)
                      .+++|+|||..|+|.+++.....      .    ..+++..+.+.|+.|||.|+.||-++   .+|||||..+|+||.++
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~  639 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGEN  639 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccc
Confidence            99999999999999999964421      1    23488999999999999999999999   99999999999999999


Q ss_pred             CceEEeeccCccccCCCCccc-eeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhc
Q 037869          181 FEPLVADFGFAKLIPEGVSHM-TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITE  258 (380)
Q Consensus       181 ~~vkl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~  258 (380)
                      ..|||+|||+++.+-...... .....-.++|||||.+..+.||.+|||||+||+|||+++ |..||.+.+...      
T Consensus       640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E------  713 (774)
T KOG1026|consen  640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE------  713 (774)
T ss_pred             eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH------
Confidence            999999999998753322222 223345889999999999999999999999999999999 999998865421      


Q ss_pred             cchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          259 WAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                                +-+.+..+-.-..+.+++.++++|+..||+.+|.+||+++||-..|..+.
T Consensus       714 ----------VIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  714 ----------VIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             ----------HHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence                      11112222224678889999999999999999999999999999987653

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-47  Score=314.93  Aligned_cols=260  Identities=21%  Similarity=0.298  Sum_probs=216.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEec--ccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ..+.|.+.+.||+|.|+.|++..+ .+|+.+|+|++.  +.+..+.+.+.+|+.+-+.|+||||+++++.+.+....|+|
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            567899999999999999999865 679999999886  34455677899999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---CCceEEeeccCcc
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS---DFEPLVADFGFAK  192 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~---~~~vkl~Dfgl~~  192 (380)
                      +|++.|++|...|-.+    ..+++..+-..+.||++||.|+|.+   +|||||+||+|+++.+   ..-+||+|||++.
T Consensus        89 Fe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi  161 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAI  161 (355)
T ss_pred             EecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEE
Confidence            9999999998777543    4688899999999999999999999   9999999999999954   3469999999999


Q ss_pred             ccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      .++.  ......+.|||.|+|||++...+|+..+|||+.|+|||-|+.|.+||.+.+...  ...+     ...+.    
T Consensus       162 ~l~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~r--lye~-----I~~g~----  228 (355)
T KOG0033|consen  162 EVND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYEQ-----IKAGA----  228 (355)
T ss_pred             EeCC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHH--HHHH-----Hhccc----
Confidence            9873  344556789999999999999999999999999999999999999997643211  0000     00111    


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCCC
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPR  320 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~~  320 (380)
                        -.......+..++++.+|+.+||..||.+|.|+.|.|+|.|..+..
T Consensus       229 --yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~  274 (355)
T KOG0033|consen  229 --YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE  274 (355)
T ss_pred             --cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence              1112233455668999999999999999999999999998876554

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.7e-44  Score=350.46  Aligned_cols=254  Identities=19%  Similarity=0.246  Sum_probs=208.6

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CC-CcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SD-GLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ..|.+.+.||+|++|.||+|.. .+ +..||+|.+..........+.+|+.+++.++||||+++++++...+..|+||||
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~  146 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEY  146 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEEC
Confidence            3499999999999999999976 34 678899987665555556778899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++|+|.+++........++++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++..+....
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~  223 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV  223 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence            999999998865434455789999999999999999999999   99999999999999999999999999998765432


Q ss_pred             c-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          199 S-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       199 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      . ......+||+.|+|||++.+..++.++|||||||++|+|++|..||......      ...         ..... ..
T Consensus       224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~------~~~---------~~~~~-~~  287 (478)
T PTZ00267        224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR------EIM---------QQVLY-GK  287 (478)
T ss_pred             ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH------HHH---------HHHHh-CC
Confidence            2 1233456899999999999999999999999999999999999999653210      000         00000 01


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT  313 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~  313 (380)
                      ....+...+..+.++|.+||..||+.||++.+++.+
T Consensus       288 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        288 YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            112233445789999999999999999999999876

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.1e-45  Score=306.21  Aligned_cols=252  Identities=29%  Similarity=0.434  Sum_probs=215.1

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      -++|++.+.||+|-||.||+|+. +++..||+|++.+.   ......++.+|+++-++|+||||++++++|.++...|++
T Consensus        21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi  100 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI  100 (281)
T ss_pred             hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence            35788999999999999999986 56888999998752   222345788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      +||..+|++...+..+.  ..++++...+.++.|++.||.|+|..   +|+||||||+|+|++..+.+||+|||-+-.-+
T Consensus       101 lEya~~gel~k~L~~~~--~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEGR--MKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP  175 (281)
T ss_pred             EEecCCchHHHHHHhcc--cccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecC
Confidence            99999999999997542  35689999999999999999999998   99999999999999999999999999987643


Q ss_pred             CCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                         .....+.+||..|.+||...+..++..+|+|++|++.||++.|.+||+....               ...+..+.. 
T Consensus       176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~---------------~etYkrI~k-  236 (281)
T KOG0580|consen  176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH---------------SETYKRIRK-  236 (281)
T ss_pred             ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---------------HHHHHHHHH-
Confidence               3445667899999999999999999999999999999999999999976431               111122211 


Q ss_pred             cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                       ....+++.++..+.++|.+|+.++|.+|.+..+++.|.|.
T Consensus       237 -~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI  276 (281)
T KOG0580|consen  237 -VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWI  276 (281)
T ss_pred             -ccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHH
Confidence             1223456677899999999999999999999999999874

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=338.87  Aligned_cols=248  Identities=26%  Similarity=0.438  Sum_probs=211.8

Q ss_pred             CCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecC
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMP  120 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  120 (380)
                      +...-++-||.|+.|.||+|+.. ++.||||+++....       .+++-|++|+||||+.+.|+|....-++||||||.
T Consensus       124 e~IsELeWlGSGaQGAVF~Grl~-netVAVKKV~elkE-------TdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa  195 (904)
T KOG4721|consen  124 EEISELEWLGSGAQGAVFLGRLH-NETVAVKKVRELKE-------TDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA  195 (904)
T ss_pred             HHhhhhhhhccCcccceeeeecc-CceehhHHHhhhhh-------hhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence            33445788999999999999885 78999999876432       47888999999999999999999999999999999


Q ss_pred             CCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCcc
Q 037869          121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH  200 (380)
Q Consensus       121 ~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~  200 (380)
                      .|-|...++..    ..+.......|..+|+.|+.|||.+   .|||||||.=||||+.+..|||+|||-++.....  .
T Consensus       196 ~GqL~~VLka~----~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--S  266 (904)
T KOG4721|consen  196 QGQLYEVLKAG----RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDK--S  266 (904)
T ss_pred             cccHHHHHhcc----CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhh--h
Confidence            99999999653    5788889999999999999999999   9999999999999999999999999999876543  2


Q ss_pred             ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCC
Q 037869          201 MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGD  280 (380)
Q Consensus       201 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      ..-.++||..|||||++...+.++|+||||||||||||+||..||...+..               .-+.-.-...+.-.
T Consensus       267 TkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss---------------AIIwGVGsNsL~Lp  331 (904)
T KOG4721|consen  267 TKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS---------------AIIWGVGSNSLHLP  331 (904)
T ss_pred             hhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh---------------eeEEeccCCccccc
Confidence            233478999999999999999999999999999999999999999764321               01111222344556


Q ss_pred             CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCCC
Q 037869          281 FDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPR  320 (380)
Q Consensus       281 ~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~~  320 (380)
                      .+..+++-+.-|+++||+..|..|||+.+|+.||....+.
T Consensus       332 vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pe  371 (904)
T KOG4721|consen  332 VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPE  371 (904)
T ss_pred             CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHH
Confidence            7788889999999999999999999999999999876554

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.3e-44  Score=337.90  Aligned_cols=263  Identities=22%  Similarity=0.261  Sum_probs=208.4

Q ss_pred             HHHHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEec
Q 037869           33 YKELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG  108 (380)
Q Consensus        33 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  108 (380)
                      ..++....++|++.+.||+|+||.||++++ .+++.||+|++...   .......+.+|+.+++.++||||+++++++..
T Consensus        35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~  114 (371)
T cd05622          35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD  114 (371)
T ss_pred             HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence            334455668999999999999999999987 46889999998642   22233457789999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          109 TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       109 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                      ++..++||||+++|+|.+++...     .+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~Df  186 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADF  186 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeC
Confidence            99999999999999999998643     578889999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCccceeccccccCccCccccccC----CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG----KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI  264 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  264 (380)
                      |++...............||+.|+|||++.+.    .++.++|||||||++|+|++|..||......  ..         
T Consensus       187 G~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~---------  255 (371)
T cd05622         187 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GT---------  255 (371)
T ss_pred             CceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH--HH---------
Confidence            99987654322233455799999999998753    3789999999999999999999999753310  00         


Q ss_pred             hccccccccCC--cccCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHHhcCCC
Q 037869          265 VKGKFKELVDP--KLRGDFDENQLKQAINVAVLCVQSEPEK--RPNMKEVVNTLTGYD  318 (380)
Q Consensus       265 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~P~~--Rps~~~ll~~l~~~~  318 (380)
                          +..+...  .+........+..+.++|.+||..++.+  |+++.++++|++..+
T Consensus       256 ----~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~  309 (371)
T cd05622         256 ----YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  309 (371)
T ss_pred             ----HHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence                0111110  0111112245578899999999854443  789999999987543

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.5e-44  Score=326.78  Aligned_cols=245  Identities=19%  Similarity=0.311  Sum_probs=199.1

Q ss_pred             ceeccCCceEEEEEEeCCCcEEEEEEecccChhh---HHHHHHHHHHHhcCCCCcceeEeeEEec----CCeEEEEEEec
Q 037869           47 NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKA---EMEFAVEVEVLGRVRHKNLLGLRGYCAG----TDQRLIVYDYM  119 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~  119 (380)
                      ..||+|++|.||+|.. +|+.||||+++......   ...+.+|+.+|++++||||+++++++.+    ....++||||+
T Consensus        26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~  104 (283)
T PHA02988         26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC  104 (283)
T ss_pred             eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence            6799999999999988 58899999997643222   4567899999999999999999999876    35689999999


Q ss_pred             CCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc
Q 037869          120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS  199 (380)
Q Consensus       120 ~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~  199 (380)
                      ++|+|.+++...    ..+++...+.++.|++.||.|||+..  +++||||||+||+++.++.+||+|||+++...... 
T Consensus       105 ~~g~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-  177 (283)
T PHA02988        105 TRGYLREVLDKE----KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-  177 (283)
T ss_pred             CCCcHHHHHhhC----CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence            999999999653    46889999999999999999999731  78899999999999999999999999998654321 


Q ss_pred             cceeccccccCccCcccccc--CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          200 HMTTRVKGTLGYLAPEYAMW--GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       200 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                         ....|+..|+|||++.+  ..++.++|||||||++|||++|..||......      .+..         .......
T Consensus       178 ---~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~------~~~~---------~i~~~~~  239 (283)
T PHA02988        178 ---FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK------EIYD---------LIINKNN  239 (283)
T ss_pred             ---ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH------HHHH---------HHHhcCC
Confidence               22357899999999976  68999999999999999999999999754311      0000         0111111


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      +...+..++..+.+++.+||+.||++|||+.++++.|..+
T Consensus       240 ~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~  279 (283)
T PHA02988        240 SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLY  279 (283)
T ss_pred             CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            1223334567899999999999999999999999988754

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-44  Score=330.90  Aligned_cols=244  Identities=24%  Similarity=0.315  Sum_probs=200.1

Q ss_pred             eccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCCCH
Q 037869           49 LGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSL  124 (380)
Q Consensus        49 Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  124 (380)
                      ||+|+||.||+|.+ .+++.||+|+++..   .......+.+|+.++..++||||+++++++...+..|+||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999987 46889999998742   233445677899999999999999999999999999999999999999


Q ss_pred             HHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccceec
Q 037869          125 LSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR  204 (380)
Q Consensus       125 ~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~~~  204 (380)
                      .+++...    ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.++|+|||++....... .....
T Consensus        81 ~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~  152 (312)
T cd05585          81 FHHLQRE----GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNT  152 (312)
T ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccc
Confidence            9999643    4689999999999999999999999   99999999999999999999999999987543221 22334


Q ss_pred             cccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHH
Q 037869          205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN  284 (380)
Q Consensus       205 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      ..||+.|+|||++.+..++.++||||+||++|+|++|..||......      ...         ......  ...++..
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~---------~~~~~~--~~~~~~~  215 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMY---------RKILQE--PLRFPDG  215 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHH---------HHHHcC--CCCCCCc
Confidence            56899999999999999999999999999999999999999753210      000         000100  1122334


Q ss_pred             HHHHHHHHHHhhcCCCCCCCC---CHHHHHHHhcCC
Q 037869          285 QLKQAINVAVLCVQSEPEKRP---NMKEVVNTLTGY  317 (380)
Q Consensus       285 ~~~~~~~li~~cl~~~P~~Rp---s~~~ll~~l~~~  317 (380)
                      .+..+.+++.+||..||.+||   ++.++++|.+..
T Consensus       216 ~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~  251 (312)
T cd05585         216 FDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFS  251 (312)
T ss_pred             CCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcC
Confidence            557889999999999999997   579999997644

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-44  Score=339.23  Aligned_cols=256  Identities=21%  Similarity=0.293  Sum_probs=204.6

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ++|++.+.||+|+||+||+|++ .+++.||||++....   ......+.+|+.++..++||||+++++++.+.+..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            4799999999999999999987 468999999997532   233446778999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+|||++..+..
T Consensus        81 E~~~~g~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  153 (364)
T cd05599          81 EYLPGGDMMTLLMKK----DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK  153 (364)
T ss_pred             CCCCCcHHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccc
Confidence            999999999998643    4689999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCcc-------------------------------------ceeccccccCccCccccccCCCCccchhhhhhHHHHHHH
Q 037869          197 GVSH-------------------------------------MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL  239 (380)
Q Consensus       197 ~~~~-------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell  239 (380)
                      ....                                     .....+||+.|+|||++.+..++.++|||||||++|+|+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~  233 (364)
T cd05599         154 SHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEML  233 (364)
T ss_pred             cccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhh
Confidence            1100                                     111245899999999999999999999999999999999


Q ss_pred             hCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCC---HHHHHHHhcC
Q 037869          240 TGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPN---MKEVVNTLTG  316 (380)
Q Consensus       240 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps---~~~ll~~l~~  316 (380)
                      +|..||.......  ....    . .  .+.    ..+........+.++.++|.+|+. +|.+|++   +.+++.|.+.
T Consensus       234 ~G~~Pf~~~~~~~--~~~~----i-~--~~~----~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~  299 (364)
T cd05599         234 VGYPPFCSDNPQE--TYRK----I-I--NWK----ETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFF  299 (364)
T ss_pred             cCCCCCCCCCHHH--HHHH----H-H--cCC----CccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCc
Confidence            9999997543210  0000    0 0  000    000001111235688899999997 9999997   9999999765


Q ss_pred             C
Q 037869          317 Y  317 (380)
Q Consensus       317 ~  317 (380)
                      .
T Consensus       300 ~  300 (364)
T cd05599         300 K  300 (364)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.9e-44  Score=340.06  Aligned_cols=260  Identities=27%  Similarity=0.418  Sum_probs=205.1

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe------CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCC
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT------SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTD  110 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  110 (380)
                      ..++|++.+.||+|+||.||+|.+      .++..||||+++... ......+.+|+.+++.+ +||||+++++++...+
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~  112 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGG  112 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCC
Confidence            455799999999999999999963      235689999997432 33445788899999999 8999999999999999


Q ss_pred             eEEEEEEecCCCCHHHhhccCCC---------------------------------------------------------
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYA---------------------------------------------------------  133 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~---------------------------------------------------------  133 (380)
                      ..++||||+++|+|.+++.....                                                         
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            99999999999999999864311                                                         


Q ss_pred             --------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc
Q 037869          134 --------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS  199 (380)
Q Consensus       134 --------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~  199 (380)
                                    ....+++..++.++.|++.||+|||+.   +++||||||+|||++.++.++|+|||++........
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~  269 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN  269 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCccc
Confidence                          112578899999999999999999998   999999999999999999999999999987643221


Q ss_pred             cc-eeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          200 HM-TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       200 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      .. .....++..|+|||++.+..++.++|||||||++|+|++ |..||.......  ..             ........
T Consensus       270 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~-------------~~~~~~~~  334 (375)
T cd05104         270 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KF-------------YKMIKEGY  334 (375)
T ss_pred             ccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HH-------------HHHHHhCc
Confidence            11 112234667999999999999999999999999999998 888986543211  00             00111111


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ....+...+.++.+|+.+||+.||++|||+.+|++.|+.
T Consensus       335 ~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         335 RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence            111222334689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.9e-44  Score=322.75  Aligned_cols=256  Identities=27%  Similarity=0.381  Sum_probs=205.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe----CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT----SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ..++|++.+.||+|+||.||+|.+    ..+..||+|.++... ......+.+|+.+++.++||||+++++++...+..+
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            346799999999999999999964    236789999998643 333457889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++++|||.+..
T Consensus        83 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~  156 (266)
T cd05064          83 IVTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQE  156 (266)
T ss_pred             EEEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCccccc
Confidence            999999999999998653   24689999999999999999999999   999999999999999999999999998765


Q ss_pred             cCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      .............++..|+|||.+.+..++.++|||||||++||+++ |..||.......  ..              ..
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~--------------~~  220 (266)
T cd05064         157 DKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VI--------------KA  220 (266)
T ss_pred             ccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HH--------------HH
Confidence            43221111112234678999999999999999999999999999775 999997543210  00              00


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .........+..++..+.+++.+||+.+|.+||++.+|++.|..
T Consensus       221 ~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~  264 (266)
T cd05064         221 VEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSK  264 (266)
T ss_pred             HHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHh
Confidence            01111122344556789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2.1e-44  Score=350.07  Aligned_cols=263  Identities=23%  Similarity=0.293  Sum_probs=212.6

Q ss_pred             HHHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC
Q 037869           34 KELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD  110 (380)
Q Consensus        34 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  110 (380)
                      .+.....++|++.+.||+|+||+||+|++ .+++.||||++...  .......+.+|+..+..++|+||+++++.+....
T Consensus        25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD  104 (496)
T ss_pred             ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence            44455678999999999999999999986 57899999998643  3444557888999999999999999988765332


Q ss_pred             --------eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc
Q 037869          111 --------QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE  182 (380)
Q Consensus       111 --------~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~  182 (380)
                              .+++||||+++|+|.+++.........+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~  181 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGL  181 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCC
Confidence                    36899999999999999976544456799999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccCccccCCCC-ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccch
Q 037869          183 PLVADFGFAKLIPEGV-SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE  261 (380)
Q Consensus       183 vkl~Dfgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  261 (380)
                      +||+|||+++.+.... ........||+.|+|||++.+..++.++|||||||++|||++|..||......      .+..
T Consensus       182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~------~~~~  255 (496)
T PTZ00283        182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME------EVMH  255 (496)
T ss_pred             EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH------HHHH
Confidence            9999999998764321 12233457899999999999999999999999999999999999999653210      0000


Q ss_pred             hhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          262 PLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .         .. .......+...+.++.+++.+||+.||.+||++.++++|.+
T Consensus       256 ~---------~~-~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~  299 (496)
T PTZ00283        256 K---------TL-AGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPI  299 (496)
T ss_pred             H---------Hh-cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHH
Confidence            0         00 11112234455678999999999999999999999998743

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.9e-44  Score=336.97  Aligned_cols=255  Identities=22%  Similarity=0.271  Sum_probs=201.0

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      .|++++.||+|+||+||+|++ .++..||+|++...   .......+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            588999999999999999987 56889999999753   22334568889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+++|+|.+++...    ..+++..+..++.|++.||.|||+.   ||+||||||+|||++.++.++|+|||++..+...
T Consensus        82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~  154 (381)
T cd05626          82 YIPGGDMMSLLIRM----EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWT  154 (381)
T ss_pred             cCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccc
Confidence            99999999998653    4688999999999999999999999   9999999999999999999999999997543110


Q ss_pred             Cc----------------------------------------------cceeccccccCccCccccccCCCCccchhhhh
Q 037869          198 VS----------------------------------------------HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSF  231 (380)
Q Consensus       198 ~~----------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  231 (380)
                      ..                                              .......||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (381)
T cd05626         155 HNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeeh
Confidence            00                                              00123469999999999998899999999999


Q ss_pred             hHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhh--cCCCCCCCCCHHH
Q 037869          232 GILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLC--VQSEPEKRPNMKE  309 (380)
Q Consensus       232 G~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c--l~~~P~~Rps~~~  309 (380)
                      ||++|||++|..||.........  ..     ..  .+    ............+.++.+||.+|  +..+|..||++.+
T Consensus       235 G~il~elltG~~Pf~~~~~~~~~--~~-----i~--~~----~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~  301 (381)
T cd05626         235 GVILFEMLVGQPPFLAPTPTETQ--LK-----VI--NW----ENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD  301 (381)
T ss_pred             hhHHHHHHhCCCCCcCCCHHHHH--HH-----HH--cc----ccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence            99999999999999754321100  00     00  00    00011111123457888999884  4556666999999


Q ss_pred             HHHHhcC
Q 037869          310 VVNTLTG  316 (380)
Q Consensus       310 ll~~l~~  316 (380)
                      +++|.+.
T Consensus       302 ~l~hp~f  308 (381)
T cd05626         302 IKAHPFF  308 (381)
T ss_pred             HhcCccc
Confidence            9999764

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.3e-44  Score=335.95  Aligned_cols=257  Identities=24%  Similarity=0.274  Sum_probs=206.5

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ++|++.+.||+|+||+||++.+ .+++.||+|+++...   ......+..|+.+++.++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            4799999999999999999987 468999999997532   223446778999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++|+|.+++...   ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~  154 (330)
T cd05601          81 EYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTA  154 (330)
T ss_pred             CCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCC
Confidence            999999999999754   24689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCccceeccccccCccCccccc------cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAM------WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      ..........||+.|+|||++.      +..++.++|||||||++|+|++|..||.......  ....    .. .  ..
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~~~~----i~-~--~~  225 (330)
T cd05601         155 NKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK--TYNN----IM-N--FQ  225 (330)
T ss_pred             CCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH--HHHH----HH-c--CC
Confidence            3332333446899999999987      4567899999999999999999999997533210  0000    00 0  00


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                          .....+.....+.++.+|+..||+ +|.+|||+.+++.|.+..
T Consensus       226 ----~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~  267 (330)
T cd05601         226 ----RFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFS  267 (330)
T ss_pred             ----CccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcC
Confidence                000011112345788999999998 999999999999997643

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=2.9e-44  Score=333.96  Aligned_cols=256  Identities=25%  Similarity=0.291  Sum_probs=205.3

Q ss_pred             CCCCcceeccCCceEEEEEEe----CCCcEEEEEEeccc----ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT----SDGLQIAVKKLKAM----NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  112 (380)
                      .|++.+.||+|+||+||++++    .++..||+|++...    .......+..|+.+++.+ +||||+++++++..++..
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            488999999999999999975    35789999998742    222344677899999999 589999999999999999


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      ++||||+++|+|.+++...    ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.++|+|||++.
T Consensus        81 ~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~  153 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQR----DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSK  153 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCc
Confidence            9999999999999998643    4689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      ..............||+.|+|||++.+. .++.++|||||||++|+|++|..||.........  ..+...         
T Consensus       154 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~~~~---------  222 (332)
T cd05614         154 EFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEVSRR---------  222 (332)
T ss_pred             cccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHHHHH---------
Confidence            7544333333445799999999999865 4789999999999999999999999643221110  000000         


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhcCC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLTGY  317 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~~~  317 (380)
                      ..  ......+...+..+.+++.+||+.||++||     +++++++|.+..
T Consensus       223 ~~--~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~  271 (332)
T cd05614         223 IL--KCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK  271 (332)
T ss_pred             Hh--cCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcC
Confidence            00  011122334457889999999999999999     889999997754

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.7e-44  Score=335.87  Aligned_cols=251  Identities=22%  Similarity=0.244  Sum_probs=206.6

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC-C-CcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS-D-GLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ..++|++.+.||+|+||.||+|.+. + +..||+|++...   .......+.+|+.+++.++||||+++++++...+..|
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~  107 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY  107 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence            4467999999999999999999753 3 468999998642   2233456788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||+++|+|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++..
T Consensus       108 lv~Ey~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~  180 (340)
T PTZ00426        108 LVLEFVIGGEFFTFLRRN----KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKV  180 (340)
T ss_pred             EEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCee
Confidence            999999999999999653    4689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                      ....    .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ..             ..+.
T Consensus       181 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--~~-------------~~i~  241 (340)
T PTZ00426        181 VDTR----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL--IY-------------QKIL  241 (340)
T ss_pred             cCCC----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH--HH-------------HHHh
Confidence            6432    234568999999999998889999999999999999999999997532210  00             0000


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhcCC
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLTGY  317 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~~~  317 (380)
                      ...  ..++...+..+.++|.+||+.||.+|+     +++++++|.+.-
T Consensus       242 ~~~--~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~  288 (340)
T PTZ00426        242 EGI--IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFG  288 (340)
T ss_pred             cCC--CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcC
Confidence            000  112333446788999999999999995     999999997653

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.1e-43  Score=327.72  Aligned_cols=245  Identities=29%  Similarity=0.354  Sum_probs=195.6

Q ss_pred             ceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhc-CCCCcceeEeeEEecCCeEEEEEEecCC
Q 037869           47 NKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGR-VRHKNLLGLRGYCAGTDQRLIVYDYMPN  121 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  121 (380)
                      +.||+|+||.||+|.+ .+++.||+|+++..   .......+..|..++.. .+||||+++++++...+..++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999987 46889999999752   22233445566667665 4899999999999999999999999999


Q ss_pred             CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccc
Q 037869          122 LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM  201 (380)
Q Consensus       122 g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~  201 (380)
                      |+|..++...    ..+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++....... ..
T Consensus        81 g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~  152 (316)
T cd05592          81 GDLMFHIQSS----GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GK  152 (316)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cc
Confidence            9999998643    4689999999999999999999999   99999999999999999999999999997643222 22


Q ss_pred             eeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCC
Q 037869          202 TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF  281 (380)
Q Consensus       202 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||......  ...    ..         +..  ....+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--~~~----~~---------i~~--~~~~~  215 (316)
T cd05592         153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--ELF----DS---------ILN--DRPHF  215 (316)
T ss_pred             cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--HHH----HH---------HHc--CCCCC
Confidence            33456899999999999999999999999999999999999999753310  000    00         000  01122


Q ss_pred             CHHHHHHHHHHHHhhcCCCCCCCCCHH-HHHHHhcC
Q 037869          282 DENQLKQAINVAVLCVQSEPEKRPNMK-EVVNTLTG  316 (380)
Q Consensus       282 ~~~~~~~~~~li~~cl~~~P~~Rps~~-~ll~~l~~  316 (380)
                      +...+.++.+++.+||+.||.+||++. ++++|.+.
T Consensus       216 ~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~  251 (316)
T cd05592         216 PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFF  251 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCccc
Confidence            333457789999999999999999865 77777553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.4e-43  Score=325.20  Aligned_cols=270  Identities=19%  Similarity=0.287  Sum_probs=203.4

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccCh-hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ..++|++.+.||+|+||+||+|++. +++.||+|+++.... .....+.+|+.+++.++||||+++++++..+...++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           3 KADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             ccccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence            3578999999999999999999874 688999999875332 22335678999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+. ++|.+++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.....
T Consensus        83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  155 (303)
T cd07869          83 EYVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSV  155 (303)
T ss_pred             ECCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccC
Confidence            9995 5888887643   34688999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh--hcccc----
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI--VKGKF----  269 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~----  269 (380)
                      .. .......+++.|+|||++.+ ..++.++||||+||++|+|++|..||....... ..+........  ....+    
T Consensus       156 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         156 PS-HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ-DQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             CC-ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHH-HHHHHHHHHhCCCChhhccchh
Confidence            21 12233457999999999875 458999999999999999999999997643210 00000000000  00000    


Q ss_pred             --ccccCCcccCCCCH---------HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          270 --KELVDPKLRGDFDE---------NQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       270 --~~~~~~~~~~~~~~---------~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                        ............+.         ..+..+.+|+.+||+.||++|||+.++++|.+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~  292 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFS  292 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccc
Confidence              00000000000000         1235688999999999999999999999997754

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=5.9e-44  Score=331.07  Aligned_cols=246  Identities=25%  Similarity=0.293  Sum_probs=201.6

Q ss_pred             ceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCC
Q 037869           47 NKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNL  122 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  122 (380)
                      +.||+|+||.||++++ .+++.||+|++...   .......+.+|+.+++.++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999987 56899999999753   2234456788999999999999999999999999999999999999


Q ss_pred             CHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccce
Q 037869          123 SLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMT  202 (380)
Q Consensus       123 ~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~  202 (380)
                      +|.+.+...    ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++...... ....
T Consensus        81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~  152 (328)
T cd05593          81 ELFFHLSRE----RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATM  152 (328)
T ss_pred             CHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCc-cccc
Confidence            999888643    4689999999999999999999999   9999999999999999999999999998754222 1223


Q ss_pred             eccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCC
Q 037869          203 TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD  282 (380)
Q Consensus       203 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||.......  .    ..         ....  ....++
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~--~----~~---------~~~~--~~~~~p  215 (328)
T cd05593         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--L----FE---------LILM--EDIKFP  215 (328)
T ss_pred             ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH--H----HH---------Hhcc--CCccCC
Confidence            34568999999999999899999999999999999999999996532110  0    00         0000  011223


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhcCC
Q 037869          283 ENQLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLTGY  317 (380)
Q Consensus       283 ~~~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~~~  317 (380)
                      ...+.++.++|.+||+.||.+||     ++.++++|.+..
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~  255 (328)
T cd05593         216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFT  255 (328)
T ss_pred             CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcC
Confidence            34557889999999999999997     899999997643

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.6e-44  Score=331.19  Aligned_cols=246  Identities=24%  Similarity=0.299  Sum_probs=201.2

Q ss_pred             ceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCC
Q 037869           47 NKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNL  122 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  122 (380)
                      +.||+|+||.||++++ .++..||+|+++..   .......+.+|+.+++.++||||+++++++...+..|+||||+++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            4699999999999987 56899999999753   2233456778999999999999999999999999999999999999


Q ss_pred             CHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccce
Q 037869          123 SLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMT  202 (380)
Q Consensus       123 ~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~  202 (380)
                      +|..++...    ..+++..++.++.||+.||.|||++   ||+||||||+|||++.++.+||+|||++....... ...
T Consensus        81 ~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~  152 (323)
T cd05595          81 ELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATM  152 (323)
T ss_pred             cHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccc
Confidence            999888643    4689999999999999999999999   99999999999999999999999999987532211 122


Q ss_pred             eccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCC
Q 037869          203 TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD  282 (380)
Q Consensus       203 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      ....|++.|+|||++.+..++.++|||||||++|+|++|..||.......  ..             ......  ....+
T Consensus       153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--~~-------------~~~~~~--~~~~p  215 (323)
T cd05595         153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LF-------------ELILME--EIRFP  215 (323)
T ss_pred             ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--HH-------------HHHhcC--CCCCC
Confidence            33568999999999999999999999999999999999999996532210  00             000000  01123


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhcCC
Q 037869          283 ENQLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLTGY  317 (380)
Q Consensus       283 ~~~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~~~  317 (380)
                      ...+.++.++|.+||+.||.+||     ++.++++|.+..
T Consensus       216 ~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~  255 (323)
T cd05595         216 RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL  255 (323)
T ss_pred             CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcC
Confidence            34457889999999999999998     999999997654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.1e-43  Score=318.00  Aligned_cols=251  Identities=27%  Similarity=0.442  Sum_probs=203.2

Q ss_pred             CCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecC
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMP  120 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  120 (380)
                      +.|++.+.||+|+||.||++...++..+|+|.+.... .....+.+|+.+++.++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   82 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME   82 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence            5688899999999999999998777889999987433 334578889999999999999999999999999999999999


Q ss_pred             CCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCcc
Q 037869          121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH  200 (380)
Q Consensus       121 ~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~  200 (380)
                      +|+|.+++...   ...+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++.........
T Consensus        83 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~  156 (256)
T cd05114          83 NGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT  156 (256)
T ss_pred             CCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCcee
Confidence            99999998643   23588999999999999999999999   9999999999999999999999999999865433222


Q ss_pred             ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCcccC
Q 037869          201 MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG  279 (380)
Q Consensus       201 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......  ....     ...+         ...
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~--~~~~-----i~~~---------~~~  220 (256)
T cd05114         157 SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE--VVEM-----ISRG---------FRL  220 (256)
T ss_pred             ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH--HHHH-----HHCC---------CCC
Confidence            2222235668999999998889999999999999999999 899986533210  0000     0000         001


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 037869          280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL  314 (380)
Q Consensus       280 ~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l  314 (380)
                      ..+...+..+.+++.+||+.+|.+|||+.++++.|
T Consensus       221 ~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         221 YRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            11222346789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=7.6e-44  Score=319.80  Aligned_cols=256  Identities=27%  Similarity=0.438  Sum_probs=208.8

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ..++|++.++||+|++|.||+|...++..||+|.+.... .....+.+|+.+++.++|+||+++++++...+..+++|||
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           4 PRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             chHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEec
Confidence            457899999999999999999998778889999987533 3355788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++++|.+++...  ....+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          83 MAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            9999999999754  234688889999999999999999998   99999999999999999999999999998765432


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      ........++..|+|||.+.+..++.++|||||||++|+|++ |..||.......  ....          +.    ...
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~----------~~----~~~  221 (261)
T cd05072         158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSA----------LQ----RGY  221 (261)
T ss_pred             eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHH----------HH----cCC
Confidence            222222345678999999998889999999999999999998 999996532210  0000          00    001


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ........+.++.+++.+||..+|++||+++++++.|+.
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         222 RMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             CCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            111222345688999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.3e-43  Score=335.45  Aligned_cols=263  Identities=19%  Similarity=0.220  Sum_probs=202.3

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ..+|++.+.||+|+||.||++.+ .+++.||+|....      ..+.+|+.++++++||||+++++++......++|+|+
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~  164 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR  164 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence            36899999999999999999987 5788999997542      2467899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +. ++|..++...    ..+++..++.++.|++.||.|||++   +|+||||||+|||++.++.++|+|||++.......
T Consensus       165 ~~-~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        165 YK-TDLYCYLAAK----RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             CC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence            95 6888888543    4688999999999999999999999   99999999999999999999999999997543322


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCccc-----chhccchh---------hh
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKR-----TITEWAEP---------LI  264 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-----~~~~~~~~---------~~  264 (380)
                      ........||+.|+|||++.+..++.++|||||||++|||++|..||.........     .+..+...         ..
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            22334457999999999999999999999999999999999999887543211100     00000000         00


Q ss_pred             hccccccc---------cCCcccCCC--CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          265 VKGKFKEL---------VDPKLRGDF--DENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       265 ~~~~~~~~---------~~~~~~~~~--~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ....+...         ..+..+...  ....+.++.+||.+||+.||.+|||++++++|.+.
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f  379 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAF  379 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhh
Confidence            00000000         000000000  11345689999999999999999999999999764

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.4e-45  Score=307.88  Aligned_cols=257  Identities=26%  Similarity=0.365  Sum_probs=210.1

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-------h-hhHHHHHHHHHHHhcC-CCCcceeEeeEEe
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-------S-KAEMEFAVEVEVLGRV-RHKNLLGLRGYCA  107 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-------~-~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  107 (380)
                      ..-+.|.-.+.||.|..++|-.... .++..+|+|++....       . .-.+.-..|+.+|+++ .||+|+.+.++|+
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~ye   93 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYE   93 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeecc
Confidence            3446788889999999999988764 678899999985311       1 1123455699999998 6999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEee
Q 037869          108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD  187 (380)
Q Consensus       108 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~D  187 (380)
                      ++...++|+|.|+.|.|+|++..    ...+++....+|+.|+++|++|||.+   +||||||||+|||++++-+++|+|
T Consensus        94 s~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isD  166 (411)
T KOG0599|consen   94 SDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISD  166 (411)
T ss_pred             CcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEec
Confidence            99999999999999999999954    46799999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccCCCCccceeccccccCccCcccccc------CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccch
Q 037869          188 FGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW------GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE  261 (380)
Q Consensus       188 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  261 (380)
                      ||++..+..+  ......||||+|+|||.+..      ..|+..+|+|++|+|||.|+.|++||.......       .-
T Consensus       167 FGFa~~l~~G--ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml-------ML  237 (411)
T KOG0599|consen  167 FGFACQLEPG--EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML-------ML  237 (411)
T ss_pred             cceeeccCCc--hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH-------HH
Confidence            9999998764  34456789999999999874      468999999999999999999999995311000       00


Q ss_pred             hhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          262 PLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .....++      -....+...+.++...+||.+||+.||.+|.|++|+|.|.+.
T Consensus       238 R~ImeGk------yqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff  286 (411)
T KOG0599|consen  238 RMIMEGK------YQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFF  286 (411)
T ss_pred             HHHHhcc------cccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHH
Confidence            0001111      122334456778899999999999999999999999999765

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.3e-43  Score=322.06  Aligned_cols=257  Identities=26%  Similarity=0.478  Sum_probs=207.7

Q ss_pred             CCCCCcceeccCCceEEEEEEeCC-C-----cEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTSD-G-----LQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ++|++.+.||+|+||.||+|.... +     ..|++|.++... ......+.+|+.+++.++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~   84 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC   84 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence            478899999999999999997532 2     579999987543 333456888999999999999999999999889999


Q ss_pred             EEEEecCCCCHHHhhccCCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC
Q 037869          114 IVYDYMPNLSLLSHLHGQYA------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF  181 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~  181 (380)
                      ++|||+++++|.+++.....            ....+++..++.++.|++.||+|||+.   +++||||||+||+++.++
T Consensus        85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~  161 (283)
T cd05048          85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGL  161 (283)
T ss_pred             EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCC
Confidence            99999999999999965321            114688899999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhcc
Q 037869          182 EPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEW  259 (380)
Q Consensus       182 ~vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~  259 (380)
                      .++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.....       
T Consensus       162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~-------  234 (283)
T cd05048         162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE-------  234 (283)
T ss_pred             cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------
Confidence            999999999976533221 12223346788999999998899999999999999999998 999987543210       


Q ss_pred             chhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          260 AEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                               +...+........+..++.++.+|+.+||+.||.+||++.+|+++|..
T Consensus       235 ---------~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         235 ---------VIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             ---------HHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence                     001111112223345566899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=4.9e-44  Score=337.09  Aligned_cols=261  Identities=25%  Similarity=0.411  Sum_probs=205.2

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeC------CCcEEEEEEecccC-hhhHHHHHHHHHHHhcC-CCCcceeEeeEEecC
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTS------DGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGT  109 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  109 (380)
                      ...++|++.+.||+|+||.||+|.+.      ++..||+|+++... ......+.+|+.+++.+ +|+||+++++++...
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            34568999999999999999998742      23579999997533 33445688899999999 899999999999999


Q ss_pred             CeEEEEEEecCCCCHHHhhccCC---------------------------------------------------------
Q 037869          110 DQRLIVYDYMPNLSLLSHLHGQY---------------------------------------------------------  132 (380)
Q Consensus       110 ~~~~lv~e~~~~g~L~~~i~~~~---------------------------------------------------------  132 (380)
                      ...++||||+++|+|.+++....                                                         
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            99999999999999999885421                                                         


Q ss_pred             ---------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCcc-ce
Q 037869          133 ---------AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH-MT  202 (380)
Q Consensus       133 ---------~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~-~~  202 (380)
                               ....++++..+++++.|++.||+|||++   |++||||||+||+++.++.++|+|||+++........ ..
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                     0123578899999999999999999998   9999999999999999999999999999865433221 11


Q ss_pred             eccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCC
Q 037869          203 TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF  281 (380)
Q Consensus       203 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ....++..|+|||++.+..++.++|||||||++|+|++ |..||.......  .             +............
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~-------------~~~~~~~~~~~~~  336 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--K-------------FYKMVKRGYQMSR  336 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--H-------------HHHHHHcccCccC
Confidence            12234667999999998899999999999999999997 999997532211  0             0001111111112


Q ss_pred             CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          282 DENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       282 ~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      +...+.++.+++.+||+.||.+|||+.++++.|..
T Consensus       337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~  371 (374)
T cd05106         337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQR  371 (374)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            22335789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-44  Score=337.79  Aligned_cols=256  Identities=21%  Similarity=0.249  Sum_probs=201.9

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ++|++.+.||+|+||+||++.+ .+++.||||++...   .......+.+|+.+++.++||||+++++++.+....|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            4799999999999999999986 57899999998642   2233456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||+.   ||+||||||+|||++.++.++|+|||+++.+..
T Consensus        81 E~~~gg~L~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~  153 (377)
T cd05629          81 EFLPGGDLMTMLIKY----DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHK  153 (377)
T ss_pred             eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccc
Confidence            999999999998643    4688999999999999999999999   999999999999999999999999999864321


Q ss_pred             CCcc----------------------------------------------ceeccccccCccCccccccCCCCccchhhh
Q 037869          197 GVSH----------------------------------------------MTTRVKGTLGYLAPEYAMWGKVSESCDVYS  230 (380)
Q Consensus       197 ~~~~----------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Diws  230 (380)
                      ....                                              ......||+.|+|||++.+..++.++||||
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS  233 (377)
T cd05629         154 QHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWS  233 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEe
Confidence            0000                                              001246899999999999999999999999


Q ss_pred             hhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCC---CCH
Q 037869          231 FGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKR---PNM  307 (380)
Q Consensus       231 lG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~R---ps~  307 (380)
                      |||++|||++|..||.......  ....+.       .+.    ..+..+.....+.++.+||.+||. +|.+|   +|+
T Consensus       234 lGvil~elltG~~Pf~~~~~~~--~~~~i~-------~~~----~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~  299 (377)
T cd05629         234 LGAIMFECLIGWPPFCSENSHE--TYRKII-------NWR----ETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGA  299 (377)
T ss_pred             cchhhhhhhcCCCCCCCCCHHH--HHHHHH-------ccC----CccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCH
Confidence            9999999999999996533210  000000       000    000001111234678999999998 66665   699


Q ss_pred             HHHHHHhcCC
Q 037869          308 KEVVNTLTGY  317 (380)
Q Consensus       308 ~~ll~~l~~~  317 (380)
                      .+++.|.+..
T Consensus       300 ~~~l~hp~~~  309 (377)
T cd05629         300 HEIKSHPFFR  309 (377)
T ss_pred             HHHhcCCCcC
Confidence            9999997754

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.3e-43  Score=327.82  Aligned_cols=270  Identities=22%  Similarity=0.285  Sum_probs=207.4

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ..++|++.++||.|+||.||++.+. ++..||+|.+... .......+.+|+++++.++||||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   82 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   82 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEE
Confidence            4578999999999999999999874 6888999988753 3334457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++|+|.+++...    ..+++..+..++.|++.||.|||+..  +++||||||+||+++.++.++|+|||++.....
T Consensus        83 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~  156 (333)
T cd06650          83 EHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID  156 (333)
T ss_pred             ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhh
Confidence            999999999999643    46889999999999999999999741  699999999999999999999999999976533


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhc-----cchhh------hh
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITE-----WAEPL------IV  265 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~-----~~~~~------~~  265 (380)
                      .   ......|+..|+|||++.+..++.++|||||||++|+|++|..||.............     .....      ..
T Consensus       157 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (333)
T cd06650         157 S---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRP  233 (333)
T ss_pred             h---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCC
Confidence            2   1233468999999999998899999999999999999999999996432210000000     00000      00


Q ss_pred             cc-----------------ccccccCCcccCCCC-HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          266 KG-----------------KFKELVDPKLRGDFD-ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       266 ~~-----------------~~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ..                 ..............+ ...+.++.+|+.+||+.||++|||+.+++.|.+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~  303 (333)
T cd06650         234 PGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIK  303 (333)
T ss_pred             ccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHh
Confidence            00                 000000000000011 12346789999999999999999999999997643

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.5e-43  Score=335.33  Aligned_cols=254  Identities=22%  Similarity=0.280  Sum_probs=201.0

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      .|++++.||+|+||+||+|++ .+++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            688999999999999999987 568899999987532   2334467889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+++|+|.+++.+.    ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++|+|||++..+...
T Consensus        82 ~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~  154 (382)
T cd05625          82 YIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT  154 (382)
T ss_pred             CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCcccccc
Confidence            99999999998653    4688999999999999999999999   9999999999999999999999999997532100


Q ss_pred             C----------------------------------------------ccceeccccccCccCccccccCCCCccchhhhh
Q 037869          198 V----------------------------------------------SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSF  231 (380)
Q Consensus       198 ~----------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl  231 (380)
                      .                                              ........||+.|+|||++.+..++.++|||||
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSl  234 (382)
T cd05625         155 HDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV  234 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEec
Confidence            0                                              000123468999999999999999999999999


Q ss_pred             hHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCC---HH
Q 037869          232 GILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPN---MK  308 (380)
Q Consensus       232 G~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps---~~  308 (380)
                      ||++|||++|..||.......  ....     ..  .    .............+.++.++|.+|+ .+|.+|++   +.
T Consensus       235 Gvil~elltG~~Pf~~~~~~~--~~~~-----i~--~----~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~  300 (382)
T cd05625         235 GVILYEMLVGQPPFLAQTPLE--TQMK-----VI--N----WQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD  300 (382)
T ss_pred             hHHHHHHHhCCCCCCCCCHHH--HHHH-----HH--c----cCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence            999999999999997533210  0000     00  0    0001111112234577888998876 49999987   99


Q ss_pred             HHHHHhcC
Q 037869          309 EVVNTLTG  316 (380)
Q Consensus       309 ~ll~~l~~  316 (380)
                      ++++|.+.
T Consensus       301 ei~~hp~f  308 (382)
T cd05625         301 EIKAHPFF  308 (382)
T ss_pred             HHhcCCCc
Confidence            99999664

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1e-43  Score=335.79  Aligned_cols=256  Identities=21%  Similarity=0.290  Sum_probs=202.3

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ..|++.+.||+|+||.||+|++ .+++.||+|++....   ......+.+|+.+++.++||||+++++.+...+.+++||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            3699999999999999999987 468999999986422   223446778999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++|+|.+++...    ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.++|+|||++..+..
T Consensus        81 E~~~~g~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~  153 (376)
T cd05598          81 DYIPGGDMMSLLIRL----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRW  153 (376)
T ss_pred             eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccc
Confidence            999999999999653    4688999999999999999999999   999999999999999999999999999753210


Q ss_pred             C------------------------------------------CccceeccccccCccCccccccCCCCccchhhhhhHH
Q 037869          197 G------------------------------------------VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGIL  234 (380)
Q Consensus       197 ~------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  234 (380)
                      .                                          .........||+.|+|||++.+..++.++|||||||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  233 (376)
T cd05598         154 THDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI  233 (376)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccce
Confidence            0                                          0000113468999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC---CHHHHH
Q 037869          235 LLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRP---NMKEVV  311 (380)
Q Consensus       235 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp---s~~~ll  311 (380)
                      +|+|++|..||..........  .     ..  .+    ............+..+.++|.+|+ .+|.+|+   ++.+++
T Consensus       234 lyell~G~~Pf~~~~~~~~~~--~-----i~--~~----~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell  299 (376)
T cd05598         234 LYEMLVGQPPFLADTPAETQL--K-----VI--NW----ETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIK  299 (376)
T ss_pred             eeehhhCCCCCCCCCHHHHHH--H-----Hh--cc----CccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHh
Confidence            999999999997543211000  0     00  00    001111111234567888998876 4999999   999999


Q ss_pred             HHhcCC
Q 037869          312 NTLTGY  317 (380)
Q Consensus       312 ~~l~~~  317 (380)
                      +|.+..
T Consensus       300 ~h~~~~  305 (376)
T cd05598         300 AHPFFK  305 (376)
T ss_pred             CCCCcC
Confidence            997643

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-43  Score=313.59  Aligned_cols=260  Identities=23%  Similarity=0.275  Sum_probs=216.3

Q ss_pred             CCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ..|+++++||.|.-|+||+++.. ++..+|+|++.+..   .+...+...|.+||..++||.++.++..|+.++..+++|
T Consensus        77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m  156 (459)
T KOG0610|consen   77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM  156 (459)
T ss_pred             HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence            57889999999999999999974 56889999997533   333446667999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      |||+||+|..+.+++.  +..+++..++.++..++-||+|||-.   |||.|||||+||||.++|+|-|+||.|+.....
T Consensus       157 eyCpGGdL~~LrqkQp--~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  157 EYCPGGDLHSLRQKQP--GKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             ecCCCccHHHHHhhCC--CCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            9999999999998763  56899999999999999999999999   999999999999999999999999998754310


Q ss_pred             ---------------------------------C-C---------------------ccceeccccccCccCccccccCC
Q 037869          197 ---------------------------------G-V---------------------SHMTTRVKGTLGYLAPEYAMWGK  221 (380)
Q Consensus       197 ---------------------------------~-~---------------------~~~~~~~~gt~~y~aPE~~~~~~  221 (380)
                                                       . .                     ......++||-.|+|||++.|..
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                             0 0                     01122356899999999999999


Q ss_pred             CCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCC
Q 037869          222 VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEP  301 (380)
Q Consensus       222 ~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P  301 (380)
                      .+.++|.|+|||.+|||+.|..||.+...               ...+..++...+.-.-.+..+..+.+||.++|.+||
T Consensus       312 HgsAVDWWtfGIflYEmLyG~TPFKG~~~---------------~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP  376 (459)
T KOG0610|consen  312 HGSAVDWWTFGIFLYEMLYGTTPFKGSNN---------------KETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDP  376 (459)
T ss_pred             CCchhhHHHHHHHHHHHHhCCCCcCCCCc---------------hhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccCh
Confidence            99999999999999999999999987543               222333444444444444677899999999999999


Q ss_pred             CCCCC----HHHHHHHh--cCCCCC
Q 037869          302 EKRPN----MKEVVNTL--TGYDPR  320 (380)
Q Consensus       302 ~~Rps----~~~ll~~l--~~~~~~  320 (380)
                      .+|..    +.||.+|.  +..++.
T Consensus       377 ~kRlg~~rGA~eIK~HpFF~gVnWa  401 (459)
T KOG0610|consen  377 SKRLGSKRGAAEIKRHPFFEGVNWA  401 (459)
T ss_pred             hhhhccccchHHhhcCccccCCChh
Confidence            99987    99999994  344444

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5.8e-44  Score=342.96  Aligned_cols=267  Identities=21%  Similarity=0.283  Sum_probs=201.0

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecC-------
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT-------  109 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------  109 (380)
                      ....+|++.+.||+|+||.||+|.+ .+++.||||++....    ....+|+.+++.++||||+++++++...       
T Consensus        63 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~  138 (440)
T PTZ00036         63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEK  138 (440)
T ss_pred             CcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCC
Confidence            3456899999999999999999987 468899999886432    1334699999999999999998876432       


Q ss_pred             -CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC-ceEEee
Q 037869          110 -DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF-EPLVAD  187 (380)
Q Consensus       110 -~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~-~vkl~D  187 (380)
                       ..+++||||+++ +|.+++.........+++..++.++.|++.||+|||+.   +|+||||||+|||++.++ .+||+|
T Consensus       139 ~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~D  214 (440)
T PTZ00036        139 NIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCD  214 (440)
T ss_pred             ceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeec
Confidence             246799999975 78777754333456799999999999999999999999   999999999999998664 799999


Q ss_pred             ccCccccCCCCccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccch----h
Q 037869          188 FGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE----P  262 (380)
Q Consensus       188 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~----~  262 (380)
                      ||+++.+....  ......||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.....  .+..+..    +
T Consensus       215 FGla~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~--~~~~i~~~~~~p  290 (440)
T PTZ00036        215 FGSAKNLLAGQ--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD--QLVRIIQVLGTP  290 (440)
T ss_pred             cccchhccCCC--CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCC
Confidence            99998764322  22334689999999998764 68999999999999999999999997543211  0000000    0


Q ss_pred             hh-----hccccc-----cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          263 LI-----VKGKFK-----ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       263 ~~-----~~~~~~-----~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ..     ....+.     ......+...++...+.++.+||.+||..||.+|||+.+++.|.+.
T Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f  354 (440)
T PTZ00036        291 TEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFF  354 (440)
T ss_pred             CHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhH
Confidence            00     000000     0111111122333445789999999999999999999999999764

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1e-43  Score=334.19  Aligned_cols=257  Identities=20%  Similarity=0.266  Sum_probs=200.5

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ++|++.+.||+|+||+||+|.+ .+++.||+|+++...   ......+..|+.++..++|+||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            4789999999999999999986 468999999997532   223346778999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||++||+|.+++...    ..+++..+..++.|++.||+|||++   ||+||||||+|||++.++.++|+|||++..+..
T Consensus        81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~  153 (363)
T cd05628          81 EFLPGGDMMTLLMKK----DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK  153 (363)
T ss_pred             cCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccc
Confidence            999999999999653    4789999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCc----------------------------------cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCC
Q 037869          197 GVS----------------------------------HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGR  242 (380)
Q Consensus       197 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  242 (380)
                      ...                                  ......+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~  233 (363)
T cd05628         154 AHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (363)
T ss_pred             cccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCC
Confidence            110                                  0012346999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcC--CCCCCCCCHHHHHHHhcCC
Q 037869          243 KPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQ--SEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~--~~P~~Rps~~~ll~~l~~~  317 (380)
                      .||.......  ....     ...  +.    ..+..+.....+.++.++|.+++.  .++..||++++|++|.+.-
T Consensus       234 ~Pf~~~~~~~--~~~~-----i~~--~~----~~~~~p~~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~hp~f~  297 (363)
T cd05628         234 PPFCSETPQE--TYKK-----VMN--WK----ETLIFPPEVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTNPFFE  297 (363)
T ss_pred             CCCCCCCHHH--HHHH-----HHc--Cc----CcccCCCcCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCCCCCC
Confidence            9997533210  0000     000  00    000000011234678888888654  2334569999999996643

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.4e-43  Score=331.95  Aligned_cols=253  Identities=25%  Similarity=0.359  Sum_probs=199.7

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ..|++.+.||+|+||+||+|.+ .+++.||||++.... ......+.+|+.+++.++|+||+++++++...+.+++||||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  153 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF  153 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence            5677889999999999999987 468999999986533 23345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +.+|+|.+..        ...+..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++..+....
T Consensus       154 ~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~  222 (353)
T PLN00034        154 MDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM  222 (353)
T ss_pred             CCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence            9999986532        356778889999999999999999   99999999999999999999999999998764322


Q ss_pred             ccceeccccccCccCcccccc-----CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMW-----GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                       .......||..|+|||++..     ...+.++|||||||++|||++|..||.......      |......       .
T Consensus       223 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~------~~~~~~~-------~  288 (353)
T PLN00034        223 -DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD------WASLMCA-------I  288 (353)
T ss_pred             -ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc------HHHHHHH-------H
Confidence             12233468999999998753     234578999999999999999999997322111      0000000       0


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      ........+...+.++.+||.+||+.||++|||+.++++|.+...
T Consensus       289 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~  333 (353)
T PLN00034        289 CMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR  333 (353)
T ss_pred             hccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence            000111223345578999999999999999999999999976543

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.1e-43  Score=323.77  Aligned_cols=265  Identities=20%  Similarity=0.310  Sum_probs=197.7

Q ss_pred             CCCCCcceeccCCceEEEEEEe-C-CCcEEEEEEecccC--hhhHHHHHHHHHHHhcC---CCCcceeEeeEEe-----c
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-S-DGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRV---RHKNLLGLRGYCA-----G  108 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~-----~  108 (380)
                      ++|++.+.||+|+||+||+|++ . ++..||+|.++...  ......+.+|+.+++.+   +||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            4799999999999999999986 3 46789999987432  22223455677766655   6999999999885     2


Q ss_pred             CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          109 TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       109 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                      ...+++||||+. ++|.+++...  ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.++|+||
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Df  154 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADF  154 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccc
Confidence            456899999996 5899888653  234589999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh--hc
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI--VK  266 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~  266 (380)
                      |++......  .......|++.|+|||++.+..++.++|||||||++|||++|.+||.......  ....+.....  ..
T Consensus       155 g~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~--~~~~i~~~~~~~~~  230 (290)
T cd07862         155 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGLPGE  230 (290)
T ss_pred             cceEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCCh
Confidence            999876432  22334568999999999998899999999999999999999999997643211  0000000000  00


Q ss_pred             ccccc-------ccCCcc---cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          267 GKFKE-------LVDPKL---RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       267 ~~~~~-------~~~~~~---~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ..+..       ...+..   ........+..+.+++.+||+.||++|||+.++++|.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~  289 (290)
T cd07862         231 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY  289 (290)
T ss_pred             hhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCC
Confidence            00000       000000   00111234567889999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.5e-44  Score=332.85  Aligned_cols=268  Identities=19%  Similarity=0.281  Sum_probs=200.4

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecC-----CeEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT-----DQRL  113 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~  113 (380)
                      +|++.+.||+|+||.||+|.+ .++..||||++...  .......+.+|+.+++.++||||+++++++...     ...|
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            689999999999999999987 46899999998742  223345688899999999999999999987543     3589


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||+. ++|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus        81 lv~e~~~-~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~  152 (338)
T cd07859          81 VVFELME-SDLHQVIKAN----DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARV  152 (338)
T ss_pred             EEEecCC-CCHHHHHHhc----ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccc
Confidence            9999995 6898888643    4689999999999999999999999   999999999999999999999999999976


Q ss_pred             cCCCCc--cceeccccccCccCcccccc--CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccch-hccch-------
Q 037869          194 IPEGVS--HMTTRVKGTLGYLAPEYAMW--GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI-TEWAE-------  261 (380)
Q Consensus       194 ~~~~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~-~~~~~-------  261 (380)
                      ......  .......|++.|+|||++.+  ..++.++|||||||++|+|++|.+||........... .....       
T Consensus       153 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  232 (338)
T cd07859         153 AFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETI  232 (338)
T ss_pred             cccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHH
Confidence            432211  11234568999999999875  6789999999999999999999999975432110000 00000       


Q ss_pred             hhhhcccccc---ccCCcccCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          262 PLIVKGKFKE---LVDPKLRGD---FDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       262 ~~~~~~~~~~---~~~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ..........   .........   .....+..+.+++.+||+.||++|||++++++|.+..
T Consensus       233 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~  294 (338)
T cd07859         233 SRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK  294 (338)
T ss_pred             HHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhh
Confidence            0000000000   000000000   0112346788999999999999999999999997643

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=8.8e-44  Score=319.32  Aligned_cols=256  Identities=32%  Similarity=0.491  Sum_probs=212.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ....|++.+.||.|+||.||+|.+.++..+++|.+..........+..|+.+++.++||||+++++++...+..++||||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   83 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL   83 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence            45679999999999999999999877899999999876665666888999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++++|.+++...  ....+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~  158 (261)
T cd05148          84 MEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV  158 (261)
T ss_pred             cccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCcc
Confidence            9999999999754  234689999999999999999999999   99999999999999999999999999998764432


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      .. .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......  ...              ......
T Consensus       159 ~~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~--~~~--------------~~~~~~  221 (261)
T cd05148         159 YL-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE--VYD--------------QITAGY  221 (261)
T ss_pred             cc-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH--HHH--------------HHHhCC
Confidence            21 112335678999999998889999999999999999998 899996543110  000              000111


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ....+...+..+.+++.+||+.||.+|||+.+|++.|..
T Consensus       222 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         222 RMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhc
Confidence            222334455788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.8e-43  Score=316.53  Aligned_cols=253  Identities=26%  Similarity=0.452  Sum_probs=204.4

Q ss_pred             hCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEec
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYM  119 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  119 (380)
                      .+.|++.+.||+|+||+||+|++.++..||+|.++.... ....+.+|+.+++.++||||+++++++......++||||+
T Consensus         3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcC
Confidence            356889999999999999999887677799999875432 3457889999999999999999999999888999999999


Q ss_pred             CCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc
Q 037869          120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS  199 (380)
Q Consensus       120 ~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~  199 (380)
                      .+|+|.+++...   ...+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.+||+|||+++.......
T Consensus        82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~  155 (256)
T cd05113          82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY  155 (256)
T ss_pred             CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCce
Confidence            999999998653   23689999999999999999999999   999999999999999999999999999886644322


Q ss_pred             cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          200 HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       200 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   .   ... ..         ....
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~---~~~-~~---------~~~~  219 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---T---VEK-VS---------QGLR  219 (256)
T ss_pred             eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---H---HHH-Hh---------cCCC
Confidence            22222235678999999998889999999999999999998 999986533210   0   000 00         0011


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ...+...+..+.+++.+||+.+|.+||++.+|+..++
T Consensus       220 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         220 LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            1112223478899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.2e-43  Score=328.70  Aligned_cols=249  Identities=25%  Similarity=0.334  Sum_probs=200.2

Q ss_pred             CCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHH---hcCCCCcceeEeeEEecCCeEEEE
Q 037869           43 FSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVL---GRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        43 y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l---~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      |++.+.||+|+||.||+|.+ .+++.||||+++...   ......+..|..++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            78899999999999999986 468999999997432   22334555665554   567899999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |||+++|+|...+..     ..+++..++.++.|++.||.|||+.   |++||||||+||+++.++.+||+|||++....
T Consensus        81 ~E~~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~  152 (324)
T cd05589          81 MEYAAGGDLMMHIHT-----DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGM  152 (324)
T ss_pred             EcCCCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCC
Confidence            999999999988853     3689999999999999999999999   99999999999999999999999999987532


Q ss_pred             CCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      .. ........|++.|+|||++.+..++.++|||||||++|+|++|..||.......  ..    .         .+...
T Consensus       153 ~~-~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~--~~----~---------~i~~~  216 (324)
T cd05589         153 GF-GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE--VF----D---------SIVND  216 (324)
T ss_pred             CC-CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH--HH----H---------HHHhC
Confidence            21 122334568999999999999999999999999999999999999997533210  00    0         00000


Q ss_pred             cccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhcCC
Q 037869          276 KLRGDFDENQLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLTGY  317 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~~~  317 (380)
                        ....+...+..+.++|.+||+.||.+||     ++.++++|.+..
T Consensus       217 --~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~  261 (324)
T cd05589         217 --EVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFR  261 (324)
T ss_pred             --CCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcC
Confidence              0112333457789999999999999999     699999987643

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-43  Score=316.17  Aligned_cols=256  Identities=31%  Similarity=0.464  Sum_probs=208.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ..++|++.+.||+|++|.||+|.+.++..||+|.++... .....+.+|+.++++++||||+++++++...+..++||||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeec
Confidence            457799999999999999999988777889999987543 2345788899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++++|.+++....  ...+++..+..++.|++.||.+||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            99999999997542  34689999999999999999999998   99999999999999999999999999998765322


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      .........+..|+|||.+.+..++.++||||||+++|+|++ |..||.......  ...              ......
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~--------------~~~~~~  221 (261)
T cd05068         158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--VLQ--------------QVDQGY  221 (261)
T ss_pred             ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHH--------------HHHcCC
Confidence            221222223457999999998899999999999999999999 999986532110  000              000111


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ....+...+..+.+++.+||+.+|.+||++.+|+..|+.
T Consensus       222 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         222 RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhc
Confidence            112233445789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.5e-43  Score=327.86  Aligned_cols=247  Identities=24%  Similarity=0.320  Sum_probs=200.7

Q ss_pred             cceeccCCceEEEEEEe----CCCcEEEEEEeccc----ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           46 DNKLGEGGFGSVYWGRT----SDGLQIAVKKLKAM----NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ++.||+|+||.||++++    .+++.||+|+++..    .......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            36899999999999975    35788999998742    22334467789999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+++++|.+++...    ..+.+..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||+++.....
T Consensus        81 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (323)
T cd05584          81 YLSGGELFMHLERE----GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE  153 (323)
T ss_pred             CCCCchHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence            99999999998643    4678889999999999999999999   9999999999999999999999999998754322


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      . .......|++.|+|||++.+..++.++|||||||++|||++|..||......  ..             +..+...  
T Consensus       154 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~--~~-------------~~~~~~~--  215 (323)
T cd05584         154 G-TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRK--KT-------------IDKILKG--  215 (323)
T ss_pred             C-CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHH--HH-------------HHHHHcC--
Confidence            1 1223356899999999999888999999999999999999999999753311  00             0001010  


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhcCC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLTGY  317 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~~~  317 (380)
                      ....+...+..+.++|.+||+.+|++||     ++.++++|.+..
T Consensus       216 ~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~  260 (323)
T cd05584         216 KLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFR  260 (323)
T ss_pred             CCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcC
Confidence            1122334457889999999999999999     899999997643

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-43  Score=314.58  Aligned_cols=253  Identities=25%  Similarity=0.358  Sum_probs=206.7

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh-----hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS-----KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      +.|.+.+.||.|++|.||.+.+ .+++.|++|.+.....     .....+.+|+.++++++||||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            5799999999999999999986 4689999999864321     123467889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      |+||+++++|.+.+...    ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++...
T Consensus        82 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~  154 (263)
T cd06625          82 FMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRL  154 (263)
T ss_pred             EEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceec
Confidence            99999999999998643    4688999999999999999999999   9999999999999999999999999999765


Q ss_pred             CCCCccce--eccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          195 PEGVSHMT--TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       195 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      ........  ....++..|+|||.+.+..++.++||||+|+++|+|++|..||........               ....
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---------------~~~~  219 (263)
T cd06625         155 QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA---------------IFKI  219 (263)
T ss_pred             cccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH---------------HHHH
Confidence            43221111  234578899999999998899999999999999999999999965321100               0001


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .........+...+..+.+++.+||..+|.+|||+.++++|.+
T Consensus       220 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  262 (263)
T cd06625         220 ATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF  262 (263)
T ss_pred             hccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCC
Confidence            1111122334445678899999999999999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.2e-43  Score=317.31  Aligned_cols=256  Identities=28%  Similarity=0.416  Sum_probs=208.2

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ....|.+.+.||+|++|.||+|.+ ..+..|++|.+.... .....+.+|+.+++.++|+||+++++++..++..++|||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (263)
T cd05052           4 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   82 (263)
T ss_pred             chHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence            345688899999999999999986 458889999987543 345578889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+++++|.+++....  ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~  157 (263)
T cd05052          83 FMTYGNLLDYLRECN--RQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  157 (263)
T ss_pred             eCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence            999999999986532  34689999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      .........++..|+|||.+.+..++.++|||||||++|+|++ |..||......      ..          .......
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~------~~----------~~~~~~~  221 (263)
T cd05052         158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS------QV----------YELLEKG  221 (263)
T ss_pred             eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH------HH----------HHHHHCC
Confidence            2222222234668999999998999999999999999999998 89998653211      00          0001111


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .....+...+.++.+++.+||+.+|++|||+.++++.|..
T Consensus       222 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~  261 (263)
T cd05052         222 YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFET  261 (263)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHh
Confidence            1223334456789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=3.1e-43  Score=325.25  Aligned_cols=246  Identities=26%  Similarity=0.309  Sum_probs=198.8

Q ss_pred             ceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEEEEEecCC
Q 037869           47 NKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLIVYDYMPN  121 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  121 (380)
                      +.||+|+||+||+|.+ .+++.||+|+++..   .......+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999987 46889999998742   223344566788888776 699999999999999999999999999


Q ss_pred             CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccc
Q 037869          122 LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM  201 (380)
Q Consensus       122 g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~  201 (380)
                      |+|.+++...    ..+++..+..++.|++.||+|||++   +++||||||+|||++.++.++|+|||++....... ..
T Consensus        81 g~L~~~i~~~----~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~-~~  152 (320)
T cd05590          81 GDLMFHIQKS----RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG-KT  152 (320)
T ss_pred             chHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC-Cc
Confidence            9999988653    4689999999999999999999999   99999999999999999999999999987543221 12


Q ss_pred             eeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCC
Q 037869          202 TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF  281 (380)
Q Consensus       202 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ..    .         .+...  ....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~--~~----~---------~i~~~--~~~~  215 (320)
T cd05590         153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD--LF----E---------AILND--EVVY  215 (320)
T ss_pred             ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--HH----H---------HHhcC--CCCC
Confidence            334568999999999999999999999999999999999999997543210  00    0         00000  0112


Q ss_pred             CHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHHHhcCC
Q 037869          282 DENQLKQAINVAVLCVQSEPEKRPNM------KEVVNTLTGY  317 (380)
Q Consensus       282 ~~~~~~~~~~li~~cl~~~P~~Rps~------~~ll~~l~~~  317 (380)
                      +...+.++.+++.+||+.||.+||++      +++++|.+..
T Consensus       216 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~  257 (320)
T cd05590         216 PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFK  257 (320)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcC
Confidence            23345788999999999999999998      8999986643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=4.8e-43  Score=315.64  Aligned_cols=257  Identities=25%  Similarity=0.343  Sum_probs=206.0

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ...+|++.+.||+|+||.||+|.+ .+++.||+|++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e   86 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME   86 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence            456899999999999999999987 5688999999976554555578889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+++++|.+++...    ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++......
T Consensus        87 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06646          87 YCGGGSLQDIYHVT----GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITAT  159 (267)
T ss_pred             CCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence            99999999998643    4689999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CccceeccccccCccCccccc---cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          198 VSHMTTRVKGTLGYLAPEYAM---WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      .. ......++..|+|||.+.   ...++.++||||+||++|+|++|..||..........  .+.     ...   ...
T Consensus       160 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~~~-----~~~---~~~  228 (267)
T cd06646         160 IA-KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LMS-----KSN---FQP  228 (267)
T ss_pred             cc-ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--eee-----cCC---CCC
Confidence            21 122345789999999885   3457889999999999999999999986433211100  000     000   000


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      +..  ......+..+.+++.+||+.+|++|||+++++++++
T Consensus       229 ~~~--~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         229 PKL--KDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             CCC--ccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            000  111234578899999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=3.1e-43  Score=319.21  Aligned_cols=251  Identities=25%  Similarity=0.314  Sum_probs=201.4

Q ss_pred             eccCCceEEEEEEe-CCCcEEEEEEecccCh---hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCCCH
Q 037869           49 LGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS---KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSL  124 (380)
Q Consensus        49 Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  124 (380)
                      ||+|+||+||++.+ .+++.||+|.+.....   .....+..|+.+++.++|+||+++.+++......++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999987 4688999999874322   2234567899999999999999999999999999999999999999


Q ss_pred             HHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccceec
Q 037869          125 LSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR  204 (380)
Q Consensus       125 ~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~~~  204 (380)
                      ...+.........+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++........ ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            988754333445799999999999999999999999   999999999999999999999999999977644322 2233


Q ss_pred             cccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHH
Q 037869          205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN  284 (380)
Q Consensus       205 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      ..|++.|+|||++.+..++.++|||||||++|+|++|..||..........  .     .    .......  ....+..
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~-----~----~~~~~~~--~~~~~~~  223 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--E-----L----KQRILND--SVTYPDK  223 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--H-----H----HHhhccc--CCCCccc
Confidence            468999999999999999999999999999999999999997533211000  0     0    0000000  1122334


Q ss_pred             HHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhcC
Q 037869          285 QLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLTG  316 (380)
Q Consensus       285 ~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~~  316 (380)
                      .+..+.+++.+||+.||++||     +++++++|.+.
T Consensus       224 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~  260 (280)
T cd05608         224 FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLF  260 (280)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhh
Confidence            567889999999999999999     88999998664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.3e-43  Score=323.99  Aligned_cols=253  Identities=21%  Similarity=0.285  Sum_probs=200.9

Q ss_pred             ceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEEEEEecCC
Q 037869           47 NKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLIVYDYMPN  121 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  121 (380)
                      +.||+|+||.||+|.+ .+++.||+|+++..   .......+..|..++..+ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999987 46889999999753   223344577899999888 699999999999999999999999999


Q ss_pred             CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccc
Q 037869          122 LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM  201 (380)
Q Consensus       122 g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~  201 (380)
                      |+|.+++...    ..+++..++.++.|++.||.|||++   |++||||||+||+++.++.++|+|||++...... ...
T Consensus        81 g~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~  152 (329)
T cd05588          81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDT  152 (329)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccC-CCc
Confidence            9999888543    4799999999999999999999999   9999999999999999999999999998753221 122


Q ss_pred             eeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCc--ccchhccchhhhhccccccccCCcccC
Q 037869          202 TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGV--KRTITEWAEPLIVKGKFKELVDPKLRG  279 (380)
Q Consensus       202 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ......+......        ...  .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~--------~~~--~  222 (329)
T cd05588         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVIL--------EKQ--I  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHH--------cCC--C
Confidence            334578999999999999999999999999999999999999996432211  0000011101011        111  1


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCC------HHHHHHHhcCC
Q 037869          280 DFDENQLKQAINVAVLCVQSEPEKRPN------MKEVVNTLTGY  317 (380)
Q Consensus       280 ~~~~~~~~~~~~li~~cl~~~P~~Rps------~~~ll~~l~~~  317 (380)
                      ..+...+..+.++|.+||+.||.+||+      ++++++|.+..
T Consensus       223 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~  266 (329)
T cd05588         223 RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR  266 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCC
Confidence            123334577899999999999999987      78999997653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=3.4e-43  Score=318.76  Aligned_cols=257  Identities=28%  Similarity=0.480  Sum_probs=207.0

Q ss_pred             hCCCCCcceeccCCceEEEEEEeC------CCcEEEEEEecccChh-hHHHHHHHHHHHhcCCCCcceeEeeEEecCCeE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTS------DGLQIAVKKLKAMNSK-AEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  112 (380)
                      ..+|.+.+.||+|+||.||+|.+.      ++..||+|.++..... ....+.+|+++++.++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP   83 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence            457889999999999999999753      2478999999865443 456788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHhhccCC----------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc
Q 037869          113 LIVYDYMPNLSLLSHLHGQY----------AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE  182 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~----------~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~  182 (380)
                      ++||||+++++|.+++....          .....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~  160 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLV  160 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCe
Confidence            99999999999999996531          2234588999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccc
Q 037869          183 PLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWA  260 (380)
Q Consensus       183 vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~  260 (380)
                      ++|+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||.......  ..    
T Consensus       161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~----  234 (280)
T cd05049         161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VI----  234 (280)
T ss_pred             EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HH----
Confidence            99999999876432211 11222335788999999999999999999999999999998 999986543211  00    


Q ss_pred             hhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          261 EPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .. ..         .......+...+..+.+++.+||+.||.+||++.++++.|.
T Consensus       235 ~~-~~---------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         235 EC-IT---------QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HH-HH---------cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            00 00         11111222345578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.1e-43  Score=329.16  Aligned_cols=246  Identities=24%  Similarity=0.287  Sum_probs=200.0

Q ss_pred             ceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCC
Q 037869           47 NKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNL  122 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  122 (380)
                      +.||+|+||.||++.+ .++..||+|+++..   .......+..|++++..++||||+++++++...+..++||||+++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            4699999999999986 57899999999753   2233456778999999999999999999999999999999999999


Q ss_pred             CHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccc
Q 037869          123 SLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH-EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM  201 (380)
Q Consensus       123 ~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~-~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~  201 (380)
                      +|..++...    ..+++..+..++.||+.||.|||+ .   ||+||||||+|||++.++.+||+|||++....... ..
T Consensus        81 ~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~  152 (325)
T cd05594          81 ELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG-AT  152 (325)
T ss_pred             cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC-cc
Confidence            999888643    468999999999999999999997 6   99999999999999999999999999987543221 12


Q ss_pred             eeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCC
Q 037869          202 TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF  281 (380)
Q Consensus       202 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||........      ...         ....  ...+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~------~~~---------i~~~--~~~~  215 (325)
T cd05594         153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL------FEL---------ILME--EIRF  215 (325)
T ss_pred             cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHH------HHH---------HhcC--CCCC
Confidence            2335689999999999999999999999999999999999999965321100      000         0000  0112


Q ss_pred             CHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhcCC
Q 037869          282 DENQLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLTGY  317 (380)
Q Consensus       282 ~~~~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~~~  317 (380)
                      +...+.++.+++.+||+.||.+|+     ++.++++|.+..
T Consensus       216 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~  256 (325)
T cd05594         216 PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFA  256 (325)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcC
Confidence            233457889999999999999996     999999997644

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=8.6e-43  Score=313.94  Aligned_cols=260  Identities=19%  Similarity=0.295  Sum_probs=209.2

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecc---cChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKA---MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      .+|++.+.||+|+||.||+|++ .++..||||.++.   ........+.+|+.+++.++||||+++++++...+..++|+
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL   81 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence            5799999999999999999986 4789999998764   22334456888999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++++|.+++.........+++..++.++.|++.||+|||++   +++||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~  158 (267)
T cd08228          82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence            99999999998864333345689999999999999999999999   999999999999999999999999999887643


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      ... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||..........    ...      +..   ..
T Consensus       159 ~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~----~~~------~~~---~~  224 (267)
T cd08228         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSL----CQK------IEQ---CD  224 (267)
T ss_pred             hhH-HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHH----HHH------Hhc---CC
Confidence            221 1223457889999999998889999999999999999999999986432111000    000      000   01


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .........+..+.+++.+||+.+|++|||+.++++.+..+
T Consensus       225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            11112234557899999999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-43  Score=319.60  Aligned_cols=256  Identities=28%  Similarity=0.346  Sum_probs=206.6

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      .|++.+.||+|+||+||++.+ .+++.||+|++....   ......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            488899999999999999987 468899999987532   1223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+++|+|.+++...  ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05605          81 LMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG  155 (285)
T ss_pred             ccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCC
Confidence            99999999888643  234689999999999999999999999   9999999999999999999999999999875432


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      .  ......|+..|+|||++.+..++.++||||+||++|+|++|..||........  ...+          ..... ..
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~~~~----------~~~~~-~~  220 (285)
T cd05605         156 E--TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--REEV----------ERRVK-ED  220 (285)
T ss_pred             C--ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--HHHH----------HHHhh-hc
Confidence            2  12234689999999999988999999999999999999999999975332110  0000          00000 01


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhcCC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLTGY  317 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~~~  317 (380)
                      ...++...+..+.+|+.+||+.||.+||     ++.++++|.+.-
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~  265 (285)
T cd05605         221 QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFR  265 (285)
T ss_pred             ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCcc
Confidence            1123344567889999999999999999     899999996643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.1e-42  Score=322.40  Aligned_cols=252  Identities=22%  Similarity=0.293  Sum_probs=200.3

Q ss_pred             ceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEEEEEecCC
Q 037869           47 NKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLIVYDYMPN  121 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  121 (380)
                      +.||+|+||.||+|.+ .+++.||+|+++...   ......+..|..++.++ +||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4799999999999987 467899999997532   23344677899998888 699999999999999999999999999


Q ss_pred             CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccc
Q 037869          122 LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM  201 (380)
Q Consensus       122 g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~  201 (380)
                      |+|..++...    ..+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++|+|||++...... ...
T Consensus        81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~  152 (327)
T cd05617          81 GDLMFHMQRQ----RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDT  152 (327)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCc
Confidence            9999888643    4699999999999999999999999   9999999999999999999999999998753221 122


Q ss_pred             eeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCC
Q 037869          202 TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF  281 (380)
Q Consensus       202 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||....................        ..  ....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--------~~--~~~~  222 (327)
T cd05617         153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL--------EK--PIRI  222 (327)
T ss_pred             eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH--------hC--CCCC
Confidence            3345789999999999999999999999999999999999999965432211111111111010        01  1122


Q ss_pred             CHHHHHHHHHHHHhhcCCCCCCCCC------HHHHHHHhcC
Q 037869          282 DENQLKQAINVAVLCVQSEPEKRPN------MKEVVNTLTG  316 (380)
Q Consensus       282 ~~~~~~~~~~li~~cl~~~P~~Rps------~~~ll~~l~~  316 (380)
                      +...+..+.+++.+||+.||.+|++      ++++++|.+.
T Consensus       223 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f  263 (327)
T cd05617         223 PRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFF  263 (327)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCC
Confidence            3334577899999999999999997      5799998654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.9e-43  Score=314.43  Aligned_cols=257  Identities=28%  Similarity=0.468  Sum_probs=208.2

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ...+.|++.++||+|+||.||+|...++..||+|.+..... ....+.+|+.+++.++|+||+++++++. .+..+++||
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence            35678999999999999999999988889999999875443 3457888999999999999999999874 567899999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+.+++|.+++...  ....+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  155 (260)
T cd05067          81 YMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDN  155 (260)
T ss_pred             cCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCC
Confidence            99999999998653  234689999999999999999999998   9999999999999999999999999999876532


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      .........++..|+|||.+.+..++.++||||||+++|++++ |..||.......   .   ..          .....
T Consensus       156 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~---~~----------~~~~~  219 (260)
T cd05067         156 EYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE---V---IQ----------NLERG  219 (260)
T ss_pred             CcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH---H---HH----------HHHcC
Confidence            2222223345678999999998889999999999999999999 999997543210   0   00          00011


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .....+...+.++.+++.+||+.+|++||+++++++.|+.+
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         220 YRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence            11122233456899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3e-43  Score=325.99  Aligned_cols=250  Identities=26%  Similarity=0.339  Sum_probs=201.7

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCC-cceeEeeEEecCCeEEEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHK-NLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~  116 (380)
                      .|++.+.||+|+||.||+|.+ .+++.||+|+++..   .......+..|..++..++|+ +|+++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            488999999999999999987 45789999998752   223445677899999999764 6888999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++|+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+|||++.....
T Consensus        81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~  153 (324)
T cd05587          81 EYVNGGDLMYHIQQV----GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF  153 (324)
T ss_pred             cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCC
Confidence            999999999998643    4688999999999999999999999   999999999999999999999999999875322


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      .. .......||+.|+|||++.+..++.++||||+||++|+|++|..||.......  ..             ..+..  
T Consensus       154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~~-------------~~i~~--  215 (324)
T cd05587         154 GG-KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--LF-------------QSIME--  215 (324)
T ss_pred             CC-CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH--HH-------------HHHHc--
Confidence            11 12334568999999999999999999999999999999999999997533110  00             00000  


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHHHhcC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNM-----KEVVNTLTG  316 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~-----~~ll~~l~~  316 (380)
                      ....++...+..+.+++.+||..||.+|++.     .++++|.+.
T Consensus       216 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~  260 (324)
T cd05587         216 HNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFF  260 (324)
T ss_pred             CCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCc
Confidence            0112233445788999999999999999976     788888653

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-45  Score=312.94  Aligned_cols=261  Identities=25%  Similarity=0.301  Sum_probs=223.0

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      +.+-|.++++||+|+||.||+|.+ .+|+.+|||.+...  .+..++..|+.+|.+.+.|++|+++|.|.....+|||||
T Consensus        31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            445688999999999999999976 56999999998764  467789999999999999999999999998899999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      ||..|++.+.++.+   +.++++.++..++...++||+|||..   .-+|||||..|||++.+|..||+|||.+-++.+.
T Consensus       109 YCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT  182 (502)
T KOG0574|consen  109 YCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT  182 (502)
T ss_pred             hcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence            99999999999754   57899999999999999999999998   8899999999999999999999999999887543


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                       -....++.||+.|+|||++..-.|+.++||||||++..||.-|++||....+...-              +.-...+..
T Consensus       183 -MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI--------------FMIPT~PPP  247 (502)
T KOG0574|consen  183 -MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI--------------FMIPTKPPP  247 (502)
T ss_pred             -HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee--------------EeccCCCCC
Confidence             23456678999999999999999999999999999999999999999765432110              111112222


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCCCCc
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGK  322 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~~~~  322 (380)
                      .-..+...+.++.+++.+||-++|++|.|+.++++|....+....
T Consensus       248 TF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~  292 (502)
T KOG0574|consen  248 TFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGC  292 (502)
T ss_pred             CCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcc
Confidence            334466778999999999999999999999999999876665543

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-43  Score=313.39  Aligned_cols=251  Identities=27%  Similarity=0.448  Sum_probs=203.1

Q ss_pred             CCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecC
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMP  120 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  120 (380)
                      ..|++.+.||+|+||.||++.+.++..+|+|.+..... ....+.+|+.+++.++||||+++++++...+..++||||++
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~   82 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA   82 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence            46889999999999999999887777899999865322 33467889999999999999999999999999999999999


Q ss_pred             CCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCcc
Q 037869          121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH  200 (380)
Q Consensus       121 ~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~  200 (380)
                      +++|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||+++........
T Consensus        83 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~  156 (256)
T cd05059          83 NGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT  156 (256)
T ss_pred             CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceeccccccc
Confidence            99999999653   23689999999999999999999999   9999999999999999999999999999765432211


Q ss_pred             ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCcccC
Q 037869          201 MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG  279 (380)
Q Consensus       201 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......  ...              ........
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~--------------~~~~~~~~  220 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE--VVE--------------SVSAGYRL  220 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH--HHH--------------HHHcCCcC
Confidence            1111223457999999998899999999999999999999 899986533210  000              00011111


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 037869          280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL  314 (380)
Q Consensus       280 ~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l  314 (380)
                      ..+...+..+.+++.+||+.+|++|||+.++++.|
T Consensus       221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence            22233567899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.6e-42  Score=321.67  Aligned_cols=253  Identities=22%  Similarity=0.299  Sum_probs=200.1

Q ss_pred             ceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEEEEEecCC
Q 037869           47 NKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLIVYDYMPN  121 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  121 (380)
                      +.||+|+||.||+|.+ .+++.||+|+++..   .......+..|..++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999987 46889999999753   233344577788888776 799999999999999999999999999


Q ss_pred             CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccc
Q 037869          122 LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM  201 (380)
Q Consensus       122 g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~  201 (380)
                      |+|..++...    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.++|+|||++...... ...
T Consensus        81 ~~L~~~~~~~----~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~  152 (329)
T cd05618          81 GDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDT  152 (329)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCc
Confidence            9999888543    4689999999999999999999999   9999999999999999999999999998753221 112


Q ss_pred             eeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCccc--chhccchhhhhccccccccCCcccC
Q 037869          202 TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKR--TITEWAEPLIVKGKFKELVDPKLRG  279 (380)
Q Consensus       202 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.........  ....+....        ....  ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------i~~~--~~  222 (329)
T cd05618         153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------ILEK--QI  222 (329)
T ss_pred             cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH--------HhcC--CC
Confidence            33456899999999999999999999999999999999999999643221110  000000000        0011  11


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCC------HHHHHHHhcCC
Q 037869          280 DFDENQLKQAINVAVLCVQSEPEKRPN------MKEVVNTLTGY  317 (380)
Q Consensus       280 ~~~~~~~~~~~~li~~cl~~~P~~Rps------~~~ll~~l~~~  317 (380)
                      ..+...+..+.++|.+||+.||.+||+      +.++++|.+..
T Consensus       223 ~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~  266 (329)
T cd05618         223 RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR  266 (329)
T ss_pred             CCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCC
Confidence            233445578899999999999999998      57999997653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.6e-43  Score=313.58  Aligned_cols=255  Identities=29%  Similarity=0.472  Sum_probs=206.4

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ..++|++.++||+|+||.||+|.+.++..||+|.++.... ....+.+|+.++++++|+|++++++++. ....+++|||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            4568999999999999999999887788899999876433 3457889999999999999999999875 4568999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++++|.+++...  ....+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++..+....
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          82 MSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            9999999999653  234589999999999999999999999   99999999999999999999999999998764432


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.......  ..    ..          .....
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~----~~----------~~~~~  220 (260)
T cd05070         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE--VL----EQ----------VERGY  220 (260)
T ss_pred             cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH--HH----HH----------HHcCC
Confidence            222222335668999999988889999999999999999999 889986532110  00    00          01111


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ....+...+..+.+++.+||..+|.+|||+.++++.|+.
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         221 RMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            122334455789999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.9e-43  Score=319.26  Aligned_cols=260  Identities=27%  Similarity=0.477  Sum_probs=208.4

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe------CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT------SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  112 (380)
                      .++.|.+.+.||+|+||.||++.+      .++..||+|.+..........+.+|+.++++++||||+++++++...+..
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   82 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   82 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence            457899999999999999999974      23456899999876666666789999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHhhccCC---------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCce
Q 037869          113 LIVYDYMPNLSLLSHLHGQY---------AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEP  183 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~---------~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~v  183 (380)
                      ++||||+++++|.+++....         .....+++..++.++.|++.||+|||+.   |++||||||+||+++.++.+
T Consensus        83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcE
Confidence            99999999999999986442         1223589999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccch
Q 037869          184 LVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAE  261 (380)
Q Consensus       184 kl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~  261 (380)
                      +|+|||++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||.......  ...    
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~----  233 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIE----  233 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH----
Confidence            9999999986533211 11222335778999999998899999999999999999998 899986543210  000    


Q ss_pred             hhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          262 PLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      . ...+.         ....+...+.++.+|+.+||+.||.+|||+.++++.|..+
T Consensus       234 ~-i~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~  279 (288)
T cd05093         234 C-ITQGR---------VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNL  279 (288)
T ss_pred             H-HHcCC---------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            0 00010         0111223446799999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1e-43  Score=328.95  Aligned_cols=257  Identities=25%  Similarity=0.395  Sum_probs=222.1

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC---CC--cEEEEEEecc-cChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS---DG--LQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~---~~--~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  112 (380)
                      ..+..+..++||.|.||.||.|...   .|  -.||||..+. ..+.+.+.|..|..+|++++||||++++|+|.+ ...
T Consensus       387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~  465 (974)
T KOG4257|consen  387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPM  465 (974)
T ss_pred             ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cce
Confidence            4556677889999999999999642   23  4589999986 555667789999999999999999999999984 779


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      |||||+++.|.|..+++..   ...++......+++||+.||+|||+.   .+|||||..+|||+.+.-.|||+|||+++
T Consensus       466 WivmEL~~~GELr~yLq~n---k~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR  539 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQN---KDSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSR  539 (974)
T ss_pred             eEEEecccchhHHHHHHhc---cccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhh
Confidence            9999999999999999865   45788899999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      .+.+..........-.+.|+|||-+....++.+||||.||+++||++. |..||.+..+                ..+--
T Consensus       540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkN----------------sDVI~  603 (974)
T KOG4257|consen  540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKN----------------SDVIG  603 (974)
T ss_pred             hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccc----------------cceEE
Confidence            998776666555556889999999999999999999999999999987 9999987543                12222


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      -+..+-+.+.|++++..+..|+.+||+.+|.+||.+.+|...|....
T Consensus       604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~  650 (974)
T KOG4257|consen  604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL  650 (974)
T ss_pred             EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence            34566677889999999999999999999999999999988776543

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1e-42  Score=313.33  Aligned_cols=255  Identities=27%  Similarity=0.463  Sum_probs=205.5

Q ss_pred             hCCCCCcceeccCCceEEEEEEeC----CCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTS----DGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      .++|++.+.||+|+||+||+|.+.    +...||+|.++... ......+.+|+.+++.++||||+++++++...+..++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            467999999999999999999863    24579999987543 3344578889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ||||+++++|.+++...   ...+++..++.++.|++.||+|||++   +++||||+|+||+++.++.++|+|||++...
T Consensus        83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~  156 (266)
T cd05033          83 ITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRL  156 (266)
T ss_pred             EEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence            99999999999999653   24789999999999999999999998   9999999999999999999999999999887


Q ss_pred             CCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          195 PEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       195 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      ...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......  ..              ..
T Consensus       157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~--~~--------------~~  220 (266)
T cd05033         157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD--VI--------------KA  220 (266)
T ss_pred             cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH--HH--------------HH
Confidence            421111 1112234678999999998899999999999999999998 999986432110  00              00


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .........+...+..+.+++.+||+.+|++||++.+++++|..
T Consensus       221 ~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~  264 (266)
T cd05033         221 VEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDK  264 (266)
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence            00011111223445788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=6.9e-43  Score=330.84  Aligned_cols=261  Identities=26%  Similarity=0.390  Sum_probs=206.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC------CCcEEEEEEecccC-hhhHHHHHHHHHHHhcCC-CCcceeEeeEEecCC
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS------DGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVR-HKNLLGLRGYCAGTD  110 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  110 (380)
                      ..++|++.++||+|+||.||+|.+.      .+..||||+++... ......+.+|+++++++. ||||+++++++....
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~  114 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSG  114 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCC
Confidence            5779999999999999999999752      23479999997533 333457889999999996 999999999999999


Q ss_pred             eEEEEEEecCCCCHHHhhccCCC---------------------------------------------------------
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYA---------------------------------------------------------  133 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~---------------------------------------------------------  133 (380)
                      ..|+|||||++|+|.+++.....                                                         
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (400)
T cd05105         115 PIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEI  194 (400)
T ss_pred             ceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhh
Confidence            99999999999999998864310                                                         


Q ss_pred             -----------------------------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC
Q 037869          134 -----------------------------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLD  178 (380)
Q Consensus       134 -----------------------------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~  178 (380)
                                                         ....+++..+..++.|++.||.|||+.   +++||||||+||+++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~  271 (400)
T cd05105         195 KEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEe
Confidence                                               012478888999999999999999998   999999999999999


Q ss_pred             CCCceEEeeccCccccCCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccch
Q 037869          179 SDFEPLVADFGFAKLIPEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTI  256 (380)
Q Consensus       179 ~~~~vkl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~  256 (380)
                      .++.++|+|||++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||........  .
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~--~  349 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST--F  349 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH--H
Confidence            9999999999999865432211 1222346788999999998899999999999999999997 8899865321100  0


Q ss_pred             hccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          257 TEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                                   ............+...+..+.+++.+||+.+|++|||+.+|.+.|...
T Consensus       350 -------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l  397 (400)
T cd05105         350 -------------YNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESL  397 (400)
T ss_pred             -------------HHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHH
Confidence                         000011111223344567899999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1e-42  Score=322.04  Aligned_cols=245  Identities=24%  Similarity=0.294  Sum_probs=198.6

Q ss_pred             ceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEEEEEecCC
Q 037869           47 NKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLIVYDYMPN  121 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  121 (380)
                      +.||+|+||.||+|++ .+++.||+|+++..   .......+..|..++..+ +||||+++++++...+..|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999987 45889999998753   223344567788888866 799999999999999999999999999


Q ss_pred             CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccc
Q 037869          122 LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM  201 (380)
Q Consensus       122 g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~  201 (380)
                      |+|...+...    ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.++|+|||++....... ..
T Consensus        81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~-~~  152 (321)
T cd05591          81 GDLMFQIQRS----RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG-VT  152 (321)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCC-cc
Confidence            9999988643    4688999999999999999999999   99999999999999999999999999987543221 22


Q ss_pred             eeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCC
Q 037869          202 TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF  281 (380)
Q Consensus       202 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ..             ..+....  ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--~~-------------~~i~~~~--~~~  215 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD--LF-------------ESILHDD--VLY  215 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH--HH-------------HHHHcCC--CCC
Confidence            334568999999999999899999999999999999999999997543210  00             0000000  012


Q ss_pred             CHHHHHHHHHHHHhhcCCCCCCCC-------CHHHHHHHhcC
Q 037869          282 DENQLKQAINVAVLCVQSEPEKRP-------NMKEVVNTLTG  316 (380)
Q Consensus       282 ~~~~~~~~~~li~~cl~~~P~~Rp-------s~~~ll~~l~~  316 (380)
                      +...+.++.+++.+||+.||++||       ++.++++|.+.
T Consensus       216 p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~  257 (321)
T cd05591         216 PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFF  257 (321)
T ss_pred             CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCcc
Confidence            223457889999999999999999       99999999764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.4e-43  Score=317.73  Aligned_cols=249  Identities=35%  Similarity=0.556  Sum_probs=195.5

Q ss_pred             CcceeccCCceEEEEEEeC-----CCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           45 DDNKLGEGGFGSVYWGRTS-----DGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        45 ~~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      +.+.||.|.||.||+|...     .+..|+||.++... ......+.+|++.+++++||||+++++++...+..++|+||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~   82 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY   82 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence            5678999999999999765     36789999997543 34467899999999999999999999999988889999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++|+|.+++...  ....+++..++.++.|++.||+|||+.   +++||+|+++||+++.++.+||+|||++.......
T Consensus        83 ~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   83 CPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             -TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccc--ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            9999999999764  235789999999999999999999999   99999999999999999999999999998763221


Q ss_pred             c-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          199 S-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       199 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      . ...........|+|||.+.+..++.++||||||+++|||++ |..||.......                +...+...
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~----------------~~~~~~~~  221 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE----------------IIEKLKQG  221 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH----------------HHHHHHTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccc----------------cccccccc
Confidence            1 12223346788999999998889999999999999999999 678886542110                00011111


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL  314 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l  314 (380)
                      .+...+..++..+.+++.+||+.+|.+|||+.+|++.|
T Consensus       222 ~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  222 QRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             EETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            12223334557899999999999999999999999875

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.3e-43  Score=325.68  Aligned_cols=262  Identities=24%  Similarity=0.356  Sum_probs=204.9

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEeC------CCcEEEEEEecccC-hhhHHHHHHHHHHHhcC-CCCcceeEeeEEec
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRTS------DGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAG  108 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  108 (380)
                      ..+..+|++.+.||.|+||.||+|...      +++.||+|+++... ......+..|+.++.++ +|+||+++++++..
T Consensus         3 ~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           3 EFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             ccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            346678999999999999999999632      35789999987533 23345677899999999 79999999998764


Q ss_pred             -CCeEEEEEEecCCCCHHHhhccCCCC-----------------------------------------------------
Q 037869          109 -TDQRLIVYDYMPNLSLLSHLHGQYAG-----------------------------------------------------  134 (380)
Q Consensus       109 -~~~~~lv~e~~~~g~L~~~i~~~~~~-----------------------------------------------------  134 (380)
                       +..++++|||+++++|.+++......                                                     
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence             45688999999999999988542110                                                     


Q ss_pred             ----CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCcc-ceecccccc
Q 037869          135 ----EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH-MTTRVKGTL  209 (380)
Q Consensus       135 ----~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~-~~~~~~gt~  209 (380)
                          ...+++..+..++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++..+...... ......++.
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~  239 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  239 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCc
Confidence                12688999999999999999999999   9999999999999999999999999999876432221 122234567


Q ss_pred             CccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHH
Q 037869          210 GYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQ  288 (380)
Q Consensus       210 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (380)
                      .|+|||++.+..++.++|||||||++|+|++ |..||........  .             ............+...+.+
T Consensus       240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~-------------~~~~~~~~~~~~~~~~~~~  304 (337)
T cd05054         240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--F-------------CRRLKEGTRMRAPEYATPE  304 (337)
T ss_pred             cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--H-------------HHHHhccCCCCCCccCCHH
Confidence            8999999999999999999999999999998 9999965322100  0             0000011111122334578


Q ss_pred             HHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          289 AINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       289 ~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      +.+++.+||+.+|++||++.+++++|..
T Consensus       305 ~~~l~~~cl~~~p~~RPs~~ell~~l~~  332 (337)
T cd05054         305 IYSIMLDCWHNNPEDRPTFSELVEILGD  332 (337)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            8999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-42  Score=322.82  Aligned_cols=259  Identities=22%  Similarity=0.226  Sum_probs=202.2

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ++|++.+.||+|+||+||++++ .+++.||+|++...   .......+.+|+.++..++|+||+++++++.+++..|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            4799999999999999999986 46889999998742   2233445788999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++|+|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+|||++.....
T Consensus        81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  154 (331)
T cd05597          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA  154 (331)
T ss_pred             ecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence            999999999999642   34689999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCccceeccccccCccCcccccc-----CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMW-----GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      ..........||+.|+|||++.+     ..++.++||||+||++|+|++|..||........  .    .........  
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~--~----~~i~~~~~~--  226 (331)
T cd05597         155 DGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVET--Y----GKIMNHKEH--  226 (331)
T ss_pred             CCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHH--H----HHHHcCCCc--
Confidence            32222233468999999999873     4578899999999999999999999965321100  0    000000000  


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHHhcCC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEK--RPNMKEVVNTLTGY  317 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~--Rps~~~ll~~l~~~  317 (380)
                         ..+ .......+..+.+++.+||..++++  ||++.++++|.+..
T Consensus       227 ---~~~-~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~  270 (331)
T cd05597         227 ---FQF-PPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFE  270 (331)
T ss_pred             ---ccC-CCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCC
Confidence               000 0111224578889999988654443  78999999997754

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.1e-42  Score=321.37  Aligned_cols=246  Identities=27%  Similarity=0.336  Sum_probs=199.5

Q ss_pred             ceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEEEEEecCC
Q 037869           47 NKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLIVYDYMPN  121 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  121 (380)
                      +.||+|+||+||+|.+ .++..||+|+++..   .......+..|..++..+ +||||+++++++...+.+++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999987 46889999999753   223344567788888877 699999999999999999999999999


Q ss_pred             CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccc
Q 037869          122 LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM  201 (380)
Q Consensus       122 g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~  201 (380)
                      |+|...+...    ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++....... ..
T Consensus        81 ~~L~~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~  152 (318)
T cd05570          81 GDLMFHIQRS----GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG-VT  152 (318)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCC-Cc
Confidence            9999988653    4689999999999999999999999   99999999999999999999999999987532211 12


Q ss_pred             eeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCC
Q 037869          202 TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF  281 (380)
Q Consensus       202 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .....|++.|+|||++.+..++.++|||||||++|+|++|..||.......  .    ..         .+...  ....
T Consensus       153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~--~----~~---------~i~~~--~~~~  215 (318)
T cd05570         153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE--L----FQ---------SILED--EVRY  215 (318)
T ss_pred             ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH--H----HH---------HHHcC--CCCC
Confidence            233468999999999999999999999999999999999999997533110  0    00         00000  0112


Q ss_pred             CHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHHHhcCC
Q 037869          282 DENQLKQAINVAVLCVQSEPEKRPNM-----KEVVNTLTGY  317 (380)
Q Consensus       282 ~~~~~~~~~~li~~cl~~~P~~Rps~-----~~ll~~l~~~  317 (380)
                      +...+..+.+||.+||+.||.+|||+     .++++|.+..
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~  256 (318)
T cd05570         216 PRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFR  256 (318)
T ss_pred             CCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcC
Confidence            23345788999999999999999999     9999996653

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=7.3e-43  Score=313.74  Aligned_cols=256  Identities=29%  Similarity=0.487  Sum_probs=205.9

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ..++|++.++||+|+||.||+|.+.++..||+|+++.... ....+.+|+++++.++||||+++++.+. ....++||||
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY   81 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEc
Confidence            4578999999999999999999886667799999985332 3347888999999999999999999875 4568999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++|+|.+++....  ...+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||.+..+....
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~  156 (262)
T cd05071          82 MSKGSLLDFLKGEM--GKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  156 (262)
T ss_pred             CCCCcHHHHHhhcc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence            99999999997532  23578999999999999999999998   99999999999999999999999999998765433


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      ........++..|+|||...+..++.++|||||||++|+|++ |..||.......  ..    ..         . ....
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~--~~----~~---------~-~~~~  220 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE--VL----DQ---------V-ERGY  220 (262)
T ss_pred             cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH--HH----HH---------H-hcCC
Confidence            222223345678999999988889999999999999999999 888886532110  00    00         0 0011


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ....+...+..+.+++.+||+.+|.+||++.++++.|..+
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         221 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            1122334567889999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=8.1e-43  Score=315.99  Aligned_cols=259  Identities=24%  Similarity=0.410  Sum_probs=204.1

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeC------CCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTS------DGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD  110 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  110 (380)
                      ...++|++.+.||+|+||.||+|.+.      .+..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus         3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~   82 (277)
T cd05062           3 VAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ   82 (277)
T ss_pred             ccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            35678999999999999999998742      25679999986432 234456888999999999999999999999889


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCC------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceE
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAG------EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL  184 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~------~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vk  184 (380)
                      ..++||||+++++|.+++......      ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~  159 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVK  159 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEE
Confidence            999999999999999998653211      23467888999999999999999998   999999999999999999999


Q ss_pred             EeeccCccccCCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchh
Q 037869          185 VADFGFAKLIPEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP  262 (380)
Q Consensus       185 l~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~  262 (380)
                      |+|||++......... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ..   . 
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~---~~---~-  232 (277)
T cd05062         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ---VL---R-  232 (277)
T ss_pred             ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HH---H-
Confidence            9999998765332211 1112235778999999998889999999999999999999 788886532210   00   0 


Q ss_pred             hhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ......         ....+...+..+.+++.+||+.+|++|||+.++++.++
T Consensus       233 ~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         233 FVMEGG---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             HHHcCC---------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            000000         01122334568899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-44  Score=331.55  Aligned_cols=260  Identities=28%  Similarity=0.428  Sum_probs=213.9

Q ss_pred             HHHhhCCCCCcceeccCCceEEEEEEeC--CC---cEEEEEEecc---cChhhHHHHHHHHHHHhcCCCCcceeEeeEEe
Q 037869           36 LHTATNGFSDDNKLGEGGFGSVYWGRTS--DG---LQIAVKKLKA---MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA  107 (380)
Q Consensus        36 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~--~~---~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  107 (380)
                      +....++.++.++||+|+||.||+|+..  ++   ..||+|..+.   ........+.+|+++|++++|||||+++|++.
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            4445667778899999999999999752  22   2389999885   33556678999999999999999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEee
Q 037869          108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD  187 (380)
Q Consensus       108 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~D  187 (380)
                      ....+++|||+|.||+|.++++..   ...++..+...++++.+.||+|||+.   +++||||..+|||++.++.+||+|
T Consensus       232 ~~~Pl~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISD  305 (474)
T KOG0194|consen  232 LEEPLMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISD  305 (474)
T ss_pred             CCCccEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCc
Confidence            999999999999999999999865   23699999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccCCCCcccee-ccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhh
Q 037869          188 FGFAKLIPEGVSHMTT-RVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIV  265 (380)
Q Consensus       188 fgl~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~  265 (380)
                      ||+++.-..  ..... ...-...|+|||.+....|+.++|||||||++||+.+ |..||.+....            ..
T Consensus       306 FGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~------------~v  371 (474)
T KOG0194|consen  306 FGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY------------EV  371 (474)
T ss_pred             cccccCCcc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH------------HH
Confidence            999876431  11111 1134789999999999999999999999999999999 88899775421            00


Q ss_pred             ccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          266 KGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                         ...+.....+...+...+..+..++.+||..+|++|||+.++.+.+....
T Consensus       372 ---~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~  421 (474)
T KOG0194|consen  372 ---KAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALE  421 (474)
T ss_pred             ---HHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHH
Confidence               11122334445555567788999999999999999999999999877653

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.1e-42  Score=320.89  Aligned_cols=246  Identities=26%  Similarity=0.318  Sum_probs=196.6

Q ss_pred             ceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEEEEEecCC
Q 037869           47 NKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLIVYDYMPN  121 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  121 (380)
                      +.||+|+||.||+|++ .++..||+|+++...   ......+..|..++... +||||+++++++...+..|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4799999999999987 468899999997531   22334566677777654 899999999999999999999999999


Q ss_pred             CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccc
Q 037869          122 LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM  201 (380)
Q Consensus       122 g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~  201 (380)
                      |+|..++...    ..+++..+..++.|++.||+|||++   ||+||||||+||+++.++.++|+|||++...... ...
T Consensus        81 g~L~~~i~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~  152 (316)
T cd05620          81 GDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNR  152 (316)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCc
Confidence            9999988643    4688999999999999999999999   9999999999999999999999999998753221 122


Q ss_pred             eeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCC
Q 037869          202 TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF  281 (380)
Q Consensus       202 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .....||+.|+|||++.+..++.++||||+||++|+|++|..||......  ...    ..         +..  .....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~----~~---------~~~--~~~~~  215 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELF----ES---------IRV--DTPHY  215 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHH----HH---------HHh--CCCCC
Confidence            34456899999999999999999999999999999999999999753311  000    00         000  00112


Q ss_pred             CHHHHHHHHHHHHhhcCCCCCCCCCH-HHHHHHhcCC
Q 037869          282 DENQLKQAINVAVLCVQSEPEKRPNM-KEVVNTLTGY  317 (380)
Q Consensus       282 ~~~~~~~~~~li~~cl~~~P~~Rps~-~~ll~~l~~~  317 (380)
                      +...+.++.++|.+||+.||++||++ .++++|.+..
T Consensus       216 ~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~  252 (316)
T cd05620         216 PRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFK  252 (316)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcC
Confidence            22345688999999999999999998 5788786543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-44  Score=330.08  Aligned_cols=257  Identities=27%  Similarity=0.392  Sum_probs=213.6

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      .+.+.|.-++.||.|+||.||.|++ .+++.||||++.-.   +...-..++.|+..|+.++|||++.+-|+|..+...|
T Consensus        23 DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaW  102 (948)
T KOG0577|consen   23 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAW  102 (948)
T ss_pred             CHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHH
Confidence            3456788899999999999999998 56888999998732   2233347889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||| -|+-.|++.-.   +.++.+..+..|+.+.+.||+|||++   +.||||||..|||+++.|.|||+|||.+..
T Consensus       103 LVMEYC-lGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi  175 (948)
T KOG0577|consen  103 LVMEYC-LGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASI  175 (948)
T ss_pred             HHHHHH-hccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhh
Confidence            999999 45888888644   46899999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCccceeccccccCccCccccc---cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAM---WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      ...     ...++|||.|||||++.   .+.|+-++|||||||+..||.-+.+|+........            ...+.
T Consensus       176 ~~P-----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSA------------LYHIA  238 (948)
T KOG0577|consen  176 MAP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA------------LYHIA  238 (948)
T ss_pred             cCc-----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHH------------HHHHH
Confidence            643     45678999999999987   57899999999999999999999999865432110            11122


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCCCC
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRG  321 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~~~  321 (380)
                      +.-.|.+.   ....+..+.+|+..||++-|.+|||.++++.|..-...+.
T Consensus       239 QNesPtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp  286 (948)
T KOG0577|consen  239 QNESPTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP  286 (948)
T ss_pred             hcCCCCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence            22223332   4456688999999999999999999999999977665544

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=1.5e-42  Score=315.19  Aligned_cols=258  Identities=25%  Similarity=0.444  Sum_probs=205.0

Q ss_pred             CCCCCcceeccCCceEEEEEEe-----CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-----SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      ..|++.+.||+|+||+||+|..     ..+..|++|.++... ......+.+|+.+++.++||||+++++++......++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   84 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM   84 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence            4688899999999999999974     246789999997533 3334578889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCC-------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC
Q 037869          115 VYDYMPNLSLLSHLHGQYA-------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF  181 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~-------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~  181 (380)
                      ||||+++++|.+++.....             ....+++..++.++.|++.||+|||++   +++||||||+||+++.++
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~  161 (283)
T cd05090          85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQL  161 (283)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCC
Confidence            9999999999999853211             123578899999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhcc
Q 037869          182 EPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEW  259 (380)
Q Consensus       182 ~vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~  259 (380)
                      .++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||......   .... 
T Consensus       162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~---~~~~-  237 (283)
T cd05090         162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ---EVIE-  237 (283)
T ss_pred             cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHH-
Confidence            999999999987543221 12223345678999999998889999999999999999998 88898653210   0000 


Q ss_pred             chhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          260 AEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                                  ..........+..++..+.+++.+||+.||.+||++.+|++++..+
T Consensus       238 ------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05090         238 ------------MVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRSW  283 (283)
T ss_pred             ------------HHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhcC
Confidence                        0001111122334457889999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4e-42  Score=309.42  Aligned_cols=259  Identities=20%  Similarity=0.308  Sum_probs=210.7

Q ss_pred             CCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecc---cChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKA---MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ++|++.+.||+|++|.||+|.+. +++.||+|.++.   ........+.+|+.++++++|+||+++++++..++..++||
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~   81 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL   81 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence            57999999999999999999875 789999998863   22333557889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++++|.+++.........+++..++.++.+++.||.|||+.   |++||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~  158 (267)
T cd08224          82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence            99999999999865434455689999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      .... .....++..|+|||.+.+..++.++||||||+++|+|++|..||............              .....
T Consensus       159 ~~~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~--------------~~~~~  223 (267)
T cd08224         159 KTTA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK--------------KIEKC  223 (267)
T ss_pred             CCcc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHh--------------hhhcC
Confidence            3221 22345788999999999888999999999999999999999998643211000000              00011


Q ss_pred             ccCCCCH-HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          277 LRGDFDE-NQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       277 ~~~~~~~-~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .....+. ..+..+.++|.+||..+|++|||+.+|++.+..+
T Consensus       224 ~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~  265 (267)
T cd08224         224 DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEM  265 (267)
T ss_pred             CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHh
Confidence            1112222 4557889999999999999999999999988654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=7.4e-43  Score=329.44  Aligned_cols=267  Identities=21%  Similarity=0.284  Sum_probs=203.2

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC-----eEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD-----QRL  113 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~  113 (380)
                      .|.+.+.||+|+||.||++.+ .+++.||+|++...  .......+.+|+.+++.++||||+++++++....     ..|
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999987 57899999998643  2234457888999999999999999999998766     789


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||+. ++|.+.+...    ..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++..
T Consensus        81 lv~e~~~-~~l~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~  152 (372)
T cd07853          81 VVTELMQ-SDLHKIIVSP----QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARV  152 (372)
T ss_pred             EEeeccc-cCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceee
Confidence            9999996 5788877532    4689999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchh----hh----
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEP----LI----  264 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~----~~----  264 (380)
                      .............+++.|+|||++.+. .++.++||||+||++|||++|..||........  ...+...    ..    
T Consensus       153 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~g~~~~~~~~  230 (372)
T cd07853         153 EEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ--LDLITDLLGTPSLEAMR  230 (372)
T ss_pred             cccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHH--HHHHHHHcCCCCHHHHH
Confidence            543322223334578999999998874 589999999999999999999999976432110  0000000    00    


Q ss_pred             --hccccccccCCccc-------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          265 --VKGKFKELVDPKLR-------GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       265 --~~~~~~~~~~~~~~-------~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                        .......+......       .......+.++.+||.+||+.||.+|||+.++++|.+...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~  293 (372)
T cd07853         231 SACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE  293 (372)
T ss_pred             HhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCC
Confidence              00000000000000       0111223567899999999999999999999999976443

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.4e-42  Score=320.29  Aligned_cols=245  Identities=28%  Similarity=0.360  Sum_probs=195.7

Q ss_pred             ceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhc-CCCCcceeEeeEEecCCeEEEEEEecCC
Q 037869           47 NKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGR-VRHKNLLGLRGYCAGTDQRLIVYDYMPN  121 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~~~~~~lv~e~~~~  121 (380)
                      +.||+|+||+||+|++ .+++.||+|+++...   .........|..++.. ++||||+++++++.+.+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999987 458899999997531   2233455667777775 4899999999999999999999999999


Q ss_pred             CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccc
Q 037869          122 LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM  201 (380)
Q Consensus       122 g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~  201 (380)
                      |+|.+++...    ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++....... ..
T Consensus        81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  152 (316)
T cd05619          81 GDLMFHIQSC----HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AK  152 (316)
T ss_pred             CcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cc
Confidence            9999999643    4688999999999999999999999   99999999999999999999999999987532211 12


Q ss_pred             eeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCC
Q 037869          202 TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF  281 (380)
Q Consensus       202 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .....||+.|+|||++.+..++.++||||+||++|+|++|..||......   ..   .....       ...    ..+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~---~~~i~-------~~~----~~~  215 (316)
T cd05619         153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---EL---FQSIR-------MDN----PCY  215 (316)
T ss_pred             eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HH---HHHHH-------hCC----CCC
Confidence            33456899999999999989999999999999999999999999753211   00   00000       000    112


Q ss_pred             CHHHHHHHHHHHHhhcCCCCCCCCCHH-HHHHHhcC
Q 037869          282 DENQLKQAINVAVLCVQSEPEKRPNMK-EVVNTLTG  316 (380)
Q Consensus       282 ~~~~~~~~~~li~~cl~~~P~~Rps~~-~ll~~l~~  316 (380)
                      +...+.++.+++.+||+.||.+||++. ++++|.+.
T Consensus       216 ~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~  251 (316)
T cd05619         216 PRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFF  251 (316)
T ss_pred             CccCCHHHHHHHHHHhccCHhhcCCChHHHHcCccc
Confidence            223456789999999999999999997 78777553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.6e-43  Score=329.42  Aligned_cols=256  Identities=20%  Similarity=0.278  Sum_probs=202.4

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      +.|++.+.||+|+||+||++.+ .+++.||+|+++..   .......+..|+.++..++||||+++++.+...+.+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4688999999999999999987 46899999999742   2233456778999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||++||+|.+++...    ..+++..+..++.|++.||.|||+.   ||+||||||+|||++.++.++|+|||++.....
T Consensus        81 E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~  153 (360)
T cd05627          81 EFLPGGDMMTLLMKK----DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKK  153 (360)
T ss_pred             eCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCccccc
Confidence            999999999999643    4689999999999999999999999   999999999999999999999999999875422


Q ss_pred             CCc----------------------------------cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCC
Q 037869          197 GVS----------------------------------HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGR  242 (380)
Q Consensus       197 ~~~----------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~  242 (380)
                      ...                                  ......+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~  233 (360)
T cd05627         154 AHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGY  233 (360)
T ss_pred             ccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCC
Confidence            100                                  0112346899999999999999999999999999999999999


Q ss_pred             CCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC---CHHHHHHHhcCC
Q 037869          243 KPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRP---NMKEVVNTLTGY  317 (380)
Q Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp---s~~~ll~~l~~~  317 (380)
                      .||........  ...    .. .  +    ...+..+.....+.++.+||.+|+. ||.+|+   ++.++++|.+..
T Consensus       234 ~Pf~~~~~~~~--~~~----i~-~--~----~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~  297 (360)
T cd05627         234 PPFCSETPQET--YRK----VM-N--W----KETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFE  297 (360)
T ss_pred             CCCCCCCHHHH--HHH----HH-c--C----CCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCC
Confidence            99975432110  000    00 0  0    0000000011234678889998774 999998   589999997644

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2e-42  Score=314.37  Aligned_cols=268  Identities=28%  Similarity=0.414  Sum_probs=205.4

Q ss_pred             CCC-CCcceeccCCceEEEEEEe-----CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecC--Ce
Q 037869           41 NGF-SDDNKLGEGGFGSVYWGRT-----SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT--DQ  111 (380)
Q Consensus        41 ~~y-~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~  111 (380)
                      ++| ++.+.||+|+||+||++..     .++..||+|.++... ......+.+|+.+++.++||||+++++++...  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            455 8999999999999988642     357789999997543 23455788899999999999999999987653  45


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA  191 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~  191 (380)
                      .++||||+++++|.+++...     .+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++
T Consensus        83 ~~lv~e~~~~~~l~~~~~~~-----~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~  154 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPKH-----KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLA  154 (283)
T ss_pred             EEEEecCCCCCCHHHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccc
Confidence            89999999999999999643     589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCccc--eeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccc
Q 037869          192 KLIPEGVSHM--TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKF  269 (380)
Q Consensus       192 ~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  269 (380)
                      ..........  .....++..|+|||.+.+..++.++||||||+++|+|++|..||............. .........+
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~  233 (283)
T cd05080         155 KAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGP-KQGQMTVVRL  233 (283)
T ss_pred             cccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcc-cccccchhhh
Confidence            8764322211  122235667999999998889999999999999999999999986543221111100 0000000111


Q ss_pred             ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ............+...+..+.+++.+||+.+|++|||++++++.|..+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~  281 (283)
T cd05080         234 IELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEM  281 (283)
T ss_pred             hhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHh
Confidence            111222222233445567899999999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-43  Score=348.52  Aligned_cols=262  Identities=28%  Similarity=0.413  Sum_probs=216.3

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe--CCCc----EEEEEEecc-cChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT--SDGL----QIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQ  111 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~--~~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  111 (380)
                      .....+..+.||+|.||.||.|..  ..+.    .||||.++. .+..+...|.+|..+|+.++|||||+++|++.....
T Consensus       690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~  769 (1025)
T KOG1095|consen  690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP  769 (1025)
T ss_pred             ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence            356777889999999999999964  3343    489999875 445666789999999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHhhccCCC---CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYA---GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~---~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                      .+|++|||+||+|..+|+....   ....++..+.+.++.|+|+|+.||+++   ++|||||..+|+|++....|||+||
T Consensus       770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEccc
Confidence            9999999999999999975421   245689999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCccceec-cccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhc
Q 037869          189 GFAKLIPEGVSHMTTR-VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVK  266 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~  266 (380)
                      |+|+.+-......... -.-...|||||.+....++.|+|||||||++||++| |..||....+.               
T Consensus       847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~---------------  911 (1025)
T KOG1095|consen  847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF---------------  911 (1025)
T ss_pred             chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchH---------------
Confidence            9999543322222211 133679999999999999999999999999999999 89999764431               


Q ss_pred             cccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCC
Q 037869          267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP  319 (380)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~  319 (380)
                       .+...+..+-+-+.|..++..+.++|..||+.+|++||++..|++.+.....
T Consensus       912 -~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~  963 (1025)
T KOG1095|consen  912 -EVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN  963 (1025)
T ss_pred             -HHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence             1111112222567778888999999999999999999999999998665543

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=8.8e-43  Score=322.72  Aligned_cols=249  Identities=26%  Similarity=0.330  Sum_probs=200.4

Q ss_pred             CCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC---hhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      .|++.+.||+|+||.||+|.+. +++.||+|+++...   ......+..|..++..+ .|++|+++++++...+..|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            4888999999999999999874 67899999987532   22333566677888777 5899999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++|+|.+.+...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus        81 E~~~~g~L~~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~  153 (323)
T cd05616          81 EYVNGGDLMYQIQQV----GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW  153 (323)
T ss_pred             cCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCC
Confidence            999999999998643    4688999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      .. .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ..             ..+... 
T Consensus       154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~--~~-------------~~i~~~-  216 (323)
T cd05616         154 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE--LF-------------QSIMEH-  216 (323)
T ss_pred             CC-CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH--HH-------------HHHHhC-
Confidence            11 12334568999999999999999999999999999999999999997533210  00             000000 


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHHHhc
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNM-----KEVVNTLT  315 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~-----~~ll~~l~  315 (380)
                       ...++...+.++.+++.+||+.||.+|++.     .++++|.+
T Consensus       217 -~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~  259 (323)
T cd05616         217 -NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF  259 (323)
T ss_pred             -CCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCC
Confidence             112233455788999999999999999984     78887744

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3e-42  Score=315.30  Aligned_cols=256  Identities=21%  Similarity=0.306  Sum_probs=209.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      +..+|++.+.||+|++|.||+|.+ .++..|++|.+..........+.+|+.+++.+.|+||+++++.+..+...++|||
T Consensus        18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e   97 (296)
T cd06654          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (296)
T ss_pred             cccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence            457999999999999999999986 5688999999876555555678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+++++|.+++..     ..+++..+..++.|++.||+|||+.   |++||||||+||+++.++.++|+|||++......
T Consensus        98 ~~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          98 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             ccCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            9999999999864     2578899999999999999999999   9999999999999999999999999998765432


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      .. ......+++.|+|||.+.+..++.++|||||||++|+|++|..||........  ...    .        ......
T Consensus       170 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~----~--------~~~~~~  234 (296)
T cd06654         170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYL----I--------ATNGTP  234 (296)
T ss_pred             cc-ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHH----H--------hcCCCC
Confidence            21 12234588999999999988899999999999999999999999965332100  000    0        000000


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ....+...+..+.+++.+||..+|.+||++.+++++.+..
T Consensus       235 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~  274 (296)
T cd06654         235 ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK  274 (296)
T ss_pred             CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhh
Confidence            1112334557789999999999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.9e-42  Score=321.51  Aligned_cols=255  Identities=23%  Similarity=0.242  Sum_probs=202.8

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ++|++.+.||+|+||+||++++ .+++.||+|++...   .......+..|..++..++|+||+++++++...+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4799999999999999999987 46888999998642   2223345778999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||++||+|.+++...   ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.++|+|||++.....
T Consensus        81 Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  154 (331)
T cd05624          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQ  154 (331)
T ss_pred             eCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccC
Confidence            999999999999753   24689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCccceeccccccCccCcccccc-----CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMW-----GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      ..........|++.|+|||++.+     ..++.++||||+||++|+|++|..||.......  ..             ..
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--~~-------------~~  219 (331)
T cd05624         155 DGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--TY-------------GK  219 (331)
T ss_pred             CCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH--HH-------------HH
Confidence            33222333568999999999875     467899999999999999999999996532110  00             00


Q ss_pred             ccCCccc---CCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHHhcC
Q 037869          272 LVDPKLR---GDFDENQLKQAINVAVLCVQSEPEK--RPNMKEVVNTLTG  316 (380)
Q Consensus       272 ~~~~~~~---~~~~~~~~~~~~~li~~cl~~~P~~--Rps~~~ll~~l~~  316 (380)
                      +.....+   .......+..+.+++.+||..++.+  |++++++++|.+.
T Consensus       220 i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f  269 (331)
T cd05624         220 IMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFF  269 (331)
T ss_pred             HHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCc
Confidence            0000000   0111234578999999999876654  5799999999764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.9e-42  Score=313.48  Aligned_cols=272  Identities=25%  Similarity=0.395  Sum_probs=205.8

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-----CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEec--CCeE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-----SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG--TDQR  112 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~  112 (380)
                      .++|++.+.||+|+||+||++..     .++..||+|.+..........+.+|+++++.++||||+++++++..  ....
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   82 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   82 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCce
Confidence            35789999999999999999863     3578999999987666666788899999999999999999998743  3468


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      ++||||+++++|.+++...   ...+++..++.++.|++.||+|||++   |++||||||+||+++.++.++|+|||++.
T Consensus        83 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          83 RLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             EEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccc
Confidence            9999999999999999643   24689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCccc--eeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          193 LIPEGVSHM--TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       193 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      .........  .....++..|+|||++.+..++.++||||||+++|||++|..|+.......................+.
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            764432211  111223456999999998899999999999999999999887764322110000000000000000001


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ...........+...+..+.+|+.+||+.+|++|||+.+|++.|...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            11111111222334557899999999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.1e-42  Score=317.77  Aligned_cols=263  Identities=29%  Similarity=0.415  Sum_probs=209.1

Q ss_pred             HHHhhCCCCCcceeccCCceEEEEEEeC------CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEe
Q 037869           36 LHTATNGFSDDNKLGEGGFGSVYWGRTS------DGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCA  107 (380)
Q Consensus        36 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  107 (380)
                      +....++|++.+.||+|+||.||++...      ....||+|.+... .......+.+|+.++..+ +|+||+++++++.
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   86 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT   86 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence            4456678999999999999999999753      2367899998753 334445688899999999 7999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHhhccCC------------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCe
Q 037869          108 GTDQRLIVYDYMPNLSLLSHLHGQY------------AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNV  175 (380)
Q Consensus       108 ~~~~~~lv~e~~~~g~L~~~i~~~~------------~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Ni  175 (380)
                      .++..+++|||+++|+|..++....            .....+++..++.++.|++.||+|||+.   +++||||||+||
T Consensus        87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Ni  163 (293)
T cd05053          87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNV  163 (293)
T ss_pred             CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeE
Confidence            9999999999999999999986431            2345689999999999999999999998   999999999999


Q ss_pred             eeCCCCceEEeeccCccccCCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcc
Q 037869          176 LLDSDFEPLVADFGFAKLIPEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVK  253 (380)
Q Consensus       176 ll~~~~~vkl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~  253 (380)
                      +++.++.++|+|||+++.+...... ......++..|+|||++.+..++.++|||||||++|+|++ |..||....... 
T Consensus       164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-  242 (293)
T cd05053         164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-  242 (293)
T ss_pred             EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-
Confidence            9999999999999999876432211 1122234678999999988899999999999999999998 899986533110 


Q ss_pred             cchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          254 RTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                                     .............+...+..+.+|+.+||..||.+|||+.++++.|...
T Consensus       243 ---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         243 ---------------LFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             ---------------HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence                           0001111111123334457899999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-43  Score=318.71  Aligned_cols=253  Identities=22%  Similarity=0.327  Sum_probs=217.4

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      +..-|.+.+.||+|-|..|-+|++ .+|++||||++.+..  ......+..|+.-|+.++|||||+++++......+|+|
T Consensus        16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLi   95 (864)
T KOG4717|consen   16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLI   95 (864)
T ss_pred             eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEE
Confidence            457899999999999999999987 689999999997543  33345788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-CCceEEeeccCcccc
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS-DFEPLVADFGFAKLI  194 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~-~~~vkl~Dfgl~~~~  194 (380)
                      +|+-.+|+|+++|-..   +..+.+..+..+|.||+.|+.|+|+.   .+|||||||+|+.+-+ -|-|||+|||++..+
T Consensus        96 LELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf  169 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF  169 (864)
T ss_pred             EEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccC
Confidence            9999999999999765   46799999999999999999999999   8999999999998765 589999999999887


Q ss_pred             CCCCccceeccccccCccCccccccCCCC-ccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAMWGKVS-ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                      ..+  ...++.||+..|.|||++.|..|+ +++||||||+|||.|++|++||........               +..++
T Consensus       170 ~PG--~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmIm  232 (864)
T KOG4717|consen  170 QPG--KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIM  232 (864)
T ss_pred             CCc--chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhh
Confidence            664  345667899999999999999885 679999999999999999999986543211               11122


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      +  ..-..|...+.+..+||.+||..||.+|.|.++|..+.|-
T Consensus       233 D--CKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wl  273 (864)
T KOG4717|consen  233 D--CKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWL  273 (864)
T ss_pred             c--ccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccc
Confidence            2  1224577888999999999999999999999999998663

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.4e-43  Score=324.81  Aligned_cols=246  Identities=24%  Similarity=0.325  Sum_probs=199.5

Q ss_pred             cceeccCCceEEEEEEe----CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEec
Q 037869           46 DNKLGEGGFGSVYWGRT----SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYM  119 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  119 (380)
                      ++.||+|+||.||++++    .+++.||+|++....  ......+..|++++++++||||+++++++...+..|+||||+
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            36799999999999875    357899999997532  223345677999999999999999999999999999999999


Q ss_pred             CCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc
Q 037869          120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS  199 (380)
Q Consensus       120 ~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~  199 (380)
                      ++|+|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++....... 
T Consensus        81 ~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-  152 (318)
T cd05582          81 RGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-  152 (318)
T ss_pred             CCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-
Confidence            999999998643    4689999999999999999999999   99999999999999999999999999997654321 


Q ss_pred             cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccC
Q 037869          200 HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG  279 (380)
Q Consensus       200 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                      .......|++.|+|||++.+..++.++|||||||++|+|++|..||......  ...             ..+...  ..
T Consensus       153 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~-------------~~i~~~--~~  215 (318)
T cd05582         153 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--ETM-------------TMILKA--KL  215 (318)
T ss_pred             CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--HHH-------------HHHHcC--CC
Confidence            2233456899999999999888999999999999999999999999753210  000             000000  01


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHhcC
Q 037869          280 DFDENQLKQAINVAVLCVQSEPEKRPN-----MKEVVNTLTG  316 (380)
Q Consensus       280 ~~~~~~~~~~~~li~~cl~~~P~~Rps-----~~~ll~~l~~  316 (380)
                      ..+...+..+.++|.+||+.||.+||+     +.++++|.+.
T Consensus       216 ~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~  257 (318)
T cd05582         216 GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFF  257 (318)
T ss_pred             CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCc
Confidence            223334578899999999999999999     6778877653

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=7e-42  Score=310.22  Aligned_cols=255  Identities=22%  Similarity=0.306  Sum_probs=203.2

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ++|.+.+.||+|+||.||+|.+ .+++.||+|.+... .......+.+|+.++.+++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   80 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF   80 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence            4688899999999999999986 57889999998653 333445788899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++++|..+.        .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++...... 
T Consensus        81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-  148 (279)
T cd06619          81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-  148 (279)
T ss_pred             CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-
Confidence            9999986542        467888999999999999999999   9999999999999999999999999999865432 


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccch-hccchhhhhccccccccCCcc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI-TEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  277 (380)
                        ......|+..|+|||++.+..++.++||||||+++|+|++|..||........... ..... .        ......
T Consensus       149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~--------~~~~~~  217 (279)
T cd06619         149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ-C--------IVDEDP  217 (279)
T ss_pred             --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH-H--------HhccCC
Confidence              22334689999999999988999999999999999999999999965332111100 00000 0        000000


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      ........+.++.+++.+||+.+|.+||+++++++|.+...
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~  258 (279)
T cd06619         218 PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQ  258 (279)
T ss_pred             CCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccc
Confidence            00011223467899999999999999999999999977543

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=9.3e-43  Score=320.64  Aligned_cols=268  Identities=21%  Similarity=0.311  Sum_probs=202.9

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh-hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ++|++.+.||+|+||.||+|++ .++..||+|.++.... .....+.+|+.+++.++||||+++++++..++..++||||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   85 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY   85 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence            6799999999999999999987 4678899999875332 2234577899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++ +|.+++...   ...+++..+..++.|++.||+|||+.   ||+||||||+||+++.++.++|+|||++.......
T Consensus        86 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  158 (309)
T cd07872          86 LDK-DLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPT  158 (309)
T ss_pred             CCC-CHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence            975 888887543   24588899999999999999999999   99999999999999999999999999997653322


Q ss_pred             ccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchh----------ccchhhhhcc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTIT----------EWAEPLIVKG  267 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~----------~~~~~~~~~~  267 (380)
                      . ......+++.|+|||++.+ ..++.++|||||||++|+|++|..||............          .|... ....
T Consensus       159 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  236 (309)
T cd07872         159 K-TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGI-SSND  236 (309)
T ss_pred             c-ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhh-cchh
Confidence            1 1223357899999998875 46899999999999999999999999754321110000          00000 0000


Q ss_pred             ccccccCCccc----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          268 KFKELVDPKLR----GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       268 ~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .+.....+...    .......+.++.+||.+||+.||.+|||+.++++|.+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~  290 (309)
T cd07872         237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFR  290 (309)
T ss_pred             hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhh
Confidence            00000000000    001123456789999999999999999999999997654

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.7e-42  Score=309.63  Aligned_cols=256  Identities=29%  Similarity=0.484  Sum_probs=205.7

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ..++|++.+.||.|++|.||+|.+..+..||+|.+..... ....+.+|+.+++.++|+|++++++++. .+..++||||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05069           4 PRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF   81 (260)
T ss_pred             ChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence            4467999999999999999999887667899998875432 3456888999999999999999999875 4668999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +.+++|.+++...  ....+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          82 MGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             CCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            9999999999753  234588999999999999999999998   99999999999999999999999999998764332


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      ........++..|+|||.+.+..++.++||||||+++|+|++ |..||.......  ...             . .....
T Consensus       157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~-------------~-~~~~~  220 (260)
T cd05069         157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLE-------------Q-VERGY  220 (260)
T ss_pred             ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHH-------------H-HHcCC
Confidence            222222345678999999988889999999999999999999 899987533210  000             0 00011


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ....+...+..+.+++.+||+.||.+||+++++++.|+.+
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  260 (260)
T cd05069         221 RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLEDY  260 (260)
T ss_pred             CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            1122334567899999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2e-42  Score=319.38  Aligned_cols=256  Identities=25%  Similarity=0.411  Sum_probs=203.8

Q ss_pred             hCCCCCcceeccCCceEEEEEEeC-CCc----EEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTS-DGL----QIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ..+|++.+.||+|+||.||+|.+. ++.    .||+|.++.. .......+.+|+.+++.++||||+++++++.. ...+
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~-~~~~   84 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQ   84 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcC-CCce
Confidence            457999999999999999999753 333    4899998753 33445678889999999999999999999875 4578


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +|+||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~  158 (316)
T cd05108          85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (316)
T ss_pred             eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEcccccccc
Confidence            999999999999999753   24688999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCccc-eeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          194 IPEGVSHM-TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       194 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      ........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||.......   .             ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~-------------~~  222 (316)
T cd05108         159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---I-------------SS  222 (316)
T ss_pred             ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---H-------------HH
Confidence            65432211 122234678999999999999999999999999999998 999986532110   0             00


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      ..........+..++.++.+++.+||..+|..||++.+++.++....
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~  269 (316)
T cd05108         223 ILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMA  269 (316)
T ss_pred             HHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence            11111111222334467899999999999999999999999977553

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.8e-42  Score=325.26  Aligned_cols=267  Identities=26%  Similarity=0.309  Sum_probs=201.3

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC----
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD----  110 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----  110 (380)
                      ...++|++.+.||+|+||.||++.+ .++..||+|++...  .......+.+|+.+++.++||||+++++++....    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            3568999999999999999999987 56899999998642  2334456778999999999999999999986543    


Q ss_pred             --eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          111 --QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       111 --~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                        ..|+||||+.+ +|...+..      .+++..+..++.|++.||.|||++   ||+||||||+||+++.++.++|+||
T Consensus        98 ~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Df  167 (359)
T cd07876          98 FQDVYLVMELMDA-NLCQVIHM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  167 (359)
T ss_pred             cceeEEEEeCCCc-CHHHHHhc------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecC
Confidence              47999999965 67666642      478889999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccc--hh-------cc
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRT--IT-------EW  259 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~--~~-------~~  259 (380)
                      |++......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||..........  ..       .+
T Consensus       168 g~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  245 (359)
T cd07876         168 GLARTACTN--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEF  245 (359)
T ss_pred             CCccccccC--ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHH
Confidence            999764322  22233468999999999999999999999999999999999999997543210000  00       00


Q ss_pred             -------chhhhh-ccc-----cccccCCc---ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          260 -------AEPLIV-KGK-----FKELVDPK---LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       260 -------~~~~~~-~~~-----~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                             ...... ...     +.+....-   .........+..+.+||.+||+.||++|||+.++++|.+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~  318 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI  318 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence                   000000 000     00000000   0000111234678999999999999999999999999764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.9e-42  Score=313.27  Aligned_cols=260  Identities=23%  Similarity=0.297  Sum_probs=209.3

Q ss_pred             HHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           36 LHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        36 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      ...+.+.|++.+.||.|+||.||+|.+ .++..|++|.+..........+.+|+.+++.++||||+++++++..+...++
T Consensus         7 ~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (292)
T cd06644           7 DLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI   86 (292)
T ss_pred             ccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence            345667899999999999999999987 4588999999987766667788899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ||||+++++|..++...   ...+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++...
T Consensus        87 v~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  160 (292)
T cd06644          87 MIEFCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKN  160 (292)
T ss_pred             EEecCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceec
Confidence            99999999998887543   24689999999999999999999998   9999999999999999999999999998764


Q ss_pred             CCCCccceeccccccCccCccccc-----cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccc
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAM-----WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKF  269 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  269 (380)
                      .... .......++..|+|||++.     ...++.++|||||||++|+|++|..||.......  ....          +
T Consensus       161 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~----------~  227 (292)
T cd06644         161 VKTL-QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLK----------I  227 (292)
T ss_pred             cccc-cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--HHHH----------H
Confidence            3221 1223345788999999885     3457889999999999999999999986532100  0000          0


Q ss_pred             ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .....+  ....+...+.++.+++.+||..+|++||++.++++|.+.
T Consensus       228 ~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  272 (292)
T cd06644         228 AKSEPP--TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFV  272 (292)
T ss_pred             hcCCCc--cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence            000000  111223445678999999999999999999999998653

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=4.6e-42  Score=307.09  Aligned_cols=251  Identities=25%  Similarity=0.356  Sum_probs=207.2

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEecc--cChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKA--MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      .|++.+.||+|++|.||+|.+ .+++.|++|.+..  ........+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY   80 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence            478889999999999999987 4689999999864  2345566788899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++++|.+++...  ....+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~  155 (256)
T cd08529          81 AENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT  155 (256)
T ss_pred             CCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCcc
Confidence            9999999999753  235789999999999999999999998   99999999999999999999999999988765432


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      . ......|++.|+|||++.+..++.++|+||||+++|+|++|..||.......   .            .... .....
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~------------~~~~-~~~~~  218 (256)
T cd08529         156 N-FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA---L------------ILKI-IRGVF  218 (256)
T ss_pred             c-hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---H------------HHHH-HcCCC
Confidence            2 2233457899999999998889999999999999999999999996533100   0            0000 01111


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL  314 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l  314 (380)
                      ...+...+..+.+++.+||+.+|++||++.+++++.
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~  254 (256)
T cd08529         219 PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNP  254 (256)
T ss_pred             CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCC
Confidence            222334557899999999999999999999999874

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-42  Score=309.58  Aligned_cols=257  Identities=30%  Similarity=0.495  Sum_probs=208.9

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ...++|++.+.||.|+||.||+|.+.++..||+|.+..... ....+.+|+.+++.++|+||+++++++......++|||
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence            35678999999999999999999987788899999885432 34578899999999999999999999998899999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+++++|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~~~~L~~~i~~~~--~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~  156 (261)
T cd05034          82 YMSKGSLLDFLKSGE--GKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDD  156 (261)
T ss_pred             ccCCCCHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccch
Confidence            999999999997532  24689999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      .........++..|+|||.+.+..++.++||||+|+++|+|++ |..||......  .....              ....
T Consensus       157 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~--~~~~~--------------~~~~  220 (261)
T cd05034         157 EYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR--EVLEQ--------------VERG  220 (261)
T ss_pred             hhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHH--------------HHcC
Confidence            2222222234678999999998889999999999999999998 99998653211  00000              0001


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .....+...+..+.+++.+||+.+|.+||++.++++.|..
T Consensus       221 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         221 YRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            1112222335789999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.8e-42  Score=312.53  Aligned_cols=247  Identities=27%  Similarity=0.372  Sum_probs=194.0

Q ss_pred             eccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCCCH
Q 037869           49 LGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSL  124 (380)
Q Consensus        49 Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  124 (380)
                      ||+|+||+||++++ .+++.||+|.+....   ......+..|++++++++||||+++++++..+...++||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999987 468999999986421   11233456699999999999999999999999999999999999999


Q ss_pred             HHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccceec
Q 037869          125 LSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR  204 (380)
Q Consensus       125 ~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~~~  204 (380)
                      .+++...  ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.......  ....
T Consensus        81 ~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~--~~~~  153 (277)
T cd05607          81 KYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK--TITQ  153 (277)
T ss_pred             HHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc--eeec
Confidence            9888543  234588999999999999999999999   99999999999999999999999999998764422  2233


Q ss_pred             cccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHH
Q 037869          205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN  284 (380)
Q Consensus       205 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      ..|+..|+|||++.+..++.++||||+||++|+|++|..||........  ...     ....    ....... .....
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~-----~~~~----~~~~~~~-~~~~~  221 (277)
T cd05607         154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEE-----LKRR----TLEDEVK-FEHQN  221 (277)
T ss_pred             cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHH-----HHHH----hhccccc-ccccc
Confidence            4689999999999988899999999999999999999999965322110  000     0000    0000000 01123


Q ss_pred             HHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 037869          285 QLKQAINVAVLCVQSEPEKRPNMKEVVNTL  314 (380)
Q Consensus       285 ~~~~~~~li~~cl~~~P~~Rps~~~ll~~l  314 (380)
                      .+.++.+|+.+||+.||.+||++.++++++
T Consensus       222 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         222 FTEESKDICRLFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             CCHHHHHHHHHHhccCHhhCCCCccchhhh
Confidence            457889999999999999999996655443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=3.3e-42  Score=310.14  Aligned_cols=259  Identities=20%  Similarity=0.323  Sum_probs=209.0

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      .+|++.+.||.|++|.||+|.+ .++..|+||.+...   .......+.+|+.+++.++||||+++++++..++..+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   81 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL   81 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence            4688899999999999999986 57899999988642   2334457888999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++++|.+++.........+++..++.++.|++.||+|||++   |++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~  158 (267)
T cd08229          82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  158 (267)
T ss_pred             EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence            99999999998865333345789999999999999999999999   999999999999999999999999999887643


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      ... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||............          .+..   ..
T Consensus       159 ~~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~----------~~~~---~~  224 (267)
T cd08229         159 KTT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK----------KIEQ---CD  224 (267)
T ss_pred             CCc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh----------hhhc---CC
Confidence            322 122345889999999999888999999999999999999999999643221100000          0000   01


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .........+..+.+++.+||+.+|.+|||+.+|++.+..
T Consensus       225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~  264 (267)
T cd08229         225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKR  264 (267)
T ss_pred             CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhh
Confidence            1111123456789999999999999999999999887764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2e-42  Score=311.69  Aligned_cols=256  Identities=23%  Similarity=0.360  Sum_probs=205.0

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|.++.........+.+|+.+++.++||||+++++++...+..++|||
T Consensus         7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e   86 (267)
T cd06645           7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME   86 (267)
T ss_pred             cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence            345888999999999999999986 5688999999886555555567889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+++++|.+++...    ..+++..++.++.|++.||.|||+.   |++|+||||+||+++.++.++|+|||++......
T Consensus        87 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06645          87 FCGGGSLQDIYHVT----GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITAT  159 (267)
T ss_pred             ccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence            99999999998643    4689999999999999999999999   9999999999999999999999999998765432


Q ss_pred             CccceeccccccCccCccccc---cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          198 VSHMTTRVKGTLGYLAPEYAM---WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      .. ......|+..|+|||++.   ...++.++|||||||++|+|++|..||...........       .....   ...
T Consensus       160 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~-------~~~~~---~~~  228 (267)
T cd06645         160 IA-KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-------MTKSN---FQP  228 (267)
T ss_pred             cc-ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh-------hhccC---CCC
Confidence            21 223346899999999874   45688999999999999999999999865332110000       00000   000


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL  314 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l  314 (380)
                      +...  .....+..+.++|.+||+.+|++|||+.+|++|.
T Consensus       229 ~~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~  266 (267)
T cd06645         229 PKLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHP  266 (267)
T ss_pred             Cccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCC
Confidence            0000  0112345788999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-43  Score=327.97  Aligned_cols=249  Identities=28%  Similarity=0.425  Sum_probs=214.4

Q ss_pred             eeccCCceEEEEEEeC-CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCCCHHH
Q 037869           48 KLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLS  126 (380)
Q Consensus        48 ~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  126 (380)
                      .||+|.||+||.|++. +...+|||.+........+-+..|+.+.++|+|.|||+++|++.+++.+-|.||.++||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            7999999999999984 567899999988777777788899999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCccC--CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-CCceEEeeccCccccCCCCcccee
Q 037869          127 HLHGQYAGEVQL--DWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS-DFEPLVADFGFAKLIPEGVSHMTT  203 (380)
Q Consensus       127 ~i~~~~~~~~~~--~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~-~~~vkl~Dfgl~~~~~~~~~~~~~  203 (380)
                      +++..+   +++  .+..+-.+..||++||.|||+.   .|||||||-+|+||+. .|.+||+|||-++++.. ....+.
T Consensus       662 LLrskW---GPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg-inP~TE  734 (1226)
T KOG4279|consen  662 LLRSKW---GPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG-INPCTE  734 (1226)
T ss_pred             HHHhcc---CCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhcc-CCcccc
Confidence            998653   456  8889999999999999999999   9999999999999975 58999999999998753 455677


Q ss_pred             ccccccCccCccccccC--CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCC
Q 037869          204 RVKGTLGYLAPEYAMWG--KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF  281 (380)
Q Consensus       204 ~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      ++.||.-|||||++..+  .|..++|||||||++.||.||++||.........              +.+.-.-...++.
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--------------MFkVGmyKvHP~i  800 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--------------MFKVGMYKVHPPI  800 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--------------hhhhcceecCCCC
Confidence            88899999999999854  5899999999999999999999999765432111              1111222345678


Q ss_pred             CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          282 DENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       282 ~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      |...++++..+|.+|+.++|.+||++.++|....-.
T Consensus       801 Peelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq  836 (1226)
T KOG4279|consen  801 PEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQ  836 (1226)
T ss_pred             cHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccc
Confidence            889999999999999999999999999999875543

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.9e-42  Score=307.07  Aligned_cols=247  Identities=28%  Similarity=0.465  Sum_probs=198.0

Q ss_pred             ceeccCCceEEEEEEe-CCCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCCCH
Q 037869           47 NKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSL  124 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  124 (380)
                      +.||+|+||.||+|.+ .++..||+|.+... .......+.+|+++++.++||||+++++++......++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            4799999999999987 47889999988653 334455788999999999999999999999999999999999999999


Q ss_pred             HHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccce-e
Q 037869          125 LSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMT-T  203 (380)
Q Consensus       125 ~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~-~  203 (380)
                      .+++...   ...+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++........... .
T Consensus        81 ~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  154 (252)
T cd05084          81 LTFLRTE---GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG  154 (252)
T ss_pred             HHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence            9998643   34688999999999999999999999   999999999999999999999999999876543211111 1


Q ss_pred             ccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCC
Q 037869          204 RVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD  282 (380)
Q Consensus       204 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      ....+..|+|||.+.+..++.++||||||+++|+|++ |..||.......                .............+
T Consensus       155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~----------------~~~~~~~~~~~~~~  218 (252)
T cd05084         155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ----------------TREAIEQGVRLPCP  218 (252)
T ss_pred             CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH----------------HHHHHHcCCCCCCc
Confidence            1123456999999998889999999999999999998 888886432210                00001111112233


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          283 ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       283 ~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       219 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         219 ELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            344578999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.3e-42  Score=313.90  Aligned_cols=258  Identities=22%  Similarity=0.372  Sum_probs=204.4

Q ss_pred             CCCCCcceeccCCceEEEEEEeC------CCcEEEEEEecccCh-hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTS------DGLQIAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ..|++.+.||+|+||.||+|.+.      .+..||+|+++.... .....+..|+.++..++||||+++++++......+
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~   84 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLS   84 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceE
Confidence            35778899999999999999753      257899999985432 23456888999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCC------------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC
Q 037869          114 IVYDYMPNLSLLSHLHGQY------------AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF  181 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~------------~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~  181 (380)
                      +++||+.+++|.+++....            .....+++..++.++.|++.||.|||++   +++||||||+||+++.++
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~  161 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKL  161 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCC
Confidence            9999999999999985321            1123588889999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhcc
Q 037869          182 EPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEW  259 (380)
Q Consensus       182 ~vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~  259 (380)
                      .+||+|||+++....... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......      .+
T Consensus       162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~  235 (283)
T cd05091         162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------DV  235 (283)
T ss_pred             ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------HH
Confidence            999999999886543221 11222345778999999988889999999999999999998 88888653211      00


Q ss_pred             chhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          260 AEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .          ...........+..++..+.+++.+||+.+|.+||++.+|+..|+.+
T Consensus       236 ~----------~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~  283 (283)
T cd05091         236 I----------EMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRTW  283 (283)
T ss_pred             H----------HHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhCC
Confidence            0          00111111223445567899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.5e-42  Score=312.66  Aligned_cols=256  Identities=22%  Similarity=0.286  Sum_probs=206.3

Q ss_pred             CCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEec
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYM  119 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  119 (380)
                      +.|++.+.||.|+||.||++.+. ++..+++|.+..........+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~   84 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC   84 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEec
Confidence            34788899999999999999874 57888999987766666677889999999999999999999999999999999999


Q ss_pred             CCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc
Q 037869          120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS  199 (380)
Q Consensus       120 ~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~  199 (380)
                      ++++|..++...   ...+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++....... 
T Consensus        85 ~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-  157 (282)
T cd06643          85 AGGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-  157 (282)
T ss_pred             CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccc-
Confidence            999999887642   34689999999999999999999999   99999999999999999999999999987653321 


Q ss_pred             cceeccccccCccCccccc-----cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          200 HMTTRVKGTLGYLAPEYAM-----WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       200 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      .......++..|+|||++.     +..++.++||||+||++|+|++|.+||.......  .....     ..     ...
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~-----~~-----~~~  225 (282)
T cd06643         158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLKI-----AK-----SEP  225 (282)
T ss_pred             cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHHH-----hh-----cCC
Confidence            1223345899999999884     3457889999999999999999999996533110  00000     00     000


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      +  ....+...+..+.++|.+||+.+|.+||++.++++|.+..
T Consensus       226 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  266 (282)
T cd06643         226 P--TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVT  266 (282)
T ss_pred             C--CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEe
Confidence            0  0112233457899999999999999999999999997644

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.5e-42  Score=314.13  Aligned_cols=259  Identities=27%  Similarity=0.474  Sum_probs=208.8

Q ss_pred             hCCCCCcceeccCCceEEEEEEeC------CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTS------DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ..+|.+.+.||+|+||.||+|.+.      ++..+++|.+..........+.+|+.++++++|+||+++++++......+
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceE
Confidence            356888999999999999999742      34568999988766666667889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC
Q 037869          114 IVYDYMPNLSLLSHLHGQYA------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF  181 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~  181 (380)
                      +||||+++++|.+++.....            ....+++..++.++.|++.||+|||++   +++||||||+||+++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~  160 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANL  160 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCC
Confidence            99999999999999965321            224589999999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhcc
Q 037869          182 EPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEW  259 (380)
Q Consensus       182 ~vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~  259 (380)
                      .++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......  ..   
T Consensus       161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~---  235 (291)
T cd05094         161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VI---  235 (291)
T ss_pred             cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HH---
Confidence            999999999976543221 11223346788999999999999999999999999999999 999986543211  00   


Q ss_pred             chhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          260 AEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                       .          ..........+...+..+.+++.+||+.+|++|||+.++++.|...
T Consensus       236 -~----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~  282 (291)
T cd05094         236 -E----------CITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHAL  282 (291)
T ss_pred             -H----------HHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence             0          0011111112233457889999999999999999999999998755

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=9.7e-43  Score=312.10  Aligned_cols=255  Identities=30%  Similarity=0.460  Sum_probs=203.2

Q ss_pred             CCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHH--HHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEec
Q 037869           43 FSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEM--EFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYM  119 (380)
Q Consensus        43 y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~--~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  119 (380)
                      |++.+.||+|+||+||++++ .+++.||+|++.........  ....|+.++++++||||+++++++......++||||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~   80 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC   80 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence            77899999999999999997 45778999999876544433  3455999999999999999999999999999999999


Q ss_pred             CCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc
Q 037869          120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS  199 (380)
Q Consensus       120 ~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~  199 (380)
                      .+++|.+++..    ...+++..++.++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||.+...... .
T Consensus        81 ~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~-~  152 (260)
T PF00069_consen   81 PGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN-N  152 (260)
T ss_dssp             TTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTST-T
T ss_pred             ccccccccccc----cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc-c
Confidence            99999999972    35789999999999999999999999   9999999999999999999999999999764221 2


Q ss_pred             cceeccccccCccCccccc-cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          200 HMTTRVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       200 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      .......++..|+|||++. +..++.++||||+|+++|+|++|..||.............  .. . .......    . 
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~--~~-~-~~~~~~~----~-  223 (260)
T PF00069_consen  153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIE--KI-L-KRPLPSS----S-  223 (260)
T ss_dssp             SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHH--HH-H-HTHHHHH----T-
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh--hc-c-ccccccc----c-
Confidence            2344456899999999998 8889999999999999999999999997641100000000  00 0 0000000    0 


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                       .........+.+++.+||+.||++|||+.++++|.+
T Consensus       224 -~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~  259 (260)
T PF00069_consen  224 -QQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPW  259 (260)
T ss_dssp             -TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGG
T ss_pred             -cccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCC
Confidence             000011278999999999999999999999999865

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.3e-42  Score=321.59  Aligned_cols=245  Identities=29%  Similarity=0.349  Sum_probs=195.0

Q ss_pred             ceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHH-HHhcCCCCcceeEeeEEecCCeEEEEEEecCC
Q 037869           47 NKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVE-VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPN  121 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  121 (380)
                      +.||+|+||+||+|.+ .+++.||+|++....   ......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            4699999999999987 478999999987421   222234445544 56789999999999999999999999999999


Q ss_pred             CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccc
Q 037869          122 LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM  201 (380)
Q Consensus       122 g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~  201 (380)
                      |+|..++...    ..+++..+..++.||+.||.|||++   ||+||||||+|||++.++.+||+|||++...... ...
T Consensus        81 g~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~  152 (323)
T cd05575          81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKT  152 (323)
T ss_pred             CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCc
Confidence            9999988643    4689999999999999999999999   9999999999999999999999999998754222 122


Q ss_pred             eeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCC
Q 037869          202 TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF  281 (380)
Q Consensus       202 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||......  ...    .         .+....  ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~----~---------~i~~~~--~~~  215 (323)
T cd05575         153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA--EMY----D---------NILNKP--LRL  215 (323)
T ss_pred             cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH--HHH----H---------HHHcCC--CCC
Confidence            33456899999999999999999999999999999999999999753210  000    0         000000  012


Q ss_pred             CHHHHHHHHHHHHhhcCCCCCCCCCH----HHHHHHhcC
Q 037869          282 DENQLKQAINVAVLCVQSEPEKRPNM----KEVVNTLTG  316 (380)
Q Consensus       282 ~~~~~~~~~~li~~cl~~~P~~Rps~----~~ll~~l~~  316 (380)
                      +...+..+.++|.+||+.||.+||++    .++++|.+.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~  254 (323)
T cd05575         216 KPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFF  254 (323)
T ss_pred             CCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCc
Confidence            22335788999999999999999987    588888654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-42  Score=306.87  Aligned_cols=256  Identities=25%  Similarity=0.357  Sum_probs=209.0

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      .++|++.+.||.|+||.||+|.+ .++..+++|.+..........+.+|+.+++.++||||+++++++.....++++|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~   81 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEY   81 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeC
Confidence            57899999999999999999987 46788999999876555667888999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++++|.+++...   ...+++..++.++.|++.||+|||++   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  155 (262)
T cd06613          82 CGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI  155 (262)
T ss_pred             CCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence            9999999988643   24689999999999999999999998   99999999999999999999999999998764322


Q ss_pred             ccceeccccccCccCccccccC---CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWG---KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                       .......++..|+|||.+.+.   .++.++||||||+++|+|++|..||........  ...     ....   ..  .
T Consensus       156 -~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~--~~~-----~~~~---~~--~  222 (262)
T cd06613         156 -AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA--LFL-----ISKS---NF--P  222 (262)
T ss_pred             -hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHH-----HHhc---cC--C
Confidence             122334578899999998876   789999999999999999999999975432110  000     0000   00  0


Q ss_pred             cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 037869          276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL  314 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l  314 (380)
                      ..........+.++.+++.+||..+|..|||+.+++.|-
T Consensus       223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~  261 (262)
T cd06613         223 PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHP  261 (262)
T ss_pred             CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCC
Confidence            001112334567899999999999999999999999873

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=8.9e-43  Score=327.01  Aligned_cols=268  Identities=22%  Similarity=0.257  Sum_probs=208.1

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCC-C-----CcceeEeeEEecCCe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR-H-----KNLLGLRGYCAGTDQ  111 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~~~~~~~~~~~  111 (380)
                      ..-+|.+++.||+|+||.|.+|.+ .+++.||||+++... ....+...|+.+|..|+ |     -|+|+++++|...++
T Consensus       184 i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  184 IAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             eEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            344899999999999999999987 679999999998754 33446777999999986 3     489999999999999


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC--CceEEeecc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD--FEPLVADFG  189 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~--~~vkl~Dfg  189 (380)
                      ++||+|.+. -+|.++++...  ...++...++.++.||+.||..||..   +|||+||||+|||+..-  ..|||+|||
T Consensus       263 lciVfELL~-~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFG  336 (586)
T KOG0667|consen  263 LCIVFELLS-TNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFG  336 (586)
T ss_pred             eeeeehhhh-hhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecc
Confidence            999999995 59999998753  34699999999999999999999999   99999999999999753  579999999


Q ss_pred             CccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCccc-------------ch
Q 037869          190 FAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKR-------------TI  256 (380)
Q Consensus       190 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-------------~~  256 (380)
                      .++.....    ...+..+..|+|||++.|.+|+.+.||||||||++||++|.+-|.+..+....             .+
T Consensus       337 SSc~~~q~----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL  412 (586)
T KOG0667|consen  337 SSCFESQR----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKML  412 (586)
T ss_pred             cccccCCc----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            99976542    23566799999999999999999999999999999999999888765432111             00


Q ss_pred             hccchh--hhh--cccc-------------------------ccccCC----cccCCCCHHHHHHHHHHHHhhcCCCCCC
Q 037869          257 TEWAEP--LIV--KGKF-------------------------KELVDP----KLRGDFDENQLKQAINVAVLCVQSEPEK  303 (380)
Q Consensus       257 ~~~~~~--~~~--~~~~-------------------------~~~~~~----~~~~~~~~~~~~~~~~li~~cl~~~P~~  303 (380)
                      ..+...  +..  .+.+                         .....+    .+...........+.+++.+||..||..
T Consensus       413 ~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~  492 (586)
T KOG0667|consen  413 DTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAE  492 (586)
T ss_pred             HhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchh
Confidence            000000  000  0000                         000000    0111111233467899999999999999


Q ss_pred             CCCHHHHHHHhcCC
Q 037869          304 RPNMKEVVNTLTGY  317 (380)
Q Consensus       304 Rps~~~ll~~l~~~  317 (380)
                      |+|+.+.++|.+..
T Consensus       493 R~tp~qal~Hpfl~  506 (586)
T KOG0667|consen  493 RITPAQALNHPFLT  506 (586)
T ss_pred             cCCHHHHhcCcccc
Confidence            99999999997755

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.3e-42  Score=312.55  Aligned_cols=257  Identities=27%  Similarity=0.449  Sum_probs=206.6

Q ss_pred             hCCCCCcceeccCCceEEEEEEe------CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT------SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ..+|.+.++||+|+||.||++..      .++..|++|.+..........+.+|+++++.++|+||+++++++......+
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceE
Confidence            46788899999999999999963      235678999988776666778999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCC-----------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc
Q 037869          114 IVYDYMPNLSLLSHLHGQYA-----------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE  182 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~-----------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~  182 (380)
                      ++|||+++++|.+++.....           ....+++..++.++.|++.||+|||+.   +++||||||+||+++.++.
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~  160 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLV  160 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCC
Confidence            99999999999999975421           113588999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccc
Q 037869          183 PLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWA  260 (380)
Q Consensus       183 vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~  260 (380)
                      ++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |.+||........  .    
T Consensus       161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~--~----  234 (280)
T cd05092         161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA--I----  234 (280)
T ss_pred             EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH--H----
Confidence            99999999976533211 11222335678999999998999999999999999999998 8999865332110  0    


Q ss_pred             hhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          261 EPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .          ..........+..++..+.+++.+||+.||.+||++.+|++.|.
T Consensus       235 ~----------~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         235 E----------CITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             H----------HHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            0          00000111122334567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6.6e-42  Score=318.04  Aligned_cols=255  Identities=22%  Similarity=0.234  Sum_probs=201.5

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ++|++.+.||+|+||+||++.. .+++.||+|++...   .......+..|+.++..++|+||+++++++...+.+++||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            4799999999999999999987 45788999998642   2223335778999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++|+|.+++...   ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.++|+|||++.....
T Consensus        81 ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~  154 (332)
T cd05623          81 DYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLME  154 (332)
T ss_pred             eccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheeccc
Confidence            999999999999653   24689999999999999999999999   999999999999999999999999999876543


Q ss_pred             CCccceeccccccCccCccccc-----cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAM-----WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      ..........||+.|+|||++.     ...++.++|||||||++|||++|..||.......  ..             ..
T Consensus       155 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~--~~-------------~~  219 (332)
T cd05623         155 DGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--TY-------------GK  219 (332)
T ss_pred             CCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH--HH-------------HH
Confidence            3222233456899999999986     3468999999999999999999999997532100  00             00


Q ss_pred             ccCCcc---cCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHHhcC
Q 037869          272 LVDPKL---RGDFDENQLKQAINVAVLCVQSEPEK--RPNMKEVVNTLTG  316 (380)
Q Consensus       272 ~~~~~~---~~~~~~~~~~~~~~li~~cl~~~P~~--Rps~~~ll~~l~~  316 (380)
                      +.....   ........+.++.+|+.+|+..++.+  |+++.++++|.+.
T Consensus       220 i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f  269 (332)
T cd05623         220 IMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFF  269 (332)
T ss_pred             HhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCc
Confidence            000000   01112234578899999998765554  6899999999664

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.7e-42  Score=307.10  Aligned_cols=250  Identities=20%  Similarity=0.284  Sum_probs=204.8

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEec
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYM  119 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  119 (380)
                      +|++.+.||.|+||.||++.+ .++..||+|.++.. .......+.+|+.+++.++|+||+++++++..++.+|+||||+
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC   80 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence            588999999999999999987 46899999998643 3344567888999999999999999999999999999999999


Q ss_pred             CCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc
Q 037869          120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS  199 (380)
Q Consensus       120 ~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~  199 (380)
                      ++++|.+++...  ....+++..++.++.|++.||.|||++   +++|+||+|+||+++.++.++|+|||++........
T Consensus        81 ~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  155 (255)
T cd08219          81 DGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA  155 (255)
T ss_pred             CCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence            999999988643  234588999999999999999999999   999999999999999999999999999977643221


Q ss_pred             cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccC
Q 037869          200 HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG  279 (380)
Q Consensus       200 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                       ......|+..|+|||++.+..++.++|+||||+++|+|++|..||.......  ..    .          ........
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~----~----------~~~~~~~~  218 (255)
T cd08219         156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN--LI----L----------KVCQGSYK  218 (255)
T ss_pred             -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH--HH----H----------HHhcCCCC
Confidence             2233468899999999998889999999999999999999999996532100  00    0          00011111


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 037869          280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT  313 (380)
Q Consensus       280 ~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~  313 (380)
                      ..+...+..+.+++.+||+.||.+|||+.+++..
T Consensus       219 ~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         219 PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            2233445678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.8e-42  Score=314.16  Aligned_cols=264  Identities=20%  Similarity=0.295  Sum_probs=196.2

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcC---CCCcceeEeeEEec-----CC
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRV---RHKNLLGLRGYCAG-----TD  110 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~-----~~  110 (380)
                      +|++.+.||+|+||+||+|.+ .+++.||+|.++...  ......+.+|+.+++.+   +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            589999999999999999987 468899999987432  11223455666666655   79999999998764     34


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccC
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGF  190 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl  190 (380)
                      ..++||||+.+ +|.+++....  ...+++..+..++.|++.||.|||+.   |++||||||+||+++.++.++|+|||+
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~  154 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGL  154 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCc
Confidence            57999999975 8888886532  24589999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh--hccc
Q 037869          191 AKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI--VKGK  268 (380)
Q Consensus       191 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~  268 (380)
                      +.......  ......++..|+|||++.+..++.++||||+||++|+|++|.+||.......  ....+.....  ....
T Consensus       155 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~--~~~~~~~~~~~~~~~~  230 (288)
T cd07863         155 ARIYSCQM--ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLIGLPPEDD  230 (288)
T ss_pred             cccccCcc--cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH--HHHHHHHHhCCCChhh
Confidence            98764321  2233457999999999998899999999999999999999999996533211  0000000000  0000


Q ss_pred             ccc-------ccCCc---ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          269 FKE-------LVDPK---LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       269 ~~~-------~~~~~---~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      +..       ...+.   ......+..+..+.+++.+||+.||.+|||+.+++.|.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~  287 (288)
T cd07863         231 WPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF  287 (288)
T ss_pred             CcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence            000       00000   000111234567899999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3e-42  Score=313.52  Aligned_cols=255  Identities=28%  Similarity=0.388  Sum_probs=204.6

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      .|++.+.||+|+||+||++.+ .+++.||+|.+....   ......+.+|+.+++.++|++|+++++.+...+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            377889999999999999987 568899999986432   2223456789999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+++++|.+++...  ....+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  155 (285)
T cd05630          81 LMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  155 (285)
T ss_pred             ecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCC
Confidence            99999999988543  224589999999999999999999998   9999999999999999999999999998765432


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      .  ......|+..|+|||++.+..++.++||||+|+++|+|++|..||...........            ..... ...
T Consensus       156 ~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~------------~~~~~-~~~  220 (285)
T cd05630         156 Q--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE------------VERLV-KEV  220 (285)
T ss_pred             c--cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHH------------HHhhh-hhh
Confidence            2  12234689999999999988999999999999999999999999975332110000            00000 000


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHhcC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPN-----MKEVVNTLTG  316 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps-----~~~ll~~l~~  316 (380)
                      ....+...+.++.+|+.+||+.||++|||     ++++++|.+.
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~  264 (285)
T cd05630         221 QEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLF  264 (285)
T ss_pred             hhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhh
Confidence            11122334567899999999999999999     9999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6.9e-42  Score=305.02  Aligned_cols=247  Identities=29%  Similarity=0.471  Sum_probs=199.9

Q ss_pred             ceeccCCceEEEEEEeCCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCCCHH
Q 037869           47 NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL  125 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  125 (380)
                      +.||+|+||.||+|...++..||+|.++... ......+.+|+.+++.++||||+++++++......++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            4699999999999987778899999987643 333446888999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccceecc
Q 037869          126 SHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRV  205 (380)
Q Consensus       126 ~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~~~~  205 (380)
                      +++...   ...+++..++.++.|++.||.|||++   +++||||+|+||+++.++.++|+|||++..............
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (250)
T cd05085          81 SFLRKK---KDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLK  154 (250)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCC
Confidence            998643   24578999999999999999999998   999999999999999999999999999976543322222222


Q ss_pred             ccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHH
Q 037869          206 KGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN  284 (380)
Q Consensus       206 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      .++..|+|||++.+..++.++||||||+++|++++ |..||.......  ..    .          ..........+..
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~--~~----~----------~~~~~~~~~~~~~  218 (250)
T cd05085         155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ--AR----E----------QVEKGYRMSCPQK  218 (250)
T ss_pred             CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH--HH----H----------HHHcCCCCCCCCC
Confidence            34667999999998889999999999999999998 999986532110  00    0          0001111122334


Q ss_pred             HHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          285 QLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       285 ~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .+..+.+++.+||+.+|++||++.++++.|.
T Consensus       219 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         219 CPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            4578999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-44  Score=331.03  Aligned_cols=260  Identities=22%  Similarity=0.286  Sum_probs=216.9

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeCC-CcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      .+.+.|.|+..||.|+||.||+|.+++ +-.-|.|++...+....+.+.-|+.||...+||+||++++.|..++.+||+.
T Consensus        29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili  108 (1187)
T KOG0579|consen   29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI  108 (1187)
T ss_pred             CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence            355678899999999999999998754 4445788888888888889999999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      |||.||.+...+..-   +..+.+..+..+++|++.||.|||+.   +|+|||||..|||++-+|.|+|+|||.+.....
T Consensus       109 EFC~GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~  182 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS  182 (1187)
T ss_pred             eecCCchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchh
Confidence            999999998887543   45799999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCccceeccccccCccCccccc-----cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAM-----WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                       .......+.|||+|||||+..     ..+|+.++||||||++|.||..+.+|......            ..+.-++..
T Consensus       183 -t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp------------MRVllKiaK  249 (1187)
T KOG0579|consen  183 -TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP------------MRVLLKIAK  249 (1187)
T ss_pred             -HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch------------HHHHHHHhh
Confidence             234466788999999999876     46799999999999999999999999876442            111111111


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      .-.|  .-..|+..+..+.+++.+||.+||..||++.+|++|.+.-+
T Consensus       250 SePP--TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~  294 (1187)
T KOG0579|consen  250 SEPP--TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQN  294 (1187)
T ss_pred             cCCC--cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCccccc
Confidence            1111  11245667789999999999999999999999999987654

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=4.7e-42  Score=311.03  Aligned_cols=258  Identities=29%  Similarity=0.401  Sum_probs=203.9

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC------CCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS------DGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQ  111 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  111 (380)
                      .+++|.+.+.||+|++|.||+|.+.      .+..|++|.+.... ......+..|+.+++.++|+||+++++++.+...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            4567999999999999999999864      45778999887543 3334568889999999999999999999998889


Q ss_pred             EEEEEEecCCCCHHHhhccCCC---CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC---ceEE
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYA---GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF---EPLV  185 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~---~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~---~vkl  185 (380)
                      .++||||+++++|.+++.....   ....+++..++.++.|++.||+|||+.   +++||||||+||+++.++   .++|
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEe
Confidence            9999999999999999965421   123589999999999999999999999   999999999999998654   5999


Q ss_pred             eeccCccccCCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhh
Q 037869          186 ADFGFAKLIPEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPL  263 (380)
Q Consensus       186 ~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~  263 (380)
                      +|||+++........ .......+..|+|||++.+..++.++|||||||++|+|++ |..||.......   .   ..  
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~---~---~~--  232 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE---V---ME--  232 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---H---HH--
Confidence            999999876322111 1111223567999999998899999999999999999997 999987533210   0   00  


Q ss_pred             hhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                              ..........+...+..+.+++.+||+.+|++|||+.+++++|.
T Consensus       233 --------~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         233 --------FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             --------HHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                    00011111223344578899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=5.7e-42  Score=307.56  Aligned_cols=256  Identities=27%  Similarity=0.461  Sum_probs=207.0

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ...++|++.++||+|+||.||++.+.++..|++|.+.... .....+.+|+.+++.++|+||+++++++.. ...+++||
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence            3568999999999999999999987777889999887542 334578889999999999999999999877 77899999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+++++|.+++...  ....+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~  155 (260)
T cd05073          81 FMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDN  155 (260)
T ss_pred             eCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCC
Confidence            99999999999754  234678889999999999999999998   9999999999999999999999999999876433


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      .........++..|+|||.+.+..++.++|+|||||++|++++ |..||.......   ...             .....
T Consensus       156 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~-------------~~~~~  219 (260)
T cd05073         156 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIR-------------ALERG  219 (260)
T ss_pred             CcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHH-------------HHhCC
Confidence            2222222335677999999998889999999999999999999 899997533210   000             00001


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .....+...+.++.+++.+||+.+|++||++.++++.|..
T Consensus       220 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         220 YRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             CCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            1111223345689999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-42  Score=312.09  Aligned_cols=258  Identities=25%  Similarity=0.399  Sum_probs=206.4

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC------CCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS------DGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQ  111 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  111 (380)
                      ..++|++.+.||+|+||.||+|.+.      ++..||+|.+.... ......+.+|+.++..++||||+++++++.....
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            4578999999999999999999753      24689999987543 3444578889999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHhhccCCC------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEE
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYA------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV  185 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl  185 (380)
                      .++||||+++|+|.+++.....      ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEE
Confidence            9999999999999999965422      123478899999999999999999998   9999999999999999999999


Q ss_pred             eeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhh
Q 037869          186 ADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPL  263 (380)
Q Consensus       186 ~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~  263 (380)
                      +|||+++.+..... .......++..|+|||.+.+..++.++|||||||++|++++ |..||........  .    .  
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~--~----~--  232 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEV--L----K--  232 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHH--H----H--
Confidence            99999976543221 11223346788999999988889999999999999999998 8999865332110  0    0  


Q ss_pred             hhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                              ..........+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       233 --------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         233 --------FVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             --------HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence                    00011111223334678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=7.8e-42  Score=312.57  Aligned_cols=265  Identities=24%  Similarity=0.399  Sum_probs=203.9

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC-----------------CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcce
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS-----------------DGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLL  100 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv  100 (380)
                      +.++|++.+.||+|+||.||++++.                 +...||+|+++.. .......+.+|+.+++.++|+||+
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcc
Confidence            4568999999999999999998542                 2346899998754 333455788999999999999999


Q ss_pred             eEeeEEecCCeEEEEEEecCCCCHHHhhccCCCC-------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 037869          101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAG-------EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKAS  173 (380)
Q Consensus       101 ~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~-------~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~  173 (380)
                      ++++++..++..++||||+++++|.+++......       ...+++..++.++.|++.||+|||+.   +++||||||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~  159 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLATR  159 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChh
Confidence            9999999999999999999999999998754211       23477889999999999999999999   9999999999


Q ss_pred             CeeeCCCCceEEeeccCccccCCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh--CCCCCCCCCC
Q 037869          174 NVLLDSDFEPLVADFGFAKLIPEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT--GRKPIEKLPG  250 (380)
Q Consensus       174 Nill~~~~~vkl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~p~~~~~~  250 (380)
                      ||+++.++.++|+|||++..+...... ......++..|+|||...+..++.++|||||||++|||++  |..||.....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            999999999999999999865432211 1222334678999999888889999999999999999998  6788864332


Q ss_pred             CcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          251 GVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ..  .... ......      ..........+..++..+.+|+.+||+.||.+|||+.+|++.|.
T Consensus       240 ~~--~~~~-~~~~~~------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         240 EQ--VIEN-TGEFFR------DQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             HH--HHHH-HHHHHh------hccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            11  0000 000000      00001111122334578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.1e-41  Score=313.26  Aligned_cols=263  Identities=23%  Similarity=0.315  Sum_probs=205.9

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ++|++.+.||+|+||.||++.+ .++..||+|.+... .......+.+|++++++++||||+++++++..++..++||||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey   80 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH   80 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence            4689999999999999999986 46888999988753 333445688899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH-EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~-~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      +++++|.+++...    ..+++..+..++.|++.||.|||+ .   +++||||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (308)
T cd06615          81 MDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  153 (308)
T ss_pred             cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhC---CEEECCCChHHEEEecCCcEEEccCCCccccccc
Confidence            9999999999653    468999999999999999999997 5   8999999999999999999999999998765332


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccc---------
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGK---------  268 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------  268 (380)
                         ......++..|+|||.+.+..++.++||||||+++|+|++|..||........   ..+.........         
T Consensus       154 ---~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  227 (308)
T cd06615         154 ---MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL---EAMFGRPVSEGEAKESHRPVS  227 (308)
T ss_pred             ---ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhH---HHhhcCccccccccCCccccc
Confidence               12334689999999999888899999999999999999999999864321110   000000000000         


Q ss_pred             ---------------cccccCCcccCCCC-HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          269 ---------------FKELVDPKLRGDFD-ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       269 ---------------~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                                     ...... ......+ ...+.++.+++.+||..+|++|||+.++++|.+..
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~  291 (308)
T cd06615         228 GHPPDSPRPMAIFELLDYIVN-EPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK  291 (308)
T ss_pred             CCCCCccchhhHHHHHHHHhc-CCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence                           000000 0000111 12456789999999999999999999999998754

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.9e-42  Score=313.03  Aligned_cols=256  Identities=21%  Similarity=0.292  Sum_probs=209.7

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ...+|++.+.||.|++|.||++.+ .+++.||+|.+..........+.+|+.+++.++|+||+++++++..++..++|||
T Consensus        17 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   96 (297)
T cd06656          17 PKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   96 (297)
T ss_pred             hhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence            457999999999999999999986 5789999999976555555678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+++++|.+++...     .+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++......
T Consensus        97 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          97 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             ccCCCCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            99999999998643     578889999999999999999998   9999999999999999999999999998765432


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      .. ......+++.|+|||.+.+..++.++|+||+||++|+|++|..||..........  .          .  ......
T Consensus       169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~--~----------~--~~~~~~  233 (297)
T cd06656         169 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY--L----------I--ATNGTP  233 (297)
T ss_pred             cc-CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee--e----------e--ccCCCC
Confidence            21 1223457899999999998889999999999999999999999996533211000  0          0  000000


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ....+...+..+.+++.+||..+|++||++.++++|.+..
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~  273 (297)
T cd06656         234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLK  273 (297)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhc
Confidence            1112233456788999999999999999999999996643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=7.6e-42  Score=311.72  Aligned_cols=257  Identities=27%  Similarity=0.393  Sum_probs=204.4

Q ss_pred             CCCCcceeccCCceEEEEEEeC------CCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRTS------DGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      +|++.+.||+|+||.||+|.+.      ....+++|.+.... ......+.+|+.+++.++||||+++++.+..++..++
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL   80 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence            4788999999999999999752      23568888887543 3345578889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCC--------------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 037869          115 VYDYMPNLSLLSHLHGQYA--------------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASN  174 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~--------------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~N  174 (380)
                      ++||+.+++|.+++.....                    ....+++..++.++.|++.||.|||+.   +++||||||+|
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~n  157 (290)
T cd05045          81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARN  157 (290)
T ss_pred             EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---Ceehhhhhhhe
Confidence            9999999999998864211                    123588999999999999999999998   99999999999


Q ss_pred             eeeCCCCceEEeeccCccccCCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCc
Q 037869          175 VLLDSDFEPLVADFGFAKLIPEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGV  252 (380)
Q Consensus       175 ill~~~~~vkl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~  252 (380)
                      |+++.++.++|+|||+++........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......
T Consensus       158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            99999999999999999865332211 1222335678999999988889999999999999999998 999986532110


Q ss_pred             ccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          253 KRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                                      +............+...+.++.+++.+||+.+|.+||++.++++.|..+
T Consensus       238 ----------------~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~  286 (290)
T cd05045         238 ----------------LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKM  286 (290)
T ss_pred             ----------------HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHH
Confidence                            0111111122223344557899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=4.8e-42  Score=312.26  Aligned_cols=264  Identities=22%  Similarity=0.324  Sum_probs=207.4

Q ss_pred             HHHHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcC-CCCcceeEeeEEe---
Q 037869           33 YKELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCA---  107 (380)
Q Consensus        33 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~---  107 (380)
                      ++.+..+.++|++.+.||+|+||.||+|.+ .+++.||+|++..... ....+.+|+.+++.+ +||||+++++++.   
T Consensus        10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   88 (286)
T cd06638          10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKKD   88 (286)
T ss_pred             eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence            455666889999999999999999999987 4688999998875332 234677899999999 6999999999873   


Q ss_pred             --cCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEE
Q 037869          108 --GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV  185 (380)
Q Consensus       108 --~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl  185 (380)
                        .++..++||||+++++|.+++.........+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl  165 (286)
T cd06638          89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKL  165 (286)
T ss_pred             cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEE
Confidence              34678999999999999998864433445789999999999999999999998   9999999999999999999999


Q ss_pred             eeccCccccCCCCccceeccccccCccCcccccc-----CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccc
Q 037869          186 ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW-----GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWA  260 (380)
Q Consensus       186 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~  260 (380)
                      +|||++........ ......|+..|+|||++.+     ..++.++||||+||++|+|++|..||.......  ....  
T Consensus       166 ~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~--~~~~--  240 (286)
T cd06638         166 VDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR--ALFK--  240 (286)
T ss_pred             ccCCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH--HHhh--
Confidence            99999887643211 2223458999999998853     457899999999999999999999996543211  0000  


Q ss_pred             hhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          261 EPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                              ......+  ....+...+..+.+++.+||+.||++|||+.++++|++
T Consensus       241 --------~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         241 --------IPRNPPP--TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             --------ccccCCC--cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence                    0000000  00112223467899999999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=3.4e-42  Score=315.67  Aligned_cols=269  Identities=22%  Similarity=0.313  Sum_probs=204.1

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ++|++.+.||.|+||.||+|.+ .++..||+|.++... ......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~   85 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   85 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence            5799999999999999999987 468899999987432 22334677899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +. ++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        86 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  158 (301)
T cd07873          86 LD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  158 (301)
T ss_pred             cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence            97 5898888643   34688999999999999999999999   99999999999999999999999999997653322


Q ss_pred             ccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccch----------hccchhhhhcc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI----------TEWAEPLIVKG  267 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~----------~~~~~~~~~~~  267 (380)
                      .. .....+++.|+|||++.+ ..++.++|||||||++|+|++|.+||...+.......          ..|.. .....
T Consensus       159 ~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  236 (301)
T cd07873         159 KT-YSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPG-ILSNE  236 (301)
T ss_pred             Cc-ccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchh-hhccc
Confidence            11 222346889999999875 4578999999999999999999999975432110000          00000 00000


Q ss_pred             ccccccCCcccC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          268 KFKELVDPKLRG----DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       268 ~~~~~~~~~~~~----~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      .+.....+....    ......+..+.+||.+||+.||.+|||+.++++|.+...
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~  291 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC  291 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            000000011110    111234567899999999999999999999999977543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-41  Score=307.79  Aligned_cols=256  Identities=27%  Similarity=0.389  Sum_probs=201.7

Q ss_pred             CCCcceeccCCceEEEEEEeC----CCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCe-----
Q 037869           43 FSDDNKLGEGGFGSVYWGRTS----DGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQ-----  111 (380)
Q Consensus        43 y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-----  111 (380)
                      |.+.+.||+|+||.||.|...    .+..||+|.++..  .......+.+|+..++.++||||+++++++.....     
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            678899999999999999753    2477999998753  23344578889999999999999999998866554     


Q ss_pred             -EEEEEEecCCCCHHHhhccCCC--CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          112 -RLIVYDYMPNLSLLSHLHGQYA--GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       112 -~~lv~e~~~~g~L~~~i~~~~~--~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                       .+++|||+++|+|..++.....  ....+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~df  157 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADF  157 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCc
Confidence             7999999999999998854321  234689999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccCCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhc
Q 037869          189 GFAKLIPEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVK  266 (380)
Q Consensus       189 gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~  266 (380)
                      |+++.+...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......   .   ..     
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~---~---~~-----  226 (273)
T cd05035         158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE---I---YD-----  226 (273)
T ss_pred             cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH---H---HH-----
Confidence            999876432211 1112234678999999988889999999999999999999 888886533210   0   00     


Q ss_pred             cccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                           ..........+...+..+.+++.+||+.||.+|||+.+++++|..+
T Consensus       227 -----~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         227 -----YLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             -----HHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                 0001111122334557899999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4e-42  Score=310.47  Aligned_cols=256  Identities=23%  Similarity=0.305  Sum_probs=203.7

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecC------
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGT------  109 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~------  109 (380)
                      .+.+.|++.+.||+|+||.||+|.+ .+++.||+|.+.... .....+..|+.+++.+ +|+||+++++++...      
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            4678899999999999999999986 468899999987543 3345778899999998 699999999998653      


Q ss_pred             CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeecc
Q 037869          110 DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG  189 (380)
Q Consensus       110 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfg  189 (380)
                      ...|+||||+.+++|.+++...  ....+++..+..++.|++.||+|||++   +++||||+|+||+++.++.++|+|||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCC
Confidence            4689999999999999998753  234688999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCccceeccccccCccCccccc-----cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh
Q 037869          190 FAKLIPEGVSHMTTRVKGTLGYLAPEYAM-----WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI  264 (380)
Q Consensus       190 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  264 (380)
                      ++....... .......|+..|+|||++.     +..++.++||||+||++|+|++|..||..........        .
T Consensus       157 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~--------~  227 (272)
T cd06637         157 VSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF--------L  227 (272)
T ss_pred             Cceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHH--------H
Confidence            997654322 2233456899999999986     3358889999999999999999999996432211000        0


Q ss_pred             hccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          265 VKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .       .............+..+.+|+.+||..+|.+|||+.++++|.+
T Consensus       228 ~-------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  271 (272)
T cd06637         228 I-------PRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPF  271 (272)
T ss_pred             H-------hcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCC
Confidence            0       0001111112234467899999999999999999999999865

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.2e-42  Score=320.34  Aligned_cols=244  Identities=28%  Similarity=0.337  Sum_probs=192.7

Q ss_pred             ceeccCCceEEEEEEeC-CCcEEEEEEecccC---hhhHHHHHHHH-HHHhcCCCCcceeEeeEEecCCeEEEEEEecCC
Q 037869           47 NKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN---SKAEMEFAVEV-EVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPN  121 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~-~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  121 (380)
                      +.||+|+||+||+|++. +++.||+|++....   ......+..|. .+++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            46999999999999874 67889999987422   12223344444 456788999999999999999999999999999


Q ss_pred             CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccc
Q 037869          122 LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM  201 (380)
Q Consensus       122 g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~  201 (380)
                      |+|.+++...    ..+.+..+..++.||+.||.|||+.   ||+||||||+|||++.++.++|+|||++....... ..
T Consensus        81 ~~L~~~~~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~  152 (325)
T cd05602          81 GELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GT  152 (325)
T ss_pred             CcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CC
Confidence            9999998643    4688889999999999999999999   99999999999999999999999999987543221 22


Q ss_pred             eeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCC
Q 037869          202 TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF  281 (380)
Q Consensus       202 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ..             ..+....  ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~-------------~~i~~~~--~~~  215 (325)
T cd05602         153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE--MY-------------DNILNKP--LQL  215 (325)
T ss_pred             cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH--HH-------------HHHHhCC--cCC
Confidence            334568999999999999999999999999999999999999997533110  00             0000000  112


Q ss_pred             CHHHHHHHHHHHHhhcCCCCCCCCCHH----HHHHHhc
Q 037869          282 DENQLKQAINVAVLCVQSEPEKRPNMK----EVVNTLT  315 (380)
Q Consensus       282 ~~~~~~~~~~li~~cl~~~P~~Rps~~----~ll~~l~  315 (380)
                      ....+..+.+++.+||+.||.+||++.    ++++|.+
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~  253 (325)
T cd05602         216 KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIF  253 (325)
T ss_pred             CCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcc
Confidence            233457889999999999999999876    6666654

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.6e-42  Score=318.48  Aligned_cols=249  Identities=25%  Similarity=0.346  Sum_probs=199.8

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCC-CCcceeEeeEEecCCeEEEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVR-HKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  116 (380)
                      .|++.+.||+|+||+||+|.+ .+++.||+|+++..   .......+..|..++..+. |++|+++++++...+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            477889999999999999987 46899999998752   2233345677888888885 577888999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++|+|.+++...    ..+++..+..++.|++.||.|||++   |++||||||+|||++.++.++|+|||++.....
T Consensus        81 Ey~~~g~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~  153 (323)
T cd05615          81 EYVNGGDLMYHIQQV----GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV  153 (323)
T ss_pred             cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCC
Confidence            999999999998643    4689999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      .. .......||+.|+|||++.+..++.++||||+||++|+|++|..||.......  .             ...+... 
T Consensus       154 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~--~-------------~~~i~~~-  216 (323)
T cd05615         154 DG-VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE--L-------------FQSIMEH-  216 (323)
T ss_pred             CC-ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH--H-------------HHHHHhC-
Confidence            21 12233468999999999999899999999999999999999999997543110  0             0000000 


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHhc
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPN-----MKEVVNTLT  315 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps-----~~~ll~~l~  315 (380)
                       ...++...+.++.+++.+||+.+|.+|++     .+++++|.+
T Consensus       217 -~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~  259 (323)
T cd05615         217 -NVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAF  259 (323)
T ss_pred             -CCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcc
Confidence             11223344578899999999999999997     467887754

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1e-41  Score=305.29  Aligned_cols=246  Identities=26%  Similarity=0.416  Sum_probs=197.5

Q ss_pred             eeccCCceEEEEEEe---CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCC
Q 037869           48 KLGEGGFGSVYWGRT---SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNL  122 (380)
Q Consensus        48 ~Lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  122 (380)
                      .||+|+||.||+|.+   .++..||+|+++...  ......+.+|+.+++.++||||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            689999999999964   357889999987432  334557888999999999999999999875 45779999999999


Q ss_pred             CHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccc-
Q 037869          123 SLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM-  201 (380)
Q Consensus       123 ~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~-  201 (380)
                      +|.+++...    ..+++..+..++.|++.||+|||++   +++||||||.||+++.++.++|+|||++.......... 
T Consensus        81 ~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~  153 (257)
T cd05116          81 PLNKFLQKN----KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK  153 (257)
T ss_pred             cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeee
Confidence            999999643    4689999999999999999999999   99999999999999999999999999998764332211 


Q ss_pred             -eeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCcccC
Q 037869          202 -TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG  279 (380)
Q Consensus       202 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                       .....++..|+|||.+.+..++.++|||||||++|||++ |..||.......   .             ..........
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~-------------~~~i~~~~~~  217 (257)
T cd05116         154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE---V-------------TQMIESGERM  217 (257)
T ss_pred             ecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH---H-------------HHHHHCCCCC
Confidence             111223578999999988889999999999999999998 999997543210   0             0011111222


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       280 ~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ..+...+.++.++|.+||+.||.+||++.+|...|..+
T Consensus       218 ~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         218 ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence            33344567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=6.6e-42  Score=312.96  Aligned_cols=255  Identities=22%  Similarity=0.313  Sum_probs=209.2

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ...+|++.+.||.|++|.||+|.+ .+++.|++|.+..........+.+|+.+++.++||||+++++++...+..++|+|
T Consensus        17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   96 (296)
T cd06655          17 PKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME   96 (296)
T ss_pred             CcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence            446799999999999999999986 5789999999876554555678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+++++|..++..     ..+++..+..++.|++.||+|||+.   |++||||+|+||+++.++.++|+|||++......
T Consensus        97 ~~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~  168 (296)
T cd06655          97 YLAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE  168 (296)
T ss_pred             ecCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccc
Confidence            9999999998864     3589999999999999999999999   9999999999999999999999999998865433


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      .. ......++..|+|||.+.+..++.++|||||||++|+|++|..||.........  ..     ....       ...
T Consensus       169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~--~~-----~~~~-------~~~  233 (296)
T cd06655         169 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL--YL-----IATN-------GTP  233 (296)
T ss_pred             cc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HH-----HHhc-------CCc
Confidence            22 122345788999999999888999999999999999999999999654321100  00     0000       000


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ....+...+..+.++|.+||..||.+||++.+++.|.+.
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~  272 (296)
T cd06655         234 ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL  272 (296)
T ss_pred             ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence            011223345678999999999999999999999999664

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-42  Score=310.65  Aligned_cols=259  Identities=24%  Similarity=0.328  Sum_probs=210.1

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      +.++|++.+.||.|++|.||++.+ .++..||+|.+..........+..|+.++++++||||+++++++..+...++|||
T Consensus         3 ~~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           3 PNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             chhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            457899999999999999999987 4688999999987666666788899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+++++|.+++...   ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~  156 (280)
T cd06611          83 FCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST  156 (280)
T ss_pred             ccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence            99999999998643   24689999999999999999999999   9999999999999999999999999998765332


Q ss_pred             CccceeccccccCccCccccc-----cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAM-----WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      .. ......+++.|+|||.+.     ...++.++||||||+++|+|++|..||.......  ....          +...
T Consensus       157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~~----------~~~~  223 (280)
T cd06611         157 LQ-KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLLK----------ILKS  223 (280)
T ss_pred             cc-ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHHH----------HhcC
Confidence            21 223345899999999875     3457889999999999999999999997543210  0000          0000


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      ..+  ....+...+..+.+++.+||+.+|.+||++.++++|.+...
T Consensus       224 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~  267 (280)
T cd06611         224 EPP--TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSD  267 (280)
T ss_pred             CCC--CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcc
Confidence            000  01112334568899999999999999999999999976543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.3e-41  Score=304.23  Aligned_cols=253  Identities=24%  Similarity=0.338  Sum_probs=208.2

Q ss_pred             hCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      .++|++.+.||.|+||.||+|.+. ++..|++|.++....  ...+.+|+.+++.++||||+++++++..+...|+++||
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~   79 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEY   79 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEec
Confidence            468999999999999999999875 478999999876432  56888999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++++|.+++...   ...+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.......
T Consensus        80 ~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (256)
T cd06612          80 CGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM  153 (256)
T ss_pred             CCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence            9999999998643   35789999999999999999999999   99999999999999999999999999998765432


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      . ......++..|+|||++.+..++.++||||||+++|+|++|..||...........        ..    .  .....
T Consensus       154 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~--------~~----~--~~~~~  218 (256)
T cd06612         154 A-KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM--------IP----N--KPPPT  218 (256)
T ss_pred             c-ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh--------hc----c--CCCCC
Confidence            1 22334478899999999988999999999999999999999999975432110000        00    0  00001


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ...+...+..+.+++.+||+.||.+|||+.+++.|.+
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~  255 (256)
T cd06612         219 LSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPF  255 (256)
T ss_pred             CCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCC
Confidence            1122344578999999999999999999999998754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-41  Score=304.37  Aligned_cols=251  Identities=32%  Similarity=0.489  Sum_probs=206.9

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ..+.|++.+.||.|++|.||+|... ++.||+|.++.... ....+.+|+.+++.++|+||+++++++......++||||
T Consensus         4 ~~~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           4 NSKELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             ChhhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            3568899999999999999999875 78899999986544 456788999999999999999999999988999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++++|.+++...  ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+++......
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~  156 (256)
T cd05039          82 MAKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ  156 (256)
T ss_pred             cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc
Confidence            9999999999654  123689999999999999999999999   99999999999999999999999999998763321


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      .    ....+..|+|||.+.+..++.++||||||+++|++++ |..||.......   .             ........
T Consensus       157 ~----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~-------------~~~~~~~~  216 (256)
T cd05039         157 D----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---V-------------VPHVEKGY  216 (256)
T ss_pred             c----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH---H-------------HHHHhcCC
Confidence            1    2234678999999988889999999999999999997 999986532110   0             00000111


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ....+...+..+.+++.+||..+|.+|||+.++++.|..
T Consensus       217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         217 RMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             CCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence            112233345789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.3e-41  Score=304.70  Aligned_cols=247  Identities=26%  Similarity=0.420  Sum_probs=197.5

Q ss_pred             eeccCCceEEEEEEeC---CCcEEEEEEecccCh-hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCCC
Q 037869           48 KLGEGGFGSVYWGRTS---DGLQIAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLS  123 (380)
Q Consensus        48 ~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~  123 (380)
                      .||+|+||.||+|.+.   ++..||+|++..... .....+.+|+.++++++||||+++++++. ....++||||+++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~   80 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP   80 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence            4899999999999753   356799999876433 33456889999999999999999999886 457899999999999


Q ss_pred             HHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccce-
Q 037869          124 LLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMT-  202 (380)
Q Consensus       124 L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~-  202 (380)
                      |.+++...   ...+++..++.++.|++.||.|||++   +++||||||+||+++.++.++|+|||++........... 
T Consensus        81 L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          81 LNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            99998643   34689999999999999999999999   999999999999999999999999999976543322111 


Q ss_pred             -eccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCcccCC
Q 037869          203 -TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGD  280 (380)
Q Consensus       203 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                       ....++..|+|||.+.+..++.++|||||||++|++++ |..||.......                +...+.......
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----------------~~~~~~~~~~~~  218 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE----------------VMSFIEQGKRLD  218 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH----------------HHHHHHCCCCCC
Confidence             11123568999999988889999999999999999996 999997543210                011111122223


Q ss_pred             CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          281 FDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       281 ~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .+..++.++.+++.+||..+|++||++.+|.+.|..+
T Consensus       219 ~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         219 CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            4445568899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-41  Score=311.72  Aligned_cols=265  Identities=23%  Similarity=0.385  Sum_probs=202.8

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCC---------------CcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSD---------------GLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGL  102 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~---------------~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~  102 (380)
                      ..++|++.+.||+|+||.||++.+..               ...||+|.++.. .......+.+|++++++++|+||+++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~   82 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRL   82 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeE
Confidence            35689999999999999999987532               235899998754 33344578899999999999999999


Q ss_pred             eeEEecCCeEEEEEEecCCCCHHHhhccCCC--------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 037869          103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYA--------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASN  174 (380)
Q Consensus       103 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~--------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~N  174 (380)
                      ++++...+..++||||+.+++|.+++.....        ....+++..++.++.|++.||+|||+.   +++||||||+|
T Consensus        83 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~N  159 (295)
T cd05097          83 LGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRN  159 (295)
T ss_pred             EEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhh
Confidence            9999999999999999999999999854311        112478889999999999999999999   99999999999


Q ss_pred             eeeCCCCceEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh--CCCCCCCCCCC
Q 037869          175 VLLDSDFEPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT--GRKPIEKLPGG  251 (380)
Q Consensus       175 ill~~~~~vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~p~~~~~~~  251 (380)
                      |+++.++.+||+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|++  +..||......
T Consensus       160 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~  239 (295)
T cd05097         160 CLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDE  239 (295)
T ss_pred             EEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence            9999999999999999976533221 11222335678999999998889999999999999999998  56777643321


Q ss_pred             cccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          252 VKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .  .........       ...........+...+..+.+|+.+||+.+|++|||+.+|++.|.
T Consensus       240 ~--~~~~~~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         240 Q--VIENTGEFF-------RNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             H--HHHHHHHhh-------hhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            0  000000000       000011111122234578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=5.4e-42  Score=324.61  Aligned_cols=263  Identities=25%  Similarity=0.379  Sum_probs=206.8

Q ss_pred             HHHhhCCCCCcceeccCCceEEEEEEeC------CCcEEEEEEecccC-hhhHHHHHHHHHHHhcCC-CCcceeEeeEEe
Q 037869           36 LHTATNGFSDDNKLGEGGFGSVYWGRTS------DGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVR-HKNLLGLRGYCA  107 (380)
Q Consensus        36 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~  107 (380)
                      +....++|.+.+.||+|+||.||+|++.      .+..||+|+++... ......+.+|+.+|..+. ||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~  111 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT  111 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence            3345667889999999999999999753      34679999998543 233446888999999997 999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHhhccCCC------------------------------------------------------
Q 037869          108 GTDQRLIVYDYMPNLSLLSHLHGQYA------------------------------------------------------  133 (380)
Q Consensus       108 ~~~~~~lv~e~~~~g~L~~~i~~~~~------------------------------------------------------  133 (380)
                      ..+..++||||+.+|+|.++++....                                                      
T Consensus       112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence            98999999999999999999965321                                                      


Q ss_pred             ----------------------------------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 037869          134 ----------------------------------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKAS  173 (380)
Q Consensus       134 ----------------------------------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~  173 (380)
                                                              ....+++..++.++.|++.||+|||+.   +++||||||+
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~  268 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAAR  268 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcc
Confidence                                                    112467778899999999999999998   9999999999


Q ss_pred             CeeeCCCCceEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCC
Q 037869          174 NVLLDSDFEPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGG  251 (380)
Q Consensus       174 Nill~~~~~vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~  251 (380)
                      |||++.++.++|+|||+++....... .......++..|+|||.+.+..++.++||||||+++|||++ |..||......
T Consensus       269 NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         269 NVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             eEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            99999999999999999986532211 11222346788999999998889999999999999999998 88898653211


Q ss_pred             cccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          252 VKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ..               .........+...+...+..+.+|+.+||..+|..||++.+|++.|+.
T Consensus       349 ~~---------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~  398 (401)
T cd05107         349 EQ---------------FYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD  398 (401)
T ss_pred             HH---------------HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            00               000111111222333455789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=3.2e-42  Score=346.22  Aligned_cols=261  Identities=19%  Similarity=0.304  Sum_probs=203.6

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEec--CCe
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG--TDQ  111 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~  111 (380)
                      ....++|++.+.||+|+||+||+|.+ .++..||+|++...  .......+..|+.++..++||||++++++|..  ...
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            34567999999999999999999987 45778999988742  33445678889999999999999999998854  456


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcC----CCCeEecCCCCCCeeeCC--------
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV----TPHIIHRDIKASNVLLDS--------  179 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~----~~~ivHrdlkp~Nill~~--------  179 (380)
                      +||||||+++|+|.++|.........+++..++.|+.||+.||.|||+..    ..+|+||||||+||||+.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            89999999999999999765444457999999999999999999999851    125999999999999964        


Q ss_pred             ---------CCceEEeeccCccccCCCCccceeccccccCccCcccccc--CCCCccchhhhhhHHHHHHHhCCCCCCCC
Q 037869          180 ---------DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW--GKVSESCDVYSFGILLLEILTGRKPIEKL  248 (380)
Q Consensus       180 ---------~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~  248 (380)
                               .+.+||+|||++..+...  .......||+.|+|||++.+  ..++.++||||||||||+|++|..||...
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                     245899999999876432  12234568999999999864  45899999999999999999999999653


Q ss_pred             CCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          249 PGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ...     ..+.....      ..  +.+   .....+.++.+||..||+.+|.+||++.++|.+.+
T Consensus       247 ~~~-----~qli~~lk------~~--p~l---pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~  297 (1021)
T PTZ00266        247 NNF-----SQLISELK------RG--PDL---PIKGKSKELNILIKNLLNLSAKERPSALQCLGYQI  297 (1021)
T ss_pred             CcH-----HHHHHHHh------cC--CCC---CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHH
Confidence            221     00000000      00  000   01123468899999999999999999999998744

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=8.6e-42  Score=312.43  Aligned_cols=257  Identities=27%  Similarity=0.425  Sum_probs=202.5

Q ss_pred             CCCCCcceeccCCceEEEEEEeC-CC--cEEEEEEeccc-ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTS-DG--LQIAVKKLKAM-NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~--~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ++|++.+.||+|+||.||+|... ++  ..+++|.++.. .......+.+|+.++.++ +||||+++++++...+..++|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            57999999999999999999763 33  35788888743 334455788899999999 799999999999998999999


Q ss_pred             EEecCCCCHHHhhccCCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCce
Q 037869          116 YDYMPNLSLLSHLHGQYA------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEP  183 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~v  183 (380)
                      |||+++++|.+++.....            ....+++..++.++.|++.||+|||++   |++||||||+||+++.++.+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeE
Confidence            999999999999965321            123588999999999999999999998   99999999999999999999


Q ss_pred             EEeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchh
Q 037869          184 LVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP  262 (380)
Q Consensus       184 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~  262 (380)
                      ||+|||++........  ......+..|+|||.+.+..++.++|||||||++|+|++ |..||.......  .    .  
T Consensus       159 kl~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--~----~--  228 (297)
T cd05089         159 KIADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--L----Y--  228 (297)
T ss_pred             EECCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--H----H--
Confidence            9999999864322111  111123557999999998889999999999999999997 999996533210  0    0  


Q ss_pred             hhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                              ...........+..++..+.+|+.+||+.+|.+|||+.++++.|..+.
T Consensus       229 --------~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  276 (297)
T cd05089         229 --------EKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML  276 (297)
T ss_pred             --------HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                    001111112223345578899999999999999999999999876553

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7e-42  Score=314.50  Aligned_cols=260  Identities=30%  Similarity=0.416  Sum_probs=205.7

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC--------CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEec
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS--------DGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAG  108 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  108 (380)
                      ..++|.+.+.||+|+||.||+|.+.        +...||+|.++.. .......+..|+.+++.+ +||||+++++++..
T Consensus        16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (307)
T cd05098          16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   95 (307)
T ss_pred             ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            3468999999999999999999752        2346999999753 234455688899999999 79999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHhhccCCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCee
Q 037869          109 TDQRLIVYDYMPNLSLLSHLHGQYA------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVL  176 (380)
Q Consensus       109 ~~~~~lv~e~~~~g~L~~~i~~~~~------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nil  176 (380)
                      .+..|+||||+++|+|.+++.....            ....+++..++.++.|++.||+|||++   |++||||||+||+
T Consensus        96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nil  172 (307)
T cd05098          96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVL  172 (307)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheE
Confidence            9999999999999999999975421            123588999999999999999999998   9999999999999


Q ss_pred             eCCCCceEEeeccCccccCCCCccc-eeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCccc
Q 037869          177 LDSDFEPLVADFGFAKLIPEGVSHM-TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKR  254 (380)
Q Consensus       177 l~~~~~vkl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~  254 (380)
                      ++.++.++|+|||++.......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||...+.    
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~----  248 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV----  248 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCH----
Confidence            9999999999999987654321111 111223568999999998889999999999999999998 8888864321    


Q ss_pred             chhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          255 TITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                        .....          ..........+...+.++.+++.+||..+|.+|||+.++++.|..+
T Consensus       249 --~~~~~----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~  299 (307)
T cd05098         249 --EELFK----------LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  299 (307)
T ss_pred             --HHHHH----------HHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence              00000          0111111223334557899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=5e-42  Score=321.88  Aligned_cols=267  Identities=24%  Similarity=0.280  Sum_probs=201.7

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecC-----
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT-----  109 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----  109 (380)
                      ...++|++.+.||+|+||.||++.+ ..++.||+|++...  .......+.+|+.+++.++||||+++++++...     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            4568999999999999999999987 46889999998753  233345677899999999999999999988543     


Q ss_pred             -CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          110 -DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       110 -~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                       ...|+||||+++ +|.+.+..      .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+||
T Consensus        94 ~~~~~lv~e~~~~-~l~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Df  163 (355)
T cd07874          94 FQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  163 (355)
T ss_pred             cceeEEEhhhhcc-cHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeC
Confidence             357999999965 67776642      478889999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccc--hh---------
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRT--IT---------  257 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~--~~---------  257 (380)
                      |+++.....  .......||+.|+|||++.+..++.++|||||||++|+|++|..||..........  ..         
T Consensus       164 g~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (355)
T cd07874         164 GLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF  241 (355)
T ss_pred             cccccCCCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999865432  22234568999999999999999999999999999999999999997543110000  00         


Q ss_pred             --ccc---hhhh-hccccccccCCc-----c---cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          258 --EWA---EPLI-VKGKFKELVDPK-----L---RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       258 --~~~---~~~~-~~~~~~~~~~~~-----~---~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                        .+.   .... ..........+.     .   ...........+.+||.+||+.||++|||+.++++|.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~  314 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYI  314 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcch
Confidence              000   0000 000000000000     0   001112234678999999999999999999999999764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=9.6e-42  Score=315.02  Aligned_cols=264  Identities=21%  Similarity=0.332  Sum_probs=191.5

Q ss_pred             cceeccCCceEEEEEEeC---CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEec--CCeEEEEEEecC
Q 037869           46 DNKLGEGGFGSVYWGRTS---DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG--TDQRLIVYDYMP  120 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~  120 (380)
                      .++||+|+||+||+|++.   ++..||+|.+.....  ...+.+|+.+++.++||||+++++++..  +...++||||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999853   567899999875432  2356789999999999999999999854  456899999995


Q ss_pred             CCCHHHhhccCC-----CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee----CCCCceEEeeccCc
Q 037869          121 NLSLLSHLHGQY-----AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLL----DSDFEPLVADFGFA  191 (380)
Q Consensus       121 ~g~L~~~i~~~~-----~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill----~~~~~vkl~Dfgl~  191 (380)
                       ++|.+++....     .....+++..+..++.|++.||.|||+.   ||+||||||+|||+    +.++.+||+|||++
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence             48887775321     1123589999999999999999999999   99999999999999    45678999999999


Q ss_pred             cccCCCCcc--ceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccch----hccchhhh
Q 037869          192 KLIPEGVSH--MTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI----TEWAEPLI  264 (380)
Q Consensus       192 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~----~~~~~~~~  264 (380)
                      +........  ......||+.|+|||++.+ ..++.++||||+||++|+|++|.+||...........    ........
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  239 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence            876433211  2234568999999999886 4689999999999999999999999975433211100    00000000


Q ss_pred             hcc-----cccc-------------ccCCccc--------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          265 VKG-----KFKE-------------LVDPKLR--------GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       265 ~~~-----~~~~-------------~~~~~~~--------~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ..+     .+..             .......        ..........+.+||.+||+.||.+|||++++++|.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~  316 (317)
T cd07868         240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY  316 (317)
T ss_pred             hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence            000     0000             0000000        0000011246889999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=307.60  Aligned_cols=253  Identities=25%  Similarity=0.338  Sum_probs=208.3

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ++|++.+.||.|++|.||+|.+ .+++.|++|.+.... ......+.+|+.+++.++|+||+++++++..+...++|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY   80 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence            4788999999999999999987 468899999987543 34445688899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++++|.+++...     .+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~  152 (274)
T cd06609          81 CGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM  152 (274)
T ss_pred             eCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccc
Confidence            9999999999643     789999999999999999999998   99999999999999999999999999998775432


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      . ......++..|+|||.+.+..++.++||||||+++|+|++|..||.......  ..          ..+.    ....
T Consensus       153 ~-~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~----------~~~~----~~~~  215 (274)
T cd06609         153 S-KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VL----------FLIP----KNNP  215 (274)
T ss_pred             c-ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HH----------HHhh----hcCC
Confidence            2 2233457889999999998889999999999999999999999996533110  00          0000    0011


Q ss_pred             CCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          279 GDFDEN-QLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       279 ~~~~~~-~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      ...... .+..+.+++.+||..+|++|||++++++|.+...
T Consensus       216 ~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~  256 (274)
T cd06609         216 PSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKK  256 (274)
T ss_pred             CCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcC
Confidence            111111 4567899999999999999999999999976544

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=7.2e-42  Score=313.83  Aligned_cols=257  Identities=27%  Similarity=0.437  Sum_probs=202.0

Q ss_pred             hCCCCCcceeccCCceEEEEEEeC-CCc--EEEEEEeccc-ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTS-DGL--QIAVKKLKAM-NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  114 (380)
                      .+.|++.+.||+|+||.||+|.+. ++.  .+++|.++.. .......+.+|+.++.++ +|+||+++++++..++..|+
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            467899999999999999999863 444  4577777643 233445788899999999 89999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc
Q 037869          115 VYDYMPNLSLLSHLHGQYA------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE  182 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~  182 (380)
                      ||||+++++|.+++.....            ....+++..++.++.|++.||+|||++   |++||||||+||+++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCc
Confidence            9999999999999965321            123688999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccch
Q 037869          183 PLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAE  261 (380)
Q Consensus       183 vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~  261 (380)
                      ++|+|||++.......  ......++..|+|||.+.+..++.++|||||||++|+|++ |..||........      ..
T Consensus       163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~~  234 (303)
T cd05088         163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YE  234 (303)
T ss_pred             EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHH------HH
Confidence            9999999986432111  1111223567999999988889999999999999999998 9999965332100      00


Q ss_pred             hhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          262 PLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                                ..........+...+.++.+|+.+||+.+|++||++.+++..+...
T Consensus       235 ----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         235 ----------KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             ----------HHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                      0001111112223456789999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2e-41  Score=309.80  Aligned_cols=265  Identities=27%  Similarity=0.407  Sum_probs=205.6

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCC-----------------CcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcce
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSD-----------------GLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLL  100 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv  100 (380)
                      ..++|++.+.||+|+||.||+|.+..                 +..||+|.+.... ......+.+|+.++++++||||+
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~   82 (296)
T cd05051           3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIA   82 (296)
T ss_pred             chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEe
Confidence            45789999999999999999987532                 2458999987543 33456788899999999999999


Q ss_pred             eEeeEEecCCeEEEEEEecCCCCHHHhhccCCC-------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 037869          101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYA-------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKAS  173 (380)
Q Consensus       101 ~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~-------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~  173 (380)
                      ++++++..++..+++|||+.+++|.+++.....       ....+++..++.++.|++.||+|||+.   +++||||||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~  159 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATR  159 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Cccccccchh
Confidence            999999999999999999999999999865421       123689999999999999999999998   9999999999


Q ss_pred             CeeeCCCCceEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh--CCCCCCCCCC
Q 037869          174 NVLLDSDFEPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT--GRKPIEKLPG  250 (380)
Q Consensus       174 Nill~~~~~vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~p~~~~~~  250 (380)
                      ||+++.++.++|+|||+++....... .......++..|+|||.+.+..++.++|||||||++|+|++  +..||.....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTD  239 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcCh
Confidence            99999999999999999976533221 12223345778999999988889999999999999999998  6777754321


Q ss_pred             CcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          251 GVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ..  .....       ...............+...+.++.+++.+||+.||.+|||+.+|++.|.
T Consensus       240 ~~--~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         240 QQ--VIENA-------GHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HH--HHHHH-------HhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            10  00000       0000000011111122334578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.3e-42  Score=320.16  Aligned_cols=245  Identities=27%  Similarity=0.325  Sum_probs=193.9

Q ss_pred             ceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHH-HHhcCCCCcceeEeeEEecCCeEEEEEEecCC
Q 037869           47 NKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVE-VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPN  121 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  121 (380)
                      +.||+|+||+||+|++ .+++.||+|++...   .......+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            4699999999999987 56899999998743   2223334555554 56778999999999999999999999999999


Q ss_pred             CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccc
Q 037869          122 LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM  201 (380)
Q Consensus       122 g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~  201 (380)
                      |+|...+...    ..+++..+..++.||+.||.|||+.   ||+||||||+|||++.++.++|+|||++....... ..
T Consensus        81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~  152 (325)
T cd05604          81 GELFFHLQRE----RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS-DT  152 (325)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-CC
Confidence            9999888643    4789999999999999999999999   99999999999999999999999999987542221 22


Q ss_pred             eeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCC
Q 037869          202 TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF  281 (380)
Q Consensus       202 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .....|++.|+|||++.+..++.++|||||||++|+|++|..||......  ...    .         ......  ...
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~----~---------~~~~~~--~~~  215 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVA--EMY----D---------NILHKP--LVL  215 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHH--HHH----H---------HHHcCC--ccC
Confidence            33456899999999999999999999999999999999999999753211  000    0         000000  011


Q ss_pred             CHHHHHHHHHHHHhhcCCCCCCCCCHH----HHHHHhcC
Q 037869          282 DENQLKQAINVAVLCVQSEPEKRPNMK----EVVNTLTG  316 (380)
Q Consensus       282 ~~~~~~~~~~li~~cl~~~P~~Rps~~----~ll~~l~~  316 (380)
                      ....+..+.+++.+||..+|.+||++.    ++++|.+.
T Consensus       216 ~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f  254 (325)
T cd05604         216 RPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFF  254 (325)
T ss_pred             CCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCc
Confidence            223446788999999999999999774    77777543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=9.9e-42  Score=309.99  Aligned_cols=267  Identities=22%  Similarity=0.320  Sum_probs=201.4

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      .|++.+.||.|++|.||+|.+ .++..||+|+++...  ......+.+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF   80 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence            488999999999999999987 468999999987432  22235678899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      ++ ++|.+++.... ....+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  155 (285)
T cd07861          81 LS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV  155 (285)
T ss_pred             CC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCc
Confidence            97 58888886542 235789999999999999999999999   99999999999999999999999999997654322


Q ss_pred             ccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccc----------hhccchhhhhcc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRT----------ITEWAEPLIVKG  267 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~----------~~~~~~~~~~~~  267 (380)
                      . ......+++.|+|||++.+. .++.++|||||||++|+|++|.+||..........          ...|...... .
T Consensus       156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  233 (285)
T cd07861         156 R-VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL-P  233 (285)
T ss_pred             c-cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh-H
Confidence            1 12223568899999988754 57899999999999999999999997543210000          0000000000 0


Q ss_pred             ccccccC---CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          268 KFKELVD---PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       268 ~~~~~~~---~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .+.....   ...........+.++.++|.+||+.||.+|||+.+|++|.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~  284 (285)
T cd07861         234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY  284 (285)
T ss_pred             HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCC
Confidence            0000000   00000111224567889999999999999999999999854

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.5e-41  Score=308.00  Aligned_cols=254  Identities=26%  Similarity=0.413  Sum_probs=200.1

Q ss_pred             CCCCCcceeccCCceEEEEEEeC-CCc----EEEEEEecccCh-hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTS-DGL----QIAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      ++|++.+.||+|+||+||+|.+. ++.    .|++|.+..... .....+..|+.+++.+.||||+++++++. +...++
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~   85 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL   85 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence            57888999999999999999863 344    477888764332 23356777888999999999999999875 456789


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ++||+++|+|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++..
T Consensus        86 i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~  159 (279)
T cd05111          86 VTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLL  159 (279)
T ss_pred             EEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceec
Confidence            99999999999999753   34689999999999999999999998   9999999999999999999999999999876


Q ss_pred             CCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          195 PEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       195 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      ...... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ..             ..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~-------------~~  223 (279)
T cd05111         160 YPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE---VP-------------DL  223 (279)
T ss_pred             cCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---HH-------------HH
Confidence            432221 1223446778999999998899999999999999999998 999986543211   00             00


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .........+..++.++.+++.+||..+|..|||+.++++.|..+
T Consensus       224 ~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~  268 (279)
T cd05111         224 LEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM  268 (279)
T ss_pred             HHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            111111111222346788999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.1e-41  Score=320.55  Aligned_cols=265  Identities=24%  Similarity=0.279  Sum_probs=201.5

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecC-----
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT-----  109 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----  109 (380)
                      ...++|++.+.||+|+||.||++.+ ..++.||||++...  .......+.+|+.+++.++||||+++++++...     
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            3568999999999999999999987 46889999998753  233445677899999999999999999987543     


Q ss_pred             -CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          110 -DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       110 -~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                       ...|+||||+.+ +|.+.+..      .+++..+..++.|++.||+|||++   ||+||||||+||+++.++.++|+||
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  170 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  170 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh------cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeC
Confidence             357999999965 77777742      478889999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccch-------
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE-------  261 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~-------  261 (380)
                      |+++.....  .......+|..|+|||++.+..++.++|||||||++|+|++|..||........  ......       
T Consensus       171 G~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~~~~~  246 (364)
T cd07875         171 GLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCP  246 (364)
T ss_pred             CCccccCCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCCH
Confidence            999865432  122344689999999999999999999999999999999999999975432100  000000       


Q ss_pred             -----------hhhh-ccc-----cccccCCc---ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          262 -----------PLIV-KGK-----FKELVDPK---LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       262 -----------~~~~-~~~-----~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                                 .... ...     +.......   ............+.+||.+||+.||.+|||+.++++|.+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~  321 (364)
T cd07875         247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI  321 (364)
T ss_pred             HHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCccc
Confidence                       0000 000     00000000   0001111223578999999999999999999999999764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.1e-41  Score=303.00  Aligned_cols=252  Identities=23%  Similarity=0.328  Sum_probs=207.1

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      +|++.+.||.|+||.||.+++ .+++.|++|.+...  .......+.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~   80 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY   80 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence            589999999999999999986 56889999997643  344456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++++|.+++....  ...+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.+||+|||++.......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~  155 (256)
T cd08221          81 ANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY  155 (256)
T ss_pred             cCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEccccc
Confidence            99999999997542  34689999999999999999999998   99999999999999999999999999998764432


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      . ......+++.|+|||.+.+..++.++||||||+++|+|++|..||......  ...    .. ...+.         .
T Consensus       156 ~-~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--~~~----~~-~~~~~---------~  218 (256)
T cd08221         156 S-MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL--NLV----VK-IVQGN---------Y  218 (256)
T ss_pred             c-cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH--HHH----HH-HHcCC---------C
Confidence            2 223346899999999999888999999999999999999999998653210  000    00 00011         1


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ...+...+..+.+++.+||..+|.+||++.++++++.
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~  255 (256)
T cd08221         219 TPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPL  255 (256)
T ss_pred             CCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcC
Confidence            1122344578899999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-41  Score=303.99  Aligned_cols=250  Identities=32%  Similarity=0.485  Sum_probs=204.7

Q ss_pred             ceeccCCceEEEEEEeCC----CcEEEEEEecccChhh-HHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCC
Q 037869           47 NKLGEGGFGSVYWGRTSD----GLQIAVKKLKAMNSKA-EMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPN  121 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  121 (380)
                      +.||+|+||.||+|.+..    +..|++|.++...... ...+.+|+..++.++|+||+++++++..+...++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            479999999999998743    7889999998644333 56788899999999999999999999999999999999999


Q ss_pred             CCHHHhhccCCCC-----CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          122 LSLLSHLHGQYAG-----EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       122 g~L~~~i~~~~~~-----~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ++|.+++......     ...+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999764221     36799999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          197 GVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       197 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      ... .......++..|+|||.+.+..++.++||||+|+++|+|++ |..||.......      ..          ....
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~----------~~~~  221 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE------VL----------EYLR  221 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH------HH----------HHHH
Confidence            321 12233457889999999988889999999999999999999 699997642110      00          0000


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .......+...+.++.+++.+||+.+|.+|||+.+++++|+
T Consensus       222 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         222 KGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             cCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            11122334445688999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.5e-42  Score=318.48  Aligned_cols=245  Identities=27%  Similarity=0.342  Sum_probs=193.8

Q ss_pred             ceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHH-HHhcCCCCcceeEeeEEecCCeEEEEEEecCC
Q 037869           47 NKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVE-VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPN  121 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  121 (380)
                      +.||+|+||.||+|++ .+++.||+|++....   ......+..|.. +++.++||||+++++++...+..|+||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999987 468899999987432   222334555554 67889999999999999999999999999999


Q ss_pred             CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccc
Q 037869          122 LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM  201 (380)
Q Consensus       122 g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~  201 (380)
                      |+|...+...    ..+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||++...... ...
T Consensus        81 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~  152 (321)
T cd05603          81 GELFFHLQRE----RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EET  152 (321)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCc
Confidence            9999888543    4688999999999999999999998   9999999999999999999999999998753222 122


Q ss_pred             eeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCC
Q 037869          202 TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF  281 (380)
Q Consensus       202 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||......      ....         .+...  ....
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~~~---------~i~~~--~~~~  215 (321)
T cd05603         153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QMYD---------NILHK--PLQL  215 (321)
T ss_pred             cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HHHH---------HHhcC--CCCC
Confidence            33456899999999999889999999999999999999999999753210      0000         00111  0122


Q ss_pred             CHHHHHHHHHHHHhhcCCCCCCCCCH----HHHHHHhcC
Q 037869          282 DENQLKQAINVAVLCVQSEPEKRPNM----KEVVNTLTG  316 (380)
Q Consensus       282 ~~~~~~~~~~li~~cl~~~P~~Rps~----~~ll~~l~~  316 (380)
                      +...+..+.+++.+||+.||.+||++    .++++|.+.
T Consensus       216 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~  254 (321)
T cd05603         216 PGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFF  254 (321)
T ss_pred             CCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCc
Confidence            33345678999999999999999875    477777653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.5e-41  Score=305.68  Aligned_cols=253  Identities=25%  Similarity=0.392  Sum_probs=204.5

Q ss_pred             CCCCcceeccCCceEEEEEEeCCCcEEEEEEecccC------hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMN------SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      +|++.+.||+|+||.||+|.+.+++.+|+|.++...      ......+.+|+.+++.++|+||+++++++...+..++|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            588999999999999999988788999999986422      12234678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      +||+++++|.+++.+.    ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  153 (265)
T cd06631          81 MEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLA  153 (265)
T ss_pred             EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhh
Confidence            9999999999999643    3688999999999999999999998   99999999999999999999999999987653


Q ss_pred             CCC-----ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          196 EGV-----SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       196 ~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      ...     ........++..|+|||.+.+..++.++||||||+++|+|++|..||.........        .... .  
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~--------~~~~-~--  222 (265)
T cd06631         154 WVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM--------FYIG-A--  222 (265)
T ss_pred             hccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH--------HHhh-h--
Confidence            211     11122345889999999999888999999999999999999999999653221000        0000 0  


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                         ........+...+..+.++|.+||..+|.+||++.++++|.+
T Consensus       223 ---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~  264 (265)
T cd06631         223 ---HRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDF  264 (265)
T ss_pred             ---ccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence               000111223345578899999999999999999999998754

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.7e-41  Score=306.32  Aligned_cols=255  Identities=27%  Similarity=0.369  Sum_probs=197.9

Q ss_pred             CCCcceeccCCceEEEEEEeCC-Cc--EEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecC------Ce
Q 037869           43 FSDDNKLGEGGFGSVYWGRTSD-GL--QIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT------DQ  111 (380)
Q Consensus        43 y~~~~~Lg~G~~g~Vy~~~~~~-~~--~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~  111 (380)
                      |.+.+.||+|+||.||+|.+.. +.  .||+|.++..  .......+..|+.+++.++|+||+++++++...      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4578899999999999998643 32  6899988743  344456788899999999999999999987432      24


Q ss_pred             EEEEEEecCCCCHHHhhccCC--CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeecc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQY--AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG  189 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~--~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfg  189 (380)
                      .+++|||+.+|+|.+++....  .....+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCC
Confidence            689999999999998874321  1234589999999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCccc-eeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhcc
Q 037869          190 FAKLIPEGVSHM-TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKG  267 (380)
Q Consensus       190 l~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~  267 (380)
                      ++..+....... .....+++.|+|||.+.+..++.++|||||||++|+|++ |..||.......   .   ... ...+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~---~~~-~~~~  230 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE---I---YDY-LRQG  230 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---H---HHH-HHcC
Confidence            998764332111 122235778999999999999999999999999999999 788986532210   0   000 0000


Q ss_pred             ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                               .....+...+..+.++|.+||+.||++|||+.+|+++|..
T Consensus       231 ---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~  270 (272)
T cd05075         231 ---------NRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEK  270 (272)
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence                     0111223345678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3e-41  Score=305.69  Aligned_cols=253  Identities=24%  Similarity=0.312  Sum_probs=209.2

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ...|+..+.||.|+||.||+|.+ .++..||+|.+.... ......+.+|+.+++.+.||||+++++++..+...++|||
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            35688899999999999999987 468899999987533 3445678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+++++|.+++..     .++++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06640          83 YLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             cCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence            9999999999864     3588889999999999999999998   9999999999999999999999999999776432


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      .. ......++..|+|||.+.+..++.++|+|||||++|+|++|..||.........                .......
T Consensus       155 ~~-~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----------------~~~~~~~  217 (277)
T cd06640         155 QI-KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL----------------FLIPKNN  217 (277)
T ss_pred             cc-ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh----------------hhhhcCC
Confidence            21 222345788999999999888999999999999999999999999753321000                0011111


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ........+..+.+++.+||+.+|.+||++.+++.|.+..
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  257 (277)
T cd06640         218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIV  257 (277)
T ss_pred             CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhh
Confidence            2234455678899999999999999999999999996644

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.1e-42  Score=319.35  Aligned_cols=267  Identities=21%  Similarity=0.279  Sum_probs=201.2

Q ss_pred             HHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecC---
Q 037869           36 LHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT---  109 (380)
Q Consensus        36 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---  109 (380)
                      .....++|++.+.||.|+||+||+|.+ .++..||||++....  ......+.+|+.+++.++||||+++++++...   
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (343)
T cd07878          10 VWEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI   89 (343)
T ss_pred             HhhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence            334678999999999999999999986 568899999987532  22334577899999999999999999987543   


Q ss_pred             ---CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEe
Q 037869          110 ---DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVA  186 (380)
Q Consensus       110 ---~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~  186 (380)
                         ...|++++++ +++|.+++..     ..+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+
T Consensus        90 ~~~~~~~~~~~~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~  160 (343)
T cd07878          90 ENFNEVYLVTNLM-GADLNNIVKC-----QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRIL  160 (343)
T ss_pred             cccCcEEEEeecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEc
Confidence               3478999998 7799888753     3689999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccCCCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchh---
Q 037869          187 DFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEP---  262 (380)
Q Consensus       187 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~---  262 (380)
                      |||++......    .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||......  .....+...   
T Consensus       161 Dfg~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~~~~  234 (343)
T cd07878         161 DFGLARQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYI--DQLKRIMEVVGT  234 (343)
T ss_pred             CCccceecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCC
Confidence            99999875432    233468999999999876 56899999999999999999999999653211  000000000   


Q ss_pred             ---hhh----ccccccccC--CcccC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          263 ---LIV----KGKFKELVD--PKLRG----DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       263 ---~~~----~~~~~~~~~--~~~~~----~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                         ...    .........  +....    .........+.+|+.+||..||.+|||+.++++|.+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~  302 (343)
T cd07878         235 PSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFS  302 (343)
T ss_pred             CCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchh
Confidence               000    000000000  00000    00011234678999999999999999999999997654

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.2e-41  Score=309.54  Aligned_cols=255  Identities=26%  Similarity=0.337  Sum_probs=204.0

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      .|++.+.||+|+||+||+|.+ .+++.||+|.+....   ......+.+|+.+++.++|+||+++++.+..++..++|||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            477889999999999999987 568899999987532   2223457789999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+.+++|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  155 (285)
T cd05632          81 IMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG  155 (285)
T ss_pred             eccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCC
Confidence            99999999888643  234699999999999999999999998   9999999999999999999999999999765432


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      .  ......|+..|+|||++.+..++.++|+||+||++|+|++|..||........  ...+      ......     .
T Consensus       156 ~--~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~--~~~~------~~~~~~-----~  220 (285)
T cd05632         156 E--SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK--REEV------DRRVLE-----T  220 (285)
T ss_pred             C--cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH--HHHH------HHhhhc-----c
Confidence            1  22334689999999999988999999999999999999999999975322100  0000      000000     0


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHhcC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPN-----MKEVVNTLTG  316 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps-----~~~ll~~l~~  316 (380)
                      ...++...+..+.+|+.+||+.||.+||+     +.+++.|.+.
T Consensus       221 ~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~  264 (285)
T cd05632         221 EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFF  264 (285)
T ss_pred             ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhh
Confidence            01122334567889999999999999999     8899988543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8.1e-42  Score=309.89  Aligned_cols=261  Identities=25%  Similarity=0.380  Sum_probs=207.6

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeCC-----CcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEec-CC
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTSD-----GLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG-TD  110 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~  110 (380)
                      ...++|++.+.||+|+||.||+|.+..     +..|++|.++.. .......+.+|+.+++.++|+||+++++++.. ..
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   82 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE   82 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            356789999999999999999998754     688999998753 33445568889999999999999999998765 46


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCC----CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEe
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAG----EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVA  186 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~----~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~  186 (380)
                      ..+++++|+++++|.+++......    ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+
T Consensus        83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~  159 (280)
T cd05043          83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKIT  159 (280)
T ss_pred             CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEEC
Confidence            789999999999999998654322    14689999999999999999999998   99999999999999999999999


Q ss_pred             eccCccccCCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhh
Q 037869          187 DFGFAKLIPEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLI  264 (380)
Q Consensus       187 Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~  264 (380)
                      |||+++.+...... ......++..|+|||++.+..++.++|||||||++|++++ |..||......   ....      
T Consensus       160 d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~------  230 (280)
T cd05043         160 DNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPF---EMAA------  230 (280)
T ss_pred             CCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHH---HHHH------
Confidence            99999866432211 1122335678999999998889999999999999999999 99999653211   0000      


Q ss_pred             hccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          265 VKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                             ..........+..++.++.+++.+||..+|++|||+.++++.|..+
T Consensus       231 -------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~  276 (280)
T cd05043         231 -------YLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDF  276 (280)
T ss_pred             -------HHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                   0001111112233457889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-41  Score=319.37  Aligned_cols=264  Identities=20%  Similarity=0.261  Sum_probs=196.8

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      .....|++.+.||+|+||.||+|.+ .++..||+|+....      ....|+.++++++||||+++++++......++||
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  136 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL  136 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence            3456899999999999999999987 45788999975432      2346899999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      |++. ++|.+++...   ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.++|+|||++.....
T Consensus       137 e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~  209 (357)
T PHA03209        137 PHYS-SDLYTYLTKR---SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV  209 (357)
T ss_pred             EccC-CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence            9995 5888888643   34689999999999999999999999   999999999999999999999999999975322


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCc-ccch----hccchhhhh----cc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGV-KRTI----TEWAEPLIV----KG  267 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~----~~~~~~~~~----~~  267 (380)
                      .  .......||..|+|||++.+..++.++|||||||++|||+++..|+....... ....    ..+......    ..
T Consensus       210 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  287 (357)
T PHA03209        210 A--PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPE  287 (357)
T ss_pred             C--cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChh
Confidence            1  12233568999999999999999999999999999999998655543222111 0000    000000000    00


Q ss_pred             ccc---------cccC--CcccCCC-------CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          268 KFK---------ELVD--PKLRGDF-------DENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       268 ~~~---------~~~~--~~~~~~~-------~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .+.         ....  ...+...       ....+.++.+||.+||+.||.+|||+.++++|.+.
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f  354 (357)
T PHA03209        288 EFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF  354 (357)
T ss_pred             hcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchh
Confidence            000         0000  0000000       01234567789999999999999999999999764

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-41  Score=305.67  Aligned_cols=251  Identities=25%  Similarity=0.396  Sum_probs=204.0

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChh---------hHHHHHHHHHHHhcCCCCcceeEeeEEecCCe
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSK---------AEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQ  111 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~---------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  111 (380)
                      +|++...||.|++|.||+|.+ .++..||+|.+......         ....+.+|+.+++.++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            588899999999999999987 46889999988643221         12457789999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA  191 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~  191 (380)
                      .++||||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~  153 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGIS  153 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCC
Confidence            99999999999999999653    4688899999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCc-----cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhc
Q 037869          192 KLIPEGVS-----HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVK  266 (380)
Q Consensus       192 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  266 (380)
                      ........     .......|+..|+|||.+.+..++.++|+||+||++|+|++|..||.......  ..          
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~----------  221 (267)
T cd06628         154 KKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ--AI----------  221 (267)
T ss_pred             cccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH--HH----------
Confidence            87642211     11122457889999999998889999999999999999999999997532210  00          


Q ss_pred             cccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                         .... .......+...+..+.++|.+||+.||.+||++.+++++.+
T Consensus       222 ---~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  266 (267)
T cd06628         222 ---FKIG-ENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPF  266 (267)
T ss_pred             ---HHHh-ccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCC
Confidence               0000 01122233445678899999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.4e-41  Score=302.73  Aligned_cols=252  Identities=23%  Similarity=0.337  Sum_probs=204.1

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEec-CCeEEEEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG-TDQRLIVYD  117 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e  117 (380)
                      .|++.+.||+|++|.||++.+ .+++.||+|.+...  .......+.+|+.+++.++|+|++++++.+.. +..++++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            589999999999999999987 45788999998643  23344568889999999999999999998764 446899999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+++++|.+++...  ....+++..++.++.|++.||++||+.   +++||||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~  155 (257)
T cd08223          81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ  155 (257)
T ss_pred             ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEeccc
Confidence            99999999999753  234689999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      . .......+++.|+|||++.+..++.++||||+|+++++|++|..||......      ..... ..         ...
T Consensus       156 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~~~-~~---------~~~  218 (257)
T cd08223         156 C-DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLVYR-II---------EGK  218 (257)
T ss_pred             C-CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHHHH-HH---------hcC
Confidence            2 2223345789999999999989999999999999999999999998643210      00000 00         011


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ....+...+..+.+++.+||+.+|.+|||+.++++|.+
T Consensus       219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~  256 (257)
T cd08223         219 LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPY  256 (257)
T ss_pred             CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCC
Confidence            11233455678999999999999999999999999854

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2e-41  Score=314.24  Aligned_cols=267  Identities=17%  Similarity=0.234  Sum_probs=199.2

Q ss_pred             CcceeccC--CceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEec
Q 037869           45 DDNKLGEG--GFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYM  119 (380)
Q Consensus        45 ~~~~Lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  119 (380)
                      ++++||+|  +|++||++.+ .+|+.||+|++....  ......+.+|+.+++.++||||+++++++..++..++||||+
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~   81 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM   81 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence            56789999  7889999986 578999999997532  333456778999999999999999999999999999999999


Q ss_pred             CCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc
Q 037869          120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS  199 (380)
Q Consensus       120 ~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~  199 (380)
                      ++|+|.+++....  ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++++||+..........
T Consensus        82 ~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~  156 (327)
T cd08227          82 AYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQ  156 (327)
T ss_pred             CCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccc
Confidence            9999999996532  23588999999999999999999999   999999999999999999999999987544321111


Q ss_pred             c------ceeccccccCccCcccccc--CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhh--------
Q 037869          200 H------MTTRVKGTLGYLAPEYAMW--GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL--------  263 (380)
Q Consensus       200 ~------~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~--------  263 (380)
                      .      ......++..|+|||++.+  ..++.++|||||||++|+|++|..||......... ........        
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~  235 (327)
T cd08227         157 RLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML-LEKLNGTVPCLLDTTT  235 (327)
T ss_pred             cccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH-HHHhcCCccccccccc
Confidence            0      1112346778999999975  46899999999999999999999999753321100 00000000        


Q ss_pred             hhccc-------------c---------ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          264 IVKGK-------------F---------KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       264 ~~~~~-------------~---------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .....             +         ................+..+.+|+.+||+.||++|||+.++++|.+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~  311 (327)
T cd08227         236 IPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  311 (327)
T ss_pred             hhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhh
Confidence            00000             0         000000001112234456899999999999999999999999997753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.4e-41  Score=309.08  Aligned_cols=269  Identities=25%  Similarity=0.394  Sum_probs=203.2

Q ss_pred             CCCCCcceeccCCceEEEEEEe-----CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecC--CeE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-----SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT--DQR  112 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  112 (380)
                      .-|++.+.||+|+||.||++..     .++..||+|.++... ......+.+|+.+++.++||||+++++++...  ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            4578999999999999999973     357889999987543 33445788999999999999999999998775  568


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      ++||||++|++|.+++...   ...+++..++.++.|++.||+|||++   |++||||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             EEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCcccc
Confidence            9999999999999998643   23589999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcc--ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          193 LIPEGVSH--MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       193 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      ........  ......++..|+|||.+.+..++.++|||||||++|+|+++..|+..................... ...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~  236 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT-RLV  236 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH-HHH
Confidence            76432211  112344677899999999888999999999999999999987765321110000000000000000 000


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ...........+..++..+.+|+.+||+.+|.+|||+.++++.+..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~  282 (284)
T cd05079         237 RVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA  282 (284)
T ss_pred             HHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHh
Confidence            0001111112233456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.6e-41  Score=303.75  Aligned_cols=252  Identities=25%  Similarity=0.449  Sum_probs=202.4

Q ss_pred             hCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEec
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYM  119 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  119 (380)
                      ...|++.+.||.|+||.||+|.+..+..+++|.+..... ....+.+|+++++.++||||+++++++......++||||+
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcC
Confidence            357888999999999999999886678899999875332 2347888999999999999999999999999999999999


Q ss_pred             CCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc
Q 037869          120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS  199 (380)
Q Consensus       120 ~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~  199 (380)
                      ++++|.+++...   ...+++..++.++.|++.||++||+.   +++||||+|+||+++.++.++|+|||++........
T Consensus        82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~  155 (256)
T cd05112          82 EHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY  155 (256)
T ss_pred             CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence            999999998643   24688999999999999999999999   999999999999999999999999999876543222


Q ss_pred             cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          200 HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       200 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      .......++..|+|||.+.+..++.++||||||+++|+|++ |..||......      ......          .....
T Consensus       156 ~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~~~~~----------~~~~~  219 (256)
T cd05112         156 TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS------EVVETI----------NAGFR  219 (256)
T ss_pred             cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH------HHHHHH----------hCCCC
Confidence            11122234678999999998889999999999999999998 89998643210      000000          00001


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL  314 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l  314 (380)
                      ...+...+..+.+|+.+||+.+|.+|||+.++++.|
T Consensus       220 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         220 LYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            111122347899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.4e-41  Score=312.18  Aligned_cols=261  Identities=28%  Similarity=0.417  Sum_probs=207.0

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe--------CCCcEEEEEEeccc-ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEe
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT--------SDGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCA  107 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~--------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  107 (380)
                      ....+|++.+.||+|+||.||+|+.        .++..||+|.+... .......+.+|+.+++.+ +||||+++++++.
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   91 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT   91 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe
Confidence            4567899999999999999999963        12457999998753 234456788999999999 8999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHhhccCCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCe
Q 037869          108 GTDQRLIVYDYMPNLSLLSHLHGQYA------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNV  175 (380)
Q Consensus       108 ~~~~~~lv~e~~~~g~L~~~i~~~~~------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Ni  175 (380)
                      .....++||||+++|+|.+++.....            ....+++..+..++.|++.||+|||++   |++||||||+||
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Ni  168 (304)
T cd05101          92 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNV  168 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceE
Confidence            99999999999999999999975421            123578889999999999999999999   999999999999


Q ss_pred             eeCCCCceEEeeccCccccCCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcc
Q 037869          176 LLDSDFEPLVADFGFAKLIPEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVK  253 (380)
Q Consensus       176 ll~~~~~vkl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~  253 (380)
                      +++.++.++|+|||+++........ ......++..|+|||++.+..++.++||||||+++|+|++ |..||...+..  
T Consensus       169 li~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--  246 (304)
T cd05101         169 LVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--  246 (304)
T ss_pred             EEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--
Confidence            9999999999999999876432211 1222235678999999998889999999999999999998 78888643210  


Q ss_pred             cchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          254 RTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                          .+..          ..........+..++..+.+++.+||+.+|.+|||+.++++.|..+
T Consensus       247 ----~~~~----------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~  296 (304)
T cd05101         247 ----ELFK----------LLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI  296 (304)
T ss_pred             ----HHHH----------HHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence                0000          0111111122334567899999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.2e-41  Score=312.26  Aligned_cols=260  Identities=27%  Similarity=0.425  Sum_probs=206.7

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEe------CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcC-CCCcceeEeeEEec
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRT------SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAG  108 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  108 (380)
                      ....++|.+.+.||+|+||.||++.+      ..+..||+|.++... ......+.+|+.+++++ +||||+++++++..
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            34556899999999999999999964      235579999987543 33345788899999999 79999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          109 TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       109 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                      .+..++||||+.+|+|.+++....  ...+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+||
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~df  185 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDF  185 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCC
Confidence            999999999999999999997532  23489999999999999999999998   9999999999999999999999999


Q ss_pred             cCccccCCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhc
Q 037869          189 GFAKLIPEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVK  266 (380)
Q Consensus       189 gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~  266 (380)
                      |++......... ......++..|+|||.+.+..++.++||||+||++|+|++ |..||........  .          
T Consensus       186 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~----------  253 (302)
T cd05055         186 GLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--F----------  253 (302)
T ss_pred             cccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--H----------
Confidence            999865432211 1122335778999999998899999999999999999998 9999865432110  0          


Q ss_pred             cccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                         ............+...+..+.+++.+||..+|++|||+.+++..|..
T Consensus       254 ---~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~  300 (302)
T cd05055         254 ---YKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGK  300 (302)
T ss_pred             ---HHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHh
Confidence               00111111111222334689999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-42  Score=318.64  Aligned_cols=264  Identities=25%  Similarity=0.407  Sum_probs=216.9

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhH-HHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAE-MEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      +.....+.++||+|.||.|.++....+.+||||.++....+.. ..|..|+++|.+++||||++++++|..++.+++|+|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~E  615 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITE  615 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHH
Confidence            6678899999999999999999887779999999997665554 689999999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |++.|+|..++.......  +......+++.||+.|++||.+.   ++|||||.++|||++.++++||+|||+++.+-.+
T Consensus       616 YmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccC
Confidence            999999999998763322  45566678999999999999999   9999999999999999999999999999965443


Q ss_pred             Ccc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh--CCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          198 VSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT--GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       198 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      ... .....+-..+|+|||.+.-++++.+||+|+||+++||+++  ...||.......  ..       ...+.+..--.
T Consensus       691 ~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~--vv-------en~~~~~~~~~  761 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ--VV-------ENAGEFFRDQG  761 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH--HH-------HhhhhhcCCCC
Confidence            333 2334456889999999999999999999999999999876  788987654311  00       01111111112


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .......|.-++..+.+++.+||+.+.++|||+++|..+|..
T Consensus       762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence            223334566777899999999999999999999999998753

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.2e-41  Score=310.13  Aligned_cols=261  Identities=26%  Similarity=0.398  Sum_probs=204.4

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeC------CCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTS------DGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD  110 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  110 (380)
                      ...++|++.+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+.+++.++||||+++++++....
T Consensus         3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            45689999999999999999998642      24579999887433 233446778999999999999999999999889


Q ss_pred             eEEEEEEecCCCCHHHhhccCCC------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceE
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYA------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL  184 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vk  184 (380)
                      ..++||||+++|+|.+++.....      .....++..++.++.|++.||.|||++   +++||||||+||+++.++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEE
Confidence            99999999999999999965311      123457788899999999999999999   999999999999999999999


Q ss_pred             EeeccCccccCCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchh
Q 037869          185 VADFGFAKLIPEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP  262 (380)
Q Consensus       185 l~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~  262 (380)
                      |+|||+++........ ......++..|+|||.+.+..++.++|||||||++|||++ |..||......      .....
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~------~~~~~  233 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE------QVLKF  233 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH------HHHHH
Confidence            9999998865332211 1122235678999999998899999999999999999998 78888653211      00000


Q ss_pred             hhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                       ...+         .....+...+..+.+++.+||+.||++|||+.++++.+...
T Consensus       234 -~~~~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~  278 (288)
T cd05061         234 -VMDG---------GYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD  278 (288)
T ss_pred             -HHcC---------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence             0000         01112223357899999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.7e-41  Score=307.59  Aligned_cols=256  Identities=26%  Similarity=0.417  Sum_probs=202.9

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCc----EEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGL----QIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  112 (380)
                      ...+|++.+.||+|+||+||+|.+ .+++    .||+|+++.. .......+.+|+.++..++||||+++++++.. ...
T Consensus         5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~   83 (279)
T cd05109           5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV   83 (279)
T ss_pred             chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence            456889999999999999999975 3444    4899998753 33345578889999999999999999999875 457


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      ++++||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+|||+++
T Consensus        84 ~l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~  157 (279)
T cd05109          84 QLVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLAR  157 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCcee
Confidence            8999999999999998643   34689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCccc-eeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          193 LIPEGVSHM-TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       193 ~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      ......... .....++..|+|||.+.+..++.++|||||||++|||++ |..||......   ....            
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~------------  222 (279)
T cd05109         158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR---EIPD------------  222 (279)
T ss_pred             ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH------------
Confidence            764322211 111234678999999998899999999999999999998 88998653211   0000            


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                       ..........+...+.++.+++.+||+.||+.||++.++++.+...
T Consensus       223 -~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~  268 (279)
T cd05109         223 -LLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRM  268 (279)
T ss_pred             -HHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence             0111111122233457889999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.7e-41  Score=312.87  Aligned_cols=262  Identities=29%  Similarity=0.419  Sum_probs=206.0

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEeC--------CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcC-CCCcceeEeeEE
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRTS--------DGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYC  106 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~  106 (380)
                      .....+|++.+.||+|+||.||+|.+.        ....||+|.++.. .......+..|+.+++.+ +||||+++++++
T Consensus         8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099           8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            345678999999999999999999642        2456899998753 234455688899999999 699999999999


Q ss_pred             ecCCeEEEEEEecCCCCHHHhhccCCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 037869          107 AGTDQRLIVYDYMPNLSLLSHLHGQYA------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASN  174 (380)
Q Consensus       107 ~~~~~~~lv~e~~~~g~L~~~i~~~~~------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~N  174 (380)
                      ......++||||+++|+|.+++.....            ....+++..+..++.|++.||.|||++   |++||||||+|
T Consensus        88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~N  164 (314)
T cd05099          88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARN  164 (314)
T ss_pred             ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeecccccee
Confidence            988899999999999999999965321            234588999999999999999999998   99999999999


Q ss_pred             eeeCCCCceEEeeccCccccCCCCccc-eeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCc
Q 037869          175 VLLDSDFEPLVADFGFAKLIPEGVSHM-TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGV  252 (380)
Q Consensus       175 ill~~~~~vkl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~  252 (380)
                      |+++.++.++|+|||+++......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||...+...
T Consensus       165 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         165 VLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             EEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999998664321111 111223467999999998899999999999999999999 888886533210


Q ss_pred             ccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          253 KRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                         .   ..          ..........+..++.++.+++.+||+.+|++|||+.++++.|...
T Consensus       245 ---~---~~----------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         245 ---L---FK----------LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             ---H---HH----------HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence               0   00          0001111122334456888999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.4e-41  Score=329.73  Aligned_cols=271  Identities=21%  Similarity=0.276  Sum_probs=196.1

Q ss_pred             HHHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCC------CCcceeEeeEE
Q 037869           34 KELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR------HKNLLGLRGYC  106 (380)
Q Consensus        34 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~~~~~~  106 (380)
                      +++....++|++.+.||+|+||+||+|.+ .+++.||||+++... ........|+.++..++      |.+++++++++
T Consensus       122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~  200 (467)
T PTZ00284        122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF  200 (467)
T ss_pred             CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence            33444568999999999999999999987 468889999997532 22234455666666554      45688999988


Q ss_pred             ecC-CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCCCC---
Q 037869          107 AGT-DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH-EVTPHIIHRDIKASNVLLDSDF---  181 (380)
Q Consensus       107 ~~~-~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~-~~~~~ivHrdlkp~Nill~~~~---  181 (380)
                      ... ...++|||++ |++|.+++...    ..+++..+..++.||+.||.|||+ .   ||+||||||+|||++.++   
T Consensus       201 ~~~~~~~~iv~~~~-g~~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~  272 (467)
T PTZ00284        201 QNETGHMCIVMPKY-GPCLLDWIMKH----GPFSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVV  272 (467)
T ss_pred             EcCCceEEEEEecc-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCccc
Confidence            754 5788999988 67898888643    468999999999999999999997 6   999999999999998765   


Q ss_pred             -------------ceEEeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCC
Q 037869          182 -------------EPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKL  248 (380)
Q Consensus       182 -------------~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  248 (380)
                                   .+||+|||++.....    ......||+.|+|||++.+..|+.++|||||||++|||++|..||...
T Consensus       273 ~~~~~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~  348 (467)
T PTZ00284        273 DPVTNRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTH  348 (467)
T ss_pred             ccccccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                         499999998864322    233457899999999999999999999999999999999999999754


Q ss_pred             CCCcccch---------hccchh---------hhhccccccccCCcc-------cCCCCHHHHHHHHHHHHhhcCCCCCC
Q 037869          249 PGGVKRTI---------TEWAEP---------LIVKGKFKELVDPKL-------RGDFDENQLKQAINVAVLCVQSEPEK  303 (380)
Q Consensus       249 ~~~~~~~~---------~~~~~~---------~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~cl~~~P~~  303 (380)
                      ........         ..|...         ....+.+.....+..       ...........+.+||.+||+.||.+
T Consensus       349 ~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~  428 (467)
T PTZ00284        349 DNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQK  428 (467)
T ss_pred             ChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhh
Confidence            32110000         000000         000000000000000       00000011356789999999999999


Q ss_pred             CCCHHHHHHHhcCC
Q 037869          304 RPNMKEVVNTLTGY  317 (380)
Q Consensus       304 Rps~~~ll~~l~~~  317 (380)
                      |||+.|+++|.+..
T Consensus       429 R~ta~e~L~Hp~~~  442 (467)
T PTZ00284        429 RLNARQMTTHPYVL  442 (467)
T ss_pred             CCCHHHHhcCcccc
Confidence            99999999997754

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2e-41  Score=309.08  Aligned_cols=267  Identities=24%  Similarity=0.346  Sum_probs=209.5

Q ss_pred             eccHHHHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcC-CCCcceeEeeEEe
Q 037869           30 IFTYKELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCA  107 (380)
Q Consensus        30 ~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  107 (380)
                      .+++.++..+.++|.+.+.||+|+||.||++.+ .+++.||+|++..... ....+.+|+.+++++ +|||++++++++.
T Consensus        11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~   89 (291)
T cd06639          11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFY   89 (291)
T ss_pred             hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence            355667777889999999999999999999987 5688999999875432 234677899999998 7999999999986


Q ss_pred             cC-----CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc
Q 037869          108 GT-----DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE  182 (380)
Q Consensus       108 ~~-----~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~  182 (380)
                      ..     ...++||||+++++|.+++.........+++..++.++.|++.||.|||+.   +++||||||+||+++.++.
T Consensus        90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~  166 (291)
T cd06639          90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGG  166 (291)
T ss_pred             eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCC
Confidence            53     358999999999999998865433445789999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccCccccCCCCccceeccccccCccCccccccC-----CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchh
Q 037869          183 PLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG-----KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTIT  257 (380)
Q Consensus       183 vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~  257 (380)
                      ++|+|||++........ ......|+..|+|||.+...     .++.++|||||||++|+|++|..||.......  ...
T Consensus       167 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~--~~~  243 (291)
T cd06639         167 VKLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK--TLF  243 (291)
T ss_pred             EEEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH--HHH
Confidence            99999999887543221 12234578999999987643     36899999999999999999999996532210  000


Q ss_pred             ccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          258 EWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .+     ....     .+..  ..+......+.++|.+||+.+|++||++.++++|.+
T Consensus       244 ~~-----~~~~-----~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~  289 (291)
T cd06639         244 KI-----PRNP-----PPTL--LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF  289 (291)
T ss_pred             HH-----hcCC-----CCCC--CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcc
Confidence            00     0000     0000  112234467899999999999999999999999864

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.1e-41  Score=308.58  Aligned_cols=251  Identities=25%  Similarity=0.329  Sum_probs=205.2

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      .+.|++.+.||+|+||.||+|.+ .++..||+|.+.... ......+.+|+.+++.++||||+++++++......++|||
T Consensus         3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            34577888999999999999986 467889999987433 3344578889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+++++|.+++..     ..+++..+..++.|++.|+.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  154 (277)
T cd06642          83 YLGGGSALDLLKP-----GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT  154 (277)
T ss_pred             ccCCCcHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence            9999999998853     3688999999999999999999998   9999999999999999999999999999776432


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      .. ......++..|+|||.+.+..++.++|||||||++|+|++|..||.........                .......
T Consensus       155 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----------------~~~~~~~  217 (277)
T cd06642         155 QI-KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVL----------------FLIPKNS  217 (277)
T ss_pred             ch-hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHH----------------hhhhcCC
Confidence            21 122345788999999999888999999999999999999999998653221100                0000111


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ........+..+.+++.+||+.+|.+||++.++++|.+
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  255 (277)
T cd06642         218 PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKF  255 (277)
T ss_pred             CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHH
Confidence            11223344577899999999999999999999999865

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.5e-41  Score=304.61  Aligned_cols=255  Identities=26%  Similarity=0.442  Sum_probs=204.0

Q ss_pred             hCCCCCcceeccCCceEEEEEEeC-C---CcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTS-D---GLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      ..+|++.+.||+|+||.||+|.+. +   +..||+|.++... ......+.+|+.++++++||||+++++++..++..++
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            457899999999999999999763 2   3479999987532 3345578889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ||||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++...
T Consensus        83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~  156 (267)
T cd05066          83 VTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVL  156 (267)
T ss_pred             EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence            99999999999999653   24689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCcccee--ccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          195 PEGVSHMTT--RVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       195 ~~~~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      .........  ...++..|+|||.+.+..++.++|+|||||++|++++ |..||.......  ....          +. 
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~--~~~~----------~~-  223 (267)
T cd05066         157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD--VIKA----------IE-  223 (267)
T ss_pred             ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH--HHHH----------Hh-
Confidence            543221111  1223567999999998889999999999999999887 999986543210  0000          00 


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                         .......+...+..+.+++.+||+.+|.+||++.++++.|..
T Consensus       224 ---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  265 (267)
T cd05066         224 ---EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDK  265 (267)
T ss_pred             ---CCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHh
Confidence               001112223345788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.3e-41  Score=307.90  Aligned_cols=257  Identities=21%  Similarity=0.339  Sum_probs=206.2

Q ss_pred             CCCCCcceeccCCceEEEEEEeC-CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ++|++.+.||+|+||.||++.+. ++..||+|.++.. .......+.+|+.++++++||||+++++.+...+..++||||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY   80 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence            46889999999999999999874 7899999998753 334456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH-EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~-~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      +++++|..++... .....+++..+..++.|++.||.|||+ .   +++||||+|+||+++.++.++|+|||++..+...
T Consensus        81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          81 MDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEH---NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             cCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcC---CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            9999999888653 123478999999999999999999996 5   8999999999999999999999999998765332


Q ss_pred             CccceeccccccCccCccccccC------CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWG------KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                         ......++..|+|||.+.+.      .++.++|||||||++|+|++|..||.......  ...          .+..
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~----------~~~~  221 (286)
T cd06622         157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN--IFA----------QLSA  221 (286)
T ss_pred             ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh--HHH----------HHHH
Confidence               12233578899999998643      35889999999999999999999996432100  000          0000


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .. .......+...+.++.++|.+||+.+|.+||++.++++|.+..
T Consensus       222 ~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~  266 (286)
T cd06622         222 IV-DGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLV  266 (286)
T ss_pred             Hh-hcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhh
Confidence            00 1111223444668899999999999999999999999997643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5e-41  Score=302.44  Aligned_cols=252  Identities=25%  Similarity=0.356  Sum_probs=200.8

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-----hhhHHHHHHHHHHHhcCCCCcceeEeeEEec--CCeE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-----SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG--TDQR  112 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~  112 (380)
                      ..|++.+.||+|+||.||+|.+ .++..|++|++....     ......+.+|+.+++.++||||+++++++..  ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4789999999999999999987 468899999886422     2233467889999999999999999998865  3678


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      ++++||+++++|.+++...    ..+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++.
T Consensus        82 ~l~~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~  154 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCcc
Confidence            9999999999999999643    3588999999999999999999998   99999999999999999999999999987


Q ss_pred             ccCCCCc--cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          193 LIPEGVS--HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       193 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      .......  .......++..|+|||.+.+..++.++||||+||++|+|++|..||.......               .+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~---------------~~~  219 (266)
T cd06651         155 RLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA---------------AIF  219 (266)
T ss_pred             ccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH---------------HHH
Confidence            6532111  11122457889999999998889999999999999999999999997532100               000


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ...........+...+..+.+++ +||..+|++||++++|++|.+
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~  263 (266)
T cd06651         220 KIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPF  263 (266)
T ss_pred             HHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcc
Confidence            11111112233444556778888 688899999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=3.2e-41  Score=302.87  Aligned_cols=253  Identities=21%  Similarity=0.317  Sum_probs=207.4

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEecc--cChhhHHHHHHHHHHHhcCCCCcceeEeeEEec--CCeEEEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKA--MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG--TDQRLIVY  116 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  116 (380)
                      +|++.+.||.|+||.||+|.+ .++..||+|.+..  ........+..|+.+++.++||||+++++.+..  ....+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            588999999999999999986 5688999999864  334445578889999999999999999998754  45689999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHh-----hcCCCCeEecCCCCCCeeeCCCCceEEeeccCc
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH-----HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA  191 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH-----~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~  191 (380)
                      ||+++++|.+++.........+++..++.++.|++.||.|||     +.   +++|+||+|+||+++.++.++|+|||++
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~~~~~~kl~d~g~~  157 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLDANNNVKLGDFGLA  157 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEecCCCEEEeccccc
Confidence            999999999999765444567999999999999999999999     66   9999999999999999999999999999


Q ss_pred             cccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          192 KLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       192 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      ........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.....   ....             .
T Consensus       158 ~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~-------------~  220 (265)
T cd08217         158 KILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLA-------------S  220 (265)
T ss_pred             ccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHH-------------H
Confidence            87654322 12234589999999999988899999999999999999999999975331   0000             0


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL  314 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l  314 (380)
                      ..........+...+..+.+++.+||+.+|.+||++.+|++|.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~  263 (265)
T cd08217         221 KIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLP  263 (265)
T ss_pred             HHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCC
Confidence            1111112233445567899999999999999999999999984

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.3e-41  Score=307.20  Aligned_cols=262  Identities=23%  Similarity=0.306  Sum_probs=206.8

Q ss_pred             cHHHHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcC-CCCcceeEeeEEec-
Q 037869           32 TYKELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAG-  108 (380)
Q Consensus        32 ~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-  108 (380)
                      +..+...+.+.|++.+.||.|+||.||+|.+ .+++.||+|++.... .....+..|+.+++.+ +|+||+++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            4455666788999999999999999999987 568899999986543 3344678899999998 69999999999853 


Q ss_pred             -----CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCce
Q 037869          109 -----TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEP  183 (380)
Q Consensus       109 -----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~v  183 (380)
                           ....+++|||+++|+|.+++....  ...+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.+
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~  160 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEV  160 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCE
Confidence                 457899999999999999986532  24578888999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccCCCCccceeccccccCccCccccc-----cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhc
Q 037869          184 LVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-----WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITE  258 (380)
Q Consensus       184 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~  258 (380)
                      +|+|||++........ ......|+..|+|||.+.     ...++.++|||||||++|+|++|..||........  .. 
T Consensus       161 ~l~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~--~~-  236 (282)
T cd06636         161 KLVDFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA--LF-  236 (282)
T ss_pred             EEeeCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh--hh-
Confidence            9999999876532211 223345889999999886     34688899999999999999999999965321100  00 


Q ss_pred             cchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          259 WAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                                  ..............++..+.++|.+||+.||.+|||+.+|++|.+
T Consensus       237 ------------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~  281 (282)
T cd06636         237 ------------LIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPF  281 (282)
T ss_pred             ------------hHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCC
Confidence                        000011111112234578999999999999999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.8e-41  Score=303.43  Aligned_cols=255  Identities=25%  Similarity=0.476  Sum_probs=203.9

Q ss_pred             hCCCCCcceeccCCceEEEEEEeC-CC---cEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTS-DG---LQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      .+.|+..+.||+|+||.||+|... ++   ..+++|.++.. .......+.+|+.+++.++||||+++++++...+..++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            457888999999999999999863 33   36899998754 33445678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ||||+++++|.+++...   ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++...
T Consensus        84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~  157 (268)
T cd05063          84 ITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVL  157 (268)
T ss_pred             EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceec
Confidence            99999999999998643   34689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCccceec--cccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          195 PEGVSHMTTR--VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       195 ~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      ..........  ...+..|+|||++.+..++.++|||||||++|+|++ |..||......  ..    ...         
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~----~~~---------  222 (268)
T cd05063         158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EV----MKA---------  222 (268)
T ss_pred             ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HH----HHH---------
Confidence            4322211111  123457999999998889999999999999999997 99999653210  00    000         


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                       .........+...+..+.+++.+||+.+|.+||++.++++.|..
T Consensus       223 -i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~  266 (268)
T cd05063         223 -INDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDK  266 (268)
T ss_pred             -HhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHh
Confidence             00111112223345788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-42  Score=321.06  Aligned_cols=264  Identities=27%  Similarity=0.391  Sum_probs=231.4

Q ss_pred             HHHHHhhCCCCCcceeccCCceEEEEEEeCC-CcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeE
Q 037869           34 KELHTATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        34 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  112 (380)
                      +++.-.....+...+||-|.||.||.|.++. .-.||||.++... ....+|+.|..+|+.++|||+|+++|+|.....+
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt-MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF  338 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF  338 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc-hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence            5666677788889999999999999999854 6679999998643 4566999999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      |||+|||..|+|.++++.+  .+..++.-..+.++.||..|++||..+   ++|||||..+|+||.++..||++||||++
T Consensus       339 YIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsR  413 (1157)
T KOG4278|consen  339 YIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSR  413 (1157)
T ss_pred             EEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhh
Confidence            9999999999999999875  345678888899999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      .+............-.+.|.|||-+....++.|+|||+||++|||+.| |-.||.+.+                ...+..
T Consensus       414 lMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid----------------lSqVY~  477 (1157)
T KOG4278|consen  414 LMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID----------------LSQVYG  477 (1157)
T ss_pred             hhcCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc----------------HHHHHH
Confidence            997766554444445788999999999999999999999999999999 888987643                233456


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP  319 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~  319 (380)
                      ++..+++.+.+..|++.+.+|+..||+.+|.+||++.|+...++.+-.
T Consensus       478 LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  478 LLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             HHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            778888889999999999999999999999999999999988776543

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-41  Score=305.89  Aligned_cols=259  Identities=26%  Similarity=0.373  Sum_probs=205.7

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCC-----
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTD-----  110 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~-----  110 (380)
                      .++++|++.+.||.|++|.||+|.+ .+++.|++|++..... ....+.+|+.+++++ .|+||+++++++....     
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND   81 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence            4678999999999999999999987 4678999999876543 345788999999999 6999999999986544     


Q ss_pred             -eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeecc
Q 037869          111 -QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG  189 (380)
Q Consensus       111 -~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfg  189 (380)
                       ..++||||+++++|.+++.........+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~  158 (275)
T cd06608          82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFG  158 (275)
T ss_pred             eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCc
Confidence             48999999999999999875433346789999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCccceeccccccCccCcccccc-----CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh
Q 037869          190 FAKLIPEGVSHMTTRVKGTLGYLAPEYAMW-----GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI  264 (380)
Q Consensus       190 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  264 (380)
                      ++....... .......++..|+|||++.+     ..++.++|||||||++|+|++|..||......  .....     .
T Consensus       159 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--~~~~~-----~  230 (275)
T cd06608         159 VSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM--RALFK-----I  230 (275)
T ss_pred             cceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH--HHHHH-----h
Confidence            987654322 22233458899999998753     34788999999999999999999999643211  00000     0


Q ss_pred             hccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          265 VKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ...     ..+  ....+...+..+.+++.+||..||++|||+.++++|.+
T Consensus       231 ~~~-----~~~--~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~  274 (275)
T cd06608         231 PRN-----PPP--TLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPF  274 (275)
T ss_pred             hcc-----CCC--CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCC
Confidence            000     000  11112235578999999999999999999999999864

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-41  Score=321.66  Aligned_cols=265  Identities=18%  Similarity=0.220  Sum_probs=203.1

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe---CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT---SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ...+|++.+.||+|+||.||++..   ..+..|++|.+....     ...+|+.+++.++||||+++++++......++|
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv  164 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRWKSTVCMV  164 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence            456899999999999999999964   246789999886532     345799999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      ||++. ++|.+++..    ...+++..++.++.||+.||.|||+.   ||+||||||+|||++.++.++|+|||++....
T Consensus       165 ~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~  236 (392)
T PHA03207        165 MPKYK-CDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLD  236 (392)
T ss_pred             ehhcC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccC
Confidence            99995 688888843    35789999999999999999999999   99999999999999999999999999997664


Q ss_pred             CCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcc-cchhccchhhh-------hc
Q 037869          196 EGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVK-RTITEWAEPLI-------VK  266 (380)
Q Consensus       196 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~-~~~~~~~~~~~-------~~  266 (380)
                      .... .......||+.|+|||++.+..++.++|||||||++|||++|..||.+...... ..+........       ..
T Consensus       237 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~  316 (392)
T PHA03207        237 AHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQN  316 (392)
T ss_pred             cccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCc
Confidence            3322 122345689999999999999999999999999999999999999976432210 00000000000       00


Q ss_pred             ------cccccccCCcccCCC-------CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          267 ------GKFKELVDPKLRGDF-------DENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       267 ------~~~~~~~~~~~~~~~-------~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                            ..+... ....+..+       ....+.++.++|.+||..||.+|||+.+++.|.+..
T Consensus       317 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~  379 (392)
T PHA03207        317 GSTNLCKHFKQY-AIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFT  379 (392)
T ss_pred             cchhHHHHHHhh-cccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhh
Confidence                  000000 00001000       012345788999999999999999999999997654

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.1e-41  Score=316.07  Aligned_cols=261  Identities=23%  Similarity=0.350  Sum_probs=201.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe------CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcC-CCCcceeEeeEEec-C
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT------SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAG-T  109 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~-~  109 (380)
                      ..++|++.+.||+|+||.||+|.+      .+++.||||+++... ......+.+|+.++.++ +||||+++++++.. +
T Consensus         5 ~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~   84 (343)
T cd05103           5 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   84 (343)
T ss_pred             chhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCC
Confidence            457899999999999999999963      346789999997533 23345688899999999 68999999998765 4


Q ss_pred             CeEEEEEEecCCCCHHHhhccCCC--------------------------------------------------------
Q 037869          110 DQRLIVYDYMPNLSLLSHLHGQYA--------------------------------------------------------  133 (380)
Q Consensus       110 ~~~~lv~e~~~~g~L~~~i~~~~~--------------------------------------------------------  133 (380)
                      ...++||||+++|+|.+++.....                                                        
T Consensus        85 ~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (343)
T cd05103          85 GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE  164 (343)
T ss_pred             CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhh
Confidence            568999999999999999864310                                                        


Q ss_pred             -------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCcc-ceecc
Q 037869          134 -------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH-MTTRV  205 (380)
Q Consensus       134 -------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~-~~~~~  205 (380)
                             ....+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++|+|||++......... .....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         165 EAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                   012467888899999999999999999   9999999999999999999999999999865332111 11222


Q ss_pred             ccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHH
Q 037869          206 KGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN  284 (380)
Q Consensus       206 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      .++..|+|||.+.+..++.++||||||+++|+|++ |..||........  .   ..          ..........+..
T Consensus       242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~---~~----------~~~~~~~~~~~~~  306 (343)
T cd05103         242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F---CR----------RLKEGTRMRAPDY  306 (343)
T ss_pred             CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--H---HH----------HHhccCCCCCCCC
Confidence            35678999999998899999999999999999997 8899865322100  0   00          0000111111222


Q ss_pred             HHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          285 QLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       285 ~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .+..+.+++.+||+.+|.+|||+.+|+++|...
T Consensus       307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~  339 (343)
T cd05103         307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  339 (343)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            346789999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.4e-41  Score=298.96  Aligned_cols=247  Identities=28%  Similarity=0.494  Sum_probs=199.7

Q ss_pred             ceeccCCceEEEEEEeCCCcEEEEEEecccChh-hHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCCCHH
Q 037869           47 NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSK-AEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL  125 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~  125 (380)
                      ++||+|++|.||++.+.+++.|++|.+...... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            479999999999998866999999998764333 4567889999999999999999999999999999999999999999


Q ss_pred             HhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccce-ec
Q 037869          126 SHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMT-TR  204 (380)
Q Consensus       126 ~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~-~~  204 (380)
                      +++...   ...+++..+..++.+++.||.|||++   +++||||+|+||+++.++.++|+|||++........... ..
T Consensus        81 ~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  154 (251)
T cd05041          81 TFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL  154 (251)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence            998643   23688999999999999999999999   999999999999999999999999999986542221111 11


Q ss_pred             cccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCH
Q 037869          205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDE  283 (380)
Q Consensus       205 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  283 (380)
                      ..++..|+|||.+.+..++.++||||||+++|+|++ |..||.........                ...........+.
T Consensus       155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~----------------~~~~~~~~~~~~~  218 (251)
T cd05041         155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR----------------ERIESGYRMPAPQ  218 (251)
T ss_pred             CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHH----------------HHHhcCCCCCCCc
Confidence            223567999999998889999999999999999999 88888654321000                0001111112233


Q ss_pred             HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          284 NQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       284 ~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ..+..+.+++.+||..+|.+|||+.++++.|.
T Consensus       219 ~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         219 LCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             cCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            44578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.9e-41  Score=304.63  Aligned_cols=256  Identities=24%  Similarity=0.370  Sum_probs=204.2

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCC----CcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSD----GLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ...+|++.+.||+|+||.||+|.+.+    ...|++|...... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcE
Confidence            34678999999999999999997532    3468999887654 4455678899999999999999999998874 5678


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++..
T Consensus        83 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~  156 (270)
T cd05056          83 IVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRY  156 (270)
T ss_pred             EEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeee
Confidence            999999999999999653   23589999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      .............++..|+|||.+.+..++.++||||||+++|++++ |..||.........  .          .+.  
T Consensus       157 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~--~----------~~~--  222 (270)
T cd05056         157 LEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI--G----------RIE--  222 (270)
T ss_pred             cccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH--H----------HHH--
Confidence            64432222222234568999999988889999999999999999986 99999754321100  0          000  


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                        .......+...+..+.+++.+||..+|.+|||+.++++.|...
T Consensus       223 --~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~  265 (270)
T cd05056         223 --NGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDI  265 (270)
T ss_pred             --cCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              0011122334457899999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.1e-41  Score=306.73  Aligned_cols=265  Identities=21%  Similarity=0.281  Sum_probs=207.6

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      .++|++.+.||+|+||+||++.+ .++..||+|++.... ......+.+|+++++.++||||+++++++.....+++|||
T Consensus         4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence            46788999999999999999987 468889999886532 3345678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH-EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~-~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      |+++++|.+++...    ..+++..+..++.+++.||.|||+ .   +++||||+|+||+++.++.++|+|||++.....
T Consensus        84 ~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~  156 (284)
T cd06620          84 FMDCGSLDRIYKKG----GPIPVEILGKIAVAVVEGLTYLYNVH---RIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN  156 (284)
T ss_pred             cCCCCCHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHhc---CeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence            99999999988643    468999999999999999999997 4   899999999999999999999999999875432


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      .   ......|+..|+|||++.+..++.++|||||||++|+|++|..||.............    ......+.......
T Consensus       157 ~---~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~----~~~~~~~~~~~~~~  229 (284)
T cd06620         157 S---IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDP----MGILDLLQQIVQEP  229 (284)
T ss_pred             h---ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhh----hHHHHHHHHHhhcc
Confidence            2   1223468999999999988899999999999999999999999997543211100000    00000000111000


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      .........+..+.+|+.+||+.||.+|||+.+++++++...
T Consensus       230 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         230 PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            011111225568899999999999999999999999876544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6.4e-41  Score=302.01  Aligned_cols=256  Identities=25%  Similarity=0.394  Sum_probs=204.2

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ..+.......||+|+||.||+|.+ .++..|++|.+..........+.+|+.+++.++|+||+++++++..++..++|+|
T Consensus         6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   85 (268)
T cd06624           6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME   85 (268)
T ss_pred             ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence            445555667899999999999986 4678899999887666666788899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccC--CHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-CCceEEeeccCcccc
Q 037869          118 YMPNLSLLSHLHGQYAGEVQL--DWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS-DFEPLVADFGFAKLI  194 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~--~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~-~~~vkl~Dfgl~~~~  194 (380)
                      |+++++|.+++....   ..+  ++..+..++.|++.||+|||+.   +++||||||+||+++. ++.++|+|||++...
T Consensus        86 ~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~  159 (268)
T cd06624          86 QVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRL  159 (268)
T ss_pred             cCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence            999999999997532   234  7888899999999999999998   9999999999999976 679999999998765


Q ss_pred             CCCCccceeccccccCccCccccccC--CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAMWG--KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      ..... ......++..|+|||.+.+.  .++.++||||+|+++|+|++|..||..........   +           ..
T Consensus       160 ~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~---~-----------~~  224 (268)
T cd06624         160 AGINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM---F-----------KV  224 (268)
T ss_pred             ccCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhH---h-----------hh
Confidence            43221 12233578999999998754  37899999999999999999999996532110000   0           00


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .........+...+.++.+++.+||+.+|.+|||+.+++.|.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~  267 (268)
T cd06624         225 GMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPF  267 (268)
T ss_pred             hhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCC
Confidence            0001112234445678999999999999999999999999865

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=6.7e-41  Score=301.39  Aligned_cols=252  Identities=23%  Similarity=0.309  Sum_probs=202.3

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-----hhhHHHHHHHHHHHhcCCCCcceeEeeEEecC--CeE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-----SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT--DQR  112 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  112 (380)
                      +.|++.+.||+|+||.||++.+ .++..|++|.+....     ......+.+|+.+++.++||||+++++++.+.  ..+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            5799999999999999999987 468999999886321     22345678899999999999999999988663  468


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      +++|||+++++|.+++...    ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.
T Consensus        82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~  154 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK  154 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCcccc
Confidence            8999999999999998643    3578889999999999999999999   99999999999999999999999999997


Q ss_pred             ccCCCCc--cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          193 LIPEGVS--HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       193 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      .......  .......++..|+|||++.+..++.++|||||||++|+|++|..||.......               ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---------------~~~  219 (265)
T cd06652         155 RLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA---------------AIF  219 (265)
T ss_pred             ccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH---------------HHH
Confidence            6532111  11223457889999999988889999999999999999999999996532110               001


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ...........+...+..+.+++.+||. +|.+||+++++++|.+
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~  263 (265)
T cd06652         220 KIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTF  263 (265)
T ss_pred             HHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcc
Confidence            1111112223445566788899999995 9999999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=8.1e-41  Score=300.82  Aligned_cols=259  Identities=26%  Similarity=0.363  Sum_probs=208.1

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ++|++.+.||.|++|+||+|.+ .++..|++|++.... ......+.+|+.+++.++|+||+++++.+..++..++|||+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~   80 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY   80 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence            4799999999999999999986 468899999987432 33556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++++|.+++..... ...+++..+..++.|++.||++||+.   |++||||+|+||+++.++.++|+|||++..+....
T Consensus        81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          81 LSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             cCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            999999999975421 24689999999999999999999999   99999999999999999999999999997765432


Q ss_pred             cc---ceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          199 SH---MTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       199 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      ..   ......|+..|+|||.+... .++.++|+||||+++|+|++|..||........  .....     .     ...
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~-----~-----~~~  224 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTL-----Q-----NDP  224 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHh-----c-----CCC
Confidence            22   12334588999999998866 789999999999999999999999975432110  00000     0     000


Q ss_pred             CcccCCC-CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          275 PKLRGDF-DENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       275 ~~~~~~~-~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      +.+.... ....+..+.+++.+||..||++|||+.+|++|.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~  266 (267)
T cd06610         225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF  266 (267)
T ss_pred             CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCC
Confidence            1111111 1245578899999999999999999999999864

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.1e-41  Score=307.33  Aligned_cols=258  Identities=24%  Similarity=0.410  Sum_probs=204.3

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC------CCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS------DGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQ  111 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  111 (380)
                      ..++|++.+.||+|+||.||+|.+.      ++..||+|.+.... ......+.+|+.+++.++||||+++++++..+..
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            4578999999999999999999753      46789999987543 3334568889999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHhhccCC------------------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 037869          112 RLIVYDYMPNLSLLSHLHGQY------------------AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKAS  173 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~------------------~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~  173 (380)
                      .++||||+++|+|.+++....                  .....+++..++.++.|++.||.|||+.   +++||||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHh
Confidence            999999999999999996431                  1123578899999999999999999998   9999999999


Q ss_pred             CeeeCCCCceEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCC
Q 037869          174 NVLLDSDFEPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGG  251 (380)
Q Consensus       174 Nill~~~~~vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~  251 (380)
                      ||+++.++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|+|++ |..||......
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999876533211 11122234667999999998899999999999999999998 87888643211


Q ss_pred             cccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          252 VKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                            ..... ...+.         ....+...+..+.+++.+||+.+|.+|||+.++++.|+
T Consensus       240 ------~~~~~-~~~~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         240 ------EVIYY-VRDGN---------VLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             ------HHHHH-HhcCC---------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence                  00000 00000         11122334578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.5e-41  Score=304.16  Aligned_cols=258  Identities=25%  Similarity=0.389  Sum_probs=204.8

Q ss_pred             hCCCCCcceeccCCceEEEEEEeC------CCcEEEEEEecccChh-hHHHHHHHHHHHhcCCCCcceeEeeEEecCCeE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTS------DGLQIAVKKLKAMNSK-AEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  112 (380)
                      .++|++.+.||.|+||.||+|+..      +...|++|.+...... ....+.+|+.++++++|+||+++++++......
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH   83 (275)
T ss_pred             hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence            467899999999999999999853      2457899988754433 345788999999999999999999999988899


Q ss_pred             EEEEEecCCCCHHHhhccCCCC-----CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEee
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAG-----EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD  187 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~-----~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~D  187 (380)
                      ++||||+++|+|.+++......     ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~  160 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSL  160 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcc
Confidence            9999999999999999754311     12689999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhc
Q 037869          188 FGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVK  266 (380)
Q Consensus       188 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~  266 (380)
                      ||++...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   .   ..     
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~---~---~~-----  229 (275)
T cd05046         161 LSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE---V---LN-----  229 (275)
T ss_pred             cccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH---H---HH-----
Confidence            99987543222222223346778999999988888999999999999999998 788886432210   0   00     


Q ss_pred             cccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                          ...........+...+..+.+++.+||+.+|.+|||+.+++..|.
T Consensus       230 ----~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         230 ----RLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             ----HHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence                000011111122334578999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-41  Score=300.49  Aligned_cols=247  Identities=28%  Similarity=0.481  Sum_probs=196.8

Q ss_pred             ceeccCCceEEEEEEeC-C---CcEEEEEEecccCh-hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCC
Q 037869           47 NKLGEGGFGSVYWGRTS-D---GLQIAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPN  121 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  121 (380)
                      ++||+|+||.||+|.+. .   +..||+|.+..... .....+.+|+.+++.+.|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            47999999999999752 2   36899999885443 34557888999999999999999999876 5578999999999


Q ss_pred             CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccc
Q 037869          122 LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM  201 (380)
Q Consensus       122 g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~  201 (380)
                      ++|.+++...    ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||+++.........
T Consensus        80 ~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~  152 (257)
T cd05060          80 GPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY  152 (257)
T ss_pred             CcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence            9999999754    3689999999999999999999998   99999999999999999999999999998764332221


Q ss_pred             eec--cccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          202 TTR--VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       202 ~~~--~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      ...  ..++..|+|||.+.+..++.++|||||||++|+|++ |..||......   ....             .......
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~---~~~~-------------~~~~~~~  216 (257)
T cd05060         153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA---EVIA-------------MLESGER  216 (257)
T ss_pred             ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHH---HHHH-------------HHHcCCc
Confidence            111  123467999999998899999999999999999998 99999654321   0000             0000111


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ...+...+..+.++|.+||..+|++|||+.++++.|..+
T Consensus       217 ~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         217 LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            122334457889999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.6e-41  Score=322.20  Aligned_cols=264  Identities=22%  Similarity=0.208  Sum_probs=199.4

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ...|.+.+.||+|+||.||+|.+ ..++.||||....      ..+.+|+.+|++++|+||+++++++...+..++|||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~  241 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK  241 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            44799999999999999999987 4588899996432      2456799999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +. ++|.+++...   ...+++..++.++.|++.||.|||+.   ||+||||||+|||++.++.++|+|||+++......
T Consensus       242 ~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~  314 (461)
T PHA03211        242 YR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW  314 (461)
T ss_pred             cC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence            95 6888888643   23699999999999999999999999   99999999999999999999999999998654322


Q ss_pred             cc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCccc-----chhccchhhhh-cccccc
Q 037869          199 SH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKR-----TITEWAEPLIV-KGKFKE  271 (380)
Q Consensus       199 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-----~~~~~~~~~~~-~~~~~~  271 (380)
                      .. ......||..|+|||++.+..++.++|||||||++|||++|..|+.........     .+..+...... ...+..
T Consensus       315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence            11 122356899999999999999999999999999999999988766433221110     00000000000 000000


Q ss_pred             c----------------cCCcccCCCC---HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          272 L----------------VDPKLRGDFD---ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       272 ~----------------~~~~~~~~~~---~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .                ..+.......   .....++.+||.+||+.||.+|||+.|+|+|.+.
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f  458 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLF  458 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCccc
Confidence            0                0000000000   1223578899999999999999999999999764

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=3.5e-41  Score=303.93  Aligned_cols=254  Identities=26%  Similarity=0.461  Sum_probs=202.2

Q ss_pred             CCCCCcceeccCCceEEEEEEeC-CC---cEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTS-DG---LQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~---~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ..|++.+.||+|+||.||+|... ++   ..|++|.+... .......+..|+.+++.++||||+++++++..+...++|
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   83 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMII   83 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEE
Confidence            45889999999999999999863 33   36999998754 344456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |||+++++|.+++...   ...+++..++.++.|++.||+|||+.   |++||||||+||+++.++.++|+|||++....
T Consensus        84 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~  157 (269)
T cd05065          84 TEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  157 (269)
T ss_pred             EecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccc
Confidence            9999999999998653   34689999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCccc--eeccc--cccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          196 EGVSHM--TTRVK--GTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       196 ~~~~~~--~~~~~--gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      ......  .....  .+..|+|||.+.+..++.++||||+||++||+++ |..||.......   ...   .      + 
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~---~~~---~------i-  224 (269)
T cd05065         158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD---VIN---A------I-  224 (269)
T ss_pred             cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH---HHH---H------H-
Confidence            322111  11111  1457999999998899999999999999999886 999986533210   000   0      0 


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                         ........+..++..+.+++.+||+.+|.+||++.+++..|..
T Consensus       225 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  267 (269)
T cd05065         225 ---EQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDK  267 (269)
T ss_pred             ---HcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence               0001111223445678999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.8e-41  Score=300.81  Aligned_cols=249  Identities=29%  Similarity=0.410  Sum_probs=201.0

Q ss_pred             hCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEe-cCCeEEEEEEe
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA-GTDQRLIVYDY  118 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~  118 (380)
                      ..+|++.+.||+|+||.||++... +..|++|.++...  ....+.+|+.+++.++|+|++++++++. .++..++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           5 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             HHhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            457899999999999999999764 7789999987543  3447889999999999999999999764 45678999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++++|.+++....  ...+++..++.++.|++.||+|||++   |++||||||+||+++.++.++|+|||++.......
T Consensus        82 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  156 (256)
T cd05082          82 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ  156 (256)
T ss_pred             CCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence            99999999987532  23588999999999999999999998   99999999999999999999999999987653321


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                          ....++..|+|||++.+..++.++|||||||++|+|++ |..||.....      ......          .....
T Consensus       157 ----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~~~----------~~~~~  216 (256)
T cd05082         157 ----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVVPR----------VEKGY  216 (256)
T ss_pred             ----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHHHH----------HhcCC
Confidence                12234678999999998889999999999999999998 9999864321      000000          00111


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ....+..++..+.+++.+||+.+|++|||+.++++.|..
T Consensus       217 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         217 KMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhc
Confidence            112233445788999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.8e-41  Score=302.66  Aligned_cols=255  Identities=23%  Similarity=0.385  Sum_probs=206.2

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC------hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN------SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      +|++.+.||+|++|.||++.+ .+++.||+|++....      ......+..|++++++++|+||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            488899999999999999986 578999999987432      1234578889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC-ceEEeeccCccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF-EPLVADFGFAKL  193 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~-~vkl~Dfgl~~~  193 (380)
                      |+||+++++|.+++...    .++++..++.++.|++.||.|||+.   |++|+||+|+||+++.++ .++|+|||++..
T Consensus        81 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~  153 (268)
T cd06630          81 FVEWMAGGSVSHLLSKY----GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAAR  153 (268)
T ss_pred             EEeccCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccc
Confidence            99999999999998643    4688999999999999999999999   999999999999998775 599999999977


Q ss_pred             cCCCCcc---ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          194 IPEGVSH---MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       194 ~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      .......   ......++..|+|||.+.+..++.++||||+|+++|+|++|..||..........            .+.
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~------------~~~  221 (268)
T cd06630         154 LAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA------------LIF  221 (268)
T ss_pred             cccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH------------HHH
Confidence            6433111   1223457889999999988889999999999999999999999996432110000            000


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ...........+...+.++.+++.+||..+|..||++.++++|.+
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~  266 (268)
T cd06630         222 KIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPV  266 (268)
T ss_pred             HHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcc
Confidence            111111123344556688999999999999999999999998854

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-42  Score=316.80  Aligned_cols=245  Identities=24%  Similarity=0.277  Sum_probs=191.9

Q ss_pred             eccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcC---CCCcceeEeeEEecCCeEEEEEEecCC
Q 037869           49 LGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRV---RHKNLLGLRGYCAGTDQRLIVYDYMPN  121 (380)
Q Consensus        49 Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~~~lv~e~~~~  121 (380)
                      ||+|+||+||+|++ .+++.||+|++....   .........|..++...   .||||+++++++......|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999987 468999999986421   12223445566666655   699999999999999999999999999


Q ss_pred             CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccc
Q 037869          122 LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM  201 (380)
Q Consensus       122 g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~  201 (380)
                      |+|..++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.++|+|||++....... ..
T Consensus        81 g~L~~~l~~~----~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~-~~  152 (330)
T cd05586          81 GELFWHLQKE----GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDN-KT  152 (330)
T ss_pred             ChHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC-CC
Confidence            9999988643    4689999999999999999999999   99999999999999999999999999987543221 22


Q ss_pred             eeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCC
Q 037869          202 TTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGD  280 (380)
Q Consensus       202 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.......  .    ... ...+..      .+   
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~--~----~~~-i~~~~~------~~---  216 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ--M----YRN-IAFGKV------RF---  216 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH--H----HHH-HHcCCC------CC---
Confidence            3345689999999998754 58999999999999999999999996532110  0    000 000000      00   


Q ss_pred             CCHHHHHHHHHHHHhhcCCCCCCCC----CHHHHHHHhcCC
Q 037869          281 FDENQLKQAINVAVLCVQSEPEKRP----NMKEVVNTLTGY  317 (380)
Q Consensus       281 ~~~~~~~~~~~li~~cl~~~P~~Rp----s~~~ll~~l~~~  317 (380)
                      .....+.++.+++.+||+.||.+||    ++.++++|.+..
T Consensus       217 ~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~  257 (330)
T cd05586         217 PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFA  257 (330)
T ss_pred             CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCcccc
Confidence            0112346788999999999999998    789999987654

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-41  Score=310.20  Aligned_cols=256  Identities=23%  Similarity=0.261  Sum_probs=206.1

Q ss_pred             CCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccCh---hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNS---KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ++|++.+.||+|++|+||+|.+. +++.||+|.+.....   .....+..|+++++.++||||+++++.+......++||
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            47899999999999999999874 589999999875332   23456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+.+++|.+++...  ....+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  155 (316)
T cd05574          81 DYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDV  155 (316)
T ss_pred             EecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccc
Confidence            999999999998743  235689999999999999999999999   999999999999999999999999999875432


Q ss_pred             CCcc----------------------------ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCC
Q 037869          197 GVSH----------------------------MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKL  248 (380)
Q Consensus       197 ~~~~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  248 (380)
                      ....                            ......|+..|+|||++.+..++.++||||||+++|+|++|..||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         156 EPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence            1110                            111235788999999999888999999999999999999999999754


Q ss_pred             CCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCC----HHHHHHHhcC
Q 037869          249 PGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPN----MKEVVNTLTG  316 (380)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps----~~~ll~~l~~  316 (380)
                      .....               +................+..+.+++.+||..||++|||    +.+++.|.+.
T Consensus       236 ~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~  292 (316)
T cd05574         236 NRDET---------------FSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF  292 (316)
T ss_pred             chHHH---------------HHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchh
Confidence            32100               00011111111111124578999999999999999999    9999998553

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3e-41  Score=313.92  Aligned_cols=265  Identities=29%  Similarity=0.409  Sum_probs=208.0

Q ss_pred             HHHHhhCCCCCcceeccCCceEEEEEEeC--------CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcC-CCCcceeEee
Q 037869           35 ELHTATNGFSDDNKLGEGGFGSVYWGRTS--------DGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRV-RHKNLLGLRG  104 (380)
Q Consensus        35 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~  104 (380)
                      ++.....+|++.+.||+|+||.||+|++.        +...||+|.++.. .......+.+|+++++++ +||||+++++
T Consensus         6 ~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (334)
T cd05100           6 KWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLG   85 (334)
T ss_pred             ccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeE
Confidence            34445678999999999999999999742        1236899988753 233456788999999999 7999999999


Q ss_pred             EEecCCeEEEEEEecCCCCHHHhhccCC------------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 037869          105 YCAGTDQRLIVYDYMPNLSLLSHLHGQY------------AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKA  172 (380)
Q Consensus       105 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~------------~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp  172 (380)
                      ++...+..++++||+++|+|.+++....            .....+++..+..++.|++.||+|||++   |++||||||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp  162 (334)
T cd05100          86 ACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAA  162 (334)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceecccccc
Confidence            9999999999999999999999986532            1234588899999999999999999999   999999999


Q ss_pred             CCeeeCCCCceEEeeccCccccCCCCccc-eeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCC
Q 037869          173 SNVLLDSDFEPLVADFGFAKLIPEGVSHM-TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG  250 (380)
Q Consensus       173 ~Nill~~~~~vkl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~  250 (380)
                      +||+++.++.++|+|||+++......... .....++..|+|||++.+..++.++|||||||++|+|++ |..||...+.
T Consensus       163 ~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~  242 (334)
T cd05100         163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV  242 (334)
T ss_pred             ceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence            99999999999999999998654322111 111223567999999999999999999999999999998 8888865321


Q ss_pred             CcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          251 GVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      .      .+..          ..........+...+..+.+++.+||+.+|.+|||+.+++++|....
T Consensus       243 ~------~~~~----------~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~  294 (334)
T cd05100         243 E------ELFK----------LLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL  294 (334)
T ss_pred             H------HHHH----------HHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence            0      0000          00111112223344578899999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5.3e-41  Score=336.12  Aligned_cols=259  Identities=22%  Similarity=0.318  Sum_probs=201.4

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ++|++.++||+|+||.||+|.+ .+++.||+|+++..   .......+.+|+.+++.++||||+++++++.+.+..++||
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM   81 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM   81 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence            5899999999999999999987 46899999998742   2233457888999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCC-------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeecc
Q 037869          117 DYMPNLSLLSHLHGQYA-------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG  189 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~-------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfg  189 (380)
                      ||++||+|.+++.....       .....++..++.++.|++.||+|||+.   ||+||||||+||+++.++.++|+|||
T Consensus        82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFG  158 (932)
T PRK13184         82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWG  158 (932)
T ss_pred             EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecC
Confidence            99999999998864211       123456778899999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCc-----------------cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCc
Q 037869          190 FAKLIPEGVS-----------------HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGV  252 (380)
Q Consensus       190 l~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  252 (380)
                      ++........                 .......||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus       159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k  238 (932)
T PRK13184        159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK  238 (932)
T ss_pred             cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence            9986521100                 01123468999999999999999999999999999999999999996532210


Q ss_pred             ccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHHHhcC
Q 037869          253 KRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPN-MKEVVNTLTG  316 (380)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps-~~~ll~~l~~  316 (380)
                      ....          ..   ...+... ......+..+.+++.+||+.||++||+ ++++++.|..
T Consensus       239 i~~~----------~~---i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~  289 (932)
T PRK13184        239 ISYR----------DV---ILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEP  289 (932)
T ss_pred             hhhh----------hh---ccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            0000          00   0000000 001234467889999999999999964 5556555443

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=5.6e-41  Score=300.43  Aligned_cols=248  Identities=30%  Similarity=0.451  Sum_probs=199.3

Q ss_pred             ceeccCCceEEEEEEeCC--C--cEEEEEEecccCh-hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCC
Q 037869           47 NKLGEGGFGSVYWGRTSD--G--LQIAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPN  121 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  121 (380)
                      +.||+|++|.||+|.+.+  +  ..||+|.+..... .....+.+|+.++++++||||+++++.+.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            468999999999998632  2  3689999987555 556678899999999999999999999987 889999999999


Q ss_pred             CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCcc-
Q 037869          122 LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH-  200 (380)
Q Consensus       122 g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~-  200 (380)
                      ++|.+++.....  ..+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++..+...... 
T Consensus        80 ~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~  154 (257)
T cd05040          80 GSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY  154 (257)
T ss_pred             CcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccce
Confidence            999999976422  4689999999999999999999999   9999999999999999999999999999876432211 


Q ss_pred             -ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          201 -MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       201 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                       ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......  ....    ...         ....
T Consensus       155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~----~~~---------~~~~  219 (257)
T cd05040         155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKK----IDK---------EGER  219 (257)
T ss_pred             ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHH----HHh---------cCCc
Confidence             1122346788999999998899999999999999999998 999986432210  0000    000         0011


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ...+...+..+.+++.+||+.+|++|||+.++++.|.
T Consensus       220 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         220 LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            1122334578999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.5e-42  Score=314.54  Aligned_cols=258  Identities=21%  Similarity=0.307  Sum_probs=206.8

Q ss_pred             HHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecc--cChhhHHHHHHHHHHHhcCC-CCcceeEeeEEecCCeE
Q 037869           36 LHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKA--MNSKAEMEFAVEVEVLGRVR-HKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        36 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  112 (380)
                      +......|+++++||.||.+.||++...+..-||+|++..  .......-+.+|+..|.+|+ |.+||+++++-..++.+
T Consensus       356 i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  356 IKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL  435 (677)
T ss_pred             EEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence            4456679999999999999999999988788899998763  44555668999999999995 89999999999999999


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      |+||||- ..+|..++.+..   ..++.-.+..+..|++.|+.++|.+   ||||.||||.|+|+-. |.+||+|||++.
T Consensus       436 YmvmE~G-d~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlVk-G~LKLIDFGIA~  507 (677)
T KOG0596|consen  436 YMVMECG-DIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLVK-GRLKLIDFGIAN  507 (677)
T ss_pred             EEEeecc-cccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEEe-eeEEeeeechhc
Confidence            9999987 459999997653   2333337888999999999999999   9999999999999965 599999999999


Q ss_pred             ccCCCCcc-ceeccccccCccCccccccCC-----------CCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccc
Q 037869          193 LIPEGVSH-MTTRVKGTLGYLAPEYAMWGK-----------VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWA  260 (380)
Q Consensus       193 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~  260 (380)
                      .+...... .....+||+.||+||.+....           .++++||||||||||+|+.|++||.....          
T Consensus       508 aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n----------  577 (677)
T KOG0596|consen  508 AIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN----------  577 (677)
T ss_pred             ccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH----------
Confidence            88765433 345568999999999886422           56899999999999999999999975321          


Q ss_pred             hhhhhccccccccCCcccCCCCHHHH-HHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          261 EPLIVKGKFKELVDPKLRGDFDENQL-KQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                          .-.++..+.++...-+++.--. .+++++++.||+.||.+|||+.+||+|..
T Consensus       578 ----~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpF  629 (677)
T KOG0596|consen  578 ----QIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPF  629 (677)
T ss_pred             ----HHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcc
Confidence                1122333444433223322111 23999999999999999999999999965

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-43  Score=331.95  Aligned_cols=259  Identities=26%  Similarity=0.444  Sum_probs=222.9

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC----CCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS----DGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      .....+|.+.||.|.||.|+.|+.+    ....||||.++... .+.+..|+.|+.||-+++||||+++.|+........
T Consensus       627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM  706 (996)
T KOG0196|consen  627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM  706 (996)
T ss_pred             ChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence            3456678999999999999999853    24579999999643 455668999999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      ||+|||++|+|..+++..   ++.+.+.++..++..|+.|+.||-+.   ++|||||..+||||+.+-.+|++|||+++.
T Consensus       707 IiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRv  780 (996)
T KOG0196|consen  707 IITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV  780 (996)
T ss_pred             EEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceee
Confidence            999999999999999865   56799999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCccceecc--ccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          194 IPEGVSHMTTRV--KGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       194 ~~~~~~~~~~~~--~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      +.++.....+..  .-..+|.|||.+....+|.+|||||+|++|||.++ |..||-+.++                ..+.
T Consensus       781 ledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN----------------QdVI  844 (996)
T KOG0196|consen  781 LEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN----------------QDVI  844 (996)
T ss_pred             cccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch----------------HHHH
Confidence            866543332222  22679999999999999999999999999999887 9999976543                2233


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCC
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP  319 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~  319 (380)
                      ..++.+++-+-|.+++..+.+|+..||++|-.+||.+.+|+..|..+-.
T Consensus       845 kaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr  893 (996)
T KOG0196|consen  845 KAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR  893 (996)
T ss_pred             HHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc
Confidence            3455667777788999999999999999999999999999999876633

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.8e-41  Score=308.21  Aligned_cols=265  Identities=19%  Similarity=0.268  Sum_probs=199.5

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      +|++.+.||.|+||.||+|++ .+|+.|++|.++...  ......+.+|+.+++.++||||+++++++......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY   80 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence            588999999999999999987 468999999987432  22234677899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      ++ ++|.+++...   ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  153 (284)
T cd07839          81 CD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV  153 (284)
T ss_pred             CC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCC
Confidence            97 4788877542   34689999999999999999999999   99999999999999999999999999998654322


Q ss_pred             ccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhh--cc---ccccc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIV--KG---KFKEL  272 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~---~~~~~  272 (380)
                      . ......++..|+|||++.+. .++.++|||||||++|+|++|..|+........ ...........  ..   .+...
T Consensus       154 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07839         154 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEESWPGVSKL  231 (284)
T ss_pred             C-CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHH-HHHHHHHHhCCCChHHhHHhhhc
Confidence            1 12233568899999998764 479999999999999999999988643222110 00000000000  00   00000


Q ss_pred             cC----Cccc-----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          273 VD----PKLR-----GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       273 ~~----~~~~-----~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ..    +...     .......+.++.++|.+||+.||.+|||+.++++|.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~  283 (284)
T cd07839         232 PDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY  283 (284)
T ss_pred             ccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCC
Confidence            00    0000     0111234578899999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.2e-41  Score=300.04  Aligned_cols=250  Identities=27%  Similarity=0.398  Sum_probs=204.8

Q ss_pred             CCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC-----hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN-----SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      +|+..+.||+|++|.||+|.+. ++..|++|.+....     ......+.+|+.+++.++|+||+++++++..+...+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            5888899999999999999875 78999999986532     23445788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      +||+++++|.+++...    ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~  153 (258)
T cd06632          81 LELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVV  153 (258)
T ss_pred             EEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceecc
Confidence            9999999999999653    3588999999999999999999999   99999999999999999999999999988754


Q ss_pred             CCCccceeccccccCccCccccccCC-CCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      ...  ......++..|+|||.+.... ++.++|+||||+++|+|++|..||......  .....             ...
T Consensus       154 ~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~--~~~~~-------------~~~  216 (258)
T cd06632         154 EFS--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV--AAVFK-------------IGR  216 (258)
T ss_pred             ccc--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH--HHHHH-------------HHh
Confidence            322  223445889999999988766 899999999999999999999999654310  00000             000


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .......+...+..+.+++.+||+.+|.+||++.+++.|.+
T Consensus       217 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~  257 (258)
T cd06632         217 SKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPF  257 (258)
T ss_pred             cccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCC
Confidence            00111223344578899999999999999999999998853

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=7.9e-41  Score=304.15  Aligned_cols=267  Identities=22%  Similarity=0.308  Sum_probs=203.0

Q ss_pred             CCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ++|++.+.||+|++|.||+|.+. +++.||+|++....  ......+.+|+.+++.++||||+++++++..+...++|||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            47999999999999999999874 68999999986432  2223467789999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+++++|..++...    ..+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07847          81 YCDHTVLNELEKNP----RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGP  153 (286)
T ss_pred             ccCccHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence            99998887776432    3689999999999999999999998   9999999999999999999999999999876543


Q ss_pred             CccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchh-----ccchh---hhhccc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTIT-----EWAEP---LIVKGK  268 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~-----~~~~~---~~~~~~  268 (380)
                      .. ......++..|+|||.+.+ ..++.++||||+|+++|+|++|..||.+..........     .+...   ......
T Consensus       154 ~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07847         154 GD-DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ  232 (286)
T ss_pred             cc-cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence            21 1223357889999999876 55889999999999999999999999754421110000     00000   000000


Q ss_pred             c-ccccCCcccC-----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          269 F-KELVDPKLRG-----DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       269 ~-~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      + .....+....     ......+..+.+|+.+||+.+|++||++.+++.|.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~  285 (286)
T cd07847         233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY  285 (286)
T ss_pred             ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCC
Confidence            0 0000000000     001123577899999999999999999999998864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=5e-41  Score=306.31  Aligned_cols=248  Identities=28%  Similarity=0.339  Sum_probs=206.2

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ++|++.+.||+|++|.||++.+ .+++.||+|++....   ......+.+|++++++++||||+++++++..++..++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            4789999999999999999987 468999999986432   233456888999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~  153 (290)
T cd05580          81 EYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG  153 (290)
T ss_pred             ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCC
Confidence            999999999999653    4789999999999999999999998   999999999999999999999999999987644


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      .    .....+++.|+|||.+.+..++.++||||||+++|+|++|..||......  ...             .....  
T Consensus       154 ~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~-------------~~~~~--  212 (290)
T cd05580         154 R----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI--QIY-------------EKILE--  212 (290)
T ss_pred             C----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HHH-------------HHHhc--
Confidence            3    23346899999999998888899999999999999999999999653310  000             00000  


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhcC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLTG  316 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~~  316 (380)
                      .....+...+..+.+++.+||..||.+|+     +++++++|.+.
T Consensus       213 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~  257 (290)
T cd05580         213 GKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWF  257 (290)
T ss_pred             CCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccc
Confidence            01122333457889999999999999999     99999998663

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=6.5e-41  Score=309.39  Aligned_cols=263  Identities=21%  Similarity=0.332  Sum_probs=190.5

Q ss_pred             ceeccCCceEEEEEEeC---CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEec--CCeEEEEEEecCC
Q 037869           47 NKLGEGGFGSVYWGRTS---DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG--TDQRLIVYDYMPN  121 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~  121 (380)
                      .+||+|+||+||+|+..   ++..||+|.+.....  ...+.+|+.+++.++||||+++++++..  +...++||||+.+
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            58999999999999853   457899999875432  2357789999999999999999998853  5678999999964


Q ss_pred             CCHHHhhccCC-----CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee----CCCCceEEeeccCcc
Q 037869          122 LSLLSHLHGQY-----AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLL----DSDFEPLVADFGFAK  192 (380)
Q Consensus       122 g~L~~~i~~~~-----~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill----~~~~~vkl~Dfgl~~  192 (380)
                       +|.+++....     .....+++..++.++.|++.||.|||+.   +++||||||+||++    +.++.+||+|||+++
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence             7877774321     1223588999999999999999999999   99999999999999    456789999999998


Q ss_pred             ccCCCCcc--ceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchh----ccchhhhh
Q 037869          193 LIPEGVSH--MTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTIT----EWAEPLIV  265 (380)
Q Consensus       193 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~----~~~~~~~~  265 (380)
                      ........  ......+|+.|+|||++.+ ..++.++|||||||++|||++|.+||............    ........
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            76443221  1233468999999999876 45899999999999999999999999754332111000    00000000


Q ss_pred             c-----ccccc---------ccC---------Ccc---cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          266 K-----GKFKE---------LVD---------PKL---RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       266 ~-----~~~~~---------~~~---------~~~---~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .     ..+..         ...         ...   ...........+.+|+.+||..||.+|||+.++++|.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~  316 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY  316 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCC
Confidence            0     00000         000         000   00001112346889999999999999999999999865

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-41  Score=302.08  Aligned_cols=249  Identities=27%  Similarity=0.459  Sum_probs=195.3

Q ss_pred             ceeccCCceEEEEEEeC-CCc--EEEEEEecccC-hhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEEEEEecCC
Q 037869           47 NKLGEGGFGSVYWGRTS-DGL--QIAVKKLKAMN-SKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLIVYDYMPN  121 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~~~~  121 (380)
                      +.||+|+||.||+|.+. ++.  .+++|.++... ......+.+|+.++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            46899999999999864 343  56888887533 34455788899999999 799999999999999999999999999


Q ss_pred             CCHHHhhccCCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeecc
Q 037869          122 LSLLSHLHGQYA------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG  189 (380)
Q Consensus       122 g~L~~~i~~~~~------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfg  189 (380)
                      |+|.+++.....            ....+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCC
Confidence            999999865321            123578999999999999999999998   99999999999999999999999999


Q ss_pred             CccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccc
Q 037869          190 FAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGK  268 (380)
Q Consensus       190 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (380)
                      ++.......  .......+..|+|||++.+..++.++|||||||++|+|++ |..||.......   .   ..       
T Consensus       158 l~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~---~---~~-------  222 (270)
T cd05047         158 LSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE---L---YE-------  222 (270)
T ss_pred             Cccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH---H---HH-------
Confidence            986432111  1111223567999999988889999999999999999997 999996532110   0   00       


Q ss_pred             cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                         ..........+...+.++.+++.+||+.+|.+|||+.+++..|..
T Consensus       223 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~  267 (270)
T cd05047         223 ---KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNR  267 (270)
T ss_pred             ---HHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHH
Confidence               001111112223345678999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=8.4e-41  Score=299.10  Aligned_cols=252  Identities=23%  Similarity=0.343  Sum_probs=205.4

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      +|++.+.||+|+||.||++.+ .+++.|++|.+...  .......+.+|+.+++.++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY   80 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence            589999999999999999986 46889999998742  334445788899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +.+++|.+.+...  ....+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~  155 (256)
T cd08218          81 CEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV  155 (256)
T ss_pred             CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcch
Confidence            9999999988643  123578899999999999999999998   99999999999999999999999999998664322


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      . ......|++.|+|||++.+..++.++|+|||||++++|++|..||.....  ...    ..         ... ....
T Consensus       156 ~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~--~~~----~~---------~~~-~~~~  218 (256)
T cd08218         156 E-LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM--KNL----VL---------KII-RGSY  218 (256)
T ss_pred             h-hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCH--HHH----HH---------HHh-cCCC
Confidence            1 12234578899999999988899999999999999999999999864211  000    00         000 0111


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ...+...+.++.++|.+||+.+|.+||++.++++|.+
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~  255 (256)
T cd08218         219 PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNF  255 (256)
T ss_pred             CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcC
Confidence            1223344578999999999999999999999999854

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.1e-40  Score=299.50  Aligned_cols=252  Identities=29%  Similarity=0.440  Sum_probs=205.1

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh--hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS--KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      +|.+.+.||+|+||.||++.+ .++..|++|.++....  .....+.+|+.+++.++|+||+++++++...+..++|+||
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY   80 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence            689999999999999999986 4688999999875443  3566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++++|.+++...    ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~  153 (264)
T cd06626          81 CSGGTLEELLEHG----RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNT  153 (264)
T ss_pred             CCCCcHHHHHhhc----CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCC
Confidence            9999999999643    3578899999999999999999999   99999999999999999999999999998765432


Q ss_pred             ccce---eccccccCccCccccccCC---CCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          199 SHMT---TRVKGTLGYLAPEYAMWGK---VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       199 ~~~~---~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      ....   ....++..|+|||.+.+..   ++.++||||||+++|++++|..||.......       ........     
T Consensus       154 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-------~~~~~~~~-----  221 (264)
T cd06626         154 TTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-------QIMFHVGA-----  221 (264)
T ss_pred             CcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-------HHHHHHhc-----
Confidence            2221   1345788999999998766   8999999999999999999999997542110       00000000     


Q ss_pred             cCCcccCCCCH--HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          273 VDPKLRGDFDE--NQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       273 ~~~~~~~~~~~--~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                         ......+.  ..+..+.+++.+||+.+|.+|||+.+++.|.+
T Consensus       222 ---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~  263 (264)
T cd06626         222 ---GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPF  263 (264)
T ss_pred             ---CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCC
Confidence               00111111  23577889999999999999999999998754

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5.9e-41  Score=304.97  Aligned_cols=267  Identities=21%  Similarity=0.286  Sum_probs=204.8

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      +|++.+.||.|++|.||+|.+ .++..|++|++....  ......+.+|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   80 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY   80 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence            588999999999999999987 468999999987543  33345788899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      + +++|.+++...   ...+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~-~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~  153 (286)
T cd07832          81 M-PSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE  153 (286)
T ss_pred             c-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC
Confidence            9 99999998653   25699999999999999999999999   99999999999999999999999999998765433


Q ss_pred             ccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCccc--chhccchhhh-------hccc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKR--TITEWAEPLI-------VKGK  268 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~~-------~~~~  268 (380)
                      ........++..|+|||.+.+. .++.++||||+|+++|+|++|.+||.........  .......+..       ....
T Consensus       154 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd07832         154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPD  233 (286)
T ss_pred             CCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcch
Confidence            2223334589999999998754 4689999999999999999998887543221000  0000000000       0000


Q ss_pred             cccccCCcc----cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          269 FKELVDPKL----RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       269 ~~~~~~~~~----~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      +.....+..    ......+.+..+.+++.+||+.+|++|||++++++|.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~  284 (286)
T cd07832         234 YNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY  284 (286)
T ss_pred             hhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcC
Confidence            000000000    00111233578899999999999999999999999965

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=6.2e-41  Score=301.41  Aligned_cols=256  Identities=25%  Similarity=0.341  Sum_probs=207.4

Q ss_pred             CCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ++|++.+.||.|++|.||++.+. +++.|++|.+.... ......+.+|+++++.++||||+++++++..+...++++||
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY   80 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence            46888999999999999999874 68899999987543 34455788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH-EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~-~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      +++++|.+++....   ..+++..+..++.|++.||+|||+ .   +++||||+|+||+++.++.++|+|||.+......
T Consensus        81 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~  154 (265)
T cd06605          81 MDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS  154 (265)
T ss_pred             cCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHH
Confidence            99999999997542   578999999999999999999999 7   9999999999999999999999999998765322


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      ..   ....++..|+|||.+.+..++.++||||||+++|+|++|..||............. .         ..... ..
T Consensus       155 ~~---~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~---------~~~~~-~~  220 (265)
T cd06605         155 LA---KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFEL-L---------QYIVN-EP  220 (265)
T ss_pred             Hh---hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHH-H---------HHHhc-CC
Confidence            11   12568899999999999899999999999999999999999996543211111000 0         00000 01


Q ss_pred             cCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          278 RGDFDEN-QLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       278 ~~~~~~~-~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ....+.. .+..+.++|.+||..+|.+|||+.+++.+.+.
T Consensus       221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  260 (265)
T cd06605         221 PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFI  260 (265)
T ss_pred             CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchh
Confidence            1112222 56789999999999999999999999998664

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.3e-40  Score=297.84  Aligned_cols=251  Identities=30%  Similarity=0.496  Sum_probs=201.8

Q ss_pred             CCCcceeccCCceEEEEEEeCC-----CcEEEEEEecccChh-hHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           43 FSDDNKLGEGGFGSVYWGRTSD-----GLQIAVKKLKAMNSK-AEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        43 y~~~~~Lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      +++.+.||.|+||.||++.+..     +..||+|.++..... ....+..|+.++..++|+||+++++++...+..+++|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~   80 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVM   80 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEE
Confidence            4678899999999999998743     388999999765433 5567888999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++++|.+++....  ...+++..++.++.|++.||++||+.   +++||||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       81 EYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             eccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceeccc
Confidence            9999999999997542  11289999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      ..........++..|+|||.+.+..++.++||||+|+++++|++ |..||......   ..   ..          ....
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~---~~---~~----------~~~~  219 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE---EV---LE----------YLKK  219 (258)
T ss_pred             ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH---HH---HH----------HHhc
Confidence            32222212236789999999988889999999999999999998 78888652210   00   00          0001


Q ss_pred             cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 037869          276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL  314 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l  314 (380)
                      ......+...+.++.+++.+||..+|++|||+.++++.|
T Consensus       220 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      220 GYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            111122233567899999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.1e-40  Score=299.58  Aligned_cols=240  Identities=20%  Similarity=0.341  Sum_probs=189.3

Q ss_pred             ceeccCCceEEEEEEeCC-------------CcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           47 NKLGEGGFGSVYWGRTSD-------------GLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      +.||+|+||.||+|....             ...|++|.+..........+..|+.+++.++||||+++++++......+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            469999999999997421             2358899887655455557888999999999999999999999888999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc-------eEEe
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE-------PLVA  186 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~-------vkl~  186 (380)
                      +||||+++|+|..++...   ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.       ++++
T Consensus        81 lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~  154 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLS  154 (262)
T ss_pred             EEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeC
Confidence            999999999999888643   34689999999999999999999999   9999999999999986654       8999


Q ss_pred             eccCccccCCCCccceeccccccCccCccccc-cCCCCccchhhhhhHHHHHHH-hCCCCCCCCCCCcccchhccchhhh
Q 037869          187 DFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEIL-TGRKPIEKLPGGVKRTITEWAEPLI  264 (380)
Q Consensus       187 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell-~g~~p~~~~~~~~~~~~~~~~~~~~  264 (380)
                      |||++......     ....++..|+|||.+. +..++.++|||||||++|+|+ .|..||.........       .  
T Consensus       155 d~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-------~--  220 (262)
T cd05077         155 DPGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-------R--  220 (262)
T ss_pred             CCCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-------H--
Confidence            99998765321     2234788899999887 567899999999999999998 488887543211000       0  


Q ss_pred             hccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          265 VKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                             ......  ......+.++.+||.+||+.||.+||++.+|+++++
T Consensus       221 -------~~~~~~--~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         221 -------FYEGQC--MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             -------HHhcCc--cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence                   000000  011112367889999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.8e-41  Score=307.36  Aligned_cols=255  Identities=22%  Similarity=0.349  Sum_probs=205.3

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      .+.|.....||+|+||.||++.+ .++..||||.+..........+.+|+.+++.++|+||+++++.+...+..++||||
T Consensus        21 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          21 REYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            34455567899999999999986 46889999998765555566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++++|.+++..     ..+++..++.++.|++.||.|||++   +++||||||+||+++.++.++|+|||++.......
T Consensus       101 ~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~  172 (292)
T cd06658         101 LEGGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV  172 (292)
T ss_pred             CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence            999999998853     2588999999999999999999999   99999999999999999999999999987654322


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      . ......|+..|+|||.+.+..++.++||||+|+++|||++|..||.......  ...          .+.....+...
T Consensus       173 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~----------~~~~~~~~~~~  239 (292)
T cd06658         173 P-KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--AMR----------RIRDNLPPRVK  239 (292)
T ss_pred             c-cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHH----------HHHhcCCCccc
Confidence            2 2233458899999999988889999999999999999999999996532210  000          00000111111


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                        .....+..+.+++.+||..||.+|||++++++|.+..
T Consensus       240 --~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~  276 (292)
T cd06658         240 --DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLK  276 (292)
T ss_pred             --cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhh
Confidence              1112346788999999999999999999999985543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2.5e-40  Score=301.23  Aligned_cols=264  Identities=25%  Similarity=0.308  Sum_probs=206.3

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh-hhHHHHHHHHHHHhcCCCCcceeEeeEEec--CCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLLGLRGYCAG--TDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~lv~  116 (380)
                      ++|+..++||.|++|.||++.+ .+++.||+|.+..... .....+.+|+++++.++||||+++++++..  .+.+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            4688899999999999999987 4688999999875332 345578899999999999999999998854  34689999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++++|.+++.........+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~  157 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN  157 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence            99999999988764333445689999999999999999999999   999999999999999999999999999876533


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      ..   .....++..|+|||.+.+..++.++|||||||++|+|++|..||........... ..... ...     ...+.
T Consensus       158 ~~---~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~-~~~-----~~~~~  227 (287)
T cd06621         158 SL---AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI-ELLSY-IVN-----MPNPE  227 (287)
T ss_pred             cc---cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChH-HHHHH-Hhc-----CCchh
Confidence            21   1234578899999999988999999999999999999999999975432100000 00000 000     00011


Q ss_pred             ccCCCC--HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          277 LRGDFD--ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       277 ~~~~~~--~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      +.....  ...+..+.+++.+||..+|++|||+.+++.|.+..
T Consensus       228 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~  270 (287)
T cd06621         228 LKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK  270 (287)
T ss_pred             hccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccc
Confidence            111111  22457889999999999999999999999997754

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.3e-40  Score=300.64  Aligned_cols=256  Identities=24%  Similarity=0.391  Sum_probs=202.0

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh----------hhHHHHHHHHHHHhcCCCCcceeEeeEEecCC
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS----------KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD  110 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  110 (380)
                      +|.+.+.||.|++|.||+|.+ .+++.||+|.++....          ...+.+..|+.+++.++||||+++++++...+
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            588899999999999999986 4688999998863211          11235778999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccC
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGF  190 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl  190 (380)
                      ..++||||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||+
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~  154 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGI  154 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccc
Confidence            999999999999999999654    4689999999999999999999998   999999999999999999999999999


Q ss_pred             ccccCCCCcc-ceeccccccCccCccccccCC--CCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcc
Q 037869          191 AKLIPEGVSH-MTTRVKGTLGYLAPEYAMWGK--VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKG  267 (380)
Q Consensus       191 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  267 (380)
                      +......... ......++..|+|||.+....  ++.++|+||||+++|++++|..||.......     .+..   .. 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-----~~~~---~~-  225 (272)
T cd06629         155 SKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA-----AMFK---LG-  225 (272)
T ss_pred             cccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH-----HHHH---hh-
Confidence            9765432111 122345788999999987654  8999999999999999999999986422110     0000   00 


Q ss_pred             ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                        ................+..+.+++.+||..+|..|||+.++++|.+
T Consensus       226 --~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  271 (272)
T cd06629         226 --NKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF  271 (272)
T ss_pred             --ccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCC
Confidence              0000111111222234578999999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.5e-40  Score=299.72  Aligned_cols=254  Identities=25%  Similarity=0.361  Sum_probs=202.6

Q ss_pred             CCCCcceeccCCceEEEEEEeC--CCcEEEEEEeccc----------ChhhHHHHHHHHHHHhc-CCCCcceeEeeEEec
Q 037869           42 GFSDDNKLGEGGFGSVYWGRTS--DGLQIAVKKLKAM----------NSKAEMEFAVEVEVLGR-VRHKNLLGLRGYCAG  108 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~  108 (380)
                      .|++.+.||+|+||.||+|.+.  .+..+|+|.+...          .......+..|+.++.. ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            4888999999999999999874  4788999987532          22334457778888875 799999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCCCCceEEee
Q 037869          109 TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH-EVTPHIIHRDIKASNVLLDSDFEPLVAD  187 (380)
Q Consensus       109 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~-~~~~~ivHrdlkp~Nill~~~~~vkl~D  187 (380)
                      ++..++||||+++++|.+++.........+++..++.++.|++.||.|||+ .   +++|+||+|+||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK---RIVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC---ceeecCCCHHHEEECCCCcEEEec
Confidence            999999999999999999886533344579999999999999999999996 5   899999999999999999999999


Q ss_pred             ccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcc
Q 037869          188 FGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKG  267 (380)
Q Consensus       188 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  267 (380)
                      ||++.......  ......++..|+|||.+.+..++.++||||||+++|+|++|..||.......  ...     .... 
T Consensus       158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~--~~~-----~~~~-  227 (269)
T cd08528         158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS--LAT-----KIVE-  227 (269)
T ss_pred             ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH--HHH-----HHhh-
Confidence            99998765432  2334468899999999998889999999999999999999999986432100  000     0000 


Q ss_pred             ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                             ...........+..+.+++.+||+.||++||++.++..++.
T Consensus       228 -------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         228 -------AVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             -------ccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                   00000111123468899999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.2e-40  Score=302.53  Aligned_cols=258  Identities=24%  Similarity=0.350  Sum_probs=200.3

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHHH-HhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVEV-LGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ++|++.+.||+|+||.||+|.+ .+++.||+|+++... ......+..|+.. ++.++||||+++++++..++..|++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            4689999999999999999987 469999999987532 2333455556664 566789999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |++ |+|.+++.........+++..++.++.|++.||+|||++.  +++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~  157 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS  157 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            996 5888887654344467999999999999999999999742  7999999999999999999999999999875432


Q ss_pred             CccceeccccccCccCcccccc----CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMW----GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                      .  ......++..|+|||.+.+    ..++.++|+||+||++|+|++|..||......... .             ....
T Consensus       158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~-~-------------~~~~  221 (283)
T cd06617         158 V--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQ-L-------------KQVV  221 (283)
T ss_pred             c--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHH-H-------------HHHH
Confidence            1  1222457889999998865    45689999999999999999999999643211000 0             0000


Q ss_pred             CCcccCCC-CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          274 DPKLRGDF-DENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       274 ~~~~~~~~-~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      .. ..... ....+.++.++|.+||..+|.+||++.++++|.+...
T Consensus       222 ~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~  266 (283)
T cd06617         222 EE-PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFEL  266 (283)
T ss_pred             hc-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhh
Confidence            00 00111 1224578999999999999999999999999876543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.8e-40  Score=303.16  Aligned_cols=255  Identities=22%  Similarity=0.306  Sum_probs=207.9

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ..+|++.+.||+|+||.||++.+ .++..|++|.+..........+.+|+.+++.++||||+++++++...+..|+|+||
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~   97 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY   97 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence            47899999999999999999986 46889999998755445556788899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++++|.+++...     .+++..+..++.|++.||.|||++   +++||||+|+||+++.++.++|+|||++.......
T Consensus        98 ~~~~~L~~~~~~~-----~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~  169 (293)
T cd06647          98 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  169 (293)
T ss_pred             CCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccc
Confidence            9999999998643     578889999999999999999999   99999999999999999999999999987654322


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      . ......+++.|+|||.+.+..++.++|+||||+++|++++|..||........  ...+            .......
T Consensus       170 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~--~~~~------------~~~~~~~  234 (293)
T cd06647         170 S-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA--LYLI------------ATNGTPE  234 (293)
T ss_pred             c-ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh--eeeh------------hcCCCCC
Confidence            2 22234578899999999888899999999999999999999999965332110  0000            0000001


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ...+...+..+.++|.+||..+|.+||++.+++.|.+..
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~  273 (293)
T cd06647         235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK  273 (293)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHh
Confidence            112233456789999999999999999999999996543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-41  Score=305.29  Aligned_cols=268  Identities=24%  Similarity=0.328  Sum_probs=204.7

Q ss_pred             CCCCCcceeccCCceEEEEEEeC-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ++|++.+.||+|++|.||+|.+. +++.|++|.++..  .......+.+|+++++.++|+||+++++++..++..++|||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            47999999999999999999874 6889999998753  22334578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |++++.+..+...    ...+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~  153 (288)
T cd07833          81 YVERTLLELLEAS----PGGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRAR  153 (288)
T ss_pred             cCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence            9998766665543    24589999999999999999999999   9999999999999999999999999999876544


Q ss_pred             CccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchh-ccc--------hhhhhcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTIT-EWA--------EPLIVKG  267 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~-~~~--------~~~~~~~  267 (380)
                      .........++..|+|||++.+. .++.++||||||+++|+|++|.+||............ ...        .......
T Consensus       154 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07833         154 PASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP  233 (288)
T ss_pred             ccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCc
Confidence            33233345678999999999887 8899999999999999999999999753321100000 000        0000000


Q ss_pred             ccc-----cccCC-cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          268 KFK-----ELVDP-KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       268 ~~~-----~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .+.     ....+ .....++...+..+.++|.+||..+|++|||+++++++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~  287 (288)
T cd07833         234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY  287 (288)
T ss_pred             cccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCC
Confidence            000     00000 0000122233678999999999999999999999998754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.8e-40  Score=296.83  Aligned_cols=250  Identities=20%  Similarity=0.338  Sum_probs=204.0

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      +|++.+.||+|++|.||++.+ .+++.||+|.+...  .......+.+|+.+++.++||||+++++.+..++..++||||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY   80 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence            588999999999999999986 56889999998643  334456788899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-CceEEeeccCccccCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD-FEPLVADFGFAKLIPEG  197 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~-~~vkl~Dfgl~~~~~~~  197 (380)
                      +++++|.+++....  ...+++..+..++.+++.||+|||++   +++||||+|+||+++.+ +.++|+|||++......
T Consensus        81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (256)
T cd08220          81 APGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK  155 (256)
T ss_pred             CCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC
Confidence            99999999997532  34589999999999999999999999   99999999999999865 46899999999876443


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      .  ......++..|+|||.+.+..++.++||||+|+++|+|++|..||.......  ....             .. ...
T Consensus       156 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~-------------~~-~~~  217 (256)
T cd08220         156 S--KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--LVLK-------------IM-SGT  217 (256)
T ss_pred             c--cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--HHHH-------------HH-hcC
Confidence            2  2223457899999999998889999999999999999999999986532110  0000             00 001


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL  314 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l  314 (380)
                      ....+...+..+.+++.+||+.+|.+|||+.+++.|.
T Consensus       218 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p  254 (256)
T cd08220         218 FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQP  254 (256)
T ss_pred             CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCC
Confidence            1122233457889999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=5.8e-41  Score=305.10  Aligned_cols=267  Identities=23%  Similarity=0.323  Sum_probs=202.1

Q ss_pred             CCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccCh--hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNS--KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ++|++.+.||+|+||.||+|.+. +++.||+|++.....  .....+.+|+++++.++||||+++++++..++..++|||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            47899999999999999999874 689999999864322  234467789999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+++++|..+....    ..+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~  153 (286)
T cd07846          81 FVDHTVLDDLEKYP----NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP  153 (286)
T ss_pred             cCCccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCC
Confidence            99998888776532    3589999999999999999999999   9999999999999999999999999998876433


Q ss_pred             CccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccc-hhccch-------hhhhccc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRT-ITEWAE-------PLIVKGK  268 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-~~~~~~-------~~~~~~~  268 (380)
                      . .......++..|+|||.+.+ ..++.++||||||+++|+|++|.+||.......... ...+..       .......
T Consensus       154 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07846         154 G-EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP  232 (286)
T ss_pred             c-cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence            2 22233457899999999875 457889999999999999999999986433210000 000000       0000000


Q ss_pred             c-ccccCCccc-----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          269 F-KELVDPKLR-----GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       269 ~-~~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      + .....+...     ....+..+..+.+++.+||+.+|++||++.+++.|.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~  285 (286)
T cd07846         233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF  285 (286)
T ss_pred             HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCC
Confidence            0 000000000     0112234578999999999999999999999998854

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.4e-40  Score=302.13  Aligned_cols=270  Identities=27%  Similarity=0.438  Sum_probs=206.7

Q ss_pred             CCCCCcceeccCCceEEEEEEeC-----CCcEEEEEEecccChh-hHHHHHHHHHHHhcCCCCcceeEeeEEec--CCeE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTS-----DGLQIAVKKLKAMNSK-AEMEFAVEVEVLGRVRHKNLLGLRGYCAG--TDQR  112 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~  112 (380)
                      ..|++.+.||+|+||.||+|...     ++..||+|.++..... ....+.+|+++++.++|+||+++++++..  ....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            46788899999999999999742     3688999999865443 45678999999999999999999999876  5578


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      ++||||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.
T Consensus        84 ~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~  157 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK  157 (284)
T ss_pred             EEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEccccccc
Confidence            9999999999999999754   23589999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCccc--eeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          193 LIPEGVSHM--TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       193 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      .........  .....++..|+|||.+.+..++.++||||||+++|+|++|..|+................. .....+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~  236 (284)
T cd05038         158 VLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQ-MIVTRLL  236 (284)
T ss_pred             ccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccccccc-ccHHHHH
Confidence            765322111  1122345679999999888999999999999999999999999865332111100000000 0000011


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ...........+..++.++.+++.+||+.+|.+|||+.+|++.|..+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            11111112222334457899999999999999999999999998653

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.7e-40  Score=298.59  Aligned_cols=252  Identities=27%  Similarity=0.347  Sum_probs=205.3

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      +-|++.+.||.|+||.||+|.+ .++..||+|.+.... ......+.+|+.+++.++||||+++++++..+...++||||
T Consensus         4 ~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             HhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            4578899999999999999986 468899999986432 33345788899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++++|.+++..     ..+++..+..++.|++.|+.+||+.   +++|+||+|+||+++.++.++|+|||++.......
T Consensus        84 ~~~~~l~~~i~~-----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06641          84 LGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ  155 (277)
T ss_pred             CCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccch
Confidence            999999999864     3688999999999999999999998   99999999999999999999999999987654322


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      . ......++..|+|||.+.+..++.++|+||+||++|+|++|..||.......  ..    .          .......
T Consensus       156 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~----~----------~~~~~~~  218 (277)
T cd06641         156 I-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--VL----F----------LIPKNNP  218 (277)
T ss_pred             h-hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--HH----H----------HHhcCCC
Confidence            1 1223457889999999988888999999999999999999999996532210  00    0          0000111


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .......+.++.+++.+||+.+|.+||++.++++|.+..
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~  257 (277)
T cd06641         219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIV  257 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHh
Confidence            122334457889999999999999999999999986543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-40  Score=302.63  Aligned_cols=266  Identities=22%  Similarity=0.326  Sum_probs=199.3

Q ss_pred             hCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccCh-hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      -++|++.+.||.|++|.||+|.+. +++.||+|.+..... .....+.+|+.+++.++|+||+++++++...+..++|||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFE   83 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEe
Confidence            368999999999999999999874 689999999875322 122356689999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+.+ +|.+++...   ...+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||+++.....
T Consensus        84 ~~~~-~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~  156 (291)
T cd07844          84 YLDT-DLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVP  156 (291)
T ss_pred             cCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCC
Confidence            9975 899988654   23688999999999999999999999   9999999999999999999999999998754322


Q ss_pred             CccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh--hcccc-----
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI--VKGKF-----  269 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~-----  269 (380)
                      ... .....++..|+|||++.+ ..++.++||||+|+++|+|++|..||......... .........  ....+     
T Consensus       157 ~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07844         157 SKT-YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQ-LHKIFRVLGTPTEETWPGVSS  234 (291)
T ss_pred             Ccc-ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHH-HHHHHHhcCCCChhhhhhhhh
Confidence            111 122246888999999875 45899999999999999999999999654311100 000000000  00000     


Q ss_pred             ----cc-----ccCCcccCCCCHHH--HHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          270 ----KE-----LVDPKLRGDFDENQ--LKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       270 ----~~-----~~~~~~~~~~~~~~--~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                          ..     .....+... ....  ...+.+++.+||+.+|++|||+.+++.|.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~  290 (291)
T cd07844         235 NPEFKPYSFPFYPPRPLINH-APRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY  290 (291)
T ss_pred             ccccccccccccCChhHHHh-CcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCC
Confidence                00     000000000 0011  267789999999999999999999998764

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=5e-40  Score=296.43  Aligned_cols=254  Identities=25%  Similarity=0.391  Sum_probs=192.1

Q ss_pred             ceeccCCceEEEEEEeC---CCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCC
Q 037869           47 NKLGEGGFGSVYWGRTS---DGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNL  122 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  122 (380)
                      +.||+|+||.||+|...   ++..+++|.++... ......+.+|+.++++++||||+++++++.+....++||||+++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG   80 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence            46999999999999753   35679999987643 233457888999999999999999999999888999999999999


Q ss_pred             CHHHhhccCCC-CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc-c
Q 037869          123 SLLSHLHGQYA-GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS-H  200 (380)
Q Consensus       123 ~L~~~i~~~~~-~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~-~  200 (380)
                      +|.+++..... .....++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++........ .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~  157 (269)
T cd05087          81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYV  157 (269)
T ss_pred             cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceee
Confidence            99999975422 223567788889999999999999999   999999999999999999999999999875432211 1


Q ss_pred             ceeccccccCccCccccccC-------CCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          201 MTTRVKGTLGYLAPEYAMWG-------KVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       201 ~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      ......++..|+|||++.+.       .++.++||||||+++|||++ |..||........  ..     ..........
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~--~~-----~~~~~~~~~~  230 (269)
T cd05087         158 TPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV--LT-----YTVREQQLKL  230 (269)
T ss_pred             cCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH--HH-----HHhhcccCCC
Confidence            12234567889999988642       35889999999999999996 9999965432110  00     0000100111


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ..+.    .....+..+.+++.+|| .+|++|||+.+|+..|.
T Consensus       231 ~~~~----~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         231 PKPR----LKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCc----cCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            1111    11123456888999999 58999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.4e-40  Score=304.40  Aligned_cols=255  Identities=21%  Similarity=0.318  Sum_probs=205.0

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEec
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYM  119 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  119 (380)
                      ..|.....||+|+||.||+|.+ .++..||+|.+..........+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus        21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~  100 (297)
T cd06659          21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL  100 (297)
T ss_pred             hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence            4555667899999999999987 468899999987544445567888999999999999999999999999999999999


Q ss_pred             CCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc
Q 037869          120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS  199 (380)
Q Consensus       120 ~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~  199 (380)
                      ++++|..++..     ..+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++........
T Consensus       101 ~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~  172 (297)
T cd06659         101 QGGALTDIVSQ-----TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP  172 (297)
T ss_pred             CCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccc
Confidence            99999988753     3588999999999999999999999   999999999999999999999999999876543221


Q ss_pred             cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccC
Q 037869          200 HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG  279 (380)
Q Consensus       200 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                       ......++..|+|||++.+..++.++|||||||++|+|++|..||.......  ....      ...    ....  ..
T Consensus       173 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~------~~~----~~~~--~~  237 (297)
T cd06659         173 -KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQ--AMKR------LRD----SPPP--KL  237 (297)
T ss_pred             -cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH------Hhc----cCCC--Cc
Confidence             1233458999999999998889999999999999999999999996432110  0000      000    0000  00


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       280 ~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      ......+..+.+++.+||+.+|.+||++.++++|.+...
T Consensus       238 ~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~  276 (297)
T cd06659         238 KNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQ  276 (297)
T ss_pred             cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhcc
Confidence            111223467889999999999999999999999866443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-42  Score=319.40  Aligned_cols=258  Identities=25%  Similarity=0.363  Sum_probs=219.0

Q ss_pred             HHHHHhhCCCCCcceeccCCceEEEEEEeC--CC--cEEEEEEecccChh-hHHHHHHHHHHHhcCCCCcceeEeeEEec
Q 037869           34 KELHTATNGFSDDNKLGEGGFGSVYWGRTS--DG--LQIAVKKLKAMNSK-AEMEFAVEVEVLGRVRHKNLLGLRGYCAG  108 (380)
Q Consensus        34 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~  108 (380)
                      ..+....++.++.++||+|.||.|+.|.|.  .|  ..||||.++..... ....|++|+.+|.+|+|+|++++||+..+
T Consensus       103 lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~  182 (1039)
T KOG0199|consen  103 LKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD  182 (1039)
T ss_pred             cceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc
Confidence            334556677888999999999999999863  23  45899999865444 56689999999999999999999999886


Q ss_pred             CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          109 TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       109 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                       ....+|||+++.|+|.+.++.  .....+-......++.||+.|+.||.++   ++|||||..+|+++-....|||+||
T Consensus       183 -qp~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DF  256 (1039)
T KOG0199|consen  183 -QPAMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDF  256 (1039)
T ss_pred             -chhhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecc
Confidence             788999999999999999987  3456788999999999999999999999   9999999999999999989999999


Q ss_pred             cCccccCCCCccc--eeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhh
Q 037869          189 GFAKLIPEGVSHM--TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIV  265 (380)
Q Consensus       189 gl~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~  265 (380)
                      ||.+-+.......  .....-...|+|||.+....++.++|||++|+++|||++ |+.||.+..+               
T Consensus       257 GLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g---------------  321 (1039)
T KOG0199|consen  257 GLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRG---------------  321 (1039)
T ss_pred             cceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCH---------------
Confidence            9999886543332  222335778999999999999999999999999999999 8999976432               


Q ss_pred             ccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 037869          266 KGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT  313 (380)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~  313 (380)
                       ..+-+.++.+.+-..+..+++++++++++||..+|.+|||+..|.+.
T Consensus       322 -~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  322 -IQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             -HHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHh
Confidence             12333455666677788899999999999999999999999999754

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=4.3e-40  Score=302.60  Aligned_cols=252  Identities=26%  Similarity=0.383  Sum_probs=201.8

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      +.+.|.+.+.||+|+||+||+|.+ .+++.||+|.+....   ......+.+|+.+++.++||||+++++++..++..++
T Consensus        13 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~l   92 (307)
T cd06607          13 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWL   92 (307)
T ss_pred             cchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEE
Confidence            456799999999999999999987 468999999986432   2334568889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ||||+. |++.+.+...   ...+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++...
T Consensus        93 v~e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~  165 (307)
T cd06607          93 VMEYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLV  165 (307)
T ss_pred             EHHhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceec
Confidence            999997 5777776532   24689999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCccceeccccccCccCccccc---cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAM---WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      ...     ....++..|+|||++.   ...++.++||||||+++|+|++|..||........  ..             .
T Consensus       166 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~--~~-------------~  225 (307)
T cd06607         166 SPA-----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LY-------------H  225 (307)
T ss_pred             CCC-----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH--HH-------------H
Confidence            322     2345788999999874   45688999999999999999999999865321100  00             0


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      +.............+..+.+++.+||+.+|.+||++.+++.|.+..
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  271 (307)
T cd06607         226 IAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVL  271 (307)
T ss_pred             HhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhc
Confidence            0000001111223557899999999999999999999999987644

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.8e-41  Score=327.51  Aligned_cols=275  Identities=20%  Similarity=0.238  Sum_probs=194.5

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeC--CCcEEEEE------------------EecccChhhHHHHHHHHHHHhcCCCC
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTS--DGLQIAVK------------------KLKAMNSKAEMEFAVEVEVLGRVRHK   97 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK------------------~~~~~~~~~~~~~~~E~~~l~~l~h~   97 (380)
                      ...++|++.+.||+|+||+||++..+  .+..++.|                  .+. ........+.+|+.+|+.++||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCC
Confidence            34578999999999999999998642  22222222                  111 1122344678899999999999


Q ss_pred             cceeEeeEEecCCeEEEEEEecCCCCHHHhhccCCC-CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCee
Q 037869           98 NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYA-GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVL  176 (380)
Q Consensus        98 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~-~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nil  176 (380)
                      ||+++++++...+..|+|++++. ++|.+++..... .........+..++.||+.||.|||++   ||+||||||+|||
T Consensus       224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~NIL  299 (501)
T PHA03210        224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIF  299 (501)
T ss_pred             CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEE
Confidence            99999999999999999999995 577777654321 122344667788999999999999999   9999999999999


Q ss_pred             eCCCCceEEeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCC-CCCCCCCcccc
Q 037869          177 LDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP-IEKLPGGVKRT  255 (380)
Q Consensus       177 l~~~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p-~~~~~~~~~~~  255 (380)
                      ++.++.+||+|||++..+............||..|+|||++.+..++.++|||||||++|||++|..+ +..........
T Consensus       300 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~  379 (501)
T PHA03210        300 LNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQ  379 (501)
T ss_pred             ECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHH
Confidence            99999999999999987754433333445799999999999999999999999999999999998754 43322211111


Q ss_pred             hhccchhhh-hcc-------ccccccCC----cccCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          256 ITEWAEPLI-VKG-------KFKELVDP----KLRGDFD-----ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       256 ~~~~~~~~~-~~~-------~~~~~~~~----~~~~~~~-----~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      +........ ...       .+...+..    ......+     ...+.++.++|.+||+.||.+|||+.|++.|.+..
T Consensus       380 ~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~  458 (501)
T PHA03210        380 LLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFS  458 (501)
T ss_pred             HHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhh
Confidence            111000000 000       00000000    0000000     01235678889999999999999999999997753

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.8e-40  Score=295.92  Aligned_cols=254  Identities=26%  Similarity=0.348  Sum_probs=209.4

Q ss_pred             CCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccCh-hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ++|.+.+.||.|++|.||+|.+. +++.|++|++..... .....+.+|+..+..++|+||+++++++..++..++||||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY   80 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence            46889999999999999999875 599999999876543 4456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH-EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~-~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      +++++|.+++...    ..+++..++.++.|++.||+|||+ .   +++||||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~  153 (264)
T cd06623          81 MDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENT  153 (264)
T ss_pred             cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence            9999999999653    578999999999999999999999 8   9999999999999999999999999999876443


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      ... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...........            ..... ...
T Consensus       154 ~~~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~------------~~~~~-~~~  219 (264)
T cd06623         154 LDQ-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFEL------------MQAIC-DGP  219 (264)
T ss_pred             CCc-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHH------------HHHHh-cCC
Confidence            222 2234578999999999988999999999999999999999999976432000000            00000 111


Q ss_pred             cCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          278 RGDFDEN-QLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       278 ~~~~~~~-~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ....+.. .+..+.++|.+||..+|++|||+.+++++.+
T Consensus       220 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~  258 (264)
T cd06623         220 PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPF  258 (264)
T ss_pred             CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHH
Confidence            1122233 5678999999999999999999999999854

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.2e-40  Score=296.21  Aligned_cols=246  Identities=30%  Similarity=0.473  Sum_probs=199.4

Q ss_pred             CCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecC
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMP  120 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  120 (380)
                      +.|++.+.||+|+||.||++.. +++.||+|.++...  ....+.+|+.+++.++||||+++++++.. +..++||||+.
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence            5689999999999999999875 57789999987543  33578889999999999999999999875 45799999999


Q ss_pred             CCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCcc
Q 037869          121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH  200 (380)
Q Consensus       121 ~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~  200 (380)
                      +++|.+++...  ....+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++......   
T Consensus        82 ~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~---  153 (254)
T cd05083          82 KGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG---  153 (254)
T ss_pred             CCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence            99999999754  234688999999999999999999998   9999999999999999999999999998764322   


Q ss_pred             ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCcccC
Q 037869          201 MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG  279 (380)
Q Consensus       201 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                       ......+..|+|||.+.+..++.++|+|||||++|+|++ |..||.......      ..          .........
T Consensus       154 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~~----------~~~~~~~~~  216 (254)
T cd05083         154 -VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------VK----------ECVEKGYRM  216 (254)
T ss_pred             -CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------HH----------HHHhCCCCC
Confidence             112234568999999988899999999999999999998 999986533110      00          001111111


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       280 ~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ..+...+..+.+++.+||+.+|..||++.+++..|.
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  252 (254)
T cd05083         217 EPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLE  252 (254)
T ss_pred             CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHc
Confidence            223344578899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1e-41  Score=292.33  Aligned_cols=276  Identities=22%  Similarity=0.305  Sum_probs=210.0

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEe-CC----CcEEEEEEecccCh--hhHHHHHHHHHHHhcCCCCcceeEeeEEec-
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRT-SD----GLQIAVKKLKAMNS--KAEMEFAVEVEVLGRVRHKNLLGLRGYCAG-  108 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~----~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-  108 (380)
                      ...-..|++...||+|.||.||+|.. ++    +..+|||+++....  ......-+|+.+++.++|||++.+..+|.+ 
T Consensus        20 ve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~   99 (438)
T KOG0666|consen   20 VEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH   99 (438)
T ss_pred             HHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc
Confidence            34557899999999999999999942 22    34789999986532  223467789999999999999999999877 


Q ss_pred             CCeEEEEEEecCCCCHHHhhccCC-CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC----Cce
Q 037869          109 TDQRLIVYDYMPNLSLLSHLHGQY-AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD----FEP  183 (380)
Q Consensus       109 ~~~~~lv~e~~~~g~L~~~i~~~~-~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~----~~v  183 (380)
                      +..+++++||.+. +|...|+-.. .....++...+.+|++||+.|+.|||++   =|+||||||.||||..+    |+|
T Consensus       100 d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~V  175 (438)
T KOG0666|consen  100 DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRV  175 (438)
T ss_pred             CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCee
Confidence            8889999999987 8888886432 2335799999999999999999999998   69999999999999887    999


Q ss_pred             EEeeccCccccCCCCccc--eeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcc----cch
Q 037869          184 LVADFGFAKLIPEGVSHM--TTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVK----RTI  256 (380)
Q Consensus       184 kl~Dfgl~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~----~~~  256 (380)
                      ||+|+|+++.+.......  ...++-|.||+|||.+.|. .||.+.|||+.|||+.||+|..+-|.+......    ...
T Consensus       176 KIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~  255 (438)
T KOG0666|consen  176 KIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQH  255 (438)
T ss_pred             EeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchH
Confidence            999999999987654433  3456789999999999874 699999999999999999999998875433221    122


Q ss_pred             hccchhhhhccccccccCCccc--------------CCCCH-----------HHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 037869          257 TEWAEPLIVKGKFKELVDPKLR--------------GDFDE-----------NQLKQAINVAVLCVQSEPEKRPNMKEVV  311 (380)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~-----------~~~~~~~~li~~cl~~~P~~Rps~~~ll  311 (380)
                      ++....+.+.+....-..+.+.              ..+.+           .-+....+|+.++|..||.+|.|+++.+
T Consensus       256 dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAl  335 (438)
T KOG0666|consen  256 DQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQAL  335 (438)
T ss_pred             HHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHh
Confidence            2222333222222111111110              00000           0123488999999999999999999999


Q ss_pred             HHhcC
Q 037869          312 NTLTG  316 (380)
Q Consensus       312 ~~l~~  316 (380)
                      +|...
T Consensus       336 eh~yF  340 (438)
T KOG0666|consen  336 EHPYF  340 (438)
T ss_pred             ccccc
Confidence            99653

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.1e-40  Score=299.76  Aligned_cols=239  Identities=23%  Similarity=0.372  Sum_probs=187.6

Q ss_pred             eeccCCceEEEEEEeC-------------------------CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeE
Q 037869           48 KLGEGGFGSVYWGRTS-------------------------DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGL  102 (380)
Q Consensus        48 ~Lg~G~~g~Vy~~~~~-------------------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~  102 (380)
                      .||+|+||.||+|...                         ....|++|.+..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            6999999999998631                         113588998876544445578889999999999999999


Q ss_pred             eeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC-
Q 037869          103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF-  181 (380)
Q Consensus       103 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~-  181 (380)
                      ++++......++||||+++|+|..++...   ...+++..+..++.|++.||+|||+.   +|+||||||+||+++..+ 
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARLGL  155 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEeccCc
Confidence            99999999999999999999999988642   34688999999999999999999998   999999999999997543 


Q ss_pred             ------ceEEeeccCccccCCCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHH-hCCCCCCCCCCCcc
Q 037869          182 ------EPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEIL-TGRKPIEKLPGGVK  253 (380)
Q Consensus       182 ------~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell-~g~~p~~~~~~~~~  253 (380)
                            .++++|||++......     ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||........
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence                  4899999988654221     12246788999998875 56899999999999999995 68999865432110


Q ss_pred             cchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          254 RTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .   ..    . .        ..  ...+......+.++|.+||+.+|++|||+.+++++|.
T Consensus       231 ~---~~----~-~--------~~--~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 E---RF----Y-E--------KK--HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             H---HH----H-H--------hc--cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            0   00    0 0        00  0111112357889999999999999999999999873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=6.2e-41  Score=300.51  Aligned_cols=240  Identities=22%  Similarity=0.358  Sum_probs=190.3

Q ss_pred             ceeccCCceEEEEEEeC-C-------CcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           47 NKLGEGGFGSVYWGRTS-D-------GLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~-~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      +.||.|+||.||+|.+. .       ...|++|.+..........+..|+.+++.++||||+++++++..+...++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            47999999999999753 2       234888887655445556788899999999999999999999988999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc--------eEEeeccC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE--------PLVADFGF  190 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~--------vkl~Dfgl  190 (380)
                      +++|+|..++...   ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.        ++++|||+
T Consensus        81 ~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~  154 (258)
T cd05078          81 VKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI  154 (258)
T ss_pred             CCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEeccccc
Confidence            9999999999754   23688999999999999999999999   9999999999999987654        69999999


Q ss_pred             ccccCCCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCC-CCCCCCCCCcccchhccchhhhhccc
Q 037869          191 AKLIPEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGR-KPIEKLPGGVKRTITEWAEPLIVKGK  268 (380)
Q Consensus       191 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~-~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (380)
                      +.....     .....++..|+|||++.+ ..++.++||||||+++|+|++|. .||..........        ...  
T Consensus       155 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~--------~~~--  219 (258)
T cd05078         155 SITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ--------FYE--  219 (258)
T ss_pred             ccccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH--------HHH--
Confidence            875432     122457889999999986 45899999999999999999984 6654322110000        000  


Q ss_pred             cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                              .....+...+.++.+++.+||+.+|++|||++++++.|+
T Consensus       220 --------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         220 --------DRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             --------ccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                    011222233467899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5e-40  Score=298.01  Aligned_cols=255  Identities=27%  Similarity=0.429  Sum_probs=203.2

Q ss_pred             hCCCCCcceeccCCceEEEEEEeC-CCc----EEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTS-DGL----QIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ..+|++.+.||+|+||.||+|.+. ++.    .||+|.+.... ......+.+|+.++..++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~   84 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ   84 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence            467889999999999999999853 333    58999887543 3345678889999999999999999999986 7899


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||+++.
T Consensus        85 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~  158 (279)
T cd05057          85 LITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKL  158 (279)
T ss_pred             EEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCccccc
Confidence            999999999999999754   34589999999999999999999998   999999999999999999999999999987


Q ss_pred             cCCCCccce-eccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          194 IPEGVSHMT-TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       194 ~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      ......... ....++..|+|||.+....++.++||||||+++||+++ |..||......      .+..          
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------~~~~----------  222 (279)
T cd05057         159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV------EIPD----------  222 (279)
T ss_pred             ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH------HHHH----------
Confidence            653322111 11223567999999988889999999999999999998 99999653211      0000          


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ..........+..++..+.+++.+||..+|..||++.++++.+..+
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         223 LLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             HHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            0111111122223446788999999999999999999999998755

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-40  Score=297.74  Aligned_cols=250  Identities=22%  Similarity=0.326  Sum_probs=203.0

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCC---CCcceeEeeEEecCCeEEEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVR---HKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~  116 (380)
                      .|++.+.||.|+||.||+|.+ .++..|++|.++.. .......+.+|+.+++.++   |||++++++++......++||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            588899999999999999986 57899999998753 3344556888999999986   999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++++|.+++...     .+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~L~~~~~~~-----~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  153 (277)
T cd06917          82 EYAEGGSVRTLMKAG-----PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ  153 (277)
T ss_pred             ecCCCCcHHHHHHcc-----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence            999999999998642     688999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      ... ......|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||..........            .....   
T Consensus       154 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~------------~~~~~---  217 (277)
T cd06917         154 NSS-KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMM------------LIPKS---  217 (277)
T ss_pred             Ccc-ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhh------------ccccC---
Confidence            332 2233458899999998875 457899999999999999999999997533210000            00000   


Q ss_pred             cccCCCCH-HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          276 KLRGDFDE-NQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       276 ~~~~~~~~-~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                       .....+. ..+.++.+++.+||+.||.+||++.+++++.+.
T Consensus       218 -~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~  258 (277)
T cd06917         218 -KPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWI  258 (277)
T ss_pred             -CCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHh
Confidence             0011111 145688999999999999999999999998664

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=4.5e-40  Score=294.07  Aligned_cols=254  Identities=25%  Similarity=0.353  Sum_probs=210.1

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      +|.+.+.||.|++|.||++.+ .++..|++|++....  ......+..|+++++.++|||++++++.+......++|+||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~   80 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY   80 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence            588999999999999999987 468999999987543  24556788899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++++|.+++.........+++..+..++.+++.||.+||+.   |++|+||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~  157 (258)
T cd08215          81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV  157 (258)
T ss_pred             cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence            999999999976543446799999999999999999999999   99999999999999999999999999998765432


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                       .......|++.|+|||.+.+..++.++|+||+|+++++|++|..||......      .....         . .....
T Consensus       158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~~---------~-~~~~~  220 (258)
T cd08215         158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELALK---------I-LKGQY  220 (258)
T ss_pred             -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHHH---------H-hcCCC
Confidence             2233346889999999998888999999999999999999999998653210      00000         0 01111


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ...+...+..+.+++.+||..+|++|||+.+++++.+
T Consensus       221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~  257 (258)
T cd08215         221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPF  257 (258)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCC
Confidence            2233345578999999999999999999999998854

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.6e-40  Score=298.09  Aligned_cols=250  Identities=30%  Similarity=0.474  Sum_probs=197.4

Q ss_pred             ceeccCCceEEEEEEeCC-------CcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           47 NKLGEGGFGSVYWGRTSD-------GLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      +.||+|+||.||+|...+       +..|++|.+.... ......+.+|+.+++.++||||+++++++......++||||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL   80 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence            369999999999997532       2578999886532 23455788899999999999999999999988999999999


Q ss_pred             cCCCCHHHhhccCCC---CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC-----ceEEeeccC
Q 037869          119 MPNLSLLSHLHGQYA---GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF-----EPLVADFGF  190 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~---~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~-----~vkl~Dfgl  190 (380)
                      +++++|.+++.....   ....+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++     .++|+|||+
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            999999999965322   224578899999999999999999998   999999999999999877     899999999


Q ss_pred             ccccCCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccc
Q 037869          191 AKLIPEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGK  268 (380)
Q Consensus       191 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (380)
                      +......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   ..   .       
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~---~-------  224 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VL---Q-------  224 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HH---H-------
Confidence            9765332111 1122235678999999998899999999999999999998 999986432110   00   0       


Q ss_pred             cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                         ..........+...+..+.+++.+||..+|.+||++.++++.|.
T Consensus       225 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         225 ---HVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             ---HHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence               00011111223345678899999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-40  Score=304.43  Aligned_cols=270  Identities=20%  Similarity=0.313  Sum_probs=201.4

Q ss_pred             CCCCcceeccCCceEEEEEEeC---CCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecC--CeEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRTS---DGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT--DQRL  113 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~  113 (380)
                      +|.+.+.||+|++|.||+|.+.   ++..||+|.+....   ......+.+|+.+++.++||||+++++++...  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            5889999999999999999873   57899999998632   33345677899999999999999999999887  7899


Q ss_pred             EEEEecCCCCHHHhhccCCCCC-ccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC----CCceEEeec
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGE-VQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS----DFEPLVADF  188 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~-~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~----~~~vkl~Df  188 (380)
                      +||||+++ +|.+.+....... ..+++..++.++.|++.||.|||+.   +++||||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            99999975 7777775433322 3789999999999999999999999   9999999999999999    899999999


Q ss_pred             cCccccCCCCc--cceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccch-------hc
Q 037869          189 GFAKLIPEGVS--HMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI-------TE  258 (380)
Q Consensus       189 gl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~-------~~  258 (380)
                      |++........  .......++..|+|||++.+ ..++.++|||||||++|+|++|.+||...........       ..
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99987643322  11233457899999998876 4589999999999999999999999976543221000       00


Q ss_pred             cchh-----------hhhccccccccCCcccCCCC---------H--HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          259 WAEP-----------LIVKGKFKELVDPKLRGDFD---------E--NQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       259 ~~~~-----------~~~~~~~~~~~~~~~~~~~~---------~--~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      +...           ......+............+         .  ..+..+.+++.+||+.||++|||+.++++|.+
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~  315 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY  315 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCC
Confidence            0000           00000000000000000011         0  23457899999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=6e-40  Score=300.28  Aligned_cols=267  Identities=23%  Similarity=0.298  Sum_probs=203.3

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChh-----hHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSK-----AEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      +|++.+.||.|++|.||+|.+ .+++.|++|.++.....     ....+..|+.+++.++|+||+++++++...+..++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            588899999999999999987 46899999999754322     234567899999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |||+ +++|.+++....   ..+++..++.++.|+++||.|||+.   +++||||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~  153 (298)
T cd07841          81 FEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG  153 (298)
T ss_pred             Eccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeecc
Confidence            9999 889999996541   3699999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhh----h----hc
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL----I----VK  266 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~----~----~~  266 (380)
                      ..... .....++..|+|||.+.+ ..++.++|||||||++|+|++|.+||........  ........    .    ..
T Consensus       154 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         154 SPNRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ--LGKIFEALGTPTEENWPGV  230 (298)
T ss_pred             CCCcc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH--HHHHHHHcCCCchhhhhhc
Confidence            43221 222346788999998864 4678999999999999999999888765332110  00000000    0    00


Q ss_pred             cccccccCCcc-----cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          267 GKFKELVDPKL-----RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       267 ~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      ...........     ........+..+.++|.+||+.+|++|||+.++++|-+.-+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~  287 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSN  287 (298)
T ss_pred             ccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccC
Confidence            00000000000     00112234578899999999999999999999999966443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.1e-40  Score=298.82  Aligned_cols=251  Identities=24%  Similarity=0.314  Sum_probs=207.1

Q ss_pred             CCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      +|++.+.||.|+||.||+|.+. ++..||+|.+....   ......+.+|++++++++||||+++++.+......++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            5889999999999999999874 68999999997532   2345678889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+.+++|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  153 (258)
T cd05578          81 LLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD  153 (258)
T ss_pred             CCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCC
Confidence            99999999999643    4789999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      .  ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||............             ..... .
T Consensus       154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-------------~~~~~-~  217 (258)
T cd05578         154 T--LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR-------------AKQET-A  217 (258)
T ss_pred             c--cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH-------------HHhcc-c
Confidence            2  223345788999999999888999999999999999999999999764421100000             00000 1


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCH--HHHHHHhc
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNM--KEVVNTLT  315 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~--~~ll~~l~  315 (380)
                      ....+...+..+.++|.+||+.||.+||++  +++++|.+
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~  257 (258)
T cd05578         218 DVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPY  257 (258)
T ss_pred             cccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCC
Confidence            123334455889999999999999999999  88887643

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=4.8e-40  Score=295.20  Aligned_cols=249  Identities=29%  Similarity=0.421  Sum_probs=191.4

Q ss_pred             ceeccCCceEEEEEEeC----CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEe-cCCeEEEEEEecC
Q 037869           47 NKLGEGGFGSVYWGRTS----DGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA-GTDQRLIVYDYMP  120 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~~lv~e~~~  120 (380)
                      +.||+|+||.||+|.+.    ....||+|.+... .......+..|+.+++.++||||+++++++. .+...++||||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999752    2457999998643 3344567888999999999999999999775 4556899999999


Q ss_pred             CCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc-
Q 037869          121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS-  199 (380)
Q Consensus       121 ~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~-  199 (380)
                      +|+|.+++...   ....++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+|||+++....... 
T Consensus        81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~  154 (262)
T cd05058          81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY  154 (262)
T ss_pred             CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence            99999999653   23467778889999999999999998   999999999999999999999999999976533211 


Q ss_pred             --cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhC-CCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          200 --HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTG-RKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       200 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                        .......++..|+|||.+.+..++.++|||||||++|||++| .+||......   ..   ..          .....
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~---~~----------~~~~~  218 (262)
T cd05058         155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DI---TV----------YLLQG  218 (262)
T ss_pred             eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HH---HH----------HHhcC
Confidence              111223457789999999888899999999999999999995 5566432210   00   00          00000


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .....+...+..+.+++.+||+.+|++||++.++++.+...
T Consensus       219 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         219 RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            11111223346789999999999999999999999998643

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=6.1e-40  Score=295.73  Aligned_cols=254  Identities=25%  Similarity=0.359  Sum_probs=189.7

Q ss_pred             ceeccCCceEEEEEEeCCC---cEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCC
Q 037869           47 NKLGEGGFGSVYWGRTSDG---LQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNL  122 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  122 (380)
                      +.||+|+||+||++...++   ..+++|.++... ......+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence            3699999999999975332   345677666433 334567889999999999999999999999999999999999999


Q ss_pred             CHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC-ccc
Q 037869          123 SLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV-SHM  201 (380)
Q Consensus       123 ~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~-~~~  201 (380)
                      +|.+++..........++..++.++.|++.||+|||+.   +++||||||+|||++.++.++|+|||++....... ...
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            99999976533334577788889999999999999998   99999999999999999999999999986432111 111


Q ss_pred             eeccccccCccCcccccc-------CCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          202 TTRVKGTLGYLAPEYAMW-------GKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       202 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                      .....++..|+|||++..       ..++.++|||||||++|||++ +..||......  ....    . ...+......
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~--~~~~----~-~~~~~~~~~~  230 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR--EVLN----H-VIKDQQVKLF  230 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH--HHHH----H-HHhhcccccC
Confidence            223457889999998753       245789999999999999997 56777543221  0000    0 0011111112


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .+..    ....+..+.+++..|| .+|++||++.+|++.|.
T Consensus       231 ~~~~----~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQL----ELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCcc----CCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            2222    2224467888999999 67999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-41  Score=333.37  Aligned_cols=261  Identities=24%  Similarity=0.275  Sum_probs=217.8

Q ss_pred             HHHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecc---cChhhHHHHHHHHHHHhcCCCCcceeEeeEEecC
Q 037869           34 KELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKA---MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT  109 (380)
Q Consensus        34 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  109 (380)
                      .++......|.|++.||+|+||.|.+++. .+++.||+|++++   ....+..-|..|-.+|..-+.+.|++++-+|++.
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~  147 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE  147 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence            45556678999999999999999999987 5688899999986   3344455788899999988999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeecc
Q 037869          110 DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG  189 (380)
Q Consensus       110 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfg  189 (380)
                      .++|+||||++||+|..++...    .++++..++.++..++.||..||+.   |+|||||||+|||++..|+|||+|||
T Consensus       148 ~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFG  220 (1317)
T KOG0612|consen  148 RYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFG  220 (1317)
T ss_pred             cceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccch
Confidence            9999999999999999999754    3799999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCccceeccccccCccCccccc----c-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh
Q 037869          190 FAKLIPEGVSHMTTRVKGTLGYLAPEYAM----W-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI  264 (380)
Q Consensus       190 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  264 (380)
                      .+-.+.....-.+...+|||.|++||++.    + +.|+..+|.||+||++|||+.|..||....-              
T Consensus       221 sClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadsl--------------  286 (1317)
T KOG0612|consen  221 SCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSL--------------  286 (1317)
T ss_pred             hHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHH--------------
Confidence            99988755444556667999999999996    3 5699999999999999999999999975221              


Q ss_pred             hccccccccCCcccCCCC--HHHHHHHHHHHHhhcCCCCCCCCC---HHHHHHHhcCC
Q 037869          265 VKGKFKELVDPKLRGDFD--ENQLKQAINVAVLCVQSEPEKRPN---MKEVVNTLTGY  317 (380)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~cl~~~P~~Rps---~~~ll~~l~~~  317 (380)
                       .+.+..+..-.-.-.+|  ..++.++.+||.+.+. +|+.|..   ++++..|++..
T Consensus       287 -veTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~  342 (1317)
T KOG0612|consen  287 -VETYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFE  342 (1317)
T ss_pred             -HHHHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCcccc
Confidence             11222222222222233  3467899999998877 8888887   99999997654

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=3.1e-40  Score=295.13  Aligned_cols=251  Identities=25%  Similarity=0.333  Sum_probs=208.3

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      +|++.+.||.|++|.||++.+ .+++.|++|.+...  .......+..|+.+++.++|+||+++++++......++||||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY   80 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence            588999999999999999976 46889999998742  334455777899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++++|.+++.........+++..++.++.|++.||+|||+.   |++|+||+|.||+++.++.++|+|||++...... 
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-  156 (256)
T cd08530          81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKN-  156 (256)
T ss_pred             cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence            999999999876433345789999999999999999999999   9999999999999999999999999999876543 


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                        ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.......                +.........
T Consensus       157 --~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~----------------~~~~~~~~~~  218 (256)
T cd08530         157 --MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD----------------LRYKVQRGKY  218 (256)
T ss_pred             --CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH----------------HHHHHhcCCC
Confidence              2223457889999999999899999999999999999999999996543210                0000111112


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL  314 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l  314 (380)
                      ...+...+.++.+++.+||+.+|.+||++.++++|.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p  254 (256)
T cd08530         219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP  254 (256)
T ss_pred             CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence            233345667899999999999999999999999885

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.4e-40  Score=302.76  Aligned_cols=255  Identities=27%  Similarity=0.455  Sum_probs=200.7

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCc----EEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGL----QIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~----~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      .++|++.+.||+|+||.||+|.+ .++.    .||+|.+.... ......+.+|+.+++.++||||+++++++.. ...+
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~   84 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS-PTIQ   84 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC-CCce
Confidence            46788899999999999999986 3444    57888887543 2333467889999999999999999999875 4578


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +++||+++|+|.+++...   ...+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++.
T Consensus        85 ~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~  158 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARL  158 (303)
T ss_pred             eeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEcccccccc
Confidence            999999999999998643   34688999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          194 IPEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       194 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      ....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.......   ...             
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~-------------  222 (303)
T cd05110         159 LEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPD-------------  222 (303)
T ss_pred             ccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHH-------------
Confidence            6432221 1222335678999999998899999999999999999997 889986532110   000             


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ..........+..++..+.+++.+||..+|++||++.++++.+...
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         223 LLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             HHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            0001111111223346789999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.7e-41  Score=314.54  Aligned_cols=248  Identities=24%  Similarity=0.400  Sum_probs=198.6

Q ss_pred             CCcceeccCCceEEEEEEe-CCCcEEEEEEec----ccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCe--EEEEE
Q 037869           44 SDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLK----AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQ--RLIVY  116 (380)
Q Consensus        44 ~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~----~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~lv~  116 (380)
                      +..+.||+|+|-+||+|.+ .+|..||=-.++    ...+...+.|..|+.+|+.|+||||++++++|.+...  +.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            3567899999999999987 467777632222    2445666889999999999999999999999988765  78999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-CceEEeeccCccccC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD-FEPLVADFGFAKLIP  195 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~-~~vkl~Dfgl~~~~~  195 (380)
                      |++..|+|..+..+.    ..++...+..|+.||++||.|||++ .++|+|||||-+||||+++ |.|||+|+|||....
T Consensus       123 EL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r  197 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR  197 (632)
T ss_pred             ecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence            999999999999875    4788889999999999999999998 7889999999999999876 999999999999875


Q ss_pred             CCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      ..   ....+.|||.|||||+.. ..|++.+||||||++|+||+|+..||..=..           +...-.++.....|
T Consensus       198 ~s---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n-----------~AQIYKKV~SGiKP  262 (632)
T KOG0584|consen  198 KS---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN-----------PAQIYKKVTSGIKP  262 (632)
T ss_pred             cc---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC-----------HHHHHHHHHcCCCH
Confidence            42   233478999999999776 8899999999999999999999999964221           11111111111111


Q ss_pred             cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .   .+..-...++.+||.+||.. .++|||+.|||.+.+
T Consensus       263 ~---sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~F  298 (632)
T KOG0584|consen  263 A---ALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPF  298 (632)
T ss_pred             H---HhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChh
Confidence            1   11111136889999999999 999999999999854

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=8.8e-40  Score=291.04  Aligned_cols=252  Identities=28%  Similarity=0.417  Sum_probs=207.4

Q ss_pred             CCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecC
Q 037869           42 GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMP  120 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  120 (380)
                      .|++.+.||.|++|.||++.+. ++..|++|++..........+.+|+.+++.++|+|++++++++..+...++++||++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~   80 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS   80 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence            4788999999999999999874 688999999987655566688899999999999999999999999999999999999


Q ss_pred             CCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCcc
Q 037869          121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH  200 (380)
Q Consensus       121 ~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~  200 (380)
                      +++|.+++....   ..+++..+..++.|++.||.+||+.   +++||||+|+||+++.++.++|+|||.+........ 
T Consensus        81 ~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-  153 (253)
T cd05122          81 GGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-  153 (253)
T ss_pred             CCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeecccccccccccc-
Confidence            999999986542   4789999999999999999999998   999999999999999999999999999987654332 


Q ss_pred             ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCC
Q 037869          201 MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGD  280 (380)
Q Consensus       201 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                       .....++..|+|||.+.+..++.++|+||||+++|+|++|..||..........        ...    ....+..  .
T Consensus       154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~--------~~~----~~~~~~~--~  218 (253)
T cd05122         154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF--------KIA----TNGPPGL--R  218 (253)
T ss_pred             -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH--------HHH----hcCCCCc--C
Confidence             334568899999999998889999999999999999999999997542110000        000    0000000  0


Q ss_pred             CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          281 FDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       281 ~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .....+..+.++|.+||+.||++|||+.++++|.+
T Consensus       219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            11112578999999999999999999999998853

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.3e-40  Score=294.25  Aligned_cols=237  Identities=22%  Similarity=0.392  Sum_probs=189.1

Q ss_pred             ceeccCCceEEEEEEeCC-C----------cEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           47 NKLGEGGFGSVYWGRTSD-G----------LQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      +.||+|+||.||+|.+.. +          ..|++|.+...... ...+.+|+.+++.++||||+++++++.. ...++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence            469999999999998743 3          25788877654433 5678899999999999999999999987 778999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC-------ceEEeec
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF-------EPLVADF  188 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~-------~vkl~Df  188 (380)
                      |||+++|+|.+++....   ..+++..+..++.|++.||+|||++   +++||||||+||+++.++       .++|+||
T Consensus        79 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          79 EEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCC
Confidence            99999999999997542   2688999999999999999999998   999999999999999887       7999999


Q ss_pred             cCccccCCCCccceeccccccCccCccccccC--CCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhh
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG--KVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIV  265 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~  265 (380)
                      |++.....     .....++..|+|||++.+.  .++.++||||||+++|+|++ |..||..........      ....
T Consensus       153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~------~~~~  221 (259)
T cd05037         153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER------FYQD  221 (259)
T ss_pred             Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH------HHhc
Confidence            99987543     2223467789999999876  78999999999999999999 577776543111000      0000


Q ss_pred             ccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 037869          266 KGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL  314 (380)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l  314 (380)
                      .            ...+......+.+++.+||..+|.+|||+.++++.|
T Consensus       222 ~------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         222 Q------------HRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             C------------CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            0            000111116888999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-40  Score=294.36  Aligned_cols=252  Identities=23%  Similarity=0.319  Sum_probs=203.9

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc-----ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecC--CeE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM-----NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT--DQR  112 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~  112 (380)
                      ..|++.+.||+|+||.||+|.+ .++..|++|.+...     .......+.+|+.++++++|+||+++++++...  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            5799999999999999999987 56899999987531     223445788899999999999999999998654  468


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      ++++||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||+++
T Consensus        82 ~~v~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~  154 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK  154 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcccccc
Confidence            8999999999999998643    3588999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCc--cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          193 LIPEGVS--HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       193 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      .......  .......++..|+|||.+.+..++.++|+|||||++|+|++|..||......               ..+.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---------------~~~~  219 (264)
T cd06653         155 RIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAM---------------AAIF  219 (264)
T ss_pred             ccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHH---------------HHHH
Confidence            6532111  1122345889999999999888999999999999999999999999653211               0011


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ...........+...+..+.+++.+||. +|..||++.++++|..
T Consensus       220 ~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~  263 (264)
T cd06653         220 KIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPF  263 (264)
T ss_pred             HHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCC
Confidence            1112222234455666889999999999 5799999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=8.5e-40  Score=294.88  Aligned_cols=253  Identities=24%  Similarity=0.378  Sum_probs=189.1

Q ss_pred             ceeccCCceEEEEEEeC---CCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCC
Q 037869           47 NKLGEGGFGSVYWGRTS---DGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNL  122 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g  122 (380)
                      +.||+|+||.||+|...   ....+++|.+.... ......+.+|+.+++.++||||+++++.+......++||||+++|
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence            36999999999999643   34568888876433 233456788999999999999999999999999999999999999


Q ss_pred             CHHHhhccCCCC-CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc-c
Q 037869          123 SLLSHLHGQYAG-EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS-H  200 (380)
Q Consensus       123 ~L~~~i~~~~~~-~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~-~  200 (380)
                      +|.+++...... ....++..+..++.|++.||+|||++   +|+||||||+||+++.++.++|+|||++........ .
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  157 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYI  157 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchhee
Confidence            999999764321 23356788899999999999999999   999999999999999999999999999875432211 1


Q ss_pred             ceeccccccCccCcccccc-------CCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          201 MTTRVKGTLGYLAPEYAMW-------GKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       201 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      ......++..|+|||++..       ..++.++|||||||++|+|++ |..||.......  ...    . .........
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~----~-~~~~~~~~~  230 (269)
T cd05042         158 TKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--VLK----Q-VVREQDIKL  230 (269)
T ss_pred             ccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHH----H-HhhccCccC
Confidence            1122335678999998753       356889999999999999999 788886532210  000    0 000000011


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL  314 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l  314 (380)
                      ..    ...+...+..+.+++..|| .||++|||+++|++.+
T Consensus       231 ~~----~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         231 PK----PQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             CC----CcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            11    1122344567788999999 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5.8e-40  Score=307.62  Aligned_cols=265  Identities=25%  Similarity=0.295  Sum_probs=202.8

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecC-----
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT-----  109 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----  109 (380)
                      ...++|++.+.||+|+||.||+|.+ .+++.||+|++...  .......+.+|+.+++.++||||+++++++...     
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            3568999999999999999999987 47899999998642  233445677899999999999999999988643     


Q ss_pred             -CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          110 -DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       110 -~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                       ...|+||||+. ++|.+.+..      .+++..+..++.|++.||+|||+.   |++||||||+||+++.++.++|+||
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Df  162 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  162 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccC
Confidence             35799999996 488888753      288889999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccc--------
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWA--------  260 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~--------  260 (380)
                      |++.......  ......++..|+|||.+.+..++.++|||||||++|+|++|..||.......  ......        
T Consensus       163 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~  238 (353)
T cd07850         163 GLARTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID--QWNKIIEQLGTPSD  238 (353)
T ss_pred             ccceeCCCCC--CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHhcCCCCH
Confidence            9998764322  1233457889999999999999999999999999999999999997543210  000000        


Q ss_pred             ----------hhhhhc------cccccccC----CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          261 ----------EPLIVK------GKFKELVD----PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       261 ----------~~~~~~------~~~~~~~~----~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                                ......      ..+.....    +..........+..+.++|.+||+.||++|||+.+++.|.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~  314 (353)
T cd07850         239 EFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYI  314 (353)
T ss_pred             HHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhH
Confidence                      000000      00000000    000111122345678999999999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=7e-40  Score=298.89  Aligned_cols=269  Identities=21%  Similarity=0.279  Sum_probs=199.8

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh-hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      +.+.|++.+.||+|+||.||+|.+ .++..|++|.+..... .....+.+|+.+++.++|+||+++++++..+...++||
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            457899999999999999999986 4688999999875332 22335678999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+. +++.+++...   ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....
T Consensus        83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  155 (291)
T cd07870          83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSI  155 (291)
T ss_pred             eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCC
Confidence            9995 6777776533   23577888899999999999999999   999999999999999999999999999876432


Q ss_pred             CCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhh----------hh
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL----------IV  265 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~----------~~  265 (380)
                      ... ......++..|+|||.+.+ ..++.++||||||+++|+|++|..||.............+....          ..
T Consensus       156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         156 PSQ-TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             CCC-CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence            211 1222346889999999875 45789999999999999999999999754321111000000000          00


Q ss_pred             cccc-ccccCCcccCCC---C--HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          266 KGKF-KELVDPKLRGDF---D--ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       266 ~~~~-~~~~~~~~~~~~---~--~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .... ............   .  ...+..+.+++.+|+..||++|||+.+++.|.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~  290 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY  290 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCC
Confidence            0000 000000000000   0  011367889999999999999999999998864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=9.8e-40  Score=299.96  Aligned_cols=256  Identities=22%  Similarity=0.274  Sum_probs=201.5

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      +.|++.+.||+|+||.||++.+ .+++.|++|.+....   ......+.+|+.+++.++||||+++++.+..++..++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            4689999999999999999987 457899999987532   223446778999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||++|++|.+++...    ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||+++....
T Consensus        81 e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~  153 (305)
T cd05609          81 EYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLM  153 (305)
T ss_pred             ecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCc
Confidence            999999999999643    4689999999999999999999999   999999999999999999999999999864210


Q ss_pred             CC--------------ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchh
Q 037869          197 GV--------------SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEP  262 (380)
Q Consensus       197 ~~--------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  262 (380)
                      ..              ........++..|+|||.+.+..++.++|||||||++|+|++|..||.+....      .+...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~~~  227 (305)
T cd05609         154 SLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELFGQ  227 (305)
T ss_pred             CccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHHHH
Confidence            00              00111234688999999998888999999999999999999999999643211      00000


Q ss_pred             hhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCC---HHHHHHHhcCC
Q 037869          263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPN---MKEVVNTLTGY  317 (380)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps---~~~ll~~l~~~  317 (380)
                      .. .+.   ...+    ......+..+.++|.+||+.+|++||+   +.+++++.+..
T Consensus       228 ~~-~~~---~~~~----~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~  277 (305)
T cd05609         228 VI-SDD---IEWP----EGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL  277 (305)
T ss_pred             HH-hcc---cCCC----CccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcccc
Confidence            00 000   0000    011134567899999999999999998   68888886543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=289.03  Aligned_cols=259  Identities=24%  Similarity=0.282  Sum_probs=205.9

Q ss_pred             HhhCCCCCc-ceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcC-CCCcceeEeeEEec----CC
Q 037869           38 TATNGFSDD-NKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAG----TD  110 (380)
Q Consensus        38 ~~~~~y~~~-~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~----~~  110 (380)
                      ..++.|++. ++||-|-.|.|..+.. .+++++|+|++....     ..++|+++.-.. .|||||.++++|+.    ..
T Consensus        58 ~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~-----KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rk  132 (400)
T KOG0604|consen   58 SITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP-----KARREVELHWMASGHPHIVSIIDVYENSYQGRK  132 (400)
T ss_pred             cchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH-----HHHhHhhhhhhhcCCCceEEeehhhhhhccCce
Confidence            356777765 4899999999998875 679999999997643     445677765444 69999999999865    34


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---CCceEEee
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS---DFEPLVAD  187 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~---~~~vkl~D  187 (380)
                      .+.+|||.++||.|+..|+.+  ....+++..+..|+.||..|+.|||+.   +|.||||||+|+|.+.   +..+||+|
T Consensus       133 cLLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtD  207 (400)
T KOG0604|consen  133 CLLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTD  207 (400)
T ss_pred             eeEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecc
Confidence            578999999999999999865  345799999999999999999999999   9999999999999965   46799999


Q ss_pred             ccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcc
Q 037869          188 FGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKG  267 (380)
Q Consensus       188 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  267 (380)
                      ||+++....  .....+.+-|+.|.|||++....|+..+|+||+|+++|.|++|.+||....+..   ++    +    +
T Consensus       208 fGFAK~t~~--~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---is----p----g  274 (400)
T KOG0604|consen  208 FGFAKETQE--PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---IS----P----G  274 (400)
T ss_pred             cccccccCC--CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---CC----h----h
Confidence            999997654  233444567999999999998899999999999999999999999997644311   10    0    0


Q ss_pred             ccccccCC--cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCC
Q 037869          268 KFKELVDP--KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP  319 (380)
Q Consensus       268 ~~~~~~~~--~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~  319 (380)
                      --..+...  .+..+-...++++..++|..+|..+|++|.|+.++++|.|-...
T Consensus       275 Mk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  275 MKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             HHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence            00011111  11223345678899999999999999999999999999886543

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.4e-40  Score=302.82  Aligned_cols=270  Identities=23%  Similarity=0.323  Sum_probs=201.9

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChh--hHHHHHHHHHHHhcCCCCcceeEeeEEecC--CeEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSK--AEMEFAVEVEVLGRVRHKNLLGLRGYCAGT--DQRL  113 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~  113 (380)
                      ..++|++.+.||.|+||.||+|.+ .+++.||+|+++.....  ....+.+|+.+++.++|+||+++++++...  +..+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF   84 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence            346899999999999999999987 46899999998743222  223566799999999999999999998754  5689


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||+.+ +|.+++...   ...+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++..
T Consensus        85 lv~e~~~~-~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~  157 (309)
T cd07845          85 LVMEYCEQ-DLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLART  157 (309)
T ss_pred             EEEecCCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeee
Confidence            99999964 888888643   25689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh--hcccc-
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI--VKGKF-  269 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~-  269 (380)
                      ...... ......++..|+|||++.+ ..++.++||||+||++|+|++|.+||........  .........  ....+ 
T Consensus       158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~--~~~~~~~~~~~~~~~~~  234 (309)
T cd07845         158 YGLPAK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ--LDLIIQLLGTPNESIWP  234 (309)
T ss_pred             cCCccC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCChhhch
Confidence            654321 1222235788999999875 5689999999999999999999999975432111  000000000  00000 


Q ss_pred             --------cccc-CCcccCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          270 --------KELV-DPKLRGD---FDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       270 --------~~~~-~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                              .... .......   .....+..+.++|.+||+.||++|||+.+++.|.+...
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~  295 (309)
T cd07845         235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE  295 (309)
T ss_pred             hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence                    0000 0000000   00123567889999999999999999999999987643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1e-39  Score=296.93  Aligned_cols=253  Identities=23%  Similarity=0.339  Sum_probs=205.1

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecC
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMP  120 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  120 (380)
                      .|...+.||.|++|.||++.+ .+++.|++|++..........+.+|+.+++.++||||+++++++...+..++|+||++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~   99 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLE   99 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccC
Confidence            566678999999999999986 5688999999876555555678899999999999999999999999999999999999


Q ss_pred             CCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCcc
Q 037869          121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH  200 (380)
Q Consensus       121 ~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~  200 (380)
                      +++|.+++..     ..+++..+..++.|++.||+|||++   +++||||+|+||+++.++.++|+|||++........ 
T Consensus       100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-  170 (285)
T cd06648         100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-  170 (285)
T ss_pred             CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-
Confidence            9999999864     3588999999999999999999999   999999999999999999999999998876543222 


Q ss_pred             ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCC
Q 037869          201 MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGD  280 (380)
Q Consensus       201 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      ......|+..|+|||.+.+..++.++||||+|+++|+|++|..||.......  ..    ..      ......+..  .
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~--~~----~~------~~~~~~~~~--~  236 (285)
T cd06648         171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ--AM----KR------IRDNLPPKL--K  236 (285)
T ss_pred             ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH--HH----HH------HHhcCCCCC--c
Confidence            1223458899999999998889999999999999999999999986532100  00    00      000000000  0


Q ss_pred             CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          281 FDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       281 ~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .....+..+.+++.+||+.+|++||++.++++|.+..
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  273 (285)
T cd06648         237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLA  273 (285)
T ss_pred             ccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccc
Confidence            1112446899999999999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.2e-40  Score=298.97  Aligned_cols=258  Identities=25%  Similarity=0.379  Sum_probs=210.6

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ...++.|++.+.||+|++|.||+|.+. ++..|++|++..... ....+.+|+.+++.++|+||+++++.+......++|
T Consensus        15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence            456778999999999999999999874 688999999986544 455788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      +||+++++|.+++....   ..+++..++.++.|++.||+|||+.   |++|+||+|+||+++.++.++|+|||++....
T Consensus        94 ~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          94 MEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             EeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            99999999999997542   3789999999999999999999998   99999999999999999999999999987654


Q ss_pred             CCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      .... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......  ....             ....
T Consensus       168 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~--~~~~-------------~~~~  231 (286)
T cd06614         168 KEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR--ALFL-------------ITTK  231 (286)
T ss_pred             cchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-------------HHhc
Confidence            3221 2223357889999999998889999999999999999999999986532210  0000             0000


Q ss_pred             cc-cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          276 KL-RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       276 ~~-~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .. ........+..+.++|.+||+.+|..|||+.+++++.+..
T Consensus       232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  274 (286)
T cd06614         232 GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK  274 (286)
T ss_pred             CCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhh
Confidence            00 0011122457899999999999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.5e-39  Score=300.32  Aligned_cols=256  Identities=26%  Similarity=0.400  Sum_probs=204.2

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      ..+.|...+.||+|+||.||+|.+ .++..||+|.+...   .......+.+|+.+++.++|||++++++++..+...++
T Consensus        23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l  102 (317)
T cd06635          23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL  102 (317)
T ss_pred             chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence            445688899999999999999986 46889999998642   22334568889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ||||+.| +|.+.+...   ...+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++...
T Consensus       103 v~e~~~g-~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~  175 (317)
T cd06635         103 VMEYCLG-SASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIA  175 (317)
T ss_pred             EEeCCCC-CHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCcccc
Confidence            9999975 787777533   34689999999999999999999999   9999999999999999999999999998754


Q ss_pred             CCCCccceeccccccCccCccccc---cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAM---WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      ..     .....++..|+|||.+.   ...++.++|||||||++|+|++|..||.......  ...             .
T Consensus       176 ~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~-------------~  235 (317)
T cd06635         176 SP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALY-------------H  235 (317)
T ss_pred             CC-----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH--HHH-------------H
Confidence            32     22345788999999874   4568999999999999999999999986532100  000             0


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCCCC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRG  321 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~~~  321 (380)
                      ..............+..+.+++.+||+.+|.+||++.++++|++.+....
T Consensus       236 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         236 IAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             HHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence            00011111112234567899999999999999999999999988765544

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=5.1e-40  Score=298.62  Aligned_cols=264  Identities=21%  Similarity=0.301  Sum_probs=200.1

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      .|++.+.||.|++|.||+|++ .++..||||+++...  ......+.+|++++++++||||+++++++...+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~   80 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF   80 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence            488999999999999999987 468899999987432  22334688899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +. ++|..++...  ....+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~  154 (284)
T cd07860          81 LH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV  154 (284)
T ss_pred             cc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCc
Confidence            96 5898888653  234689999999999999999999999   99999999999999999999999999987654322


Q ss_pred             ccceeccccccCccCccccccCC-CCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhh------------
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIV------------  265 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~------------  265 (380)
                      . ......++..|+|||++.+.. ++.++||||||+++|+|+||..||......  ............            
T Consensus       155 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07860         155 R-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEI--DQLFRIFRTLGTPDEVVWPGVTSL  231 (284)
T ss_pred             c-ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHhCCCChhhhhhhhHH
Confidence            1 122234688999999887644 688999999999999999999999653321  000000000000            


Q ss_pred             ---ccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          266 ---KGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       266 ---~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                         ...+........ .......+..+.++|.+||+.||.+|||+.++++|.+
T Consensus       232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~  283 (284)
T cd07860         232 PDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF  283 (284)
T ss_pred             HHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCC
Confidence               000000000000 0011123467889999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.5e-40  Score=300.07  Aligned_cols=268  Identities=20%  Similarity=0.258  Sum_probs=198.8

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh--hhHHHHHHHHHHHhcCC-CCcceeEeeEEecCCe-----
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS--KAEMEFAVEVEVLGRVR-HKNLLGLRGYCAGTDQ-----  111 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~-----  111 (380)
                      ++|++.+.||.|+||.||+|.+ .+++.||+|+++....  .....+.+|+.+++.+. ||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4799999999999999999987 4689999999864322  22346778999999995 6999999999877665     


Q ss_pred             EEEEEEecCCCCHHHhhccCCCC-CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-CCceEEeecc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAG-EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS-DFEPLVADFG  189 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~-~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~-~~~vkl~Dfg  189 (380)
                      .|+||||+++ +|.+++...... ...+++..++.++.|++.||.|||+.   +++||||+|+||+++. ++.++|+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999985 888888654222 35689999999999999999999999   9999999999999998 8899999999


Q ss_pred             CccccCCCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh-h-c
Q 037869          190 FAKLIPEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI-V-K  266 (380)
Q Consensus       190 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-~-~  266 (380)
                      ++......... .....+++.|+|||.+.+ ..++.++||||||+++|+|++|..||.........  ........ . .
T Consensus       157 ~~~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~~~~~~~~~~~  233 (295)
T cd07837         157 LGRAFSIPVKS-YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LHIFKLLGTPTE  233 (295)
T ss_pred             cceecCCCccc-cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HHHHHHhCCCCh
Confidence            98865332211 122346889999998865 46799999999999999999999999753321100  00000000 0 0


Q ss_pred             cccc---cccC----Cccc----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          267 GKFK---ELVD----PKLR----GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       267 ~~~~---~~~~----~~~~----~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ..+.   ....    +...    .......+..+.++|.+||..||.+||++.+++.|.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~  293 (295)
T cd07837         234 QVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY  293 (295)
T ss_pred             hhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCC
Confidence            0000   0000    0000    0011234567899999999999999999999999865

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.2e-40  Score=299.54  Aligned_cols=267  Identities=24%  Similarity=0.344  Sum_probs=202.0

Q ss_pred             CCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccCh--hhHHHHHHHHHHHhcCCCCcceeEeeEEecC--CeEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNS--KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT--DQRLIV  115 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv  115 (380)
                      +.|++.+.||.|+||.||+|.+. +++.|++|.++....  .....+.+|+.+++.++||||+++++++...  ...|+|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            57999999999999999999874 688999999975332  2233567899999999999999999998877  889999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |||+.+ +|.+++...   ...+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++....
T Consensus        85 ~e~~~~-~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~  157 (293)
T cd07843          85 MEYVEH-DLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYG  157 (293)
T ss_pred             ehhcCc-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeecc
Confidence            999974 898888653   23689999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccch--h--------ccch---
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI--T--------EWAE---  261 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~--~--------~~~~---  261 (380)
                      .... ......++..|+|||.+.+. .++.++||||+|+++|+|++|.+||...........  .        .|..   
T Consensus       158 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         158 SPLK-PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             CCcc-ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            4321 12233468899999988754 468999999999999999999999975432110000  0        0000   


Q ss_pred             -hhhhccccccccCCcccCCCCHH-HHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          262 -PLIVKGKFKELVDPKLRGDFDEN-QLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       262 -~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                       +......+.......+...++.. .+..+.++|.+||+.+|++|||+.+++.|-+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~  292 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY  292 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCC
Confidence             00000000001111111222222 3577899999999999999999999998854

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=1.1e-39  Score=294.65  Aligned_cols=255  Identities=27%  Similarity=0.396  Sum_probs=198.0

Q ss_pred             CCCcceeccCCceEEEEEEe----CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC------
Q 037869           43 FSDDNKLGEGGFGSVYWGRT----SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD------  110 (380)
Q Consensus        43 y~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------  110 (380)
                      |++.+.||+|+||+||+|..    .++..||||++...  .......+.+|+++++.++||||+++++++....      
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            67889999999999999974    24688999998753  3344557888999999999999999999886532      


Q ss_pred             eEEEEEEecCCCCHHHhhccCCC--CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYA--GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~--~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                      ..+++++|+.+|+|.+++.....  ....+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~df  157 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADF  157 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcc
Confidence            24789999999999988753321  223578899999999999999999998   9999999999999999999999999


Q ss_pred             cCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhc
Q 037869          189 GFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVK  266 (380)
Q Consensus       189 gl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~  266 (380)
                      |+++....... .......++..|++||.+.+..++.++|||||||++|+|++ |.+||......   ....    ....
T Consensus       158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~----~~~~  230 (273)
T cd05074         158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYN----YLIK  230 (273)
T ss_pred             cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHH----HHHc
Confidence            99987643221 11222335678999999998889999999999999999999 88888653321   0000    0000


Q ss_pred             cccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .         .....+...+..+.+++.+||+.+|++|||+.+++..|..
T Consensus       231 ~---------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~  271 (273)
T cd05074         231 G---------NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLEL  271 (273)
T ss_pred             C---------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHh
Confidence            0         0001122344689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.3e-39  Score=292.57  Aligned_cols=246  Identities=27%  Similarity=0.320  Sum_probs=201.4

Q ss_pred             eccCCceEEEEEEeC-CCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCCCH
Q 037869           49 LGEGGFGSVYWGRTS-DGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSL  124 (380)
Q Consensus        49 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  124 (380)
                      ||.|++|.||+|.+. ++..|++|++....   ......+.+|+.+++.++||||+++++.+..+...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            799999999999874 58899999987432   23345788899999999999999999999999999999999999999


Q ss_pred             HHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccceec
Q 037869          125 LSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR  204 (380)
Q Consensus       125 ~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~~~  204 (380)
                      .+++.+.    ..+++..+..++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||++.......  ....
T Consensus        81 ~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~  151 (262)
T cd05572          81 WTILRDR----GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWT  151 (262)
T ss_pred             HHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccc
Confidence            9999653    3588999999999999999999998   99999999999999999999999999998765432  2233


Q ss_pred             cccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHH
Q 037869          205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN  284 (380)
Q Consensus       205 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      ..++..|+|||.+.+..++.++|+||+|+++|+|++|..||...........             ............+..
T Consensus       152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~  218 (262)
T cd05572         152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY-------------NDILKGNGKLEFPNY  218 (262)
T ss_pred             ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH-------------HHHhccCCCCCCCcc
Confidence            4678999999999888899999999999999999999999976432110000             011111111223333


Q ss_pred             HHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHhcC
Q 037869          285 QLKQAINVAVLCVQSEPEKRPN-----MKEVVNTLTG  316 (380)
Q Consensus       285 ~~~~~~~li~~cl~~~P~~Rps-----~~~ll~~l~~  316 (380)
                      .+.++.++|.+||+.+|.+||+     +.++++|.+.
T Consensus       219 ~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~  255 (262)
T cd05572         219 IDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF  255 (262)
T ss_pred             cCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhh
Confidence            3678999999999999999999     9999998764

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.7e-39  Score=289.08  Aligned_cols=253  Identities=28%  Similarity=0.398  Sum_probs=209.8

Q ss_pred             CCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccCh--hhHHHHHHHHHHHhcCCCCcceeEeeEEecC--CeEEEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNS--KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT--DQRLIVY  116 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~  116 (380)
                      +|++.+.||+|++|.||+|.+. ++..|++|++.....  .....+.+|+.++++++||||+++++.+...  ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4788899999999999999875 688999999876442  4456788999999999999999999999888  8899999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++++|.+++...    ..+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.++|+|||.+.....
T Consensus        81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~  153 (260)
T cd06606          81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGD  153 (260)
T ss_pred             EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEeccc
Confidence            999999999999754    2789999999999999999999998   999999999999999999999999999987754


Q ss_pred             CCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          197 GVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       197 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      .... ......++..|+|||.+.+..++.++||||||+++|+|++|..||........              ........
T Consensus       154 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--------------~~~~~~~~  219 (260)
T cd06606         154 IETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMA--------------ALYKIGSS  219 (260)
T ss_pred             ccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--------------HHHhcccc
Confidence            3321 12334578999999999888899999999999999999999999976441000              00111111


Q ss_pred             cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ......+...+..+.+++.+||..+|.+||++.+++.|.+
T Consensus       220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~  259 (260)
T cd06606         220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPF  259 (260)
T ss_pred             CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCC
Confidence            2222344445688999999999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=265.21  Aligned_cols=262  Identities=20%  Similarity=0.280  Sum_probs=203.2

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      .|.-.++||+|.||+||+|++ .+++.||+|+++...  ..-.....+|+-+|+.++|.|||+++++...++.+.+|+||
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~   82 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF   82 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence            466678999999999999987 568999999988532  23345788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      |.. +|..+....   ++.++.+.+.+++.|+++||.++|++   ++.||||||+|++|+.+|.+|++|||+++.+.-+.
T Consensus        83 cdq-dlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipv  155 (292)
T KOG0662|consen   83 CDQ-DLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV  155 (292)
T ss_pred             hhH-HHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCce
Confidence            954 788777643   46799999999999999999999999   99999999999999999999999999999875432


Q ss_pred             ccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhcccccc-----
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKE-----  271 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  271 (380)
                      . .....+-|.||++|.++.|. -|+...|+||.|||+.|+.. |.+-|.+.+-  ...+   ...+...+...+     
T Consensus       156 r-cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dv--ddql---krif~~lg~p~ed~wps  229 (292)
T KOG0662|consen  156 R-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV--DDQL---KRIFRLLGTPTEDQWPS  229 (292)
T ss_pred             E-eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcH--HHHH---HHHHHHhCCCccccCCc
Confidence            2 22233469999999999875 58999999999999999997 6666655332  1111   111111221111     


Q ss_pred             ---ccCCcccCCCC---------HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          272 ---LVDPKLRGDFD---------ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       272 ---~~~~~~~~~~~---------~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                         +.+-.....++         +.....-++++++.|.-+|..|.+++..++|...
T Consensus       230 ~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf  286 (292)
T KOG0662|consen  230 MTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYF  286 (292)
T ss_pred             cccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccc
Confidence               11111111222         2233456899999999999999999999998654

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=7.1e-40  Score=293.11  Aligned_cols=252  Identities=21%  Similarity=0.355  Sum_probs=203.5

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      +|++.+.||.|+||.||++.+ .++..||+|.+...  .......+.+|+.+++.++|+||+++++.+..+...++|+||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~   80 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY   80 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence            588899999999999999987 46888999998643  223445778899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC-ceEEeeccCccccCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF-EPLVADFGFAKLIPEG  197 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~-~vkl~Dfgl~~~~~~~  197 (380)
                      +++++|.+++...  ....+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++ .++|+|||.+......
T Consensus        81 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~  155 (257)
T cd08225          81 CDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS  155 (257)
T ss_pred             CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCC
Confidence            9999999998653  223579999999999999999999998   999999999999999885 4699999999876543


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      .. ......|++.|+|||.+.+..++.++|+||||+++|+|++|..||......      ....         ...... 
T Consensus       156 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~---------~~~~~~-  218 (257)
T cd08225         156 ME-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVL---------KICQGY-  218 (257)
T ss_pred             cc-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHH---------HHhccc-
Confidence            22 222345889999999998888999999999999999999999998643210      0000         000000 


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ........+.++.+++.+||..+|++|||+.++++|.+
T Consensus       219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~  256 (257)
T cd08225         219 FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPF  256 (257)
T ss_pred             CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCC
Confidence            11122234468999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.2e-39  Score=296.05  Aligned_cols=266  Identities=22%  Similarity=0.333  Sum_probs=201.7

Q ss_pred             CCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEec
Q 037869           42 GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYM  119 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  119 (380)
                      +|++.++||.|++|.||+|.+. ++..||+|+++... ......+.+|+.+++.++|+||+++++++...+..++||||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   80 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM   80 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence            5889999999999999999974 68899999987543 223446778999999999999999999999999999999999


Q ss_pred             CCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc
Q 037869          120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS  199 (380)
Q Consensus       120 ~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~  199 (380)
                      ++ +|.+++.... ....+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~~-~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~  155 (284)
T cd07836          81 DK-DLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN  155 (284)
T ss_pred             Cc-cHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence            85 8888886542 234689999999999999999999998   999999999999999999999999999976543221


Q ss_pred             cceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhh--hhcccccccc-CC
Q 037869          200 HMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL--IVKGKFKELV-DP  275 (380)
Q Consensus       200 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-~~  275 (380)
                       ......++..|++||++.+ ..++.++||||||+++|+|++|..||........  ........  .....+..+. .+
T Consensus       156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07836         156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ--LLKIFRIMGTPTESTWPGISQLP  232 (284)
T ss_pred             -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhHHHHhcCc
Confidence             1122346889999998865 4578999999999999999999999975432110  00000000  0000000000 00


Q ss_pred             ccc-----------CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          276 KLR-----------GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       276 ~~~-----------~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .+.           ....+..+..+.+++.+||+.||.+||++.++++|.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~  283 (284)
T cd07836         233 EYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW  283 (284)
T ss_pred             hhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCC
Confidence            000           0111233567889999999999999999999998854

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.2e-40  Score=306.96  Aligned_cols=252  Identities=23%  Similarity=0.357  Sum_probs=215.0

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecc--cChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKA--MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      -...|.+...||+|.|+.|.+|++ -++..||||.+.+  ........+.+|+++|..++|||||+++.+.+....+|+|
T Consensus        54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV  133 (596)
T KOG0586|consen   54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV  133 (596)
T ss_pred             cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence            456899999999999999999986 5799999999975  3344455688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |||+.+|.+++++...    ..+.+..+..+|.|+++|++|||++   +|+|||||.+|||++.+-++||+|||++..+.
T Consensus       134 ~eya~~ge~~~yl~~~----gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  134 MEYASGGELFDYLVKH----GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             EEeccCchhHHHHHhc----ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeec
Confidence            9999999999999764    5677789999999999999999999   99999999999999999999999999999886


Q ss_pred             CCCccceeccccccCccCccccccCCC-CccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      .  .......+|++.|.|||++.|..| .+.+|+||+|+++|.|+.|..||++..                   +..+..
T Consensus       207 ~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~-------------------lk~Lr~  265 (596)
T KOG0586|consen  207 Y--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN-------------------LKELRP  265 (596)
T ss_pred             c--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcc-------------------cccccc
Confidence            4  445667789999999999998877 789999999999999999999998532                   111111


Q ss_pred             CcccCC--CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          275 PKLRGD--FDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       275 ~~~~~~--~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      .-++..  .+...+.+..++|.++|-++|.+|++.+++.++.|...
T Consensus       266 rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~  311 (596)
T KOG0586|consen  266 RVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRND  311 (596)
T ss_pred             hheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccch
Confidence            111111  23334578889999999999999999999999977554

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.5e-39  Score=294.58  Aligned_cols=248  Identities=27%  Similarity=0.335  Sum_probs=198.1

Q ss_pred             eccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCCCH
Q 037869           49 LGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSL  124 (380)
Q Consensus        49 Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  124 (380)
                      ||+|+||+||++.+ .+++.|++|.+....   ......+..|+.+++.++||||+++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999986 468899999986422   22334567899999999999999999999999999999999999999


Q ss_pred             HHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccceec
Q 037869          125 LSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR  204 (380)
Q Consensus       125 ~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~~~  204 (380)
                      .+++....  ...+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.......  ....
T Consensus        81 ~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~  153 (277)
T cd05577          81 KYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKG  153 (277)
T ss_pred             HHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccc
Confidence            99986542  24689999999999999999999999   99999999999999999999999999987654321  2223


Q ss_pred             cccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHH
Q 037869          205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN  284 (380)
Q Consensus       205 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      ..++..|+|||.+.+..++.++||||+|+++|+|++|..||..........  .     .... .     .......+..
T Consensus       154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~--~-----~~~~-~-----~~~~~~~~~~  220 (277)
T cd05577         154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKE--E-----LKRR-T-----LEMAVEYPDK  220 (277)
T ss_pred             ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHH--H-----HHhc-c-----ccccccCCcc
Confidence            357889999999988889999999999999999999999996543211000  0     0000 0     0011122333


Q ss_pred             HHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhcC
Q 037869          285 QLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLTG  316 (380)
Q Consensus       285 ~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~~  316 (380)
                      .+..+.++|.+||+.+|.+||     ++.++++|.+.
T Consensus       221 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~  257 (277)
T cd05577         221 FSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF  257 (277)
T ss_pred             CCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhh
Confidence            457889999999999999999     88889988654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.9e-39  Score=294.27  Aligned_cols=246  Identities=23%  Similarity=0.260  Sum_probs=192.4

Q ss_pred             eeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHH---HhcCCCCcceeEeeEEecCCeEEEEEEecC
Q 037869           48 KLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEV---LGRVRHKNLLGLRGYCAGTDQRLIVYDYMP  120 (380)
Q Consensus        48 ~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~---l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  120 (380)
                      .||+|+||.||++.+ .+++.||+|.+....   ......+.+|..+   +....||||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            489999999999987 468899999886422   1112233344433   334579999999999998999999999999


Q ss_pred             CCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCcc
Q 037869          121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH  200 (380)
Q Consensus       121 ~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~  200 (380)
                      +++|.+++...    ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.......  
T Consensus        81 ~~~L~~~i~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--  151 (279)
T cd05633          81 GGDLHYHLSQH----GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (279)
T ss_pred             CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccC--
Confidence            99999988643    4699999999999999999999999   99999999999999999999999999987654321  


Q ss_pred             ceeccccccCccCccccc-cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccC
Q 037869          201 MTTRVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG  279 (380)
Q Consensus       201 ~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                       .....|+..|+|||.+. +..++.++||||+||++|+|++|..||..............              ......
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--------------~~~~~~  216 (279)
T cd05633         152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM--------------TLTVNV  216 (279)
T ss_pred             -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHH--------------hhcCCc
Confidence             22345899999999886 45689999999999999999999999975432111110000              001112


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhcCC
Q 037869          280 DFDENQLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLTGY  317 (380)
Q Consensus       280 ~~~~~~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~~~  317 (380)
                      ..+...+.++.++|.+||+.||.+||     |++++++|.+.-
T Consensus       217 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~  259 (279)
T cd05633         217 ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFK  259 (279)
T ss_pred             CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCcccc
Confidence            23444567899999999999999999     699999997654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-40  Score=307.07  Aligned_cols=268  Identities=21%  Similarity=0.316  Sum_probs=199.8

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecC-----Ce
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT-----DQ  111 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~  111 (380)
                      .+++|++.+.||+|+||.||+|.+ .+++.||+|+++... ......+..|+.+++.++||||+++++++...     ..
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            457899999999999999999986 578999999987432 23344677899999999999999999886543     35


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA  191 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~  191 (380)
                      .++|+||+.+ +|...+..     ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++
T Consensus        83 ~~lv~e~~~~-~l~~~~~~-----~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~  153 (336)
T cd07849          83 VYIVQELMET-DLYKLIKT-----QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLA  153 (336)
T ss_pred             EEEEehhccc-CHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccce
Confidence            7999999964 88877753     3689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc--ceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh--hc
Q 037869          192 KLIPEGVSH--MTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI--VK  266 (380)
Q Consensus       192 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~  266 (380)
                      .........  ......|+..|+|||.+.+ ..++.++||||+||++|+|++|..||.......  ....+.....  ..
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~--~~~~~~~~~~~~~~  231 (336)
T cd07849         154 RIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH--QLNLILGVLGTPSQ  231 (336)
T ss_pred             eeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCCH
Confidence            775432211  1223467899999998764 568999999999999999999999996532100  0000000000  00


Q ss_pred             cccccccC-----------CcccC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          267 GKFKELVD-----------PKLRG---DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       267 ~~~~~~~~-----------~~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ..+..+..           .....   ...+..+..+.+++.+||+.+|++|||+.++++|.+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~  296 (336)
T cd07849         232 EDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLE  296 (336)
T ss_pred             HHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence            00000000           00000   01112356789999999999999999999999996543

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.2e-39  Score=296.75  Aligned_cols=260  Identities=26%  Similarity=0.355  Sum_probs=198.8

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCC-CCcceeEeeEEecCCeEEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVR-HKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ..|...+.||+|+||.||++.+ .+++.||+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            3566778999999999999987 468999999987532 334557888999999996 9999999999998899999999


Q ss_pred             ecCCCCHHHhhccCC-CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          118 YMPNLSLLSHLHGQY-AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~-~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      |+.. ++.++..... .....+++..+..++.|++.||+|||+..  +++||||||+||+++.++.++|+|||++.....
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            9864 6555432111 12357899999999999999999999621  899999999999999999999999999976543


Q ss_pred             CCccceeccccccCccCccccccC---CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWG---KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                      ...  .....|+..|+|||++.+.   .++.++||||+||++|+|++|..||......    ...       ........
T Consensus       161 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~----~~~-------~~~~~~~~  227 (288)
T cd06616         161 SIA--KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSV----FDQ-------LTQVVKGD  227 (288)
T ss_pred             CCc--cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchH----HHH-------HhhhcCCC
Confidence            221  2223578899999999866   6899999999999999999999999653210    000       00000000


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .+.+........+..+.+|+.+||+.+|++|||+.+|+.|.+.
T Consensus       228 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~  270 (288)
T cd06616         228 PPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFI  270 (288)
T ss_pred             CCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhh
Confidence            1111122223456789999999999999999999999999664

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.4e-39  Score=293.78  Aligned_cols=262  Identities=22%  Similarity=0.258  Sum_probs=196.2

Q ss_pred             CCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCC-CCcceeEeeEEecC--CeEEEEEE
Q 037869           43 FSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVR-HKNLLGLRGYCAGT--DQRLIVYD  117 (380)
Q Consensus        43 y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~lv~e  117 (380)
                      |++.+.||+|+||.||+|.+ .++..||+|+++... .........|+.++.++. |+||+++++++.+.  +..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            77889999999999999986 468899999987532 222334457888898885 99999999999877  88999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |++ ++|.+.+...   ...+++..++.++.|++.||+|||+.   +++||||+|+||+++. +.++|+|||++......
T Consensus        81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~  152 (282)
T cd07831          81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSK  152 (282)
T ss_pred             cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence            997 5888887643   24689999999999999999999999   9999999999999999 99999999999876432


Q ss_pred             CccceeccccccCccCccccc-cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCccc-c--------hhccchhhhhcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKR-T--------ITEWAEPLIVKG  267 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-~--------~~~~~~~~~~~~  267 (380)
                      ..  .....++..|+|||.+. +..++.++||||+||++|+|++|..||......... .        ...+... ....
T Consensus       153 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  229 (282)
T cd07831         153 PP--YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKK-FRKS  229 (282)
T ss_pred             CC--cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHh-hccc
Confidence            21  22345789999999765 455789999999999999999999999754321100 0        0000000 0000


Q ss_pred             ccccccCCccc----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          268 KFKELVDPKLR----GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       268 ~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .......+...    .......+..+.++|.+||+.+|++||++.++++|.+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~  281 (282)
T cd07831         230 RHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY  281 (282)
T ss_pred             ccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCC
Confidence            00000000000    0111234688999999999999999999999999864

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-39  Score=296.80  Aligned_cols=264  Identities=25%  Similarity=0.355  Sum_probs=201.5

Q ss_pred             CCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecC--CeEEEEEE
Q 037869           43 FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT--DQRLIVYD  117 (380)
Q Consensus        43 y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~lv~e  117 (380)
                      |++.+.||.|++|.||+|.+. +++.||+|++....  ......+.+|+.+++.++|+|++++++++...  +..++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            678899999999999999874 58899999998652  33345678899999999999999999999887  78999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+++ +|.+++...   ...+++..++.++.|++.||++||+.   +++|+||+|+||+++.++.++|+|||++......
T Consensus        81 ~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~  153 (287)
T cd07840          81 YMDH-DLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKR  153 (287)
T ss_pred             cccc-cHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence            9975 888888643   24789999999999999999999998   9999999999999999999999999999876544


Q ss_pred             CccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhh--hhcccccc---
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL--IVKGKFKE---  271 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~---  271 (380)
                      .........++..|+|||.+.+ ..++.++||||||+++|+|++|..||.......  .........  .....+..   
T Consensus       154 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  231 (287)
T cd07840         154 NSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELE--QLEKIFELCGSPTDENWPGVSK  231 (287)
T ss_pred             CcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCchhhcccccc
Confidence            3222333456889999998765 457999999999999999999999997543211  000000000  00000000   


Q ss_pred             -----------ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          272 -----------LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       272 -----------~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                                 .....+...+...++..+.+++.+||+.+|.+||++.+++++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~  286 (287)
T cd07840         232 LPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEY  286 (287)
T ss_pred             chhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcC
Confidence                       00000000111112578899999999999999999999998854

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-39  Score=294.24  Aligned_cols=264  Identities=22%  Similarity=0.297  Sum_probs=199.7

Q ss_pred             CCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEec
Q 037869           43 FSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYM  119 (380)
Q Consensus        43 y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  119 (380)
                      |++.+.||.|++|.||+|.+ .++..||+|++....  ......+.+|+.+++.++|||++++++++...+..+++|||+
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~   80 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL   80 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence            67889999999999999986 478999999987432  222346778999999999999999999999999999999999


Q ss_pred             CCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc
Q 037869          120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS  199 (380)
Q Consensus       120 ~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~  199 (380)
                      + ++|.+++....  ...+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~  154 (283)
T cd07835          81 D-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR  154 (283)
T ss_pred             C-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc
Confidence            5 68999886542  24689999999999999999999998   999999999999999999999999999976543221


Q ss_pred             cceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh-----------hcc
Q 037869          200 HMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI-----------VKG  267 (380)
Q Consensus       200 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-----------~~~  267 (380)
                      . .....++..|+|||++.+. .++.++||||||+++|+|++|..||.......  ....+.....           ...
T Consensus       155 ~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         155 T-YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID--QLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             c-cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChHHhhhhhhch
Confidence            1 1222468899999988754 57899999999999999999999997543210  0000000000           000


Q ss_pred             cccccc---CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          268 KFKELV---DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       268 ~~~~~~---~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .+....   ............+..+.++|.+||+.+|.+|||+++++.+.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~  282 (283)
T cd07835         232 DYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY  282 (283)
T ss_pred             hhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCC
Confidence            000000   000001112234467899999999999999999999998854

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-39  Score=286.87  Aligned_cols=249  Identities=26%  Similarity=0.388  Sum_probs=206.5

Q ss_pred             CCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccCh--hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           42 GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNS--KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      +|++.+.||+|++|.||++.+. +++.|++|.+.....  .....+.+|++++++++|+|++++++++..++..+++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY   80 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence            5889999999999999999874 678999999976543  4556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++++|.+++...    ..+++..++.++.|++.||.+||+.   |++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  153 (254)
T cd06627          81 AENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS  153 (254)
T ss_pred             CCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCc
Confidence            9999999998653    5789999999999999999999999   99999999999999999999999999998765433


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      .. .....++..|+|||.+.+..++.++||||+|+++|+|++|..||........  .  +.        ..    ....
T Consensus       154 ~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~--~--~~--------~~----~~~~  216 (254)
T cd06627         154 KD-DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA--L--FR--------IV----QDDH  216 (254)
T ss_pred             cc-ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH--H--HH--------Hh----ccCC
Confidence            21 2334578999999999888899999999999999999999999965331000  0  00        00    0111


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL  314 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l  314 (380)
                      ...+...+..+.+++.+||..+|++|||+.+++.+-
T Consensus       217 ~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~  252 (254)
T cd06627         217 PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHP  252 (254)
T ss_pred             CCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCC
Confidence            123334457889999999999999999999999863

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=7e-40  Score=305.11  Aligned_cols=268  Identities=21%  Similarity=0.300  Sum_probs=201.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecC-----C
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT-----D  110 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~  110 (380)
                      ..++|.+.+.||+|+||+||+|++ .++..||||.+...  .......+.+|+.+++.++|+||+++++++...     .
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            356899999999999999999986 56899999998742  223344677899999999999999999987643     3


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccC
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGF  190 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl  190 (380)
                      ..|+|+||+. ++|.+++...    ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~  154 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSS----QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGL  154 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCcc
Confidence            4799999995 6888888643    4699999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccc-hhccc-------h
Q 037869          191 AKLIPEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRT-ITEWA-------E  261 (380)
Q Consensus       191 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-~~~~~-------~  261 (380)
                      +....... .......++..|+|||.+.+ ..++.++|||||||++|+|++|..||.......... .....       .
T Consensus       155 ~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  233 (337)
T cd07858         155 ARTTSEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDL  233 (337)
T ss_pred             ccccCCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHh
Confidence            98764322 22233457889999998864 568999999999999999999999996532100000 00000       0


Q ss_pred             hhhhccccccc-------cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          262 PLIVKGKFKEL-------VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       262 ~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ...........       ..... .......+..+.++|.+||+.+|++|||+.++++|.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~  294 (337)
T cd07858         234 GFIRNEKARRYIRSLPYTPRQSF-ARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL  294 (337)
T ss_pred             hhcCchhhhHHHHhcCcccccCH-HHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcch
Confidence            00000000000       00000 01112345778999999999999999999999999654

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=336.98  Aligned_cols=256  Identities=28%  Similarity=0.370  Sum_probs=212.6

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      .+-+|.....||.|.||.||.|.+ .+|+-.|+|.++-..  .+......+|+.++..++|||+|+++|+-...+..+|.
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IF 1312 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIF 1312 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHH
Confidence            344677788999999999999986 679999999987432  23334577899999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      ||||.+|+|.+.+...    .-.++.....+..|++.|++|||++   |||||||||.||+++.+|.+|++|||.+..+.
T Consensus      1313 MEyC~~GsLa~ll~~g----ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~ 1385 (1509)
T KOG4645|consen 1313 MEYCEGGSLASLLEHG----RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIK 1385 (1509)
T ss_pred             HHHhccCcHHHHHHhc----chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEec
Confidence            9999999999999653    4577778888999999999999999   99999999999999999999999999998876


Q ss_pred             CCCcc---ceeccccccCccCccccccC---CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccc
Q 037869          196 EGVSH---MTTRVKGTLGYLAPEYAMWG---KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKF  269 (380)
Q Consensus       196 ~~~~~---~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  269 (380)
                      .....   ......||+.|||||++.+.   .-..++||||||||+.||+||+.||...+..       |        .+
T Consensus      1386 ~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~--------aI 1450 (1509)
T KOG4645|consen 1386 NNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------W--------AI 1450 (1509)
T ss_pred             CchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------h--------HH
Confidence            54322   23346799999999999864   3567899999999999999999999875431       1        11


Q ss_pred             ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .--+..+..+..|...+.+..++|.+||..||+.|+++.||++|-..
T Consensus      1451 My~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1451 MYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred             HhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcc
Confidence            11223344556677788999999999999999999999999999554

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2.5e-39  Score=296.72  Aligned_cols=268  Identities=24%  Similarity=0.350  Sum_probs=200.9

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC----
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD----  110 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----  110 (380)
                      ...++|++.+.||+|+||.||+|.+. +++.||+|+++...  ......+.+|+.+++.++||||+++++++.+..    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            35678999999999999999999874 68899999997532  223346778999999999999999999987654    


Q ss_pred             ------eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceE
Q 037869          111 ------QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL  184 (380)
Q Consensus       111 ------~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vk  184 (380)
                            ..++|+||+++ ++...+...   ...+++..++.++.|++.||+|||+.   +++||||+|+||+++.++.+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~k  156 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIK  156 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEE
Confidence                  78999999976 777777543   34689999999999999999999999   999999999999999999999


Q ss_pred             EeeccCccccCCCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhh
Q 037869          185 VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL  263 (380)
Q Consensus       185 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  263 (380)
                      |+|||++...............++..|+|||.+.+ ..++.++|||||||++|+|++|.+||.......  ....+....
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~--~~~~~~~~~  234 (302)
T cd07864         157 LADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA--QLELISRLC  234 (302)
T ss_pred             eCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHh
Confidence            99999998765433222222345788999998865 457899999999999999999999997532210  000000000


Q ss_pred             --hhccccccccC--------------CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          264 --IVKGKFKELVD--------------PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       264 --~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                        .....+..+..              .... ......+..+.+++.+||+.+|.+||++.+++.|.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~  301 (302)
T cd07864         235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW  301 (302)
T ss_pred             CCCChhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence              00000000000              0000 011123578899999999999999999999998854

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=279.66  Aligned_cols=256  Identities=24%  Similarity=0.348  Sum_probs=200.5

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      +...++..||.|+.|.||+++. .+|...|||.+.... ..+..+++..+.++..- .+|+||+++|+|..+...+|.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            3445678899999999999987 468999999998644 44455777788776655 48999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      .+.. .+..++.+.   ..++++..+..+...++.||.||...+  +|+|||+||+|||++..|+|||||||++-++-+.
T Consensus       172 lMs~-C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  172 LMST-CAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HHHH-HHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc
Confidence            9843 455555543   357999999999999999999999875  9999999999999999999999999999887543


Q ss_pred             CccceeccccccCccCccccc---cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          198 VSHMTTRVKGTLGYLAPEYAM---WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                        .......|-+.|||||.+.   ...|+-.+||||||++++||.||+.||.+-..... .++          .+.+...
T Consensus       246 --kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe-~lt----------kvln~eP  312 (391)
T KOG0983|consen  246 --KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE-VLT----------KVLNEEP  312 (391)
T ss_pred             --cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH-HHH----------HHHhcCC
Confidence              3344456889999999987   34689999999999999999999999986332111 111          0111111


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      +.+...  ...+.++.+++..||.+|+.+||.+.+|++|..-.
T Consensus       313 P~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~  353 (391)
T KOG0983|consen  313 PLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIK  353 (391)
T ss_pred             CCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcCccee
Confidence            222111  12568899999999999999999999999996543

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=5.7e-39  Score=297.88  Aligned_cols=265  Identities=22%  Similarity=0.302  Sum_probs=197.9

Q ss_pred             cceeccC--CceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecC
Q 037869           46 DNKLGEG--GFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMP  120 (380)
Q Consensus        46 ~~~Lg~G--~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  120 (380)
                      ...||.|  +||+||+|.+ .+++.||+|++...  .......+.+|+.+++.++||||+++++++...+..++||||+.
T Consensus         3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            3567777  9999999987 57999999998743  23344678889999999999999999999999999999999999


Q ss_pred             CCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCcc
Q 037869          121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH  200 (380)
Q Consensus       121 ~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~  200 (380)
                      +++|.+++....  ...+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++++||+.+.........
T Consensus        83 ~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          83 YGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             CCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            999999987542  23588999999999999999999998   9999999999999999999999999865433211111


Q ss_pred             c------eeccccccCccCccccccC--CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchh----------
Q 037869          201 M------TTRVKGTLGYLAPEYAMWG--KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEP----------  262 (380)
Q Consensus       201 ~------~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~----------  262 (380)
                      .      .....++..|+|||++.+.  .++.++||||+||++|+|++|..||......... ......+          
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~  236 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML-LQKLKGPPYSPLDITTF  236 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH-HHHhcCCCCCCcccccc
Confidence            0      1112346679999999763  4789999999999999999999999754321100 0000000          


Q ss_pred             ---------------------hhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          263 ---------------------LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       263 ---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                                           ..............+........+..+.+|+.+||+.||++|||+.++++|.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~  311 (328)
T cd08226         237 PCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF  311 (328)
T ss_pred             chhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHH
Confidence                                 000000001111112222334566789999999999999999999999999763

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.6e-39  Score=294.32  Aligned_cols=251  Identities=22%  Similarity=0.328  Sum_probs=202.1

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecC
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMP  120 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  120 (380)
                      .|....+||+|+||.||++.. .+++.||+|++..........+.+|+.+++.++|+||+++++.+...+..++||||++
T Consensus        21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  100 (292)
T cd06657          21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE  100 (292)
T ss_pred             HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence            344457899999999999987 5789999999876555556678889999999999999999999999999999999999


Q ss_pred             CCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCcc
Q 037869          121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH  200 (380)
Q Consensus       121 ~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~  200 (380)
                      +++|.+++..     ..+++..++.++.|++.||+|||+.   |++||||+|+||+++.++.++|+|||++........ 
T Consensus       101 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-  171 (292)
T cd06657         101 GGALTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-  171 (292)
T ss_pred             CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccc-
Confidence            9999988753     2578999999999999999999999   999999999999999999999999999876543221 


Q ss_pred             ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCC
Q 037869          201 MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGD  280 (380)
Q Consensus       201 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                      ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.......  ....          ........+.  
T Consensus       172 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~--~~~~----------~~~~~~~~~~--  237 (292)
T cd06657         172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKM----------IRDNLPPKLK--  237 (292)
T ss_pred             cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH----------HHhhCCcccC--
Confidence            1233457899999999988888999999999999999999999986532110  0000          0000001110  


Q ss_pred             CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          281 FDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       281 ~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .....+..+.+++.+||+.+|.+||++.++++|.+
T Consensus       238 ~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~  272 (292)
T cd06657         238 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPF  272 (292)
T ss_pred             CcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChH
Confidence            11223467889999999999999999999999855

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.2e-39  Score=295.32  Aligned_cols=251  Identities=27%  Similarity=0.379  Sum_probs=206.6

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCC-CCcceeEeeEEecCCeEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVR-HKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv  115 (380)
                      ++|.+.+.||+|++|.||+|.+ .++..|++|++...   .......+..|+.+++.++ ||||+++++++..++..++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            4799999999999999999987 47899999998652   2233456788999999998 99999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |||+++++|.+++...    ..+++..++.++.|++.||.+||+.   +++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~  153 (280)
T cd05581          81 LEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLD  153 (280)
T ss_pred             EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccC
Confidence            9999999999999654    3799999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCc-------------------cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccch
Q 037869          196 EGVS-------------------HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI  256 (380)
Q Consensus       196 ~~~~-------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  256 (380)
                      ....                   .......++..|+|||++.+..++.++||||||++++++++|..||......  ...
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~  231 (280)
T cd05581         154 PNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY--LTF  231 (280)
T ss_pred             CccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH--HHH
Confidence            3321                   1222345788999999998888999999999999999999999999754310  000


Q ss_pred             hccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH----HHHHHHhc
Q 037869          257 TEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNM----KEVVNTLT  315 (380)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~----~~ll~~l~  315 (380)
                                   ....  ......+...+..+.+++.+||+.+|.+|||+    +++++|.+
T Consensus       232 -------------~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~  279 (280)
T cd05581         232 -------------QKIL--KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF  279 (280)
T ss_pred             -------------HHHH--hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCC
Confidence                         0000  01112333345788999999999999999999    99998864

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=8.2e-40  Score=304.31  Aligned_cols=269  Identities=20%  Similarity=0.295  Sum_probs=202.7

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEec----CCe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG----TDQ  111 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~  111 (380)
                      ...+|++.+.||.|++|.||+|.+ .++..||+|++....  ......+.+|+.+++.++||||+++++++..    ...
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   82 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD   82 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence            347899999999999999999986 468999999987532  2334567789999999999999999998753    356


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA  191 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~  191 (380)
                      .++||||+. ++|.+++...    ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++
T Consensus        83 ~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~  154 (334)
T cd07855          83 VYVVMDLME-SDLHHIIHSD----QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMA  154 (334)
T ss_pred             EEEEEehhh-hhHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccc
Confidence            899999995 5898888543    4589999999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCcc---ceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchh-----
Q 037869          192 KLIPEGVSH---MTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEP-----  262 (380)
Q Consensus       192 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-----  262 (380)
                      .........   ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||........  ...+...     
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~--~~~~~~~~g~~~  232 (334)
T cd07855         155 RGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ--LKLILSVLGSPS  232 (334)
T ss_pred             eeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH--HHHHHHHhCCCh
Confidence            765432211   1223468899999998865 5689999999999999999999999965332100  0000000     


Q ss_pred             -hh----hccccccccC-CcccC-----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          263 -LI----VKGKFKELVD-PKLRG-----DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       263 -~~----~~~~~~~~~~-~~~~~-----~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                       ..    ....+..... .....     ......+.++.++|.+||+.+|.+|||+.+++.|.+.-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~  298 (334)
T cd07855         233 EEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA  298 (334)
T ss_pred             hHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhh
Confidence             00    0000000000 00000     11123457899999999999999999999999997754

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.8e-40  Score=303.61  Aligned_cols=265  Identities=23%  Similarity=0.301  Sum_probs=204.3

Q ss_pred             CCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC-----eEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD-----QRL  113 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~  113 (380)
                      +|++.+.||.|++|.||+|.+. ++..|++|++....  ......+.+|+.+++.++|+||+++++++....     ..|
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5899999999999999999874 58999999987643  344557888999999999999999999987765     789


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||++ ++|.+++...    ..+++..++.++.|++.||++||+.   |++||||||+||+++.++.++|+|||++..
T Consensus        81 lv~e~~~-~~l~~~l~~~----~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~  152 (330)
T cd07834          81 IVTELME-TDLHKVIKSP----QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARG  152 (330)
T ss_pred             EEecchh-hhHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEe
Confidence            9999997 4888888643    3799999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCc--cceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhh-------
Q 037869          194 IPEGVS--HMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL-------  263 (380)
Q Consensus       194 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-------  263 (380)
                      ......  .......++..|+|||++.+. .++.++|+||||+++|+|++|.+||........  ........       
T Consensus       153 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~  230 (330)
T cd07834         153 VDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ--LNLIVEVLGTPSEED  230 (330)
T ss_pred             ecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH--HHHHHHhcCCCChhH
Confidence            654321  122334578999999999877 789999999999999999999999975432100  00000000       


Q ss_pred             ---hhcccccccc---CCcc---cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          264 ---IVKGKFKELV---DPKL---RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       264 ---~~~~~~~~~~---~~~~---~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                         ..........   ....   ........+..+.++|.+||+.+|.+|||+.+++.|.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~  292 (330)
T cd07834         231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYL  292 (330)
T ss_pred             hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccH
Confidence               0000000000   0000   000112245788999999999999999999999999654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.6e-39  Score=295.35  Aligned_cols=254  Identities=25%  Similarity=0.378  Sum_probs=201.8

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      +.+.|...+.||+|++|.||+|++ .++..|++|.+...   .......+.+|+.+++.++|+|++++++++......++
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   92 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL   92 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence            445688889999999999999987 46788999998642   22334567789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ||||+. |++.+.+...   ...+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++...
T Consensus        93 v~e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  165 (308)
T cd06634          93 VMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM  165 (308)
T ss_pred             EEEccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceee
Confidence            999996 5887777533   24588999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCccceeccccccCccCccccc---cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAM---WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      ...     ....++..|+|||.+.   ...++.++|||||||++|+|++|..||........  ..             .
T Consensus       166 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~-------------~  225 (308)
T cd06634         166 APA-----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LY-------------H  225 (308)
T ss_pred             cCc-----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH--HH-------------H
Confidence            321     2345788999999875   35678899999999999999999999865321100  00             0


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP  319 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~  319 (380)
                      ..............+..+.++|.+||+.+|.+||++.+++++.+....
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         226 IAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             HhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence            000000111122455778999999999999999999999999876643

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.7e-38  Score=286.09  Aligned_cols=253  Identities=25%  Similarity=0.266  Sum_probs=197.6

Q ss_pred             HHHHHhhCCCCCccee--ccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecC
Q 037869           34 KELHTATNGFSDDNKL--GEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGT  109 (380)
Q Consensus        34 ~~~~~~~~~y~~~~~L--g~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  109 (380)
                      .+.....+.|++.+.+  |.|+||.||++.. .++..+|+|.+........     |+.....+ +||||+++++.+...
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~   81 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTL   81 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecC
Confidence            3445556788888877  9999999999986 5688899999875322211     22222212 699999999999999


Q ss_pred             CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC-ceEEeec
Q 037869          110 DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF-EPLVADF  188 (380)
Q Consensus       110 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~-~vkl~Df  188 (380)
                      +..++||||+++++|.+++...    ..+++..++.++.|++.||.|||+.   +++||||+|+||+++.++ .++|+||
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~df  154 (267)
T PHA03390         82 KGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDY  154 (267)
T ss_pred             CeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecC
Confidence            9999999999999999999654    3789999999999999999999999   999999999999999988 9999999


Q ss_pred             cCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccc
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGK  268 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (380)
                      |++......     ....++..|+|||++.+..++.++||||+|+++|+|++|..||....... .....+.        
T Consensus       155 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~--------  220 (267)
T PHA03390        155 GLCKIIGTP-----SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLL--------  220 (267)
T ss_pred             ccceecCCC-----ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHH--------
Confidence            998765432     12357899999999998899999999999999999999999997433211 0000000        


Q ss_pred             cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHHHhcC
Q 037869          269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPN-MKEVVNTLTG  316 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps-~~~ll~~l~~  316 (380)
                        ...  ..........+..+.++|.+||+.+|.+||+ ++++++|.+.
T Consensus       221 --~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~  265 (267)
T PHA03390        221 --KRQ--QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFL  265 (267)
T ss_pred             --Hhh--cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcc
Confidence              000  0011222345678999999999999999996 6999998653

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.1e-39  Score=294.68  Aligned_cols=270  Identities=22%  Similarity=0.335  Sum_probs=196.9

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC-----
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD-----  110 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----  110 (380)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||.+....  ......+.+|+.+++.++||||+++++++....     
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            345799999999999999999987 468999999986432  222335567999999999999999999986543     


Q ss_pred             ---eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEee
Q 037869          111 ---QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD  187 (380)
Q Consensus       111 ---~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~D  187 (380)
                         ..++||||+.+ +|.+.+...   ...+++..++.++.|++.||+|||++   +++|+||+|+||+++.++.++|+|
T Consensus        90 ~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~d  162 (310)
T cd07865          90 YKGSFYLVFEFCEH-DLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLAD  162 (310)
T ss_pred             CCceEEEEEcCCCc-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECc
Confidence               45999999964 888877543   24689999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccCCCCcc---ceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccch-hccch-
Q 037869          188 FGFAKLIPEGVSH---MTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI-TEWAE-  261 (380)
Q Consensus       188 fgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~-~~~~~-  261 (380)
                      ||++.........   ......++..|+|||.+.+. .++.++||||||+++|+|++|..||........... ..... 
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T cd07865         163 FGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGS  242 (310)
T ss_pred             CCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            9999866432211   12234568899999988764 478999999999999999999999965432110000 00000 


Q ss_pred             --hhh-hcc----ccccccCCc-----ccCCC-CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          262 --PLI-VKG----KFKELVDPK-----LRGDF-DENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       262 --~~~-~~~----~~~~~~~~~-----~~~~~-~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                        +.. ...    .+.....+.     ..... +......+.++|.+||..||.+|||+.++++|.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~  309 (310)
T cd07865         243 ITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF  309 (310)
T ss_pred             CChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCC
Confidence              000 000    000000000     00000 0012356789999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-39  Score=291.37  Aligned_cols=265  Identities=23%  Similarity=0.295  Sum_probs=202.6

Q ss_pred             CCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh--hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEec
Q 037869           43 FSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS--KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYM  119 (380)
Q Consensus        43 y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  119 (380)
                      |++.+.||.|++|.||++.+ .+++.+++|.+.....  .....+..|+.+++.++|+||+++++++......++|+||+
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   80 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM   80 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence            67889999999999999987 4688999999875332  23457788999999999999999999999999999999999


Q ss_pred             CCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc
Q 037869          120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS  199 (380)
Q Consensus       120 ~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~  199 (380)
                      ++ +|..++...   ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+....... 
T Consensus        81 ~~-~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-  152 (283)
T cd05118          81 DT-DLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-  152 (283)
T ss_pred             CC-CHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-
Confidence            75 888888653   25789999999999999999999999   99999999999999999999999999998765432 


Q ss_pred             cceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCccc--chhccchhh-hhcccccc----
Q 037869          200 HMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKR--TITEWAEPL-IVKGKFKE----  271 (380)
Q Consensus       200 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~~~~~~~~~-~~~~~~~~----  271 (380)
                      .......++..|+|||.+.+. .++.++|+||||+++|+|++|..||.........  ....+..+. .....+..    
T Consensus       153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd05118         153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARN  232 (283)
T ss_pred             ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhh
Confidence            112223578899999998876 7899999999999999999999999654321100  000000000 00000000    


Q ss_pred             ----ccC--CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          272 ----LVD--PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       272 ----~~~--~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                          ...  ...........+..+.++|.+||+.||.+||++.+++.|.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~  282 (283)
T cd05118         233 YKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPY  282 (283)
T ss_pred             hhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCC
Confidence                000  00001122345678999999999999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.1e-38  Score=294.10  Aligned_cols=267  Identities=18%  Similarity=0.205  Sum_probs=197.1

Q ss_pred             CCCcceeccCCceEEEEEEeCCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecC
Q 037869           43 FSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMP  120 (380)
Q Consensus        43 y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  120 (380)
                      |.+.+.+|.|+++.||.+.. +++.||+|+++..  .......+.+|+.+++.++|+||+++++++...+..+++|||++
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA   82 (314)
T ss_pred             hhhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence            34455555555555555444 6899999998753  34555678899999999999999999999999999999999999


Q ss_pred             CCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc-
Q 037869          121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS-  199 (380)
Q Consensus       121 ~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~-  199 (380)
                      +|+|.+++....  ...+++..+..++.|++.||+|||++   +|+||||||+||+++.++.++|+|||.+........ 
T Consensus        83 ~~~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~  157 (314)
T cd08216          83 YGSCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR  157 (314)
T ss_pred             CCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence            999999997542  23588999999999999999999999   999999999999999999999999998875532111 


Q ss_pred             -----cceeccccccCccCcccccc--CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchh----------
Q 037869          200 -----HMTTRVKGTLGYLAPEYAMW--GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEP----------  262 (380)
Q Consensus       200 -----~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~----------  262 (380)
                           .......++..|+|||++.+  ..++.++||||+||++|+|++|..||........ ........          
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~  236 (314)
T cd08216         158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLDKSTY  236 (314)
T ss_pred             ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccccCch
Confidence                 11122346788999999875  3588999999999999999999999975432110 00000000          


Q ss_pred             hhhcccccc--------ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          263 LIVKGKFKE--------LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       263 ~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .........        ..............+.++.+++.+||+.||++|||+.++++|.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~  298 (314)
T cd08216         237 PLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFF  298 (314)
T ss_pred             hhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchH
Confidence            000000000        000011112233455788999999999999999999999999764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=8.4e-39  Score=291.62  Aligned_cols=255  Identities=25%  Similarity=0.331  Sum_probs=201.7

Q ss_pred             CCCCcceeccCCceEEEEEEe----CCCcEEEEEEecccC----hhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT----SDGLQIAVKKLKAMN----SKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  112 (380)
                      .|++.+.||.|+||.||+|.+    .++..||+|+++...    ......+.+|+.++..+ +|+||+++++++..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            488899999999999999976    368899999987532    22345677899999999 589999999999999999


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      ++||||+++++|.+++...    ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~  153 (290)
T cd05613          81 HLILDYINGGELFTHLSQR----ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSK  153 (290)
T ss_pred             EEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccce
Confidence            9999999999999998643    4688999999999999999999998   99999999999999999999999999998


Q ss_pred             ccCCCCccceeccccccCccCccccccC--CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAMWG--KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      ..............|+..|+|||.+.+.  .++.++||||||+++|+|++|..||.....  ......+.....      
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~--~~~~~~~~~~~~------  225 (290)
T cd05613         154 EFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE--KNSQAEISRRIL------  225 (290)
T ss_pred             ecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCc--cccHHHHHHHhh------
Confidence            7644322223345688999999998753  478899999999999999999999863211  001111000000      


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhcC
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLTG  316 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~~  316 (380)
                         .  .....+...+..+.+++.+||+.||.+||     ++.+++.|.+.
T Consensus       226 ---~--~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~  271 (290)
T cd05613         226 ---K--SEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFF  271 (290)
T ss_pred             ---c--cCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccc
Confidence               0  01122333457789999999999999997     88999998653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=7.6e-40  Score=323.43  Aligned_cols=251  Identities=27%  Similarity=0.384  Sum_probs=191.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecC-------
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT-------  109 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------  109 (380)
                      -...|+.++.||+||||.||+++++ +|..||||++... .......+.+|+..|++|+|||||+++.+|.++       
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            4467888899999999999999984 8999999999854 334455788899999999999999998654310       


Q ss_pred             --------------------------------------------------------------------------------
Q 037869          110 --------------------------------------------------------------------------------  109 (380)
Q Consensus       110 --------------------------------------------------------------------------------  109 (380)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------------CeEEEEEEecCCCCHHHhhccCCCCCccC-CHHHHHHHHHHHHHHHHH
Q 037869          110 --------------------------------DQRLIVYDYMPNLSLLSHLHGQYAGEVQL-DWKRRMKIAIGSAEGILY  156 (380)
Q Consensus       110 --------------------------------~~~~lv~e~~~~g~L~~~i~~~~~~~~~~-~~~~~~~i~~ql~~al~~  156 (380)
                                                      ..+||-||||+..++.+++.+..    .. .....|++|.+|++||+|
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~----~~~~~d~~wrLFreIlEGLaY  712 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH----FNSQRDEAWRLFREILEGLAY  712 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc----cchhhHHHHHHHHHHHHHHHH
Confidence                                            13588999999877777776531    11 477899999999999999


Q ss_pred             HhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC-----------------CCCccceeccccccCccCcccccc
Q 037869          157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP-----------------EGVSHMTTRVKGTLGYLAPEYAMW  219 (380)
Q Consensus       157 LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~  219 (380)
                      +|+.   |+|||||||.|||+++++.|||+|||++....                 .......+..+||..|+|||++.+
T Consensus       713 IH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~  789 (1351)
T KOG1035|consen  713 IHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSD  789 (1351)
T ss_pred             HHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcc
Confidence            9999   99999999999999999999999999998721                 001112344679999999999986


Q ss_pred             CC---CCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCccc--CCCCHHHHHHHHHHHH
Q 037869          220 GK---VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR--GDFDENQLKQAINVAV  294 (380)
Q Consensus       220 ~~---~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~  294 (380)
                      ..   |+.|+|+|||||||+||+.   ||...-+     .         -..+..+.+..+.  ..+..+..+.-..+|.
T Consensus       790 ~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsME-----R---------a~iL~~LR~g~iP~~~~f~~~~~~~e~slI~  852 (1351)
T KOG1035|consen  790 TSSNKYNSKIDMYSLGIVLFEMLY---PFGTSME-----R---------ASILTNLRKGSIPEPADFFDPEHPEEASLIR  852 (1351)
T ss_pred             cccccccchhhhHHHHHHHHHHhc---cCCchHH-----H---------HHHHHhcccCCCCCCcccccccchHHHHHHH
Confidence            54   9999999999999999985   5642111     0         0011111112221  1223333355678999


Q ss_pred             hhcCCCCCCCCCHHHHHHH
Q 037869          295 LCVQSEPEKRPNMKEVVNT  313 (380)
Q Consensus       295 ~cl~~~P~~Rps~~~ll~~  313 (380)
                      +|++.||++||||.+||+.
T Consensus       853 ~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  853 WLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             HHhcCCCccCCCHHHHhhc
Confidence            9999999999999999986

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3.5e-39  Score=289.34  Aligned_cols=253  Identities=21%  Similarity=0.320  Sum_probs=200.8

Q ss_pred             CCCCcceeccCCceEEEEEEeC-CCcEEEEEEeccc-----ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAM-----NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      +|.+.+.||+|+||.||++.+. .+..+++|.++..     .......+..|+.+++.++||||+++++++......++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            6899999999999999999874 3455666665531     223334566799999999999999999999988899999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |||+++++|.+++.........+++..++.++.|++.||.|||+.   +++|+||+|+||+++. +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999998865433446799999999999999999999999   9999999999999975 579999999987654


Q ss_pred             CCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      ... .......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||.....  ...    ..         .. ..
T Consensus       157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~--~~~----~~---------~~-~~  219 (260)
T cd08222         157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF--LSV----VL---------RI-VE  219 (260)
T ss_pred             CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH--HHH----HH---------HH-Hc
Confidence            322 222334578899999999888889999999999999999999999864221  000    00         00 01


Q ss_pred             cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ......+...+.++.++|.+||..+|++||++.++++|.+
T Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~  259 (260)
T cd08222         220 GPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPF  259 (260)
T ss_pred             CCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCC
Confidence            1112234456678999999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-39  Score=302.36  Aligned_cols=272  Identities=21%  Similarity=0.257  Sum_probs=205.8

Q ss_pred             eccHHHHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEE
Q 037869           30 IFTYKELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYC  106 (380)
Q Consensus        30 ~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~  106 (380)
                      ....+++....++|.+.+.||+|+||.||+|.+ .+++.||+|++....  ......+.+|+.+++.++||||+++++++
T Consensus         6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~   85 (345)
T cd07877           6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF   85 (345)
T ss_pred             hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence            456677888999999999999999999999986 578999999987532  22345677899999999999999999987


Q ss_pred             ecC------CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC
Q 037869          107 AGT------DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD  180 (380)
Q Consensus       107 ~~~------~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~  180 (380)
                      ...      ...+++++++ +++|.+++..     ..+++..++.++.|++.||+|||+.   +++||||||+||+++.+
T Consensus        86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~  156 (345)
T cd07877          86 TPARSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNED  156 (345)
T ss_pred             eecccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCC
Confidence            543      3468888887 7799888753     2589999999999999999999999   99999999999999999


Q ss_pred             CceEEeeccCccccCCCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhcc
Q 037869          181 FEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEW  259 (380)
Q Consensus       181 ~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~  259 (380)
                      +.++|+|||++.....    ......++..|+|||.+.+ ..++.++||||+||++|+|++|..||.......  .....
T Consensus       157 ~~~kl~dfg~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~--~~~~~  230 (345)
T cd07877         157 CELKILDFGLARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLI  230 (345)
T ss_pred             CCEEEecccccccccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHH
Confidence            9999999999876532    2223457899999998876 568899999999999999999999996533211  00000


Q ss_pred             ch------hhh----hcc---ccccccCCc---ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          260 AE------PLI----VKG---KFKELVDPK---LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       260 ~~------~~~----~~~---~~~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ..      +..    ...   .+.......   .........+..+.++|.+||+.||.+||++.++++|.+.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f  303 (345)
T cd07877         231 LRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF  303 (345)
T ss_pred             HHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhh
Confidence            00      000    000   000000000   0000011234678999999999999999999999999764

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-41  Score=303.24  Aligned_cols=297  Identities=23%  Similarity=0.309  Sum_probs=244.1

Q ss_pred             HHHhhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecc---cChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCe
Q 037869           36 LHTATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKA---MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQ  111 (380)
Q Consensus        36 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  111 (380)
                      -...-..++++..||-|+||.|=++... ....+|+|++++   ...+..+....|-++|...+.|.||+++..|.++.+
T Consensus       415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky  494 (732)
T KOG0614|consen  415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY  494 (732)
T ss_pred             cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence            3345567888899999999999998754 333589998875   334445577889999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA  191 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~  191 (380)
                      .|++||-|-||.|...++.    ++.+++.....++..+++|++|||++   |||.|||||+|++++.+|-+||.|||++
T Consensus       495 vYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFA  567 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFA  567 (732)
T ss_pred             hhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhH
Confidence            9999999999999999965    46899999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          192 KLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       192 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      +.+..  ...+.+++|||.|.|||++.++..+.++|.||||+++|||++|.+||.+.++...               +..
T Consensus       568 Kki~~--g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmkt---------------Yn~  630 (732)
T KOG0614|consen  568 KKIGS--GRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKT---------------YNL  630 (732)
T ss_pred             HHhcc--CCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHH---------------HHH
Confidence            99865  4567889999999999999999999999999999999999999999987554211               112


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHhc--CCCCCC----cccccchhhccchhhhhcc
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPN-----MKEVVNTLT--GYDPRG----KVMQTRIETLAYKEELLAF  340 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps-----~~~ll~~l~--~~~~~~----~~~~~~~~~~~~~~~~~~~  340 (380)
                      ++...-...+|..+.....+||.+++..+|.+|..     +.+|.+|-|  .+++.+    .........+....+...|
T Consensus       631 ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va~ptD~s~F  710 (732)
T KOG0614|consen  631 ILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVANPTDVSNF  710 (732)
T ss_pred             HHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccCCCCccccCCCcccchhc
Confidence            22222233456667788999999999999999964     889999955  445543    3344556667778888889


Q ss_pred             cCcCCCCCCCCCCCcc
Q 037869          341 DQTTDDDDRDPGNQEL  356 (380)
Q Consensus       341 ~~~~~~~~~~~~~~~~  356 (380)
                      +....+++..|..+..
T Consensus       711 d~~p~dnd~pppde~S  726 (732)
T KOG0614|consen  711 DNFPPDNDEPPPDELS  726 (732)
T ss_pred             cCCCcccCCCCchhcc
Confidence            9888888887755543

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4.3e-39  Score=289.05  Aligned_cols=245  Identities=25%  Similarity=0.354  Sum_probs=197.0

Q ss_pred             eccCCceEEEEEEeC-CCcEEEEEEecccCh---hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCCCH
Q 037869           49 LGEGGFGSVYWGRTS-DGLQIAVKKLKAMNS---KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSL  124 (380)
Q Consensus        49 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  124 (380)
                      ||.|+||.||++.+. +++.|++|.+.....   .....+.+|+.+++.++||||+++++.+......|+++||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            689999999999875 589999999875433   3455788899999999999999999999999999999999999999


Q ss_pred             HHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc-----
Q 037869          125 LSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS-----  199 (380)
Q Consensus       125 ~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~-----  199 (380)
                      .+++.+.    ..+++..+..++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++........     
T Consensus        81 ~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  153 (265)
T cd05579          81 ASLLENV----GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND  153 (265)
T ss_pred             HHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccc
Confidence            9999754    3689999999999999999999999   999999999999999999999999999876533211     


Q ss_pred             --cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          200 --HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       200 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                        .......++..|+|||.+.+..++.++||||||+++|+|++|..||.......      ...         .......
T Consensus       154 ~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~~~---------~~~~~~~  218 (265)
T cd05579         154 DEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------IFQ---------NILNGKI  218 (265)
T ss_pred             ccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------HHH---------HHhcCCc
Confidence              12223457889999999988889999999999999999999999996533110      000         0000000


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCH---HHHHHHhc
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNM---KEVVNTLT  315 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~---~~ll~~l~  315 (380)
                      ........+..+.+++.+||+.+|.+|||+   .+++++.+
T Consensus       219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~  259 (265)
T cd05579         219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPF  259 (265)
T ss_pred             CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCcc
Confidence            000011125788999999999999999999   88888764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.1e-38  Score=291.48  Aligned_cols=267  Identities=21%  Similarity=0.303  Sum_probs=198.9

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ++|++.+.||.|++|+||+|.+ .+++.||+|.+....  ......+.+|+++++.++||||+++++++..+...++|||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            5799999999999999999987 468999999986432  2233467889999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-CCceEEeeccCccccCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS-DFEPLVADFGFAKLIPE  196 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~-~~~vkl~Dfgl~~~~~~  196 (380)
                      |++ ++|.+.+...  ....+++..++.++.|++.||+|||++   +++||||+|+||+++. ++.+||+|||++.....
T Consensus        82 ~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~  155 (294)
T PLN00009         82 YLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI  155 (294)
T ss_pred             ccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCC
Confidence            996 5888877543  223468889999999999999999999   9999999999999985 56799999999976533


Q ss_pred             CCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh--hcccc----
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI--VKGKF----  269 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~----  269 (380)
                      .. .......+++.|+|||.+.+ ..++.++||||+|+++|+|++|..||.......  ..........  ....+    
T Consensus       156 ~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~  232 (294)
T PLN00009        156 PV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEID--ELFKIFRILGTPNEETWPGVT  232 (294)
T ss_pred             Cc-cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCChhhccccc
Confidence            21 11223356889999998875 457899999999999999999999997533210  0000000000  00000    


Q ss_pred             --ccc--cCCcccC----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          270 --KEL--VDPKLRG----DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       270 --~~~--~~~~~~~----~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                        ...  ..+....    ......+..+.+++.+||+.+|++||++.++++|.+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~  287 (294)
T PLN00009        233 SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYF  287 (294)
T ss_pred             cchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchH
Confidence              000  0000000    0112334678999999999999999999999998653

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.3e-38  Score=291.95  Aligned_cols=250  Identities=25%  Similarity=0.348  Sum_probs=198.2

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      +.|...+.||+|+||+||+|.+ .++..|++|++...   .......+.+|+.+++.++|||++++++++.+....|+||
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  100 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM  100 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence            3477788999999999999986 46889999998642   2233346788999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+. |++.+++...   ...+++..++.++.|++.||.|||+.   |++||||+|+||+++.++.++|+|||++.....
T Consensus       101 e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~  173 (313)
T cd06633         101 EYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP  173 (313)
T ss_pred             ecCC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccCC
Confidence            9996 5787777543   34689999999999999999999999   999999999999999999999999999864322


Q ss_pred             CCccceeccccccCccCccccc---cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAM---WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                           .....|+..|+|||.+.   ...++.++|||||||++|+|++|..||...........               ..
T Consensus       174 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~---------------~~  233 (313)
T cd06633         174 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---------------IA  233 (313)
T ss_pred             -----CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---------------HH
Confidence                 22346889999999984   45688999999999999999999999865322110000               00


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ............+..+.+++.+||+.+|.+||++.+++.|.+.-
T Consensus       234 ~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~  277 (313)
T cd06633         234 QNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVR  277 (313)
T ss_pred             hcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccC
Confidence            00000111122345789999999999999999999999996643

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.1e-38  Score=291.48  Aligned_cols=259  Identities=18%  Similarity=0.180  Sum_probs=186.4

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCC----CcEEEEEEecccChhh-----------HHHHHHHHHHHhcCCCCcceeEe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSD----GLQIAVKKLKAMNSKA-----------EMEFAVEVEVLGRVRHKNLLGLR  103 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~  103 (380)
                      ..++|++.++||+|+||+||+|.+.+    +..+|+|+........           ......++..+..+.|+||++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            45799999999999999999998643    4456666543222111           01122344556677899999999


Q ss_pred             eEEecCC----eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC
Q 037869          104 GYCAGTD----QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS  179 (380)
Q Consensus       104 ~~~~~~~----~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~  179 (380)
                      +++....    ..+++++++. .++.+.+...    ...++..+..++.|++.||+|||+.   +++||||||+|||++.
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~Nill~~  161 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKLV-ENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPENIMVDG  161 (294)
T ss_pred             EeeeEecCCceEEEEEEehhc-cCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcC
Confidence            8765433    3478888774 3666666432    2357788899999999999999999   9999999999999999


Q ss_pred             CCceEEeeccCccccCCCCc------cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcc
Q 037869          180 DFEPLVADFGFAKLIPEGVS------HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVK  253 (380)
Q Consensus       180 ~~~vkl~Dfgl~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  253 (380)
                      ++.++|+|||+++.+.....      .......||+.|+|||++.+..++.++|||||||++|||++|..||........
T Consensus       162 ~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~  241 (294)
T PHA02882        162 NNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGN  241 (294)
T ss_pred             CCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchH
Confidence            99999999999987632211      111224589999999999999999999999999999999999999976532111


Q ss_pred             cchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 037869          254 RTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL  314 (380)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l  314 (380)
                      ..... ..     ..+..+.....   .....+..+.+++..||..+|++||++.+|++.+
T Consensus       242 ~~~~~-~~-----~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        242 LIHAA-KC-----DFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHh-HH-----HHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            00000 00     00011111111   1122357899999999999999999999999865

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=3.7e-39  Score=300.27  Aligned_cols=267  Identities=22%  Similarity=0.300  Sum_probs=200.4

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecC--Ce
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGT--DQ  111 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~--~~  111 (380)
                      ...++|++.+.||+|+||.||+|.+. ++..||+|++...  .......+..|+.+++++ +||||+++++++...  ..
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            35678999999999999999999874 6889999988542  223344677899999999 999999999998643  46


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA  191 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~  191 (380)
                      .++||||+. ++|..++...     .+++..++.++.|++.||+|||+.   |++||||+|+||+++.++.++|+|||++
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~  154 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRAN-----ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLA  154 (337)
T ss_pred             EEEEecccc-cCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccch
Confidence            899999997 5998888542     678889999999999999999998   9999999999999999999999999999


Q ss_pred             cccCCCCc----cceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchh----
Q 037869          192 KLIPEGVS----HMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEP----  262 (380)
Q Consensus       192 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~----  262 (380)
                      ........    .......|+..|+|||.+.+ ..++.++||||||+++|+|++|..||........  .......    
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~--~~~~~~~~~~~  232 (337)
T cd07852         155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ--LEKIIEVIGPP  232 (337)
T ss_pred             hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHHHhCCC
Confidence            87643321    12233468999999998764 5578999999999999999999999965432110  0000000    


Q ss_pred             ----------hhhccccccccCCc--ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          263 ----------LIVKGKFKELVDPK--LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       263 ----------~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                                ......+.......  .........+.++.++|.+||+.+|.+|||+.+++++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~  297 (337)
T cd07852         233 SAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPY  297 (337)
T ss_pred             CHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChh
Confidence                      00000000000000  000111124578899999999999999999999999843

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=285.84  Aligned_cols=245  Identities=23%  Similarity=0.278  Sum_probs=191.0

Q ss_pred             ceeccCCceEEEEEEe-CCCcEEEEEEecccCh---hhHHHHHHHHHH-HhcCCCCcceeEeeEEecCCeEEEEEEecCC
Q 037869           47 NKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS---KAEMEFAVEVEV-LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPN  121 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  121 (380)
                      +.||.|+||.||+|.+ .+++.||+|.++....   .....+..|..+ ....+|+|++++++++..++..|+|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            5799999999999987 4688999999875322   112234445444 4455899999999999999999999999999


Q ss_pred             CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccc
Q 037869          122 LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM  201 (380)
Q Consensus       122 g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~  201 (380)
                      ++|.+++...    ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.....     
T Consensus        82 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----  149 (260)
T cd05611          82 GDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----  149 (260)
T ss_pred             CCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc-----
Confidence            9999999643    4689999999999999999999998   999999999999999999999999999876432     


Q ss_pred             eeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCC
Q 037869          202 TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF  281 (380)
Q Consensus       202 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                      .....++..|+|||.+.+..++.++||||+|+++|+|++|..||.......  ...    .. ..+.      .......
T Consensus       150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~----~~-~~~~------~~~~~~~  216 (260)
T cd05611         150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA--VFD----NI-LSRR------INWPEEV  216 (260)
T ss_pred             cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH--HHH----HH-Hhcc------cCCCCcc
Confidence            223357889999999988889999999999999999999999996532210  000    00 0000      0011112


Q ss_pred             CHHHHHHHHHHHHhhcCCCCCCCCCH---HHHHHHhcC
Q 037869          282 DENQLKQAINVAVLCVQSEPEKRPNM---KEVVNTLTG  316 (380)
Q Consensus       282 ~~~~~~~~~~li~~cl~~~P~~Rps~---~~ll~~l~~  316 (380)
                      ...++..+.+++.+||+.+|++||++   ++++.|.+.
T Consensus       217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~  254 (260)
T cd05611         217 KEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFF  254 (260)
T ss_pred             cccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHh
Confidence            22345789999999999999999955   688888653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.8e-38  Score=287.75  Aligned_cols=246  Identities=22%  Similarity=0.272  Sum_probs=192.0

Q ss_pred             eeccCCceEEEEEEe-CCCcEEEEEEecccCh---hhHHHHHHH---HHHHhcCCCCcceeEeeEEecCCeEEEEEEecC
Q 037869           48 KLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS---KAEMEFAVE---VEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMP  120 (380)
Q Consensus        48 ~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E---~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  120 (380)
                      .||+|+||.||+|.+ .+++.||+|.+.....   .....+..|   +..++...||+|+++++++...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999987 4688999999865321   111123333   344555689999999999999999999999999


Q ss_pred             CCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCcc
Q 037869          121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH  200 (380)
Q Consensus       121 ~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~  200 (380)
                      |++|.+++...    ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++..+....  
T Consensus        81 g~~L~~~l~~~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--  151 (278)
T cd05606          81 GGDLHYHLSQH----GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--  151 (278)
T ss_pred             CCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccC--
Confidence            99999888543    4699999999999999999999998   99999999999999999999999999987654321  


Q ss_pred             ceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccC
Q 037869          201 MTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG  279 (380)
Q Consensus       201 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (380)
                       .....|+..|+|||++.+. .++.++||||+|+++|+|++|..||.............             . ......
T Consensus       152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-------------~-~~~~~~  216 (278)
T cd05606         152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-------------M-TLTMAV  216 (278)
T ss_pred             -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH-------------H-hhccCC
Confidence             2234689999999998744 68999999999999999999999997542211100000             0 000111


Q ss_pred             CCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhcCC
Q 037869          280 DFDENQLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLTGY  317 (380)
Q Consensus       280 ~~~~~~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~~~  317 (380)
                      ..+...+..+.+++.+||..+|.+||     ++.++++|.+..
T Consensus       217 ~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~  259 (278)
T cd05606         217 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFR  259 (278)
T ss_pred             CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCcccc
Confidence            22333457899999999999999999     999999987643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.1e-39  Score=302.48  Aligned_cols=268  Identities=20%  Similarity=0.281  Sum_probs=199.1

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecC---------
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT---------  109 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---------  109 (380)
                      ..+|++.+.||.|+||.||+|.+ .++..||+|.+..........+.+|+.+++.++||||+++++++...         
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            57899999999999999999987 56899999999766555566788899999999999999999876543         


Q ss_pred             -----CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-CCce
Q 037869          110 -----DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS-DFEP  183 (380)
Q Consensus       110 -----~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~-~~~v  183 (380)
                           ...++||||++ ++|.+++..     ..+++..++.++.|++.||.|||+.   |++||||||+||+++. ++.+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~  154 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLEQ-----GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVL  154 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceE
Confidence                 35799999997 588888753     3688999999999999999999999   9999999999999974 5678


Q ss_pred             EEeeccCccccCCCCcc--ceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccc
Q 037869          184 LVADFGFAKLIPEGVSH--MTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWA  260 (380)
Q Consensus       184 kl~Dfgl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~  260 (380)
                      +|+|||++.........  ......++..|+|||.+.+ ..++.++|||||||++|+|++|..||...............
T Consensus       155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~  234 (342)
T cd07854         155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILES  234 (342)
T ss_pred             EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            99999999865432111  1122357889999998764 56889999999999999999999999754321100000000


Q ss_pred             hhhhhc-------cccccccC-CcccC-----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          261 EPLIVK-------GKFKELVD-PKLRG-----DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       261 ~~~~~~-------~~~~~~~~-~~~~~-----~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .+....       ..+..... .....     ......+.++.+++.+||+.||.+|||+.+++.|.+.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~  303 (342)
T cd07854         235 VPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYM  303 (342)
T ss_pred             cCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCcc
Confidence            000000       00000000 00000     0111244678899999999999999999999999664

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.1e-38  Score=296.83  Aligned_cols=269  Identities=23%  Similarity=0.278  Sum_probs=200.6

Q ss_pred             hhCCCCC-cceeccCCceEEEEEEe-CCCcEEEEEEecccChhh--------------HHHHHHHHHHHhcCCCCcceeE
Q 037869           39 ATNGFSD-DNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKA--------------EMEFAVEVEVLGRVRHKNLLGL  102 (380)
Q Consensus        39 ~~~~y~~-~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~--------------~~~~~~E~~~l~~l~h~niv~~  102 (380)
                      ..++|.. .+.||.|+||+||+|.+ .+++.||+|+++......              ...+.+|+.+++.++|+||+++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   85 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL   85 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence            4567864 57799999999999987 468999999986532221              1146789999999999999999


Q ss_pred             eeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc
Q 037869          103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE  182 (380)
Q Consensus       103 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~  182 (380)
                      ++++...+..++||||+. |+|.+++...    ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.
T Consensus        86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~----~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~  157 (335)
T PTZ00024         86 VDVYVEGDFINLVMDIMA-SDLKKVVDRK----IRLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGI  157 (335)
T ss_pred             eEEEecCCcEEEEEeccc-cCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCC
Confidence            999999999999999996 5899888543    4689999999999999999999998   9999999999999999999


Q ss_pred             eEEeeccCccccCCCC-------------ccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCC
Q 037869          183 PLVADFGFAKLIPEGV-------------SHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKL  248 (380)
Q Consensus       183 vkl~Dfgl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~  248 (380)
                      ++|+|||++.......             ........++..|+|||.+.+. .++.++|||||||++|+|++|.+||...
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~  237 (335)
T PTZ00024        158 CKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGE  237 (335)
T ss_pred             EEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999997654110             1111223468899999998764 4799999999999999999999999754


Q ss_pred             CCCcccchhccchhh--hhccccccccC-----------CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          249 PGGVKRTITEWAEPL--IVKGKFKELVD-----------PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       249 ~~~~~~~~~~~~~~~--~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .....  ........  .....+.....           +..........+..+.++|.+||+.+|++|||+++++.|.+
T Consensus       238 ~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~  315 (335)
T PTZ00024        238 NEIDQ--LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEY  315 (335)
T ss_pred             CHHHH--HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcc
Confidence            32110  00000000  00000000000           00000011223567899999999999999999999999977


Q ss_pred             CC
Q 037869          316 GY  317 (380)
Q Consensus       316 ~~  317 (380)
                      ..
T Consensus       316 ~~  317 (335)
T PTZ00024        316 FK  317 (335)
T ss_pred             cC
Confidence            54

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-40  Score=282.89  Aligned_cols=250  Identities=26%  Similarity=0.319  Sum_probs=208.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      .-+.|..++.||+|.||.|.+++. .+++.||+|++++.   ...+...-+.|-.+|.+.+||.+..+--.|+..+++++
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF  245 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF  245 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence            446788899999999999999986 57999999999862   23334456678899999999999999889999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ||||..||.|+-.+.+.    ..+++...+.+-..|+.||.|||++   +||.||||.+|+|++.+|++||+|||+++.-
T Consensus       246 VMeyanGGeLf~HLsre----r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~  318 (516)
T KOG0690|consen  246 VMEYANGGELFFHLSRE----RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEE  318 (516)
T ss_pred             EEEEccCceEeeehhhh----hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhc
Confidence            99999999999888653    5789999999999999999999998   9999999999999999999999999999753


Q ss_pred             CCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      -. ......++||||.|+|||++....|..++|.|.+|+++|||++|+.||...+......+               ++.
T Consensus       319 I~-~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL---------------Il~  382 (516)
T KOG0690|consen  319 IK-YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL---------------ILM  382 (516)
T ss_pred             cc-ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHH---------------HHh
Confidence            22 13356678999999999999999999999999999999999999999976432111111               111


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHH
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRP-----NMKEVVNT  313 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~  313 (380)
                      .  .-.+|...++++..|+..+|.+||.+|.     .+.||.+|
T Consensus       383 e--d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  383 E--DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             h--hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence            1  1134555668899999999999999994     67888777

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-38  Score=286.23  Aligned_cols=263  Identities=22%  Similarity=0.336  Sum_probs=197.3

Q ss_pred             CCCcceeccCCceEEEEEEeC-CCcEEEEEEecccCh--hhHHHHHHHHHHHhcC---CCCcceeEeeEEecCCe-----
Q 037869           43 FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNS--KAEMEFAVEVEVLGRV---RHKNLLGLRGYCAGTDQ-----  111 (380)
Q Consensus        43 y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~~~~-----  111 (380)
                      |++.+.||.|+||.||+|.+. ++..||+|.++....  .....+.+|+.+++++   +|+||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            678899999999999999975 589999999974322  2233455677766655   69999999999987776     


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA  191 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~  191 (380)
                      .+++|||+.+ +|.+++....  ...+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~  154 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLA  154 (287)
T ss_pred             eEEEehhccc-CHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcc
Confidence            9999999975 8988886532  23589999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcc--cc
Q 037869          192 KLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKG--KF  269 (380)
Q Consensus       192 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~  269 (380)
                      ........  .....++..|+|||.+.+..++.++|+||+||++|+|++|.+||.......  ....+........  .+
T Consensus       155 ~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  230 (287)
T cd07838         155 RIYSFEMA--LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEAD--QLDKIFDVIGLPSEEEW  230 (287)
T ss_pred             eeccCCcc--cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHH--HHHHHHHHcCCCChHhc
Confidence            87643321  222347889999999998899999999999999999999999987543211  0000000000000  00


Q ss_pred             -------ccccCCcc---cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          270 -------KELVDPKL---RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       270 -------~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                             ........   ........+..+.++|.+||+.||.+||++.+++.|.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~  286 (287)
T cd07838         231 PRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY  286 (287)
T ss_pred             CCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcC
Confidence                   00000000   01112244577899999999999999999999998854

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=279.49  Aligned_cols=261  Identities=23%  Similarity=0.315  Sum_probs=206.3

Q ss_pred             cceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCC-CCcceeEeeEEecCCeEEEEEEecCCCC
Q 037869           46 DNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR-HKNLLGLRGYCAGTDQRLIVYDYMPNLS  123 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~  123 (380)
                      .+.||+|+|+.|-.+.. .++..||||++.+.....+.+..+|++++.+.+ |+||+.++++|+++..+|+|||-+.||+
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGp  162 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGP  162 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCch
Confidence            46799999999988865 789999999999887778889999999999985 9999999999999999999999999999


Q ss_pred             HHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc---eEEeeccCccccCC--CC
Q 037869          124 LLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE---PLVADFGFAKLIPE--GV  198 (380)
Q Consensus       124 L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~---vkl~Dfgl~~~~~~--~~  198 (380)
                      |...|+.+    ..+++.++.++..+|+.||.+||.+   ||.||||||+|||....+.   ||||||.+...+..  ..
T Consensus       163 lLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~  235 (463)
T KOG0607|consen  163 LLSHIQKR----KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDC  235 (463)
T ss_pred             HHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCC
Confidence            99999765    5899999999999999999999999   9999999999999976544   89999988765421  11


Q ss_pred             c----cceeccccccCccCccccc-----cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhh---hhc
Q 037869          199 S----HMTTRVKGTLGYLAPEYAM-----WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL---IVK  266 (380)
Q Consensus       199 ~----~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~---~~~  266 (380)
                      .    ....+.+|+..|||||+..     ...|+.++|.||||+|+|.|++|.+||.+.-+..    -.|..-.   ...
T Consensus       236 spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~d----CGWdrGe~Cr~CQ  311 (463)
T KOG0607|consen  236 SPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGAD----CGWDRGEVCRVCQ  311 (463)
T ss_pred             CCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCc----CCccCCCccHHHH
Confidence            1    1223456899999999874     2458999999999999999999999997653311    0111100   000


Q ss_pred             cccccccCCcc---cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          267 GKFKELVDPKL---RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       267 ~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ..+.+-+..+.   ...-...++.+..++|..+|..++..|.++.++++|+|.-
T Consensus       312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~  365 (463)
T KOG0607|consen  312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQ  365 (463)
T ss_pred             HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccc
Confidence            11111111111   1122346678899999999999999999999999997743

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.6e-39  Score=298.01  Aligned_cols=263  Identities=22%  Similarity=0.289  Sum_probs=196.4

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecC-----
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT-----  109 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----  109 (380)
                      ....+|.+.+.||+|+||.||+|.+ .+++.||+|++....  ......+.+|+.+++.++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~   91 (342)
T cd07879          12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDE   91 (342)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCC
Confidence            3458999999999999999999987 468999999986432  22234677899999999999999999998654     


Q ss_pred             -CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          110 -DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       110 -~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                       ...++|+||+.. +|...+.      ..+++..+..++.|++.||+|||+.   +++||||||+||+++.++.++|+||
T Consensus        92 ~~~~~lv~e~~~~-~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~df  161 (342)
T cd07879          92 FQDFYLVMPYMQT-DLQKIMG------HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDF  161 (342)
T ss_pred             CceEEEEeccccc-CHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeC
Confidence             346899999964 6766552      3588999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhh----
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL----  263 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~----  263 (380)
                      |++......    .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||.......  .........    
T Consensus       162 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~  235 (342)
T cd07879         162 GLARHADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPG  235 (342)
T ss_pred             CCCcCCCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCC
Confidence            998765321    223357889999999876 468999999999999999999999997533110  000000000    


Q ss_pred             --h----hc---cccccccCCcccCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          264 --I----VK---GKFKELVDPKLRGD---FDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       264 --~----~~---~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                        .    ..   ..............   ..+..+..+.++|.+||+.||.+||++.+++.|.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f  300 (342)
T cd07879         236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYF  300 (342)
T ss_pred             HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcch
Confidence              0    00   00000000000000   011234678899999999999999999999999554

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-38  Score=296.06  Aligned_cols=267  Identities=24%  Similarity=0.290  Sum_probs=202.1

Q ss_pred             HHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC-
Q 037869           35 ELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD-  110 (380)
Q Consensus        35 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-  110 (380)
                      ++....++|++.+.||+|+||.||+|.+ .++..||||++....  ......+.+|+.+++.++||||+++++++..+. 
T Consensus         9 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   88 (343)
T cd07880           9 TIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS   88 (343)
T ss_pred             hhhccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence            4455678999999999999999999986 578999999986422  223346778999999999999999999987654 


Q ss_pred             -----eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEE
Q 037869          111 -----QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV  185 (380)
Q Consensus       111 -----~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl  185 (380)
                           ..++||||+ +++|.+++..     ..+++..++.++.|++.||+|||+.   |++||||||+||+++.++.++|
T Consensus        89 ~~~~~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl  159 (343)
T cd07880          89 LDRFHDFYLVMPFM-GTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKI  159 (343)
T ss_pred             ccccceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence                 358999999 7799888753     3689999999999999999999999   9999999999999999999999


Q ss_pred             eeccCccccCCCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccch---
Q 037869          186 ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE---  261 (380)
Q Consensus       186 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~---  261 (380)
                      +|||++......    .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||........  ......   
T Consensus       160 ~dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~--~~~~~~~~~  233 (343)
T cd07880         160 LDFGLARQTDSE----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ--LMEIMKVTG  233 (343)
T ss_pred             eecccccccccC----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcC
Confidence            999999865432    223356889999999876 4588999999999999999999999975332100  000000   


Q ss_pred             --------hhh---hccccccc--cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          262 --------PLI---VKGKFKEL--VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       262 --------~~~---~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                              ...   .......+  ..+..........+..+.++|.+||+.||.+|||+.+++.|.+.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~  301 (343)
T cd07880         234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYF  301 (343)
T ss_pred             CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccH
Confidence                    000   00000000  00000001112344678999999999999999999999998654

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=6.8e-38  Score=329.60  Aligned_cols=261  Identities=28%  Similarity=0.596  Sum_probs=204.1

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ...|+....||+|+||.||+|.+ .++..||||++.......    ..|++.+++++||||+++++++...+..++||||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~----~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey  764 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP----SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY  764 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc----HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence            35677888999999999999987 578999999987543222    2468889999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++|+|.++++       .+++..+..++.|++.||+|||..++++|+||||||+||+++.++..++. ||.......  
T Consensus       765 ~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--  834 (968)
T PLN00113        765 IEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--  834 (968)
T ss_pred             CCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--
Confidence            99999999994       37899999999999999999996555599999999999999998887775 665543221  


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                         .....+++.|+|||++.+..++.++|||||||++|||++|+.||..... .......|..............++.+.
T Consensus       835 ---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  910 (968)
T PLN00113        835 ---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIR  910 (968)
T ss_pred             ---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCcccc
Confidence               1122578999999999999999999999999999999999999954322 122222333222222222333333332


Q ss_pred             C--CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          279 G--DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       279 ~--~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      .  ........++.+++.+||+.||++|||+.++++.|....
T Consensus       911 ~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~  952 (968)
T PLN00113        911 GDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESAS  952 (968)
T ss_pred             CCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhh
Confidence            2  233455667889999999999999999999999998653

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.6e-38  Score=289.22  Aligned_cols=258  Identities=24%  Similarity=0.369  Sum_probs=198.3

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC-hhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ..+.|++.+.||+|++|.||+|.+. +++.||||.++... ......+..|+.++... .||||+++++++..+...|++
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            4578999999999999999999875 48999999997533 22334566677766666 499999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH-EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~-~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      |||+. +++.+++...   ...+++..+..++.|++.||+|||+ .   +++||||+|+||+++.++.++|+|||++..+
T Consensus        93 ~e~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          93 MELMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKH---GVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             eeccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC---CEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            99985 4777776542   2378999999999999999999997 5   8999999999999999999999999999766


Q ss_pred             CCCCccceeccccccCccCccccccCC----CCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAMWGK----VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      .....  .....++..|+|||.+.+..    ++.++||||||+++|+|++|..||....... .....     .....  
T Consensus       166 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~-----~~~~~--  235 (296)
T cd06618         166 VDSKA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF-EVLTK-----ILQEE--  235 (296)
T ss_pred             cCCCc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH-HHHHH-----HhcCC--
Confidence            43221  12234788999999987553    7899999999999999999999996422110 00000     00000  


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                         .+..  ......+.++.+|+.+||+.||.+||++.+++.|.+...
T Consensus       236 ---~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~  278 (296)
T cd06618         236 ---PPSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRR  278 (296)
T ss_pred             ---CCCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhc
Confidence               0000  011124567899999999999999999999999977443

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.5e-38  Score=292.61  Aligned_cols=269  Identities=24%  Similarity=0.312  Sum_probs=196.5

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChh--hHHHHHHHHHHHhcCCCCcceeEeeEEecC-------
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSK--AEMEFAVEVEVLGRVRHKNLLGLRGYCAGT-------  109 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------  109 (380)
                      .++|++.+.||.|+||.||+|.+ .+++.|++|++......  ....+.+|+++++.++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            57899999999999999999987 46899999998643222  233567899999999999999999987543       


Q ss_pred             -CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          110 -DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       110 -~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                       ..+++||||+.+ +|...+...   ...+++..+..++.|+++||+|||+.   +++||||||+||+++.++.++|+||
T Consensus        87 ~~~~~lv~~~~~~-~l~~~~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  159 (311)
T cd07866          87 RGSVYMVTPYMDH-DLSGLLENP---SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADF  159 (311)
T ss_pred             CceEEEEEecCCc-CHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcC
Confidence             346999999965 677766532   34699999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCcc----------ceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchh
Q 037869          189 GFAKLIPEGVSH----------MTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTIT  257 (380)
Q Consensus       189 gl~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~  257 (380)
                      |++.........          ......+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||............
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~  239 (311)
T cd07866         160 GLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLI  239 (311)
T ss_pred             ccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999765432211          1122356888999998865 45899999999999999999999999653321100000


Q ss_pred             ----------ccchhhhhccccccccCCcccCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          258 ----------EWAEPLIVKGKFKELVDPKLRGD---FDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       258 ----------~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                                .+.....................   ........+.++|.+||+.||.+|||+.+++.|.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~  310 (311)
T cd07866         240 FKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPY  310 (311)
T ss_pred             HHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCC
Confidence                      00000000000000000000000   00122357889999999999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-38  Score=287.06  Aligned_cols=265  Identities=24%  Similarity=0.308  Sum_probs=199.6

Q ss_pred             CCCcceeccCCceEEEEEEeC-CCcEEEEEEecccCh-hhHHHHHHHHHHHhcCC-CCcceeEeeEEecCCeEEEEEEec
Q 037869           43 FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNS-KAEMEFAVEVEVLGRVR-HKNLLGLRGYCAGTDQRLIVYDYM  119 (380)
Q Consensus        43 y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~  119 (380)
                      |++.+.||.|++|+||+|... +++.|+||++..... .......+|+..+++++ |+||+++++++..++..++||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            678899999999999999874 578899999875322 23334557999999998 999999999999999999999999


Q ss_pred             CCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc
Q 037869          120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS  199 (380)
Q Consensus       120 ~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~  199 (380)
                       +|+|.+.+....  ...+++..+..++.|++.+|.|||+.   +++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 -~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-  153 (283)
T cd07830          81 -EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-  153 (283)
T ss_pred             -CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCC-
Confidence             789998886542  24689999999999999999999998   99999999999999999999999999998664321 


Q ss_pred             cceeccccccCccCccccc-cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccc----------hhccchhhhhccc
Q 037869          200 HMTTRVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRT----------ITEWAEPLIVKGK  268 (380)
Q Consensus       200 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~----------~~~~~~~~~~~~~  268 (380)
                       ......++..|+|||++. +..++.++|+||||+++++|++|.+||..........          ...|.........
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         154 -PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             -CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence             223345788999999875 4568999999999999999999999996543211000          0000000000000


Q ss_pred             cccccCCcc---cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          269 FKELVDPKL---RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       269 ~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      +........   ........+..+.++|.+||+.+|++|||+++++.+.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~  282 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY  282 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCC
Confidence            000000000   00111112467899999999999999999999998854

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=3.6e-38  Score=287.16  Aligned_cols=254  Identities=26%  Similarity=0.332  Sum_probs=197.7

Q ss_pred             CCCCcceeccCCceEEEEEEe----CCCcEEEEEEecccC----hhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT----SDGLQIAVKKLKAMN----SKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~  112 (380)
                      .|++.+.||+|++|.||++.+    .++..||+|.++...    ......+.+|+.++.++ +||||+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            478899999999999999974    356889999987432    22334677899999999 599999999999999999


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      ++||||+.+|+|.+++...    ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++.
T Consensus        81 ~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~  153 (288)
T cd05583          81 HLILDYVNGGELFTHLYQR----EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSK  153 (288)
T ss_pred             EEEEecCCCCcHHHHHhhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECcccc
Confidence            9999999999999998643    4688999999999999999999998   99999999999999999999999999988


Q ss_pred             ccCCCCccceeccccccCccCccccccCC--CCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAMWGK--VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      ..............|+..|+|||.+.+..  .+.++||||||+++|+|++|..||......  .....+....       
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~--~~~~~~~~~~-------  224 (288)
T cd05583         154 EFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQ--NSQSEISRRI-------  224 (288)
T ss_pred             ccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCccc--chHHHHHHHH-------
Confidence            75443222223345789999999987654  788999999999999999999999632211  0000100000       


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH---HHHHHhc
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMK---EVVNTLT  315 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~---~ll~~l~  315 (380)
                        ..  .....+...+..+.+++.+||+.||+.|||+.   ++++|.+
T Consensus       225 --~~--~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~  268 (288)
T cd05583         225 --LK--SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPF  268 (288)
T ss_pred             --Hc--cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcc
Confidence              00  01122233446789999999999999999965   4455543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4e-38  Score=292.02  Aligned_cols=268  Identities=22%  Similarity=0.300  Sum_probs=201.3

Q ss_pred             HHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEec-CCe
Q 037869           36 LHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG-TDQ  111 (380)
Q Consensus        36 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~  111 (380)
                      +....++|++.+.||.|+||.||+|.+ .++..||+|++...  .......+..|+.+++.++||||+++++++.. ...
T Consensus         5 ~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   84 (328)
T cd07856           5 VFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLED   84 (328)
T ss_pred             eeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence            345788999999999999999999986 47899999988642  22234567789999999999999999999865 567


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA  191 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~  191 (380)
                      .++|+||+ +++|..++..     ..+++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++
T Consensus        85 ~~lv~e~~-~~~L~~~~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~  155 (328)
T cd07856          85 IYFVTELL-GTDLHRLLTS-----RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLA  155 (328)
T ss_pred             EEEEeehh-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccc
Confidence            89999998 5688888753     3578888999999999999999999   9999999999999999999999999998


Q ss_pred             cccCCCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCccc-ch--------hccch
Q 037869          192 KLIPEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKR-TI--------TEWAE  261 (380)
Q Consensus       192 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-~~--------~~~~~  261 (380)
                      ......    .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||......... ..        ..+..
T Consensus       156 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  231 (328)
T cd07856         156 RIQDPQ----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN  231 (328)
T ss_pred             cccCCC----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            764321    123356889999998765 57899999999999999999999999653320000 00        00000


Q ss_pred             hhhhccccccccCCcccCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          262 PLIVKGKFKELVDPKLRGDFD-----ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .........-..........+     ...+..+.++|.+||+.+|++||++.+++.+.+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~  291 (328)
T cd07856         232 TICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYL  291 (328)
T ss_pred             hccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcc
Confidence            000000000000000001111     1234788999999999999999999999999654

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-39  Score=302.09  Aligned_cols=264  Identities=23%  Similarity=0.334  Sum_probs=200.6

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC------eE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD------QR  112 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~  112 (380)
                      .-|...+.||+|+||.||++++ .+|+.||||.++... ....+.--+|+++|++|+|+|||+++++-++..      ..
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            3455678999999999999996 679999999998743 233445667999999999999999999865433      46


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC--CCC--ceEEeec
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLD--SDF--EPLVADF  188 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~--~~~--~vkl~Df  188 (380)
                      .+|||||.||+|...+.+. .+...+++..++.+..++..||.|||.+   ||+||||||.||++-  .+|  .-||+||
T Consensus        93 vlvmEyC~gGsL~~~L~~P-EN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDf  168 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSP-ENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDF  168 (732)
T ss_pred             eEEEeecCCCcHHHHhcCc-ccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecc
Confidence            8999999999999999765 4456799999999999999999999999   999999999999994  334  3699999


Q ss_pred             cCccccCCCCccceeccccccCccCccccc-cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhc-
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVK-  266 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-  266 (380)
                      |.|+.+.++.  ....++||..|++||+.. ...|+..+|.|||||++|+++||..||....+........|....... 
T Consensus       169 G~Arel~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~  246 (732)
T KOG4250|consen  169 GAARELDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS  246 (732)
T ss_pred             cccccCCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence            9999987654  567788999999999998 588999999999999999999999999755443221111122111111 


Q ss_pred             -----------cccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC--CHHHH
Q 037869          267 -----------GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRP--NMKEV  310 (380)
Q Consensus       267 -----------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp--s~~~l  310 (380)
                                 +.+.--..-.............+...+..+|..+|.+|.  .+.+.
T Consensus       247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~  303 (732)
T KOG4250|consen  247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRF  303 (732)
T ss_pred             ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchH
Confidence                       111000000112223344455677888889999999998  44443

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.5e-38  Score=295.32  Aligned_cols=265  Identities=21%  Similarity=0.298  Sum_probs=201.8

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCe---
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQ---  111 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---  111 (380)
                      ...++|++.+.||.|++|.||+|++ .++..||+|++...  .......+.+|+.+++.++||||+++++++...+.   
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            4578899999999999999999987 46889999998642  22334567789999999999999999998766554   


Q ss_pred             ---EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          112 ---RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       112 ---~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                         .++|+||+ +++|.+++..     ..+++..++.++.|++.||+|||+.   |++||||+|+||+++.++.++|+||
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~df  162 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDF  162 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEccc
Confidence               89999999 6699998864     3689999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhh----
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL----  263 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~----  263 (380)
                      |++......    .....++..|+|||.+.+ ..++.++|||||||++|+|++|..||......  .....+....    
T Consensus       163 g~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~--~~~~~i~~~~~~~~  236 (343)
T cd07851         163 GLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHI--DQLKRIMNLVGTPD  236 (343)
T ss_pred             ccccccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHhcCCCC
Confidence            999876432    223457889999998865 46789999999999999999999999753321  0000000000    


Q ss_pred             --hhc-------cccccccCCcccCC---CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          264 --IVK-------GKFKELVDPKLRGD---FDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       264 --~~~-------~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                        ...       ..+...........   .....+..+.++|.+||+.+|.+|||+.+|+.|.+.-
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~  302 (343)
T cd07851         237 EELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLA  302 (343)
T ss_pred             HHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCcc
Confidence              000       00000000000000   0112357899999999999999999999999997644

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-38  Score=285.11  Aligned_cols=264  Identities=25%  Similarity=0.343  Sum_probs=201.3

Q ss_pred             CCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEec
Q 037869           43 FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYM  119 (380)
Q Consensus        43 y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  119 (380)
                      |++.+.||.|++|.||+|.+. +++.|++|.+....  ......+..|+.+++.++|+||+++++++......++||||+
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~   80 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC   80 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence            677889999999999999874 58999999998642  333456778999999999999999999999999999999999


Q ss_pred             CCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc
Q 037869          120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS  199 (380)
Q Consensus       120 ~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~  199 (380)
                      + ++|.+++....   ..+++..++.++.|++.||++||+.   +++||||+|+||+++.++.++|+|||++........
T Consensus        81 ~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  153 (282)
T cd07829          81 D-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR  153 (282)
T ss_pred             C-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCcc
Confidence            7 58999997542   4689999999999999999999999   999999999999999999999999999987644322


Q ss_pred             cceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccc-h---------hccchhhhh---
Q 037869          200 HMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRT-I---------TEWAEPLIV---  265 (380)
Q Consensus       200 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-~---------~~~~~~~~~---  265 (380)
                       ......++..|+|||.+.+. .++.++|||||||++|+|++|..||.......... .         ..|......   
T Consensus       154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07829         154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY  232 (282)
T ss_pred             -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence             12223457889999998766 78999999999999999999999996533110000 0         000000000   


Q ss_pred             ccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          266 KGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ...+......... ...+..+..+.+++.+||..||++||++.++++|.+
T Consensus       233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~  281 (282)
T cd07829         233 KPTFPKFPPKDLE-KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPY  281 (282)
T ss_pred             cccccccCccchH-HhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcC
Confidence            0000000000000 011122568999999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-39  Score=288.82  Aligned_cols=257  Identities=28%  Similarity=0.357  Sum_probs=213.5

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ...+.|+.-+.||+|+||.||-++. .+|+.||.|.+.+..   .......++|-.+|..++.+.||.+--+|++.+.++
T Consensus       182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC  261 (591)
T KOG0986|consen  182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC  261 (591)
T ss_pred             ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence            4457889999999999999999875 579999999886422   223346778999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +|+..|+||+|.-.|-+.  .+..+++..++.++.+|+.||++||+.   +||.|||||+|||+++.|+|+|+|+|||..
T Consensus       262 lVLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAve  336 (591)
T KOG0986|consen  262 LVLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVE  336 (591)
T ss_pred             EEEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEe
Confidence            999999999999888654  346799999999999999999999999   999999999999999999999999999998


Q ss_pred             cCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCccc-chhccchhhhhccccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKR-TITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  272 (380)
                      +..+...  ...+||.+|||||++.+..|+...|.|||||++|||+.|..||.....-+.. .+.+..            
T Consensus       337 i~~g~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~------------  402 (591)
T KOG0986|consen  337 IPEGKPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRT------------  402 (591)
T ss_pred             cCCCCcc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHH------------
Confidence            8765433  3347999999999999999999999999999999999999999764432222 111100            


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhc
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLT  315 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~  315 (380)
                        ......++...++++.+|....|.+||.+|.     .+.++.+|..
T Consensus       403 --~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~Hpf  448 (591)
T KOG0986|consen  403 --LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPF  448 (591)
T ss_pred             --hcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcc
Confidence              0112245667778999999999999999995     6778988844

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-39  Score=294.79  Aligned_cols=257  Identities=24%  Similarity=0.346  Sum_probs=210.6

Q ss_pred             HhhCCCCC--cceeccCCceEEEEEEe-CCCcEEEEEEecc--cChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeE
Q 037869           38 TATNGFSD--DNKLGEGGFGSVYWGRT-SDGLQIAVKKLKA--MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        38 ~~~~~y~~--~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  112 (380)
                      ...+-|.|  .+.||.|.||+||-|.+ ++|+.||||++.+  ...+...++++|+.+|.++.||.||.+.-.|++.+..
T Consensus       559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~erv  638 (888)
T KOG4236|consen  559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERV  638 (888)
T ss_pred             hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceE
Confidence            34444544  57999999999999986 6899999999975  3345557899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC---CceEEeecc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD---FEPLVADFG  189 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~---~~vkl~Dfg  189 (380)
                      ++|||-+.| +..+.|..  +..+++++.....++.||+.||.|||..   +|+|+||||+|||+.+.   -++||||||
T Consensus       639 FVVMEKl~G-DMLEMILS--sEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFG  712 (888)
T KOG4236|consen  639 FVVMEKLHG-DMLEMILS--SEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFG  712 (888)
T ss_pred             EEEehhhcc-hHHHHHHH--hhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeecccc
Confidence            999999965 66666644  3467899999999999999999999999   99999999999999654   579999999


Q ss_pred             CccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccc
Q 037869          190 FAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKF  269 (380)
Q Consensus       190 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  269 (380)
                      .++.+.+  ......++||+.|+|||++..+.|...-|+||.|+|+|--++|..||....+ .   .++++     +   
T Consensus       713 fARiIgE--ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd-I---ndQIQ-----N---  778 (888)
T KOG4236|consen  713 FARIIGE--KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED-I---NDQIQ-----N---  778 (888)
T ss_pred             ceeecch--hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccc-h---hHHhh-----c---
Confidence            9999865  3455667899999999999999999999999999999999999999975321 0   00000     0   


Q ss_pred             ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                         ..-.....-..+++..+++||..+|+..-++|.|....+.|.|--
T Consensus       779 ---AaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq  823 (888)
T KOG4236|consen  779 ---AAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQ  823 (888)
T ss_pred             ---cccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhh
Confidence               011112223456678899999999999999999999999997743

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-38  Score=301.46  Aligned_cols=263  Identities=24%  Similarity=0.315  Sum_probs=220.2

Q ss_pred             HHHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcC-CCCcceeEeeEEec---
Q 037869           34 KELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAG---  108 (380)
Q Consensus        34 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~---  108 (380)
                      +.....+..|+|.+.||.|.+|.||+++. ++++..|+|++...... .+++..|.++|+.+ .|||++.++++|..   
T Consensus        12 ~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~-deEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   12 SSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE-EEEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             hhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc-cHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            34445778899999999999999999986 56888899988765433 34778899999988 59999999999853   


Q ss_pred             --CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEe
Q 037869          109 --TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVA  186 (380)
Q Consensus       109 --~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~  186 (380)
                        ++.+|||||||.||++.|+++...  +..+.|..+..|+..++.||.+||..   .++|||||-.|||++.++.|||+
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLv  165 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLV  165 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEe
Confidence              678999999999999999998764  67899999999999999999999998   89999999999999999999999


Q ss_pred             eccCccccCCCCccceeccccccCccCccccccC-----CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccch
Q 037869          187 DFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG-----KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE  261 (380)
Q Consensus       187 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  261 (380)
                      |||++.++... .....+..||+.|||||++...     .|+..+|+||||++..||.-|.+|+....+....       
T Consensus       166 DFGvSaQldsT-~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL-------  237 (953)
T KOG0587|consen  166 DFGVSAQLDST-VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL-------  237 (953)
T ss_pred             eeeeeeeeecc-cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh-------
Confidence            99999988654 3455667899999999999753     4788999999999999999999999765431111       


Q ss_pred             hhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          262 PLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                             +.-...|......+...+.++.++|..||.+|-.+||+..++++|...-
T Consensus       238 -------F~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~  286 (953)
T KOG0587|consen  238 -------FLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT  286 (953)
T ss_pred             -------ccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence                   1112233444455778889999999999999999999999999996654

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=277.15  Aligned_cols=242  Identities=30%  Similarity=0.383  Sum_probs=198.2

Q ss_pred             eccCCceEEEEEEeC-CCcEEEEEEecccCh---hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCCCH
Q 037869           49 LGEGGFGSVYWGRTS-DGLQIAVKKLKAMNS---KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSL  124 (380)
Q Consensus        49 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  124 (380)
                      ||.|+||.||++.+. +++.|++|.++....   .....+..|+.+++.++||||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            799999999999874 588999999875332   2345778899999999999999999999999999999999999999


Q ss_pred             HHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccceec
Q 037869          125 LSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR  204 (380)
Q Consensus       125 ~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~~~  204 (380)
                      .+++...    ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++....... .....
T Consensus        81 ~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~  152 (250)
T cd05123          81 FSHLSKE----GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNT  152 (250)
T ss_pred             HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccC
Confidence            9999654    3689999999999999999999998   99999999999999999999999999998764322 12334


Q ss_pred             cccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHH
Q 037869          205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN  284 (380)
Q Consensus       205 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      ..++..|+|||.+.+...+.++|+||||+++|++++|..||......   ..            ......  .....+..
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~---~~------------~~~~~~--~~~~~~~~  215 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK---EI------------YEKILK--DPLRFPEF  215 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HH------------HHHHhc--CCCCCCCC
Confidence            45788999999998888899999999999999999999999654320   00            000000  11123333


Q ss_pred             HHHHHHHHHHhhcCCCCCCCCCH---HHHHHHhc
Q 037869          285 QLKQAINVAVLCVQSEPEKRPNM---KEVVNTLT  315 (380)
Q Consensus       285 ~~~~~~~li~~cl~~~P~~Rps~---~~ll~~l~  315 (380)
                      .+..+.+++.+||..||++||++   .++++|.+
T Consensus       216 ~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~  249 (250)
T cd05123         216 LSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF  249 (250)
T ss_pred             CCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCC
Confidence            35788999999999999999999   88888754

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=8.4e-38  Score=290.55  Aligned_cols=266  Identities=21%  Similarity=0.268  Sum_probs=195.6

Q ss_pred             CCCCcceeccCCceEEEEEEeC-C--CcEEEEEEeccc--ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecC----Ce
Q 037869           42 GFSDDNKLGEGGFGSVYWGRTS-D--GLQIAVKKLKAM--NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGT----DQ  111 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~~-~--~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~----~~  111 (380)
                      +|++.+.||+|+||.||++++. .  +..||+|++...  .......+.+|+.+++++ +||||+++++.+...    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            5888999999999999999863 4  778999998742  222344677899999999 599999999875432    45


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA  191 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~  191 (380)
                      .|++++|+. ++|.+.+..    ...+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++
T Consensus        81 ~~~~~e~~~-~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a  152 (332)
T cd07857          81 LYLYEELME-ADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLA  152 (332)
T ss_pred             EEEEEeccc-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCc
Confidence            789999985 689888854    34689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCc---cceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCc-------------cc
Q 037869          192 KLIPEGVS---HMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGV-------------KR  254 (380)
Q Consensus       192 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-------------~~  254 (380)
                      ........   .......|+..|+|||.+.+ ..++.++||||+|+++|+|++|.+||.......             ..
T Consensus       153 ~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (332)
T cd07857         153 RGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEE  232 (332)
T ss_pred             eecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            87643211   11223468999999998765 568999999999999999999999997533100             00


Q ss_pred             chhccchhhhhc--cccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          255 TITEWAEPLIVK--GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       255 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ....+..+....  ...... ............+..+.+++.+||+.||.+|||+.+++.+.+-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~  295 (332)
T cd07857         233 TLSRIGSPKAQNYIRSLPNI-PKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYL  295 (332)
T ss_pred             HHHhhhhhhHHHHHHhcccc-CCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhh
Confidence            000000000000  000000 0000000111234678999999999999999999999998664

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=308.76  Aligned_cols=264  Identities=27%  Similarity=0.394  Sum_probs=216.0

Q ss_pred             HHHHhhCCCCCcceeccCCceEEEEEEe----CC----CcEEEEEEeccc-ChhhHHHHHHHHHHHhcC-CCCcceeEee
Q 037869           35 ELHTATNGFSDDNKLGEGGFGSVYWGRT----SD----GLQIAVKKLKAM-NSKAEMEFAVEVEVLGRV-RHKNLLGLRG  104 (380)
Q Consensus        35 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~----~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~  104 (380)
                      .+....++..+.+.||.|.||.|++|.-    ..    ...||||.++.. ...+...+..|+++|..+ +|+||+.++|
T Consensus       290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG  369 (609)
T KOG0200|consen  290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLG  369 (609)
T ss_pred             ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence            3445566667888999999999999952    11    457999999853 334566888999999999 6999999999


Q ss_pred             EEecCCeEEEEEEecCCCCHHHhhccCC---C-------CC--ccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 037869          105 YCAGTDQRLIVYDYMPNLSLLSHLHGQY---A-------GE--VQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKA  172 (380)
Q Consensus       105 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~---~-------~~--~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp  172 (380)
                      ++..++.+++|+||+..|+|.++++...   .       ..  ..++....+++++||+.|++||++.   +++||||..
T Consensus       370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAa  446 (609)
T KOG0200|consen  370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAA  446 (609)
T ss_pred             eeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchhhhh
Confidence            9999999999999999999999998664   0       01  2388999999999999999999999   999999999


Q ss_pred             CCeeeCCCCceEEeeccCccccCCCCccceeccc--cccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCC
Q 037869          173 SNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK--GTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLP  249 (380)
Q Consensus       173 ~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~  249 (380)
                      +|||++.+..+||+|||+++..............  -...|+|||.+....|+.++||||+|++|||+++ |..||.+..
T Consensus       447 RNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~  526 (609)
T KOG0200|consen  447 RNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP  526 (609)
T ss_pred             hhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence            9999999999999999999965443332222112  2456999999999999999999999999999999 889987632


Q ss_pred             CCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          250 GGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .               ...+.+.+..+.+...|..++.++.+++..||+.+|++||++.++.+.+..
T Consensus       527 ~---------------~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~  578 (609)
T KOG0200|consen  527 P---------------TEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEK  578 (609)
T ss_pred             c---------------HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHH
Confidence            1               111122455666667788888999999999999999999999999998865

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-38  Score=296.05  Aligned_cols=244  Identities=25%  Similarity=0.327  Sum_probs=201.1

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ..+.|.+...+|.|+|+.|-.+.+ .+++..++|++.....    ...+|+.++... +||||+++.+.+.+..+.|+||
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~  395 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM  395 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence            367899999999999999988875 5788899999986521    233466555444 7999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee-CCCCceEEeeccCccccC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLL-DSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill-~~~~~vkl~Dfgl~~~~~  195 (380)
                      |++.|+.+.+.+...     +.....+..|+.+|+.|+.|||++   |+|||||||+|||+ ++.++++|+|||.++...
T Consensus       396 e~l~g~ell~ri~~~-----~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~  467 (612)
T KOG0603|consen  396 ELLDGGELLRRIRSK-----PEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELE  467 (612)
T ss_pred             hhccccHHHHHHHhc-----chhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCc
Confidence            999999999988653     222267778999999999999998   99999999999999 588999999999999875


Q ss_pred             CCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      ..    ..+.+-|..|.|||++....|++++|+||||++||+|++|..||...+.+ .                 ++...
T Consensus       468 ~~----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~-----------------ei~~~  525 (612)
T KOG0603|consen  468 RS----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-I-----------------EIHTR  525 (612)
T ss_pred             hh----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-H-----------------HHHHh
Confidence            53    33334589999999999999999999999999999999999999876543 0                 01111


Q ss_pred             cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ...+.+...++..+.+|+.+||+.||.+||++.++..|.|.
T Consensus       526 i~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  526 IQMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             hcCCccccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            11222335667899999999999999999999999999886

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.4e-37  Score=275.20  Aligned_cols=227  Identities=21%  Similarity=0.244  Sum_probs=183.0

Q ss_pred             CCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCCCHHHhhcc
Q 037869           52 GGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHG  130 (380)
Q Consensus        52 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~  130 (380)
                      |.+|.||++.+ .+++.||+|.++....     ...|...+....||||+++++++...+..++||||+++|+|.+++..
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~   78 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK   78 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence            89999999987 5789999999976432     22344444556799999999999999999999999999999999865


Q ss_pred             CCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccceeccccccC
Q 037869          131 QYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG  210 (380)
Q Consensus       131 ~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~  210 (380)
                      .    ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++++|||.+......    .....++..
T Consensus        79 ~----~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~  147 (237)
T cd05576          79 F----LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENM  147 (237)
T ss_pred             h----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCcc
Confidence            3    3589999999999999999999998   9999999999999999999999999988665432    122345778


Q ss_pred             ccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHH
Q 037869          211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAI  290 (380)
Q Consensus       211 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (380)
                      |+|||.+.+..++.++||||+|+++|+|++|..|+........                     .......+...+..+.
T Consensus       148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~  206 (237)
T cd05576         148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN---------------------THTTLNIPEWVSEEAR  206 (237)
T ss_pred             ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc---------------------cccccCCcccCCHHHH
Confidence            9999999888899999999999999999999988754221000                     0000112233457789


Q ss_pred             HHHHhhcCCCCCCCCCH-----HHHHHHhc
Q 037869          291 NVAVLCVQSEPEKRPNM-----KEVVNTLT  315 (380)
Q Consensus       291 ~li~~cl~~~P~~Rps~-----~~ll~~l~  315 (380)
                      ++|.+||+.||++||++     +++++|.+
T Consensus       207 ~li~~~l~~dp~~R~~~~~~~~~~~~~h~~  236 (237)
T cd05576         207 SLLQQLLQFNPTERLGAGVAGVEDIKSHPF  236 (237)
T ss_pred             HHHHHHccCCHHHhcCCCccchHHHHcCCC
Confidence            99999999999999986     88887754

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.1e-37  Score=308.87  Aligned_cols=146  Identities=26%  Similarity=0.351  Sum_probs=131.2

Q ss_pred             hCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      .++|++.++||+|+||+||+|.+. +++.||||+++...   ......+..|+.++..++||||+++++++......|+|
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV   82 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV   82 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence            368999999999999999999874 68999999997532   23345788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      |||+.+++|.+++...    ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||+++
T Consensus        83 mEy~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999999643    3688899999999999999999998   99999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9e-40  Score=272.91  Aligned_cols=272  Identities=22%  Similarity=0.339  Sum_probs=202.7

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecc--cChhhHHHHHHHHHHHhcCCCCcceeEeeEEec-------
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKA--MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG-------  108 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------  108 (380)
                      ....|.-..+||+|.||.||+|+. .++++||+|++.-  ....-.....+|+++|..|+|+|++.+++.|..       
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence            345677788999999999999986 5688899887643  223334567889999999999999999988743       


Q ss_pred             -CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEee
Q 037869          109 -TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD  187 (380)
Q Consensus       109 -~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~D  187 (380)
                       ...+|+||++|+. +|..++...   ..+++..++..++.++..||.|+|+.   .|+|||+|+.|+||+.+|.+||+|
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklAD  167 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLAD  167 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeec
Confidence             2348999999976 888888643   36799999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccCCCC---ccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhh
Q 037869          188 FGFAKLIPEGV---SHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL  263 (380)
Q Consensus       188 fgl~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  263 (380)
                      ||+++.+....   ....+..+.|.+|++||.+.| ..|+++.|||..|||+.||.+|.+-+.+.++.....+....--.
T Consensus       168 FGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs  247 (376)
T KOG0669|consen  168 FGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGS  247 (376)
T ss_pred             cccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhcc
Confidence            99998764322   222333456999999999886 57999999999999999999999888765543222111100000


Q ss_pred             hhcccccc--------cc-CCcccCC-C--CHHH------HHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          264 IVKGKFKE--------LV-DPKLRGD-F--DENQ------LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       264 ~~~~~~~~--------~~-~~~~~~~-~--~~~~------~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .....|..        .+ .+.+... +  -.+.      ..+..+|+..+|..||.+|+++.++++|-+.+
T Consensus       248 ~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~  319 (376)
T KOG0669|consen  248 ITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFW  319 (376)
T ss_pred             CCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhh
Confidence            00011110        00 0000000 0  0011      24788999999999999999999999997655

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-37  Score=275.79  Aligned_cols=265  Identities=26%  Similarity=0.345  Sum_probs=200.5

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhc--CCCCcceeEeeEEecCC----e
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGR--VRHKNLLGLRGYCAGTD----Q  111 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~  111 (380)
                      +...+.++.+.||+|.||.||+|+++ |+.||||++....   +....+|.++...  |+|+||+.++++-..+.    +
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc-CCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            66789999999999999999999996 8899999998653   3366666666654  59999999999865443    5


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEecCCCCCCeeeCCCCceEEe
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE-----VTPHIIHRDIKASNVLLDSDFEPLVA  186 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~-----~~~~ivHrdlkp~Nill~~~~~vkl~  186 (380)
                      +|+|++|.+.|||+|++.+.     .++....++++..++.||++||..     ..+.|.|||||..||||..++...|+
T Consensus       284 LwLvTdYHe~GSL~DyL~r~-----tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNRN-----TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             EEEeeecccCCcHHHHHhhc-----cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence            89999999999999999764     789999999999999999999973     35579999999999999999999999


Q ss_pred             eccCccccCCCCc---cceeccccccCccCccccccCC----C--CccchhhhhhHHHHHHHhC----------CCCCCC
Q 037869          187 DFGFAKLIPEGVS---HMTTRVKGTLGYLAPEYAMWGK----V--SESCDVYSFGILLLEILTG----------RKPIEK  247 (380)
Q Consensus       187 Dfgl~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DiwslG~il~ell~g----------~~p~~~  247 (380)
                      |+||+-.......   ......+||.+|||||++...-    +  -..+||||||.|+||++.+          ++||.+
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd  438 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD  438 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence            9999977654432   2345578999999999987432    1  2358999999999999864          256654


Q ss_pred             CCCCcccchhccchhhhhccccccccCCcccC-CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          248 LPGGVKRTITEWAEPLIVKGKFKELVDPKLRG-DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ..+..... .     .+..-.-.+-+.|.... .........+-++++.||..||..|-|+-.|.+.|..+
T Consensus       439 ~Vp~DPs~-e-----eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l  503 (513)
T KOG2052|consen  439 VVPSDPSF-E-----EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL  503 (513)
T ss_pred             CCCCCCCH-H-----HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence            32211100 0     00000001111121111 12335567889999999999999999999998887654

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-38  Score=298.38  Aligned_cols=254  Identities=28%  Similarity=0.442  Sum_probs=217.3

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCC----cEEEEEEecc-cChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDG----LQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~----~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ..+-.++||.|+||+||+|.+ .++    -+||||++.. ...+...++..|+-+|..++|||++++++++..+. +-||
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            344578999999999999986 344    4689998864 44555678999999999999999999999998654 8899


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      ++|+++|+|.++++..   +..+-.+..+.|.+||++|+.|||.+   .+|||||..+|+||..-..+||+|||+++.+.
T Consensus       776 tq~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~  849 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLA  849 (1177)
T ss_pred             HHhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence            9999999999999864   56788999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCccce-eccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          196 EGVSHMT-TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       196 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                      ....... ....-.+.|+|-|.+....|+.++|||||||++||++| |..|+.+.+                ...+..++
T Consensus       850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~----------------~~eI~dll  913 (1177)
T KOG1025|consen  850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP----------------AEEIPDLL  913 (1177)
T ss_pred             cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC----------------HHHhhHHH
Confidence            5433322 22234778999999999999999999999999999999 999998754                23355566


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      +.+.+-..|+.++.++..++.+||..|+..||+++++...+..+.
T Consensus       914 e~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~a  958 (1177)
T KOG1025|consen  914 EKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMA  958 (1177)
T ss_pred             hccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHh
Confidence            777777888889999999999999999999999999998876553

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-39  Score=271.01  Aligned_cols=273  Identities=24%  Similarity=0.334  Sum_probs=204.6

Q ss_pred             CCCCCccceeccHHHHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh-hhHHHHHHHHHHHhcC-CCC
Q 037869           21 TTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS-KAEMEFAVEVEVLGRV-RHK   97 (380)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l-~h~   97 (380)
                      ..|..+-.-.|+-+.++.       +..||.|+||+|++..+ ..|+..|||+++.... .+..+++.|.....+- ++|
T Consensus        51 ~~p~~~~~~~F~~~~Lqd-------lg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp  123 (361)
T KOG1006|consen   51 KLPDDAHLHTFTSDNLQD-------LGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCP  123 (361)
T ss_pred             ecCCcccccccccchHHH-------HHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCc
Confidence            334444444555444443       67899999999999976 5799999999986544 5666788888865544 799


Q ss_pred             cceeEeeEEecCCeEEEEEEecCCCCHHHhhccCC-CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCee
Q 037869           98 NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQY-AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVL  176 (380)
Q Consensus        98 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~-~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nil  176 (380)
                      |||+++|++...+..||.||+|. .+|..+...-+ .....+++..+..|....+.||.||....  .|+|||+||+|||
T Consensus       124 ~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNIL  200 (361)
T KOG1006|consen  124 NIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNIL  200 (361)
T ss_pred             HHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheE
Confidence            99999999988999999999994 46655443211 12457999999999999999999999863  7999999999999


Q ss_pred             eCCCCceEEeeccCccccCCCCccceeccccccCccCccccc--cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCccc
Q 037869          177 LDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM--WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKR  254 (380)
Q Consensus       177 l~~~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  254 (380)
                      ++..|.|||||||++-.+....  ..+.-.|-..|+|||.+.  +..|+-+|||||||++|||+.||..|+..... ...
T Consensus       201 ldr~G~vKLCDFGIcGqLv~Si--AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-vfe  277 (361)
T KOG1006|consen  201 LDRHGDVKLCDFGICGQLVDSI--AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-VFE  277 (361)
T ss_pred             EecCCCEeeecccchHhHHHHH--HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-HHH
Confidence            9999999999999998765432  223335788999999987  34599999999999999999999999975332 000


Q ss_pred             chhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          255 TITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .+     ...+.+....+..+    ...-..+..+..+|.-||.+|-+.||++.+|+++..
T Consensus       278 ql-----~~Vv~gdpp~l~~~----~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~f  329 (361)
T KOG1006|consen  278 QL-----CQVVIGDPPILLFD----KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPF  329 (361)
T ss_pred             HH-----HHHHcCCCCeecCc----ccccccCHHHHHHHHHHhhcccccCcchhhhhcCch
Confidence            00     11222222222111    111245678999999999999999999999998743

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=279.17  Aligned_cols=268  Identities=24%  Similarity=0.332  Sum_probs=198.0

Q ss_pred             CCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhc--CCCCcceeEeeEEecCC----eEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGR--VRHKNLLGLRGYCAGTD----QRLI  114 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~~----~~~l  114 (380)
                      ....+.+.||+|.||.||+|... ++.||||++...   +...+.+|-++.+.  ++|+||++++++-....    .++|
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywL  285 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWL  285 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-CceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeE
Confidence            44566889999999999999874 689999998753   44577777776654  58999999999865544    7899


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhc------CCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE------VTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~------~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                      |++|.+.|+|.+++...     .++|....+++..+++||+|||+.      +.+.|+|||||.+||||.+|++..|+||
T Consensus       286 Vt~fh~kGsL~dyL~~n-----tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF  360 (534)
T KOG3653|consen  286 VTEFHPKGSLCDYLKAN-----TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF  360 (534)
T ss_pred             EeeeccCCcHHHHHHhc-----cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence            99999999999999765     799999999999999999999984      2558999999999999999999999999


Q ss_pred             cCccccCCCCcc-ceeccccccCccCccccccCC-C-----CccchhhhhhHHHHHHHhCCCCCC-CCCCCcccchhccc
Q 037869          189 GFAKLIPEGVSH-MTTRVKGTLGYLAPEYAMWGK-V-----SESCDVYSFGILLLEILTGRKPIE-KLPGGVKRTITEWA  260 (380)
Q Consensus       189 gl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~-~-----~~~~DiwslG~il~ell~g~~p~~-~~~~~~~~~~~~~~  260 (380)
                      |++.++..+... .....+||.+|||||++.|.- +     -.+.||||+|.|||||+++..-+. +..+........-.
T Consensus       361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev  440 (534)
T KOG3653|consen  361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV  440 (534)
T ss_pred             ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence            999988654322 233367999999999998643 2     236899999999999999776553 11111111111001


Q ss_pred             hhhhhccccc-cccCCcccCCCCH-----HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          261 EPLIVKGKFK-ELVDPKLRGDFDE-----NQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       261 ~~~~~~~~~~-~~~~~~~~~~~~~-----~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .....-+.+. ..+..+.+..++.     .....+.+.+..||..||+.|.|+.=+-+++..+
T Consensus       441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l  503 (534)
T KOG3653|consen  441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL  503 (534)
T ss_pred             cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence            0000000111 1111222222222     3346788999999999999999998887776654

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.6e-37  Score=284.77  Aligned_cols=284  Identities=22%  Similarity=0.300  Sum_probs=210.5

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh---hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS---KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ..-|..++.||-|+||+|.+++. .++..||+|.+++..-   ........|..||..-.++.||+++-.|.+.+.+|+|
T Consensus       628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence            34677889999999999999975 4577899999986332   2233566799999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc-
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI-  194 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~-  194 (380)
                      |+|++||++..++.+.    +-|.+..++.++..+..|+++.|..   |+|||||||+||||+.+|.|||+||||+.-+ 
T Consensus       708 MdYIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfR  780 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR  780 (1034)
T ss_pred             EeccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccce
Confidence            9999999999998765    5799999999999999999999999   9999999999999999999999999998543 


Q ss_pred             --------CCCCc--------------------------------cceeccccccCccCccccccCCCCccchhhhhhHH
Q 037869          195 --------PEGVS--------------------------------HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGIL  234 (380)
Q Consensus       195 --------~~~~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i  234 (380)
                              ..+..                                -.....+||+.|+|||++....|+..+|.||.|+|
T Consensus       781 WTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvi  860 (1034)
T KOG0608|consen  781 WTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVI  860 (1034)
T ss_pred             eccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHH
Confidence                    10000                                00112459999999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCCCccc-chhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC---CHHHH
Q 037869          235 LLEILTGRKPIEKLPGGVKR-TITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRP---NMKEV  310 (380)
Q Consensus       235 l~ell~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp---s~~~l  310 (380)
                      ||||+.|++||......... .+.          .|...+.    -.+..+.+.++.++|.+++. +++.|.   -+++|
T Consensus       861 l~em~~g~~pf~~~tp~~tq~kv~----------nw~~~l~----~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~v  925 (1034)
T KOG0608|consen  861 LYEMLVGQPPFLADTPGETQYKVI----------NWRNFLH----IPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQV  925 (1034)
T ss_pred             HHHHhhCCCCccCCCCCcceeeee----------ehhhccc----cccccccCHHHHHHHHHHhc-Chhhhhcccchhhh
Confidence            99999999999765543221 222          2222222    23334455677777776444 566663   56678


Q ss_pred             HHHhcC--CCCCC--cccccchhhccchhhhhcccCcCC
Q 037869          311 VNTLTG--YDPRG--KVMQTRIETLAYKEELLAFDQTTD  345 (380)
Q Consensus       311 l~~l~~--~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  345 (380)
                      ..|.+.  ++...  +....-+....-.++.-.|+...+
T Consensus       926 KaHpfFkgIDfsslRkq~ApYIP~ItHptDTSNFdpvdp  964 (1034)
T KOG0608|consen  926 KAHPFFKGIDFSSLRKQRAPYIPRITHPTDTSNFDPVDP  964 (1034)
T ss_pred             hcCccccccchHhhhhccCCcCccccCCCccccCCcCCc
Confidence            888543  33322  111122333344445555555443

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=273.58  Aligned_cols=271  Identities=22%  Similarity=0.304  Sum_probs=203.2

Q ss_pred             HHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCC--CC----cceeEeeEEec
Q 037869           36 LHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR--HK----NLLGLRGYCAG  108 (380)
Q Consensus        36 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--h~----niv~~~~~~~~  108 (380)
                      ....+++|.+...||+|.||.|-.+.+ ..+..||||+++.... -.+..+-|+++|.++.  .|    -+|.+.++|.-
T Consensus        84 gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k-YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy  162 (415)
T KOG0671|consen   84 GDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK-YREAALIEIEVLQKINESDPNGKFRCVQMRDWFDY  162 (415)
T ss_pred             ccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH-HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc
Confidence            334689999999999999999999876 3478999999986542 3345666899999883  22    26777778888


Q ss_pred             CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---------
Q 037869          109 TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS---------  179 (380)
Q Consensus       109 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~---------  179 (380)
                      .++.+||+|.+ |.++.+++...  +..+++...++.+.+||++++++||+.   +++|-||||+|||+.+         
T Consensus       163 rghiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~  236 (415)
T KOG0671|consen  163 RGHICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNP  236 (415)
T ss_pred             cCceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEecc
Confidence            99999999999 66999999763  356799999999999999999999999   9999999999999931         


Q ss_pred             -----------CCceEEeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCC
Q 037869          180 -----------DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKL  248 (380)
Q Consensus       180 -----------~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  248 (380)
                                 +..|+|+|||.+......    ....+.|..|+|||++.+-.++..+||||+||||+|+.+|..-|...
T Consensus       237 k~~~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH  312 (415)
T KOG0671|consen  237 KKKVCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH  312 (415)
T ss_pred             CCccceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence                       234899999999875432    24556899999999999999999999999999999999999998765


Q ss_pred             CCCccc-chhccchhh-------------hhccc--cccccCCc--------c-----cCCCCHHHHHHHHHHHHhhcCC
Q 037869          249 PGGVKR-TITEWAEPL-------------IVKGK--FKELVDPK--------L-----RGDFDENQLKQAINVAVLCVQS  299 (380)
Q Consensus       249 ~~~~~~-~~~~~~~~~-------------~~~~~--~~~~~~~~--------~-----~~~~~~~~~~~~~~li~~cl~~  299 (380)
                      ++.... ....+..+.             ...+.  |.+...++        .     ...........+++|+.+||..
T Consensus       313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f  392 (415)
T KOG0671|consen  313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF  392 (415)
T ss_pred             CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence            432111 000000000             00000  00000000        0     0011123345799999999999


Q ss_pred             CCCCCCCHHHHHHHhcCC
Q 037869          300 EPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       300 ~P~~Rps~~~ll~~l~~~  317 (380)
                      ||.+|+|+.|++.|.+..
T Consensus       393 DP~~RiTl~EAL~HpFF~  410 (415)
T KOG0671|consen  393 DPARRITLREALSHPFFA  410 (415)
T ss_pred             CccccccHHHHhcCHHhh
Confidence            999999999999997643

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-37  Score=278.01  Aligned_cols=262  Identities=24%  Similarity=0.319  Sum_probs=204.2

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhh-------HHHHHHHHHHHhcCCCCcceeEeeEEec
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKA-------EMEFAVEVEVLGRVRHKNLLGLRGYCAG  108 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~  108 (380)
                      .+..++|-++.+||+|+|+.||+|.+ ..++.||+|+-.....+.       ....-+|..+.+.|.||.||+++++|.-
T Consensus       459 ptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfsl  538 (775)
T KOG1151|consen  459 PTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSL  538 (775)
T ss_pred             cchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeee
Confidence            35678999999999999999999987 567888999864322221       1234569999999999999999999854


Q ss_pred             -CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---CCceE
Q 037869          109 -TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS---DFEPL  184 (380)
Q Consensus       109 -~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~---~~~vk  184 (380)
                       .+.++-|+|||+|-+|.-++...    ..+++.++++|+.||+.||.||... +++|+|-||||.|||+.+   -|.+|
T Consensus       539 DtdsFCTVLEYceGNDLDFYLKQh----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIK  613 (775)
T KOG1151|consen  539 DTDSFCTVLEYCEGNDLDFYLKQH----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIK  613 (775)
T ss_pred             ccccceeeeeecCCCchhHHHHhh----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeE
Confidence             46688999999999998888765    5799999999999999999999998 678999999999999954   48899


Q ss_pred             EeeccCccccCCCCcc------ceeccccccCccCcccccc----CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCccc
Q 037869          185 VADFGFAKLIPEGVSH------MTTRVKGTLGYLAPEYAMW----GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKR  254 (380)
Q Consensus       185 l~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  254 (380)
                      |+|||++..+......      .+....||.||++||++.-    ...+.++||||+|+|+|+.+.|+.||.....  ..
T Consensus       614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs--QQ  691 (775)
T KOG1151|consen  614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS--QQ  691 (775)
T ss_pred             eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh--HH
Confidence            9999999998654332      2345679999999999863    3478999999999999999999999965321  11


Q ss_pred             chhccchhhhhccccccccCCc-ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          255 TITEWAEPLIVKGKFKELVDPK-LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .+.       ....   ++... +.-+.-+.++.++.++|.+||+..-++|....+|..+..
T Consensus       692 dIL-------qeNT---IlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpy  743 (775)
T KOG1151|consen  692 DIL-------QENT---ILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPY  743 (775)
T ss_pred             HHH-------hhhc---hhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCcc
Confidence            000       0000   11111 111112345578999999999999999999999988744

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.8e-36  Score=294.98  Aligned_cols=270  Identities=18%  Similarity=0.189  Sum_probs=176.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CC----CcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeE------Ee
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SD----GLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY------CA  107 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~------~~  107 (380)
                      ..++|.+.+.||+|+||.||+|.+ .+    +..||+|++.......  ....+  .++...+.+++.++..      ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e--~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE--IWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH--HHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            557999999999999999999987 44    6899999987533221  11111  1222222223222221      23


Q ss_pred             cCCeEEEEEEecCCCCHHHhhccCCC----------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 037869          108 GTDQRLIVYDYMPNLSLLSHLHGQYA----------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIK  171 (380)
Q Consensus       108 ~~~~~~lv~e~~~~g~L~~~i~~~~~----------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlk  171 (380)
                      .+...++|+||+.+++|.+++.....                .........+..++.|++.||.|||++   +|+|||||
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDLK  282 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDVK  282 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcCC
Confidence            46679999999999999999864310                011122345678999999999999999   99999999


Q ss_pred             CCCeeeCC-CCceEEeeccCccccCCCCccceeccccccCccCccccccC----------------------CCCccchh
Q 037869          172 ASNVLLDS-DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG----------------------KVSESCDV  228 (380)
Q Consensus       172 p~Nill~~-~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Di  228 (380)
                      |+|||++. ++.+||+|||+++.+............+++.|+|||.+...                      .++.++||
T Consensus       283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV  362 (566)
T PLN03225        283 PQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI  362 (566)
T ss_pred             HHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence            99999986 57999999999987654433444556789999999976422                      23456799


Q ss_pred             hhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCC------CCHHHHHHHHHHHHhhcCCCCC
Q 037869          229 YSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGD------FDENQLKQAINVAVLCVQSEPE  302 (380)
Q Consensus       229 wslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~cl~~~P~  302 (380)
                      |||||++|||+++..|+..........+..   .......+.....+.....      ..........+||.+||+.||+
T Consensus       363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~  439 (566)
T PLN03225        363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKR---NDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR  439 (566)
T ss_pred             HHHHHHHHHHHhCcCCCchHHHHHHHHHHh---cCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence            999999999998766543210000000000   0000000111111110000      0001123456899999999999


Q ss_pred             CCCCHHHHHHHhcCCC
Q 037869          303 KRPNMKEVVNTLTGYD  318 (380)
Q Consensus       303 ~Rps~~~ll~~l~~~~  318 (380)
                      +|||+.++++|.+.-.
T Consensus       440 kR~ta~e~L~Hpff~~  455 (566)
T PLN03225        440 QRISAKAALAHPYFDR  455 (566)
T ss_pred             cCCCHHHHhCCcCcCC
Confidence            9999999999977543

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.1e-37  Score=272.54  Aligned_cols=242  Identities=26%  Similarity=0.338  Sum_probs=198.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  113 (380)
                      -...|..+..||+|+||.|.+|.. .+.+.||||++++.   ...+.+--..|-++|... +-|.++.++.+|++-+.+|
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLy  426 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLY  426 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhee
Confidence            456889999999999999999975 46788999999852   222232333466677655 4688999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||+.||+|...|++-    +.+.+..+..++..|+-||-+||++   ||+.||||.+||+++.+|.|||+|||++..
T Consensus       427 FVMEyvnGGDLMyhiQQ~----GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKE  499 (683)
T KOG0696|consen  427 FVMEYVNGGDLMYHIQQV----GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE  499 (683)
T ss_pred             eEEEEecCchhhhHHHHh----cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccc
Confidence            999999999999999764    5788888999999999999999999   999999999999999999999999999975


Q ss_pred             cCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                      --- ....+.+++|||.|+|||++.-.+|+.++|.||+|++||||+.|++||++.++....               ..+.
T Consensus       500 ni~-~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF---------------~aI~  563 (683)
T KOG0696|consen  500 NIF-DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELF---------------QAIM  563 (683)
T ss_pred             ccc-CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---------------HHHH
Confidence            221 123456789999999999999999999999999999999999999999876542111               1111


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRP  305 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp  305 (380)
                      +  ..-.+|...+.++.++++..|.+.|.+|.
T Consensus       564 e--hnvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  564 E--HNVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             H--ccCcCcccccHHHHHHHHHHhhcCCcccc
Confidence            1  11246677788999999999999999994

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2e-35  Score=283.23  Aligned_cols=272  Identities=18%  Similarity=0.273  Sum_probs=187.2

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-----------------CCCcEEEEEEecccChhhHHHH--------------HHH
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-----------------SDGLQIAVKKLKAMNSKAEMEF--------------AVE   87 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~~~--------------~~E   87 (380)
                      ..++|++.++||+|+||+||+|..                 ..++.||||+++.........+              ..|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            367899999999999999999853                 2356799999875433322223              336


Q ss_pred             HHHHhcCCCCc-----ceeEeeEEec--------CCeEEEEEEecCCCCHHHhhccCCC--------------------C
Q 037869           88 VEVLGRVRHKN-----LLGLRGYCAG--------TDQRLIVYDYMPNLSLLSHLHGQYA--------------------G  134 (380)
Q Consensus        88 ~~~l~~l~h~n-----iv~~~~~~~~--------~~~~~lv~e~~~~g~L~~~i~~~~~--------------------~  134 (380)
                      +.++.+++|.+     +++++++|..        ....++||||+++++|.+++.....                    .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            66677776554     3667776643        3568999999999999998864211                    1


Q ss_pred             CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccceeccccccCccCc
Q 037869          135 EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP  214 (380)
Q Consensus       135 ~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aP  214 (380)
                      ...+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++...............+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence            12356778899999999999999998   999999999999999999999999999976543322222222358899999


Q ss_pred             cccccCC--------------------C--CccchhhhhhHHHHHHHhCCC-CCCCCCCCcccchhccchhhhhcccccc
Q 037869          215 EYAMWGK--------------------V--SESCDVYSFGILLLEILTGRK-PIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       215 E~~~~~~--------------------~--~~~~DiwslG~il~ell~g~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      |.+....                    |  ..+.||||+||++++|+++.. ||...... ......+..   ....+..
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f-~~~~~~~~~---~~~~~r~  455 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLF-NTELRQYDN---DLNRWRM  455 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhh-hhHHhhccc---hHHHHHh
Confidence            9886432                    1  234799999999999999875 66432110 000000000   0000111


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCC---CCCCCHHHHHHHhcCC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEP---EKRPNMKEVVNTLTGY  317 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P---~~Rps~~~ll~~l~~~  317 (380)
                      .......-......+....+|+.+||..+|   .+|+|+.++|+|.+..
T Consensus       456 ~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        456 YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            111111111223445788999999999866   6899999999998754

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-37  Score=294.87  Aligned_cols=257  Identities=23%  Similarity=0.320  Sum_probs=197.1

Q ss_pred             CCCCCcceeccCCceEE-EEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEEEEEe
Q 037869           41 NGFSDDNKLGEGGFGSV-YWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~V-y~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      .-|.-.+.+|.|+.|+| |+|.. +++.||||++-...   .....+|+..|+.- .|||||++++.-.+++..||..|.
T Consensus       509 ~~~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  509 LFFSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             eeeccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            34555678999999975 88876 57899999886533   33667899999887 699999999998889999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---C--CceEEeeccCccc
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS---D--FEPLVADFGFAKL  193 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~---~--~~vkl~Dfgl~~~  193 (380)
                      |. .+|.+++...............+.+..|++.||++||+.   +||||||||+||||+.   +  .+++|+|||+++.
T Consensus       585 C~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  585 CA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             hh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            95 599999986411111122245678899999999999998   9999999999999975   3  4689999999999


Q ss_pred             cCCCCccc--eeccccccCccCccccccCCCCccchhhhhhHHHHHHHhC-CCCCCCCCCCcccchhccchhhhhccccc
Q 037869          194 IPEGVSHM--TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTG-RKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       194 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      +..+....  .....||-+|+|||++.....+.++||||+||++|+.++| ..||..........+..       ...+.
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~-------~~~L~  733 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTG-------NYTLV  733 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcC-------cccee
Confidence            87654332  3456799999999999988888999999999999999995 89997643221111110       00011


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCCCC
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRG  321 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~~~  321 (380)
                      .+      .... +  .++.+||.+|++++|..||+|.+++.|+..++..+
T Consensus       734 ~L------~~~~-d--~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ek  775 (903)
T KOG1027|consen  734 HL------EPLP-D--CEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEK  775 (903)
T ss_pred             ee------ccCc-h--HHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHH
Confidence            00      0011 1  17899999999999999999999999998887644

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=5.3e-35  Score=258.47  Aligned_cols=238  Identities=28%  Similarity=0.389  Sum_probs=194.1

Q ss_pred             CceEEEEEEeC-CCcEEEEEEecccChhh-HHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCCCHHHhhcc
Q 037869           53 GFGSVYWGRTS-DGLQIAVKKLKAMNSKA-EMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHG  130 (380)
Q Consensus        53 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~  130 (380)
                      +||.||+|.+. +++.|++|++....... ...+.+|+..++.++|+||+++++.+..+...++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999875 58999999998654443 56888999999999999999999999998999999999999999999865


Q ss_pred             CCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccceeccccccC
Q 037869          131 QYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG  210 (380)
Q Consensus       131 ~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~  210 (380)
                      .    ..+++..++.++.+++.++.+||+.   +++|+||+|.||+++.++.++|+|||.+.......  ......++..
T Consensus        81 ~----~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~  151 (244)
T smart00220       81 R----GRLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPE  151 (244)
T ss_pred             c----cCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcC
Confidence            4    2388999999999999999999999   99999999999999999999999999998765432  2334457889


Q ss_pred             ccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCH--HHHHH
Q 037869          211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDE--NQLKQ  288 (380)
Q Consensus       211 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~  288 (380)
                      |++||.+.+..++.++||||+|++++++++|..||.......     .+          ..............  ..+..
T Consensus       152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~-----~~----------~~~~~~~~~~~~~~~~~~~~~  216 (244)
T smart00220      152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL-----EL----------FKKIGKPKPPFPPPEWKISPE  216 (244)
T ss_pred             CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH-----HH----------HHHHhccCCCCccccccCCHH
Confidence            999999998889999999999999999999999996531110     00          00000000000000  14478


Q ss_pred             HHHHHHhhcCCCCCCCCCHHHHHHHh
Q 037869          289 AINVAVLCVQSEPEKRPNMKEVVNTL  314 (380)
Q Consensus       289 ~~~li~~cl~~~P~~Rps~~~ll~~l  314 (380)
                      +.+++.+||..+|++||++.+++++.
T Consensus       217 ~~~~i~~~l~~~p~~Rp~~~~~~~~~  242 (244)
T smart00220      217 AKDLIRKLLVKDPEKRLTAEEALQHP  242 (244)
T ss_pred             HHHHHHHHccCCchhccCHHHHhhCC
Confidence            89999999999999999999999864

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-35  Score=254.53  Aligned_cols=257  Identities=21%  Similarity=0.305  Sum_probs=201.0

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  113 (380)
                      .-+.|++++.||+|+|..|.+++. ++.+.||+|++++.   ..++..=...|-.+..+- +||.+|.++.+|++...++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            346899999999999999999986 57889999999852   223333344466666555 6999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +|.||++||+|.-.++++    ..++++.++.+...|+.||.|||++   ||+.||||..|+|++..|.+||+|||+++.
T Consensus       328 fvieyv~ggdlmfhmqrq----rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke  400 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKE  400 (593)
T ss_pred             EEEEEecCcceeeehhhh----hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhc
Confidence            999999999998888765    4799999999999999999999999   999999999999999999999999999976


Q ss_pred             cCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCc-ccchhccchhhhhccccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGV-KRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  272 (380)
                      --. ....+.+++|||.|.|||++.|..|...+|.|+||++++||+.|+.||....... ......+....        +
T Consensus       401 ~l~-~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv--------i  471 (593)
T KOG0695|consen  401 GLG-PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV--------I  471 (593)
T ss_pred             CCC-CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH--------H
Confidence            322 2345667899999999999999999999999999999999999999997433211 11111111111        1


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC------CHHHHHHH
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRP------NMKEVVNT  313 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp------s~~~ll~~  313 (380)
                      +....+  .|...+-.+-.+++.-|++||.+|.      .+.++..|
T Consensus       472 lekqir--iprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h  516 (593)
T KOG0695|consen  472 LEKQIR--IPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSH  516 (593)
T ss_pred             hhhccc--ccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcc
Confidence            222222  2222333455688888999999983      45677666

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-35  Score=258.33  Aligned_cols=266  Identities=23%  Similarity=0.282  Sum_probs=219.1

Q ss_pred             HHHHHHhhCCCCCcceeccCCceEEEEEEeC------CCcEEEEEEecc-cChhhHHHHHHHHHHHhcCCCCcceeEeeE
Q 037869           33 YKELHTATNGFSDDNKLGEGGFGSVYWGRTS------DGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRGY  105 (380)
Q Consensus        33 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~  105 (380)
                      ..++..-..+++....+-+|.||.||.|.+.      +.+.|.+|.++. .++-....++.|.-++....|||+..+.++
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V  355 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV  355 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence            3455566678999999999999999999542      346678888875 444555678889999999999999999998


Q ss_pred             Eec-CCeEEEEEEecCCCCHHHhhccCCC----CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC
Q 037869          106 CAG-TDQRLIVYDYMPNLSLLSHLHGQYA----GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD  180 (380)
Q Consensus       106 ~~~-~~~~~lv~e~~~~g~L~~~i~~~~~----~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~  180 (380)
                      +.+ ....+.++.+..-|+|..++..++.    ....+...+...++.|++.|++|||++   +++|.||..+|++|++.
T Consensus       356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~  432 (563)
T KOG1024|consen  356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQ  432 (563)
T ss_pred             EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhhhhcceehhh
Confidence            754 5668899999999999999974432    223467778889999999999999999   99999999999999999


Q ss_pred             CceEEeeccCccccCCCCccc-eeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhc
Q 037869          181 FEPLVADFGFAKLIPEGVSHM-TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITE  258 (380)
Q Consensus       181 ~~vkl~Dfgl~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~  258 (380)
                      -+|||+|=.+++.+-....+. .........||+||.+....|+.++|+||||++||||+| |+.|+...++        
T Consensus       433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDP--------  504 (563)
T KOG1024|consen  433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDP--------  504 (563)
T ss_pred             eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCH--------
Confidence            999999999998765443332 122235778999999999999999999999999999999 9999976442        


Q ss_pred             cchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          259 WAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                              ..+...+..+.+-..|.+++++++.++.-||+..|++||+++++...|..+
T Consensus       505 --------fEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  505 --------FEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             --------HHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence                    234455666777778889999999999999999999999999999988655

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=5.1e-35  Score=241.27  Aligned_cols=262  Identities=18%  Similarity=0.271  Sum_probs=198.7

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCC-CCcceeEeeEEecC--CeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR-HKNLLGLRGYCAGT--DQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~--~~~~l  114 (380)
                      ..+.|++.+++|+|.++.||.|.+ .++++++||+++...   ...+.+|+++|.+|. ||||++++++..+.  ....+
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL  112 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL  112 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence            457899999999999999999986 678999999998754   347889999999997 99999999998664  45789


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-CceEEeeccCccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD-FEPLVADFGFAKL  193 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~-~~vkl~Dfgl~~~  193 (380)
                      |+||+.+.+...+.       ..++...+..++.+++.||.|+|+.   ||.|||+||.|++|+.. -.++|+|||++..
T Consensus       113 iFE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF  182 (338)
T KOG0668|consen  113 IFEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEF  182 (338)
T ss_pred             HhhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhh
Confidence            99999886655554       3577888999999999999999999   99999999999999975 5699999999998


Q ss_pred             cCCCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccch-----------
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE-----------  261 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~-----------  261 (380)
                      +..+..  ..-.+.+..|.-||.+.. ..|+.+-|+|||||++..|+....||......... +..+..           
T Consensus       183 YHp~~e--YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQ-LVkIakVLGt~el~~Yl  259 (338)
T KOG0668|consen  183 YHPGKE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVKIAKVLGTDELYAYL  259 (338)
T ss_pred             cCCCce--eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHH-HHHHHHHhChHHHHHHH
Confidence            765432  222345778899999885 45899999999999999999999998643322111 110000           


Q ss_pred             -h--hhhccccccccCCcccC--------CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          262 -P--LIVKGKFKELVDPKLRG--------DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       262 -~--~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                       .  ......+..++....+.        ....-.++++.+|+.+.|..|-.+|+|+.|.+.|...
T Consensus       260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF  325 (338)
T KOG0668|consen  260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYF  325 (338)
T ss_pred             HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchH
Confidence             0  00111111111111111        1111224789999999999999999999999999654

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-33  Score=255.48  Aligned_cols=267  Identities=24%  Similarity=0.286  Sum_probs=196.6

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCC-----C---CcceeEeeEEec---
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR-----H---KNLLGLRGYCAG---  108 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~~~~~~~~---  108 (380)
                      .+|.+.++||+|-|++||++.+ ...+.||+|+.+... .-.+....|+++|.+++     |   .+||++++.|..   
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            7999999999999999999987 567789999988542 22346777999998873     2   479999999865   


Q ss_pred             -CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-------
Q 037869          109 -TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD-------  180 (380)
Q Consensus       109 -~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~-------  180 (380)
                       +.++++|+|++ |.+|..+|...  .-..++...+..|+.|++.||.|||..+  ||+|-||||+|||+..+       
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s--~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~  231 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYS--NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKD  231 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHh--CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhh
Confidence             56799999999 67999999754  3356899999999999999999999987  99999999999998100       


Q ss_pred             --------------------------------------------------------------------------------
Q 037869          181 --------------------------------------------------------------------------------  180 (380)
Q Consensus       181 --------------------------------------------------------------------------------  180 (380)
                                                                                                      
T Consensus       232 ~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~  311 (590)
T KOG1290|consen  232 AREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRING  311 (590)
T ss_pred             hhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCc
Confidence                                                                                            


Q ss_pred             -------------------------------------------------------------------------------C
Q 037869          181 -------------------------------------------------------------------------------F  181 (380)
Q Consensus       181 -------------------------------------------------------------------------------~  181 (380)
                                                                                                     -
T Consensus       312 ~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di  391 (590)
T KOG1290|consen  312 NESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDI  391 (590)
T ss_pred             cccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccce
Confidence                                                                                           0


Q ss_pred             ceEEeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCccc----chh
Q 037869          182 EPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKR----TIT  257 (380)
Q Consensus       182 ~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~----~~~  257 (380)
                      +|||+|||-++.+..    ..+.-..|..|+|||++.|..|+..+||||++|+++||+||...|+...+....    .+.
T Consensus       392 ~vKIaDlGNACW~~k----hFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA  467 (590)
T KOG1290|consen  392 RVKIADLGNACWVHK----HFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIA  467 (590)
T ss_pred             eEEEeeccchhhhhh----hhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHH
Confidence            134444444443211    111122577899999999999999999999999999999999999754443211    111


Q ss_pred             ccc-------hhhhhc-----------cccccccCCcc---------cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 037869          258 EWA-------EPLIVK-----------GKFKELVDPKL---------RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEV  310 (380)
Q Consensus       258 ~~~-------~~~~~~-----------~~~~~~~~~~~---------~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~l  310 (380)
                      .+.       ......           +.+..+..-..         .-.++.....++.+++.-||+.+|++||||.++
T Consensus       468 ~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~c  547 (590)
T KOG1290|consen  468 LIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQC  547 (590)
T ss_pred             HHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHH
Confidence            111       011111           11111111110         123556777889999999999999999999999


Q ss_pred             HHHhcCC
Q 037869          311 VNTLTGY  317 (380)
Q Consensus       311 l~~l~~~  317 (380)
                      ++|.|--
T Consensus       548 l~hPwLn  554 (590)
T KOG1290|consen  548 LKHPWLN  554 (590)
T ss_pred             hcCcccc
Confidence            9998854

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-36  Score=252.09  Aligned_cols=267  Identities=22%  Similarity=0.323  Sum_probs=198.1

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC-----eEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD-----QRL  113 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----~~~  113 (380)
                      ...-.+.||.|+||.||.+.+ ++|+.|++|++...  +-.....+.+|+++|.-++|.|++..++...-..     .+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            445678999999999999988 68999999998642  2233456788999999999999999988765432     357


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +|+|++.. +|...|-.    ...++...+.-+.+||++||.|||+.   +|.||||||.|+|++++..+||||||+++.
T Consensus       134 V~TELmQS-DLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARv  205 (449)
T KOG0664|consen  134 VLTELMQS-DLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLART  205 (449)
T ss_pred             HHHHHHHh-hhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccc
Confidence            88888843 77777643    35788889999999999999999998   999999999999999999999999999998


Q ss_pred             cCCCCccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccc-hhccch-hh------h
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRT-ITEWAE-PL------I  264 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-~~~~~~-~~------~  264 (380)
                      .........+..+-|..|+|||++.|. .|+.+.||||.|||+.||+.++.-|..-.+-.... +.+... +.      -
T Consensus       206 ee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~A  285 (449)
T KOG0664|consen  206 WDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYA  285 (449)
T ss_pred             cchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHH
Confidence            655444455555679999999999864 69999999999999999999888886543211111 110000 00      0


Q ss_pred             hccccccccCCcccCC---------CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          265 VKGKFKELVDPKLRGD---------FDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       265 ~~~~~~~~~~~~~~~~---------~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ..+.-..++....+.+         -+.....+...++..++..||+.|.+..+.+.|+..
T Consensus       286 CEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  286 CEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             hhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence            0010111111111110         111334577889999999999999999999988653

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=4.1e-35  Score=266.97  Aligned_cols=279  Identities=20%  Similarity=0.193  Sum_probs=212.8

Q ss_pred             eeccHHHHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCC------Cccee
Q 037869           29 RIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRH------KNLLG  101 (380)
Q Consensus        29 ~~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~  101 (380)
                      +.|++.-......+|.+....|+|-|++|..|.+ ..|..||||+++...-. ...=+.|+++|+.|+.      -|+++
T Consensus       420 GYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M-~KtGl~EleiLkKL~~AD~Edk~Hclr  498 (752)
T KOG0670|consen  420 GYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM-HKTGLKELEILKKLNDADPEDKFHCLR  498 (752)
T ss_pred             ceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH-hhhhhHHHHHHHHhhccCchhhhHHHH
Confidence            3455544556789999999999999999999987 45889999999864322 2244569999999952      48999


Q ss_pred             EeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-
Q 037869          102 LRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD-  180 (380)
Q Consensus       102 ~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~-  180 (380)
                      ++..|...+++++|||.+. .+|.+++... ..+..+....+..++.|++-||..|...   ||+|.||||.||||++. 
T Consensus       499 l~r~F~hknHLClVFE~Ls-lNLRevLKKy-G~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k  573 (752)
T KOG0670|consen  499 LFRHFKHKNHLCLVFEPLS-LNLREVLKKY-GRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESK  573 (752)
T ss_pred             HHHHhhhcceeEEEehhhh-chHHHHHHHh-CcccceeehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCc
Confidence            9999999999999999884 5899999765 5566788999999999999999999999   99999999999999875 


Q ss_pred             CceEEeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCccc-chhcc
Q 037869          181 FEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKR-TITEW  259 (380)
Q Consensus       181 ~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-~~~~~  259 (380)
                      ..+||||||.|......   ..+++..+..|.|||++.|-+|+...|+||.||+||||.||..-|.+.++.... .....
T Consensus       574 ~iLKLCDfGSA~~~~en---eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~  650 (752)
T KOG0670|consen  574 NILKLCDFGSASFASEN---EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMEL  650 (752)
T ss_pred             ceeeeccCccccccccc---cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHh
Confidence            67899999999876542   344555688999999999999999999999999999999999999775532100 00000


Q ss_pred             c--------------h-------------hhhhc----cccccccCC------cc-----cCCCCHHHHHHHHHHHHhhc
Q 037869          260 A--------------E-------------PLIVK----GKFKELVDP------KL-----RGDFDENQLKQAINVAVLCV  297 (380)
Q Consensus       260 ~--------------~-------------~~~~~----~~~~~~~~~------~~-----~~~~~~~~~~~~~~li~~cl  297 (380)
                      .              .             ...+.    ..+...+.|      .+     ...-.......+.+|+..||
T Consensus       651 KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml  730 (752)
T KOG0670|consen  651 KGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKML  730 (752)
T ss_pred             cCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHh
Confidence            0              0             00000    001111111      11     11122344567899999999


Q ss_pred             CCCCCCCCCHHHHHHHhcC
Q 037869          298 QSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       298 ~~~P~~Rps~~~ll~~l~~  316 (380)
                      ..||++|.|..+.|.|.+.
T Consensus       731 ~LdP~KRit~nqAL~HpFi  749 (752)
T KOG0670|consen  731 ILDPEKRITVNQALKHPFI  749 (752)
T ss_pred             ccChhhcCCHHHHhcCCcc
Confidence            9999999999999999753

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=234.18  Aligned_cols=209  Identities=25%  Similarity=0.374  Sum_probs=174.1

Q ss_pred             HHHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecc-cChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCC
Q 037869           34 KELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTD  110 (380)
Q Consensus        34 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  110 (380)
                      ..+....+...-...||+|++|.|-+.++ .+|...|+|.++. .+.+...++++|+.+..+- .+|.+|.++|.+....
T Consensus        39 ~~~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg  118 (282)
T KOG0984|consen   39 RNFEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG  118 (282)
T ss_pred             CccccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc
Confidence            33555667777788999999999988886 6799999999985 3344556788888876654 7999999999998889


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccC
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGF  190 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl  190 (380)
                      ..+|.||.+. .+|..+-..-...+..+++..+.+++..+++||.|||++.  .++|||+||+||||+.+|+||+||||+
T Consensus       119 dvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGI  195 (282)
T KOG0984|consen  119 DVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGI  195 (282)
T ss_pred             cEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccc
Confidence            9999999995 4787766554455678999999999999999999999974  799999999999999999999999999


Q ss_pred             ccccCCCCccceeccccccCccCcccccc----CCCCccchhhhhhHHHHHHHhCCCCCCC
Q 037869          191 AKLIPEGVSHMTTRVKGTLGYLAPEYAMW----GKVSESCDVYSFGILLLEILTGRKPIEK  247 (380)
Q Consensus       191 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~ell~g~~p~~~  247 (380)
                      +-.+.+....  +.-.|-..|+|||.+..    ..|+-+|||||||+++.||.+++.||+.
T Consensus       196 sG~L~dSiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  196 SGYLVDSIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             ceeehhhhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence            9877543222  11346788999998863    4699999999999999999999999964

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-35  Score=271.90  Aligned_cols=260  Identities=24%  Similarity=0.314  Sum_probs=214.1

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      .+..+|....++|.|.||.||+|++ .+++..|+|+++.....+...+..|+-+++.-+||||+.+++.+...+.+||.|
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM   91 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM   91 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence            4778999999999999999999998 679999999999877777778888999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      |||.||+|.+.-+.    ..++++.++...+...+.||+|||+.   |-+|||||-.||++++.|.+|++|||.+..+..
T Consensus        92 EycgggslQdiy~~----TgplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqita  164 (829)
T KOG0576|consen   92 EYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITA  164 (829)
T ss_pred             EecCCCcccceeee----cccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhh
Confidence            99999999998864    46899999999999999999999999   899999999999999999999999999987654


Q ss_pred             CCccceeccccccCccCccccc---cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAM---WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                      .. .....+.||+.|+|||+..   .+.|.+.+|||++|++..|+--.++|.....+.....+.       .    ....
T Consensus       165 ti-~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm-------T----kS~~  232 (829)
T KOG0576|consen  165 TI-AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM-------T----KSGF  232 (829)
T ss_pred             hh-hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh-------h----ccCC
Confidence            32 3455678999999999875   567999999999999999998888886543321111000       0    0011


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .+... .-.....+.+.+|++.||.++|.+||+++.+|.|..-.
T Consensus       233 qpp~l-kDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs  275 (829)
T KOG0576|consen  233 QPPTL-KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVS  275 (829)
T ss_pred             CCCcc-cCCccchHHHHHHHHHHhcCCCccCCChhhheeceeec
Confidence            11111 11223456788999999999999999999999875433

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-34  Score=247.32  Aligned_cols=261  Identities=25%  Similarity=0.289  Sum_probs=201.9

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC----
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD----  110 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----  110 (380)
                      +...+|.-+..+|.|.- .|..|.+ -.++.||+|++...  ......+..+|+..+..++|+||++++.+|.-..    
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~   92 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEE   92 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHH
Confidence            35578999999999999 6667765 46899999987542  1223346778999999999999999999986543    


Q ss_pred             --eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          111 --QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       111 --~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                        ..|+|||++. ++|...+.      ..++-..+..+++|++.|+.|||+.   ||+||||||+||++..++.+||.||
T Consensus        93 ~~e~y~v~e~m~-~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~df  162 (369)
T KOG0665|consen   93 FQEVYLVMELMD-ANLCQVIL------MELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDF  162 (369)
T ss_pred             HHhHHHHHHhhh-hHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccc
Confidence              4699999995 59998886      2577888999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccc
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGK  268 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (380)
                      |+++.-...  -..+.++.|..|.|||++.+-.|.+.+||||+||++.||++|..-|.+.     ..+++|.......+.
T Consensus       163 g~ar~e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~-----d~idQ~~ki~~~lgt  235 (369)
T KOG0665|consen  163 GLARTEDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK-----DHIDQWNKIIEQLGT  235 (369)
T ss_pred             hhhcccCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc-----hHHHHHHHHHHHhcC
Confidence            999864332  3556678899999999999988999999999999999999999988753     233333322211111


Q ss_pred             c---------------------------ccccCCcc-cC--CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          269 F---------------------------KELVDPKL-RG--DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       269 ~---------------------------~~~~~~~~-~~--~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .                           .+++.... ..  ..+......+.+++.+||-.||++|.|++++|+|.-.
T Consensus       236 pd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~  313 (369)
T KOG0665|consen  236 PDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYI  313 (369)
T ss_pred             CCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCee
Confidence            0                           11110000 00  0111223567899999999999999999999999654

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-34  Score=261.21  Aligned_cols=197  Identities=25%  Similarity=0.362  Sum_probs=171.1

Q ss_pred             CCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC--------hhhHHHHHHHHHHHhcCC---CCcceeEeeEEec
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN--------SKAEMEFAVEVEVLGRVR---HKNLLGLRGYCAG  108 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~  108 (380)
                      ..|+..+.||.|+||.|++|.++ ++..|+||.+.+.+        ....-..-.|++||..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            35899999999999999999874 57789999987532        111113445999999997   9999999999999


Q ss_pred             CCeEEEEEEe-cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEee
Q 037869          109 TDQRLIVYDY-MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD  187 (380)
Q Consensus       109 ~~~~~lv~e~-~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~D  187 (380)
                      ++++||+||- -+|.+|+++|...    ..+++..+.-||.|++.|+++||+.   ||||||||-+|+.++++|-+||+|
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~k----p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFK----PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhcc----CccchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEee
Confidence            9999999995 5688999999754    5799999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccCCCCccceeccccccCccCccccccCCC-CccchhhhhhHHHHHHHhCCCCCCC
Q 037869          188 FGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEK  247 (380)
Q Consensus       188 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~  247 (380)
                      ||.+.....   .....+.||..|.|||++.|..| ...-|||++|++||.++....||..
T Consensus       714 fgsaa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  714 FGSAAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             ccchhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            999987654   34566789999999999999887 5668999999999999999999853

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=2.3e-31  Score=229.68  Aligned_cols=211  Identities=36%  Similarity=0.582  Sum_probs=184.1

Q ss_pred             eccCCceEEEEEEeC-CCcEEEEEEecccChh-hHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCCCHHH
Q 037869           49 LGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSK-AEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLS  126 (380)
Q Consensus        49 Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~  126 (380)
                      ||.|.+|.||++... +++.+++|++...... ....+.+|+..++.++|++|+++++++......++++|++.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            689999999999874 4899999999865432 34578899999999999999999999998899999999999999999


Q ss_pred             hhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-CCceEEeeccCccccCCCCccceecc
Q 037869          127 HLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS-DFEPLVADFGFAKLIPEGVSHMTTRV  205 (380)
Q Consensus       127 ~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~-~~~vkl~Dfgl~~~~~~~~~~~~~~~  205 (380)
                      ++....   ..+++..++.++.+++.++.+||+.   +++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus        81 ~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~  153 (215)
T cd00180          81 LLKENE---GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTI  153 (215)
T ss_pred             HHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcc
Confidence            986531   4688999999999999999999999   9999999999999999 89999999999987654321 12234


Q ss_pred             ccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHH
Q 037869          206 KGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN  284 (380)
Q Consensus       206 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (380)
                      .+...|.+||.+... .++.++|+|++|+++++|                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            578899999999877 889999999999999999                                              


Q ss_pred             HHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 037869          285 QLKQAINVAVLCVQSEPEKRPNMKEVVNTL  314 (380)
Q Consensus       285 ~~~~~~~li~~cl~~~P~~Rps~~~ll~~l  314 (380)
                        ..+.+++..|++.+|.+||++.++++++
T Consensus       188 --~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 --PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             --HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence              3577899999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.97  E-value=6.5e-32  Score=241.30  Aligned_cols=270  Identities=23%  Similarity=0.318  Sum_probs=202.8

Q ss_pred             HHHhhCCCCCcceeccCCceEEEEEEeC----CCcEEEEEEecccChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCC
Q 037869           36 LHTATNGFSDDNKLGEGGFGSVYWGRTS----DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTD  110 (380)
Q Consensus        36 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  110 (380)
                      +....+.|.++++||.|.|++||++.+.    .++.||+|.+...+  ....+.+|+++|..+ .+.||+++.+++...+
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            3356679999999999999999999752    57889999987643  333688999999999 5899999999999999


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-CceEEeecc
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD-FEPLVADFG  189 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~-~~vkl~Dfg  189 (380)
                      ...+|+||++...-.++..       .++...+..+++.++.||+++|..   |||||||||+|++.+.. ++-.|+|||
T Consensus       109 ~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFg  178 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFG  178 (418)
T ss_pred             eeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEech
Confidence            9999999999988888874       467888999999999999999999   99999999999999865 778999999


Q ss_pred             CccccCCC--------------Cc-----------------------------cceeccccccCccCcccccc-CCCCcc
Q 037869          190 FAKLIPEG--------------VS-----------------------------HMTTRVKGTLGYLAPEYAMW-GKVSES  225 (380)
Q Consensus       190 l~~~~~~~--------------~~-----------------------------~~~~~~~gt~~y~aPE~~~~-~~~~~~  225 (380)
                      ++......              ..                             .......||++|+|||++.. +..+.+
T Consensus       179 LA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qtta  258 (418)
T KOG1167|consen  179 LAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTA  258 (418)
T ss_pred             hHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCc
Confidence            99732100              00                             00111349999999999985 457999


Q ss_pred             chhhhhhHHHHHHHhCCCCCCCCCCCcccchh---------------------ccch-----hhhhcccccccc-C---C
Q 037869          226 CDVYSFGILLLEILTGRKPIEKLPGGVKRTIT---------------------EWAE-----PLIVKGKFKELV-D---P  275 (380)
Q Consensus       226 ~DiwslG~il~ell~g~~p~~~~~~~~~~~~~---------------------~~~~-----~~~~~~~~~~~~-~---~  275 (380)
                      +||||.|+|+.-++++..||.....+......                     -|..     .......+..+. .   +
T Consensus       259 iDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~  338 (418)
T KOG1167|consen  259 IDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYK  338 (418)
T ss_pred             cceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccc
Confidence            99999999999999999999765443222110                     0110     000000011110 0   0


Q ss_pred             -----cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          276 -----KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       276 -----~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                           ..........+..+.+|+.+|+..||.+|.|+++.|+|....
T Consensus       339 ~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~  385 (418)
T KOG1167|consen  339 SRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD  385 (418)
T ss_pred             ccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence                 011111223345889999999999999999999999997654

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=1.8e-30  Score=227.11  Aligned_cols=199  Identities=33%  Similarity=0.499  Sum_probs=173.7

Q ss_pred             CCCcceeccCCceEEEEEEeC-CCcEEEEEEecccChh-hHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecC
Q 037869           43 FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSK-AEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMP  120 (380)
Q Consensus        43 y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  120 (380)
                      |++.+.||.|++|.||++... +++.+++|.+...... ....+.+|+..++.++|+|++++++++......++++|+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE   80 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence            677899999999999999875 4889999999865544 56688889999999999999999999998899999999999


Q ss_pred             CCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCcc
Q 037869          121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH  200 (380)
Q Consensus       121 ~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~  200 (380)
                      +++|.+++....   ..+++..++.++.+++.++.+||+.   +++|+||+|.||+++.++.++|+|||++.........
T Consensus        81 ~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~  154 (225)
T smart00221       81 GGDLFDYLRKKG---GKLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA  154 (225)
T ss_pred             CCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence            999999997542   1188999999999999999999999   9999999999999999999999999999887543211


Q ss_pred             ceeccccccCccCcccc-ccCCCCccchhhhhhHHHHHHHhCCCCCCC
Q 037869          201 MTTRVKGTLGYLAPEYA-MWGKVSESCDVYSFGILLLEILTGRKPIEK  247 (380)
Q Consensus       201 ~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~p~~~  247 (380)
                      ......++..|++||.+ ....++.++|+|+||+++++|++|..||..
T Consensus       155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            22334578899999998 667788899999999999999999999964

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-31  Score=224.57  Aligned_cols=251  Identities=21%  Similarity=0.306  Sum_probs=186.2

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcC-CCCcceeEeeE-EecCCeEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGY-CAGTDQRLI  114 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~-~~~~~~~~l  114 (380)
                      ...+.|+|.+.||+|.||.+-++++ .++..+++|.+.... .....|.+|...--.| .|.||+.-+++ |++.+.+++
T Consensus        21 ~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~-tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF   99 (378)
T KOG1345|consen   21 DLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ-TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF   99 (378)
T ss_pred             chhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch-hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence            4568999999999999999999987 467889999887643 3345788888766666 48899987765 677788899


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC--CCCceEEeeccCcc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLD--SDFEPLVADFGFAK  192 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~--~~~~vkl~Dfgl~~  192 (380)
                      ++||++.|+|..-+..     ..+-+.....++.|+++|+.|+|+.   ++||||||.+||||-  +..+|||||||+++
T Consensus       100 ~qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~  171 (378)
T KOG1345|consen  100 VQEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTR  171 (378)
T ss_pred             eeccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeeccccc
Confidence            9999999999988854     3678888899999999999999999   999999999999994  33589999999998


Q ss_pred             ccCCCCccceeccccccCccCcccccc---C--CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcc
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAMW---G--KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKG  267 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~--~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  267 (380)
                      .....    .....-+..|.+||+...   .  ...+.+|||.||++++.++||..||.........   .|.......+
T Consensus       172 k~g~t----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~---Y~~~~~w~~r  244 (378)
T KOG1345|consen  172 KVGTT----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKP---YWEWEQWLKR  244 (378)
T ss_pred             ccCce----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCch---HHHHHHHhcc
Confidence            75432    222234677999997652   2  2478899999999999999999999743221111   1111111111


Q ss_pred             ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 037869          268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEV  310 (380)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~l  310 (380)
                      ..     +.+ +......++.+..+.++-|..+|++|--..+.
T Consensus       245 k~-----~~~-P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~  281 (378)
T KOG1345|consen  245 KN-----PAL-PKKFNPFSEKALRLFKKSLTPRFKDRCKIWTA  281 (378)
T ss_pred             cC-----ccC-chhhcccCHHHHHHHHHhcCCcccccchhHHH
Confidence            11     111 11122334678889999999999999444333

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=3.1e-30  Score=265.08  Aligned_cols=201  Identities=16%  Similarity=0.175  Sum_probs=142.4

Q ss_pred             cCCC-CcceeEeeEE-------ecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 037869           93 RVRH-KNLLGLRGYC-------AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH  164 (380)
Q Consensus        93 ~l~h-~niv~~~~~~-------~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~  164 (380)
                      .++| +||.+++++|       .....++.++|++ +++|.+++...   ...+++..++.++.||+.||.|||++   |
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---g  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQ---G  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhC---C
Confidence            3445 5777777766       2334677888987 56999999643   34699999999999999999999999   9


Q ss_pred             eEecCCCCCCeeeCCCC-------------------ceEEeeccCccccCCCC---------------ccceeccccccC
Q 037869          165 IIHRDIKASNVLLDSDF-------------------EPLVADFGFAKLIPEGV---------------SHMTTRVKGTLG  210 (380)
Q Consensus       165 ivHrdlkp~Nill~~~~-------------------~vkl~Dfgl~~~~~~~~---------------~~~~~~~~gt~~  210 (380)
                      |+||||||+||||+..+                   .+|++|||+++......               ........||++
T Consensus       101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  180 (793)
T PLN00181        101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW  180 (793)
T ss_pred             eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence            99999999999996544                   45566666655321100               000112357899


Q ss_pred             ccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHH
Q 037869          211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAI  290 (380)
Q Consensus       211 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (380)
                      |+|||++.+..|+.++|||||||+||||++|.+|+.....    ....+.         .....+     ..........
T Consensus       181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~---------~~~~~~-----~~~~~~~~~~  242 (793)
T PLN00181        181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLR---------HRVLPP-----QILLNWPKEA  242 (793)
T ss_pred             eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHH---------HhhcCh-----hhhhcCHHHH
Confidence            9999999999999999999999999999998888653110    000000         000000     0011123456


Q ss_pred             HHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          291 NVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       291 ~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      +++.+||+++|.+||++.++++|.+...
T Consensus       243 ~~~~~~L~~~P~~Rps~~eil~h~~~~~  270 (793)
T PLN00181        243 SFCLWLLHPEPSCRPSMSELLQSEFINE  270 (793)
T ss_pred             HHHHHhCCCChhhCcChHHHhhchhhhh
Confidence            8889999999999999999999977543

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=3.9e-28  Score=204.66  Aligned_cols=167  Identities=19%  Similarity=0.187  Sum_probs=126.2

Q ss_pred             CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccc
Q 037869          122 LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM  201 (380)
Q Consensus       122 g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~  201 (380)
                      |+|.+++...   +..+++..++.++.|++.||.|||+.   +      ||+||+++.++.+++  ||++.......   
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~~---   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPEQ---   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeecccc---
Confidence            6889998643   34699999999999999999999998   6      999999999999999  99998754321   


Q ss_pred             eeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCC
Q 037869          202 TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF  281 (380)
Q Consensus       202 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (380)
                         ..|++.|+|||++.+..++.++|||||||++|||++|..||....... .....+...      .... .+. ....
T Consensus        64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-~~~~~~~~~------~~~~-~~~-~~~~  131 (176)
T smart00750       64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-AILEILLNG------MPAD-DPR-DRSN  131 (176)
T ss_pred             ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-HHHHHHHHH------hccC-Ccc-cccc
Confidence               257999999999999999999999999999999999999996532211 000000000      0000 000 0011


Q ss_pred             CHHHHH--HHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          282 DENQLK--QAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       282 ~~~~~~--~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      +.....  .+.+++.+||..+|.+||++.++++|++..
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence            223333  689999999999999999999999998644

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-27  Score=218.69  Aligned_cols=258  Identities=22%  Similarity=0.277  Sum_probs=195.1

Q ss_pred             CCCCcceeccCCceEEEEEEeCC--CcEEEEEEecccChhhHHHHHHHHHHHhcCC----CCcceeEeeEE-ecCCeEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRTSD--GLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR----HKNLLGLRGYC-AGTDQRLI  114 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~----h~niv~~~~~~-~~~~~~~l  114 (380)
                      +|++.++||+|+||.||++.+..  ...+|+|............+..|..++..+.    .+++..+++.. ......|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            89999999999999999998754  3578999887643333336777888888886    26899999998 57778999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-----CceEEeecc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD-----FEPLVADFG  189 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~-----~~vkl~Dfg  189 (380)
                      ||+.+ |.+|.++.....  ...++..++..++.|++.+|.+||+.   |++||||||.|+++...     ..++|.|||
T Consensus        99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfG  172 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFG  172 (322)
T ss_pred             EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecC
Confidence            99999 779999886553  56899999999999999999999999   99999999999999764     469999999


Q ss_pred             Ccc--ccCCCCc-----c-c-eeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccc
Q 037869          190 FAK--LIPEGVS-----H-M-TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWA  260 (380)
Q Consensus       190 l~~--~~~~~~~-----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~  260 (380)
                      +++  .+.....     . . ...+.||..|.++.++.+...+++.|+||++.++.+++.|..||...........    
T Consensus       173 lar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~----  248 (322)
T KOG1164|consen  173 LARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSK----  248 (322)
T ss_pred             CCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHH----
Confidence            999  3321111     1 1 2235599999999999999999999999999999999999999976543211000    


Q ss_pred             hhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          261 EPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                              +................+..+.++...+-..+...+|....+...+...
T Consensus       249 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  249 --------FEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             --------HHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence                    0000000000001222335566666666668999999999998886543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=4.7e-27  Score=195.69  Aligned_cols=260  Identities=21%  Similarity=0.240  Sum_probs=203.5

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCC-CcceeEeeEEecCCeEEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRH-KNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv  115 (380)
                      ...+.|+++++||.|+||.+|+|.. .+|+.||||+-+...  ...++..|..+.+.|++ ..|..+..++.+.....+|
T Consensus        12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlV   89 (341)
T KOG1163|consen   12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLV   89 (341)
T ss_pred             eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceee
Confidence            3568999999999999999999976 789999999976532  22367789999999975 6777788888888899999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---CCceEEeeccCcc
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS---DFEPLVADFGFAK  192 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~---~~~vkl~Dfgl~~  192 (380)
                      |+++ |.+|++++.-+   ...++..+++-++-|++.-++|+|.+   +++||||||+|+|..-   ...+.++|||+++
T Consensus        90 MdLL-GPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaK  162 (341)
T KOG1163|consen   90 MDLL-GPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAK  162 (341)
T ss_pred             eecc-CccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchh
Confidence            9999 77999888654   34789999999999999999999999   9999999999999964   3679999999998


Q ss_pred             ccCCCCccc------eeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhc
Q 037869          193 LIPEGVSHM------TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVK  266 (380)
Q Consensus       193 ~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  266 (380)
                      .+.+.....      .....||.+|.+-..+.+...+...|+-|+|.+|.++.-|..||.+.....+....+-       
T Consensus       163 ky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEk-------  235 (341)
T KOG1163|consen  163 KYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEK-------  235 (341)
T ss_pred             hhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHH-------
Confidence            875432221      2234689999998888888889999999999999999999999988654333322221       


Q ss_pred             cccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                        +.+.........++...+.++.-.+.-|-..--++-|....|-+.+.
T Consensus       236 --I~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  236 --ISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             --HHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence              11111111222344556678888888999999999998877766533

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=3e-26  Score=211.23  Aligned_cols=166  Identities=20%  Similarity=0.183  Sum_probs=129.8

Q ss_pred             HHHhhCCCCCcceeccCCceEEEEEEeC--CCcEEEEEEeccc-----ChhhHHHHHHHHHHHhcCCCCccee-EeeEEe
Q 037869           36 LHTATNGFSDDNKLGEGGFGSVYWGRTS--DGLQIAVKKLKAM-----NSKAEMEFAVEVEVLGRVRHKNLLG-LRGYCA  107 (380)
Q Consensus        36 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~  107 (380)
                      +.....+|++.+.||+|+||+||+|++.  +++.||||++...     .......+.+|+++|+.++|+|+++ +++   
T Consensus        13 ~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---   89 (365)
T PRK09188         13 IPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---   89 (365)
T ss_pred             cccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---
Confidence            3456788999999999999999999763  5777899987532     2223456889999999999999985 443   


Q ss_pred             cCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC-CCCCeeeCCCCceEEe
Q 037869          108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDI-KASNVLLDSDFEPLVA  186 (380)
Q Consensus       108 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdl-kp~Nill~~~~~vkl~  186 (380)
                       .+..|+||||++|++|.. +..       ..   ...++.|++.||.|||++   ||+|||| ||+|||++.++.++|+
T Consensus        90 -~~~~~LVmE~~~G~~L~~-~~~-------~~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLi  154 (365)
T PRK09188         90 -TGKDGLVRGWTEGVPLHL-ARP-------HG---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVI  154 (365)
T ss_pred             -cCCcEEEEEccCCCCHHH-hCc-------cc---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEE
Confidence             246899999999999963 211       11   145788999999999999   9999999 9999999999999999


Q ss_pred             eccCccccCCCCccc-------eeccccccCccCcccccc
Q 037869          187 DFGFAKLIPEGVSHM-------TTRVKGTLGYLAPEYAMW  219 (380)
Q Consensus       187 Dfgl~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~~  219 (380)
                      |||+++.+.......       .....++..|.|||.+..
T Consensus       155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            999998765432111       124567888999998864

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=5.4e-26  Score=197.55  Aligned_cols=258  Identities=18%  Similarity=0.201  Sum_probs=199.3

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ...-.|++.++||+|+||.++.|.+ -+|+.||||.-...  .+..++..|....+.| ..++|..++-+..++.+..+|
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV  102 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV  102 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence            3567899999999999999999986 67999999976543  2345778888888887 479999998888888889999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-----CceEEeeccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD-----FEPLVADFGF  190 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~-----~~vkl~Dfgl  190 (380)
                      +|++ |-+|+|++.-+   +..|+..++.-++.|++.-++|+|++   .+|.|||||+|+||...     ..|.++|||+
T Consensus       103 idLL-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm  175 (449)
T KOG1165|consen  103 IDLL-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM  175 (449)
T ss_pred             hhhh-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccc
Confidence            9999 77998888644   45799999999999999999999999   99999999999999643     4689999999


Q ss_pred             ccccCCCCccc------eeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh
Q 037869          191 AKLIPEGVSHM------TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI  264 (380)
Q Consensus       191 ~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  264 (380)
                      ++.+.+.....      .....||.+||+-..+.|.+.+...|+-|||-++.+.|-|..||.++.........+-     
T Consensus       176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK-----  250 (449)
T KOG1165|consen  176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK-----  250 (449)
T ss_pred             hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH-----
Confidence            99886543322      2335699999999999999999999999999999999999999988654322221110     


Q ss_pred             hccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 037869          265 VKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT  313 (380)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~  313 (380)
                          +.+.....-...++...+.++..-+.-.-..+-.+-|..+-+...
T Consensus       251 ----IGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~L  295 (449)
T KOG1165|consen  251 ----IGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKL  295 (449)
T ss_pred             ----hccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHH
Confidence                000011111122344555666666666667777788887665543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.9e-27  Score=198.88  Aligned_cols=264  Identities=25%  Similarity=0.356  Sum_probs=204.4

Q ss_pred             CCCccceeccHHHHHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecc--cChhhHHHHHHHHHHHhcCCCCcce
Q 037869           23 PNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKA--MNSKAEMEFAVEVEVLGRVRHKNLL  100 (380)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv  100 (380)
                      +..+....|+.-    .-.+..+..+|.....|..|+|+++ |..+++|+++.  -.......|..|.-.|+-+.||||+
T Consensus       176 ~rdatlsr~~gi----d~~~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnil  250 (448)
T KOG0195|consen  176 TRDATLSRYTGI----DVSSLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNIL  250 (448)
T ss_pred             ccccccccccCc----chhhhhhhhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchh
Confidence            344445555542    2234566788999999999999997 45677788764  2233344788899999999999999


Q ss_pred             eEeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC
Q 037869          101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD  180 (380)
Q Consensus       101 ~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~  180 (380)
                      .+++.|....++.++..|++.|+|+..++.+  ....++..++.+++.++++|++|||+. .+-|.---|....++|+++
T Consensus       251 pvlgacnsppnlv~isq~mp~gslynvlhe~--t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmided  327 (448)
T KOG0195|consen  251 PVLGACNSPPNLVIISQYMPFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDED  327 (448)
T ss_pred             hhhhhccCCCCceEeeeeccchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecch
Confidence            9999999999999999999999999999865  345678889999999999999999997 3334455788999999998


Q ss_pred             CceEE--eeccCccccCCCCccceeccccccCccCccccccCC---CCccchhhhhhHHHHHHHhCCCCCCCCCCCcccc
Q 037869          181 FEPLV--ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK---VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRT  255 (380)
Q Consensus       181 ~~vkl--~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  255 (380)
                      -+.+|  +|--++.+.    .    ...-.+.|++||.+...+   --.++|+|||++++|||.|+..||...++..   
T Consensus       328 ltarismad~kfsfqe----~----gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspme---  396 (448)
T KOG0195|consen  328 LTARISMADTKFSFQE----V----GRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPME---  396 (448)
T ss_pred             hhhheecccceeeeec----c----ccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchh---
Confidence            66555  443332221    1    112478999999998654   3468999999999999999999998765421   


Q ss_pred             hhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          256 ITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                                  --..+...+++...++..+..+.+|+.-|++.||.+||.+..++-.|+.+
T Consensus       397 ------------cgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  397 ------------CGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             ------------hhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence                        11234456677788888889999999999999999999999998877643

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.93  E-value=2.4e-24  Score=198.55  Aligned_cols=261  Identities=29%  Similarity=0.385  Sum_probs=198.4

Q ss_pred             CCCcceeccCCceEEEEEEeCCCcEEEEEEecccChh---hHHHHHHHHHHHhcCCCC-cceeEeeEEecCCeEEEEEEe
Q 037869           43 FSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSK---AEMEFAVEVEVLGRVRHK-NLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        43 y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~-niv~~~~~~~~~~~~~lv~e~  118 (380)
                      |++.+.||.|+||.||++.+.  ..+++|.+......   ....+.+|+.+++.+.|+ +|+++.+.+......++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~   79 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY   79 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence            788899999999999999886  78899998753332   356788899999999988 799999999877778999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC-ceEEeeccCccccCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF-EPLVADFGFAKLIPEG  197 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~-~vkl~Dfgl~~~~~~~  197 (380)
                      +.++++.+++...... ..+.......++.|++.++.|+|+.   +++|||+||+||+++..+ .++++|||++......
T Consensus        80 ~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~  155 (384)
T COG0515          80 VDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDP  155 (384)
T ss_pred             CCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCC
Confidence            9999999777543211 3688999999999999999999999   999999999999999988 7999999999866443


Q ss_pred             Ccc-----ceeccccccCccCcccccc---CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccc
Q 037869          198 VSH-----MTTRVKGTLGYLAPEYAMW---GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKF  269 (380)
Q Consensus       198 ~~~-----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  269 (380)
                      ...     ......|+..|+|||.+.+   ..++...|+||+|++++++++|..||......  ..............  
T Consensus       156 ~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~--~~~~~~~~~~~~~~--  231 (384)
T COG0515         156 GSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS--SATSQTLKIILELP--  231 (384)
T ss_pred             CccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc--ccHHHHHHHHHhcC--
Confidence            322     2355679999999999987   57899999999999999999999997654321  00000000000000  


Q ss_pred             ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 037869          270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT  313 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~  313 (380)
                      ...................+.+++..|+..+|..|.+......+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         232 TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             CcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            00000000000002223578899999999999999999888775

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=3.1e-26  Score=224.49  Aligned_cols=259  Identities=21%  Similarity=0.236  Sum_probs=192.3

Q ss_pred             CCC-CCcceeccCCceEEEEEEe-CCCcEEEEEEec-----ccChhhHH-HHHHHHHHHhcCCCCcceeEeeEEecCCeE
Q 037869           41 NGF-SDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLK-----AMNSKAEM-EFAVEVEVLGRVRHKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        41 ~~y-~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~-----~~~~~~~~-~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  112 (380)
                      +.| .....+|.|++|.|+.+.. ...+.++.|.++     ........ .+..|+-+-..+.|+|++..+..+.+....
T Consensus       317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~  396 (601)
T KOG0590|consen  317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI  396 (601)
T ss_pred             cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence            335 5678999999998887764 334444555443     11111111 255588888889999998888777666666


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      +-+||||++ +|+.++...    ..+....+..++.|++.|+.|||+.   |+.|||+||+|++++.+|.+||+|||.+.
T Consensus       397 ~~~mE~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~Dfg~~~  468 (601)
T KOG0590|consen  397 LQSMEYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIIDFGAAS  468 (601)
T ss_pred             hhhhhcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEeecCcce
Confidence            666999999 999999643    4688889999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCc---cceeccccccCccCccccccCCCCc-cchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccc
Q 037869          193 LIPEGVS---HMTTRVKGTLGYLAPEYAMWGKVSE-SCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGK  268 (380)
Q Consensus       193 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (380)
                      .+.....   ......+|+..|+|||++.+..|++ ..||||.|+++..|++|+.||............      ...  
T Consensus       469 vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~------~~~--  540 (601)
T KOG0590|consen  469 VFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKT------NNY--  540 (601)
T ss_pred             eeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhh------hcc--
Confidence            8754433   3455678999999999999998854 689999999999999999999754432221100      000  


Q ss_pred             cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .................+...+.+|.+||+.+|.+|.|+++|++--|
T Consensus       541 ~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W  587 (601)
T KOG0590|consen  541 SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEW  587 (601)
T ss_pred             ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChH
Confidence            00000111111223455677889999999999999999999998755

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.92  E-value=8.6e-25  Score=187.80  Aligned_cols=173  Identities=13%  Similarity=0.112  Sum_probs=135.1

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHH---H------HHHHHHHHhcCCCCcceeEeeEEec
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEM---E------FAVEVEVLGRVRHKNLLGLRGYCAG  108 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~---~------~~~E~~~l~~l~h~niv~~~~~~~~  108 (380)
                      ...++|++.+.||.|+||.||++.+ ++..+|+|+++........   .      +.+|+..+.++.|++|..+.+++..
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~  106 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL  106 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence            4678999999999999999999866 5778999999753322221   2      5789999999999999999888653


Q ss_pred             C--------CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC
Q 037869          109 T--------DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD  180 (380)
Q Consensus       109 ~--------~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~  180 (380)
                      .        ...++||||++|.+|.+...        +++    ....+++.++..+|+.   |++|||++|+||+++.+
T Consensus       107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~  171 (232)
T PRK10359        107 AERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKN  171 (232)
T ss_pred             cccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCC
Confidence            3        35789999999999987742        222    2456899999999999   99999999999999998


Q ss_pred             CceEEeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh
Q 037869          181 FEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT  240 (380)
Q Consensus       181 ~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~  240 (380)
                      | ++|+|||.........  ....           .+....|..++|+||||+++.....
T Consensus       172 g-i~liDfg~~~~~~e~~--a~d~-----------~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        172 G-LRIIDLSGKRCTAQRK--AKDR-----------IDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             C-EEEEECCCcccccchh--hHHH-----------HHHHhHhcccccccceeEeehHHHH
Confidence            8 9999999887653211  1111           2344557789999999999887653

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.91  E-value=7.1e-26  Score=222.88  Aligned_cols=248  Identities=19%  Similarity=0.219  Sum_probs=183.8

Q ss_pred             CCCCcceeccCCceEEEEEEeCCCcEEEEEEecccC-hhhHH---HHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMN-SKAEM---EFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~---~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      .|...+.||.+.|=.|.+|++.+|. |+||++-... .-...   +.+.|++ ...+++||++++.-+.+.+...|+|-+
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq  101 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ  101 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence            6778899999999999999998887 8999986533 22233   3344555 556689999999988888888899999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc--C
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI--P  195 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~--~  195 (380)
                      |... +|.|.+..    +.-+...+...|+.||+.||..+|..   ||+|||||.+||||++=+-+.|+||..-+..  +
T Consensus       102 yvkh-nLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLP  173 (1431)
T KOG1240|consen  102 YVKH-NLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLP  173 (1431)
T ss_pred             HHhh-hhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCC
Confidence            9965 99999954    35678888889999999999999999   9999999999999999999999999876432  2


Q ss_pred             CCCcc----ceeccccccCccCccccccC-----------CCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhcc
Q 037869          196 EGVSH----MTTRVKGTLGYLAPEYAMWG-----------KVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEW  259 (380)
Q Consensus       196 ~~~~~----~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~  259 (380)
                      ++.+.    ...+.....+|+|||.+...           ..+++-||||+||++.||++ |.+||.-..-    .....
T Consensus       174 eDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL----~aYr~  249 (1431)
T KOG1240|consen  174 EDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQL----LAYRS  249 (1431)
T ss_pred             CCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHH----HhHhc
Confidence            22222    12223346689999987531           15788999999999999999 7888853110    00000


Q ss_pred             chhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          260 AEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .........+..+-+            ..++++|..|++.||++|.|+++.|+.-.
T Consensus       250 ~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  250 GNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             cCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence            000001111111111            36788999999999999999999998733

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=1.7e-23  Score=177.74  Aligned_cols=141  Identities=14%  Similarity=0.134  Sum_probs=109.0

Q ss_pred             CcceeccCCceEEEEEEeCCCcEEEEEEecccChh--h------------------------HHHHHHHHHHHhcCCCCc
Q 037869           45 DDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSK--A------------------------EMEFAVEVEVLGRVRHKN   98 (380)
Q Consensus        45 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~------------------------~~~~~~E~~~l~~l~h~n   98 (380)
                      +...||+|++|.||+|.+.+|+.||||+++.....  .                        ......|++.+..+.+++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           1 INGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            35789999999999999878999999999753211  0                        012234999999998777


Q ss_pred             ceeEeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEecCCCCCCeee
Q 037869           99 LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL-HHEVTPHIIHRDIKASNVLL  177 (380)
Q Consensus        99 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~L-H~~~~~~ivHrdlkp~Nill  177 (380)
                      +........  ...+|||||++|+++...+..    ...+++..+..++.|++.+|.+| |+.   ||+||||||+||++
T Consensus        81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~----~~~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli  151 (190)
T cd05147          81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLK----DAPLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLY  151 (190)
T ss_pred             CCCCcEEEe--cCCEEEEEEeCCCCCcchhhh----cCCCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEE
Confidence            643322222  223899999998776654322    24688999999999999999999 688   99999999999999


Q ss_pred             CCCCceEEeeccCccccC
Q 037869          178 DSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       178 ~~~~~vkl~Dfgl~~~~~  195 (380)
                      + ++.++|+|||++....
T Consensus       152 ~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         152 H-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             E-CCcEEEEEccccccCC
Confidence            8 4789999999997643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.89  E-value=8.9e-24  Score=198.35  Aligned_cols=245  Identities=24%  Similarity=0.371  Sum_probs=178.6

Q ss_pred             HhcCCCCcceeEeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 037869           91 LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDI  170 (380)
Q Consensus        91 l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdl  170 (380)
                      |+.+.|.|+.+++|.+..+...++|.+||..|+|.+.+...   ...+++.....++.+++.||+|||+.  +...|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~---~~~~d~~F~~s~~rdi~~Gl~ylh~s--~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE---DIKLDYFFILSFIRDISKGLAYLHNS--PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc---ccCccHHHHHHHHHHHHHHHHHHhcC--cceeeeee
Confidence            46789999999999999999999999999999999999763   56799999999999999999999986  23399999


Q ss_pred             CCCCeeeCCCCceEEeeccCccccCCC-CccceeccccccCccCccccccCC-------CCccchhhhhhHHHHHHHhCC
Q 037869          171 KASNVLLDSDFEPLVADFGFAKLIPEG-VSHMTTRVKGTLGYLAPEYAMWGK-------VSESCDVYSFGILLLEILTGR  242 (380)
Q Consensus       171 kp~Nill~~~~~vkl~Dfgl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~ell~g~  242 (380)
                      ++.|++++..+.+||+|||+....... .........-...|.|||.+.+..       .+.+.||||+|++++|+++..
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~  155 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRS  155 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhcc
Confidence            999999999999999999999876421 111111122466899999998641       477899999999999999999


Q ss_pred             CCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCH--HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCCC
Q 037869          243 KPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDE--NQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPR  320 (380)
Q Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~~  320 (380)
                      .||.........  .++...  ...    ...+..++....  ....++..++.+||..+|..||+++.+-..+......
T Consensus       156 ~~~~~~~~~~~~--~eii~~--~~~----~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~~  227 (484)
T KOG1023|consen  156 GPFDLRNLVEDP--DEIILR--VKK----GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINKG  227 (484)
T ss_pred             CccccccccCCh--HHHHHH--HHh----cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhccc
Confidence            999864332221  111111  000    111112222221  3345789999999999999999999999998877664


Q ss_pred             Cc-------ccccchhhccchhhhhcccCcCCCCC
Q 037869          321 GK-------VMQTRIETLAYKEELLAFDQTTDDDD  348 (380)
Q Consensus       321 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (380)
                      ..       .+....+.+....+....+.|.+...
T Consensus       228 ~~~~~nl~D~m~~~le~Y~~nLe~~v~eRt~~l~~  262 (484)
T KOG1023|consen  228 GSSKGNLMDSLFRMLESYADNLEKLVDERTAELEE  262 (484)
T ss_pred             ccccchhHHHHHHHHHHHHhhhHHHHHHHHHHHHH
Confidence            31       23445556655555554444444333

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.89  E-value=1.5e-22  Score=179.03  Aligned_cols=234  Identities=18%  Similarity=0.191  Sum_probs=150.3

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCC----------CcceeEeeEEe
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRH----------KNLLGLRGYCA  107 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h----------~niv~~~~~~~  107 (380)
                      .++..+.||.|+++.||.+.+ .+++.+|+|++...   .....+.+++|.-....+.+          -.++-.++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            455678999999999999998 56999999998632   22334566666655544322          12333333221


Q ss_pred             ---------cCC--------eEEEEEEecCCCCHHHhhcc---CCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 037869          108 ---------GTD--------QRLIVYDYMPNLSLLSHLHG---QYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH  167 (380)
Q Consensus       108 ---------~~~--------~~~lv~e~~~~g~L~~~i~~---~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivH  167 (380)
                               ...        +.+++|+-+ -++|.+++..   .......+.......+..|+++.+++||+.   |++|
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVH  168 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVH  168 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEE
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEe
Confidence                     111        236788877 4588777642   111233455566678889999999999999   9999


Q ss_pred             cCCCCCCeeeCCCCceEEeeccCccccCCCCccceeccccccCccCcccccc--------CCCCccchhhhhhHHHHHHH
Q 037869          168 RDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW--------GKVSESCDVYSFGILLLEIL  239 (380)
Q Consensus       168 rdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell  239 (380)
                      +||+|+|++++.+|.++|+||+........  ...  ...+..|.+||....        -.++.+.|.|+||+++|.|.
T Consensus       169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~--~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW  244 (288)
T PF14531_consen  169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTR--YRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW  244 (288)
T ss_dssp             ST-SGGGEEE-TTS-EEE--GGGEEETTEE--EEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred             cccceeeEEEcCCCCEEEcChHHHeecCce--eec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence            999999999999999999999887764321  111  234678999997753        24789999999999999999


Q ss_pred             hCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 037869          240 TGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKR  304 (380)
Q Consensus       240 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~R  304 (380)
                      ++..||...........                    ....+. +.++.+..||..+|+.||.+|
T Consensus       245 C~~lPf~~~~~~~~~~~--------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  245 CGRLPFGLSSPEADPEW--------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HSS-STCCCGGGSTSGG--------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HccCCCCCCCccccccc--------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            99999975432111000                    111233 778899999999999999988

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.89  E-value=2.1e-22  Score=171.55  Aligned_cols=142  Identities=19%  Similarity=0.195  Sum_probs=111.6

Q ss_pred             CcceeccCCceEEEEEEeCCCcEEEEEEecccChh---------------------h-----HHHHHHHHHHHhcCCCCc
Q 037869           45 DDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSK---------------------A-----EMEFAVEVEVLGRVRHKN   98 (380)
Q Consensus        45 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---------------------~-----~~~~~~E~~~l~~l~h~n   98 (380)
                      +...||+|++|.||+|.+.+|+.||||+++.....                     .     ...+..|...+.++.|++
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           1 INGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CCceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            46789999999999998778999999998753211                     0     112356889999999988


Q ss_pred             ceeEeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeee
Q 037869           99 LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH-EVTPHIIHRDIKASNVLL  177 (380)
Q Consensus        99 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~-~~~~~ivHrdlkp~Nill  177 (380)
                      +.....+...  ..++||||++|+++......    ...++...+..++.|++.++.++|+ .   ||+||||||+||++
T Consensus        81 i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll  151 (190)
T cd05145          81 VPVPEPILLK--KNVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILY  151 (190)
T ss_pred             CCCceEEEec--CCEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEE
Confidence            7443333322  24899999998865443221    2357788899999999999999999 8   99999999999999


Q ss_pred             CCCCceEEeeccCccccCC
Q 037869          178 DSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       178 ~~~~~vkl~Dfgl~~~~~~  196 (380)
                      + ++.++|+|||++.....
T Consensus       152 ~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         152 H-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             E-CCCEEEEEcccceecCC
Confidence            9 78999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.7e-21  Score=163.95  Aligned_cols=185  Identities=16%  Similarity=0.085  Sum_probs=139.7

Q ss_pred             CCcceeccCCceEEEEEEeCCCcEEEEEEecccChhh----HHHHHHHHHHHhcCC-CCcceeEeeEEecCCeEEEEEEe
Q 037869           44 SDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKA----EMEFAVEVEVLGRVR-HKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        44 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      .+...|+.|+||+||.+.. .+.+++.+.+.......    ...+.+|+++|++|. |+++++++++    +..+++|||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey   79 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY   79 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence            4577899999999998866 67888888877543321    225778999999995 5889999886    457999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC-CCCCeeeCCCCceEEeeccCccccCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDI-KASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdl-kp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      +.|.+|...+..           ....++.|++.+|.++|++   ||+|||| ||+|||++.++.++|+|||++......
T Consensus        80 I~G~~L~~~~~~-----------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~  145 (218)
T PRK12274         80 LAGAAMYQRPPR-----------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPR  145 (218)
T ss_pred             ecCccHHhhhhh-----------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceecCCc
Confidence            999888654321           0134778999999999999   9999999 799999999999999999999865432


Q ss_pred             Ccc----c--------eeccccccCccCccccccC-CC-CccchhhhhhHHHHHHHhCCCCCCC
Q 037869          198 VSH----M--------TTRVKGTLGYLAPEYAMWG-KV-SESCDVYSFGILLLEILTGRKPIEK  247 (380)
Q Consensus       198 ~~~----~--------~~~~~gt~~y~aPE~~~~~-~~-~~~~DiwslG~il~ell~g~~p~~~  247 (380)
                      ...    .        ......++.|++|+...-- .. -...+.++.|+-+|.++|+..|+..
T Consensus       146 ~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        146 ARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             chHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            210    0        0112257778888754421 22 2567889999999999999988754

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=5.8e-22  Score=198.53  Aligned_cols=206  Identities=22%  Similarity=0.227  Sum_probs=168.2

Q ss_pred             ceeccHHHHHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCC---CCcceeEee
Q 037869           28 WRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR---HKNLLGLRG  104 (380)
Q Consensus        28 ~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~  104 (380)
                      .+.-...++....+.|.|.+.||+|+||.||+|...+++.||+|+-+..+..+   |.-=.+++.+|+   -+.|..+..
T Consensus       685 ~~l~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~  761 (974)
T KOG1166|consen  685 PKLNPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISS  761 (974)
T ss_pred             cccCccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHH
Confidence            33444455666788999999999999999999998779999999998877663   222233444444   245666666


Q ss_pred             EEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-----
Q 037869          105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS-----  179 (380)
Q Consensus       105 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~-----  179 (380)
                      ++.-.+.-++|+||.+.|+|.+++.    ....+++..+..++.|++..+..||..   +||||||||+|+||..     
T Consensus       762 a~~~~~~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~  834 (974)
T KOG1166|consen  762 AHVFQNASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICAD  834 (974)
T ss_pred             HHccCCcceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCC
Confidence            6666778899999999999999997    346899999999999999999999999   9999999999999942     


Q ss_pred             --CCceEEeeccCccccCCCC-ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCC
Q 037869          180 --DFEPLVADFGFAKLIPEGV-SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRK  243 (380)
Q Consensus       180 --~~~vkl~Dfgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~  243 (380)
                        .-.++|+|||.+..+.--. .......++|-.+-.+|+..|++++.++|.|.++-+++-|+.|..
T Consensus       835 ~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  835 SDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             CcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence              3459999999997653221 235566788999999999999999999999999999999999874

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.86  E-value=3.4e-23  Score=194.65  Aligned_cols=231  Identities=26%  Similarity=0.293  Sum_probs=184.8

Q ss_pred             eeccCCceEEEEEEe----CCCcEEEEEEecccCh--hhHHHHHHHHHHHhcCC-CCcceeEeeEEecCCeEEEEEEecC
Q 037869           48 KLGEGGFGSVYWGRT----SDGLQIAVKKLKAMNS--KAEMEFAVEVEVLGRVR-HKNLLGLRGYCAGTDQRLIVYDYMP  120 (380)
Q Consensus        48 ~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~  120 (380)
                      .+|+|.||.|++++.    ..+..+|+|++++...  ........|..++...+ ||.+++++-.++.+..+++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            379999999999863    2367789998875321  11224445788888886 9999999999999999999999999


Q ss_pred             CCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCcc
Q 037869          121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH  200 (380)
Q Consensus       121 ~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~  200 (380)
                      ||.|...+...    ..+.+.....+...++-|+.++|+.   +++|||+|++||+++.+|.+++.|||+++..-.... 
T Consensus        81 gg~lft~l~~~----~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~-  152 (612)
T KOG0603|consen   81 GGDLFTRLSKE----VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI-  152 (612)
T ss_pred             cchhhhccccC----CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhh-
Confidence            99999888543    4677788888889999999999999   999999999999999999999999999987533221 


Q ss_pred             ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCC
Q 037869          201 MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGD  280 (380)
Q Consensus       201 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (380)
                          .+||..|+|||++.  ....++|.||+|++++||++|..||...                   ....++  .....
T Consensus       153 ----~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~-------------------~~~~Il--~~~~~  205 (612)
T KOG0603|consen  153 ----ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD-------------------TMKRIL--KAELE  205 (612)
T ss_pred             ----cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH-------------------HHHHHh--hhccC
Confidence                18999999999998  5678999999999999999999999650                   011111  11234


Q ss_pred             CCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHHH
Q 037869          281 FDENQLKQAINVAVLCVQSEPEKRPNM-----KEVVNT  313 (380)
Q Consensus       281 ~~~~~~~~~~~li~~cl~~~P~~Rps~-----~~ll~~  313 (380)
                      .+......+.+++..++..+|..|.-.     .++++|
T Consensus       206 ~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h  243 (612)
T KOG0603|consen  206 MPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQH  243 (612)
T ss_pred             CchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhcc
Confidence            566777889999999999999999543     555555

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=8.5e-21  Score=162.64  Aligned_cols=138  Identities=16%  Similarity=0.241  Sum_probs=107.1

Q ss_pred             CCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcC-----CCCcceeEeeEEecCC---eEE-
Q 037869           43 FSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-----RHKNLLGLRGYCAGTD---QRL-  113 (380)
Q Consensus        43 y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~~~~~~~~---~~~-  113 (380)
                      +.-.+.||+|+||.||. .-.++.. +||++..........+.+|+.+++.+     .||||++++++++++.   ..+ 
T Consensus         4 L~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~   81 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD   81 (210)
T ss_pred             cCCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence            44567899999999996 3233444 79988765444556789999999999     5799999999998864   334 


Q ss_pred             EEEEe--cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHH-HHHhhcCCCCeEecCCCCCCeeeCC----CCceEEe
Q 037869          114 IVYDY--MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI-LYLHHEVTPHIIHRDIKASNVLLDS----DFEPLVA  186 (380)
Q Consensus       114 lv~e~--~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al-~~LH~~~~~~ivHrdlkp~Nill~~----~~~vkl~  186 (380)
                      +|+||  +.+|+|.+++.+.     .+++.  ..++.+++.++ +|||++   +|+||||||+||+++.    +++++|+
T Consensus        82 ~I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~Li  151 (210)
T PRK10345         82 VIADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVC  151 (210)
T ss_pred             EEecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEE
Confidence            78999  5579999999643     35554  35677888777 999999   9999999999999973    3489999


Q ss_pred             eccCcc
Q 037869          187 DFGFAK  192 (380)
Q Consensus       187 Dfgl~~  192 (380)
                      ||+.+.
T Consensus       152 Dg~G~~  157 (210)
T PRK10345        152 DNIGES  157 (210)
T ss_pred             ECCCCc
Confidence            954443

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=3.8e-20  Score=162.47  Aligned_cols=142  Identities=15%  Similarity=0.164  Sum_probs=111.7

Q ss_pred             CCCCcceeccCCceEEEEEE--eCCCcEEEEEEecccChh------------------------hHHHHHHHHHHHhcCC
Q 037869           42 GFSDDNKLGEGGFGSVYWGR--TSDGLQIAVKKLKAMNSK------------------------AEMEFAVEVEVLGRVR   95 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~------------------------~~~~~~~E~~~l~~l~   95 (380)
                      -|.+.+.||+|++|.||+|.  ..+|+.||+|+++.....                        ....+..|+..+..+.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            58999999999999999998  467999999998743210                        1123567999999997


Q ss_pred             CC--cceeEeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC-eEecCCCC
Q 037869           96 HK--NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH-IIHRDIKA  172 (380)
Q Consensus        96 h~--niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~-ivHrdlkp  172 (380)
                      +.  .+.++++.    ...++||||++|++|......    ...+....+..++.|++.++.+||+.   | ++||||||
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp  177 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK----DVEPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSE  177 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccc----cCCcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCCh
Confidence            53  33444432    235899999999888765532    23456667788999999999999999   9 99999999


Q ss_pred             CCeeeCCCCceEEeeccCccccC
Q 037869          173 SNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       173 ~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      +||+++ ++.++|+|||.+....
T Consensus       178 ~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      178 YNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hhEEEE-CCCEEEEEChhhhccC
Confidence            999999 8899999999987643

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.82  E-value=2.1e-21  Score=179.33  Aligned_cols=175  Identities=23%  Similarity=0.356  Sum_probs=131.8

Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccC
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGF  190 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl  190 (380)
                      ++||.|++|.-.+|.+++.+.. .....++...+.++.|++.|+.|   +   +.+|+|+||.||+...+..+||+|||+
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl  402 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGL  402 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhh
Confidence            5899999999999999997553 33467788899999999999999   5   999999999999999999999999999


Q ss_pred             ccccCCCC-----ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhh
Q 037869          191 AKLIPEGV-----SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLI  264 (380)
Q Consensus       191 ~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~  264 (380)
                      ........     ....+...||.+|++||.+.+..|+.++||||||++|+|+++ -..+++...               
T Consensus       403 ~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~---------------  467 (516)
T KOG1033|consen  403 VTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA---------------  467 (516)
T ss_pred             eeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH---------------
Confidence            98775543     223344569999999999999999999999999999999998 333433211               


Q ss_pred             hccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHH
Q 037869          265 VKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV  311 (380)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll  311 (380)
                         .+..+.+..+......+ -+.-.+|+.+++.+.|.+||++.+.-
T Consensus       468 ---t~~d~r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~  510 (516)
T KOG1033|consen  468 ---TLTDIRDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPSAIEVA  510 (516)
T ss_pred             ---hhhhhhcCCCChHHhhc-CcHHHHHHHHhcCCCcccCchHHHHh
Confidence               11111111111011111 13345799999999999999554443

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.82  E-value=1.2e-20  Score=186.14  Aligned_cols=218  Identities=22%  Similarity=0.268  Sum_probs=149.5

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      .-...|..++.|..|+||.||+++++ +.+.+|+ ++++..    .-+++   ++....+|.+|                
T Consensus        80 p~e~df~~IklisngAygavylvrh~~trqrfa~-kiNkq~----lilRn---ilt~a~npfvv----------------  135 (1205)
T KOG0606|consen   80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAM-KINKQN----LILRN---ILTFAGNPFVV----------------  135 (1205)
T ss_pred             CCccccceeEeeccCCCCceeeeeccccccchhh-cccccc----hhhhc---cccccCCccee----------------
Confidence            34578999999999999999999875 5778888 443321    01111   33333344443                


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                           |+-...+...    +.++..        ++.+++|||+.   ||+|||+||+|.+|+.-|.+|++|||+......
T Consensus       136 -----gDc~tllk~~----g~lPvd--------mvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLm  195 (1205)
T KOG0606|consen  136 -----GDCATLLKNI----GPLPVD--------MVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM  195 (1205)
T ss_pred             -----chhhhhcccC----CCCcch--------hhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence                 3333333321    233332        27799999999   999999999999999999999999999865311


Q ss_pred             CC-------------cc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchh
Q 037869          197 GV-------------SH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEP  262 (380)
Q Consensus       197 ~~-------------~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  262 (380)
                      ..             .. ....++||+.|+|||++....|...+|.|++|+|+||.+.|+.||.+.......  ..... 
T Consensus       196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf--g~vis-  272 (1205)
T KOG0606|consen  196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF--GQVIS-  272 (1205)
T ss_pred             hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH--hhhhh-
Confidence            10             01 122358999999999999999999999999999999999999999875321110  00000 


Q ss_pred             hhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCC---CCHHHHHHH
Q 037869          263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKR---PNMKEVVNT  313 (380)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~R---ps~~~ll~~  313 (380)
                              .   .....+-....+.++.++|.++|+.+|..|   +.+-++.+|
T Consensus       273 --------d---~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h  315 (1205)
T KOG0606|consen  273 --------D---DIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQH  315 (1205)
T ss_pred             --------h---hccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhc
Confidence                    0   000011123344789999999999999999   455666665

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.81  E-value=3.8e-19  Score=154.31  Aligned_cols=134  Identities=19%  Similarity=0.303  Sum_probs=112.2

Q ss_pred             ceeccCCceEEEEEEeCCCcEEEEEEecccChh--------hHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           47 NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSK--------AEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      +.||+|++|.||+|.+ .+..|++|+.......        ....+.+|+.++..+.|+++.....++......+++|||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            6799999999999987 5778999986642211        123577899999999999887777777667788999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      ++|++|.+.+...       .. ....++.+++.+|.+||+.   +++|||++|.||+++ ++.++|+|||++..
T Consensus        81 ~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999998542       11 7788999999999999999   999999999999999 78999999998875

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.80  E-value=5.8e-19  Score=151.56  Aligned_cols=146  Identities=18%  Similarity=0.175  Sum_probs=113.8

Q ss_pred             HHHHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChh----------------------hHHHHHHHHHHH
Q 037869           34 KELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSK----------------------AEMEFAVEVEVL   91 (380)
Q Consensus        34 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~----------------------~~~~~~~E~~~l   91 (380)
                      .++......|.+.+.||.|+||.||++...+|+.||||+++.....                      .......|..++
T Consensus         8 ~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   87 (198)
T cd05144           8 HTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAAL   87 (198)
T ss_pred             HHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHH
Confidence            3455555569999999999999999998878999999987642210                      112356688888


Q ss_pred             hcCCCCc--ceeEeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 037869           92 GRVRHKN--LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRD  169 (380)
Q Consensus        92 ~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrd  169 (380)
                      ..+.|++  +...++    ....++||||++|++|......          .....++.+++.++.++|+.   |++|||
T Consensus        88 ~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~---gi~H~D  150 (198)
T cd05144          88 KALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKH---GIIHGD  150 (198)
T ss_pred             HHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHC---CCCcCC
Confidence            8887763  444443    2456899999999998765421          23457889999999999998   999999


Q ss_pred             CCCCCeeeCCCCceEEeeccCccccCC
Q 037869          170 IKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       170 lkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      |+|+||+++.++.++|+|||++.....
T Consensus       151 l~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         151 LSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCcccEEEcCCCcEEEEECCccccCCC
Confidence            999999999999999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.80  E-value=3.2e-19  Score=159.13  Aligned_cols=195  Identities=22%  Similarity=0.252  Sum_probs=138.7

Q ss_pred             CCCcceeEeeEEec---------------------------CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHH
Q 037869           95 RHKNLLGLRGYCAG---------------------------TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIA  147 (380)
Q Consensus        95 ~h~niv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~  147 (380)
                      +|||||++.++|.+                           ...+|+||.-++ .+|..++-.+     ..+.....-++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-----~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-----HRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-----CCchHHHHHHH
Confidence            59999999887643                           235789999875 4888888543     34445566789


Q ss_pred             HHHHHHHHHHhhcCCCCeEecCCCCCCeeeC--CC--CceEEeeccCccccCCCC---cccee--ccccccCccCccccc
Q 037869          148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLD--SD--FEPLVADFGFAKLIPEGV---SHMTT--RVKGTLGYLAPEYAM  218 (380)
Q Consensus       148 ~ql~~al~~LH~~~~~~ivHrdlkp~Nill~--~~--~~vkl~Dfgl~~~~~~~~---~~~~~--~~~gt~~y~aPE~~~  218 (380)
                      .|+++|+.|||.+   ||.|||+|.+|||+.  +|  -.+.|+|||.+---....   +..+.  ..-|...-+|||+..
T Consensus       348 aQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  348 AQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             HHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhh
Confidence            9999999999999   999999999999994  34  357899999885432210   00011  123677889999886


Q ss_pred             cCC------CCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHH
Q 037869          219 WGK------VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINV  292 (380)
Q Consensus       219 ~~~------~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  292 (380)
                      .-+      --.++|.|+.|-+.||+++...||....+......           .+.+    .....+++.++..+.++
T Consensus       425 a~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r-----------~Yqe----~qLPalp~~vpp~~rql  489 (598)
T KOG4158|consen  425 AVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR-----------TYQE----SQLPALPSRVPPVARQL  489 (598)
T ss_pred             cCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh-----------hhhh----hhCCCCcccCChHHHHH
Confidence            322      23589999999999999999999976322111111           0111    11224556677889999


Q ss_pred             HHhhcCCCCCCCCCHHHHHHH
Q 037869          293 AVLCVQSEPEKRPNMKEVVNT  313 (380)
Q Consensus       293 i~~cl~~~P~~Rps~~~ll~~  313 (380)
                      +...|+.||++|+|..-..+-
T Consensus       490 V~~lL~r~pskRvsp~iAANv  510 (598)
T KOG4158|consen  490 VFDLLKRDPSKRVSPNIAANV  510 (598)
T ss_pred             HHHHhcCCccccCCccHHHhH
Confidence            999999999999987666554

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.79  E-value=6.1e-19  Score=151.60  Aligned_cols=131  Identities=21%  Similarity=0.298  Sum_probs=105.7

Q ss_pred             eeccCCceEEEEEEeCCCcEEEEEEecccCh--------hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEec
Q 037869           48 KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNS--------KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYM  119 (380)
Q Consensus        48 ~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  119 (380)
                      .||+|++|.||+|.. ++..|++|.......        .....+.+|+++++.+.|+++.....++......++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            489999999999985 577899998653211        11245778999999998887654444455566779999999


Q ss_pred             CCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       120 ~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      +|++|.+.+....    .       .++.+++.+|.+||+.   +++|||++|.||+++ ++.++++|||++...
T Consensus        80 ~g~~l~~~~~~~~----~-------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        80 EGKPLKDVIEEGN----D-------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CCccHHHHHhhcH----H-------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999998875321    1       6889999999999999   999999999999999 789999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=1.9e-18  Score=170.17  Aligned_cols=140  Identities=19%  Similarity=0.249  Sum_probs=112.6

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEec-c-cC------hhhHHHHHHHHHHHhcCCCCcceeEeeEEecC
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLK-A-MN------SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT  109 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~-~-~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  109 (380)
                      .....|...+.||+|+||+||++.+..+ .+++|+.. . ..      ......+.+|+++++.++|++++....++...
T Consensus       330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~  408 (535)
T PRK09605        330 EVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP  408 (535)
T ss_pred             ccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence            3445667789999999999999987543 34444322 1 11      11234678899999999999998877777777


Q ss_pred             CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeecc
Q 037869          110 DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG  189 (380)
Q Consensus       110 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfg  189 (380)
                      ...++||||++|++|.+++.            ....++.+++.+|.+||+.   +++||||||+||++ .++.++|+|||
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~NILl-~~~~~~liDFG  472 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSNFIV-RDDRLYLIDFG  472 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC---CCccCCCChHHEEE-ECCcEEEEeCc
Confidence            78899999999999998884            2456899999999999999   99999999999999 67799999999


Q ss_pred             Ccccc
Q 037869          190 FAKLI  194 (380)
Q Consensus       190 l~~~~  194 (380)
                      +++..
T Consensus       473 la~~~  477 (535)
T PRK09605        473 LGKYS  477 (535)
T ss_pred             ccccC
Confidence            99763

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.74  E-value=2.9e-19  Score=175.62  Aligned_cols=262  Identities=23%  Similarity=0.268  Sum_probs=197.9

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC--CCcEEEEEEecccC--hhhHHHHHHHHHHHhcCC-CCcceeEeeEEecCCeEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS--DGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVR-HKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  113 (380)
                      ....|.+.+.||+|+|+.|-++...  ....+|+|.+....  .........|..+-..+. |+|++..++.....+..+
T Consensus        18 ~~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   18 PNSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             ccccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            4567888889999999999888653  34556777665432  222334445777777776 999999999999999999


Q ss_pred             EEEEecCCCCHHHhh-ccCCCCCccCCHHHHHHHHHHHHHHHHHHh-hcCCCCeEecCCCCCCeeeCCCC-ceEEeeccC
Q 037869          114 IVYDYMPNLSLLSHL-HGQYAGEVQLDWKRRMKIAIGSAEGILYLH-HEVTPHIIHRDIKASNVLLDSDF-EPLVADFGF  190 (380)
Q Consensus       114 lv~e~~~~g~L~~~i-~~~~~~~~~~~~~~~~~i~~ql~~al~~LH-~~~~~~ivHrdlkp~Nill~~~~-~vkl~Dfgl  190 (380)
                      ++++|..|+++.+.+ ...   ....+....-.++.|+..++.|+| ..   ++.|+|+||+|.+++..+ .+++.|||+
T Consensus        98 ~~~~~s~g~~~f~~i~~~~---~~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~  171 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPD---STGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGL  171 (601)
T ss_pred             cccCcccccccccccccCC---ccCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchh
Confidence            999999999999988 322   124556667789999999999999 77   999999999999999999 999999999


Q ss_pred             ccccCC--CCccceecccc-ccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhc
Q 037869          191 AKLIPE--GVSHMTTRVKG-TLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVK  266 (380)
Q Consensus       191 ~~~~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  266 (380)
                      +..+..  +........+| ++.|.|||...+. ...+..|+||+|+++.-+++|..|+......... ...|....   
T Consensus       172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~-~~~~~~~~---  247 (601)
T KOG0590|consen  172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGR-YSSWKSNK---  247 (601)
T ss_pred             hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccccc-ceeecccc---
Confidence            988765  44445556678 9999999999885 4578899999999999999999999754332111 11111100   


Q ss_pred             cccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                              ................+++.+++..+|..|.+.+++....+...
T Consensus       248 --------~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  248 --------GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             --------cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence                    00011222334467788999999999999999999987755443

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.73  E-value=3e-17  Score=134.15  Aligned_cols=136  Identities=18%  Similarity=0.124  Sum_probs=113.4

Q ss_pred             CcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCC--CcceeEeeEEecCCeEEEEEEecCCC
Q 037869           45 DDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRH--KNLLGLRGYCAGTDQRLIVYDYMPNL  122 (380)
Q Consensus        45 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g  122 (380)
                      +.+.||.|.++.||++...+ ..+++|.......  ...+..|+..++.+++  .++++++.+....+..+++|||+.++
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~   78 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE   78 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence            46789999999999998854 7899999876443  4578889999999976  58899998888778899999999887


Q ss_pred             CHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          123 SLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       123 ~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      .+..+           +......++.+++.++++||.....+++|+|++|.||+++..+.++++|||.+...
T Consensus        79 ~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~  139 (155)
T cd05120          79 TLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG  139 (155)
T ss_pred             ecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence            66543           44556678899999999999863347999999999999999899999999998753

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.73  E-value=2.6e-17  Score=140.00  Aligned_cols=139  Identities=19%  Similarity=0.194  Sum_probs=98.6

Q ss_pred             CcceeccCCceEEEEEEeCCCcEEEEEEecccChhh--HHH----------------------HHHHHHHHhcCCCC--c
Q 037869           45 DDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKA--EME----------------------FAVEVEVLGRVRHK--N   98 (380)
Q Consensus        45 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~--~~~----------------------~~~E~~~l~~l~h~--n   98 (380)
                      +.+.||+|+||+||+|.+.+++.||||+++......  ...                      ...|...+..+.+.  .
T Consensus         1 ~~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           1 VGGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CCcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            357899999999999998789999999987532111  111                      12455555555333  2


Q ss_pred             ceeEeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeee
Q 037869           99 LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH-EVTPHIIHRDIKASNVLL  177 (380)
Q Consensus        99 iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~-~~~~~ivHrdlkp~Nill  177 (380)
                      +.+.++.    ...++||||++++.+.......    .... ..+..++.+++.++.++|. .   +++||||+|+||++
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~----~~~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili  148 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKD----VRLL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILV  148 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhh----hhhc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEE
Confidence            3444432    3468999999986543211111    0011 5677899999999999999 7   99999999999999


Q ss_pred             CCCCceEEeeccCccccCC
Q 037869          178 DSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       178 ~~~~~vkl~Dfgl~~~~~~  196 (380)
                      + ++.++|+|||.+.....
T Consensus       149 ~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         149 D-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             E-CCcEEEEECcccccccC
Confidence            9 88999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=2.5e-16  Score=138.61  Aligned_cols=136  Identities=18%  Similarity=0.225  Sum_probs=104.6

Q ss_pred             cceec-cCCceEEEEEEeCCCcEEEEEEecccC-------------hhhHHHHHHHHHHHhcCCCCcc--eeEeeEEecC
Q 037869           46 DNKLG-EGGFGSVYWGRTSDGLQIAVKKLKAMN-------------SKAEMEFAVEVEVLGRVRHKNL--LGLRGYCAGT  109 (380)
Q Consensus        46 ~~~Lg-~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------~~~~~~~~~E~~~l~~l~h~ni--v~~~~~~~~~  109 (380)
                      ...|| .|+.|+||.+... +..++||.+....             ......+.+|+.++..+.|++|  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            34687 8899999998774 7789999885311             1223467789999999988775  6666664332


Q ss_pred             -C---eEEEEEEecCC-CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceE
Q 037869          110 -D---QRLIVYDYMPN-LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL  184 (380)
Q Consensus       110 -~---~~~lv~e~~~~-g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vk  184 (380)
                       .   ..++|||+++| .+|.+++...     .+++.    .+.+++.+|.+||+.   ||+||||||.|||++.++.++
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-----~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~  182 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQEA-----PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFW  182 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhcC-----CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEE
Confidence             2   23599999997 6888887532     34443    356899999999999   999999999999999988999


Q ss_pred             EeeccCcccc
Q 037869          185 VADFGFAKLI  194 (380)
Q Consensus       185 l~Dfgl~~~~  194 (380)
                      |+|||.+...
T Consensus       183 LIDfg~~~~~  192 (239)
T PRK01723        183 LIDFDRGELR  192 (239)
T ss_pred             EEECCCcccC
Confidence            9999998764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.63  E-value=4.5e-16  Score=146.75  Aligned_cols=251  Identities=22%  Similarity=0.225  Sum_probs=190.8

Q ss_pred             hhCCCCCcceecc--CCceEEEEEEe---CCCcEEEEEEecc--cChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCC
Q 037869           39 ATNGFSDDNKLGE--GGFGSVYWGRT---SDGLQIAVKKLKA--MNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTD  110 (380)
Q Consensus        39 ~~~~y~~~~~Lg~--G~~g~Vy~~~~---~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  110 (380)
                      ....+-+.+.+|.  |.+|.||.++.   .++..+|+|.-+.  ..+.....-.+|+...+.+ .|+|.++.+..+..++
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence            4567778899999  99999999976   3578899998442  2233333445577777777 4999999999999999


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHH----HHHHHhhcCCCCeEecCCCCCCeeeCCC-CceEE
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE----GILYLHHEVTPHIIHRDIKASNVLLDSD-FEPLV  185 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~----al~~LH~~~~~~ivHrdlkp~Nill~~~-~~vkl  185 (380)
                      .+++-+|+|. .+|..+....   ...++...++..+.+...    ||.++|+.   +++|-|+||.||+...+ ...++
T Consensus       192 ~lfiqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~  264 (524)
T KOG0601|consen  192 ILFIQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKL  264 (524)
T ss_pred             cceeeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeec
Confidence            9999999995 6888877643   234788888899999999    99999998   99999999999999999 78899


Q ss_pred             eeccCccccCCCCcc----ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccch
Q 037869          186 ADFGFAKLIPEGVSH----MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE  261 (380)
Q Consensus       186 ~Dfgl~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  261 (380)
                      +|||+...+..+.-.    ......|...|++||... +-++.++|||++|.++.+..++..++.....           
T Consensus       265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-----------  332 (524)
T KOG0601|consen  265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN-----------  332 (524)
T ss_pred             CCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC-----------
Confidence            999999887654311    112225788999999765 6779999999999999999998776643211           


Q ss_pred             hhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 037869          262 PLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT  313 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~  313 (380)
                           ..|.++....+..++......++...+..|++.+|..|++++.+.++
T Consensus       333 -----~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  333 -----SSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             -----CCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence                 11222222222233333444566669999999999999999999886

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.61  E-value=5e-16  Score=135.73  Aligned_cols=209  Identities=18%  Similarity=0.229  Sum_probs=146.8

Q ss_pred             HHHHhcCCCCcceeEeeEEecCC-----eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCC
Q 037869           88 VEVLGRVRHKNLLGLRGYCAGTD-----QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT  162 (380)
Q Consensus        88 ~~~l~~l~h~niv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~  162 (380)
                      +.-|-.+.|.|||+++.++.+.+     ...+++||+..|++..++++.......+....-.+|+.||+.||.|||+. .
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~  196 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-D  196 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-C
Confidence            33444567999999999986543     46899999999999999988766667788888899999999999999997 7


Q ss_pred             CCeEecCCCCCCeeeCCCCceEEeeccCccccCCC----CccceeccccccCccCccccccCCCCccchhhhhhHHHHHH
Q 037869          163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG----VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEI  238 (380)
Q Consensus       163 ~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  238 (380)
                      +.|+|+++..+.|++..+|-||++- +....+...    .......-.+-++|.+||.=.....+.++|||++|+...+|
T Consensus       197 PpiihgnlTc~tifiq~ngLIkig~-~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem  275 (458)
T KOG1266|consen  197 PPIIHGNLTCDTIFIQHNGLIKIGS-VAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM  275 (458)
T ss_pred             CccccCCcchhheeecCCceEEecc-cCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence            7899999999999999998888752 111111100    00111112367899999977667778899999999999999


Q ss_pred             HhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          239 LTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       239 l~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ..+..--.......  ....      ........+..+           --..++..|++..|..||++.+++.|+..+
T Consensus       276 ailEiq~tnseS~~--~~ee------~ia~~i~~len~-----------lqr~~i~kcl~~eP~~rp~ar~llfHpllf  335 (458)
T KOG1266|consen  276 AILEIQSTNSESKV--EVEE------NIANVIIGLENG-----------LQRGSITKCLEGEPNGRPDARLLLFHPLLF  335 (458)
T ss_pred             HHheeccCCCccee--ehhh------hhhhheeeccCc-----------cccCcCcccccCCCCCCcchhhhhcCceee
Confidence            98875422211100  0000      000000011111           113578899999999999999999986544

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.55  E-value=3.4e-14  Score=135.70  Aligned_cols=142  Identities=20%  Similarity=0.268  Sum_probs=99.2

Q ss_pred             cceeccCCceEEEEEEeCCCcEEEEEEecccChhh----------------------------------------HHHHH
Q 037869           46 DNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKA----------------------------------------EMEFA   85 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~----------------------------------------~~~~~   85 (380)
                      .+.||.|++|.||+|+..+|+.||||+.+..-...                                        +..+.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            36799999999999999899999999986431110                                        01233


Q ss_pred             HHHHHHhcC----CCCcceeEeeEEe-cCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHH-HHHHHhh
Q 037869           86 VEVEVLGRV----RHKNLLGLRGYCA-GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE-GILYLHH  159 (380)
Q Consensus        86 ~E~~~l~~l----~h~niv~~~~~~~-~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~-al~~LH~  159 (380)
                      +|...+.++    ++.+-+.+-.++. -....++||||++|++|.+......   ...+   ...++..++. .+..+|.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~---~~~~---~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDE---AGLD---RKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHh---cCCC---HHHHHHHHHHHHHHHHHh
Confidence            455444444    3333344433332 2345799999999999988764221   1122   2345555555 4678898


Q ss_pred             cCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       160 ~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      .   |++|+|++|.||+++.+++++++|||++..+..
T Consensus       276 ~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 D---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             C---CceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            8   999999999999999999999999999987753

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.50  E-value=2.6e-14  Score=138.08  Aligned_cols=144  Identities=15%  Similarity=0.196  Sum_probs=96.7

Q ss_pred             CCCCcceeccCCceEEEEEEeCC-CcEEEEEEecccChh----------------------------------hHH----
Q 037869           42 GFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKLKAMNSK----------------------------------AEM----   82 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----------------------------------~~~----   82 (380)
                      .|+. +.||.|++|.||+|+.++ |+.||||+.+..-..                                  ...    
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4665 799999999999999876 999999999743110                                  011    


Q ss_pred             --HHHHHHHHHhcC----CCCcceeEeeEEec-CCeEEEEEEecCCCCHHHhh--ccCCCCCccCCHHHHHHHHHHHHHH
Q 037869           83 --EFAVEVEVLGRV----RHKNLLGLRGYCAG-TDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEG  153 (380)
Q Consensus        83 --~~~~E~~~l~~l----~h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~i--~~~~~~~~~~~~~~~~~i~~ql~~a  153 (380)
                        .+.+|+..+.++    .+.+.+.+-.++.+ ....++||||++|+.+.+..  .........+....+..++.|++  
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif--  277 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF--  277 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH--
Confidence              133344433333    24444444444432 45678999999999998743  22111112344445555555554  


Q ss_pred             HHHHhhcCCCCeEecCCCCCCeeeCCCC----ceEEeeccCccccCC
Q 037869          154 ILYLHHEVTPHIIHRDIKASNVLLDSDF----EPLVADFGFAKLIPE  196 (380)
Q Consensus       154 l~~LH~~~~~~ivHrdlkp~Nill~~~~----~vkl~Dfgl~~~~~~  196 (380)
                           ..   |++|+|++|.||+++.++    +++++|||++..++.
T Consensus       278 -----~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 -----RD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----hC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 34   999999999999999888    999999999987754

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.49  E-value=8.4e-13  Score=126.14  Aligned_cols=166  Identities=16%  Similarity=0.160  Sum_probs=127.3

Q ss_pred             eCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHH
Q 037869           62 TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWK  141 (380)
Q Consensus        62 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~  141 (380)
                      ..++.+|.|+..+...........+-++.|+.++||||+++++.++++..+|+|+|-+  -.|..++..       +...
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~-------l~~~  104 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKE-------LGKE  104 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHH-------hHHH
Confidence            4568889999888655544456778899999999999999999999999999999988  366767753       2255


Q ss_pred             HHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccceeccccccCccCccccccCC
Q 037869          142 RRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK  221 (380)
Q Consensus       142 ~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  221 (380)
                      .+.--+.||+.||.+||+.+  +++|++|.-..|+|+..|..||++|.++........ ......---.|..|+.+....
T Consensus       105 ~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  105 EVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence            56667899999999998654  899999999999999999999999998876533221 111112233456666443222


Q ss_pred             CCccchhhhhhHHHHHHHhC
Q 037869          222 VSESCDVYSFGILLLEILTG  241 (380)
Q Consensus       222 ~~~~~DiwslG~il~ell~g  241 (380)
                        -..|.|.|||++++++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              456999999999999998

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.47  E-value=2.4e-13  Score=113.53  Aligned_cols=131  Identities=16%  Similarity=0.114  Sum_probs=96.2

Q ss_pred             cceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcce-eEeeEEecCCeEEEEEEecCCCCH
Q 037869           46 DNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLL-GLRGYCAGTDQRLIVYDYMPNLSL  124 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e~~~~g~L  124 (380)
                      .+.|+.|.++.||+++.. +..|++|....... ....+..|+.+++.+.+.+++ +++...  ....++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence            467899999999999875 77899999765432 123567788888888654443 455443  2345899999999877


Q ss_pred             HHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          125 LSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV--TPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       125 ~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~--~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      ...-         .   ....++.+++++|+.||+..  ..+++|||++|.||+++ ++.++++|||.+..
T Consensus        79 ~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          79 LTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            5430         0   11235678999999999982  11259999999999999 66899999998864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.42  E-value=4.4e-12  Score=106.96  Aligned_cols=138  Identities=12%  Similarity=0.106  Sum_probs=99.0

Q ss_pred             cceeccCCceEEEEEEeCC-------CcEEEEEEeccc-------------C---------hhhHHHHH----HHHHHHh
Q 037869           46 DNKLGEGGFGSVYWGRTSD-------GLQIAVKKLKAM-------------N---------SKAEMEFA----VEVEVLG   92 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~-------------~---------~~~~~~~~----~E~~~l~   92 (380)
                      ...||.|--+.||.|...+       +..+|||+.+..             .         ......+.    +|+..|.
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4679999999999997643       478999987520             0         01122233    6999998


Q ss_pred             cCCC--CcceeEeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHH-hhcCCCCeEecC
Q 037869           93 RVRH--KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL-HHEVTPHIIHRD  169 (380)
Q Consensus        93 ~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~L-H~~~~~~ivHrd  169 (380)
                      ++..  -++.+.+++    ...+|||||+.+..+.....    ....++......+..+++.+|..| |..   |++|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L----kd~~~~~~~~~~i~~~i~~~l~~l~H~~---glVHGD  150 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL----KDAKLNDEEMKNAYYQVLSMMKQLYKEC---NLVHAD  150 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh----hccccCHHHHHHHHHHHHHHHHHHHHhC---CeecCC
Confidence            8853  455666654    56789999997654422111    112345556677889999999998 888   999999


Q ss_pred             CCCCCeeeCCCCceEEeeccCccccC
Q 037869          170 IKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       170 lkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |++.||++. ++.++|+|||.+-...
T Consensus       151 Ls~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         151 LSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCHHHEEEE-CCcEEEEECCCceeCC
Confidence            999999997 4689999999886653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.39  E-value=2.6e-13  Score=128.26  Aligned_cols=257  Identities=18%  Similarity=0.149  Sum_probs=182.5

Q ss_pred             eccHHH-HHHhhCCCCCcceeccCCceEEEEEEe--CCCcEEEEEEecccChhhH--HHHHHHHHHHhcC-CCCcceeEe
Q 037869           30 IFTYKE-LHTATNGFSDDNKLGEGGFGSVYWGRT--SDGLQIAVKKLKAMNSKAE--MEFAVEVEVLGRV-RHKNLLGLR  103 (380)
Q Consensus        30 ~~~~~~-~~~~~~~y~~~~~Lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~--~~~~~E~~~l~~l-~h~niv~~~  103 (380)
                      .|.-.+ ......+|-.+..||.|.|+.|+....  .++..|++|.+...-....  ..-..|+.+...+ .|.+++++.
T Consensus       253 i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~  332 (524)
T KOG0601|consen  253 IFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN  332 (524)
T ss_pred             eecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC
Confidence            444443 334556888899999999999998753  4678899998875332222  2333477666666 588999988


Q ss_pred             eEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-Cc
Q 037869          104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD-FE  182 (380)
Q Consensus       104 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~-~~  182 (380)
                      ..|......|+--|||+++++...+..    ...+++...+++..|++.++.++|+.   .++|+|++|+||++..+ +.
T Consensus       333 ~~W~~~r~~~ip~e~~~~~s~~l~~~~----~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~  405 (524)
T KOG0601|consen  333 SSWSQLRQGYIPLEFCEGGSSSLRSVT----SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFF  405 (524)
T ss_pred             CCccccccccCchhhhcCcchhhhhHH----HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccchhh
Confidence            888888888999999999988777632    24577888899999999999999998   99999999999999886 77


Q ss_pred             eEEeeccCccccCCCCccceeccccccCc-cCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccch
Q 037869          183 PLVADFGFAKLIPEGVSHMTTRVKGTLGY-LAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE  261 (380)
Q Consensus       183 vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  261 (380)
                      -+++|||....+.....   .....+..| .+++......+..+.|++|||..+.+.+++.+--.....           
T Consensus       406 ~~~~~~~~~t~~~~~~~---~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~-----------  471 (524)
T KOG0601|consen  406 SKLGDFGCWTRLAFSSG---VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ-----------  471 (524)
T ss_pred             hhccccccccccceecc---cccccccccccchhhccccccccccccccccccccccccCcccCccccc-----------
Confidence            88999999875322111   111123333 355555577889999999999999999987643221110           


Q ss_pred             hhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          262 PLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                             +..+ ..+..... .....++..+.+.+...++..||++.++..+...
T Consensus       472 -------~~~i-~~~~~p~~-~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  472 -------SLTI-RSGDTPNL-PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             -------ceee-ecccccCC-CchHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence                   0001 11111111 2222677888999999999999999998877543

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.30  E-value=3.2e-11  Score=105.23  Aligned_cols=142  Identities=20%  Similarity=0.242  Sum_probs=107.4

Q ss_pred             ceeccCCceEEEEEEeCCCcEEEEEEecccCh-hhHHHHHHHHHHHhcCCC--CcceeEeeEEecC---CeEEEEEEecC
Q 037869           47 NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNS-KAEMEFAVEVEVLGRVRH--KNLLGLRGYCAGT---DQRLIVYDYMP  120 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~---~~~~lv~e~~~  120 (380)
                      +.|+.|.++.||++...+|..+++|....... .....+..|++++..+.+  ..+.+++.+....   +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            67899999999999876668999999765322 133467889999999865  3456677766543   25689999999


Q ss_pred             CCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcC---------------------------------------
Q 037869          121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV---------------------------------------  161 (380)
Q Consensus       121 ~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~---------------------------------------  161 (380)
                      |.++.+.+..     ..++......++.+++.+|..||+..                                       
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9888776531     24666677777788888888887531                                       


Q ss_pred             --------------CCCeEecCCCCCCeeeCC--CCceEEeeccCccc
Q 037869          162 --------------TPHIIHRDIKASNVLLDS--DFEPLVADFGFAKL  193 (380)
Q Consensus       162 --------------~~~ivHrdlkp~Nill~~--~~~vkl~Dfgl~~~  193 (380)
                                    ...++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                          135799999999999998  56789999998864

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.29  E-value=1.2e-12  Score=130.35  Aligned_cols=253  Identities=21%  Similarity=0.228  Sum_probs=174.8

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecc---cChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKA---MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      ....+.+.+-+-.|.++.++.+.- ..+...++|....   ....+......+-.++-...+|-++...-.+......++
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence            445666777899999999998864 3354444444432   111122233333333333455666655555555678899


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      +++|+.+++|...++.-    ...+.......+..+..++++||+.   .+.|+|++|.|+++..++..+++|||.....
T Consensus       882 ~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             hhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCCcccCcccccccc
Confidence            99999999999998754    2466666777888899999999997   7999999999999999999999999844322


Q ss_pred             CC---------------------CC---------ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCC
Q 037869          195 PE---------------------GV---------SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP  244 (380)
Q Consensus       195 ~~---------------------~~---------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p  244 (380)
                      .-                     ..         ........+|+.|.+||.+.+..-...+|.|+.|++++|.++|.+|
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp 1034 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPP 1034 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCC
Confidence            10                     00         0011224589999999999999999999999999999999999999


Q ss_pred             CCCCCCCcccchhccchhhhhccccccccCCccc-CCCCHHHHHHHHHHHHhhcCCCCCCCCCHH---HHHHH
Q 037869          245 IEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR-GDFDENQLKQAINVAVLCVQSEPEKRPNMK---EVVNT  313 (380)
Q Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~P~~Rps~~---~ll~~  313 (380)
                      |.......               .+..+...... ..-+...+....+++.+.+..+|.+|..+.   ++-.|
T Consensus      1035 ~na~tpq~---------------~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~ 1092 (1205)
T KOG0606|consen 1035 FNAETPQQ---------------IFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGH 1092 (1205)
T ss_pred             CCCcchhh---------------hhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccC
Confidence            97643311               01111111111 112233456788999999999999997776   55554

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.29  E-value=9.5e-11  Score=109.08  Aligned_cols=218  Identities=14%  Similarity=0.196  Sum_probs=154.5

Q ss_pred             CceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEec----CCeEEEEEEecCC-CCHHH
Q 037869           53 GFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG----TDQRLIVYDYMPN-LSLLS  126 (380)
Q Consensus        53 ~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv~e~~~~-g~L~~  126 (380)
                      ...+.|++.. .+|..|++|++...........-.-+++++++.|+|+|++.++|..    +..+++|++|+++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            5567899964 6899999999943222222123345778999999999999999863    5678999999874 46666


Q ss_pred             hhccC-----------CCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          127 HLHGQ-----------YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       127 ~i~~~-----------~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      .--..           ...+...++..+|.++.||..||.++|+.   |+.-+-|.|.+|+++++-+++|...|+...+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceeeec
Confidence            54322           12345688999999999999999999998   99999999999999999999999888876654


Q ss_pred             CCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      ...             .+|  +.+   -.+-|.=.||.++..|.||..--...+.                      ...
T Consensus       445 ~d~-------------~~~--le~---~Qq~D~~~lG~ll~aLAt~~~ns~~~d~----------------------~~~  484 (655)
T KOG3741|consen  445 EDP-------------TEP--LES---QQQNDLRDLGLLLLALATGTENSNRTDS----------------------TQS  484 (655)
T ss_pred             CCC-------------Ccc--hhH---HhhhhHHHHHHHHHHHhhcccccccccc----------------------hHH
Confidence            322             001  111   2456889999999999998643111000                      000


Q ss_pred             cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 037869          276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL  314 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l  314 (380)
                      .........++.++.+++.-....++++ -++.+++.++
T Consensus       485 s~~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~  522 (655)
T KOG3741|consen  485 SHLTRITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMI  522 (655)
T ss_pred             HHHHHhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHH
Confidence            0011223345677888888888888887 6788887763

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.24  E-value=1.2e-10  Score=95.06  Aligned_cols=132  Identities=22%  Similarity=0.277  Sum_probs=96.5

Q ss_pred             ceeccCCceEEEEEEeCCCcEEEEEEe-cccC-------hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           47 NKLGEGGFGSVYWGRTSDGLQIAVKKL-KAMN-------SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~-~~~~-------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ..+++|+-+.+|.+.+. |.++++|.= ++.-       .-....-.+|+.+++.++--.|.--+-+..+.....|+|||
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~   80 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY   80 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence            46889999999999664 445666642 2210       11123456699999888644443333344556778899999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ++|-.|.+.+...           ...++..+-.-+.-||..   ||+|+||.++||++.+++ +.++|||++...
T Consensus        81 I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          81 IEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             eCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            9998888888543           134667777888999999   999999999999998874 999999999853

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.15  E-value=3.4e-10  Score=95.14  Aligned_cols=126  Identities=24%  Similarity=0.283  Sum_probs=82.9

Q ss_pred             EEEEEEeCCCcEEEEEEeccc---------------C------h-----hhHHHHHHHHHHHhcCCCC--cceeEeeEEe
Q 037869           56 SVYWGRTSDGLQIAVKKLKAM---------------N------S-----KAEMEFAVEVEVLGRVRHK--NLLGLRGYCA  107 (380)
Q Consensus        56 ~Vy~~~~~~~~~vavK~~~~~---------------~------~-----~~~~~~~~E~~~l~~l~h~--niv~~~~~~~  107 (380)
                      .||.|...++..+|+|..+..               .      .     .......+|.+.|..+..-  ++.+.+++. 
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~-   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN-   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence            489999988999999997531               0      0     0123456799999999765  456666542 


Q ss_pred             cCCeEEEEEEecC--CCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHH-HhhcCCCCeEecCCCCCCeeeCCCCceE
Q 037869          108 GTDQRLIVYDYMP--NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY-LHHEVTPHIIHRDIKASNVLLDSDFEPL  184 (380)
Q Consensus       108 ~~~~~~lv~e~~~--~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~-LH~~~~~~ivHrdlkp~Nill~~~~~vk  184 (380)
                         ..+|||||++  |..+..+...      .++......++.+++..+.. +|..   |++||||.+.||+++.+ .+.
T Consensus        80 ---~~~ivME~I~~~G~~~~~l~~~------~~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~  146 (188)
T PF01163_consen   80 ---RNVIVMEYIGEDGVPLPRLKDV------DLSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVY  146 (188)
T ss_dssp             ---TTEEEEE--EETTEEGGCHHHC------GGGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEE
T ss_pred             ---CCEEEEEecCCCccchhhHHhc------cccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEE
Confidence               4579999998  6555443322      11133445677788885555 5787   99999999999999988 999


Q ss_pred             EeeccCccccC
Q 037869          185 VADFGFAKLIP  195 (380)
Q Consensus       185 l~Dfgl~~~~~  195 (380)
                      ++|||.+....
T Consensus       147 iIDf~qav~~~  157 (188)
T PF01163_consen  147 IIDFGQAVDSS  157 (188)
T ss_dssp             E--GTTEEETT
T ss_pred             EEecCcceecC
Confidence            99999887643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.13  E-value=7.5e-10  Score=90.12  Aligned_cols=143  Identities=22%  Similarity=0.242  Sum_probs=101.2

Q ss_pred             CcceeccCCceEEEEEEeCCCcEEEEEEeccc--------ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           45 DDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAM--------NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        45 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~--------~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ....|-+|+-+.|+++.+. |+.++||.=...        ..-...+..+|+++|.++.--.|.--.-++.+...-.|+|
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M   89 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM   89 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence            5778999999999999874 777777753211        1112335667888888875333332233455566778999


Q ss_pred             EecCC-CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC---ceEEeeccCcc
Q 037869          117 DYMPN-LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF---EPLVADFGFAK  192 (380)
Q Consensus       117 e~~~~-g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~---~vkl~Dfgl~~  192 (380)
                      ||++| -++.+++.....  ..........++..+-+.+.-||..   +++||||..+||++.+++   .+.++|||++.
T Consensus        90 E~~~g~~~vk~~i~~~~~--~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   90 EFIDGASTVKDFILSTME--DESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EeccchhHHHHHHHHHcc--CcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCCCcCceEEEeecchh
Confidence            99976 377788765422  1223333367888888999999999   999999999999997653   35899999987


Q ss_pred             c
Q 037869          193 L  193 (380)
Q Consensus       193 ~  193 (380)
                      .
T Consensus       165 ~  165 (229)
T KOG3087|consen  165 V  165 (229)
T ss_pred             c
Confidence            5

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.11  E-value=8.5e-09  Score=94.09  Aligned_cols=262  Identities=16%  Similarity=0.161  Sum_probs=161.7

Q ss_pred             CCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcC-CCCcceeEeeE-----E--ecCCeEEEE
Q 037869           44 SDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGY-----C--AGTDQRLIV  115 (380)
Q Consensus        44 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~-----~--~~~~~~~lv  115 (380)
                      ...+.||+|+-+.+|-.-.. + ..+.|++....+-...+...|   |... .||-+..-+.+     +  ..+...-++
T Consensus        14 ~~gr~LgqGgea~ly~l~e~-~-d~VAKIYh~Pppa~~aqk~a~---la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV-R-DQVAKIYHAPPPAAQAQKVAE---LAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecchh-h-chhheeecCCCchHHHHHHHH---hccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            45678999999999976332 1 235588776554433333333   3333 46644331211     0  112336788


Q ss_pred             EEecCCCCHH-Hhhc--cCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          116 YDYMPNLSLL-SHLH--GQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       116 ~e~~~~g~L~-~~i~--~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      |+.++|..-. .+..  .+...-...+|...++....|+.+.+.||.+   |.+-||++++|+|+++++.|.|.|-..-.
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEccccee
Confidence            9988775222 2221  1112334688999999999999999999999   99999999999999999999999844332


Q ss_pred             ccCCCCccceeccccccCccCccccc-----cCCCCccchhhhhhHHHHHHHhC-CCCCCCCCCCcccchhccchhhhhc
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAM-----WGKVSESCDVYSFGILLLEILTG-RKPIEKLPGGVKRTITEWAEPLIVK  266 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~  266 (380)
                      .-..+.  ..-..+|...|.+||.-.     +-.-+..+|.|.||+++++++.| ..||.+........-.-  ...+..
T Consensus       166 i~~ng~--~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~--E~~Ia~  241 (637)
T COG4248         166 INANGT--LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL--ETDIAH  241 (637)
T ss_pred             eccCCc--eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc--hhhhhc
Confidence            221211  122235899999999654     34567889999999999999986 99998754321110000  000000


Q ss_pred             cccc------cccCCcccCCCCHHHHHHHHHHHHhhcCC--CCCCCCCHHHHHHHhcCC
Q 037869          267 GKFK------ELVDPKLRGDFDENQLKQAINVAVLCVQS--EPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       267 ~~~~------~~~~~~~~~~~~~~~~~~~~~li~~cl~~--~P~~Rps~~~ll~~l~~~  317 (380)
                      +.+.      ....+.....-..-.+.++..|..+|+..  ++.-|||++..+..|-..
T Consensus       242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al  300 (637)
T COG4248         242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDAL  300 (637)
T ss_pred             ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHH
Confidence            1110      01111111112234457788889999875  356899998887765433

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.11  E-value=6.3e-10  Score=96.31  Aligned_cols=136  Identities=21%  Similarity=0.227  Sum_probs=99.4

Q ss_pred             CCCCcceeccCCceEEEEEEeCCCcEEEEEEeccc--------------------C--hhhHHHHHHHHHHHhcCCCC--
Q 037869           42 GFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAM--------------------N--SKAEMEFAVEVEVLGRVRHK--   97 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~--------------------~--~~~~~~~~~E~~~l~~l~h~--   97 (380)
                      -+.+...||-|--|.||.|.+.+|.++|||.=+..                    +  ...+....+|.++|..|...  
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            45678899999999999999999999999964311                    0  11234567799999999654  


Q ss_pred             cceeEeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 037869           98 NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLL  177 (380)
Q Consensus        98 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill  177 (380)
                      .+.+.+++    +...+|||+++|-.|...-         ++....-.++..|+.-+.-+-..   |+||||+++-||++
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~---GiVHGDlSefNIlV  235 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRR---GIVHGDLSEFNILV  235 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHc---CccccCCchheEEE
Confidence            66666664    6778999999885554332         12333334455555555544456   99999999999999


Q ss_pred             CCCCceEEeeccCccc
Q 037869          178 DSDFEPLVADFGFAKL  193 (380)
Q Consensus       178 ~~~~~vkl~Dfgl~~~  193 (380)
                      +++|.++++||--+..
T Consensus       236 ~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         236 TEDGDIVVIDWPQAVP  251 (304)
T ss_pred             ecCCCEEEEeCccccc
Confidence            9999999999966543

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.03  E-value=9.8e-09  Score=91.51  Aligned_cols=141  Identities=16%  Similarity=0.048  Sum_probs=97.9

Q ss_pred             ceeccCCceEEEEEEeCCCcEEEEEEecccChhh-H----------HHHHHHHHHHhcCCCCc--ceeEeeEEec-----
Q 037869           47 NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKA-E----------MEFAVEVEVLGRVRHKN--LLGLRGYCAG-----  108 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-~----------~~~~~E~~~l~~l~h~n--iv~~~~~~~~-----  108 (380)
                      +.+-......|+.+.. +|+.|.||......... .          ..+.+|...+..+..-+  .+..+.+.+.     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            3444444555666654 57789999775433111 1          13667888887774322  2334444432     


Q ss_pred             CCeEEEEEEecCCC-CHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-------C
Q 037869          109 TDQRLIVYDYMPNL-SLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS-------D  180 (380)
Q Consensus       109 ~~~~~lv~e~~~~g-~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~-------~  180 (380)
                      ....++|||++++. +|.+++....  ....+......++.+++..+.-||..   ||+|+|+++.|||++.       +
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~  181 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREED  181 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCC
Confidence            23578999999876 7888875321  23455667778999999999999999   9999999999999975       4


Q ss_pred             CceEEeeccCccc
Q 037869          181 FEPLVADFGFAKL  193 (380)
Q Consensus       181 ~~vkl~Dfgl~~~  193 (380)
                      +.+.++||+.+..
T Consensus       182 ~~~~LIDl~r~~~  194 (268)
T PRK15123        182 LKLSVIDLHRAQI  194 (268)
T ss_pred             ceEEEEECCcccc
Confidence            6899999998854

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.92  E-value=4.3e-10  Score=108.29  Aligned_cols=155  Identities=19%  Similarity=0.299  Sum_probs=108.1

Q ss_pred             HHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccce--------eccccccCccCccccccC
Q 037869          149 GSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMT--------TRVKGTLGYLAPEYAMWG  220 (380)
Q Consensus       149 ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~--------~~~~gt~~y~aPE~~~~~  220 (380)
                      +.+.|+.|+|..  +++||++|.|++|.++.++..||+.|+.+-..........        .-..-...|.|||++.+.
T Consensus       107 ~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT  184 (700)
T ss_pred             cccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence            344899999986  4899999999999999999999999988765433221111        111235689999999998


Q ss_pred             CCCccchhhhhhHHHHHHHhCCCC-CCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCC
Q 037869          221 KVSESCDVYSFGILLLEILTGRKP-IEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQS  299 (380)
Q Consensus       221 ~~~~~~DiwslG~il~ell~g~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~  299 (380)
                      ..+.++|+||+|+++|.+..|..+ +..........             ........-...+..+.+.++.+-+.+++..
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-------------~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~  251 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-------------FSRNLLNAGAFGYSNNLPSELRESLKKLLNG  251 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhh-------------hhhcccccccccccccCcHHHHHHHHHHhcC
Confidence            889999999999999999854444 33221111111             1111111112233456678899999999999


Q ss_pred             CCCCCCCHHHHHHHhcCCC
Q 037869          300 EPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       300 ~P~~Rps~~~ll~~l~~~~  318 (380)
                      ++..||++..+......-+
T Consensus       252 ~~~~rp~~~~l~~~~ff~D  270 (700)
T KOG2137|consen  252 DSAVRPTLDLLLSIPFFSD  270 (700)
T ss_pred             CcccCcchhhhhcccccCC
Confidence            9999998888876654433

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.78  E-value=6.2e-08  Score=83.46  Aligned_cols=124  Identities=23%  Similarity=0.202  Sum_probs=88.6

Q ss_pred             CCcEEEEEEeccc-C------hhhHHHHHHHHHHHhcCCCC--cceeEeeEEecC----CeEEEEEEecCCC-CHHHhhc
Q 037869           64 DGLQIAVKKLKAM-N------SKAEMEFAVEVEVLGRVRHK--NLLGLRGYCAGT----DQRLIVYDYMPNL-SLLSHLH  129 (380)
Q Consensus        64 ~~~~vavK~~~~~-~------~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~~~----~~~~lv~e~~~~g-~L~~~i~  129 (380)
                      .++.|.+|..... .      ........+|...+..|..-  ...+.+.+.+..    ...++|+|++++. +|.+++.
T Consensus        31 ~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~  110 (206)
T PF06293_consen   31 VGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQ  110 (206)
T ss_pred             cceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHH
Confidence            3556666654321 1      12233567788877777432  244455555432    2458999999874 7888886


Q ss_pred             cCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC---ceEEeeccCcccc
Q 037869          130 GQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF---EPLVADFGFAKLI  194 (380)
Q Consensus       130 ~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~---~vkl~Dfgl~~~~  194 (380)
                      ...    ..+......++.+++..++-||..   ||+|+|+++.|||++.++   .+.++||+-++..
T Consensus       111 ~~~----~~~~~~~~~ll~~l~~~i~~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  111 QWE----QLDPSQRRELLRALARLIAKLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             hhc----ccchhhHHHHHHHHHHHHHHHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            531    255666788999999999999999   999999999999999886   8999999987754

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.77  E-value=3.9e-08  Score=94.92  Aligned_cols=143  Identities=15%  Similarity=0.212  Sum_probs=93.4

Q ss_pred             ceeccCCceEEEEEEeCCCcEEEEEEecccC----------------------h------------------hhHHHHHH
Q 037869           47 NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMN----------------------S------------------KAEMEFAV   86 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------------~------------------~~~~~~~~   86 (380)
                      +.|+.++-|.||+|+..+|+.||||+.+..-                      +                  ..+..+.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            6899999999999999889999999975411                      0                  00112344


Q ss_pred             HHHHHhcC----CCCcceeEeeEE-ecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcC
Q 037869           87 EVEVLGRV----RHKNLLGLRGYC-AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV  161 (380)
Q Consensus        87 E~~~l~~l----~h~niv~~~~~~-~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~  161 (380)
                      |..-+.++    ++.--+++=.++ +-.....++|||++|..+.+...-..   ..++...+.....++.----+-  . 
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~---~g~d~k~ia~~~~~~f~~q~~~--d-  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS---AGIDRKELAELLVRAFLRQLLR--D-  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh---cCCCHHHHHHHHHHHHHHHHHh--c-
Confidence            55555444    222223333333 22567799999999999888753221   2344333332222222111122  2 


Q ss_pred             CCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       162 ~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                        |++|.|..|.||++..+|++.+.|||+...++..
T Consensus       285 --gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         285 --GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             --CccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence              9999999999999999999999999999877543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.77  E-value=2.1e-07  Score=79.20  Aligned_cols=139  Identities=15%  Similarity=0.131  Sum_probs=91.6

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHH---------HHHHHH---HHhcCCCCcceeEeeE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEME---------FAVEVE---VLGRVRHKNLLGLRGY  105 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~---------~~~E~~---~l~~l~h~niv~~~~~  105 (380)
                      ...++|.+.+.+-......|.+... +|..+++|..+.........         ..+++.   .++...-...+.++-+
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            4568899999998888888877766 47889999887533222111         112222   2322222222222222


Q ss_pred             -----EecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC
Q 037869          106 -----CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD  180 (380)
Q Consensus       106 -----~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~  180 (380)
                           +.-....+++|||++|..|.+...        +++    .+...+..++.-||+.   |++|+|..|.|++++.+
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~  171 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNN  171 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECC
Confidence                 222345578999999987766542        222    2445677889999999   99999999999999865


Q ss_pred             CceEEeeccCccc
Q 037869          181 FEPLVADFGFAKL  193 (380)
Q Consensus       181 ~~vkl~Dfgl~~~  193 (380)
                       .++++||+..+.
T Consensus       172 -~i~iID~~~k~~  183 (229)
T PF06176_consen  172 -GIRIIDTQGKRM  183 (229)
T ss_pred             -cEEEEECccccc
Confidence             599999977653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.73  E-value=2.7e-07  Score=80.57  Aligned_cols=140  Identities=14%  Similarity=0.130  Sum_probs=85.3

Q ss_pred             ceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCc--ceeEeeEEecCCeEEEEEEecCCCC-
Q 037869           47 NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKN--LLGLRGYCAGTDQRLIVYDYMPNLS-  123 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~~~~g~-  123 (380)
                      ..||+|..+.||+.   .+..+++|......  ......+|.++++.+..-.  +.+.+++....+...+|||+++|.+ 
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~   81 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS   81 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence            57999999999984   25567888877533  2335688999998885332  4667777777778899999999863 


Q ss_pred             HHHhh---------------------ccCCCCCccCCHHHHHHHHH----------HHHH-HHHHHhhcC-CCCeEecCC
Q 037869          124 LLSHL---------------------HGQYAGEVQLDWKRRMKIAI----------GSAE-GILYLHHEV-TPHIIHRDI  170 (380)
Q Consensus       124 L~~~i---------------------~~~~~~~~~~~~~~~~~i~~----------ql~~-al~~LH~~~-~~~ivHrdl  170 (380)
                      +...+                     +........+... ...+..          .+.. ...+|.... ...++|+|+
T Consensus        82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~  160 (226)
T TIGR02172        82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF  160 (226)
T ss_pred             hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence            11111                     1110011111100 000000          0001 122222111 235789999


Q ss_pred             CCCCeeeCCCCceEEeeccCccc
Q 037869          171 KASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       171 kp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      .|.||++++++ +.++||+.+..
T Consensus       161 ~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       161 QIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CCCcEEEcCCC-cEEEechhcCc
Confidence            99999999887 99999988763

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.69  E-value=2.3e-09  Score=102.44  Aligned_cols=198  Identities=18%  Similarity=0.144  Sum_probs=143.2

Q ss_pred             ccHHHHHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCc-ceeEeeEEecC
Q 037869           31 FTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKN-LLGLRGYCAGT  109 (380)
Q Consensus        31 ~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~  109 (380)
                      |.-..++..++-|...+-+++|+++.+++.+....+....+.+...     ....-++++|.+++||| .++.++.+..+
T Consensus       232 ~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E  306 (829)
T KOG0576|consen  232 FQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGE  306 (829)
T ss_pred             CCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcc
Confidence            3334444556666677889999999999998643333345555443     34556888999999999 78888888888


Q ss_pred             CeEEEEEEecCCC-CHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          110 DQRLIVYDYMPNL-SLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       110 ~~~~lv~e~~~~g-~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                      ...++.++++.++ +....+.   ..+..+..-....+..--.++++++|+.   .-+|+|    ||+..+ +..+.+||
T Consensus       307 ~~~~i~~~i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~~  375 (829)
T KOG0576|consen  307 DYLWIPMRICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLDF  375 (829)
T ss_pred             cccchhhhhhcCCccccccCC---hhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-cccccccc
Confidence            8999999999877 2222221   1122333334445555667889999986   458888    776655 58999999


Q ss_pred             cCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCC
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE  246 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~  246 (380)
                      +....+....  ......+++.|+|||+.....+..+.|+|++|.-..++.-|.+|-.
T Consensus       376 ~v~~~L~~~~--~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  376 AVPPQLTRTM--KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cCCcccCccc--ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            9998776533  3444568999999999999999999999999987777777776654

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.64  E-value=6.3e-07  Score=77.13  Aligned_cols=159  Identities=20%  Similarity=0.236  Sum_probs=105.6

Q ss_pred             CccceeccHHHHHHhhCCCCCcceec---cCCceEEEEEEeCCCcEEEEEEecccChh-------------------hHH
Q 037869           25 NATWRIFTYKELHTATNGFSDDNKLG---EGGFGSVYWGRTSDGLQIAVKKLKAMNSK-------------------AEM   82 (380)
Q Consensus        25 ~~~~~~~~~~~~~~~~~~y~~~~~Lg---~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-------------------~~~   82 (380)
                      ...++.-+...+.....+..+....|   .|--+.||+|...++..||+|+++.....                   ...
T Consensus        29 ~~v~D~~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr  108 (268)
T COG1718          29 DEVFDKRTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRR  108 (268)
T ss_pred             hhhhhhHHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHH
Confidence            34555666777777777777776655   55566899999888999999998642110                   111


Q ss_pred             H-----HHHHHHHHhcCC--CCcceeEeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHH
Q 037869           83 E-----FAVEVEVLGRVR--HKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGIL  155 (380)
Q Consensus        83 ~-----~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~  155 (380)
                      .     ...|+.-|+++.  +-.+.+-+.+    ....+||||+....    ..........+.......+..++++.+.
T Consensus       109 ~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g----~pAP~LkDv~~e~~e~~~~~~~~v~~~~  180 (268)
T COG1718         109 KLVFAWARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDG----LPAPRLKDVPLELEEAEGLYEDVVEYMR  180 (268)
T ss_pred             HHHHHHHHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCC----CCCCCcccCCcCchhHHHHHHHHHHHHH
Confidence            1     223666666653  2233333443    34579999995531    1111122333444467778888888888


Q ss_pred             HHhh-cCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          156 YLHH-EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       156 ~LH~-~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      -|-. .   ++||+||+.-|||+. ++.+.++|||-+-...
T Consensus       181 ~l~~~a---~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         181 RLYKEA---GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHHhc---CcccccchhhheEEE-CCeEEEEECccccccC
Confidence            7776 5   999999999999999 7899999999886543

>PRK09902 hypothetical protein; Provisional

Probab=98.61  E-value=1.3e-06  Score=74.03  Aligned_cols=155  Identities=11%  Similarity=0.121  Sum_probs=108.5

Q ss_pred             cHHHHHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecc------cChhhHHHHHHHHHHHhcCCC--CcceeEe
Q 037869           32 TYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKA------MNSKAEMEFAVEVEVLGRVRH--KNLLGLR  103 (380)
Q Consensus        32 ~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~h--~niv~~~  103 (380)
                      +++.+......+.-.---|.||-+-|+..... |..+-+|+-..      .-+.....|.+|+..+..|..  -.+.+.+
T Consensus         9 ~f~~~w~~~~~wve~pN~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv   87 (216)
T PRK09902          9 EFNHWWATEGDWVEEPNYRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV   87 (216)
T ss_pred             hHHHHHhCCCceecCCCcCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc
Confidence            34455555555543334466899999987653 44788998651      113345689999999998853  2244444


Q ss_pred             eEEec-----CCeEEEEEEecCC-CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 037869          104 GYCAG-----TDQRLIVYDYMPN-LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLL  177 (380)
Q Consensus       104 ~~~~~-----~~~~~lv~e~~~~-g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill  177 (380)
                       ++..     ....+||+|-+.| -+|.+++....  ..+.+......++.+++.+++-||+.   |+.|+|+.+.||++
T Consensus        88 -f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll  161 (216)
T PRK09902         88 -FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYV  161 (216)
T ss_pred             -eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheee
Confidence             3321     1236799997753 47888875431  22556777788999999999999999   99999999999999


Q ss_pred             CCCCc--eEEeeccCccc
Q 037869          178 DSDFE--PLVADFGFAKL  193 (380)
Q Consensus       178 ~~~~~--vkl~Dfgl~~~  193 (380)
                      +.++.  +.++||.-++.
T Consensus       162 ~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        162 KTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             cCCCCeeEEEEEhhccch
Confidence            86667  99999987764

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.56  E-value=1.2e-06  Score=76.91  Aligned_cols=145  Identities=21%  Similarity=0.155  Sum_probs=84.1

Q ss_pred             cceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCC--cceeEeeEEe---cCCeEEEEEEecC
Q 037869           46 DNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHK--NLLGLRGYCA---GTDQRLIVYDYMP  120 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~~~---~~~~~~lv~e~~~  120 (380)
                      ++.|+.|..+.||++...+ ..+++|.....  .....+..|..+++.+...  .+.+++....   .....+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            4679999999999999876 59999997664  3445677888888877432  3455665432   2345789999999


Q ss_pred             CCCHHH----------------hh---ccCCCCCccCCHHH---------HHHH------------HHHHHH-HHHHHhh
Q 037869          121 NLSLLS----------------HL---HGQYAGEVQLDWKR---------RMKI------------AIGSAE-GILYLHH  159 (380)
Q Consensus       121 ~g~L~~----------------~i---~~~~~~~~~~~~~~---------~~~i------------~~ql~~-al~~LH~  159 (380)
                      |..+..                .+   +.............         ....            ...+.. .+..+++
T Consensus        79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (239)
T PF01636_consen   79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA  158 (239)
T ss_dssp             SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence            987776                11   11100011111100         0000            111222 2333332


Q ss_pred             c----CCCCeEecCCCCCCeeeC-CCCceEEeeccCccc
Q 037869          160 E----VTPHIIHRDIKASNVLLD-SDFEPLVADFGFAKL  193 (380)
Q Consensus       160 ~----~~~~ivHrdlkp~Nill~-~~~~vkl~Dfgl~~~  193 (380)
                      .    ....++|+|+.|.||+++ .++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            1    133799999999999999 667778999987754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.48  E-value=1e-06  Score=85.01  Aligned_cols=142  Identities=14%  Similarity=0.203  Sum_probs=91.8

Q ss_pred             cceeccCCceEEEEEEeCCCcEEEEEEecccCh-------------------------------hh------HHHHHHHH
Q 037869           46 DNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNS-------------------------------KA------EMEFAVEV   88 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-------------------------------~~------~~~~~~E~   88 (380)
                      .+.||.-+.|.|++|+.++|+.||||+-+..-.                               +-      +..|.+|.
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            468999999999999998999999999653110                               00      11233344


Q ss_pred             HHHh----cCCCCc------ceeEeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHh
Q 037869           89 EVLG----RVRHKN------LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH  158 (380)
Q Consensus        89 ~~l~----~l~h~n------iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH  158 (380)
                      +-..    .+.|-+      |.+++-.+  .....++|||++|..+.+.-.-   ....++...+..-+.+...-+=+-|
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~~~qIf~~  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAYLEQIFKT  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHHHHHHHhc
Confidence            4332    233444      33332222  4567999999999877655321   1234665555444444332222222


Q ss_pred             hcCCCCeEecCCCCCCeeeCC----CCceEEeeccCccccCCC
Q 037869          159 HEVTPHIIHRDIKASNVLLDS----DFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       159 ~~~~~~ivHrdlkp~Nill~~----~~~vkl~Dfgl~~~~~~~  197 (380)
                           |++|+|-.|.||++..    ++.+.+.|||+.......
T Consensus       321 -----GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~~  358 (538)
T KOG1235|consen  321 -----GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISHK  358 (538)
T ss_pred             -----CCccCCCCCCcEEEecCCCCCccEEEEcccccccccHH
Confidence                 9999999999999983    678999999999876543

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.47  E-value=2.9e-06  Score=75.19  Aligned_cols=143  Identities=17%  Similarity=0.171  Sum_probs=85.3

Q ss_pred             ceeccCCc-eEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCC-CCcceeEeeEEecCCeEEEEEEecCCCCH
Q 037869           47 NKLGEGGF-GSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR-HKNLLGLRGYCAGTDQRLIVYDYMPNLSL  124 (380)
Q Consensus        47 ~~Lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~L  124 (380)
                      +.|-.|.+ ..||++... +..+++|......   ...+.+|+.+++.+. +--+.+++++....+..++|||+++|.++
T Consensus         4 ~~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l   79 (244)
T cd05150           4 ERVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA   79 (244)
T ss_pred             eecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence            34555655 788999764 4688889876543   235667888887773 33456677777666678999999998777


Q ss_pred             HHhh-------------------ccCCCCCccCCHH--HHHHHHH--------------------HHHHHHHHHhhc---
Q 037869          125 LSHL-------------------HGQYAGEVQLDWK--RRMKIAI--------------------GSAEGILYLHHE---  160 (380)
Q Consensus       125 ~~~i-------------------~~~~~~~~~~~~~--~~~~i~~--------------------ql~~al~~LH~~---  160 (380)
                      ....                   +.......++...  .......                    .+...+..|-..   
T Consensus        80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  159 (244)
T cd05150          80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA  159 (244)
T ss_pred             hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence            6432                   1110001111100  0000000                    011112222111   


Q ss_pred             -CCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          161 -VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       161 -~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                       ..+.++|+|+.|.||++++++.+.|+||+.+..
T Consensus       160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             cCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence             123689999999999999987788999987753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PLN02876 acyl-CoA dehydrogenase

Probab=98.31  E-value=1e-05  Score=84.03  Aligned_cols=79  Identities=13%  Similarity=0.270  Sum_probs=56.7

Q ss_pred             cceeccCCceEEEEEEeCCC---cEEEEEEecccC-hhhHHHHHHHHHHHhcCC-CCcc--eeEeeEEecC---CeEEEE
Q 037869           46 DNKLGEGGFGSVYWGRTSDG---LQIAVKKLKAMN-SKAEMEFAVEVEVLGRVR-HKNL--LGLRGYCAGT---DQRLIV  115 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~~~---~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~-h~ni--v~~~~~~~~~---~~~~lv  115 (380)
                      .+.|+.|.+..+|+.....+   ..+++|+..... ......+.+|+.+|+.+. |+++  .+++.++.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            67889999999999876443   467888764321 122346788999999985 6654  7777777653   467899


Q ss_pred             EEecCCCCH
Q 037869          116 YDYMPNLSL  124 (380)
Q Consensus       116 ~e~~~~g~L  124 (380)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999987643

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.30  E-value=5e-06  Score=67.83  Aligned_cols=131  Identities=20%  Similarity=0.237  Sum_probs=92.2

Q ss_pred             CCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCccee-EeeEEecCCeEEEEEEecC
Q 037869           42 GFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG-LRGYCAGTDQRLIVYDYMP  120 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-~~~~~~~~~~~~lv~e~~~  120 (380)
                      .....+.|++|.+|.||++.+. |..+|+|+-+..+  .+..+..|+++|..+.-.++.+ ++.+.    ..++.|||+.
T Consensus        23 ~~~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~   95 (201)
T COG2112          23 ELRVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYID   95 (201)
T ss_pred             hhhhhhhhhcccccEEEEeecc-CceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhc
Confidence            3445788999999999999886 5588999876544  3457888999999888766644 44432    3345699999


Q ss_pred             CCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC-CCCeeeCCCCceEEeeccCccc
Q 037869          121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIK-ASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       121 ~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlk-p~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      |-.|.+.-...       +..    ....++++.--|-..   ||-|+.|. |...++.+++.+.|+||..++.
T Consensus        96 G~~L~~~~~~~-------~rk----~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          96 GRPLGKLEIGG-------DRK----HLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             Ccchhhhhhcc-------cHH----HHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            87877665321       222    333455554445555   99999997 5555555555999999998874

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.23  E-value=5.5e-05  Score=63.89  Aligned_cols=104  Identities=22%  Similarity=0.220  Sum_probs=80.8

Q ss_pred             HHHHHHhcCCC-CcceeEeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC
Q 037869           86 VEVEVLGRVRH-KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH  164 (380)
Q Consensus        86 ~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~  164 (380)
                      .|.-++..+++ +++.+++|+|-    .++|.||...+++...-.. ...-...+|..+..++.++++.+.+|++.....
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~-l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRP-LSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccc-cccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            47778888875 69999999983    3678899987666432100 011135789999999999999999999864446


Q ss_pred             eEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          165 IIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       165 ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      +.-+|++|+|+-++++|++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            888999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.19  E-value=6.4e-05  Score=63.84  Aligned_cols=132  Identities=16%  Similarity=0.209  Sum_probs=90.4

Q ss_pred             cceeccCCceEEEEEEeCCCcEEEEEEecccC----------------hhhHHHHHHHHHHHhcCC------CCcceeEe
Q 037869           46 DNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMN----------------SKAEMEFAVEVEVLGRVR------HKNLLGLR  103 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~----------------~~~~~~~~~E~~~l~~l~------h~niv~~~  103 (380)
                      ...||+|+.-.||.-  .++...+||+.....                .....+..+|+.-...+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~H--P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQH--PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEEC--CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            467999999999864  345567889887644                112335555655544444      88999999


Q ss_pred             eEEecCCeEEEEEEecC------CCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 037869          104 GYCAGTDQRLIVYDYMP------NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLL  177 (380)
Q Consensus       104 ~~~~~~~~~~lv~e~~~------~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill  177 (380)
                      |+.+++....+|+|.+.      .-+|.+++...     .++. .....+   -+-..||-+.   .|+.+|++|.||++
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-----~~~~-~~~~~L---~~f~~~l~~~---~Iv~~dl~~~NIv~  151 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-----GLTE-ELRQAL---DEFKRYLLDH---HIVIRDLNPHNIVV  151 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-----CccH-HHHHHH---HHHHHHHHHc---CCeecCCCcccEEE
Confidence            99999999999999763      23677777432     4554 333333   3445566666   89999999999999


Q ss_pred             CCC---C-ceEEee-ccCc
Q 037869          178 DSD---F-EPLVAD-FGFA  191 (380)
Q Consensus       178 ~~~---~-~vkl~D-fgl~  191 (380)
                      ...   . .+.|+| ||..
T Consensus       152 ~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  152 QRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             EecCCCceEEEEEeCCCCc
Confidence            533   2 577887 4443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.16  E-value=2.3e-05  Score=69.01  Aligned_cols=74  Identities=15%  Similarity=0.104  Sum_probs=46.0

Q ss_pred             cceeccCCce-EEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCC---cceeEeeEEecC---CeEEEEEEe
Q 037869           46 DNKLGEGGFG-SVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHK---NLLGLRGYCAGT---DQRLIVYDY  118 (380)
Q Consensus        46 ~~~Lg~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~~~---~~~~lv~e~  118 (380)
                      ++.|+.|+.. .||..    +..+++|..+...  ....+.+|.++++.+...   -+.+++......   ...+++|++
T Consensus         2 ~~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~   75 (235)
T cd05155           2 IEPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW   75 (235)
T ss_pred             ceeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence            3567877776 48876    2357778755422  234688899988877532   234444433322   235889999


Q ss_pred             cCCCCHH
Q 037869          119 MPNLSLL  125 (380)
Q Consensus       119 ~~~g~L~  125 (380)
                      ++|.++.
T Consensus        76 i~G~~l~   82 (235)
T cd05155          76 LEGETAT   82 (235)
T ss_pred             ecCCCCC
Confidence            9987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.14  E-value=3.9e-05  Score=67.49  Aligned_cols=74  Identities=9%  Similarity=0.110  Sum_probs=49.0

Q ss_pred             cceeccCCceEEEEEEeCC--CcEEEEEEecccChhhHHHHHHHHHHHhcCCCCc-ceeEeeEEecCCeEEEEEEecCCC
Q 037869           46 DNKLGEGGFGSVYWGRTSD--GLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKN-LLGLRGYCAGTDQRLIVYDYMPNL  122 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~e~~~~g  122 (380)
                      .+.|..|-...+|++...+  +..|++|+....... .....+|+.+++.+...+ ..+++..+.    ..+||||++|-
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~-~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~   77 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL-IIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGR   77 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc-eecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCC
Confidence            4678889999999998754  678999977643221 123446888888774333 344444332    24899999887


Q ss_pred             CH
Q 037869          123 SL  124 (380)
Q Consensus       123 ~L  124 (380)
                      ++
T Consensus        78 ~l   79 (235)
T cd05157          78 TL   79 (235)
T ss_pred             cC
Confidence            65

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=98.14  E-value=5.8e-05  Score=68.83  Aligned_cols=80  Identities=10%  Similarity=0.093  Sum_probs=57.8

Q ss_pred             CCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCC---CcceeEeeEEec---CCeEEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRH---KNLLGLRGYCAG---TDQRLIV  115 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~---~~~~~lv  115 (380)
                      .-.-.+.||.|..+.||.....++ .+++|..+...  ....+..|...|+.+..   -.+.++++++..   .+..++|
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LV   91 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLL   91 (297)
T ss_pred             hhheeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEE
Confidence            344466899999999999977555 47777754421  22377889999988843   357778877643   3668999


Q ss_pred             EEecCCCCH
Q 037869          116 YDYMPNLSL  124 (380)
Q Consensus       116 ~e~~~~g~L  124 (380)
                      ||+++|+++
T Consensus        92 mE~i~G~~~  100 (297)
T PRK10593         92 LERLRGVSV  100 (297)
T ss_pred             EeccCCEec
Confidence            999998765

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.13  E-value=1.2e-05  Score=82.52  Aligned_cols=201  Identities=21%  Similarity=0.224  Sum_probs=140.2

Q ss_pred             HHHHHHHHHHhcCCCCcceeEeeEEecCCeE----EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHH
Q 037869           82 MEFAVEVEVLGRVRHKNLLGLRGYCAGTDQR----LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL  157 (380)
Q Consensus        82 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~----~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~L  157 (380)
                      .....|+..+....|+|++.++.+..+....    .+..++|..-++...+..    -..++....+.+..++..||+|+
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHH
Confidence            3445578888888999999999887654332    345567877777777743    35788999999999999999999


Q ss_pred             hhcCCCCeEecCCCCC---CeeeCCCCceEEe--eccCccccCCCCccceeccccccCccCccccccCCCCcc--chhhh
Q 037869          158 HHEVTPHIIHRDIKAS---NVLLDSDFEPLVA--DFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSES--CDVYS  230 (380)
Q Consensus       158 H~~~~~~ivHrdlkp~---Nill~~~~~vkl~--Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~Diws  230 (380)
                      |+.   ...|.-|...   +--.+..+.+.++  ||+....+.........  ..+..|.+||......+..+  .|+|.
T Consensus       303 h~~---~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~--~~~~~~~~~e~~~~~~~~~~r~~dL~~  377 (1351)
T KOG1035|consen  303 HSL---SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSD--LLAEIRNADEDLKENTAKKSRLTDLWC  377 (1351)
T ss_pred             HHh---ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhh--cCccccccccccccccchhhhhhHHHH
Confidence            998   5555555544   4444566777777  89888776543322222  24667888888776665544  79999


Q ss_pred             hhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 037869          231 FGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEV  310 (380)
Q Consensus       231 lG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~l  310 (380)
                      +|..+..+..+..+-....                  ....+        .+........+....|+..++++|+++.++
T Consensus       378 lgll~~~~~~~~~i~~~~~------------------~~~~~--------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~l  431 (1351)
T KOG1035|consen  378 LGLLLLQLSQGEDISEKSA------------------VPVSL--------LDVLSTSELLDALPKCLDEDSEERLSALEL  431 (1351)
T ss_pred             HHHHHhhhhhcCccccccc------------------chhhh--------hccccchhhhhhhhhhcchhhhhccchhhh
Confidence            9999999998775532110                  00000        111111256778889999999999999999


Q ss_pred             HHHhcCC
Q 037869          311 VNTLTGY  317 (380)
Q Consensus       311 l~~l~~~  317 (380)
                      +.+....
T Consensus       432 l~~~f~~  438 (1351)
T KOG1035|consen  432 LTHPFLR  438 (1351)
T ss_pred             hhchhcc
Confidence            9996544

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.11  E-value=2.3e-05  Score=69.98  Aligned_cols=140  Identities=13%  Similarity=0.090  Sum_probs=78.9

Q ss_pred             eeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcc-eeEeeEEecCCeEEEEEEecCCCCHHH
Q 037869           48 KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL-LGLRGYCAGTDQRLIVYDYMPNLSLLS  126 (380)
Q Consensus        48 ~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~L~~  126 (380)
                      .+..|-.+.+|+... ++..+++|........-.....+|..+++.+....+ .+++....    .++||||++|..+..
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~   77 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL   77 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence            466788889999874 467888887654221111235678888888854333 33333322    378999998866532


Q ss_pred             h-----------------hccCCCCCccCCHH-HHHHHHHHH---------HHHHHHHhhc-----CCCCeEecCCCCCC
Q 037869          127 H-----------------LHGQYAGEVQLDWK-RRMKIAIGS---------AEGILYLHHE-----VTPHIIHRDIKASN  174 (380)
Q Consensus       127 ~-----------------i~~~~~~~~~~~~~-~~~~i~~ql---------~~al~~LH~~-----~~~~ivHrdlkp~N  174 (380)
                      .                 ++.......+++.. .+..+..++         ...+..+-..     ....++|+|+.|.|
T Consensus        78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N  157 (256)
T TIGR02721        78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN  157 (256)
T ss_pred             ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence            1                 12211111122221 111111111         1112222111     02258999999999


Q ss_pred             eeeCCCCceEEeeccCccc
Q 037869          175 VLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       175 ill~~~~~vkl~Dfgl~~~  193 (380)
                      |++++++ +.|+||..+..
T Consensus       158 il~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       158 LVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             EEEeCCC-CEEEeccccCc
Confidence            9999876 78999988764

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.11  E-value=8.3e-05  Score=62.74  Aligned_cols=125  Identities=25%  Similarity=0.328  Sum_probs=88.5

Q ss_pred             CCCCCcceeccCCc-eEEEEEEeCCCcEEEEEEecc---cCh------------------hhHHHHHHHHHHHhcCC---
Q 037869           41 NGFSDDNKLGEGGF-GSVYWGRTSDGLQIAVKKLKA---MNS------------------KAEMEFAVEVEVLGRVR---   95 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~-g~Vy~~~~~~~~~vavK~~~~---~~~------------------~~~~~~~~E~~~l~~l~---   95 (380)
                      ..++.++.||.|.- |.||+++.. |+.||+|.++.   ..+                  .-...|..|-....+|+   
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            78999999999999 999999884 77999999432   000                  01124667877777764   


Q ss_pred             CCcc--eeEeeEEecC------------------CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHH
Q 037869           96 HKNL--LGLRGYCAGT------------------DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGIL  155 (380)
Q Consensus        96 h~ni--v~~~~~~~~~------------------~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~  155 (380)
                      +.++  |+++|+..-+                  ....||.||.+...             .+..    .-+.++.+-+.
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~~----~~~~~~~~dl~  178 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQI----RDIPQMLRDLK  178 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccch----hHHHHHHHHHH
Confidence            4566  9999987322                  12357888775532             1222    24456677788


Q ss_pred             HHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCc
Q 037869          156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA  191 (380)
Q Consensus       156 ~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~  191 (380)
                      .+|..   ||+-+|+++.|..     .-+|+|||.+
T Consensus       179 ~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence            89998   9999999999975     3488999864

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.01  E-value=7.3e-06  Score=73.19  Aligned_cols=136  Identities=15%  Similarity=0.122  Sum_probs=96.9

Q ss_pred             CCCCcceeccCCceEEEEEEeCCCcEEEEEEecccC--------h--------------hhHHHHHHHHHHHhcCC-C-C
Q 037869           42 GFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMN--------S--------------KAEMEFAVEVEVLGRVR-H-K   97 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~--------------~~~~~~~~E~~~l~~l~-h-~   97 (380)
                      -+.+...||-|--+.||.+-+.+|.+.++|.-+...        .              -++....+|+..|+.|. | -
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            467889999999999999999989999999643210        0              11234556888888884 2 2


Q ss_pred             cceeEeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 037869           98 NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLL  177 (380)
Q Consensus        98 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill  177 (380)
                      -+.+.+++    +..++|||++.|-.|...-+-       .   ....+...+..-+.-|..+   |+||||+.--||++
T Consensus       173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v-------~---d~~~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv  235 (465)
T KOG2268|consen  173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV-------E---DPPTLYDDLMGLIVRLANH---GLIHGDFNEFNIMV  235 (465)
T ss_pred             CCCCcccc----cceeeHHHhhcccceeeeeec-------C---ChHHHHHHHHHHHHHHHHc---CceecccchheeEE
Confidence            34445553    567899999988776654321       1   1233445555556667777   99999999999999


Q ss_pred             CCCCceEEeeccCcccc
Q 037869          178 DSDFEPLVADFGFAKLI  194 (380)
Q Consensus       178 ~~~~~vkl~Dfgl~~~~  194 (380)
                      ..++.++++||--.-..
T Consensus       236 ~dd~~i~vIDFPQmvS~  252 (465)
T KOG2268|consen  236 KDDDKIVVIDFPQMVST  252 (465)
T ss_pred             ecCCCEEEeechHhhcc
Confidence            99999999999655433

>PRK05231 homoserine kinase; Provisional

Probab=98.01  E-value=0.00017  Score=66.55  Aligned_cols=144  Identities=17%  Similarity=0.234  Sum_probs=76.9

Q ss_pred             cceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcC-----CCCcceeEe-e--EEecCCeEEEEEE
Q 037869           46 DNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-----RHKNLLGLR-G--YCAGTDQRLIVYD  117 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~-~--~~~~~~~~~lv~e  117 (380)
                      .+.|+.|....+|.....+| .+++|++......   .+..|+.++..|     ..|.+++.. |  +....+..+++++
T Consensus        27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~~---~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~  102 (319)
T PRK05231         27 LKGIAEGIENSNFFLTTTQG-EYVLTLFERLTAE---DLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT  102 (319)
T ss_pred             cchhccccccceEEEEeCCC-cEEEEEeccCChH---HhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence            45677888889999987655 6899987622222   333344444444     233333211 0  1123456799999


Q ss_pred             ecCCCCHH-----------Hhh---ccC---CC----CCccCCH-HHHHH------------HHHH-HHHHHHHHhhc--
Q 037869          118 YMPNLSLL-----------SHL---HGQ---YA----GEVQLDW-KRRMK------------IAIG-SAEGILYLHHE--  160 (380)
Q Consensus       118 ~~~~g~L~-----------~~i---~~~---~~----~~~~~~~-~~~~~------------i~~q-l~~al~~LH~~--  160 (380)
                      |++|..+.           ..+   +..   +.    ....+.+ .....            .+.+ +...+..+...  
T Consensus       103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  182 (319)
T PRK05231        103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW  182 (319)
T ss_pred             ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence            99887432           111   110   00    0001111 11110            1111 11122222210  


Q ss_pred             --CCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          161 --VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       161 --~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                        ...+++|+|+.|.||+++.+...-|+||+.+..
T Consensus       183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence              244899999999999999775568999998764

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.98  E-value=9e-05  Score=67.62  Aligned_cols=144  Identities=19%  Similarity=0.233  Sum_probs=83.6

Q ss_pred             cceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCC--cceeEeeE------EecCCeEEEEEE
Q 037869           46 DNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHK--NLLGLRGY------CAGTDQRLIVYD  117 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~------~~~~~~~~lv~e  117 (380)
                      .+.|..|....+|+....+ ..+++|+....   ....+..|+.++..+.+.  .+.+++..      ....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            5678888889999987643 47899987652   233566677777766422  23444331      123456789999


Q ss_pred             ecCCCCHHH--------------hhccC---CCCC----ccCCHHHHH----------HHHHHHHHHHHHHhh----cCC
Q 037869          118 YMPNLSLLS--------------HLHGQ---YAGE----VQLDWKRRM----------KIAIGSAEGILYLHH----EVT  162 (380)
Q Consensus       118 ~~~~g~L~~--------------~i~~~---~~~~----~~~~~~~~~----------~i~~ql~~al~~LH~----~~~  162 (380)
                      +++|..+..              .++..   ....    ....+....          .....+..++.++..    ...
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            998876532              00110   0000    001111100          011112233444443    113


Q ss_pred             CCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       163 ~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      .+++|+|+.|.||++++++.+.|+||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            3799999999999999987778999988754

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.81  E-value=0.00044  Score=65.17  Aligned_cols=76  Identities=14%  Similarity=0.222  Sum_probs=53.6

Q ss_pred             cceeccCCceEEEEEEeCCC-cEEEEEEeccc-----C--hhhHHHHHHHHHHHhcCC---CCcceeEeeEEecCCeEEE
Q 037869           46 DNKLGEGGFGSVYWGRTSDG-LQIAVKKLKAM-----N--SKAEMEFAVEVEVLGRVR---HKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~~~-~~vavK~~~~~-----~--~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~l  114 (380)
                      .+.||.|.+..||++.+.+| +.|+||.-...     .  +........|.+.|..+.   ..++.+++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            46899999999999998766 58999985421     1  223446667888888763   2456667666  3456789


Q ss_pred             EEEecCCCC
Q 037869          115 VYDYMPNLS  123 (380)
Q Consensus       115 v~e~~~~g~  123 (380)
                      |||++++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999997644

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.80  E-value=0.00057  Score=62.73  Aligned_cols=145  Identities=18%  Similarity=0.202  Sum_probs=81.3

Q ss_pred             cceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCc--ceeEeeE------EecCCeEEEEEE
Q 037869           46 DNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKN--LLGLRGY------CAGTDQRLIVYD  117 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~------~~~~~~~~lv~e  117 (380)
                      .+.++.|....+|++...++ .+++|+......  ...+..|++++..|....  +.+++..      ....+..+++++
T Consensus        27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e  103 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE  103 (307)
T ss_pred             ccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence            55677888889999876544 688898765322  223445666666663211  3333332      122456789999


Q ss_pred             ecCCCCHHH--------------hhccC---CCCCc-----cCCHHHHH------------HHHHHHHHHHHHHhh----
Q 037869          118 YMPNLSLLS--------------HLHGQ---YAGEV-----QLDWKRRM------------KIAIGSAEGILYLHH----  159 (380)
Q Consensus       118 ~~~~g~L~~--------------~i~~~---~~~~~-----~~~~~~~~------------~i~~ql~~al~~LH~----  159 (380)
                      |++|..+..              .++..   +....     .-.|....            .....+...++++..    
T Consensus       104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~  183 (307)
T TIGR00938       104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR  183 (307)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence            998854321              11110   00000     00111000            001112334444532    


Q ss_pred             cCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       160 ~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      ....+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             cCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            1234899999999999999887778999998753

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.76  E-value=0.00021  Score=65.40  Aligned_cols=75  Identities=19%  Similarity=0.239  Sum_probs=49.2

Q ss_pred             cceeccCCceEEEEEEeCC-------CcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcc-eeEeeEEecCCeEEEEEE
Q 037869           46 DNKLGEGGFGSVYWGRTSD-------GLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL-LGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e  117 (380)
                      ++.|..|-...+|++...+       ++.|++|+..... .......+|..++..+....+ .+++.++.    -.+|+|
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~----~~~v~e   77 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP----NGRIEE   77 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC----CCchhh
Confidence            3567778888999997644       5789999976533 222356678888877753333 34555543    236899


Q ss_pred             ecCCCCHH
Q 037869          118 YMPNLSLL  125 (380)
Q Consensus       118 ~~~~g~L~  125 (380)
                      |++|.++.
T Consensus        78 ~i~G~~l~   85 (302)
T cd05156          78 FIPSRTLT   85 (302)
T ss_pred             eeCCCcCC
Confidence            99887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.68  E-value=0.00049  Score=62.87  Aligned_cols=141  Identities=15%  Similarity=0.192  Sum_probs=92.8

Q ss_pred             CCcceeccCCceEEEEEEeCCCcEEEEEEeccc------------------------ChhhHHH--HHHHHHHHhcCCCC
Q 037869           44 SDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAM------------------------NSKAEME--FAVEVEVLGRVRHK   97 (380)
Q Consensus        44 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~------------------------~~~~~~~--~~~E~~~l~~l~h~   97 (380)
                      .|...|..|--+.||.|...+|..+|||+++..                        ++...-.  ...|+.-|.++...
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            355677788888999999888999999997530                        0111111  22366666666544


Q ss_pred             cceeEeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 037869           98 NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLL  177 (380)
Q Consensus        98 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill  177 (380)
                      .|. +-.-.. -....|||+++....-..    .......++...+..+-.+++.-+.-|-+.+  ++||.||.--|+|+
T Consensus       227 GIP-~PePIl-Lk~hVLVM~FlGrdgw~a----PkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  227 GIP-CPEPIL-LKNHVLVMEFLGRDGWAA----PKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY  298 (520)
T ss_pred             CCC-CCCcee-eecceEeeeeccCCCCcC----cccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE
Confidence            432 111111 134579999995322111    1123456777778888888888888887765  89999999999988


Q ss_pred             CCCCceEEeeccCccc
Q 037869          178 DSDFEPLVADFGFAKL  193 (380)
Q Consensus       178 ~~~~~vkl~Dfgl~~~  193 (380)
                       .+|.++++|.+-+-.
T Consensus       299 -hdG~lyiIDVSQSVE  313 (520)
T KOG2270|consen  299 -HDGKLYIIDVSQSVE  313 (520)
T ss_pred             -ECCEEEEEEcccccc
Confidence             456999999877654

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.67  E-value=2.9e-06  Score=88.87  Aligned_cols=207  Identities=11%  Similarity=-0.050  Sum_probs=136.7

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhH-----HHHHHHHHHHhcCCCCcceeEeeEEe--cCC
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAE-----MEFAVEVEVLGRVRHKNLLGLRGYCA--GTD  110 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~--~~~  110 (380)
                      .+-..|++.=-+|-|.++.--.-+.+ -.-+.+|+.+...-+..     +....|...++...|+++.....-..  ++.
T Consensus      1226 s~~e~~EV~l~i~~~~~~R~k~Lr~k-id~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ 1304 (2724)
T KOG1826|consen 1226 SAMEHSEVNLGISNHFHFRNKWLRSK-IDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSEST 1304 (2724)
T ss_pred             HHhhhhheeeecccceeeccchHhhh-hceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCCh
Confidence            33445555444444444332111111 11245666654322222     22334555666678988877655432  234


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV--TPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~--~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                      ..|..++|+.+|.+++.|-........++...+.....+.+.+..-+|+..  +.-.+|++||+-|.+|..+..++++++
T Consensus      1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred             HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence            568999999999999999776444445555544444444466666766653  223789999999999999999999999


Q ss_pred             cCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCC
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE  246 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~  246 (380)
                      |+.+.... .........+++.|++|++...-.++.++|+|+.|+-+|....|..+|-
T Consensus      1385 gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1385 GLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred             ccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence            99984332 2333445567889999998887788889999999999999999888874

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.46  E-value=0.0018  Score=58.33  Aligned_cols=30  Identities=27%  Similarity=0.489  Sum_probs=25.5

Q ss_pred             CeEecCCCCCCeeeCCCCc-eEEeeccCccc
Q 037869          164 HIIHRDIKASNVLLDSDFE-PLVADFGFAKL  193 (380)
Q Consensus       164 ~ivHrdlkp~Nill~~~~~-vkl~Dfgl~~~  193 (380)
                      .++|+|+.|.||+++.+++ .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            5899999999999997565 46999998865

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.46  E-value=0.0021  Score=58.54  Aligned_cols=141  Identities=16%  Similarity=0.203  Sum_probs=86.5

Q ss_pred             CCCcceeccCCceEEEEEEeCCCcEEEEEEecc--cChhhHHHHHHHHHHHhcCCC--CcceeEeeEEecCC--eEEEEE
Q 037869           43 FSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKA--MNSKAEMEFAVEVEVLGRVRH--KNLLGLRGYCAGTD--QRLIVY  116 (380)
Q Consensus        43 y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~--~~~lv~  116 (380)
                      ..+.+.+-.|....+|..... ++++++. ...  ..........+|+.+++.+.-  --+...++.|.++.  ..|.||
T Consensus        27 ~~~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~  104 (321)
T COG3173          27 LLIVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM  104 (321)
T ss_pred             CceeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence            344555555555556666554 7777777 331  222333456668888887742  33455667776665  679999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHH-HHHHHHHHHhhc-----------------------------------
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAI-GSAEGILYLHHE-----------------------------------  160 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~-ql~~al~~LH~~-----------------------------------  160 (380)
                      +|++|..+.+.....     ...    .+++. .++..|+-||+.                                   
T Consensus       105 ~~veGe~~~~~~~~~-----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~  175 (321)
T COG3173         105 EWVEGEVVWSALPPE-----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGG  175 (321)
T ss_pred             EEecceeccCcCCcc-----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccC
Confidence            999885333222111     000    12222 445555555542                                   


Q ss_pred             ---------------C-----CCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          161 ---------------V-----TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       161 ---------------~-----~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                                     .     ...++|||+.+.|++++.++-+-|.||+++..-
T Consensus       176 ~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         176 RIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             CCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence                           1     236999999999999999888999999998753

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.34  E-value=0.0026  Score=57.49  Aligned_cols=76  Identities=14%  Similarity=0.146  Sum_probs=48.2

Q ss_pred             CCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCC---CCcceeEeeEEecCCeEEEEEEec
Q 037869           43 FSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR---HKNLLGLRGYCAGTDQRLIVYDYM  119 (380)
Q Consensus        43 y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~  119 (380)
                      .+-.+.++.|....+|... .++..+.||+-...   ....+..|..-|+.|.   --.+.+++++....+..++||||+
T Consensus        19 i~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l   94 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD-TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL   94 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE-TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred             eeeeEecCCCChhheEEEE-CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence            4456689999999999987 46778999987632   2236777888888773   345778888887777789999999


Q ss_pred             CCC
Q 037869          120 PNL  122 (380)
Q Consensus       120 ~~g  122 (380)
                      +.+
T Consensus        95 ~~~   97 (288)
T PF03881_consen   95 EMG   97 (288)
T ss_dssp             ---
T ss_pred             cCC
Confidence            766

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02236 choline kinase

Probab=97.13  E-value=0.0053  Score=57.26  Aligned_cols=143  Identities=15%  Similarity=0.141  Sum_probs=81.1

Q ss_pred             cceeccCCceEEEEEEeC-----CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcc-eeEeeEEecCCeEEEEEEec
Q 037869           46 DNKLGEGGFGSVYWGRTS-----DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL-LGLRGYCAGTDQRLIVYDYM  119 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~  119 (380)
                      ...|-.|-...+|++...     .++.|++++...... ......+|..+++.+..-++ .++++.+...    .|.+|+
T Consensus        41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi  115 (344)
T PLN02236         41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI  115 (344)
T ss_pred             EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence            456666888899998642     236789898765432 22234668888888754444 3455655322    578998


Q ss_pred             CCCCHHHh-----------------hccCCCC-Cc-cCCHHHHHHHHHHH-----------------HHHHHHHh----h
Q 037869          120 PNLSLLSH-----------------LHGQYAG-EV-QLDWKRRMKIAIGS-----------------AEGILYLH----H  159 (380)
Q Consensus       120 ~~g~L~~~-----------------i~~~~~~-~~-~~~~~~~~~i~~ql-----------------~~al~~LH----~  159 (380)
                      ++.++...                 +++.... .. ...+..+..+..++                 ...+..|.    .
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            77665421                 1111100 11 11122222322111                 11122221    1


Q ss_pred             -cCCCCeEecCCCCCCeeeCC-CCceEEeeccCccc
Q 037869          160 -EVTPHIIHRDIKASNVLLDS-DFEPLVADFGFAKL  193 (380)
Q Consensus       160 -~~~~~ivHrdlkp~Nill~~-~~~vkl~Dfgl~~~  193 (380)
                       .....++|+|+++.||+++. ++.+.++||..+..
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence             11226899999999999986 46899999987753

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.13  E-value=0.0071  Score=55.56  Aligned_cols=32  Identities=19%  Similarity=0.280  Sum_probs=28.4

Q ss_pred             CCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       162 ~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      ..+++|+|+.+.|+++++++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            34799999999999999999999999987764

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.12  E-value=0.0051  Score=56.46  Aligned_cols=30  Identities=30%  Similarity=0.488  Sum_probs=25.9

Q ss_pred             CCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       163 ~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      .+++|||+.+.||+++. +.+.|+||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            47999999999999988 6789999987653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.82  E-value=0.04  Score=52.07  Aligned_cols=74  Identities=15%  Similarity=0.177  Sum_probs=50.1

Q ss_pred             CcceeccCCceEEEEEEeCCCcEEEEEEecc----cCh---hhHHHHHHHHHHHhcCC---CCcceeEeeEEecCCeEEE
Q 037869           45 DDNKLGEGGFGSVYWGRTSDGLQIAVKKLKA----MNS---KAEMEFAVEVEVLGRVR---HKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        45 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~----~~~---~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~l  114 (380)
                      ..+.||.|....||+..+. +..|+||+-..    .+.   ....+-..|...|+.+.   ..++.+++.++.  +..++
T Consensus        36 ~~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vl  112 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALI  112 (418)
T ss_pred             eEEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEE
Confidence            3678999999999999874 45699998541    111   12333444566666553   246777888776  55688


Q ss_pred             EEEecCC
Q 037869          115 VYDYMPN  121 (380)
Q Consensus       115 v~e~~~~  121 (380)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            9999976

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.79  E-value=0.02  Score=53.07  Aligned_cols=73  Identities=15%  Similarity=0.152  Sum_probs=48.0

Q ss_pred             eeccCCceEEEEEEeCCC-cEEEEEEecc-------cChhhHHHHHHHHHHHhcCC--CC-cceeEeeEEecCCeEEEEE
Q 037869           48 KLGEGGFGSVYWGRTSDG-LQIAVKKLKA-------MNSKAEMEFAVEVEVLGRVR--HK-NLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        48 ~Lg~G~~g~Vy~~~~~~~-~~vavK~~~~-------~~~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~lv~  116 (380)
                      .||.|....||++.+.++ ..|+||.-..       .-+....+...|...|+...  .| .+.+++.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            579999999999987644 6899997431       11333445556777777653  34 44445443  345667999


Q ss_pred             EecCCC
Q 037869          117 DYMPNL  122 (380)
Q Consensus       117 e~~~~g  122 (380)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            998543

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.68  E-value=0.083  Score=48.89  Aligned_cols=93  Identities=11%  Similarity=0.028  Sum_probs=52.4

Q ss_pred             eccHHHHHHhhCCCCCc---c-eeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCC--cceeEe
Q 037869           30 IFTYKELHTATNGFSDD---N-KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHK--NLLGLR  103 (380)
Q Consensus        30 ~~~~~~~~~~~~~y~~~---~-~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~  103 (380)
                      ..+-+.+..+-..+-+.   + ..-.+.-..||.....++..+++|+.+... .....+..|+..+..|...  .++...
T Consensus        10 ~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~p~   88 (325)
T PRK11768         10 TLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVAPL   88 (325)
T ss_pred             CCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCCCc
Confidence            34444455444444321   1 222445667899988778889999886432 2344666677777666321  122211


Q ss_pred             ---e--EEecCCeEEEEEEecCCCC
Q 037869          104 ---G--YCAGTDQRLIVYDYMPNLS  123 (380)
Q Consensus       104 ---~--~~~~~~~~~lv~e~~~~g~  123 (380)
                         |  ....++..+.++++++|..
T Consensus        89 ~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         89 AFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cCCCCEEEEECCEEEEEEeeeCCCC
Confidence               1  1222456788999998764

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.68  E-value=0.016  Score=53.69  Aligned_cols=143  Identities=12%  Similarity=0.193  Sum_probs=79.0

Q ss_pred             cceeccCCceEEEEEEeCC----CcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcc-eeEeeEEecCCeEEEEEEecC
Q 037869           46 DNKLGEGGFGSVYWGRTSD----GLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL-LGLRGYCAGTDQRLIVYDYMP  120 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~  120 (380)
                      .+.|..|-...+|++...+    +..|++++...... ..-...+|..+++.+..-++ .++++++. ..   +|.+|++
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~fi~   93 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSFIN   93 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehhhc
Confidence            4566668888899886432    24788888765332 22244568888888865444 34555553 22   5889987


Q ss_pred             CCCHHH-----------------hhccCCCC-Cc-cCCHHHHHHHHHHH----------------------HHHHHH---
Q 037869          121 NLSLLS-----------------HLHGQYAG-EV-QLDWKRRMKIAIGS----------------------AEGILY---  156 (380)
Q Consensus       121 ~g~L~~-----------------~i~~~~~~-~~-~~~~~~~~~i~~ql----------------------~~al~~---  156 (380)
                      |-++..                 .++..... .. .-.+..+..+..++                      ..-+..   
T Consensus        94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  173 (330)
T PLN02421         94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE  173 (330)
T ss_pred             CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence            765521                 01111100 01 11122222222111                      111222   


Q ss_pred             Hh-hc-CCCCeEecCCCCCCeeeCC-CCceEEeeccCccc
Q 037869          157 LH-HE-VTPHIIHRDIKASNVLLDS-DFEPLVADFGFAKL  193 (380)
Q Consensus       157 LH-~~-~~~~ivHrdlkp~Nill~~-~~~vkl~Dfgl~~~  193 (380)
                      +. .. ...-++|+|+.+.||++++ ++.++++||..+..
T Consensus       174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            11 11 0113789999999999975 57899999988754

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.62  E-value=0.011  Score=54.28  Aligned_cols=73  Identities=14%  Similarity=0.172  Sum_probs=57.7

Q ss_pred             CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          109 TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       109 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                      ..+.|++|++. |+++. .+       ....++++..++++.+..+.-+....  ..-||++...||+|+ +|+|-|+||
T Consensus       298 ~~y~yl~~kdh-gt~is-~i-------k~~~~~e~lsff~s~~sil~~lekkf--~fehrnlt~~niLId-~GnvtLIDf  365 (488)
T COG5072         298 TLYLYLHFKDH-GTPIS-II-------KADRSEEELSFFWSCISILDILEKKF--PFEHRNLTLDNILID-EGNVTLIDF  365 (488)
T ss_pred             ceEEEEEEecC-Cceee-ee-------ecccHHHHHHHHHHHHHHHhhhhhcC--Ccccccccccceeee-cCceEEEEe
Confidence            44567888876 43443 22       23456788899999999888888764  689999999999999 999999999


Q ss_pred             cCccc
Q 037869          189 GFAKL  193 (380)
Q Consensus       189 gl~~~  193 (380)
                      -+++.
T Consensus       366 klsRl  370 (488)
T COG5072         366 KLSRL  370 (488)
T ss_pred             eeeec
Confidence            99984

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.62  E-value=0.0015  Score=62.27  Aligned_cols=166  Identities=19%  Similarity=0.229  Sum_probs=91.3

Q ss_pred             HHHHHHHHHhcCCCCcceeEeeEEec-CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcC
Q 037869           83 EFAVEVEVLGRVRHKNLLGLRGYCAG-TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV  161 (380)
Q Consensus        83 ~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~  161 (380)
                      ++.-.+++++.+.|+|...++++... .....+|||++ +.+|++....+.     +...       +   ++  -|   
T Consensus        28 ~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-----l~~~-------s---~~--~~---   86 (725)
T KOG1093|consen   28 QILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-----LKDE-------S---LL--AH---   86 (725)
T ss_pred             HHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-----cchh-------h---hc--cc---
Confidence            66678889999999999999988754 34578999999 559999886542     1100       0   00  11   


Q ss_pred             CCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhC
Q 037869          162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTG  241 (380)
Q Consensus       162 ~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g  241 (380)
                        ++.|-     |       .++.+| -+....                   |-     ...+|+||||+|.++.++..|
T Consensus        87 --~~~~~-----~-------~~~~td-~~~t~~-------------------~~-----~~~pKsdVwsl~~i~~el~L~  127 (725)
T KOG1093|consen   87 --GVLHL-----N-------IIYITD-HFLTKY-------------------PS-----PIGPKSDVWSLGFIILELYLG  127 (725)
T ss_pred             --cccee-----h-------hhhccc-cccccC-------------------CC-----CCCcchhhhhHHHHHHHHHHh
Confidence              33332     2       233333 010000                   10     011499999999999999988


Q ss_pred             CCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 037869          242 RKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT  313 (380)
Q Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~  313 (380)
                      ..-+..........  .+..-...+.....+..   .....-.+...+.++...|+-..|..||...++.++
T Consensus       128 ~~l~~~~~~s~~l~--~i~k~~~~d~~~~~~a~---e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~  194 (725)
T KOG1093|consen  128 ISLEAELTESEYLE--ILLKYYTDDQELLSTAM---EHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKR  194 (725)
T ss_pred             hHHHHHHHHHHHHH--HHHHhccCchhHHHHHH---HHHHHHhhhHhHHHHhccCCccccccccchhHHhcC
Confidence            76664432211000  00000000000000000   001112334567788999999999999977666553

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.56  E-value=0.014  Score=49.78  Aligned_cols=102  Identities=14%  Similarity=0.197  Sum_probs=65.4

Q ss_pred             EEEEEecccChh-hHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHH
Q 037869           68 IAVKKLKAMNSK-AEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKI  146 (380)
Q Consensus        68 vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i  146 (380)
                      ..+|+++...-. ....+.++..++.++.  .|+++..-  ..-.+-+|.|+|.....             ..    ..+
T Consensus        88 L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i-------------~~----~N~  146 (308)
T PF07387_consen   88 LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI-------------NF----SNF  146 (308)
T ss_pred             hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc-------------ch----hHH
Confidence            455666543222 3345677888888764  36666521  22345689999853110             00    011


Q ss_pred             HHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCc
Q 037869          147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA  191 (380)
Q Consensus       147 ~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~  191 (380)
                      +.-=+.+|.-.|+. +.+.+|||..|+||+-+..|.+||.|-+..
T Consensus       147 i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  147 ITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             HHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhh
Confidence            11124678888965 558999999999999999999999997643

The function of this family is unknown.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.41  E-value=0.045  Score=50.45  Aligned_cols=142  Identities=23%  Similarity=0.292  Sum_probs=80.8

Q ss_pred             eeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCC---Cc---ceeEeeE--EecCC--eEEEEEE
Q 037869           48 KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRH---KN---LLGLRGY--CAGTD--QRLIVYD  117 (380)
Q Consensus        48 ~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~n---iv~~~~~--~~~~~--~~~lv~e  117 (380)
                      .|.+ .-..||...+.++.. ++|+....  ....++..|+..|..|.-   +=   +...=|-  ..-..  ..+-|++
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            3444 556788888766655 88888775  334466667777777631   11   1111111  11133  7889999


Q ss_pred             ecCCCCHHH-hh--------------c---cCC-----CCCccCCHHH-------------HHHHHHHHHHHHHHHhhc-
Q 037869          118 YMPNLSLLS-HL--------------H---GQY-----AGEVQLDWKR-------------RMKIAIGSAEGILYLHHE-  160 (380)
Q Consensus       118 ~~~~g~L~~-~i--------------~---~~~-----~~~~~~~~~~-------------~~~i~~ql~~al~~LH~~-  160 (380)
                      |++|..+.. .-              +   +.+     .......|..             -.....++...+..+.+. 
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999887772 11              0   000     1111122220             011233334444444432 


Q ss_pred             ---CCCC---eEecCCCCCCeeeCCCCc-eEEeeccCccc
Q 037869          161 ---VTPH---IIHRDIKASNVLLDSDFE-PLVADFGFAKL  193 (380)
Q Consensus       161 ---~~~~---ivHrdlkp~Nill~~~~~-vkl~Dfgl~~~  193 (380)
                         ...+   +||+|+.|.||+++.+.. +-+.||+-+..
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence               1223   999999999999999875 88999987753

>PRK06148 hypothetical protein; Provisional

Probab=96.39  E-value=0.09  Score=56.19  Aligned_cols=151  Identities=19%  Similarity=0.230  Sum_probs=82.9

Q ss_pred             hhCCCCCc---ceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcC-------CCCcceeEee----
Q 037869           39 ATNGFSDD---NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-------RHKNLLGLRG----  104 (380)
Q Consensus        39 ~~~~y~~~---~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-------~h~niv~~~~----  104 (380)
                      ....|-+.   +.|+ |..-.+|++...++..+++|+.+.....  .....|.+.|..|       ..|.+++..+    
T Consensus        20 ~~~~ygl~~~~~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~   96 (1013)
T PRK06148         20 LAQHFGISATATPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASL   96 (1013)
T ss_pred             HHHHcCCceEEeecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeE
Confidence            33445442   4564 4567889998877889999999864322  2333444555433       3344444321    


Q ss_pred             -EEec-CC--eEEEEEEecCCCCHHHhhc-----------------c---CCCC---CccCCHH----------------
Q 037869          105 -YCAG-TD--QRLIVYDYMPNLSLLSHLH-----------------G---QYAG---EVQLDWK----------------  141 (380)
Q Consensus       105 -~~~~-~~--~~~lv~e~~~~g~L~~~i~-----------------~---~~~~---~~~~~~~----------------  141 (380)
                       .... ++  ..+.+++|++|..+.+...                 .   .+..   ...+.|.                
T Consensus        97 ~~v~~~~G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d  176 (1013)
T PRK06148         97 ASAQDPDGEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDD  176 (1013)
T ss_pred             EEeecCCCceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCC
Confidence             1111 22  4678899999977754110                 0   0000   0111111                


Q ss_pred             -HHHHHHHHHHHHHH-----HHhhcCCCCeEecCCCCCCeeeCCCC--ceE-EeeccCccc
Q 037869          142 -RRMKIAIGSAEGIL-----YLHHEVTPHIIHRDIKASNVLLDSDF--EPL-VADFGFAKL  193 (380)
Q Consensus       142 -~~~~i~~ql~~al~-----~LH~~~~~~ivHrdlkp~Nill~~~~--~vk-l~Dfgl~~~  193 (380)
                       ....++..++..+.     .+.+. ..++||+|+.+.||+++.++  ++. |+|||-+..
T Consensus       177 ~~~r~~l~~~~~~~~~~v~p~l~~L-p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        177 PEDRALVERFLARFERNVAPRLAAL-PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHhcC-CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence             11122222322221     22222 34799999999999999875  565 999998865

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.20  E-value=0.016  Score=49.88  Aligned_cols=30  Identities=30%  Similarity=0.520  Sum_probs=21.2

Q ss_pred             CeEecCCCCCCeee-CCCCceEEeeccCccc
Q 037869          164 HIIHRDIKASNVLL-DSDFEPLVADFGFAKL  193 (380)
Q Consensus       164 ~ivHrdlkp~Nill-~~~~~vkl~Dfgl~~~  193 (380)
                      .++|+|+.|.||++ +.++.++++||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            58899999999999 8889999999988753

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.18  E-value=0.028  Score=52.78  Aligned_cols=74  Identities=12%  Similarity=0.159  Sum_probs=49.9

Q ss_pred             cceeccCCceEEEEEEeCC-CcEEEEEEecc------cChhhHHHHHHHHHHHhcCC--CC-cceeEeeEEecCCeEEEE
Q 037869           46 DNKLGEGGFGSVYWGRTSD-GLQIAVKKLKA------MNSKAEMEFAVEVEVLGRVR--HK-NLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~------~~~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~lv  115 (380)
                      .+.||.|....||++.+.+ +..|+||.-..      .-+-...+...|...|+...  .| ++.+++.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            5689999999999998742 56799997431      11334456666778887663  34 45555443  34567899


Q ss_pred             EEecCC
Q 037869          116 YDYMPN  121 (380)
Q Consensus       116 ~e~~~~  121 (380)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998854

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.73  E-value=0.24  Score=42.77  Aligned_cols=77  Identities=17%  Similarity=0.199  Sum_probs=53.9

Q ss_pred             CcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCC---CCcceeEeeEEecCCeEEEEEEecCC
Q 037869           45 DDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR---HKNLLGLRGYCAGTDQRLIVYDYMPN  121 (380)
Q Consensus        45 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~~  121 (380)
                      ..+.+.-|---..|...+. ..+|.||+=..   .....|..|+.-|+.|.   --.+.+++.+..+..+.|+|+||++.
T Consensus        20 er~~v~gG~inea~~v~dg-~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~   95 (286)
T COG3001          20 EREEVSGGDINEAWRLRDG-TDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPT   95 (286)
T ss_pred             cccccCCccccceeEeecC-CcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccC
Confidence            3455666666666776663 56788886432   23446777877776663   35678888888888999999999987


Q ss_pred             CCHH
Q 037869          122 LSLL  125 (380)
Q Consensus       122 g~L~  125 (380)
                      +.+.
T Consensus        96 ~~~d   99 (286)
T COG3001          96 GPLD   99 (286)
T ss_pred             CCCC
Confidence            6654

>PTZ00384 choline kinase; Provisional

Probab=95.39  E-value=0.19  Score=47.57  Aligned_cols=76  Identities=13%  Similarity=0.228  Sum_probs=45.5

Q ss_pred             CcceeccCCceEEEEEEeCCC--cE-----EEEEEecccChhhHHHHHHHHHHHhcCCCCcc-eeEeeEEecCCeEEEEE
Q 037869           45 DDNKLGEGGFGSVYWGRTSDG--LQ-----IAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL-LGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        45 ~~~~Lg~G~~g~Vy~~~~~~~--~~-----vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~  116 (380)
                      ..+.|..|-...+|++...++  ..     |.+... .......-...+|+.+++.+...++ .++++.+.    .++|.
T Consensus        54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~-g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g~l~  128 (383)
T PTZ00384         54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS-STYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DFTIQ  128 (383)
T ss_pred             EEEEeCCcccceEEEEEecCCCCCccccceEEEEec-cCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CEEEE
Confidence            455777788999999964322  23     333332 1111112234568888888865555 44555553    36999


Q ss_pred             EecCCCCHH
Q 037869          117 DYMPNLSLL  125 (380)
Q Consensus       117 e~~~~g~L~  125 (380)
                      ||++|-+|.
T Consensus       129 efIeGr~l~  137 (383)
T PTZ00384        129 EWVEGNTMG  137 (383)
T ss_pred             EEeccccCC
Confidence            999887664

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=95.00  E-value=0.15  Score=45.13  Aligned_cols=81  Identities=17%  Similarity=0.119  Sum_probs=55.8

Q ss_pred             CCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEec-CCC
Q 037869           44 SDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYM-PNL  122 (380)
Q Consensus        44 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~-~~g  122 (380)
                      +....+..|..+.|+.++..+|.+.++|+......... +. .....|+..+-...|++++.-  .....+++|.+ ++-
T Consensus         5 ~~~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~~-E~-~g~~~L~~w~G~GaVrll~~d--~~~~AlLLErl~~g~   80 (253)
T PF04655_consen    5 TPDGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAEH-EA-RGEAALRWWNGRGAVRLLAAD--PERGALLLERLDPGR   80 (253)
T ss_pred             ccCCCCCCCcceEEEEEEcCCCCeEEEEecCCcccchh-hh-hHHhHhheeCCCCceeeeccc--cccchhhhhhccCCC
Confidence            34456778999999999998999999999875432111 11 112447777777888988864  34667888988 444


Q ss_pred             CHHHhh
Q 037869          123 SLLSHL  128 (380)
Q Consensus       123 ~L~~~i  128 (380)
                      +|.+..
T Consensus        81 ~L~~~~   86 (253)
T PF04655_consen   81 SLASLP   86 (253)
T ss_pred             chhhcc
Confidence            665444

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	380
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-69
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		9e-69
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		5e-49
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-48
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		7e-43
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-42
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-42
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		6e-40
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		4e-25
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-25
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-24
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		7e-24
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-23
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		2e-23
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-23
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-23
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-23
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		4e-23
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-23
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-23
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		4e-23
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-23
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-23
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-23
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		5e-23
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-23
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-23
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-23
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-22
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-22
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-22
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		5e-22
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-21
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-21
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-21
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-21
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-20
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-20
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-20
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-20
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-20
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-20
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-20
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-20
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-20
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-20
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-20
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-20
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-20
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-20
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-20
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-20
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-20
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-20
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-20
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-20
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-20
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-20
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		8e-20
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-19
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-19
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-19
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-19
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-19
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-19
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-19
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-19
3a4o_X	286	Lyn Kinase Domain Length = 286		2e-19
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-19
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-19
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-19
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-19
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-19
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-19
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-19
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-19
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-19
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-19
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-19
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-19
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-19
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-19
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-19
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-19
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-19
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-19
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-19
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-19
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-19
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		5e-19
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-19
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-19
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		5e-19
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-19
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-19
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-19
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-19
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-19
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		6e-19
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		6e-19
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-19
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		7e-19
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-19
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-19
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		9e-19
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		9e-19
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-19
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		9e-19
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-18
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-18
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-18
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-18
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-18
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-18
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-18
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-18
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-18
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		2e-18
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-18
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-18
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		3e-18
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-18
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-18
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-18
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		4e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-18
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-18
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-18
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-18
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-18
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-18
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		5e-18
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-18
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-18
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-18
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		5e-18
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-18
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-18
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-18
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-18
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-18
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-18
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-17
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-17
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-17
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		3e-17
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-17
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-17
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		4e-17
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		4e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		4e-17
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		4e-17
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		4e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		4e-17
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		5e-17
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		5e-17
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		5e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		8e-17
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		9e-17
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-16
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		1e-16
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-16
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-16
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		2e-16
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		2e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-16
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-16
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-16
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-16
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-16
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-16
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-16
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-16
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		5e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		6e-16
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-15
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-15
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-15
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-15
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-15
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-15
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-15
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		6e-15
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-15
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		6e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-15
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-15
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-15
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		7e-15
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		7e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		7e-15
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		7e-15
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		7e-15
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		7e-15
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		8e-15
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		8e-15
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-15
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		8e-15
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		8e-15
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		8e-15
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		8e-15
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		8e-15
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		9e-15
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		9e-15
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		9e-15
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-14
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-14
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-14
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-14
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-14
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-14
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-14
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-14
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-14
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-14
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-14
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-14
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-14
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-14
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-14
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-14
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-14
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-14
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		4e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		4e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-14
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-14
1oec_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-14
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-14
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		5e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		5e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		5e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		5e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		5e-14
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		6e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		6e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-14
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		6e-14
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		6e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		6e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		7e-14
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		7e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		7e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		8e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		8e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		8e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		9e-14
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		9e-14
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-13
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		1e-13
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		2e-13
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-13
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-13
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-13
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-13
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-13
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-13
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-13
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-13
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-13
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-13
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		3e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-13
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		3e-13
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-13
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-13
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-13
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		3e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		4e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-13
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-13
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		5e-13
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		5e-13
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		5e-13
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-13
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-13
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		7e-13
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		7e-13
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		8e-13
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		8e-13
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		8e-13
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		8e-13
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		8e-13
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-13
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-13
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		9e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		9e-13
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-12
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-12
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-12
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-12
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-12
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-12
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		3e-12
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-12
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		4e-12
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-12
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-12
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-12
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		4e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		4e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		5e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		5e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		5e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		6e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		6e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		7e-12
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-12
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-12
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		7e-12
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-12
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		8e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		8e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		8e-12
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		9e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		9e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		9e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		9e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		9e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		9e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		9e-12
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		9e-12
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		9e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		9e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		9e-12
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-11
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-11
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-11
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		1e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-11
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-11
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		1e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		1e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-11
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		2e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		2e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		2e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		2e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		2e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		2e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		2e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-11
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		2e-11
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-11
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-11
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		3e-11
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-11
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-11
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-11
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-11
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-11
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		4e-11
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-11
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-11
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		5e-11
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		5e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		5e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-11
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		6e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		6e-11
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		7e-11
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		7e-11
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		7e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		7e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-11
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		7e-11
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		8e-11
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-11
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		8e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		8e-11
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		8e-11
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		9e-11
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		9e-11
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		9e-11
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		9e-11
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-10
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-10
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-10
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-10
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-10
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-10
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-10
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-10
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-10
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-10
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-10
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-10
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-10
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-10
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-10
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-10
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-10
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-10
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		1e-10
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		1e-10
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-10
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-10
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-10
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-10
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-10
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-10
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-10
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-10
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-10
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-10
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-10
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-10
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		2e-10
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-10
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-10
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-10
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-10
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-10
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-10
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-10
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-10
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-10
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-10
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-10
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-10
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		3e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-10
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-10
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-10
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-10
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-10
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		5e-10
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		5e-10
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		5e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		5e-10
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		5e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		5e-10
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		5e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		6e-10
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		6e-10
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		6e-10
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-10
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		6e-10
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		6e-10
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-10
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		6e-10
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		6e-10
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		6e-10
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-10
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		7e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-10
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-10
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-10
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		7e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		7e-10
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		7e-10
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		8e-10
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-10
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		8e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		8e-10
4exu_A	371	Mapk13, Inactive Form Length = 371		8e-10
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		9e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		9e-10
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-10
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		9e-10
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		9e-10
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		9e-10
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-09
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-09
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-09
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-09
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-09
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-09
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-09
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-09
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-09
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		2e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		2e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-09
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-09
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-09
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-09
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-09
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-09
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-09
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-09
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-09
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-09
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-09
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-09
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-09
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-09
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-09
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-09
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		2e-09
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		3e-09
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-09
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-09
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-09
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		3e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		3e-09
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		3e-09
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-09
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-09
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		3e-09
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-09
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-09
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-09
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		4e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-09
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		4e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-09
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-09
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		4e-09
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		4e-09
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-09
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-09
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-09
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-09
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		4e-09
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		4e-09
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		4e-09
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		4e-09
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		4e-09
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		4e-09
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-09
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-09
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-09
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-09
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-09
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-09
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-09
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-09
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-09
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-09
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-09
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-09
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-09
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-09
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		5e-09
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		5e-09
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-09
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-09
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-09
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-09
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-09
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-09
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-09
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-09
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		6e-09
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		6e-09
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-09
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		7e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		7e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		7e-09
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		7e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-09
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-09
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		7e-09
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		8e-09
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		8e-09
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-09
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-09
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-09
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-08
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		1e-08
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-08
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-08
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-08
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-08
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-08
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-08
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-08
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-08
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-08
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-08
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-08
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-08
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-08
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-08
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-08
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-08
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-08
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-08
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-08
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-08
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-08
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-08
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-08
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-08
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-08
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-08
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-08
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-08
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-08
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-08
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-08
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-08
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-08
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-08
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-08
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-08
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-08
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-08
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-08
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		3e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		3e-08
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		3e-08
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-08
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		4e-08
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		4e-08
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-08
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		4e-08
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		4e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-08
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-08
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-08
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-08
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		5e-08
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		5e-08
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		5e-08
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		5e-08
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-08
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		6e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-08
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		6e-08
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		6e-08
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-08
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		6e-08
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		6e-08
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		6e-08
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		6e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		6e-08
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		7e-08
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		7e-08
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		7e-08
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		7e-08
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		7e-08
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		8e-08
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		8e-08
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-08
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		8e-08
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		8e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		8e-08
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		8e-08
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		8e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		8e-08
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		8e-08
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		9e-08
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		9e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		9e-08
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		9e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		9e-08
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		9e-08
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		9e-08
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		9e-08
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		1e-07
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		1e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		1e-07
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-07
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-07
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-07
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		1e-07
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-07
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-07
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		1e-07
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-07
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-07
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-07
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		1e-07
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-07
2oza_A	356	Structure Of P38alpha Complex Length = 356		1e-07
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		1e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		1e-07
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-07
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-07
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-07
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-07
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		1e-07
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-07
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-07
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		1e-07
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		1e-07
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		1e-07
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		1e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-07
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-07
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-07
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-07
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-07
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-07
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		2e-07
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-07
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-07
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-07
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-07
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		2e-07
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		2e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-07
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-07
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-07
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-07
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		3e-07
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-07
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-07
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-07
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		4e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-07
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		5e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-07
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		5e-07
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		5e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		6e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		6e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-07
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		6e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-07
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-07
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		7e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		7e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-07
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		9e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		9e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		1e-06
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		1e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-06
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-06
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-06
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-06
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-06
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-06
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-06
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		3e-06
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-06
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		3e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-06
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-06
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		5e-06
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-06
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		6e-06
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-06
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		6e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		6e-06
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		7e-06
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		8e-06
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		8e-06
3soa_A	444	Full-Length Human Camkii Length = 444		9e-06
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		9e-06
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-05
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-05

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  259 bits (663), Expect = 1e-69,   Method: Compositional matrix adjust.
 Identities = 128/289 (44%), Positives = 188/289 (65%), Gaps = 3/289 (1%)
Query: 31  FTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKA-EMEFAVEVE 89
           F+ +EL  A++ FS+ N LG GGFG VY GR +DG  +AVK+LK    +  E++F  EVE
Sbjct: 28  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVE 87
Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIG 149
           ++    H+NLL LRG+C    +RL+VY YM N S+ S L  +   +  LDW +R +IA+G
Sbjct: 88  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 147
Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
           SA G+ YLH    P IIHRD+KA+N+LLD +FE +V DFG AKL+     H+   V+GT+
Sbjct: 148 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTI 207
Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE--KLPGGVKRTITEWAEPLIVKG 267
           G++APEY   GK SE  DV+ +G++LLE++TG++  +  +L       + +W + L+ + 
Sbjct: 208 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 267
Query: 268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
           K + LVD  L+G++ + +++Q I VA+LC QS P +RP M EVV  L G
Sbjct: 268 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  257 bits (656), Expect = 9e-69,   Method: Compositional matrix adjust.
 Identities = 126/289 (43%), Positives = 187/289 (64%), Gaps = 3/289 (1%)
Query: 31  FTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKA-EMEFAVEVE 89
           F+ +EL  A++ F + N LG GGFG VY GR +DG  +AVK+LK   ++  E++F  EVE
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVE 79
Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIG 149
           ++    H+NLL LRG+C    +RL+VY YM N S+ S L  +   +  LDW +R +IA+G
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
           SA G+ YLH    P IIHRD+KA+N+LLD +FE +V DFG AKL+     H+   V+G +
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXI 199
Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE--KLPGGVKRTITEWAEPLIVKG 267
           G++APEY   GK SE  DV+ +G++LLE++TG++  +  +L       + +W + L+ + 
Sbjct: 200 GHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEK 259
Query: 268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
           K + LVD  L+G++ + +++Q I VA+LC QS P +RP M EVV  L G
Sbjct: 260 KLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  191 bits (486), Expect = 5e-49,   Method: Compositional matrix adjust.
 Identities = 114/313 (36%), Positives = 180/313 (57%), Gaps = 8/313 (2%)
Query: 1   MGSAFSCCGSEKVEEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWG 60
           MGS +S   +  + + L++       ++R+    +L  ATN F     +G G FG VY G
Sbjct: 1   MGSKYSK-ATNSINDALSSSYLVPFESYRV-PLVDLEEATNNFDHKFLIGHGVFGKVYKG 58
Query: 61  RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMP 120
              DG ++A+K+    +S+   EF  E+E L   RH +L+ L G+C   ++ +++Y YM 
Sbjct: 59  VLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118
Query: 121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD 180
           N +L  HL+G     + + W++R++I IG+A G+ YLH   T  IIHRD+K+ N+LLD +
Sbjct: 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDEN 175
Query: 181 FEPLVADFGFAKLIPE-GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
           F P + DFG +K   E G +H+   VKGTLGY+ PEY + G+++E  DVYSFG++L E+L
Sbjct: 176 FVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235
Query: 240 TGRKPI-EKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQ 298
             R  I + LP  +   + EWA      G+ +++VDP L        L++  + AV C+ 
Sbjct: 236 CARSAIVQSLPREMV-NLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLA 294
Query: 299 SEPEKRPNMKEVV 311
              E RP+M +V+
Sbjct: 295 LSSEDRPSMGDVL 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  189 bits (479), Expect = 3e-48,   Method: Compositional matrix adjust.
 Identities = 113/313 (36%), Positives = 179/313 (57%), Gaps = 8/313 (2%)
Query: 1   MGSAFSCCGSEKVEEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWG 60
           MGS +S   +  + + L++       ++R+    +L  ATN F     +G G FG VY G
Sbjct: 1   MGSKYSK-ATNSINDALSSSYLVPFESYRV-PLVDLEEATNNFDHKFLIGHGVFGKVYKG 58
Query: 61  RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMP 120
              DG ++A+K+    +S+   EF  E+E L   RH +L+ L G+C   ++ +++Y YM 
Sbjct: 59  VLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118
Query: 121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD 180
           N +L  HL+G     + + W++R++I IG+A G+ YLH   T  IIHRD+K+ N+LLD +
Sbjct: 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDEN 175
Query: 181 FEPLVADFGFAKLIPE-GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
           F P + DFG +K   E   +H+   VKGTLGY+ PEY + G+++E  DVYSFG++L E+L
Sbjct: 176 FVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235
Query: 240 TGRKPI-EKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQ 298
             R  I + LP  +   + EWA      G+ +++VDP L        L++  + AV C+ 
Sbjct: 236 CARSAIVQSLPREMV-NLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLA 294
Query: 299 SEPEKRPNMKEVV 311
              E RP+M +V+
Sbjct: 295 LSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  171 bits (433), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 111/312 (35%), Positives = 171/312 (54%), Gaps = 39/312 (12%)
Query: 24  NNATWRIFTYKELHTATNGFSDD------NKLGEGGFGSVYWGRTSDGLQIAVKKLKAM- 76
           ++  +  F++ EL   TN F +       NK+GEGGFG VY G  ++   +AVKKL AM 
Sbjct: 8   SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMV 66
Query: 77  ---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYA 133
                + + +F  E++V+ + +H+NL+ L G+ +  D   +VY YMPN SLL  L     
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLD 125
Query: 134 GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL 193
           G   L W  R KIA G+A GI +LH     H IHRDIK++N+LLD  F   ++DFG A+ 
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARA 182
Query: 194 IPE-GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGV 252
             +   + M +R+ GT  Y+APE A+ G+++   D+YSFG++LLEI+TG      LP   
Sbjct: 183 SEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG------LPA-- 233
Query: 253 KRTITEWAEPLIV----------KGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPE 302
              + E  EP ++          +   ++ +D K+  D D   ++   +VA  C+  +  
Sbjct: 234 ---VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKN 289
Query: 303 KRPNMKEVVNTL 314
           KRP++K+V   L
Sbjct: 290 KRPDIKKVQQLL 301

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 111/312 (35%), Positives = 170/312 (54%), Gaps = 39/312 (12%)
Query: 24  NNATWRIFTYKELHTATNGFSDD------NKLGEGGFGSVYWGRTSDGLQIAVKKLKAM- 76
           ++  +  F++ EL   TN F +       NK+GEGGFG VY G  ++   +AVKKL AM 
Sbjct: 8   SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMV 66
Query: 77  ---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYA 133
                + + +F  E++V+ + +H+NL+ L G+ +  D   +VY YMPN SLL  L     
Sbjct: 67  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLD 125
Query: 134 GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL 193
           G   L W  R KIA G+A GI +LH     H IHRDIK++N+LLD  F   ++DFG A+ 
Sbjct: 126 GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARA 182
Query: 194 IPE-GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGV 252
             +   + M  R+ GT  Y+APE A+ G+++   D+YSFG++LLEI+TG      LP   
Sbjct: 183 SEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG------LPA-- 233
Query: 253 KRTITEWAEPLIV----------KGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPE 302
              + E  EP ++          +   ++ +D K+  D D   ++   +VA  C+  +  
Sbjct: 234 ---VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKN 289
Query: 303 KRPNMKEVVNTL 314
           KRP++K+V   L
Sbjct: 290 KRPDIKKVQQLL 301

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 111/312 (35%), Positives = 169/312 (54%), Gaps = 39/312 (12%)
Query: 24  NNATWRIFTYKELHTATNGFSDD------NKLGEGGFGSVYWGRTSDGLQIAVKKLKAM- 76
           ++  +  F++ EL   TN F +       NK+GEGGFG VY G  ++   +AVKKL AM 
Sbjct: 2   SDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMV 60
Query: 77  ---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYA 133
                + + +F  E++V+ + +H+NL+ L G+ +  D   +VY YMPN SLL  L     
Sbjct: 61  DITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRL-SCLD 119
Query: 134 GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL 193
           G   L W  R KIA G+A GI +LH     H IHRDIK++N+LLD  F   ++DFG A+ 
Sbjct: 120 GTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARA 176
Query: 194 IPEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGV 252
             +     M  R+ GT  Y+APE A+ G+++   D+YSFG++LLEI+TG      LP   
Sbjct: 177 SEKFAQXVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIITG------LPA-- 227
Query: 253 KRTITEWAEPLIV----------KGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPE 302
              + E  EP ++          +   ++ +D K+  D D   ++   +VA  C+  +  
Sbjct: 228 ---VDEHREPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKN 283
Query: 303 KRPNMKEVVNTL 314
           KRP++K+V   L
Sbjct: 284 KRPDIKKVQQLL 295

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 109/308 (35%), Positives = 163/308 (52%), Gaps = 39/308 (12%)
Query: 28  WRIFTYKELHTATNGFSDD------NKLGEGGFGSVYWGRTSDGLQIAVKKLKAM----N 77
           +  F++ EL   TN F +       NK GEGGFG VY G  ++   +AVKKL AM     
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITT 61
Query: 78  SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ 137
            + + +F  E++V  + +H+NL+ L G+ +  D   +VY Y PN SLL  L     G   
Sbjct: 62  EELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRL-SCLDGTPP 120
Query: 138 LDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG 197
           L W  R KIA G+A GI +LH     H IHRDIK++N+LLD  F   ++DFG A+   + 
Sbjct: 121 LSWHXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKF 177
Query: 198 VSHM-TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
              +  +R+ GT  Y APE A+ G+++   D+YSFG++LLEI+TG      LP      +
Sbjct: 178 AQXVXXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIITG------LPA-----V 225
Query: 257 TEWAEPLIV----------KGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPN 306
            E  EP ++          +   ++ +D K   D D   ++   +VA  C+  +  KRP+
Sbjct: 226 DEHREPQLLLDIKEEIEDEEKTIEDYIDKK-XNDADSTSVEAXYSVASQCLHEKKNKRPD 284
Query: 307 MKEVVNTL 314
           +K+V   L
Sbjct: 285 IKKVQQLL 292

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 88/271 (32%), Positives = 136/271 (50%), Gaps = 25/271 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEM--EFAVEVEVLGRVRHKNLLGLRGY 105
           K+G G FG+V+      G  +AVK L   +  AE   EF  EV ++ R+RH N++   G 
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
                   IV +Y+   SL   LH   A E QLD +RR+ +A   A+G+ YLH+   P I
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGARE-QLDERRRLSMAYDVAKGMNYLHNR-NPPI 160
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR-VKGTLGYLAPEYAMWGKVSE 224
           +HR++K+ N+L+D  +   V DFG ++L  +  + ++++   GT  ++APE       +E
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 225 SCDVYSFGILLLEILTGRKPIEKL-PGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDE 283
             DVYSFG++L E+ T ++P   L P  V            V  K K L  P+       
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNPAQVVAA---------VGFKCKRLEIPR------- 262
Query: 284 NQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           N   Q   +   C  +EP KRP+   +++ L
Sbjct: 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 134/271 (49%), Gaps = 25/271 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEM--EFAVEVEVLGRVRHKNLLGLRGY 105
           K+G G FG+V+      G  +AVK L   +  AE   EF  EV ++ R+RH N++   G 
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
                   IV +Y+   SL   LH   A E QLD +RR+ +A   A+G+ YLH+   P I
Sbjct: 103 VTQPPNLSIVTEYLSRGSLYRLLHKSGARE-QLDERRRLSMAYDVAKGMNYLHNR-NPPI 160
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR-VKGTLGYLAPEYAMWGKVSE 224
           +HRD+K+ N+L+D  +   V DFG ++L  +    + ++   GT  ++APE       +E
Sbjct: 161 VHRDLKSPNLLVDKKYTVKVCDFGLSRL--KASXFLXSKXAAGTPEWMAPEVLRDEPSNE 218
Query: 225 SCDVYSFGILLLEILTGRKPIEKL-PGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDE 283
             DVYSFG++L E+ T ++P   L P  V            V  K K L  P+       
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNPAQVVAA---------VGFKCKRLEIPR------- 262
Query: 284 NQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           N   Q   +   C  +EP KRP+   +++ L
Sbjct: 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMDLL 293

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 86/276 (31%), Positives = 134/276 (48%), Gaps = 41/276 (14%)
Query: 49  LGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           +G G FG V    W R  D   +A+K++++ + +    F VE+  L RV H N++ L G 
Sbjct: 16  VGRGAFGVVCKAKW-RAKD---VAIKQIESESERKA--FIVELRQLSRVNHPNIVKLYGA 69
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQ-----YAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           C   +   +V +Y    SL + LHG      Y     + W       +  ++G+ YLH  
Sbjct: 70  C--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSM 121
Query: 161 VTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
               +IHRD+K  N+LL +    L + DFG A  I    +HMT   KG+  ++APE    
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNN-KGSAAWMAPEVFEG 177
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
              SE CDV+S+GI+L E++T RKP +++ G   R +  WA            V    R 
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--WA------------VHNGTRP 223
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
              +N  K   ++   C   +P +RP+M+E+V  +T
Sbjct: 224 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 86/276 (31%), Positives = 134/276 (48%), Gaps = 41/276 (14%)
Query: 49  LGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           +G G FG V    W R  D   +A+K++++ + +    F VE+  L RV H N++ L G 
Sbjct: 17  VGRGAFGVVCKAKW-RAKD---VAIKQIESESERKA--FIVELRQLSRVNHPNIVKLYGA 70
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQ-----YAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           C   +   +V +Y    SL + LHG      Y     + W       +  ++G+ YLH  
Sbjct: 71  C--LNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW------CLQCSQGVAYLHSM 122
Query: 161 VTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
               +IHRD+K  N+LL +    L + DFG A  I    +HMT   KG+  ++APE    
Sbjct: 123 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI---QTHMTNN-KGSAAWMAPEVFEG 178
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
              SE CDV+S+GI+L E++T RKP +++ G   R +  WA            V    R 
Sbjct: 179 SNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIM--WA------------VHNGTRP 224
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
              +N  K   ++   C   +P +RP+M+E+V  +T
Sbjct: 225 PLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 260

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 138/272 (50%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           KLG+G FG V+ G  +   ++A+K LK      E  F  E +V+ ++RH+ L+ L  Y  
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAV 71
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            +++ + IV +YM   SLL  L G+    ++L   + + +A   A G+ Y+      + +
Sbjct: 72  VSEEPIXIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYVERM---NYV 126
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+  +    VADFG A+LI +         K  + + APE A++G+ +   
Sbjct: 127 HRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 186
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL E+ T GR P    PG V R + +  E    +G ++    P+         
Sbjct: 187 DVWSFGILLTELTTKGRVP---YPGMVNREVLDQVE----RG-YRMPCPPECPESLH--- 235
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
                ++   C + EPE+RP  + +   L  Y
Sbjct: 236 -----DLMCQCWRKEPEERPTFEYLQAFLEDY 262

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 143/295 (48%), Gaps = 38/295 (12%)
Query: 37  HTATNGFSDDN------------KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEF 84
           H  T G + D             KLG+G FG V+ G  +   ++A+K LK      E  F
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-F 60
Query: 85  AVEVEVLGRVRHKNLLGLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRR 143
             E +V+ ++RH+ L+ L  Y   +++ + IV +YM   SLL  L G+    ++L   + 
Sbjct: 61  LQEAQVMKKIRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQL 116
Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT 203
           + +A   A G+ Y+      + +HRD++A+N+L+  +    VADFG A+LI +       
Sbjct: 117 VDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 173
Query: 204 RVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP 262
             K  + + APE A++G+ +   DV+SFGILL E+ T GR P    PG V R + +  E 
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP---YPGMVNREVLDQVE- 229
Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
              +G ++    P+              ++   C + +PE+RP  + +   L  Y
Sbjct: 230 ---RG-YRMPCPPECPESLH--------DLMCQCWRKDPEERPTFEYLQAFLEDY 272

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 138/272 (50%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           KLG+G FG V+ G  +   ++A+K LK      E  F  E +V+ ++RH+ L+ L  Y  
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAV 247
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            +++ + IV +YM   SLL  L G+    ++L   + + +A   A G+ Y+      + +
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYVERM---NYV 302
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+  +    VADFG A+LI +         K  + + APE A++G+ +   
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL E+ T GR P    PG V R + +  E    +G ++    P+         
Sbjct: 363 DVWSFGILLTELTTKGRVP---YPGMVNREVLDQVE----RG-YRMPCPPECPESLH--- 411
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
                ++   C + EPE+RP  + +   L  Y
Sbjct: 412 -----DLMCQCWRKEPEERPTFEYLQAFLEDY 438

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 138/272 (50%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           KLG+G FG V+ G  +   ++A+K LK      E  F  E +V+ ++RH+ L+ L  Y  
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAV 247
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            +++ + IV +YM   SLL  L G+    ++L   + + +A   A G+ Y+      + +
Sbjct: 248 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYVERM---NYV 302
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+  +    VADFG A+LI +         K  + + APE A++G+ +   
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL E+ T GR P    PG V R + +  E    +G ++    P+         
Sbjct: 363 DVWSFGILLTELTTKGRVP---YPGMVNREVLDQVE----RG-YRMPCPPECPESLH--- 411
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
                ++   C + EPE+RP  + +   L  Y
Sbjct: 412 -----DLMCQCWRKEPEERPTFEYLQAFLEDY 438

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 143/295 (48%), Gaps = 38/295 (12%)
Query: 37  HTATNGFSDDN------------KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEF 84
           H  T G + D             KLG+G FG V+ G  +   ++A+K LK      E  F
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-F 60
Query: 85  AVEVEVLGRVRHKNLLGLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRR 143
             E +V+ ++RH+ L+ L  Y   +++ + IV +YM   SLL  L G+    ++L   + 
Sbjct: 61  LQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRL--PQL 116
Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT 203
           + +A   A G+ Y+      + +HRD++A+N+L+  +    VADFG A+LI +       
Sbjct: 117 VDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQ 173
Query: 204 RVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP 262
             K  + + APE A++G+ +   DV+SFGILL E+ T GR P    PG V R + +  E 
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP---YPGMVNREVLDQVE- 229
Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
              +G ++    P+              ++   C + +PE+RP  + +   L  Y
Sbjct: 230 ---RG-YRMPCPPECPESLH--------DLMCQCWRKDPEERPTFEYLQAFLEDY 272

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 138/272 (50%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           KLG+G FG V+ G  +   ++A+K LK      E  F  E +V+ ++RH+ L+ L  Y  
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAV 330
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            +++ + IV +YM   SLL  L G+    ++L   + + +A   A G+ Y+      + +
Sbjct: 331 VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYVERM---NYV 385
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+  +    VADFG A+LI +         K  + + APE A++G+ +   
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL E+ T GR P    PG V R + +  E    +G ++    P+         
Sbjct: 446 DVWSFGILLTELTTKGRVP---YPGMVNREVLDQVE----RG-YRMPCPPECPESLH--- 494
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
                ++   C + EPE+RP  + +   L  Y
Sbjct: 495 -----DLMCQCWRKEPEERPTFEYLQAFLEDY 521

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 138/272 (50%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           KLG+G FG V+ G  +   ++A+K LK      E  F  E +V+ ++RH+ L+ L  Y  
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAV 74
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            +++ + IV +YM   SLL  L G+    ++L   + + +A   A G+ Y+      + +
Sbjct: 75  VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYVERM---NYV 129
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+  +    VADFG A+LI +         K  + + APE A++G+ +   
Sbjct: 130 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 189
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL E+ T GR P    PG V R + +  E    +G ++    P+         
Sbjct: 190 DVWSFGILLTELTTKGRVPY---PGMVNREVLDQVE----RG-YRMPCPPECPESLH--- 238
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
                ++   C + EPE+RP  + +   L  Y
Sbjct: 239 -----DLMCQCWRKEPEERPTFEYLQAFLEDY 265

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 136/272 (50%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           KLG+G FG V+ G  +   ++A+K LK      E  F  E +V+ ++RH+ L+ L  Y  
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAV 78
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            +++ + IV +YM   SLL  L G+    ++L     M   I S  G+ Y+      + +
Sbjct: 79  VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIAS--GMAYVERM---NYV 133
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+  +    VADFG A+LI +         K  + + APE A++G+ +   
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 193
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL E+ T GR P    PG V R + +  E    +G ++    P+         
Sbjct: 194 DVWSFGILLTELTTKGRVP---YPGMVNREVLDQVE----RG-YRMPCPPECPESLH--- 242
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
                ++   C + EPE+RP  + +   L  Y
Sbjct: 243 -----DLMCQCWRKEPEERPTFEYLQAFLEDY 269

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 138/272 (50%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           KLG+G FG V+ G  +   ++A+K LK  N   E  F  E +V+ ++RH+ L+ L  Y  
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEA-FLQEAQVMKKLRHEKLVQL--YAV 248
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            +++ + IV +YM   SLL  L G+    ++L   + + +A   A G+ Y+      + +
Sbjct: 249 VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVERM---NYV 303
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+  +    VADFG  +LI +         K  + + APE A++G+ +   
Sbjct: 304 HRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 363
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL E+ T GR P    PG V R + +  E    +G ++    P+         
Sbjct: 364 DVWSFGILLTELTTKGRVP---YPGMVNREVLDQVE----RG-YRMPCPPECPESLH--- 412
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
                ++   C + +PE+RP  + +   L  Y
Sbjct: 413 -----DLMCQCWRKDPEERPTFEYLQAFLEDY 439

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 143/295 (48%), Gaps = 38/295 (12%)
Query: 37  HTATNGFSDDN------------KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEF 84
           H  T G + D             KLG+G FG V+ G  +   ++A+K LK      E  F
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-F 60
Query: 85  AVEVEVLGRVRHKNLLGLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRR 143
             E +V+ ++RH+ L+ L  Y   +++ + IV +YM   SLL  L G+    ++L   + 
Sbjct: 61  LQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRL--PQL 116
Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT 203
           + +A   A G+ Y+      + +HRD++A+N+L+  +    VADFG A+LI +       
Sbjct: 117 VDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 173
Query: 204 RVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP 262
             K  + + APE A++G+ +   DV+SFGILL E+ T GR P    PG V R + +  E 
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP---YPGMVNREVLDQVE- 229
Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
              +G ++    P+              ++   C + +PE+RP  + +   L  Y
Sbjct: 230 ---RG-YRMPCPPECPESLH--------DLMCQCWRKDPEERPTFEYLQAFLEDY 272

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 143/295 (48%), Gaps = 38/295 (12%)
Query: 37  HTATNGFSDDN------------KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEF 84
           H  T G + D             KLG+G FG V+ G  +   ++A+K LK      E  F
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-F 60
Query: 85  AVEVEVLGRVRHKNLLGLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRR 143
             E +V+ ++RH+ L+ L  Y   +++ + IV +YM   SLL  L G+    ++L   + 
Sbjct: 61  LQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQL 116
Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT 203
           + +A   A G+ Y+      + +HRD++A+N+L+  +    VADFG A+LI +       
Sbjct: 117 VDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 173
Query: 204 RVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP 262
             K  + + APE A++G+ +   DV+SFGILL E+ T GR P    PG V R + +  E 
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP---YPGMVNREVLDQVE- 229
Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
              +G ++    P+              ++   C + +PE+RP  + +   L  Y
Sbjct: 230 ---RG-YRMPCPPECPESLH--------DLMCQCWRKDPEERPTFEYLQAFLEDY 272

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 143/295 (48%), Gaps = 38/295 (12%)
Query: 37  HTATNGFSDDN------------KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEF 84
           H  T G + D             KLG+G FG V+ G  +   ++A+K LK      E  F
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-F 60
Query: 85  AVEVEVLGRVRHKNLLGLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRR 143
             E +V+ ++RH+ L+ L  Y   +++ + IV +YM   SLL  L G+    ++L   + 
Sbjct: 61  LQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRL--PQL 116
Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT 203
           + +A   A G+ Y+      + +HRD++A+N+L+  +    VADFG A+LI +       
Sbjct: 117 VDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 173
Query: 204 RVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP 262
             K  + + APE A++G+ +   DV+SFGILL E+ T GR P    PG V R + +  E 
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVP---YPGMVNREVLDQVE- 229
Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
              +G ++    P+              ++   C + +PE+RP  + +   L  Y
Sbjct: 230 ---RG-YRMPCPPECPESLH--------DLMCQCWRKDPEERPTFEYLQAFLEDY 272

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 136/272 (50%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           KLG+G FG V+ G  +   ++A+K LK      E  F  E +V+ ++RH+ L+ L  Y  
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAV 78
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            +++ + IV +YM   SLL  L G+    ++L     M   I S  G+ Y+      + +
Sbjct: 79  VSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIAS--GMAYVERM---NYV 133
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+  +    VADFG A+LI +         K  + + APE A++G+ +   
Sbjct: 134 HRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKS 193
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL E+ T GR P    PG V R + +  E    +G ++    P+         
Sbjct: 194 DVWSFGILLTELTTKGRVPY---PGMVNREVLDQVE----RG-YRMPCPPECPESLH--- 242
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
                ++   C + EPE+RP  + +   L  Y
Sbjct: 243 -----DLMCQCWRKEPEERPTFEYLQAFLEDY 269

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 138/272 (50%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           KLG+G FG V+ G  +   ++A+K LK      E  F  E +V+ ++RH+ L+ L  Y  
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAV 247
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            +++ + IV +YM   SLL  L G+    ++L   + + +A   A G+ Y+      + +
Sbjct: 248 VSEEPIYIVGEYMSKGSLLDFLKGETGKYLRL--PQLVDMAAQIASGMAYVERM---NYV 302
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+  +    VADFG A+LI +         K  + + APE A++G+ +   
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL E+ T GR P    PG V R + +  E    +G ++    P+         
Sbjct: 363 DVWSFGILLTELTTKGRVP---YPGMVNREVLDQVE----RG-YRMPCPPECPESLH--- 411
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
                ++   C + EPE+RP  + +   L  Y
Sbjct: 412 -----DLMCQCWRKEPEERPTFEYLQAFLEDY 438

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 138/272 (50%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           KLG+G FG V+ G  +   ++A+K LK      E  F  E +V+ ++RH+ L+ L  Y  
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAV 72
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            +++ + IV +YM   SLL  L G+    ++L   + + +A   A G+ Y+      + +
Sbjct: 73  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVERM---NYV 127
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+  +    VADFG A+LI +         K  + + APE A++G+ +   
Sbjct: 128 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL E+ T GR P    PG V R + +  E    +G ++    P+         
Sbjct: 188 DVWSFGILLTELTTKGRVP---YPGMVNREVLDQVE----RG-YRMPCPPECPESLH--- 236
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
                ++   C + +PE+RP  + +   L  Y
Sbjct: 237 -----DLMCQCWRKDPEERPTFEYLQAFLEDY 263

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 138/272 (50%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           KLG+G FG V+ G  +   ++A+K LK      E  F  E +V+ ++RH+ L+ L  Y  
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-FLQEAQVMKKLRHEKLVQL--YAV 70
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            +++ + IV +YM   SLL  L G+    ++L   + + +A   A G+ Y+      + +
Sbjct: 71  VSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQLVDMAAQIASGMAYVERM---NYV 125
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+  +    VADFG A+LI +         K  + + APE A++G+ +   
Sbjct: 126 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 185
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL E+ T GR P    PG V R + +  E    +G ++    P+         
Sbjct: 186 DVWSFGILLTELTTKGRVP---YPGMVNREVLDQVE----RG-YRMPCPPECPESLH--- 234
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
                ++   C + +PE+RP  + +   L  Y
Sbjct: 235 -----DLMCQCWRKDPEERPTFEYLQAFLEDY 261

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 86/295 (29%), Positives = 142/295 (48%), Gaps = 38/295 (12%)
Query: 37  HTATNGFSDDN------------KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEF 84
           H  T G + D             KLG+G FG V+ G  +   ++A+K LK      E  F
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-F 60
Query: 85  AVEVEVLGRVRHKNLLGLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRR 143
             E +V+ ++RH+ L+ L  Y   +++ + IV +YM   SLL  L G+    ++L   + 
Sbjct: 61  LQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRL--PQL 116
Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT 203
           + +A   A G+ Y+      + +HRD+ A+N+L+  +    VADFG A+LI +       
Sbjct: 117 VDMAAQIASGMAYVERM---NYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQ 173
Query: 204 RVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP 262
             K  + + APE A++G+ +   DV+SFGILL E+ T GR P    PG V R + +  E 
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY---PGMVNREVLDQVE- 229
Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
              +G ++    P+              ++   C + +PE+RP  + +   L  Y
Sbjct: 230 ---RG-YRMPCPPECPESLH--------DLMCQCWRKDPEERPTFEYLQAFLEDY 272

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 85/295 (28%), Positives = 142/295 (48%), Gaps = 38/295 (12%)
Query: 37  HTATNGFSDDN------------KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEF 84
           H  T G + D             KLG+G FG V+ G  +   ++A+K LK      E  F
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-F 60
Query: 85  AVEVEVLGRVRHKNLLGLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRR 143
             E +V+ ++RH+ L+ L  Y   +++ + IV +YM    LL  L G+    ++L   + 
Sbjct: 61  LQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRL--PQL 116
Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT 203
           + +A   A G+ Y+      + +HRD++A+N+L+  +    VADFG A+LI +       
Sbjct: 117 VDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 173
Query: 204 RVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP 262
             K  + + APE A++G+ +   DV+SFGILL E+ T GR P    PG V R + +  E 
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY---PGMVNREVLDQVE- 229
Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
              +G ++    P+              ++   C + +PE+RP  + +   L  Y
Sbjct: 230 ---RG-YRMPCPPECPESLH--------DLMCQCWRKDPEERPTFEYLQAFLEDY 272

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 85/295 (28%), Positives = 142/295 (48%), Gaps = 38/295 (12%)
Query: 37  HTATNGFSDDN------------KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEF 84
           H  T G + D             KLG+G FG V+ G  +   ++A+K LK      E  F
Sbjct: 2   HMQTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA-F 60
Query: 85  AVEVEVLGRVRHKNLLGLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRR 143
             E +V+ ++RH+ L+ L  Y   +++ + IV +YM    LL  L G+    ++L   + 
Sbjct: 61  LQEAQVMKKLRHEKLVQL--YAVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRL--PQL 116
Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT 203
           + +A   A G+ Y+      + +HRD++A+N+L+  +    VADFG A+LI +       
Sbjct: 117 VDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ 173
Query: 204 RVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP 262
             K  + + APE A++G+ +   DV+SFGILL E+ T GR P    PG V R + +  E 
Sbjct: 174 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPY---PGMVNREVLDQVE- 229
Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
              +G ++    P+              ++   C + +PE+RP  + +   L  Y
Sbjct: 230 ---RG-YRMPCPPECPESLH--------DLMCQCWRKDPEERPTFEYLQAFLEDY 272

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 104/205 (50%), Gaps = 11/205 (5%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           ++G G FG+VY G+    + + +  + A   +    F  EV VL + RH N+L   GY  
Sbjct: 19  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 78
Query: 108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH 167
              Q  IV  +    SL  HLH   A E + + K+ + IA  +A G+ YLH      IIH
Sbjct: 79  -KPQLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLH---AKSIIH 131
Query: 168 RDIKASNVLLDSDFEPLVADFGFAKLIPE-GVSHMTTRVKGTLGYLAPEYAMW---GKVS 223
           RD+K++N+ L  D    + DFG A +      SH   ++ G++ ++APE          S
Sbjct: 132 RDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 191
Query: 224 ESCDVYSFGILLLEILTGRKPIEKL 248
              DVY+FGI+L E++TG+ P   +
Sbjct: 192 FQSDVYAFGIVLYELMTGQLPYSNI 216

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 86/293 (29%), Positives = 141/293 (48%), Gaps = 49/293 (16%)
Query: 47  NKLGEGGFGSVYWGR------TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLL 100
            +LGEG FG V+         T D + +AVK LK     A  +F  E E+L  ++H++++
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 101 GLRGYCAGTDQRLIVYDYMP--NLSLLSHLHG------------QYAGEVQLDWKRRMKI 146
              G C   D  ++V++YM   +L+     HG            Q  GE+ L   + + I
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS--QMLHI 138
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
           A   A G++YL    + H +HRD+   N L+ ++    + DFG ++ +    S    RV 
Sbjct: 139 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV---YSTDYYRVG 192
Query: 207 G----TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAE 261
           G     + ++ PE  M+ K +   DV+SFG++L EI T G++P  +L        TE  E
Sbjct: 193 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN------TEVIE 246
Query: 262 PLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
             I +G+  E   P++         K+  +V + C Q EP++R N+KE+   L
Sbjct: 247 -CITQGRVLE--RPRVCP-------KEVYDVMLGCWQREPQQRLNIKEIYKIL 289

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           ++G G FG+VY G+    + + +  + A   +    F  EV VL + RH N+L   GY  
Sbjct: 31  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH 167
              Q  IV  +    SL  HLH   A E + + K+ + IA  +A G+ YLH      IIH
Sbjct: 91  AP-QLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLH---AKSIIH 143
Query: 168 RDIKASNVLLDSDFEPLVADFGFAKLIPE-GVSHMTTRVKGTLGYLAPEYAMW---GKVS 223
           RD+K++N+ L  D    + DFG A        SH   ++ G++ ++APE          S
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 224 ESCDVYSFGILLLEILTGRKPIEKL 248
              DVY+FGI+L E++TG+ P   +
Sbjct: 204 FQSDVYAFGIVLYELMTGQLPYSNI 228

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/205 (33%), Positives = 103/205 (50%), Gaps = 11/205 (5%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           ++G G FG+VY G+    + + +  + A   +    F  EV VL + RH N+L   GY  
Sbjct: 31  RIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST 90
Query: 108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH 167
              Q  IV  +    SL  HLH   A E + + K+ + IA  +A G+ YLH      IIH
Sbjct: 91  -KPQLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLH---AKSIIH 143
Query: 168 RDIKASNVLLDSDFEPLVADFGFAKLIPE-GVSHMTTRVKGTLGYLAPEYAMW---GKVS 223
           RD+K++N+ L  D    + DFG A        SH   ++ G++ ++APE          S
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 203
Query: 224 ESCDVYSFGILLLEILTGRKPIEKL 248
              DVY+FGI+L E++TG+ P   +
Sbjct: 204 FQSDVYAFGIVLYELMTGQLPYSNI 228

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 11/206 (5%)
Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            ++G G FG+VY G+    + + +  + A   +    F  EV VL + RH N+L   GY 
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
               Q  IV  +    SL  HLH     E + +  + + IA  +A+G+ YLH +    II
Sbjct: 74  TAP-QLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAK---SII 126
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGV-SHMTTRVKGTLGYLAPEYA-MWGK--V 222
           HRD+K++N+ L  D    + DFG A +      SH   ++ G++ ++APE   M  K   
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 223 SESCDVYSFGILLLEILTGRKPIEKL 248
           S   DVY+FGI+L E++TG+ P   +
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 107/206 (51%), Gaps = 11/206 (5%)
Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            ++G G FG+VY G+    + + +  + A   +    F  EV VL + RH N+L   GY 
Sbjct: 19  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 77
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
           +   Q  IV  +    SL  HLH     E + +  + + IA  +A+G+ YLH +    II
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAK---SII 131
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPE-GVSHMTTRVKGTLGYLAPEYA-MWGK--V 222
           HRD+K++N+ L  D    + DFG A +      SH   ++ G++ ++APE   M  K   
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 223 SESCDVYSFGILLLEILTGRKPIEKL 248
           S   DVY+FGI+L E++TG+ P   +
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLPYSNI 217

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 107/206 (51%), Gaps = 11/206 (5%)
Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            ++G G FG+VY G+    + + +  + A   +    F  EV VL + RH N+L   GY 
Sbjct: 16  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 74
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
           +   Q  IV  +    SL  HLH     E + +  + + IA  +A+G+ YLH +    II
Sbjct: 75  STKPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAK---SII 128
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGV-SHMTTRVKGTLGYLAPEYA-MWGK--V 222
           HRD+K++N+ L  D    + DFG A +      SH   ++ G++ ++APE   M  K   
Sbjct: 129 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 188
Query: 223 SESCDVYSFGILLLEILTGRKPIEKL 248
           S   DVY+FGI+L E++TG+ P   +
Sbjct: 189 SFQSDVYAFGIVLYELMTGQLPYSNI 214

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 107/206 (51%), Gaps = 11/206 (5%)
Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            ++G G FG+VY G+    + + +  + A   +    F  EV VL + RH N+L   GY 
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
           +   Q  IV  +    SL  HLH     E + +  + + IA  +A+G+ YLH +    II
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAK---SII 126
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGV-SHMTTRVKGTLGYLAPEYA-MWGK--V 222
           HRD+K++N+ L  D    + DFG A +      SH   ++ G++ ++APE   M  K   
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 223 SESCDVYSFGILLLEILTGRKPIEKL 248
           S   DVY+FGI+L E++TG+ P   +
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 107/206 (51%), Gaps = 11/206 (5%)
Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            ++G G FG+VY G+    + + +  + A   +    F  EV VL + RH N+L   GY 
Sbjct: 19  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 77
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
           +   Q  IV  +    SL  HLH     E + +  + + IA  +A+G+ YLH +    II
Sbjct: 78  STKPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAK---SII 131
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGV-SHMTTRVKGTLGYLAPEYA-MWGK--V 222
           HRD+K++N+ L  D    + DFG A +      SH   ++ G++ ++APE   M  K   
Sbjct: 132 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 191
Query: 223 SESCDVYSFGILLLEILTGRKPIEKL 248
           S   DVY+FGI+L E++TG+ P   +
Sbjct: 192 SFQSDVYAFGIVLYELMTGQLPYSNI 217

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            ++G G FG+VY G+    + + +  + A   +    F  EV VL + RH N+L   GY 
Sbjct: 41  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
               Q  IV  +    SL  HLH     E + +  + + IA  +A+G+ YLH      II
Sbjct: 101 T-KPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLH---AKSII 153
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPE-GVSHMTTRVKGTLGYLAPEYA-MWGK--V 222
           HRD+K++N+ L  D    + DFG A +      SH   ++ G++ ++APE   M  K   
Sbjct: 154 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 213
Query: 223 SESCDVYSFGILLLEILTGRKPIEKL 248
           S   DVY+FGI+L E++TG+ P   +
Sbjct: 214 SFQSDVYAFGIVLYELMTGQLPYSNI 239

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            ++G G FG+VY G+    + + +  + A   +    F  EV VL + RH N+L   GY 
Sbjct: 42  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
               Q  IV  +    SL  HLH     E + +  + + IA  +A+G+ YLH      II
Sbjct: 102 T-KPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLH---AKSII 154
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPE-GVSHMTTRVKGTLGYLAPEYA-MWGK--V 222
           HRD+K++N+ L  D    + DFG A +      SH   ++ G++ ++APE   M  K   
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 223 SESCDVYSFGILLLEILTGRKPIEKL 248
           S   DVY+FGI+L E++TG+ P   +
Sbjct: 215 SFQSDVYAFGIVLYELMTGQLPYSNI 240

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 132/272 (48%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G FG V+ G  +   ++AVK LK   S +   F  E  ++ +++H+ L+  R Y  
Sbjct: 28  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV--RLYAV 84
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            T + + I+ +YM N SL+  L  +    ++L   + + +A   AEG+ ++      + I
Sbjct: 85  VTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 139
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+       +ADFG A+LI +         K  + + APE   +G  +   
Sbjct: 140 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 199
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL EI+T GR P    PG     + +  E      +   +V P       +N 
Sbjct: 200 DVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLE------RGYRMVRP-------DNC 243
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
            ++   +  LC +  PE RP    + + L  +
Sbjct: 244 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 275

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 132/272 (48%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G FG V+ G  +   ++AVK LK   S +   F  E  ++ +++H+ L+  R Y  
Sbjct: 29  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV--RLYAV 85
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            T + + I+ +YM N SL+  L  +    ++L   + + +A   AEG+ ++      + I
Sbjct: 86  VTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 140
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+       +ADFG A+LI +         K  + + APE   +G  +   
Sbjct: 141 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 200
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL EI+T GR P    PG     + +  E      +   +V P       +N 
Sbjct: 201 DVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLE------RGYRMVRP-------DNC 244
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
            ++   +  LC +  PE RP    + + L  +
Sbjct: 245 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 276

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 132/272 (48%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G FG V+ G  +   ++AVK LK   S +   F  E  ++ +++H+ L+  R Y  
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV--RLYAV 82
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            T + + I+ +YM N SL+  L  +    ++L   + + +A   AEG+ ++      + I
Sbjct: 83  VTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 137
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+       +ADFG A+LI +         K  + + APE   +G  +   
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL EI+T GR P    PG     + +  E      +   +V P       +N 
Sbjct: 198 DVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLE------RGYRMVRP-------DNC 241
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
            ++   +  LC +  PE RP    + + L  +
Sbjct: 242 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 273

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 132/272 (48%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G FG V+ G  +   ++AVK LK   S +   F  E  ++ +++H+ L+  R Y  
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV--RLYAV 76
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            T + + I+ +YM N SL+  L  +    ++L   + + +A   AEG+ ++      + I
Sbjct: 77  VTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+       +ADFG A+LI +         K  + + APE   +G  +   
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL EI+T GR P    PG     + +  E      +   +V P       +N 
Sbjct: 192 DVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLE------RGYRMVRP-------DNC 235
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
            ++   +  LC +  PE RP    + + L  +
Sbjct: 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 132/272 (48%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G FG V+ G  +   ++AVK LK   S +   F  E  ++ +++H+ L+  R Y  
Sbjct: 22  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV--RLYAV 78
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            T + + I+ +YM N SL+  L  +    ++L   + + +A   AEG+ ++      + I
Sbjct: 79  VTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 133
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+       +ADFG A+LI +         K  + + APE   +G  +   
Sbjct: 134 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 193
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL EI+T GR P    PG     + +  E      +   +V P       +N 
Sbjct: 194 DVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLE------RGYRMVRP-------DNC 237
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
            ++   +  LC +  PE RP    + + L  +
Sbjct: 238 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 269

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 73/274 (26%), Positives = 131/274 (47%), Gaps = 24/274 (8%)
Query: 46  DNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           + KLG G FG V+    +   ++AVK +K  +   E  F  E  V+  ++H  L+ L   
Sbjct: 20  EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHA- 77
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               +   I+ ++M   SLL  L      +  L   + +  +   AEG+ ++      + 
Sbjct: 78  VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NY 132
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSES 225
           IHRD++A+N+L+ +     +ADFG A++I +         K  + + APE   +G  +  
Sbjct: 133 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 192
Query: 226 CDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN 284
            DV+SFGILL+EI+T GR P    PG         + P +++      ++   R    EN
Sbjct: 193 SDVWSFGILLMEIVTYGRIP---YPGM--------SNPEVIRA-----LERGYRMPRPEN 236
Query: 285 QLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD 318
             ++  N+ + C ++ PE+RP  + + + L  ++
Sbjct: 237 CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFE 270

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 132/272 (48%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G FG V+ G  +   ++AVK LK   S +   F  E  ++ +++H+ L+  R Y  
Sbjct: 21  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV--RLYAV 77
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            T + + I+ +YM N SL+  L  +    ++L   + + +A   AEG+ ++      + I
Sbjct: 78  VTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 132
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+       +ADFG A+LI +         K  + + APE   +G  +   
Sbjct: 133 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 192
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL EI+T GR P    PG     + +  E      +   +V P       +N 
Sbjct: 193 DVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLE------RGYRMVRP-------DNC 236
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
            ++   +  LC +  PE RP    + + L  +
Sbjct: 237 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 268

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 132/272 (48%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G FG V+ G  +   ++AVK LK   S +   F  E  ++ +++H+ L+  R Y  
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV--RLYAV 76
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            T + + I+ +YM N SL+  L  +    ++L   + + +A   AEG+ ++      + I
Sbjct: 77  VTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+       +ADFG A+LI +         K  + + APE   +G  +   
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL EI+T GR P    PG     + +  E      +   +V P       +N 
Sbjct: 192 DVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLE------RGYRMVRP-------DNC 235
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
            ++   +  LC +  PE RP    + + L  +
Sbjct: 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 132/272 (48%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G FG V+ G  +   ++AVK LK   S +   F  E  ++ +++H+ L+  R Y  
Sbjct: 26  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV--RLYAV 82
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            T + + I+ +YM N SL+  L  +    ++L   + + +A   AEG+ ++      + I
Sbjct: 83  VTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 137
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+       +ADFG A+LI +         K  + + APE   +G  +   
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL EI+T GR P    PG     + +  E      +   +V P       +N 
Sbjct: 198 DVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLE------RGYRMVRP-------DNC 241
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
            ++   +  LC +  PE RP    + + L  +
Sbjct: 242 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 273

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 132/272 (48%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G FG V+ G  +   ++AVK LK   S +   F  E  ++ +++H+ L+  R Y  
Sbjct: 25  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV--RLYAV 81
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            T + + I+ +YM N SL+  L  +    ++L   + + +A   AEG+ ++      + I
Sbjct: 82  VTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 136
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+       +ADFG A+LI +         K  + + APE   +G  +   
Sbjct: 137 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 196
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL EI+T GR P    PG     + +  E      +   +V P       +N 
Sbjct: 197 DVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLE------RGYRMVRP-------DNC 240
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
            ++   +  LC +  PE RP    + + L  +
Sbjct: 241 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 272

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 132/272 (48%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G FG V+ G  +   ++AVK LK   S +   F  E  ++ +++H+ L+  R Y  
Sbjct: 30  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV--RLYAV 86
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            T + + I+ +YM N SL+  L  +    ++L   + + +A   AEG+ ++      + I
Sbjct: 87  VTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 141
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+       +ADFG A+LI +         K  + + APE   +G  +   
Sbjct: 142 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 201
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL EI+T GR P    PG     + +  E      +   +V P       +N 
Sbjct: 202 DVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLE------RGYRMVRP-------DNC 245
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
            ++   +  LC +  PE RP    + + L  +
Sbjct: 246 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 277

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 132/272 (48%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G FG V+ G  +   ++AVK LK   S +   F  E  ++ +++H+ L+  R Y  
Sbjct: 15  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV--RLYAV 71
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            T + + I+ +YM N SL+  L  +    ++L   + + +A   AEG+ ++      + I
Sbjct: 72  VTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 126
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+       +ADFG A+LI +         K  + + APE   +G  +   
Sbjct: 127 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 186
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL EI+T GR P    PG     + +  E      +   +V P       +N 
Sbjct: 187 DVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLE------RGYRMVRP-------DNC 230
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
            ++   +  LC +  PE RP    + + L  +
Sbjct: 231 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 262

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 132/272 (48%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G FG V+ G  +   ++AVK LK   S +   F  E  ++ +++H+ L+  R Y  
Sbjct: 20  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV--RLYAV 76
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            T + + I+ +YM N SL+  L  +    ++L   + + +A   AEG+ ++      + I
Sbjct: 77  VTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+       +ADFG A+LI +         K  + + APE   +G  +   
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL EI+T GR P    PG     + +  E      +   +V P       +N 
Sbjct: 192 DVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLE------RGYRMVRP-------DNC 235
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
            ++   +  LC +  PE RP    + + L  +
Sbjct: 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 11/206 (5%)
Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            ++G G FG+VY G+    + + +  + A   +    F  EV VL + RH N+L   GY 
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 72
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
           +   Q  IV  +    SL  HLH     E + +  + + IA  +A+G+ YLH +    II
Sbjct: 73  STKPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLHAK---SII 126
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGV-SHMTTRVKGTLGYLAPEYA-MWGK--V 222
           HRD+K++N+ L  D    + DFG A        SH   ++ G++ ++APE   M  K   
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186
Query: 223 SESCDVYSFGILLLEILTGRKPIEKL 248
           S   DVY+FGI+L E++TG+ P   +
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNI 212

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 105/206 (50%), Gaps = 11/206 (5%)
Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            ++G G FG+VY G+    + + +  + A   +    F  EV VL + RH N+L   GY 
Sbjct: 34  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY- 92
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
           +   Q  IV  +    SL  HLH     E + +  + + IA  +A+G+ YLH      II
Sbjct: 93  STKPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLH---AKSII 146
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPE-GVSHMTTRVKGTLGYLAPEYA-MWGK--V 222
           HRD+K++N+ L  D    + DFG A        SH   ++ G++ ++APE   M  K   
Sbjct: 147 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 206
Query: 223 SESCDVYSFGILLLEILTGRKPIEKL 248
           S   DVY+FGI+L E++TG+ P   +
Sbjct: 207 SFQSDVYAFGIVLYELMTGQLPYSNI 232

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 104/206 (50%), Gaps = 11/206 (5%)
Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            ++G G FG+VY G+    + + +  + A   +    F  EV VL + RH N+L   GY 
Sbjct: 42  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
               Q  IV  +    SL  HLH     E + +  + + IA  +A+G+ YLH      II
Sbjct: 102 T-KPQLAIVTQWCEGSSLYHHLH---IIETKFEMIKLIDIARQTAQGMDYLH---AKSII 154
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPE-GVSHMTTRVKGTLGYLAPEYA-MWGK--V 222
           HRD+K++N+ L  D    + DFG A        SH   ++ G++ ++APE   M  K   
Sbjct: 155 HRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 214
Query: 223 SESCDVYSFGILLLEILTGRKPIEKL 248
           S   DVY+FGI+L E++TG+ P   +
Sbjct: 215 SFQSDVYAFGIVLYELMTGQLPYSNI 240

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 130/273 (47%), Gaps = 24/273 (8%)
Query: 46  DNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           + KLG G FG V+    +   ++AVK +K  +   E  F  E  V+  ++H  L+ L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHA- 250
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               +   I+ ++M   SLL  L      +  L   + +  +   AEG+ ++      + 
Sbjct: 251 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NY 305
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSES 225
           IHRD++A+N+L+ +     +ADFG A++I +         K  + + APE   +G  +  
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 226 CDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN 284
            DV+SFGILL+EI+T GR P    PG         + P +++   +    P+      EN
Sbjct: 366 SDVWSFGILLMEIVTYGRIP---YPG--------MSNPEVIRALERGYRMPR-----PEN 409
Query: 285 QLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
             ++  N+ + C ++ PE+RP  + + + L  +
Sbjct: 410 CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 132/272 (48%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G FG V+ G  +   ++AVK LK   S +   F  E  ++ +++H+ L+  R Y  
Sbjct: 16  RLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV--RLYAV 72
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            T + + I+ +YM N SL+  L  +    ++L   + + +A   AEG+ ++      + I
Sbjct: 73  VTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 127
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HR+++A+N+L+       +ADFG A+LI +         K  + + APE   +G  +   
Sbjct: 128 HRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 187
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL EI+T GR P    PG     + +  E      +   +V P       +N 
Sbjct: 188 DVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLE------RGYRMVRP-------DNC 231
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
            ++   +  LC +  PE RP    + + L  +
Sbjct: 232 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 263

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 70/203 (34%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAE--MEFAVEVEVLGRVRHKNLLGLRGY 105
           ++G G FG+VY G+      +AVK LK ++   E    F  EV VL + RH N+L   GY
Sbjct: 43  RIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY 100
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               D   IV  +    SL  HLH Q   E +    + + IA  +A+G+ YLH     +I
Sbjct: 101 MT-KDNLAIVTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLH---AKNI 153
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV-SHMTTRVKGTLGYLAPEYAMW---GK 221
           IHRD+K++N+ L       + DFG A +      S    +  G++ ++APE         
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNP 213
Query: 222 VSESCDVYSFGILLLEILTGRKP 244
            S   DVYS+GI+L E++TG  P
Sbjct: 214 FSFQSDVYSYGIVLYELMTGELP 236

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 138/293 (47%), Gaps = 40/293 (13%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAE-------MEFAVEVEV 90
           A N    + ++G+GGFG V+ GR   D   +A+K L   +S+ E        EF  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 91  LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
           +  + H N++ L G      +  +V +++P   L   L  +      + W  ++++ +  
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDI 131
Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFE--PL---VADFGFAKLIPEGVSHMTTRV 205
           A GI Y+ ++  P I+HRD+++ N+ L S  E  P+   VADFG +    +   H  + +
Sbjct: 132 ALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS----QQSVHSVSGL 186
Query: 206 KGTLGYLAPEY--AMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL 263
            G   ++APE   A     +E  D YSF ++L  ILTG  P ++   G            
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG------------ 234
Query: 264 IVKGKFKELV-DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
             K KF  ++ +  LR    E+   +  NV  LC   +P+KRP+   +V  L+
Sbjct: 235 --KIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 82/268 (30%), Positives = 119/268 (44%), Gaps = 28/268 (10%)
Query: 47  NKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +KLG G FG VY   W + S  L +AVK LK    + E EF  E  V+  ++H NL+ L 
Sbjct: 17  HKLGGGQFGEVYEGVWKKYS--LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 73
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G C       I+ ++M   +LL +L      EV       M   I SA  + YL  +   
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA--MEYLEKK--- 128
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + IHRD+ A N L+  +    VADFG ++L+           K  + + APE   + K S
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFS 188
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV++FG+LL EI T G  P                 P I   +  EL++   R +  
Sbjct: 189 IKSDVWAFGVLLWEIATYGMSPY----------------PGIDPSQVYELLEKDYRMERP 232
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           E   ++   +   C Q  P  RP+  E+
Sbjct: 233 EGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 84/276 (30%), Positives = 130/276 (47%), Gaps = 19/276 (6%)
Query: 49  LGEGGFGSV---YWGRTSDGL--QIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGL 102
           LGEG FG V    +  T+DG    +AVK LKA    +    +  E+++L  + H++++  
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 103 RGYC--AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           +G C  AG     +V +Y+P  SL  +L     G  QL     +  A    EG+ YLH +
Sbjct: 99  KGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHAQ 153
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG--TLGYLAPEYAM 218
              H IHRD+ A NVLLD+D    + DFG AK +PEG      R  G   + + APE   
Sbjct: 154 ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLK 210
Query: 219 WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR 278
             K   + DV+SFG+ L E+LT     +  P      I   A+  +   +  EL++   R
Sbjct: 211 EYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIG-IAQGQMTVLRLTELLERGER 269
Query: 279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
               +    +  ++   C ++E   RP  + ++  L
Sbjct: 270 LPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPIL 305

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 133/272 (48%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G FG V+ G  +   ++A+K LK      E  F  E +++ +++H  L+ L  Y  
Sbjct: 16  RLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPE-SFLEEAQIMKKLKHDKLVQL--YAV 72
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            +++ + IV +YM   SLL  L       ++L     + +A   A G+ Y+      + I
Sbjct: 73  VSEEPIYIVTEYMNKGSLLDFLKDGEGRALKL--PNLVDMAAQVAAGMAYIERM---NYI 127
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++++N+L+ +     +ADFG A+LI +         K  + + APE A++G+ +   
Sbjct: 128 HRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKS 187
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL E++T GR P    PG   R + E  E    +G          R    ++ 
Sbjct: 188 DVWSFGILLTELVTKGRVP---YPGMNNREVLEQVE----RG---------YRMPCPQDC 231
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
                 + + C + +PE+RP  + + + L  Y
Sbjct: 232 PISLHELMIHCWKKDPEERPTFEYLQSFLEDY 263

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 82/293 (27%), Positives = 138/293 (47%), Gaps = 40/293 (13%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAE-------MEFAVEVEV 90
           A N    + ++G+GGFG V+ GR   D   +A+K L   +S+ E        EF  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 91  LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
           +  + H N++ L G      +  +V +++P   L   L  +      + W  ++++ +  
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDI 131
Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFE--PL---VADFGFAKLIPEGVSHMTTRV 205
           A GI Y+ ++  P I+HRD+++ N+ L S  E  P+   VADFG +    +   H  + +
Sbjct: 132 ALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTS----QQSVHSVSGL 186
Query: 206 KGTLGYLAPEY--AMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL 263
            G   ++APE   A     +E  D YSF ++L  ILTG  P ++   G            
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG------------ 234
Query: 264 IVKGKFKELV-DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
             K KF  ++ +  LR    E+   +  NV  LC   +P+KRP+   +V  L+
Sbjct: 235 --KIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 123/269 (45%), Gaps = 24/269 (8%)
Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            +LG G FG V  G+      +AVK +K   S +E EF  E + + ++ H  L+   G C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
           +      IV +Y+ N  LL++L     G   L+  + +++     EG+ +L    +   I
Sbjct: 73  SKEYPIYIVTEYISNGCLLNYLRSHGKG---LEPSQLLEMCYDVCEGMAFLE---SHQFI 126
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD+ A N L+D D    V+DFG  + + +     +   K  + + APE   + K S   
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV++FGIL+ E+ + G+ P +             +E ++   +   L  P L  D     
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTN---------SEVVLKVSQGHRLYRPHLASD----- 232
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                 +   C    PEKRP  +++++++
Sbjct: 233 --TIYQIMYSCWHELPEKRPTFQQLLSSI 259

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 102/217 (47%), Gaps = 14/217 (6%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVE 89
           K+   A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE
Sbjct: 27  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 86
Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIG 149
           +   +RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R       
Sbjct: 87  IQSHLRHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITE 142
Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
            A  + Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S   T + GTL
Sbjct: 143 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTL 196
Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
            YL PE        E  D++S G+L  E L G+ P E
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 102/217 (47%), Gaps = 14/217 (6%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVE 89
           K+   A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIG 149
           +   +RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R       
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITE 117
Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
            A  + Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S   T + GTL
Sbjct: 118 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHAP---SSRRTTLSGTL 171
Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
            YL PE        E  D++S G+L  E L G+ P E
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 131/272 (48%), Gaps = 26/272 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G  G V+ G  +   ++AVK LK   S +   F  E  ++ +++H+ L+  R Y  
Sbjct: 20  RLGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLV--RLYAV 76
Query: 108 GTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
            T + + I+ +YM N SL+  L  +    ++L   + + +A   AEG+ ++      + I
Sbjct: 77  VTQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYI 131
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD++A+N+L+       +ADFG A+LI +         K  + + APE   +G  +   
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           DV+SFGILL EI+T GR P    PG     + +  E      +   +V P       +N 
Sbjct: 192 DVWSFGILLTEIVTHGRIP---YPGMTNPEVIQNLE------RGYRMVRP-------DNC 235
Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
            ++   +  LC +  PE RP    + + L  +
Sbjct: 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 105/200 (52%), Gaps = 11/200 (5%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           +LG G FG V+ G  ++  ++AVK LK   M+ +A +E   E  ++  ++H  L+ L   
Sbjct: 20  RLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE---EANLMKTLQHDKLVRLYAV 76
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               +   I+ +YM   SLL  L     G+V L   + +  +   AEG+ Y+  +   + 
Sbjct: 77  VTREEPIYIITEYMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERK---NY 131
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSES 225
           IHRD++A+NVL+       +ADFG A++I +         K  + + APE   +G  +  
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 191
Query: 226 CDVYSFGILLLEILT-GRKP 244
            DV+SFGILL EI+T G+ P
Sbjct: 192 SDVWSFGILLYEIVTYGKIP 211

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 102/217 (47%), Gaps = 14/217 (6%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVE 89
           K+   A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE
Sbjct: 18  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 77
Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIG 149
           +   +RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R       
Sbjct: 78  IQSHLRHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITE 133
Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
            A  + Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S   T + GTL
Sbjct: 134 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTL 187
Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
            YL PE        E  D++S G+L  E L G+ P E
Sbjct: 188 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 224

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVEVLGRV 94
           A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
           RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R        A  +
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S   T + GTL YL P
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTELCGTLDYLPP 175
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
           E        E  D++S G+L  E L G+ P E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 102/217 (47%), Gaps = 14/217 (6%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVE 89
           K+   A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIG 149
           +   +RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R       
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITE 121
Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
            A  + Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S   T + GTL
Sbjct: 122 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTL 175
Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
            YL PE        E  D++S G+L  E L G+ P E
Sbjct: 176 DYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 102/217 (47%), Gaps = 14/217 (6%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVE 89
           K+   A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIG 149
           +   +RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R       
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITE 119
Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
            A  + Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S   T + GTL
Sbjct: 120 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTL 173
Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
            YL PE        E  D++S G+L  E L G+ P E
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 119/268 (44%), Gaps = 28/268 (10%)
Query: 47  NKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +KLG G +G VY   W + S  L +AVK LK    + E EF  E  V+  ++H NL+ L 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYS--LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 73
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G C       I+ ++M   +LL +L      EV       M   I SA  + YL  +   
Sbjct: 74  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA--MEYLEKK--- 128
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + IHRD+ A N L+  +    VADFG ++L+           K  + + APE   + K S
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFS 188
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV++FG+LL EI T G  P                 P I   +  EL++   R +  
Sbjct: 189 IKSDVWAFGVLLWEIATYGMSPY----------------PGIDPSQVYELLEKDYRMERP 232
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           E   ++   +   C Q  P  RP+  E+
Sbjct: 233 EGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVEVLGRV 94
           A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
           RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R        A  +
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S   T + GTL YL P
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPP 175
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
           E        E  D++S G+L  E L G+ P E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 102/217 (47%), Gaps = 14/217 (6%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVE 89
           K+   A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIG 149
           +   +RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R       
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITE 121
Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
            A  + Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S   T + GTL
Sbjct: 122 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTL 175
Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
            YL PE        E  D++S G+L  E L G+ P E
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 102/217 (47%), Gaps = 14/217 (6%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVE 89
           K+   A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE
Sbjct: 1   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIG 149
           +   +RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R       
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITE 116
Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
            A  + Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S   T + GTL
Sbjct: 117 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGTL 170
Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
            YL PE        E  D++S G+L  E L G+ P E
Sbjct: 171 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 74/221 (33%), Positives = 102/221 (46%), Gaps = 22/221 (9%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVE 89
           K+   A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ----LDWKRRMK 145
           +   +RH N+L L GY     +  ++ +Y P         G+   E+Q     D +R   
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPR--------GEVYKELQKLSKFDEQRTAT 117
Query: 146 IAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRV 205
                A  + Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S   T +
Sbjct: 118 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTL 171
Query: 206 KGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
            GTL YL PE        E  D++S G+L  E L G+ P E
Sbjct: 172 CGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 102/217 (47%), Gaps = 14/217 (6%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVE 89
           K+   A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIG 149
           +   +RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R       
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITE 117
Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
            A  + Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S   T + GTL
Sbjct: 118 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGTL 171
Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
            YL PE        E  D++S G+L  E L G+ P E
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 137/293 (46%), Gaps = 40/293 (13%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAE-------MEFAVEVEV 90
           A N    + ++G+GGFG V+ GR   D   +A+K L   +S+ E        EF  EV +
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 91  LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
           +  + H N++ L G      +  +V +++P   L   L  +      + W  ++++ +  
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAH---PIKWSVKLRLMLDI 131
Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFE--PL---VADFGFAKLIPEGVSHMTTRV 205
           A GI Y+ ++  P I+HRD+++ N+ L S  E  P+   VADF  +    +   H  + +
Sbjct: 132 ALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLS----QQSVHSVSGL 186
Query: 206 KGTLGYLAPEY--AMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL 263
            G   ++APE   A     +E  D YSF ++L  ILTG  P ++   G            
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG------------ 234
Query: 264 IVKGKFKELV-DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
             K KF  ++ +  LR    E+   +  NV  LC   +P+KRP+   +V  L+
Sbjct: 235 --KIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELS 285

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 127/299 (42%), Gaps = 36/299 (12%)
Query: 16  GLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQIAVKK 72
           G    ++PN   W +             +  +KLG G +G VY   W + S  L +AVK 
Sbjct: 1   GAMDPSSPNYDKWEM--------ERTDITMKHKLGGGQYGEVYEGVWKKYS--LTVAVKT 50
Query: 73  LKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQY 132
           LK    + E EF  E  V+  ++H NL+ L G C       I+ ++M   +LL +L    
Sbjct: 51  LKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN 109
Query: 133 AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
             EV       M   I SA  + YL  +   + IHRD+ A N L+  +    VADFG ++
Sbjct: 110 RQEVNAVVLLYMATQISSA--MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 164
Query: 193 LIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGG 251
           L+           K  + + APE   + K S   DV++FG+LL EI T G  P       
Sbjct: 165 LMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY------ 218
Query: 252 VKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEV 310
                     P I   +  EL++   R +  E   ++   +   C Q  P  RP+  E+
Sbjct: 219 ----------PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 102/217 (47%), Gaps = 14/217 (6%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVE 89
           K+   A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIG 149
           +   +RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R       
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITE 121
Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
            A  + Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S   T + GTL
Sbjct: 122 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGTL 175
Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
            YL PE        E  D++S G+L  E L G+ P E
Sbjct: 176 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 102/217 (47%), Gaps = 14/217 (6%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVE 89
           K+   A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIG 149
           +   +RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R       
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITE 119
Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
            A  + Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S   T + GTL
Sbjct: 120 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTL 173
Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
            YL PE        E  D++S G+L  E L G+ P E
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVEVLGRV 94
           A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
           RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R        A  +
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S   T + GTL YL P
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGTLDYLPP 175
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
           E        E  D++S G+L  E L G+ P E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVEVLGRV 94
           A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
           RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R        A  +
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S   T + GTL YL P
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTXLCGTLDYLPP 175
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
           E        E  D++S G+L  E L G+ P E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 119/268 (44%), Gaps = 28/268 (10%)
Query: 47  NKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +KLG G +G VY   W + S  L +AVK LK    + E EF  E  V+  ++H NL+ L 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYS--LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 76
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G C       I+ ++M   +LL +L      EV       M   I SA  + YL  +   
Sbjct: 77  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA--MEYLEKK--- 131
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + IHRD+ A N L+  +    VADFG ++L+           K  + + APE   + K S
Sbjct: 132 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFS 191
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV++FG+LL EI T G  P                 P I   +  EL++   R +  
Sbjct: 192 IKSDVWAFGVLLWEIATYGMSPY----------------PGIDLSQVYELLEKDYRMERP 235
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           E   ++   +   C Q  P  RP+  E+
Sbjct: 236 EGCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 119/268 (44%), Gaps = 28/268 (10%)
Query: 47  NKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +KLG G +G VY   W + S  L +AVK LK    + E EF  E  V+  ++H NL+ L 
Sbjct: 20  HKLGGGQYGEVYEGVWKKYS--LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 76
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G C       I+ ++M   +LL +L      EV       M   I SA  + YL  +   
Sbjct: 77  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA--MEYLEKK--- 131
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + IHRD+ A N L+  +    VADFG ++L+           K  + + APE   + K S
Sbjct: 132 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFS 191
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV++FG+LL EI T G  P                 P I   +  EL++   R +  
Sbjct: 192 IKSDVWAFGVLLWEIATYGMSPY----------------PGIDLSQVYELLEKDYRMERP 235
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           E   ++   +   C Q  P  RP+  E+
Sbjct: 236 EGCPEKVYELMRACWQWNPSDRPSFAEI 263

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 119/268 (44%), Gaps = 28/268 (10%)
Query: 47  NKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +KLG G +G VY   W + S  L +AVK LK    + E EF  E  V+  ++H NL+ L 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYS--LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 77
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G C       I+ ++M   +LL +L      EV       M   I SA  + YL  +   
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA--MEYLEKK--- 132
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + IHRD+ A N L+  +    VADFG ++L+           K  + + APE   + K S
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFS 192
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV++FG+LL EI T G  P                 P I   +  EL++   R +  
Sbjct: 193 IKSDVWAFGVLLWEIATYGMSPY----------------PGIDLSQVYELLEKDYRMERP 236
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           E   ++   +   C Q  P  RP+  E+
Sbjct: 237 EGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVEVLGRV 94
           A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE+   +
Sbjct: 5   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 64
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
           RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R        A  +
Sbjct: 65  RHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITELANAL 120
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S   T + GTL YL P
Sbjct: 121 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPP 174
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
           E        E  D++S G+L  E L G+ P E
Sbjct: 175 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 127/299 (42%), Gaps = 36/299 (12%)
Query: 16  GLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQIAVKK 72
           G    ++PN   W +             +  +KLG G +G VY   W + S  L +AVK 
Sbjct: 1   GAMDPSSPNYDKWEM--------ERTDITMKHKLGGGQYGEVYEGVWKKYS--LTVAVKT 50
Query: 73  LKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQY 132
           LK    + E EF  E  V+  ++H NL+ L G C       I+ ++M   +LL +L    
Sbjct: 51  LKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN 109
Query: 133 AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
             EV       M   I SA  + YL  +   + IHRD+ A N L+  +    VADFG ++
Sbjct: 110 RQEVSAVVLLYMATQISSA--MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 164
Query: 193 LIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGG 251
           L+           K  + + APE   + K S   DV++FG+LL EI T G  P       
Sbjct: 165 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY------ 218
Query: 252 VKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEV 310
                     P I   +  EL++   R +  E   ++   +   C Q  P  RP+  E+
Sbjct: 219 ----------PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 119/268 (44%), Gaps = 28/268 (10%)
Query: 47  NKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +KLG G +G VY   W + S  L +AVK LK    + E EF  E  V+  ++H NL+ L 
Sbjct: 17  HKLGGGQYGEVYEGVWKKYS--LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 73
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G C       I+ ++M   +LL +L      EV       M   I SA  + YL  +   
Sbjct: 74  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA--MEYLEKK--- 128
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + IHRD+ A N L+  +    VADFG ++L+           K  + + APE   + K S
Sbjct: 129 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFS 188
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV++FG+LL EI T G  P                 P I   +  EL++   R +  
Sbjct: 189 IKSDVWAFGVLLWEIATYGMSPY----------------PGIDPSQVYELLEKDYRMERP 232
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           E   ++   +   C Q  P  RP+  E+
Sbjct: 233 EGCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 85/299 (28%), Positives = 127/299 (42%), Gaps = 36/299 (12%)
Query: 16  GLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQIAVKK 72
           G    ++PN   W +             +  +KLG G +G VY   W + S  L +AVK 
Sbjct: 1   GAMDPSSPNYDKWEM--------ERTDITMKHKLGGGQYGEVYEGVWKKYS--LTVAVKT 50
Query: 73  LKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQY 132
           LK    + E EF  E  V+  ++H NL+ L G C       I+ ++M   +LL +L    
Sbjct: 51  LKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN 109
Query: 133 AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
             EV       M   I SA  + YL  +   + IHRD+ A N L+  +    VADFG ++
Sbjct: 110 RQEVNAVVLLYMATQISSA--MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSR 164
Query: 193 LIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGG 251
           L+           K  + + APE   + K S   DV++FG+LL EI T G  P       
Sbjct: 165 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY------ 218
Query: 252 VKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEV 310
                     P I   +  EL++   R +  E   ++   +   C Q  P  RP+  E+
Sbjct: 219 ----------PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 119/268 (44%), Gaps = 28/268 (10%)
Query: 47  NKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +KLG G +G VY   W + S  L +AVK LK    + E EF  E  V+  ++H NL+ L 
Sbjct: 24  HKLGGGQYGEVYEGVWKKYS--LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 80
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G C       I+ ++M   +LL +L      EV       M   I SA  + YL  +   
Sbjct: 81  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA--MEYLEKK--- 135
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + IHRD+ A N L+  +    VADFG ++L+           K  + + APE   + K S
Sbjct: 136 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 195
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV++FG+LL EI T G  P                 P I   +  EL++   R +  
Sbjct: 196 IKSDVWAFGVLLWEIATYGMSPY----------------PGIDLSQVYELLEKDYRMERP 239
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           E   ++   +   C Q  P  RP+  E+
Sbjct: 240 EGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 84/294 (28%), Positives = 126/294 (42%), Gaps = 36/294 (12%)
Query: 21  TTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMN 77
           ++PN   W +             +  +KLG G +G VY   W + S  L +AVK LK   
Sbjct: 6   SSPNYDKWEM--------ERTDITMKHKLGGGQYGEVYEGVWKKYS--LTVAVKTLKEDT 55
Query: 78  SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ 137
            + E EF  E  V+  ++H NL+ L G C       I+ ++M   +LL +L      EV 
Sbjct: 56  MEVE-EFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVN 114
Query: 138 LDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG 197
                 M   I SA  + YL  +   + IHRD+ A N L+  +    VADFG ++L+   
Sbjct: 115 AVVLLYMATQISSA--MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 169
Query: 198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTI 256
                   K  + + APE   + K S   DV++FG+LL EI T G  P            
Sbjct: 170 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY----------- 218
Query: 257 TEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEV 310
                P I   +  EL++   R +  E   ++   +   C Q  P  RP+  E+
Sbjct: 219 -----PGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVEVLGRV 94
           A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE+   +
Sbjct: 10  ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 69
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
           RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R        A  +
Sbjct: 70  RHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITELANAL 125
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S   T + GTL YL P
Sbjct: 126 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPP 179
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
           E        E  D++S G+L  E L G+ P E
Sbjct: 180 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 211

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 119/268 (44%), Gaps = 28/268 (10%)
Query: 47  NKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +KLG G +G VY   W + S  L +AVK LK    + E EF  E  V+  ++H NL+ L 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYS--LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 75
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G C       I+ ++M   +LL +L      EV       M   I SA  + YL  +   
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA--MEYLEKK--- 130
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + IHRD+ A N L+  +    VADFG ++L+           K  + + APE   + K S
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV++FG+LL EI T G  P                 P I   +  EL++   R +  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPY----------------PGIDLSQVYELLEKDYRMERP 234
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           E   ++   +   C Q  P  RP+  E+
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 18/202 (8%)
Query: 49  LGEGGFGSV---YWGRTSDGL--QIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGL 102
           LGEG FG V    +  T+DG    +AVK LKA    +    +  E+++L  + H++++  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 103 RGYC--AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           +G C   G     +V +Y+P  SL  +L     G  QL     +  A    EG+ YLH +
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHSQ 136
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG--TLGYLAPEYAM 218
              H IHR++ A NVLLD+D    + DFG AK +PEG  +   R  G   + + APE   
Sbjct: 137 ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 193
Query: 219 WGKVSESCDVYSFGILLLEILT 240
             K   + DV+SFG+ L E+LT
Sbjct: 194 EYKFYYASDVWSFGVTLYELLT 215

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 119/268 (44%), Gaps = 28/268 (10%)
Query: 47  NKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +KLG G +G VY   W + S  L +AVK LK    + E EF  E  V+  ++H NL+ L 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYS--LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 75
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G C       I+ ++M   +LL +L      EV       M   I SA  + YL  +   
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA--MEYLEKK--- 130
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + IHRD+ A N L+  +    VADFG ++L+           K  + + APE   + K S
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV++FG+LL EI T G  P                 P I   +  EL++   R +  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPY----------------PGIDLSQVYELLEKDYRMERP 234
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           E   ++   +   C Q  P  RP+  E+
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 119/268 (44%), Gaps = 28/268 (10%)
Query: 47  NKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +KLG G +G VY   W + S  L +AVK LK    + E EF  E  V+  ++H NL+ L 
Sbjct: 23  HKLGGGQYGEVYEGVWKKYS--LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 79
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G C       I+ ++M   +LL +L      EV       M   I SA  + YL  +   
Sbjct: 80  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA--MEYLEKK--- 134
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + IHRD+ A N L+  +    VADFG ++L+           K  + + APE   + K S
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV++FG+LL EI T G  P                 P I   +  EL++   R +  
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPY----------------PGIDLSQVYELLEKDYRMERP 238
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           E   ++   +   C Q  P  RP+  E+
Sbjct: 239 EGCPEKVYELMRACWQWNPSDRPSFAEI 266

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 119/268 (44%), Gaps = 28/268 (10%)
Query: 47  NKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +KLG G +G VY   W + S  L +AVK LK    + E EF  E  V+  ++H NL+ L 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYS--LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 75
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G C       I+ ++M   +LL +L      EV       M   I SA  + YL  +   
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA--MEYLEKK--- 130
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + IHRD+ A N L+  +    VADFG ++L+           K  + + APE   + K S
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV++FG+LL EI T G  P                 P I   +  EL++   R +  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPY----------------PGIDLSQVYELLEKDYRMERP 234
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           E   ++   +   C Q  P  RP+  E+
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 119/268 (44%), Gaps = 28/268 (10%)
Query: 47  NKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +KLG G +G VY   W + S  L +AVK LK    + E EF  E  V+  ++H NL+ L 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYS--LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 77
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G C       I+ ++M   +LL +L      EV       M   I SA  + YL  +   
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA--MEYLEKK--- 132
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + IHRD+ A N L+  +    VADFG ++L+           K  + + APE   + K S
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 192
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV++FG+LL EI T G  P                 P I   +  EL++   R +  
Sbjct: 193 IKSDVWAFGVLLWEIATYGMSPY----------------PGIDLSQVYELLEKDYRMERP 236
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           E   ++   +   C Q  P  RP+  E+
Sbjct: 237 EGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 119/268 (44%), Gaps = 28/268 (10%)
Query: 47  NKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +KLG G +G VY   W + S  L +AVK LK    + E EF  E  V+  ++H NL+ L 
Sbjct: 21  HKLGGGQYGEVYEGVWKKYS--LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 77
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G C       I+ ++M   +LL +L      EV       M   I SA  + YL  +   
Sbjct: 78  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA--MEYLEKK--- 132
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + IHRD+ A N L+  +    VADFG ++L+           K  + + APE   + K S
Sbjct: 133 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 192
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV++FG+LL EI T G  P                 P I   +  EL++   R +  
Sbjct: 193 IKSDVWAFGVLLWEIATYGMSPY----------------PGIDLSQVYELLEKDYRMERP 236
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           E   ++   +   C Q  P  RP+  E+
Sbjct: 237 EGCPEKVYELMRACWQWNPSDRPSFAEI 264

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 119/268 (44%), Gaps = 28/268 (10%)
Query: 47  NKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +KLG G +G VY   W + S  L +AVK LK    + E EF  E  V+  ++H NL+ L 
Sbjct: 32  HKLGGGQYGEVYEGVWKKYS--LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 88
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G C       I+ ++M   +LL +L      EV       M   I SA  + YL  +   
Sbjct: 89  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA--MEYLEKK--- 143
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + IHRD+ A N L+  +    VADFG ++L+           K  + + APE   + K S
Sbjct: 144 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 203
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV++FG+LL EI T G  P                 P I   +  EL++   R +  
Sbjct: 204 IKSDVWAFGVLLWEIATYGMSPY----------------PGIDLSQVYELLEKDYRMERP 247
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           E   ++   +   C Q  P  RP+  E+
Sbjct: 248 EGCPEKVYELMRACWQWNPSDRPSFAEI 275

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 119/268 (44%), Gaps = 28/268 (10%)
Query: 47  NKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +KLG G +G VY   W + S  L +AVK LK    + E EF  E  V+  ++H NL+ L 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYS--LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 75
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G C       I+ ++M   +LL +L      EV       M   I SA  + YL  +   
Sbjct: 76  GVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA--MEYLEKK--- 130
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + IHRD+ A N L+  +    VADFG ++L+           K  + + APE   + K S
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV++FG+LL EI T G  P                 P I   +  EL++   R +  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPY----------------PGIDLSQVYELLEKDYRMERP 234
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           E   ++   +   C Q  P  RP+  E+
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 18/202 (8%)
Query: 49  LGEGGFGSV---YWGRTSDGL--QIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGL 102
           LGEG FG V    +  T+DG    +AVK LKA    +    +  E+++L  + H++++  
Sbjct: 22  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKY 81
Query: 103 RGYC--AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           +G C   G     +V +Y+P  SL  +L     G  QL     +  A    EG+ YLH +
Sbjct: 82  KGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHAQ 136
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG--TLGYLAPEYAM 218
              H IHR++ A NVLLD+D    + DFG AK +PEG  +   R  G   + + APE   
Sbjct: 137 ---HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 193
Query: 219 WGKVSESCDVYSFGILLLEILT 240
             K   + DV+SFG+ L E+LT
Sbjct: 194 EYKFYYASDVWSFGVTLYELLT 215

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 119/268 (44%), Gaps = 28/268 (10%)
Query: 47  NKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +KLG G +G VY   W + S  L +AVK LK    + E EF  E  V+  ++H NL+ L 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYS--LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 75
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G C       I+ ++M   +LL +L      EV       M   I SA  + YL  +   
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA--MEYLEKK--- 130
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + IHRD+ A N L+  +    VADFG ++L+           K  + + APE   + K S
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV++FG+LL EI T G  P                 P I   +  EL++   R +  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPY----------------PGIDLSQVYELLEKDYRMERP 234
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           E   ++   +   C Q  P  RP+  E+
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 81/268 (30%), Positives = 119/268 (44%), Gaps = 28/268 (10%)
Query: 47  NKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +KLG G +G VY   W + S  L +AVK LK    + E EF  E  V+  ++H NL+ L 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYS--LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 75
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G C       I+ ++M   +LL +L      EV       M   I SA  + YL  +   
Sbjct: 76  GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA--MEYLEKK--- 130
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + IHRD+ A N L+  +    VADFG ++L+           K  + + APE   + K S
Sbjct: 131 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV++FG+LL EI T G  P                 P I   +  EL++   R +  
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPY----------------PGIDLSQVYELLEKDYRMERP 234
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           E   ++   +   C Q  P  RP+  E+
Sbjct: 235 EGCPEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 71/212 (33%), Positives = 100/212 (47%), Gaps = 14/212 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL-KAMNSKA--EMEFAVEVEVLGRV 94
           A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE+   +
Sbjct: 3   ALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 62
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
           RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R        A  +
Sbjct: 63  RHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITELANAL 118
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S   T + GTL YL P
Sbjct: 119 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPP 172
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
           E        E  D++S G+L  E L G+ P E
Sbjct: 173 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 73/221 (33%), Positives = 101/221 (45%), Gaps = 22/221 (9%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVE 89
           K+   A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ----LDWKRRMK 145
           +   +RH N+L L GY     +  ++ +Y P         G+   E+Q     D +R   
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPR--------GEVYKELQKLSKFDEQRTAT 117
Query: 146 IAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRV 205
                A  + Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S     +
Sbjct: 118 YITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRXXL 171
Query: 206 KGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
            GTL YL PE        E  D++S G+L  E L G+ P E
Sbjct: 172 XGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 49  LGEGGFGSV---YWGRTSDGL--QIAVKKLK-AMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
           LGEG FG V    +  T+DG    +AVK LK     +    +  E+E+L  + H++++  
Sbjct: 16  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 103 RGYC--AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           +G C   G     +V +Y+P  SL  +L     G  QL     +  A    EG+ YLH +
Sbjct: 76  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEGMAYLHAQ 130
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGYLAPEYAM 218
              H IHR + A NVLLD+D    + DFG AK +PEG  +   R  G   + + APE   
Sbjct: 131 ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 187
Query: 219 WGKVSESCDVYSFGILLLEILT 240
             K   + DV+SFG+ L E+LT
Sbjct: 188 ECKFYYASDVWSFGVTLYELLT 209

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 102/202 (50%), Gaps = 18/202 (8%)
Query: 49  LGEGGFGSV---YWGRTSDGL--QIAVKKLK-AMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
           LGEG FG V    +  T+DG    +AVK LK     +    +  E+E+L  + H++++  
Sbjct: 17  LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 103 RGYC--AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           +G C   G     +V +Y+P  SL  +L     G  QL     +  A    EG+ YLH +
Sbjct: 77  KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEGMAYLHAQ 131
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGYLAPEYAM 218
              H IHR + A NVLLD+D    + DFG AK +PEG  +   R  G   + + APE   
Sbjct: 132 ---HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK 188
Query: 219 WGKVSESCDVYSFGILLLEILT 240
             K   + DV+SFG+ L E+LT
Sbjct: 189 ECKFYYASDVWSFGVTLYELLT 210

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 101/212 (47%), Gaps = 14/212 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVEVLGRV 94
           A   F     LG+G FG+VY  R  +    +A+K L KA   KA  E +   EVE+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
           RH N+L L GY   + +  ++ +Y P    L  ++ +     + D +R        A  +
Sbjct: 66  RHPNILRLYGYFHDSTRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S     + GTL YL P
Sbjct: 122 SYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRAALCGTLDYLPP 175
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
           E        E  D++S G+L  E L G+ P E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 102/217 (47%), Gaps = 14/217 (6%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVE 89
           K+   A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIG 149
           +   +RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R       
Sbjct: 63  IQSHLRHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITE 118
Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
            A  + Y H   +  +IHRDIK  N+LL S  E  +A+FG++   P   S   T + GTL
Sbjct: 119 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAP---SSRRTTLCGTL 172
Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
            YL PE        E  D++S G+L  E L G+ P E
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 64/200 (32%), Positives = 105/200 (52%), Gaps = 11/200 (5%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           KLG G FG V+ G  ++  ++AVK LK   M+ +A +E   E  ++  ++H  L+ L   
Sbjct: 19  KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLE---EANLMKTLQHDKLVRLYAV 75
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               +   I+ ++M   SLL  L     G+V L   + +  +   AEG+ Y+  +   + 
Sbjct: 76  VTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIERK---NY 130
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSES 225
           IHRD++A+NVL+       +ADFG A++I +         K  + + APE   +G  +  
Sbjct: 131 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIK 190
Query: 226 CDVYSFGILLLEILT-GRKP 244
            +V+SFGILL EI+T G+ P
Sbjct: 191 SNVWSFGILLYEIVTYGKIP 210

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/323 (26%), Positives = 152/323 (47%), Gaps = 50/323 (15%)
Query: 21  TTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWG--RTSDG---LQIAVKKLKA 75
           + PN A  +  T  E+H +    +    +G G FG VY G  +TS G   + +A+K LKA
Sbjct: 28  SDPNQAVLKFTT--EIHPSC--VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKA 83
Query: 76  -MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAG 134
               K  ++F  E  ++G+  H N++ L G  +     +I+ +YM N +L   L  +  G
Sbjct: 84  GYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLR-EKDG 142
Query: 135 EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI 194
           E  +   + + +  G A G+ YL +    + +HRD+ A N+L++S+    V+DFG ++++
Sbjct: 143 EFSV--LQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197
Query: 195 ---PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
              PE  ++ T+  K  + + APE   + K + + DV+SFGI++ E++T G +P  +L  
Sbjct: 198 EDDPEA-TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS- 255
Query: 251 GVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEV 310
                            +  + ++   R     +       + + C Q E  +RP   ++
Sbjct: 256 ---------------NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADI 300
Query: 311 VN-------------TLTGYDPR 320
           V+             TL  +DPR
Sbjct: 301 VSILDKLIRAPDSLKTLADFDPR 323

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 101/217 (46%), Gaps = 14/217 (6%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVE 89
           K+   A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE
Sbjct: 27  KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 86
Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIG 149
           +   +RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R       
Sbjct: 87  IQSHLRHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITE 142
Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
            A  + Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S     + GTL
Sbjct: 143 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRDDLCGTL 196
Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
            YL PE        E  D++S G+L  E L G+ P E
Sbjct: 197 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 101/217 (46%), Gaps = 14/217 (6%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVE 89
           K+   A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE
Sbjct: 3   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 62
Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIG 149
           +   +RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R       
Sbjct: 63  IQSHLRHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITE 118
Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
            A  + Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S     + GTL
Sbjct: 119 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRXXLCGTL 172
Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
            YL PE        E  D++S G+L  E L G+ P E
Sbjct: 173 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 102/217 (47%), Gaps = 14/217 (6%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVE 89
           K+   A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIG 149
           +   +RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R       
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITE 119
Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
            A  + Y H   +  +IHRDIK  N+LL S  E  +A+FG++   P   S   T + GTL
Sbjct: 120 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHAP---SSRRTTLCGTL 173
Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
            YL PE        E  D++S G+L  E L G+ P E
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 101/217 (46%), Gaps = 14/217 (6%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVE 89
           K+   A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIG 149
           +   +RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R       
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITE 117
Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
            A  + Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S     + GTL
Sbjct: 118 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRDTLCGTL 171
Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
            YL PE        E  D++S G+L  E L G+ P E
Sbjct: 172 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 99/212 (46%), Gaps = 14/212 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVEVLGRV 94
           A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
           RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R        A  +
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S     + GTL YL P
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRAALCGTLDYLPP 178
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
           E        E  D++S G+L  E L G+ P E
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 101/217 (46%), Gaps = 14/217 (6%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVE 89
           K+   A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE
Sbjct: 4   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIG 149
           +   +RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R       
Sbjct: 64  IQSHLRHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITE 119
Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
            A  + Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S     + GTL
Sbjct: 120 LANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRXXLCGTL 173
Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
            YL PE        E  D++S G+L  E L G+ P E
Sbjct: 174 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 99/212 (46%), Gaps = 14/212 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVEVLGRV 94
           A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
           RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R        A  +
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S     + GTL YL P
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRAALCGTLDYLPP 175
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
           E        E  D++S G+L  E L G+ P E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 99/212 (46%), Gaps = 14/212 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVEVLGRV 94
           A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE+   +
Sbjct: 6   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 65
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
           RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R        A  +
Sbjct: 66  RHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITELANAL 121
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S     + GTL YL P
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRXXLCGTLDYLPP 175
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
           E        E  D++S G+L  E L G+ P E
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 119/268 (44%), Gaps = 28/268 (10%)
Query: 47  NKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +KLG G +G VY   W + S  L +AVK LK    + E EF  E  V+  ++H NL+ L 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYS--LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 282
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G C       I+ ++M   +LL +L      EV       M   I SA  + YL  +   
Sbjct: 283 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA--MEYLEKK--- 337
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + IHR++ A N L+  +    VADFG ++L+           K  + + APE   + K S
Sbjct: 338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 397
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV++FG+LL EI T G  P                 P I   +  EL++   R +  
Sbjct: 398 IKSDVWAFGVLLWEIATYGMSPY----------------PGIDLSQVYELLEKDYRMERP 441
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           E   ++   +   C Q  P  RP+  E+
Sbjct: 442 EGCPEKVYELMRACWQWNPSDRPSFAEI 469

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 48  KLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +LG+G FGSV   R  D LQ      +AVKKL+    +   +F  E+E+L  ++H N++ 
Sbjct: 20  QLGKGNFGSVEMCRY-DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 102 LRGYC--AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            +G C  AG     ++ +Y+P  SL  +L    A   ++D  + ++      +G+ YL  
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQ---AHAERIDHIKLLQYTSQICKGMEYLG- 134
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGYLAPEYA 217
             T   IHRD+   N+L++++    + DFG  K++P+       +  G   + + APE  
Sbjct: 135 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
              K S + DV+SFG++L E+ T  +  +  P    R I
Sbjct: 193 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 231

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/268 (29%), Positives = 119/268 (44%), Gaps = 28/268 (10%)
Query: 47  NKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +KLG G +G VY   W + S  L +AVK LK    + E EF  E  V+  ++H NL+ L 
Sbjct: 265 HKLGGGQYGEVYEGVWKKYS--LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 321
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G C       I+ ++M   +LL +L      EV       M   I SA  + YL  +   
Sbjct: 322 GVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSA--MEYLEKK--- 376
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + IHR++ A N L+  +    VADFG ++L+           K  + + APE   + K S
Sbjct: 377 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 436
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV++FG+LL EI T G  P                 P I   +  EL++   R +  
Sbjct: 437 IKSDVWAFGVLLWEIATYGMSPY----------------PGIDLSQVYELLEKDYRMERP 480
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           E   ++   +   C Q  P  RP+  E+
Sbjct: 481 EGCPEKVYELMRACWQWNPSDRPSFAEI 508

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 128/273 (46%), Gaps = 34/273 (12%)
Query: 46  DNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           + KLG G FG V+    +   ++AVK +K  +   E  F  E  V+  ++H  L+ L   
Sbjct: 187 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEA-FLAEANVMKTLQHDKLVKLHA- 244
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               +   I+ ++M   SLL  L      +  L   + +  +   AEG+ ++      + 
Sbjct: 245 VVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NY 299
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSES 225
           IHRD++A+N+L+ +     +ADFG A++            K  + + APE   +G  +  
Sbjct: 300 IHRDLRAANILVSASLVCKIADFGLARV----------GAKFPIKWTAPEAINFGSFTIK 349
Query: 226 CDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN 284
            DV+SFGILL+EI+T GR P    PG         + P +++      ++   R    EN
Sbjct: 350 SDVWSFGILLMEIVTYGRIP---YPGM--------SNPEVIRA-----LERGYRMPRPEN 393
Query: 285 QLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
             ++  N+ + C ++ PE+RP  + + + L  +
Sbjct: 394 CPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 426

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 99/212 (46%), Gaps = 14/212 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVEVLGRV 94
           A   F     LG+G FG+VY  R       +A+K L KA   KA  E +   EVE+   +
Sbjct: 9   ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHL 68
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
           RH N+L L GY     +  ++ +Y P    L  ++ +     + D +R        A  +
Sbjct: 69  RHPNILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSKFDEQRTATYITELANAL 124
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            Y H   +  +IHRDIK  N+LL S  E  +ADFG++   P   S     + GTL YL P
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRDDLCGTLDYLPP 178
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
           E        E  D++S G+L  E L G+ P E
Sbjct: 179 EMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 48  KLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +LG+G FGSV   R  D LQ      +AVKKL+    +   +F  E+E+L  ++H N++ 
Sbjct: 17  QLGKGNFGSVEMCRY-DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 102 LRGYC--AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            +G C  AG     ++ +Y+P  SL  +L      + ++D  + ++      +G+ YL  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLG- 131
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGYLAPEYA 217
             T   IHRD+   N+L++++    + DFG  K++P+       +  G   + + APE  
Sbjct: 132 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189
Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
              K S + DV+SFG++L E+ T  +  +  P    R I
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/241 (29%), Positives = 121/241 (50%), Gaps = 20/241 (8%)
Query: 16  GLTTITTPN---NATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGR----TSDGLQI 68
           GL T   P+   + T  +  + +   ATN  S D  +G G FG V  GR    +   + +
Sbjct: 18  GLRTFVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 69  AVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSH 127
           A+K LK     K   +F  E  ++G+  H N++ L G    +   +IV +YM N SL S 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 128 LHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD 187
           L      + Q    + + +  G A G+ YL        +HRD+ A N+L++S+    V+D
Sbjct: 137 LRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSD 190
Query: 188 FGFAKLI---PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRK 243
           FG A+++   PE  ++ T   K  + + +PE   + K + + DV+S+GI+L E+++ G +
Sbjct: 191 FGLARVLEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 244 P 244
           P
Sbjct: 250 P 250

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 48  KLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +LG+G FGSV   R  D LQ      +AVKKL+    +   +F  E+E+L  ++H N++ 
Sbjct: 16  QLGKGNFGSVEMCRY-DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 102 LRGYC--AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            +G C  AG     ++ +Y+P  SL  +L      + ++D  + ++      +G+ YL  
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLG- 130
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGYLAPEYA 217
             T   IHRD+   N+L++++    + DFG  K++P+       +  G   + + APE  
Sbjct: 131 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 188
Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
              K S + DV+SFG++L E+ T  +  +  P    R I
Sbjct: 189 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 227

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/208 (33%), Positives = 98/208 (47%), Gaps = 14/208 (6%)
Query: 43  FSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVEVLGRVRHKN 98
           F     LG+G FG+VY  R       +A+K L K    KA  E +   EVE+   +RH N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           +L L GY     +  ++ +Y P    L  ++ +     + D +R        A  + Y H
Sbjct: 74  ILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSRFDEQRTATYITELANALSYCH 129
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM 218
              +  +IHRDIK  N+LL S+ E  +ADFG++   P   S   T + GTL YL PE   
Sbjct: 130 ---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIE 183
Query: 219 WGKVSESCDVYSFGILLLEILTGRKPIE 246
                E  D++S G+L  E L G  P E
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAE---MEFAVEVEVLGRVRHKNLLGL 102
           +KLG GG  +VY    T   +++A+K +     + E     F  EV    ++ H+N++ +
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76
Query: 103 RGYCAGTDQRLIVYDYM--PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
                  D   +V +Y+  P LS     HG  + +  +++  ++       +GI + H  
Sbjct: 77  IDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQI------LDGIKHAH-- 128
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
               I+HRDIK  N+L+DS+    + DFG AK + E     T  V GT+ Y +PE A   
Sbjct: 129 -DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE 187
Query: 221 KVSESCDVYSFGILLLEILTGRKP 244
              E  D+YS GI+L E+L G  P
Sbjct: 188 ATDECTDIYSIGIVLYEMLVGEPP 211

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 48  KLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +LG+G FGSV   R  D LQ      +AVKKL+    +   +F  E+E+L  ++H N++ 
Sbjct: 17  QLGKGNFGSVEMCRY-DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 102 LRGYC--AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            +G C  AG     ++ +Y+P  SL  +L      + ++D  + ++      +G+ YL  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLG- 131
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGYLAPEYA 217
             T   IHRD+   N+L++++    + DFG  K++P+       +  G   + + APE  
Sbjct: 132 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
              K S + DV+SFG++L E+ T  +  +  P    R I
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 48  KLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +LG+G FGSV   R  D LQ      +AVKKL+    +   +F  E+E+L  ++H N++ 
Sbjct: 15  QLGKGNFGSVEMCRY-DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 102 LRGYC--AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            +G C  AG     ++ +Y+P  SL  +L      + ++D  + ++      +G+ YL  
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLG- 129
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGYLAPEYA 217
             T   IHRD+   N+L++++    + DFG  K++P+       +  G   + + APE  
Sbjct: 130 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 187
Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
              K S + DV+SFG++L E+ T  +  +  P    R I
Sbjct: 188 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 226

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 48  KLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +LG+G FGSV   R  D LQ      +AVKKL+    +   +F  E+E+L  ++H N++ 
Sbjct: 22  QLGKGNFGSVEMCRY-DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 102 LRGYC--AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            +G C  AG     ++ +Y+P  SL  +L      + ++D  + ++      +G+ YL  
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLG- 136
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGYLAPEYA 217
             T   IHRD+   N+L++++    + DFG  K++P+       +  G   + + APE  
Sbjct: 137 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 194
Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
              K S + DV+SFG++L E+ T  +  +  P    R I
Sbjct: 195 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 233

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 48  KLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +LG+G FGSV   R  D LQ      +AVKKL+    +   +F  E+E+L  ++H N++ 
Sbjct: 48  QLGKGNFGSVEMCRY-DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 102 LRGYC--AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            +G C  AG     ++ +Y+P  SL  +L      + ++D  + ++      +G+ YL  
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLG- 162
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGYLAPEYA 217
             T   IHRD+   N+L++++    + DFG  K++P+       +  G   + + APE  
Sbjct: 163 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 220
Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
              K S + DV+SFG++L E+ T  +  +  P    R I
Sbjct: 221 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 259

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 48  KLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +LG+G FGSV   R  D LQ      +AVKKL+    +   +F  E+E+L  ++H N++ 
Sbjct: 20  QLGKGNFGSVEMCRY-DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 102 LRGYC--AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            +G C  AG     ++ +Y+P  SL  +L      + ++D  + ++      +G+ YL  
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLG- 134
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGYLAPEYA 217
             T   IHRD+   N+L++++    + DFG  K++P+       +  G   + + APE  
Sbjct: 135 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
              K S + DV+SFG++L E+ T  +  +  P    R I
Sbjct: 193 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 231

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 81/267 (30%), Positives = 117/267 (43%), Gaps = 28/267 (10%)
Query: 47  NKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +KLG G +G VY   W + S  L +AVK LK    + E EF  E  V+  ++H NL+ L 
Sbjct: 38  HKLGGGQYGEVYVGVWKKYS--LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLL 94
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G C       IV +YMP  +LL +L      EV       M   I SA  + YL  +   
Sbjct: 95  GVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSA--MEYLEKK--- 149
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + IHRD+ A N L+  +    VADFG ++L+           K  + + APE   +   S
Sbjct: 150 NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFS 209
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV++FG+LL EI T G  P                 P I   +  +L++   R +  
Sbjct: 210 IKSDVWAFGVLLWEIATYGMSPY----------------PGIDLSQVYDLLEKGYRMEQP 253
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKE 309
           E    +   +   C +  P  RP+  E
Sbjct: 254 EGCPPKVYELMRACWKWSPADRPSFAE 280

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 48  KLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +LG+G FGSV   R  D LQ      +AVKKL+    +   +F  E+E+L  ++H N++ 
Sbjct: 23  QLGKGNFGSVEMCRY-DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 102 LRGYC--AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            +G C  AG     ++ +Y+P  SL  +L      + ++D  + ++      +G+ YL  
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLG- 137
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGYLAPEYA 217
             T   IHRD+   N+L++++    + DFG  K++P+       +  G   + + APE  
Sbjct: 138 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 195
Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
              K S + DV+SFG++L E+ T  +  +  P    R I
Sbjct: 196 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 234

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 48  KLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +LG+G FGSV   R  D LQ      +AVKKL+    +   +F  E+E+L  ++H N++ 
Sbjct: 21  QLGKGNFGSVEMCRY-DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 102 LRGYC--AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            +G C  AG     ++ +Y+P  SL  +L      + ++D  + ++      +G+ YL  
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLG- 135
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGYLAPEYA 217
             T   IHRD+   N+L++++    + DFG  K++P+       +  G   + + APE  
Sbjct: 136 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 193
Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
              K S + DV+SFG++L E+ T  +  +  P    R I
Sbjct: 194 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 232

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 48  KLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +LG+G FGSV   R  D LQ      +AVKKL+    +   +F  E+E+L  ++H N++ 
Sbjct: 17  QLGKGNFGSVEMCRY-DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 102 LRGYC--AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            +G C  AG     ++ +Y+P  SL  +L      + ++D  + ++      +G+ YL  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLG- 131
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGYLAPEYA 217
             T   IHRD+   N+L++++    + DFG  K++P+       +  G   + + APE  
Sbjct: 132 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 189
Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
              K S + DV+SFG++L E+ T  +  +  P    R I
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 228

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 117/231 (50%), Gaps = 17/231 (7%)
Query: 23  PNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGR----TSDGLQIAVKKLKA-MN 77
           P  +T  +  + +   ATN  S D  +G G FG V  GR    +   + +A+K LK    
Sbjct: 16  PRGSTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT 74
Query: 78  SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ 137
            K   +F  E  ++G+  H N++ L G    +   +IV +YM N SL S L      + Q
Sbjct: 75  EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH---DAQ 131
Query: 138 LDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI--- 194
               + + +  G A G+ YL        +HRD+ A N+L++S+    V+DFG ++++   
Sbjct: 132 FTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 188
Query: 195 PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
           PE  ++ T   K  + + +PE   + K + + DV+S+GI+L E+++ G +P
Sbjct: 189 PEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 238

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 48  KLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +LG+G FGSV   R  D LQ      +AVKKL+    +   +F  E+E+L  ++H N++ 
Sbjct: 24  QLGKGNFGSVEMCRY-DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 102 LRGYC--AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            +G C  AG     ++ +Y+P  SL  +L      + ++D  + ++      +G+ YL  
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLG- 138
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGYLAPEYA 217
             T   IHRD+   N+L++++    + DFG  K++P+       +  G   + + APE  
Sbjct: 139 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 196
Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
              K S + DV+SFG++L E+ T  +  +  P    R I
Sbjct: 197 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 235

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 121/241 (50%), Gaps = 20/241 (8%)
Query: 16  GLTTITTPN---NATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGR----TSDGLQI 68
           GL T   P+   + T  +  + +   ATN  S D  +G G FG V  GR    +   + +
Sbjct: 18  GLRTFVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 69  AVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSH 127
           A+K LK     K   +F  E  ++G+  H N++ L G    +   +IV +YM N SL S 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 128 LHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD 187
           L      + Q    + + +  G A G+ YL        +HRD+ A N+L++S+    V+D
Sbjct: 137 LRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GFVHRDLAARNILINSNLVCKVSD 190
Query: 188 FGFAKLI---PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRK 243
           FG ++++   PE  ++ T   K  + + +PE   + K + + DV+S+GI+L E+++ G +
Sbjct: 191 FGLSRVLEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 244 P 244
           P
Sbjct: 250 P 250

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 48  KLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +LG+G FGSV   R  D LQ      +AVKKL+    +   +F  E+E+L  ++H N++ 
Sbjct: 35  QLGKGNFGSVEMCRY-DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 102 LRGYC--AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            +G C  AG     ++ +Y+P  SL  +L      + ++D  + ++      +G+ YL  
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLG- 149
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGYLAPEYA 217
             T   IHRD+   N+L++++    + DFG  K++P+       +  G   + + APE  
Sbjct: 150 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
              K S + DV+SFG++L E+ T  +  +  P    R I
Sbjct: 208 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 246

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 48  KLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +LG+G FGSV   R  D LQ      +AVKKL+    +   +F  E+E+L  ++H N++ 
Sbjct: 35  QLGKGNFGSVEMCRY-DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 102 LRGYC--AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            +G C  AG     ++ +Y+P  SL  +L      + ++D  + ++      +G+ YL  
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLG- 149
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGYLAPEYA 217
             T   IHRD+   N+L++++    + DFG  K++P+       +  G   + + APE  
Sbjct: 150 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 207
Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
              K S + DV+SFG++L E+ T  +  +  P    R I
Sbjct: 208 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 246

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 121/241 (50%), Gaps = 20/241 (8%)
Query: 16  GLTTITTPN---NATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGR----TSDGLQI 68
           GL T   P+   + T  +  + +   ATN  S D  +G G FG V  GR    +   + +
Sbjct: 18  GLRTFVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 69  AVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSH 127
           A+K LK     K   +F  E  ++G+  H N++ L G    +   +IV +YM N SL S 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 128 LHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD 187
           L      + Q    + + +  G A G+ YL        +HRD+ A N+L++S+    V+D
Sbjct: 137 LRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSD 190
Query: 188 FGFAKLI---PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRK 243
           FG ++++   PE  ++ T   K  + + +PE   + K + + DV+S+GI+L E+++ G +
Sbjct: 191 FGLSRVLEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 244 P 244
           P
Sbjct: 250 P 250

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 121/241 (50%), Gaps = 20/241 (8%)
Query: 16  GLTTITTPN---NATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGR----TSDGLQI 68
           GL T   P+   + T  +  + +   ATN  S D  +G G FG V  GR    +   + +
Sbjct: 18  GLRTFVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 69  AVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSH 127
           A+K LK     K   +F  E  ++G+  H N++ L G    +   +IV +YM N SL S 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 128 LHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD 187
           L      + Q    + + +  G A G+ YL        +HRD+ A N+L++S+    V+D
Sbjct: 137 LRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSD 190
Query: 188 FGFAKLI---PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRK 243
           FG ++++   PE  ++ T   K  + + +PE   + K + + DV+S+GI+L E+++ G +
Sbjct: 191 FGLSRVLEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 244 P 244
           P
Sbjct: 250 P 250

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 111/219 (50%), Gaps = 17/219 (7%)
Query: 48  KLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +LG+G FGSV   R  D LQ      +AVKKL+    +   +F  E+E+L  ++H N++ 
Sbjct: 18  QLGKGNFGSVEMCRY-DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 102 LRGYC--AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            +G C  AG     ++ +Y+P  SL  +L      + ++D  + ++      +G+ YL  
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLG- 132
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGYLAPEYA 217
             T   IHR++   N+L++++    + DFG  K++P+   +   +  G   + + APE  
Sbjct: 133 --TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 190
Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
              K S + DV+SFG++L E+ T  +  +  P    R I
Sbjct: 191 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 229

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 121/241 (50%), Gaps = 20/241 (8%)
Query: 16  GLTTITTPN---NATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGR----TSDGLQI 68
           GL T   P+   + T  +  + +   ATN  S D  +G G FG V  GR    +   + +
Sbjct: 16  GLRTYVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISV 74
Query: 69  AVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSH 127
           A+K LK     K   +F  E  ++G+  H N++ L G    +   +IV +YM N SL S 
Sbjct: 75  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 134
Query: 128 LHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD 187
           L      + Q    + + +  G A G+ YL        +HRD+ A N+L++S+    V+D
Sbjct: 135 LRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSD 188
Query: 188 FGFAKLI---PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRK 243
           FG ++++   PE  ++ T   K  + + +PE   + K + + DV+S+GI+L E+++ G +
Sbjct: 189 FGLSRVLEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 247
Query: 244 P 244
           P
Sbjct: 248 P 248

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 120/241 (49%), Gaps = 20/241 (8%)
Query: 16  GLTTITTPN---NATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGR----TSDGLQI 68
           GL T   P+   + T  +  + +   ATN  S D  +G G FG V  GR    +   + +
Sbjct: 18  GLRTFVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 69  AVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSH 127
           A+K LK     K   +F  E  ++G+  H N++ L G    +   +IV +YM N SL S 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 128 LHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD 187
           L      + Q    + + +  G A G+ YL        +HRD+ A N+L++S+    V+D
Sbjct: 137 LRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSD 190
Query: 188 FGFAKLI---PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRK 243
           FG  +++   PE  ++ T   K  + + +PE   + K + + DV+S+GI+L E+++ G +
Sbjct: 191 FGLGRVLEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 244 P 244
           P
Sbjct: 250 P 250

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 121/241 (50%), Gaps = 20/241 (8%)
Query: 16  GLTTITTPN---NATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGR----TSDGLQI 68
           GL T   P+   + T  +  + +   ATN  S D  +G G FG V  GR    +   + +
Sbjct: 18  GLRTYVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 69  AVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSH 127
           A+K LK     K   +F  E  ++G+  H N++ L G    +   +IV +YM N SL S 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 128 LHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD 187
           L      + Q    + + +  G A G+ YL        +HRD+ A N+L++S+    V+D
Sbjct: 137 LRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSD 190
Query: 188 FGFAKLI---PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRK 243
           FG ++++   PE  ++ T   K  + + +PE   + K + + DV+S+GI+L E+++ G +
Sbjct: 191 FGLSRVLEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 244 P 244
           P
Sbjct: 250 P 250

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/241 (29%), Positives = 121/241 (50%), Gaps = 20/241 (8%)
Query: 16  GLTTITTPN---NATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGR----TSDGLQI 68
           GL T   P+   + T  +  + +   ATN  S D  +G G FG V  GR    +   + +
Sbjct: 18  GLRTYVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 69  AVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSH 127
           A+K LK     K   +F  E  ++G+  H N++ L G    +   +IV +YM N SL S 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136
Query: 128 LHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD 187
           L      + Q    + + +  G A G+ YL        +HRD+ A N+L++S+    V+D
Sbjct: 137 LRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSD 190
Query: 188 FGFAKLI---PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRK 243
           FG ++++   PE  ++ T   K  + + +PE   + K + + DV+S+GI+L E+++ G +
Sbjct: 191 FGLSRVLEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 244 P 244
           P
Sbjct: 250 P 250

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/219 (28%), Positives = 110/219 (50%), Gaps = 17/219 (7%)
Query: 48  KLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +LG+G FGSV   R  D LQ      +AVKKL+    +   +F  E+E+L  ++H N++ 
Sbjct: 20  QLGKGNFGSVEMCRY-DPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 102 LRGYC--AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            +G C  AG     ++ +++P  SL  +L      + ++D  + ++      +G+ YL  
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKH---KERIDHIKLLQYTSQICKGMEYLG- 134
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGYLAPEYA 217
             T   IHRD+   N+L++++    + DFG  K++P+       +  G   + + APE  
Sbjct: 135 --TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESL 192
Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
              K S + DV+SFG++L E+ T  +  +  P    R I
Sbjct: 193 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMI 231

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 132/294 (44%), Gaps = 42/294 (14%)
Query: 37  HTATNGFSDDNKLGEGGFGSVYWGRT------SDGLQIAVKKLKAMNSKAEMEFAVEVEV 90
           H   +      +LGEG FG V+           D + +AVK LK  +  A  +F  E E+
Sbjct: 9   HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAEL 68
Query: 91  LGRVRHKNLLGLRGYCAGTDQRLIVYDYMP--NLSLLSHLHGQYA-------GEVQLDWK 141
           L  ++H++++   G C   D  ++V++YM   +L+     HG  A          +L   
Sbjct: 69  LTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQS 128
Query: 142 RRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM 201
           + + IA   A G++YL    + H +HRD+   N L+  +    + DFG ++ +    S  
Sbjct: 129 QMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDV---YSTD 182
Query: 202 TTRVKG----TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTI 256
             RV G     + ++ PE  M+ K +   DV+S G++L EI T G++P  +L       +
Sbjct: 183 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN---EV 239
Query: 257 TEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEV 310
            E     I +G+   L  P+          ++   + + C Q EP  R N+K +
Sbjct: 240 IE----CITQGRV--LQRPR-------TCPQEVYELMLGCWQREPHMRKNIKGI 280

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 121/253 (47%), Gaps = 32/253 (12%)
Query: 10  SEKVEEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGL 66
           +E VE    + T PN A  RI    EL            LG G FG+VY   W    + +
Sbjct: 14  TELVEPLTPSGTAPNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETV 66
Query: 67  QIAVKKLKAMNS----KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNL 122
           +I V  +K +N     KA +EF  E  ++  + H +L+ L G C     +L+    MP+ 
Sbjct: 67  KIPVA-IKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVT-QLMPHG 124
Query: 123 SLLSHLH---GQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS 179
            LL ++H        ++ L+W       +  A+G++YL       ++HRD+ A NVL+ S
Sbjct: 125 CLLEYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEER---RLVHRDLAARNVLVKS 175
Query: 180 DFEPLVADFGFAKLIPEG--VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLE 237
                + DFG A+L+ EG    +     K  + ++A E   + K +   DV+S+G+ + E
Sbjct: 176 PNHVKITDFGLARLL-EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWE 234
Query: 238 ILT-GRKPIEKLP 249
           ++T G KP + +P
Sbjct: 235 LMTFGGKPYDGIP 247

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 114/220 (51%), Gaps = 18/220 (8%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGR----TSDGLQIAVKKLKA-MNSKAEMEFAVEV 88
           KEL  ATN  S D  +G G FG V  GR    +   + +A+K LK     K   +F  E 
Sbjct: 11  KELD-ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 68
Query: 89  EVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAI 148
            ++G+  H N++ L G    +   +IV +YM N SL S L      + Q    + + +  
Sbjct: 69  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLR 125
Query: 149 GSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTRV 205
           G A G+ YL        +HRD+ A N+L++S+    V+DFG ++++   PE  ++ T   
Sbjct: 126 GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA-AYTTRGG 181
Query: 206 KGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
           K  + + +PE   + K + + DV+S+GI+L E+++ G +P
Sbjct: 182 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 127/273 (46%), Gaps = 30/273 (10%)
Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            ++G G FG V+ G   +  ++A+K +K   S +E +F  E EV+ ++ H  L+ L G C
Sbjct: 33  QEIGSGQFGLVHLGYWLNKDKVAIKTIKE-GSMSEDDFIEEAEVMMKLSHPKLVQLYGVC 91
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQ---YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                  +V+++M +  L  +L  Q   +A E  L       + +   EG+ YL      
Sbjct: 92  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG------MCLDVCEGMAYLEEAC-- 143
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
            +IHRD+ A N L+  +    V+DFG  + + +     +T  K  + + +PE   + + S
Sbjct: 144 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 202
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV+SFG+L+ E+ + G+ P E       R+ +E  E   +   F+ L  P+L     
Sbjct: 203 SKSDVWSFGVLMWEVFSEGKIPYE------NRSNSEVVED--ISTGFR-LYKPRLAS--- 250
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
              + Q +N    C +  PE RP    ++  L 
Sbjct: 251 -THVYQIMN---HCWKERPEDRPAFSRLLRQLA 279

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 97/208 (46%), Gaps = 14/208 (6%)
Query: 43  FSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSKA--EMEFAVEVEVLGRVRHKN 98
           F     LG+G FG+VY  R       +A+K L K    KA  E +   EVE+   +RH N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           +L L GY     +  ++ +Y P    L  ++ +     + D +R        A  + Y H
Sbjct: 74  ILRLYGYFHDATRVYLILEYAP----LGTVYRELQKLSRFDEQRTATYITELANALSYCH 129
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM 218
              +  +IHRDIK  N+LL S+ E  +ADFG++   P   S     + GTL YL PE   
Sbjct: 130 ---SKRVIHRDIKPENLLLGSNGELKIADFGWSVHAP---SSRRDTLCGTLDYLPPEMIE 183
Query: 219 WGKVSESCDVYSFGILLLEILTGRKPIE 246
                E  D++S G+L  E L G  P E
Sbjct: 184 GRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 72/279 (25%), Positives = 128/279 (45%), Gaps = 30/279 (10%)
Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            ++G G FG V+ G   +  ++A+K ++   + +E +F  E EV+ ++ H  L+ L G C
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQ---YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                  +V+++M +  L  +L  Q   +A E  L       + +   EG+ YL      
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG------MCLDVCEGMAYLEE---A 122
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
            +IHRD+ A N L+  +    V+DFG  + + +     +T  K  + + +PE   + + S
Sbjct: 123 SVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV+SFG+L+ E+ + G+ P E       R+ +E  E   +   F+ L  P+L     
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYE------NRSNSEVVED--ISTGFR-LYKPRLAS--- 230
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRG 321
              + Q +N    C +  PE RP    ++  L      G
Sbjct: 231 -THVYQIMN---HCWKERPEDRPAFSRLLRQLAAIAASG 265

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 126/268 (47%), Gaps = 24/268 (8%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G FG V +G+      +A+K +K   S +E EF  E +V+  + H+ L+ L G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH 167
                 I+ +YM N  LL++L        +   ++ +++     E + YL    +   +H
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLH 143
Query: 168 RDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCD 227
           RD+ A N L++      V+DFG ++ + +     +   K  + +  PE  M+ K S   D
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 228 VYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQL 286
           +++FG+L+ EI + G+ P E+       T +E AE  I +G    L  P L  +      
Sbjct: 204 IWAFGVLMWEIYSLGKMPYERF------TNSETAEH-IAQG--LRLYRPHLASE------ 248
Query: 287 KQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +   +   C   + ++RP  K +++ +
Sbjct: 249 -KVYTIMYSCWHEKADERPTFKILLSNI 275

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/241 (28%), Positives = 115/241 (47%), Gaps = 30/241 (12%)
Query: 21  TTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMN 77
           T PN A  RI    EL            LG G FG+VY   W    + ++I V  +K +N
Sbjct: 2   TAPNQAQLRILKETELKRV-------KVLGSGAFGTVYKGIWVPEGETVKIPVA-IKILN 53
Query: 78  S----KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLH---G 130
                KA +EF  E  ++  + H +L+ L G C     +L+    MP+  LL ++H    
Sbjct: 54  ETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVT-QLMPHGCLLEYVHEHKD 112
Query: 131 QYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGF 190
               ++ L+W       +  A+G++YL       ++HRD+ A NVL+ S     + DFG 
Sbjct: 113 NIGSQLLLNW------CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGL 163
Query: 191 AKLIP-EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKL 248
           A+L+  +   +     K  + ++A E   + K +   DV+S+G+ + E++T G KP + +
Sbjct: 164 ARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 223
Query: 249 P 249
           P
Sbjct: 224 P 224

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 127/273 (46%), Gaps = 30/273 (10%)
Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            ++G G FG V+ G   +  ++A+K ++   + +E +F  E EV+ ++ H  L+ L G C
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQ---YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                  +V+++M +  L  +L  Q   +A E  L       + +   EG+ YL      
Sbjct: 72  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG------MCLDVCEGMAYLEEAC-- 123
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
            +IHRD+ A N L+  +    V+DFG  + + +     +T  K  + + +PE   + + S
Sbjct: 124 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 182
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV+SFG+L+ E+ + G+ P E       R+ +E  E   +   F+ L  P+L     
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYE------NRSNSEVVED--ISTGFR-LYKPRLAS--- 230
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
              + Q +N    C +  PE RP    ++  L 
Sbjct: 231 -THVYQIMN---HCWKERPEDRPAFSRLLRQLA 259

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 126/268 (47%), Gaps = 24/268 (8%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G FG V +G+      +A+K +K   S +E EF  E +V+  + H+ L+ L G C 
Sbjct: 15  ELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 73
Query: 108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH 167
                 I+ +YM N  LL++L        +   ++ +++     E + YL    +   +H
Sbjct: 74  KQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLH 127
Query: 168 RDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCD 227
           RD+ A N L++      V+DFG ++ + +     +   K  + +  PE  M+ K S   D
Sbjct: 128 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 187
Query: 228 VYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQL 286
           +++FG+L+ EI + G+ P E+       T +E AE  I +G    L  P L  +      
Sbjct: 188 IWAFGVLMWEIYSLGKMPYERF------TNSETAEH-IAQG--LRLYRPHLASE------ 232
Query: 287 KQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +   +   C   + ++RP  K +++ +
Sbjct: 233 -KVYTIMYSCWHEKADERPTFKILLSNI 259

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 127/273 (46%), Gaps = 30/273 (10%)
Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            ++G G FG V+ G   +  ++A+K ++   + +E +F  E EV+ ++ H  L+ L G C
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQ---YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                  +V+++M +  L  +L  Q   +A E  L       + +   EG+ YL      
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG------MCLDVCEGMAYLEEAC-- 121
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
            +IHRD+ A N L+  +    V+DFG  + + +     +T  K  + + +PE   + + S
Sbjct: 122 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV+SFG+L+ E+ + G+ P E       R+ +E  E   +   F+ L  P+L     
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYE------NRSNSEVVED--ISTGFR-LYKPRLAS--- 228
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
              + Q +N    C +  PE RP    ++  L 
Sbjct: 229 -THVYQIMN---HCWKERPEDRPAFSRLLRQLA 257

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 126/268 (47%), Gaps = 24/268 (8%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G FG V +G+      +A+K +K   S +E EF  E +V+  + H+ L+ L G C 
Sbjct: 31  ELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH 167
                 I+ +YM N  LL++L        +   ++ +++     E + YL    +   +H
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLH 143
Query: 168 RDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCD 227
           RD+ A N L++      V+DFG ++ + +     +   K  + +  PE  M+ K S   D
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 203
Query: 228 VYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQL 286
           +++FG+L+ EI + G+ P E+       T +E AE  I +G    L  P L  +      
Sbjct: 204 IWAFGVLMWEIYSLGKMPYERF------TNSETAEH-IAQG--LRLYRPHLASE------ 248
Query: 287 KQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +   +   C   + ++RP  K +++ +
Sbjct: 249 -KVYTIMYSCWHEKADERPTFKILLSNI 275

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 126/268 (47%), Gaps = 24/268 (8%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G FG V +G+      +A+K +K   S +E EF  E +V+  + H+ L+ L G C 
Sbjct: 22  ELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 80
Query: 108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH 167
                 I+ +YM N  LL++L        +   ++ +++     E + YL    +   +H
Sbjct: 81  KQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLH 134
Query: 168 RDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCD 227
           RD+ A N L++      V+DFG ++ + +     +   K  + +  PE  M+ K S   D
Sbjct: 135 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 194
Query: 228 VYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQL 286
           +++FG+L+ EI + G+ P E+       T +E AE  I +G    L  P L  +      
Sbjct: 195 IWAFGVLMWEIYSLGKMPYERF------TNSETAEH-IAQG--LRLYRPHLASE------ 239
Query: 287 KQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +   +   C   + ++RP  K +++ +
Sbjct: 240 -KVYTIMYSCWHEKADERPTFKILLSNI 266

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 127/273 (46%), Gaps = 30/273 (10%)
Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            ++G G FG V+ G   +  ++A+K ++   + +E +F  E EV+ ++ H  L+ L G C
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQ---YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                  +V+++M +  L  +L  Q   +A E  L       + +   EG+ YL      
Sbjct: 75  LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLG------MCLDVCEGMAYLEEAC-- 126
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
            +IHRD+ A N L+  +    V+DFG  + + +     +T  K  + + +PE   + + S
Sbjct: 127 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 185
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV+SFG+L+ E+ + G+ P E       R+ +E  E   +   F+ L  P+L     
Sbjct: 186 SKSDVWSFGVLMWEVFSEGKIPYE------NRSNSEVVED--ISTGFR-LYKPRLAS--- 233
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
              + Q +N    C +  PE RP    ++  L 
Sbjct: 234 -THVYQIMN---HCWRERPEDRPAFSRLLRQLA 262

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 126/268 (47%), Gaps = 24/268 (8%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G FG V +G+      +A+K +K   S +E EF  E +V+  + H+ L+ L G C 
Sbjct: 11  ELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH 167
                 I+ +YM N  LL++L        +   ++ +++     E + YL    +   +H
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLH 123
Query: 168 RDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCD 227
           RD+ A N L++      V+DFG ++ + +     +   K  + +  PE  M+ K S   D
Sbjct: 124 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 183
Query: 228 VYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQL 286
           +++FG+L+ EI + G+ P E+       T +E AE  I +G    L  P L  +      
Sbjct: 184 IWAFGVLMWEIYSLGKMPYERF------TNSETAEH-IAQG--LRLYRPHLASE------ 228
Query: 287 KQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +   +   C   + ++RP  K +++ +
Sbjct: 229 -KVYTIMYSCWHEKADERPTFKILLSNI 255

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 126/268 (47%), Gaps = 24/268 (8%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G FG V +G+      +A+K +K   S +E EF  E +V+  + H+ L+ L G C 
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH 167
                 I+ +YM N  LL++L        +   ++ +++     E + YL    +   +H
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLH 128
Query: 168 RDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCD 227
           RD+ A N L++      V+DFG ++ + +     +   K  + +  PE  M+ K S   D
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSD 188
Query: 228 VYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQL 286
           +++FG+L+ EI + G+ P E+       T +E AE  I +G    L  P L  +      
Sbjct: 189 IWAFGVLMWEIYSLGKMPYERF------TNSETAEH-IAQG--LRLYRPHLASE------ 233
Query: 287 KQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +   +   C   + ++RP  K +++ +
Sbjct: 234 -KVYTIMYSCWHEKADERPTFKILLSNI 260

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/268 (25%), Positives = 126/268 (47%), Gaps = 24/268 (8%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G FG V +G+      +A+K +K   S +E EF  E +V+  + H+ L+ L G C 
Sbjct: 16  ELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 74
Query: 108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH 167
                 I+ +YM N  LL++L        +   ++ +++     E + YL    +   +H
Sbjct: 75  KQRPIFIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLE---SKQFLH 128
Query: 168 RDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCD 227
           RD+ A N L++      V+DFG ++ + +     +   K  + +  PE  M+ K S   D
Sbjct: 129 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSD 188
Query: 228 VYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQL 286
           +++FG+L+ EI + G+ P E+       T +E AE  I +G    L  P L  +      
Sbjct: 189 IWAFGVLMWEIYSLGKMPYERF------TNSETAEH-IAQG--LRLYRPHLASE------ 233
Query: 287 KQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +   +   C   + ++RP  K +++ +
Sbjct: 234 -KVYTIMYSCWHEKADERPTFKILLSNI 260

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 120/241 (49%), Gaps = 20/241 (8%)
Query: 16  GLTTITTPN---NATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGR----TSDGLQI 68
           GL T   P+   + T  +  + +   ATN  S D  +G G FG V  GR    +   + +
Sbjct: 18  GLRTFVDPHTFEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 69  AVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSH 127
           A+K LK     K   +F  E  ++G+  H N++ L G    +   +IV + M N SL S 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSF 136
Query: 128 LHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD 187
           L      + Q    + + +  G A G+ YL        +HRD+ A N+L++S+    V+D
Sbjct: 137 LRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GAVHRDLAARNILINSNLVCKVSD 190
Query: 188 FGFAKLI---PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRK 243
           FG ++++   PE  ++ T   K  + + +PE   + K + + DV+S+GI+L E+++ G +
Sbjct: 191 FGLSRVLEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 244 P 244
           P
Sbjct: 250 P 250

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 122/273 (44%), Gaps = 34/273 (12%)
Query: 49  LGEGGFG-SVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           LG+G FG ++       G  + +K+L   + + +  F  EV+V+  + H N+L   G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH 167
              +   + +Y+   +L   +      + Q  W +R+  A   A G+ YLH   + +IIH
Sbjct: 78  KDKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLH---SMNIIH 131
Query: 168 RDIKASNVLLDSDFEPLVADFGFAKLI------PEGVSHMTT-------RVKGTLGYLAP 214
           RD+ + N L+  +   +VADFG A+L+      PEG+  +          V G   ++AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD 274
           E        E  DV+SFGI+L EI+ GR  +   P  + RT+      L V+G       
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEII-GR--VNADPDYLPRTMDFG---LNVRGFLDRYCP 245
Query: 275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNM 307
           P     F          + V C   +PEKRP+ 
Sbjct: 246 PNCPPSF--------FPITVRCCDLDPEKRPSF 270

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 106/202 (52%), Gaps = 16/202 (7%)
Query: 49  LGEGGFGSVYWGR-----TSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLGL 102
           LGEG FG V   R      + G Q+AVK LK  +    + +   E+E+L  + H+N++  
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 103 RGYCA--GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           +G C   G +   ++ +++P+ SL  +L      + +++ K+++K A+   +G+ YL   
Sbjct: 89  KGICTEDGGNGIKLIMEFLPSGSLKEYLP---KNKNKINLKQQLKYAVQICKGMDYLG-- 143
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR--VKGTLGYLAPEYAM 218
            +   +HRD+ A NVL++S+ +  + DFG  K I       T +      + + APE  M
Sbjct: 144 -SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 202
Query: 219 WGKVSESCDVYSFGILLLEILT 240
             K   + DV+SFG+ L E+LT
Sbjct: 203 QSKFYIASDVWSFGVTLHELLT 224

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 70/241 (29%), Positives = 120/241 (49%), Gaps = 20/241 (8%)
Query: 16  GLTTITTPN---NATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGR----TSDGLQI 68
           GL T   P+   + T  +  + +   ATN  S D  +G G FG V  GR    +   + +
Sbjct: 18  GLRTYVDPHTYEDPTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISV 76
Query: 69  AVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSH 127
           A+K LK     K   +F  E  ++G+  H N++ L G    +   +IV + M N SL S 
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSF 136
Query: 128 LHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD 187
           L      + Q    + + +  G A G+ YL        +HRD+ A N+L++S+    V+D
Sbjct: 137 LRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSD 190
Query: 188 FGFAKLI---PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRK 243
           FG ++++   PE  ++ T   K  + + +PE   + K + + DV+S+GI+L E+++ G +
Sbjct: 191 FGLSRVLEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
Query: 244 P 244
           P
Sbjct: 250 P 250

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 106/202 (52%), Gaps = 16/202 (7%)
Query: 49  LGEGGFGSVYWGR-----TSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLGL 102
           LGEG FG V   R      + G Q+AVK LK  +    + +   E+E+L  + H+N++  
Sbjct: 17  LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 103 RGYCA--GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           +G C   G +   ++ +++P+ SL  +L      + +++ K+++K A+   +G+ YL   
Sbjct: 77  KGICTEDGGNGIKLIMEFLPSGSLKEYLP---KNKNKINLKQQLKYAVQICKGMDYLG-- 131
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR--VKGTLGYLAPEYAM 218
            +   +HRD+ A NVL++S+ +  + DFG  K I       T +      + + APE  M
Sbjct: 132 -SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLM 190
Query: 219 WGKVSESCDVYSFGILLLEILT 240
             K   + DV+SFG+ L E+LT
Sbjct: 191 QSKFYIASDVWSFGVTLHELLT 212

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 132/287 (45%), Gaps = 48/287 (16%)
Query: 48  KLGEGGFGSVYWGRT------SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +LGEG FG V+           D + +AVK LK  +  A  +F  E E+L  ++H++++ 
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 102 LRGYCAGTDQRLIVYDYM-------------PNLSLLSHLHGQYAGEVQLDWKRRMKIAI 148
             G C      L+V++YM             P+  LL+   G+      L   + + +A 
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLA--GGEDVAPGPLGLGQLLAVAS 165
Query: 149 GSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG- 207
             A G++YL      H +HRD+   N L+       + DFG ++ I    S    RV G 
Sbjct: 166 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI---YSTDYYRVGGR 219
Query: 208 ---TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPL 263
               + ++ PE  ++ K +   DV+SFG++L EI T G++P  +L      + TE A   
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL------SNTE-AIDC 272
Query: 264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           I +G  +EL  P+           +   +   C Q EP++R ++K+V
Sbjct: 273 ITQG--RELERPR-------ACPPEVYAIMRGCWQREPQQRHSIKDV 310

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 113/220 (51%), Gaps = 18/220 (8%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGR----TSDGLQIAVKKLKA-MNSKAEMEFAVEV 88
           KEL  ATN  S D  +G G FG V  GR    +   + +A+K LK     K   +F  E 
Sbjct: 11  KELD-ATN-ISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEA 68
Query: 89  EVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAI 148
            ++G+  H N++ L G    +   +IV + M N SL S L      + Q    + + +  
Sbjct: 69  SIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKH---DAQFTVIQLVGMLR 125
Query: 149 GSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTRV 205
           G A G+ YL        +HRD+ A N+L++S+    V+DFG ++++   PE  ++ T   
Sbjct: 126 GIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA-AYTTRGG 181
Query: 206 KGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
           K  + + +PE   + K + + DV+S+GI+L E+++ G +P
Sbjct: 182 KIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/273 (26%), Positives = 126/273 (46%), Gaps = 30/273 (10%)
Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            ++G G FG V+ G   +  ++A+K ++   + +E +F  E EV+ ++ H  L+ L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQ---YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                  +V ++M +  L  +L  Q   +A E  L       + +   EG+ YL      
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLG------MCLDVCEGMAYLEEAC-- 124
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
            +IHRD+ A N L+  +    V+DFG  + + +     +T  K  + + +PE   + + S
Sbjct: 125 -VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS 183
Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV+SFG+L+ E+ + G+ P E       R+ +E  E   +   F+ L  P+L     
Sbjct: 184 SKSDVWSFGVLMWEVFSEGKIPYE------NRSNSEVVED--ISTGFR-LYKPRLAS--- 231
Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
              + Q +N    C +  PE RP    ++  L 
Sbjct: 232 -THVYQIMN---HCWRERPEDRPAFSRLLRQLA 260

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 132/287 (45%), Gaps = 48/287 (16%)
Query: 48  KLGEGGFGSVYWGRT------SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +LGEG FG V+           D + +AVK LK  +  A  +F  E E+L  ++H++++ 
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 102 LRGYCAGTDQRLIVYDYM-------------PNLSLLSHLHGQYAGEVQLDWKRRMKIAI 148
             G C      L+V++YM             P+  LL+   G+      L   + + +A 
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLA--GGEDVAPGPLGLGQLLAVAS 142
Query: 149 GSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG- 207
             A G++YL      H +HRD+   N L+       + DFG ++ I    S    RV G 
Sbjct: 143 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI---YSTDYYRVGGR 196
Query: 208 ---TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPL 263
               + ++ PE  ++ K +   DV+SFG++L EI T G++P  +L      + TE A   
Sbjct: 197 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL------SNTE-AIDC 249
Query: 264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           I +G  +EL  P+           +   +   C Q EP++R ++K+V
Sbjct: 250 ITQG--RELERPR-------ACPPEVYAIMRGCWQREPQQRHSIKDV 287

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 132/287 (45%), Gaps = 48/287 (16%)
Query: 48  KLGEGGFGSVYWGRT------SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +LGEG FG V+           D + +AVK LK  +  A  +F  E E+L  ++H++++ 
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 102 LRGYCAGTDQRLIVYDYM-------------PNLSLLSHLHGQYAGEVQLDWKRRMKIAI 148
             G C      L+V++YM             P+  LL+   G+      L   + + +A 
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLA--GGEDVAPGPLGLGQLLAVAS 136
Query: 149 GSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG- 207
             A G++YL      H +HRD+   N L+       + DFG ++ I    S    RV G 
Sbjct: 137 QVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI---YSTDYYRVGGR 190
Query: 208 ---TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPL 263
               + ++ PE  ++ K +   DV+SFG++L EI T G++P  +L      + TE A   
Sbjct: 191 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL------SNTE-AIDC 243
Query: 264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEV 310
           I +G  +EL  P+           +   +   C Q EP++R ++K+V
Sbjct: 244 ITQG--RELERPR-------ACPPEVYAIMRGCWQREPQQRHSIKDV 281

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 118/286 (41%), Gaps = 50/286 (17%)
Query: 49  LGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           +G GGFG VY   W      ++ A        S+       E ++   ++H N++ LRG 
Sbjct: 15  IGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGV 74
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQ-YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
           C       +V ++     L   L G+    ++ ++W      A+  A G+ YLH E    
Sbjct: 75  CLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIARGMNYLHDEAIVP 128
Query: 165 IIHRDIKASNVLLDSDFEP--------LVADFGFAKLIPEGVSHMTTRVK--GTLGYLAP 214
           IIHRD+K+SN+L+    E          + DFG A+       H TT++   G   ++AP
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR-----EWHRTTKMSAAGAYAWMAP 183
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPG-----GVKRTITEWAEPLIVKGKF 269
           E       S+  DV+S+G+LL E+LTG  P   + G     GV         P      F
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPF 243
Query: 270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
            +L++                     C   +P  RP+   +++ LT
Sbjct: 244 AKLMED--------------------CWNPDPHSRPSFTNILDQLT 269

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 47  NKLGEGGFGSVYWGR-----TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           ++LG+G FGSV   R      + G  +AVK+L+      + +F  E+++L  +    ++ 
Sbjct: 16  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 75
Query: 102 LRG--YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            RG  Y  G     +V +Y+P+  L   L    A   +LD  R +  +    +G+ YL  
Sbjct: 76  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLG- 131
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG--TLGYLAPEYA 217
             +   +HRD+ A N+L++S+    +ADFG AKL+P    +   R  G   + + APE  
Sbjct: 132 --SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 189
Query: 218 MWGKVSESCDVYSFGILLLEILT 240
                S   DV+SFG++L E+ T
Sbjct: 190 SDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 47  NKLGEGGFGSVYWGR-----TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           ++LG+G FGSV   R      + G  +AVK+L+      + +F  E+++L  +    ++ 
Sbjct: 17  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 76
Query: 102 LRG--YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            RG  Y  G     +V +Y+P+  L   L    A   +LD  R +  +    +G+ YL  
Sbjct: 77  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGS 133
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG--TLGYLAPEYA 217
                 +HRD+ A N+L++S+    +ADFG AKL+P    +   R  G   + + APE  
Sbjct: 134 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 190
Query: 218 MWGKVSESCDVYSFGILLLEILT 240
                S   DV+SFG++L E+ T
Sbjct: 191 SDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 101/203 (49%), Gaps = 15/203 (7%)
Query: 47  NKLGEGGFGSVYWGR-----TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           ++LG+G FGSV   R      + G  +AVK+L+      + +F  E+++L  +    ++ 
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88
Query: 102 LRG--YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            RG  Y  G     +V +Y+P+  L   L    A   +LD  R +  +    +G+ YL  
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLG- 144
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGYLAPEYA 217
             +   +HRD+ A N+L++S+    +ADFG AKL+P    +   R  G   + + APE  
Sbjct: 145 --SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202
Query: 218 MWGKVSESCDVYSFGILLLEILT 240
                S   DV+SFG++L E+ T
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFT 225

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/203 (30%), Positives = 100/203 (49%), Gaps = 15/203 (7%)
Query: 47  NKLGEGGFGSVYWGR-----TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           ++LG+G FGSV   R      + G  +AVK+L+      + +F  E+++L  +    ++ 
Sbjct: 13  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 72
Query: 102 LRG--YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            RG  Y  G  +  +V +Y+P+  L   L    A   +LD  R +  +    +G+ YL  
Sbjct: 73  YRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRA---RLDASRLLLYSSQICKGMEYLGS 129
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG--TLGYLAPEYA 217
                 +HRD+ A N+L++S+    +ADFG AKL+P        R  G   + + APE  
Sbjct: 130 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESL 186
Query: 218 MWGKVSESCDVYSFGILLLEILT 240
                S   DV+SFG++L E+ T
Sbjct: 187 SDNIFSRQSDVWSFGVVLYELFT 209

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 99/203 (48%), Gaps = 14/203 (6%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG 108
           +G+G FG V  G    G ++AVK +K  N      F  E  V+ ++RH NL+ L G    
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 109 TDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH 167
               L IV +YM   SL+ +L  +  G   L     +K ++   E + YL      + +H
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 312
Query: 168 RDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCD 227
           RD+ A NVL+  D    V+DFG  K   E  S   T  K  + + APE     K S   D
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTG-KLPVKWTAPEALREKKFSTKSD 368
Query: 228 VYSFGILLLEILT-GRKPIEKLP 249
           V+SFGILL EI + GR P  ++P
Sbjct: 369 VWSFGILLWEIYSFGRVPYPRIP 391

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 65/222 (29%), Positives = 105/222 (47%), Gaps = 18/222 (8%)
Query: 36  LHTATNG-FSDDNKLGEGGFGSVY-WGRTSDGLQIAVKKLKA-MNSKAEMEFAVEVEVLG 92
           L T T G +    +LG GGFG V  W     G Q+A+K+ +  ++ K    + +E++++ 
Sbjct: 8   LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMK 67
Query: 93  RVRHKNLLGLRGYCAG------TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKI 146
           ++ H N++  R    G       D  L+  +Y     L  +L+ Q+     L       +
Sbjct: 68  KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTL 126
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV---ADFGFAKLIPEGVSHMTT 203
               +  + YLH      IIHRD+K  N++L    + L+    D G+AK + +G   + T
Sbjct: 127 LSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG--ELCT 181
Query: 204 RVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
              GTL YLAPE     K + + D +SFG L  E +TG +P 
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 108/228 (47%), Gaps = 30/228 (13%)
Query: 36  LHTATNG-FSDDNKLGEGGFGSVY-WGRTSDGLQIAVKKLKA-MNSKAEMEFAVEVEVLG 92
           L T T G +    +LG GGFG V  W     G Q+A+K+ +  ++ K    + +E++++ 
Sbjct: 9   LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMK 68
Query: 93  RVRHKNLLGLRGYCAG------TDQRLIVYDYMPNLSLLSHLH------GQYAGEVQLDW 140
           ++ H N++  R    G       D  L+  +Y     L  +L+      G   G +    
Sbjct: 69  KLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI---- 124
Query: 141 KRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV---ADFGFAKLIPEG 197
            R +   I SA  + YLH      IIHRD+K  N++L    + L+    D G+AK + +G
Sbjct: 125 -RTLLSDISSA--LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG 178
Query: 198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
              + T   GTL YLAPE     K + + D +SFG L  E +TG +P 
Sbjct: 179 --ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPF 224

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 129/260 (49%), Gaps = 23/260 (8%)
Query: 49  LGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           LG+G +G VY GR  S+ ++IA+K++   +S+       E+ +   ++HKN++   G  +
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH 167
                 I  + +P  SL + L  ++ G ++ + +          EG+ YLH      I+H
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 168 RDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK--VSE 224
           RDIK  NVL+++    L ++DFG +K +  G++  T    GTL Y+APE    G     +
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGPRGYGK 204
Query: 225 SCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN 284
           + D++S G  ++E+ TG+ P  +L         E    +   G FK  V P++     E+
Sbjct: 205 AADIWSLGCTIIEMATGKPPFYEL--------GEPQAAMFKVGMFK--VHPEI----PES 250
Query: 285 QLKQAINVAVLCVQSEPEKR 304
              +A    + C + +P+KR
Sbjct: 251 MSAEAKAFILKCFEPDPDKR 270

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 99/203 (48%), Gaps = 14/203 (6%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG 108
           +G+G FG V  G    G ++AVK +K  N      F  E  V+ ++RH NL+ L G    
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 109 TDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH 167
               L IV +YM   SL+ +L  +  G   L     +K ++   E + YL      + +H
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 125
Query: 168 RDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCD 227
           RD+ A NVL+  D    V+DFG  K   E  S   T  K  + + APE     K S   D
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTG-KLPVKWTAPEALREKKFSTKSD 181
Query: 228 VYSFGILLLEILT-GRKPIEKLP 249
           V+SFGILL EI + GR P  ++P
Sbjct: 182 VWSFGILLWEIYSFGRVPYPRIP 204

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 129/260 (49%), Gaps = 23/260 (8%)
Query: 49  LGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           LG+G +G VY GR  S+ ++IA+K++   +S+       E+ +   ++HKN++   G  +
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH 167
                 I  + +P  SL + L  ++ G ++ + +          EG+ YLH      I+H
Sbjct: 76  ENGFIKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 131
Query: 168 RDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK--VSE 224
           RDIK  NVL+++    L ++DFG +K +  G++  T    GTL Y+APE    G     +
Sbjct: 132 RDIKGDNVLINTYSGVLKISDFGTSKRL-AGINPCTETFTGTLQYMAPEIIDKGPRGYGK 190
Query: 225 SCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN 284
           + D++S G  ++E+ TG+ P  +L         E    +   G FK  V P++     E+
Sbjct: 191 AADIWSLGCTIIEMATGKPPFYEL--------GEPQAAMFKVGMFK--VHPEI----PES 236
Query: 285 QLKQAINVAVLCVQSEPEKR 304
              +A    + C + +P+KR
Sbjct: 237 MSAEAKAFILKCFEPDPDKR 256

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 68/234 (29%), Positives = 118/234 (50%), Gaps = 31/234 (13%)
Query: 32  TYKELHTATNGFSDD---------NKLGEGGFGSVYWGRTS----DGLQIAVKKLKA-MN 77
           TY++ + A + F+ +           +G G FG V  GR        + +A+K LK    
Sbjct: 25  TYEDPNRAVHQFAKELDASCIKIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYT 84
Query: 78  SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLH---GQYAG 134
            K   +F  E  ++G+  H N++ L G        +IV ++M N +L + L    GQ+  
Sbjct: 85  EKQRRDFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFT- 143
Query: 135 EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI 194
            +QL     + +  G A G+ YL        +HRD+ A N+L++S+    V+DFG +++I
Sbjct: 144 VIQL-----VGMLRGIAAGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVI 195
Query: 195 ---PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
              PE V + TT  K  + + APE   + K + + DV+S+GI++ E+++ G +P
Sbjct: 196 EDDPEAV-YTTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 71/203 (34%), Positives = 99/203 (48%), Gaps = 14/203 (6%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG 108
           +G+G FG V  G    G ++AVK +K  N      F  E  V+ ++RH NL+ L G    
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 109 TDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH 167
               L IV +YM   SL+ +L  +  G   L     +K ++   E + YL      + +H
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 140
Query: 168 RDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCD 227
           RD+ A NVL+  D    V+DFG  K   E  S   T  K  + + APE     K S   D
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTG-KLPVKWTAPEALREKKFSTKSD 196
Query: 228 VYSFGILLLEILT-GRKPIEKLP 249
           V+SFGILL EI + GR P  ++P
Sbjct: 197 VWSFGILLWEIYSFGRVPYPRIP 219

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/248 (27%), Positives = 120/248 (48%), Gaps = 32/248 (12%)
Query: 15  EGLTTITTPNNATWRIFTYKELHTATNGFSDD---------NKLGEGGFGSVYWGRTS-- 63
           +G+ T   P       FT+++ + A   F+ +           +G G FG V  GR    
Sbjct: 1   QGVRTFVDP-------FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVP 53
Query: 64  --DGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMP 120
               + +A+K LKA    K   +F  E  ++G+  H N++ L G        +I+ +YM 
Sbjct: 54  GKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYME 113
Query: 121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD 180
           N SL + L  +  G   +     M   IGS  G+ YL        +HRD+ A N+L++S+
Sbjct: 114 NGSLDAFLR-KNDGRFTVIQLVGMLRGIGS--GMKYLSDMSA---VHRDLAARNILVNSN 167
Query: 181 FEPLVADFGFAKLI---PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLE 237
               V+DFG ++++   PE  ++ T   K  + + APE   + K + + DV+S+GI++ E
Sbjct: 168 LVCKVSDFGMSRVLEDDPEA-AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 226
Query: 238 ILT-GRKP 244
           +++ G +P
Sbjct: 227 VMSYGERP 234

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 102/204 (50%), Gaps = 14/204 (6%)
Query: 49  LGEGGFGSVYWGRT----SDGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +G G  G V +GR        + +A+K LKA    +   +F  E  ++G+  H N++ L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G        +IV +YM N SL + L      + Q    + + +  G   G+ YL      
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL--- 170
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE--GVSHMTTRVKGTLGYLAPEYAMWGK 221
             +HRD+ A NVL+DS+    V+DFG ++++ +    ++ TT  K  + + APE   +  
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT 230
Query: 222 VSESCDVYSFGILLLEILT-GRKP 244
            S + DV+SFG+++ E+L  G +P
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 70/203 (34%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG 108
           +G+G FG V  G    G ++AVK +K  N      F  E  V+ ++RH NL+ L G    
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 109 TDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH 167
               L IV +YM   SL+ +L  +  G   L     +K ++   E + YL      + +H
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVH 131
Query: 168 RDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCD 227
           RD+ A NVL+  D    V+DFG  K   E  S   T  K  + + APE       S   D
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTK---EASSTQDTG-KLPVKWTAPEALREAAFSTKSD 187
Query: 228 VYSFGILLLEILT-GRKPIEKLP 249
           V+SFGILL EI + GR P  ++P
Sbjct: 188 VWSFGILLWEIYSFGRVPYPRIP 210

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 72/274 (26%), Positives = 114/274 (41%), Gaps = 39/274 (14%)
Query: 48  KLGEGGFG-SVYWGRTSDGLQIAVKKLKA--MNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           K+GEG FG ++    T DG Q  +K++    M+SK   E   EV VL  ++H N++  R 
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQ----YAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
                    IV DY     L   ++ Q    +  +  LDW  ++ +A         L H 
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLA---------LKHV 141
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
               I+HRDIK+ N+ L  D    + DFG A+++   V  +     GT  YL+PE     
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-ELARACIGTPYYLSPEICENK 200
Query: 221 KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGD 280
             +   D+++ G +L E+ T +   E                    G  K LV   + G 
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFE-------------------AGSMKNLVLKIISGS 241
Query: 281 FDENQLKQAINVAVLCVQ---SEPEKRPNMKEVV 311
           F    L  + ++  L  Q     P  RP++  ++
Sbjct: 242 FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSIL 275

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 140/308 (45%), Gaps = 55/308 (17%)
Query: 32  TYKELHTATNGFSDDNK---------LGEGGFGSVYWGRTS----DGLQIAVKKLKA-MN 77
           TY++ + A + F+ + +         +G G FG V  GR        L +A+K LK    
Sbjct: 4   TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 78  SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLH---GQYAG 134
            K   +F  E  ++G+  H N++ L G    +   +IV +YM N SL + L    GQ+  
Sbjct: 64  EKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFT- 122
Query: 135 EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI 194
            +QL    R     G + G+ YL        +HRD+ A N+L++S+    V+DFG ++++
Sbjct: 123 VIQLVGMLR-----GISAGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVL 174
Query: 195 ---PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
              PE  ++ T   K  + + APE   + K + + DV+S+GI++ E+++ G +P  ++  
Sbjct: 175 EDDPEA-AYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTN 233
Query: 251 -GVKRTITE---WAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPN 306
             V + + E      P+       +L+                    + C Q E   RP 
Sbjct: 234 QDVIKAVEEGYRLPSPMDCPAALYQLM--------------------LDCWQKERNSRPK 273
Query: 307 MKEVVNTL 314
             E+VN L
Sbjct: 274 FDEIVNML 281

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 101/204 (49%), Gaps = 14/204 (6%)
Query: 49  LGEGGFGSVYWGRT----SDGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +G G  G V +GR        + +A+K LKA    +   +F  E  ++G+  H N++ L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G        +IV +YM N SL + L      + Q    + + +  G   G+ YL      
Sbjct: 117 GVVTRGRLAMIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL--- 170
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE--GVSHMTTRVKGTLGYLAPEYAMWGK 221
             +HRD+ A NVL+DS+    V+DFG ++++ +    +  TT  K  + + APE   +  
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRT 230
Query: 222 VSESCDVYSFGILLLEILT-GRKP 244
            S + DV+SFG+++ E+L  G +P
Sbjct: 231 FSSASDVWSFGVVMWEVLAYGERP 254

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 121/279 (43%), Gaps = 26/279 (9%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLK-AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           ++G G FG V+ GR  +D   +AVK  +  +    + +F  E  +L +  H N++ L G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
           C       IV + +     L+ L  + A   +L  K  +++   +A G+ YL  +     
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLESKCC--- 234
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT-LGYLAPEYAMWGKVSE 224
           IHRD+ A N L+       ++DFG ++   +GV   +  ++   + + APE   +G+ S 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 225 SCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDE 283
             DV+SFGILL E  + G  P   L     R   E         K   L  P+L  D   
Sbjct: 295 ESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE---------KGGRLPCPELCPDAVF 345
Query: 284 NQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGK 322
             ++Q       C   EP +RP+   +   L     R +
Sbjct: 346 RLMEQ-------CWAYEPGQRPSFSTIYQELQSIRKRHR 377

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 121/288 (42%), Gaps = 48/288 (16%)
Query: 49  LGEGGFGSVYWGRTS------DGLQIAVKKLKAMNSKA-EMEFAVEVEVLGRVRHKNLLG 101
           LG G FG VY G+ S        LQ+AVK L  + S+  E++F +E  ++ ++ H+N++ 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLH------GQYAGEVQLDWKRRMKIAIGSAEGIL 155
             G    +  R I+ + M    L S L        Q +    LD    + +A   A G  
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVA---DFGFAKLIPEGVSHMTTRVKG----- 207
           YL      H IHRDI A N LL       VA   DFG A+     +   +   KG     
Sbjct: 170 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAML 222
Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVK 266
            + ++ PE  M G  +   D +SFG+LL EI + G  P    P    + + E+    +  
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP---YPSKSNQEVLEF----VTS 275
Query: 267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           G          R D  +N       +   C Q +PE RPN   ++  +
Sbjct: 276 GG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 121/288 (42%), Gaps = 48/288 (16%)
Query: 49  LGEGGFGSVYWGRTS------DGLQIAVKKLKAMNSKA-EMEFAVEVEVLGRVRHKNLLG 101
           LG G FG VY G+ S        LQ+AVK L  + S+  E++F +E  ++ ++ H+N++ 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLH------GQYAGEVQLDWKRRMKIAIGSAEGIL 155
             G    +  R I+ + M    L S L        Q +    LD    + +A   A G  
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVA---DFGFAKLIPEGVSHMTTRVKG----- 207
           YL      H IHRDI A N LL       VA   DFG A+     +   +   KG     
Sbjct: 156 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAML 208
Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVK 266
            + ++ PE  M G  +   D +SFG+LL EI + G  P    P    + + E+    +  
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP---YPSKSNQEVLEF----VTS 261
Query: 267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           G          R D  +N       +   C Q +PE RPN   ++  +
Sbjct: 262 GG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 115/236 (48%), Gaps = 31/236 (13%)
Query: 31  FTYKELHTATNGFSDD---------NKLGEGGFGSVYWGRTS----DGLQIAVKKLKA-M 76
           FT+++ + A   F+ +           +G G FG V  G         + +A+K LK+  
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 73
Query: 77  NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLH---GQYA 133
             K   +F  E  ++G+  H N++ L G    +   +I+ ++M N SL S L    GQ+ 
Sbjct: 74  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT 133
Query: 134 GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL 193
             +QL    R     G A G+ YL      + +HRD+ A N+L++S+    V+DFG ++ 
Sbjct: 134 -VIQLVGMLR-----GIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 184
Query: 194 IPEGVSHMTTRV----KGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
           + +  S  T       K  + + APE   + K + + DV+S+GI++ E+++ G +P
Sbjct: 185 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 240

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 105/205 (51%), Gaps = 16/205 (7%)
Query: 49  LGEGGFGSVYWGRTS----DGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +G G FG V  GR        + +A+K LKA    K   +F  E  ++G+  H N++ L 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 81
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G        +I+ +YM N SL + L  +  G   +     M   IGS  G+ YL      
Sbjct: 82  GVVTKCKPVMIITEYMENGSLDAFLR-KNDGRFTVIQLVGMLRGIGS--GMKYLSDM--- 135
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTRVKGTLGYLAPEYAMWG 220
             +HRD+ A N+L++S+    V+DFG ++++   PE  ++ T   K  + + APE   + 
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEA-AYTTRGGKIPIRWTAPEAIAYR 194
Query: 221 KVSESCDVYSFGILLLEILT-GRKP 244
           K + + DV+S+GI++ E+++ G +P
Sbjct: 195 KFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 14/214 (6%)
Query: 37  HTATNGFSDDNKLGEGGFGSVYWGRTSDG-LQIAVKKL-KAMNSK--AEMEFAVEVEVLG 92
           H   + F     LG+G FG+VY  R       +A+K L K+   K   E +   E+E+  
Sbjct: 19  HFTIDDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQA 78
Query: 93  RVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE 152
            + H N+L L  Y     +  ++ +Y P       L+ +       D +R   I    A+
Sbjct: 79  HLHHPNILRLYNYFYDRRRIYLILEYAPR----GELYKELQKSCTFDEQRTATIMEELAD 134
Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYL 212
            ++Y H +    +IHRDIK  N+LL    E  +ADFG++   P   S     + GTL YL
Sbjct: 135 ALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWSVHAP---SLRRKTMCGTLDYL 188
Query: 213 APEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
            PE       +E  D++  G+L  E+L G  P E
Sbjct: 189 PPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 120/288 (41%), Gaps = 48/288 (16%)
Query: 49  LGEGGFGSVYWGRTS------DGLQIAVKKLKAMNSKA-EMEFAVEVEVLGRVRHKNLLG 101
           LG G FG VY G+ S        LQ+AVK L  + S+  E++F +E  ++ +  H+N++ 
Sbjct: 65  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLH------GQYAGEVQLDWKRRMKIAIGSAEGIL 155
             G    +  R I+ + M    L S L        Q +    LD    + +A   A G  
Sbjct: 125 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 181
Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVA---DFGFAKLIPEGVSHMTTRVKG----- 207
           YL      H IHRDI A N LL       VA   DFG A+     +   +   KG     
Sbjct: 182 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAML 234
Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVK 266
            + ++ PE  M G  +   D +SFG+LL EI + G  P    P    + + E+    +  
Sbjct: 235 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP---YPSKSNQEVLEF----VTS 287
Query: 267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           G          R D  +N       +   C Q +PE RPN   ++  +
Sbjct: 288 GG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 326

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 132/295 (44%), Gaps = 53/295 (17%)
Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           + +   ++AVK LK+  ++ ++ +   E+E++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQ------------YAGEVQLDWKRRMKI 146
           ++ L G C       ++ +Y    +L  +L  +            +  E QL  K  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
           A   A G+ YL    +   IHRD+ A NVL+  D    +ADFG A+     + H+    K
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDXXKK 208
Query: 207 GTLG-----YLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEW 259
            T G     ++APE A++ ++ +   DV+SFG+LL EI T G  P   +P          
Sbjct: 209 TTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---------- 257
Query: 260 AEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L
Sbjct: 258 -----VEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 80/303 (26%), Positives = 129/303 (42%), Gaps = 44/303 (14%)
Query: 24  NNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKA 80
           N    RIF   EL            LG G FG+V+   W    + ++I V      +   
Sbjct: 21  NKVLARIFKETELRKL-------KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG 73
Query: 81  EMEFAVEVE---VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLH---GQYAG 134
              F    +    +G + H +++ L G C G+  +L+   Y+P  SLL H+    G    
Sbjct: 74  RQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGALGP 132
Query: 135 EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI 194
           ++ L+W       +  A+G+ YL       ++HR++ A NVLL S  +  VADFG A L+
Sbjct: 133 QLLLNW------GVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLL 183
Query: 195 PEGVSHMT-TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGV 252
           P     +  +  K  + ++A E   +GK +   DV+S+G+ + E++T G +P   L    
Sbjct: 184 PPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGL---- 239
Query: 253 KRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
                  AE   +  K + L  P++              V V C   +   RP  KE+ N
Sbjct: 240 -----RLAEVPDLLEKGERLAQPQI-------CTIDVYMVMVKCWMIDENIRPTFKELAN 287
Query: 313 TLT 315
             T
Sbjct: 288 EFT 290

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 105/205 (51%), Gaps = 16/205 (7%)
Query: 49  LGEGGFGSVYWGRTS----DGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +G G FG V  GR        + +A+K LKA    K   +F  E  ++G+  H N++ L 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLE 75
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G        +I+ +YM N SL + L  +  G   +     M   IGS  G+ YL      
Sbjct: 76  GVVTKCKPVMIITEYMENGSLDAFLR-KNDGRFTVIQLVGMLRGIGS--GMKYLSDM--- 129
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTRVKGTLGYLAPEYAMWG 220
             +HRD+ A N+L++S+    V+DFG ++++   PE  ++ T   K  + + APE   + 
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEA-AYTTRGGKIPIRWTAPEAIAYR 188
Query: 221 KVSESCDVYSFGILLLEILT-GRKP 244
           K + + DV+S+GI++ E+++ G +P
Sbjct: 189 KFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 120/288 (41%), Gaps = 48/288 (16%)
Query: 49  LGEGGFGSVYWGRTS------DGLQIAVKKLKAMNSKA-EMEFAVEVEVLGRVRHKNLLG 101
           LG G FG VY G+ S        LQ+AVK L  + S+  E++F +E  ++ +  H+N++ 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLH------GQYAGEVQLDWKRRMKIAIGSAEGIL 155
             G    +  R I+ + M    L S L        Q +    LD    + +A   A G  
Sbjct: 113 CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVA---DFGFAKLIPEGVSHMTTRVKG----- 207
           YL      H IHRDI A N LL       VA   DFG A+     +   +   KG     
Sbjct: 170 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAML 222
Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVK 266
            + ++ PE  M G  +   D +SFG+LL EI + G  P    P    + + E+    +  
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP---YPSKSNQEVLEF----VTS 275
Query: 267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           G          R D  +N       +   C Q +PE RPN   ++  +
Sbjct: 276 GG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 120/288 (41%), Gaps = 48/288 (16%)
Query: 49  LGEGGFGSVYWGRTS------DGLQIAVKKLKAMNSKA-EMEFAVEVEVLGRVRHKNLLG 101
           LG G FG VY G+ S        LQ+AVK L  + S+  E++F +E  ++ +  H+N++ 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLH------GQYAGEVQLDWKRRMKIAIGSAEGIL 155
             G    +  R I+ + M    L S L        Q +    LD    + +A   A G  
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVA---DFGFAKLIPEGVSHMTTRVKG----- 207
           YL      H IHRDI A N LL       VA   DFG A+     +   +   KG     
Sbjct: 156 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAML 208
Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVK 266
            + ++ PE  M G  +   D +SFG+LL EI + G  P    P    + + E+    +  
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP---YPSKSNQEVLEF----VTS 261
Query: 267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           G          R D  +N       +   C Q +PE RPN   ++  +
Sbjct: 262 GG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 120/288 (41%), Gaps = 48/288 (16%)
Query: 49  LGEGGFGSVYWGRTS------DGLQIAVKKLKAMNSKA-EMEFAVEVEVLGRVRHKNLLG 101
           LG G FG VY G+ S        LQ+AVK L  + S+  E++F +E  ++ +  H+N++ 
Sbjct: 55  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLH------GQYAGEVQLDWKRRMKIAIGSAEGIL 155
             G    +  R I+ + M    L S L        Q +    LD    + +A   A G  
Sbjct: 115 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 171
Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVA---DFGFAKLIPEGVSHMTTRVKG----- 207
           YL      H IHRDI A N LL       VA   DFG A+     +   +   KG     
Sbjct: 172 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAML 224
Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVK 266
            + ++ PE  M G  +   D +SFG+LL EI + G  P    P    + + E+    +  
Sbjct: 225 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP---YPSKSNQEVLEF----VTS 277
Query: 267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           G          R D  +N       +   C Q +PE RPN   ++  +
Sbjct: 278 GG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 316

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 74/279 (26%), Positives = 121/279 (43%), Gaps = 26/279 (9%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLK-AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           ++G G FG V+ GR  +D   +AVK  +  +    + +F  E  +L +  H N++ L G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
           C       IV + +     L+ L  + A   +L  K  +++   +A G+ YL  +     
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTEGA---RLRVKTLLQMVGDAAAGMEYLESKCC--- 234
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT-LGYLAPEYAMWGKVSE 224
           IHRD+ A N L+       ++DFG ++   +GV   +  ++   + + APE   +G+ S 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSS 294
Query: 225 SCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDE 283
             DV+SFGILL E  + G  P   L     R   E         K   L  P+L  D   
Sbjct: 295 ESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE---------KGGRLPCPELCPDAVF 345
Query: 284 NQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGK 322
             ++Q       C   EP +RP+   +   L     R +
Sbjct: 346 RLMEQ-------CWAYEPGQRPSFSTIYQELQSIRKRHR 377

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 118/284 (41%), Gaps = 40/284 (14%)
Query: 49  LGEGGFGSVYWGRTS------DGLQIAVKKLKAMNSKA-EMEFAVEVEVLGRVRHKNLLG 101
           LG G FG VY G+ S        LQ+AVK L  + S+  E++F +E  ++ +  H+N++ 
Sbjct: 79  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLH------GQYAGEVQLDWKRRMKIAIGSAEGIL 155
             G    +  R I+ + M    L S L        Q +    LD    + +A   A G  
Sbjct: 139 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 195
Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVA---DFGFAKLI-PEGVSHMTTRVKGTLGY 211
           YL      H IHRDI A N LL       VA   DFG A+ I   G           + +
Sbjct: 196 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 212 LAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFK 270
           + PE  M G  +   D +SFG+LL EI + G  P    P    + + E+    +  G   
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP---YPSKSNQEVLEF----VTSGG-- 303
Query: 271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                  R D  +N       +   C Q +PE RPN   ++  +
Sbjct: 304 -------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 340

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 120/288 (41%), Gaps = 48/288 (16%)
Query: 49  LGEGGFGSVYWGRTS------DGLQIAVKKLKAMNSKA-EMEFAVEVEVLGRVRHKNLLG 101
           LG G FG VY G+ S        LQ+AVK L  + S+  E++F +E  ++ +  H+N++ 
Sbjct: 45  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLH------GQYAGEVQLDWKRRMKIAIGSAEGIL 155
             G    +  R I+ + M    L S L        Q +    LD    + +A   A G  
Sbjct: 105 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 161
Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVA---DFGFAKLIPEGVSHMTTRVKG----- 207
           YL      H IHRDI A N LL       VA   DFG A+     +   +   KG     
Sbjct: 162 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAML 214
Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVK 266
            + ++ PE  M G  +   D +SFG+LL EI + G  P    P    + + E+    +  
Sbjct: 215 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP---YPSKSNQEVLEF----VTS 267
Query: 267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           G          R D  +N       +   C Q +PE RPN   ++  +
Sbjct: 268 GG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 306

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 120/288 (41%), Gaps = 48/288 (16%)
Query: 49  LGEGGFGSVYWGRTS------DGLQIAVKKLKAMNSKA-EMEFAVEVEVLGRVRHKNLLG 101
           LG G FG VY G+ S        LQ+AVK L  + S+  E++F +E  ++ +  H+N++ 
Sbjct: 30  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLH------GQYAGEVQLDWKRRMKIAIGSAEGIL 155
             G    +  R I+ + M    L S L        Q +    LD    + +A   A G  
Sbjct: 90  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 146
Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVA---DFGFAKLIPEGVSHMTTRVKG----- 207
           YL      H IHRDI A N LL       VA   DFG A+     +   +   KG     
Sbjct: 147 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAML 199
Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVK 266
            + ++ PE  M G  +   D +SFG+LL EI + G  P    P    + + E+    +  
Sbjct: 200 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP---YPSKSNQEVLEF----VTS 252
Query: 267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           G          R D  +N       +   C Q +PE RPN   ++  +
Sbjct: 253 GG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 291

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 132/295 (44%), Gaps = 53/295 (17%)
Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           + +   ++AVK LK+  ++ ++ +   E+E++  + +HKN
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQ------------YAGEVQLDWKRRMKI 146
           ++ L G C       ++ +Y    +L  +L  +            +  E QL  K  +  
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
           A   A G+ YL    +   IHRD+ A NVL+  D    +ADFG A+     + H+    K
Sbjct: 197 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKK 249
Query: 207 GTLG-----YLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEW 259
            T G     ++APE A++ ++ +   DV+SFG+LL EI T G  P   +P          
Sbjct: 250 TTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---------- 298
Query: 260 AEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L
Sbjct: 299 -----VEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 347

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 120/288 (41%), Gaps = 48/288 (16%)
Query: 49  LGEGGFGSVYWGRTS------DGLQIAVKKLKAMNSKA-EMEFAVEVEVLGRVRHKNLLG 101
           LG G FG VY G+ S        LQ+AVK L  + S+  E++F +E  ++ +  H+N++ 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLH------GQYAGEVQLDWKRRMKIAIGSAEGIL 155
             G    +  R I+ + M    L S L        Q +    LD    + +A   A G  
Sbjct: 98  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 154
Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVA---DFGFAKLIPEGVSHMTTRVKG----- 207
           YL      H IHRDI A N LL       VA   DFG A+     +   +   KG     
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAML 207
Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVK 266
            + ++ PE  M G  +   D +SFG+LL EI + G  P    P    + + E+    +  
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP---YPSKSNQEVLEF----VTS 260
Query: 267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           G          R D  +N       +   C Q +PE RPN   ++  +
Sbjct: 261 GG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 132/295 (44%), Gaps = 53/295 (17%)
Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           + +   ++AVK LK+  ++ ++ +   E+E++  + +HKN
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQ------------YAGEVQLDWKRRMKI 146
           ++ L G C       ++ +Y    +L  +L  +            +  E QL  K  +  
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
           A   A G+ YL    +   IHRD+ A NVL+  D    +ADFG A+     + H+    K
Sbjct: 148 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKK 200
Query: 207 GTLG-----YLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEW 259
            T G     ++APE A++ ++ +   DV+SFG+LL EI T G  P   +P          
Sbjct: 201 TTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---------- 249
Query: 260 AEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L
Sbjct: 250 -----VEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 298

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 120/288 (41%), Gaps = 48/288 (16%)
Query: 49  LGEGGFGSVYWGRTS------DGLQIAVKKLKAMNSKA-EMEFAVEVEVLGRVRHKNLLG 101
           LG G FG VY G+ S        LQ+AVK L  + S+  E++F +E  ++ +  H+N++ 
Sbjct: 38  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLH------GQYAGEVQLDWKRRMKIAIGSAEGIL 155
             G    +  R I+ + M    L S L        Q +    LD    + +A   A G  
Sbjct: 98  CIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 154
Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVA---DFGFAKLIPEGVSHMTTRVKG----- 207
           YL      H IHRDI A N LL       VA   DFG A+     +   +   KG     
Sbjct: 155 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAML 207
Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVK 266
            + ++ PE  M G  +   D +SFG+LL EI + G  P    P    + + E+    +  
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP---YPSKSNQEVLEF----VTS 260
Query: 267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           G          R D  +N       +   C Q +PE RPN   ++  +
Sbjct: 261 GG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 299

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 132/295 (44%), Gaps = 53/295 (17%)
Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           + +   ++AVK LK+  ++ ++ +   E+E++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQ------------YAGEVQLDWKRRMKI 146
           ++ L G C       ++ +Y    +L  +L  +            +  E QL  K  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
           A   A G+ YL    +   IHRD+ A NVL+  D    +ADFG A+     + H+    K
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKK 208
Query: 207 GTLG-----YLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEW 259
            T G     ++APE A++ ++ +   DV+SFG+LL EI T G  P   +P          
Sbjct: 209 TTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---------- 257
Query: 260 AEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L
Sbjct: 258 -----VEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 132/295 (44%), Gaps = 53/295 (17%)
Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           + +   ++AVK LK+  ++ ++ +   E+E++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQ------------YAGEVQLDWKRRMKI 146
           ++ L G C       ++ +Y    +L  +L  +            +  E QL  K  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
           A   A G+ YL    +   IHRD+ A NVL+  D    +ADFG A+     + H+    K
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKK 208
Query: 207 GTLG-----YLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEW 259
            T G     ++APE A++ ++ +   DV+SFG+LL EI T G  P   +P          
Sbjct: 209 TTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---------- 257
Query: 260 AEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L
Sbjct: 258 -----VEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 118/284 (41%), Gaps = 40/284 (14%)
Query: 49  LGEGGFGSVYWGRTS------DGLQIAVKKLKAMNSKA-EMEFAVEVEVLGRVRHKNLLG 101
           LG G FG VY G+ S        LQ+AVK L  + S+  E++F +E  ++ +  H+N++ 
Sbjct: 56  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLH------GQYAGEVQLDWKRRMKIAIGSAEGIL 155
             G    +  R I+ + M    L S L        Q +    LD    + +A   A G  
Sbjct: 116 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 172
Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVA---DFGFAKLI-PEGVSHMTTRVKGTLGY 211
           YL      H IHRDI A N LL       VA   DFG A+ I   G           + +
Sbjct: 173 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 229
Query: 212 LAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFK 270
           + PE  M G  +   D +SFG+LL EI + G  P    P    + + E+    +  G   
Sbjct: 230 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP---YPSKSNQEVLEF----VTSGG-- 280
Query: 271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                  R D  +N       +   C Q +PE RPN   ++  +
Sbjct: 281 -------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 317

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 120/288 (41%), Gaps = 48/288 (16%)
Query: 49  LGEGGFGSVYWGRTS------DGLQIAVKKLKAMNSKA-EMEFAVEVEVLGRVRHKNLLG 101
           LG G FG VY G+ S        LQ+AVK L  + S+  E++F +E  ++ +  H+N++ 
Sbjct: 39  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLH------GQYAGEVQLDWKRRMKIAIGSAEGIL 155
             G    +  R I+ + M    L S L        Q +    LD    + +A   A G  
Sbjct: 99  CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 155
Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVA---DFGFAKLIPEGVSHMTTRVKG----- 207
           YL      H IHRDI A N LL       VA   DFG A    + +   +   KG     
Sbjct: 156 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMA----QDIYRASYYRKGGCAML 208
Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVK 266
            + ++ PE  M G  +   D +SFG+LL EI + G  P    P    + + E+    +  
Sbjct: 209 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP---YPSKSNQEVLEF----VTS 261
Query: 267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           G          R D  +N       +   C Q +PE RPN   ++  +
Sbjct: 262 GG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 300

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 132/295 (44%), Gaps = 53/295 (17%)
Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           + +   ++AVK LK+  ++ ++ +   E+E++  + +HKN
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQ------------YAGEVQLDWKRRMKI 146
           ++ L G C       ++ +Y    +L  +L  +            +  E QL  K  +  
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
           A   A G+ YL    +   IHRD+ A NVL+  D    +ADFG A+     + H+    K
Sbjct: 145 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKK 197
Query: 207 GTLG-----YLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEW 259
            T G     ++APE A++ ++ +   DV+SFG+LL EI T G  P   +P          
Sbjct: 198 TTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---------- 246
Query: 260 AEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L
Sbjct: 247 -----VEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 295

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 81/288 (28%), Positives = 120/288 (41%), Gaps = 48/288 (16%)
Query: 49  LGEGGFGSVYWGRTS------DGLQIAVKKLKAMNSKA-EMEFAVEVEVLGRVRHKNLLG 101
           LG G FG VY G+ S        LQ+AVK L  + S+  E++F +E  ++ +  H+N++ 
Sbjct: 53  LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLH------GQYAGEVQLDWKRRMKIAIGSAEGIL 155
             G    +  R I+ + M    L S L        Q +    LD    + +A   A G  
Sbjct: 113 CIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL---LHVARDIACGCQ 169
Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVA---DFGFAKLIPEGVSHMTTRVKG----- 207
           YL      H IHRDI A N LL       VA   DFG A+     +   +   KG     
Sbjct: 170 YLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAML 222
Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVK 266
            + ++ PE  M G  +   D +SFG+LL EI + G  P    P    + + E+    +  
Sbjct: 223 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP---YPSKSNQEVLEF----VTS 275
Query: 267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           G          R D  +N       +   C Q +PE RPN   ++  +
Sbjct: 276 GG---------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERI 314

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 132/295 (44%), Gaps = 53/295 (17%)
Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           + +   ++AVK LK+  ++ ++ +   E+E++  + +HKN
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQ------------YAGEVQLDWKRRMKI 146
           ++ L G C       ++ +Y    +L  +L  +            +  E QL  K  +  
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
           A   A G+ YL    +   IHRD+ A NVL+  D    +ADFG A+     + H+    K
Sbjct: 141 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKK 193
Query: 207 GTLG-----YLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEW 259
            T G     ++APE A++ ++ +   DV+SFG+LL EI T G  P   +P          
Sbjct: 194 TTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---------- 242
Query: 260 AEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L
Sbjct: 243 -----VEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 132/295 (44%), Gaps = 53/295 (17%)
Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           + +   ++AVK LK+  ++ ++ +   E+E++  + +HKN
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQ------------YAGEVQLDWKRRMKI 146
           ++ L G C       ++ +Y    +L  +L  +            +  E QL  K  +  
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
           A   A G+ YL    +   IHRD+ A NVL+  D    +ADFG A+     + H+    K
Sbjct: 149 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKK 201
Query: 207 GTLG-----YLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEW 259
            T G     ++APE A++ ++ +   DV+SFG+LL EI T G  P   +P          
Sbjct: 202 TTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---------- 250
Query: 260 AEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L
Sbjct: 251 -----VEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 299

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 22/209 (10%)
Query: 49  LGEGGFGSVYWGR-TSDGLQ---IAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +G G FG V  GR  + G +   +A+K LK     +   EF  E  ++G+  H N++ L 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 83
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLH---GQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G    +   +I+ ++M N +L S L    GQ+   +QL     + +  G A G+ YL   
Sbjct: 84  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFT-VIQL-----VGMLRGIASGMRYLAEM 137
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRV----KGTLGYLAPEY 216
                +HRD+ A N+L++S+    V+DFG ++ + E  S  T       K  + + APE 
Sbjct: 138 ---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEA 194
Query: 217 AMWGKVSESCDVYSFGILLLEILT-GRKP 244
             + K + + D +S+GI++ E+++ G +P
Sbjct: 195 IAFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 132/295 (44%), Gaps = 53/295 (17%)
Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           + +   ++AVK LK+  ++ ++ +   E+E++  + +HKN
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQ------------YAGEVQLDWKRRMKI 146
           ++ L G C       ++ +Y    +L  +L  +            +  E QL  K  +  
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
           A   A G+ YL    +   IHRD+ A NVL+  D    +ADFG A+     + H+    K
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKK 208
Query: 207 GTLG-----YLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEW 259
            T G     ++APE A++ ++ +   DV+SFG+LL EI T G  P   +P          
Sbjct: 209 TTNGRLPVKWMAPE-ALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP---------- 257
Query: 260 AEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L
Sbjct: 258 -----VEELFK-LLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 306

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/209 (29%), Positives = 106/209 (50%), Gaps = 22/209 (10%)
Query: 49  LGEGGFGSVYWGR-TSDGLQ---IAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +G G FG V  GR  + G +   +A+K LK     +   EF  E  ++G+  H N++ L 
Sbjct: 22  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLE 81
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLH---GQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G    +   +I+ ++M N +L S L    GQ+   +QL     + +  G A G+ YL   
Sbjct: 82  GVVTNSMPVMILTEFMENGALDSFLRLNDGQFT-VIQL-----VGMLRGIASGMRYLAEM 135
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRV----KGTLGYLAPEY 216
                +HRD+ A N+L++S+    V+DFG ++ + E  S  T       K  + + APE 
Sbjct: 136 ---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEA 192
Query: 217 AMWGKVSESCDVYSFGILLLEILT-GRKP 244
             + K + + D +S+GI++ E+++ G +P
Sbjct: 193 IAFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 111/237 (46%), Gaps = 42/237 (17%)
Query: 49  LGEGGFGSVYWGRTS-DGLQI--AVKKLKAMNSKAE-MEFAVEVEVLGRV-RHKNLLGLR 103
           +GEG FG V   R   DGL++  A+K++K   SK +  +FA E+EVL ++  H N++ L 
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ------------LDWKRRMKIAIGSA 151
           G C       +  +Y P+ +LL  L      E              L  ++ +  A   A
Sbjct: 83  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 142
Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG- 210
            G+ YL  +     IHRD+ A N+L+  ++   +ADFG ++            VK T+G 
Sbjct: 143 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGR 192
Query: 211 ----YLAPEYAMWGKVSESCDVYSFGILLLEI----------LTGRKPIEKLPGGVK 253
               ++A E   +   + + DV+S+G+LL EI          +T  +  EKLP G +
Sbjct: 193 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 249

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 124/277 (44%), Gaps = 30/277 (10%)
Query: 49  LGEGGFGSVYWGRTSDG----LQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLGLR 103
           +G G FG VY G   D     +  AVK L  +    E+ +F  E  ++    H N+L L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 104 GYCAGTD-QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G C  ++   L+V  YM +  L + +  +       D    +   +  A+G+ YL    +
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL---AS 150
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLI--PEGVS-HMTTRVKGTLGYLAPEYAMW 219
              +HRD+ A N +LD  F   VADFG A+ +   E  S H  T  K  + ++A E    
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQT 210
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
            K +   DV+SFG+LL E++T   P    P      IT +    +++G  + L+ P+   
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVY----LLQG--RRLLQPEYCP 262
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
           D           V + C   + E RP+  E+V+ ++ 
Sbjct: 263 D-------PLYEVMLKCWHPKAEMRPSFSELVSRISA 292

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 123/277 (44%), Gaps = 30/277 (10%)
Query: 49  LGEGGFGSVYWGRTSDG----LQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLGLR 103
           +G G FG VY G   D     +  AVK L  +    E+ +F  E  ++    H N+L L 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 104 GYCAGTD-QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G C  ++   L+V  YM +  L + +  +       D    +   +  A+G+ YL    +
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL---AS 150
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG---VSHMTTRVKGTLGYLAPEYAMW 219
              +HRD+ A N +LD  F   VADFG A+ + +      H  T  K  + ++A E    
Sbjct: 151 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 210
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
            K +   DV+SFG+LL E++T   P    P      IT +    +++G  + L+ P+   
Sbjct: 211 QKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVY----LLQG--RRLLQPEYCP 262
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
           D           V + C   + E RP+  E+V+ ++ 
Sbjct: 263 D-------PLYEVMLKCWHPKAEMRPSFSELVSRISA 292

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 111/237 (46%), Gaps = 42/237 (17%)
Query: 49  LGEGGFGSVYWGRTS-DGLQI--AVKKLKAMNSKAE-MEFAVEVEVLGRV-RHKNLLGLR 103
           +GEG FG V   R   DGL++  A+K++K   SK +  +FA E+EVL ++  H N++ L 
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ------------LDWKRRMKIAIGSA 151
           G C       +  +Y P+ +LL  L      E              L  ++ +  A   A
Sbjct: 93  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 152
Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG- 210
            G+ YL  +     IHRD+ A N+L+  ++   +ADFG ++            VK T+G 
Sbjct: 153 RGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGR 202
Query: 211 ----YLAPEYAMWGKVSESCDVYSFGILLLEI----------LTGRKPIEKLPGGVK 253
               ++A E   +   + + DV+S+G+LL EI          +T  +  EKLP G +
Sbjct: 203 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 259

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 126/295 (42%), Gaps = 58/295 (19%)
Query: 49  LGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +G GGFG V+  +   DG    ++++K  N KAE E    V+ L ++ H N++   G   
Sbjct: 20  IGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAERE----VKALAKLDHVNIVHYNGCWD 75
Query: 108 G-------TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDW-----------KRR------ 143
           G       +D  L   DY P  S  S         +Q+++           KRR      
Sbjct: 76  GFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDK 135
Query: 144 ---MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH 200
              +++     +G+ Y+H   +  +IHRD+K SN+ L    +  + DFG    +      
Sbjct: 136 VLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKR 192
Query: 201 MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWA 260
             TR KGTL Y++PE        +  D+Y+ G++L E+L            V  T  E +
Sbjct: 193 --TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL-----------HVCDTAFETS 239
Query: 261 EPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
           +       F +L D  +   FD    K+   +    +  +PE RPN  E++ TLT
Sbjct: 240 KF------FTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEILRTLT 284

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/278 (26%), Positives = 123/278 (44%), Gaps = 37/278 (13%)
Query: 49  LGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEMEFAVEVE---VLGRVRHKNLLGL 102
           LG G FG+V+   W    + ++I V      +      F    +    +G + H +++ L
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRL 80
Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHLH---GQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            G C G+  +L+   Y+P  SLL H+    G    ++ L+W       +  A+G+ YL  
Sbjct: 81  LGLCPGSSLQLVT-QYLPLGSLLDHVRQHRGALGPQLLLNW------GVQIAKGMYYLEE 133
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMT-TRVKGTLGYLAPEYAM 218
                ++HR++ A NVLL S  +  VADFG A L+P     +  +  K  + ++A E   
Sbjct: 134 H---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 219 WGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL 277
           +GK +   DV+S+G+ + E++T G +P   L           AE   +  K + L  P++
Sbjct: 191 FGKYTHQSDVWSYGVTVWELMTFGAEPYAGL---------RLAEVPDLLEKGERLAQPQI 241
Query: 278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
                         V V C   +   RP  KE+ N  T
Sbjct: 242 -------CTIDVYMVMVKCWMIDENIRPTFKELANEFT 272

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 123/277 (44%), Gaps = 30/277 (10%)
Query: 49  LGEGGFGSVYWGRTSDG----LQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLGLR 103
           +G G FG VY G   D     +  AVK L  +    E+ +F  E  ++    H N+L L 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 104 GYCAGTD-QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G C  ++   L+V  YM +  L + +  +       D    +   +  A+G+ YL    +
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL---AS 149
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG---VSHMTTRVKGTLGYLAPEYAMW 219
              +HRD+ A N +LD  F   VADFG A+ + +      H  T  K  + ++A E    
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 209
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
            K +   DV+SFG+LL E++T   P    P      IT +    +++G  + L+ P+   
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVY----LLQG--RRLLQPEYCP 261
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
           D           V + C   + E RP+  E+V+ ++ 
Sbjct: 262 D-------PLYEVMLKCWHPKAEMRPSFSELVSRISA 291

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 123/277 (44%), Gaps = 30/277 (10%)
Query: 49  LGEGGFGSVYWGRTSDG----LQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLGLR 103
           +G G FG VY G   D     +  AVK L  +    E+ +F  E  ++    H N+L L 
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 104 GYCAGTD-QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G C  ++   L+V  YM +  L + +  +       D    +   +  A+G+ YL    +
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL---AS 146
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG---VSHMTTRVKGTLGYLAPEYAMW 219
              +HRD+ A N +LD  F   VADFG A+ + +      H  T  K  + ++A E    
Sbjct: 147 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 206
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
            K +   DV+SFG+LL E++T   P    P      IT +    +++G  + L+ P+   
Sbjct: 207 QKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVY----LLQG--RRLLQPEYCP 258
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
           D           V + C   + E RP+  E+V+ ++ 
Sbjct: 259 D-------PLYEVMLKCWHPKAEMRPSFSELVSRISA 288

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 25/223 (11%)
Query: 38  TATNGFSDDNKLGE----GGFGSVYWGRT-SDGLQIAVKKLKA---MNSKAEMEFAVEVE 89
           T  +  SD  +LGE    GG   V+  R   D   +AVK L+A    +    + F  E +
Sbjct: 5   TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQ 64
Query: 90  VLGRVRHKNLLGLRGYCAGTDQR------LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRR 143
               + H  ++ +  Y  G  +        IV +Y+  ++L   +H     E  +  KR 
Sbjct: 65  NAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRA 118
Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM-- 201
           +++   + + + + H      IIHRD+K +N+L+ +     V DFG A+ I +  + +  
Sbjct: 119 IEVIADACQALNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQ 175
Query: 202 TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           T  V GT  YL+PE A    V    DVYS G +L E+LTG  P
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 123/277 (44%), Gaps = 30/277 (10%)
Query: 49  LGEGGFGSVYWGRTSDG----LQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLGLR 103
           +G G FG VY G   D     +  AVK L  +    E+ +F  E  ++    H N+L L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 104 GYCAGTD-QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G C  ++   L+V  YM +  L + +  +       D    +   +  A+G+ YL    +
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL---AS 151
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG---VSHMTTRVKGTLGYLAPEYAMW 219
              +HRD+ A N +LD  F   VADFG A+ + +      H  T  K  + ++A E    
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
            K +   DV+SFG+LL E++T   P    P      IT +    +++G  + L+ P+   
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVY----LLQG--RRLLQPEYCP 263
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
           D           V + C   + E RP+  E+V+ ++ 
Sbjct: 264 D-------PLYEVMLKCWHPKAEMRPSFSELVSRISA 293

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 84/315 (26%), Positives = 139/315 (44%), Gaps = 56/315 (17%)
Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           +  + + +AVK LK   ++ ++ +   E+E++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHG------QYAGEV------QLDWKRRMKI 146
           ++ L G C       ++ +Y    +L  +L        +Y+ ++      Q+ +K  +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE-GVSHMTTRV 205
               A G+ YL  +     IHRD+ A NVL+  +    +ADFG A+ I        TT  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 206 KGTLGYLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPL 263
           +  + ++APE A++ +V +   DV+SFG+L+ EI T G  P   +P              
Sbjct: 220 RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-------------- 264
Query: 264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGKV 323
            V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L         
Sbjct: 265 -VEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL--------- 313
Query: 324 MQTRIETLAYKEELL 338
              RI TL   EE L
Sbjct: 314 --DRILTLTTNEEYL 326

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 123/277 (44%), Gaps = 30/277 (10%)
Query: 49  LGEGGFGSVYWGRTSDG----LQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLGLR 103
           +G G FG VY G   D     +  AVK L  +    E+ +F  E  ++    H N+L L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 104 GYCAGTD-QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G C  ++   L+V  YM +  L + +  +       D    +   +  A+G+ YL    +
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL---AS 151
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG---VSHMTTRVKGTLGYLAPEYAMW 219
              +HRD+ A N +LD  F   VADFG A+ + +      H  T  K  + ++A E    
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 211
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
            K +   DV+SFG+LL E++T   P    P      IT +    +++G  + L+ P+   
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVY----LLQG--RRLLQPEYCP 263
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
           D           V + C   + E RP+  E+V+ ++ 
Sbjct: 264 D-------PLYEVMLKCWHPKAEMRPSFSELVSRISA 293

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 123/277 (44%), Gaps = 30/277 (10%)
Query: 49  LGEGGFGSVYWGRTSDG----LQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLGLR 103
           +G G FG VY G   D     +  AVK L  +    E+ +F  E  ++    H N+L L 
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 104 GYCAGTD-QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G C  ++   L+V  YM +  L + +  +       D    +   +  A+G+ YL    +
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL---AS 143
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG---VSHMTTRVKGTLGYLAPEYAMW 219
              +HRD+ A N +LD  F   VADFG A+ + +      H  T  K  + ++A E    
Sbjct: 144 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 203
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
            K +   DV+SFG+LL E++T   P    P      IT +    +++G  + L+ P+   
Sbjct: 204 QKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVY----LLQG--RRLLQPEYCP 255
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
           D           V + C   + E RP+  E+V+ ++ 
Sbjct: 256 D-------PLYEVMLKCWHPKAEMRPSFSELVSRISA 285

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 123/277 (44%), Gaps = 30/277 (10%)
Query: 49  LGEGGFGSVYWGRTSDG----LQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLGLR 103
           +G G FG VY G   D     +  AVK L  +    E+ +F  E  ++    H N+L L 
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 104 GYCAGTD-QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G C  ++   L+V  YM +  L + +  +       D    +   +  A+G+ YL    +
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL---AS 148
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG---VSHMTTRVKGTLGYLAPEYAMW 219
              +HRD+ A N +LD  F   VADFG A+ + +      H  T  K  + ++A E    
Sbjct: 149 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 208
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
            K +   DV+SFG+LL E++T   P    P      IT +    +++G  + L+ P+   
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVY----LLQG--RRLLQPEYCP 260
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
           D           V + C   + E RP+  E+V+ ++ 
Sbjct: 261 D-------PLYEVMLKCWHPKAEMRPSFSELVSRISA 290

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 123/277 (44%), Gaps = 30/277 (10%)
Query: 49  LGEGGFGSVYWGRTSDG----LQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLGLR 103
           +G G FG VY G   D     +  AVK L  +    E+ +F  E  ++    H N+L L 
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 104 GYCAGTD-QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G C  ++   L+V  YM +  L + +  +       D    +   +  A+G+ YL    +
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL---AS 170
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG---VSHMTTRVKGTLGYLAPEYAMW 219
              +HRD+ A N +LD  F   VADFG A+ + +      H  T  K  + ++A E    
Sbjct: 171 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 230
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
            K +   DV+SFG+LL E++T   P    P      IT +    +++G  + L+ P+   
Sbjct: 231 QKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVY----LLQG--RRLLQPEYCP 282
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
           D           V + C   + E RP+  E+V+ ++ 
Sbjct: 283 D-------PLYEVMLKCWHPKAEMRPSFSELVSRISA 312

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 84/315 (26%), Positives = 136/315 (43%), Gaps = 56/315 (17%)
Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           +  + + +AVK LK   ++ ++ +   E+E++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQY------------AGEVQLDWKRRMKI 146
           ++ L G C       ++ +Y    +L  +L  +               E Q+ +K  +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSC 162
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE-GVSHMTTRV 205
               A G+ YL  +     IHRD+ A NVL+  +    +ADFG A+ I        TT  
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNG 219
Query: 206 KGTLGYLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPL 263
           +  + ++APE A++ +V +   DV+SFG+L+ EI T G  P   +P              
Sbjct: 220 RLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP-------------- 264
Query: 264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGKV 323
            V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L         
Sbjct: 265 -VEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL--------- 313
Query: 324 MQTRIETLAYKEELL 338
              RI TL   EE L
Sbjct: 314 --DRILTLTTNEEYL 326

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 123/277 (44%), Gaps = 30/277 (10%)
Query: 49  LGEGGFGSVYWGRTSDG----LQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLGLR 103
           +G G FG VY G   D     +  AVK L  +    E+ +F  E  ++    H N+L L 
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 104 GYCAGTD-QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G C  ++   L+V  YM +  L + +  +       D    +   +  A+G+ YL    +
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKYL---AS 169
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG---VSHMTTRVKGTLGYLAPEYAMW 219
              +HRD+ A N +LD  F   VADFG A+ + +      H  T  K  + ++A E    
Sbjct: 170 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQT 229
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
            K +   DV+SFG+LL E++T   P    P      IT +    +++G  + L+ P+   
Sbjct: 230 QKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVY----LLQG--RRLLQPEYCP 281
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
           D           V + C   + E RP+  E+V+ ++ 
Sbjct: 282 D-------PLYEVMLKCWHPKAEMRPSFSELVSRISA 311

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 138/314 (43%), Gaps = 58/314 (18%)
Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           +  + + +AVK LK   ++ ++ +   E+E++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHG------QYAGEV------QLDWKRRMKI 146
           ++ L G C       ++ +Y    +L  +L        +Y+ ++      Q+ +K  +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
               A G+ YL  +     IHRD+ A NVL+  +    +ADFG A+ I   + +      
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKNTTN 218
Query: 207 GTL--GYLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP 262
           G L   ++APE A++ +V +   DV+SFG+L+ EI T G  P   +P             
Sbjct: 219 GRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------------- 264
Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGK 322
             V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L        
Sbjct: 265 --VEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL-------- 313
Query: 323 VMQTRIETLAYKEE 336
               RI TL   EE
Sbjct: 314 ---DRILTLTTNEE 324

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 138/314 (43%), Gaps = 58/314 (18%)
Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           +  + + +AVK LK   ++ ++ +   E+E++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHG------QYAGEV------QLDWKRRMKI 146
           ++ L G C       ++ +Y    +L  +L        +Y+ ++      Q+ +K  +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
               A G+ YL  +     IHRD+ A NVL+  +    +ADFG A+ I   + +      
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDI-NNIDYYKKTTN 218
Query: 207 GTL--GYLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP 262
           G L   ++APE A++ +V +   DV+SFG+L+ EI T G  P   +P             
Sbjct: 219 GRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------------- 264
Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGK 322
             V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L        
Sbjct: 265 --VEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL-------- 313
Query: 323 VMQTRIETLAYKEE 336
               RI TL   EE
Sbjct: 314 ---DRILTLTTNEE 324

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 30/277 (10%)
Query: 49  LGEGGFGSVYWGRTSDG----LQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLGLR 103
           +G G FG VY G   D     +  AVK L  +    E+ +F  E  ++    H N+L L 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 104 GYCAGTD-QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G C  ++   L+V  YM +  L + +  +       D    +   +  A+G+ +L    +
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKFL---AS 152
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE---GVSHMTTRVKGTLGYLAPEYAMW 219
              +HRD+ A N +LD  F   VADFG A+ + +      H  T  K  + ++A E    
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
            K +   DV+SFG+LL E++T   P    P      IT +    +++G  + L+ P+   
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVY----LLQG--RRLLQPEYCP 264
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
           D           V + C   + E RP+  E+V+ ++ 
Sbjct: 265 D-------PLYEVMLKCWHPKAEMRPSFSELVSRISA 294

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 138/314 (43%), Gaps = 58/314 (18%)
Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           +  + + +AVK LK   ++ ++ +   E+E++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHG------QYAGEV------QLDWKRRMKI 146
           ++ L G C       ++ +Y    +L  +L        +Y+ ++      Q+ +K  +  
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
               A G+ YL  +     IHRD+ A NVL+  +    +ADFG A+ I   + +      
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTN 218
Query: 207 GTL--GYLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP 262
           G L   ++APE A++ +V +   DV+SFG+L+ EI T G  P   +P             
Sbjct: 219 GRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------------- 264
Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGK 322
             V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L        
Sbjct: 265 --VEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL-------- 313
Query: 323 VMQTRIETLAYKEE 336
               RI TL   EE
Sbjct: 314 ---DRILTLTTNEE 324

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 128/285 (44%), Gaps = 40/285 (14%)
Query: 49  LGEGGFGSVY------WGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRV-RHKNLL 100
           LG G FG V        G+    L++AVK LK+     E E    E++++  + +H+N++
Sbjct: 46  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 105
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ------LDWKRRMKIAIGSAEGI 154
            L G C      L++ +Y     LL+ L  +   ++       L+ +  +  +   A+G+
Sbjct: 106 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 165
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT----LG 210
            +L    + + IHRD+ A NVLL +     + DFG A+ I    +++   VKG     + 
Sbjct: 166 AFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI---VKGNARLPVK 219
Query: 211 YLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKF 269
           ++APE       +   DV+S+GILL EI + G  P    PG            ++V  KF
Sbjct: 220 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP---YPG------------ILVNSKF 264
Query: 270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +LV    +        K   ++   C   EP  RP  +++ + L
Sbjct: 265 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 309

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/285 (26%), Positives = 128/285 (44%), Gaps = 40/285 (14%)
Query: 49  LGEGGFGSVY------WGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRV-RHKNLL 100
           LG G FG V        G+    L++AVK LK+     E E    E++++  + +H+N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ------LDWKRRMKIAIGSAEGI 154
            L G C      L++ +Y     LL+ L  +   ++       L+ +  +  +   A+G+
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGM 173
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT----LG 210
            +L    + + IHRD+ A NVLL +     + DFG A+ I    +++   VKG     + 
Sbjct: 174 AFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI---VKGNARLPVK 227
Query: 211 YLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKF 269
           ++APE       +   DV+S+GILL EI + G  P    PG            ++V  KF
Sbjct: 228 WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP---YPG------------ILVNSKF 272
Query: 270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +LV    +        K   ++   C   EP  RP  +++ + L
Sbjct: 273 YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 317

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 30/277 (10%)
Query: 49  LGEGGFGSVYWGRTSDG----LQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLGLR 103
           +G G FG VY G   D     +  AVK L  +    E+ +F  E  ++    H N+L L 
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 104 GYCAGTD-QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G C  ++   L+V  YM +  L + +  +       D    +   +  A+G+ +L    +
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKFL---AS 156
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE---GVSHMTTRVKGTLGYLAPEYAMW 219
              +HRD+ A N +LD  F   VADFG A+ + +      H  T  K  + ++A E    
Sbjct: 157 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 216
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
            K +   DV+SFG+LL E++T   P    P      IT +    +++G  + L+ P+   
Sbjct: 217 QKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVY----LLQG--RRLLQPEYCP 268
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
           D           V + C   + E RP+  E+V+ ++ 
Sbjct: 269 D-------PLYEVMLKCWHPKAEMRPSFSELVSRISA 298

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 25/223 (11%)
Query: 38  TATNGFSDDNKLGE----GGFGSVYWGRT-SDGLQIAVKKLKA---MNSKAEMEFAVEVE 89
           T  +  SD  +LGE    GG   V+  R   D   +AVK L+A    +    + F  E +
Sbjct: 5   TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQ 64
Query: 90  VLGRVRHKNLLGLRGYCAGTDQR------LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRR 143
               + H  ++ +  Y  G  +        IV +Y+  ++L   +H     E  +  KR 
Sbjct: 65  NAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRA 118
Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMT- 202
           +++   + + + + H      IIHRD+K +N+++ +     V DFG A+ I +  + +T 
Sbjct: 119 IEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 203 -TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
              V GT  YL+PE A    V    DVYS G +L E+LTG  P
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 30/277 (10%)
Query: 49  LGEGGFGSVYWGRTSDG----LQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLGLR 103
           +G G FG VY G   D     +  AVK L  +    E+ +F  E  ++    H N+L L 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 104 GYCAGTD-QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G C  ++   L+V  YM +  L + +  +       D    +   +  A+G+ +L    +
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKFL---AS 152
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE---GVSHMTTRVKGTLGYLAPEYAMW 219
              +HRD+ A N +LD  F   VADFG A+ + +      H  T  K  + ++A E    
Sbjct: 153 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQT 212
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
            K +   DV+SFG+LL E++T   P    P      IT +    +++G  + L+ P+   
Sbjct: 213 QKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVY----LLQG--RRLLQPEYCP 264
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
           D           V + C   + E RP+  E+V+ ++ 
Sbjct: 265 D-------PLYEVMLKCWHPKAEMRPSFSELVSRISA 294

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 25/223 (11%)
Query: 38  TATNGFSDDNKLGE----GGFGSVYWGRT-SDGLQIAVKKLKA---MNSKAEMEFAVEVE 89
           T  +  SD  +LGE    GG   V+  R   D   +AVK L+A    +    + F  E +
Sbjct: 5   TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQ 64
Query: 90  VLGRVRHKNLLGLRGYCAGTDQR------LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRR 143
               + H  ++ +  Y  G  +        IV +Y+  ++L   +H     E  +  KR 
Sbjct: 65  NAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRA 118
Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMT- 202
           +++   + + + + H      IIHRD+K +N+++ +     V DFG A+ I +  + +T 
Sbjct: 119 IEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 203 -TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
              V GT  YL+PE A    V    DVYS G +L E+LTG  P
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 120/273 (43%), Gaps = 40/273 (14%)
Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKL----KAMNSKAEMEFAVEVEVLGRVRHK 97
           FSD  ++G G FG+VY+ R   +   +A+KK+    K  N K + +   EV  L ++RH 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ-DIIKEVRFLQKLRHP 75
Query: 98  NLLGLRGYCAGTDQRLIVYDY-MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
           N +  RG         +V +Y + + S L  +H +   EV++       +  G+ +G+ Y
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAVTHGALQGLAY 130
Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
           LH   + ++IHRD+KA N+LL       + DFG A ++            GT  ++APE 
Sbjct: 131 LH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NXFVGTPYWMAPEV 182
Query: 217 AMW---GKVSESCDVYSFGILLLEILTGRKPIEKLPG-GVKRTITEWAEPLIVKGKFKEL 272
            +    G+     DV+S GI  +E+   + P+  +        I +   P +  G + E 
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 242
Query: 273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRP 305
                             N    C+Q  P+ RP
Sbjct: 243 FR----------------NFVDSCLQKIPQDRP 259

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 30/277 (10%)
Query: 49  LGEGGFGSVYWGRTSDG----LQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLGLR 103
           +G G FG VY G   D     +  AVK L  +    E+ +F  E  ++    H N+L L 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 104 GYCAGTD-QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G C  ++   L+V  YM +  L + +  +       D    +   +  A+G+ +L    +
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKFL---AS 149
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE---GVSHMTTRVKGTLGYLAPEYAMW 219
              +HRD+ A N +LD  F   VADFG A+ + +      H  T  K  + ++A E    
Sbjct: 150 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 209
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
            K +   DV+SFG+LL E++T   P    P      IT +    +++G  + L+ P+   
Sbjct: 210 QKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVY----LLQG--RRLLQPEYCP 261
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
           D           V + C   + E RP+  E+V+ ++ 
Sbjct: 262 D-------PLYEVMLKCWHPKAEMRPSFSELVSRISA 291

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 132/301 (43%), Gaps = 36/301 (11%)
Query: 30  IFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNS-KAEM 82
           +F   E   +    +   +LG+G FG VY G   D ++      +AVK +    S +  +
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 83  EFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHG------QYAGEV 136
           EF  E  V+      +++ L G  +     L+V + M +  L S+L           G  
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 137 QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE 196
               +  +++A   A+G+ YL+ +     +HRD+ A N ++  DF   + DFG  + I E
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 182
Query: 197 GVSHMTTRVKGTLG--YLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVK 253
             ++     KG L   ++APE    G  + S D++SFG++L EI +   +P + L     
Sbjct: 183 -TAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS---- 237
Query: 254 RTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT 313
               E     ++ G + +  D         N  ++  ++  +C Q  P+ RP   E+VN 
Sbjct: 238 ---NEQVLKFVMDGGYLDQPD---------NCPERVTDLMRMCWQFNPKMRPTFLEIVNL 285
Query: 314 L 314
           L
Sbjct: 286 L 286

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 30/277 (10%)
Query: 49  LGEGGFGSVYWGRTSDG----LQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLGLR 103
           +G G FG VY G   D     +  AVK L  +    E+ +F  E  ++    H N+L L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 104 GYCAGTD-QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G C  ++   L+V  YM +  L + +  +       D    +   +  A+G+ +L    +
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKFL---AS 151
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE---GVSHMTTRVKGTLGYLAPEYAMW 219
              +HRD+ A N +LD  F   VADFG A+ + +      H  T  K  + ++A E    
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
            K +   DV+SFG+LL E++T   P    P      IT +    +++G  + L+ P+   
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVY----LLQG--RRLLQPEYCP 263
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
           D           V + C   + E RP+  E+V+ ++ 
Sbjct: 264 D-------PLYEVMLKCWHPKAEMRPSFSELVSRISA 293

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/273 (26%), Positives = 120/273 (43%), Gaps = 40/273 (14%)
Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKL----KAMNSKAEMEFAVEVEVLGRVRHK 97
           FSD  ++G G FG+VY+ R   +   +A+KK+    K  N K + +   EV  L ++RH 
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQ-DIIKEVRFLQKLRHP 114
Query: 98  NLLGLRGYCAGTDQRLIVYDY-MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
           N +  RG         +V +Y + + S L  +H +   EV++       +  G+ +G+ Y
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEI-----AAVTHGALQGLAY 169
Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
           LH   + ++IHRD+KA N+LL       + DFG A ++            GT  ++APE 
Sbjct: 170 LH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----NXFVGTPYWMAPEV 221
Query: 217 AMW---GKVSESCDVYSFGILLLEILTGRKPIEKLPG-GVKRTITEWAEPLIVKGKFKEL 272
            +    G+     DV+S GI  +E+   + P+  +        I +   P +  G + E 
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY 281
Query: 273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRP 305
                             N    C+Q  P+ RP
Sbjct: 282 FR----------------NFVDSCLQKIPQDRP 298

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 66/211 (31%), Positives = 95/211 (45%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTS-DGLQIAVKKLK---AMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V+  R+  +G   A+K LK    +  K       E  +L  V H  ++ + G
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAIGSAEGI 154
                 Q  ++ DY+    L S L             YA EV L               +
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL--------------AL 119
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  II+RD+K  N+LLD +    + DFGFAK +P+    +T  + GT  Y+AP
Sbjct: 120 EYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYXLCGTPDYIAP 172
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E       ++S D +SFGIL+ E+L G  P 
Sbjct: 173 EVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 120/259 (46%), Gaps = 28/259 (10%)
Query: 16  GLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AV 70
           G+ +   PN A  RI    E       F     LG G FG+VY   W    + ++I  A+
Sbjct: 4   GIRSGEAPNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAI 56
Query: 71  KKLK-AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL- 128
           K+L+ A + KA  E   E  V+  V + ++  L G C  +  +LI    MP   LL ++ 
Sbjct: 57  KELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVR 115
Query: 129 -HGQYAG-EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVA 186
            H    G +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + 
Sbjct: 116 EHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT 166
Query: 187 DFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
           DFG AKL+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP
Sbjct: 167 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226
Query: 245 IEKLPGGVKRTITEWAEPL 263
            + +P     +I E  E L
Sbjct: 227 YDGIPASEISSILEKGERL 245

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 30/277 (10%)
Query: 49  LGEGGFGSVYWGRTSDG----LQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLGLR 103
           +G G FG VY G   D     +  AVK L  +    E+ +F  E  ++    H N+L L 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 104 GYCAGTD-QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G C  ++   L+V  YM +  L + +  +       D    +   +  A+G+ +L    +
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKFL---AS 151
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE---GVSHMTTRVKGTLGYLAPEYAMW 219
              +HRD+ A N +LD  F   VADFG A+ + +      H  T  K  + ++A E    
Sbjct: 152 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 211
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
            K +   DV+SFG+LL E++T   P    P      IT +    +++G  + L+ P+   
Sbjct: 212 QKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVY----LLQG--RRLLQPEYCP 263
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
           D           V + C   + E RP+  E+V+ ++ 
Sbjct: 264 D-------PLYEVMLKCWHPKAEMRPSFSELVSRISA 293

>pdb|1OEC|A Chain A, Fgfr2 Kinase Domain Length = 316

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 138/314 (43%), Gaps = 58/314 (18%)
Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           +  + + +AVK LK   ++ ++ +   E+E++  + +HKN
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHG------QYAGEV------QLDWKRRMKI 146
           ++ L G C       ++ +Y    +L  +L        +Y+ ++      Q+ +K  +  
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 154
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
               A G+ YL  +     IHRD+ A NVL+  +    +ADFG A+ I   + +      
Sbjct: 155 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTN 210
Query: 207 GTL--GYLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP 262
           G L   ++APE A++ +V +   DV+SFG+L+ EI T G  P   +P             
Sbjct: 211 GRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------------- 256
Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGK 322
             V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L        
Sbjct: 257 --VEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL-------- 305
Query: 323 VMQTRIETLAYKEE 336
               RI TL   EE
Sbjct: 306 ---DRILTLTTNEE 316

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 138/314 (43%), Gaps = 58/314 (18%)
Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           +  + + +AVK LK   ++ ++ +   E+E++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHG------QYAGEV------QLDWKRRMKI 146
           ++ L G C       ++ +Y    +L  +L        +Y+ ++      Q+ +K  +  
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
               A G+ YL  +     IHRD+ A NVL+  +    +ADFG A+ I   + +      
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTN 218
Query: 207 GTL--GYLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP 262
           G L   ++APE A++ +V +   DV+SFG+L+ EI T G  P   +P             
Sbjct: 219 GRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------------- 264
Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGK 322
             V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L        
Sbjct: 265 --VEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL-------- 313
Query: 323 VMQTRIETLAYKEE 336
               RI TL   EE
Sbjct: 314 ---DRILTLTTNEE 324

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 111/237 (46%), Gaps = 42/237 (17%)
Query: 49  LGEGGFGSVYWGRTS-DGLQI--AVKKLKAMNSKAE-MEFAVEVEVLGRV-RHKNLLGLR 103
           +GEG FG V   R   DGL++  A+K++K   SK +  +FA E+EVL ++  H N++ L 
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ------------LDWKRRMKIAIGSA 151
           G C       +  +Y P+ +LL  L      E              L  ++ +  A   A
Sbjct: 90  GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 149
Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG- 210
            G+ YL  +     IHR++ A N+L+  ++   +ADFG ++            VK T+G 
Sbjct: 150 RGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSR-------GQEVYVKKTMGR 199
Query: 211 ----YLAPEYAMWGKVSESCDVYSFGILLLEI----------LTGRKPIEKLPGGVK 253
               ++A E   +   + + DV+S+G+LL EI          +T  +  EKLP G +
Sbjct: 200 LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 256

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 123/277 (44%), Gaps = 30/277 (10%)
Query: 49  LGEGGFGSVYWGRTSDG----LQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLGLR 103
           +G G FG VY G   D     +  AVK L  +    E+ +F  E  ++    H N+L L 
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 104 GYCAGTD-QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G C  ++   L+V  YM +  L + +  +       D    +   +  A+G+ +L    +
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL---IGFGLQVAKGMKFL---AS 210
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE---GVSHMTTRVKGTLGYLAPEYAMW 219
              +HRD+ A N +LD  F   VADFG A+ + +      H  T  K  + ++A E    
Sbjct: 211 KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
            K +   DV+SFG+LL E++T   P    P      IT +    +++G  + L+ P+   
Sbjct: 271 QKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNTFDITVY----LLQG--RRLLQPEYCP 322
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
           D           V + C   + E RP+  E+V+ ++ 
Sbjct: 323 D-------PLYEVMLKCWHPKAEMRPSFSELVSRISA 352

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 131/301 (43%), Gaps = 36/301 (11%)
Query: 30  IFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNS-KAEM 82
           +F   E   +    +   +LG+G FG VY G   D ++      +AVK +    S +  +
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 83  EFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHG------QYAGEV 136
           EF  E  V+      +++ L G  +     L+V + M +  L S+L           G  
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 137 QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE 196
               +  +++A   A+G+ YL+ +     +HRD+ A N ++  DF   + DFG  + I E
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE 182
Query: 197 GVSHMTTRVKGTLG--YLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVK 253
              +     KG L   ++APE    G  + S D++SFG++L EI +   +P + L     
Sbjct: 183 -TDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS---- 237
Query: 254 RTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT 313
               E     ++ G + +  D         N  ++  ++  +C Q  P+ RP   E+VN 
Sbjct: 238 ---NEQVLKFVMDGGYLDQPD---------NCPERVTDLMRMCWQFNPKMRPTFLEIVNL 285
Query: 314 L 314
           L
Sbjct: 286 L 286

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 138/314 (43%), Gaps = 58/314 (18%)
Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           +  + + +AVK LK   ++ ++ +   E+E++  + +HKN
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHG------QYAGEV------QLDWKRRMKI 146
           ++ L G C       ++ +Y    +L  +L        +Y+ ++      Q+ +K  +  
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 151
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
               A G+ YL  +     IHRD+ A NVL+  +    +ADFG A+ I   + +      
Sbjct: 152 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTN 207
Query: 207 GTL--GYLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP 262
           G L   ++APE A++ +V +   DV+SFG+L+ EI T G  P   +P             
Sbjct: 208 GRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------------- 253
Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGK 322
             V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L        
Sbjct: 254 --VEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL-------- 302
Query: 323 VMQTRIETLAYKEE 336
               RI TL   EE
Sbjct: 303 ---DRILTLTTNEE 313

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 132/292 (45%), Gaps = 47/292 (16%)
Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           +  + + +AVK LK   ++ ++ +   E+E++  + +HKN
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHG------QYAGEV------QLDWKRRMKI 146
           ++ L G C       ++ +Y    +L  +L        +Y+ ++      Q+ +K  +  
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 149
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
               A G+ YL  +     IHRD+ A NVL+  +    +ADFG A+ I   + +      
Sbjct: 150 TYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTN 205
Query: 207 GTL--GYLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP 262
           G L   ++APE A++ +V +   DV+SFG+L+ EI T G  P   +P             
Sbjct: 206 GRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------------- 251
Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
             V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L
Sbjct: 252 --VEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 300

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 138/314 (43%), Gaps = 58/314 (18%)
Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           +  + + +AVK LK   ++ ++ +   E+E++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHG------QYAGEV------QLDWKRRMKI 146
           ++ L G C       ++ +Y    +L  +L        +Y+ ++      Q+ +K  +  
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
               A G+ YL  +     IHRD+ A NVL+  +    +ADFG A+ I   + +      
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTN 218
Query: 207 GTL--GYLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP 262
           G L   ++APE A++ +V +   DV+SFG+L+ EI T G  P   +P             
Sbjct: 219 GRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------------- 264
Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGK 322
             V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L        
Sbjct: 265 --VEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL-------- 313
Query: 323 VMQTRIETLAYKEE 336
               RI TL   EE
Sbjct: 314 ---DRILTLTTNEE 324

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 118/253 (46%), Gaps = 28/253 (11%)
Query: 22  TPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-A 75
            PN A  RI    E       F     LG G FG+VY   W    + ++I  A+K+L+ A
Sbjct: 3   APNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 55
Query: 76  MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYA 133
            + KA  E   E  V+  V + ++  L G C  +  +LI+   MP   LL ++  H    
Sbjct: 56  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNI 114
Query: 134 G-EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
           G +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + DFG AK
Sbjct: 115 GSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165
Query: 193 LI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
           L+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP + +P 
Sbjct: 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225
Query: 251 GVKRTITEWAEPL 263
               +I E  E L
Sbjct: 226 SEISSILEKGERL 238

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 118/253 (46%), Gaps = 28/253 (11%)
Query: 22  TPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-A 75
            PN A  RI    E       F     LG G FG+VY   W    + ++I  A+K+L+ A
Sbjct: 4   APNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 56
Query: 76  MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYA 133
            + KA  E   E  V+  V + ++  L G C  +  +LI+   MP   LL ++  H    
Sbjct: 57  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNI 115
Query: 134 G-EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
           G +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + DFG AK
Sbjct: 116 GSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 166
Query: 193 LI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
           L+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP + +P 
Sbjct: 167 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 226
Query: 251 GVKRTITEWAEPL 263
               +I E  E L
Sbjct: 227 SEISSILEKGERL 239

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 118/253 (46%), Gaps = 28/253 (11%)
Query: 22  TPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-A 75
            PN A  RI    E       F     LG G FG+VY   W    + ++I  A+K+L+ A
Sbjct: 5   APNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 57
Query: 76  MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYA 133
            + KA  E   E  V+  V + ++  L G C  +  +LI+   MP   LL ++  H    
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNI 116
Query: 134 G-EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
           G +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + DFG AK
Sbjct: 117 GSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 167
Query: 193 LI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
           L+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP + +P 
Sbjct: 168 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 227
Query: 251 GVKRTITEWAEPL 263
               +I E  E L
Sbjct: 228 SEISSILEKGERL 240

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 116/253 (45%), Gaps = 28/253 (11%)
Query: 22  TPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-A 75
            PN A  RI    E       F     LG G FG+VY   W    + ++I  A+K+L+ A
Sbjct: 6   APNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 58
Query: 76  MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLH---GQY 132
            + KA  E   E  V+  V + ++  L G C  +  +LI+   MP   LL ++       
Sbjct: 59  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNI 117
Query: 133 AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
             +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + DFG AK
Sbjct: 118 GSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 168
Query: 193 LI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
           L+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP + +P 
Sbjct: 169 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 228
Query: 251 GVKRTITEWAEPL 263
               +I E  E L
Sbjct: 229 SEISSILEKGERL 241

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 138/314 (43%), Gaps = 58/314 (18%)
Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           +  + + +AVK LK   ++ ++ +   E+E++  + +HKN
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHG------QYAGEV------QLDWKRRMKI 146
           ++ L G C       ++ +Y    +L  +L        +Y+ ++      Q+ +K  +  
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 208
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
               A G+ YL  +     IHRD+ A NVL+  +    +ADFG A+ I   + +      
Sbjct: 209 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTN 264
Query: 207 GTL--GYLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP 262
           G L   ++APE A++ +V +   DV+SFG+L+ EI T G  P   +P             
Sbjct: 265 GRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------------- 310
Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGK 322
             V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L        
Sbjct: 311 --VEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL-------- 359
Query: 323 VMQTRIETLAYKEE 336
               RI TL   EE
Sbjct: 360 ---DRILTLTTNEE 370

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 116/253 (45%), Gaps = 28/253 (11%)
Query: 22  TPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-A 75
            PN A  RI    E       F     LG G FG+VY   W    + ++I  A+K+L+ A
Sbjct: 7   APNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 59
Query: 76  MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLH---GQY 132
            + KA  E   E  V+  V + ++  L G C  +  +LI+   MP   LL ++       
Sbjct: 60  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNI 118
Query: 133 AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
             +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + DFG AK
Sbjct: 119 GSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 169
Query: 193 LI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
           L+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP + +P 
Sbjct: 170 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 229
Query: 251 GVKRTITEWAEPL 263
               +I E  E L
Sbjct: 230 SEISSILEKGERL 242

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 130/301 (43%), Gaps = 36/301 (11%)
Query: 30  IFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNS-KAEM 82
           +F   E   +    +   +LG+G FG VY G   D ++      +AVK +    S +  +
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 83  EFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHG------QYAGEV 136
           EF  E  V+      +++ L G  +     L+V + M +  L S+L           G  
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 125
Query: 137 QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE 196
               +  +++A   A+G+ YL+ +     +HRD+ A N ++  DF   + DFG  + I E
Sbjct: 126 PPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE 182
Query: 197 GVSHMTTRVKGTLG--YLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVK 253
                    KG L   ++APE    G  + S D++SFG++L EI +   +P + L     
Sbjct: 183 -TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS---- 237
Query: 254 RTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT 313
               E     ++ G + +  D         N  ++  ++  +C Q  P+ RP   E+VN 
Sbjct: 238 ---NEQVLKFVMDGGYLDQPD---------NCPERVTDLMRMCWQFNPKMRPTFLEIVNL 285
Query: 314 L 314
           L
Sbjct: 286 L 286

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 28/253 (11%)
Query: 22  TPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-A 75
            PN A  RI    E       F     LG G FG+VY   W    + ++I  A+K+L+ A
Sbjct: 13  APNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 65
Query: 76  MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYA 133
            + KA  E   E  V+  V + ++  L G C  +  +LI    MP   LL ++  H    
Sbjct: 66  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 124
Query: 134 G-EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
           G +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + DFG AK
Sbjct: 125 GSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 175
Query: 193 LI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
           L+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP + +P 
Sbjct: 176 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 235
Query: 251 GVKRTITEWAEPL 263
               +I E  E L
Sbjct: 236 SEISSILEKGERL 248

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 41  NGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKL--KAMNSK--AEMEFAVEVEVLGRVRH 96
           + F     LG+G FG+VY  R      I   K+  K+   K   E +   E+E+   +RH
Sbjct: 15  DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 74
Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGI 154
            N+L +  Y     +  ++ ++ P   L   L  HG++      D +R        A+ +
Sbjct: 75  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF------DEQRSATFMEELADAL 128
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            Y H      +IHRDIK  N+L+    E  +ADFG++   P   S     + GTL YL P
Sbjct: 129 HYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP---SLRRRXMCGTLDYLPP 182
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
           E        E  D++  G+L  E L G  P +
Sbjct: 183 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 214

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 77/291 (26%), Positives = 128/291 (43%), Gaps = 46/291 (15%)
Query: 49  LGEGGFGSVY------WGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRV-RHKNLL 100
           LG G FG V        G+    L++AVK LK+     E E    E++++  + +H+N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHL------------HGQYAGEVQLDWKRRMKIAI 148
            L G C      L++ +Y     LL+ L            +  +  E QL  +  +  + 
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSS 173
Query: 149 GSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT 208
             A+G+ +L    + + IHRD+ A NVLL +     + DFG A+ I    +++   VKG 
Sbjct: 174 QVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI---VKGN 227
Query: 209 ----LGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPL 263
               + ++APE       +   DV+S+GILL EI + G  P    PG            +
Sbjct: 228 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP---YPG------------I 272
Query: 264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           +V  KF +LV    +        K   ++   C   EP  RP  +++ + L
Sbjct: 273 LVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 323

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 126/283 (44%), Gaps = 36/283 (12%)
Query: 48  KLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLL 100
           +LG+G FG VY G   D ++      +AVK +    S +  +EF  E  V+      +++
Sbjct: 23  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 82
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHG------QYAGEVQLDWKRRMKIAIGSAEGI 154
            L G  +     L+V + M +  L S+L           G      +  +++A   A+G+
Sbjct: 83  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 142
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG--YL 212
            YL+ +     +HRD+ A N ++  DF   + DFG  + I E   +     KG L   ++
Sbjct: 143 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVRWM 198
Query: 213 APEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKE 271
           APE    G  + S D++SFG++L EI +   +P + L         E     ++ G + +
Sbjct: 199 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-------NEQVLKFVMDGGYLD 251
Query: 272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
             D         N  ++  ++  +C Q  P+ RP   E+VN L
Sbjct: 252 QPD---------NCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 285

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 137/314 (43%), Gaps = 58/314 (18%)
Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           +  + + +AVK LK   ++ ++ +   E+E++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHG------QYAGEV------QLDWKRRMKI 146
           ++ L G C       ++  Y    +L  +L        +Y+ ++      Q+ +K  +  
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
               A G+ YL  +     IHRD+ A NVL+  +    +ADFG A+ I   + +      
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTN 218
Query: 207 GTL--GYLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP 262
           G L   ++APE A++ +V +   DV+SFG+L+ EI T G  P   +P             
Sbjct: 219 GRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------------- 264
Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGK 322
             V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L        
Sbjct: 265 --VEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL-------- 313
Query: 323 VMQTRIETLAYKEE 336
               RI TL   EE
Sbjct: 314 ---DRILTLTTNEE 324

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 118/253 (46%), Gaps = 28/253 (11%)
Query: 22  TPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-A 75
            PN A  RI    E       F     LG G FG+VY   W    + ++I  A+K+L+ A
Sbjct: 4   APNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 56
Query: 76  MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYA 133
            + KA  E   E  V+  V + ++  L G C  +  +LI+   MP   LL ++  H    
Sbjct: 57  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGXLLDYVREHKDNI 115
Query: 134 G-EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
           G +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + DFG AK
Sbjct: 116 GSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 166
Query: 193 LI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
           L+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP + +P 
Sbjct: 167 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 226
Query: 251 GVKRTITEWAEPL 263
               +I E  E L
Sbjct: 227 SEISSILEKGERL 239

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 28/253 (11%)
Query: 22  TPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-A 75
            PN A  RI    E       F     LG G FG+VY   W    + ++I  A+K+L+ A
Sbjct: 3   APNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 55
Query: 76  MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYA 133
            + KA  E   E  V+  V + ++  L G C  +  +LI    MP   LL ++  H    
Sbjct: 56  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 114
Query: 134 G-EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
           G +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + DFG AK
Sbjct: 115 GSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165
Query: 193 LI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
           L+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP + +P 
Sbjct: 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225
Query: 251 GVKRTITEWAEPL 263
               +I E  E L
Sbjct: 226 SEISSILEKGERL 238

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 28/253 (11%)
Query: 22  TPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-A 75
            PN A  RI    E       F     LG G FG+VY   W    + ++I  A+K+L+ A
Sbjct: 6   APNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 58
Query: 76  MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYA 133
            + KA  E   E  V+  V + ++  L G C  +  +LI    MP   LL ++  H    
Sbjct: 59  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 117
Query: 134 G-EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
           G +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + DFG AK
Sbjct: 118 GSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 168
Query: 193 LI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
           L+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP + +P 
Sbjct: 169 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 228
Query: 251 GVKRTITEWAEPL 263
               +I E  E L
Sbjct: 229 SEISSILEKGERL 241

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 72/253 (28%), Positives = 115/253 (45%), Gaps = 28/253 (11%)
Query: 22  TPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-A 75
            PN A  RI    E       F     LG G FG+VY   W    + ++I  A+K+L+ A
Sbjct: 28  APNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 80
Query: 76  MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLH---GQY 132
            + KA  E   E  V+  V + ++  L G C  +  +LI    MP   LL ++       
Sbjct: 81  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 139
Query: 133 AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
             +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + DFG AK
Sbjct: 140 GSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 190
Query: 193 LI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
           L+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP + +P 
Sbjct: 191 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 250
Query: 251 GVKRTITEWAEPL 263
               +I E  E L
Sbjct: 251 SEISSILEKGERL 263

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 130/301 (43%), Gaps = 36/301 (11%)
Query: 30  IFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNS-KAEM 82
           +F   E   +    +   +LG+G FG VY G   D ++      +AVK +    S +  +
Sbjct: 3   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 62
Query: 83  EFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHG------QYAGEV 136
           EF  E  V+      +++ L G  +     L+V + M +  L S+L           G  
Sbjct: 63  EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 122
Query: 137 QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE 196
               +  +++A   A+G+ YL+ +     +HRD+ A N ++  DF   + DFG  + I E
Sbjct: 123 PPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE 179
Query: 197 GVSHMTTRVKGTLG--YLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVK 253
                    KG L   ++APE    G  + S D++SFG++L EI +   +P + L     
Sbjct: 180 -TDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS---- 234
Query: 254 RTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT 313
               E     ++ G + +  D         N  ++  ++  +C Q  P+ RP   E+VN 
Sbjct: 235 ---NEQVLKFVMDGGYLDQPD---------NCPERVTDLMRMCWQFNPKMRPTFLEIVNL 282
Query: 314 L 314
           L
Sbjct: 283 L 283

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 83/314 (26%), Positives = 137/314 (43%), Gaps = 58/314 (18%)
Query: 49  LGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKN 98
           LGEG FG V           +  + + +AVK LK   ++ ++ +   E+E++  + +HKN
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHG------QYAGEV------QLDWKRRMKI 146
           ++ L G C       ++  Y    +L  +L        +Y+ ++      Q+ +K  +  
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSC 162
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
               A G+ YL  +     IHRD+ A NVL+  +    +ADFG A+ I   + +      
Sbjct: 163 TYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDI-NNIDYYKKTTN 218
Query: 207 GTL--GYLAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP 262
           G L   ++APE A++ +V +   DV+SFG+L+ EI T G  P   +P             
Sbjct: 219 GRLPVKWMAPE-ALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP------------- 264
Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGK 322
             V+  FK L+    R D   N   +   +   C  + P +RP  K++V  L        
Sbjct: 265 --VEELFK-LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDL-------- 313
Query: 323 VMQTRIETLAYKEE 336
               RI TL   EE
Sbjct: 314 ---DRILTLTTNEE 324

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 28/253 (11%)
Query: 22  TPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-A 75
            PN A  RI    E       F     LG G FG+VY   W    + ++I  A+K+L+ A
Sbjct: 5   APNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 57
Query: 76  MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYA 133
            + KA  E   E  V+  V + ++  L G C  +  +LI    MP   LL ++  H    
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 116
Query: 134 G-EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
           G +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + DFG AK
Sbjct: 117 GSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 167
Query: 193 LI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
           L+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP + +P 
Sbjct: 168 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 227
Query: 251 GVKRTITEWAEPL 263
               +I E  E L
Sbjct: 228 SEISSILEKGERL 240

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 28/253 (11%)
Query: 22  TPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-A 75
            PN A  RI    E       F     LG G FG+VY   W    + ++I  A+K+L+ A
Sbjct: 6   APNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 58
Query: 76  MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYA 133
            + KA  E   E  V+  V + ++  L G C  +  +LI    MP   LL ++  H    
Sbjct: 59  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 117
Query: 134 G-EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
           G +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + DFG AK
Sbjct: 118 GSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 168
Query: 193 LI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
           L+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP + +P 
Sbjct: 169 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 228
Query: 251 GVKRTITEWAEPL 263
               +I E  E L
Sbjct: 229 SEISSILEKGERL 241

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 28/253 (11%)
Query: 22  TPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-A 75
            PN A  RI    E       F     LG G FG+VY   W    + ++I  A+K+L+ A
Sbjct: 3   APNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 55
Query: 76  MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYA 133
            + KA  E   E  V+  V + ++  L G C  +  +LI    MP   LL ++  H    
Sbjct: 56  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 114
Query: 134 G-EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
           G +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + DFG AK
Sbjct: 115 GSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165
Query: 193 LI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
           L+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP + +P 
Sbjct: 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225
Query: 251 GVKRTITEWAEPL 263
               +I E  E L
Sbjct: 226 SEISSILEKGERL 238

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 28/253 (11%)
Query: 22  TPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-A 75
            PN A  RI    E       F     LG G FG+VY   W    + ++I  A+K+L+ A
Sbjct: 6   APNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 58
Query: 76  MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYA 133
            + KA  E   E  V+  V + ++  L G C  +  +LI    MP   LL ++  H    
Sbjct: 59  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 117
Query: 134 G-EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
           G +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + DFG AK
Sbjct: 118 GSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 168
Query: 193 LI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
           L+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP + +P 
Sbjct: 169 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 228
Query: 251 GVKRTITEWAEPL 263
               +I E  E L
Sbjct: 229 SEISSILEKGERL 241

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 28/253 (11%)
Query: 22  TPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-A 75
            PN A  RI    E       F     LG G FG+VY   W    + ++I  A+K+L+ A
Sbjct: 9   APNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 61
Query: 76  MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYA 133
            + KA  E   E  V+  V + ++  L G C  +  +LI    MP   LL ++  H    
Sbjct: 62  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 120
Query: 134 G-EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
           G +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + DFG AK
Sbjct: 121 GSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 171
Query: 193 LI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
           L+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP + +P 
Sbjct: 172 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 231
Query: 251 GVKRTITEWAEPL 263
               +I E  E L
Sbjct: 232 SEISSILEKGERL 244

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 18/212 (8%)
Query: 41  NGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKL--KAMNSK--AEMEFAVEVEVLGRVRH 96
           + F     LG+G FG+VY  R      I   K+  K+   K   E +   E+E+   +RH
Sbjct: 14  DDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGI 154
            N+L +  Y     +  ++ ++ P   L   L  HG++      D +R        A+ +
Sbjct: 74  PNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF------DEQRSATFMEELADAL 127
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            Y H      +IHRDIK  N+L+    E  +ADFG++   P   S     + GTL YL P
Sbjct: 128 HYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP---SLRRRXMCGTLDYLPP 181
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
           E        E  D++  G+L  E L G  P +
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 127/283 (44%), Gaps = 35/283 (12%)
Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLKA----MNSKAEMEFAVEVEVLGRV-RHKNLLGL 102
           LG+G FG V+        Q  A+K LK     M+   E    VE  VL     H  L  +
Sbjct: 26  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT-MVEKRVLSLAWEHPFLTHM 84
Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
                  +    V +Y+    L+ H+   +    + D  R    A     G+ +LH   +
Sbjct: 85  FCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLH---S 137
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
             I++RD+K  N+LLD D    +ADFG  K    G +  T    GT  Y+APE  +  K 
Sbjct: 138 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNEFCGTPDYIAPEILLGQKY 196
Query: 223 SESCDVYSFGILLLEILTGRKPI-----EKLPGGVK-------RTITEWAEPLIVKGKFK 270
           + S D +SFG+LL E+L G+ P      E+L   ++       R + + A+ L+VK   +
Sbjct: 197 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 256
Query: 271 ELVDPK----LRGDFDENQLKQAINVAVLCVQS-EPEKRPNMK 308
           E   P+    +RGD  ++ L + IN   L  +  +P  RP +K
Sbjct: 257 E---PEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVK 296

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 28/253 (11%)
Query: 22  TPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-A 75
            PN A  RI    E       F     LG G FG+VY   W    + ++I  A+K+L+ A
Sbjct: 3   APNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 55
Query: 76  MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYA 133
            + KA  E   E  V+  V + ++  L G C  +  +LI    MP   LL ++  H    
Sbjct: 56  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGXLLDYVREHKDNI 114
Query: 134 G-EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
           G +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + DFG AK
Sbjct: 115 GSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165
Query: 193 LI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
           L+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP + +P 
Sbjct: 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225
Query: 251 GVKRTITEWAEPL 263
               +I E  E L
Sbjct: 226 SEISSILEKGERL 238

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 22/209 (10%)
Query: 49  LGEGGFGSVYWGRTS----DGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           +G G FG V  G         + +A+K LK+    K   +F  E  ++G+  H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLH---GQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G    +   +I+ ++M N SL S L    GQ+   +QL    R     G A G+ YL   
Sbjct: 75  GVVTKSTPVMIITEFMENGSLDSFLRQNDGQFT-VIQLVGMLR-----GIAAGMKYL--- 125
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRV----KGTLGYLAPEY 216
              + +HR + A N+L++S+    V+DFG ++ + +  S  T       K  + + APE 
Sbjct: 126 ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 185
Query: 217 AMWGKVSESCDVYSFGILLLEILT-GRKP 244
             + K + + DV+S+GI++ E+++ G +P
Sbjct: 186 IQYRKFTSASDVWSYGIVMWEVMSYGERP 214

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/259 (28%), Positives = 118/259 (45%), Gaps = 28/259 (10%)
Query: 16  GLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AV 70
           G+ +   PN A  RI    E       F     LG G FG+VY   W    + ++I  A+
Sbjct: 4   GIRSGEAPNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAI 56
Query: 71  KKLK-AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLH 129
           K+L+ A + KA  E   E  V+  V + ++  L G C  +  +LI    MP   LL ++ 
Sbjct: 57  KELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVR 115
Query: 130 ---GQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVA 186
                   +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + 
Sbjct: 116 EHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT 166
Query: 187 DFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
           DFG AKL+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP
Sbjct: 167 DFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226
Query: 245 IEKLPGGVKRTITEWAEPL 263
            + +P     +I E  E L
Sbjct: 227 YDGIPASEISSILEKGERL 245

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 73/283 (25%), Positives = 124/283 (43%), Gaps = 36/283 (12%)
Query: 48  KLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLL 100
           +LG+G FG VY G   D ++      +AVK +    S +  +EF  E  V+      +++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHG------QYAGEVQLDWKRRMKIAIGSAEGI 154
            L G  +     L+V + M +  L S+L           G      +  +++A   A+G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG--YL 212
            YL+ +     +HRD+ A N ++  DF   + DFG  + I E         KG L   ++
Sbjct: 144 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXE-TDXXRKGGKGLLPVRWM 199
Query: 213 APEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKE 271
           APE    G  + S D++SFG++L EI +   +P + L         E     ++ G + +
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-------NEQVLKFVMDGGYLD 252
Query: 272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
             D         N  ++  ++  +C Q  P  RP   E+VN L
Sbjct: 253 QPD---------NCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 127/283 (44%), Gaps = 35/283 (12%)
Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLKA----MNSKAEMEFAVEVEVLGRV-RHKNLLGL 102
           LG+G FG V+        Q  A+K LK     M+   E    VE  VL     H  L  +
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT-MVEKRVLSLAWEHPFLTHM 83
Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
                  +    V +Y+    L+ H+   +    + D  R    A     G+ +LH   +
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLH---S 136
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
             I++RD+K  N+LLD D    +ADFG  K    G +  T    GT  Y+APE  +  K 
Sbjct: 137 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK-TNXFCGTPDYIAPEILLGQKY 195
Query: 223 SESCDVYSFGILLLEILTGRKPI-----EKLPGGVK-------RTITEWAEPLIVKGKFK 270
           + S D +SFG+LL E+L G+ P      E+L   ++       R + + A+ L+VK   +
Sbjct: 196 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 255
Query: 271 ELVDPK----LRGDFDENQLKQAINVAVLCVQS-EPEKRPNMK 308
           E   P+    +RGD  ++ L + IN   L  +  +P  RP +K
Sbjct: 256 E---PEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVK 295

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/259 (28%), Positives = 120/259 (46%), Gaps = 28/259 (10%)
Query: 16  GLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AV 70
           G+ +   PN A  RI    E       F     L  G FG+VY   W    + ++I  A+
Sbjct: 4   GIRSGEAPNQALLRILKETE-------FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAI 56
Query: 71  KKLK-AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL- 128
           K+L+ A + KA  E   E  V+  V + ++  L G C  +  +LI+   MP   LL ++ 
Sbjct: 57  KELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVR 115
Query: 129 -HGQYAG-EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVA 186
            H    G +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + 
Sbjct: 116 EHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT 166
Query: 187 DFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
           DFG AKL+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP
Sbjct: 167 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226
Query: 245 IEKLPGGVKRTITEWAEPL 263
            + +P     +I E  E L
Sbjct: 227 YDGIPASEISSILEKGERL 245

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 73/247 (29%), Positives = 118/247 (47%), Gaps = 22/247 (8%)
Query: 43  FSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKL--KAMNSKAEMEFAV--EVEVLGRVRHK 97
           F   N LG+G F  VY   +   GL++A+K +  KAM  KA M   V  EV++  +++H 
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAM-YKAGMVQRVQNEVKIHCQLKHP 71
Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
           ++L L  Y   ++   +V +   N  +  +L  +     + + +  M   I    G+LYL
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQII---TGMLYL 128
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA-KLIPEGVSHMTTRVKGTLGYLAPEY 216
           H   +  I+HRD+  SN+LL  +    +ADFG A +L      H T  + GT  Y++PE 
Sbjct: 129 H---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEI 183
Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTIT-----EWAEPLIVKGKFKE 271
           A         DV+S G +   +L GR P +     VK T+      ++  P  +  + K+
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPPFDT--DTVKNTLNKVVLADYEMPSFLSIEAKD 241
Query: 272 LVDPKLR 278
           L+   LR
Sbjct: 242 LIHQLLR 248

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 118/253 (46%), Gaps = 28/253 (11%)
Query: 22  TPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-A 75
            PN A  RI    E       F     LG G FG+VY   W    + ++I  A+K+L+ A
Sbjct: 7   APNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 59
Query: 76  MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYA 133
            + KA  E   E  V+  V + ++  L G C  +  +LI+   MP   LL ++  H    
Sbjct: 60  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNI 118
Query: 134 G-EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
           G +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + DFG AK
Sbjct: 119 GSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAK 169
Query: 193 LI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
           L+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP + +P 
Sbjct: 170 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 229
Query: 251 GVKRTITEWAEPL 263
               +I E  E L
Sbjct: 230 SEISSILEKGERL 242

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 118/253 (46%), Gaps = 28/253 (11%)
Query: 22  TPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-A 75
            PN A  RI    E       F     LG G FG+VY   W    + ++I  A+K+L+ A
Sbjct: 5   APNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 57
Query: 76  MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYA 133
            + KA  E   E  V+  V + ++  L G C  +  +LI+   MP   LL ++  H    
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNI 116
Query: 134 G-EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
           G +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + DFG AK
Sbjct: 117 GSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAK 167
Query: 193 LI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
           L+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP + +P 
Sbjct: 168 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 227
Query: 251 GVKRTITEWAEPL 263
               +I E  E L
Sbjct: 228 SEISSILEKGERL 240

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 84/313 (26%), Positives = 135/313 (43%), Gaps = 46/313 (14%)
Query: 21  TTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWG-RTSDG----LQIAVKKLKA 75
             PN A  RI    EL            LG G FG+VY G    DG    + +A+K L+ 
Sbjct: 4   AAPNQALLRILKETELRKV-------KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRE 56
Query: 76  MNS-KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLH---GQ 131
             S KA  E   E  V+  V    +  L G C  +  +L+    MP   LL H+    G+
Sbjct: 57  NTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTSTVQLVT-QLMPYGCLLDHVRENRGR 115
Query: 132 YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA 191
              +  L+W  ++      A+G+ YL       ++HRD+ A NVL+ S     + DFG A
Sbjct: 116 LGSQDLLNWCMQI------AKGMSYLEDV---RLVHRDLAARNVLVKSPNHVKITDFGLA 166
Query: 192 KLIP-EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLP 249
           +L+  +   +     K  + ++A E  +  + +   DV+S+G+ + E++T G KP + +P
Sbjct: 167 RLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 226
Query: 250 GGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKE 309
               R I +  E      K + L  P +              + V C   + E RP  +E
Sbjct: 227 A---REIPDLLE------KGERLPQPPI-------CTIDVYMIMVKCWMIDSECRPRFRE 270
Query: 310 VVNTLT--GYDPR 320
           +V+  +    DP+
Sbjct: 271 LVSEFSRMARDPQ 283

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 118/253 (46%), Gaps = 28/253 (11%)
Query: 22  TPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-A 75
            PN A  RI    E       F     LG G FG+VY   W    + ++I  A+K+L+ A
Sbjct: 5   APNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 57
Query: 76  MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYA 133
            + KA  E   E  V+  V + ++  L G C  +  +LI+   MP   LL ++  H    
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIM-QLMPFGCLLDYVREHKDNI 116
Query: 134 G-EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
           G +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + DFG AK
Sbjct: 117 GSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAK 167
Query: 193 LI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
           L+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP + +P 
Sbjct: 168 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 227
Query: 251 GVKRTITEWAEPL 263
               +I E  E L
Sbjct: 228 SEISSILEKGERL 240

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 127/279 (45%), Gaps = 27/279 (9%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKA---MNSKAEMEFAVEVEVLGRVRHK 97
            F  + K+G G F  VY      DG+ +A+KK++    M++KA  +   E+++L ++ H 
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKR---RMKIAIGSAEGI 154
           N++         ++  IV + + +   LS +   +  + +L  +R   +  + + SA   
Sbjct: 93  NVIKYYASFIEDNELNIVLE-LADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA--- 148
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
             L H  +  ++HRDIK +NV + +     + D G  +      +   + V GT  Y++P
Sbjct: 149 --LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV-GTPYYMSP 205
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD 274
           E       +   D++S G LL E+   + P      G K  +    +      K ++   
Sbjct: 206 ERIHENGYNFKSDIWSLGCLLYEMAALQSPFY----GDKMNLYSLCK------KIEQCDY 255
Query: 275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT 313
           P L  D    +L+Q +N   +C+  +PEKRP++  V + 
Sbjct: 256 PPLPSDHYSEELRQLVN---MCINPDPEKRPDVTYVYDV 291

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 28/253 (11%)
Query: 22  TPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-A 75
            PN A  RI    E       F     LG G FG+VY   W    + ++I  A+K+L+ A
Sbjct: 5   APNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 57
Query: 76  MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYA 133
            + KA  E   E  V+  V + ++  L G C  +  +LI    MP   LL ++  H    
Sbjct: 58  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 116
Query: 134 G-EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
           G +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + DFG AK
Sbjct: 117 GSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAK 167
Query: 193 LI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
           L+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP + +P 
Sbjct: 168 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 227
Query: 251 GVKRTITEWAEPL 263
               +I E  E L
Sbjct: 228 SEISSILEKGERL 240

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 125/297 (42%), Gaps = 58/297 (19%)
Query: 49  LGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           LG+G FG V   R + D    A+KK++    K     + EV +L  + H+ ++  R Y A
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS-EVMLLASLNHQYVV--RYYAA 70
Query: 108 GTDQR---------------LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE 152
             ++R                I  +Y  N +L   +H +   + + ++ R  +  +   E
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL---E 127
Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE-------------GVS 199
            + Y+H   +  IIHRD+K  N+ +D      + DFG AK +               G S
Sbjct: 128 ALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 200 HMTTRVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITE 258
              T   GT  Y+A E     G  +E  D+YS GI+  E+      I     G++R    
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM------IYPFSTGMERV--- 235
Query: 259 WAEPLIVKGKFKEL--VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT 313
                      K+L  V  +   DFD+N++K    +  L +  +P KRP  + ++N+
Sbjct: 236 --------NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 28/259 (10%)
Query: 16  GLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AV 70
           G+ +   PN A  RI    E       F     L  G FG+VY   W    + ++I  A+
Sbjct: 4   GIRSGEAPNQALLRILKETE-------FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAI 56
Query: 71  KKLK-AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLH 129
           K+L+ A + KA  E   E  V+  V + ++  L G C  +  +LI    MP   LL ++ 
Sbjct: 57  KELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVR 115
Query: 130 ---GQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVA 186
                   +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + 
Sbjct: 116 EHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKIT 166
Query: 187 DFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
           DFG AKL+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP
Sbjct: 167 DFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 226
Query: 245 IEKLPGGVKRTITEWAEPL 263
            + +P     +I E  E L
Sbjct: 227 YDGIPASEISSILEKGERL 245

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 74/253 (29%), Positives = 117/253 (46%), Gaps = 28/253 (11%)
Query: 22  TPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-A 75
            PN A  RI    E       F     LG G FG+VY   W    + ++I  A+K+L+ A
Sbjct: 3   APNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 55
Query: 76  MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYA 133
            + KA  E   E  V+  V + ++  L G C  +  +LI    MP   LL ++  H    
Sbjct: 56  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 114
Query: 134 G-EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
           G +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + DFG AK
Sbjct: 115 GSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGRAK 165
Query: 193 LI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
           L+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP + +P 
Sbjct: 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225
Query: 251 GVKRTITEWAEPL 263
               +I E  E L
Sbjct: 226 SEISSILEKGERL 238

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 113/261 (43%), Gaps = 32/261 (12%)
Query: 67  QIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPN---L 122
           ++A+K++     +  M E   E++ + +  H N++         D+  +V   +     L
Sbjct: 42  KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 101
Query: 123 SLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD 180
            ++ H+   G++   V LD      I     EG+ YLH       IHRD+KA N+LL  D
Sbjct: 102 DIIKHIVAKGEHKSGV-LDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGED 157
Query: 181 FEPLVADFGFAKLIPEGVSHMTTRVK----GTLGYLAPEYAMWGKVSE-SCDVYSFGILL 235
               +ADFG +  +  G      +V+    GT  ++APE     +  +   D++SFGI  
Sbjct: 158 GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITA 217
Query: 236 LEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQL-----KQAI 290
           +E+ TG  P  K P      +T   +P            P L     + ++     K   
Sbjct: 218 IELATGAAPYHKYPPMKVLMLTLQNDP------------PSLETGVQDKEMLKKYGKSFR 265
Query: 291 NVAVLCVQSEPEKRPNMKEVV 311
            +  LC+Q +PEKRP   E++
Sbjct: 266 KMISLCLQKDPEKRPTAAELL 286

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 118/264 (44%), Gaps = 28/264 (10%)
Query: 11  EKVEEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQ 67
           E VE    +   PN A  RI    E       F     LG G FG+VY   W    + ++
Sbjct: 26  ELVEPLTPSGEAPNQALLRILKETE-------FKKIKVLGSGAFGTVYKGLWIPEGEKVK 78
Query: 68  IAVKKLK---AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSL 124
           I V  ++   A + KA  E   E  V+  V + ++  L G C  +  +LI    MP   L
Sbjct: 79  IPVAIMELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCL 137
Query: 125 LSHL--HGQYAG-EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF 181
           L ++  H    G +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +  
Sbjct: 138 LDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQ 188
Query: 182 EPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT 240
              + DFG AKL+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T
Sbjct: 189 HVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 248
Query: 241 -GRKPIEKLPGGVKRTITEWAEPL 263
            G KP + +P     +I E  E L
Sbjct: 249 FGSKPYDGIPASEISSILEKGERL 272

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 67/261 (25%), Positives = 113/261 (43%), Gaps = 32/261 (12%)
Query: 67  QIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPN---L 122
           ++A+K++     +  M E   E++ + +  H N++         D+  +V   +     L
Sbjct: 37  KVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVL 96
Query: 123 SLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD 180
            ++ H+   G++   V LD      I     EG+ YLH       IHRD+KA N+LL  D
Sbjct: 97  DIIKHIVAKGEHKSGV-LDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGED 152
Query: 181 FEPLVADFGFAKLIPEGVSHMTTRVK----GTLGYLAPEYAMWGKVSE-SCDVYSFGILL 235
               +ADFG +  +  G      +V+    GT  ++APE     +  +   D++SFGI  
Sbjct: 153 GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITA 212
Query: 236 LEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQL-----KQAI 290
           +E+ TG  P  K P      +T   +P            P L     + ++     K   
Sbjct: 213 IELATGAAPYHKYPPMKVLMLTLQNDP------------PSLETGVQDKEMLKKYGKSFR 260
Query: 291 NVAVLCVQSEPEKRPNMKEVV 311
            +  LC+Q +PEKRP   E++
Sbjct: 261 KMISLCLQKDPEKRPTAAELL 281

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 127/287 (44%), Gaps = 40/287 (13%)
Query: 49  LGEGGFGSVY------WGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRV-RHKNLL 100
           LG G FG V        G+    L++AVK LK+     E E    E++++  + +H+N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L G C      L++ +Y     LL+ L  + +  ++ D    +  +  S   +L+   +
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRK-SRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 161 V--------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT---- 208
           V        + + IHRD+ A NVLL +     + DFG A+ I    +++   VKG     
Sbjct: 173 VAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI---VKGNARLP 229
Query: 209 LGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKG 267
           + ++APE       +   DV+S+GILL EI + G  P    PG            ++V  
Sbjct: 230 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP---YPG------------ILVNS 274
Query: 268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           KF +LV    +        K   ++   C   EP  RP  +++ + L
Sbjct: 275 KFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 25/223 (11%)
Query: 38  TATNGFSDDNKLGE----GGFGSVYWGRTSD-GLQIAVKKLKA---MNSKAEMEFAVEVE 89
           T  +  SD  +LGE    GG   V+  R       +AVK L+A    +    + F  E +
Sbjct: 5   TTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 64
Query: 90  VLGRVRHKNLLGLRGYCAGTDQR------LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRR 143
               + H  ++ +  Y  G  +        IV +Y+  ++L   +H     E  +  KR 
Sbjct: 65  NAAALNHPAIVAV--YATGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRA 118
Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMT- 202
           +++   + + + + H      IIHRD+K +N+++ +     V DFG A+ I +  + +T 
Sbjct: 119 IEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 203 -TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
              V GT  YL+PE A    V    DVYS G +L E+LTG  P
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 121/283 (42%), Gaps = 34/283 (12%)
Query: 48  KLGEGGFGSVYWGR----TSDGLQIAVKKLKA---MNSKAEMEFAVEVEVLGRVRHKNLL 100
           KLG+G FG V  G     +   + +AVK LK       +A  +F  EV  +  + H+NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L G       +++  +  P  SLL  L  ++ G   L    R  + +  AEG+ YL   
Sbjct: 79  RLYGVVLTPPMKMVT-ELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQV--AEGMGYLE-- 132
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLGYLAPEYAM 218
            +   IHRD+ A N+LL +     + DFG  + +P+   H  M    K    + APE   
Sbjct: 133 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 219 WGKVSESCDVYSFGILLLEILT-GRKPIEKLPGG-VKRTITEWAEPLIVKGKFKELVDPK 276
               S + D + FG+ L E+ T G++P   L G  +   I +  E L           P+
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-----------PR 240
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP 319
                 E+  +   NV V C   +PE RP    + + L    P
Sbjct: 241 -----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 278

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 112/221 (50%), Gaps = 28/221 (12%)
Query: 43  FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +++ + +GEG +G V     + + +++A+KK+     +   +  + E+++L R RH+N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G+         R    + M ++ L++HL G        D  + +K    S + I Y  ++
Sbjct: 105 GINDII-----RAPTIEQMKDVYLVTHLMGA-------DLYKLLKTQHLSNDHICYFLYQ 152
Query: 161 V--------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           +        + +++HRD+K SN+LL++  +  + DFG A++      H    T    T  
Sbjct: 153 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE  +  K  ++S D++S G +L E+L+ R PI   PG
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI--FPG 250

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 121/283 (42%), Gaps = 34/283 (12%)
Query: 48  KLGEGGFGSVYWGR----TSDGLQIAVKKLKA---MNSKAEMEFAVEVEVLGRVRHKNLL 100
           KLG+G FG V  G     +   + +AVK LK       +A  +F  EV  +  + H+NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L G       +++  +  P  SLL  L  ++ G   L    R  + +  AEG+ YL   
Sbjct: 85  RLYGVVLTPPMKMVT-ELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQV--AEGMGYLE-- 138
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLGYLAPEYAM 218
            +   IHRD+ A N+LL +     + DFG  + +P+   H  M    K    + APE   
Sbjct: 139 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 197
Query: 219 WGKVSESCDVYSFGILLLEILT-GRKPIEKLPGG-VKRTITEWAEPLIVKGKFKELVDPK 276
               S + D + FG+ L E+ T G++P   L G  +   I +  E L           P+
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-----------PR 246
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP 319
                 E+  +   NV V C   +PE RP    + + L    P
Sbjct: 247 -----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 24/211 (11%)
Query: 49  LGEGGFGSVYWGRTSDG--------LQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLL 100
           LG G +G V+  R   G        +++  K      +K       E +VL  +R    L
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 101 GLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
               Y   T+ +L ++ DY+    L +HL        Q +     ++ I   E +L L H
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLS-------QRERFTEHEVQIYVGEIVLALEH 174
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK---GTLGYLAPEY 216
                II+RDIK  N+LLDS+   ++ DFG +K   E V+  T R     GT+ Y+AP+ 
Sbjct: 175 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK---EFVADETERAYDFCGTIEYMAPDI 231
Query: 217 AMWGKV--SESCDVYSFGILLLEILTGRKPI 245
              G     ++ D +S G+L+ E+LTG  P 
Sbjct: 232 VRGGDSGHDKAVDWWSLGVLMYELLTGASPF 262

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 121/283 (42%), Gaps = 34/283 (12%)
Query: 48  KLGEGGFGSVYWGR----TSDGLQIAVKKLKA---MNSKAEMEFAVEVEVLGRVRHKNLL 100
           KLG+G FG V  G     +   + +AVK LK       +A  +F  EV  +  + H+NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L G       +++  +  P  SLL  L  ++ G   L    R  + +  AEG+ YL   
Sbjct: 85  RLYGVVLTPPMKMVT-ELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQV--AEGMGYLE-- 138
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLGYLAPEYAM 218
            +   IHRD+ A N+LL +     + DFG  + +P+   H  M    K    + APE   
Sbjct: 139 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 197
Query: 219 WGKVSESCDVYSFGILLLEILT-GRKPIEKLPGG-VKRTITEWAEPLIVKGKFKELVDPK 276
               S + D + FG+ L E+ T G++P   L G  +   I +  E L           P+
Sbjct: 198 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-----------PR 246
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP 319
                 E+  +   NV V C   +PE RP    + + L    P
Sbjct: 247 -----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 284

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/217 (31%), Positives = 99/217 (45%), Gaps = 19/217 (8%)
Query: 37  HTATNGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKA---MNSKAEMEFAVEVEVLG 92
           H   + F     +G+G FG V   R  ++ +  AVK L+    +  K E     E  VL 
Sbjct: 34  HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLL 93
Query: 93  R-VRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIA-IGS 150
           + V+H  L+GL       D+   V DY+    L  HL  +      L+ + R   A I S
Sbjct: 94  KNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE---RCFLEPRARFYAAEIAS 150
Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGT 208
           A G  YLH   + +I++RD+K  N+LLDS    ++ DFG  K   E + H   T+   GT
Sbjct: 151 ALG--YLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGT 202
Query: 209 LGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
             YLAPE         + D +  G +L E+L G  P 
Sbjct: 203 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 125/283 (44%), Gaps = 36/283 (12%)
Query: 48  KLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLL 100
           +LG+G FG VY G   D ++      +AVK +    S +  +EF  E  V+      +++
Sbjct: 25  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 84
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHG------QYAGEVQLDWKRRMKIAIGSAEGI 154
            L G  +     L+V + M +  L S+L           G      +  +++A   A+G+
Sbjct: 85  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 144
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG--YL 212
            YL+ +     +HR++ A N ++  DF   + DFG  + I E   +     KG L   ++
Sbjct: 145 AYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVRWM 200
Query: 213 APEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKE 271
           APE    G  + S D++SFG++L EI +   +P + L         E     ++ G + +
Sbjct: 201 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-------NEQVLKFVMDGGYLD 253
Query: 272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
             D         N  ++  ++  +C Q  P  RP   E+VN L
Sbjct: 254 QPD---------NCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 287

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/297 (25%), Positives = 125/297 (42%), Gaps = 58/297 (19%)
Query: 49  LGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           LG+G FG V   R + D    A+KK++    K     + EV +L  + H+ ++  R Y A
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS-EVMLLASLNHQYVV--RYYAA 70
Query: 108 GTDQR---------------LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE 152
             ++R                I  +Y  N +L   +H +   + + ++ R  +  +   E
Sbjct: 71  WLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL---E 127
Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE-------------GVS 199
            + Y+H   +  IIHRD+K  N+ +D      + DFG AK +               G S
Sbjct: 128 ALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 200 HMTTRVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITE 258
              T   GT  Y+A E     G  +E  D+YS GI+  E+      I     G++R    
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM------IYPFSTGMERV--- 235
Query: 259 WAEPLIVKGKFKEL--VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT 313
                      K+L  V  +   DFD+N++K    +  L +  +P KRP  + ++N+
Sbjct: 236 --------NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS 284

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/283 (25%), Positives = 125/283 (44%), Gaps = 36/283 (12%)
Query: 48  KLGEGGFGSVYWGRTSDGLQ------IAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLL 100
           +LG+G FG VY G   D ++      +AVK +    S +  +EF  E  V+      +++
Sbjct: 24  ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 83
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHG------QYAGEVQLDWKRRMKIAIGSAEGI 154
            L G  +     L+V + M +  L S+L           G      +  +++A   A+G+
Sbjct: 84  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 143
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG--YL 212
            YL+ +     +HR++ A N ++  DF   + DFG  + I E   +     KG L   ++
Sbjct: 144 AYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYE-TDYYRKGGKGLLPVRWM 199
Query: 213 APEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKE 271
           APE    G  + S D++SFG++L EI +   +P + L         E     ++ G + +
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS-------NEQVLKFVMDGGYLD 252
Query: 272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
             D         N  ++  ++  +C Q  P  RP   E+VN L
Sbjct: 253 QPD---------NCPERVTDLMRMCWQFNPNMRPTFLEIVNLL 286

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 73/253 (28%), Positives = 116/253 (45%), Gaps = 28/253 (11%)
Query: 22  TPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-A 75
            PN A  RI    E       F     L  G FG+VY   W    + ++I  A+K+L+ A
Sbjct: 3   APNQALLRILKETE-------FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREA 55
Query: 76  MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYA 133
            + KA  E   E  V+  V + ++  L G C  +  +LI    MP   LL ++  H    
Sbjct: 56  TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNI 114
Query: 134 G-EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
           G +  L+W       +  A+G+ YL       ++HRD+ A NVL+ +     + DFG AK
Sbjct: 115 GSQYLLNW------CVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK 165
Query: 193 LI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
           L+  E   +     K  + ++A E  +    +   DV+S+G+ + E++T G KP + +P 
Sbjct: 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225
Query: 251 GVKRTITEWAEPL 263
               +I E  E L
Sbjct: 226 SEISSILEKGERL 238

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 121/283 (42%), Gaps = 34/283 (12%)
Query: 48  KLGEGGFGSVYWGR----TSDGLQIAVKKLKA---MNSKAEMEFAVEVEVLGRVRHKNLL 100
           KLG+G FG V  G     +   + +AVK LK       +A  +F  EV  +  + H+NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L G       +++  +  P  SLL  L  ++ G   L    R  + +  AEG+ YL   
Sbjct: 75  RLYGVVLTPPMKMVT-ELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQV--AEGMGYLE-- 128
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLGYLAPEYAM 218
            +   IHRD+ A N+LL +     + DFG  + +P+   H  M    K    + APE   
Sbjct: 129 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 219 WGKVSESCDVYSFGILLLEILT-GRKPIEKLPGG-VKRTITEWAEPLIVKGKFKELVDPK 276
               S + D + FG+ L E+ T G++P   L G  +   I +  E L           P+
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-----------PR 236
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP 319
                 E+  +   NV V C   +PE RP    + + L    P
Sbjct: 237 -----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 274

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 121/283 (42%), Gaps = 34/283 (12%)
Query: 48  KLGEGGFGSVYWGR----TSDGLQIAVKKLKA---MNSKAEMEFAVEVEVLGRVRHKNLL 100
           KLG+G FG V  G     +   + +AVK LK       +A  +F  EV  +  + H+NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L G       +++  +  P  SLL  L  ++ G   L    R  + +  AEG+ YL   
Sbjct: 75  RLYGVVLTPPMKMVT-ELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQV--AEGMGYLE-- 128
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLGYLAPEYAM 218
            +   IHRD+ A N+LL +     + DFG  + +P+   H  M    K    + APE   
Sbjct: 129 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLK 187
Query: 219 WGKVSESCDVYSFGILLLEILT-GRKPIEKLPGG-VKRTITEWAEPLIVKGKFKELVDPK 276
               S + D + FG+ L E+ T G++P   L G  +   I +  E L           P+
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-----------PR 236
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP 319
                 E+  +   NV V C   +PE RP    + + L    P
Sbjct: 237 -----PEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP 274

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 111/232 (47%), Gaps = 21/232 (9%)
Query: 43  FSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-AMNSKAEMEFAVEVEVLGRVRH 96
           F     LG G FG+VY   W    + ++I  A+K+L+ A + KA  E   E  V+  V +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYAG-EVQLDWKRRMKIAIGSAEG 153
            ++  L G C  +  +LI    MP   LL ++  H    G +  L+W       +  AEG
Sbjct: 74  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAEG 126
Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYL 212
           + YL       ++HRD+ A NVL+ +     + DFG AKL+  E   +     K  + ++
Sbjct: 127 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 183
Query: 213 APEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPL 263
           A E  +    +   DV+S+G+ + E++T G KP + +P     +I E  E L
Sbjct: 184 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 235

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 80/305 (26%), Positives = 130/305 (42%), Gaps = 63/305 (20%)
Query: 37  HTATNGFSDDNK----LGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVL 91
           HT    F  D K    +G GGFG V+  +   DG    +K++K  N KAE E    V+ L
Sbjct: 3   HTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAERE----VKAL 58
Query: 92  GRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSH---------LHGQYAGEVQLD-W- 140
            ++ H N++   G   G       +DY P  S  +          +  ++  +  L+ W 
Sbjct: 59  AKLDHVNIVHYNGCWDG-------FDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI 111
Query: 141 -KRR---------MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGF 190
            KRR         +++     +G+ Y+H   +  +I+RD+K SN+ L    +  + DFG 
Sbjct: 112 EKRRGEKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGL 168
Query: 191 AKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPG 250
              +         R KGTL Y++PE        +  D+Y+ G++L E+L           
Sbjct: 169 VTSLKNDGKRX--RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL----------- 215
Query: 251 GVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEV 310
            V  T  E ++       F +L D  +   FD    K+   +    +  +PE RPN  E+
Sbjct: 216 HVCDTAFETSKF------FTDLRDGIISDIFD----KKEKTLLQKLLSKKPEDRPNTSEI 265
Query: 311 VNTLT 315
           + TLT
Sbjct: 266 LRTLT 270

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 125/289 (43%), Gaps = 44/289 (15%)
Query: 49  LGEGGFGSVY------WGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRV-RHKNLL 100
           LG G FG V        G+    L++AVK LK+     E E    E++++  + +H+N++
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 113
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQY----------AGEVQLDWKRRMKIAIGS 150
            L G C      L++ +Y     LL+ L  +                L  +  +  +   
Sbjct: 114 NLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQV 173
Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT-- 208
           A+G+ +L    + + IHRD+ A NVLL +     + DFG A+ I    +++   VKG   
Sbjct: 174 AQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI---VKGNAR 227
Query: 209 --LGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIV 265
             + ++APE       +   DV+S+GILL EI + G  P    PG            ++V
Sbjct: 228 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP---YPG------------ILV 272
Query: 266 KGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
             KF +LV    +        K   ++   C   EP  RP  +++ + L
Sbjct: 273 NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 321

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 117/271 (43%), Gaps = 34/271 (12%)
Query: 48  KLGEGGFGSVYWGR----TSDGLQIAVKKLKA---MNSKAEMEFAVEVEVLGRVRHKNLL 100
           KLG+G FG V  G     +   + +AVK LK       +A  +F  EV  +  + H+NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L G       +++  +  P  SLL  L  ++ G   L    R  + +  AEG+ YL   
Sbjct: 79  RLYGVVLTPPMKMVT-ELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQV--AEGMGYLE-- 132
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLGYLAPEYAM 218
            +   IHRD+ A N+LL +     + DFG  + +P+   H  M    K    + APE   
Sbjct: 133 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 191
Query: 219 WGKVSESCDVYSFGILLLEILT-GRKPIEKLPGG-VKRTITEWAEPLIVKGKFKELVDPK 276
               S + D + FG+ L E+ T G++P   L G  +   I +  E L           P+
Sbjct: 192 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-----------PR 240
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNM 307
                 E+  +   NV V C   +PE RP  
Sbjct: 241 -----PEDCPQDIYNVMVQCWAHKPEDRPTF 266

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 117/271 (43%), Gaps = 34/271 (12%)
Query: 48  KLGEGGFGSVYWGR----TSDGLQIAVKKLKA---MNSKAEMEFAVEVEVLGRVRHKNLL 100
           KLG+G FG V  G     +   + +AVK LK       +A  +F  EV  +  + H+NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L G       +++  +  P  SLL  L  ++ G   L    R  + +  AEG+ YL   
Sbjct: 75  RLYGVVLTPPMKMVT-ELAPLGSLLDRLR-KHQGHFLLGTLSRYAVQV--AEGMGYLE-- 128
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLGYLAPEYAM 218
            +   IHRD+ A N+LL +     + DFG  + +P+   H  M    K    + APE   
Sbjct: 129 -SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187
Query: 219 WGKVSESCDVYSFGILLLEILT-GRKPIEKLPGG-VKRTITEWAEPLIVKGKFKELVDPK 276
               S + D + FG+ L E+ T G++P   L G  +   I +  E L           P+
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-----------PR 236
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNM 307
                 E+  +   NV V C   +PE RP  
Sbjct: 237 -----PEDCPQDIYNVMVQCWAHKPEDRPTF 262

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 32/278 (11%)
Query: 49  LGEGGFGSVYWGRTSDGLQI----AVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG+GGF   +    +D  ++     V K   +      + ++E+ +   + H++++G  G
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
           +    D   +V +     SLL  LH +     + + +  ++  +    G  YLH      
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVL---GCQYLHRN---R 141
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
           +IHRD+K  N+ L+ D E  + DFG A  + E        + GT  Y+APE       S 
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKTLCGTPNYIAPEVLSKKGHSF 200
Query: 225 SCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN 284
             DV+S G ++  +L G+ P E          T   +   ++ K  E   PK       +
Sbjct: 201 EVDVWSIGCIMYTLLVGKPPFE----------TSCLKETYLRIKKNEYSIPKHINPVAAS 250
Query: 285 QLKQAINVAVLCVQSEPEKRPNMKEVVNT---LTGYDP 319
            +++ +       Q++P  RP + E++N     +GY P
Sbjct: 251 LIQKML-------QTDPTARPTINELLNDEFFTSGYIP 281

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 25/223 (11%)
Query: 38  TATNGFSDDNKLGE----GGFGSVYWGRTSD-GLQIAVKKLKA---MNSKAEMEFAVEVE 89
           T  +  SD  +LGE    GG   V+  R       +AVK L+A    +    + F  E +
Sbjct: 5   TTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 64
Query: 90  VLGRVRHKNLLGLRGYCAGTDQR------LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRR 143
               + H  ++ +  Y  G  +        IV +Y+  ++L   +H     E  +  KR 
Sbjct: 65  NAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRA 118
Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMT- 202
           +++   + + + + H      IIHRD+K +N+++ +     V DFG A+ I +  + +T 
Sbjct: 119 IEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175
Query: 203 -TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
              V GT  YL+PE A    V    DVYS G +L E+LTG  P
Sbjct: 176 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 32/278 (11%)
Query: 49  LGEGGFGSVYWGRTSDGLQI----AVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG+GGF   +    +D  ++     V K   +      + ++E+ +   + H++++G  G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
           +    D   +V +     SLL  LH +     + + +  ++  +    G  YLH      
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVL---GCQYLHRN---R 137
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
           +IHRD+K  N+ L+ D E  + DFG A  + E        + GT  Y+APE       S 
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 225 SCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN 284
             DV+S G ++  +L G+ P E          T   +   ++ K  E   PK       +
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFE----------TSCLKETYLRIKKNEYSIPKHINPVAAS 246
Query: 285 QLKQAINVAVLCVQSEPEKRPNMKEVVNT---LTGYDP 319
            +++ +       Q++P  RP + E++N     +GY P
Sbjct: 247 LIQKML-------QTDPTARPTINELLNDEFFTSGYIP 277

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 32/278 (11%)
Query: 49  LGEGGFGSVYWGRTSDGLQI----AVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG+GGF   +    +D  ++     V K   +      + ++E+ +   + H++++G  G
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
           +    D   +V +     SLL  LH +     + + +  ++  +    G  YLH      
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVL---GCQYLHRN---R 137
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
           +IHRD+K  N+ L+ D E  + DFG A  + E        + GT  Y+APE       S 
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKTLCGTPNYIAPEVLSKKGHSF 196
Query: 225 SCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN 284
             DV+S G ++  +L G+ P E          T   +   ++ K  E   PK       +
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFE----------TSCLKETYLRIKKNEYSIPKHINPVAAS 246
Query: 285 QLKQAINVAVLCVQSEPEKRPNMKEVVNT---LTGYDP 319
            +++ +       Q++P  RP + E++N     +GY P
Sbjct: 247 LIQKML-------QTDPTARPTINELLNDEFFTSGYIP 277

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 25/223 (11%)
Query: 38  TATNGFSDDNKLGE----GGFGSVYWGRTSD-GLQIAVKKLKA---MNSKAEMEFAVEVE 89
           T  +  SD  +LGE    GG   V+  R       +AVK L+A    +    + F  E +
Sbjct: 22  TTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQ 81
Query: 90  VLGRVRHKNLLGLRGYCAGTDQR------LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRR 143
               + H  ++ +  Y  G  +        IV +Y+  ++L   +H     E  +  KR 
Sbjct: 82  NAAALNHPAIVAV--YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT----EGPMTPKRA 135
Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMT- 202
           +++   + + + + H      IIHRD+K +N+++ +     V DFG A+ I +  + +T 
Sbjct: 136 IEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 192
Query: 203 -TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
              V GT  YL+PE A    V    DVYS G +L E+LTG  P
Sbjct: 193 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 117/220 (53%), Gaps = 17/220 (7%)
Query: 38  TATNGFSDDNKLGEGGFGSVYWG-RTSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVR 95
           ++++ F    KLG G + +VY G   + G+ +A+K++K  + +     A+ E+ ++  ++
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK 61
Query: 96  HKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGE----VQLDWKRRMKIAIGSA 151
           H+N++ L       ++  +V+++M N  L  ++  +  G     ++L+  +  +  +   
Sbjct: 62  HENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQL--L 118
Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGY 211
           +G+ + H      I+HRD+K  N+L++   +  + DFG A+     V+  ++ V  TL Y
Sbjct: 119 QGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWY 174
Query: 212 LAPEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEKLPG 250
            AP+  M  +  S S D++S G +L E++TG KP+   PG
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITG-KPL--FPG 211

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 12/202 (5%)
Query: 49  LGEGGFGSVYWGRTSDGLQI----AVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG+GGF   Y     D  ++     V K   +    + + + E+ +   + + +++G  G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
           +    D   +V +     SLL  LH +     + + +  M+  I   +G+ YLH+     
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI---QGVQYLHNN---R 162
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
           +IHRD+K  N+ L+ D +  + DFG A  I E        + GT  Y+APE       S 
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKXLCGTPNYIAPEVLCKKGHSF 221
Query: 225 SCDVYSFGILLLEILTGRKPIE 246
             D++S G +L  +L G+ P E
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFE 243

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 111/232 (47%), Gaps = 21/232 (9%)
Query: 43  FSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLK-AMNSKAEMEFAVEVEVLGRVRH 96
           F     LG G FG+VY   W    + ++I  A+K+L+ A + KA  E   E  V+  V +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYAG-EVQLDWKRRMKIAIGSAEG 153
            ++  L G C  +  +LI    MP   LL ++  H    G +  L+W       +  A+G
Sbjct: 71  PHVCRLLGICLTSTVQLIT-QLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKG 123
Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYL 212
           + YL       ++HRD+ A NVL+ +     + DFG AKL+  E   +     K  + ++
Sbjct: 124 MNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 213 APEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPL 263
           A E  +    +   DV+S+G+ + E++T G KP + +P     +I E  E L
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL 232

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 12/202 (5%)
Query: 49  LGEGGFGSVYWGRTSDGLQI----AVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG+GGF   Y     D  ++     V K   +    + + + E+ +   + + +++G  G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
           +    D   +V +     SLL  LH +     + + +  M+  I   +G+ YLH+     
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI---QGVQYLHNN---R 162
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
           +IHRD+K  N+ L+ D +  + DFG A  I E        + GT  Y+APE       S 
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKTLCGTPNYIAPEVLCKKGHSF 221
Query: 225 SCDVYSFGILLLEILTGRKPIE 246
             D++S G +L  +L G+ P E
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFE 243

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 32/278 (11%)
Query: 49  LGEGGFGSVYWGRTSDGLQI----AVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG+GGF   +    +D  ++     V K   +      + ++E+ +   + H++++G  G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
           +    D   +V +     SLL  LH +     + + +  ++  +    G  YLH      
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIV---LGCQYLHRN---R 161
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
           +IHRD+K  N+ L+ D E  + DFG A  + E        + GT  Y+APE       S 
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPNYIAPEVLSKKGHSF 220
Query: 225 SCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN 284
             DV+S G ++  +L G+ P E          T   +   ++ K  E   PK       +
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFE----------TSCLKETYLRIKKNEYSIPKHINPVAAS 270
Query: 285 QLKQAINVAVLCVQSEPEKRPNMKEVVNT---LTGYDP 319
            +++ +       Q++P  RP + E++N     +GY P
Sbjct: 271 LIQKML-------QTDPTARPTINELLNDEFFTSGYIP 301

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 66/278 (23%), Positives = 119/278 (42%), Gaps = 32/278 (11%)
Query: 49  LGEGGFGSVYWGRTSDGLQI----AVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG+GGF   +    +D  ++     V K   +      + ++E+ +   + H++++G  G
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
           +    D   +V +     SLL  LH +     + + +  ++  +    G  YLH      
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVL---GCQYLHRN---R 159
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
           +IHRD+K  N+ L+ D E  + DFG A  + E        + GT  Y+APE       S 
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPNYIAPEVLSKKGHSF 218
Query: 225 SCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN 284
             DV+S G ++  +L G+ P E          T   +   ++ K  E   PK       +
Sbjct: 219 EVDVWSIGCIMYTLLVGKPPFE----------TSCLKETYLRIKKNEYSIPKHINPVAAS 268
Query: 285 QLKQAINVAVLCVQSEPEKRPNMKEVVNT---LTGYDP 319
            +++ +       Q++P  RP + E++N     +GY P
Sbjct: 269 LIQKML-------QTDPTARPTINELLNDEFFTSGYIP 299

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 12/202 (5%)
Query: 49  LGEGGFGSVYWGRTSDGLQI----AVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG+GGF   Y     D  ++     V K   +    + + + E+ +   + + +++G  G
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 93
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
           +    D   +V +     SLL  LH +     + + +  M+  I   +G+ YLH+     
Sbjct: 94  FFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI---QGVQYLHNN---R 146
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
           +IHRD+K  N+ L+ D +  + DFG A  I E        + GT  Y+APE       S 
Sbjct: 147 VIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKDLCGTPNYIAPEVLCKKGHSF 205
Query: 225 SCDVYSFGILLLEILTGRKPIE 246
             D++S G +L  +L G+ P E
Sbjct: 206 EVDIWSLGCILYTLLVGKPPFE 227

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 120/279 (43%), Gaps = 34/279 (12%)
Query: 49  LGEGGFGSVYWGRTSDGLQI----AVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG+GGF   +    +D  ++     V K   +      + ++E+ +   + H++++G  G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMK-IAIGSAEGILYLHHEVTP 163
           +    D   +V +     SLL  LH +     + + +  ++ I +G      YLH     
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQ----YLHRN--- 134
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
            +IHRD+K  N+ L+ D E  + DFG A  + E        + GT  Y+APE       S
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPNYIAPEVLSKKGHS 193
Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDE 283
              DV+S G ++  +L G+ P E          T   +   ++ K  E   PK       
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFE----------TSCLKETYLRIKKNEYSIPKHINPVAA 243
Query: 284 NQLKQAINVAVLCVQSEPEKRPNMKEVVNT---LTGYDP 319
           + +++ +       Q++P  RP + E++N     +GY P
Sbjct: 244 SLIQKML-------QTDPTARPTINELLNDEFFTSGYIP 275

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 92/202 (45%), Gaps = 12/202 (5%)
Query: 49  LGEGGFGSVYWGRTSDGLQI----AVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG+GGF   Y     D  ++     V K   +    + + + E+ +   + + +++G  G
Sbjct: 50  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHG 109
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
           +    D   +V +     SLL  LH +     + + +  M+  I   +G+ YLH+     
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTI---QGVQYLHNN---R 162
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
           +IHRD+K  N+ L+ D +  + DFG A  I E        + GT  Y+APE       S 
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKDLCGTPNYIAPEVLCKKGHSF 221
Query: 225 SCDVYSFGILLLEILTGRKPIE 246
             D++S G +L  +L G+ P E
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFE 243

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 49  LGEGGFGSVYWGRT---SDGLQI-AVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
           LG+G FG V+  +    SD  Q+ A+K LK   +  +  +   +E ++L  V H  ++ L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 103 RGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
             Y   T+ +L ++ D++    L + L    + EV    +    +    AE  L L H  
Sbjct: 92  H-YAFQTEGKLYLILDFLRGGDLFTRL----SKEVMFTEE---DVKFYLAELALALDHLH 143
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK--GTLGYLAPEYAMW 219
           +  II+RD+K  N+LLD +    + DFG +K   E + H        GT+ Y+APE    
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIE 246
              ++S D +SFG+L+ E+LTG  P +
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPFQ 227

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 12/199 (6%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG-LRGY 105
           K+G+G  G+VY     + G ++A++++       +     E+ V+   ++ N++  L  Y
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
             G D+  +V +Y+   SL          E  +D  +   +     + + +LH      +
Sbjct: 87  LVG-DELWVVMEYLAGGSLTD-----VVTETCMDEGQIAAVCRECLQALEFLHSN---QV 137
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSES 225
           IHRDIK+ N+LL  D    + DFGF   I    S  +T V GT  ++APE          
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 196
Query: 226 CDVYSFGILLLEILTGRKP 244
            D++S GI+ +E++ G  P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 43/218 (19%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV--RHKNLLG---- 101
           ++G+G +G V+ G+   G ++AVK      +  E  +  E E+   V  RH+N+LG    
Sbjct: 44  QIGKGRYGEVWMGKWR-GEKVAVK---VFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99
Query: 102 -LRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            ++G  + T Q  ++ DY  N SL  +L         LD K  +K+A  S  G+ +LH E
Sbjct: 100 DIKGTGSWT-QLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 161 V-----TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM----TTRVKGTLGY 211
           +      P I HRD+K+ N+L+  +    +AD G A       + +     TRV GT  Y
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRY 212
Query: 212 LAPEYAMWGKVSES-----------CDVYSFGILLLEI 238
           + PE      + ES            D+YSFG++L E+
Sbjct: 213 MPPEV-----LDESLNRNHFQSYIMADMYSFGLILWEV 245

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 49  LGEGGFGSVYWGRT---SDGLQI-AVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
           LG+G FG V+  +    SD  Q+ A+K LK   +  +  +   +E ++L  V H  ++ L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 103 RGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
             Y   T+ +L ++ D++    L + L    + EV    +    +    AE  L L H  
Sbjct: 92  H-YAFQTEGKLYLILDFLRGGDLFTRL----SKEVMFTEE---DVKFYLAELALALDHLH 143
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK--GTLGYLAPEYAMW 219
           +  II+RD+K  N+LLD +    + DFG +K   E + H        GT+ Y+APE    
Sbjct: 144 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNR 200
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIE 246
              ++S D +SFG+L+ E+LTG  P +
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPFQ 227

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 103/207 (49%), Gaps = 20/207 (9%)
Query: 49  LGEGGFGSVYWGRT---SDGLQI-AVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
           LG+G FG V+  +    SD  Q+ A+K LK   +  +  +   +E ++L  V H  ++ L
Sbjct: 33  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 92
Query: 103 RGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
             Y   T+ +L ++ D++    L + L    + EV    +    +    AE  L L H  
Sbjct: 93  H-YAFQTEGKLYLILDFLRGGDLFTRL----SKEVMFTEE---DVKFYLAELALALDHLH 144
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK--GTLGYLAPEYAMW 219
           +  II+RD+K  N+LLD +    + DFG +K   E + H        GT+ Y+APE    
Sbjct: 145 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNR 201
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIE 246
              ++S D +SFG+L+ E+LTG  P +
Sbjct: 202 RGHTQSADWWSFGVLMFEMLTGTLPFQ 228

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 97/206 (47%), Gaps = 17/206 (8%)
Query: 49  LGEGGFGSVYWG--RTSDG--LQIAVKKLKAMNSKAEM--EFAVEVEVLGRVRHKNLLGL 102
           LGEG FGSV  G  +  DG  L++AVK +K  NS      EF  E   +    H N++ L
Sbjct: 42  LGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRL 101
Query: 103 RGYC-----AGTDQRLIVYDYMPNLSLLSHLHGQY--AGEVQLDWKRRMKIAIGSAEGIL 155
            G C      G  + +++  +M    L ++L       G   +  +  +K  +  A G+ 
Sbjct: 102 LGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGME 161
Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRV-KGTLGYLAP 214
           YL +    + +HRD+ A N +L  D    VADFG +K I  G  +   R+ K  + ++A 
Sbjct: 162 YLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 218
Query: 215 EYAMWGKVSESCDVYSFGILLLEILT 240
           E       +   DV++FG+ + EI T
Sbjct: 219 ESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 115/245 (46%), Gaps = 16/245 (6%)
Query: 41  NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRVRH 96
           N F     LG+GGFG V   +  + G   A KKL+    K     A+   E ++L +V  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
           + ++ L       D   +V   M    L  H++  + G+      R +  A     G+  
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFPEARAVFYAAEICCGLED 301
Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
           LH E    I++RD+K  N+LLD      ++D G A  +PEG + +  RV GT+GY+APE 
Sbjct: 302 LHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEV 356
Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI--VKGKFKELVD 274
               + + S D ++ G LL E++ G+ P ++    +KR   E  E L+  V  ++ E   
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEVPEEYSERFS 413
Query: 275 PKLRG 279
           P+ R 
Sbjct: 414 PQARS 418

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/245 (29%), Positives = 115/245 (46%), Gaps = 16/245 (6%)
Query: 41  NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRVRH 96
           N F     LG+GGFG V   +  + G   A KKL+    K     A+   E ++L +V  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
           + ++ L       D   +V   M    L  H++  + G+      R +  A     G+  
Sbjct: 244 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIY--HMGQAGFPEARAVFYAAEICCGLED 301
Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
           LH E    I++RD+K  N+LLD      ++D G A  +PEG + +  RV GT+GY+APE 
Sbjct: 302 LHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGYMAPEV 356
Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI--VKGKFKELVD 274
               + + S D ++ G LL E++ G+ P ++    +KR   E  E L+  V  ++ E   
Sbjct: 357 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEVERLVKEVPEEYSERFS 413
Query: 275 PKLRG 279
           P+ R 
Sbjct: 414 PQARS 418

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 73/295 (24%), Positives = 122/295 (41%), Gaps = 54/295 (18%)
Query: 49  LGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           LG+G FG V   R + D    A+KK++    K     + EV +L  + H+ ++  R Y A
Sbjct: 14  LGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILS-EVXLLASLNHQYVV--RYYAA 70
Query: 108 GTDQR---------------LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE 152
             ++R                I  +Y  N +L   +H +   + + ++ R  +  +   E
Sbjct: 71  WLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL---E 127
Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE-------------GVS 199
            + Y+H   +  IIHR++K  N+ +D      + DFG AK +               G S
Sbjct: 128 ALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 200 HMTTRVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITE 258
              T   GT  Y+A E     G  +E  D YS GI+  E       I     G +R    
Sbjct: 185 DNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE------XIYPFSTGXER---- 234
Query: 259 WAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT 313
               + +  K +  V  +   DFD+N+ K    +  L +  +P KRP  + ++N+
Sbjct: 235 ----VNILKKLRS-VSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNS 284

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 93/213 (43%), Gaps = 11/213 (5%)
Query: 38  TATNGFSDDNKLGEGGFGSVYW-GRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVR 95
           T  + F    KLG G FG V+     S GL+  +K +    S+  ME    E+EVL  + 
Sbjct: 19  TIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD 78
Query: 96  HKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGIL 155
           H N++ +           IV +      LL  +    A    L      ++       + 
Sbjct: 79  HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALA 138
Query: 156 YLHHEVTPHIIHRDIKASNVLLD--SDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYL 212
           Y H +   H++H+D+K  N+L    S   P+ + DFG A+L        +T   GT  Y+
Sbjct: 139 YFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTNAAGTALYM 193
Query: 213 APEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           APE      V+  CD++S G+++  +LTG  P 
Sbjct: 194 APE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPF 225

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG-LRGY 105
           K+G+G  G+VY     + G ++A++++       +     E+ V+   ++ N++  L  Y
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
             G D+  +V +Y+   SL          E  +D  +   +     + + +LH   +  +
Sbjct: 87  LVG-DELWVVMEYLAGGSLTD-----VVTETCMDEGQIAAVCRECLQALEFLH---SNQV 137
Query: 166 IHRDIKASNVLLDSDFEPLVADFGF-AKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
           IHRDIK+ N+LL  D    + DFGF A++ PE      + + GT  ++APE         
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SEMVGTPYWMAPEVVTRKAYGP 195
Query: 225 SCDVYSFGILLLEILTGRKP 244
             D++S GI+ +E++ G  P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/271 (25%), Positives = 115/271 (42%), Gaps = 27/271 (9%)
Query: 43  FSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKNLL 100
           F+   ++G+G FG V+ G  +   Q+   K+  +    +    +  E+ VL +     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
              G      +  I+ +Y+   S L  L      E Q+    +  +     +G+ YLH E
Sbjct: 85  KYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEIL-----KGLDYLHSE 139
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
                IHRDIKA+NVLL    +  +ADFG A  + +      T V GT  ++APE     
Sbjct: 140 KK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIQQS 195
Query: 221 KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGD 280
                 D++S GI  +E+  G  P   +             P+ V     +   P L GD
Sbjct: 196 AYDSKADIWSLGITAIELAKGEPPNSDM------------HPMRVLFLIPKNNPPTLVGD 243
Query: 281 FDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
           F ++  K+ I+    C+  +P  RP  KE++
Sbjct: 244 FTKS-FKEFIDA---CLNKDPSFRPTAKELL 270

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 116/272 (42%), Gaps = 29/272 (10%)
Query: 43  FSDDNKLGEGGFGSVYWG---RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL 99
           F+   K+G+G FG V+ G   RT   + I +  L+    + E     E+ VL +     +
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYV 67
Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
               G      +  I+ +Y+   S L  L      E Q+    R  +     +G+ YLH 
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL-----KGLDYLHS 122
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
           E     IHRDIKA+NVLL    E  +ADFG A  + +      T V GT  ++APE    
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQ 178
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
                  D++S GI  +E+  G  P  +L             P+ V     +   P L G
Sbjct: 179 SAYDSKADIWSLGITAIELARGEPPHSEL------------HPMKVLFLIPKNNPPTLEG 226
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
           ++ +  LK+ +     C+  EP  RP  KE++
Sbjct: 227 NYSK-PLKEFVEA---CLNKEPSFRPTAKELL 254

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG-LRGY 105
           K+G+G  G+VY     + G ++A++++       +     E+ V+   ++ N++  L  Y
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
             G D+  +V +Y+   SL          E  +D  +   +     + + +LH   +  +
Sbjct: 88  LVG-DELWVVMEYLAGGSLTD-----VVTETCMDEGQIAAVCRECLQALEFLH---SNQV 138
Query: 166 IHRDIKASNVLLDSDFEPLVADFGF-AKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
           IHRDIK+ N+LL  D    + DFGF A++ PE      + + GT  ++APE         
Sbjct: 139 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVTRKAYGP 196
Query: 225 SCDVYSFGILLLEILTGRKP 244
             D++S GI+ +E++ G  P
Sbjct: 197 KVDIWSLGIMAIEMIEGEPP 216

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG-LRGY 105
           K+G+G  G+VY     + G ++A++++       +     E+ V+   ++ N++  L  Y
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
             G D+  +V +Y+   SL          E  +D  +   +     + + +LH   +  +
Sbjct: 87  LVG-DELWVVMEYLAGGSLTD-----VVTETCMDEGQIAAVCRECLQALEFLH---SNQV 137
Query: 166 IHRDIKASNVLLDSDFEPLVADFGF-AKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
           IHRDIK+ N+LL  D    + DFGF A++ PE      + + GT  ++APE         
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--SXMVGTPYWMAPEVVTRKAYGP 195
Query: 225 SCDVYSFGILLLEILTGRKP 244
             D++S GI+ +E++ G  P
Sbjct: 196 KVDIWSLGIMAIEMIEGEPP 215

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 116/272 (42%), Gaps = 29/272 (10%)
Query: 43  FSDDNKLGEGGFGSVYWG---RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL 99
           F+   K+G+G FG V+ G   RT   + I +  L+    + E     E+ VL +     +
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYV 87
Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
               G      +  I+ +Y+   S L  L      E Q+    R  +     +G+ YLH 
Sbjct: 88  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL-----KGLDYLHS 142
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
           E     IHRDIKA+NVLL    E  +ADFG A  + +      T V GT  ++APE    
Sbjct: 143 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVIKQ 198
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
                  D++S GI  +E+  G  P  +L             P+ V     +   P L G
Sbjct: 199 SAYDSKADIWSLGITAIELARGEPPHSEL------------HPMKVLFLIPKNNPPTLEG 246
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
           ++ +  LK+ +     C+  EP  RP  KE++
Sbjct: 247 NYSK-PLKEFVEA---CLNKEPSFRPTAKELL 274

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 35/213 (16%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV--RHKNLLGLRGYC 106
           +G+G +G V W     G  +AVK     +S+ E  +  E E+   V  RH N+LG     
Sbjct: 16  VGKGRYGEV-WRGLWHGESVAVK---IFSSRDEQSWFRETEIYNTVLLRHDNILGF---- 67
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQ-----YAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
             +D  +   +    L L++H H       +     L+    +++A+ +A G+ +LH E+
Sbjct: 68  IASD--MTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLALRLAVSAACGLAHLHVEI 125
Query: 162 -----TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM----TTRVKGTLGYL 212
                 P I HRD K+ NVL+ S+ +  +AD G A +  +G  ++      RV GT  Y+
Sbjct: 126 FGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRV-GTKRYM 184
Query: 213 APEYAMWGKVSESC-------DVYSFGILLLEI 238
           APE  +  ++   C       D+++FG++L EI
Sbjct: 185 APE-VLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 49  LGEGGFGSVYW----GRTSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
           LG+G FG V+      R   G   A+K LK   +  +  +   +E ++L  V H  ++ L
Sbjct: 36  LGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVKL 95
Query: 103 RGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
             Y   T+ +L ++ D++    L + L    + EV    +    +    AE  L L H  
Sbjct: 96  H-YAFQTEGKLYLILDFLRGGDLFTRL----SKEVMFTEE---DVKFYLAELALGLDHLH 147
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK--GTLGYLAPEYAMW 219
           +  II+RD+K  N+LLD +    + DFG +K   E + H        GT+ Y+APE    
Sbjct: 148 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---EAIDHEKKAYSFCGTVEYMAPEVVNR 204
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIE 246
              S S D +S+G+L+ E+LTG  P +
Sbjct: 205 QGHSHSADWWSYGVLMFEMLTGSLPFQ 231

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 94/199 (47%), Gaps = 12/199 (6%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG-LRGY 105
           K+G+G  G+VY     + G ++A++++       +     E+ V+   ++ N++  L  Y
Sbjct: 28  KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 87
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
             G D+  +V +Y+   SL          E  +D  +   +     + + +LH   +  +
Sbjct: 88  LVG-DELWVVMEYLAGGSLTD-----VVTETCMDEGQIAAVCRECLQALEFLH---SNQV 138
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSES 225
           IHR+IK+ N+LL  D    + DFGF   I    S  +T V GT  ++APE          
Sbjct: 139 IHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 197
Query: 226 CDVYSFGILLLEILTGRKP 244
            D++S GI+ +E++ G  P
Sbjct: 198 VDIWSLGIMAIEMIEGEPP 216

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 105/204 (51%), Gaps = 17/204 (8%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAVEVEV--LGRVRHKNLLGLRG 104
           LGEG FG V     T+ G ++A+K + K + +K++M+  +E E+  L  +RH +++ L  
Sbjct: 21  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                D+ ++V +Y  N  L  ++  Q     + + +R  +  I + E   Y H      
Sbjct: 81  VIKSKDEIIMVIEYAGN-ELFDYI-VQRDKMSEQEARRFFQQIISAVE---YCHRH---K 132
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV-- 222
           I+HRD+K  N+LLD      +ADFG + ++ +G    T+   G+  Y APE  + GK+  
Sbjct: 133 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VISGKLYA 189
Query: 223 SESCDVYSFGILLLEILTGRKPIE 246
               DV+S G++L  +L  R P +
Sbjct: 190 GPEVDVWSCGVILYVMLCRRLPFD 213

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 127/298 (42%), Gaps = 53/298 (17%)
Query: 49  LGEGGFGSVY------WGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRV-RHKNLL 100
           LG G FG V        G+    L++AVK LK+     E E    E++++  + +H+N++
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIV 98
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV-------------------QLDWK 141
            L G C      L++ +Y     LL+ L  +    +                    L+ +
Sbjct: 99  NLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELR 158
Query: 142 RRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM 201
             +  +   A+G+ +L    + + IHRD+ A NVLL +     + DFG A+ I    +++
Sbjct: 159 DLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 215
Query: 202 TTRVKGT----LGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTI 256
              VKG     + ++APE       +   DV+S+GILL EI + G  P    PG      
Sbjct: 216 ---VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP---YPG------ 263
Query: 257 TEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                 ++V  KF +LV    +        K   ++   C   EP  RP  +++ + L
Sbjct: 264 ------ILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFL 315

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 105/204 (51%), Gaps = 17/204 (8%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAVEVEV--LGRVRHKNLLGLRG 104
           LGEG FG V     T+ G ++A+K + K + +K++M+  +E E+  L  +RH +++ L  
Sbjct: 16  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                D+ ++V +Y  N  L  ++  Q     + + +R  +  I + E   Y H      
Sbjct: 76  VIKSKDEIIMVIEYAGN-ELFDYI-VQRDKMSEQEARRFFQQIISAVE---YCHRH---K 127
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV-- 222
           I+HRD+K  N+LLD      +ADFG + ++ +G    T+   G+  Y APE  + GK+  
Sbjct: 128 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VISGKLYA 184
Query: 223 SESCDVYSFGILLLEILTGRKPIE 246
               DV+S G++L  +L  R P +
Sbjct: 185 GPEVDVWSCGVILYVMLCRRLPFD 208

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 105/204 (51%), Gaps = 17/204 (8%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAVEVEV--LGRVRHKNLLGLRG 104
           LGEG FG V     T+ G ++A+K + K + +K++M+  +E E+  L  +RH +++ L  
Sbjct: 12  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                D+ ++V +Y  N  L  ++  Q     + + +R  +  I + E   Y H      
Sbjct: 72  VIKSKDEIIMVIEYAGN-ELFDYI-VQRDKMSEQEARRFFQQIISAVE---YCHRH---K 123
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV-- 222
           I+HRD+K  N+LLD      +ADFG + ++ +G    T+   G+  Y APE  + GK+  
Sbjct: 124 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VISGKLYA 180
Query: 223 SESCDVYSFGILLLEILTGRKPIE 246
               DV+S G++L  +L  R P +
Sbjct: 181 GPEVDVWSCGVILYVMLCRRLPFD 204

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 105/204 (51%), Gaps = 17/204 (8%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAVEVEV--LGRVRHKNLLGLRG 104
           LGEG FG V     T+ G ++A+K + K + +K++M+  +E E+  L  +RH +++ L  
Sbjct: 22  LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                D+ ++V +Y  N  L  ++  Q     + + +R  +  I + E   Y H      
Sbjct: 82  VIKSKDEIIMVIEYAGN-ELFDYI-VQRDKMSEQEARRFFQQIISAVE---YCHRH---K 133
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV-- 222
           I+HRD+K  N+LLD      +ADFG + ++ +G    T+   G+  Y APE  + GK+  
Sbjct: 134 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAPE-VISGKLYA 190
Query: 223 SESCDVYSFGILLLEILTGRKPIE 246
               DV+S G++L  +L  R P +
Sbjct: 191 GPEVDVWSCGVILYVMLCRRLPFD 214

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 114/272 (41%), Gaps = 25/272 (9%)
Query: 36  LHTATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL--KAMNSKAEMEFAVEVEVLG 92
           +H   N FS    +G GGFG VY  R +D G   A+K L  K +  K     A+   ++ 
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 93  RVRHKN---LLGLRGYCAGTDQRL-IVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKI 146
            +        +    Y   T  +L  + D M    L  HL  HG ++            +
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---------EADM 294
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
              +AE IL L H     +++RD+K +N+LLD      ++D G A    +   H +    
Sbjct: 295 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 351
Query: 207 GTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIV 265
           GT GY+APE    G     S D +S G +L ++L G  P  +     K  I      L +
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTM 409
Query: 266 KGKFKELVDPKLRGDFDENQLKQAINVAVLCV 297
             +  +   P+LR    E  L++ +N  + C+
Sbjct: 410 AVELPDSFSPELRS-LLEGLLQRDVNRRLGCL 440

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 114/272 (41%), Gaps = 25/272 (9%)
Query: 36  LHTATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL--KAMNSKAEMEFAVEVEVLG 92
           +H   N FS    +G GGFG VY  R +D G   A+K L  K +  K     A+   ++ 
Sbjct: 183 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 242
Query: 93  RVRHKN---LLGLRGYCAGTDQRL-IVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKI 146
            +        +    Y   T  +L  + D M    L  HL  HG ++            +
Sbjct: 243 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---------EADM 293
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
              +AE IL L H     +++RD+K +N+LLD      ++D G A    +   H +    
Sbjct: 294 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 350
Query: 207 GTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIV 265
           GT GY+APE    G     S D +S G +L ++L G  P  +     K  I      L +
Sbjct: 351 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTM 408
Query: 266 KGKFKELVDPKLRGDFDENQLKQAINVAVLCV 297
             +  +   P+LR    E  L++ +N  + C+
Sbjct: 409 AVELPDSFSPELRS-LLEGLLQRDVNRRLGCL 439

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 114/272 (41%), Gaps = 25/272 (9%)
Query: 36  LHTATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL--KAMNSKAEMEFAVEVEVLG 92
           +H   N FS    +G GGFG VY  R +D G   A+K L  K +  K     A+   ++ 
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 93  RVRHKN---LLGLRGYCAGTDQRL-IVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKI 146
            +        +    Y   T  +L  + D M    L  HL  HG ++            +
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---------EADM 294
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
              +AE IL L H     +++RD+K +N+LLD      ++D G A    +   H +    
Sbjct: 295 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 351
Query: 207 GTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIV 265
           GT GY+APE    G     S D +S G +L ++L G  P  +     K  I      L +
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTM 409
Query: 266 KGKFKELVDPKLRGDFDENQLKQAINVAVLCV 297
             +  +   P+LR    E  L++ +N  + C+
Sbjct: 410 AVELPDSFSPELRS-LLEGLLQRDVNRRLGCL 440

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 114/272 (41%), Gaps = 25/272 (9%)
Query: 36  LHTATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL--KAMNSKAEMEFAVEVEVLG 92
           +H   N FS    +G GGFG VY  R +D G   A+K L  K +  K     A+   ++ 
Sbjct: 184 IHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIML 243
Query: 93  RVRHKN---LLGLRGYCAGTDQRL-IVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKI 146
            +        +    Y   T  +L  + D M    L  HL  HG ++            +
Sbjct: 244 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS---------EADM 294
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
              +AE IL L H     +++RD+K +N+LLD      ++D G A    +   H +    
Sbjct: 295 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV--- 351
Query: 207 GTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIV 265
           GT GY+APE    G     S D +S G +L ++L G  P  +     K  I      L +
Sbjct: 352 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--LTM 409
Query: 266 KGKFKELVDPKLRGDFDENQLKQAINVAVLCV 297
             +  +   P+LR    E  L++ +N  + C+
Sbjct: 410 AVELPDSFSPELRS-LLEGLLQRDVNRRLGCL 440

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 30/220 (13%)
Query: 46  DNKLGEGGFGSVYWG---RTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLG 101
           D +LG G FGSV  G        + +A+K LK    KA+ E    E +++ ++ +  ++ 
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74
Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
           L G C      L++      ++    LH    G       +R +I + +   +L   H+V
Sbjct: 75  LIGVCQAEALMLVM-----EMAGGGPLHKFLVG-------KREEIPVSNVAELL---HQV 119
Query: 162 T--------PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT--LGY 211
           +         + +HRD+ A NVLL +     ++DFG +K +    S+ T R  G   L +
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 179
Query: 212 LAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
            APE   + K S   DV+S+G+ + E L+ G+KP +K+ G
Sbjct: 180 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 111/254 (43%), Gaps = 33/254 (12%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGLRGYC 106
           +LG+G FG VY  +  +   +A  K+    S+ E+E + VE+++L    H N++ L    
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL---- 99
Query: 107 AGTDQRLIVYDYMPNL-SLLSHLHGQYAGEVQLDWKRRMK------IAIGSAEGILYLHH 159
                 L  + Y  NL  L+    G     V L+ +R +       +   + + + YLH 
Sbjct: 100 ------LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
                IIHRD+KA N+L   D +  +ADFG +      +    + + GT  ++APE  M 
Sbjct: 154 N---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI-GTPYWMAPEVVMC 209
Query: 220 GKVSE-----SCDVYSFGILLLEILTGRKPIEKL-PGGVKRTITEWAEPLIVK-----GK 268
               +       DV+S GI L+E+     P  +L P  V   I +   P + +       
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 269
Query: 269 FKELVDPKLRGDFD 282
           FK+ +   L  + D
Sbjct: 270 FKDFLKKCLEKNVD 283

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 111/254 (43%), Gaps = 33/254 (12%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGLRGYC 106
           +LG+G FG VY  +  +   +A  K+    S+ E+E + VE+++L    H N++ L    
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL---- 99
Query: 107 AGTDQRLIVYDYMPNL-SLLSHLHGQYAGEVQLDWKRRMK------IAIGSAEGILYLHH 159
                 L  + Y  NL  L+    G     V L+ +R +       +   + + + YLH 
Sbjct: 100 ------LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
                IIHRD+KA N+L   D +  +ADFG +      +    + + GT  ++APE  M 
Sbjct: 154 N---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMC 209
Query: 220 GKVSE-----SCDVYSFGILLLEILTGRKPIEKL-PGGVKRTITEWAEPLIVK-----GK 268
               +       DV+S GI L+E+     P  +L P  V   I +   P + +       
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 269
Query: 269 FKELVDPKLRGDFD 282
           FK+ +   L  + D
Sbjct: 270 FKDFLKKCLEKNVD 283

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 116/268 (43%), Gaps = 30/268 (11%)
Query: 48  KLGEGGFGSVYWG-RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
           K+GEG  G V        G Q+AVKK+     +       EV ++    H N++ +    
Sbjct: 52  KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSY 111
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
              D+  +V +++   +L   +      E Q+       + +     + YLH++    +I
Sbjct: 112 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----ATVCLSVLRALSYLHNQ---GVI 163
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRDIK+ ++LL SD    ++DFGF   + + V      V GT  ++APE           
Sbjct: 164 HRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLV-GTPYWMAPEVISRLPYGTEV 222
Query: 227 DVYSFGILLLEILTGRKP-IEKLPGGVKRTITEWAEPLIVKGKFKEL--VDPKLRGDFDE 283
           D++S GI+++E++ G  P   + P    R I +   P     + K+L  V   LRG  D 
Sbjct: 223 DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDSLPP-----RVKDLHKVSSVLRGFLD- 276
Query: 284 NQLKQAINVAVLCVQSEPEKRPNMKEVV 311
                      L +  EP +R   +E++
Sbjct: 277 -----------LMLVREPSQRATAQELL 293

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 95
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 96  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 149
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+        MT  V  T  Y APE  + W 
Sbjct: 150 SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYV-ATRWYRAPEIMLNWM 205
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGR 227

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 95
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 96  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 149
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+        MT  V  T  Y APE  + W 
Sbjct: 150 SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYV-ATRWYRAPEIMLNWM 205
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGR 227

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 43  FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +++ + +GEG +G V     + + +++A+KK+     +   +  + E+++L R RH+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G+         R    + M ++ ++  L       ++ D  + +K    S + I Y  ++
Sbjct: 85  GINDII-----RAPTIEQMKDVYIVQDL-------METDLYKLLKTQHLSNDHICYFLYQ 132
Query: 161 V--------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           +        + +++HRD+K SN+LL++  +  + DFG A++      H    T    T  
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE  +  K  ++S D++S G +L E+L+ R PI   PG
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI--FPG 230

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 95
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 96  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 149
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+        MT  V  T  Y APE  + W 
Sbjct: 150 SADIIHRDLKPSNLAVNEDCELKILDFGLAR---HTADEMTGYV-ATRWYRAPEIMLNWM 205
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGR 227

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 43  FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +++ + +GEG +G V     + + +++A+KK+     +   +  + E+++L R RH+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G+         R    + M ++ ++  L       ++ D  + +K    S + I Y  ++
Sbjct: 85  GINDII-----RAPTIEQMKDVYIVQDL-------METDLYKLLKTQHLSNDHICYFLYQ 132
Query: 161 V--------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           +        + +++HRD+K SN+LL++  +  + DFG A++      H    T    T  
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE  +  K  ++S D++S G +L E+L+ R PI   PG
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI--FPG 230

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 127/301 (42%), Gaps = 48/301 (15%)
Query: 41  NGFSDDNKLGEGGFGSVY----WG--RTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGR 93
           N  S    LG G FG V     +G  ++   + +AVK LK      E E    E++VL  
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 94  V-RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV--------------QL 138
           +  H N++ L G C      L++ +Y     LL+ L  +    +               L
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 139 DWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV 198
           D +  +  +   A+G+ +L    + + IHRD+ A N+LL       + DFG A+ I    
Sbjct: 166 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDS 222
Query: 199 SHMTTRVKGT----LGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVK 253
           +++   VKG     + ++APE       +   DV+S+GI L E+ + G  P   +P    
Sbjct: 223 NYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP---- 275
Query: 254 RTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT 313
                      V  KF +++    R    E+   +  ++   C  ++P KRP  K++V  
Sbjct: 276 -----------VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 324
Query: 314 L 314
           +
Sbjct: 325 I 325

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 43  FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +++ + +GEG +G V     + + +++A+KK+     +   +  + E+++L R RH+N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G+         R    + M ++ ++  L       ++ D  + +K    S + I Y  ++
Sbjct: 87  GINDII-----RAPTIEQMKDVYIVQDL-------METDLYKLLKTQHLSNDHICYFLYQ 134
Query: 161 V--------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           +        + +++HRD+K SN+LL++  +  + DFG A++      H    T    T  
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE  +  K  ++S D++S G +L E+L+ R PI   PG
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI--FPG 232

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 43  FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +++ + +GEG +G V     + + +++A+KK+     +   +  + E+++L R RH+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G+         R    + M ++ ++  L       ++ D  + +K    S + I Y  ++
Sbjct: 89  GINDII-----RAPTIEQMKDVYIVQDL-------METDLYKLLKTQHLSNDHICYFLYQ 136
Query: 161 V--------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           +        + +++HRD+K SN+LL++  +  + DFG A++      H    T    T  
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE  +  K  ++S D++S G +L E+L+ R PI   PG
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI--FPG 234

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 67/268 (25%), Positives = 123/268 (45%), Gaps = 28/268 (10%)
Query: 48  KLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGL-RGY 105
           K+GEG  G V   R    G Q+AVK +     +       EV ++   +H N++ + + Y
Sbjct: 52  KIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSY 111
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
             G ++  ++ +++   +L          +V+L+ ++   +     + + YLH +    +
Sbjct: 112 LVG-EELWVLMEFLQGGAL-----TDIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GV 162
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSES 225
           IHRDIK+ ++LL  D    ++DFGF   I + V      V GT  ++APE       +  
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV-GTPYWMAPEVISRSLYATE 221
Query: 226 CDVYSFGILLLEILTGRKP-IEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN 284
            D++S GI+++E++ G  P     P    + + +   P   K K    V P LR DF E 
Sbjct: 222 VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP---KLKNSHKVSPVLR-DFLER 277
Query: 285 QLKQAINVAVLCVQSEPEKRPNMKEVVN 312
            L +           +P++R   +E+++
Sbjct: 278 MLVR-----------DPQERATAQELLD 294

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 43  FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +++ + +GEG +G V     + + +++A+KK+     +   +  + E+++L R RH+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G+         R    + M ++ ++  L       ++ D  + +K    S + I Y  ++
Sbjct: 89  GINDII-----RAPTIEQMKDVYIVQDL-------METDLYKLLKCQHLSNDHICYFLYQ 136
Query: 161 V--------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           +        + +++HRD+K SN+LL++  +  + DFG A++      H    T    T  
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE  +  K  ++S D++S G +L E+L+ R PI   PG
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI--FPG 234

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL K   S    +    E+ +L  ++H+N++GL   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 100
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 101 -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 154
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 155 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 210
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGR 232

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 43  FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +++ + +GEG +G V     + + +++A+KK+     +   +  + E+++L R RH+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G+         R    + M ++ ++  L       ++ D  + +K    S + I Y  ++
Sbjct: 85  GINDII-----RAPTIEQMKDVYIVQDL-------METDLYKLLKTQHLSNDHICYFLYQ 132
Query: 161 V--------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           +        + +++HRD+K SN+LL++  +  + DFG A++      H    T    T  
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE  +  K  ++S D++S G +L E+L+ R PI   PG
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI--FPG 230

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 43  FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +++ + +GEG +G V     + + +++A+KK+     +   +  + E+++L R RH+N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G+         R    + M ++ ++  L       ++ D  + +K    S + I Y  ++
Sbjct: 90  GINDII-----RAPTIEQMKDVYIVQDL-------METDLYKLLKTQHLSNDHICYFLYQ 137
Query: 161 V--------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           +        + +++HRD+K SN+LL++  +  + DFG A++      H    T    T  
Sbjct: 138 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 197
Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE  +  K  ++S D++S G +L E+L+ R PI   PG
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI--FPG 235

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 43  FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +++ + +GEG +G V     + + +++A+KK+     +   +  + E+++L R RH+N++
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G+         R    + M ++ ++  L       ++ D  + +K    S + I Y  ++
Sbjct: 91  GINDII-----RAPTIEQMKDVYIVQDL-------METDLYKLLKTQHLSNDHICYFLYQ 138
Query: 161 V--------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           +        + +++HRD+K SN+LL++  +  + DFG A++      H    T    T  
Sbjct: 139 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 198
Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE  +  K  ++S D++S G +L E+L+ R PI   PG
Sbjct: 199 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI--FPG 236

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 43  FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +++ + +GEG +G V     + + +++A+KK+     +   +  + E+++L R RH+N++
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G+         R    + M ++ ++  L       ++ D  + +K    S + I Y  ++
Sbjct: 82  GINDII-----RAPTIEQMKDVYIVQDL-------METDLYKLLKTQHLSNDHICYFLYQ 129
Query: 161 V--------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           +        + +++HRD+K SN+LL++  +  + DFG A++      H    T    T  
Sbjct: 130 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 189
Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE  +  K  ++S D++S G +L E+L+ R PI   PG
Sbjct: 190 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI--FPG 227

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 43  FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +++ + +GEG +G V     + + +++A+KK+     +   +  + E+++L R RH+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G+         R    + M ++ ++  L       ++ D  + +K    S + I Y  ++
Sbjct: 89  GINDII-----RAPTIEQMKDVYIVQDL-------METDLYKLLKTQHLSNDHICYFLYQ 136
Query: 161 V--------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           +        + +++HRD+K SN+LL++  +  + DFG A++      H    T    T  
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE  +  K  ++S D++S G +L E+L+ R PI   PG
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI--FPG 234

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 43  FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +++ + +GEG +G V     + + +++A+KK+     +   +  + E+++L R RH+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G+         R    + M ++ ++  L       ++ D  + +K    S + I Y  ++
Sbjct: 89  GINDII-----RAPTIEQMKDVYIVQDL-------METDLYKLLKTQHLSNDHICYFLYQ 136
Query: 161 V--------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           +        + +++HRD+K SN+LL++  +  + DFG A++      H    T    T  
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE  +  K  ++S D++S G +L E+L+ R PI   PG
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI--FPG 234

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 43  FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +++ + +GEG +G V     + + +++A+KK+     +   +  + E+++L R RH+N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G+         R    + M ++ ++  L       ++ D  + +K    S + I Y  ++
Sbjct: 83  GINDII-----RAPTIEQMKDVYIVQDL-------METDLYKLLKTQHLSNDHICYFLYQ 130
Query: 161 V--------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           +        + +++HRD+K SN+LL++  +  + DFG A++      H    T    T  
Sbjct: 131 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE  +  K  ++S D++S G +L E+L+ R PI   PG
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI--FPG 228

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 97/206 (47%), Gaps = 19/206 (9%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFA-VEVEVLGRVRHKNLLGLRG 104
           LG+G FG V       T +   I + K   +    ++E   VE  VL  +     L    
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 105 YCAGTDQRL-IVYDYMPNLSLLSHLH--GQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
            C  T  RL  V +Y+    L+ H+   G++     + +   + I      G+ +LH   
Sbjct: 87  SCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISI------GLFFLHKR- 139
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAK-LIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
              II+RD+K  NV+LDS+    +ADFG  K  + +GV+  T    GT  Y+APE   + 
Sbjct: 140 --GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVT--TREFCGTPDYIAPEIIAYQ 195
Query: 221 KVSESCDVYSFGILLLEILTGRKPIE 246
              +S D +++G+LL E+L G+ P +
Sbjct: 196 PYGKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 43  FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +++ + +GEG +G V     + + +++A+KK+     +   +  + E+++L R RH+N++
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G+         R    + M ++ ++  L       ++ D  + +K    S + I Y  ++
Sbjct: 83  GINDII-----RAPTIEQMKDVYIVQDL-------METDLYKLLKTQHLSNDHICYFLYQ 130
Query: 161 V--------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           +        + +++HRD+K SN+LL++  +  + DFG A++      H    T    T  
Sbjct: 131 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 190
Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE  +  K  ++S D++S G +L E+L+ R PI   PG
Sbjct: 191 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI--FPG 228

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 95/203 (46%), Gaps = 14/203 (6%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           LGEG F +V   R   TS    I + + + +  + ++ +   E +V+ R+ H   + L  
Sbjct: 45  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY- 103
Query: 105 YCAGTDQRLIV-YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           +C   D++L     Y  N  LL ++  +  G       R     I SA  + YLH +   
Sbjct: 104 FCFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLHGK--- 156
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
            IIHRD+K  N+LL+ D    + DFG AK++ PE          GT  Y++PE       
Sbjct: 157 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSA 216
Query: 223 SESCDVYSFGILLLEILTGRKPI 245
            +S D+++ G ++ +++ G  P 
Sbjct: 217 CKSSDLWALGCIIYQLVAGLPPF 239

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 43  FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +++ + +GEG +G V     + + +++A+KK+     +   +  + E+++L R RH+N++
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G+         R    + M ++ ++  L       ++ D  + +K    S + I Y  ++
Sbjct: 93  GINDII-----RAPTIEQMKDVYIVQDL-------METDLYKLLKTQHLSNDHICYFLYQ 140
Query: 161 V--------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           +        + +++HRD+K SN+LL++  +  + DFG A++      H    T    T  
Sbjct: 141 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 200
Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE  +  K  ++S D++S G +L E+L+ R PI   PG
Sbjct: 201 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI--FPG 238

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 43  FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +++ + +GEG +G V     + + +++A+KK+     +   +  + E+++L R RH+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G+         R    + M ++ ++  L       ++ D  + +K    S + I Y  ++
Sbjct: 85  GINDII-----RAPTIEQMKDVYIVQDL-------METDLYKLLKTQHLSNDHICYFLYQ 132
Query: 161 V--------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           +        + +++HRD+K SN+LL++  +  + DFG A++      H    T    T  
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE  +  K  ++S D++S G +L E+L+ R PI   PG
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI--FPG 230

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 138/291 (47%), Gaps = 44/291 (15%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVKK-LKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +GEG +G V   R  D G  +A+KK L++ + K   + A+ E+++L ++RH+NL+ L   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
           C    +  +V++++ + ++L  L     G   LD++   K       GI + H   + +I
Sbjct: 93  CKKKKRWYLVFEFVDH-TILDDLELFPNG---LDYQVVQKYLFQIINGIGFCH---SHNI 145
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG-KVSE 224
           IHRDIK  N+L+       + DFGFA+ +          V  T  Y APE  +   K  +
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV-ATRWYRAPELLVGDVKYGK 204
Query: 225 SCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN 284
           + DV++ G L+ E+  G +P+   PG     I +    ++  G       P+ +  F++N
Sbjct: 205 AVDVWAIGCLVTEMFMG-EPL--FPGD--SDIDQLYHIMMCLGNLI----PRHQELFNKN 255
Query: 285 ---------QLKQ--------------AINVAVLCVQSEPEKRPNMKEVVN 312
                    ++K+               I++A  C+  +P+KRP   E+++
Sbjct: 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH 306

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           K+GEG +G VY  + S G  +A+K+++  A +         E+ +L  + H N++ L   
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA-EGILYLHHEVTPH 164
                   +V+++M    L   L     G +Q     ++KI +     G+ + H      
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVLDENKTG-LQ---DSQIKIYLYQLLRGVAHCHQH---R 139
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG-KVS 223
           I+HRD+K  N+L++SD    +ADFG A+     V   T  V  TL Y AP+  M   K S
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYS 198
Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPG 250
            S D++S G +  E++TG KP+   PG
Sbjct: 199 TSVDIWSIGCIFAEMITG-KPL--FPG 222

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 125/301 (41%), Gaps = 48/301 (15%)
Query: 41  NGFSDDNKLGEGGFGSVYWG------RTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGR 93
           N  S    LG G FG V         ++   + +AVK LK      E E    E++VL  
Sbjct: 46  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 105
Query: 94  V-RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV--------------QL 138
           +  H N++ L G C      L++ +Y     LL+ L  +    +               L
Sbjct: 106 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 165
Query: 139 DWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV 198
           D +  +  +   A+G+ +L    + + IHRD+ A N+LL       + DFG A+ I    
Sbjct: 166 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 222
Query: 199 SHMTTRVKGT----LGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVK 253
           +++   VKG     + ++APE       +   DV+S+GI L E+ + G  P   +P    
Sbjct: 223 NYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP---- 275
Query: 254 RTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT 313
                      V  KF +++    R    E+   +  ++   C  ++P KRP  K++V  
Sbjct: 276 -----------VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 324
Query: 314 L 314
           +
Sbjct: 325 I 325

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/301 (24%), Positives = 127/301 (42%), Gaps = 48/301 (15%)
Query: 41  NGFSDDNKLGEGGFGSVY----WG--RTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGR 93
           N  S    LG G FG V     +G  ++   + +AVK LK      E E    E++VL  
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 94  V-RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV--------------QL 138
           +  H N++ L G C      L++ +Y     LL+ L  +    +               L
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 139 DWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV 198
           D +  +  +   A+G+ +L    + + IHRD+ A N+LL       + DFG A+ I    
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 199 SHMTTRVKGT----LGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVK 253
           +++   VKG     + ++APE       +   DV+S+GI L E+ + G  P   +P    
Sbjct: 200 NYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP---- 252
Query: 254 RTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT 313
                      V  KF +++    R    E+   +  ++   C  ++P KRP  K++V  
Sbjct: 253 -----------VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301
Query: 314 L 314
           +
Sbjct: 302 I 302

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 125/301 (41%), Gaps = 48/301 (15%)
Query: 41  NGFSDDNKLGEGGFGSVYWG------RTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGR 93
           N  S    LG G FG V         ++   + +AVK LK      E E    E++VL  
Sbjct: 41  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 100
Query: 94  V-RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV--------------QL 138
           +  H N++ L G C      L++ +Y     LL+ L  +    +               L
Sbjct: 101 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 160
Query: 139 DWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV 198
           D +  +  +   A+G+ +L    + + IHRD+ A N+LL       + DFG A+ I    
Sbjct: 161 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 217
Query: 199 SHMTTRVKGT----LGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVK 253
           +++   VKG     + ++APE       +   DV+S+GI L E+ + G  P   +P    
Sbjct: 218 NYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP---- 270
Query: 254 RTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT 313
                      V  KF +++    R    E+   +  ++   C  ++P KRP  K++V  
Sbjct: 271 -----------VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 319
Query: 314 L 314
           +
Sbjct: 320 I 320

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 26/228 (11%)
Query: 29  RIFTYKELHTATNGF---SDDNKLGEGGFGSVY-WGRTSDGLQIAVKKLKAMNSKAEMEF 84
           RI T K+   A N F   S    LG G FG V+    T+ GL++A K +K    K + E 
Sbjct: 76  RIVTAKQ--GAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEV 133
Query: 85  AVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRM 144
             E+ V+ ++ H NL+ L       +  ++V +Y+    L   +  +     +LD    M
Sbjct: 134 KNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFM 193
Query: 145 KIAIGSAEGILYLHHEVTPHIIHRDIKASNVL-LDSDFEPL-VADFGFAKLIPEGVSHMT 202
           K      EGI ++H     +I+H D+K  N+L ++ D + + + DFG A+          
Sbjct: 194 K---QICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLAR-------RYK 240
Query: 203 TRVK-----GTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
            R K     GT  +LAPE   +  VS   D++S G++   +L+G  P 
Sbjct: 241 PREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPF 288

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 115/272 (42%), Gaps = 29/272 (10%)
Query: 43  FSDDNKLGEGGFGSVYWG---RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL 99
           F+   K+G+G FG V+ G   RT   + I +  L+    + E     E+ VL +     +
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYV 82
Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
               G      +  I+ +Y+   S L  L      E Q+    R  +     +G+ YLH 
Sbjct: 83  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL-----KGLDYLHS 137
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
           E     IHRDIKA+NVLL    E  +ADFG A  + +        V GT  ++APE    
Sbjct: 138 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQ 193
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
                  D++S GI  +E+  G  P  +L             P+ V     +   P L G
Sbjct: 194 SAYDSKADIWSLGITAIELARGEPPHSEL------------HPMKVLFLIPKNNPPTLEG 241
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
           ++ +  LK+ +     C+  EP  RP  KE++
Sbjct: 242 NYSK-PLKEFVEA---CLNKEPSFRPTAKELL 269

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 43  FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +++ + +GEG +G V     + + +++A+KK+     +   +  + E+++L R RH+N++
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G+         R    + M ++ ++  L       ++ D  + +K    S + I Y  ++
Sbjct: 105 GINDII-----RAPTIEQMKDVYIVQDL-------METDLYKLLKTQHLSNDHICYFLYQ 152
Query: 161 V--------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           +        + +++HRD+K SN+LL++  +  + DFG A++      H    T    T  
Sbjct: 153 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 212
Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE  +  K  ++S D++S G +L E+L+ R PI   PG
Sbjct: 213 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI--FPG 250

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           LG+G FG V   R   T D   + V K   +    ++E  + E  +L   R+   L    
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 105 YCAGTDQRLI-VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
            C  T  RL  V +++    L+ H+        + D  R    A      +++LH +   
Sbjct: 91  CCFQTPDRLFFVMEFVNGGDLMFHIQKSR----RFDEARARFYAAEIISALMFLHDK--- 143
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLGYLAPEYAMWGK 221
            II+RD+K  NVLLD +    +ADFG  K   EG+ +   T    GT  Y+APE      
Sbjct: 144 GIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCGTPDYIAPEILQEML 200
Query: 222 VSESCDVYSFGILLLEILTGRKPIE 246
              + D ++ G+LL E+L G  P E
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAPFE 225

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 93
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 94  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 147
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 148 SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 203
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGR 225

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/272 (27%), Positives = 115/272 (42%), Gaps = 29/272 (10%)
Query: 43  FSDDNKLGEGGFGSVYWG---RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL 99
           F+   K+G+G FG V+ G   RT   + I +  L+    + E     E+ VL +     +
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI-QQEITVLSQCDSPYV 67
Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
               G      +  I+ +Y+   S L  L      E Q+    R  +     +G+ YLH 
Sbjct: 68  TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREIL-----KGLDYLHS 122
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
           E     IHRDIKA+NVLL    E  +ADFG A  + +        V GT  ++APE    
Sbjct: 123 EKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQ 178
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
                  D++S GI  +E+  G  P  +L             P+ V     +   P L G
Sbjct: 179 SAYDSKADIWSLGITAIELARGEPPHSEL------------HPMKVLFLIPKNNPPTLEG 226
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
           ++ +  LK+ +     C+  EP  RP  KE++
Sbjct: 227 NYSK-PLKEFVEA---CLNKEPSFRPTAKELL 254

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 74/301 (24%), Positives = 125/301 (41%), Gaps = 48/301 (15%)
Query: 41  NGFSDDNKLGEGGFGSVYWG------RTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGR 93
           N  S    LG G FG V         ++   + +AVK LK      E E    E++VL  
Sbjct: 39  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 98
Query: 94  V-RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV--------------QL 138
           +  H N++ L G C      L++ +Y     LL+ L  +    +               L
Sbjct: 99  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 158
Query: 139 DWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV 198
           D +  +  +   A+G+ +L    + + IHRD+ A N+LL       + DFG A+ I    
Sbjct: 159 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 215
Query: 199 SHMTTRVKGT----LGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVK 253
           +++   VKG     + ++APE       +   DV+S+GI L E+ + G  P   +P    
Sbjct: 216 NYV---VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP---- 268
Query: 254 RTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT 313
                      V  KF +++    R    E+   +  ++   C  ++P KRP  K++V  
Sbjct: 269 -----------VDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 317
Query: 314 L 314
           +
Sbjct: 318 I 318

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 16/207 (7%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           K+GEG +G VY  + S G  +A+K+++  A +         E+ +L  + H N++ L   
Sbjct: 28  KVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA-EGILYLHHEVTPH 164
                   +V+++M    L   L     G +Q     ++KI +     G+ + H      
Sbjct: 88  IHSERCLTLVFEFMEK-DLKKVLDENKTG-LQ---DSQIKIYLYQLLRGVAHCHQH---R 139
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG-KVS 223
           I+HRD+K  N+L++SD    +ADFG A+     V   T  V  TL Y AP+  M   K S
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYS 198
Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPG 250
            S D++S G +  E++TG KP+   PG
Sbjct: 199 TSVDIWSIGCIFAEMITG-KPL--FPG 222

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 67/254 (26%), Positives = 110/254 (43%), Gaps = 33/254 (12%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGLRGYC 106
           +LG+G FG VY  +  +   +A  K+    S+ E+E + VE+++L    H N++ L    
Sbjct: 44  ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKL---- 99
Query: 107 AGTDQRLIVYDYMPNL-SLLSHLHGQYAGEVQLDWKRRMK------IAIGSAEGILYLHH 159
                 L  + Y  NL  L+    G     V L+ +R +       +   + + + YLH 
Sbjct: 100 ------LDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 153
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
                IIHRD+KA N+L   D +  +ADFG +      +      + GT  ++APE  M 
Sbjct: 154 N---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI-GTPYWMAPEVVMC 209
Query: 220 GKVSE-----SCDVYSFGILLLEILTGRKPIEKL-PGGVKRTITEWAEPLIVK-----GK 268
               +       DV+S GI L+E+     P  +L P  V   I +   P + +       
Sbjct: 210 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSN 269
Query: 269 FKELVDPKLRGDFD 282
           FK+ +   L  + D
Sbjct: 270 FKDFLKKCLEKNVD 283

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 43  FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +++ + +GEG +G V     + + +++A+KK+     +   +  + E+++L R RH+N++
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G+         R    + M ++ ++  L       ++ D  + +K    S + I Y  ++
Sbjct: 85  GINDII-----RAPTIEQMKDVYIVQDL-------METDLYKLLKTQHLSNDHICYFLYQ 132
Query: 161 V--------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           +        + +++HRD+K SN+LL++  +  + DFG A++      H    T    T  
Sbjct: 133 ILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRW 192
Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE  +  K  ++S D++S G +L E+L+ R PI   PG
Sbjct: 193 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI--FPG 230

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 89  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGXV-ATRWYRAPEIMLNWM 198
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 93
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 94  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 147
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 148 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 203
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 87
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 88  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 141
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 142 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 197
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 198 HYNQTVDIWSVGCIMAELLTGR 219

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 89  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 198
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 99
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 100 -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 153
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 154 SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 209
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 210 HYNQTVDIWSVGCIMAELLTGR 231

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 89  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 198
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 85
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 86  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 139
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 140 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 195
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 196 HYNQTVDIWSVGCIMAELLTGR 217

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 90
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 91  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 144
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 145 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 200
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGR 222

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 93
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 94  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 147
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 148 SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 203
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGR 225

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 90
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 91  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 144
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 145 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 200
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGR 222

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 89  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 198
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 89  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 198
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 84
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 85  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 138
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 194
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGR 216

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 89  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 198
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 89  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 198
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 89  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 198
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 99
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 100 -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 153
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 154 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 209
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 210 HYNQTVDIWSVGCIMAELLTGR 231

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 95
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 96  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 149
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 150 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 205
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 206 HYNQTVDIWSVGCIMAELLTGR 227

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 85
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 86  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 139
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 140 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 195
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 196 HYNQTVDIWSVGCIMAELLTGR 217

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 86
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 87  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 140
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 141 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 196
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 197 HYNQTVDIWSVGCIMAELLTGR 218

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 111/221 (50%), Gaps = 28/221 (12%)
Query: 43  FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +++ + +GEG +G V     + + +++A++K+     +   +  + E+++L R RH+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G+         R    + M ++ ++  L       ++ D  + +K    S + I Y  ++
Sbjct: 89  GINDII-----RAPTIEQMKDVYIVQDL-------METDLYKLLKTQHLSNDHICYFLYQ 136
Query: 161 V--------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           +        + +++HRD+K SN+LL++  +  + DFG A++      H    T    T  
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196
Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE  +  K  ++S D++S G +L E+L+ R PI   PG
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI--FPG 234

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 100
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 101 -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 154
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 155 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 210
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGR 232

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 100
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 101 -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 154
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 155 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 210
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 211 HYNQTVDIWSVGCIMAELLTGR 232

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 90
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 91  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 144
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 145 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 200
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGR 222

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 94
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 95  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 148
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 149 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 204
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGR 226

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 89  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 143 SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 198
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 94
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 95  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 148
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 149 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 204
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGR 226

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 108
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 109 -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 162
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 163 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 218
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGR 240

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 89  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 198
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 107
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 108 -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 161
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 162 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 217
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 218 HYNQTVDIWSVGCIMAELLTGR 239

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 111
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 112 -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 165
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 166 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 221
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 222 HYNQTVDIWSVGCIMAELLTGR 243

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 93
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 94  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 147
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 148 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 203
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 204 HYNQTVDIWSVGCIMAELLTGR 225

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 103/211 (48%), Gaps = 21/211 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGLRGYC 106
           +LG+G FG VY  +  +   +A  K+    S+ E+E + VE+E+L    H  ++ L G  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 107 AGTDQRLIVYDYMP----NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
               +  I+ ++ P    +  +L    G    ++Q+  ++ +       E + +LH   +
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML-------EALNFLH---S 127
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
             IIHRD+KA NVL+  + +  +ADFG +    + +    + + GT  ++APE  M   +
Sbjct: 128 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETM 186
Query: 223 SES-----CDVYSFGILLLEILTGRKPIEKL 248
            ++      D++S GI L+E+     P  +L
Sbjct: 187 KDTPYDYKADIWSLGITLIEMAQIEPPHHEL 217

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 94
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 95  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 148
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 149 SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 204
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGR 226

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/202 (30%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 90
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 91  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 144
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 145 SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 200
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 201 HYNQTVDIWSVGCIMAELLTGR 222

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 43  FSDDNKLGEGGFGSVYW---GRTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHK 97
           + D   +G G +G+V     GRT  G ++A+KKL +   S+   + A  E+ +L  +RH+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRT--GAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
           N++GL       +      D+   +  +    G+     +L   R   +     +G+ Y+
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 144
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           H      IIHRD+K  N+ ++ D E  + DFG A+   +  S M   V  T  Y APE  
Sbjct: 145 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEMXGXVV-TRWYRAPEVI 197
Query: 218 M-WGKVSESCDVYSFGILLLEILTGR 242
           + W + +++ D++S G ++ E++TG+
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/211 (26%), Positives = 103/211 (48%), Gaps = 21/211 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGLRGYC 106
           +LG+G FG VY  +  +   +A  K+    S+ E+E + VE+E+L    H  ++ L G  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 107 AGTDQRLIVYDYMP----NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
               +  I+ ++ P    +  +L    G    ++Q+  ++ +       E + +LH   +
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQML-------EALNFLH---S 135
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
             IIHRD+KA NVL+  + +  +ADFG +    + +    + + GT  ++APE  M   +
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEVVMCETM 194
Query: 223 SES-----CDVYSFGILLLEILTGRKPIEKL 248
            ++      D++S GI L+E+     P  +L
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQIEPPHHEL 225

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 67/292 (22%), Positives = 128/292 (43%), Gaps = 41/292 (14%)
Query: 49  LGEGGFGSVY------WGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRV-RHKNLL 100
           LG G FG V         +T   +Q+AVK LK     +E E    E++++ ++  H+N++
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQ----YAGEVQLDWKRRMK----IAIGSAE 152
            L G C  +    ++++Y     LL++L  +       E++ + ++R++    + + + E
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 153 GILYLHHEVTP--------HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT- 203
            +L   ++V            +HRD+ A NVL+       + DFG A+ I    +++   
Sbjct: 173 DLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRG 232
Query: 204 RVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP 262
             +  + ++APE    G  +   DV+S+GILL EI + G  P   +P             
Sbjct: 233 NARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP------------- 279
Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
             V   F +L+    + D      ++   +   C   +  KRP+   + + L
Sbjct: 280 --VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFA-VEVEVLGRVRHKNLLGLRG 104
           LG+G FG V       T +   + + K   +    ++E   VE  VL        L    
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 105 YCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
            C  T  RL  V +Y+    L+ H+  Q  G  +      +  A   A G+ +L    + 
Sbjct: 88  SCFQTMDRLYFVMEYVNGGDLMYHI--QQVG--RFKEPHAVFYAAEIAIGLFFLQ---SK 140
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKL-IPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
            II+RD+K  NV+LDS+    +ADFG  K  I +GV+  T    GT  Y+APE   +   
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPDYIAPEIIAYQPY 198
Query: 223 SESCDVYSFGILLLEILTGRKPIE 246
            +S D ++FG+LL E+L G+ P E
Sbjct: 199 GKSVDWWAFGVLLYEMLAGQAPFE 222

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 15/204 (7%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFA-VEVEVLGRVRHKNLLGLRG 104
           LG+G FG V       T +   + + K   +    ++E   VE  VL        L    
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 105 YCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
            C  T  RL  V +Y+    L+ H+  Q  G  +      +  A   A G+ +L    + 
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDLMYHI--QQVG--RFKEPHAVFYAAEIAIGLFFLQ---SK 461
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKL-IPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
            II+RD+K  NV+LDS+    +ADFG  K  I +GV+  T    GT  Y+APE   +   
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT--TKXFCGTPDYIAPEIIAYQPY 519
Query: 223 SESCDVYSFGILLLEILTGRKPIE 246
            +S D ++FG+LL E+L G+ P E
Sbjct: 520 GKSVDWWAFGVLLYEMLAGQAPFE 543

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 16/203 (7%)
Query: 49  LGEGGFGSVYWGRTSDGLQ-IAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKNLLGLRGY 105
           LG+G FG V   +     Q  AVK +   ++K +    +  EVE+L ++ H N++ L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
              +    IV +      L   +  +     + D  R +K       GI Y+H     +I
Sbjct: 90  LEDSSSFYIVGELYTGGELFDEIIKRKRFS-EHDAARIIKQVFS---GITYMHKH---NI 142
Query: 166 IHRDIKASNVLLDS---DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
           +HRD+K  N+LL+S   D +  + DFG +    +  + M  R+ GT  Y+APE  + G  
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPE-VLRGTY 199
Query: 223 SESCDVYSFGILLLEILTGRKPI 245
            E CDV+S G++L  +L+G  P 
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPF 222

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 25/205 (12%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 111
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 112 -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 165
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG---TLGYLAPEYAM 218
           +  IIHRD+K SN+ ++ D E  + DFG A+       H    + G   T  Y APE  +
Sbjct: 166 SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGYVATRWYRAPEIML 218
Query: 219 -WGKVSESCDVYSFGILLLEILTGR 242
            W   +++ D++S G ++ E+LTGR
Sbjct: 219 NWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 70/302 (23%), Positives = 131/302 (43%), Gaps = 38/302 (12%)
Query: 30  IFTYKELHTATNGFSDDNKLGEGGFGSVYWG------RTSDGLQIAVKKL-KAMNSKAEM 82
           +F   E   A    +   +LG+G FG VY G      +     ++A+K + +A + +  +
Sbjct: 5   VFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 64
Query: 83  EFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLD--- 139
           EF  E  V+      +++ L G  +     L++ + M    L S+L      E++ +   
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPEMENNPVL 123
Query: 140 ----WKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP 195
                 + +++A   A+G+ YL+       +HRD+ A N ++  DF   + DFG  + I 
Sbjct: 124 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 180
Query: 196 EGVSHMTTRVKGTLG--YLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGV 252
           E   +     KG L   +++PE    G  +   DV+SFG++L EI T   +P + L    
Sbjct: 181 E-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--- 236
Query: 253 KRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
                E     +++G            D  +N       +  +C Q  P+ RP+  E+++
Sbjct: 237 ----NEQVLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 283
Query: 313 TL 314
           ++
Sbjct: 284 SI 285

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 82/172 (47%), Gaps = 21/172 (12%)
Query: 145 KIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR 204
           KI + + + + +L   +   IIHRDIK SN+LLD      + DFG +  + + ++   TR
Sbjct: 129 KITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TR 184
Query: 205 VKGTLGYLAPE----YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWA 260
             G   Y+APE     A         DV+S GI L E+ TGR P  K    V   +T+  
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW-NSVFDQLTQ-- 241
Query: 261 EPLIVKGKFKELVDPKLRGDFDENQLKQA-INVAVLCVQSEPEKRPNMKEVV 311
              +VKG      DP    + +E +   + IN   LC+  +  KRP  KE++
Sbjct: 242 ---VVKG------DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 49  LGEGGFGSVYWGRTSDGLQ-IAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKNLLGLRGY 105
           LG+G FG V   +     Q  AVK +   ++K +    +  EVE+L ++ H N++ L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
              +    IV      L     L  +     +       +I      GI Y+H     +I
Sbjct: 90  LEDSSSFYIV----GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NI 142
Query: 166 IHRDIKASNVLLDS---DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
           +HRD+K  N+LL+S   D +  + DFG +    +  + M  R+ GT  Y+APE  + G  
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPE-VLRGTY 199
Query: 223 SESCDVYSFGILLLEILTGRKPI 245
            E CDV+S G++L  +L+G  P 
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPF 222

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 105/220 (47%), Gaps = 30/220 (13%)
Query: 46  DNKLGEGGFGSVYWG---RTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLG 101
           D +LG G FGSV  G        + +A+K LK    KA+ E    E +++ ++ +  ++ 
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400
Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
           L G C      L++      ++    LH    G       +R +I + +   +L   H+V
Sbjct: 401 LIGVCQAEALMLVM-----EMAGGGPLHKFLVG-------KREEIPVSNVAELL---HQV 445
Query: 162 T--------PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG--TLGY 211
           +         + +HR++ A NVLL +     ++DFG +K +    S+ T R  G   L +
Sbjct: 446 SMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 505
Query: 212 LAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
            APE   + K S   DV+S+G+ + E L+ G+KP +K+ G
Sbjct: 506 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 102/212 (48%), Gaps = 22/212 (10%)
Query: 49  LGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYC 106
           +GEG +G V          ++A+KK+     +   +  + E+++L R RH+N++G+R   
Sbjct: 51  IGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDIL 110
Query: 107 -AGTDQRL----IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
            A T + +    IV D M    L   L  Q     QL              G+ Y+H   
Sbjct: 111 RASTLEAMRDVYIVQDLM-ETDLYKLLKSQ-----QLSNDHICYFLYQILRGLKYIH--- 161
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLGYLAPEYAMW 219
           + +++HRD+K SN+L+++  +  + DFG A++      H    T    T  Y APE  + 
Sbjct: 162 SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLN 221
Query: 220 GK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
            K  ++S D++S G +L E+L+ R PI   PG
Sbjct: 222 SKGYTKSIDIWSVGCILAEMLSNR-PI--FPG 250

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 94/203 (46%), Gaps = 16/203 (7%)
Query: 49  LGEGGFGSVYWGRTSDGLQ-IAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKNLLGLRGY 105
           LG+G FG V   +     Q  AVK +   ++K +    +  EVE+L ++ H N++ L   
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
              +    IV      L     L  +     +       +I      GI Y+H     +I
Sbjct: 90  LEDSSSFYIV----GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NI 142
Query: 166 IHRDIKASNVLLDS---DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
           +HRD+K  N+LL+S   D +  + DFG +    +  + M  R+ GT  Y+APE  + G  
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPE-VLRGTY 199
Query: 223 SESCDVYSFGILLLEILTGRKPI 245
            E CDV+S G++L  +L+G  P 
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPF 222

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/301 (22%), Positives = 127/301 (42%), Gaps = 36/301 (11%)
Query: 30  IFTYKELHTATNGFSDDNKLGEGGFGSVYWG------RTSDGLQIAVKKL-KAMNSKAEM 82
           ++   E   A    +   +LG+G FG VY G      +     ++A+K + +A + +  +
Sbjct: 4   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 63
Query: 83  EFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ----- 137
           EF  E  V+      +++ L G  +     L++ + M    L S+L              
Sbjct: 64  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 123
Query: 138 -LDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE 196
                + +++A   A+G+ YL+       +HRD+ A N ++  DF   + DFG  + I E
Sbjct: 124 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 180
Query: 197 GVSHMTTRVKGTLG--YLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVK 253
              +     KG L   +++PE    G  +   DV+SFG++L EI T   +P + L     
Sbjct: 181 -TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---- 235
Query: 254 RTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT 313
               E     +++G            D  +N       +  +C Q  P+ RP+  E++++
Sbjct: 236 ---NEQVLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 283
Query: 314 L 314
           +
Sbjct: 284 I 284

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 89  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + D+G A+   +    MT  V  T  Y APE  + W 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 198
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 68/301 (22%), Positives = 127/301 (42%), Gaps = 36/301 (11%)
Query: 30  IFTYKELHTATNGFSDDNKLGEGGFGSVYWG------RTSDGLQIAVKKL-KAMNSKAEM 82
           ++   E   A    +   +LG+G FG VY G      +     ++A+K + +A + +  +
Sbjct: 14  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 73
Query: 83  EFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ----- 137
           EF  E  V+      +++ L G  +     L++ + M    L S+L              
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133
Query: 138 -LDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE 196
                + +++A   A+G+ YL+       +HRD+ A N ++  DF   + DFG  + I E
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
Query: 197 GVSHMTTRVKGTLG--YLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVK 253
              +     KG L   +++PE    G  +   DV+SFG++L EI T   +P + L     
Sbjct: 191 -TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS---- 245
Query: 254 RTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT 313
               E     +++G            D  +N       +  +C Q  P+ RP+  E++++
Sbjct: 246 ---NEQVLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293
Query: 314 L 314
           +
Sbjct: 294 I 294

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 12/202 (5%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           LGEG F +V   R   TS    I + + + +  + ++ +   E +V+ R+ H   + L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                ++      Y  N  LL ++  +  G       R     I SA  + YLH +    
Sbjct: 100 TFQDDEKLYFGLSYAKNGCLLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLHGK---G 152
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           IIHRD+K  N+LL+ D    + DFG AK++ PE          GT  Y++PE       S
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAS 212
Query: 224 ESCDVYSFGILLLEILTGRKPI 245
           +S D+++ G ++ +++ G  P 
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPF 234

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 43  FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +++ + +GEG +G V     + + +++A+KK+     +   +  + E+++L R RH+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G+         R    + M ++ ++  L       ++ D  + +K    S + I Y  ++
Sbjct: 89  GINDII-----RAPTIEQMKDVYIVQDL-------METDLYKLLKTQHLSNDHICYFLYQ 136
Query: 161 V--------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           +        + +++HRD+K SN+LL++  +  + DFG A++      H         T  
Sbjct: 137 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 196
Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE  +  K  ++S D++S G +L E+L+ R PI   PG
Sbjct: 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI--FPG 234

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 43  FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +++ + +GEG +G V     + + +++A+KK+     +   +  + E+++L R RH+N++
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G+         R    + M ++ ++  L       ++ D  + +K    S + I Y  ++
Sbjct: 90  GINDII-----RAPTIEQMKDVYIVQDL-------METDLYKLLKTQHLSNDHICYFLYQ 137
Query: 161 V--------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           +        + +++HRD+K SN+LL++  +  + DFG A++      H         T  
Sbjct: 138 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRW 197
Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE  +  K  ++S D++S G +L E+L+ R PI   PG
Sbjct: 198 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI--FPG 235

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 131/302 (43%), Gaps = 38/302 (12%)
Query: 30  IFTYKELHTATNGFSDDNKLGEGGFGSVYWG------RTSDGLQIAVKKL-KAMNSKAEM 82
           ++   E   A    +   +LG+G FG VY G      +     ++A+K + +A + +  +
Sbjct: 8   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 67
Query: 83  EFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLD--- 139
           EF  E  V+      +++ L G  +     L++ + M    L S+L      E++ +   
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPEMENNPVL 126
Query: 140 ----WKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP 195
                 + +++A   A+G+ YL+       +HRD+ A N ++  DF   + DFG  + I 
Sbjct: 127 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 183
Query: 196 EGVSHMTTRVKGTLG--YLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGV 252
           E   +     KG L   +++PE    G  +   DV+SFG++L EI T   +P + L    
Sbjct: 184 E-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--- 239
Query: 253 KRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
                E     +++G            D  +N       +  +C Q  P+ RP+  E+++
Sbjct: 240 ----NEQVLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 286
Query: 313 TL 314
           ++
Sbjct: 287 SI 288

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 131/302 (43%), Gaps = 38/302 (12%)
Query: 30  IFTYKELHTATNGFSDDNKLGEGGFGSVYWG------RTSDGLQIAVKKL-KAMNSKAEM 82
           ++   E   A    +   +LG+G FG VY G      +     ++A+K + +A + +  +
Sbjct: 7   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 66
Query: 83  EFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLD--- 139
           EF  E  V+      +++ L G  +     L++ + M    L S+L      E++ +   
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPEMENNPVL 125
Query: 140 ----WKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP 195
                 + +++A   A+G+ YL+       +HRD+ A N ++  DF   + DFG  + I 
Sbjct: 126 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 182
Query: 196 EGVSHMTTRVKGTLG--YLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGV 252
           E   +     KG L   +++PE    G  +   DV+SFG++L EI T   +P + L    
Sbjct: 183 E-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--- 238
Query: 253 KRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
                E     +++G            D  +N       +  +C Q  P+ RP+  E+++
Sbjct: 239 ----NEQVLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 285
Query: 313 TL 314
           ++
Sbjct: 286 SI 287

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 85/289 (29%), Positives = 128/289 (44%), Gaps = 46/289 (15%)
Query: 41  NGFSDD----NKLGEGGFGSVYWGRTS-DGLQIAVKKLK------AMNSKAEMEFAVEVE 89
            G SD      KLG G +G V   +    G + A+K +K        NS A ++   EV 
Sbjct: 17  QGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLD---EVA 73
Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSH--LHGQYAGEVQLDWKRRMKIA 147
           VL ++ H N++ L  +        +V +      L     L  +++   ++D    MK  
Sbjct: 74  VLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFS---EVDAAVIMKQV 130
Query: 148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLDS---DFEPLVADFGFAKLIPEGVSHMTTR 204
           +    G  YLH     +I+HRD+K  N+LL+S   D    + DFG +     G   M  R
Sbjct: 131 LS---GTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG-GKMKER 183
Query: 205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI 264
           + GT  Y+APE  +  K  E CDV+S G++L  +L G  P     G   + I +  E   
Sbjct: 184 L-GTAYYIAPE-VLRKKYDEKCDVWSCGVILYILLCGYPP---FGGQTDQEILKRVE--- 235
Query: 265 VKGKFKELVDPKLRGDFDENQLK-QAINVAVLCVQSEPEKRPNMKEVVN 312
            KGKF    DP      D  Q+  +A  +  L +  EP KR + +E +N
Sbjct: 236 -KGKFS--FDPP-----DWTQVSDEAKQLVKLMLTYEPSKRISAEEALN 276

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 43  FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +++ + +GEG +G V     + + +++A+KK+     +   +  + E+++L   RH+N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G+         R    + M ++ ++  L       ++ D  + +K    S + I Y  ++
Sbjct: 87  GINDII-----RAPTIEQMKDVYIVQDL-------METDLYKLLKTQHLSNDHICYFLYQ 134
Query: 161 V--------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           +        + +++HRD+K SN+LL++  +  + DFG A++      H    T    T  
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE  +  K  ++S D++S G +L E+L+ R PI   PG
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI--FPG 232

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 89  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG  +   +    MT  V  T  Y APE  + W 
Sbjct: 143 SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDD---EMTGYV-ATRWYRAPEIMLNWM 198
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 82/278 (29%), Positives = 125/278 (44%), Gaps = 42/278 (15%)
Query: 48  KLGEGGFGSVYWGRTS-DGLQIAVKKLK------AMNSKAEMEFAVEVEVLGRVRHKNLL 100
           KLG G +G V   +    G + A+K +K        NS A ++   EV VL ++ H N++
Sbjct: 11  KLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLD---EVAVLKQLDHPNIM 67
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSH--LHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
            L  +        +V +      L     L  +++   ++D    MK  +    G  YLH
Sbjct: 68  KLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFS---EVDAAVIMKQVLS---GTTYLH 121
Query: 159 HEVTPHIIHRDIKASNVLLDS---DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPE 215
                +I+HRD+K  N+LL+S   D    + DFG +     G   M  R+ GT  Y+APE
Sbjct: 122 KH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG-GKMKERL-GTAYYIAPE 176
Query: 216 YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP 275
             +  K  E CDV+S G++L  +L G  P     G   + I +  E    KGKF    DP
Sbjct: 177 -VLRKKYDEKCDVWSCGVILYILLCGYPP---FGGQTDQEILKRVE----KGKFS--FDP 226
Query: 276 KLRGDFDENQLK-QAINVAVLCVQSEPEKRPNMKEVVN 312
                 D  Q+  +A  +  L +  EP KR + +E +N
Sbjct: 227 P-----DWTQVSDEAKQLVKLMLTYEPSKRISAEEALN 259

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 131/302 (43%), Gaps = 38/302 (12%)
Query: 30  IFTYKELHTATNGFSDDNKLGEGGFGSVYWG------RTSDGLQIAVKKL-KAMNSKAEM 82
           ++   E   A    +   +LG+G FG VY G      +     ++A+K + +A + +  +
Sbjct: 36  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 95
Query: 83  EFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLD--- 139
           EF  E  V+      +++ L G  +     L++ + M    L S+L      E++ +   
Sbjct: 96  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPEMENNPVL 154
Query: 140 ----WKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP 195
                 + +++A   A+G+ YL+       +HRD+ A N ++  DF   + DFG  + I 
Sbjct: 155 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 211
Query: 196 EGVSHMTTRVKGTLG--YLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGV 252
           E   +     KG L   +++PE    G  +   DV+SFG++L EI T   +P + L    
Sbjct: 212 E-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--- 267
Query: 253 KRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
                E     +++G            D  +N       +  +C Q  P+ RP+  E+++
Sbjct: 268 ----NEQVLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 314
Query: 313 TL 314
           ++
Sbjct: 315 SI 316

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 131/302 (43%), Gaps = 38/302 (12%)
Query: 30  IFTYKELHTATNGFSDDNKLGEGGFGSVYWG------RTSDGLQIAVKKL-KAMNSKAEM 82
           ++   E   A    +   +LG+G FG VY G      +     ++A+K + +A + +  +
Sbjct: 7   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 66
Query: 83  EFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLD--- 139
           EF  E  V+      +++ L G  +     L++ + M    L S+L      E++ +   
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPEMENNPVL 125
Query: 140 ----WKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP 195
                 + +++A   A+G+ YL+       +HRD+ A N ++  DF   + DFG  + I 
Sbjct: 126 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 182
Query: 196 EGVSHMTTRVKGTLG--YLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGV 252
           E   +     KG L   +++PE    G  +   DV+SFG++L EI T   +P + L    
Sbjct: 183 E-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--- 238
Query: 253 KRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
                E     +++G            D  +N       +  +C Q  P+ RP+  E+++
Sbjct: 239 ----NEQVLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 285
Query: 313 TL 314
           ++
Sbjct: 286 SI 287

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 130/302 (43%), Gaps = 38/302 (12%)
Query: 30  IFTYKELHTATNGFSDDNKLGEGGFGSVYWG------RTSDGLQIAVKKL-KAMNSKAEM 82
           ++   E   A    +   +LG+G FG VY G      +     ++A+K + +A + +  +
Sbjct: 8   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 67
Query: 83  EFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLD--- 139
           EF  E  V+      +++ L G  +     L++ + M    L S+L      E++ +   
Sbjct: 68  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPEMENNPVL 126
Query: 140 ----WKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP 195
                 + +++A   A+G+ YL+       +HRD+ A N ++  DF   + DFG  + I 
Sbjct: 127 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIX 183
Query: 196 EGVSHMTTRVKGTLG--YLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGV 252
           E         KG L   +++PE    G  +   DV+SFG++L EI T   +P + L    
Sbjct: 184 E-TDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--- 239
Query: 253 KRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
                E     +++G            D  +N       +  +C Q  P+ RP+  E+++
Sbjct: 240 ----NEQVLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 286
Query: 313 TL 314
           ++
Sbjct: 287 SI 288

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 35/213 (16%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV--RHKNLLGLRGYC 106
           +G+G FG V+ G+   G ++AVK     +S+ E  +  E E+   V  RH+N+LG   + 
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILG---FI 64
Query: 107 AGTD-------QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           A  +       Q  +V DY  + SL  +L+ +Y   V+      +K+A+ +A G+ +LH 
Sbjct: 65  AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVE----GMIKLALSTASGLAHLHM 119
Query: 160 EVT-----PHIIHRDIKASNVLLDSDFEPLVADFGFA---KLIPEGVSHMTTRVKGTLGY 211
           E+      P I HRD+K+ N+L+  +    +AD G A       + +        GT  Y
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 179
Query: 212 LAPEY---AMWGKVSES---CDVYSFGILLLEI 238
           +APE    ++  K  ES    D+Y+ G++  EI
Sbjct: 180 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 35/213 (16%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV--RHKNLLGLRGYC 106
           +G+G FG V+ G+   G ++AVK     +S+ E  +  E E+   V  RH+N+LG   + 
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILG---FI 66
Query: 107 AGTD-------QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           A  +       Q  +V DY  + SL  +L+ +Y   V+      +K+A+ +A G+ +LH 
Sbjct: 67  AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVE----GMIKLALSTASGLAHLHM 121
Query: 160 EVT-----PHIIHRDIKASNVLLDSDFEPLVADFGFA---KLIPEGVSHMTTRVKGTLGY 211
           E+      P I HRD+K+ N+L+  +    +AD G A       + +        GT  Y
Sbjct: 122 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 181
Query: 212 LAPEY---AMWGKVSES---CDVYSFGILLLEI 238
           +APE    ++  K  ES    D+Y+ G++  EI
Sbjct: 182 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 110/221 (49%), Gaps = 28/221 (12%)
Query: 43  FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +++ + +GEG +G V     + + +++A+KK+     +   +  + E+++L   RH+N++
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           G+         R    + M ++ ++  L       ++ D  + +K    S + I Y  ++
Sbjct: 87  GINDII-----RAPTIEQMKDVYIVQDL-------METDLYKLLKTQHLSNDHICYFLYQ 134
Query: 161 V--------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           +        + +++HRD+K SN+LL++  +  + DFG A++      H    T    T  
Sbjct: 135 ILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRW 194
Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE  +  K  ++S D++S G +L E+L+ R PI   PG
Sbjct: 195 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR-PI--FPG 232

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 131/302 (43%), Gaps = 38/302 (12%)
Query: 30  IFTYKELHTATNGFSDDNKLGEGGFGSVYWG------RTSDGLQIAVKKL-KAMNSKAEM 82
           ++   E   A    +   +LG+G FG VY G      +     ++A+K + +A + +  +
Sbjct: 14  VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 73
Query: 83  EFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLD--- 139
           EF  E  V+      +++ L G  +     L++ + M    L S+L      E++ +   
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPEMENNPVL 132
Query: 140 ----WKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP 195
                 + +++A   A+G+ YL+       +HRD+ A N ++  DF   + DFG  + I 
Sbjct: 133 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIY 189
Query: 196 EGVSHMTTRVKGTLG--YLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGV 252
           E   +     KG L   +++PE    G  +   DV+SFG++L EI T   +P + L    
Sbjct: 190 E-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--- 245
Query: 253 KRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
                E     +++G            D  +N       +  +C Q  P+ RP+  E+++
Sbjct: 246 ----NEQVLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 292
Query: 313 TL 314
           ++
Sbjct: 293 SI 294

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 109/238 (45%), Gaps = 41/238 (17%)
Query: 36  LHTATNGFSDDNKLGEGGFGSVYWG-RTSDGLQIAVKKLKAMNSKAEMEFAV----EVEV 90
           ++  ++ F   + LGEG +G V        G  +A+KK++  +      FA+    E+++
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL---FALRTLREIKI 62
Query: 91  LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
           L   +H+N++ +        QR   ++    + ++  L       +Q D  R +   + S
Sbjct: 63  LKHFKHENIITIFNI-----QRPDSFENFNEVYIIQEL-------MQTDLHRVISTQMLS 110
Query: 151 AEGILYLHHEVT--------PHIIHRDIKASNVLLDSDFEPLVADFGFAKLI-------- 194
            + I Y  ++           ++IHRD+K SN+L++S+ +  V DFG A++I        
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 195 -PEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPG 250
            P G     T    T  Y APE  +   K S + DV+S G +L E+   R+PI   PG
Sbjct: 171 EPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI--FPG 225

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 35/213 (16%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV--RHKNLLGLRGYC 106
           +G+G FG V+ G+   G ++AVK     +S+ E  +  E E+   V  RH+N+LG   + 
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILG---FI 89
Query: 107 AGTD-------QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           A  +       Q  +V DY  + SL  +L+ +Y   V+      +K+A+ +A G+ +LH 
Sbjct: 90  AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVE----GMIKLALSTASGLAHLHM 144
Query: 160 EVT-----PHIIHRDIKASNVLLDSDFEPLVADFGFA---KLIPEGVSHMTTRVKGTLGY 211
           E+      P I HRD+K+ N+L+  +    +AD G A       + +        GT  Y
Sbjct: 145 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 204
Query: 212 LAPEY---AMWGKVSES---CDVYSFGILLLEI 238
           +APE    ++  K  ES    D+Y+ G++  EI
Sbjct: 205 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 35/213 (16%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV--RHKNLLGLRGYC 106
           +G+G FG V+ G+   G ++AVK     +S+ E  +  E E+   V  RH+N+LG   + 
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILG---FI 69
Query: 107 AGTD-------QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           A  +       Q  +V DY  + SL  +L+ +Y   V+      +K+A+ +A G+ +LH 
Sbjct: 70  AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVE----GMIKLALSTASGLAHLHM 124
Query: 160 EVT-----PHIIHRDIKASNVLLDSDFEPLVADFGFA---KLIPEGVSHMTTRVKGTLGY 211
           E+      P I HRD+K+ N+L+  +    +AD G A       + +        GT  Y
Sbjct: 125 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 184
Query: 212 LAPEY---AMWGKVSES---CDVYSFGILLLEI 238
           +APE    ++  K  ES    D+Y+ G++  EI
Sbjct: 185 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 99/212 (46%), Gaps = 23/212 (10%)
Query: 46  DNKLGEGGFGSVYWGRTSDG----LQIAVKKLKAMNSKAEMEFAVEVEVLGR-VRHKNLL 100
           D  +G+G FG VY G   D     +Q A+K L  +    ++E  +   +L R + H N+L
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHG---QYAGEVQLDWKRRMKIAIG--SAEGIL 155
            L G        ++  + +P++ L    HG   Q+    Q +   +  I+ G   A G+ 
Sbjct: 86  ALIGI-------MLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGME 138
Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR---VKGTLGYL 212
           YL  +     +HRD+ A N +LD  F   VADFG A+ I +   +   +    +  + + 
Sbjct: 139 YLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195
Query: 213 APEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           A E     + +   DV+SFG+LL E+LT   P
Sbjct: 196 ALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 35/213 (16%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV--RHKNLLGLRGYC 106
           +G+G FG V+ G+   G ++AVK     +S+ E  +  E E+   V  RH+N+LG   + 
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILG---FI 102
Query: 107 AGTD-------QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           A  +       Q  +V DY  + SL  +L+ +Y   V+      +K+A+ +A G+ +LH 
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVE----GMIKLALSTASGLAHLHM 157
Query: 160 EVT-----PHIIHRDIKASNVLLDSDFEPLVADFGFA---KLIPEGVSHMTTRVKGTLGY 211
           E+      P I HRD+K+ N+L+  +    +AD G A       + +        GT  Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217
Query: 212 LAPEY---AMWGKVSES---CDVYSFGILLLEI 238
           +APE    ++  K  ES    D+Y+ G++  EI
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 105/213 (49%), Gaps = 35/213 (16%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV--RHKNLLGLRGYC 106
           +G+G FG V+ G+   G ++AVK     +S+ E  +  E E+   V  RH+N+LG   + 
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVK---IFSSREERSWFREAEIYQTVMLRHENILG---FI 63
Query: 107 AGTD-------QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           A  +       Q  +V DY  + SL  +L+ +Y   V+      +K+A+ +A G+ +LH 
Sbjct: 64  AADNKDNGTWTQLWLVSDYHEHGSLFDYLN-RYTVTVE----GMIKLALSTASGLAHLHM 118
Query: 160 EVT-----PHIIHRDIKASNVLLDSDFEPLVADFGFA---KLIPEGVSHMTTRVKGTLGY 211
           E+      P I HRD+K+ N+L+  +    +AD G A       + +        GT  Y
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 178
Query: 212 LAPEY---AMWGKVSES---CDVYSFGILLLEI 238
           +APE    ++  K  ES    D+Y+ G++  EI
Sbjct: 179 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 18/205 (8%)
Query: 48  KLGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           KLG G +G V   R   T     I + +  ++++ +  +   EV VL  + H N++ L  
Sbjct: 44  KLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYD 103
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL-HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           +        +V +      L   + H     EV  D    +K  +    G+ YLH     
Sbjct: 104 FFEDKRNYYLVMECYKGGELFDEIIHRMKFNEV--DAAVIIKQVLS---GVTYLHKH--- 155
Query: 164 HIIHRDIKASNVLLDS---DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
           +I+HRD+K  N+LL+S   D    + DFG + +  E    M  R+ GT  Y+APE  +  
Sbjct: 156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF-ENQKKMKERL-GTAYYIAPE-VLRK 212
Query: 221 KVSESCDVYSFGILLLEILTGRKPI 245
           K  E CDV+S G++L  +L G  P 
Sbjct: 213 KYDEKCDVWSIGVILFILLAGYPPF 237

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 70/298 (23%), Positives = 126/298 (42%), Gaps = 46/298 (15%)
Query: 34  KELHTATNGFSDDNK-------LGEGGFGSVYWG-RTSDGLQIAVKKL--KAMNSKAEME 83
           +EL T   G S+D +       +G G F +VY G  T   +++A  +L  + +       
Sbjct: 12  EELETKAVGXSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR 71
Query: 84  FAVEVEVLGRVRHKNLLGL----RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQL- 138
           F  E E L  ++H N++           G    ++V +   + +L ++L      ++++ 
Sbjct: 72  FKEEAEXLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVL 131
Query: 139 -DWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPE 196
             W R++       +G+ +LH   TP IIHRD+K  N+ +      + + D G A L   
Sbjct: 132 RSWCRQI------LKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL--- 181
Query: 197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVK--R 254
             +     V GT  + APE     K  ES DVY+FG   LE  T   P  +     +  R
Sbjct: 182 KRASFAKAVIGTPEFXAPE-XYEEKYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYR 240
Query: 255 TITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
            +T   +P                  FD+  + +   +   C++   ++R ++K+++N
Sbjct: 241 RVTSGVKP----------------ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 282

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 109/238 (45%), Gaps = 41/238 (17%)
Query: 36  LHTATNGFSDDNKLGEGGFGSVYWG-RTSDGLQIAVKKLKAMNSKAEMEFAV----EVEV 90
           ++  ++ F   + LGEG +G V        G  +A+KK++  +      FA+    E+++
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL---FALRTLREIKI 62
Query: 91  LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
           L   +H+N++ +        QR   ++    + ++  L       +Q D  R +   + S
Sbjct: 63  LKHFKHENIITIFNI-----QRPDSFENFNEVYIIQEL-------MQTDLHRVISTQMLS 110
Query: 151 AEGILYLHHEVT--------PHIIHRDIKASNVLLDSDFEPLVADFGFAKLI-------- 194
            + I Y  ++           ++IHRD+K SN+L++S+ +  V DFG A++I        
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 195 -PEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPG 250
            P G     T    T  Y APE  +   K S + DV+S G +L E+   R+PI   PG
Sbjct: 171 EPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI--FPG 225

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 69/302 (22%), Positives = 131/302 (43%), Gaps = 38/302 (12%)
Query: 30  IFTYKELHTATNGFSDDNKLGEGGFGSVYWG------RTSDGLQIAVKKL-KAMNSKAEM 82
           ++   E   A    +   +LG+G FG VY G      +     ++A+K + +A + +  +
Sbjct: 1   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 60
Query: 83  EFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLD--- 139
           EF  E  V+      +++ L G  +     L++ + M    L S+L      E++ +   
Sbjct: 61  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPEMENNPVL 119
Query: 140 ----WKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP 195
                 + +++A   A+G+ YL+       +HRD+ A N  +  DF   + DFG  + I 
Sbjct: 120 APPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIY 176
Query: 196 EGVSHMTTRVKGTLG--YLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGV 252
           E   +     KG L   +++PE    G  +   DV+SFG++L EI T   +P + L    
Sbjct: 177 E-TDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS--- 232
Query: 253 KRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
                E     +++G            D  +N     + +  +C Q  P+ RP+  E+++
Sbjct: 233 ----NEQVLRFVMEGGLL---------DKPDNCPDMLLELMRMCWQYNPKMRPSFLEIIS 279
Query: 313 TL 314
           ++
Sbjct: 280 SI 281

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 35/213 (16%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV--RHKNLLGLRGYC 106
           +G+G +G V W  +  G  +AVK     +S+ E  +  E E+   V  RH+N+LG     
Sbjct: 16  VGKGRYGEV-WRGSWQGENVAVK---IFSSRDEKSWFRETELYNTVMLRHENILGF---- 67
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHG-----QYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
             +D  +        L L++H H       Y     LD    ++I +  A G+ +LH E+
Sbjct: 68  IASD--MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 162 -----TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT----RVKGTLGYL 212
                 P I HRD+K+ N+L+  + +  +AD G A +  +  + +      RV GT  Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYM 184
Query: 213 APEYAMWGKVSESC-------DVYSFGILLLEI 238
           APE  +   +   C       D+++FG++L E+
Sbjct: 185 APE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 35/213 (16%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV--RHKNLLGLRGYC 106
           +G+G +G V W  +  G  +AVK     +S+ E  +  E E+   V  RH+N+LG     
Sbjct: 16  VGKGRYGEV-WRGSWQGENVAVK---IFSSRDEKSWFRETELYNTVMLRHENILGF---- 67
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHG-----QYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
             +D  +        L L++H H       Y     LD    ++I +  A G+ +LH E+
Sbjct: 68  IASD--MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 162 -----TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT----RVKGTLGYL 212
                 P I HRD+K+ N+L+  + +  +AD G A +  +  + +      RV GT  Y+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYM 184
Query: 213 APEYAMWGKVSESC-------DVYSFGILLLEI 238
           APE  +   +   C       D+++FG++L E+
Sbjct: 185 APE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 216

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  G ++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 89  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 198
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  G ++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 98
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 99  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 152
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 153 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 208
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 209 HYNQTVDIWSVGCIMAELLTGR 230

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 21/203 (10%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG- 104
           +G G +GSV        GL+IAVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV 118
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHE 160
           +   T       +   ++ L++HL G     +    +L       +      G+ Y+H  
Sbjct: 119 FTPATS-----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH-- 171
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-W 219
            +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W
Sbjct: 172 -SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNW 226
Query: 220 GKVSESCDVYSFGILLLEILTGR 242
              + + D++S G ++ E+LTGR
Sbjct: 227 MHYNMTVDIWSVGCIMAELLTGR 249

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 129/297 (43%), Gaps = 38/297 (12%)
Query: 35  ELHTATNGFSDDNKLGEGGFGSVYWG------RTSDGLQIAVKKL-KAMNSKAEMEFAVE 87
           E   A    +   +LG+G FG VY G      +     ++A+K + +A + +  +EF  E
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 63
Query: 88  VEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLD-------W 140
             V+      +++ L G  +     L++ + M    L S+L      E++ +        
Sbjct: 64  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPEMENNPVLAPPSL 122
Query: 141 KRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH 200
            + +++A   A+G+ YL+       +HRD+ A N ++  DF   + DFG  + I E    
Sbjct: 123 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXE-TDX 178
Query: 201 MTTRVKGTLG--YLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTIT 257
                KG L   +++PE    G  +   DV+SFG++L EI T   +P + L         
Sbjct: 179 XRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------N 231
Query: 258 EWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           E     +++G            D  +N     + +  +C Q  P+ RP+  E+++++
Sbjct: 232 EQVLRFVMEGGLL---------DKPDNCPDMLLELMRMCWQYNPKMRPSFLEIISSI 279

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 37/210 (17%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKNLLGLRGY 105
           K+GEG +G VY  + + G   A+KK++       +      E+ +L  ++H N++ L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE------------- 152
                + ++V++++                   D K+ + +  G  E             
Sbjct: 69  IHTKKRLVLVFEHLDQ-----------------DLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYL 212
           GI Y H      ++HRD+K  N+L++ + E  +ADFG A+     V   T  V  TL Y 
Sbjct: 112 GIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYR 167
Query: 213 APEYAMWG-KVSESCDVYSFGILLLEILTG 241
           AP+  M   K S + D++S G +  E++ G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 89/211 (42%), Gaps = 16/211 (7%)
Query: 41  NGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFA---VEVEVLGRVRH 96
           N F     LG+G FG V   R  + G   A+K L+     A+ E A    E  VL   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
             L  L+      D+   V +Y     L  HL    + E     +R           + Y
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEY 120
Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT--RVKGTLGYLAP 214
           LH   +  +++RDIK  N++LD D    + DFG  K   EG+S   T     GT  YLAP
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAP 174
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E         + D +  G+++ E++ GR P 
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 12/202 (5%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           LGEG F +V   R   TS    I + + + +  + ++ +   E +V+ R+ H   + L  
Sbjct: 18  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 77
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                ++      Y  N  LL ++     G       R     I SA  + YLH +    
Sbjct: 78  TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSA--LEYLHGK---G 130
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           IIHRD+K  N+LL+ D    + DFG AK++ PE          GT  Y++PE        
Sbjct: 131 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 190
Query: 224 ESCDVYSFGILLLEILTGRKPI 245
           +S D+++ G ++ +++ G  P 
Sbjct: 191 KSSDLWALGCIIYQLVAGLPPF 212

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 89/211 (42%), Gaps = 16/211 (7%)
Query: 41  NGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFA---VEVEVLGRVRH 96
           N F     LG+G FG V   R  + G   A+K L+     A+ E A    E  VL   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
             L  L+      D+   V +Y     L  HL    + E     +R           + Y
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEY 120
Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT--RVKGTLGYLAP 214
           LH   +  +++RDIK  N++LD D    + DFG  K   EG+S   T     GT  YLAP
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAP 174
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E         + D +  G+++ E++ GR P 
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/297 (23%), Positives = 129/297 (43%), Gaps = 38/297 (12%)
Query: 35  ELHTATNGFSDDNKLGEGGFGSVYWG------RTSDGLQIAVKKL-KAMNSKAEMEFAVE 87
           E   A    +   +LG+G FG VY G      +     ++A+K + +A + +  +EF  E
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 88  VEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLD-------W 140
             V+      +++ L G  +     L++ + M    L S+L      E++ +        
Sbjct: 66  ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRS-LRPEMENNPVLAPPSL 124
Query: 141 KRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH 200
            + +++A   A+G+ YL+       +HRD+ A N ++  DF   + DFG  + I E   +
Sbjct: 125 SKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE-TDY 180
Query: 201 MTTRVKGTLG--YLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTIT 257
                KG L   +++PE    G  +   DV+SFG++L EI T   +P + L         
Sbjct: 181 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS-------N 233
Query: 258 EWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           E     +++G            D  +N       +  +C Q  P+ RP+  E+++++
Sbjct: 234 EQVLRFVMEGGLL---------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSI 281

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 89/211 (42%), Gaps = 16/211 (7%)
Query: 41  NGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFA---VEVEVLGRVRH 96
           N F     LG+G FG V   R  + G   A+K L+     A+ E A    E  VL   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
             L  L+      D+   V +Y     L  HL    + E     +R           + Y
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEY 120
Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT--RVKGTLGYLAP 214
           LH   +  +++RDIK  N++LD D    + DFG  K   EG+S   T     GT  YLAP
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAP 174
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E         + D +  G+++ E++ GR P 
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 93/210 (44%), Gaps = 37/210 (17%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKNLLGLRGY 105
           K+GEG +G VY  + + G   A+KK++       +      E+ +L  ++H N++ L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE------------- 152
                + ++V++++                   D K+ + +  G  E             
Sbjct: 69  IHTKKRLVLVFEHLDQ-----------------DLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYL 212
           GI Y H      ++HRD+K  N+L++ + E  +ADFG A+     V   T  V  TL Y 
Sbjct: 112 GIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-TLWYR 167
Query: 213 APEYAMWG-KVSESCDVYSFGILLLEILTG 241
           AP+  M   K S + D++S G +  E++ G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 12/202 (5%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           LGEG F +V   R   TS    I + + + +  + ++ +   E +V+ R+ H   + L  
Sbjct: 17  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 76
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                ++      Y  N  LL ++     G       R     I SA  + YLH +    
Sbjct: 77  TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSA--LEYLHGK---G 129
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           IIHRD+K  N+LL+ D    + DFG AK++ PE          GT  Y++PE        
Sbjct: 130 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 189
Query: 224 ESCDVYSFGILLLEILTGRKPI 245
           +S D+++ G ++ +++ G  P 
Sbjct: 190 KSSDLWALGCIIYQLVAGLPPF 211

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  G ++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 94
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 95  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 148
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 149 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 204
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 205 HYNQTVDIWSVGCIMAELLTGR 226

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 89/211 (42%), Gaps = 16/211 (7%)
Query: 41  NGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFA---VEVEVLGRVRH 96
           N F     LG+G FG V   R  + G   A+K L+     A+ E A    E  VL   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
             L  L+      D+   V +Y     L  HL    + E     +R           + Y
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEY 120
Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT--RVKGTLGYLAP 214
           LH   +  +++RDIK  N++LD D    + DFG  K   EG+S   T     GT  YLAP
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAP 174
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E         + D +  G+++ E++ GR P 
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  G ++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 107
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 108 -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 161
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 162 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 217
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 218 HYNQTVDIWSVGCIMAELLTGR 239

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 89/211 (42%), Gaps = 16/211 (7%)
Query: 41  NGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFA---VEVEVLGRVRH 96
           N F     LG+G FG V   R  + G   A+K L+     A+ E A    E  VL   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
             L  L+      D+   V +Y     L  HL    + E     +R           + Y
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEY 120
Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT--RVKGTLGYLAP 214
           LH   +  +++RDIK  N++LD D    + DFG  K   EG+S   T     GT  YLAP
Sbjct: 121 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAP 174
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E         + D +  G+++ E++ GR P 
Sbjct: 175 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  G ++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 84
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 85  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 138
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 194
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGR 216

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 100/213 (46%), Gaps = 35/213 (16%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV--RHKNLLGLRGYC 106
           +G+G +G V W  +  G  +AVK     +S+ E  +  E E+   V  RH+N+LG     
Sbjct: 45  VGKGRYGEV-WRGSWQGENVAVK---IFSSRDEKSWFRETELYNTVMLRHENILGF---- 96
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHG-----QYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
             +D  +        L L++H H       Y     LD    ++I +  A G+ +LH E+
Sbjct: 97  IASD--MTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEI 154
Query: 162 -----TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT----RVKGTLGYL 212
                 P I HRD+K+ N+L+  + +  +AD G A +  +  + +      RV GT  Y+
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRYM 213
Query: 213 APEYAMWGKVSESC-------DVYSFGILLLEI 238
           APE  +   +   C       D+++FG++L E+
Sbjct: 214 APE-VLDETIQVDCFDSYKRVDIWAFGLVLWEV 245

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 89/211 (42%), Gaps = 16/211 (7%)
Query: 41  NGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFA---VEVEVLGRVRH 96
           N F     LG+G FG V   R  + G   A+K L+     A+ E A    E  VL   RH
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
             L  L+      D+   V +Y     L  HL    + E     +R           + Y
Sbjct: 70  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEY 125
Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT--RVKGTLGYLAP 214
           LH   +  +++RDIK  N++LD D    + DFG  K   EG+S   T     GT  YLAP
Sbjct: 126 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAP 179
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E         + D +  G+++ E++ GR P 
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 12/202 (5%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           LGEG F +V   R   TS    I + + + +  + ++ +   E +V+ R+ H   + L  
Sbjct: 15  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 74
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                ++      Y  N  LL ++     G       R     I SA  + YLH +    
Sbjct: 75  TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSA--LEYLHGK---G 127
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           IIHRD+K  N+LL+ D    + DFG AK++ PE          GT  Y++PE        
Sbjct: 128 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 187
Query: 224 ESCDVYSFGILLLEILTGRKPI 245
           +S D+++ G ++ +++ G  P 
Sbjct: 188 KSSDLWALGCIIYQLVAGLPPF 209

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  G ++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 108
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 109 -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 162
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  + W 
Sbjct: 163 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 218
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 219 HYNQTVDIWSVGCIMAELLTGR 240

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 89/211 (42%), Gaps = 16/211 (7%)
Query: 41  NGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFA---VEVEVLGRVRH 96
           N F     LG+G FG V   R  + G   A+K L+     A+ E A    E  VL   RH
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
             L  L+      D+   V +Y     L  HL    + E     +R           + Y
Sbjct: 68  PFLTALKYAFQTHDRLCFVMEYANGGELFFHL----SRERVFTEERARFYGAEIVSALEY 123
Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT--RVKGTLGYLAP 214
           LH   +  +++RDIK  N++LD D    + DFG  K   EG+S   T     GT  YLAP
Sbjct: 124 LH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAP 177
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E         + D +  G+++ E++ GR P 
Sbjct: 178 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 208

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 12/202 (5%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           LGEG F +V   R   TS    I + + + +  + ++ +   E +V+ R+ H   + L  
Sbjct: 16  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 75
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                ++      Y  N  LL ++     G       R     I SA  + YLH +    
Sbjct: 76  TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSA--LEYLHGK---G 128
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           IIHRD+K  N+LL+ D    + DFG AK++ PE          GT  Y++PE        
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 188
Query: 224 ESCDVYSFGILLLEILTGRKPI 245
           +S D+++ G ++ +++ G  P 
Sbjct: 189 KSSDLWALGCIIYQLVAGLPPF 210

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 27/206 (13%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  G ++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 84
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV---- 161
              T  R +  +   ++ L++HL G        D    +K A  + + + +L +++    
Sbjct: 85  -VFTPARSL--EEFNDVYLVTHLMGA-------DLNNIVKCAKLTDDHVQFLIYQILRGL 134
Query: 162 ----TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
               +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIM 190
Query: 218 M-WGKVSESCDVYSFGILLLEILTGR 242
           + W   +++ D++S G ++ E+LTGR
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  G ++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 89  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   + ++        T  Y APE  + W 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV----ATRWYRAPEIMLNWM 198
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  G ++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 89  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   + ++        T  Y APE  + W 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV----ATRWYRAPEIMLNWM 198
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 92/210 (43%), Gaps = 13/210 (6%)
Query: 41  NGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFA---VEVEVLGRVRH 96
           N F     LG+G FG V   +  + G   A+K LK     A+ E A    E  VL   RH
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
             L  L+      D+   V +Y     L  HL  +       D  R     I SA  + Y
Sbjct: 211 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSA--LDY 266
Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL-IPEGVSHMTTRVKGTLGYLAPE 215
           LH E   ++++RD+K  N++LD D    + DFG  K  I +G +  T    GT  YLAPE
Sbjct: 267 LHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPE 322
Query: 216 YAMWGKVSESCDVYSFGILLLEILTGRKPI 245
                    + D +  G+++ E++ GR P 
Sbjct: 323 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           LGEG F +V   R   TS    I + + + +  + ++ +   E +V+ R+ H   + L  
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 100
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                ++      Y  N  LL ++  +  G       R     I SA  + YLH +    
Sbjct: 101 TFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLHGK---G 153
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           IIHRD+K  N+LL+ D    + DFG AK++ PE          GT  Y++PE        
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 213
Query: 224 ESCDVYSFGILLLEILTGRKPI 245
           +S D+++ G ++ +++ G  P 
Sbjct: 214 KSSDLWALGCIIYQLVAGLPPF 235

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           LGEG F +V   R   TS    I + + + +  + ++ +   E +V+ R+ H   + L  
Sbjct: 41  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 100
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                ++      Y  N  LL ++  +  G       R     I SA  + YLH +    
Sbjct: 101 TFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLHGK---G 153
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           IIHRD+K  N+LL+ D    + DFG AK++ PE          GT  Y++PE        
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 213
Query: 224 ESCDVYSFGILLLEILTGRKPI 245
           +S D+++ G ++ +++ G  P 
Sbjct: 214 KSSDLWALGCIIYQLVAGLPPF 235

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 92/210 (43%), Gaps = 13/210 (6%)
Query: 41  NGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFA---VEVEVLGRVRH 96
           N F     LG+G FG V   +  + G   A+K LK     A+ E A    E  VL   RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
             L  L+      D+   V +Y     L  HL  +       D  R     I SA  + Y
Sbjct: 208 PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSA--LDY 263
Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL-IPEGVSHMTTRVKGTLGYLAPE 215
           LH E   ++++RD+K  N++LD D    + DFG  K  I +G +  T    GT  YLAPE
Sbjct: 264 LHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPE 319
Query: 216 YAMWGKVSESCDVYSFGILLLEILTGRKPI 245
                    + D +  G+++ E++ GR P 
Sbjct: 320 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           LGEG F +V   R   TS    I + + + +  + ++ +   E +V+ R+ H   + L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                ++      Y  N  LL ++  +  G       R     I SA  + YLH +    
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLHGK---G 152
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           IIHRD+K  N+LL+ D    + DFG AK++ PE          GT  Y++PE        
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 224 ESCDVYSFGILLLEILTGRKPI 245
           +S D+++ G ++ +++ G  P 
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPF 234

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           +G+G F  V   R    G ++AVK +    +NS +  +   EV ++  + H N++ L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 106 CAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                   +V +Y     +  +L  HG+   E +   K R  ++      + Y H +   
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR-MKEKEARAKFRQIVS-----AVQYCHQKF-- 133
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
            I+HRD+KA N+LLD+D    +ADFGF+     G  +      G+  Y APE     K  
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG--NKLDTFCGSPPYAAPELFQGKKYD 190
Query: 224 -ESCDVYSFGILLLEILTGRKPIE 246
               DV+S G++L  +++G  P +
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 89  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  +  FG A+   +    MT  V  T  Y APE  + W 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 198
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 37/210 (17%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKNLLGLRGY 105
           K+GEG +G VY  + + G   A+KK++       +      E+ +L  ++H N++ L   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE------------- 152
                + ++V++++                   D K+ + +  G  E             
Sbjct: 69  IHTKKRLVLVFEHLDQ-----------------DLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYL 212
           GI Y H      ++HRD+K  N+L++ + E  +ADFG A+     V   T  +  TL Y 
Sbjct: 112 GIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYR 167
Query: 213 APEYAMWG-KVSESCDVYSFGILLLEILTG 241
           AP+  M   K S + D++S G +  E++ G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 36/232 (15%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHK 97
            ++D   +G G FG VY  +  D G  +A+KK+   KA  ++       E++++ ++ H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-------ELQIMRKLDHC 73
Query: 98  NLLGLRGYCAGTDQRL------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
           N++ LR +   + ++       +V DY+P        H  Y+   Q      +K+ +   
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQL 131
Query: 152 -EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEG---VSHMTTRVK 206
              + Y+H   +  I HRDIK  N+LLD D   L + DFG AK +  G   VS++ +R  
Sbjct: 132 FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 187
Query: 207 GTLGYLAPEYAMWGKV--SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
               Y APE  ++G    + S DV+S G +L E+L G +PI     GV + +
Sbjct: 188 ----YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 233

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 20/240 (8%)
Query: 48  KLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGL-RGY 105
           K+GEG  G V      S G  +AVKK+     +       EV ++   +H+N++ +   Y
Sbjct: 158 KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 217
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
             G D+  +V +++   +L   +      E Q+       + +   + +  LH +    +
Sbjct: 218 LVG-DELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQ---GV 268
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSES 225
           IHRDIK+ ++LL  D    ++DFGF   + + V      V GT  ++APE          
Sbjct: 269 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPE 327
Query: 226 CDVYSFGILLLEILTGRKP-IEKLPGGVKRTITEWAEPLIVKGKFKEL--VDPKLRGDFD 282
            D++S GI+++E++ G  P   + P    + I +   P     + K L  V P L+G  D
Sbjct: 328 VDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-----RLKNLHKVSPSLKGFLD 382

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/204 (27%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLKA--MNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           +G+G F  V   R    G ++AVK +    +NS +  +   EV ++  + H N++ L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 106 CAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                   +V +Y     +  +L  HG+   E +   K R  ++      + Y H +   
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR-MKEKEARAKFRQIVS-----AVQYCHQKF-- 133
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
            I+HRD+KA N+LLD+D    +ADFGF+     G    T    G+  Y APE     K  
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQGKKYD 190
Query: 224 -ESCDVYSFGILLLEILTGRKPIE 246
               DV+S G++L  +++G  P +
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           LGEG F +V   R   TS    I + + + +  + ++ +   E +V+ R+ H   + L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                ++      Y  N  LL ++  +  G       R     I SA  + YLH +    
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLHGK---G 150
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           IIHRD+K  N+LL+ D    + DFG AK++ PE          GT  Y++PE        
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 224 ESCDVYSFGILLLEILTGRKPI 245
           +S D+++ G ++ +++ G  P 
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPF 232

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 89  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + D G A+   +    MT  V  T  Y APE  + W 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 198
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 100/205 (48%), Gaps = 25/205 (12%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  G ++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 108
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 109 -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 162
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG---YLAPEYAM 218
           +  IIHRD+K SN+ ++ D E  + DFG A+       H    + G +    Y APE  +
Sbjct: 163 SADIIHRDLKPSNLAVNEDCELKILDFGLAR-------HTDDEMXGXVATRWYRAPEIML 215
Query: 219 -WGKVSESCDVYSFGILLLEILTGR 242
            W   +++ D++S G ++ E+LTGR
Sbjct: 216 NWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  G ++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 84
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 85  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 138
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   + ++        T  Y APE  + W 
Sbjct: 139 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFV----ATRWYRAPEIMLNWM 194
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 195 HYNQTVDIWSVGCIMAELLTGR 216

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           LGEG F +V   R   TS    I + + + +  + ++ +   E +V+ R+ H   + L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                ++      Y  N  LL ++  +  G       R     I SA  + YLH +    
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLHGK---G 152
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           IIHRD+K  N+LL+ D    + DFG AK++ PE          GT  Y++PE        
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 224 ESCDVYSFGILLLEILTGRKPI 245
           +S D+++ G ++ +++ G  P 
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPF 234

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 47  NKLGEGGFGSVYWGRTS-DGLQIAVK-----KLKAMNSKAEMEFAVEVEVLGRVRHKNLL 100
           + LG G FG V  G+    G ++AVK     K+++++   ++    E++ L   RH +++
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQNLKLFRHPHII 79
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L    +      +V +Y+    L  ++        +LD K   ++      G+ Y H  
Sbjct: 80  KLYQVISTPSDIFMVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYCHRH 135
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
           +   ++HRD+K  NVLLD+     +ADFG + ++ +G         G+  Y APE  + G
Sbjct: 136 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRXSCGSPNYAAPE-VISG 189
Query: 221 KV--SESCDVYSFGILLLEILTGRKPIE 246
           ++      D++S G++L  +L G  P +
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPFD 217

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           LGEG F +V   R   TS    I + + + +  + ++ +   E +V+ R+ H   + L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                ++      Y  N  LL ++  +  G       R     I SA  + YLH +    
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLHGK---G 150
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           IIHRD+K  N+LL+ D    + DFG AK++ PE          GT  Y++PE        
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 224 ESCDVYSFGILLLEILTGRKPI 245
           +S D+++ G ++ +++ G  P 
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPF 232

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 106/239 (44%), Gaps = 18/239 (7%)
Query: 48  KLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
           K+GEG  G V      S G  +AVKK+     +       EV ++   +H+N++ +    
Sbjct: 38  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 97
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
              D+  +V +++   +L   +      E Q+       + +   + +  LH +    +I
Sbjct: 98  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQ---GVI 149
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRDIK+ ++LL  D    ++DFGF   + + V      V GT  ++APE           
Sbjct: 150 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEV 208
Query: 227 DVYSFGILLLEILTGRKP-IEKLPGGVKRTITEWAEPLIVKGKFKEL--VDPKLRGDFD 282
           D++S GI+++E++ G  P   + P    + I +   P     + K L  V P L+G  D
Sbjct: 209 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-----RLKNLHKVSPSLKGFLD 262

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 68/232 (29%), Positives = 113/232 (48%), Gaps = 36/232 (15%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHK 97
            ++D   +G G FG VY  +  D G  +A+KK+   KA  ++       E++++ ++ H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-------ELQIMRKLDHC 73
Query: 98  NLLGLRGYCAGTDQRL------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
           N++ LR +   + ++       +V DY+P        H  Y+   Q      +K+ +   
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQL 131
Query: 152 -EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEG---VSHMTTRVK 206
              + Y+H   +  I HRDIK  N+LLD D   L + DFG AK +  G   VS++ +R  
Sbjct: 132 FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 187
Query: 207 GTLGYLAPEYAMWGKV--SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
               Y APE  ++G    + S DV+S G +L E+L G +PI     GV + +
Sbjct: 188 ----YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 233

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           LGEG F +V   R   TS    I + + + +  + ++ +   E +V+ R+ H   + L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                ++      Y  N  LL ++  +  G       R     I SA  + YLH +    
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLHGK---G 152
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           IIHRD+K  N+LL+ D    + DFG AK++ PE          GT  Y++PE        
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 224 ESCDVYSFGILLLEILTGRKPI 245
           +S D+++ G ++ +++ G  P 
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPF 234

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 106/239 (44%), Gaps = 18/239 (7%)
Query: 48  KLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
           K+GEG  G V      S G  +AVKK+     +       EV ++   +H+N++ +    
Sbjct: 36  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 95
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
              D+  +V +++   +L   +      E Q+       + +   + +  LH +    +I
Sbjct: 96  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQ---GVI 147
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRDIK+ ++LL  D    ++DFGF   + + V      V GT  ++APE           
Sbjct: 148 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEV 206
Query: 227 DVYSFGILLLEILTGRKP-IEKLPGGVKRTITEWAEPLIVKGKFKEL--VDPKLRGDFD 282
           D++S GI+++E++ G  P   + P    + I +   P     + K L  V P L+G  D
Sbjct: 207 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-----RLKNLHKVSPSLKGFLD 260

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 12/202 (5%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           LGEG F +V   R   TS    I + + + +  + ++ +   E +V+ R+ H   + L  
Sbjct: 22  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 81
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                ++      Y  N  LL ++     G       R     I SA  + YLH +    
Sbjct: 82  TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSA--LEYLHGK---G 134
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           IIHRD+K  N+LL+ D    + DFG AK++ PE          GT  Y++PE        
Sbjct: 135 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 194
Query: 224 ESCDVYSFGILLLEILTGRKPI 245
           +S D+++ G ++ +++ G  P 
Sbjct: 195 KSSDLWALGCIIYQLVAGLPPF 216

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 12/202 (5%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           LGEG F +V   R   TS    I + + + +  + ++ +   E +V+ R+ H   + L  
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 96
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                ++      Y  N  LL ++     G       R     I SA  + YLH +    
Sbjct: 97  TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSA--LEYLHGK---G 149
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           IIHRD+K  N+LL+ D    + DFG AK++ PE          GT  Y++PE        
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 209
Query: 224 ESCDVYSFGILLLEILTGRKPI 245
           +S D+++ G ++ +++ G  P 
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPF 231

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           LGEG F +V   R   TS    I + + + +  + ++ +   E +V+ R+ H   + L  
Sbjct: 43  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 102
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                ++      Y  N  LL ++  +  G       R     I SA  + YLH +    
Sbjct: 103 TFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLHGK---G 155
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           IIHRD+K  N+LL+ D    + DFG AK++ PE          GT  Y++PE        
Sbjct: 156 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 215
Query: 224 ESCDVYSFGILLLEILTGRKPI 245
           +S D+++ G ++ +++ G  P 
Sbjct: 216 KSSDLWALGCIIYQLVAGLPPF 237

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 89  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + D G A+   +    MT  V  T  Y APE  + W 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 198
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           LGEG F +V   R   TS    I + + + +  + ++ +   E +V+ R+ H   + L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                ++      Y  N  LL ++  +  G       R     I SA  + YLH +    
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLHGK---G 152
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           IIHRD+K  N+LL+ D    + DFG AK++ PE          GT  Y++PE        
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 212
Query: 224 ESCDVYSFGILLLEILTGRKPI 245
           +S D+++ G ++ +++ G  P 
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPF 234

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           LGEG F +V   R   TS    I + + + +  + ++ +   E +V+ R+ H   + L  
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                ++      Y  N  LL ++  +  G       R     I SA  + YLH +    
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLHGK---G 150
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           IIHRD+K  N+LL+ D    + DFG AK++ PE          GT  Y++PE        
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSAC 210
Query: 224 ESCDVYSFGILLLEILTGRKPI 245
           +S D+++ G ++ +++ G  P 
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPF 232

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 12/202 (5%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           LGEG F +V   R   TS    I + + + +  + ++ +   E +V+ R+ H   + L  
Sbjct: 37  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 96
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                ++      Y  N  LL ++     G       R     I SA  + YLH +    
Sbjct: 97  TFQDDEKLYFGLSYAKNGELLKYIRK--IGSFDETCTRFYTAEIVSA--LEYLHGK---G 149
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           IIHRD+K  N+LL+ D    + DFG AK++ PE          GT  Y++PE        
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 209
Query: 224 ESCDVYSFGILLLEILTGRKPI 245
           +S D+++ G ++ +++ G  P 
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPF 231

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 106/239 (44%), Gaps = 18/239 (7%)
Query: 48  KLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
           K+GEG  G V      S G  +AVKK+     +       EV ++   +H+N++ +    
Sbjct: 81  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 140
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
              D+  +V +++   +L   +      E Q+       + +   + +  LH +    +I
Sbjct: 141 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQ---GVI 192
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRDIK+ ++LL  D    ++DFGF   + + V      V GT  ++APE           
Sbjct: 193 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEV 251
Query: 227 DVYSFGILLLEILTGRKP-IEKLPGGVKRTITEWAEPLIVKGKFKEL--VDPKLRGDFD 282
           D++S GI+++E++ G  P   + P    + I +   P     + K L  V P L+G  D
Sbjct: 252 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-----RLKNLHKVSPSLKGFLD 305

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 106/239 (44%), Gaps = 18/239 (7%)
Query: 48  KLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
           K+GEG  G V      S G  +AVKK+     +       EV ++   +H+N++ +    
Sbjct: 27  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
              D+  +V +++   +L   +      E Q+       + +   + +  LH +    +I
Sbjct: 87  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQ---GVI 138
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRDIK+ ++LL  D    ++DFGF   + + V      V GT  ++APE           
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEV 197
Query: 227 DVYSFGILLLEILTGRKP-IEKLPGGVKRTITEWAEPLIVKGKFKEL--VDPKLRGDFD 282
           D++S GI+++E++ G  P   + P    + I +   P     + K L  V P L+G  D
Sbjct: 198 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-----RLKNLHKVSPSLKGFLD 251

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 12/202 (5%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           LGEG F +V   R   TS    I + + + +  + ++ +   E +V+ R+ H   + L  
Sbjct: 40  LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 99
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                ++      Y  N  LL ++  +  G       R     I SA  + YLH +    
Sbjct: 100 TFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLHGK---G 152
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           IIHRD+K  N+LL+ D    + DFG AK++ PE          GT  Y++PE        
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAX 212
Query: 224 ESCDVYSFGILLLEILTGRKPI 245
           +S D+++ G ++ +++ G  P 
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPF 234

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           +G+G F  V   R    G ++AVK +    +NS +  +   EV ++  + H N++ L   
Sbjct: 15  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 106 CAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                   +V +Y     +  +L  HG +  E +   K R  ++      + Y H +   
Sbjct: 75  IETEKTLYLVMEYASGGEVFDYLVAHG-WMKEKEARAKFRQIVS-----AVQYCHQKF-- 126
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
            I+HRD+KA N+LLD+D    +ADFGF+     G  +      G+  Y APE     K  
Sbjct: 127 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG--NKLDTFCGSPPYAAPELFQGKKYD 183
Query: 224 -ESCDVYSFGILLLEILTGRKPIE 246
               DV+S G++L  +++G  P +
Sbjct: 184 GPEVDVWSLGVILYTLVSGSLPFD 207

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 106/239 (44%), Gaps = 18/239 (7%)
Query: 48  KLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
           K+GEG  G V      S G  +AVKK+     +       EV ++   +H+N++ +    
Sbjct: 31  KIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 90
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
              D+  +V +++   +L   +      E Q+       + +   + +  LH +    +I
Sbjct: 91  LVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLHAQ---GVI 142
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRDIK+ ++LL  D    ++DFGF   + + V      V GT  ++APE           
Sbjct: 143 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-GTPYWMAPELISRLPYGPEV 201
Query: 227 DVYSFGILLLEILTGRKP-IEKLPGGVKRTITEWAEPLIVKGKFKEL--VDPKLRGDFD 282
           D++S GI+++E++ G  P   + P    + I +   P     + K L  V P L+G  D
Sbjct: 202 DIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-----RLKNLHKVSPSLKGFLD 255

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 39  ATNGFSDDNK----LGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEME---FAVEVEV 90
           +T  FSD  K    LG+G FG V   +    G + AVK +     K + +      EV++
Sbjct: 26  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 85
Query: 91  LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
           L ++ H N++ L  +        +V +      L   +  +     ++D  R ++  +  
Sbjct: 86  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS-EVDAARIIRQVLS- 143
Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDS---DFEPLVADFGFAKLIPEGVSHMTTRVKG 207
             GI Y+H      I+HRD+K  N+LL+S   D    + DFG +    E    M  ++ G
Sbjct: 144 --GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKI-G 196
Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           T  Y+APE  + G   E CDV+S G++L  +L+G  P 
Sbjct: 197 TAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPF 233

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 64/232 (27%), Positives = 104/232 (44%), Gaps = 41/232 (17%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEV--LGRVRHKNLLGL---- 102
           +G G +G+VY G + D   +AVK     N +    F  E  +  +  + H N+       
Sbjct: 21  IGRGRYGAVYKG-SLDERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDNIARFIVGD 76
Query: 103 -RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
            R    G  + L+V +Y PN SL  +L    +     DW    ++A     G+ YLH E+
Sbjct: 77  ERVTADGRMEYLLVMEYYPNGSLXKYLSLHTS-----DWVSSCRLAHSVTRGLAYLHTEL 131
Query: 162 ------TPHIIHRDIKASNVLLDSDFEPLVADFGFA------KLI-PEGVSHMTTRVKGT 208
                  P I HRD+ + NVL+ +D   +++DFG +      +L+ P    +      GT
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191
Query: 209 LGYLAPEYAMWGKVS--------ESCDVYSFGILLLEIL---TGRKPIEKLP 249
           + Y+APE  + G V+        +  D+Y+ G++  EI    T   P E +P
Sbjct: 192 IRYMAPE-VLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 108/238 (45%), Gaps = 41/238 (17%)
Query: 36  LHTATNGFSDDNKLGEGGFGSVYWG-RTSDGLQIAVKKLKAMNSKAEMEFAV----EVEV 90
           ++  ++ F   + LGEG +G V        G  +A+KK++  +      FA+    E+++
Sbjct: 6   VYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPL---FALRTLREIKI 62
Query: 91  LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
           L   +H+N++ +        QR   ++    + ++  L       +Q D  R +   + S
Sbjct: 63  LKHFKHENIITIFNI-----QRPDSFENFNEVYIIQEL-------MQTDLHRVISTQMLS 110
Query: 151 AEGILYLHHEVT--------PHIIHRDIKASNVLLDSDFEPLVADFGFAKLI-------- 194
            + I Y  ++           ++IHRD+K SN+L++S+ +  V DFG A++I        
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNS 170
Query: 195 -PEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPG 250
            P G          T  Y APE  +   K S + DV+S G +L E+   R+PI   PG
Sbjct: 171 EPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI--FPG 225

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           +G+G F  V   R    G ++AV+ +    +NS +  +   EV ++  + H N++ L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 106 CAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                   +V +Y     +  +L  HG+   E +   K R  ++      + Y H +   
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR-MKEKEARAKFRQIVS-----AVQYCHQKF-- 133
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
            I+HRD+KA N+LLD+D    +ADFGF+     G  +      G+  Y APE     K  
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG--NKLDEFCGSPPYAAPELFQGKKYD 190
Query: 224 -ESCDVYSFGILLLEILTGRKPIE 246
               DV+S G++L  +++G  P +
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 91/211 (43%), Gaps = 15/211 (7%)
Query: 41  NGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFA---VEVEVLGRVRH 96
           N F     LG+G FG V   +  + G   A+K LK     A+ E A    E  VL   RH
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
             L  L+      D+   V +Y     L  HL  +       D  R     I SA  + Y
Sbjct: 68  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSA--LDY 123
Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT--RVKGTLGYLAP 214
           LH E   ++++RD+K  N++LD D    + DFG  K   EG+    T     GT  YLAP
Sbjct: 124 LHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAP 178
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E         + D +  G+++ E++ GR P 
Sbjct: 179 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 209

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 91/211 (43%), Gaps = 15/211 (7%)
Query: 41  NGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFA---VEVEVLGRVRH 96
           N F     LG+G FG V   +  + G   A+K LK     A+ E A    E  VL   RH
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
             L  L+      D+   V +Y     L  HL  +       D  R     I SA  + Y
Sbjct: 70  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSA--LDY 125
Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT--RVKGTLGYLAP 214
           LH E   ++++RD+K  N++LD D    + DFG  K   EG+    T     GT  YLAP
Sbjct: 126 LHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAP 180
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E         + D +  G+++ E++ GR P 
Sbjct: 181 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 89  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + D G A+   +    MT  V  T  Y APE  + W 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 198
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 91/211 (43%), Gaps = 15/211 (7%)
Query: 41  NGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFA---VEVEVLGRVRH 96
           N F     LG+G FG V   +  + G   A+K LK     A+ E A    E  VL   RH
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
             L  L+      D+   V +Y     L  HL  +       D  R     I SA  + Y
Sbjct: 69  PFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSA--LDY 124
Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT--RVKGTLGYLAP 214
           LH E   ++++RD+K  N++LD D    + DFG  K   EG+    T     GT  YLAP
Sbjct: 125 LHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAP 179
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E         + D +  G+++ E++ GR P 
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           +G+G F  V   R    G ++AVK +    +NS +  +   EV ++  + H N++ L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 106 CAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                   +V +Y     +  +L  HG+   E +   K R  ++      + Y H +   
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR-MKEKEARAKFRQIVS-----AVQYCHQKF-- 133
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
            I+HRD+KA N+LLD+D    +ADFGF+     G  +      G   Y APE     K  
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFG--NKLDAFCGAPPYAAPELFQGKKYD 190
Query: 224 -ESCDVYSFGILLLEILTGRKPIE 246
               DV+S G++L  +++G  P +
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 113/232 (48%), Gaps = 36/232 (15%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHK 97
            ++D   +G G FG VY  +  D G  +A+KK+   KA  ++       E++++ ++ H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNR-------ELQIMRKLDHC 73
Query: 98  NLLGLRGYCAGTDQRL------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
           N++ LR +   + ++       +V DY+P  + +  +   Y+   Q      +K+ +   
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ATVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 152 -EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEG---VSHMTTRVK 206
              + Y+H      I HRDIK  N+LLD D   L + DFG AK +  G   VS + +R  
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY- 187
Query: 207 GTLGYLAPEYAMWGKV--SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
               Y APE  ++G    + S DV+S G +L E+L G +PI     GV + +
Sbjct: 188 ----YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 233

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           +G+G F  V   R    G ++AVK +    +N  +  +   EV ++  + H N++ L   
Sbjct: 23  IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 106 CAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                   +V +Y     +  +L  HG+   E +   K R  ++      + Y H +   
Sbjct: 83  IETEKTLYLVMEYASGGEVFDYLVAHGRMK-EKEARAKFRQIVS-----AVQYCHQK--- 133
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           +I+HRD+KA N+LLD D    +ADFGF+      V +      G+  Y APE     K  
Sbjct: 134 YIVHRDLKAENLLLDGDMNIKIADFGFSNEFT--VGNKLDTFCGSPPYAAPELFQGKKYD 191
Query: 224 -ESCDVYSFGILLLEILTGRKPIE 246
               DV+S G++L  +++G  P +
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 17/204 (8%)
Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           +G+G F  V   R    G ++AV+ +    +NS +  +   EV ++  + H N++ L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 106 CAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                   +V +Y     +  +L  HG+   E +   K R  ++      + Y H +   
Sbjct: 82  IETEKTLYLVMEYASGGEVFDYLVAHGR-MKEKEARAKFRQIVS-----AVQYCHQKF-- 133
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
            I+HRD+KA N+LLD+D    +ADFGF+     G    T    G+  Y APE     K  
Sbjct: 134 -IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDT--FCGSPPYAAPELFQGKKYD 190
Query: 224 -ESCDVYSFGILLLEILTGRKPIE 246
               DV+S G++L  +++G  P +
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 41  NGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKN 98
           + F   ++LG G  G V+         +  +KL  +  K  +   +  E++VL       
Sbjct: 68  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           ++G  G      +  I  ++M   SL   L  + AG +      ++ IA+   +G+ YL 
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAV--IKGLTYLR 183
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM 218
            +    I+HRD+K SN+L++S  E  + DFG +  +   +  M     GT  Y++PE   
Sbjct: 184 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQ 238
Query: 219 WGKVSESCDVYSFGILLLEILTGRKPI 245
               S   D++S G+ L+E+  GR PI
Sbjct: 239 GTHYSVQSDIWSMGLSLVEMAVGRYPI 265

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  GL++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 89  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG- 220
           +  IIHRD+K SN+ ++ D E  + DFG A+   +    MT  V  T  Y APE  +   
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTGYV-ATRWYRAPEIMLNAM 198
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 20/208 (9%)
Query: 47  NKLGEGGFGSVYWGRTS-DGLQIAVK-----KLKAMNSKAEMEFAVEVEVLGRVRHKNLL 100
           + LG G FG V  G     G ++AVK     K+++++   +++   E++ L   RH +++
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHII 74
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L    +      +V +Y+    L  ++     G V+    RR+   I SA  + Y H  
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSA--VDYCHRH 130
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
           +   ++HRD+K  NVLLD+     +ADFG + ++ +G    T+   G+  Y APE  + G
Sbjct: 131 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPE-VISG 184
Query: 221 KV--SESCDVYSFGILLLEILTGRKPIE 246
           ++      D++S G++L  +L G  P +
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 21/218 (9%)
Query: 39  ATNGFSDDNK----LGEGGFGSVYWGRTS-DGLQIAVKKL--KAMNSKAEMEFAV-EVEV 90
           +T  FSD  K    LG+G FG V   +    G + AVK +  + +  K + E  + EV++
Sbjct: 20  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 79
Query: 91  LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
           L ++ H N++ L  +        +V +      L   +  +     ++D  R ++  +  
Sbjct: 80  LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS-EVDAARIIRQVLS- 137
Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDS---DFEPLVADFGFAKLIPEGVSHMTTRVKG 207
             GI Y+H      I+HRD+K  N+LL+S   D    + DFG +    E    M  ++ G
Sbjct: 138 --GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKI-G 190
Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           T  Y+APE  + G   E CDV+S G++L  +L+G  P 
Sbjct: 191 TAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPF 227

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 41  NGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKN 98
           + F   ++LG G  G V+         +  +KL  +  K  +   +  E++VL       
Sbjct: 33  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           ++G  G      +  I  ++M   SL   L  + AG +      ++ IA+   +G+ YL 
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAV--IKGLTYLR 148
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM 218
            +    I+HRD+K SN+L++S  E  + DFG +  +   +  M     GT  Y++PE   
Sbjct: 149 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQ 203
Query: 219 WGKVSESCDVYSFGILLLEILTGRKPI 245
               S   D++S G+ L+E+  GR PI
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGRYPI 230

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 12/202 (5%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           LGEG F +    R   TS    I + + + +  + ++ +   E +V+ R+ H   + L  
Sbjct: 38  LGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                ++      Y  N  LL ++  +  G       R     I SA  + YLH +    
Sbjct: 98  TFQDDEKLYFGLSYAKNGELLKYI--RKIGSFDETCTRFYTAEIVSA--LEYLHGK---G 150
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           IIHRD+K  N+LL+ D    + DFG AK++ PE          GT  Y++PE        
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAC 210
Query: 224 ESCDVYSFGILLLEILTGRKPI 245
           +S D+++ G ++ +++ G  P 
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPF 232

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/276 (24%), Positives = 122/276 (44%), Gaps = 22/276 (7%)
Query: 41  NGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKN 98
           + F   ++LG G  G V+         +  +KL  +  K  +   +  E++VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           ++G  G      +  I  ++M   SL   L  + AG +      ++ IA+   +G+ YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAV--IKGLTYLR 121
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM 218
            +    I+HRD+K SN+L++S  E  + DFG +  +   +  M     GT  Y++PE   
Sbjct: 122 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQ 176
Query: 219 WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD---P 275
               S   D++S G+ L+E+  GR PI   P   K    +   P+ +      +V+   P
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPIP--PPDAKE---DSRPPMAIFELLDYIVNEPPP 231
Query: 276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
           KL       + +  +N    C+   P +R ++K+++
Sbjct: 232 KLPSGVFSLEFQDFVNK---CLIKNPAERADLKQLM 264

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 36/232 (15%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHK 97
            ++D   +G G FG VY  +  D G  +A+KK+   K   ++       E++++ ++ H 
Sbjct: 49  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 101
Query: 98  NLLGLRGYCAGTDQRL------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
           N++ LR +   + ++       +V DY+P        H  Y+   Q      +K+ +   
Sbjct: 102 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQL 159
Query: 152 -EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEG---VSHMTTRVK 206
              + Y+H      I HRDIK  N+LLD D   L + DFG AK +  G   VS++ +R  
Sbjct: 160 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 215
Query: 207 GTLGYLAPEYAMWGKV--SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
               Y APE  ++G    + S DV+S G +L E+L G +PI     GV + +
Sbjct: 216 ----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 261

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 39  ATNGFSDDNK----LGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEME---FAVEVEV 90
           +T  FSD  K    LG+G FG V   +    G + AVK +     K + +      EV++
Sbjct: 43  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 102
Query: 91  LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
           L ++ H N++ L  +        +V +      L   +  +     ++D  R ++  +  
Sbjct: 103 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS-EVDAARIIRQVLS- 160
Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDS---DFEPLVADFGFAKLIPEGVSHMTTRVKG 207
             GI Y+H      I+HRD+K  N+LL+S   D    + DFG +    E    M  ++ G
Sbjct: 161 --GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKI-G 213
Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           T  Y+APE  + G   E CDV+S G++L  +L+G  P 
Sbjct: 214 TAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPF 250

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 39  ATNGFSDDNK----LGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEME---FAVEVEV 90
           +T  FSD  K    LG+G FG V   +    G + AVK +     K + +      EV++
Sbjct: 44  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 103
Query: 91  LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
           L ++ H N++ L  +        +V +      L   +  +     ++D  R ++  +  
Sbjct: 104 LKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS-EVDAARIIRQVLS- 161
Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDS---DFEPLVADFGFAKLIPEGVSHMTTRVKG 207
             GI Y+H      I+HRD+K  N+LL+S   D    + DFG +    E    M  ++ G
Sbjct: 162 --GITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKMKDKI-G 214
Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           T  Y+APE  + G   E CDV+S G++L  +L+G  P 
Sbjct: 215 TAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPF 251

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 96/199 (48%), Gaps = 12/199 (6%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG-YC 106
           KLGEG +GSVY     +  QI   K   + S  + E   E+ ++ +    +++   G Y 
Sbjct: 36  KLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-EIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 107 AGTDQRLIV-YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
             TD  +++ Y    ++S +  L  +   E ++       I   + +G+ YLH       
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEI-----ATILQSTLKGLEYLHFM---RK 146
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSES 225
           IHRDIKA N+LL+++    +ADFG A  + + ++     V GT  ++APE       +  
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNX-VIGTPFWMAPEVIQEIGYNCV 205
Query: 226 CDVYSFGILLLEILTGRKP 244
            D++S GI  +E+  G+ P
Sbjct: 206 ADIWSLGITAIEMAEGKPP 224

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 49  LGEGGFGSV----YWGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGLR 103
           +GEG FG V    Y    +  L +A+K  K   S +  E F  E   + +  H +++ L 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHG-QYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G        +I+      L  L  L       +  LD    +  A   +  + YL    +
Sbjct: 75  GVITENPVWIIM-----ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---S 126
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
              +HRDI A NVL+ S+    + DFG ++ + +   +  ++ K  + ++APE   + + 
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 223 SESCDVYSFGILLLEILT-GRKPIE 246
           + + DV+ FG+ + EIL  G KP +
Sbjct: 187 TSASDVWMFGVCMWEILMHGVKPFQ 211

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 77/169 (45%), Gaps = 22/169 (13%)
Query: 87  EVEVLGRVR-HKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMK 145
           EV++L +V  H N++ L+          +V+D M    L  +L      +V L  K   K
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRK 115
Query: 146 IAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRV 205
           I     E I  LH     +I+HRD+K  N+LLD D    + DFGF+  +  G       V
Sbjct: 116 IMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREV 170
Query: 206 KGTLGYLAPE---------YAMWGKVSESCDVYSFGILLLEILTGRKPI 245
            GT  YLAPE         +  +GK     D++S G+++  +L G  P 
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGK---EVDMWSTGVIMYTLLAGSPPF 216

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 36/232 (15%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHK 97
            ++D   +G G FG VY  +  D G  +A+KK+   K   ++       E++++ ++ H 
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 107
Query: 98  NLLGLRGYCAGTDQRL------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
           N++ LR +   + ++       +V DY+P        H  Y+   Q      +K+ +   
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQL 165
Query: 152 -EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEG---VSHMTTRVK 206
              + Y+H      I HRDIK  N+LLD D   L + DFG AK +  G   VS++ +R  
Sbjct: 166 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 221
Query: 207 GTLGYLAPEYAMWGKV--SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
               Y APE  ++G    + S DV+S G +L E+L G +PI     GV + +
Sbjct: 222 ----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 267

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 77/169 (45%), Gaps = 22/169 (13%)
Query: 87  EVEVLGRVR-HKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMK 145
           EV++L +V  H N++ L+          +V+D M    L  +L      +V L  K   K
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRK 128
Query: 146 IAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRV 205
           I     E I  LH     +I+HRD+K  N+LLD D    + DFGF+  +  G       V
Sbjct: 129 IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREV 183
Query: 206 KGTLGYLAPE---------YAMWGKVSESCDVYSFGILLLEILTGRKPI 245
            GT  YLAPE         +  +GK     D++S G+++  +L G  P 
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGK---EVDMWSTGVIMYTLLAGSPPF 229

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 49  LGEGGFGSV----YWGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGLR 103
           +GEG FG V    Y    +  L +A+K  K   S +  E F  E   + +  H +++ L 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHG-QYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G        +I+      L  L  L       +  LD    +  A   +  + YL    +
Sbjct: 80  GVITENPVWIIM-----ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---S 131
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
              +HRDI A NVL+ S+    + DFG ++ + +   +  ++ K  + ++APE   + + 
Sbjct: 132 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 191
Query: 223 SESCDVYSFGILLLEILT-GRKPIE 246
           + + DV+ FG+ + EIL  G KP +
Sbjct: 192 TSASDVWMFGVCMWEILMHGVKPFQ 216

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 36/232 (15%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHK 97
            ++D   +G G FG VY  +  D G  +A+KK+   K   ++       E++++ ++ H 
Sbjct: 57  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 109
Query: 98  NLLGLRGYCAGTDQRL------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
           N++ LR +   + ++       +V DY+P        H  Y+   Q      +K+ +   
Sbjct: 110 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQL 167
Query: 152 -EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEG---VSHMTTRVK 206
              + Y+H      I HRDIK  N+LLD D   L + DFG AK +  G   VS++ +R  
Sbjct: 168 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 223
Query: 207 GTLGYLAPEYAMWGKV--SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
               Y APE  ++G    + S DV+S G +L E+L G +PI     GV + +
Sbjct: 224 ----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 269

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 17/204 (8%)
Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           +G+G F  V   R    G ++AVK +    +NS +  +   EV +   + H N++ L   
Sbjct: 22  IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 106 CAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                   +V +Y     +  +L  HG+   E +   K R  ++      + Y H +   
Sbjct: 82  IETEKTLYLVXEYASGGEVFDYLVAHGR-XKEKEARAKFRQIVS-----AVQYCHQKF-- 133
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
            I+HRD+KA N+LLD+D    +ADFGF+     G  +      G   Y APE     K  
Sbjct: 134 -IVHRDLKAENLLLDADXNIKIADFGFSNEFTFG--NKLDAFCGAPPYAAPELFQGKKYD 190
Query: 224 -ESCDVYSFGILLLEILTGRKPIE 246
               DV+S G++L  +++G  P +
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLPFD 214

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 36/232 (15%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHK 97
            ++D   +G G FG VY  +  D G  +A+KK+   K   ++       E++++ ++ H 
Sbjct: 26  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 78
Query: 98  NLLGLRGYCAGTDQRL------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
           N++ LR +   + ++       +V DY+P        H  Y+   Q      +K+ +   
Sbjct: 79  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQL 136
Query: 152 -EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEG---VSHMTTRVK 206
              + Y+H      I HRDIK  N+LLD D   L + DFG AK +  G   VS++ +R  
Sbjct: 137 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 192
Query: 207 GTLGYLAPEYAMWGKV--SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
               Y APE  ++G    + S DV+S G +L E+L G +PI     GV + +
Sbjct: 193 ----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 238

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 49  LGEGGFGSV----YWGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGLR 103
           +GEG FG V    Y    +  L +A+K  K   S +  E F  E   + +  H +++ L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHG-QYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G        +I+      L  L  L       +  LD    +  A   +  + YL  +  
Sbjct: 78  GVITENPVWIIM-----ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK-- 130
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
              +HRDI A NVL+ S+    + DFG ++ + +   +  ++ K  + ++APE   + + 
Sbjct: 131 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 223 SESCDVYSFGILLLEILT-GRKPIE 246
           + + DV+ FG+ + EIL  G KP +
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 99/225 (44%), Gaps = 32/225 (14%)
Query: 29  RIFTYKELHTATNGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKL--KAMNSKAEMEFA 85
           +IF +KE             LG G F  V      + G   AVK +  KA+  K E    
Sbjct: 22  KIFEFKET------------LGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGK-ESSIE 68
Query: 86  VEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRR 143
            E+ VL +++H+N++ L       +   +V   +    L   +   G Y  +      R+
Sbjct: 69  NEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQ 128
Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLL---DSDFEPLVADFGFAKLIPEGVSH 200
           +       + + YLH      I+HRD+K  N+L    D + + +++DFG +K+  EG   
Sbjct: 129 V------LDAVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKGD 177
Query: 201 MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           + +   GT GY+APE       S++ D +S G++   +L G  P 
Sbjct: 178 VMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF 222

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 49  LGEGGFGSV----YWGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGLR 103
           +GEG FG V    Y    +  L +A+K  K   S +  E F  E   + +  H +++ L 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHG-QYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G        +I+      L  L  L       +  LD    +  A   +  + YL  +  
Sbjct: 106 GVITENPVWIIM-----ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK-- 158
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
              +HRDI A NVL+ S+    + DFG ++ + +   +  ++ K  + ++APE   + + 
Sbjct: 159 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 217
Query: 223 SESCDVYSFGILLLEILT-GRKPIE 246
           + + DV+ FG+ + EIL  G KP +
Sbjct: 218 TSASDVWMFGVCMWEILMHGVKPFQ 242

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 49  LGEGGFGSV----YWGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGLR 103
           +GEG FG V    Y    +  L +A+K  K   S +  E F  E   + +  H +++ L 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHG-QYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G        +I+      L  L  L       +  LD    +  A   +  + YL    +
Sbjct: 81  GVITENPVWIIM-----ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLE---S 132
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
              +HRDI A NVL+ S+    + DFG ++ + +   +  ++ K  + ++APE   + + 
Sbjct: 133 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 192
Query: 223 SESCDVYSFGILLLEILT-GRKPIE 246
           + + DV+ FG+ + EIL  G KP +
Sbjct: 193 TSASDVWMFGVCMWEILMHGVKPFQ 217

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 36/232 (15%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHK 97
            ++D   +G G FG VY  +  D G  +A+KK+   K   ++       E++++ ++ H 
Sbjct: 59  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 111
Query: 98  NLLGLRGYCAGTDQRL------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
           N++ LR +   + ++       +V DY+P        H  Y+   Q      +K+ +   
Sbjct: 112 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQL 169
Query: 152 -EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEG---VSHMTTRVK 206
              + Y+H      I HRDIK  N+LLD D   L + DFG AK +  G   VS++ +R  
Sbjct: 170 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 225
Query: 207 GTLGYLAPEYAMWGKV--SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
               Y APE  ++G    + S DV+S G +L E+L G +PI     GV + +
Sbjct: 226 ----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 271

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 41  NGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKN 98
           + F   ++LG G  G V+         +  +KL  +  K  +   +  E++VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           ++G  G      +  I  ++M   SL   L  + AG +      ++ IA+   +G+ YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAV--IKGLTYLR 121
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM 218
            +    I+HRD+K SN+L++S  E  + DFG +  +   +  M     GT  Y++PE   
Sbjct: 122 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQ 176
Query: 219 WGKVSESCDVYSFGILLLEILTGRKPI 245
               S   D++S G+ L+E+  GR PI
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 77/169 (45%), Gaps = 22/169 (13%)
Query: 87  EVEVLGRVR-HKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMK 145
           EV++L +V  H N++ L+          +V+D M    L  +L      +V L  K   K
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETRK 128
Query: 146 IAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRV 205
           I     E I  LH     +I+HRD+K  N+LLD D    + DFGF+  +  G       V
Sbjct: 129 IMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLRSV 183
Query: 206 KGTLGYLAPE---------YAMWGKVSESCDVYSFGILLLEILTGRKPI 245
            GT  YLAPE         +  +GK     D++S G+++  +L G  P 
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGK---EVDMWSTGVIMYTLLAGSPPF 229

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 49  LGEGGFGSVYWGRTSDG--------LQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLL 100
           LG+GG+G V+  R   G        +++  K +   N+K       E  +L  V+H  ++
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 101 GLRGYCAGTDQRL-IVYDYMPNLSLLSHLH--GQYAGEVQLDWKRRMKIAIGSAEGILYL 157
            L  Y   T  +L ++ +Y+    L   L   G +  +    +   + +A+G      +L
Sbjct: 85  DLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG------HL 137
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK-LIPEGVSHMTTRVKGTLGYLAPEY 216
           H +    II+RD+K  N++L+      + DFG  K  I +G   +T    GT+ Y+APE 
Sbjct: 138 HQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEYMAPEI 192
Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPI 245
            M    + + D +S G L+ ++LTG  P 
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 97/209 (46%), Gaps = 24/209 (11%)
Query: 49  LGEGGFGSVYWGRTSDG--------LQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLL 100
           LG+GG+G V+  R   G        +++  K +   N+K       E  +L  V+H  ++
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 101 GLRGYCAGTDQRL-IVYDYMPNLSLLSHLH--GQYAGEVQLDWKRRMKIAIGSAEGILYL 157
            L  Y   T  +L ++ +Y+    L   L   G +  +    +   + +A+G      +L
Sbjct: 85  DLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALG------HL 137
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK-LIPEGVSHMTTRVKGTLGYLAPEY 216
           H +    II+RD+K  N++L+      + DFG  K  I +G   +T    GT+ Y+APE 
Sbjct: 138 HQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHXFCGTIEYMAPEI 192
Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPI 245
            M    + + D +S G L+ ++LTG  P 
Sbjct: 193 LMRSGHNRAVDWWSLGALMYDMLTGAPPF 221

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 34/231 (14%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHK 97
            ++D   +G G FG VY  +  D G  +A+KK+   K   ++       E++++ ++ H 
Sbjct: 34  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 86
Query: 98  NLLGLRGYCAGTDQRL------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
           N++ LR +   + ++       +V DY+P        H  Y+   Q      +K+ +   
Sbjct: 87  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQL 144
Query: 152 -EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEG---VSHMTTRVK 206
              + Y+H      I HRDIK  N+LLD D   L + DFG AK +  G   VS++ +R  
Sbjct: 145 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 200
Query: 207 GTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
               Y APE        + S DV+S G +L E+L G +PI     GV + +
Sbjct: 201 ----YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 246

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 41  NGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKN 98
           + F   ++LG G  G V+         +  +KL  +  K  +   +  E++VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           ++G  G      +  I  ++M   SL   L  + AG +      ++ IA+   +G+ YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAV--IKGLTYLR 121
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM 218
            +    I+HRD+K SN+L++S  E  + DFG +  +   +  M     GT  Y++PE   
Sbjct: 122 EKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQ 176
Query: 219 WGKVSESCDVYSFGILLLEILTGRKPI 245
               S   D++S G+ L+E+  GR PI
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 36/232 (15%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHK 97
            ++D   +G G FG VY  +  D G  +A+KK+   K   ++       E++++ ++ H 
Sbjct: 100 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 152
Query: 98  NLLGLRGYCAGTDQRL------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
           N++ LR +   + ++       +V DY+P        H  Y+   Q      +K+ +   
Sbjct: 153 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQL 210
Query: 152 -EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEG---VSHMTTRVK 206
              + Y+H      I HRDIK  N+LLD D   L + DFG AK +  G   VS++ +R  
Sbjct: 211 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 266
Query: 207 GTLGYLAPEYAMWGKV--SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
               Y APE  ++G    + S DV+S G +L E+L G +PI     GV + +
Sbjct: 267 ----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 312

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 92/212 (43%), Gaps = 21/212 (9%)
Query: 41  NGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKN 98
           + F   ++LG G  G V   +      I  +KL  +  K  +   +  E++VL       
Sbjct: 16  DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRM-----KIAIGSAEG 153
           ++G  G      +  I          + H+ G    +V  + KR       K++I    G
Sbjct: 76  IVGFYGAFYSDGEISIC---------MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRG 126
Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLA 213
           + YL  +    I+HRD+K SN+L++S  E  + DFG +  +   +  M     GT  Y+A
Sbjct: 127 LAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMA 181
Query: 214 PEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           PE       S   D++S G+ L+E+  GR PI
Sbjct: 182 PERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 49  LGEGGFGSV----YWGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGLR 103
           +GEG FG V    Y    +  L +A+K  K   S +  E F  E   + +  H +++ L 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHG-QYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G        +I+      L  L  L       +  LD    +  A   +  + YL  +  
Sbjct: 83  GVITENPVWIIM-----ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK-- 135
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
              +HRDI A NVL+ S+    + DFG ++ + +   +  ++ K  + ++APE   + + 
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 223 SESCDVYSFGILLLEILT-GRKPIE 246
           + + DV+ FG+ + EIL  G KP +
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKPFQ 219

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 49  LGEGGFGSV----YWGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGLR 103
           +GEG FG V    Y    +  + +A+K  K   S +  E F  E   + +  H +++ L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHG-QYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G        +I+      L  L  L       +  LD    +  A   +  + YL    +
Sbjct: 458 GVITENPVWIIM-----ELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---S 509
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
              +HRDI A NVL+ S+    + DFG ++ + +   +  ++ K  + ++APE   + + 
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 223 SESCDVYSFGILLLEILT-GRKPIE 246
           + + DV+ FG+ + EIL  G KP +
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKPFQ 594

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 66/273 (24%), Positives = 121/273 (44%), Gaps = 22/273 (8%)
Query: 41  NGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKN 98
           + F   ++LG G  G V+         +  +KL  +  K  +   +  E++VL       
Sbjct: 25  DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           ++G  G      +  I  ++M   SL   L  + AG +      ++ IA+   +G+ YL 
Sbjct: 85  IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAV--IKGLTYLR 140
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM 218
            +    I+HRD+K SN+L++S  E  + DFG +  +   +  M     GT  Y++PE   
Sbjct: 141 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQ 195
Query: 219 WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR 278
               S   D++S G+ L+E+  GR PI    G +   I E  + ++ +        PKL 
Sbjct: 196 GTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSM--AIFELLDYIVNEPP------PKLP 247
Query: 279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
                 + +  +N    C+   P +R ++K+++
Sbjct: 248 SGVFSLEFQDFVNK---CLIKNPAERADLKQLM 277

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 101/208 (48%), Gaps = 20/208 (9%)
Query: 47  NKLGEGGFGSVYWGRTS-DGLQIAVK-----KLKAMNSKAEMEFAVEVEVLGRVRHKNLL 100
           + LG G FG V  G     G ++AVK     K+++++   +++   E++ L   RH +++
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHII 74
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L    +      +V +Y+    L  ++     G V+    RR+   I SA  + Y H  
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSA--VDYCHRH 130
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
           +   ++HRD+K  NVLLD+     +ADFG + ++ +G         G+  Y APE  + G
Sbjct: 131 M---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--EFLRDSCGSPNYAAPE-VISG 184
Query: 221 KV--SESCDVYSFGILLLEILTGRKPIE 246
           ++      D++S G++L  +L G  P +
Sbjct: 185 RLYAGPEVDIWSCGVILYALLCGTLPFD 212

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 112/232 (48%), Gaps = 36/232 (15%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHK 97
            ++D   +G G FG VY  +  D G  +A+KK+   K   ++       E++++ ++ H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 73
Query: 98  NLLGLRGYCAGTDQRL------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
           N++ LR +   + ++       +V DY+P        H  Y+   Q      +K+ +   
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQL 131
Query: 152 -EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEG---VSHMTTRVK 206
              + Y+H   +  I HRDIK  N+LLD D   L + DFG AK +  G   VS++ +R  
Sbjct: 132 FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRY- 187
Query: 207 GTLGYLAPEYAMWGKV--SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
               Y APE  ++G    + S DV+S G +L E+L G +PI     GV + +
Sbjct: 188 ----YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 233

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 100/202 (49%), Gaps = 19/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV     T  G ++AVKKL +   S    +    E+ +L  ++H+N++GL   
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD- 88
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV----QLDWKRRMKIAIGSAEGILYLHHEV 161
              T  R +  +   ++ L++HL G     +    +L       +      G+ Y+H   
Sbjct: 89  -VFTPARSL--EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIH--- 142
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  IIHRD+K SN+ ++ D E  + DF  A+   +    MT  V  T  Y APE  + W 
Sbjct: 143 SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDD---EMTGYV-ATRWYRAPEIMLNWM 198
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTGR
Sbjct: 199 HYNQTVDIWSVGCIMAELLTGR 220

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 94/211 (44%), Gaps = 28/211 (13%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEM-------EFAVEVEVLGRVRHKNLLG 101
           +G G FG V   R     ++   KL    SK EM        F  E +++       ++ 
Sbjct: 83  IGRGAFGEVQLVRHKASQKVYAMKLL---SKFEMIKRSDSAFFWEERDIMAFANSPWVVQ 139
Query: 102 LRGYCAGTDQRLI--VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           L  +CA  D + +  V +YMP   L+ +L   Y  +V   W +       +AE +L L  
Sbjct: 140 L--FCAFQDDKYLYMVMEYMPGGDLV-NLMSNY--DVPEKWAK-----FYTAEVVLALDA 189
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFA-KLIPEGVSHMTTRVKGTLGYLAPEYAM 218
             +  +IHRD+K  N+LLD      +ADFG   K+   G+ H  T V GT  Y++PE   
Sbjct: 190 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAV-GTPDYISPEVLK 248
Query: 219 W----GKVSESCDVYSFGILLLEILTGRKPI 245
                G     CD +S G+ L E+L G  P 
Sbjct: 249 SQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV        G ++A+KKL +   S+   + A  E+ +L  ++H+N++GL   
Sbjct: 50  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 106 CAGTDQRLIVYDY---MPNLSL-LSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
                     YD+   MP +   L  + G    E ++ +     +     +G+ Y+H   
Sbjct: 110 FTPASSLRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQY-----LVYQMLKGLKYIH--- 161
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  ++HRD+K  N+ ++ D E  + DFG A+      + MT  V  T  Y APE  + W 
Sbjct: 162 SAGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYV-VTRWYRAPEVILSWM 217
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTG+
Sbjct: 218 HYNQTVDIWSVGCIMAEMLTGK 239

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 27/215 (12%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKNLLGLRG 104
           K+G+G FG V+  R    G ++A+KK+   N K         E+++L  ++H+N++ L  
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 105 YC---AGTDQRL-----IVYDYMPN--LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
            C   A    R      +V+D+  +    LLS++  ++      + KR M++ +    G+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS---EIKRVMQMLLN---GL 138
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG---TLGY 211
            Y+H      I+HRD+KA+NVL+  D    +ADFG A+      +    R      TL Y
Sbjct: 139 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 212 LAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPI 245
             PE  +  +      D++  G ++ E+ T R PI
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 103/225 (45%), Gaps = 39/225 (17%)
Query: 49  LGEGGFGSVYWGRTSDGLQ-IAVKKL-KAMNSKAEMEFAVEVEV--LGRVRHKNLLGLRG 104
           LGEG FG V         Q +A+K + + +  K++M   VE E+  L  +RH +++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 105 YCAG-TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDW---KRRMKIAIGS------AEGI 154
                TD  +++               +YAG    D+   K+RM    G          I
Sbjct: 77  VITTPTDIVMVI---------------EYAGGELFDYIVEKKRMTEDEGRRFFQQIICAI 121
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            Y H      I+HRD+K  N+LLD +    +ADFG + ++ +G    T+   G+  Y AP
Sbjct: 122 EYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTS--CGSPNYAAP 176
Query: 215 EYAMWGKV--SESCDVYSFGILLLEILTGRKPI--EKLPGGVKRT 255
           E  + GK+      DV+S GI+L  +L GR P   E +P   K+ 
Sbjct: 177 E-VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV 220

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 25/227 (11%)
Query: 49  LGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           LG G F  V+  +    G   A+K +K   +  +     E+ VL +++H+N++ L     
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 108 GTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSA-EGILYLHHEVTPH 164
            T    +V   +    L   +   G Y        ++   + I      + YLH      
Sbjct: 77  STTHYYLVMQLVSGGELFDRILERGVYT-------EKDASLVIQQVLSAVKYLHEN---G 126
Query: 165 IIHRDIKASNVLL---DSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK 221
           I+HRD+K  N+L    + + + ++ DFG +K+   G+  M+T   GT GY+APE      
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTAC-GTPGYVAPEVLAQKP 183
Query: 222 VSESCDVYSFGILLLEILTGRKPI-----EKLPGGVKRTITEWAEPL 263
            S++ D +S G++   +L G  P       KL   +K    E+  P 
Sbjct: 184 YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPF 230

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 41  NGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKN 98
           + F   ++LG G  G V+         +  +KL  +  K  +   +  E++VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           ++G  G      +  I  ++M   SL   L  + AG +      ++ IA+   +G+ YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAV--IKGLTYLR 121
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM 218
            +    I+HRD+K SN+L++S  E  + DFG +  +   +  M     GT  Y++PE   
Sbjct: 122 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQ 176
Query: 219 WGKVSESCDVYSFGILLLEILTGRKPI 245
               S   D++S G+ L+E+  GR PI
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 95/207 (45%), Gaps = 11/207 (5%)
Query: 41  NGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKN 98
           + F   ++LG G  G V+         +  +KL  +  K  +   +  E++VL       
Sbjct: 6   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 65
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           ++G  G      +  I  ++M   SL   L  + AG +      ++ IA+   +G+ YL 
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAV--IKGLTYLR 121
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM 218
            +    I+HRD+K SN+L++S  E  + DFG +  +   +  M     GT  Y++PE   
Sbjct: 122 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQ 176
Query: 219 WGKVSESCDVYSFGILLLEILTGRKPI 245
               S   D++S G+ L+E+  GR PI
Sbjct: 177 GTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 23/210 (10%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLK---AMNSKAEME-FAVEVEVLGRVRHKNLLGLRG 104
           +G G FG V   +  +  ++   K+     M  +AE   F  E +VL     K +  L  
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 105 YCAGTDQRLIVYDYMPN---LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
                +   +V DY      L+LLS    +   E+   +   M IAI S   +       
Sbjct: 142 AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQL------- 194
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFA-KLIPEGVSHMTTRVKGTLGYLAPEY--AM 218
             H +HRDIK  N+L+D +    +ADFG   KL+ +G    +  V GT  Y++PE   AM
Sbjct: 195 --HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAM 251
Query: 219 W---GKVSESCDVYSFGILLLEILTGRKPI 245
               G+    CD +S G+ + E+L G  P 
Sbjct: 252 EGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 92/205 (44%), Gaps = 15/205 (7%)
Query: 49  LGEGGFGSV----YWGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGLR 103
           +GEG FG V    Y    +  + +A+K  K   S +  E F  E   + +  H +++ L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHG-QYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G        +I+      L  L  L       +  LD    +  A   +  + YL  +  
Sbjct: 78  GVITENPVWIIM-----ELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK-- 130
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
              +HRDI A NVL+ S+    + DFG ++ + +   +  ++ K  + ++APE   + + 
Sbjct: 131 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 223 SESCDVYSFGILLLEILT-GRKPIE 246
           + + DV+ FG+ + EIL  G KP +
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 103/232 (44%), Gaps = 26/232 (11%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAE----MEFAV 86
           KE+  +   F ++  LGE  FG VY G     + G Q     +K +  KAE     EF  
Sbjct: 21  KEISLSAVRFMEE--LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH 78
Query: 87  EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRM 144
           E  +  R++H N++ L G         +++ Y  +  L   L     ++     D  R +
Sbjct: 79  EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 138
Query: 145 KIAIGS----------AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG-FAKL 193
           K A+            A G+ YL    + H++H+D+   NVL+       ++D G F ++
Sbjct: 139 KSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREV 195
Query: 194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
                  +       + ++APE  M+GK S   D++S+G++L E+ + G +P
Sbjct: 196 YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 247

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 108/231 (46%), Gaps = 34/231 (14%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHK 97
            ++D   +G G FG VY  +  D G  +A+KK+   K   ++       E++++ ++ H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 73
Query: 98  NLLGLR--GYCAGTDQRLI----VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
           N++ LR   Y +G  + ++    V DY+P        H  Y+   Q      +K+ +   
Sbjct: 74  NIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQL 131
Query: 152 -EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEG---VSHMTTRVK 206
              + Y+H      I HRDIK  N+LLD D   L + DFG AK +  G   VS + +R  
Sbjct: 132 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY- 187
Query: 207 GTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
               Y APE        + S DV+S G +L E+L G +PI     GV + +
Sbjct: 188 ----YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 233

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG------L 102
           +G G +G VY GR     Q+A  K+  +    E E   E+ +L +  H   +       +
Sbjct: 32  VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91
Query: 103 RGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
           +    G D +L +V ++    S+   +       ++ +W     IA    E +  L H  
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICREILRGLSHLH 146
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK 221
              +IHRDIK  NVLL  + E  + DFG +  +   V    T + GT  ++APE     +
Sbjct: 147 QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYWMAPEVIACDE 205
Query: 222 VSES-----CDVYSFGILLLEILTGRKPI 245
             ++      D++S GI  +E+  G  P+
Sbjct: 206 NPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 16/215 (7%)
Query: 45  DDNKLGEGGFGSVYWG-----RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL 99
           +D +LG G FG+V  G     +    + + + K +A +   + E   E  V+ ++ +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           + + G C      L++      ++ L  L+        +  K  +++    + G+ YL  
Sbjct: 91  VRMIGICEAESWMLVM-----EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 145
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI--PEGVSHMTTRVKGTLGYLAPEYA 217
               + +HRD+ A NVLL +     ++DFG +K +   E      T  K  + + APE  
Sbjct: 146 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 202
Query: 218 MWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGG 251
            + K S   DV+SFG+L+ E  + G+KP   + G 
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 237

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 16/215 (7%)
Query: 45  DDNKLGEGGFGSVYWG-----RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL 99
           +D +LG G FG+V  G     +    + + + K +A +   + E   E  V+ ++ +  +
Sbjct: 31  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           + + G C      L++      ++ L  L+        +  K  +++    + G+ YL  
Sbjct: 91  VRMIGICEAESWMLVM-----EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 145
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI--PEGVSHMTTRVKGTLGYLAPEYA 217
               + +HRD+ A NVLL +     ++DFG +K +   E      T  K  + + APE  
Sbjct: 146 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 202
Query: 218 MWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGG 251
            + K S   DV+SFG+L+ E  + G+KP   + G 
Sbjct: 203 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 237

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/202 (27%), Positives = 100/202 (49%), Gaps = 20/202 (9%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G +GSV        G ++A+KKL +   S+   + A  E+ +L  ++H+N++GL   
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 106 CAGTDQRLIVYDY---MPNLSL-LSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
                     YD+   MP +   L  + G    E ++ +     +     +G+ Y+H   
Sbjct: 92  FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQY-----LVYQMLKGLKYIH--- 143
Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WG 220
           +  ++HRD+K  N+ ++ D E  + DFG A+      + MT  V  T  Y APE  + W 
Sbjct: 144 SAGVVHRDLKPGNLAVNEDCELKILDFGLAR---HADAEMTGYV-VTRWYRAPEVILSWM 199
Query: 221 KVSESCDVYSFGILLLEILTGR 242
             +++ D++S G ++ E+LTG+
Sbjct: 200 HYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 110/232 (47%), Gaps = 36/232 (15%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHK 97
            ++D   +G G FG VY  +  D G  +A+KK+   K   ++       E++++ ++ H 
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 107
Query: 98  NLLGLRGYCAGTDQRL------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
           N++ LR +   + ++       +V DY+P        H  Y+   Q      +K+ +   
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQL 165
Query: 152 -EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEG---VSHMTTRVK 206
              + Y+H      I HRDIK  N+LLD D   L + DFG AK +  G   VS + +R  
Sbjct: 166 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY- 221
Query: 207 GTLGYLAPEYAMWGKV--SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
               Y APE  ++G    + S DV+S G +L E+L G +PI     GV + +
Sbjct: 222 ----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 267

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 49  LGEGGFGSV----YWGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGLR 103
           +GEG FG V    Y    +  + +A+K  K   S +  E F  E   + +  H +++ L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHG-QYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G        +I+      L  L  L       +  LD    +  A   +  + YL  +  
Sbjct: 78  GVITENPVWIIM-----ELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK-- 130
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
              +HRDI A NVL+ S+    + DFG ++ + +      ++ K  + ++APE   + + 
Sbjct: 131 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRF 189
Query: 223 SESCDVYSFGILLLEILT-GRKPIE 246
           + + DV+ FG+ + EIL  G KP +
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 24/218 (11%)
Query: 48  KLGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAE----MEFAVEVEVLGRVRHKNLL 100
           +LGE  FG VY G     + G Q     +K +  KAE     EF  E  +  R++H N++
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGS-------- 150
            L G         +++ Y  +  L   L     ++     D  R +K A+          
Sbjct: 76  CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 151 --AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG-FAKLIPEGVSHMTTRVKG 207
             A G+ YL    + H++H+D+   NVL+       ++D G F ++       +      
Sbjct: 136 QIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192
Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
            + ++APE  M+GK S   D++S+G++L E+ + G +P
Sbjct: 193 PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 16/215 (7%)
Query: 45  DDNKLGEGGFGSVYWG-----RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL 99
           +D +LG G FG+V  G     +    + + + K +A +   + E   E  V+ ++ +  +
Sbjct: 29  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           + + G C      L++      ++ L  L+        +  K  +++    + G+ YL  
Sbjct: 89  VRMIGICEAESWMLVM-----EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 143
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI--PEGVSHMTTRVKGTLGYLAPEYA 217
               + +HRD+ A NVLL +     ++DFG +K +   E      T  K  + + APE  
Sbjct: 144 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 200
Query: 218 MWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGG 251
            + K S   DV+SFG+L+ E  + G+KP   + G 
Sbjct: 201 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 235

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 16/214 (7%)
Query: 45  DDNKLGEGGFGSVYWG-----RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL 99
           +D +LG G FG+V  G     +    + + + K +A +   + E   E  V+ ++ +  +
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           + + G C      L++      ++ L  L+        +  K  +++    + G+ YL  
Sbjct: 434 VRMIGICEAESWMLVM-----EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 488
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI--PEGVSHMTTRVKGTLGYLAPEYA 217
               + +HRD+ A NVLL +     ++DFG +K +   E      T  K  + + APE  
Sbjct: 489 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 545
Query: 218 MWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
            + K S   DV+SFG+L+ E  + G+KP   + G
Sbjct: 546 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 579

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 16/214 (7%)
Query: 45  DDNKLGEGGFGSVYWG-----RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL 99
           +D +LG G FG+V  G     +    + + + K +A +   + E   E  V+ ++ +  +
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           + + G C      L++      ++ L  L+        +  K  +++    + G+ YL  
Sbjct: 433 VRMIGICEAESWMLVM-----EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 487
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI--PEGVSHMTTRVKGTLGYLAPEYA 217
               + +HRD+ A NVLL +     ++DFG +K +   E      T  K  + + APE  
Sbjct: 488 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 544
Query: 218 MWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
            + K S   DV+SFG+L+ E  + G+KP   + G
Sbjct: 545 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 578

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 11/206 (5%)
Query: 41  NGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKN 98
           + F   ++LG G  G V+         +  +KL  +  K  +   +  E++VL       
Sbjct: 9   DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           ++G  G      +  I  ++M   SL   L  + AG +      ++ IA+   +G+ YL 
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVL--KKAGRIPEQILGKVSIAV--IKGLTYLR 124
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM 218
            +    I+HRD+K SN+L++S  E  + DFG +  +   +  M     GT  Y++PE   
Sbjct: 125 EK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDEMANEFVGTRSYMSPERLQ 179
Query: 219 WGKVSESCDVYSFGILLLEILTGRKP 244
               S   D++S G+ L+E+  GR P
Sbjct: 180 GTHYSVQSDIWSMGLSLVEMAVGRYP 205

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 36/232 (15%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHK 97
            ++D   +G G FG VY  +  D G  +A+KK+   K   ++       E++++ ++ H 
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 85
Query: 98  NLLGLRGYCAGTDQRL------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
           N++ LR +   + ++       +V DY+P        H  Y+   Q      +K+ +   
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQL 143
Query: 152 -EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEG---VSHMTTRVK 206
              + Y+H   +  I HRDIK  N+LLD D   L + DFG AK +  G   VS + +R  
Sbjct: 144 FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY- 199
Query: 207 GTLGYLAPEYAMWGKV--SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
               Y APE  ++G    + S DV+S G +L E+L G +PI     GV + +
Sbjct: 200 ----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 245

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 110/232 (47%), Gaps = 36/232 (15%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHK 97
            ++D   +G G FG VY  +  D G  +A+KK+   K   ++       E++++ ++ H 
Sbjct: 40  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 92
Query: 98  NLLGLRGYCAGTDQRL------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
           N++ LR +   + ++       +V DY+P        H  Y+   Q      +K+ +   
Sbjct: 93  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQL 150
Query: 152 -EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEG---VSHMTTRVK 206
              + Y+H      I HRDIK  N+LLD D   L + DFG AK +  G   VS + +R  
Sbjct: 151 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY- 206
Query: 207 GTLGYLAPEYAMWGKV--SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
               Y APE  ++G    + S DV+S G +L E+L G +PI     GV + +
Sbjct: 207 ----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 252

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 110/232 (47%), Gaps = 36/232 (15%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHK 97
            ++D   +G G FG VY  +  D G  +A+KK+   K   ++       E++++ ++ H 
Sbjct: 29  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 81
Query: 98  NLLGLRGYCAGTDQRL------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
           N++ LR +   + ++       +V DY+P        H  Y+   Q      +K+ +   
Sbjct: 82  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQL 139
Query: 152 -EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEG---VSHMTTRVK 206
              + Y+H      I HRDIK  N+LLD D   L + DFG AK +  G   VS + +R  
Sbjct: 140 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY- 195
Query: 207 GTLGYLAPEYAMWGKV--SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
               Y APE  ++G    + S DV+S G +L E+L G +PI     GV + +
Sbjct: 196 ----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 241

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/215 (26%), Positives = 95/215 (44%), Gaps = 27/215 (12%)
Query: 48  KLGEGGFGSVYWGRTSDG-LQIAVKKLKAMN-------------SKAEMEFAVEVEVLGR 93
           KLG G +G V   +  +G  + A+K +K                 K   E   E+ +L  
Sbjct: 43  KLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKS 102
Query: 94  VRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEG 153
           + H N++ L           +V ++     L   +  ++  + + D    MK  +    G
Sbjct: 103 LDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFD-ECDAANIMKQILS---G 158
Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPL---VADFGFAKLIPEGVSHMTTRVKGTLG 210
           I YLH     +I+HRDIK  N+LL++    L   + DFG +    +    +  R+ GT  
Sbjct: 159 ICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK-LRDRL-GTAY 213
Query: 211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           Y+APE  +  K +E CDV+S G+++  +L G  P 
Sbjct: 214 YIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPF 247

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 119/278 (42%), Gaps = 43/278 (15%)
Query: 50  GEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGL-----RG 104
             G FG V+  +  +   +AVK +  +  K   +   E+     ++H+NLL       RG
Sbjct: 24  ARGRFGCVWKAQLMNDF-VAVK-IFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRG 81
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV--- 161
                +  LI   +    SL  +L G       + W     +A   + G+ YLH +V   
Sbjct: 82  SNLEVELWLITA-FHDKGSLTDYLKGNI-----ITWNELCHVAETMSRGLSYLHEDVPWC 135
Query: 162 -----TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI----PEGVSHMTTRVKGTLGYL 212
                 P I HRD K+ NVLL SD   ++ADFG A       P G +H      GT  Y+
Sbjct: 136 RGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQV---GTRRYM 192
Query: 213 APEYAMWGKVSES------CDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVK 266
           APE  + G ++         D+Y+ G++L E+++  K  +   G V   +  + E +   
Sbjct: 193 APE-VLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD---GPVDEYMLPFEEEIGQH 248
Query: 267 GKFKEL----VDPKLRGDFDENQLKQAINVAVLCVQSE 300
              +EL    V  K+R    ++ LK    +A LCV  E
Sbjct: 249 PSLEELQEVVVHKKMRPTIKDHWLKHP-GLAQLCVTIE 285

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 16/215 (7%)
Query: 45  DDNKLGEGGFGSVYWG-----RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL 99
           +D +LG G FG+V  G     +    + + + K +A +   + E   E  V+ ++ +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           + + G C      L++      ++ L  L+        +  K  +++    + G+ YL  
Sbjct: 75  VRMIGICEAESWMLVM-----EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 129
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI--PEGVSHMTTRVKGTLGYLAPEYA 217
               + +HRD+ A NVLL +     ++DFG +K +   E      T  K  + + APE  
Sbjct: 130 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 186
Query: 218 MWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGG 251
            + K S   DV+SFG+L+ E  + G+KP   + G 
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 221

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 27/215 (12%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKNLLGLRG 104
           K+G+G FG V+  R    G ++A+KK+   N K         E+++L  ++H+N++ L  
Sbjct: 24  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 83
Query: 105 YC---AGTDQRL-----IVYDYMPN--LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
            C   A    R      +V+D+  +    LLS++  ++      + KR M++ +    G+
Sbjct: 84  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS---EIKRVMQMLLN---GL 137
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG---TLGY 211
            Y+H      I+HRD+KA+NVL+  D    +ADFG A+      +    R      TL Y
Sbjct: 138 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 194
Query: 212 LAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPI 245
             PE  +  +      D++  G ++ E+ T R PI
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 228

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 27/215 (12%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKNLLGLRG 104
           K+G+G FG V+  R    G ++A+KK+   N K         E+++L  ++H+N++ L  
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 105 YC---AGTDQRL-----IVYDYMPN--LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
            C   A    R      +V+D+  +    LLS++  ++      + KR M++ +    G+
Sbjct: 85  ICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLS---EIKRVMQMLLN---GL 138
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG---TLGY 211
            Y+H      I+HRD+KA+NVL+  D    +ADFG A+      +    R      TL Y
Sbjct: 139 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 212 LAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPI 245
             PE  +  +      D++  G ++ E+ T R PI
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 27/215 (12%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKNLLGLRG 104
           K+G+G FG V+  R    G ++A+KK+   N K         E+++L  ++H+N++ L  
Sbjct: 25  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 84
Query: 105 YC---AGTDQRL-----IVYDYMPN--LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
            C   A    R      +V+D+  +    LLS++  ++      + KR M++ +    G+
Sbjct: 85  ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLS---EIKRVMQMLLN---GL 138
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG---TLGY 211
            Y+H      I+HRD+KA+NVL+  D    +ADFG A+      +    R      TL Y
Sbjct: 139 YYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 212 LAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPI 245
             PE  +  +      D++  G ++ E+ T R PI
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI 229

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 16/215 (7%)
Query: 45  DDNKLGEGGFGSVYWG-----RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL 99
           +D +LG G FG+V  G     +    + + + K +A +   + E   E  V+ ++ +  +
Sbjct: 15  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           + + G C      L++      ++ L  L+        +  K  +++    + G+ YL  
Sbjct: 75  VRMIGICEAESWMLVM-----EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 129
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI--PEGVSHMTTRVKGTLGYLAPEYA 217
               + +HRD+ A NVLL +     ++DFG +K +   E      T  K  + + APE  
Sbjct: 130 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECI 186
Query: 218 MWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGG 251
            + K S   DV+SFG+L+ E  + G+KP   + G 
Sbjct: 187 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 221

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 16/215 (7%)
Query: 45  DDNKLGEGGFGSVYWG-----RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL 99
           +D +LG G FG+V  G     +    + + + K +A +   + E   E  V+ ++ +  +
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           + + G C      L++      ++ L  L+        +  K  +++    + G+ YL  
Sbjct: 81  VRMIGICEAESWMLVM-----EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI--PEGVSHMTTRVKGTLGYLAPEYA 217
               + +HRD+ A NVLL +     ++DFG +K +   E      T  K  + + APE  
Sbjct: 136 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192
Query: 218 MWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGG 251
            + K S   DV+SFG+L+ E  + G+KP   + G 
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 227

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 14/218 (6%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           LGEG +G V       T + + + +  +K      E     E+ +   + H+N++   G+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEIXINKMLNHENVVKFYGH 73
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               + + +  +Y     L   +     G  + D +R     +    G++YLH      I
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMA---GVVYLH---GIGI 126
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIP-EGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
            HRDIK  N+LLD      ++DFG A +        +  ++ GTL Y+APE     +  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 186
Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE 261
           E  DV+S GI+L  +L G  P ++ P    +  ++W E
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKE 223

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 16/215 (7%)
Query: 45  DDNKLGEGGFGSVYWG-----RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL 99
           +D +LG G FG+V  G     +    + + + K +A +   + E   E  V+ ++ +  +
Sbjct: 9   EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           + + G C      L++      ++ L  L+        +  K  +++    + G+ YL  
Sbjct: 69  VRMIGICEAESWMLVM-----EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 123
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI--PEGVSHMTTRVKGTLGYLAPEYA 217
               + +HRD+ A NVLL +     ++DFG +K +   E      T  K  + + APE  
Sbjct: 124 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 180
Query: 218 MWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGG 251
            + K S   DV+SFG+L+ E  + G+KP   + G 
Sbjct: 181 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 215

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 110/232 (47%), Gaps = 36/232 (15%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHK 97
            ++D   +G G FG VY  +  D G  +A+KK+   K   ++       E++++ ++ H 
Sbjct: 33  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 85
Query: 98  NLLGLRGYCAGTDQRL------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
           N++ LR +   + ++       +V DY+P        H  Y+   Q      +K+ +   
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQL 143
Query: 152 -EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEG---VSHMTTRVK 206
              + Y+H      I HRDIK  N+LLD D   L + DFG AK +  G   VS + +R  
Sbjct: 144 FRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY- 199
Query: 207 GTLGYLAPEYAMWGKV--SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
               Y APE  ++G    + S DV+S G +L E+L G +PI     GV + +
Sbjct: 200 ----YRAPEL-IFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 245

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 69/146 (47%), Gaps = 10/146 (6%)
Query: 165 IIHRDIKASNVLL---DSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK 221
           ++HRD+K  N+L    + + E  + DFGFA+L P     + T    TL Y APE      
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAAPELLNQNG 185
Query: 222 VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF 281
             ESCD++S G++L  +L+G+ P +     +  T        I KG F         G+ 
Sbjct: 186 YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF------SFEGEA 239
Query: 282 DENQLKQAINVAVLCVQSEPEKRPNM 307
            +N  ++A ++    +  +P KR  M
Sbjct: 240 WKNVSQEAKDLIQGLLTVDPNKRLKM 265

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 93/204 (45%), Gaps = 17/204 (8%)
Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           +G+G F  V   R    G ++A+K +    +N  +  +   EV ++  + H N++ L   
Sbjct: 20  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 106 CAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                   ++ +Y     +  +L  HG+   E +   K R  ++      + Y H +   
Sbjct: 80  IETEKTLYLIMEYASGGEVFDYLVAHGRMK-EKEARSKFRQIVS-----AVQYCHQK--- 130
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
            I+HRD+KA N+LLD+D    +ADFGF+     G    T    G+  Y APE     K  
Sbjct: 131 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDT--FCGSPPYAAPELFQGKKYD 188
Query: 224 -ESCDVYSFGILLLEILTGRKPIE 246
               DV+S G++L  +++G  P +
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLPFD 212

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 8/176 (4%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++GL              D    + L+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 126 SHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV 185
                Q   +++LD +R   +      GI +LH   +  IIHRD+K SN+++ SD    +
Sbjct: 112 DANLSQVI-QMELDHERMSYLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKI 167
Query: 186 ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTG 241
            DFG A+    G S M T    T  Y APE  +     E+ D++S G+++ E++ G
Sbjct: 168 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 34/231 (14%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHK 97
            ++D   +G G FG VY  +  D G  +A+KK+   K   ++       E++++ ++ H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 73
Query: 98  NLLGLRGYCAGTDQRL------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
           N++ LR +   + ++       +V DY+P        H  Y+   Q      +K+ +   
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQL 131
Query: 152 -EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEG---VSHMTTRVK 206
              + Y+H   +  I HRDIK  N+LLD D   L + DFG AK +  G   VS + +R  
Sbjct: 132 FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY- 187
Query: 207 GTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
               Y APE        + S DV+S G +L E+L G +PI     GV + +
Sbjct: 188 ----YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 233

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 36/232 (15%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHK 97
            ++D   +G G FG VY  +  D G  +A+KK+   K   ++       E++++ ++ H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 73
Query: 98  NLLGLRGYCAGTDQRL------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
           N++ LR +   + ++       +V DY+P        H  Y+   Q      +K+ +   
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQL 131
Query: 152 -EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEG---VSHMTTRVK 206
              + Y+H   +  I HRDIK  N+LLD D   L + DFG AK +  G   VS + +R  
Sbjct: 132 FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY- 187
Query: 207 GTLGYLAPEYAMWGKV--SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
               Y APE  ++G    + S DV+S G +L E+L G +PI     GV + +
Sbjct: 188 ----YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 233

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 126/297 (42%), Gaps = 52/297 (17%)
Query: 49  LGEGGFGSVYWGRTSDGLQ-------IAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLL 100
           LGEG FG V    T+  L+       +AVK LK   S +E+ +   E  VL +V H +++
Sbjct: 31  LGEGEFGKVV-KATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQ--------------------YAGEVQLDW 140
            L G C+     L++ +Y    SL   L                       +  E  L  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 141 KRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH 200
              +  A   ++G+ YL       ++HRD+ A N+L+    +  ++DFG ++ + E  S+
Sbjct: 150 GDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 201 MTTRVKGTL--GYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTIT 257
           +  R +G +   ++A E       +   DV+SFG+LL EI+T G  P   +P        
Sbjct: 207 V-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP-------- 257
Query: 258 EWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                     +   L+    R +  +N  ++   + + C + EP+KRP   ++   L
Sbjct: 258 --------PERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 86/176 (48%), Gaps = 8/176 (4%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++GL              D    + L+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 126 SHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV 185
                Q   +++LD +R   +      GI +LH   +  IIHRD+K SN+++ SD    +
Sbjct: 112 DANLSQVI-QMELDHERMSYLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKI 167
Query: 186 ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTG 241
            DFG A+    G S M T    T  Y APE  +     E+ D++S G+++ E++ G
Sbjct: 168 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKG 221

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 16/215 (7%)
Query: 45  DDNKLGEGGFGSVYWG-----RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL 99
           +D +LG G FG+V  G     +    + + + K +A +   + E   E  V+ ++ +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           + + G C      L++      ++ L  L+        +  K  +++    + G+ YL  
Sbjct: 71  VRMIGICEAESWMLVM-----EMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEE 125
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI--PEGVSHMTTRVKGTLGYLAPEYA 217
               + +HRD+ A NVLL +     ++DFG +K +   E      T  K  + + APE  
Sbjct: 126 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182
Query: 218 MWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGG 251
            + K S   DV+SFG+L+ E  + G+KP   + G 
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 217

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 94/230 (40%), Gaps = 23/230 (10%)
Query: 29  RIFTYKELHTATNG---FSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFA 85
           R   +K L     G   F D   LG GGFG V+  +       A  KL A     +    
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMK-----ATGKLYACKKLNKKRLK 224
Query: 86  ---------VEVEVLGRVRHKNLLGLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGE 135
                    VE ++L +V  + ++ L  Y   T   L +V   M    +  H++      
Sbjct: 225 KRKGYQGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283
Query: 136 VQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP 195
                 R +        G+ +LH     +II+RD+K  NVLLD D    ++D G A  + 
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
            G +  T    GT G++APE  +  +   S D ++ G+ L E++  R P 
Sbjct: 341 AGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 67/232 (28%), Positives = 111/232 (47%), Gaps = 36/232 (15%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHK 97
            ++D   +G G FG VY  +  D G  +A+KK+   K   ++       E++++ ++ H 
Sbjct: 22  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 74
Query: 98  NLLGLRGYCAGTDQRL------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
           N++ LR +   + ++       +V DY+P        H  Y+   Q      +K+ +   
Sbjct: 75  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQL 132
Query: 152 -EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEG---VSHMTTRVK 206
              + Y+H   +  I HRDIK  N+LLD D   L + DFG AK +  G   VS + +R  
Sbjct: 133 FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY- 188
Query: 207 GTLGYLAPEYAMWGKV--SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
               Y APE  ++G    + S DV+S G +L E+L G +PI     GV + +
Sbjct: 189 ----YRAPE-LIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 234

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 14/218 (6%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           LGEG +G V       T + + + +  +K      E     E+ +   + H+N++   G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEIXINKMLNHENVVKFYGH 72
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               + + +  +Y     L   +     G  + D +R     +    G++YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMA---GVVYLH---GIGI 125
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIP-EGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
            HRDIK  N+LLD      ++DFG A +        +  ++ GTL Y+APE     +  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE 261
           E  DV+S GI+L  +L G  P ++ P    +  ++W E
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKE 222

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 108/231 (46%), Gaps = 34/231 (14%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHK 97
            ++D   +G G FG VY  +  D G  +A+KK+   K   ++       E++++ ++ H 
Sbjct: 25  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHC 77
Query: 98  NLLGLRGYCAGTDQRL------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
           N++ LR +   + ++       +V DY+P        H  Y+   Q      +K+ +   
Sbjct: 78  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARH--YSRAKQTLPVIYVKLYMYQL 135
Query: 152 -EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEG---VSHMTTRVK 206
              + Y+H   +  I HRDIK  N+LLD D   L + DFG AK +  G   VS + +R  
Sbjct: 136 FRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRY- 191
Query: 207 GTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI 256
               Y APE        + S DV+S G +L E+L G +PI     GV + +
Sbjct: 192 ----YRAPELIFGATDYTSSIDVWSAGCVLAELLLG-QPIFPGDSGVDQLV 237

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/228 (24%), Positives = 96/228 (42%), Gaps = 38/228 (16%)
Query: 49  LGEGGFGSVYWGRTSDGL------QIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +GEG FG V+  R    L       +AVK LK   ++  + +F  E  ++    + N++ 
Sbjct: 55  IGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVK 114
Query: 102 LRGYCAGTDQRLIVYDYMP--------------NLSLLSH------LHGQYAGEVQLDWK 141
           L G CA      ++++YM                +  LSH            G   L   
Sbjct: 115 LLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCA 174
Query: 142 RRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM 201
            ++ IA   A G+ YL        +HRD+   N L+  +    +ADFG ++ I    S  
Sbjct: 175 EQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI---YSAD 228
Query: 202 TTRVKGT----LGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
             +  G     + ++ PE   + + +   DV+++G++L EI + G +P
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 94/230 (40%), Gaps = 23/230 (10%)
Query: 29  RIFTYKELHTATNG---FSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFA 85
           R   +K L     G   F D   LG GGFG V+  +       A  KL A     +    
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMK-----ATGKLYACKKLNKKRLK 224
Query: 86  ---------VEVEVLGRVRHKNLLGLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGE 135
                    VE ++L +V  + ++ L  Y   T   L +V   M    +  H++      
Sbjct: 225 KRKGYQGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283
Query: 136 VQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP 195
                 R +        G+ +LH     +II+RD+K  NVLLD D    ++D G A  + 
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
            G +  T    GT G++APE  +  +   S D ++ G+ L E++  R P 
Sbjct: 341 AGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 94/230 (40%), Gaps = 23/230 (10%)
Query: 29  RIFTYKELHTATNG---FSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFA 85
           R   +K L     G   F D   LG GGFG V+  +       A  KL A     +    
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMK-----ATGKLYACKKLNKKRLK 224
Query: 86  ---------VEVEVLGRVRHKNLLGLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGE 135
                    VE ++L +V  + ++ L  Y   T   L +V   M    +  H++      
Sbjct: 225 KRKGYQGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283
Query: 136 VQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP 195
                 R +        G+ +LH     +II+RD+K  NVLLD D    ++D G A  + 
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
            G +  T    GT G++APE  +  +   S D ++ G+ L E++  R P 
Sbjct: 341 AGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 94/230 (40%), Gaps = 23/230 (10%)
Query: 29  RIFTYKELHTATNG---FSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFA 85
           R   +K L     G   F D   LG GGFG V+  +       A  KL A     +    
Sbjct: 170 RFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMK-----ATGKLYACKKLNKKRLK 224
Query: 86  ---------VEVEVLGRVRHKNLLGLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGE 135
                    VE ++L +V  + ++ L  Y   T   L +V   M    +  H++      
Sbjct: 225 KRKGYQGAMVEKKILAKVHSRFIVSL-AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283
Query: 136 VQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP 195
                 R +        G+ +LH     +II+RD+K  NVLLD D    ++D G A  + 
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
            G +  T    GT G++APE  +  +   S D ++ G+ L E++  R P 
Sbjct: 341 AGQTK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 14/218 (6%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           LGEG +G V       T + + + +  +K      E     E+ +   + H+N++   G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 72
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               + + +  +Y     L   +     G  + D +R     +    G++YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMA---GVVYLH---GIGI 125
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIP-EGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
            HRDIK  N+LLD      ++DFG A +        +  ++ GTL Y+APE     +  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE 261
           E  DV+S GI+L  +L G  P ++ P    +  ++W E
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQ-PSDSXQEYSDWKE 222

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/288 (22%), Positives = 122/288 (42%), Gaps = 37/288 (12%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG 108
           +G+G FG VY GR    + I +  ++  N      F  EV    + RH+N++   G C  
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 109 TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHR 168
                I+       +L S +      ++ LD  +  +IA    +G+ YLH      I+H+
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHK 154
Query: 169 DIKASNVLLDSDFEPLVADFGF---AKLIPEGVSHMTTRVK-GTLGYLAPEYAMWGK--- 221
           D+K+ NV  D+  + ++ DFG    + ++  G      R++ G L +LAPE         
Sbjct: 155 DLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213
Query: 222 ------VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP 275
                  S+  DV++ G +  E+     P +  P          AE +I +      +  
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP----------AEAIIWQ------MGT 257
Query: 276 KLRGDFDENQL-KQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGK 322
            ++ +  +  + K+  ++ + C   E E+RP   ++++ L     R +
Sbjct: 258 GMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR 305

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 106/233 (45%), Gaps = 43/233 (18%)
Query: 48  KLGEGGFGSVYWG---RTSDGLQIAVKKL--KAMNSKAEMEFAVEVEVLGRVR-HKNLLG 101
           KLG+G +G V+     RT  G  +AVKK+     NS        E+ +L  +  H+N++ 
Sbjct: 16  KLGKGAYGIVWKSIDRRT--GEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVN 73
Query: 102 LRGYCAGTDQR--LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           L       + R   +V+DYM      + LH      + L+   +  +     + I YLH 
Sbjct: 74  LLNVLRADNDRDVYLVFDYME-----TDLHAVIRANI-LEPVHKQYVVYQLIKVIKYLH- 126
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL----------IPEGVSHMT------- 202
             +  ++HRD+K SN+LL+++    VADFG ++           IP  ++  T       
Sbjct: 127 --SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 203 ---TRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGG 251
              T    T  Y APE  +   K ++  D++S G +L EIL G KPI   PG 
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG-KPI--FPGS 234

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 77/323 (23%), Positives = 136/323 (42%), Gaps = 43/323 (13%)
Query: 36  LHTATNGFSDD----NKLGEGGFGSVYWG-RTSDGLQIAVKKL--KAMNSKAEMEFAVEV 88
           +  A+  FSD+     +LG+G F  V      + GL+ A K +  K ++++   +   E 
Sbjct: 20  MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 89  EVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHG-QYAGEVQLDWKRRMKIA 147
            +  +++H N++ L           +V+D +    L   +   ++  E       +  + 
Sbjct: 80  RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL- 138
Query: 148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL---VADFGFAKLIPEGVSHMTTR 204
               E I Y H   +  I+HR++K  N+LL S  +     +ADFG A  I    S     
Sbjct: 139 ----ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHG 189
Query: 205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI-----EKLPGGVKRTITEW 259
             GT GYL+PE       S+  D+++ G++L  +L G  P       +L   +K    ++
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 249
Query: 260 AEPL--IVKGKFKELVD------PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
             P    V  + K L+D      PK R   D     QA+ V  +C +       + ++ V
Sbjct: 250 PSPEWDTVTPEAKSLIDSMLTVNPKKRITAD-----QALKVPWICNRERVASAIHRQDTV 304
Query: 312 NTLTGYDPR----GKVMQTRIET 330
           + L  ++ R    G ++ T I T
Sbjct: 305 DCLKKFNARRKLKGAILTTMIAT 327

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 39/216 (18%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFA-VEVEVLGRV-RHKNLLGLR 103
           +G G +  V   R   T     + V K + +N   ++++   E  V  +   H  L+GL 
Sbjct: 28  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 87
Query: 104 GYCAGTDQRLI-VYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAIGSAE 152
             C  T+ RL  V +Y+    L+ H+  Q          Y+ E+ L              
Sbjct: 88  S-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL-------------- 132
Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS--HMTTRVKGTLG 210
            + YLH      II+RD+K  NVLLDS+    + D+G  K   EG+     T+   GT  
Sbjct: 133 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPN 186
Query: 211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
           Y+APE         S D ++ G+L+ E++ GR P +
Sbjct: 187 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 222

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 93/217 (42%), Gaps = 38/217 (17%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEM------EFAVEVEVLGRVRHKNLL 100
           +LG G F  V   R  S GL+ A K +K   S+A        E   EV +L +V H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78
Query: 101 GLRG-YCAGTDQRLIV--------YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
            L   Y   TD  LI+        +D++     LS        +  LD            
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD------------ 126
Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKG 207
            G+ YLH   T  I H D+K  N++L     P+    + DFG A  I +GV      + G
Sbjct: 127 -GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFG 180
Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           T  ++APE   +  +    D++S G++   +L+G  P
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 93/210 (44%), Gaps = 28/210 (13%)
Query: 50  GEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT 109
             G FG V W        +AVK +  +  K   +   EV  L  ++H+N+L       G 
Sbjct: 33  ARGRFGCV-WKAQLLNEYVAVK-IFPIQDKQSWQNEYEVYSLPGMKHENILQF----IGA 86
Query: 110 DQRLIVYDYMPNLSLLSHLH-----GQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV--- 161
           ++R    D   +L L++  H       +     + W     IA   A G+ YLH ++   
Sbjct: 87  EKRGTSVDV--DLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGL 144
Query: 162 ----TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK-GTLGYLAPEY 216
                P I HRDIK+ NVLL ++    +ADFG A     G S   T  + GT  Y+APE 
Sbjct: 145 KDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE- 203
Query: 217 AMWGKVSES------CDVYSFGILLLEILT 240
            + G ++         D+Y+ G++L E+ +
Sbjct: 204 VLEGAINFQRDAFLRIDMYAMGLVLWELAS 233

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 74/291 (25%), Positives = 130/291 (44%), Gaps = 47/291 (16%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKK-LKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           LG G  G+V +  +  G  +AVK+ L      A ME  +  E      H N++  R YC+
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTE---SDDHPNVI--RYYCS 77
Query: 108 -GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRR---MKIAIGSAEGILYLHHEVTP 163
             TD+ L +   + NL+L   +  +   +  L  ++    + +    A G+ +LH   + 
Sbjct: 78  ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SL 134
Query: 164 HIIHRDIKASNVLLDS-------------DFEPLVADFGFAKLIPEGVSHMTTRVK---G 207
            IIHRD+K  N+L+ +             +   L++DFG  K +  G S   T +    G
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSG 194
Query: 208 TLGYLAPEYAMWG-------KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWA 260
           T G+ APE            +++ S D++S G +   IL+  K     P G K +     
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH----PFGDKYS----R 246
Query: 261 EPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
           E  I++G F   +D +++   D + + +A ++    +  +P KRP   +V+
Sbjct: 247 ESNIIRGIFS--LD-EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 14/218 (6%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           LGEG +G V       T + + + +  +K      E     E+ +   + H+N++   G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEIXINKMLNHENVVKFYGH 72
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               + + +  +Y     L   +     G  + D +R     +    G++YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMA---GVVYLH---GIGI 125
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIP-EGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
            HRDIK  N+LLD      ++DFG A +        +  ++ GTL Y+APE     +  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE 261
           E  DV+S GI+L  +L G  P ++ P    +  ++W E
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKE 222

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 12/217 (5%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVL--GRVRHKNLLGLRGYC 106
           LGEG +G V         +    K+  M    +    ++ E+     + H+N++   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHR 74
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
              + + +  +Y     L   +     G  + D +R     +    G++YLH      I 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMA---GVVYLH---GIGIT 127
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIP-EGVSHMTTRVKGTLGYLAPEYAMWGKV-SE 224
           HRDIK  N+LLD      ++DFG A +        +  ++ GTL Y+APE     +  +E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 225 SCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE 261
             DV+S GI+L  +L G  P ++ P    +  ++W E
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKE 223

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/164 (30%), Positives = 74/164 (45%), Gaps = 34/164 (20%)
Query: 96  HKNLLGLRGYCAGTDQRLI-VYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRM 144
           H  L+GL   C  T+ RL  V +Y+    L+ H+  Q          Y+ E+ L      
Sbjct: 112 HPFLVGLHS-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL------ 164
Query: 145 KIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV--SHMT 202
                    + YLH      II+RD+K  NVLLDS+    + D+G  K   EG+     T
Sbjct: 165 --------ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTT 210
Query: 203 TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
           +   GT  Y+APE         S D ++ G+L+ E++ GR P +
Sbjct: 211 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 39/216 (18%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFA-VEVEVLGRV-RHKNLLGLR 103
           +G G +  V   R   T     + V K + +N   ++++   E  V  +   H  L+GL 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 104 GYCAGTDQRLI-VYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAIGSAE 152
             C  T+ RL  V +Y+    L+ H+  Q          Y+ E+ L              
Sbjct: 77  S-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL-------------- 121
Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV--SHMTTRVKGTLG 210
            + YLH      II+RD+K  NVLLDS+    + D+G  K   EG+     T+   GT  
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPN 175
Query: 211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
           Y+APE         S D ++ G+L+ E++ GR P +
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 94/226 (41%), Gaps = 20/226 (8%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEME------FAVEVEVLGRVRHKNLLGL 102
           +G+G FG V   + +D  ++    +K MN +  +E         E++++  + H  L+ L
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYA--MKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
                  +   +V D +    L  HL      + +        + +   E ++ L +   
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEE-------TVKLFICELVMALDYLQN 133
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK- 221
             IIHRD+K  N+LLD      + DF  A ++P       T + GT  Y+APE     K 
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ--ITTMAGTKPYMAPEMFSSRKG 191
Query: 222 --VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIV 265
              S + D +S G+   E+L GR+P         + I    E  +V
Sbjct: 192 AGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV 237

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 26/211 (12%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEM------EFAVEVEVLGRVRHKNLL 100
           +LG G F  V   R  S GL+ A K +K   S+A        E   EV +L +V H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 101 GLRG-YCAGTDQRLIVYDYMPNLSLLS--HLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
            L   Y   TD  LI       L L+S   L    A +  L  +          +G+ YL
Sbjct: 79  TLHDVYENRTDVVLI-------LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLA 213
           H   T  I H D+K  N++L     P+    + DFG A  I +GV      + GT  ++A
Sbjct: 132 H---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVA 186
Query: 214 PEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           PE   +  +    D++S G++   +L+G  P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 94/216 (43%), Gaps = 39/216 (18%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFA-VEVEVLGRV-RHKNLLGLR 103
           +G G +  V   R   T     + V K + +N   ++++   E  V  +   H  L+GL 
Sbjct: 13  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 72
Query: 104 GYCAGTDQRLI-VYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAIGSAE 152
             C  T+ RL  V +Y+    L+ H+  Q          Y+ E+ L              
Sbjct: 73  S-CFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL-------------- 117
Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS--HMTTRVKGTLG 210
            + YLH      II+RD+K  NVLLDS+    + D+G  K   EG+     T+   GT  
Sbjct: 118 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSXFCGTPN 171
Query: 211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
           Y+APE         S D ++ G+L+ E++ GR P +
Sbjct: 172 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 207

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 14/218 (6%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           LGEG +G V       T + + + +  +K      E     E+ +   + H+N++   G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 72
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               + + +  +Y     L   +     G  + D +R     +    G++YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMA---GVVYLH---GIGI 125
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIP-EGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
            HRDIK  N+LLD      ++DFG A +        +  ++ GTL Y+APE     +  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE 261
           E  DV+S GI+L  +L G  P ++ P    +  ++W E
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKE 222

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 14/218 (6%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           LGEG +G V       T + + + +  +K      E     E+ +   + H+N++   G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 72
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               + + +  +Y     L   +     G  + D +R     +    G++YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMA---GVVYLH---GIGI 125
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIP-EGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
            HRDIK  N+LLD      ++DFG A +        +  ++ GTL Y+APE     +  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE 261
           E  DV+S GI+L  +L G  P ++ P    +  ++W E
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKE 222

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 49  LGEGGFGSV----YWGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGLR 103
           +GEG FG V    Y    +  + +A+K  K   S +  E F  E   + +  H +++ L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHG-QYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G        +I+      L  L  L       +  LD    +  A   +  + YL  +  
Sbjct: 78  GVITENPVWIIM-----ELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESK-- 130
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
              +HRDI A NVL+ +     + DFG ++ + +   +  ++ K  + ++APE   + + 
Sbjct: 131 -RFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 223 SESCDVYSFGILLLEILT-GRKPIE 246
           + + DV+ FG+ + EIL  G KP +
Sbjct: 190 TSASDVWMFGVCMWEILMHGVKPFQ 214

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 31/217 (14%)
Query: 49  LGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYC 106
           LG GGFG V+  +   D    A+K+++  N +   E  + EV+ L ++ H  ++  R + 
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV--RYFN 70
Query: 107 A----GTDQRLI-----VYDYMP-NLSLLSHLHGQYAGEVQLDWKRR---MKIAIGSAEG 153
           A     T ++L      VY Y+   L    +L     G   ++ + R   + I +  AE 
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEA 130
Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT--------RV 205
           + +LH   +  ++HRD+K SN+    D    V DFG    + +     T         R 
Sbjct: 131 VEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187
Query: 206 KGTLG---YLAPEYAMWGKVSESCDVYSFGILLLEIL 239
            G +G   Y++PE       S   D++S G++L E+L
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 26/211 (12%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEM------EFAVEVEVLGRVRHKNLL 100
           +LG G F  V   R  S GL+ A K +K   S+A        E   EV +L +V H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 101 GLRG-YCAGTDQRLIVYDYMPNLSLLS--HLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
            L   Y   TD  LI       L L+S   L    A +  L  +          +G+ YL
Sbjct: 79  TLHDVYENRTDVVLI-------LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLA 213
           H   T  I H D+K  N++L     P+    + DFG A  I +GV      + GT  ++A
Sbjct: 132 H---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVA 186
Query: 214 PEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           PE   +  +    D++S G++   +L+G  P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRVRHK 97
            F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  + H 
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHP 69
Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
           N++ L       ++  +V++++ +  L   +       + L   +     +   +G+ + 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFC 126
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           H      ++HRD+K  N+L++++    +ADFG A+     V   T  V  TL Y APE  
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 182
Query: 218 MWGK-VSESCDVYSFGILLLEILTGR 242
           +  K  S + D++S G +  E++T R
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 15/205 (7%)
Query: 49  LGEGGFGSV----YWGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGLR 103
           +GEG FG V    Y    +  + +A+K  K   S +  E F  E   + +  H +++ L 
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 457
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHG-QYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           G        +I+      L  L  L       +  LD    +  A   +  + YL    +
Sbjct: 458 GVITENPVWIIM-----ELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLE---S 509
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
              +HRDI A NVL+ +     + DFG ++ + +   +  ++ K  + ++APE   + + 
Sbjct: 510 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 223 SESCDVYSFGILLLEILT-GRKPIE 246
           + + DV+ FG+ + EIL  G KP +
Sbjct: 570 TSASDVWMFGVCMWEILMHGVKPFQ 594

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 26/211 (12%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEM------EFAVEVEVLGRVRHKNLL 100
           +LG G F  V   R  S GL+ A K +K   S+A        E   EV +L +V H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 101 GLRG-YCAGTDQRLIVYDYMPNLSLLS--HLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
            L   Y   TD  LI       L L+S   L    A +  L  +          +G+ YL
Sbjct: 79  TLHDVYENRTDVVLI-------LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLA 213
           H   T  I H D+K  N++L     P+    + DFG A  I +GV      + GT  ++A
Sbjct: 132 H---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEF--KNIFGTPEFVA 186
Query: 214 PEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           PE   +  +    D++S G++   +L+G  P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 26/211 (12%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEM------EFAVEVEVLGRVRHKNLL 100
           +LG G F  V   R  S GL+ A K +K   S+A        E   EV +L +V H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 101 GLRG-YCAGTDQRLIVYDYMPNLSLLS--HLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
            L   Y   TD  LI       L L+S   L    A +  L  +          +G+ YL
Sbjct: 79  TLHDVYENRTDVVLI-------LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLA 213
           H   T  I H D+K  N++L     P+    + DFG A  I +GV      + GT  ++A
Sbjct: 132 H---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVA 186
Query: 214 PEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           PE   +  +    D++S G++   +L+G  P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 101/209 (48%), Gaps = 13/209 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRV 94
           +   F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 60
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
            H N++ L       ++  +V++++ +  L   +       + L   +     +   +G+
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 117
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            + H      ++HRD+K  N+L++++    +ADFG A+     V   T  V  TL Y AP
Sbjct: 118 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAP 173
Query: 215 EYAMWGK-VSESCDVYSFGILLLEILTGR 242
           E  +  K  S + D++S G +  E++T R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRVRHK 97
            F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  + H 
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHP 69
Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
           N++ L       ++  +V++++ +  L   +       + L   +     +   +G+ + 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFC 126
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           H      ++HRD+K  N+L++++    +ADFG A+     V   T  V  TL Y APE  
Sbjct: 127 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 182
Query: 218 MWGK-VSESCDVYSFGILLLEILTGR 242
           +  K  S + D++S G +  E++T R
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVTRR 208

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRVRHK 97
            F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  + H 
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHP 66
Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
           N++ L       ++  +V++++ +  L   +       + L   +     +   +G+ + 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFC 123
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           H      ++HRD+K  N+L++++    +ADFG A+     V   T  V  TL Y APE  
Sbjct: 124 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 179
Query: 218 MWGK-VSESCDVYSFGILLLEILTGR 242
           +  K  S + D++S G +  E++T R
Sbjct: 180 LGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 105/222 (47%), Gaps = 28/222 (12%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVR 95
           AT+ +    ++G G +G+VY  R    G  +A+K ++  N +  +  +   EV +L R+ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 96  ---HKNLLGLRGYCAG--TDQRL---IVYDYMPNLSLLSHLHGQ----YAGEVQLDWKRR 143
              H N++ L   CA   TD+ +   +V++++ +  L ++L          E   D  R+
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT 203
                    G+ +LH      I+HRD+K  N+L+ S     +ADFG A++    ++    
Sbjct: 121 F------LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPV 171
Query: 204 RVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
            V  TL Y APE  +    +   D++S G +  E+   RKP+
Sbjct: 172 VV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 93/211 (44%), Gaps = 26/211 (12%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEM------EFAVEVEVLGRVRHKNLL 100
           +LG G F  V   R  S GL+ A K +K   S+A        E   EV +L +V H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78
Query: 101 GLRG-YCAGTDQRLIVYDYMPNLSLLS--HLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
            L   Y   TD  LI       L L+S   L    A +  L  +          +G+ YL
Sbjct: 79  TLHDVYENRTDVVLI-------LELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYL 131
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLA 213
           H   T  I H D+K  N++L     P+    + DFG A  I +GV      + GT  ++A
Sbjct: 132 H---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN--IFGTPEFVA 186
Query: 214 PEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           PE   +  +    D++S G++   +L+G  P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRVRHK 97
            F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  + H 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHP 62
Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
           N++ L       ++  +V++++ +  L   +       + L   +     +   +G+ + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFC 119
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           H      ++HRD+K  N+L++++    +ADFG A+     V   T  V  TL Y APE  
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 175
Query: 218 MWGK-VSESCDVYSFGILLLEILTGR 242
           +  K  S + D++S G +  E++T R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRVRHK 97
            F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  + H 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHP 61
Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
           N++ L       ++  +V++++ +  L   +       + L   +     +   +G+ + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFC 118
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           H      ++HRD+K  N+L++++    +ADFG A+     V   T  V  TL Y APE  
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 174
Query: 218 MWGK-VSESCDVYSFGILLLEILTGR 242
           +  K  S + D++S G +  E++T R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRVRHK 97
            F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  + H 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHP 61
Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
           N++ L       ++  +V++++ +  L   +       + L   +     +   +G+ + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFC 118
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           H      ++HRD+K  N+L++++    +ADFG A+     V   T  V  TL Y APE  
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 174
Query: 218 MWGK-VSESCDVYSFGILLLEILTGR 242
           +  K  S + D++S G +  E++T R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRVRHK 97
            F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  + H 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHP 62
Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
           N++ L       ++  +V++++ +  L   +       + L   +     +   +G+ + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFC 119
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           H      ++HRD+K  N+L++++    +ADFG A+     V   T  V  TL Y APE  
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 175
Query: 218 MWGK-VSESCDVYSFGILLLEILTGR 242
           +  K  S + D++S G +  E++T R
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/204 (25%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           +G+G F  V   R    G ++A+K +    +N  +  +   EV ++  + H N++ L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 106 CAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                   ++ +Y     +  +L  HG+   E +   K R  ++      + Y H +   
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAHGRMK-EKEARSKFRQIVS-----AVQYCHQK--- 133
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
            I+HRD+KA N+LLD+D    +ADFGF+      V        G   Y APE     K  
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFT--VGGKLDAFCGAPPYAAPELFQGKKYD 191
Query: 224 -ESCDVYSFGILLLEILTGRKPIE 246
               DV+S G++L  +++G  P +
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLPFD 215

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRVRHK 97
            F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  + H 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHP 62
Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
           N++ L       ++  +V++++ +  L   +       + L   +     +   +G+ + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFC 119
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           H      ++HRD+K  N+L++++    +ADFG A+     V   T  V  TL Y APE  
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 175
Query: 218 MWGK-VSESCDVYSFGILLLEILTGR 242
           +  K  S + D++S G +  E++T R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 101/209 (48%), Gaps = 13/209 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRV 94
           +   F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 62
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
            H N++ L       ++  +V++++ ++ L   +       + L   +     +   +G+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 119
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            + H      ++HRD+K  N+L++++    +ADFG A+     V      V  TL Y AP
Sbjct: 120 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 175
Query: 215 EYAMWGK-VSESCDVYSFGILLLEILTGR 242
           E  +  K  S + D++S G +  E++T R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/211 (28%), Positives = 101/211 (47%), Gaps = 22/211 (10%)
Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLKAMNSKAEMEFAV------EVEVLGRVRHKNLLG 101
           LGEG F +VY  R  +  QI A+KK+K +  ++E +  +      E+++L  + H N++G
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIK-LGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 102 LRGYCAGTDQRLIVYDYM-PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           L           +V+D+M  +L ++   +        +     M +     +G+ YLH  
Sbjct: 77  LLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTL-----QGLEYLHQH 131
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
               I+HRD+K +N+LLD +    +ADFG AK           +V  T  Y APE     
Sbjct: 132 ---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV-TRWYRAPELLFGA 187
Query: 221 KV-SESCDVYSFGILLLEILTGRKPIEKLPG 250
           ++     D+++ G +L E+L  R P   LPG
Sbjct: 188 RMYGVGVDMWAVGCILAELLL-RVPF--LPG 215

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 88/205 (42%), Gaps = 20/205 (9%)
Query: 49  LGEGGFGSVYWG---RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           LG G F  V      RT   + I     KA+  K E     E+ VL +++H N++ L   
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKIKHPNIVALDDI 84
Query: 106 CAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                   ++   +    L   +   G Y        +   ++     + + YLH     
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTE------RDASRLIFQVLDAVKYLH---DL 135
Query: 164 HIIHRDIKASNVL---LDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
            I+HRD+K  N+L   LD D + +++DFG +K+  E    + +   GT GY+APE     
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 221 KVSESCDVYSFGILLLEILTGRKPI 245
             S++ D +S G++   +L G  P 
Sbjct: 194 PYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 100/220 (45%), Gaps = 28/220 (12%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGRTSD---GLQIAVKKLKAMNSKAEMEFAVEVEV 90
           +E+H AT+      +LG G FG V+  R  D   G Q AVKK++    +AE     E+  
Sbjct: 90  EEVHWATHQL----RLGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRAE-----ELMA 138
Query: 91  LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
              +    ++ L G         I  + +   SL     GQ   E     + R    +G 
Sbjct: 139 CAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSL-----GQLVKEQGCLPEDRALYYLGQ 193
Query: 151 A-EGILYLHHEVTPHIIHRDIKASNVLLDSD-FEPLVADFGFA-KLIPEGV--SHMT-TR 204
           A EG+ YLH      I+H D+KA NVLL SD     + DFG A  L P+G+  S +T   
Sbjct: 194 ALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDY 250
Query: 205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           + GT  ++APE  +        DV+S   ++L +L G  P
Sbjct: 251 IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 91/211 (43%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           +G G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +YMP   + SHL         H + YA ++ L ++             
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFE------------- 155
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+L+D      VADFGFAK     V   T  + GT  YLAP
Sbjct: 156 -YLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 101/209 (48%), Gaps = 13/209 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRV 94
           +   F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 62
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
            H N++ L       ++  +V++++ ++ L   +       + L   +     +   +G+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQL--LQGL 119
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            + H      ++HRD+K  N+L++++    +ADFG A+     V      V  TL Y AP
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 175
Query: 215 EYAMWGK-VSESCDVYSFGILLLEILTGR 242
           E  +  K  S + D++S G +  E++T R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 14/218 (6%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           LGEG +G V       T + + + +  +K      E     E+ +   + H+N++   G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 72
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               + + +  +Y     L   +     G  + D +R     +    G++YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMA---GVVYLH---GIGI 125
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIP-EGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
            HRDIK  N+LLD      ++DFG A +        +  ++ GTL Y+APE     +  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE 261
           E  DV+S GI+L  +L G  P ++ P    +  ++W E
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKE 222

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 101/209 (48%), Gaps = 13/209 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRV 94
           +   F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 60
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
            H N++ L       ++  +V++++ ++ L   +       + L   +     +   +G+
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 117
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            + H      ++HRD+K  N+L++++    +ADFG A+     V      V  TL Y AP
Sbjct: 118 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 173
Query: 215 EYAMWGK-VSESCDVYSFGILLLEILTGR 242
           E  +  K  S + D++S G +  E++T R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 125/297 (42%), Gaps = 52/297 (17%)
Query: 49  LGEGGFGSVYWGRTSDGLQ-------IAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLL 100
           LGEG FG V    T+  L+       +AVK LK   S +E+ +   E  VL +V H +++
Sbjct: 31  LGEGEFGKVV-KATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQ--------------------YAGEVQLDW 140
            L G C+     L++ +Y    SL   L                       +  E  L  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 141 KRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH 200
              +  A   ++G+ YL       ++HRD+ A N+L+    +  ++DFG ++ + E  S 
Sbjct: 150 GDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 201 MTTRVKGTL--GYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTIT 257
           +  R +G +   ++A E       +   DV+SFG+LL EI+T G  P   +P        
Sbjct: 207 V-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP-------- 257
Query: 258 EWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                     +   L+    R +  +N  ++   + + C + EP+KRP   ++   L
Sbjct: 258 --------PERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 91/211 (43%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           +G G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +YMP   + SHL         H + YA ++ L ++             
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFE------------- 155
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+L+D      VADFGFAK     V   T  + GT  YLAP
Sbjct: 156 -YLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 111/276 (40%), Gaps = 35/276 (12%)
Query: 43  FSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVRHKNLL 100
           F+  +++G+G FG VY G  +   ++   K+  +    +    +  E+ VL +     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
              G    + +  I+ +Y+   S L  L      E  +       I     +G+ YLH E
Sbjct: 81  RYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEETYI-----ATILREILKGLDYLHSE 135
Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
                IHRDIKA+NVLL    +  +ADFG A  + +        V GT  ++APE     
Sbjct: 136 ---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFV-GTPFWMAPEVIKQS 191
Query: 221 KVSESCDVYSFGILLLEILTGRKPIEKL-PGGVKRTITEWAEPLIV---KGKFKELVDPK 276
                 D++S GI  +E+  G  P   L P  V   I + + P +       FKE V+  
Sbjct: 192 AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEA- 250
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
                              C+  +P  RP  KE++ 
Sbjct: 251 -------------------CLNKDPRFRPTAKELLK 267

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 48  KLGEGGFGSVYWGRT--SDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVR---HKNLL 100
           ++GEG +G V+  R   + G  +A+K+++    +  M  +   EV VL  +    H N++
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 101 GLRGYC--AGTDQRL---IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGIL 155
            L   C  + TD+     +V++++ +  L ++L       V  +  + M   +    G+ 
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQL--LRGLD 134
Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPE 215
           +LH      ++HRD+K  N+L+ S  +  +ADFG A++         T V  TL Y APE
Sbjct: 135 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPE 189
Query: 216 YAMWGKVSESCDVYSFGILLLEILTGRKPI 245
             +    +   D++S G +  E+   RKP+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 101/209 (48%), Gaps = 13/209 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRV 94
           +   F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 61
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
            H N++ L       ++  +V++++ ++ L   +       + L   +     +   +G+
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQL--LQGL 118
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            + H      ++HRD+K  N+L++++    +ADFG A+     V      V  TL Y AP
Sbjct: 119 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 174
Query: 215 EYAMWGK-VSESCDVYSFGILLLEILTGR 242
           E  +  K  S + D++S G +  E++T R
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 14/218 (6%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           LGEG +G V       T + + + +  +K      E     E+ +   + H+N++   G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 72
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               + + +  +Y     L   +     G  + D +R     +    G++YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMA---GVVYLH---GIGI 125
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIP-EGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
            HRDIK  N+LLD      ++DFG A +        +  ++ GTL Y+APE     +  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE 261
           E  DV+S GI+L  +L G  P ++ P    +  ++W E
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKE 222

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 73/297 (24%), Positives = 125/297 (42%), Gaps = 52/297 (17%)
Query: 49  LGEGGFGSVYWGRTSDGLQ-------IAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLL 100
           LGEG FG V    T+  L+       +AVK LK   S +E+ +   E  VL +V H +++
Sbjct: 31  LGEGEFGKVV-KATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQ--------------------YAGEVQLDW 140
            L G C+     L++ +Y    SL   L                       +  E  L  
Sbjct: 90  KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 141 KRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH 200
              +  A   ++G+ YL       ++HRD+ A N+L+    +  ++DFG ++ + E  S 
Sbjct: 150 GDLISFAWQISQGMQYLAEM---SLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSX 206
Query: 201 MTTRVKGTL--GYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTIT 257
           +  R +G +   ++A E       +   DV+SFG+LL EI+T G  P   +P        
Sbjct: 207 V-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP-------- 257
Query: 258 EWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                     +   L+    R +  +N  ++   + + C + EP+KRP   ++   L
Sbjct: 258 --------PERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDL 306

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 85/176 (48%), Gaps = 8/176 (4%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++GL              D    + L+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 126 SHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV 185
                Q   +++LD +R   +      GI +LH   +  IIHRD+K SN+++ SD    +
Sbjct: 112 DANLSQVI-QMELDHERMSYLLYQMLVGIKHLH---SAGIIHRDLKPSNIVVKSDATLKI 167
Query: 186 ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTG 241
            DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++ G
Sbjct: 168 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 14/218 (6%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           LGEG +G V       T + + + +  +K      E     E+ +   + H+N++   G+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 73
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               + + +  +Y     L   +     G  + D +R     +    G++YLH      I
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMA---GVVYLH---GIGI 126
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIP-EGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
            HRDIK  N+LLD      ++DFG A +        +  ++ GTL Y+APE     +  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE 261
           E  DV+S GI+L  +L G  P ++ P    +  ++W E
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKE 223

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 14/218 (6%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           LGEG +G V       T + + + +  +K      E     E+ +   + H+N++   G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 72
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               + + +  +Y     L   +     G  + D +R     +    G++YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMA---GVVYLH---GIGI 125
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIP-EGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
            HRDIK  N+LLD      ++DFG A +        +  ++ GTL Y+APE     +  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE 261
           E  DV+S GI+L  +L G  P ++ P    +  ++W E
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKE 222

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 14/218 (6%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           LGEG +G V       T + + + +  +K      E     E+ +   + H+N++   G+
Sbjct: 13  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 71
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               + + +  +Y     L   +     G  + D +R     +    G++YLH      I
Sbjct: 72  RREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMA---GVVYLH---GIGI 124
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIP-EGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
            HRDIK  N+LLD      ++DFG A +        +  ++ GTL Y+APE     +  +
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE 261
           E  DV+S GI+L  +L G  P ++ P    +  ++W E
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKE 221

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 12/217 (5%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVL--GRVRHKNLLGLRGYC 106
           LGEG +G V         +    K+  M    +    ++ E+     + H+N++   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
              + + +  +Y     L   +     G  + D +R     +    G++YLH      I 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMA---GVVYLH---GIGIT 127
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIP-EGVSHMTTRVKGTLGYLAPEYAMWGKV-SE 224
           HRDIK  N+LLD      ++DFG A +        +  ++ GTL Y+APE     +  +E
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187
Query: 225 SCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE 261
             DV+S GI+L  +L G  P ++ P    +  ++W E
Sbjct: 188 PVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKE 223

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 14/218 (6%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           LGEG +G V       T + + + +  +K      E     E+ +   + H+N++   G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 72
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               + + +  +Y     L   +     G  + D +R     +    G++YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMA---GVVYLH---GIGI 125
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIP-EGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
            HRDIK  N+LLD      ++DFG A +        +  ++ GTL Y+APE     +  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE 261
           E  DV+S GI+L  +L G  P ++ P    +  ++W E
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKE 222

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 98/220 (44%), Gaps = 28/220 (12%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGRTSD---GLQIAVKKLKAMNSKAEMEFAVEVEV 90
           +E+H AT+      +LG G FG V+  R  D   G Q AVKK++    +AE     E+  
Sbjct: 71  EEVHWATHQL----RLGRGSFGEVH--RMEDKQTGFQCAVKKVRLEVFRAE-----ELMA 119
Query: 91  LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
              +    ++ L G         I  + +   SL     GQ   E     + R    +G 
Sbjct: 120 CAGLTSPRIVPLYGAVREGPWVNIFMELLEGGSL-----GQLVKEQGCLPEDRALYYLGQ 174
Query: 151 A-EGILYLHHEVTPHIIHRDIKASNVLLDSD-FEPLVADFGFA-KLIPEGVSH---MTTR 204
           A EG+ YLH   +  I+H D+KA NVLL SD     + DFG A  L P+G+         
Sbjct: 175 ALEGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDY 231
Query: 205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           + GT  ++APE  +        DV+S   ++L +L G  P
Sbjct: 232 IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 100/206 (48%), Gaps = 13/206 (6%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRVRHK 97
            F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  + H 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHP 62
Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
           N++ L       ++  +V++++ +  L   +       + L   +     +   +G+ + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLSFC 119
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           H      ++HRD+K  N+L++++    +ADFG A+     V   T  V  TL Y APE  
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 175
Query: 218 MWGK-VSESCDVYSFGILLLEILTGR 242
           +  K  S + D++S G +  E++T R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 14/218 (6%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           LGEG +G V       T + + + +  +K      E     E+ +   + H+N++   G+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 73
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               + + +  +Y     L   +     G  + D +R     +    G++YLH      I
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMA---GVVYLH---GIGI 126
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIP-EGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
            HRDIK  N+LLD      ++DFG A +        +  ++ GTL Y+APE     +  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE 261
           E  DV+S GI+L  +L G  P ++ P    +  ++W E
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKE 223

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 14/218 (6%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           LGEG +G V       T + + + +  +K      E     E+ +   + H+N++   G+
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 72
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               + + +  +Y     L   +     G  + D +R     +    G++YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMA---GVVYLH---GIGI 125
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIP-EGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
            HRDIK  N+LLD      ++DFG A +        +  ++ GTL Y+APE     +  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE 261
           E  DV+S GI+L  +L G  P ++ P    +  ++W E
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKE 222

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 12/217 (5%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVL--GRVRHKNLLGLRGYC 106
           LGEG +G V         +    K+  M    +    ++ E+     + H+N++   G+ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 73
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
              + + +  +Y     L   +     G  + D +R     +    G++YLH      I 
Sbjct: 74  REGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMA---GVVYLH---GIGIT 126
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIP-EGVSHMTTRVKGTLGYLAPEYAMWGKV-SE 224
           HRDIK  N+LLD      ++DFG A +        +  ++ GTL Y+APE     +  +E
Sbjct: 127 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186
Query: 225 SCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE 261
             DV+S GI+L  +L G  P ++ P    +  ++W E
Sbjct: 187 PVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKE 222

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 14/218 (6%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           LGEG +G V       T + + + +  +K      E     E+ +   + H+N++   G+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 73
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               + + +  +Y     L   +     G  + D +R     +    G++YLH      I
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMA---GVVYLH---GIGI 126
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIP-EGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
            HRDIK  N+LLD      ++DFG A +        +  ++ GTL Y+APE     +  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE 261
           E  DV+S GI+L  +L G  P ++ P    +  ++W E
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKE 223

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 14/218 (6%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           LGEG +G V       T + + + +  +K      E     E+ +   + H+N++   G+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 73
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               + + +  +Y     L   +     G  + D +R     +    G++YLH      I
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMA---GVVYLH---GIGI 126
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIP-EGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
            HRDIK  N+LLD      ++DFG A +        +  ++ GTL Y+APE     +  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE 261
           E  DV+S GI+L  +L G  P ++ P    +  ++W E
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKE 223

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 97/218 (44%), Gaps = 14/218 (6%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           LGEG +G V       T + + + +  +K      E     E+ +   + H+N++   G+
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 73
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               + + +  +Y     L   +     G  + D +R     +    G++YLH      I
Sbjct: 74  RREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMA---GVVYLH---GIGI 126
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIP-EGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
            HRDIK  N+LLD      ++DFG A +        +  ++ GTL Y+APE     +  +
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE 261
           E  DV+S GI+L  +L G  P ++ P    +  ++W E
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKE 223

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 105/222 (47%), Gaps = 28/222 (12%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVR 95
           AT+ +    ++G G +G+VY  R    G  +A+K ++  N +  +  +   EV +L R+ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 96  ---HKNLLGLRGYCAG--TDQRL---IVYDYMPNLSLLSHLHGQ----YAGEVQLDWKRR 143
              H N++ L   CA   TD+ +   +V++++ +  L ++L          E   D  R+
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT 203
                    G+ +LH      I+HRD+K  N+L+ S     +ADFG A++    ++    
Sbjct: 121 F------LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPV 171
Query: 204 RVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
            V  TL Y APE  +    +   D++S G +  E+   RKP+
Sbjct: 172 VV--TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 101/206 (49%), Gaps = 13/206 (6%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRVRHK 97
            F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  + H 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHP 61
Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
           N++ L       ++  +V++++ +  L + +       + L   +     +   +G+ + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHV-HQDLKTFMDASALTGIPLPLIKSYLFQL--LQGLAFC 118
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           H      ++HRD+K  N+L++++    +ADFG A+     V   T  V  TL Y APE  
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 174
Query: 218 MWGK-VSESCDVYSFGILLLEILTGR 242
           +  K  S + D++S G +  E++T R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 84/176 (47%), Gaps = 8/176 (4%)
Query: 68  IAVKKL-KAMNSKAEMEFAVEVEVLGR-VRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A    VL + V HKN++GL              D    + L+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 126 SHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV 185
                Q   +++LD +R   +      GI +LH   +  IIHRD+K SN+++ SD    +
Sbjct: 112 DANLSQVI-QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 186 ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTG 241
            DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++ G
Sbjct: 168 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKA---MNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           +G G FG V   R     ++   KL +   M  +++  F  E   +    +   +    Y
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 106 CAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
               D+ L +V +YMP   L+ +L   Y  +V   W R       +AE +L L    +  
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLV-NLMSNY--DVPEKWAR-----FYTAEVVLALDAIHSMG 188
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFA-KLIPEGVSHMTTRVKGTLGYLAPEYAMW---- 219
            IHRD+K  N+LLD      +ADFG   K+  EG+    T V GT  Y++PE        
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGD 247
Query: 220 GKVSESCDVYSFGILLLEILTGRKPI 245
           G     CD +S G+ L E+L G  P 
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 48  KLGEGGFGSVYWGRT--SDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVR---HKNLL 100
           ++GEG +G V+  R   + G  +A+K+++    +  M  +   EV VL  +    H N++
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 101 GLRGYC--AGTDQRL---IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGIL 155
            L   C  + TD+     +V++++ +  L ++L       V  +  + M   +    G+ 
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQL--LRGLD 134
Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPE 215
           +LH      ++HRD+K  N+L+ S  +  +ADFG A++         T V  TL Y APE
Sbjct: 135 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPE 189
Query: 216 YAMWGKVSESCDVYSFGILLLEILTGRKPI 245
             +    +   D++S G +  E+   RKP+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 85/176 (48%), Gaps = 8/176 (4%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++GL              D    + L+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 126 SHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV 185
                Q   +++LD +R   +      GI +LH   +  IIHRD+K SN+++ SD    +
Sbjct: 112 DANLSQVI-QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDATLKI 167
Query: 186 ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTG 241
            DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++ G
Sbjct: 168 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 52/176 (29%), Positives = 84/176 (47%), Gaps = 8/176 (4%)
Query: 68  IAVKKL-KAMNSKAEMEFAVEVEVLGR-VRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A    VL + V HKN++GL              D    + L+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 126 SHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV 185
                Q   +++LD +R   +      GI +LH   +  IIHRD+K SN+++ SD    +
Sbjct: 112 DANLSQVI-QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDATLKI 167
Query: 186 ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTG 241
            DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++ G
Sbjct: 168 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKA---MNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           +G G FG V   R     ++   KL +   M  +++  F  E   +    +   +    Y
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 106 CAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
               D+ L +V +YMP   L+ +L   Y  +V   W R       +AE +L L    +  
Sbjct: 142 AFQDDRYLYMVMEYMPGGDLV-NLMSNY--DVPEKWAR-----FYTAEVVLALDAIHSMG 193
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFA-KLIPEGVSHMTTRVKGTLGYLAPEYAMW---- 219
            IHRD+K  N+LLD      +ADFG   K+  EG+    T V GT  Y++PE        
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGD 252
Query: 220 GKVSESCDVYSFGILLLEILTGRKPI 245
           G     CD +S G+ L E+L G  P 
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 90/206 (43%), Gaps = 18/206 (8%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKA---MNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           +G G FG V   R     ++   KL +   M  +++  F  E   +    +   +    Y
Sbjct: 82  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 141
Query: 106 CAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
               D+ L +V +YMP   L+ +L   Y  +V   W R       +AE +L L    +  
Sbjct: 142 AFQDDRYLYMVMEYMPGGDLV-NLMSNY--DVPEKWAR-----FYTAEVVLALDAIHSMG 193
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFA-KLIPEGVSHMTTRVKGTLGYLAPEYAMW---- 219
            IHRD+K  N+LLD      +ADFG   K+  EG+    T V GT  Y++PE        
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEVLKSQGGD 252
Query: 220 GKVSESCDVYSFGILLLEILTGRKPI 245
           G     CD +S G+ L E+L G  P 
Sbjct: 253 GYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 94/224 (41%), Gaps = 21/224 (9%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLK---AMNSKAEME-FAVEVE 89
           KE+      F     +G G FG V   +  +  +I   K+     M  +AE   F  E +
Sbjct: 67  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERD 126
Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPN---LSLLSHLHGQYAGEVQLDWKRRMKI 146
           VL     + +  L       +   +V DY      L+LLS    +   ++   +   M +
Sbjct: 127 VLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVL 186
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
           AI S   +         H +HRDIK  NVLLD +    +ADFG    + +  +  ++   
Sbjct: 187 AIDSIHQL---------HYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAV 237
Query: 207 GTLGYLAPEY--AM---WGKVSESCDVYSFGILLLEILTGRKPI 245
           GT  Y++PE   AM    GK    CD +S G+ + E+L G  P 
Sbjct: 238 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 281

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/210 (26%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 48  KLGEGGFGSVYWGRT--SDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVR---HKNLL 100
           ++GEG +G V+  R   + G  +A+K+++    +  M  +   EV VL  +    H N++
Sbjct: 18  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 77
Query: 101 GLRGYC--AGTDQRL---IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGIL 155
            L   C  + TD+     +V++++ +  L ++L       V  +  + M   +    G+ 
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQL--LRGLD 134
Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPE 215
           +LH      ++HRD+K  N+L+ S  +  +ADFG A++         T V  TL Y APE
Sbjct: 135 FLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIY--SFQMALTSVVVTLWYRAPE 189
Query: 216 YAMWGKVSESCDVYSFGILLLEILTGRKPI 245
             +    +   D++S G +  E+   RKP+
Sbjct: 190 VLLQSSYATPVDLWSVGCIFAEMFR-RKPL 218

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 85/176 (48%), Gaps = 8/176 (4%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++GL              D    + L+
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 112
Query: 126 SHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV 185
                Q   +++LD +R   +      GI +LH   +  IIHRD+K SN+++ SD    +
Sbjct: 113 DANLCQVI-QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 168
Query: 186 ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTG 241
            DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++ G
Sbjct: 169 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 94/224 (41%), Gaps = 21/224 (9%)
Query: 34  KELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLK---AMNSKAEME-FAVEVE 89
           KE+      F     +G G FG V   +  +  +I   K+     M  +AE   F  E +
Sbjct: 83  KEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERD 142
Query: 90  VLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPN---LSLLSHLHGQYAGEVQLDWKRRMKI 146
           VL     + +  L       +   +V DY      L+LLS    +   ++   +   M +
Sbjct: 143 VLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVL 202
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
           AI S   +         H +HRDIK  NVLLD +    +ADFG    + +  +  ++   
Sbjct: 203 AIDSIHQL---------HYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAV 253
Query: 207 GTLGYLAPEY--AM---WGKVSESCDVYSFGILLLEILTGRKPI 245
           GT  Y++PE   AM    GK    CD +S G+ + E+L G  P 
Sbjct: 254 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 297

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 85/176 (48%), Gaps = 8/176 (4%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++GL              D    + L+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 126 SHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV 185
                Q   +++LD +R   +      GI +LH   +  IIHRD+K SN+++ SD    +
Sbjct: 112 DANLCQVI-QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 186 ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTG 241
            DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++ G
Sbjct: 168 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 101/209 (48%), Gaps = 13/209 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRV 94
           +   F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 62
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
            H N++ L       ++  +V++++ +  L + +       + L   +     +   +G+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKTFMDASALTGIPLPLIKSYLFQL--LQGL 119
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            + H      ++HRD+K  N+L++++    +ADFG A+     V      V  TL Y AP
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 175
Query: 215 EYAMWGK-VSESCDVYSFGILLLEILTGR 242
           E  +  K  S + D++S G +  E++T R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 103/222 (46%), Gaps = 28/222 (12%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVR 95
           AT+ +    ++G G +G+VY  R    G  +A+K ++  N +  +  +   EV +L R+ 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 96  ---HKNLLGLRGYCAG--TDQRL---IVYDYMPNLSLLSHLHGQ----YAGEVQLDWKRR 143
              H N++ L   CA   TD+ +   +V++++ +  L ++L          E   D  R+
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDLMRQ 120
Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT 203
                    G+ +LH      I+HRD+K  N+L+ S     +ADFG A++          
Sbjct: 121 F------LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQMALD 169
Query: 204 RVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
            V  TL Y APE  +    +   D++S G +  E+   RKP+
Sbjct: 170 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 210

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 22/169 (13%)
Query: 87  EVEVLGRVR-HKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMK 145
           E  +L +V  H +++ L      +    +V+D M    L  +L      +V L  K    
Sbjct: 149 ETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL----TEKVALSEKETRS 204
Query: 146 IAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRV 205
           I     E + +LH     +I+HRD+K  N+LLD + +  ++DFGF+  +  G       +
Sbjct: 205 IMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG--EKLREL 259
Query: 206 KGTLGYLAPE---------YAMWGKVSESCDVYSFGILLLEILTGRKPI 245
            GT GYLAPE         +  +GK     D+++ G++L  +L G  P 
Sbjct: 260 CGTPGYLAPEILKCSMDETHPGYGK---EVDLWACGVILFTLLAGSPPF 305

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 85/176 (48%), Gaps = 8/176 (4%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++GL              D    + L+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 126 SHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV 185
                Q   +++LD +R   +      GI +LH   +  IIHRD+K SN+++ SD    +
Sbjct: 112 DANLCQVI-QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 186 ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTG 241
            DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++ G
Sbjct: 168 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 129/287 (44%), Gaps = 43/287 (14%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKK-LKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           LG G  G+V +  +  G  +AVK+ L      A ME  +  E      H N++  R YC+
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDD---HPNVI--RYYCS 95
Query: 108 -GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRR---MKIAIGSAEGILYLHHEVTP 163
             TD+ L +   + NL+L   +  +   +  L  ++    + +    A G+ +LH   + 
Sbjct: 96  ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SL 152
Query: 164 HIIHRDIKASNVLLDS-------------DFEPLVADFGFAKLIPEGVSHMTTRVK---G 207
            IIHRD+K  N+L+ +             +   L++DFG  K +  G       +    G
Sbjct: 153 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSG 212
Query: 208 TLGYLAPEY---AMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI 264
           T G+ APE    +   +++ S D++S G +   IL+  K     P G K +     E  I
Sbjct: 213 TSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH----PFGDKYS----RESNI 264
Query: 265 VKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
           ++G F   +D +++   D + + +A ++    +  +P KRP   +V+
Sbjct: 265 IRGIFS--LD-EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 308

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/276 (25%), Positives = 120/276 (43%), Gaps = 45/276 (16%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 100 LGLRGYCAGTDQRLIVYDYM-PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ + M P   L   +  +  G +Q +  R     +   E + + H
Sbjct: 76  IRLLDWFERPDSFVLILERMEPVQDLFDFITER--GALQEELARSFFWQV--LEAVRHCH 131
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
                 ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 132 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 185
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
            + +    S  V+S GILL +++ G  P E              +  I++G+        
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------------DEEIIRGQVF------ 226
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
               F +    +  ++   C+   P  RP  +E+ N
Sbjct: 227 ----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 258

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 129/287 (44%), Gaps = 43/287 (14%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKK-LKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           LG G  G+V +  +  G  +AVK+ L      A ME  +  E      H N++  R YC+
Sbjct: 41  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDD---HPNVI--RYYCS 95
Query: 108 -GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRR---MKIAIGSAEGILYLHHEVTP 163
             TD+ L +   + NL+L   +  +   +  L  ++    + +    A G+ +LH   + 
Sbjct: 96  ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SL 152
Query: 164 HIIHRDIKASNVLLDS-------------DFEPLVADFGFAKLIPEGVSHMTTRVK---G 207
            IIHRD+K  N+L+ +             +   L++DFG  K +  G       +    G
Sbjct: 153 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSG 212
Query: 208 TLGYLAPEY---AMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI 264
           T G+ APE    +   +++ S D++S G +   IL+  K     P G K +     E  I
Sbjct: 213 TSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKH----PFGDKYS----RESNI 264
Query: 265 VKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
           ++G F   +D +++   D + + +A ++    +  +P KRP   +V+
Sbjct: 265 IRGIFS--LD-EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 308

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 85/176 (48%), Gaps = 8/176 (4%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++GL              D    + L+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 126 SHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV 185
                Q   +++LD +R   +      GI +LH   +  IIHRD+K SN+++ SD    +
Sbjct: 112 DANLCQVI-QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 186 ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTG 241
            DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++ G
Sbjct: 168 LDFGLART--AGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 19/218 (8%)
Query: 43  FSDDNKLGEGGFGSVYWG--RTSDG--LQIAVKKLKA--MNSKAEMEFAVEVEVLGRVRH 96
           F+    LG+G FGSV     +  DG  +++AVK LKA  + S    EF  E   +    H
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 97  KNLLGLRGYCAGTDQR------LIVYDYMPNLSLLSHLHGQYAGE--VQLDWKRRMKIAI 148
            ++  L G    +  +      +++  +M +  L + L     GE    L  +  ++  +
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 149 GSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMT-TRVKG 207
             A G+ YL    + + IHRD+ A N +L  D    VADFG ++ I  G  +      K 
Sbjct: 145 DIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
            + +LA E       +   DV++FG+ + EI+T G+ P
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 20/205 (9%)
Query: 49  LGEGGFGSVYWG---RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           LG G F  V      RT   + I     +A+  K E     E+ VL +++H N++ L   
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK-EGSMENEIAVLHKIKHPNIVALDDI 84
Query: 106 CAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                   ++   +    L   +   G Y        +   ++     + + YLH     
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTE------RDASRLIFQVLDAVKYLH---DL 135
Query: 164 HIIHRDIKASNVL---LDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
            I+HRD+K  N+L   LD D + +++DFG +K+  E    + +   GT GY+APE     
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 221 KVSESCDVYSFGILLLEILTGRKPI 245
             S++ D +S G++   +L G  P 
Sbjct: 194 PYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 20/205 (9%)
Query: 49  LGEGGFGSVYWG---RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           LG G F  V      RT   + I     +A+  K E     E+ VL +++H N++ L   
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK-EGSMENEIAVLHKIKHPNIVALDDI 84
Query: 106 CAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                   ++   +    L   +   G Y        +   ++     + + YLH     
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTE------RDASRLIFQVLDAVKYLH---DL 135
Query: 164 HIIHRDIKASNVL---LDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
            I+HRD+K  N+L   LD D + +++DFG +K+  E    + +   GT GY+APE     
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 221 KVSESCDVYSFGILLLEILTGRKPI 245
             S++ D +S G++   +L G  P 
Sbjct: 194 PYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 21/218 (9%)
Query: 39  ATNGFSDDNK----LGEGGFGSVYWGRTS-DGLQIAVKKL--KAMNSKAEMEFAV-EVEV 90
           +T  FSD  K    LG+G FG V   +    G + AVK +  + +  K + E  + EV++
Sbjct: 20  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 79
Query: 91  LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
           L ++ H N+  L  +        +V +      L   +  +     ++D  R ++  +  
Sbjct: 80  LKQLDHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFS-EVDAARIIRQVLS- 137
Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDS---DFEPLVADFGFAKLIPEGVSHMTTRVKG 207
             GI Y H      I+HRD+K  N+LL+S   D    + DFG +    E       ++ G
Sbjct: 138 --GITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF-EASKKXKDKI-G 190
Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           T  Y+APE  + G   E CDV+S G++L  +L+G  P 
Sbjct: 191 TAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPF 227

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 102/225 (45%), Gaps = 31/225 (13%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKA-----EMEFAVEVEVLG 92
           AT+ +    ++G G +G+VY  R    G  +A+K ++  N         +    EV +L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 93  RVR---HKNLLGLRGYCAG--TDQRL---IVYDYMPNLSLLSHLHGQ----YAGEVQLDW 140
           R+    H N++ L   CA   TD+ +   +V++++ +  L ++L          E   D 
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLPAETIKDL 125
Query: 141 KRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH 200
            R+         G+ +LH      I+HRD+K  N+L+ S     +ADFG A++       
Sbjct: 126 MRQF------LRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIY--SYQM 174
Query: 201 MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
             T V  TL Y APE  +    +   D++S G +  E+   RKP+
Sbjct: 175 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL 218

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/205 (25%), Positives = 88/205 (42%), Gaps = 20/205 (9%)
Query: 49  LGEGGFGSVYWG---RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           LG G F  V      RT   + I     +A+  K E     E+ VL +++H N++ L   
Sbjct: 26  LGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGK-EGSMENEIAVLHKIKHPNIVALDDI 84
Query: 106 CAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                   ++   +    L   +   G Y        +   ++     + + YLH     
Sbjct: 85  YESGGHLYLIMQLVSGGELFDRIVEKGFYTE------RDASRLIFQVLDAVKYLH---DL 135
Query: 164 HIIHRDIKASNVL---LDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
            I+HRD+K  N+L   LD D + +++DFG +K+  E    + +   GT GY+APE     
Sbjct: 136 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM--EDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 221 KVSESCDVYSFGILLLEILTGRKPI 245
             S++ D +S G++   +L G  P 
Sbjct: 194 PYSKAVDCWSIGVIAYILLCGYPPF 218

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRV 94
           +   F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 62
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
            H N++ L       ++  +V++++ +  L   +       + L   +     +   +G+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 119
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            + H      ++HRD+K  N+L++++    +ADFG A+     V      V  TL Y AP
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 175
Query: 215 EYAMWGK-VSESCDVYSFGILLLEILTGR 242
           E  +  K  S + D++S G +  E++T R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRV 94
           +   F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 61
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
            H N++ L       ++  +V++++ +  L   +       + L   +     +   +G+
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 118
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            + H      ++HRD+K  N+L++++    +ADFG A+     V      V  TL Y AP
Sbjct: 119 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 174
Query: 215 EYAMWGK-VSESCDVYSFGILLLEILTGR 242
           E  +  K  S + D++S G +  E++T R
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y+P   + SHL         H + YA ++ L ++             
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------------- 155
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+L+D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 156 -YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y+P   + SHL         H + YA ++ L ++             
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------------- 155
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+L+D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 156 -YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 49  LGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEY 108
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y+P   + SHL         H + YA ++ L ++             
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------------- 155
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+L+D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 156 -YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRV 94
           +   F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 59
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
            H N++ L       ++  +V++++ +  L   +       + L   +     +   +G+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            + H      ++HRD+K  N+L++++    +ADFG A+     V      V  TL Y AP
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 172
Query: 215 EYAMWGK-VSESCDVYSFGILLLEILTGR 242
           E  +  K  S + D++S G +  E++T R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/205 (29%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGY 105
           +G G  G V     T  G+ +AVKKL +   ++   + A  E+ +L  V HKN++ L   
Sbjct: 30  IGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLN- 88
Query: 106 CAGTDQRLI-----VYDYM----PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
              T Q+ +     VY  M     NL  + H+        +LD +R   +      GI +
Sbjct: 89  -VFTPQKTLEEFQDVYLVMELMDANLCQVIHM--------ELDHERMSYLLYQMLCGIKH 139
Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
           LH   +  IIHRD+K SN+++ SD    + DFG A+      + M T    T  Y APE 
Sbjct: 140 LH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--ASTNFMMTPYVVTRYYRAPEV 194
Query: 217 AMWGKVSESCDVYSFGILLLEILTG 241
            +     E+ D++S G ++ E++ G
Sbjct: 195 ILGMGYKENVDIWSVGCIMGELVKG 219

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRV 94
           +   F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 61
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
            H N++ L       ++  +V++++ +  L   +       + L   +     +   +G+
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 118
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            + H      ++HRD+K  N+L++++    +ADFG A+     V      V  TL Y AP
Sbjct: 119 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 174
Query: 215 EYAMWGK-VSESCDVYSFGILLLEILTGR 242
           E  +  K  S + D++S G +  E++T R
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRV 94
           +   F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 59
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
            H N++ L       ++  +V++++ +  L   +       + L   +     +   +G+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            + H      ++HRD+K  N+L++++    +ADFG A+     V      V  TL Y AP
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 172
Query: 215 EYAMWGK-VSESCDVYSFGILLLEILTGR 242
           E  +  K  S + D++S G +  E++T R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRV 94
           +   F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  +
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 63
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
            H N++ L       ++  +V++++ +  L   +       + L   +     +   +G+
Sbjct: 64  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 120
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            + H      ++HRD+K  N+L++++    +ADFG A+     V      V  TL Y AP
Sbjct: 121 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 176
Query: 215 EYAMWGK-VSESCDVYSFGILLLEILTGR 242
           E  +  K  S + D++S G +  E++T R
Sbjct: 177 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 205

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRV 94
           +   F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 59
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
            H N++ L       ++  +V++++ +  L   +       + L   +     +   +G+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            + H      ++HRD+K  N+L++++    +ADFG A+     V      V  TL Y AP
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 172
Query: 215 EYAMWGK-VSESCDVYSFGILLLEILTGR 242
           E  +  K  S + D++S G +  E++T R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRV 94
           +   F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  +
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 61
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
            H N++ L       ++  +V++++ +  L   +       + L   +     +   +G+
Sbjct: 62  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 118
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            + H      ++HRD+K  N+L++++    +ADFG A+     V      V  TL Y AP
Sbjct: 119 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 174
Query: 215 EYAMWGK-VSESCDVYSFGILLLEILTGR 242
           E  +  K  S + D++S G +  E++T R
Sbjct: 175 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 203

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRV 94
           +   F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 62
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
            H N++ L       ++  +V++++ +  L   +       + L   +     +   +G+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 119
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            + H      ++HRD+K  N+L++++    +ADFG A+     V      V  TL Y AP
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 175
Query: 215 EYAMWGK-VSESCDVYSFGILLLEILTGR 242
           E  +  K  S + D++S G +  E++T R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 27/211 (12%)
Query: 49  LGEGGFGSVYWGRTS-DGLQIAVKKLK-----AMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
           +G G +G V   R    G Q+A+KK+        N+K  +    E+++L   +H N++ +
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR---ELKILKHFKHDNIIAI 118
Query: 103 RGYCAGT------DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
           +     T          +V D M      S LH        L  +           G+ Y
Sbjct: 119 KDILRPTVPYGEFKSVYVVLDLME-----SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKY 173
Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTRVKGTLGYLA 213
           +H   +  +IHRD+K SN+L++ + E  + DFG A+ +   P    +  T    T  Y A
Sbjct: 174 MH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 230
Query: 214 PEYAM-WGKVSESCDVYSFGILLLEILTGRK 243
           PE  +   + +++ D++S G +  E+L  R+
Sbjct: 231 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRV 94
           +   F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 60
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
            H N++ L       ++  +V++++ +  L   +       + L   +     +   +G+
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 117
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            + H      ++HRD+K  N+L++++    +ADFG A+     V      V  TL Y AP
Sbjct: 118 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 173
Query: 215 EYAMWGK-VSESCDVYSFGILLLEILTGR 242
           E  +  K  S + D++S G +  E++T R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRV 94
           +   F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  +
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 60
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
            H N++ L       ++  +V++++ +  L   +       + L   +     +   +G+
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 117
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            + H      ++HRD+K  N+L++++    +ADFG A+     V      V  TL Y AP
Sbjct: 118 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 173
Query: 215 EYAMWGK-VSESCDVYSFGILLLEILTGR 242
           E  +  K  S + D++S G +  E++T R
Sbjct: 174 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRV 94
           +   F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 59
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
            H N++ L       ++  +V++++ +  L   +       + L   +     +   +G+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKDFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            + H      ++HRD+K  N+L++++    +ADFG A+     V      V  TL Y AP
Sbjct: 117 AFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 172
Query: 215 EYAMWGK-VSESCDVYSFGILLLEILTGR 242
           E  +  K  S + D++S G +  E++T R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 99/206 (48%), Gaps = 13/206 (6%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRVRHK 97
            F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  + H 
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHP 63
Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
           N++ L       ++  +V++++ +  L   +       + L   +     +   +G+ + 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFC 120
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           H      ++HRD+K  N+L++++    +ADFG A+     V      V  TL Y APE  
Sbjct: 121 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 176
Query: 218 MWGK-VSESCDVYSFGILLLEILTGR 242
           +  K  S + D++S G +  E++T R
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVTRR 202

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 99/206 (48%), Gaps = 13/206 (6%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRVRHK 97
            F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  + H 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHP 61
Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
           N++ L       ++  +V++++ +  L   +       + L   +     +   +G+ + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFC 118
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           H      ++HRD+K  N+L++++    +ADFG A+     V      V  TL Y APE  
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 174
Query: 218 MWGK-VSESCDVYSFGILLLEILTGR 242
           +  K  S + D++S G +  E++T R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 99/206 (48%), Gaps = 13/206 (6%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRVRHK 97
            F    K+GEG +G VY  R    G  +A+ K++ ++++ E   +    E+ +L  + H 
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIR-LDTETEGVPSTAIREISLLKELNHP 62
Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
           N++ L       ++  +V++++ +  L   +       + L   +     +   +G+ + 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFC 119
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           H      ++HRD+K  N+L++++    +ADFG A+     V   T  V  TL Y APE  
Sbjct: 120 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 175
Query: 218 MWGK-VSESCDVYSFGILLLEILTGR 242
           +  K  S + D++S G +  E++T R
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 99/206 (48%), Gaps = 13/206 (6%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRVRHK 97
            F    K+GEG +G VY  R    G  +A+ K++ ++++ E   +    E+ +L  + H 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIR-LDTETEGVPSTAIREISLLKELNHP 61
Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
           N++ L       ++  +V++++ +  L   +       + L   +     +   +G+ + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFC 118
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           H      ++HRD+K  N+L++++    +ADFG A+     V   T  V  TL Y APE  
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV-TLWYRAPEIL 174
Query: 218 MWGK-VSESCDVYSFGILLLEILTGR 242
           +  K  S + D++S G +  E++T R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 91/211 (43%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           +G G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 49  IGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y+P   + SHL         H + YA ++ L ++             
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------------- 155
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+L+D      VADFGFAK     V   T  + GT  YLAP
Sbjct: 156 -YLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 99/206 (48%), Gaps = 13/206 (6%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRVRHK 97
            F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  + H 
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHP 61
Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
           N++ L       ++  +V++++ +  L   +       + L   +     +   +G+ + 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGLAFC 118
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           H      ++HRD+K  N+L++++    +ADFG A+     V      V  TL Y APE  
Sbjct: 119 HSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAPEIL 174
Query: 218 MWGK-VSESCDVYSFGILLLEILTGR 242
           +  K  S + D++S G +  E++T R
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 8/176 (4%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++GL              D    + L+
Sbjct: 54  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 113
Query: 126 SHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV 185
                Q   +++LD +R   +      GI +LH   +  IIHRD+K SN+++ SD    +
Sbjct: 114 DANLCQVI-QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 169
Query: 186 ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTG 241
            DFG A+    G S M      T  Y APE  +     E+ D++S G ++ E++ G
Sbjct: 170 LDFGLART--AGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRV 94
           +   F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  +
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 59
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
            H N++ L       ++  +V++++ +  L   +       + L   +     +   +G+
Sbjct: 60  NHPNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 116
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            + H      ++HRD+K  N+L++++    +ADFG A+     V      V  TL Y AP
Sbjct: 117 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 172
Query: 215 EYAMWGK-VSESCDVYSFGILLLEILTGR 242
           E  +  K  S + D++S G +  E++T R
Sbjct: 173 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 201

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 93/198 (46%), Gaps = 12/198 (6%)
Query: 48  KLGEGGFGSVYWGRTSDGLQI-AVKK-LKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG 104
           K+GEG +G V+  R  D  QI A+KK L++ +     + A+ E+ +L +++H NL+ L  
Sbjct: 10  KIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLE 69
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                 +  +V++Y  +  L  H   +Y   V     + +      A    + H+     
Sbjct: 70  VFRRKRRLHLVFEYCDHTVL--HELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN----- 122
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG-KVS 223
            IHRD+K  N+L+       + DFGFA+L+  G S        T  Y +PE  +   +  
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLL-TGPSDYYDDEVATRWYRSPELLVGDTQYG 181
Query: 224 ESCDVYSFGILLLEILTG 241
              DV++ G +  E+L+G
Sbjct: 182 PPVDVWAIGCVFAELLSG 199

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 93/211 (44%), Gaps = 27/211 (12%)
Query: 49  LGEGGFGSVYWGRTS-DGLQIAVKKLK-----AMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
           +G G +G V   R    G Q+A+KK+        N+K  +    E+++L   +H N++ +
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLR---ELKILKHFKHDNIIAI 119
Query: 103 RGYCAGT------DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
           +     T          +V D M      S LH        L  +           G+ Y
Sbjct: 120 KDILRPTVPYGEFKSVYVVLDLME-----SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKY 174
Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTRVKGTLGYLA 213
           +H   +  +IHRD+K SN+L++ + E  + DFG A+ +   P    +  T    T  Y A
Sbjct: 175 MH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 231
Query: 214 PEYAM-WGKVSESCDVYSFGILLLEILTGRK 243
           PE  +   + +++ D++S G +  E+L  R+
Sbjct: 232 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 14/218 (6%)
Query: 49  LGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           LGEG  G V       T + + + +  +K      E     E+ +   + H+N++   G+
Sbjct: 14  LGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE-NIKKEICINKMLNHENVVKFYGH 72
Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               + + +  +Y     L   +     G  + D +R     +    G++YLH      I
Sbjct: 73  RREGNIQYLFLEYCSGGELFDRIEPD-IGMPEPDAQRFFHQLMA---GVVYLH---GIGI 125
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIP-EGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
            HRDIK  N+LLD      ++DFG A +        +  ++ GTL Y+APE     +  +
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE 261
           E  DV+S GI+L  +L G  P ++ P    +  ++W E
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQ-PSDSCQEYSDWKE 222

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 70  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 129
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y+P   + SHL         H + YA ++ L ++             
Sbjct: 130 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------------- 176
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+L+D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 177 -YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 228
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 229 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y+P   + SHL         H + YA ++ L ++             
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------------- 156
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+L+D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 157 -YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 208
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y+P   + SHL         H + YA ++ L ++             
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------------- 156
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+L+D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 157 -YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 208
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y+P   + SHL         H + YA ++ L ++             
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------------- 156
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+L+D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 157 -YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 208
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 71/237 (29%), Positives = 106/237 (44%), Gaps = 32/237 (13%)
Query: 17  LTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSD---GLQIAVKKL 73
           LT    P +  +R    +E+H  T+      +LG G FG V+  R  D   G Q AVKK+
Sbjct: 56  LTEKLKPVDYEYR----EEVHWMTH----QPRLGRGSFGEVH--RMKDKQTGFQCAVKKV 105
Query: 74  KAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYA 133
           +    + E     E+     +    ++ L G         I  + +   SL     GQ  
Sbjct: 106 RLEVFRVE-----ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL-----GQLI 155
Query: 134 GEVQLDWKRRMKIAIGSA-EGILYLHHEVTPHIIHRDIKASNVLLDSD-FEPLVADFGFA 191
            ++    + R    +G A EG+ YLH   T  I+H D+KA NVLL SD     + DFG A
Sbjct: 156 KQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHA 212
Query: 192 -KLIPEGV--SHMT-TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
             L P+G+  S +T   + GT  ++APE  M        D++S   ++L +L G  P
Sbjct: 213 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 269

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y+P   + SHL         H + YA ++ L ++             
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------------- 148
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+L+D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 149 -YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 200
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 95/213 (44%), Gaps = 21/213 (9%)
Query: 40  TNGFSDDNKLGEGGFGSVYWGRTSDGLQ--IAVKKLKAMNSKAEMEFAVEVEVLGRVRHK 97
           ++ F  +++LG G    VY  +   G Q   A+K LK    K  +    E+ VL R+ H 
Sbjct: 52  SDFFEVESELGRGATSIVYRCK-QKGTQKPYALKVLKKTVDKKIVR--TEIGVLLRLSHP 108
Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGIL 155
           N++ L+       +  +V + +    L   +   G Y+     D  +++       E + 
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI------LEAVA 162
Query: 156 YLHHEVTPHIIHRDIKASNVLLDS---DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYL 212
           YLH      I+HRD+K  N+L  +   D    +ADFG +K++   V   T  V GT GY 
Sbjct: 163 YLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT--VCGTPGYC 217
Query: 213 APEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           APE           D++S GI+   +L G +P 
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 42  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 101
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y+P   + SHL         H + YA ++ L ++             
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------------- 148
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+L+D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 149 -YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 200
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 201 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 51/209 (24%), Positives = 100/209 (47%), Gaps = 13/209 (6%)
Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAV---EVEVLGRV 94
           +   F    K+GEG +G VY  R    G  +A+KK++ ++++ E   +    E+ +L  +
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKEL 62
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
            H N++ L       ++  +V++++ +  L   +       + L   +     +   +G+
Sbjct: 63  NHPNIVKLLDVIHTENKLYLVFEHV-DQDLKKFMDASALTGIPLPLIKSYLFQL--LQGL 119
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            + H      ++HRD+K  N+L++++    +ADFG A+     V      V  TL Y AP
Sbjct: 120 AFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV-TLWYRAP 175
Query: 215 EYAMWGK-VSESCDVYSFGILLLEILTGR 242
           E  +  K  S + D++S G +  E++T R
Sbjct: 176 EILLGCKYYSTAVDIWSLGCIFAEMVTRR 204

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 49  LGEGGFGSV---YWGRTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLR 103
           +G G +GSV   Y  R     ++AVKKL +   S         E+ +L  ++H+N++GL 
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 104 G-YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
             +   T        Y+    + + L+     +   D   +  +      G+ Y+H   +
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF-LVYQLLRGLKYIH---S 149
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WGK 221
             IIHRD+K SNV ++ D E  + DFG A+   E    MT  V  T  Y APE  + W  
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLARQADE---EMTGYV-ATRWYRAPEIMLNWMH 205
Query: 222 VSESCDVYSFGILLLEILTGR 242
            +++ D++S G ++ E+L G+
Sbjct: 206 YNQTVDIWSVGCIMAELLQGK 226

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y+P   + SHL         H + YA ++ L ++             
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------------- 156
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+L+D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 157 -YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 208
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y+P   + SHL         H + YA ++ L ++             
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------------- 155
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+L+D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 156 -YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y+P   + SHL         H + YA ++ L ++             
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------------- 155
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+L+D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 156 -YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y+P   + SHL         H + YA ++ L ++             
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------------- 155
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+L+D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 156 -YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 106/260 (40%), Gaps = 39/260 (15%)
Query: 2   GSAFSCCGSEK--VEEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYW 59
            +A +C GSE+  V+E L          W   T  +     + F     LG G FG V  
Sbjct: 2   NAAAACKGSEQESVKEFLAKAKEDFLKKWE--TPSQNTAQLDQFDRIKTLGTGSFGRVML 59
Query: 60  GRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV 115
            +  + G   A+K   K K +  K       E  +L  V    L+ L           +V
Sbjct: 60  VKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119
Query: 116 YDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
            +Y+    + SHL         H + YA ++ L ++              YLH   +  +
Sbjct: 120 MEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE--------------YLH---SLDL 162
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSES 225
           I+RD+K  N+L+D      V DFGFAK     V   T  + GT  YLAPE  +    +++
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKA 218
Query: 226 CDVYSFGILLLEILTGRKPI 245
            D ++ G+L+ E+  G  P 
Sbjct: 219 VDWWALGVLIYEMAAGYPPF 238

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y+P   + SHL         H + YA ++ L ++             
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------------- 156
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+L+D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 157 -YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 208
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y+P   + SHL         H + YA ++ L ++             
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------------- 155
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+L+D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 156 -YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y+P   + SHL         H + YA ++ L ++             
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------------- 155
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+L+D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 156 -YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 103/227 (45%), Gaps = 24/227 (10%)
Query: 34  KELHTATNGFSDDNKLGEG-GFGSVYWGR----TSDGLQIAVKKLKAMNSKAEMEFAVEV 88
           ++LH  +  F+D  ++ E  G GS    +     +  ++ AVK +     K++ +   E+
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII----DKSKRDPTEEI 66
Query: 89  EVLGRV-RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSH-LHGQYAGEVQLDWKRRMKI 146
           E+L R  +H N++ L+          +V + M    LL   L  ++  E     +    +
Sbjct: 67  EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE-----REASAV 121
Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVL-LDSDFEP---LVADFGFAKLIPEGVSHMT 202
                + + YLH +    ++HRD+K SN+L +D    P    + DFGFAK +      + 
Sbjct: 122 LFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLM 178
Query: 203 TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLP 249
           T    T  ++APE         +CD++S G+LL  +LTG  P    P
Sbjct: 179 TPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGP 224

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y+P   + SHL         H + YA ++ L ++             
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------------- 156
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+L+D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 157 -YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEYLAP 208
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 96/217 (44%), Gaps = 37/217 (17%)
Query: 49  LGEGGFGSV---YWGRTSDGLQIAV--KKLKAMNSKAEMEFAV----EVEVLGRVRHKNL 99
           LG G  G V   +  +T   + I +  K+  A+ S  E + A+    E+E+L ++ H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE------G 153
           + ++ +    D   IV + M    L   + G           +R+K A            
Sbjct: 78  IKIKNFFDAEDY-YIVLELMEGGELFDKVVGN----------KRLKEATCKLYFYQMLLA 126
Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPL---VADFGFAKLIPEGVSHMTTRVKGTLG 210
           + YLH      IIHRD+K  NVLL S  E     + DFG +K++  G + +   + GT  
Sbjct: 127 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPT 181
Query: 211 YLAPEYAM---WGKVSESCDVYSFGILLLEILTGRKP 244
           YLAPE  +       + + D +S G++L   L+G  P
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 90/211 (42%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 35  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 94
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y+P   + SHL         H + YA ++ L ++             
Sbjct: 95  SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------------- 141
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+L+D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 142 -YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEYLAP 193
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 194 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 49  LGEGGFGSV---YWGRTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLR 103
           +G G +GSV   Y  R     ++AVKKL +   S         E+ +L  ++H+N++GL 
Sbjct: 28  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 104 G-YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
             +   T        Y+    + + L+     +   D   +  +      G+ Y+H   +
Sbjct: 86  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-LVYQLLRGLKYIH---S 141
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WGK 221
             IIHRD+K SNV ++ D E  + DFG A+   E    MT  V  T  Y APE  + W  
Sbjct: 142 AGIIHRDLKPSNVAVNEDCELRILDFGLARQADE---EMTGYV-ATRWYRAPEIMLNWMH 197
Query: 222 VSESCDVYSFGILLLEILTGR 242
            +++ D++S G ++ E+L G+
Sbjct: 198 YNQTVDIWSVGCIMAELLQGK 218

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 116/273 (42%), Gaps = 57/273 (20%)
Query: 49  LGEGGFGSV---YWGRTSDGLQIAV--KKLKAMNSKAEMEFAV----EVEVLGRVRHKNL 99
           LG G  G V   +  +T   + I +  K+  A+ S  E + A+    E+E+L ++ H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE------G 153
           + ++ +    D   IV + M    L   + G           +R+K A            
Sbjct: 78  IKIKNFFDAEDY-YIVLELMEGGELFDKVVGN----------KRLKEATCKLYFYQMLLA 126
Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPL---VADFGFAKLIPEGVSHMTTRVKGTLG 210
           + YLH      IIHRD+K  NVLL S  E     + DFG +K++  G + +   + GT  
Sbjct: 127 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPT 181
Query: 211 YLAPEYAM---WGKVSESCDVYSFGILLLEILTGRKPI----------EKLPGGVKRTIT 257
           YLAPE  +       + + D +S G++L   L+G  P           +++  G    I 
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241
Query: 258 E-WAEPLIVKGKFKEL------VDPKLRGDFDE 283
           E WAE   V  K  +L      VDPK R   +E
Sbjct: 242 EVWAE---VSEKALDLVKKLLVVDPKARFTTEE 271

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 116/273 (42%), Gaps = 57/273 (20%)
Query: 49  LGEGGFGSV---YWGRTSD--GLQIAVKKLKAMNSKAEMEFAV----EVEVLGRVRHKNL 99
           LG G  G V   +  +T     ++I  K+  A+ S  E + A+    E+E+L ++ H  +
Sbjct: 18  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 77
Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE------G 153
           + ++ +    D   IV + M    L   + G           +R+K A            
Sbjct: 78  IKIKNFFDAEDY-YIVLELMEGGELFDKVVGN----------KRLKEATCKLYFYQMLLA 126
Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPL---VADFGFAKLIPEGVSHMTTRVKGTLG 210
           + YLH      IIHRD+K  NVLL S  E     + DFG +K++  G + +   + GT  
Sbjct: 127 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPT 181
Query: 211 YLAPEYAM---WGKVSESCDVYSFGILLLEILTGRKPI----------EKLPGGVKRTIT 257
           YLAPE  +       + + D +S G++L   L+G  P           +++  G    I 
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241
Query: 258 E-WAEPLIVKGKFKEL------VDPKLRGDFDE 283
           E WAE   V  K  +L      VDPK R   +E
Sbjct: 242 EVWAE---VSEKALDLVKKLLVVDPKARFTTEE 271

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 114/268 (42%), Gaps = 57/268 (21%)
Query: 49  LGEGGFGSV---YWGRTSD--GLQIAVKKLKAMNSKAEMEFAV----EVEVLGRVRHKNL 99
           LG G  G V   +  +T     ++I  K+  A+ S  E + A+    E+E+L ++ H  +
Sbjct: 143 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 202
Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE------G 153
           + ++ +    D   IV + M    L   + G           +R+K A            
Sbjct: 203 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGN----------KRLKEATCKLYFYQMLLA 251
Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPL---VADFGFAKLIPEGVSHMTTRVKGTLG 210
           + YLH      IIHRD+K  NVLL S  E     + DFG +K++  G + +   + GT  
Sbjct: 252 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPT 306
Query: 211 YLAPEYAM---WGKVSESCDVYSFGILLLEILTGRKPI----------EKLPGGVKRTIT 257
           YLAPE  +       + + D +S G++L   L+G  P           +++  G    I 
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366
Query: 258 E-WAEPLIVKGKFKEL------VDPKLR 278
           E WAE   V  K  +L      VDPK R
Sbjct: 367 EVWAE---VSEKALDLVKKLLVVDPKAR 391

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 116/273 (42%), Gaps = 57/273 (20%)
Query: 49  LGEGGFGSV---YWGRTSDGLQIAV--KKLKAMNSKAEMEFAV----EVEVLGRVRHKNL 99
           LG G  G V   +  +T   + I +  K+  A+ S  E + A+    E+E+L ++ H  +
Sbjct: 24  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 83
Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE------G 153
           + ++ +    D   IV + M    L   + G           +R+K A            
Sbjct: 84  IKIKNFFDAEDY-YIVLELMEGGELFDKVVGN----------KRLKEATCKLYFYQMLLA 132
Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPL---VADFGFAKLIPEGVSHMTTRVKGTLG 210
           + YLH      IIHRD+K  NVLL S  E     + DFG +K++  G + +   + GT  
Sbjct: 133 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPT 187
Query: 211 YLAPEYAM---WGKVSESCDVYSFGILLLEILTGRKPI----------EKLPGGVKRTIT 257
           YLAPE  +       + + D +S G++L   L+G  P           +++  G    I 
Sbjct: 188 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 247
Query: 258 E-WAEPLIVKGKFKEL------VDPKLRGDFDE 283
           E WAE   V  K  +L      VDPK R   +E
Sbjct: 248 EVWAE---VSEKALDLVKKLLVVDPKARFTTEE 277

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 74/273 (27%), Positives = 116/273 (42%), Gaps = 57/273 (20%)
Query: 49  LGEGGFGSV---YWGRTSDGLQIAV--KKLKAMNSKAEMEFAV----EVEVLGRVRHKNL 99
           LG G  G V   +  +T   + I +  K+  A+ S  E + A+    E+E+L ++ H  +
Sbjct: 17  LGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 76
Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE------G 153
           + ++ +    D   IV + M    L   + G           +R+K A            
Sbjct: 77  IKIKNFFDAEDY-YIVLELMEGGELFDKVVGN----------KRLKEATCKLYFYQMLLA 125
Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPL---VADFGFAKLIPEGVSHMTTRVKGTLG 210
           + YLH      IIHRD+K  NVLL S  E     + DFG +K++  G + +   + GT  
Sbjct: 126 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPT 180
Query: 211 YLAPEYAM---WGKVSESCDVYSFGILLLEILTGRKPI----------EKLPGGVKRTIT 257
           YLAPE  +       + + D +S G++L   L+G  P           +++  G    I 
Sbjct: 181 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 240
Query: 258 E-WAEPLIVKGKFKEL------VDPKLRGDFDE 283
           E WAE   V  K  +L      VDPK R   +E
Sbjct: 241 EVWAE---VSEKALDLVKKLLVVDPKARFTTEE 270

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/279 (24%), Positives = 117/279 (41%), Gaps = 42/279 (15%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
           KL E   G ++ GR   + + + V K++  +++   +F  E   L    H N+L + G C
Sbjct: 17  KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 107 AG--TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                    ++  +MP  SL + LH        +D  + +K A+  A G+ +LH  + P 
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHE--GTNFVVDQSQAVKFALDMARGMAFLH-TLEPL 133
Query: 165 IIHRDIKASNVLLDSDFEPLV--ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
           I    + + +V++D D    +  AD  F+   P  +            ++APE A+  K 
Sbjct: 134 IPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMY--------APAWVAPE-ALQKKP 184
Query: 223 SE----SCDVYSFGILLLEILTGRKPIEKLPG---GVKRTITEWAEPLIVKGKFKELVDP 275
            +    S D++SF +LL E++T   P   L     G+K  + E   P I  G     + P
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVAL-EGLRPTIPPG-----ISP 238
Query: 276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +              +  +C+  +P KRP    +V  L
Sbjct: 239 HVS------------KLMKICMNEDPAKRPKFDMIVPIL 265

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 102/230 (44%), Gaps = 27/230 (11%)
Query: 24  NNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWG-RTSDGLQIAVKKL-KAMNSKAE 81
           +N  + +       T    +     +G G  G V     T  G+ +AVKKL +   ++  
Sbjct: 7   DNQFYSVEVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTH 66
Query: 82  MEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLI-----VYDYM----PNLSLLSHLHGQ 131
            + A  E+ +L  V HKN++ L      T Q+ +     VY  M     NL  + H+   
Sbjct: 67  AKRAYRELVLLKCVNHKNIISLLN--VFTPQKTLEEFQDVYLVMELMDANLCQVIHM--- 121
Query: 132 YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA 191
                +LD +R   +      GI +LH   +  IIHRD+K SN+++ SD    + DFG A
Sbjct: 122 -----ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLA 173
Query: 192 KLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTG 241
           +      + M T    T  Y APE  +    + + D++S G ++ E++ G
Sbjct: 174 RT--ACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGELVKG 221

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 114/268 (42%), Gaps = 57/268 (21%)
Query: 49  LGEGGFGSV---YWGRTSD--GLQIAVKKLKAMNSKAEMEFAV----EVEVLGRVRHKNL 99
           LG G  G V   +  +T     ++I  K+  A+ S  E + A+    E+E+L ++ H  +
Sbjct: 157 LGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI 216
Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE------G 153
           + ++ +    D   IV + M    L   + G           +R+K A            
Sbjct: 217 IKIKNFFDAEDY-YIVLELMEGGELFDKVVGN----------KRLKEATCKLYFYQMLLA 265
Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPL---VADFGFAKLIPEGVSHMTTRVKGTLG 210
           + YLH      IIHRD+K  NVLL S  E     + DFG +K++  G + +   + GT  
Sbjct: 266 VQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCGTPT 320
Query: 211 YLAPEYAM---WGKVSESCDVYSFGILLLEILTGRKPI----------EKLPGGVKRTIT 257
           YLAPE  +       + + D +S G++L   L+G  P           +++  G    I 
Sbjct: 321 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 380
Query: 258 E-WAEPLIVKGKFKEL------VDPKLR 278
           E WAE   V  K  +L      VDPK R
Sbjct: 381 EVWAE---VSEKALDLVKKLLVVDPKAR 405

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 106/237 (44%), Gaps = 32/237 (13%)
Query: 17  LTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSD---GLQIAVKKL 73
           LT    P +  +R    +E+H  T+      ++G G FG V+  R  D   G Q AVKK+
Sbjct: 58  LTEKLKPVDYEYR----EEVHWMTH----QPRVGRGSFGEVH--RMKDKQTGFQCAVKKV 107
Query: 74  KAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYA 133
           +    + E     E+     +    ++ L G         I  + +   SL     GQ  
Sbjct: 108 RLEVFRVE-----ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL-----GQLI 157
Query: 134 GEVQLDWKRRMKIAIGSA-EGILYLHHEVTPHIIHRDIKASNVLLDSD-FEPLVADFGFA 191
            ++    + R    +G A EG+ YLH   T  I+H D+KA NVLL SD     + DFG A
Sbjct: 158 KQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHA 214
Query: 192 -KLIPEGV--SHMT-TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
             L P+G+  S +T   + GT  ++APE  M        D++S   ++L +L G  P
Sbjct: 215 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 271

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/201 (28%), Positives = 95/201 (47%), Gaps = 17/201 (8%)
Query: 49  LGEGGFGSV---YWGRTSDGLQIAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLR 103
           +G G +GSV   Y  R     ++AVKKL +   S         E+ +L  ++H+N++GL 
Sbjct: 36  VGSGAYGSVCSAYDARLRQ--KVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 104 G-YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
             +   T        Y+    + + L+     +   D   +  +      G+ Y+H   +
Sbjct: 94  DVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF-LVYQLLRGLKYIH---S 149
Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WGK 221
             IIHRD+K SNV ++ D E  + DFG A+   E    MT  V  T  Y APE  + W  
Sbjct: 150 AGIIHRDLKPSNVAVNEDSELRILDFGLARQADE---EMTGYV-ATRWYRAPEIMLNWMH 205
Query: 222 VSESCDVYSFGILLLEILTGR 242
            +++ D++S G ++ E+L G+
Sbjct: 206 YNQTVDIWSVGCIMAELLQGK 226

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 26/219 (11%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGR--VRHKNLLGLRGYC 106
           +G G FG     R  D L   +  +K +   A ++  V+ E++    +RH N++  +   
Sbjct: 28  IGSGNFGVARLMR--DKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
                  I+ +Y     L   +    AG    D  R     + S  G+ Y H   +  I 
Sbjct: 86  LTPTHLAIIMEYASGGELYERICN--AGRFSEDEARFFFQQLLS--GVSYCH---SMQIC 138
Query: 167 HRDIKASNVLLDSDFEPL--VADFGFAKLIPEGVSHMTTR-VKGTLGYLAPEYAMW---- 219
           HRD+K  N LLD    P   + DFG++K     V H   +   GT  Y+APE  +     
Sbjct: 139 HRDLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLRQEYD 195
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIE--KLPGGVKRTI 256
           GK++   DV+S G+ L  +L G  P E  + P   ++TI
Sbjct: 196 GKIA---DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTI 231

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 27/201 (13%)
Query: 74  KAMNSKAEMEFAV------------EVEVLGRV-RHKNLLGLRGYCAGTDQRLIVYDYMP 120
           + ++    ME+AV            E+E+L R  +H N++ L+          +V + M 
Sbjct: 45  RCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMR 104
Query: 121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGS-AEGILYLHHEVTPHIIHRDIKASNVL-LD 178
              LL  +  Q     +   +R     + +  + + YLH +    ++HRD+K SN+L +D
Sbjct: 105 GGELLDKILRQ-----KFFSEREASFVLHTIGKTVEYLHSQ---GVVHRDLKPSNILYVD 156
Query: 179 SDFEP---LVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILL 235
               P    + DFGFAK +      + T    T  ++APE        E CD++S GILL
Sbjct: 157 ESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILL 215
Query: 236 LEILTGRKPIEKLPGGVKRTI 256
             +L G  P    P      I
Sbjct: 216 YTMLAGYTPFANGPSDTPEEI 236

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++ L      T Q+ +  +   ++ L+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLN--VFTPQKTL--EEFQDVYLV 107
Query: 126 SHLHGQYAGEV---QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE 182
             L      +V   +LD +R   +      GI +LH   +  IIHRD+K SN+++ SD  
Sbjct: 108 MELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXT 164
Query: 183 PLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
             + DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++
Sbjct: 165 LKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 128/291 (43%), Gaps = 47/291 (16%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKK-LKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           LG G  G+V +  +  G  +AVK+ L      A ME  +  E      H N++  R YC+
Sbjct: 23  LGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTE---SDDHPNVI--RYYCS 77
Query: 108 -GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRR---MKIAIGSAEGILYLHHEVTP 163
             TD+ L +   + NL+L   +  +   +  L  ++    + +    A G+ +LH   + 
Sbjct: 78  ETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH---SL 134
Query: 164 HIIHRDIKASNVLLDS-------------DFEPLVADFGFAKLIPEGVSHMTTRVK---G 207
            IIHRD+K  N+L+ +             +   L++DFG  K +  G       +    G
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSG 194
Query: 208 TLGYLAPEYAMWG-------KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWA 260
           T G+ APE            +++ S D++S G +   IL+  K     P G K +     
Sbjct: 195 TSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH----PFGDKYS----R 246
Query: 261 EPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
           E  I++G F   +D +++   D + + +A ++    +  +P KRP   +V+
Sbjct: 247 ESNIIRGIFS--LD-EMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVL 294

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 101/246 (41%), Gaps = 45/246 (18%)
Query: 14  EEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVK- 71
           E+ L    TP+  T ++  +  + T          LG G FG V   +  + G   A+K 
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKI 73
Query: 72  --KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL- 128
             K K +  K       E  +L  V    L+ L           +V +Y+    + SHL 
Sbjct: 74  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 129 --------HGQ-YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS 179
                   H + YA ++ L ++              YLH   +  +I+RD+K  N+L+D 
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFE--------------YLH---SLDLIYRDLKPENLLIDQ 176
Query: 180 DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
                V DFGFAK     V   T  + GT  YLAPE  +    +++ D ++ G+L+ E+ 
Sbjct: 177 QGYIQVTDFGFAK----RVKGRTWXLXGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 240 TGRKPI 245
            G  P 
Sbjct: 233 AGYPPF 238

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 61/238 (25%), Positives = 99/238 (41%), Gaps = 29/238 (12%)
Query: 14  EEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVK- 71
           E+ L    TP+  T ++  +  + T          LG G FG V   +  + G   A+K 
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKI 73
Query: 72  --KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLH 129
             K K +  K       E  +L  V    L+ L           +V +Y+    + SHL 
Sbjct: 74  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 130 --GQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD 187
             G++A                +A+ +L   +  +  +I+RD+K  N+L+D      V D
Sbjct: 134 RIGRFA---------EPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTD 184
Query: 188 FGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           FGFAK     V   T  + GT  YLAPE  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 185 FGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 81/174 (46%), Gaps = 21/174 (12%)
Query: 83  EFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSH------LHGQYAGEV 136
           +F  E++++  ++++  L   G     D+  I+Y+YM N S+L        L   Y   +
Sbjct: 89  DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 137 QLDWKRRMKIAIGSA-EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP 195
            +   + +K  I S      Y+H+E   +I HRD+K SN+L+D +    ++DFG ++ + 
Sbjct: 149 PI---QVIKCIIKSVLNSFSYIHNE--KNICHRDVKPSNILMDKNGRVKLSDFGESEYM- 202
Query: 196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSE----SCDVYSFGILLLEILTGRKPI 245
             V       +GT  ++ PE+  +   S       D++S GI L  +     P 
Sbjct: 203 --VDKKIKGSRGTYEFMPPEF--FSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 101/246 (41%), Gaps = 45/246 (18%)
Query: 14  EEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVK- 71
           E+ L    TP+  T ++  +  + T          LG G FG V   +  + G   A+K 
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKI 73
Query: 72  --KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL- 128
             K K +  K       E  +L  V    L+ L           +V +Y+    + SHL 
Sbjct: 74  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 129 --------HGQ-YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS 179
                   H + YA ++ L ++              YLH   +  +I+RD+K  N+L+D 
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFE--------------YLH---SLDLIYRDLKPENLLIDQ 176
Query: 180 DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
                V DFGFAK     V   T  + GT  YLAPE  +    +++ D ++ G+L+ E+ 
Sbjct: 177 QGYIQVTDFGFAK----RVKGRTWXLAGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 240 TGRKPI 245
            G  P 
Sbjct: 233 AGYPPF 238

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 53/201 (26%), Positives = 86/201 (42%), Gaps = 27/201 (13%)
Query: 74  KAMNSKAEMEFAV------------EVEVLGRV-RHKNLLGLRGYCAGTDQRLIVYDYMP 120
           + ++    ME+AV            E+E+L R  +H N++ L+          +V + M 
Sbjct: 45  RCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKDVYDDGKHVYLVTELMR 104
Query: 121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGS-AEGILYLHHEVTPHIIHRDIKASNVL-LD 178
              LL  +  Q     +   +R     + +  + + YLH +    ++HRD+K SN+L +D
Sbjct: 105 GGELLDKILRQ-----KFFSEREASFVLHTIGKTVEYLHSQ---GVVHRDLKPSNILYVD 156
Query: 179 SDFEP---LVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILL 235
               P    + DFGFAK +      + T    T  ++APE        E CD++S GILL
Sbjct: 157 ESGNPECLRICDFGFAKQLRAENGLLMTPCY-TANFVAPEVLKRQGYDEGCDIWSLGILL 215
Query: 236 LEILTGRKPIEKLPGGVKRTI 256
             +L G  P    P      I
Sbjct: 216 YTMLAGYTPFANGPSDTPEEI 236

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 109
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y P   + SHL         H + YA ++ L ++             
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------------- 156
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+++D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 157 -YLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAP 208
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 85/177 (48%), Gaps = 8/177 (4%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++GL              D    + L+
Sbjct: 57  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 116
Query: 126 SHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV 185
                Q   +++LD +R   +      GI +LH   +  IIHRD+K SN+++ SD    +
Sbjct: 117 DANLCQVI-QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 172
Query: 186 ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGR 242
            DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++  +
Sbjct: 173 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 227

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 48  KLGEGGFGSVYWGRTSDGLQI-AVKKLKAMNSKAEMEFAV--EVEVLGRVRHKNLLGLRG 104
           K+GEG +G+V+  +  +  +I A+K+++  +    +  +   E+ +L  ++HKN++ L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                 +  +V+++      L        G+  LD +          +G+ + H     +
Sbjct: 69  VLHSDKKLTLVFEFCD--QDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGFCHSR---N 121
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
           ++HRD+K  N+L++ + E  +ADFG A+     V   +  V  TL Y  P+     K+ S
Sbjct: 122 VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEV-VTLWYRPPDVLFGAKLYS 180
Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGG 251
            S D++S G +  E+    +P+   PG 
Sbjct: 181 TSIDMWSAGCIFAELANAARPL--FPGN 206

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 106/237 (44%), Gaps = 32/237 (13%)
Query: 17  LTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSD---GLQIAVKKL 73
           LT    P +  +R    +E+H  T+      ++G G FG V+  R  D   G Q AVKK+
Sbjct: 42  LTEKLKPVDYEYR----EEVHWMTH----QPRVGRGSFGEVH--RMKDKQTGFQCAVKKV 91
Query: 74  KAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYA 133
           +    + E     E+     +    ++ L G         I  + +   SL     GQ  
Sbjct: 92  RLEVFRVE-----ELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL-----GQLI 141
Query: 134 GEVQLDWKRRMKIAIGSA-EGILYLHHEVTPHIIHRDIKASNVLLDSD-FEPLVADFGFA 191
            ++    + R    +G A EG+ YLH   T  I+H D+KA NVLL SD     + DFG A
Sbjct: 142 KQMGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHA 198
Query: 192 -KLIPEGV--SHMT-TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
             L P+G+  S +T   + GT  ++APE  M        D++S   ++L +L G  P
Sbjct: 199 LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 50/177 (28%), Positives = 85/177 (48%), Gaps = 8/177 (4%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++GL              D    + L+
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 105
Query: 126 SHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV 185
                Q   +++LD +R   +      GI +LH   +  IIHRD+K SN+++ SD    +
Sbjct: 106 DANLCQVI-QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 161
Query: 186 ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGR 242
            DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++  +
Sbjct: 162 LDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 216

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 89/211 (42%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +   V    L+ L  
Sbjct: 50  LGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEF 109
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y P   + SHL         H + YA ++ L ++             
Sbjct: 110 SFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------------- 156
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+L+D      VADFGFAK     V   T  + GT  YLAP
Sbjct: 157 -YLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAK----RVKGRTWXLCGTPEYLAP 208
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 120/276 (43%), Gaps = 45/276 (16%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVR--HKNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 100 LGLRGYCAGTDQRLIVYDY-MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +   E + + H
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQV--LEAVRHCH 127
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           +     ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 128 NX---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 181
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
            + +    S  V+S GILL +++ G  P E              +  I++G+        
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------------DEEIIRGQVF------ 222
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
               F +    +  ++   C+   P  RP  +E+ N
Sbjct: 223 ----FRQRVSXECQHLIRWCLALRPSDRPTFEEIQN 254

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 120/276 (43%), Gaps = 45/276 (16%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 100 LGLRGYCAGTDQRLIVYDYM-PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +   E + + H
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQV--LEAVRHCH 132
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           +     ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 133 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 186
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
            + +    S  V+S GILL +++ G  P E              +  I++G+        
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------------DEEIIRGQVF------ 227
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
               F +    +  ++   C+   P  RP  +E+ N
Sbjct: 228 ----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 259

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 118/287 (41%), Gaps = 41/287 (14%)
Query: 49  LGEGGFGSVYWG------RTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRV-RHKNLL 100
           LG G FG V         +T+    +AVK LK   + +E      E+++L  +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 101 GLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQ--------LDWKRRMKIAIGSA 151
            L G C      L ++ ++    +L ++L  +    V         L  +  +  +   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVA 154
Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTRVKGT 208
           +G+ +L    +   IHRD+ A N+LL       + DFG A+ I   P+ V     R+   
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL--P 209
Query: 209 LGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKG 267
           L ++APE       +   DV+SFG+LL EI + G  P      GVK           +  
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----GVK-----------IDE 254
Query: 268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           +F   +    R    +    +     + C   EP +RP   E+V  L
Sbjct: 255 EFXRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 48  KLGEGGFGSVYWGRT-SDGLQIAVKKLK----AMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
           +LG G F  V    + S G + A K LK      + +AE+   + V  L +   + ++ L
Sbjct: 36  ELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPR-VINL 94
Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV-QLDWKRRMKIAIGSAEGILYLHHEV 161
                 T + +++ +Y     + S    + A  V + D  R +K  +   EG+ YLH   
Sbjct: 95  HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL---EGVYYLHQN- 150
Query: 162 TPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
             +I+H D+K  N+LL S + PL    + DFG ++ I  G +     + GT  YLAPE  
Sbjct: 151 --NIVHLDLKPQNILLSSIY-PLGDIKIVDFGMSRKI--GHACELREIMGTPEYLAPEIL 205
Query: 218 MWGKVSESCDVYSFGILLLEILTGRKP 244
            +  ++ + D+++ GI+   +LT   P
Sbjct: 206 NYDPITTATDMWNIGIIAYMLLTHTSP 232

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 119/276 (43%), Gaps = 45/276 (16%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 100 LGLRGYCAGTDQRLIVYDYM-PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +   E + + H
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQV--LEAVRHCH 147
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
                 ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 148 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 201
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
            + +    S  V+S GILL +++ G  P E              +  I++G+        
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------------DEEIIRGQVF------ 242
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
               F +    +  ++   C+   P  RP  +E+ N
Sbjct: 243 ----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 274

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 67/142 (47%), Gaps = 12/142 (8%)
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
           AG    LIV + +    L S +  Q  G+     +   +I     E I YLH   + +I 
Sbjct: 83  AGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLH---SINIA 137
Query: 167 HRDIKASNVLLDSDFEPLV---ADFGFAKLIPEGVSHMT-TRVKGTLGYLAPEYAMWGKV 222
           HRD+K  N+L  S     +    DFGFAK   E  SH + T    T  Y+APE     K 
Sbjct: 138 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTEPCYTPYYVAPEVLGPEKY 194
Query: 223 SESCDVYSFGILLLEILTGRKP 244
            +SCD++S G+++  +L G  P
Sbjct: 195 DKSCDMWSLGVIMYILLCGYPP 216

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 120/276 (43%), Gaps = 45/276 (16%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 100 LGLRGYCAGTDQRLIVYDY-MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +   E + + H
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQV--LEAVRHCH 132
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           +     ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 133 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 186
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
            + +    S  V+S GILL +++ G  P E              +  I++G+        
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------------DEEIIRGQVF------ 227
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
               F +    +  ++   C+   P  RP  +E+ N
Sbjct: 228 ----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 259

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 119/276 (43%), Gaps = 45/276 (16%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 100 LGLRGYCAGTDQRLIVYDY-MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +   E + + H
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQV--LEAVRHCH 127
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
                 ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 128 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 181
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
            + +    S  V+S GILL +++ G  P E              +  I++G+        
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------------DEEIIRGQVF------ 222
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
               F +    +  ++   C+   P  RP  +E+ N
Sbjct: 223 ----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 118/276 (42%), Gaps = 45/276 (16%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 15  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 74
Query: 100 LGLRGYCAGTDQRLIVYDY-MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +  A     + 
Sbjct: 75  IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA-----VR 127
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           H     ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 128 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 184
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
            + +    S  V+S GILL +++ G  P E              +  I++G+        
Sbjct: 185 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------------DEEIIRGQVF------ 225
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
               F +    +  ++   C+   P  RP  +E+ N
Sbjct: 226 ----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 257

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 119/276 (43%), Gaps = 45/276 (16%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 100 LGLRGYCAGTDQRLIVYDYM-PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +   E + + H
Sbjct: 119 IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQV--LEAVRHCH 174
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
                 ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 175 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 228
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
            + +    S  V+S GILL +++ G  P E              +  I++G+        
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------------DEEIIRGQVF------ 269
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
               F +    +  ++   C+   P  RP  +E+ N
Sbjct: 270 ----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 301

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 119/276 (43%), Gaps = 45/276 (16%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 100 LGLRGYCAGTDQRLIVYDYM-PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +   E + + H
Sbjct: 111 IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQV--LEAVRHCH 166
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
                 ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 167 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 220
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
            + +    S  V+S GILL +++ G  P E              +  I++G+        
Sbjct: 221 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------------DEEIIRGQVF------ 261
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
               F +    +  ++   C+   P  RP  +E+ N
Sbjct: 262 ----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 293

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 119/276 (43%), Gaps = 45/276 (16%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 100 LGLRGYCAGTDQRLIVYDYM-PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +   E + + H
Sbjct: 91  IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQV--LEAVRHCH 146
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
                 ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 147 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 200
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
            + +    S  V+S GILL +++ G  P E              +  I++G+        
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------------DEEIIRGQVF------ 241
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
               F +    +  ++   C+   P  RP  +E+ N
Sbjct: 242 ----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 273

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y P   + SHL         H + YA ++ L ++             
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------------- 155
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+++D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 156 -YLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 14/177 (7%)
Query: 68  IAVKKL-KAMNSKAEMEFAVEVEVLGR-VRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A    VL + V HKN++ L      T Q+ +  +   ++ L+
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN--VFTPQKTL--EEFQDVYLV 100
Query: 126 SHLHGQYAGEV---QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE 182
             L      +V   +LD +R   +      GI +LH   +  IIHRD+K SN+++ SD  
Sbjct: 101 MELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXT 157
Query: 183 PLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
             + DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++
Sbjct: 158 LKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 87/177 (49%), Gaps = 14/177 (7%)
Query: 68  IAVKKL-KAMNSKAEMEFAVEVEVLGR-VRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A    VL + V HKN++ L      T Q+ +  +   ++ L+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN--VFTPQKTL--EEFQDVYLV 107
Query: 126 SHLHGQYAGEV---QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE 182
             L      +V   +LD +R   +      GI +LH   +  IIHRD+K SN+++ SD  
Sbjct: 108 MELMDANLXQVIQMELDHERMSYLLYQMLXGIKHLH---SAGIIHRDLKPSNIVVKSDXT 164
Query: 183 PLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
             + DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++
Sbjct: 165 LKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y P   + SHL         H + YA ++ L ++             
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------------- 155
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+++D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 156 -YLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 67/143 (46%), Gaps = 12/143 (8%)
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
           AG    LIV + +    L S +  Q  G+     +   +I     E I YLH   + +I 
Sbjct: 99  AGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLH---SINIA 153
Query: 167 HRDIKASNVLLDSDFEPLV---ADFGFAKLIPEGVSHMT-TRVKGTLGYLAPEYAMWGKV 222
           HRD+K  N+L  S     +    DFGFAK   E  SH + T    T  Y+APE     K 
Sbjct: 154 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKY 210
Query: 223 SESCDVYSFGILLLEILTGRKPI 245
            +SCD++S G+++  +L G  P 
Sbjct: 211 DKSCDMWSLGVIMYILLCGYPPF 233

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 72/289 (24%), Positives = 118/289 (40%), Gaps = 43/289 (14%)
Query: 49  LGEGGFGSVYWG------RTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRV-RHKNLL 100
           LG G FG V         +T+    +AVK LK   + +E      E+++L  +  H N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 101 GLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQ----------LDWKRRMKIAIG 149
            L G C      L ++ ++    +L ++L  +    V           L  +  +  +  
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTRVK 206
            A+G+ +L    +   IHRD+ A N+LL       + DFG A+ I   P+ V     R+ 
Sbjct: 157 VAKGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL- 212
Query: 207 GTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIV 265
             L ++APE       +   DV+SFG+LL EI + G  P      GVK           +
Sbjct: 213 -PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----GVK-----------I 256
Query: 266 KGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
             +F   +    R    +    +     + C   EP +RP   E+V  L
Sbjct: 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 120/276 (43%), Gaps = 45/276 (16%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 100 LGLRGYCAGTDQRLIVYDY-MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +   E + + H
Sbjct: 76  IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQV--LEAVRHCH 131
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           +     ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 132 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 185
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
            + +    S  V+S GILL +++ G  P E              +  I++G+        
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------------DEEIIRGQVF------ 226
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
               F +    +  ++   C+   P  RP  +E+ N
Sbjct: 227 ----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 258

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y P   + SHL         H + YA ++ L ++             
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------------- 155
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+++D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 156 -YLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 119/276 (43%), Gaps = 45/276 (16%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 100 LGLRGYCAGTDQRLIVYDYM-PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +   E + + H
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQV--LEAVRHCH 159
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
                 ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 160 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 213
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
            + +    S  V+S GILL +++ G  P E              +  I++G+        
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------------DEEIIRGQVF------ 254
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
               F +    +  ++   C+   P  RP  +E+ N
Sbjct: 255 ----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 286

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 94/205 (45%), Gaps = 19/205 (9%)
Query: 48  KLGEGGFGSVYW-GRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
           +LG G FG V+     + G   A K +   +   +     E++ +  +RH  L+ L    
Sbjct: 58  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 117
Query: 107 AGTDQRLIVYDYMPNLSLLSHL---HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
              ++ +++Y++M    L   +   H + + +  +++ R++       +G+ ++H     
Sbjct: 118 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV------CKGLCHMHEN--- 168
Query: 164 HIIHRDIKASNVLLDS--DFEPLVADFGF-AKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
           + +H D+K  N++  +    E  + DFG  A L P+    +TT   GT  + APE A   
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGK 225
Query: 221 KVSESCDVYSFGILLLEILTGRKPI 245
            V    D++S G+L   +L+G  P 
Sbjct: 226 PVGYYTDMWSVGVLSYILLSGLSPF 250

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 67/143 (46%), Gaps = 12/143 (8%)
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
           AG    LIV + +    L S +  Q  G+     +   +I     E I YLH   + +I 
Sbjct: 91  AGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLH---SINIA 145
Query: 167 HRDIKASNVLLDSDFEPLV---ADFGFAKLIPEGVSHMT-TRVKGTLGYLAPEYAMWGKV 222
           HRD+K  N+L  S     +    DFGFAK   E  SH + T    T  Y+APE     K 
Sbjct: 146 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKY 202
Query: 223 SESCDVYSFGILLLEILTGRKPI 245
            +SCD++S G+++  +L G  P 
Sbjct: 203 DKSCDMWSLGVIMYILLCGYPPF 225

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 67/142 (47%), Gaps = 12/142 (8%)
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
           AG    LIV + +    L S +  Q  G+     +   +I     E I YLH   + +I 
Sbjct: 83  AGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLH---SINIA 137
Query: 167 HRDIKASNVLLDSDFEPLV---ADFGFAKLIPEGVSHMT-TRVKGTLGYLAPEYAMWGKV 222
           HRD+K  N+L  S     +    DFGFAK   E  SH + T    T  Y+APE     K 
Sbjct: 138 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKY 194
Query: 223 SESCDVYSFGILLLEILTGRKP 244
            +SCD++S G+++  +L G  P
Sbjct: 195 DKSCDMWSLGVIMYILLCGYPP 216

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 67/143 (46%), Gaps = 12/143 (8%)
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
           AG    LIV + +    L S +  Q  G+     +   +I     E I YLH   + +I 
Sbjct: 89  AGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLH---SINIA 143
Query: 167 HRDIKASNVLLDSDFEPLV---ADFGFAKLIPEGVSHMT-TRVKGTLGYLAPEYAMWGKV 222
           HRD+K  N+L  S     +    DFGFAK   E  SH + T    T  Y+APE     K 
Sbjct: 144 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKY 200
Query: 223 SESCDVYSFGILLLEILTGRKPI 245
            +SCD++S G+++  +L G  P 
Sbjct: 201 DKSCDMWSLGVIMYILLCGYPPF 223

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 88/217 (40%), Gaps = 22/217 (10%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG 108
           +G G FG     R     ++   K      K +     E+     +RH N++  +     
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 109 TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHR 168
                IV +Y     L   +    AG    D  R     + S  G+ Y H      + HR
Sbjct: 87  PTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLIS--GVSYAH---AMQVAHR 139
Query: 169 DIKASNVLLDSDFEPL--VADFGFAKLIPEGVSHMTTR-VKGTLGYLAPEYAMW----GK 221
           D+K  N LLD    P   +ADFG++K     V H   +   GT  Y+APE  +     GK
Sbjct: 140 DLKLENTLLDGSPAPRLKIADFGYSK---ASVLHSQPKSAVGTPAYIAPEVLLKKEYDGK 196
Query: 222 VSESCDVYSFGILLLEILTGRKPIE--KLPGGVKRTI 256
           V+   DV+S G+ L  +L G  P E  + P   ++TI
Sbjct: 197 VA---DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 230

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 120/276 (43%), Gaps = 45/276 (16%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 76
Query: 100 LGLRGYCAGTDQRLIVYDY-MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +   E + + H
Sbjct: 77  IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQV--LEAVRHCH 132
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           +     ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 133 N---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 186
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
            + +    S  V+S GILL +++ G  P E              +  I++G+        
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------------DEEIIRGQVF------ 227
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
               F +    +  ++   C+   P  RP  +E+ N
Sbjct: 228 ----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 259

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 94/205 (45%), Gaps = 19/205 (9%)
Query: 48  KLGEGGFGSVYW-GRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
           +LG G FG V+     + G   A K +   +   +     E++ +  +RH  L+ L    
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 107 AGTDQRLIVYDYMPNLSLLSHL---HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
              ++ +++Y++M    L   +   H + + +  +++ R++       +G+ ++H     
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQV------CKGLCHMHEN--- 274
Query: 164 HIIHRDIKASNVLLDS--DFEPLVADFGF-AKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
           + +H D+K  N++  +    E  + DFG  A L P+    +TT   GT  + APE A   
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGK 331
Query: 221 KVSESCDVYSFGILLLEILTGRKPI 245
            V    D++S G+L   +L+G  P 
Sbjct: 332 PVGYYTDMWSVGVLSYILLSGLSPF 356

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 67/143 (46%), Gaps = 12/143 (8%)
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
           AG    LIV + +    L S +  Q  G+     +   +I     E I YLH   + +I 
Sbjct: 90  AGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLH---SINIA 144
Query: 167 HRDIKASNVLLDSDFEPLV---ADFGFAKLIPEGVSHMT-TRVKGTLGYLAPEYAMWGKV 222
           HRD+K  N+L  S     +    DFGFAK   E  SH + T    T  Y+APE     K 
Sbjct: 145 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKY 201
Query: 223 SESCDVYSFGILLLEILTGRKPI 245
            +SCD++S G+++  +L G  P 
Sbjct: 202 DKSCDMWSLGVIMYILLCGYPPF 224

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 119/276 (43%), Gaps = 45/276 (16%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 31  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 90
Query: 100 LGLRGYCAGTDQRLIVYDYM-PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +   E + + H
Sbjct: 91  IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQV--LEAVRHCH 146
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
                 ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 147 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 200
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
            + +    S  V+S GILL +++ G  P E              +  I++G+        
Sbjct: 201 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------------DEEIIRGQVF------ 241
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
               F +    +  ++   C+   P  RP  +E+ N
Sbjct: 242 ----FRQRVSXECQHLIRWCLALRPSDRPTFEEIQN 273

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 67/142 (47%), Gaps = 12/142 (8%)
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
           AG    LIV + +    L S +  Q  G+     +   +I     E I YLH   + +I 
Sbjct: 135 AGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLH---SINIA 189
Query: 167 HRDIKASNVLLDSDFEPLV---ADFGFAKLIPEGVSHMT-TRVKGTLGYLAPEYAMWGKV 222
           HRD+K  N+L  S     +    DFGFAK   E  SH + T    T  Y+APE     K 
Sbjct: 190 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKY 246
Query: 223 SESCDVYSFGILLLEILTGRKP 244
            +SCD++S G+++  +L G  P
Sbjct: 247 DKSCDMWSLGVIMYILLCGYPP 268

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 67/143 (46%), Gaps = 12/143 (8%)
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
           AG    LIV + +    L S +  Q  G+     +   +I     E I YLH   + +I 
Sbjct: 84  AGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLH---SINIA 138
Query: 167 HRDIKASNVLLDSDFEPLV---ADFGFAKLIPEGVSHMT-TRVKGTLGYLAPEYAMWGKV 222
           HRD+K  N+L  S     +    DFGFAK   E  SH + T    T  Y+APE     K 
Sbjct: 139 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKY 195
Query: 223 SESCDVYSFGILLLEILTGRKPI 245
            +SCD++S G+++  +L G  P 
Sbjct: 196 DKSCDMWSLGVIMYILLCGYPPF 218

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 119/276 (43%), Gaps = 45/276 (16%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 100 LGLRGYCAGTDQRLIVYDYM-PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +   E + + H
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQV--LEAVRHCH 147
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
                 ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 148 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 201
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
            + +    S  V+S GILL +++ G  P E              +  I++G+        
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------------DEEIIRGQVF------ 242
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
               F +    +  ++   C+   P  RP  +E+ N
Sbjct: 243 ----FRQRVSXECQHLIRWCLALRPSDRPTFEEIQN 274

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 101/246 (41%), Gaps = 45/246 (18%)
Query: 14  EEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVK- 71
           E+ L    TP+  T ++  +  + T          LG G FG V   +  + G   A+K 
Sbjct: 25  EDFLKKWETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKI 74
Query: 72  --KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL- 128
             K K +  K       E  +L  V    L+ L           +V +Y+    + SHL 
Sbjct: 75  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 134
Query: 129 --------HGQ-YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS 179
                   H + YA ++ L ++              YLH   +  +I+RD+K  N+L+D 
Sbjct: 135 RIGRFSEPHARFYAAQIVLTFE--------------YLH---SLDLIYRDLKPENLLIDQ 177
Query: 180 DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
                V DFGFAK     V   T  + GT  YLAPE  +    +++ D ++ G+L+ E+ 
Sbjct: 178 QGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 233
Query: 240 TGRKPI 245
            G  P 
Sbjct: 234 AGYPPF 239

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 101/246 (41%), Gaps = 45/246 (18%)
Query: 14  EEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVK- 71
           E+ L    TP+  T ++  +  + T          LG G FG V   +  + G   A+K 
Sbjct: 19  EDFLKKWETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKI 68
Query: 72  --KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL- 128
             K K +  K       E  +L  V    L+ L           +V +Y+    + SHL 
Sbjct: 69  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 128
Query: 129 --------HGQ-YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS 179
                   H + YA ++ L ++              YLH   +  +I+RD+K  N+L+D 
Sbjct: 129 RIGRFXEPHARFYAAQIVLTFE--------------YLH---SLDLIYRDLKPENLLIDQ 171
Query: 180 DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
                V DFGFAK     V   T  + GT  YLAPE  +    +++ D ++ G+L+ E+ 
Sbjct: 172 QGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 227
Query: 240 TGRKPI 245
            G  P 
Sbjct: 228 AGYPPF 233

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 118/276 (42%), Gaps = 45/276 (16%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 39  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 98
Query: 100 LGLRGYCAGTDQRLIVYDYM-PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +  A     + 
Sbjct: 99  IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA-----VR 151
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           H     ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 152 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 208
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
            + +    S  V+S GILL +++ G  P E              +  I++G+        
Sbjct: 209 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------------DEEIIRGQVF------ 249
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
               F +    +  ++   C+   P  RP  +E+ N
Sbjct: 250 ----FRQRVSXECQHLIRWCLALRPSDRPTFEEIQN 281

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 112/231 (48%), Gaps = 24/231 (10%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++ L      T Q+ +  +   ++ L+
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN--VFTPQKTL--EEFQDVYLV 145
Query: 126 SHLHGQYAGEV---QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE 182
             L      +V   +LD +R   +      GI +LH   +  IIHRD+K SN+++ SD  
Sbjct: 146 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 202
Query: 183 PLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGR 242
             + DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++  +
Sbjct: 203 LKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
Query: 243 KPIEKLPGGVKRTITEWAEPLIVKG----KFKELVDPKLRGDFDENQLKQA 289
                 PG  +  I +W + +   G    +F + + P +R ++ EN+ K A
Sbjct: 261 I---LFPG--RDYIDQWNKVIEQLGTPCPEFMKKLQPTVR-NYVENRPKYA 305

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 67/142 (47%), Gaps = 12/142 (8%)
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
           AG    LIV + +    L S +  Q  G+     +   +I     E I YLH   + +I 
Sbjct: 129 AGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLH---SINIA 183
Query: 167 HRDIKASNVLLDSDFEPLV---ADFGFAKLIPEGVSHMT-TRVKGTLGYLAPEYAMWGKV 222
           HRD+K  N+L  S     +    DFGFAK   E  SH + T    T  Y+APE     K 
Sbjct: 184 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKY 240
Query: 223 SESCDVYSFGILLLEILTGRKP 244
            +SCD++S G+++  +L G  P
Sbjct: 241 DKSCDMWSLGVIMYILLCGYPP 262

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/306 (23%), Positives = 135/306 (44%), Gaps = 38/306 (12%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKL---KAMNSKAEMEFAVEVEVLGRVRHKN 98
            +++   +G G FG V+  +  +  ++A+KK+   K   ++       E++++  V+H N
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNR-------ELQIMRIVKHPN 93
Query: 99  LLGLRGYCAGTDQRL------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE 152
           ++ L+ +      +       +V +Y+P     +  H  YA   Q      +K+ +    
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRH--YAKLKQTMPMLLIKLYMYQLL 151
Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEG---VSHMTTRVKGT 208
             L   H +   I HRDIK  N+LLD     L + DFG AK++  G   VS + +R    
Sbjct: 152 RSLAYIHSIG--ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRY--- 206
Query: 209 LGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKG 267
             Y APE        + + D++S G ++ E++ G +P+   PG  +  I +  E + V G
Sbjct: 207 --YRAPELIFGATNYTTNIDIWSTGCVMAELMQG-QPL--FPG--ESGIDQLVEIIKVLG 259
Query: 268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPRGKVMQTR 327
                    +  ++ E++  Q I          P   P+  ++++ L  Y P  ++  T 
Sbjct: 260 TPSREQIKTMNPNYMEHKFPQ-IRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARL--TA 316
Query: 328 IETLAY 333
           IE L +
Sbjct: 317 IEALCH 322

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 112/231 (48%), Gaps = 24/231 (10%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++ L      T Q+ +  +   ++ L+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLN--VFTPQKTL--EEFQDVYLV 107
Query: 126 SHLHGQYAGEV---QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE 182
             L      +V   +LD +R   +      GI +LH   +  IIHRD+K SN+++ SD  
Sbjct: 108 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDXT 164
Query: 183 PLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGR 242
             + DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++  +
Sbjct: 165 LKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222
Query: 243 KPIEKLPGGVKRTITEWAEPLIVKG----KFKELVDPKLRGDFDENQLKQA 289
                 PG  +  I +W + +   G    +F + + P +R ++ EN+ K A
Sbjct: 223 I---LFPG--RDYIDQWNKVIEQLGTPCPEFMKKLQPTVR-NYVENRPKYA 267

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 101/246 (41%), Gaps = 45/246 (18%)
Query: 14  EEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVK- 71
           E+ L    TP+  T ++  +  + T          LG G FG V   +  + G   A+K 
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKI 73
Query: 72  --KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL- 128
             K K +  K       E  +L  V    L+ L           +V +Y+    + SHL 
Sbjct: 74  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 129 --------HGQ-YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS 179
                   H + YA ++ L ++              YLH   +  +I+RD+K  N+L+D 
Sbjct: 134 RIGRFXEPHARFYAAQIVLTFE--------------YLH---SLDLIYRDLKPENLLIDQ 176
Query: 180 DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
                V DFGFAK     V   T  + GT  YLAPE  +    +++ D ++ G+L+ E+ 
Sbjct: 177 QGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 240 TGRKPI 245
            G  P 
Sbjct: 233 AGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 101/246 (41%), Gaps = 45/246 (18%)
Query: 14  EEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVK- 71
           E+ L    TP+  T ++  +  + T          LG G FG V   +  + G   A+K 
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKI 73
Query: 72  --KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL- 128
             K K +  K       E  +L  V    L+ L           +V +Y+    + SHL 
Sbjct: 74  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 129 --------HGQ-YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS 179
                   H + YA ++ L ++              YLH   +  +I+RD+K  N+L+D 
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFE--------------YLH---SLDLIYRDLKPENLLIDQ 176
Query: 180 DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
                V DFGFAK     V   T  + GT  YLAPE  +    +++ D ++ G+L+ E+ 
Sbjct: 177 QGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 240 TGRKPI 245
            G  P 
Sbjct: 233 AGYPPF 238

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 67/142 (47%), Gaps = 12/142 (8%)
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
           AG    LIV + +    L S +  Q  G+     +   +I     E I YLH   + +I 
Sbjct: 85  AGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLH---SINIA 139
Query: 167 HRDIKASNVLLDSDFEPLV---ADFGFAKLIPEGVSHMT-TRVKGTLGYLAPEYAMWGKV 222
           HRD+K  N+L  S     +    DFGFAK   E  SH + T    T  Y+APE     K 
Sbjct: 140 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKY 196
Query: 223 SESCDVYSFGILLLEILTGRKP 244
            +SCD++S G+++  +L G  P
Sbjct: 197 DKSCDMWSLGVIMYILLCGYPP 218

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 119/276 (43%), Gaps = 45/276 (16%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 64  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 123
Query: 100 LGLRGYCAGTDQRLIVYDYM-PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +   E + + H
Sbjct: 124 IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQV--LEAVRHCH 179
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
                 ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 180 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 233
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
            + +    S  V+S GILL +++ G  P E              +  I++G+        
Sbjct: 234 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------------DEEIIRGQVF------ 274
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
               F +    +  ++   C+   P  RP  +E+ N
Sbjct: 275 ----FRQRVSXECQHLIRWCLALRPSDRPTFEEIQN 306

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/290 (24%), Positives = 118/290 (40%), Gaps = 44/290 (15%)
Query: 49  LGEGGFGSVYWG------RTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRV-RHKNLL 100
           LG G FG V         +T+    +AVK LK   + +E      E+++L  +  H N++
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 101 GLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQ-----------LDWKRRMKIAI 148
            L G C      L ++ ++    +L ++L  +    V            L  +  +  + 
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSF 155
Query: 149 GSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTRV 205
             A+G+ +L    +   IHRD+ A N+LL       + DFG A+ I   P+ V     R+
Sbjct: 156 QVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARL 212
Query: 206 KGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLI 264
              L ++APE       +   DV+SFG+LL EI + G  P      GVK           
Sbjct: 213 --PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----GVK----------- 255
Query: 265 VKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           +  +F   +    R    +    +     + C   EP +RP   E+V  L
Sbjct: 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 101/246 (41%), Gaps = 45/246 (18%)
Query: 14  EEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVK- 71
           E+ L    TP+  T ++  +  + T          LG G FG V   +  + G   A+K 
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKI 73
Query: 72  --KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL- 128
             K K +  K       E  +L  V    L+ L           +V +Y+    + SHL 
Sbjct: 74  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 129 --------HGQ-YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS 179
                   H + YA ++ L ++              YLH   +  +I+RD+K  N+L+D 
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFE--------------YLH---SLDLIYRDLKPENLLIDQ 176
Query: 180 DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
                V DFGFAK     V   T  + GT  YLAPE  +    +++ D ++ G+L+ E+ 
Sbjct: 177 QGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 240 TGRKPI 245
            G  P 
Sbjct: 233 AGYPPF 238

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 112/231 (48%), Gaps = 24/231 (10%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++ L      T Q+ +  +   ++ L+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNIISLLN--VFTPQKTL--EEFQDVYLV 107
Query: 126 SHLHGQYAGEV---QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE 182
             L      +V   +LD +R   +      GI +LH   +  IIHRD+K SN+++ SD  
Sbjct: 108 MELMDANLXQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDXT 164
Query: 183 PLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGR 242
             + DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++  +
Sbjct: 165 LKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222
Query: 243 KPIEKLPGGVKRTITEWAEPLIVKG----KFKELVDPKLRGDFDENQLKQA 289
                 PG  +  I +W + +   G    +F + + P +R ++ EN+ K A
Sbjct: 223 I---LFPG--RDYIDQWNKVIEQLGTPCPEFMKKLQPTVR-NYVENRPKYA 267

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 101/246 (41%), Gaps = 45/246 (18%)
Query: 14  EEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVK- 71
           E+ L    TP+  T ++  +  + T          LG G FG V   +  + G   A+K 
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKI 73
Query: 72  --KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL- 128
             K K +  K       E  +L  V    L+ L           +V +Y+    + SHL 
Sbjct: 74  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 129 --------HGQ-YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS 179
                   H + YA ++ L ++              YLH   +  +I+RD+K  N+L+D 
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFE--------------YLH---SLDLIYRDLKPENLLIDQ 176
Query: 180 DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
                V DFGFAK     V   T  + GT  YLAPE  +    +++ D ++ G+L+ E+ 
Sbjct: 177 QGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 240 TGRKPI 245
            G  P 
Sbjct: 233 AGYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 101/246 (41%), Gaps = 45/246 (18%)
Query: 14  EEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVK- 71
           E+ L    TP+  T ++  +  + T          LG G FG V   +  + G   A+K 
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKI 73
Query: 72  --KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL- 128
             K K +  K       E  +L  V    L+ L           +V +Y+    + SHL 
Sbjct: 74  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 129 --------HGQ-YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS 179
                   H + YA ++ L ++              YLH   +  +I+RD+K  N+L+D 
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFE--------------YLH---SLDLIYRDLKPENLLIDQ 176
Query: 180 DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
                V DFGFAK     V   T  + GT  YLAPE  +    +++ D ++ G+L+ E+ 
Sbjct: 177 QGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 240 TGRKPI 245
            G  P 
Sbjct: 233 AGYPPF 238

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 101/246 (41%), Gaps = 45/246 (18%)
Query: 14  EEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVK- 71
           E+ L    TP+  T ++  +  + T          LG G FG V   +  + G   A+K 
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKI 73
Query: 72  --KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL- 128
             K K +  K       E  +L  V    L+ L           +V +Y+    + SHL 
Sbjct: 74  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 129 --------HGQ-YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS 179
                   H + YA ++ L ++              YLH   +  +I+RD+K  N+L+D 
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFE--------------YLH---SLDLIYRDLKPENLLIDQ 176
Query: 180 DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
                V DFGFAK     V   T  + GT  YLAPE  +    +++ D ++ G+L+ E+ 
Sbjct: 177 QGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 240 TGRKPI 245
            G  P 
Sbjct: 233 AGYPPF 238

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 67/143 (46%), Gaps = 12/143 (8%)
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
           AG    LIV + +    L S +  Q  G+     +   +I     E I YLH   + +I 
Sbjct: 85  AGRKCLLIVMECLDGGELFSRI--QDRGDQAFTEREASEIMKSIGEAIQYLH---SINIA 139
Query: 167 HRDIKASNVLLDSDFEPLV---ADFGFAKLIPEGVSHMT-TRVKGTLGYLAPEYAMWGKV 222
           HRD+K  N+L  S     +    DFGFAK   E  SH + T    T  Y+APE     K 
Sbjct: 140 HRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKY 196
Query: 223 SESCDVYSFGILLLEILTGRKPI 245
            +SCD++S G+++  +L G  P 
Sbjct: 197 DKSCDMWSLGVIMYILLCGYPPF 219

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 119/276 (43%), Gaps = 45/276 (16%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 32  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 91
Query: 100 LGLRGYCAGTDQRLIVYDYM-PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +   E + + H
Sbjct: 92  IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQV--LEAVRHCH 147
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
                 ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 148 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 201
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
            + +    S  V+S GILL +++ G  P E              +  I++G+        
Sbjct: 202 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------------DEEIIRGQVF------ 242
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
               F +    +  ++   C+   P  RP  +E+ N
Sbjct: 243 ----FRQRVSXECQHLIRWCLALRPXDRPTFEEIQN 274

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 112/231 (48%), Gaps = 24/231 (10%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++ L      T Q+ +  +   ++ L+
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN--VFTPQKTL--EEFQDVYLV 145
Query: 126 SHLHGQYAGEV---QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE 182
             L      +V   +LD +R   +      GI +LH   +  IIHRD+K SN+++ SD  
Sbjct: 146 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 202
Query: 183 PLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGR 242
             + DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++  +
Sbjct: 203 LKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
Query: 243 KPIEKLPGGVKRTITEWAEPLIVKG----KFKELVDPKLRGDFDENQLKQA 289
                 PG  +  I +W + +   G    +F + + P +R ++ EN+ K A
Sbjct: 261 I---LFPG--RDYIDQWNKVIEQLGTPCPEFMKKLQPTVR-NYVENRPKYA 305

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 69/276 (25%), Positives = 119/276 (43%), Gaps = 45/276 (16%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 59  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 118
Query: 100 LGLRGYCAGTDQRLIVYDYM-PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +   E + + H
Sbjct: 119 IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQV--LEAVRHCH 174
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
                 ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 175 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 228
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
            + +    S  V+S GILL +++ G  P E              +  I++G+        
Sbjct: 229 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEH-------------DEEIIRGQVF------ 269
Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
               F +    +  ++   C+   P  RP  +E+ N
Sbjct: 270 ----FRQRVSXECQHLIRWCLALRPSDRPTFEEIQN 301

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 101/246 (41%), Gaps = 45/246 (18%)
Query: 14  EEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVK- 71
           E+ L    TP+  T ++  +  + T          LG G FG V   +  + G   A+K 
Sbjct: 45  EDFLKKWETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKI 94
Query: 72  --KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL- 128
             K K +  K       E  +L  V    L+ L           +V +Y+    + SHL 
Sbjct: 95  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 154
Query: 129 --------HGQ-YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS 179
                   H + YA ++ L ++              YLH   +  +I+RD+K  N+L+D 
Sbjct: 155 RIGRFSEPHARFYAAQIVLTFE--------------YLH---SLDLIYRDLKPENLLIDQ 197
Query: 180 DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
                V DFGFAK     V   T  + GT  YLAPE  +    +++ D ++ G+L+ E+ 
Sbjct: 198 QGYIQVTDFGFAK----RVKGATWTLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 253
Query: 240 TGRKPI 245
            G  P 
Sbjct: 254 AGYPPF 259

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 101/246 (41%), Gaps = 45/246 (18%)
Query: 14  EEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVK- 71
           E+ L    TP+  T ++  +  + T          LG G FG V   +  + G   A+K 
Sbjct: 45  EDFLKKWETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKI 94
Query: 72  --KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL- 128
             K K +  K       E  +L  V    L+ L           +V +Y+    + SHL 
Sbjct: 95  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 154
Query: 129 --------HGQ-YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS 179
                   H + YA ++ L ++              YLH   +  +I+RD+K  N+L+D 
Sbjct: 155 RIGRFXEPHARFYAAQIVLTFE--------------YLH---SLDLIYRDLKPENLLIDQ 197
Query: 180 DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
                V DFGFAK     V   T  + GT  YLAPE  +    +++ D ++ G+L+ E+ 
Sbjct: 198 QGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 253
Query: 240 TGRKPI 245
            G  P 
Sbjct: 254 AGYPPF 259

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 87/217 (40%), Gaps = 22/217 (10%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG 108
           +G G FG     R     ++   K      K +     E+     +RH N++  +     
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 109 TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHR 168
                IV +Y     L   +    AG    D  R     + S  G+ Y H      + HR
Sbjct: 86  PTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLIS--GVSYCH---AMQVCHR 138
Query: 169 DIKASNVLLDSDFEPL--VADFGFAKLIPEGVSHMTTR-VKGTLGYLAPEYAMW----GK 221
           D+K  N LLD    P   + DFG++K     V H   +   GT  Y+APE  +     GK
Sbjct: 139 DLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 195
Query: 222 VSESCDVYSFGILLLEILTGRKPIE--KLPGGVKRTI 256
           V+   DV+S G+ L  +L G  P E  + P   ++TI
Sbjct: 196 VA---DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 229

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 101/246 (41%), Gaps = 45/246 (18%)
Query: 14  EEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVK- 71
           E+ L    TP+  T ++  +  + T          LG G FG V   +  + G   A+K 
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKI 73
Query: 72  --KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL- 128
             K K +  K       E  +L  V    L+ L           +V +Y+    + SHL 
Sbjct: 74  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 129 --------HGQ-YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS 179
                   H + YA ++ L ++              YLH   +  +I+RD+K  N+L+D 
Sbjct: 134 RIGRFXEPHARFYAAQIVLTFE--------------YLH---SLDLIYRDLKPENLLIDQ 176
Query: 180 DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
                V DFGFAK     V   T  + GT  YLAPE  +    +++ D ++ G+L+ E+ 
Sbjct: 177 QGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 240 TGRKPI 245
            G  P 
Sbjct: 233 AGYPPF 238

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 118/287 (41%), Gaps = 41/287 (14%)
Query: 49  LGEGGFGSVYWG------RTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRV-RHKNLL 100
           LG G FG V         +T+    +AVK LK   + +E      E+++L  +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 101 GLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQ--------LDWKRRMKIAIGSA 151
            L G C      L ++ ++    +L ++L  +    V         L  +  +  +   A
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVA 154
Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTRVKGT 208
           +G+ +L    +   IHRD+ A N+LL       + DFG A+ I   P+ V     R+   
Sbjct: 155 KGMEFL---ASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL--P 209
Query: 209 LGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKG 267
           L ++APE       +   DV+SFG+LL EI + G  P      GVK           +  
Sbjct: 210 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----GVK-----------IDE 254
Query: 268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           +F   +    R    +    +     + C   EP +RP   E+V  L
Sbjct: 255 EFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 301

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 112/231 (48%), Gaps = 24/231 (10%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++ L      T Q+ +  +   ++ L+
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN--VFTPQKTL--EEFQDVYLV 100
Query: 126 SHLHGQYAGEV---QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE 182
             L      +V   +LD +R   +      GI +LH   +  IIHRD+K SN+++ SD  
Sbjct: 101 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 157
Query: 183 PLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGR 242
             + DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++  +
Sbjct: 158 LKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
Query: 243 KPIEKLPGGVKRTITEWAEPLIVKG----KFKELVDPKLRGDFDENQLKQA 289
                 PG  +  I +W + +   G    +F + + P +R ++ EN+ K A
Sbjct: 216 I---LFPG--RDYIDQWNKVIEQLGTPCPEFMKKLQPTVR-NYVENRPKYA 260

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 101/246 (41%), Gaps = 45/246 (18%)
Query: 14  EEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVK- 71
           E+ L    TP+  T ++  +  + T          LG G FG V   +  + G   A+K 
Sbjct: 11  EDFLKKWETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKI 60
Query: 72  --KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL- 128
             K K +  K       E  +L  V    L+ L           +V +Y+    + SHL 
Sbjct: 61  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 120
Query: 129 --------HGQ-YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS 179
                   H + YA ++ L ++              YLH   +  +I+RD+K  N+L+D 
Sbjct: 121 RIGRFSEPHARFYAAQIVLTFE--------------YLH---SLDLIYRDLKPENLLIDE 163
Query: 180 DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
                V DFGFAK     V   T  + GT  YLAPE  +    +++ D ++ G+L+ E+ 
Sbjct: 164 QGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYEMA 219
Query: 240 TGRKPI 245
            G  P 
Sbjct: 220 AGYPPF 225

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 112/231 (48%), Gaps = 24/231 (10%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++ L      T Q+ +  +   ++ L+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN--VFTPQKTL--EEFQDVYLV 107
Query: 126 SHLHGQYAGEV---QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE 182
             L      +V   +LD +R   +      GI +LH   +  IIHRD+K SN+++ SD  
Sbjct: 108 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 164
Query: 183 PLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGR 242
             + DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++  +
Sbjct: 165 LKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 222
Query: 243 KPIEKLPGGVKRTITEWAEPLIVKG----KFKELVDPKLRGDFDENQLKQA 289
                 PG  +  I +W + +   G    +F + + P +R ++ EN+ K A
Sbjct: 223 I---LFPG--RDYIDQWNKVIEQLGTPCPEFMKKLQPTVR-NYVENRPKYA 267

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++ L      T Q+ +  +   ++ L+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN--VFTPQKTL--EEFQDVYLV 107
Query: 126 SHLHGQYAGEV---QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE 182
             L      +V   +LD +R   +      GI +LH   +  IIHRD+K SN+++ SD  
Sbjct: 108 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 164
Query: 183 PLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
             + DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++
Sbjct: 165 LKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 112/231 (48%), Gaps = 24/231 (10%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++ L      T Q+ +  +   ++ L+
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN--VFTPQKTL--EEFQDVYLV 108
Query: 126 SHLHGQYAGEV---QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE 182
             L      +V   +LD +R   +      GI +LH   +  IIHRD+K SN+++ SD  
Sbjct: 109 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 165
Query: 183 PLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGR 242
             + DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++  +
Sbjct: 166 LKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 223
Query: 243 KPIEKLPGGVKRTITEWAEPLIVKG----KFKELVDPKLRGDFDENQLKQA 289
                 PG  +  I +W + +   G    +F + + P +R ++ EN+ K A
Sbjct: 224 I---LFPG--RDYIDQWNKVIEQLGTPCPEFMKKLQPTVR-NYVENRPKYA 268

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 112/231 (48%), Gaps = 24/231 (10%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++ L      T Q+ +  +   ++ L+
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN--VFTPQKTL--EEFQDVYLV 101
Query: 126 SHLHGQYAGEV---QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE 182
             L      +V   +LD +R   +      GI +LH   +  IIHRD+K SN+++ SD  
Sbjct: 102 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 158
Query: 183 PLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGR 242
             + DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++  +
Sbjct: 159 LKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216
Query: 243 KPIEKLPGGVKRTITEWAEPLIVKG----KFKELVDPKLRGDFDENQLKQA 289
                 PG  +  I +W + +   G    +F + + P +R ++ EN+ K A
Sbjct: 217 I---LFPG--RDYIDQWNKVIEQLGTPCPEFMKKLQPTVR-NYVENRPKYA 261

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L  L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y P   + SHL         H + YA ++ L ++             
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------------- 156
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+++D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 157 -YLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAP 208
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L  L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y P   + SHL         H + YA ++ L ++             
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------------- 156
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+++D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 157 -YLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAP 208
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 87/206 (42%), Gaps = 12/206 (5%)
Query: 49  LGEGGFGSVY-WGRTSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           +G G +G      R SDG  +  K+L   +M    +     EV +L  ++H N++  R Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV--RYY 71
Query: 106 CAGTDQR----LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
               D+      IV +Y     L S +         LD +  +++       +   H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 162 T--PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
                ++HRD+K +NV LD      + DFG A+++    S   T V GT  Y++PE    
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNR 190
Query: 220 GKVSESCDVYSFGILLLEILTGRKPI 245
              +E  D++S G LL E+     P 
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 118/291 (40%), Gaps = 45/291 (15%)
Query: 49  LGEGGFGSVYWG------RTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRV-RHKNLL 100
           LG G FG V         +T+    +AVK LK   + +E      E+++L  +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 101 GLRGYCAGTDQRLIVY-DYMPNLSLLSHLHGQYAGEVQ------------LDWKRRMKIA 147
            L G C      L+V  ++    +L ++L  +    V             L  +  +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTR 204
              A+G+ +L    +   IHRD+ A N+LL       + DFG A+ I   P+ V     R
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPL 263
           +   L ++APE       +   DV+SFG+LL EI + G  P      GVK          
Sbjct: 203 L--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----GVK---------- 246
Query: 264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +  +F   +    R    +    +     + C   EP +RP   E+V  L
Sbjct: 247 -IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++ L      T Q+ +  +   ++ L+
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN--VFTPQKTL--EEFQDVYLV 108
Query: 126 SHLHGQYAGEV---QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE 182
             L      +V   +LD +R   +      GI +LH   +  IIHRD+K SN+++ SD  
Sbjct: 109 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 165
Query: 183 PLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
             + DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++
Sbjct: 166 LKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 220

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 88/177 (49%), Gaps = 14/177 (7%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++ L      T Q+ +  +   ++ L+
Sbjct: 51  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN--VFTPQKTL--EEFQDVYLV 106
Query: 126 SHLHGQYAGEV---QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE 182
             L      +V   +LD +R   +      GI +LH   +  IIHRD+K SN+++ SD  
Sbjct: 107 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 163
Query: 183 PLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
             + DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++
Sbjct: 164 LKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 218

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 112/231 (48%), Gaps = 24/231 (10%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++ L      T Q+ +  +   ++ L+
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN--VFTPQKTL--EEFQDVYLV 101
Query: 126 SHLHGQYAGEV---QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE 182
             L      +V   +LD +R   +      GI +LH   +  IIHRD+K SN+++ SD  
Sbjct: 102 MELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCT 158
Query: 183 PLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGR 242
             + DFG A+    G S M T    T  Y APE  +     E+ D++S G ++ E++  +
Sbjct: 159 LKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 216
Query: 243 KPIEKLPGGVKRTITEWAEPLIVKG----KFKELVDPKLRGDFDENQLKQA 289
                 PG  +  I +W + +   G    +F + + P +R ++ EN+ K A
Sbjct: 217 I---LFPG--RDYIDQWNKVIEQLGTPCPEFMKKLQPTVR-NYVENRPKYA 261

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 88/211 (41%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L  L  
Sbjct: 50  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEF 109
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y P   + SHL         H + YA ++ L ++             
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------------- 156
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+++D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 157 -YLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAK----RVKGRTWXLCGTPEYLAP 208
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 209 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 100 LGLRGYCAGTDQRLIVYDYM-PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +   E + + H
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQV--LEAVRHCH 159
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
                 ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 160 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 213
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIE 246
            + +    S  V+S GILL +++ G  P E
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 86/217 (39%), Gaps = 22/217 (10%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG 108
           +G G FG     R     ++   K      K       E+     +RH N++  +     
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILT 86
Query: 109 TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHR 168
                IV +Y     L   +    AG    D  R     + S  G+ Y H      + HR
Sbjct: 87  PTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLIS--GVSYCH---AMQVCHR 139
Query: 169 DIKASNVLLDSDFEPL--VADFGFAKLIPEGVSHMTTR-VKGTLGYLAPEYAMW----GK 221
           D+K  N LLD    P   + DFG++K     V H   +   GT  Y+APE  +     GK
Sbjct: 140 DLKLENTLLDGSPAPRLKICDFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 222 VSESCDVYSFGILLLEILTGRKPIE--KLPGGVKRTI 256
           V+   DV+S G+ L  +L G  P E  + P   ++TI
Sbjct: 197 VA---DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 230

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 100 LGLRGYCAGTDQRLIVYDYM-PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +   E + + H
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQV--LEAVRHCH 160
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
                 ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 161 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 214
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIE 246
            + +    S  V+S GILL +++ G  P E
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 118/291 (40%), Gaps = 45/291 (15%)
Query: 49  LGEGGFGSVYWG------RTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRV-RHKNLL 100
           LG G FG V         +T+    +AVK LK   + +E      E+++L  +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 101 GLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQ------------LDWKRRMKIA 147
            L G C      L ++ ++    +L ++L  +    V             L  +  +  +
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTR 204
              A+G+ +L    +   IHRD+ A N+LL       + DFG A+ I   P+ V     R
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 202
Query: 205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPL 263
           +   L ++APE       +   DV+SFG+LL EI + G  P      GVK          
Sbjct: 203 L--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----GVK---------- 246
Query: 264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +  +F   +    R    +    +     + C   EP +RP   E+V  L
Sbjct: 247 -IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 100 LGLRGYCAGTDQRLIVYDYM-PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +   E + + H
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQV--LEAVRHCH 160
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
                 ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 161 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 214
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIE 246
            + +    S  V+S GILL +++ G  P E
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 100 LGLRGYCAGTDQRLIVYDYM-PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +   E + + H
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQV--LEAVRHCH 160
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
                 ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 161 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 214
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIE 246
            + +    S  V+S GILL +++ G  P E
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 100 LGLRGYCAGTDQRLIVYDYM-PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +   E + + H
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQV--LEAVRHCH 159
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
                 ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 160 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 213
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIE 246
            + +    S  V+S GILL +++ G  P E
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 44  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 103
Query: 100 LGLRGYCAGTDQRLIVYDYM-PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +   E + + H
Sbjct: 104 IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQV--LEAVRHCH 159
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
                 ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 160 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 213
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIE 246
            + +    S  V+S GILL +++ G  P E
Sbjct: 214 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 243

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 22/210 (10%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 45  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 104
Query: 100 LGLRGYCAGTDQRLIVYDYM-PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +   E + + H
Sbjct: 105 IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQV--LEAVRHCH 160
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
                 ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 161 ---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 214
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIE 246
            + +    S  V+S GILL +++ G  P E
Sbjct: 215 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 244

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 49  LGEGGFGSVYWG-RTSDGLQIAVKKLKA--MNSKAEM----EFAVEVEVLGRVRH--KNL 99
           LG GGFGSVY G R SD L +A+K ++   ++   E+       +EV +L +V      +
Sbjct: 12  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 71
Query: 100 LGLRGYCAGTDQRLIVYDY-MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           + L  +    D  +++ +   P   L   +  +  G +Q +  R     +  A     + 
Sbjct: 72  IRLLDWFERPDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEA-----VR 124
Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           H     ++HRDIK  N+L+D +   L + DFG   L+ + V    T   GT  Y  PE+ 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWI 181
Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIE 246
            + +    S  V+S GILL +++ G  P E
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE 211

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 118/291 (40%), Gaps = 45/291 (15%)
Query: 49  LGEGGFGSVYWG------RTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRV-RHKNLL 100
           LG G FG V         +T+    +AVK LK   + +E      E+++L  +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 101 GLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQ------------LDWKRRMKIA 147
            L G C      L ++ ++    +L ++L  +    V             L  +  +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTR 204
              A+G+ +L    +   IHRD+ A N+LL       + DFG A+ I   P+ V     R
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDAR 211
Query: 205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPL 263
           +   L ++APE       +   DV+SFG+LL EI + G  P      GVK          
Sbjct: 212 L--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----GVK---------- 255
Query: 264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +  +F   +    R    +    +     + C   EP +RP   E+V  L
Sbjct: 256 -IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 25/214 (11%)
Query: 49  LGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR-HKNLLGLRGYC 106
           LGEG +  V    +  +G + AVK ++     +      EVE L + + +KN+L L  + 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
               +  +V++ +   S+L+H+  Q       + +   ++    A  + +LH   T  I 
Sbjct: 81  EDDTRFYLVFEKLQGGSILAHIQKQK----HFNEREASRVVRDVAAALDFLH---TKGIA 133
Query: 167 HRDIKASNVLLDS--DFEPL-VADFGFA-------KLIPEGVSHMTTRVKGTLGYLAPEY 216
           HRD+K  N+L +S     P+ + DF             P     +TT   G+  Y+APE 
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPC-GSAEYMAPEV 192
Query: 217 A-----MWGKVSESCDVYSFGILLLEILTGRKPI 245
                       + CD++S G++L  +L+G  P 
Sbjct: 193 VEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPF 226

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 118/291 (40%), Gaps = 45/291 (15%)
Query: 49  LGEGGFGSVYWG------RTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRV-RHKNLL 100
           LG G FG V         +T+    +AVK LK   + +E      E+++L  +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 101 GLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQ------------LDWKRRMKIA 147
            L G C      L ++ ++    +L ++L  +    V             L  +  +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTR 204
              A+G+ +L    +   IHRD+ A N+LL       + DFG A+ I   P+ V     R
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPL 263
           +   L ++APE       +   DV+SFG+LL EI + G  P      GVK          
Sbjct: 212 L--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----GVK---------- 255
Query: 264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +  +F   +    R    +    +     + C   EP +RP   E+V  L
Sbjct: 256 -IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 118/291 (40%), Gaps = 45/291 (15%)
Query: 49  LGEGGFGSVYWG------RTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRV-RHKNLL 100
           LG G FG V         +T+    +AVK LK   + +E      E+++L  +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 101 GLRGYCAGTDQRLIVY-DYMPNLSLLSHLHGQYAGEVQ------------LDWKRRMKIA 147
            L G C      L+V  ++    +L ++L  +    V             L  +  +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTR 204
              A+G+ +L    +   IHRD+ A N+LL       + DFG A+ I   P+ V     R
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPL 263
           +   L ++APE       +   DV+SFG+LL EI + G  P      GVK          
Sbjct: 203 L--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----GVK---------- 246
Query: 264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +  +F   +    R    +    +     + C   EP +RP   E+V  L
Sbjct: 247 -IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 47  NKLGEGGFGSVYWGRT--SDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLR 103
           +KLGEG + +VY G++  +D L +A+K+++  + +     A+ EV +L  ++H N++ L 
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLH 66
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                     +V++Y+ +  L  +L     G + ++             G+ Y H +   
Sbjct: 67  DIIHTEKSLTLVFEYL-DKDLKQYLDD--CGNI-INMHNVKLFLFQLLRGLAYCHRQ--- 119
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG-KV 222
            ++HRD+K  N+L++   E  +ADFG A+            V  TL Y  P+  +     
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYRPPDILLGSTDY 178
Query: 223 SESCDVYSFGILLLEILTGR 242
           S   D++  G +  E+ TGR
Sbjct: 179 STQIDMWGVGCIFYEMATGR 198

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/201 (29%), Positives = 87/201 (43%), Gaps = 28/201 (13%)
Query: 65  GLQIAVKKLKAMNSKAEMEFAVE-VEVLGRVRHKNLLGLRG-YC--------------AG 108
           GL I  K L+  N + + +FA++ ++   + R +  L  R   C              AG
Sbjct: 71  GLGINGKVLQIFNKRTQEKFALKXLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAG 130
Query: 109 TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHR 168
               LIV + +    L S +  Q  G+     +   +I     E I YLH   + +I HR
Sbjct: 131 RKCLLIVXECLDGGELFSRI--QDRGDQAFTEREASEIXKSIGEAIQYLH---SINIAHR 185
Query: 169 DIKASNVLLDSDFEPLV---ADFGFAKLIPEGVSHMT-TRVKGTLGYLAPEYAMWGKVSE 224
           D+K  N+L  S     +    DFGFAK   E  SH + T    T  Y+APE     K  +
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVLGPEKYDK 242
Query: 225 SCDVYSFGILLLEILTGRKPI 245
           SCD +S G++   +L G  P 
Sbjct: 243 SCDXWSLGVIXYILLCGYPPF 263

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 118/291 (40%), Gaps = 45/291 (15%)
Query: 49  LGEGGFGSVYWG------RTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRV-RHKNLL 100
           LG G FG V         +T+    +AVK LK   + +E      E+++L  +  H N++
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 101 GLRGYCAGTDQRLIVY-DYMPNLSLLSHLHGQYAGEVQ------------LDWKRRMKIA 147
            L G C      L+V  ++    +L ++L  +    V             L  +  +  +
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTR 204
              A+G+ +L    +   IHRD+ A N+LL       + DFG A+ I   P+ V     R
Sbjct: 146 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 202
Query: 205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPL 263
           +   L ++APE       +   DV+SFG+LL EI + G  P      GVK          
Sbjct: 203 L--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----GVK---------- 246
Query: 264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +  +F   +    R    +    +     + C   EP +RP   E+V  L
Sbjct: 247 -IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 296

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 118/291 (40%), Gaps = 45/291 (15%)
Query: 49  LGEGGFGSVYWG------RTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRV-RHKNLL 100
           LG G FG V         +T+    +AVK LK   + +E      E+++L  +  H N++
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 101 GLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQ------------LDWKRRMKIA 147
            L G C      L ++ ++    +L ++L  +    V             L  +  +  +
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYS 156
Query: 148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTR 204
              A+G+ +L    +   IHRD+ A N+LL       + DFG A+ I   P+ V     R
Sbjct: 157 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 213
Query: 205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPL 263
           +   L ++APE       +   DV+SFG+LL EI + G  P      GVK          
Sbjct: 214 L--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----GVK---------- 257
Query: 264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +  +F   +    R    +    +     + C   EP +RP   E+V  L
Sbjct: 258 -IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 307

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 101/246 (41%), Gaps = 45/246 (18%)
Query: 14  EEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVK- 71
           E+ L    TP+  T ++  +  + T          LG G FG V   +  + G   A+K 
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKI 73
Query: 72  --KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL- 128
             K K +  K       E  +L  V    L+ L           +V +Y+    + SHL 
Sbjct: 74  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 129 --------HGQ-YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS 179
                   H + YA ++ L ++              YLH   +  +I+RD+K  N+L+D 
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFE--------------YLH---SLDLIYRDLKPENLLIDQ 176
Query: 180 DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
                V DFGFAK     V   T  + GT  YLAPE  +    +++ D ++ G+L+ ++ 
Sbjct: 177 QGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIILSKGYNKAVDWWALGVLIYQMA 232
Query: 240 TGRKPI 245
            G  P 
Sbjct: 233 AGYPPF 238

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 118/291 (40%), Gaps = 45/291 (15%)
Query: 49  LGEGGFGSVYWG------RTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRV-RHKNLL 100
           LG G FG V         +T+    +AVK LK   + +E      E+++L  +  H N++
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 101 GLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQ------------LDWKRRMKIA 147
            L G C      L ++ ++    +L ++L  +    V             L  +  +  +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTR 204
              A+G+ +L    +   IHRD+ A N+LL       + DFG A+ I   P+ V     R
Sbjct: 155 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 211
Query: 205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPL 263
           +   L ++APE       +   DV+SFG+LL EI + G  P      GVK          
Sbjct: 212 L--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----GVK---------- 255
Query: 264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +  +F   +    R    +    +     + C   EP +RP   E+V  L
Sbjct: 256 -IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 72/291 (24%), Positives = 118/291 (40%), Gaps = 45/291 (15%)
Query: 49  LGEGGFGSVYWG------RTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRV-RHKNLL 100
           LG G FG V         +T+    +AVK LK   + +E      E+++L  +  H N++
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 101 GLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQ------------LDWKRRMKIA 147
            L G C      L ++ ++    +L ++L  +    V             L  +  +  +
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTR 204
              A+G+ +L    +   IHRD+ A N+LL       + DFG A+ I   P+ V     R
Sbjct: 192 FQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 248
Query: 205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPL 263
           +   L ++APE       +   DV+SFG+LL EI + G  P      GVK          
Sbjct: 249 L--PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----GVK---------- 292
Query: 264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +  +F   +    R    +    +     + C   EP +RP   E+V  L
Sbjct: 293 -IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 342

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 101/246 (41%), Gaps = 45/246 (18%)
Query: 14  EEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVK- 71
           E+ L    TP+  T ++  +  + T          LG G FG V   +  + G   A+K 
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKI 73
Query: 72  --KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL- 128
             K K +  K       E  +L  V    L+ L           +V +Y+    + SHL 
Sbjct: 74  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 129 --------HGQ-YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS 179
                   H + YA ++ L ++              YLH   +  +I+RD+K  N+++D 
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFE--------------YLH---SLDLIYRDLKPENLIIDQ 176
Query: 180 DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
                V DFGFAK     V   T  + GT  YLAPE  +    +++ D ++ G+L+ E+ 
Sbjct: 177 QGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPEIIISKGYNKAVDWWALGVLIYEMA 232
Query: 240 TGRKPI 245
            G  P 
Sbjct: 233 AGYPPF 238

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 8/177 (4%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++GL              D    + L+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 126 SHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV 185
                Q   +++LD +R   +      GI +LH   +  IIHRD+K SN+++ SD    +
Sbjct: 112 DANLCQVI-QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 186 ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGR 242
            DFG A+    G S M      T  Y APE  +     E+ D++S G ++ E++  +
Sbjct: 168 LDFGLART--AGTSFMMEPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHK 222

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 89/211 (42%), Gaps = 35/211 (16%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V   +  + G   A+K   K K +  K       E  +L  V    L+ L  
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEGI 154
                    +V +Y+    + SHL         H + YA ++ L ++             
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------------- 155
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            YLH   +  +I+RD+K  N+L+D      V DFGFAK     V   T  + GT  YLAP
Sbjct: 156 -YLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAP 207
Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           E  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 99/208 (47%), Gaps = 14/208 (6%)
Query: 48  KLGEGGFGSVYWGRTSDGLQI-AVKKLKAMNSKAEMEFAV--EVEVLGRVRHKNLLGLRG 104
           K+GEG +G+V+  +  +  +I A+K+++  +    +  +   E+ +L  ++HKN++ L  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                 +  +V+++      L        G+  LD +          +G+ + H     +
Sbjct: 69  VLHSDKKLTLVFEFCD--QDLKKYFDSCNGD--LDPEIVKSFLFQLLKGLGFCHSR---N 121
Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
           ++HRD+K  N+L++ + E  +A+FG A+     V   +  V  TL Y  P+     K+ S
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYS 180
Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGG 251
            S D++S G +  E+    +P+   PG 
Sbjct: 181 TSIDMWSAGCIFAELANAGRPL--FPGN 206

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 72/334 (21%), Positives = 135/334 (40%), Gaps = 70/334 (20%)
Query: 33  YKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGL----QIAVKKLKAMNSKAEMEFAVEV 88
           Y+ +   +N F  ++K+GEG F SVY       +    +IA+K L  + +   +  A E+
Sbjct: 13  YEAVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHL--IPTSHPIRIAAEL 70
Query: 89  EVLGRV-RHKNLLGLRGYCAGTDQRLIVYDYMPN---LSLLSHLHGQYAGEVQLDWKRRM 144
           + L       N++G++      D  +I   Y+ +   L +L+ L  Q   E  L+  + +
Sbjct: 71  QCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFKAL 130
Query: 145 KIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAK----------- 192
           K           +H      I+HRD+K SN L +   +   + DFG A+           
Sbjct: 131 K----------RIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLK 177
Query: 193 -LIPEGVSHMTTRVK---------------GTLGYLAPE-YAMWGKVSESCDVYSFGILL 235
            +  E      ++ K               GT G+ APE        + + D++S G++ 
Sbjct: 178 FVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIF 237
Query: 236 LEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVL 295
           L +L+GR P  K        +T  A+ + +            RG  +  Q  +    ++L
Sbjct: 238 LSLLSGRYPFYK----ASDDLTALAQIMTI------------RGSRETIQAAKTFGKSIL 281
Query: 296 CVQSEPEKRPNMKEVVNTLTGYDPRGKVMQTRIE 329
           C +  P +  +++++   L G D     + + I+
Sbjct: 282 CSKEVPAQ--DLRKLCERLRGMDSSTPKLTSDIQ 313

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 125/299 (41%), Gaps = 39/299 (13%)
Query: 40  TNGFSDD----NKLGEGGFGSVYWG-RTSDGLQIAVKKL--KAMNSKAEMEFAVEVEVLG 92
           +  FSD+     +LG+G F  V      + GL+ A K +  K ++++   +   E  +  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 93  RVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHG-QYAGEVQLDWKRRMKIAIGSA 151
           +++H N++ L           +V+D +    L   +   ++  E       +  +     
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----- 115
Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL---VADFGFAKLIPEGVSHMTTRVKGT 208
           E I Y H   +  I+HR++K  N+LL S  +     +ADFG A  I    S       GT
Sbjct: 116 ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGT 170
Query: 209 LGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI-----EKLPGGVKRTITEWAEPL 263
            GYL+PE       S+  D+++ G++L  +L G  P       +L   +K    ++  P 
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 230
Query: 264 --IVKGKFKELVD------PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
              V  + K L+D      PK R   D     QA+ V  +C +       + ++ V+ L
Sbjct: 231 WDTVTPEAKSLIDSMLTVNPKKRITAD-----QALKVPWICNRERVASAIHRQDXVDCL 284

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 37/212 (17%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLR 103
           LG G FG V   +  + G   A+K   K K +  K E+E  + E  +L  V    L+ L 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK-EIEHTLNEKRILQAVNFPFLVKLE 107
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEG 153
                     +V +Y P   + SHL         H + YA ++ L ++            
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------------ 155
Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLA 213
             YLH   +  +I+RD+K  N+++D      V DFG AK     V   T  + GT  YLA
Sbjct: 156 --YLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAK----RVKGRTWXLCGTPEYLA 206
Query: 214 PEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           PE  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEM------EFAVEVEVLGRVRHKNLL 100
           +LG G F  V   R  S GLQ A K +K   +K+        +   EV +L  ++H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L          +++ + +    L   L    A +  L  +   +       G+ YLH  
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 161 VTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
            +  I H D+K  N++L     P     + DFG A  I  G  +    + GT  ++APE 
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPAFVAPEI 188
Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPI 245
             +  +    D++S G++   +L+G  P 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 84/177 (47%), Gaps = 8/177 (4%)
Query: 68  IAVKKL-KAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           +A+KKL +   ++   + A  E+ ++  V HKN++GL              D    + L+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM 111
Query: 126 SHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV 185
                Q   +++LD +R   +      GI +LH   +  IIHRD+K SN+++ SD    +
Sbjct: 112 DANLCQVI-QMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKI 167
Query: 186 ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGR 242
            DFG A+    G S M      T  Y APE  +     E+ D++S G ++ E++  +
Sbjct: 168 LDFGLART--AGTSFMMEPEVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHK 222

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 92/212 (43%), Gaps = 37/212 (17%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK---KLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLR 103
           LG G FG V   +  + G   A+K   K K +  K E+E  + E  +L  V    L+ L 
Sbjct: 49  LGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLK-EIEHTLNEKRILQAVNFPFLVKLE 107
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHL---------HGQ-YAGEVQLDWKRRMKIAIGSAEG 153
                     +V +Y P   + SHL         H + YA ++ L ++            
Sbjct: 108 FSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------------ 155
Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLA 213
             YLH   +  +I+RD+K  N+++D      V DFG AK     V   T  + GT  YLA
Sbjct: 156 --YLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAK----RVKGRTWXLCGTPEYLA 206
Query: 214 PEYAMWGKVSESCDVYSFGILLLEILTGRKPI 245
           PE  +    +++ D ++ G+L+ E+  G  P 
Sbjct: 207 PEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEM------EFAVEVEVLGRVRHKNLL 100
           +LG G F  V   R  S GLQ A K +K   +K+        +   EV +L  ++H N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L          +++ + +    L   L    A +  L  +   +       G+ YLH  
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLH-- 130
Query: 161 VTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
            +  I H D+K  N++L     P     + DFG A  I  G  +    + GT  ++APE 
Sbjct: 131 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEI 187
Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPI 245
             +  +    D++S G++   +L+G  P 
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEM------EFAVEVEVLGRVRHKNLL 100
           +LG G F  V   R  S GLQ A K +K   +K+        +   EV +L  ++H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L          +++ + +    L   L    A +  L  +   +       G+ YLH  
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 161 VTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
            +  I H D+K  N++L     P     + DFG A  I  G  +    + GT  ++APE 
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEI 188
Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPI 245
             +  +    D++S G++   +L+G  P 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 86/206 (41%), Gaps = 12/206 (5%)
Query: 49  LGEGGFGSVY-WGRTSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           +G G +G      R SDG  +  K+L   +M    +     EV +L  ++H N++  R Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV--RYY 71
Query: 106 CAGTDQR----LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
               D+      IV +Y     L S +         LD +  +++       +   H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 162 T--PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
                ++HRD+K +NV LD      + DFG A+++    S     V GT  Y++PE    
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFV-GTPYYMSPEQMNR 190
Query: 220 GKVSESCDVYSFGILLLEILTGRKPI 245
              +E  D++S G LL E+     P 
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 100/246 (40%), Gaps = 45/246 (18%)
Query: 14  EEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVK- 71
           E+ L    TP+  T ++  +  + T          LG G FG V   +  + G   A+K 
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKI 73
Query: 72  --KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL- 128
             K K +  K       E  +L  V    L+ L           +V +Y+    + SHL 
Sbjct: 74  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 129 --------HGQ-YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS 179
                   H + YA ++ L ++              YLH   +  +I+RD+K  N+L+D 
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFE--------------YLH---SLDLIYRDLKPENLLIDQ 176
Query: 180 DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
                V DFGFAK     V   T  + GT  YLAP   +    +++ D ++ G+L+ E+ 
Sbjct: 177 QGYIQVTDFGFAK----RVKGRTWXLCGTPEYLAPAIILSKGYNKAVDWWALGVLIYEMA 232
Query: 240 TGRKPI 245
            G  P 
Sbjct: 233 AGYPPF 238

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEM------EFAVEVEVLGRVRHKNLL 100
           +LG G F  V   R  S GLQ A K +K   +K+        +   EV +L  ++H N++
Sbjct: 18  ELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L          +++ + +    L   L    A +  L  +   +       G+ YLH  
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 161 VTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
            +  I H D+K  N++L     P     + DFG A  I  G  +    + GT  ++APE 
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEI 188
Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPI 245
             +  +    D++S G++   +L+G  P 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEM------EFAVEVEVLGRVRHKNLL 100
           +LG G F  V   R  S GLQ A K +K   +K+        +   EV +L  ++H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L          +++ + +    L   L    A +  L  +   +       G+ YLH  
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 161 VTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
            +  I H D+K  N++L     P     + DFG A  I  G  +    + GT  ++APE 
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEI 188
Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPI 245
             +  +    D++S G++   +L+G  P 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 82/188 (43%), Gaps = 28/188 (14%)
Query: 113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKA 172
           LI+ + M    L S +  Q  G+     +   +I       I +LH   + +I HRD+K 
Sbjct: 83  LIIMECMEGGELFSRI--QERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKP 137
Query: 173 SNVLLDSDFEPLV---ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVY 229
            N+L  S  +  V    DFGFAK   E   +       T  Y+APE     K  +SCD++
Sbjct: 138 ENLLYTSKEKDAVLKLTDFGFAK---ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMW 194
Query: 230 SFGILLLEILTGRKPI-----EKLPGGVKRTI---------TEWAEPLIVKGKFKELVDP 275
           S G+++  +L G  P      + +  G+KR I          EW+E   V    K+L+  
Sbjct: 195 SLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE---VSEDAKQLIRL 251
Query: 276 KLRGDFDE 283
            L+ D  E
Sbjct: 252 LLKTDPTE 259

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 69/281 (24%), Positives = 118/281 (41%), Gaps = 39/281 (13%)
Query: 40  TNGFSDD----NKLGEGGFGSVYWG-RTSDGLQIAVKKL--KAMNSKAEMEFAVEVEVLG 92
           +  FSD+     +LG+G F  V      + GL+ A K +  K ++++   +   E  +  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 93  RVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHG-QYAGEVQLDWKRRMKIAIGSA 151
           +++H N++ L           +V+D +    L   +   ++  E       +  +     
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL----- 115
Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL---VADFGFAKLIPEGVSHMTTRVKGT 208
           E I Y H   +  I+HR++K  N+LL S  +     +ADFG A  I    S       GT
Sbjct: 116 ESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGT 170
Query: 209 LGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI-----EKLPGGVKRTITEWAEPL 263
            GYL+PE       S+  D+++ G++L  +L G  P       +L   +K    ++  P 
Sbjct: 171 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPE 230
Query: 264 --IVKGKFKELVD------PKLRGDFDENQLKQAINVAVLC 296
              V  + K L+D      PK R   D     QA+ V  +C
Sbjct: 231 WDTVTPEAKSLIDSMLTVNPKKRITAD-----QALKVPWIC 266

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEM------EFAVEVEVLGRVRHKNLL 100
           +LG G F  V   R  S GLQ A K +K   +K+        +   EV +L  ++H N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L          +++ + +    L   L    A +  L  +   +       G+ YLH  
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLH-- 130
Query: 161 VTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
            +  I H D+K  N++L     P     + DFG A  I  G  +    + GT  ++APE 
Sbjct: 131 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEI 187
Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPI 245
             +  +    D++S G++   +L+G  P 
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPF 216

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEM------EFAVEVEVLGRVRHKNLL 100
           +LG G F  V   R  S GLQ A K +K   +K+        +   EV +L  ++H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L          +++ + +    L   L    A +  L  +   +       G+ YLH  
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 161 VTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
            +  I H D+K  N++L     P     + DFG A  I  G  +    + GT  ++APE 
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEI 188
Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPI 245
             +  +    D++S G++   +L+G  P 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/188 (28%), Positives = 82/188 (43%), Gaps = 28/188 (14%)
Query: 113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKA 172
           LI+ + M    L S +  Q  G+     +   +I       I +LH   + +I HRD+K 
Sbjct: 102 LIIMECMEGGELFSRI--QERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKP 156
Query: 173 SNVLLDSDFEPLV---ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVY 229
            N+L  S  +  V    DFGFAK   E   +       T  Y+APE     K  +SCD++
Sbjct: 157 ENLLYTSKEKDAVLKLTDFGFAK---ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMW 213
Query: 230 SFGILLLEILTGRKPI-----EKLPGGVKRTI---------TEWAEPLIVKGKFKELVDP 275
           S G+++  +L G  P      + +  G+KR I          EW+E   V    K+L+  
Sbjct: 214 SLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE---VSEDAKQLIRL 270
Query: 276 KLRGDFDE 283
            L+ D  E
Sbjct: 271 LLKTDPTE 278

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 68/153 (44%), Gaps = 21/153 (13%)
Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
           IHRD+ A N+LL  +    + DFG A+ I   P+ V    TR+   L ++APE       
Sbjct: 221 IHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL--PLKWMAPESIFDKIY 278
Query: 223 SESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF 281
           S   DV+S+G+LL EI + G  P    PG            + +   F   +   +R   
Sbjct: 279 STKSDVWSYGVLLWEIFSLGGSPY---PG------------VQMDEDFCSRLREGMRMRA 323
Query: 282 DENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            E    +   + + C   +P++RP   E+V  L
Sbjct: 324 PEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEM------EFAVEVEVLGRVRHKNLL 100
           +LG G F  V   R  S GLQ A K +K   +K+        +   EV +L  ++H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L          +++ + +    L   L    A +  L  +   +       G+ YLH  
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 161 VTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
            +  I H D+K  N++L     P     + DFG A  I  G  +    + GT  ++APE 
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEI 188
Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPI 245
             +  +    D++S G++   +L+G  P 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEM------EFAVEVEVLGRVRHKNLL 100
           +LG G F  V   R  S GLQ A K +K   +K+        +   EV +L  ++H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L          +++ + +    L   L    A +  L  +   +       G+ YLH  
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 161 VTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
            +  I H D+K  N++L     P     + DFG A  I  G  +    + GT  ++APE 
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEI 188
Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPI 245
             +  +    D++S G++   +L+G  P 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 63/273 (23%), Positives = 120/273 (43%), Gaps = 28/273 (10%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKA-MNSKAEMEFAVEVEVLGR-VRHKNLLGLRG 104
           +LG G +G V   R    G  +AVK+++A +NS+ +    +++++  R V     +   G
Sbjct: 58  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 117
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRM-KIAIGSAEGILYLHHEVTP 163
                    I  + M   + L   + Q   + Q   +  + KIA+   + + +LH +++ 
Sbjct: 118 ALFREGDVWICMELMD--TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS- 174
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA----MW 219
            +IHRD+K SNVL+++  +  + DFG +  + + V+   T   G   Y+APE        
Sbjct: 175 -VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAK--TIDAGCKPYMAPERINPELNQ 231
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
              S   D++S GI ++E+   R P +            W  P     +  E   P+L  
Sbjct: 232 KGYSVKSDIWSLGITMIELAILRFPYD-----------SWGTPFQQLKQVVEEPSPQLPA 280
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
           D    +    ++    C++   ++RP   E++ 
Sbjct: 281 DKFSAEF---VDFTSQCLKKNSKERPTYPELMQ 310

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEM------EFAVEVEVLGRVRHKNLL 100
           +LG G F  V   R  S GLQ A K +K   +K+        +   EV +L  ++H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L          +++ + +    L   L    A +  L  +   +       G+ YLH  
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 161 VTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
            +  I H D+K  N++L     P     + DFG A  I  G  +    + GT  ++APE 
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEI 188
Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPI 245
             +  +    D++S G++   +L+G  P 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 104/234 (44%), Gaps = 38/234 (16%)
Query: 34  KELHTATNGFSDDNKLGEG-GFGSVYWGR----TSDGLQIAVKKLKAMNSKAEMEFAVEV 88
           ++LH  +  F+D  ++ E  G GS    +     +   + AVK +     K++ +   E+
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKII----DKSKRDPTEEI 66
Query: 89  EVLGRV-RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIA 147
           E+L R  +H N++ L+           VYD    + +++ L     GE+     R+   +
Sbjct: 67  EILLRYGQHPNIITLKD----------VYDDGKYVYVVTELXK--GGELLDKILRQKFFS 114
Query: 148 IGSAEGIL--------YLHHEVTPHIIHRDIKASNVL-LDSDFEP---LVADFGFAKLIP 195
              A  +L        YLH +    ++HRD+K SN+L +D    P    + DFGFAK + 
Sbjct: 115 EREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171
Query: 196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLP 249
                + T    T  ++APE         +CD++S G+LL   LTG  P    P
Sbjct: 172 AENGLLXTPCY-TANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGP 224

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEM------EFAVEVEVLGRVRHKNLL 100
           +LG G F  V   R  S GLQ A K +K   +K+        +   EV +L  ++H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L          +++ + +    L   L    A +  L  +   +       G+ YLH  
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 161 VTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
            +  I H D+K  N++L     P     + DFG A  I  G  +    + GT  ++APE 
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEI 188
Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPI 245
             +  +    D++S G++   +L+G  P 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 117/278 (42%), Gaps = 39/278 (14%)
Query: 43  FSDD----NKLGEGGFGSVYWG-RTSDGLQIAVKKL--KAMNSKAEMEFAVEVEVLGRVR 95
           FSD+     +LG+G F  V      + GL+ A K +  K ++++   +   E  +  +++
Sbjct: 3   FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ 62
Query: 96  HKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHG-QYAGEVQLDWKRRMKIAIGSAEGI 154
           H N++ L           +V+D +    L   +   ++  E       +  +     E I
Sbjct: 63  HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQIL-----ESI 117
Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPL---VADFGFAKLIPEGVSHMTTRVKGTLGY 211
            Y H   +  I+HR++K  N+LL S  +     +ADFG A  I    S       GT GY
Sbjct: 118 AYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGY 172
Query: 212 LAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI-----EKLPGGVKRTITEWAEPL--I 264
           L+PE       S+  D+++ G++L  +L G  P       +L   +K    ++  P    
Sbjct: 173 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDT 232
Query: 265 VKGKFKELVD------PKLRGDFDENQLKQAINVAVLC 296
           V  + K L+D      PK R   D     QA+ V  +C
Sbjct: 233 VTPEAKSLIDSMLTVNPKKRITAD-----QALKVPWIC 265

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEM------EFAVEVEVLGRVRHKNLL 100
           +LG G F  V   R  S GLQ A K +K   +K+        +   EV +L  ++H N++
Sbjct: 18  ELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L          +++ + +    L   L    A +  L  +   +       G+ YLH  
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 161 VTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
            +  I H D+K  N++L     P     + DFG A  I  G  +    + GT  ++APE 
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEI 188
Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPI 245
             +  +    D++S G++   +L+G  P 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEM------EFAVEVEVLGRVRHKNLL 100
           +LG G F  V   R  S GLQ A K +K   +K+        +   EV +L  ++H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L          +++ + +    L   L    A +  L  +   +       G+ YLH  
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 161 VTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
            +  I H D+K  N++L     P     + DFG A  I  G  +    + GT  ++APE 
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEI 188
Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPI 245
             +  +    D++S G++   +L+G  P 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/221 (24%), Positives = 94/221 (42%), Gaps = 29/221 (13%)
Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
            KLGEGGF  V       DG   A+K++     +   E   E ++     H N+L L  Y
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 106 C----AGTDQRLIVYDYMPNLSLLSHLH-----GQYAGEVQLDWKRRMKIAIGSAEGILY 156
           C        +  ++  +    +L + +      G +  E Q+ W     + +G   G+  
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILW-----LLLGICRGLEA 149
Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGF---AKLIPEGVSHMTT-----RVKGT 208
           +H        HRD+K +N+LL  + +P++ D G    A +  EG     T       + T
Sbjct: 150 IH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 209 LGYLAPE-YAMWGK--VSESCDVYSFGILLLEILTGRKPIE 246
           + Y APE +++     + E  DV+S G +L  ++ G  P +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 86/217 (39%), Gaps = 22/217 (10%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG 108
           +G G FG     R     ++   K      K +     E+     +RH N++  +     
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 109 TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHR 168
                IV +Y     L   +    AG    D  R     + S  G+ Y H      + HR
Sbjct: 87  PTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLIS--GVSYCH---AMQVCHR 139
Query: 169 DIKASNVLLDSDFEPL--VADFGFAKLIPEGVSHMTTR-VKGTLGYLAPEYAMW----GK 221
           D+K  N LLD    P   +  FG++K     V H   +   GT  Y+APE  +     GK
Sbjct: 140 DLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKDTVGTPAYIAPEVLLKKEYDGK 196
Query: 222 VSESCDVYSFGILLLEILTGRKPIE--KLPGGVKRTI 256
           V+   DV+S G+ L  +L G  P E  + P   ++TI
Sbjct: 197 VA---DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 230

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 86/217 (39%), Gaps = 22/217 (10%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG 108
           +G G FG     R     ++   K      K +     E+     +RH N++  +     
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 109 TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHR 168
                IV +Y     L   +    AG    D  R     + S  G+ Y H      + HR
Sbjct: 87  PTHLAIVMEYASGGELFERICN--AGRFSEDEARFFFQQLIS--GVSYCH---AMQVCHR 139
Query: 169 DIKASNVLLDSDFEPL--VADFGFAKLIPEGVSHMTTR-VKGTLGYLAPEYAMW----GK 221
           D+K  N LLD    P   +  FG++K     V H   +   GT  Y+APE  +     GK
Sbjct: 140 DLKLENTLLDGSPAPRLKICAFGYSK---SSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 222 VSESCDVYSFGILLLEILTGRKPIE--KLPGGVKRTI 256
           V+   DV+S G+ L  +L G  P E  + P   ++TI
Sbjct: 197 VA---DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTI 230

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 20/209 (9%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEM------EFAVEVEVLGRVRHKNLL 100
           +LG G F  V   R  S GLQ A K +K   +K+        +   EV +L  ++H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L          +++ + +    L   L    A +  L  +   +       G+ YLH  
Sbjct: 78  TLHEVYENKTDVILIGELVAGGELFDFL----AEKESLTEEEATEFLKQILNGVYYLH-- 131
Query: 161 VTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
            +  I H D+K  N++L     P     + DFG A  I  G  +    + GT  ++APE 
Sbjct: 132 -SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEI 188
Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPI 245
             +  +    D++S G++   +L+G  P 
Sbjct: 189 VNYEPLGLEADMWSIGVITYILLSGASPF 217

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 100/246 (40%), Gaps = 45/246 (18%)
Query: 14  EEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSD-GLQIAVK- 71
           E+ L    TP+  T ++  +  + T          LG G FG V   +  + G   A+K 
Sbjct: 24  EDFLKKWETPSQNTAQLDQFDRIKT----------LGTGSFGRVMLVKHKESGNHYAMKI 73
Query: 72  --KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL- 128
             K K +  K       E  +L  V    L+ L           +V +Y+    + SHL 
Sbjct: 74  LDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR 133
Query: 129 --------HGQ-YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS 179
                   H + YA ++ L ++              YLH   +  +I+RD+K  N+L+D 
Sbjct: 134 RIGRFSEPHARFYAAQIVLTFE--------------YLH---SLDLIYRDLKPENLLIDQ 176
Query: 180 DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
                V DFGFAK     V   T  + GT   LAPE  +    +++ D ++ G+L+ E+ 
Sbjct: 177 QGYIQVTDFGFAK----RVKGRTWXLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMA 232
Query: 240 TGRKPI 245
            G  P 
Sbjct: 233 AGYPPF 238

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/255 (25%), Positives = 105/255 (41%), Gaps = 32/255 (12%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
           KL E   G ++ GR   + + + V K++  +++   +F  E   L    H N+L + G C
Sbjct: 17  KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 107 AG--TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                    ++  + P  SL + LH        +D  + +K A+  A G  +LH  + P 
Sbjct: 77  QSPPAPHPTLITHWXPYGSLYNVLHE--GTNFVVDQSQAVKFALDXARGXAFLH-TLEPL 133
Query: 165 IIHRDIKASNVLLDSDFEPLV--ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
           I    + + +V +D D    +  AD  F+   P G  +          ++APE A+  K 
Sbjct: 134 IPRHALNSRSVXIDEDXTARISXADVKFSFQSP-GRXYAP-------AWVAPE-ALQKKP 184
Query: 223 SE----SCDVYSFGILLLEILTGRKPIEKLPG----------GVKRTITEWAEPLIVK-G 267
            +    S D +SF +LL E++T   P   L            G++ TI     P + K  
Sbjct: 185 EDTNRRSADXWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRPTIPPGISPHVSKLX 244
Query: 268 KFKELVDPKLRGDFD 282
           K     DP  R  FD
Sbjct: 245 KICXNEDPAKRPKFD 259

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 49  LGEGGFGSVYWG----RTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGLR 103
           LGEG FG VY G       + + +AVK  K   +    E F  E  ++  + H +++ L 
Sbjct: 16  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 75
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G     +   I+ +  P   L     G Y  E   +  + + + + S +    + +  + 
Sbjct: 76  GI-IEEEPTWIIMELYPYGEL-----GHYL-ERNKNSLKVLTLVLYSLQICKAMAYLESI 128
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + +HRDI   N+L+ S     + DFG ++ I +   +  +  +  + +++PE   + + +
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 188
Query: 224 ESCDVYSFGILLLEILT-GRKP 244
            + DV+ F + + EIL+ G++P
Sbjct: 189 TASDVWMFAVCMWEILSFGKQP 210

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 49  LGEGGFGSVYWG----RTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGLR 103
           LGEG FG VY G       + + +AVK  K   +    E F  E  ++  + H +++ L 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 79
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G     +   I+ +  P   L     G Y  E   +  + + + + S +    + +  + 
Sbjct: 80  GI-IEEEPTWIIMELYPYGEL-----GHYL-ERNKNSLKVLTLVLYSLQICKAMAYLESI 132
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + +HRDI   N+L+ S     + DFG ++ I +   +  +  +  + +++PE   + + +
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 192
Query: 224 ESCDVYSFGILLLEILT-GRKP 244
            + DV+ F + + EIL+ G++P
Sbjct: 193 TASDVWMFAVCMWEILSFGKQP 214

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 94/202 (46%), Gaps = 13/202 (6%)
Query: 49  LGEGGFGSVYWG----RTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGLR 103
           LGEG FG VY G       + + +AVK  K   +    E F  E  ++  + H +++ L 
Sbjct: 32  LGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLI 91
Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G     +   I+ +  P   L     G Y  E   +  + + + + S +    + +  + 
Sbjct: 92  GI-IEEEPTWIIMELYPYGEL-----GHYL-ERNKNSLKVLTLVLYSLQICKAMAYLESI 144
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + +HRDI   N+L+ S     + DFG ++ I +   +  +  +  + +++PE   + + +
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 204
Query: 224 ESCDVYSFGILLLEILT-GRKP 244
            + DV+ F + + EIL+ G++P
Sbjct: 205 TASDVWMFAVCMWEILSFGKQP 226

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 72/322 (22%), Positives = 130/322 (40%), Gaps = 37/322 (11%)
Query: 33  YKELHTATNGFSDD----NKLGEGGFGSVYWGRTSDGLQIAVKKL---KAMNSKAEMEFA 85
           ++ + T T  F+DD     +LG+G F  V         Q    K+   K ++++   +  
Sbjct: 20  FQXMATCTR-FTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLE 78
Query: 86  VEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMK 145
            E  +   ++H N++ L    +      +V+D +              GE+  D   R  
Sbjct: 79  REARICRLLKHPNIVRLHDSISEEGFHYLVFDLVT------------GGELFEDIVAREY 126
Query: 146 IAIGSAEGILYLHHEVTPHI-----IHRDIKASNVLLDSDFEPL---VADFGFAKLIPEG 197
            +   A   ++   E   HI     +HRD+K  N+LL S  +     +ADFG A  + +G
Sbjct: 127 YSEADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEV-QG 185
Query: 198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI-----EKLPGGV 252
                    GT GYL+PE        +  D+++ G++L  +L G  P       KL   +
Sbjct: 186 EQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQI 245
Query: 253 KRTITEWAEPL--IVKGKFKELVDPKLRGDFDEN-QLKQAINVAVLCVQSEPEKRPNMKE 309
           K    ++  P    V  + K L++  L  +  +     QA+    +C +S      + +E
Sbjct: 246 KAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQE 305
Query: 310 VVNTLTGYDPRGKVMQTRIETL 331
            V  L  ++ R K+    + T+
Sbjct: 306 TVECLRKFNARRKLKGAILTTM 327

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 46  DNKLGEGGFGSVYWG-RTSDG-------LQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHK 97
           +  LG+G F  ++ G R   G        ++ +K L   +      F     ++ ++ HK
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
           +L+   G C   D+ ++V +++   SL ++L  +    + + WK  +++A   A  + +L
Sbjct: 73  HLVLNYGVCVCGDENILVQEFVKFGSLDTYLK-KNKNCINILWK--LEVAKQLAAAMHFL 129
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG----YLA 213
                  +IH ++ A N+LL  + +    +  F KL   G+S +T   K  L     ++ 
Sbjct: 130 EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-ITVLPKDILQERIPWVP 185
Query: 214 PEYAMWGK-VSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKE 271
           PE     K ++ + D +SFG  L EI + G KP+  L    K    E            +
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE---------DRHQ 236
Query: 272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV---NTLTGYD--PRG 321
           L  PK        +L   IN    C+  EP+ RP+ + ++   N+L   D  PRG
Sbjct: 237 LPAPKAA------ELANLINN---CMDYEPDHRPSFRAIIRDLNSLFTPDLVPRG 282

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/199 (21%), Positives = 90/199 (45%), Gaps = 12/199 (6%)
Query: 49  LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG 108
           LG G FG V+    +   +  + K   +    ++    E+ +L   RH+N+L L      
Sbjct: 13  LGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES 72
Query: 109 TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHR 168
            ++ +++++++  L +   ++       +L+ +  +       E + +LH   + +I H 
Sbjct: 73  MEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLH---SHNIGHF 126
Query: 169 DIKASNVLLDSDFEPLVA--DFGFAKLIPEGVSHMTTRVKGTL-GYLAPEYAMWGKVSES 225
           DI+  N++  +     +   +FG A+ +  G +    R+  T   Y APE      VS +
Sbjct: 127 DIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYYAPEVHQHDVVSTA 183
Query: 226 CDVYSFGILLLEILTGRKP 244
            D++S G L+  +L+G  P
Sbjct: 184 TDMWSLGTLVYVLLSGINP 202

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/130 (29%), Positives = 64/130 (49%), Gaps = 12/130 (9%)
Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGY 211
           +GI YLH++    IIHRDIK SN+L+  D    +ADFG +    +G   + +   GT  +
Sbjct: 148 KGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEF-KGSDALLSNTVGTPAF 203
Query: 212 LAPEYAMWGK---VSESCDVYSFGILLLEILTGRKP-----IEKLPGGVKRTITEWAEPL 263
           +APE     +     ++ DV++ G+ L   + G+ P     I  L   +K    E+ +  
Sbjct: 204 MAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQP 263
Query: 264 IVKGKFKELV 273
            +    K+L+
Sbjct: 264 DIAEDLKDLI 273

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 104/213 (48%), Gaps = 20/213 (9%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRG-Y 105
           K+G G +G VY  +  DG       LK +  +   M    E+ +L  ++H N++ L+  +
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 87
Query: 106 CAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY-----LHH 159
            +  D+++ +++DY  +  L   +    A +     K+ +++  G  + +LY     +H+
Sbjct: 88  LSHADRKVWLLFDYAEH-DLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHY 143
Query: 160 EVTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMT--TRVKGTLGYLA 213
                ++HRD+K +N+L+  +        +AD GFA+L    +  +     V  T  Y A
Sbjct: 144 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 203
Query: 214 PEYAMWGK-VSESCDVYSFGILLLEILTGRKPI 245
           PE  +  +  +++ D+++ G +  E+LT  +PI
Sbjct: 204 PELLLGARHYTKAIDIWAIGCIFAELLTS-EPI 235

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 62/273 (22%), Positives = 119/273 (43%), Gaps = 28/273 (10%)
Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKA-MNSKAEMEFAVEVEVLGR-VRHKNLLGLRG 104
           +LG G +G V   R    G  +AVK+++A +NS+ +    +++++  R V     +   G
Sbjct: 14  ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYG 73
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRM-KIAIGSAEGILYLHHEVTP 163
                    I  + M   + L   + Q   + Q   +  + KIA+   + + +LH +++ 
Sbjct: 74  ALFREGDVWICMELMD--TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS- 130
Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA----MW 219
            +IHRD+K SNVL+++  +  + DFG +  + + V+       G   Y+APE        
Sbjct: 131 -VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDID--AGCKPYMAPERINPELNQ 187
Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
              S   D++S GI ++E+   R P +            W  P     +  E   P+L  
Sbjct: 188 KGYSVKSDIWSLGITMIELAILRFPYD-----------SWGTPFQQLKQVVEEPSPQLPA 236
Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
           D    +    ++    C++   ++RP   E++ 
Sbjct: 237 DKFSAEF---VDFTSQCLKKNSKERPTYPELMQ 266

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 43  FSDDNKLGEGGFGSVYWGRTSDGLQI--AVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLL 100
           ++ +N +G G +G V       G +I  A KK+     +    F  E+E++  + H N++
Sbjct: 11  YTLENTIGRGSWGEVKIA-VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 69
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHL-HGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            L           +V +      L   + H +   E   D  R MK  + +   + Y H 
Sbjct: 70  RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRES--DAARIMKDVLSA---VAYCHK 124
Query: 160 EVTPHIIHRDIKASNVLL--DSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
               ++ HRD+K  N L   DS   PL + DFG A     G   M T+V GT  Y++P+ 
Sbjct: 125 L---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKV-GTPYYVSPQ- 178
Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPI 245
            + G     CD +S G+++  +L G  P 
Sbjct: 179 VLEGLYGPECDEWSAGVMMYVLLCGYPPF 207

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/206 (25%), Positives = 85/206 (41%), Gaps = 12/206 (5%)
Query: 49  LGEGGFGSVY-WGRTSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           +G G +G      R SDG  +  K+L   +M    +     EV +L  ++H N++  R Y
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV--RYY 71
Query: 106 CAGTDQR----LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
               D+      IV +Y     L S +         LD +  +++       +   H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131
Query: 162 T--PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
                ++HRD+K +NV LD      + DFG A+++          V GT  Y++PE    
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFV-GTPYYMSPEQMNR 190
Query: 220 GKVSESCDVYSFGILLLEILTGRKPI 245
              +E  D++S G LL E+     P 
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 97/225 (43%), Gaps = 26/225 (11%)
Query: 35  ELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKL-------KAMNSKAEM----E 83
           ELH   + ++    +  G +G+V  G  S+G+ +A+K++       + +N  ++      
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 84  FAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRR 143
              E+ +L    H N+LGLR      ++       M  L L++ L      +V  D  +R
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEE-----PAMHKLYLVTELMRTDLAQVIHD--QR 128
Query: 144 MKIAIGSAEGILY-----LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV 198
           + I+    +  +Y     LH      ++HRD+   N+LL  + +  + DF  A+   +  
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTA 186
Query: 199 SHMTTRVKGTLGYLAPEYAMWGK-VSESCDVYSFGILLLEILTGR 242
               T       Y APE  M  K  ++  D++S G ++ E+   +
Sbjct: 187 DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/225 (22%), Positives = 97/225 (43%), Gaps = 26/225 (11%)
Query: 35  ELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKL-------KAMNSKAEM----E 83
           ELH   + ++    +  G +G+V  G  S+G+ +A+K++       + +N  ++      
Sbjct: 16  ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 84  FAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRR 143
              E+ +L    H N+LGLR      ++       M  L L++ L      +V  D  +R
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEE-----PAMHKLYLVTELMRTDLAQVIHD--QR 128
Query: 144 MKIAIGSAEGILY-----LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV 198
           + I+    +  +Y     LH      ++HRD+   N+LL  + +  + DF  A+   +  
Sbjct: 129 IVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTA 186
Query: 199 SHMTTRVKGTLGYLAPEYAMWGK-VSESCDVYSFGILLLEILTGR 242
               T       Y APE  M  K  ++  D++S G ++ E+   +
Sbjct: 187 DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 91/209 (43%), Gaps = 18/209 (8%)
Query: 43  FSDDNKLGEGGFGSVYWGRTSDGLQI--AVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLL 100
           ++ +N +G G +G V       G +I  A KK+     +    F  E+E++  + H N++
Sbjct: 28  YTLENTIGRGSWGEVKIA-VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNII 86
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHL-HGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            L           +V +      L   + H +   E   D  R MK  + +   + Y H 
Sbjct: 87  RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRES--DAARIMKDVLSA---VAYCHK 141
Query: 160 EVTPHIIHRDIKASNVLL--DSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
               ++ HRD+K  N L   DS   PL + DFG A     G   M T+V GT  Y++P+ 
Sbjct: 142 L---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKV-GTPYYVSPQ- 195
Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPI 245
            + G     CD +S G+++  +L G  P 
Sbjct: 196 VLEGLYGPECDEWSAGVMMYVLLCGYPPF 224

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 72/295 (24%), Positives = 128/295 (43%), Gaps = 44/295 (14%)
Query: 46  DNKLGEGGFGSVYWG-RTSDG-------LQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHK 97
           +  LG+G F  ++ G R   G        ++ +K L   +      F     ++ ++ HK
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
           +L+   G C   D+ ++V +++   SL ++L  +    + + WK  +++A   A  + +L
Sbjct: 73  HLVLNYGVCFCGDENILVQEFVKFGSLDTYL-KKNKNCINILWK--LEVAKQLAWAMHFL 129
Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG----YLA 213
                  +IH ++ A N+LL  + +    +  F KL   G+S +T   K  L     ++ 
Sbjct: 130 EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-ITVLPKDILQERIPWVP 185
Query: 214 PEYAMWGK-VSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKE 271
           PE     K ++ + D +SFG  L EI + G KP+  L    K    E            +
Sbjct: 186 PECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE---------DRHQ 236
Query: 272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV---NTLTGYD--PRG 321
           L  PK        +L   IN    C+  EP+ RP+ + ++   N+L   D  PRG
Sbjct: 237 LPAPKAA------ELANLINN---CMDYEPDHRPSFRAIIRDLNSLFTPDLVPRG 282

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 71/168 (42%), Gaps = 24/168 (14%)
Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTRVKG 207
           A+G+ +L    +   IHRD+ A N+LL       + DFG A+ I   P+ V     R+  
Sbjct: 203 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-- 257
Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVK 266
            L ++APE       +   DV+SFG+LL EI + G  P      GVK           + 
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----GVK-----------ID 302
Query: 267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +F   +    R    +    +     + C   EP +RP   E+V  L
Sbjct: 303 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 71/168 (42%), Gaps = 24/168 (14%)
Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTRVKG 207
           A+G+ +L    +   IHRD+ A N+LL       + DFG A+ I   P+ V     R+  
Sbjct: 208 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-- 262
Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVK 266
            L ++APE       +   DV+SFG+LL EI + G  P      GVK           + 
Sbjct: 263 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----GVK-----------ID 307
Query: 267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +F   +    R    +    +     + C   EP +RP   E+V  L
Sbjct: 308 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 355

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 71/168 (42%), Gaps = 24/168 (14%)
Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTRVKG 207
           A+G+ +L    +   IHRD+ A N+LL       + DFG A+ I   P+ V     R+  
Sbjct: 210 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-- 264
Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVK 266
            L ++APE       +   DV+SFG+LL EI + G  P      GVK           + 
Sbjct: 265 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----GVK-----------ID 309
Query: 267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +F   +    R    +    +     + C   EP +RP   E+V  L
Sbjct: 310 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 357

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/168 (27%), Positives = 71/168 (42%), Gaps = 24/168 (14%)
Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTRVKG 207
           A+G+ +L    +   IHRD+ A N+LL       + DFG A+ I   P+ V     R+  
Sbjct: 201 AKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-- 255
Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVK 266
            L ++APE       +   DV+SFG+LL EI + G  P      GVK           + 
Sbjct: 256 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP----GVK-----------ID 300
Query: 267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +F   +    R    +    +     + C   EP +RP   E+V  L
Sbjct: 301 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 348

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 91/211 (43%), Gaps = 18/211 (8%)
Query: 38  TATNGFSDDNKLGEGGFGSVYWG-RTSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRV 94
           T+ + +    KLGEG +G VY    T     +A+K+++  + +  +      EV +L  +
Sbjct: 31  TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL 90
Query: 95  RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
           +H+N++ L+       +  ++++Y  N      L         +  +           G+
Sbjct: 91  QHRNIIELKSVIHHNHRLHLIFEYAEN-----DLKKYMDKNPDVSMRVIKSFLYQLINGV 145
Query: 155 LYLHHEVTPHIIHRDIKASNVLL---DSDFEPL--VADFGFAKLIPEGVSHMTTRVKGTL 209
            + H       +HRD+K  N+LL   D+   P+  + DFG A+     +   T  +  TL
Sbjct: 146 NFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TL 201
Query: 210 GYLAPEYAMWGK-VSESCDVYSFGILLLEIL 239
            Y  PE  +  +  S S D++S   +  E+L
Sbjct: 202 WYRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 89/205 (43%), Gaps = 16/205 (7%)
Query: 48  KLGEGGFGSVYWG-RTSDGLQIAVKKL--KAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           +LG+G F  V    +   G + A K +  K ++++   +   E  +   ++H N++ L  
Sbjct: 29  ELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 88
Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHG-QYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
             +      +++D +    L   +   +Y  E       +  +     E +L+ H     
Sbjct: 89  SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL-----EAVLHCHQM--- 140
Query: 164 HIIHRDIKASNVLLDSDFEPL---VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
            ++HRD+K  N+LL S  +     +ADFG A  + EG         GT GYL+PE     
Sbjct: 141 GVVHRDLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFGFAGTPGYLSPEVLRKD 199
Query: 221 KVSESCDVYSFGILLLEILTGRKPI 245
              +  D+++ G++L  +L G  P 
Sbjct: 200 PYGKPVDLWACGVILYILLVGYPPF 224

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 37/108 (34%), Positives = 54/108 (50%), Gaps = 13/108 (12%)
Query: 143 RMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA-KLIPEGVSHM 201
           +M +AI  A   L   H V    IHRD+K SN+LLD   +  + DFG + +L+ +     
Sbjct: 128 KMTVAIVKALYYLKEKHGV----IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD- 182
Query: 202 TTRVKGTLGYLAPEYAMWGKVSES-----CDVYSFGILLLEILTGRKP 244
             R  G   Y+APE       ++       DV+S GI L+E+ TG+ P
Sbjct: 183 --RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFP 228

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 26/80 (32%), Positives = 37/80 (46%)
Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD+K  N+L+ +D    + DFG A    +          GTL Y APE       +   
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 227 DVYSFGILLLEILTGRKPIE 246
           D+Y+   +L E LTG  P +
Sbjct: 217 DIYALTCVLYECLTGSPPYQ 236

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 66/289 (22%), Positives = 124/289 (42%), Gaps = 50/289 (17%)
Query: 42  GFSDDNKLGEGGFGSVYWGRTSDGLQIAVKK-LKAMNSKAEMEFAVEVEVLGRVRHKNLL 100
            F   + LG G  G++ +    D   +AVK+ L    S A+ E  +  E      H N++
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRE---SDEHPNVI 81
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAI--GSAEGILYLH 158
             R +C   D++   + Y+  + L +    +Y  +          I +   +  G+ +LH
Sbjct: 82  --RYFCTEKDRQ---FQYIA-IELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH 135
Query: 159 HEVTPHIIHRDIKASNVLLD-----SDFEPLVADFGFAKLIPEGVSHMTTR--VKGTLGY 211
              + +I+HRD+K  N+L+         + +++DFG  K +  G    + R  V GT G+
Sbjct: 136 ---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 212 LAPEYAMWGKVSESC--------DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP 262
           +APE      +SE C        D++S G +   +++ G  P  K       ++   A  
Sbjct: 193 IAPEM-----LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK-------SLQRQANI 240
Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
           L+      + + P+   D    +L + +      +  +P+KRP+ K V+
Sbjct: 241 LLGACSL-DCLHPEKHEDVIARELIEKM------IAMDPQKRPSAKHVL 282

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 88/208 (42%), Gaps = 22/208 (10%)
Query: 48  KLGEGGFG------SVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +LG+G F        V  G+    + I  KKL A + +   +   E  +   ++H N++ 
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQ---KLEREARICRLLKHPNIVR 74
Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLHG-QYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           L    +      +++D +    L   +   +Y  E       +  +     E +L+ H  
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQIL-----EAVLHCHQM 129
Query: 161 VTPHIIHRDIKASNVLLDSDFEPL---VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
               ++HR++K  N+LL S  +     +ADFG A  + EG         GT GYL+PE  
Sbjct: 130 ---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV-EGEQQAWFGFAGTPGYLSPEVL 185
Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPI 245
                 +  D+++ G++L  +L G  P 
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPPF 213

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 103/221 (46%), Gaps = 33/221 (14%)
Query: 46  DNKLGEGGFGSVYWGRTSDGL----QIAVKKLKAMNSKAEMEFAVEVEVLGRVR-HKNLL 100
           ++ LGEG    V   +T   L    + AVK ++            EVE+L + + H+N+L
Sbjct: 18  EDVLGEGAHARV---QTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVL 74
Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHG-QYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            L  +    D+  +V++ M   S+LSH+H  ++  E++        +    A  + +LH+
Sbjct: 75  ELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS-----VVVQDVASALDFLHN 129
Query: 160 EVTPHIIHRDIKASNVLLD--SDFEPL-VADFGFAKLI-------PEGVSHMTTRVKGTL 209
           +    I HRD+K  N+L +  +   P+ + DFG    I       P     + T   G+ 
Sbjct: 130 K---GIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPC-GSA 185
Query: 210 GYLAPEY--AMWGKVS---ESCDVYSFGILLLEILTGRKPI 245
            Y+APE   A   + S   + CD++S G++L  +L+G  P 
Sbjct: 186 EYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 120/279 (43%), Gaps = 39/279 (13%)
Query: 49  LGEGGFGSVYWGRTSD-GLQIAVK-----KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
           +G+G F  V      + G Q AVK     K  +    +  +   E  +   ++H +++ L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQ------YAGEVQLDWKRRMKIAIGSAEGILY 156
               +      +V+++M    L   +  +      Y+  V   + R++       E + Y
Sbjct: 92  LETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI------LEALRY 145
Query: 157 LHHEVTPHIIHRDIKASNVLLDS--DFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLA 213
            H     +IIHRD+K  NVLL S  +  P+ + DFG A  + E       RV GT  ++A
Sbjct: 146 CHDN---NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRV-GTPHFMA 201
Query: 214 PEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV 273
           PE        +  DV+  G++L  +L+G  P      G K  + E     I+KGK+K  +
Sbjct: 202 PEVVKREPYGKPVDVWGCGVILFILLSGCLPFY----GTKERLFEG----IIKGKYK--M 251
Query: 274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
           +P+      E+    A ++    +  +P +R  + E +N
Sbjct: 252 NPRQWSHISES----AKDLVRRMLMLDPAERITVYEALN 286

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 103/216 (47%), Gaps = 22/216 (10%)
Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           F  +   G+G FG+V  G+  S G+ +A+KK+         E  + ++ L  + H N++ 
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQI-MQDLAVLHHPNIVQ 83
Query: 102 LRGY---CAGTDQRLI----VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
           L+ Y       D+R I    V +Y+P+ +L       Y  +V       +K+ +      
Sbjct: 84  LQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVA-PPPILIKVFLFQLIRS 141
Query: 155 LYLHHEVTPHIIHRDIKASNVLLD-SDFEPLVADFGFA-KLIPE--GVSHMTTRVKGTLG 210
           +   H  + ++ HRDIK  NVL++ +D    + DFG A KL P    V+++ +R      
Sbjct: 142 IGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRY----- 196
Query: 211 YLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPI 245
           Y APE     +  + + D++S G +  E++ G +PI
Sbjct: 197 YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/280 (21%), Positives = 118/280 (42%), Gaps = 39/280 (13%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVK--KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           ++G GG   V+          A+K   L+  +++    +  E+  L +++  +   +R Y
Sbjct: 35  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 106 -CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
               TDQ + +     N+ L S L  + + +    W+R+        + +L   H +  H
Sbjct: 95  DYEITDQYIYMVMECGNIDLNSWLKKKKSID---PWERK-----SYWKNMLEAVHTIHQH 146
Query: 165 -IIHRDIKASNVLLDSDFEPLVADFGFA-KLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
            I+H D+K +N L+      L+ DFG A ++ P+  S +     GT+ Y+ PE       
Sbjct: 147 GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 205
Query: 223 SES-----------CDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE 271
           S              DV+S G +L  +  G+ P +++   +               K   
Sbjct: 206 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--------------SKLHA 251
Query: 272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
           ++DP    +F +   K   +V   C++ +P++R ++ E++
Sbjct: 252 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/280 (21%), Positives = 118/280 (42%), Gaps = 39/280 (13%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVK--KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           ++G GG   V+          A+K   L+  +++    +  E+  L +++  +   +R Y
Sbjct: 16  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 106 -CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
               TDQ + +     N+ L S L  + + +    W+R+        + +L   H +  H
Sbjct: 76  DYEITDQYIYMVMECGNIDLNSWLKKKKSID---PWERK-----SYWKNMLEAVHTIHQH 127
Query: 165 -IIHRDIKASNVLLDSDFEPLVADFGFA-KLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
            I+H D+K +N L+      L+ DFG A ++ P+  S +     GT+ Y+ PE       
Sbjct: 128 GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 223 SES-----------CDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE 271
           S              DV+S G +L  +  G+ P +++   +               K   
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--------------SKLHA 232
Query: 272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
           ++DP    +F +   K   +V   C++ +P++R ++ E++
Sbjct: 233 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 59/280 (21%), Positives = 118/280 (42%), Gaps = 39/280 (13%)
Query: 48  KLGEGGFGSVYWGRTSDGLQIAVK--KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           ++G GG   V+          A+K   L+  +++    +  E+  L +++  +   +R Y
Sbjct: 15  QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 74
Query: 106 -CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
               TDQ + +     N+ L S L  + + +    W+R+        + +L   H +  H
Sbjct: 75  DYEITDQYIYMVMECGNIDLNSWLKKKKSID---PWERK-----SYWKNMLEAVHTIHQH 126
Query: 165 -IIHRDIKASNVLLDSDFEPLVADFGFA-KLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
            I+H D+K +N L+      L+ DFG A ++ P+  S +     GT+ Y+ PE       
Sbjct: 127 GIVHSDLKPANFLIVDGMLKLI-DFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 185
Query: 223 SES-----------CDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE 271
           S              DV+S G +L  +  G+ P +++   +               K   
Sbjct: 186 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--------------SKLHA 231
Query: 272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
           ++DP    +F +   K   +V   C++ +P++R ++ E++
Sbjct: 232 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 271
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	380
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-178
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-148
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-139
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-86
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-66
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-65
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-64
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-64
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-61
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-61
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-61
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	2e-59
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	3e-59
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-57
3q4u_A	301	Activin receptor type-1; structural genomics conso	5e-53
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-52
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-51
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-50
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-39
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-39
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-38
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-37
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-37
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	6e-37
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-37
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	7e-37
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	7e-37
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	9e-37
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-36
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-36
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-36
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	7e-36
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-35
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-35
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-35
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-35
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-35
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-35
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-35
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	8e-35
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	9e-35
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-34
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-34
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-34
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	2e-34
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-34
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-34
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	6e-34
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-34
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-34
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	9e-34
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-33
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-33
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	2e-33
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-33
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-33
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-33
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-32
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-32
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-32
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-32
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-32
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-32
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-32
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	8e-32
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	8e-32
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-31
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-31
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-30
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-30
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	3e-30
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-30
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-30
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	6e-30
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	6e-30
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-29
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-29
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-29
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-29
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-29
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-29
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-29
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-29
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-28
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-28
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-28
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-28
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-28
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-28
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	3e-28
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-28
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-27
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-27
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-27
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-27
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	3e-27
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-27
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-27
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-27
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	5e-27
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-27
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	7e-27
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	8e-27
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	4e-26
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-26
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-26
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-26
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-25
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-25
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-25
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	8e-25
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-24
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-24
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-24
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	5e-24
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-24
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	3e-23
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-23
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-23
3aln_A	327	Dual specificity mitogen-activated protein kinase;	4e-23
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-23
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-23
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-22
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-22
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-22
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-22
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-22
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-22
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-22
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	8e-22
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	9e-22
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-21
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-21
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-21
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-21
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-21
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-20
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-20
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	3e-20
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-20
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	4e-20
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-19
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-19
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-19
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-19
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-19
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-19
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	3e-19
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-19
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-19
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-19
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	4e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	4e-19
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	5e-19
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-19
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	8e-19
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-18
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-18
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	2e-18
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-18
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	4e-18
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-18
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-18
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	8e-18
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	9e-18
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	9e-18
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-17
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-17
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-17
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-17
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-17
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-17
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-17
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-17
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-17
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-17
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-17
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-17
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-17
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-17
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	5e-17
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-17
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	5e-17
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-17
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	7e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-16
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-16
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-16
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-16
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-16
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	2e-16
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-16
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-16
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-16
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-15
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-15
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-15
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	5e-15
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-15
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	8e-15
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-14
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-14
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-14
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-14
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	7e-14
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	7e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-13
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-13
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-13
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-12
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	9e-11
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-09
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-09
3rp9_A	458	Mitogen-activated protein kinase; structural genom	9e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-08
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-08
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	4e-08
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	4e-08
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	6e-08
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	6e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-08
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-07
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-06
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-06
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-05
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-04
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  496 bits (1279), Expect = e-178
 Identities = 130/292 (44%), Positives = 193/292 (66%), Gaps = 3/292 (1%)

Query: 28  WRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKA-EMEFAV 86
            + F+ +EL  A++ FS+ N LG GGFG VY GR +DG  +AVK+LK   ++  E++F  
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 87  EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKI 146
           EVE++    H+NLL LRG+C    +RL+VY YM N S+ S L  +   +  LDW +R +I
Sbjct: 77  EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRI 136

Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
           A+GSA G+ YLH    P IIHRD+KA+N+LLD +FE +V DFG AKL+    +H+TT V+
Sbjct: 137 ALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVR 196

Query: 207 GTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE--KLPGGVKRTITEWAEPLI 264
           GT+G++APEY   GK SE  DV+ +G++LLE++TG++  +  +L       + +W + L+
Sbjct: 197 GTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLL 256

Query: 265 VKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
            + K + LVD  L+G++ + +++Q I VA+LC QS P +RP M EVV  L G
Sbjct: 257 KEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  420 bits (1081), Expect = e-148
 Identities = 112/317 (35%), Positives = 175/317 (55%), Gaps = 6/317 (1%)

Query: 1   MGSAFSCCGSEKVEEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWG 60
           MGS +S   +   +   ++   P  +        +L  ATN F     +G G FG VY G
Sbjct: 1   MGSKYSKATNSINDALSSSYLVPFES--YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKG 58

Query: 61  RTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMP 120
              DG ++A+K+    +S+   EF  E+E L   RH +L+ L G+C   ++ +++Y YM 
Sbjct: 59  VLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYME 118

Query: 121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD 180
           N +L  HL+G     + + W++R++I IG+A G+ YLH   T  IIHRD+K+ N+LLD +
Sbjct: 119 NGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDEN 175

Query: 181 FEPLVADFGFAKLIPEG-VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEIL 239
           F P + DFG +K   E   +H++T VKGTLGY+ PEY + G+++E  DVYSFG++L E+L
Sbjct: 176 FVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235

Query: 240 TGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQS 299
             R  I +        + EWA      G+ +++VDP L        L++  + AV C+  
Sbjct: 236 CARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLAL 295

Query: 300 EPEKRPNMKEVVNTLTG 316
             E RP+M +V+  L  
Sbjct: 296 SSEDRPSMGDVLWKLEY 312

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  397 bits (1022), Expect = e-139
 Identities = 107/301 (35%), Positives = 166/301 (55%), Gaps = 21/301 (6%)

Query: 29  RIFTYKELHTATNGFSD------DNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKA-- 80
             F++ EL   TN F +       NK+GEGGFG VY G   +   +AVKKL AM      
Sbjct: 13  HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTE 71

Query: 81  --EMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQL 138
             + +F  E++V+ + +H+NL+ L G+ +  D   +VY YMPN SLL  L     G   L
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPL 130

Query: 139 DWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG- 197
            W  R KIA G+A GI +LH     H IHRDIK++N+LLD  F   ++DFG A+   +  
Sbjct: 131 SWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187

Query: 198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTIT 257
            + MT+R+ GT  Y+APE  + G+++   D+YSFG++LLEI+TG   +++      + + 
Sbjct: 188 QTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHRE--PQLLL 244

Query: 258 EWAEPLIV-KGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
           +  E +   +   ++ +D K+  D D   ++   +VA  C+  +  KRP++K+V   L  
Sbjct: 245 DIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQE 303

Query: 317 Y 317
            
Sbjct: 304 M 304

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  263 bits (675), Expect = 2e-86
 Identities = 67/307 (21%), Positives = 108/307 (35%), Gaps = 30/307 (9%)

Query: 31  FTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEV 90
              + L+  +           G FG V+  +      +AVK    +  K   +   EV  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFP-IQDKQSWQNEYEVYS 71

Query: 91  LGRVRHKNLLGLRGYC----AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKI 146
           L  ++H+N+L   G      +      ++  +    SL   L         + W     I
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCHI 126

Query: 147 AIGSAEGILYLHHEV-------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS 199
           A   A G+ YLH ++        P I HRDIK+ NVLL ++    +ADFG A     G S
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 200 H-MTTRVKGTLGYLAPEYAMWG-----KVSESCDVYSFGILLLEILTGRKPIEKLPGGVK 253
              T    GT  Y+APE                D+Y+ G++L E+ +     +       
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

Query: 254 RTITEWAEPLIVKGKFKELV-----DPKLRGDFDENQ-LKQAINVAVLCVQSEPEKRPNM 307
               E           +E+V      P LR  + ++  +         C   + E R + 
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306

Query: 308 KEVVNTL 314
             V   +
Sbjct: 307 GCVGERI 313

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  210 bits (537), Expect = 7e-66
 Identities = 85/303 (28%), Positives = 139/303 (45%), Gaps = 31/303 (10%)

Query: 15  EGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLK 74
           E L      +     I  + +L+          K+G G FG+V+      G  +AVK L 
Sbjct: 19  ENLYFQGAMDGDDMDI-PWCDLN-------IKEKIGAGSFGTVHRAEW-HGSDVAVKILM 69

Query: 75  A--MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQY 132
               +++   EF  EV ++ R+RH N++   G         IV +Y+   SL   LH   
Sbjct: 70  EQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG 129

Query: 133 AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK 192
           A E QLD +RR+ +A   A+G+ YLH+   P I+HR++K+ N+L+D  +   V DFG ++
Sbjct: 130 ARE-QLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSR 187

Query: 193 LIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGV 252
           L         +   GT  ++APE       +E  DVYSFG++L E+ T ++P   L    
Sbjct: 188 LKASTFLSSKSAA-GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL---- 242

Query: 253 KRTITEWAEPL-IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
                    P  +V     +    ++  + +  Q+   I     C  +EP KRP+   ++
Sbjct: 243 --------NPAQVVAAVGFKCKRLEIPRNLNP-QVAAIIE---GCWTNEPWKRPSFATIM 290

Query: 312 NTL 314
           + L
Sbjct: 291 DLL 293

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  208 bits (531), Expect = 3e-65
 Identities = 79/308 (25%), Positives = 137/308 (44%), Gaps = 46/308 (14%)

Query: 23  PNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAE 81
           P +    +    E+         + ++G+GGFG V+ GR   D   +A+K L   +S+ E
Sbjct: 9   PKSRLPTL-ADNEIE-------YEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGE 60

Query: 82  M-------EFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAG 134
                   EF  EV ++  + H N++ L G     +   +V +++P   L   L  +   
Sbjct: 61  TEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDK--- 115

Query: 135 EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-----VADFG 189
              + W  ++++ +  A GI Y+ ++  P I+HRD+++ N+ L S  E       VADFG
Sbjct: 116 AHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG 174

Query: 190 FAKLIPEGVSHMTTRVKGTLGYLAPE--YAMWGKVSESCDVYSFGILLLEILTGRKPIEK 247
            ++       H  + + G   ++APE   A     +E  D YSF ++L  ILTG  P ++
Sbjct: 175 LSQQ----SVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

Query: 248 LPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNM 307
              G  + I               + +  LR    E+   +  NV  LC   +P+KRP+ 
Sbjct: 231 YSYGKIKFIN-------------MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHF 277

Query: 308 KEVVNTLT 315
             +V  L+
Sbjct: 278 SYIVKELS 285

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  206 bits (527), Expect = 2e-64
 Identities = 78/274 (28%), Positives = 124/274 (45%), Gaps = 25/274 (9%)

Query: 43  FSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
              +  +G G FG V   +      +A+K+++  +      F VE+  L RV H N++ L
Sbjct: 10  IEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIVKL 66

Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
            G C   +   +V +Y    SL + LHG             M   +  ++G+ YLH    
Sbjct: 67  YGAC--LNPVCLVMEYAEGGSLYNVLHGA-EPLPYYTAAHAMSWCLQCSQGVAYLHSMQP 123

Query: 163 PHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK 221
             +IHRD+K  N+LL +    L + DFG A  I        T  KG+  ++APE      
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDI----QTHMTNNKGSAAWMAPEVFEGSN 179

Query: 222 VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF 281
            SE CDV+S+GI+L E++T RKP +++ G   R         +  G          R   
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-----IMWAVHNG---------TRPPL 225

Query: 282 DENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
            +N  K   ++   C   +P +RP+M+E+V  +T
Sbjct: 226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT 259

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  207 bits (528), Expect = 3e-64
 Identities = 68/321 (21%), Positives = 114/321 (35%), Gaps = 47/321 (14%)

Query: 31  FTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEV 90
               E     +       +G G +G+VY G + D   +AVK     N      F  E  +
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKG-SLDERPVAVKVFSFAN---RQNFINEKNI 58

Query: 91  --LGRVRHKNLLGLRGYC-----AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRR 143
             +  + H N+             G  + L+V +Y PN SL  +L          DW   
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-----TSDWVSS 113

Query: 144 MKIAIGSAEGILYLHHEVT------PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG 197
            ++A     G+ YLH E+       P I HRD+ + NVL+ +D   +++DFG +  +   
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 198 -------VSHMTTRVKGTLGYLAPEYAM-------WGKVSESCDVYSFGILLLEILTGRK 243
                    +      GT+ Y+APE               +  D+Y+ G++  EI   R 
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM-RC 232

Query: 244 PIEKLPGGVKRTITEWAEPLIVKGKFKEL----VDPKLRGDFDENQLKQAINVAVL---- 295
                   V      +   +     F+++       K R  F E   + ++ V  L    
Sbjct: 233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETI 292

Query: 296 --CVQSEPEKRPNMKEVVNTL 314
             C   + E R   +     +
Sbjct: 293 EDCWDQDAEARLTAQXAEERM 313

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  197 bits (503), Expect = 5e-61
 Identities = 78/275 (28%), Positives = 131/275 (47%), Gaps = 28/275 (10%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKA--MNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
            ++G G FG+VY G+      +AVK L       +    F  EV VL + RH N+L   G
Sbjct: 30  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 105 YCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           Y   T  +L IV  +    SL  HLH     E + + K+ + IA  +A G+ YLH     
Sbjct: 88  YS--TAPQLAIVTQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLH---AK 139

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE-GVSHMTTRVKGTLGYLAPE---YAMW 219
            IIHRD+K++N+ L  D    + DFG A        SH   ++ G++ ++APE       
Sbjct: 140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDS 199

Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
              S   DVY+FGI+L E++TG+ P   +         +    ++ +G        K+R 
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNI------NNRDQIIEMVGRGSLS-PDLSKVRS 252

Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           +  + ++K+ +     C++ + ++RP+   ++  +
Sbjct: 253 NCPK-RMKRLMA---ECLKKKRDERPSFPRILAEI 283

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  196 bits (500), Expect = 7e-61
 Identities = 68/280 (24%), Positives = 113/280 (40%), Gaps = 36/280 (12%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKA----MNSKAEMEFAVEVEVLGRVRHKNLLGL 102
             +G GGFG VY      G ++AVK  +       S+       E ++   ++H N++ L
Sbjct: 13  EIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
           RG C       +V ++     L   L G+     ++     +  A+  A G+ YLH E  
Sbjct: 72  RGVCLKEPNLCLVMEFARGGPLNRVLSGK-----RIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 163 PHIIHRDIKASNVLLDSDFEPL--------VADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
             IIHRD+K+SN+L+    E          + DFG A+      +   +   G   ++AP
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR--TTKMSAA-GAYAWMAP 183

Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD 274
           E       S+  DV+S+G+LL E+LTG  P   + G         A  + +         
Sbjct: 184 EVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG------LAVAYGVAMNK------- 230

Query: 275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
             L         +    +   C   +P  RP+   +++ L
Sbjct: 231 --LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQL 268

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  194 bits (494), Expect = 2e-59
 Identities = 69/282 (24%), Positives = 112/282 (39%), Gaps = 34/282 (12%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
             LG+G FG          G  + +K+L   + + +  F  EV+V+  + H N+L   G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
                +   + +Y+   +L   +      + Q  W +R+  A   A G+ YLH     +I
Sbjct: 76  LYKDKRLNFITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NI 129

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR-------------VKGTLGYL 212
           IHRD+ + N L+  +   +VADFG A+L+ +  +                  V G   ++
Sbjct: 130 IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWM 189

Query: 213 APEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL 272
           APE        E  DV+SFGI+L EI+                     + L     F   
Sbjct: 190 APEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--------------DPDYLPRTMDFGLN 235

Query: 273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           V   L      N       + V C   +PEKRP+  ++ + L
Sbjct: 236 VRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWL 277

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  192 bits (489), Expect = 3e-59
 Identities = 65/276 (23%), Positives = 107/276 (38%), Gaps = 34/276 (12%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKA--MNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
            KL E   G ++ GR   G  I VK LK    +++   +F  E   L    H N+L + G
Sbjct: 16  TKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 105 YCAG--TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
            C         ++  +MP  SL + LH        +D  + +K A+  A G+ +LH    
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL-E 131

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK- 221
           P I    + + +V++D D    ++            S  +        ++APE A+  K 
Sbjct: 132 PLIPRHALNSRSVMIDEDMTARISMADVKF------SFQSPGRMYAPAWVAPE-ALQKKP 184

Query: 222 ---VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR 278
                 S D++SF +LL E++T   P   L         E    + ++G         LR
Sbjct: 185 EDTNRRSADMWSFAVLLWELVTREVPFADLSNM------EIGMKVALEG---------LR 229

Query: 279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                        +  +C+  +P KRP    +V  L
Sbjct: 230 PTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPIL 265

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  189 bits (481), Expect = 2e-57
 Identities = 59/284 (20%), Positives = 112/284 (39%), Gaps = 41/284 (14%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKA--MNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
             +G+G FG VY GR     ++A++ +     N      F  EV    + RH+N++   G
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
            C       I+       +L S +      ++ LD  +  +IA    +G+ YLH      
Sbjct: 97  ACMSPPHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLH---AKG 150

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLI----PEGVSHMTTRVKGTLGYLAPEYAMWG 220
           I+H+D+K+ NV  D + + ++ DFG   +                 G L +LAPE     
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 221 KV---------SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE 271
                      S+  DV++ G +  E+     P +  P               +  +   
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQP------------AEAIIWQ--- 254

Query: 272 LVDPKLRGDFDENQLKQAI-NVAVLCVQSEPEKRPNMKEVVNTL 314
            +   ++ +  +  + + I ++ + C   E E+RP   ++++ L
Sbjct: 255 -MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDML 297

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  176 bits (449), Expect = 5e-53
 Identities = 64/299 (21%), Positives = 115/299 (38%), Gaps = 46/299 (15%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEV--LGRVRHKNLLGLRG 104
             +G+G +G V+ G +  G  +AVK      S+ E  +  E E+     +RH+N+LG   
Sbjct: 14  ECVGKGRYGEVWRG-SWQGENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIA 69

Query: 105 YCAGTD----QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
               +     Q  ++  Y    SL  +L         LD    ++I +  A G+ +LH E
Sbjct: 70  SDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASGLAHLHIE 124

Query: 161 V-----TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH----MTTRVKGTLGY 211
           +      P I HRD+K+ N+L+  + +  +AD G A +  +  +        RV GT  Y
Sbjct: 125 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV-GTKRY 183

Query: 212 LAPE------YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPG---------GVKRTI 256
           +APE              +  D+++FG++L E+         +               + 
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243

Query: 257 TEWAEPLIVKGKFKELVDPKLRGDFDENQ-LKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +  + + V  +      P +   +  +  L     +   C    P  R     +  TL
Sbjct: 244 EDMRKVVCVDQQ-----RPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTL 297

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  176 bits (449), Expect = 1e-52
 Identities = 72/297 (24%), Positives = 115/297 (38%), Gaps = 40/297 (13%)

Query: 46  DNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
             ++G+G +G V+ G    G ++AVK       +A      E+     +RH+N+LG    
Sbjct: 42  VKQIGKGRYGEVWMG-KWRGEKVAVKVFFTTE-EASWFRETEIYQTVLMRHENILGFIAA 99

Query: 106 C----AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
                    Q  ++ DY  N SL  +L         LD K  +K+A  S  G+ +LH E+
Sbjct: 100 DIKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 162 T-----PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH----MTTRVKGTLGYL 212
                 P I HRD+K+ N+L+  +    +AD G A       +       TRV GT  Y+
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRV-GTKRYM 213

Query: 213 APE------YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVK 266
            PE           +     D+YSFG++L E+           G V+     + + +   
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVS----GGIVEEYQLPYHDLVPSD 269

Query: 267 GKFKELVDP----KLRGDFDENQLKQAINVAVL-----CVQSEPEKRPNMKEVVNTL 314
             ++++ +     KLR  F            +      C    P  R     V  TL
Sbjct: 270 PSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTL 326

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  171 bits (436), Expect = 1e-50
 Identities = 64/299 (21%), Positives = 117/299 (39%), Gaps = 44/299 (14%)

Query: 46  DNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEV--LGRVRHKNLLGLR 103
              +G+G FG V+ G+   G ++AVK   +     E  +  E E+     +RH+N+LG  
Sbjct: 47  QESIGKGRFGEVWRGKW-RGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFI 102

Query: 104 GYCAGTD----QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
                 +    Q  +V DY  + SL  +L+        +  +  +K+A+ +A G+ +LH 
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHM 157

Query: 160 EVT-----PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH----MTTRVKGTLG 210
           E+      P I HRD+K+ N+L+  +    +AD G A                RV GT  
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV-GTKR 216

Query: 211 YLAPE------YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI 264
           Y+APE           +  +  D+Y+ G++  EI           G  +     + + + 
Sbjct: 217 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI----GGIHEDYQLPYYDLVP 272

Query: 265 VKGKFKELVD--------PKLRGDFDENQLKQAI-NVAVLCVQSEPEKRPNMKEVVNTL 314
                +E+          P +   +   +  + +  +   C  +    R     +  TL
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTL 331

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  141 bits (358), Expect = 3e-39
 Identities = 70/281 (24%), Positives = 120/281 (42%), Gaps = 18/281 (6%)

Query: 47  NKLGEGGFGSVYWGR-----TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           ++LG+G FGSV   R      + G  +AVK+L+      + +F  E+++L  +    ++ 
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 102 LRGYCAGTDQR--LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            RG   G  ++   +V +Y+P+  L   L        +LD  R +  +    +G+ YL  
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGS 145

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL--GYLAPEYA 217
                 +HRD+ A N+L++S+    +ADFG AKL+P    +   R  G     + APE  
Sbjct: 146 R---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESL 202

Query: 218 MWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
                S   DV+SFG++L E+ T   K     P      +      +    +  EL++  
Sbjct: 203 SDNIFSRQSDVWSFGVVLYELFTYCDKS--CSPSAEFLRMMGCERDVPALSRLLELLEEG 260

Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
            R         +   +  LC    P+ RP+   +   L   
Sbjct: 261 QRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDML 301

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  142 bits (360), Expect = 4e-39
 Identities = 72/275 (26%), Positives = 114/275 (41%), Gaps = 34/275 (12%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           ++G G FG V+ GR  +D   +AVK  +  +    + +F  E  +L +  H N++ L G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180

Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
           C       IV + +     L+ L  +     +L  K  +++   +A G+ YL  +     
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CC 234

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV--SHMTTR---VKGTLGYLAPEYAMWG 220
           IHRD+ A N L+       ++DFG ++   +GV  +    R   VK T    APE   +G
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWT----APEALNYG 290

Query: 221 KVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
           + S   DV+SFGILL E  + G  P   L            +         E V+   R 
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASPYPNLSN---------QQTR-------EFVEKGGRL 334

Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
              E        +   C   EP +RP+   +   L
Sbjct: 335 PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQEL 369

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  137 bits (348), Expect = 7e-38
 Identities = 63/240 (26%), Positives = 103/240 (42%), Gaps = 30/240 (12%)

Query: 23  PNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLKAMN 77
           PN A  RI    E             LG G FG+VY   W    + ++I  A+K+L+   
Sbjct: 4   PNQALLRILKETEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 56

Query: 78  S-KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV 136
           S KA  E   E  V+  V + ++  L G C  T    ++   MP   LL ++      + 
Sbjct: 57  SPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREH---KD 112

Query: 137 QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE 196
            +  +  +   +  A+G+ YL       ++HRD+ A NVL+ +     + DFG AKL+  
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

Query: 197 GVSHMTTR-----VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
                        +K      A E  +    +   DV+S+G+ + E++T G KP + +P 
Sbjct: 170 EEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  137 bits (346), Expect = 1e-37
 Identities = 59/285 (20%), Positives = 109/285 (38%), Gaps = 41/285 (14%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
           KLGEGGF  V       DG   A+K++     +   E   E ++     H N+L L  YC
Sbjct: 36  KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95

Query: 107 ----AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
                   +  ++  +    +L + +         L   + + + +G   G+  +H    
Sbjct: 96  LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK--------GTLGYLAP 214
               HRD+K +N+LL  + +P++ D G        V      +          T+ Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212

Query: 215 EYAMW-----GKVSESCDVYSFGILLLEILTGRKPIE--KLPGGVKRTITEWAEPLIVKG 267
           E  ++       + E  DV+S G +L  ++ G  P +     G            L V+ 
Sbjct: 213 E--LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA--------LAVQN 262

Query: 268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
           +      P+       + L Q +N     +  +P +RP++  +++
Sbjct: 263 QLSIPQSPRH-----SSALWQLLNS---MMTVDPHQRPHIPLLLS 299

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  134 bits (340), Expect = 5e-37
 Identities = 67/286 (23%), Positives = 130/286 (45%), Gaps = 17/286 (5%)

Query: 47  NKLGEGGFGSVYWGR-----TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
            +LG+G FGSV   R      + G  +AVKKL+    +   +F  E+E+L  ++H N++ 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 102 LRGYCAGTDQR--LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            +G C    +R   ++ +Y+P  SL  +L      + ++D  + ++      +G+ YL  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT 132

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL--GYLAPEYA 217
           +     IHRD+   N+L++++    + DFG  K++P+       +  G     + APE  
Sbjct: 133 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESL 189

Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL 277
              K S + DV+SFG++L E+ T  +  +  P    R I    +  ++     EL+    
Sbjct: 190 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 249

Query: 278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY--DPRG 321
           R    +    +   +   C  +   +RP+ +++   +     +  G
Sbjct: 250 RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG 295

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  138 bits (349), Expect = 6e-37
 Identities = 78/272 (28%), Positives = 127/272 (46%), Gaps = 30/272 (11%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            KLG+G FG V+ G  +   ++A+K LK      E  F  E +V+ ++RH+ L+ L    
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 107 AGTDQRLIVYDYMPNLSLLSHLH---GQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           +  +   IV +YM   SLL  L    G+Y    QL     + +A   A G+ Y+      
Sbjct: 249 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL-----VDMAAQIASGMAYVERM--- 299

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + +HRD++A+N+L+  +    VADFG A+LI +         K  + + APE A++G+ +
Sbjct: 300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 359

Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV+SFGILL E+ T GR P   +                   +  + V+   R    
Sbjct: 360 IKSDVWSFGILLTELTTKGRVPYPGMVN----------------REVLDQVERGYRMPCP 403

Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
               +   ++   C + EPE+RP  + +   L
Sbjct: 404 PECPESLHDLMCQCWRKEPEERPTFEYLQAFL 435

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  135 bits (341), Expect = 7e-37
 Identities = 66/277 (23%), Positives = 129/277 (46%), Gaps = 15/277 (5%)

Query: 47  NKLGEGGFGSVYWGR-----TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
            +LG+G FGSV   R      + G  +AVKKL+    +   +F  E+E+L  ++H N++ 
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 102 LRGYCAGTDQR--LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            +G C    +R   ++ +Y+P  SL  +L      + ++D  + ++      +G+ YL  
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGT 163

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL--GYLAPEYA 217
           +     IHRD+   N+L++++    + DFG  K++P+   +   +  G     + APE  
Sbjct: 164 K---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESL 220

Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL 277
              K S + DV+SFG++L E+ T  +  +  P    R I    +  ++     EL+    
Sbjct: 221 TESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 280

Query: 278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           R    +    +   +   C  +   +RP+ +++   +
Sbjct: 281 RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRV 317

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  134 bits (340), Expect = 7e-37
 Identities = 58/267 (21%), Positives = 113/267 (42%), Gaps = 21/267 (7%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLK---AMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           K+G G F  VY      DG+ +A+KK++    M++KA  +   E+++L ++ H N++   
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                 ++  IV +      L   +      +  +  +   K  +     + ++H     
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR--- 155

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
            ++HRDIK +NV + +     + D G  +      +   + + GT  Y++PE       +
Sbjct: 156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS-LVGTPYYMSPERIHENGYN 214

Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDE 283
              D++S G LL E+   + P       +           I +  +     P L  D   
Sbjct: 215 FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK-----KIEQCDY-----PPLPSDHYS 264

Query: 284 NQLKQAINVAVLCVQSEPEKRPNMKEV 310
            +L+Q +N   +C+  +PEKRP++  V
Sbjct: 265 EELRQLVN---MCINPDPEKRPDVTYV 288

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  135 bits (341), Expect = 7e-37
 Identities = 75/289 (25%), Positives = 118/289 (40%), Gaps = 35/289 (12%)

Query: 47  NKLGEGGFGSVYWGR-----TSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLL 100
             LGEG FG V            G  +AVK LKA         +  E+++L  + H++++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 101 GLRGYCAGTDQR--LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
             +G C         +V +Y+P  SL  +L         +   + +  A    EG+ YLH
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLH 151

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL--GYLAPEY 216
                H IHRD+ A NVLLD+D    + DFG AK +PEG  +   R  G     + APE 
Sbjct: 152 ---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPEC 208

Query: 217 AMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP 275
               K   + DV+SFG+ L E+LT            ++       +          L + 
Sbjct: 209 LKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQM-----TVLRLTEL 263

Query: 276 KLRGDFDENQLKQ------AI-NVAVLCVQSEPEKRPNMKEVVNTLTGY 317
             RG     +L +       + ++   C ++E   RP  + ++  L   
Sbjct: 264 LERG----ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV 308

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  138 bits (350), Expect = 9e-37
 Identities = 78/272 (28%), Positives = 128/272 (47%), Gaps = 30/272 (11%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            KLG+G FG V+ G  +   ++A+K LK      E  F  E +V+ ++RH+ L+ L    
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 107 AGTDQRLIVYDYMPNLSLLSHLH---GQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           +  +   IV +YM   SLL  L    G+Y    QL     + +A   A G+ Y+      
Sbjct: 332 SE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQL-----VDMAAQIASGMAYVERM--- 382

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           + +HRD++A+N+L+  +    VADFG A+LI +         K  + + APE A++G+ +
Sbjct: 383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT 442

Query: 224 ESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
              DV+SFGILL E+ T GR P   +    +  +              + V+   R    
Sbjct: 443 IKSDVWSFGILLTELTTKGRVPYPGMVN--REVL--------------DQVERGYRMPCP 486

Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
               +   ++   C + EPE+RP  + +   L
Sbjct: 487 PECPESLHDLMCQCWRKEPEERPTFEYLQAFL 518

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  137 bits (347), Expect = 2e-36
 Identities = 72/273 (26%), Positives = 117/273 (42%), Gaps = 24/273 (8%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           +KLG G +G VY G      L +AVK LK    + E EF  E  V+  ++H NL+ L G 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGV 284

Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
           C       I+ ++M   +LL +L  +     ++     + +A   +  + YL  +   + 
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 339

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSES 225
           IHR++ A N L+  +    VADFG ++L+           K  + + APE   + K S  
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399

Query: 226 CDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN 284
            DV++FG+LL EI T G  P   +                   +  EL++   R +  E 
Sbjct: 400 SDVWAFGVLLWEIATYGMSPYPGIDL----------------SQVYELLEKDYRMERPEG 443

Query: 285 QLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
             ++   +   C Q  P  RP+  E+       
Sbjct: 444 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 476

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  133 bits (336), Expect = 2e-36
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 17/209 (8%)

Query: 47  NKLGEGGFGSVYWGR-----TSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLL 100
             LGEG FG V   R      + G Q+AVK LK  +    + +   E+E+L  + H+N++
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 101 GLRGYCAGTDQR--LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
             +G C         ++ +++P+ SL  +L      + +++ K+++K A+   +G+ YL 
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLP---KNKNKINLKQQLKYAVQICKGMDYLG 143

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL--GYLAPEY 216
                  +HRD+ A NVL++S+ +  + DFG  K I     + T +        + APE 
Sbjct: 144 SR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPEC 200

Query: 217 AMWGKVSESCDVYSFGILLLEILT-GRKP 244
            M  K   + DV+SFG+ L E+LT     
Sbjct: 201 LMQSKFYIASDVWSFGVTLHELLTYCDSD 229

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  131 bits (332), Expect = 5e-36
 Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 16/203 (7%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            ++G G FG V+ G   +  ++A+K ++   + +E +F  E EV+ ++ H  L+ L G C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
                  +V ++M +  L  +L            +  + + +   EG+ YL       +I
Sbjct: 73  LEQAPICLVTEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA---CVI 126

Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGV--SHMTTR--VKGTLGYLAPEYAMWGKV 222
           HRD+ A N L+  +    V+DFG  + + +    S   T+  VK      +PE   + + 
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA----SPEVFSFSRY 182

Query: 223 SESCDVYSFGILLLEILT-GRKP 244
           S   DV+SFG+L+ E+ + G+ P
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKIP 205

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  131 bits (332), Expect = 7e-36
 Identities = 56/203 (27%), Positives = 102/203 (50%), Gaps = 16/203 (7%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            +LG G FG V +G+      +A+K +K   S +E EF  E +V+  + H+ L+ L G C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
                  I+ +YM N  LL++L        +   ++ +++     E + YL  +     +
Sbjct: 89  TKQRPIFIITEYMANGCLLNYLR---EMRHRFQTQQLLEMCKDVCEAMEYLESK---QFL 142

Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGV--SHMTTR--VKGTLGYLAPEYAMWGKV 222
           HRD+ A N L++      V+DFG ++ + +    S + ++  V+ +     PE  M+ K 
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS----PPEVLMYSKF 198

Query: 223 SESCDVYSFGILLLEILT-GRKP 244
           S   D+++FG+L+ EI + G+ P
Sbjct: 199 SSKSDIWAFGVLMWEIYSLGKMP 221

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  130 bits (330), Expect = 1e-35
 Identities = 56/212 (26%), Positives = 100/212 (47%), Gaps = 14/212 (6%)

Query: 46  DNKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLLG 101
           D +LG G FGSV    +      + +A+K LK         E   E +++ ++ +  ++ 
Sbjct: 15  DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 74

Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
           L G C   +  ++V +      L   L G+     ++      ++    + G+ YL  + 
Sbjct: 75  LIGVCQA-EALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK- 129

Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL--GYLAPEYAMW 219
             + +HRD+ A NVLL +     ++DFG +K +    S+ T R  G     + APE   +
Sbjct: 130 --NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187

Query: 220 GKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
            K S   DV+S+G+ + E L+ G+KP +K+ G
Sbjct: 188 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  130 bits (330), Expect = 1e-35
 Identities = 62/276 (22%), Positives = 116/276 (42%), Gaps = 39/276 (14%)

Query: 46  DNKLGEGGFGSVYWGR-TSDGLQIAVK--KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
           D ++G G F +VY G  T   +++A    + + +       F  E E+L  ++H N++  
Sbjct: 31  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 90

Query: 103 RGYCAGT---DQRLIVY-DYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILY 156
                 T    + +++  + M + +L ++L           +  K          +G+ +
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV------MKIKVLRSWCRQILKGLQF 144

Query: 157 LHHEVTPHIIHRDIKASNVLLDS-DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPE 215
           LH    P IIHRD+K  N+ +        + D G A L           V GT  ++APE
Sbjct: 145 LHTRTPP-IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPE 200

Query: 216 YAMWGKVSESCDVYSFGILLLEILTGRKPIEKL--PGGVKRTITEWAEPLIVKGKFKELV 273
                K  ES DVY+FG+ +LE+ T   P  +      + R +T   +P      F ++ 
Sbjct: 201 MYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS----FDKVA 255

Query: 274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKE 309
            P+++ +  E            C++   ++R ++K+
Sbjct: 256 IPEVK-EIIE-----------GCIRQNKDERYSIKD 279

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  130 bits (328), Expect = 1e-35
 Identities = 65/204 (31%), Positives = 102/204 (50%), Gaps = 20/204 (9%)

Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           +LG G FG V  G+      +AVK +K   S +E EF  E + + ++ H  L+   G C+
Sbjct: 15  ELGSGQFGVVKLGKWKGQYDVAVKMIKE-GSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 108 GTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
                 IV +Y+ N  LL++L  HG+     QL     +++     EG+ +L        
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL-----LEMCYDVCEGMAFLESH---QF 125

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV--SHMTTR--VKGTLGYLAPEYAMWGK 221
           IHRD+ A N L+D D    V+DFG  + + +    S + T+  VK +    APE   + K
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWS----APEVFHYFK 181

Query: 222 VSESCDVYSFGILLLEILT-GRKP 244
            S   DV++FGIL+ E+ + G+ P
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMP 205

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  132 bits (334), Expect = 2e-35
 Identities = 60/207 (28%), Positives = 102/207 (49%), Gaps = 14/207 (6%)

Query: 46  DNKLGEGGFGSVYWGR----TSDGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLL 100
           D  +G G FG V  GR    +   + +A+K LK     K   +F  E  ++G+  H N++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L G    +   +IV +YM N SL S L      + Q    + + +  G A G+ YL   
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM 166

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYL--APEYAM 218
                +HRD+ A N+L++S+    V+DFG  +++ +      T   G +     +PE   
Sbjct: 167 ---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223

Query: 219 WGKVSESCDVYSFGILLLEILT-GRKP 244
           + K + + DV+S+GI+L E+++ G +P
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERP 250

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  131 bits (331), Expect = 2e-35
 Identities = 62/234 (26%), Positives = 100/234 (42%), Gaps = 30/234 (12%)

Query: 23  PNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVY---WGRTSDGLQI--AVKKLKAMN 77
           PN A  RI    E             LG G FG+VY   W    + ++I  A+K+L+   
Sbjct: 4   PNQALLRILKETEFKK-------IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT 56

Query: 78  S-KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV 136
           S KA  E   E  V+  V + ++  L G C  T    ++   MP   LL ++      + 
Sbjct: 57  SPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREH---KD 112

Query: 137 QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE 196
            +  +  +   +  A+G+ YL       ++HRD+ A NVL+ +     + DFG AKL+  
Sbjct: 113 NIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169

Query: 197 GVSHMTTR-----VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
                        +K      A E  +    +   DV+S+G+ + E++T G KP
Sbjct: 170 EEKEYHAEGGKVPIKWM----ALESILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  130 bits (330), Expect = 3e-35
 Identities = 58/206 (28%), Positives = 105/206 (50%), Gaps = 15/206 (7%)

Query: 48  KLGEGGFGSVYWGR-----TSDGLQIAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLLG 101
            +G G FG VY G          + +A+K LKA  + K  ++F  E  ++G+  H N++ 
Sbjct: 51  VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110

Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
           L G  +     +I+ +YM N +L   L      + +    + + +  G A G+ YL +  
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM- 166

Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGY--LAPEYAMW 219
             + +HRD+ A N+L++S+    V+DFG ++++ +      T   G +     APE   +
Sbjct: 167 --NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224

Query: 220 GKVSESCDVYSFGILLLEILT-GRKP 244
            K + + DV+SFGI++ E++T G +P
Sbjct: 225 RKFTSASDVWSFGIVMWEVMTYGERP 250

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  129 bits (327), Expect = 4e-35
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 18/214 (8%)

Query: 46  DNKLGEGGFGSVY---WGRTSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLL 100
           D +LG G FG+V    +        +AVK LK  A +   + E   E  V+ ++ +  ++
Sbjct: 22  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 81

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHL-HGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            + G C   +  ++V +      L  +L   ++  +  +     +++    + G+ YL  
Sbjct: 82  RMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMGMKYLEE 135

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL--GYLAPEYA 217
               + +HRD+ A NVLL +     ++DFG +K +    ++   +  G     + APE  
Sbjct: 136 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 192

Query: 218 MWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
            + K S   DV+SFG+L+ E  + G+KP   + G
Sbjct: 193 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  128 bits (324), Expect = 8e-35
 Identities = 65/202 (32%), Positives = 105/202 (51%), Gaps = 14/202 (6%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            +LG G FG V+ G  +   ++AVK LK   S +   F  E  ++ +++H+ L+ L    
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQ-GSMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 107 AGTDQ-RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
             T +   I+ +YM N SL+  L  +    ++L   + + +A   AEG+ ++      + 
Sbjct: 78  --TQEPIYIITEYMENGSLVDFL--KTPSGIKLTINKLLDMAAQIAEGMAFIEER---NY 130

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGY--LAPEYAMWGKVS 223
           IHRD++A+N+L+       +ADFG A+LI +  +  T R          APE   +G  +
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAINYGTFT 188

Query: 224 ESCDVYSFGILLLEILT-GRKP 244
              DV+SFGILL EI+T GR P
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIP 210

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  129 bits (326), Expect = 9e-35
 Identities = 66/217 (30%), Positives = 92/217 (42%), Gaps = 26/217 (11%)

Query: 47  NKLGEGGFGSVYWGR------TSDGLQIAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNL 99
             LG G FG VY G+          LQ+AVK L  + S + E++F +E  ++ +  H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLH---GQYAGEVQLDWKRRMKIAIGSAEGILY 156
           +   G    +  R I+ + M    L S L     + +    L     + +A   A G  Y
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLV---ADFGFAKLIPEGVSHMTTRVKGTLGYL- 212
           L      H IHRDI A N LL       V    DFG A+ I       +   KG    L 
Sbjct: 156 LEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----SYYRKGGCAMLP 208

Query: 213 ----APEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
                PE  M G  +   D +SFG+LL EI + G  P
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  128 bits (325), Expect = 2e-34
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 30/221 (13%)

Query: 47  NKLGEGGFGSVYWGR------TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLL 100
            +LGEG FG V+           D + +AVK LK  +  A  +F  E E+L  ++H++++
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHL-----------HGQYAGEVQLDWKRRMKIAIG 149
              G C      L+V++YM +  L   L            G+      L   + + +A  
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
            A G++YL      H +HRD+   N L+       + DFG ++ I         R  G  
Sbjct: 167 VAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTD---YYR-VGGR 219

Query: 210 GYL-----APEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
             L      PE  ++ K +   DV+SFG++L EI T G++P
Sbjct: 220 TMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  131 bits (331), Expect = 2e-34
 Identities = 60/201 (29%), Positives = 97/201 (48%), Gaps = 12/201 (5%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            KLG G FG V+    +   ++AVK +K   S +   F  E  V+  ++H  L+ L    
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKP-GSMSVEAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
              +   I+ ++M   SLL  L        +    + +  +   AEG+ ++      + I
Sbjct: 253 TK-EPIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYI 306

Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGY--LAPEYAMWGKVSE 224
           HRD++A+N+L+ +     +ADFG A++I +     T R          APE   +G  + 
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIEDNE--YTAREGAKFPIKWTAPEAINFGSFTI 364

Query: 225 SCDVYSFGILLLEILT-GRKP 244
             DV+SFGILL+EI+T GR P
Sbjct: 365 KSDVWSFGILLMEIVTYGRIP 385

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  128 bits (324), Expect = 2e-34
 Identities = 59/207 (28%), Positives = 99/207 (47%), Gaps = 14/207 (6%)

Query: 46  DNKLGEGGFGSVYWGR----TSDGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLL 100
           +  +G G  G V +GR        + +A+K LKA    +   +F  E  ++G+  H N++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L G        +IV +YM N SL + L      + Q    + + +  G   G+ YL   
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL 170

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYL--APEYAM 218
                +HRD+ A NVL+DS+    V+DFG ++++ +      T   G +     APE   
Sbjct: 171 ---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227

Query: 219 WGKVSESCDVYSFGILLLEILT-GRKP 244
           +   S + DV+SFG+++ E+L  G +P
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERP 254

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  126 bits (320), Expect = 2e-34
 Identities = 63/272 (23%), Positives = 112/272 (41%), Gaps = 24/272 (8%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKK--LKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
            +G G +G     R  SDG  +  K+    +M    +     EV +L  ++H N++    
Sbjct: 13  TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72

Query: 105 -YCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH--HE 160
                T+  L IV +Y     L S +         LD +  +++       +   H   +
Sbjct: 73  RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
               ++HRD+K +NV LD      + DFG A+++    S   T V GT  Y++PE     
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFV-GTPYYMSPEQMNRM 191

Query: 221 KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGD 280
             +E  D++S G LL E+     P          +  E A   I +GKF      ++   
Sbjct: 192 SYNEKSDIWSLGCLLYELCALMPPFT------AFSQKELAG-KIREGKF-----RRIPYR 239

Query: 281 FDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
           + + +L + I      +  +   RP+++E++ 
Sbjct: 240 YSD-ELNEIIT---RMLNLKDYHRPSVEEILE 267

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  127 bits (321), Expect = 4e-34
 Identities = 61/222 (27%), Positives = 102/222 (45%), Gaps = 31/222 (13%)

Query: 47  NKLGEGGFGSVYWGR------TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLL 100
            +LGEG FG V+         T D + +AVK LK     A  +F  E E+L  ++H++++
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHL------------HGQYAGEVQLDWKRRMKIAI 148
              G C   D  ++V++YM +  L   L                  + +L   + + IA 
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 149 GSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT 208
             A G++YL    + H +HRD+   N L+ ++    + DFG ++ +     +      G 
Sbjct: 141 QIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY----RVGG 193

Query: 209 LGYL-----APEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
              L      PE  M+ K +   DV+SFG++L EI T G++P
Sbjct: 194 HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  126 bits (319), Expect = 5e-34
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 17/215 (7%)

Query: 46  DNKLGEGGFGSVYWGR----TSDGLQIAVKKLK--AMNS-KAEMEFAVEVEVLGRVRHKN 98
             KLG+G FG V  G     +   + +AVK LK   ++  +A  +F  EV  +  + H+N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           L+ L G         +V +  P  SLL  L      +         + A+  AEG+ YL 
Sbjct: 83  LIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLE 138

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGY--LAPEY 216
            +     IHRD+ A N+LL +     + DFG  + +P+   H   +    + +   APE 
Sbjct: 139 SK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 195

Query: 217 AMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
                 S + D + FG+ L E+ T G++P   L G
Sbjct: 196 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 230

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  131 bits (331), Expect = 6e-34
 Identities = 55/212 (25%), Positives = 99/212 (46%), Gaps = 14/212 (6%)

Query: 46  DNKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLLG 101
           D +LG G FGSV    +      + +A+K LK         E   E +++ ++ +  ++ 
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVR 400

Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
           L G C   +  ++V +      L   L G+     ++      ++    + G+ YL  + 
Sbjct: 401 LIGVCQA-EALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK- 455

Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGY--LAPEYAMW 219
             + +HR++ A NVLL +     ++DFG +K +    S+ T R  G       APE   +
Sbjct: 456 --NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 513

Query: 220 GKVSESCDVYSFGILLLEILT-GRKPIEKLPG 250
            K S   DV+S+G+ + E L+ G+KP +K+ G
Sbjct: 514 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  126 bits (318), Expect = 7e-34
 Identities = 64/204 (31%), Positives = 100/204 (49%), Gaps = 16/204 (7%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           +KLG G +G VY G      L +AVK LK  ++    EF  E  V+  ++H NL+ L G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
           C       I+ ++M   +LL +L  +     ++     + +A   +  + YL  +   + 
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYL--RECNRQEVSAVVLLYMATQISSAMEYLEKK---NF 132

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV--SHMTTR--VKGTLGYLAPEYAMWGK 221
           IHRD+ A N L+  +    VADFG ++L+      +H   +  +K T    APE   + K
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT----APESLAYNK 188

Query: 222 VSESCDVYSFGILLLEILT-GRKP 244
            S   DV++FG+LL EI T G  P
Sbjct: 189 FSIKSDVWAFGVLLWEIATYGMSP 212

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  127 bits (322), Expect = 7e-34
 Identities = 66/217 (30%), Positives = 91/217 (41%), Gaps = 26/217 (11%)

Query: 47  NKLGEGGFGSVYWGR------TSDGLQIAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNL 99
             LG G FG VY G+          LQ+AVK L  + S + E++F +E  ++ +  H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLH---GQYAGEVQLDWKRRMKIAIGSAEGILY 156
           +   G    +  R I+ + M    L S L     + +    L     + +A   A G  Y
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLV---ADFGFAKLIPEGVSHMTTRVKGTLGYL- 212
           L      H IHRDI A N LL       V    DFG A+ I           KG    L 
Sbjct: 197 LE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA----GYYRKGGCAMLP 249

Query: 213 ----APEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
                PE  M G  +   D +SFG+LL EI + G  P
Sbjct: 250 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  127 bits (321), Expect = 9e-34
 Identities = 66/271 (24%), Positives = 111/271 (40%), Gaps = 35/271 (12%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKK--LKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           K+GEG FG     + T DG Q  +K+  +  M+SK   E   EV VL  ++H N++  R 
Sbjct: 31  KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL---HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
                    IV DY     L   +    G    E Q+     +   +     + ++H   
Sbjct: 91  SFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQI-----LDWFVQICLALKHVHDR- 144

Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK 221
              I+HRDIK+ N+ L  D    + DFG A+++   V      + GT  YL+PE      
Sbjct: 145 --KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACI-GTPYYLSPEICENKP 201

Query: 222 VSESCDVYSFGILLLEILTGRKPIEK--LPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
            +   D+++ G +L E+ T +   E   +   V +         I+ G F     P +  
Sbjct: 202 YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLK---------IISGSF-----PPVSL 247

Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEV 310
            +    L+  ++      +  P  RP++  +
Sbjct: 248 HYSY-DLRSLVS---QLFKRNPRDRPSVNSI 274

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  126 bits (319), Expect = 1e-33
 Identities = 56/211 (26%), Positives = 98/211 (46%), Gaps = 23/211 (10%)

Query: 46  DNKLGEGGFGSVY---WGRTSDGLQI--AVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNL 99
              LG G FG+V+   W    + ++I   +K ++  +  ++       +  +G + H ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           + L G C G     +V  Y+P  SLL H+         L  +  +   +  A+G+ YL  
Sbjct: 78  VRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEE 133

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR-----VKGTLGYLAP 214
                ++HR++ A NVLL S  +  VADFG A L+P     +        +K      A 
Sbjct: 134 H---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM----AL 186

Query: 215 EYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
           E   +GK +   DV+S+G+ + E++T G +P
Sbjct: 187 ESIHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  126 bits (318), Expect = 1e-33
 Identities = 57/217 (26%), Positives = 93/217 (42%), Gaps = 26/217 (11%)

Query: 47  NKLGEGGFGSVYWGR------TSDGLQIAVKKLKAMNSKAE-MEFAVEVEVLGRVRHKNL 99
            +LG+G FG VY G            ++A+K +    S  E +EF  E  V+      ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHL------HGQYAGEVQLDWKRRMKIAIGSAEG 153
           + L G  +     L++ + M    L S+L                   + +++A   A+G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYL- 212
           + YL+       +HRD+ A N ++  DF   + DFG  + I E   +     KG  G L 
Sbjct: 151 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGGKGLLP 203

Query: 213 ----APEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
               +PE    G  +   DV+SFG++L EI T   +P
Sbjct: 204 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  126 bits (319), Expect = 2e-33
 Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 20/211 (9%)

Query: 46  DNKLGEGGFGSVYWGRTSDG----LQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLL 100
           +  +G G FG VY G   D     +  AVK L  +    E+ +F  E  ++    H N+L
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 101 GLRGYCAGTD-QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            L G C  ++   L+V  YM +  L + +            K  +   +  A+G+ +L  
Sbjct: 154 SLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKFLAS 210

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYL-----AP 214
           +     +HRD+ A N +LD  F   VADFG A+ + +           T   L     A 
Sbjct: 211 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLPVKWMAL 265

Query: 215 EYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
           E     K +   DV+SFG+LL E++T G  P
Sbjct: 266 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  125 bits (315), Expect = 2e-33
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 22/212 (10%)

Query: 46  DNKLGEGGFGSVYWGRTSDG----LQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLL 100
           +  +G G FG VY G   D     +  AVK L  +    E+ +F  E  ++    H N+L
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 101 GLRGYCAGTD-QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            L G C  ++   L+V  YM +  L + +            K  +   +  A+G+ YL  
Sbjct: 90  SLLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHNPTVKDLIGFGLQVAKGMKYLAS 146

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYL------A 213
           +     +HRD+ A N +LD  F   VADFG A+ + +   +    V    G        A
Sbjct: 147 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY---SVHNKTGAKLPVKWMA 200

Query: 214 PEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
            E     K +   DV+SFG+LL E++T G  P
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  125 bits (315), Expect = 2e-33
 Identities = 59/211 (27%), Positives = 93/211 (44%), Gaps = 20/211 (9%)

Query: 46  DNKLGEGGFGSVYWGRTSDG----LQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKNLL 100
           D  +G+G FG VY G   D     +Q A+K L  +    ++  F  E  ++  + H N+L
Sbjct: 26  DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVL 85

Query: 101 GLRGYCAGTD-QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            L G     +    ++  YM +  LL  +    + +     K  +   +  A G+ YL  
Sbjct: 86  ALIGIMLPPEGLPHVLLPYMCHGDLLQFIR---SPQRNPTVKDLISFGLQVARGMEYLAE 142

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYL-----AP 214
           +     +HRD+ A N +LD  F   VADFG A+ I +      +  +     L     A 
Sbjct: 143 Q---KFVHRDLAARNCMLDESFTVKVADFGLARDILD--REYYSVQQHRHARLPVKWTAL 197

Query: 215 EYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
           E     + +   DV+SFG+LL E+LT G  P
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  123 bits (312), Expect = 4e-33
 Identities = 51/203 (25%), Positives = 93/203 (45%), Gaps = 13/203 (6%)

Query: 48  KLGEGGFGSVYWGR----TSDGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGL 102
            +GEG FG V+ G      +  L +A+K  K   +     +F  E   + +  H +++ L
Sbjct: 22  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81

Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
            G     +   I+ +      L S L  +   +  LD    +  A   +  + YL  +  
Sbjct: 82  IGVITE-NPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK-- 135

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
              +HRDI A NVL+ S+    + DFG ++ + +   +  ++ K  + ++APE   + + 
Sbjct: 136 -RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194

Query: 223 SESCDVYSFGILLLEILT-GRKP 244
           + + DV+ FG+ + EIL  G KP
Sbjct: 195 TSASDVWMFGVCMWEILMHGVKP 217

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  123 bits (310), Expect = 1e-32
 Identities = 43/215 (20%), Positives = 89/215 (41%), Gaps = 29/215 (13%)

Query: 48  KLGEGGFGSVYWGR--------TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL 99
            LG+G F  ++ G              ++ +K L   +      F     ++ ++ HK+L
Sbjct: 15  SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74

Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           +   G C   D+ ++V +++   SL ++L      +  ++   ++++A   A  + +L  
Sbjct: 75  VLNYGVCVCGDENILVQEFVKFGSLDTYLKK---NKNCINILWKLEVAKQLAAAMHFLEE 131

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPL--------VADFGFAKLIPEGVSHMTTRVKGTLGY 211
                +IH ++ A N+LL  + +          ++D G +  +      +  R+      
Sbjct: 132 N---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-LPKDILQERIPWV--- 184

Query: 212 LAPEYAMWGKV-SESCDVYSFGILLLEILT-GRKP 244
             PE     K  + + D +SFG  L EI + G KP
Sbjct: 185 -PPECIENPKNLNLATDKWSFGTTLWEICSGGDKP 218

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  122 bits (308), Expect = 1e-32
 Identities = 70/224 (31%), Positives = 101/224 (45%), Gaps = 34/224 (15%)

Query: 39  ATNGFSDD------------NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAV 86
           A + F                 +G+G FG V  G    G ++AVK +K   +     F  
Sbjct: 7   AQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT--AQAFLA 63

Query: 87  EVEVLGRVRHKNLLGLRGYCAGTDQR---LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRR 143
           E  V+ ++RH NL+ L G     +++    IV +YM   SL+ +L  +  G   L     
Sbjct: 64  EASVMTQLRHSNLVQLLGVI--VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCL 119

Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT 203
           +K ++   E + YL      + +HRD+ A NVL+  D    V+DFG  K      +  T 
Sbjct: 120 LKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--TQDTG 174

Query: 204 R--VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
           +  VK T    APE     K S   DV+SFGILL EI + GR P
Sbjct: 175 KLPVKWT----APEALREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  123 bits (310), Expect = 2e-32
 Identities = 59/217 (27%), Positives = 94/217 (43%), Gaps = 26/217 (11%)

Query: 47  NKLGEGGFGSVYWGRTSDG----LQIAVKKLKA--MNSKAEMEFAVEVEVLGRVRHKNLL 100
             LGEG FGSV  G         L++AVK +K    + +   EF  E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 101 GLRGYC-----AGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEG 153
            L G C      G  + +++  +M    L ++L       G   +  +  +K  +  A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYL- 212
           + YL +    + +HRD+ A N +L  D    VADFG +K I  G  +     +G +  + 
Sbjct: 160 MEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY----RQGRIAKMP 212

Query: 213 ----APEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
               A E       +   DV++FG+ + EI T G  P
Sbjct: 213 VKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  122 bits (308), Expect = 2e-32
 Identities = 60/290 (20%), Positives = 111/290 (38%), Gaps = 59/290 (20%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
             +G GGFG V+  +   DG    +K++K        +   EV+ L ++ H N++   G 
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIKRVK----YNNEKAEREVKALAKLDHVNIVHYNGC 72

Query: 106 CAGTDQRL----------------IVYDYMPNLSLLSHLH---GQYAGEVQLDWKRRMKI 146
             G D                   I  ++    +L   +    G+   +V       +++
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA-----LEL 127

Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
                +G+ Y+H +    +I+RD+K SN+ L    +  + DFG    +        +  K
Sbjct: 128 FEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRS--K 182

Query: 207 GTLGYLAPEYAMWGKV--SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI 264
           GTL Y++PE          +  D+Y+ G++L E+L              +  T      +
Sbjct: 183 GTLRYMSPE--QISSQDYGKEVDLYALGLILAELLHVCDT----AFETSKFFT-----DL 231

Query: 265 VKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
             G   ++ D K +             +    +  +PE RPN  E++ TL
Sbjct: 232 RDGIISDIFDKKEK------------TLLQKLLSKKPEDRPNTSEILRTL 269

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  121 bits (306), Expect = 3e-32
 Identities = 46/203 (22%), Positives = 92/203 (45%), Gaps = 13/203 (6%)

Query: 48  KLGEGGFGSVYWGR----TSDGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGL 102
            LGEG FG VY G       + + +AVK  K       + +F  E  ++  + H +++ L
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78

Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
            G     +   I+ +  P   L  +L      +  L     +  ++   + + YL     
Sbjct: 79  IGIIEE-EPTWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI-- 132

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
            + +HRDI   N+L+ S     + DFG ++ I +   +  +  +  + +++PE   + + 
Sbjct: 133 -NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 191

Query: 223 SESCDVYSFGILLLEILT-GRKP 244
           + + DV+ F + + EIL+ G++P
Sbjct: 192 TTASDVWMFAVCMWEILSFGKQP 214

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  122 bits (307), Expect = 4e-32
 Identities = 55/218 (25%), Positives = 89/218 (40%), Gaps = 27/218 (12%)

Query: 47  NKLGEGGFGSVYWGRTSDG----LQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLL 100
             LG+G FGSV   +        +++AVK LK   + S    EF  E   +    H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 101 GLRGYC------AGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAE 152
            L G              +++  +M +  L + L           L  +  ++  +  A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYL 212
           G+ YL      + IHRD+ A N +L  D    VADFG ++ I  G  +     +G    L
Sbjct: 149 GMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY----RQGCASKL 201

Query: 213 -----APEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
                A E       +   DV++FG+ + EI+T G+ P
Sbjct: 202 PVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  124 bits (314), Expect = 5e-32
 Identities = 68/200 (34%), Positives = 93/200 (46%), Gaps = 14/200 (7%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
             +G+G FG V  G    G ++AVK +K   +     F  E  V+ ++RH NL+ L G  
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 107 AGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
                 L IV +YM   SL+ +L  +  G   L     +K ++   E + YL      + 
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NF 310

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSES 225
           +HRD+ A NVL+  D    V+DFG  K            VK T    APE     K S  
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT----APEALREKKFSTK 366

Query: 226 CDVYSFGILLLEILT-GRKP 244
            DV+SFGILL EI + GR P
Sbjct: 367 SDVWSFGILLWEIYSFGRVP 386

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  125 bits (316), Expect = 8e-32
 Identities = 50/205 (24%), Positives = 92/205 (44%), Gaps = 13/205 (6%)

Query: 46  DNKLGEGGFGSVYWGR----TSDGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLL 100
              +GEG FG V+ G      +  + +A+K  K   +     +F  E   + +  H +++
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L G     +   I+ +      L S L      +  LD    +  A   +  + YL  +
Sbjct: 455 KLIGVITE-NPVWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYLESK 510

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
                +HRDI A NVL+ S+    + DFG ++ + +   +  ++ K  + ++APE   + 
Sbjct: 511 ---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 567

Query: 221 KVSESCDVYSFGILLLEILT-GRKP 244
           + + + DV+ FG+ + EIL  G KP
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKP 592

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  120 bits (303), Expect = 8e-32
 Identities = 69/205 (33%), Positives = 97/205 (47%), Gaps = 16/205 (7%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKL-KAMNSKAEMEFAV--EVEVLGRVRHKNLLGL 102
             LG+G FG+VY  R       +A+K L KA   KA +E  +  EVE+   +RH N+L L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 103 RGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
            GY      R+ ++ +Y P  ++   L  Q     + D +R        A  + Y H + 
Sbjct: 75  YGYFH-DATRVYLILEYAPLGTVYREL--QKLS--KFDEQRTATYITELANALSYCHSK- 128

Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK 221
              +IHRDIK  N+LL S  E  +ADFG++   P           GTL YL PE      
Sbjct: 129 --RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SSRRTDL--CGTLDYLPPEMIEGRM 183

Query: 222 VSESCDVYSFGILLLEILTGRKPIE 246
             E  D++S G+L  E L G+ P E
Sbjct: 184 HDEKVDLWSLGVLCYEFLVGKPPFE 208

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  119 bits (300), Expect = 2e-31
 Identities = 51/223 (22%), Positives = 86/223 (38%), Gaps = 32/223 (14%)

Query: 47  NKLGEGGFGSVYWGR------TSDGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNL 99
            +LGE  FG VY G             +A+K LK         EF  E  +  R++H N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHL------------HGQYAGEVQLDWKRRMKIA 147
           + L G         +++ Y  +  L   L                  +  L+    + + 
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG 207
              A G+ YL      H++H+D+   NVL+       ++D G  + +             
Sbjct: 135 AQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA----DYYKLL 187

Query: 208 TLGYL-----APEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
               L     APE  M+GK S   D++S+G++L E+ + G +P
Sbjct: 188 GNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  123 bits (310), Expect = 5e-31
 Identities = 71/292 (24%), Positives = 117/292 (40%), Gaps = 38/292 (13%)

Query: 46  DNKLGEGGFGSVYWGR-TSDGLQIAVKKL-KAMNSKAEMEFAVEVEVLGRVRHKNLLGL- 102
             +LG GGFG V        G Q+A+K+  + ++ K    + +E++++ ++ H N++   
Sbjct: 19  KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR 78

Query: 103 -----RGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYAG--EVQLDWKRRMKIAIGSAEG 153
                    A  D  L+  +Y     L  +L       G  E  +   R +   I SA  
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPI---RTLLSDISSA-- 133

Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPL---VADFGFAKLIPEGVSHMTTRVKGTLG 210
           + YLH      IIHRD+K  N++L    + L   + D G+AK + +G    T  V GTL 
Sbjct: 134 LRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQG-ELCTEFV-GTLQ 188

Query: 211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE----------KLPGGVKRTITEWA 260
           YLAPE     K + + D +SFG L  E +TG +P            K+       I  + 
Sbjct: 189 YLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYD 248

Query: 261 EPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
           +          L  P         +L++ +      +     +R    +  N
Sbjct: 249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQCM---LMWHQRQRGTDPQNPN 297

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  117 bits (296), Expect = 1e-30
 Identities = 67/266 (25%), Positives = 122/266 (45%), Gaps = 25/266 (9%)

Query: 49  LGEGGFGSVYWGRTSD-GLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
           LG+G +G VY GR     ++IA+K++   +S+       E+ +   ++HKN++   G  +
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89

Query: 108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH 167
                 I  + +P  SL + L  ++ G ++ + +          EG+ YLH      I+H
Sbjct: 90  ENGFIKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145

Query: 168 RDIKASNVLLDSDFEPLV--ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV--S 223
           RDIK  NVL+++ +  ++  +DFG +K +        T   GTL Y+APE    G     
Sbjct: 146 RDIKGDNVLINT-YSGVLKISDFGTSKRLAGINPCTET-FTGTLQYMAPEIIDKGPRGYG 203

Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDE 283
           ++ D++S G  ++E+ TG+ P  +L           A   +   K    V P++      
Sbjct: 204 KAADIWSLGCTIIEMATGKPPFYELGEPQA------AMFKVGMFK----VHPEIPESMSA 253

Query: 284 NQLKQAINVAVLCVQSEPEKRPNMKE 309
               +A    + C + +P+KR    +
Sbjct: 254 ----EAKAFILKCFEPDPDKRACAND 275

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  118 bits (297), Expect = 2e-30
 Identities = 62/291 (21%), Positives = 108/291 (37%), Gaps = 46/291 (15%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR-HKNLLGLRGY 105
            L EGGF  VY  +    G + A+K+L +   +       EV  + ++  H N++     
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94

Query: 106 CAGTDQR--------LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
            +   +         L++ +      L+  L    +    L     +KI   +   + ++
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKG-QLVEFLKKMESRG-PLSCDTVLKIFYQTCRAVQHM 152

Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK----------- 206
           H +  P IIHRD+K  N+LL +     + DFG A  I     +  +  +           
Sbjct: 153 HRQKPP-IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRN 211

Query: 207 GTLGYLAPE-YAMWGK--VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL 263
            T  Y  PE   ++    + E  D+++ G +L  +   + P E   G   R         
Sbjct: 212 TTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED--GAKLR--------- 260

Query: 264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           IV GK+                    I      +Q  PE+R ++ EVV+ L
Sbjct: 261 IVNGKYSIPPHDTQ-----YTVFHSLIRA---MLQVNPEERLSIAEVVHQL 303

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  117 bits (295), Expect = 3e-30
 Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 35/227 (15%)

Query: 46  DNKLGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-R 95
              LGEG FG V           +  + + +AVK LK   ++ ++ +   E+E++  + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 96  HKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL------------HGQYAGEVQLDWKRR 143
           HKN++ L G C       ++ +Y    +L  +L                  E Q+ +K  
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT 203
           +      A G+ YL    +   IHRD+ A NVL+  +    +ADFG A+ I     +   
Sbjct: 160 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY--- 213

Query: 204 RVKGTLGYL-----APEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
             K T G L     APE       +   DV+SFG+L+ EI T G  P
Sbjct: 214 -KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  116 bits (294), Expect = 3e-30
 Identities = 59/219 (26%), Positives = 99/219 (45%), Gaps = 27/219 (12%)

Query: 46  DNKLGEGGFGSVY---WGRTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHKNLL 100
            + +GEG FG V      +    +  A+K++K   SK +  +FA E+EVL ++  H N++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHL------------HGQYAGEVQLDWKRRMKIAI 148
            L G C       +  +Y P+ +LL  L                +    L  ++ +  A 
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 149 GSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR--VK 206
             A G+ YL        IHRD+ A N+L+  ++   +ADFG ++     V     R  V+
Sbjct: 150 DVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVR 206

Query: 207 GTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
                 A E   +   + + DV+S+G+LL EI++ G  P
Sbjct: 207 WM----AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  117 bits (295), Expect = 4e-30
 Identities = 55/281 (19%), Positives = 111/281 (39%), Gaps = 37/281 (13%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVK--KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
            ++G GG   V+          A+K   L+  +++    +  E+  L +++  +   +R 
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 105 Y-CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           Y    TDQ + +     N+ L S L  +    +    ++     +   E +  +H     
Sbjct: 75  YDYEITDQYIYMVMECGNIDLNSWL--KKKKSIDPWERKSYWKNM--LEAVHTIHQH--- 127

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG-VSHMTTRVKGTLGYLAPE------- 215
            I+H D+K +N L+       + DFG A  +     S +     GT+ Y+ PE       
Sbjct: 128 GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186

Query: 216 ----YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE 271
                    K+S   DV+S G +L  +  G+ P              + + +    K   
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGKTP--------------FQQIINQISKLHA 232

Query: 272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
           ++DP    +F +   K   +V   C++ +P++R ++ E++ 
Sbjct: 233 IIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 273

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  116 bits (293), Expect = 6e-30
 Identities = 59/271 (21%), Positives = 97/271 (35%), Gaps = 36/271 (13%)

Query: 47  NKLGEGGFGSVYWGRTSD-GLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
            ++G G FG V+  +    G Q AVKK++    + E     E+     +    ++ L G 
Sbjct: 64  PRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE-----ELVACAGLSSPRIVPLYGA 118

Query: 106 CAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                   I  + +   SL   +   G    +  L +  +        EG+ YLH     
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQA------LEGLEYLHTR--- 169

Query: 164 HIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTR----VKGTLGYLAPEYAM 218
            I+H D+KA NVLL SD     + DFG A  +       +      + GT  ++APE  M
Sbjct: 170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM 229

Query: 219 WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR 278
                   D++S   ++L +L G  P              W +        K   +P   
Sbjct: 230 GKPCDAKVDIWSSCCMMLHMLNGCHP--------------WTQYFRGPLCLKIASEPPPI 275

Query: 279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKE 309
            +   +            ++ EP  R +  E
Sbjct: 276 REIPPSCAPLTAQAIQEGLRKEPVHRASAME 306

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  115 bits (291), Expect = 6e-30
 Identities = 65/304 (21%), Positives = 114/304 (37%), Gaps = 62/304 (20%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           F +   LG+G FG V   R   D    A+KK++    +       EV +L  + H+ ++ 
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR-HTEEKLSTILSEVMLLASLNHQYVVR 66

Query: 102 LRG-YCAGTDQRL------------IVYDYMPNLSLLSHL--HGQYAGEVQ-LDWKRRMK 145
               +    +               I  +Y  N +L   +          +     R++ 
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQI- 125

Query: 146 IAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV------- 198
                 E + Y+H +    IIHRD+K  N+ +D      + DFG AK +   +       
Sbjct: 126 -----LEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDS 177

Query: 199 -------SHMTTRVKGTLGYLAPE-YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPG 250
                   ++T+ + GT  Y+A E     G  +E  D+YS GI+  E++           
Sbjct: 178 QNLPGSSDNLTSAI-GTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGM---- 232

Query: 251 GVKRTITEWAEPL--IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMK 308
                  E    L  +     +    P    DFD+N++K    +  L +  +P KRP  +
Sbjct: 233 -------ERVNILKKLRSVSIEF---PP---DFDDNKMKVEKKIIRLLIDHDPNKRPGAR 279

Query: 309 EVVN 312
            ++N
Sbjct: 280 TLLN 283

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  115 bits (289), Expect = 1e-29
 Identities = 53/282 (18%), Positives = 110/282 (39%), Gaps = 39/282 (13%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVK--KLKAMNSKAEMEFAVEVEVLGRVRHKNL--LGL 102
            ++G GG   V+          A+K   L+  +++    +  E+  L +++  +   + L
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
             Y        +V +   N+ L S L  +    +    ++     +   E +  +H    
Sbjct: 94  YDYEITDQYIYMVMECG-NIDLNSWL--KKKKSIDPWERKSYWKNM--LEAVHTIHQH-- 146

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG-VSHMTTRVKGTLGYLAPE------ 215
             I+H D+K +N L+       + DFG A  +     S +     GT+ Y+ PE      
Sbjct: 147 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204

Query: 216 -----YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK 270
                     K+S   DV+S G +L  +  G+ P +++   +               K  
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------------KLH 250

Query: 271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
            ++DP    +F +   K   +V   C++ +P++R ++ E++ 
Sbjct: 251 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 292

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  116 bits (292), Expect = 2e-29
 Identities = 56/282 (19%), Positives = 110/282 (39%), Gaps = 39/282 (13%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVK--KLKAMNSKAEMEFAVEVEVLGRVRHKNL--LGL 102
            ++G GG   V+          A+K   L+  +++    +  E+  L +++  +   + L
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
             Y   TDQ + +     N+ L S L  +      +D   R        E +  +H    
Sbjct: 122 YDYEI-TDQYIYMVMECGNIDLNSWLKKKK----SIDPWERKSYWKNMLEAVHTIHQH-- 174

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG-VSHMTTRVKGTLGYLAPE------ 215
             I+H D+K +N L+       + DFG A  +     S +     G + Y+ PE      
Sbjct: 175 -GIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232

Query: 216 -----YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK 270
                     K+S   DV+S G +L  +  G+ P +++   +               K  
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------------KLH 278

Query: 271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
            ++DP    +F +   K   +V   C++ +P++R ++ E++ 
Sbjct: 279 AIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA 320

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  115 bits (290), Expect = 3e-29
 Identities = 62/227 (27%), Positives = 98/227 (43%), Gaps = 35/227 (15%)

Query: 46  DNKLGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-R 95
              LGEG FG V           +  + + +AVK LK   ++ ++ +   E+E++  + +
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 96  HKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL------------HGQYAGEVQLDWKRR 143
           HKN++ L G C       ++ +Y    +L  +L                  E Q+ +K  
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT 203
           +      A G+ YL    +   IHRD+ A NVL+  +    +ADFG A+ I     +   
Sbjct: 206 VSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY--- 259

Query: 204 RVKGTLGYL-----APEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
             K T G L     APE       +   DV+SFG+L+ EI T G  P
Sbjct: 260 -KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  113 bits (286), Expect = 3e-29
 Identities = 55/277 (19%), Positives = 101/277 (36%), Gaps = 38/277 (13%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRV-RHKN 98
           F   ++LG G +G V+  R   DG   AVK+        K       EV    +V +H  
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPC 118

Query: 99  LLGLRGYCAGTDQRL-IVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGIL 155
            + L          L +  +     SL  H    G    E Q+           +   + 
Sbjct: 119 CVRLEQ-AWEEGGILYLQTELCGP-SLQQHCEAWGASLPEAQV-----WGYLRDTLLALA 171

Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPE 215
           +LH +    ++H D+K +N+ L       + DFG    +    +      +G   Y+APE
Sbjct: 172 HLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEV--QEGDPRYMAPE 226

Query: 216 YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP 275
             + G    + DV+S G+ +LE+    +      G                  +++L   
Sbjct: 227 -LLQGSYGTAADVFSLGLTILEVACNMELPHGGEG------------------WQQLRQG 267

Query: 276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
            L  +F      +  +V V+ ++ +P+ R   + ++ 
Sbjct: 268 YLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA 304

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  113 bits (285), Expect = 4e-29
 Identities = 61/203 (30%), Positives = 94/203 (46%), Gaps = 16/203 (7%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKL-KAMNSKAEMEFAV--EVEVLGRVRHKNLLGLRG 104
           LG+G FG+VY  R   +   +A+K L K+   K  +E  +  E+E+   +RH N+L +  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81

Query: 105 YCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           Y     +R+ ++ ++ P   L   L  Q  G  + D +R        A+ + Y H     
Sbjct: 82  YFH-DRKRIYLMLEFAPRGELYKEL--QKHG--RFDEQRSATFMEELADALHYCHER--- 133

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
            +IHRDIK  N+L+    E  +ADFG++   P           GTL YL PE        
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPPEMIEGKTHD 190

Query: 224 ESCDVYSFGILLLEILTGRKPIE 246
           E  D++  G+L  E L G  P +
Sbjct: 191 EKVDLWCAGVLCYEFLVGMPPFD 213

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  115 bits (290), Expect = 5e-29
 Identities = 65/306 (21%), Positives = 118/306 (38%), Gaps = 69/306 (22%)

Query: 46  DNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRV-RHKNLLGLR 103
           +  LG G  G+V +  +  G  +AVK++         + A+ E+++L     H N++   
Sbjct: 20  EKILGYGSSGTVVFQGSFQGRPVAVKRM----LIDFCDIALMEIKLLTESDDHPNVIRYY 75

Query: 104 G-------------YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
                          C    Q L+                     ++L  +      +  
Sbjct: 76  CSETTDRFLYIALELCNLNLQDLVES------------KNVSDENLKLQKEYNPISLLRQ 123

Query: 151 -AEGILYLHHEVTPHIIHRDIKASNVLLDS-------------DFEPLVADFGFAKLIPE 196
            A G+ +LH      IIHRD+K  N+L+ +             +   L++DFG  K +  
Sbjct: 124 IASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180

Query: 197 GVSHMTTRVK---GTLGYLAPE-------YAMWGKVSESCDVYSFGILLLEILTGRKPIE 246
           G S   T +    GT G+ APE            +++ S D++S G +   IL+  K   
Sbjct: 181 GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH-- 238

Query: 247 KLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPN 306
             P G K +     E  I++G F      +++   D + + +A ++    +  +P KRP 
Sbjct: 239 --PFGDKYSR----ESNIIRGIFSL---DEMKCLHDRSLIAEATDLISQMIDHDPLKRPT 289

Query: 307 MKEVVN 312
             +V+ 
Sbjct: 290 AMKVLR 295

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  113 bits (284), Expect = 5e-29
 Identities = 58/292 (19%), Positives = 97/292 (33%), Gaps = 51/292 (17%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLK-AMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
            LG GGFG V+  +   D    A+K+++      A  +   EV+ L ++ H  ++     
Sbjct: 12  CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71

Query: 106 CAGTDQRL------------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEG 153
               +               I        +L            + +    + I +  AE 
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENL-KDWMNGRCTIEERERSVCLHIFLQIAEA 130

Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI-----------PEGVSHMT 202
           + +LH +    ++HRD+K SN+    D    V DFG    +           P       
Sbjct: 131 VEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARH 187

Query: 203 TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEP 262
           T   GT  Y++PE       S   D++S G++L E+L    P          T  E    
Sbjct: 188 TGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFS--------TQMERVRT 236

Query: 263 L--IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
           L  +   KF  L   K             +      +   P +RP    ++ 
Sbjct: 237 LTDVRNLKFPPLFTQKYP------CEYVMVQ---DMLSPSPMERPEAINIIE 279

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  113 bits (286), Expect = 7e-29
 Identities = 52/231 (22%), Positives = 87/231 (37%), Gaps = 40/231 (17%)

Query: 47  NKLGEGGFGSVYWGR------TSDGLQIAVKKLKAMNSKAE-MEFAVEVEVLGRVRHKNL 99
             +GEG FG V+  R            +AVK LK   S     +F  E  ++    + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHL--------------------HGQYAGEVQLD 139
           + L G CA      ++++YM    L   L                         G   L 
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 140 WKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS 199
              ++ IA   A G+ YL        +HRD+   N L+  +    +ADFG ++ I     
Sbjct: 173 CAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 229

Query: 200 HMTTRVKGTLGYL-----APEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
           +           +      PE   + + +   DV+++G++L EI + G +P
Sbjct: 230 Y----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  113 bits (284), Expect = 1e-28
 Identities = 56/223 (25%), Positives = 92/223 (41%), Gaps = 31/223 (13%)

Query: 46  DNKLGEGGFGSVYWG------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHK 97
              LG G FG V         +    L++AVK LK+     E      E++++  + +H+
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL----------HGQYAGEVQLDWKRRMKIA 147
           N++ L G C      L++ +Y     LL+ L                      +  +  +
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG 207
              A+G+ +L  +   + IHRD+ A NVLL +     + DFG A+ I    ++    +  
Sbjct: 171 SQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY----IVK 223

Query: 208 TLGYL-----APEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
               L     APE       +   DV+S+GILL EI + G  P
Sbjct: 224 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  111 bits (281), Expect = 1e-28
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 15/203 (7%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLK---AMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
           KLG GG  +VY    T   +++A+K +        +    F  EV    ++ H+N++ + 
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM- 76

Query: 104 GYCAGTDQRL--IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
                 +     +V +Y+   +L  ++         L     +       +GI + H   
Sbjct: 77  -IDVDEEDDCYYLVMEYIEGPTLSEYIESHGP----LSVDTAINFTNQILDGIKHAHDM- 130

Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK 221
              I+HRDIK  N+L+DS+    + DFG AK + E     T  V GT+ Y +PE A    
Sbjct: 131 --RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEA 188

Query: 222 VSESCDVYSFGILLLEILTGRKP 244
             E  D+YS GI+L E+L G  P
Sbjct: 189 TDECTDIYSIGIVLYEMLVGEPP 211

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  114 bits (286), Expect = 2e-28
 Identities = 58/280 (20%), Positives = 113/280 (40%), Gaps = 36/280 (12%)

Query: 43  FSDDNKLGEGGFGSVYWGRTSDGLQIAVKK-LKAMNSKAEMEFAVEVEVLGRV-RHKNLL 100
           F   + LG G  G++ +    D   +AVK+ L    S A+ E    V++L     H N++
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADRE----VQLLRESDEHPNVI 81

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
                      + I  +     +L  ++  +    + L+    ++       G+ +LH  
Sbjct: 82  RYFCTEKDRQFQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTT---SGLAHLHSL 137

Query: 161 VTPHIIHRDIKASNVLL-----DSDFEPLVADFGFAKLIPEGVSHMTTR--VKGTLGYLA 213
              +I+HRD+K  N+L+         + +++DFG  K +  G    + R  V GT G++A
Sbjct: 138 ---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIA 194

Query: 214 PEY---AMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK 270
           PE          + + D++S G +   +++        P G         +  I+ G   
Sbjct: 195 PEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH----PFGKS----LQRQANILLGACS 246

Query: 271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEV 310
             +D       ++   ++ I      +  +P+KRP+ K V
Sbjct: 247 --LDCLHPEKHEDVIARELIE---KMIAMDPQKRPSAKHV 281

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  111 bits (281), Expect = 2e-28
 Identities = 58/227 (25%), Positives = 90/227 (39%), Gaps = 35/227 (15%)

Query: 46  DNKLGEGGFGSVYWG------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHK 97
              LG G FG V         ++   + +AVK LK      E      E++VL  +  H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--------------HGQYAGEVQLDWKRR 143
           N++ L G C      L++ +Y     LL+ L                    E+ LD +  
Sbjct: 88  NIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT 203
           +  +   A+G+ +L    + + IHRD+ A N+LL       + DFG A+ I       + 
Sbjct: 148 LSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIKND----SN 200

Query: 204 RVKGTLGYL-----APEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
            V      L     APE       +   DV+S+GI L E+ + G  P
Sbjct: 201 YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  111 bits (281), Expect = 2e-28
 Identities = 68/296 (22%), Positives = 112/296 (37%), Gaps = 49/296 (16%)

Query: 46  DNKLGEGGFGSVYWGR------TSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHK 97
              LG G FG V          T+    +AVK LK   + +E      E+++L  +  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 98  NLLGLRGYCAGTDQ-RLIVYDYMPNLSLLSHL------------HGQYAGEVQLDWKRRM 144
           N++ L G C       +++ ++    +L ++L              +   +  L  +  +
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 145 KIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR 204
             +   A+G+ +L        IHRD+ A N+LL       + DFG A+ I +   +    
Sbjct: 152 CYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY---- 204

Query: 205 VKGTLGYL-----APEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITE 258
           V+     L     APE       +   DV+SFG+LL EI + G  P    PG     +  
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP---YPG-----VKI 256

Query: 259 WAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
             E       F   +    R    +    +     + C   EP +RP   E+V  L
Sbjct: 257 DEE-------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 305

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  111 bits (280), Expect = 3e-28
 Identities = 61/232 (26%), Positives = 97/232 (41%), Gaps = 40/232 (17%)

Query: 46  DNKLGEGGFGSVYWGR------TSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRVRHKN 98
              LGEG FG V           +    +AVK LK   S +E+ +   E  VL +V H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--------------------HGQYAGEVQL 138
           ++ L G C+     L++ +Y    SL   L                       +  E  L
Sbjct: 88  VIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 139 DWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV 198
                +  A   ++G+ YL       ++HRD+ A N+L+    +  ++DFG ++ + E  
Sbjct: 148 TMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204

Query: 199 SHMTTRVKGTLGYL-----APEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
           S+    VK + G +     A E       +   DV+SFG+LL EI+T G  P
Sbjct: 205 SY----VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  112 bits (281), Expect = 3e-28
 Identities = 48/224 (21%), Positives = 91/224 (40%), Gaps = 37/224 (16%)

Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKL-KAMNSKAEMEFAV----------------EVEV 90
            L +G F  +      D    A+KK  K++  K                       E+++
Sbjct: 38  TLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI 96

Query: 91  LGRVRHKNLLGLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIG 149
           +  ++++  L   G        + I+Y+YM N S+L     +Y   +  ++   + I + 
Sbjct: 97  ITDIKNEYCLTCEGIIT-NYDEVYIIYEYMENDSILKFD--EYFFVLDKNYTCFIPIQVI 153

Query: 150 S------AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT 203
                       Y+H+E   +I HRD+K SN+L+D +    ++DFG ++ + +      +
Sbjct: 154 KCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-GS 210

Query: 204 RVKGTLGYLAPEYAMWGKVS---ESCDVYSFGILLLEILTGRKP 244
           R  GT  ++ PE     + S      D++S GI L  +     P
Sbjct: 211 R--GTYEFMPPE-FFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  112 bits (283), Expect = 4e-28
 Identities = 66/227 (29%), Positives = 100/227 (44%), Gaps = 35/227 (15%)

Query: 46  DNKLGEGGFGSVYWG--------RTSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-R 95
              LGEG FG V           + +   ++AVK LK+  ++ ++ +   E+E++  + +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 96  HKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL------------HGQYAGEVQLDWKRR 143
           HKN++ L G C       ++ +Y    +L  +L            +  +  E QL  K  
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT 203
           +  A   A G+ YL    +   IHRD+ A NVL+  D    +ADFG A+ I         
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI----DY 246

Query: 204 RVKGTLGYL-----APEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
             K T G L     APE       +   DV+SFG+LL EI T G  P
Sbjct: 247 YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  109 bits (274), Expect = 1e-27
 Identities = 55/210 (26%), Positives = 87/210 (41%), Gaps = 27/210 (12%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG+G F  VY       GL++A+K   K     +        EV++  +++H ++L L  
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78

Query: 105 YCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS------AEGILYL 157
           Y       + +V +   N  +  +L  +          +                G+LYL
Sbjct: 79  YFE-DSNYVYLVLEMCHNGEMNRYLKNR---------VKPFSENEARHFMHQIITGMLYL 128

Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA-KLIPEGVSHMTTRVKGTLGYLAPEY 216
           H      I+HRD+  SN+LL  +    +ADFG A +L      H T    GT  Y++PE 
Sbjct: 129 HSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTL--CGTPNYISPEI 183

Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPIE 246
           A         DV+S G +   +L GR P +
Sbjct: 184 ATRSAHGLESDVWSLGCMFYTLLIGRPPFD 213

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  110 bits (277), Expect = 1e-27
 Identities = 45/237 (18%), Positives = 78/237 (32%), Gaps = 26/237 (10%)

Query: 29  RIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKK---LKAMNSKAEMEFA 85
            I    E    +      + LGEG F  VY     D      K+   LK        EF 
Sbjct: 53  AIKPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFY 112

Query: 86  VEVEVLGRVR---HKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL-HGQYAGEVQLDWK 141
           +  +++ R++       +         +  ++V +     +LL+ +   +   E  +   
Sbjct: 113 IGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQG 172

Query: 142 RRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-----------VADFGF 190
             +  A+     I  +H      IIH DIK  N +L + F              + D G 
Sbjct: 173 LVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQ 229

Query: 191 A---KLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           +   KL P+G    T +   T G+   E       +   D +     +  +L G   
Sbjct: 230 SIDMKLFPKGTI-FTAKC-ETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  108 bits (272), Expect = 3e-27
 Identities = 79/277 (28%), Positives = 114/277 (41%), Gaps = 43/277 (15%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLL 100
           F+   K+G+G FG V+ G        +A+K +    ++ E+E    E+ VL +     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE---GILYL 157
              G      +  I+ +Y+   S L  L      E Q        IA    E   G+ YL
Sbjct: 84  KYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ--------IATILREILKGLDYL 135

Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           H E     IHRDIKA+NVLL    E  +ADFG A  + +      T V GT  ++APE  
Sbjct: 136 HSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV-GTPFWMAPEVI 191

Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEP-----LIVKGKFKEL 272
                    D++S GI  +E+  G  P  +L             P     LI K      
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPPHSELH------------PMKVLFLIPKNN---- 235

Query: 273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKE 309
             P L G++ +  LK+ +     C+  EP  RP  KE
Sbjct: 236 -PPTLEGNYSK-PLKEFVE---ACLNKEPSFRPTAKE 267

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  108 bits (273), Expect = 3e-27
 Identities = 65/272 (23%), Positives = 113/272 (41%), Gaps = 32/272 (11%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
                K+GEG  G V   R    G Q+AVK +     +       EV ++   +H N++ 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106

Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE---GILYLH 158
           +       ++  ++ +++   +L   +      E Q        IA         + YLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ--------IATVCEAVLQALAYLH 158

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM 218
            +    +IHRDIK+ ++LL  D    ++DFGF   I + V    + V GT  ++APE   
Sbjct: 159 AQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-GTPYWMAPEVIS 214

Query: 219 WGKVSESCDVYSFGILLLEILTGRKPIEKL-PGGVKRTITEWAEPLIVKGKFKELVDPKL 277
               +   D++S GI+++E++ G  P     P    + + +   P +   K    V P L
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL---KNSHKVSPVL 271

Query: 278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKE 309
           R DF E             +  +P++R   +E
Sbjct: 272 R-DFLE-----------RMLVRDPQERATAQE 291

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  109 bits (273), Expect = 3e-27
 Identities = 66/288 (22%), Positives = 115/288 (39%), Gaps = 51/288 (17%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLL 100
           F     +G G +G VY GR    G   A+K +     + E E   E+ +L +   H+N+ 
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEE-EIKQEINMLKKYSHHRNIA 84

Query: 101 G-----LRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE-- 152
                 ++    G D +L +V ++    S+   +       ++ +W     IA    E  
Sbjct: 85  TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----IAYICREIL 139

Query: 153 -GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGY 211
            G+ +LH      +IHRDIK  NVLL  + E  + DFG +  +   V    T + GT  +
Sbjct: 140 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPYW 195

Query: 212 LAPEYAMWGKVSES-----CDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEP---- 262
           +APE     +  ++      D++S GI  +E+  G  P+  +             P    
Sbjct: 196 MAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH------------PMRAL 243

Query: 263 -LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKE 309
            LI +        P+L+      + +  I     C+     +RP  ++
Sbjct: 244 FLIPRNPA-----PRLKSKKWSKKFQSFIE---SCLVKNHSQRPATEQ 283

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  108 bits (271), Expect = 4e-27
 Identities = 52/203 (25%), Positives = 83/203 (40%), Gaps = 14/203 (6%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG+GGF   +           A K   K   +      + ++E+ +   + H++++G  G
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
           +    D   +V +     SLL     +    +     R     I    G  YLH      
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQI--VLGCQYLHRN---R 135

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           +IHRD+K  N+ L+ D E  + DFG A  +  +G         GT  Y+APE       S
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHS 193

Query: 224 ESCDVYSFGILLLEILTGRKPIE 246
              DV+S G ++  +L G+ P E
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFE 216

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  108 bits (271), Expect = 4e-27
 Identities = 66/272 (24%), Positives = 112/272 (41%), Gaps = 32/272 (11%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           ++   K+G+G  G+VY     + G ++A++++       +     E+ V+   ++ N++ 
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE---GILYLH 158
                   D+  +V +Y+   SL   +      E Q        IA    E    + +LH
Sbjct: 82  YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ--------IAAVCRECLQALEFLH 133

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM 218
                 +IHRDIK+ N+LL  D    + DFGF   I    S  +T V GT  ++APE   
Sbjct: 134 SN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVT 189

Query: 219 WGKVSESCDVYSFGILLLEILTGRKPIEKL-PGGVKRTITEWAEPLIVKGKFKELVDPKL 277
                   D++S GI+ +E++ G  P     P      I     P +   +  E +    
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL---QNPEKLSAIF 246

Query: 278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKE 309
           R DF              C++ + EKR + KE
Sbjct: 247 R-DFLN-----------RCLEMDVEKRGSAKE 266

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  108 bits (271), Expect = 5e-27
 Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 21/209 (10%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLK---AMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
            LG GG   V+  R   D   +AVK L+   A +    + F  E +    + H  ++ + 
Sbjct: 19  ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV- 77

Query: 104 GYCAGTDQRL------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
            Y  G  +        IV +Y+  ++L   +H +      +  KR +++   + + + + 
Sbjct: 78  -YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP----MTPKRAIEVIADACQALNFS 132

Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT--RVKGTLGYLAPE 215
           H      IIHRD+K +N+++ +     V DFG A+ I +  + +T    V GT  YL+PE
Sbjct: 133 HQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 189

Query: 216 YAMWGKVSESCDVYSFGILLLEILTGRKP 244
            A    V    DVYS G +L E+LTG  P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  108 bits (272), Expect = 5e-27
 Identities = 52/203 (25%), Positives = 83/203 (40%), Gaps = 14/203 (6%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG+GGF   +           A K   K   +      + ++E+ +   + H++++G  G
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
           +    D   +V +     SLL     +    +     R     I    G  YLH      
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELH--KRRKALTEPEARYYLRQI--VLGCQYLHRN---R 161

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           +IHRD+K  N+ L+ D E  + DFG A  +  +G         GT  Y+APE       S
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVL--CGTPNYIAPEVLSKKGHS 219

Query: 224 ESCDVYSFGILLLEILTGRKPIE 246
              DV+S G ++  +L G+ P E
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFE 242

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  108 bits (272), Expect = 6e-27
 Identities = 58/232 (25%), Positives = 94/232 (40%), Gaps = 40/232 (17%)

Query: 46  DNKLGEGGFGSVYWGR------TSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-RHK 97
              LG G FG V          T   +Q+AVK LK     +E      E++++ ++  H+
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL-------------------HGQYAGEVQL 138
           N++ L G C  +    ++++Y     LL++L                     +      L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 139 DWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV 198
            ++  +  A   A+G+ +L        +HRD+ A NVL+       + DFG A+ I    
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSD- 225

Query: 199 SHMTTRVKGTLGYL-----APEYAMWGKVSESCDVYSFGILLLEILT-GRKP 244
              +  V      L     APE    G  +   DV+S+GILL EI + G  P
Sbjct: 226 ---SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  107 bits (270), Expect = 7e-27
 Identities = 46/203 (22%), Positives = 76/203 (37%), Gaps = 15/203 (7%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLK---AMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
            +G GG G VY    T     +A+K +    + +         E    GR++  +++ + 
Sbjct: 41  LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI- 99

Query: 104 GYCAGTDQRL--IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
            +  G       +    +  + L + L  Q      L   R + I       +   H   
Sbjct: 100 -HDFGEIDGQLYVDMRLINGVDLAAMLRRQGP----LAPPRAVAIVRQIGSALDAAHAA- 153

Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK 221
                HRD+K  N+L+ +D    + DFG A    +          GTL Y+APE      
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESH 211

Query: 222 VSESCDVYSFGILLLEILTGRKP 244
            +   D+Y+   +L E LTG  P
Sbjct: 212 ATYRADIYALTCVLYECLTGSPP 234

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  108 bits (272), Expect = 8e-27
 Identities = 27/299 (9%), Positives = 63/299 (21%), Gaps = 49/299 (16%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           L  G    V+  R        A+K        +               R+  ++    R 
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 105 YC--------------------------AGTDQRLIVYDYMP--NLSLLSHLHGQYAGEV 136
                                             L++          L S L   Y    
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189

Query: 137 QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE 196
                    +          L  +    ++H      N+ +  D   ++ D      +  
Sbjct: 190 DEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246

Query: 197 GVSHMTTRVKGTLGYLAPEYAMWGK--VSESCDVYSFGILLLEILTGRKPIEKLPGGVKR 254
                +      + Y   E+        + + + +  G+ +  +     P          
Sbjct: 247 RGPASS----VPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG-------- 294

Query: 255 TITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT 313
            +T   +    +   +      L              +    +  +  +R    E + T
Sbjct: 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET 353

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  105 bits (263), Expect = 4e-26
 Identities = 54/301 (17%), Positives = 96/301 (31%), Gaps = 65/301 (21%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKK--LKAMNSKAEMEFAVEVEVLGRV-RHKN 98
           F +  K+G G FGSV+      DG   A+K+       S  E     EV     + +H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           ++      A  D  LI  +Y    SL   +   Y             + +    G+ Y+H
Sbjct: 73  VVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIH 132

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLV-------------------ADFGFAKLIPEGVS 199
                 ++H DIK SN+ +     P                      D G    I    S
Sbjct: 133 SM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI----S 185

Query: 200 HMTTRVKGTLGYLAPE-------YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGV 252
                 +G   +LA E       +          D+++  + ++                
Sbjct: 186 SPQV-EEGDSRFLANEVLQENYTH------LPKADIFALALTVVCAAGAEPLPRNGD--- 235

Query: 253 KRTITEWAEPLIVKGKFKELVDPKLRGDFDENQL-KQAINVAVLCVQSEPEKRPNMKEVV 311
                +W E  I +G+   +             L ++   +  + +  +PE+RP+   +V
Sbjct: 236 -----QWHE--IRQGRLPRI----------PQVLSQEFTELLKVMIHPDPERRPSAMALV 278

Query: 312 N 312
            
Sbjct: 279 K 279

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  107 bits (268), Expect = 4e-26
 Identities = 56/304 (18%), Positives = 110/304 (36%), Gaps = 46/304 (15%)

Query: 46  DNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLR 103
            + LG+G   +V+ GR    G   A+K    ++    ++  + E EVL ++ HKN++ L 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 104 GY--CAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMK-IAIGSAEGILYLH 158
                  T  ++++ ++ P  SL + L       G  + ++   ++ +      G+ +L 
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV----GGMNHLR 129

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
                 I+HR+IK  N++     +      + DFG A+ + +      +   GT  YL P
Sbjct: 130 EN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHP 184

Query: 215 E--------YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVK 266
           +             K   + D++S G+      TG  P    P    R   E     I+ 
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR--PFEGPRRNKEVMYK-IIT 241

Query: 267 GKFKELVDPKLRGDFDENQL---------------KQAINVAVLCVQSEPEKRPNMKEVV 311
           GK    +    + +                          V    ++++ EK     +  
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301

Query: 312 NTLT 315
              +
Sbjct: 302 AETS 305

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  105 bits (264), Expect = 4e-26
 Identities = 56/301 (18%), Positives = 105/301 (34%), Gaps = 46/301 (15%)

Query: 46  DNKLGEGGFGSVYWGR-TSDGLQIAVKKL-KAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
            + LG+G   +V+ GR    G   A+K        +       E EVL ++ HKN++ L 
Sbjct: 14  SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73

Query: 104 GY--CAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMK-IAIGSAEGILYLH 158
                  T  ++++ ++ P  SL + L       G  + ++   ++ +      G+ +L 
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV----GGMNHLR 129

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
                 I+HR+IK  N++     +      + DFG A+ + +      +   GT  YL P
Sbjct: 130 EN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD-EQFVSLY-GTEEYLHP 184

Query: 215 E--------YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVK 266
           +             K   + D++S G+      TG  P     G   R   E     I+ 
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGP--RRNKEVMYK-IIT 241

Query: 267 GKFKELVDPKLRGDFDENQL---------------KQAINVAVLCVQSEPEKRPNMKEVV 311
           GK    +    + +                          V    ++++ EK     +  
Sbjct: 242 GKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFF 301

Query: 312 N 312
            
Sbjct: 302 A 302

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  107 bits (267), Expect = 5e-26
 Identities = 30/234 (12%), Positives = 61/234 (26%), Gaps = 41/234 (17%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRH-------- 96
           LG+    +         G    V      +   S A  +   EV  L  +R         
Sbjct: 86  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145

Query: 97  --------KNLLGLRGYCAGTDQR--------LIVYDYMP-----NLSLLSHLHGQYAGE 135
                    +L+           R        L  +   P       +    L    +  
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205

Query: 136 VQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP 195
             L    R+++ +     +  LHH     ++H  ++  +++LD      +  F       
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262

Query: 196 EGVSHMTTRVKGTLGYLAPEYAMW-----GKVSESCDVYSFGILLLEILTGRKP 244
                   R        A     +       ++ + D ++ G+ +  I     P
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  105 bits (263), Expect = 1e-25
 Identities = 28/240 (11%), Positives = 68/240 (28%), Gaps = 52/240 (21%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLK----------------------------AMNSK 79
           LG+    +         G    V                                   +K
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 80  AEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYM----PNLSLLSHLHGQYAGE 135
             + F    +++   + K ++ +R            + Y        +    L    +  
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200

Query: 136 VQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP 195
             L    R+++ +     +  LHH     ++H  ++  +++LD      +  F       
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLV--R 255

Query: 196 EGVSHMTTRVKGTLGYLAPEY-----------AMWGKVSESCDVYSFGILLLEILTGRKP 244
           +G   +++    + G+  PE                 ++ S D ++ G+++  I     P
Sbjct: 256 DGARVVSS---VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  107 bits (269), Expect = 1e-25
 Identities = 38/205 (18%), Positives = 68/205 (33%), Gaps = 24/205 (11%)

Query: 48  KLGEGGFGSVYWGR--TSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNL----- 99
            +  GG G +Y       +G  + +K L              E + L  V H ++     
Sbjct: 87  CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146

Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
                   G     IV +Y+   SL      +      L     +   +     + YLH 
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK------LPVAEAIAYLLEILPALSYLHS 200

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
                +++ D+K  N++L  + +  + D G    I          + GT G+ APE    
Sbjct: 201 I---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINS-----FGYLYGTPGFQAPEIVR- 250

Query: 220 GKVSESCDVYSFGILLLEILTGRKP 244
              + + D+Y+ G  L  +      
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDLPT 275

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  106 bits (266), Expect = 2e-25
 Identities = 67/283 (23%), Positives = 120/283 (42%), Gaps = 49/283 (17%)

Query: 46  DNKLGEGGFGSVYWGR-TSDGLQIAVK--KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
             KLG G +G V   R     ++ A+K  +  ++++ +  +   EV VL  + H N++ L
Sbjct: 42  VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKL 101

Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHL--HGQY----AGEVQLDWKRRMKIAIGSAEGILY 156
             +        +V +      L   +    ++    A  +       +K  +    G+ Y
Sbjct: 102 YDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVI-------IKQVL---SGVTY 151

Query: 157 LHHEVTPHIIHRDIKASNVLLDS---DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLA 213
           LH     +I+HRD+K  N+LL+S   D    + DFG + +       M  R+ GT  Y+A
Sbjct: 152 LHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-KKMKERL-GTAYYIA 206

Query: 214 PEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV 273
           PE  +  K  E CDV+S G++L  +L G  P     G   + I       + KGK+    
Sbjct: 207 PE-VLRKKYDEKCDVWSIGVILFILLAGYPPF---GGQTDQEILR----KVEKGKY---- 254

Query: 274 DPKLRGDFDENQLK----QAINVAVLCVQSEPEKRPNMKEVVN 312
                  FD  + K     A ++    +Q + ++R + ++ + 
Sbjct: 255 ------TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE 291

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  103 bits (258), Expect = 3e-25
 Identities = 65/280 (23%), Positives = 108/280 (38%), Gaps = 25/280 (8%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLL 100
           +     +G G    V          ++A+K++     +  M+    E++ + +  H N++
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 101 GLRG-YCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWK-RRMKIAIGSAE---GI 154
                +    +  L +V   +   S+L  +    A             IA    E   G+
Sbjct: 77  SYYTSFVVKDE--LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK----GTLG 210
            YLH       IHRD+KA N+LL  D    +ADFG +  +  G      +V+    GT  
Sbjct: 135 EYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 211 YLAPEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKF 269
           ++APE     +      D++SFGI  +E+ TG  P  K P             L ++   
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP-------MKVLMLTLQNDP 244

Query: 270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKE 309
             L       +  +   K    +  LC+Q +PEKRP   E
Sbjct: 245 PSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE 284

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  102 bits (257), Expect = 3e-25
 Identities = 51/213 (23%), Positives = 97/213 (45%), Gaps = 23/213 (10%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
           +    +LG+G FG VY  +    G   A K ++  + +   ++ VE+E+L    H  ++ 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLS--HLHGQYAGEVQLDWKRRMKIAIGSAE---GILY 156
           L G      +  I+ ++ P  ++ +      +   E Q        I +   +    + +
Sbjct: 81  LLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ--------IQVVCRQMLEALNF 132

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
           LH +    IIHRD+KA NVL+  + +  +ADFG +    + +    + + GT  ++APE 
Sbjct: 133 LHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-GTPYWMAPEV 188

Query: 217 AMWGKVSES-----CDVYSFGILLLEILTGRKP 244
            M   + ++      D++S GI L+E+     P
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  102 bits (255), Expect = 8e-25
 Identities = 67/275 (24%), Positives = 113/275 (41%), Gaps = 38/275 (13%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLL 100
           F    KLGEG +GSVY       G  +A+K+   +  +++++    E+ ++ +    +++
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQ---VPVESDLQEIIKEISIMQQCDSPHVV 87

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSL--LSHLHGQYAGEVQLDWKRRMKIAIGSAE---GIL 155
              G         IV +Y    S+  +  L  +   E +        IA        G+ 
Sbjct: 88  KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE--------IATILQSTLKGLE 139

Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPE 215
           YLH       IHRDIKA N+LL+++    +ADFG A  + + ++   T + GT  ++APE
Sbjct: 140 YLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-GTPFWMAPE 195

Query: 216 YAMWGKVSESCDVYSFGILLLEILTGRKPIEKL-PGGVKRTITEWAEPLIVKGKFKELVD 274
                  +   D++S GI  +E+  G+ P   + P      I     P     +  EL  
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTF---RKPELWS 252

Query: 275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKE 309
                DF          V   C+   PE+R    +
Sbjct: 253 DNFT-DF----------VK-QCLVKSPEQRATATQ 275

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  104 bits (260), Expect = 1e-24
 Identities = 66/283 (23%), Positives = 116/283 (40%), Gaps = 50/283 (17%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
             LG+G FG V   +    G + AVK   K +      +     EV++L ++ H N++ L
Sbjct: 32  RVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKL 91

Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHL--HGQY----AGEVQLDWKRRMKIAIGSAEGILY 156
             +        +V +      L   +    ++    A  +       ++  +    GI Y
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARI-------IRQVL---SGITY 141

Query: 157 LHHEVTPHIIHRDIKASNVLLDS---DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLA 213
           +H      I+HRD+K  N+LL+S   D    + DFG +         M  ++ GT  Y+A
Sbjct: 142 MHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-KKMKDKI-GTAYYIA 196

Query: 214 PEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV 273
           PE  + G   E CDV+S G++L  +L+G  P     G  +  I +     + KGK+    
Sbjct: 197 PE-VLHGTYDEKCDVWSTGVILYILLSGCPPFN---GANEYDILK----KVEKGKY---- 244

Query: 274 DPKLRGDFDENQLK----QAINVAVLCVQSEPEKRPNMKEVVN 312
                  F+  Q K     A ++    +   P  R + ++ ++
Sbjct: 245 ------TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD 281

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  104 bits (261), Expect = 1e-24
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 16/204 (7%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLK--AMNSKAEMEFA-VEVEVLGRVRHKNLLGLRG 104
           LG GGFG V+  +     ++ A KKL    +  +   + A VE ++L +V  + ++ L  
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLA- 251

Query: 105 YCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE---GILYLHHE 160
           Y   T   L +V   M    +  H++           + R       A+   G+ +LH  
Sbjct: 252 YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ-EPRAIFYT--AQIVSGLEHLHQR 308

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
              +II+RD+K  NVLLD D    ++D G A  +  G +       GT G++APE  +  
Sbjct: 309 ---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPELLLGE 364

Query: 221 KVSESCDVYSFGILLLEILTGRKP 244
           +   S D ++ G+ L E++  R P
Sbjct: 365 EYDFSVDYFALGVTLYEMIAARGP 388

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  102 bits (257), Expect = 4e-24
 Identities = 61/213 (28%), Positives = 97/213 (45%), Gaps = 37/213 (17%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLK--AMNSKAEMEFA-VEVEVLGRVRHKNLLGLRG 104
           LG+GGFG V   +     ++ A KKL+   +  +     A  E ++L +V  + ++ L  
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA- 250

Query: 105 YCAGTDQRL-IVYDYMPNLSLLSHLHGQ------------YAGEVQLDWKRRMKIAIGSA 151
           Y   T   L +V   M    L  H++              YA E+               
Sbjct: 251 YAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICC------------- 297

Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGY 211
            G+  LH E    I++RD+K  N+LLD      ++D G A  +PEG + +  RV GT+GY
Sbjct: 298 -GLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-IKGRV-GTVGY 351

Query: 212 LAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           +APE     + + S D ++ G LL E++ G+ P
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  101 bits (252), Expect = 4e-24
 Identities = 63/297 (21%), Positives = 110/297 (37%), Gaps = 40/297 (13%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           F   ++LG G  G V+       GL +A K +      A     + E++VL       ++
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHL-HGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           G  G      +  I  ++M   SL   L       E  L      K++I   +G+ YL  
Sbjct: 95  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL-----GKVSIAVIKGLTYLRE 149

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
           +    I+HRD+K SN+L++S  E  + DFG +  + + +++  + V GT  Y++PE    
Sbjct: 150 KH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN--SFV-GTRSYMSPERLQG 204

Query: 220 GKVSESCDVYSFGILLLEILTGRKPI------------EKLPGGVKRTITEWAEPLIVKG 267
              S   D++S G+ L+E+  GR PI                 G                
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPL 264

Query: 268 KFKELVDPKLRGDFDENQL---------------KQAINVAVLCVQSEPEKRPNMKE 309
               +        F+                    +  +    C+   P +R ++K+
Sbjct: 265 NKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =   99 bits (250), Expect = 5e-24
 Identities = 53/216 (24%), Positives = 87/216 (40%), Gaps = 42/216 (19%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLKAMNSKAEMEFAVEVE-------VLGRVRHKNLL 100
           LGEG F +V   R     +  A+K L+    K  +    +V        V+ R+ H   +
Sbjct: 38  LGEGSFSTVVLARELATSREYAIKILE----KRHIIKENKVPYVTRERDVMSRLDHPFFV 93

Query: 101 GLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAIG 149
            L  +    D++L     Y  N  LL ++             Y  E+          A+ 
Sbjct: 94  KLY-FTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS--------ALE 144

Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR-VKGT 208
                 YLH +    IIHRD+K  N+LL+ D    + DFG AK++             GT
Sbjct: 145 ------YLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195

Query: 209 LGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
             Y++PE        +S D+++ G ++ +++ G  P
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPP 231

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  102 bits (255), Expect = 5e-24
 Identities = 66/282 (23%), Positives = 111/282 (39%), Gaps = 49/282 (17%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVK--KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
             LG+G FG V   +      + AVK     +  +K       EVE+L ++ H N++ L 
Sbjct: 28  CMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLF 87

Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHL--HGQY----AGEVQLDWKRRMKIAIGSAEGILYL 157
                +    IV +      L   +    ++    A  +       +K       GI Y+
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-------IKQVF---SGITYM 137

Query: 158 HHEVTPHIIHRDIKASNVLLDS---DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
           H     +I+HRD+K  N+LL+S   D +  + DFG +    +  + M  R+ GT  Y+AP
Sbjct: 138 HKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAP 192

Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD 274
           E  + G   E CDV+S G++L  +L+G  P              + +        K +  
Sbjct: 193 E-VLRGTYDEKCDVWSAGVILYILLSGTPPF-------------YGKNE--YDILKRVET 236

Query: 275 PKLRGDFDENQLK----QAINVAVLCVQSEPEKRPNMKEVVN 312
            K    FD  Q +     A ++    +   P  R    + + 
Sbjct: 237 GKY--AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE 276

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  100 bits (250), Expect = 3e-23
 Identities = 67/293 (22%), Positives = 114/293 (38%), Gaps = 60/293 (20%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLK-------------AMNSKAEMEFAVEVEVLG 92
            KLG G +G V   +  +   + A+K +K                 K   E   E+ +L 
Sbjct: 42  RKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK 101

Query: 93  RVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQY----AGEVQLDWKRRMKI 146
            + H N++ L           +V ++     L   +    ++    A  +       MK 
Sbjct: 102 SLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANI-------MKQ 154

Query: 147 AIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS---DFEPLVADFGFAKLIPEGVSHMTT 203
            +    GI YLH     +I+HRDIK  N+LL++        + DFG +    +    +  
Sbjct: 155 IL---SGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-YKLRD 207

Query: 204 RVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL 263
           R+ GT  Y+APE  +  K +E CDV+S G+++  +L G  P                +  
Sbjct: 208 RL-GTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPF-------------GGQND 252

Query: 264 IVKGKFKELVDPKLRGDFDENQLK----QAINVAVLCVQSEPEKRPNMKEVVN 312
             +   K++   K    FD N  K    +A  +  L +  +  KR   +E +N
Sbjct: 253 --QDIIKKVEKGKY--YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN 301

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 98.6 bits (246), Expect = 3e-23
 Identities = 72/285 (25%), Positives = 116/285 (40%), Gaps = 56/285 (19%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFA---VEVEVLGRVRHKN 98
           FSD  ++G G FG+VY+ R   +   +A+KK+     ++  ++     EV  L ++RH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 99  LLGLRGYCAGTDQRLIVYDYMP-NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE---GI 154
            +  RG         +V +Y   + S L  +H +   EV+        IA  +     G+
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVE--------IAAVTHGALQGL 167

Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR--VKGTLGYL 212
            YLH     ++IHRD+KA N+LL       + DFG A       S M       GT  ++
Sbjct: 168 AYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSA-------SIMAPANSFVGTPYWM 217

Query: 213 APEYAMWGKVSE---SCDVYSFGILLLEILTGRKPIEKL-PGGVKRTITEWAEPLIVKGK 268
           APE  +     +     DV+S GI  +E+   + P+  +        I +   P +  G 
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH 277

Query: 269 ----FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKE 309
               F+  VD                     C+Q  P+ RP  + 
Sbjct: 278 WSEYFRNFVD--------------------SCLQKIPQDRPTSEV 302

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 99.4 bits (248), Expect = 3e-23
 Identities = 59/207 (28%), Positives = 92/207 (44%), Gaps = 19/207 (9%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLK--AMNSKAEME-FAVEVEVLGRVRHKNLLGLRG 104
           +G G FG V   +  +  ++ A+K L    M  +AE   F  E +VL     K +  L  
Sbjct: 82  IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLH- 140

Query: 105 YCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           Y    D  L +V DY     LL+ L  ++   +  +  R        AE ++ +      
Sbjct: 141 YAFQDDNNLYLVMDYYVGGDLLTLLS-KFEDRLPEEMAR-----FYLAEMVIAIDSVHQL 194

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAK-LIPEGVSHMTTRVKGTLGYLAPE-----YA 217
           H +HRDIK  N+L+D +    +ADFG    L+ +G    +  V GT  Y++PE       
Sbjct: 195 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAV-GTPDYISPEILQAMEG 253

Query: 218 MWGKVSESCDVYSFGILLLEILTGRKP 244
             G+    CD +S G+ + E+L G  P
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETP 280

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 97.8 bits (244), Expect = 4e-23
 Identities = 72/278 (25%), Positives = 115/278 (41%), Gaps = 40/278 (14%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGR-VRHKNLLGLRG 104
           ++G G +GSV        G  +AVK++++   + E +   ++++V+ R      ++   G
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYA------GEVQLDWKRRMKIAIGSAEGILYLH 158
                    I  + M + S        Y+       E  L      KI + + + + +L 
Sbjct: 89  ALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEIL-----GKITLATVKALNHLK 142

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPE--- 215
             +   IIHRDIK SN+LLD      + DFG +  + + ++   TR  G   Y+APE   
Sbjct: 143 ENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK--TRDAGCRPYMAPERID 198

Query: 216 -YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD 274
             A         DV+S GI L E+ TGR P  K    V   +T      +VKG       
Sbjct: 199 PSASRQGYDVRSDVWSLGITLYELATGRFPYPKW-NSVFDQLT-----QVVKGD-----P 247

Query: 275 PKLRGDFDEN---QLKQAINVAVLCVQSEPEKRPNMKE 309
           P+L    +          +N   LC+  +  KRP  KE
Sbjct: 248 PQLSNSEEREFSPSFINFVN---LCLTKDESKRPKYKE 282

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 96.6 bits (241), Expect = 6e-23
 Identities = 60/276 (21%), Positives = 107/276 (38%), Gaps = 38/276 (13%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGR-VRHKNLLGLR 103
            +LG G +G V   R    G  +AVK+++A  +  E +   +++++  R V     +   
Sbjct: 13  MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFY 72

Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           G         I  + M + SL             +      KIA+   + + +LH ++  
Sbjct: 73  GALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL-- 129

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGF-AKLIPEGVSHMTTRVKGTLGYLAPE----YAM 218
            +IHRD+K SNVL+++  +  + DFG    L+            G   Y+APE       
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVD---DVAKDIDAGCKPYMAPERINPELN 186

Query: 219 WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEP-----LIVKGKFKELV 273
               S   D++S GI ++E+   R P +            W  P      +V+       
Sbjct: 187 QKGYSVKSDIWSLGITMIELAILRFPYD-----------SWGTPFQQLKQVVEEP----- 230

Query: 274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKE 309
            P+L  D    +     +    C++   ++RP   E
Sbjct: 231 SPQLPADKFSAEFVDFTS---QCLKKNSKERPTYPE 263

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 98.2 bits (245), Expect = 7e-23
 Identities = 51/209 (24%), Positives = 83/209 (39%), Gaps = 21/209 (10%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLK--AMNSKAEMEFA-VEVEVLGRVRHKNLLGLRG 104
           +G G F  V   +     Q+ A+K +    M  + E+     E +VL     + +  L  
Sbjct: 69  IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLH- 127

Query: 105 YCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
           +    +  L +V +Y     LL+ L  ++   +  +  R        AE ++ +      
Sbjct: 128 FAFQDENYLYLVMEYYVGGDLLTLLS-KFGERIPAEMAR-----FYLAEIVMAIDSVHRL 181

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAK-LIPEGVSHMTTRVKGTLGYLAPE------- 215
             +HRDIK  N+LLD      +ADFG    L  +G       V GT  YL+PE       
Sbjct: 182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAV-GTPDYLSPEILQAVGG 240

Query: 216 YAMWGKVSESCDVYSFGILLLEILTGRKP 244
               G     CD ++ G+   E+  G+ P
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 98.2 bits (245), Expect = 7e-23
 Identities = 72/331 (21%), Positives = 126/331 (38%), Gaps = 64/331 (19%)

Query: 29  RIFTYKELHTA-----TNGFSDD----NKLGEGGFGSVYWGR-TSDGLQIAVK-----KL 73
           ++F + +L             D+      LG G  G V          ++A++     K 
Sbjct: 114 KVFVFFDLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKF 173

Query: 74  KAMNS-KAEMEFAV--EVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL-- 128
              ++ +A+    V  E+E+L ++ H  ++ ++ +    +   IV + M    L   +  
Sbjct: 174 AIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVG 232

Query: 129 HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL---V 185
           + +   E     K      +     + YLH      IIHRD+K  NVLL S  E     +
Sbjct: 233 NKRL-KEA--TCKLYFYQML---LAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI 283

Query: 186 ADFGFAKLIPEGVSHMTTRVKGTLGYLAPE---YAMWGKVSESCDVYSFGILLLEILTGR 242
            DFG +K++ E  S M T   GT  YLAPE          + + D +S G++L   L+G 
Sbjct: 284 TDFGHSKILGET-SLMRTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 341

Query: 243 KP--IEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLK----QAINVAVLC 296
            P    +    +K  IT         GK+          +F          +A+++    
Sbjct: 342 PPFSEHRTQVSLKDQIT--------SGKY----------NFIPEVWAEVSEKALDLVKKL 383

Query: 297 VQSEPEKRPNMKEVVNT--LTGYDPRGKVMQ 325
           +  +P+ R   +E +    L   D + K   
Sbjct: 384 LVVDPKARFTTEEALRHPWLQDEDMKRKFQD 414

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 98.4 bits (245), Expect = 2e-22
 Identities = 59/215 (27%), Positives = 91/215 (42%), Gaps = 40/215 (18%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLK--AMNSKAEMEFA-VEVEVLGRVRHKN---LLG 101
           +G GGFG VY  R +D  ++ A+K L    +  K     A  E  +L  V   +   ++ 
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 256

Query: 102 LRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAIGS 150
           +  Y   T  +L  + D M    L  HL             YA E+ L            
Sbjct: 257 MS-YAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL------------ 303

Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG 210
             G+ ++H+     +++RD+K +N+LLD      ++D G A    +   H    V GT G
Sbjct: 304 --GLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--ASV-GTHG 355

Query: 211 YLAPEYAMWGKV-SESCDVYSFGILLLEILTGRKP 244
           Y+APE    G     S D +S G +L ++L G  P
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 95.8 bits (239), Expect = 2e-22
 Identities = 56/227 (24%), Positives = 98/227 (43%), Gaps = 34/227 (14%)

Query: 34  KELHTATNGFSDD----NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEV 88
           ++LH  +  F+D       +G G +         +  ++ AVK +     K++ +   E+
Sbjct: 11  QQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKII----DKSKRDPTEEI 66

Query: 89  EVLGR-VRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQY----AGEVQLDWK 141
           E+L R  +H N++ L+          +V + M    LL  +     +    A  V     
Sbjct: 67  EILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV----- 121

Query: 142 RRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS---DFEPL-VADFGFAKLIPEG 197
             +   I     + YLH +    ++HRD+K SN+L      + E + + DFGFAK +   
Sbjct: 122 --LFT-ITKT--VEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173

Query: 198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
              + T    T  ++APE         +CD++S G+LL  +LTG  P
Sbjct: 174 NGLLMTPC-YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 95.3 bits (237), Expect = 3e-22
 Identities = 53/247 (21%), Positives = 84/247 (34%), Gaps = 54/247 (21%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVK-----KLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
            +G+G +G V            A+K     K++ +N K       EV ++ ++ H N+  
Sbjct: 33  AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92

Query: 102 LRG-------------YCAGTD--QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKI 146
           L                C G     +L V+           +            +  +  
Sbjct: 93  LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152

Query: 147 AIGSA---------------------EGILYLHHEVTPHIIHRDIKASNVLLDSD--FEP 183
           +I                          + YLH++    I HRDIK  N L  ++  FE 
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEI 209

Query: 184 LVADFGFAKLI----PEGVSHMTTRVKGTLGYLAPE--YAMWGKVSESCDVYSFGILLLE 237
            + DFG +K            MTT+  GT  ++APE            CD +S G+LL  
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKA-GTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHL 268

Query: 238 ILTGRKP 244
           +L G  P
Sbjct: 269 LLMGAVP 275

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 94.9 bits (236), Expect = 3e-22
 Identities = 55/334 (16%), Positives = 100/334 (29%), Gaps = 90/334 (26%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLGLRG- 104
            +G GGFG V+  +   D    A+K+++  N +   E  + EV+ L ++ H  ++     
Sbjct: 13  CMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 72

Query: 105 ----------------------YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQL---- 138
                                           +      +  +     +           
Sbjct: 73  WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSP 132

Query: 139 -----------------DW-KRRMKIAIGSAEGILYLHHEVT---PHI-----IHRDIKA 172
                            DW  RR  +        L++  ++      +     +HRD+K 
Sbjct: 133 KVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKP 192

Query: 173 SNVLLDSDFEPLVADFGFAKLI------------PEGVSHMTTRVKGTLGYLAPEYAMWG 220
           SN+    D    V DFG    +                +  T +V GT  Y++PE     
Sbjct: 193 SNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQV-GTKLYMSPEQIHGN 251

Query: 221 KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL--IVKGKFKELVDPKLR 278
             S   D++S G++L E+L               T  E    +  +   KF  L   K  
Sbjct: 252 NYSHKVDIFSLGLILFELLYS-----------FSTQMERVRIITDVRNLKFPLLFTQKYP 300

Query: 279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
                 Q    +      +   P +RP   +++ 
Sbjct: 301 ------QEHMMVQ---DMLSPSPTERPEATDIIE 325

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 94.2 bits (235), Expect = 4e-22
 Identities = 55/212 (25%), Positives = 87/212 (41%), Gaps = 31/212 (14%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKL-KAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           KLG G FG V+     S GL+  +K + K  +     +   E+EVL  + H N++ +   
Sbjct: 29  KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88

Query: 106 CAGTDQRLIVYDYMP----------NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGIL 155
                   IV +               +    L   Y  E+       MK  +     + 
Sbjct: 89  FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL-------MKQMM---NALA 138

Query: 156 YLHHEVTPHIIHRDIKASNVLLDS---DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYL 212
           Y H +   H++H+D+K  N+L           + DFG A+L      H T    GT  Y+
Sbjct: 139 YFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD-EHSTNAA-GTALYM 193

Query: 213 APEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           APE      V+  CD++S G+++  +LTG  P
Sbjct: 194 APE-VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 95.4 bits (237), Expect = 5e-22
 Identities = 50/317 (15%), Positives = 95/317 (29%), Gaps = 63/317 (19%)

Query: 43  FSDDNKLGEG--GFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV--EVEVLGRVRHK 97
           +     +G+G     +V   R    G  + V+++       EM   +  E+ V     H 
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 98  NLLGLRG-YCAGTDQRL-IVYDYMPNLSLLSHLHGQYAG---EVQLDWKRRMKIAI---G 149
           N++  R  + A  +  L +V  +M   S    +   +     E+         IA    G
Sbjct: 87  NIVPYRATFIADNE--LWVVTSFMAYGSAKDLICTHFMDGMNELA--------IAYILQG 136

Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK--- 206
             + + Y+HH      +HR +KAS++L+  D +  ++       +               
Sbjct: 137 VLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPK 193

Query: 207 ---GTLGYLAPE--YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLP------------ 249
                L +L+PE             D+YS GI   E+  G  P + +P            
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253

Query: 250 -----------------GGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINV 292
                               +          +     +          +         + 
Sbjct: 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHF 313

Query: 293 AVLCVQSEPEKRPNMKE 309
              C+Q  P+ RP+   
Sbjct: 314 VEQCLQRNPDARPSAST 330

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 94.7 bits (236), Expect = 8e-22
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 38/214 (17%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLKAMNSKAEMEFA---VEVEVLGRVRHKNLLGLRG 104
           +G+G FG V   + +D  ++ A+K +         E      E++++  + H  L+ L  
Sbjct: 23  IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLW- 81

Query: 105 YCAGTDQRL-IVYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAIGSAEG 153
           Y    ++ + +V D +    L  HL             +  E+ +        A+     
Sbjct: 82  YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVM--------ALD---- 129

Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLA 213
             YL ++    IIHRD+K  N+LLD      + DF  A ++P      T  + GT  Y+A
Sbjct: 130 --YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT--MAGTKPYMA 182

Query: 214 PEYAMWGKV---SESCDVYSFGILLLEILTGRKP 244
           PE     K    S + D +S G+   E+L GR+P
Sbjct: 183 PEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 94.8 bits (236), Expect = 9e-22
 Identities = 54/217 (24%), Positives = 86/217 (39%), Gaps = 42/217 (19%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLK--AMNSKAEMEFA-VEVEVLGRVRHKNLLGLRG 104
           +G G FG V   R     ++ A+K L    M  +++  F   E +++       ++ L  
Sbjct: 77  IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF- 135

Query: 105 YCAGTDQRL-IVYDYMPNLSLLSHLHGQ---------YAGEVQLDWKRRMKIAIGSAEGI 154
           Y    D+ L +V +YMP   L++ +            Y  EV L               +
Sbjct: 136 YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVL--------------AL 181

Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
             +H       IHRD+K  N+LLD      +ADFG    + +          GT  Y++P
Sbjct: 182 DAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISP 238

Query: 215 E-------YAMWGKVSESCDVYSFGILLLEILTGRKP 244
           E          +G+    CD +S G+ L E+L G  P
Sbjct: 239 EVLKSQGGDGYYGR---ECDWWSVGVFLYEMLVGDTP 272

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 92.7 bits (231), Expect = 1e-21
 Identities = 57/209 (27%), Positives = 92/209 (44%), Gaps = 28/209 (13%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKL--KAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
            LG+G FG V   +      + AVK +   +  +K       EVE+L ++ H N++ L  
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88

Query: 105 YCAGTDQRLIVYDYMPNLSLL------SHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
               +    IV +      L              A  +       +K       GI Y+H
Sbjct: 89  ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARI-------IKQVF---SGITYMH 138

Query: 159 HEVTPHIIHRDIKASNVLLDSDFE--PL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPE 215
                +I+HRD+K  N+LL+S  +   + + DFG +    +  + M  R+ GT  Y+APE
Sbjct: 139 KH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-TKMKDRI-GTAYYIAPE 193

Query: 216 YAMWGKVSESCDVYSFGILLLEILTGRKP 244
             + G   E CDV+S G++L  +L+G  P
Sbjct: 194 -VLRGTYDEKCDVWSAGVILYILLSGTPP 221

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 92.8 bits (231), Expect = 2e-21
 Identities = 58/272 (21%), Positives = 107/272 (39%), Gaps = 33/272 (12%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGR-VRHKNLLGLRG 104
           ++G G  G V+  R    G  IAVK+++   +K E +   ++++V+ +      ++   G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 105 YCAGTDQRLIVYDYM-PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                    I  + M      L         E  L      K+ +   + + YL  +   
Sbjct: 92  TFITNTDVFIAMELMGTCAEKLKKRMQGPIPERIL-----GKMTVAIVKALYYLKEKH-- 144

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
            +IHRD+K SN+LLD   +  + DFG +  + +  +       G   Y+APE       +
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA-KDRSA-GCAAYMAPERIDPPDPT 202

Query: 224 ES-----CDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR 278
           +       DV+S GI L+E+ TG+ P +         +T      +++ +      P L 
Sbjct: 203 KPDYDIRADVWSLGISLVELATGQFPYKN-CKTDFEVLT-----KVLQEE-----PPLLP 251

Query: 279 GDFD-ENQLKQAINVAVLCVQSEPEKRPNMKE 309
           G        +  +     C+  +  KRP   +
Sbjct: 252 GHMGFSGDFQSFVK---DCLTKDHRKRPKYNK 280

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 91.1 bits (227), Expect = 3e-21
 Identities = 47/207 (22%), Positives = 79/207 (38%), Gaps = 26/207 (12%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            +G G +G V         ++ A KK+     +    F  E+E++  + H N++ L    
Sbjct: 16  TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75

Query: 107 AGTDQRLIVYDYMPNLSLL------SHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
                  +V +      L              A  +       MK  +     + Y H  
Sbjct: 76  EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI-------MKDVL---SAVAYCHKL 125

Query: 161 VTPHIIHRDIKASNVLLDS---DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
              ++ HRD+K  N L  +   D    + DFG A     G   M T+V GT  Y++P+  
Sbjct: 126 ---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG-KMMRTKV-GTPYYVSPQ-V 179

Query: 218 MWGKVSESCDVYSFGILLLEILTGRKP 244
           + G     CD +S G+++  +L G  P
Sbjct: 180 LEGLYGPECDEWSAGVMMYVLLCGYPP 206

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 91.1 bits (227), Expect = 6e-21
 Identities = 55/209 (26%), Positives = 90/209 (43%), Gaps = 30/209 (14%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            LG G F  V+  +    G   A+K +K   +  +     E+ VL +++H+N++ L    
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75

Query: 107 AGTDQRLIVYDYMPNLSLLSHL--HGQY----AGEV--QLDWKRRMKIAIGSAEGILYLH 158
             T    +V   +    L   +   G Y    A  V  Q+               + YLH
Sbjct: 76  ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQV------------LSAVKYLH 123

Query: 159 HEVTPHIIHRDIKASNVLLDSDFE--PL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPE 215
                 I+HRD+K  N+L  +  E   + + DFG +K+   G+  M+T   GT GY+APE
Sbjct: 124 EN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTAC-GTPGYVAPE 177

Query: 216 YAMWGKVSESCDVYSFGILLLEILTGRKP 244
                  S++ D +S G++   +L G  P
Sbjct: 178 VLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 90.8 bits (226), Expect = 9e-21
 Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 30/211 (14%)

Query: 46  DNKLGEGGFGSVYWGR-TSDGLQIAVKKL-KAMNSKAEMEFAVEVEVLGRVR-HKNLLGL 102
           D  LGEG F               AVK + K M +  +     E+  L     H N++ L
Sbjct: 16  DKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQK----EITALKLCEGHPNIVKL 71

Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHL--HGQY----AGEVQLDWKRRMKIAIGSAEGILY 156
                      +V + +    L   +     +    A  +       M+  + SA  + +
Sbjct: 72  HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYI-------MRK-LVSA--VSH 121

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFE--PL-VADFGFAKLIPEGVSHMTTRVKGTLGYLA 213
           +H      ++HRD+K  N+L   + +   + + DFGFA+L P     + T    TL Y A
Sbjct: 122 MHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC-FTLHYAA 177

Query: 214 PEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           PE        ESCD++S G++L  +L+G+ P
Sbjct: 178 PELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 90.9 bits (226), Expect = 3e-20
 Identities = 61/213 (28%), Positives = 87/213 (40%), Gaps = 37/213 (17%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLKAMNSKAEMEFA---VEVEVLGRVRHKNLLGLRG 104
           LG+G FG V   +     +  A+K LK     A+ E A    E  VL   RH  L  L+ 
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214

Query: 105 YCAGTDQRL-IVYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAIGSAEG 153
           Y   T  RL  V +Y     L  HL  +          Y  E+                 
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS--------------A 260

Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLGY 211
           + YLH E   ++++RD+K  N++LD D    + DFG  K   EG+          GT  Y
Sbjct: 261 LDYLHSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKTFCGTPEY 315

Query: 212 LAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           LAPE         + D +  G+++ E++ GR P
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 89.7 bits (223), Expect = 3e-20
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 29/214 (13%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVK-----KLKAMNSK-AEMEFAV--EVEVLGRVRHKN 98
            LG G  G V          ++A+K     K    +++ A+    V  E+E+L ++ H  
Sbjct: 17  TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76

Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILY 156
           ++ ++ +    +   IV + M    L   +  + +     +   K      +     + Y
Sbjct: 77  IIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLK---EATCKLYFYQML---LAVQY 129

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPL---VADFGFAKLIPEGVSHMTTRVKGTLGYLA 213
           LH      IIHRD+K  NVLL S  E     + DFG +K++ E  S M T   GT  YLA
Sbjct: 130 LHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-SLMRTLC-GTPTYLA 184

Query: 214 PE---YAMWGKVSESCDVYSFGILLLEILTGRKP 244
           PE          + + D +S G++L   L+G  P
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 88.9 bits (221), Expect = 3e-20
 Identities = 58/229 (25%), Positives = 95/229 (41%), Gaps = 34/229 (14%)

Query: 39  ATNGFSDD----NKLGEGGFGSVYWGR-TSDGLQIAVK---KLKAMNSKAEMEFAV---- 86
           +T+GF ++      LG G    V          + AVK        +  AE    +    
Sbjct: 11  STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70

Query: 87  --EVEVLGRV-RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWK 141
             EV++L +V  H N++ L+          +V+D M    L  +L      + E   + +
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLS-EK--ETR 127

Query: 142 RRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM 201
           + M+  +   E I  LH     +I+HRD+K  N+LLD D    + DFGF+  +  G   +
Sbjct: 128 KIMRALL---EVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-EKL 180

Query: 202 TTRVKGTLGYLAPE------YAMWGKVSESCDVYSFGILLLEILTGRKP 244
                GT  YLAPE              +  D++S G+++  +L G  P
Sbjct: 181 REVC-GTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 89.6 bits (223), Expect = 3e-20
 Identities = 61/213 (28%), Positives = 103/213 (48%), Gaps = 22/213 (10%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV------EVEVLGRVRHKNL 99
           + LGEG F +VY  R  +    +A+KK+K +  ++E +  +      E+++L  + H N+
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIK-LGHRSEAKDGINRTALREIKLLQELSHPNI 74

Query: 100 LGLRGYCAGTDQRLIVYDYMPN-LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           +GL           +V+D+M   L ++   +        +  K  M + +   +G+ YLH
Sbjct: 75  IGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHI--KAYMLMTL---QGLEYLH 129

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM 218
                 I+HRD+K +N+LLD +    +ADFG AK         T +V  T  Y APE   
Sbjct: 130 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVV-TRWYRAPELLF 185

Query: 219 WGKV-SESCDVYSFGILLLEILTGRKPIEKLPG 250
             ++     D+++ G +L E+L  R P   LPG
Sbjct: 186 GARMYGVGVDMWAVGCILAELLL-RVPF--LPG 215

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 89.7 bits (223), Expect = 4e-20
 Identities = 51/212 (24%), Positives = 86/212 (40%), Gaps = 25/212 (11%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVK-----KLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
            +G+G F  V        G Q AVK     K  +    +  +   E  +   ++H +++ 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90

Query: 102 LRGYCAGTDQRLIVYDYMPNLSLL------SHLHGQYAGEVQLDWKRRMKIAIGSAEGIL 155
           L    +      +V+++M    L       +     Y+  V   + R++       E + 
Sbjct: 91  LLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI------LEALR 144

Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFE--PL-VADFGFAKLIPEGVSHMTTRVKGTLGYL 212
           Y H     +IIHRD+K   VLL S     P+ +  FG A  + E       RV GT  ++
Sbjct: 145 YCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV-GTPHFM 200

Query: 213 APEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           APE        +  DV+  G++L  +L+G  P
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLP 232

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 87.6 bits (218), Expect = 1e-19
 Identities = 61/215 (28%), Positives = 100/215 (46%), Gaps = 40/215 (18%)

Query: 49  LGEGGFGSVYWGR---TSDGLQI-AVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
           LG+G FG V+  +    SD  Q+ A+K LK   +  +  +   +E ++L  V H  ++ L
Sbjct: 32  LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91

Query: 103 RGYCAGTDQRL-IVYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAIGSA 151
             Y   T+ +L ++ D++    L + L  +          Y  E+ L             
Sbjct: 92  H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELAL------------- 137

Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTL 209
             + +LH      II+RD+K  N+LLD +    + DFG +K   E + H        GT+
Sbjct: 138 -ALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTV 190

Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
            Y+APE       ++S D +SFG+L+ E+LTG  P
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLP 225

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 86.8 bits (216), Expect = 1e-19
 Identities = 53/218 (24%), Positives = 89/218 (40%), Gaps = 39/218 (17%)

Query: 40  TNGFSDD----NKLGEGGFGSVYWGR-TSDGLQIAVKKL--KAMNSKAEMEFAVEVEVLG 92
           +  FSD+     +LG+G F  V      + GL+ A K +  K ++++   +   E  +  
Sbjct: 1   STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60

Query: 93  RVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQY----AGEV--QLDWKRRM 144
           +++H N++ L           +V+D +    L   +     Y    A     Q+      
Sbjct: 61  KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQI------ 114

Query: 145 KIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL---VADFGFAKLIPEGVSHM 201
                  E I Y H      I+HR++K  N+LL S  +     +ADFG A  + +     
Sbjct: 115 ------LESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAW 164

Query: 202 TTRVKGTLGYLAPEYAMWGKVSESCDVYSFG----ILL 235
                GT GYL+PE       S+  D+++ G    ILL
Sbjct: 165 HGFA-GTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 59/257 (22%), Positives = 100/257 (38%), Gaps = 41/257 (15%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR-HKNLLGLRGYC 106
           LGEG    V          + AVK ++            EVE+L + + H+N+L L  + 
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 107 AGTDQRLIVYDYMPNLSLLSHLH--GQY----AGEVQLDWKRRMKIAIGSAEGILYLHHE 160
              D+  +V++ M   S+LSH+H    +    A  V       ++  + SA  + +LH  
Sbjct: 81  EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVV-------VQD-VASA--LDFLH-- 128

Query: 161 VTPHIIHRDIKASNVLLDSDFE--PL-VADFGFAKLIPEGVSH-------MTTRVKGTLG 210
               I HRD+K  N+L +   +  P+ + DF     I             + T   G+  
Sbjct: 129 -NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC-GSAE 186

Query: 211 YLAPE-----YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIV 265
           Y+APE             + CD++S G++L  +L+G  P      G   +   W      
Sbjct: 187 YMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFV----GRCGSDCGWDRGEAC 242

Query: 266 KGKFKELVDPKLRGDFD 282
                 L +    G ++
Sbjct: 243 PACQNMLFESIQEGKYE 259

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 51/221 (23%), Positives = 86/221 (38%), Gaps = 41/221 (18%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVK---KLKAMNSKAEMEFAV-----EVEVLGRVR-HK 97
            +G G    V      + G + AVK         S  ++E        E  +L +V  H 
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160

Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQY----AGEV--QLDWKRRMKIAIG 149
           +++ L      +    +V+D M    L  +L             +   L           
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSL----------- 209

Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
             E + +LH     +I+HRD+K  N+LLD + +  ++DFGF+  +  G   +     GT 
Sbjct: 210 -LEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG-EKLRELC-GTP 263

Query: 210 GYLAPE------YAMWGKVSESCDVYSFGILLLEILTGRKP 244
           GYLAPE              +  D+++ G++L  +L G  P
Sbjct: 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 58/236 (24%), Positives = 93/236 (39%), Gaps = 43/236 (18%)

Query: 31  FTYKELHTATNGFSDD-----NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEF 84
             ++         +DD       LG G  G V        G + A+K L      +    
Sbjct: 14  VLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL----YDSPKAR 69

Query: 85  AVEVEVLGRV-RHKNLLGLRGYC----AGTDQRLIVYDYMPNLSLLSHL----HGQY--- 132
             EV+   +     +++ +         G    LI+ + M    L S +       +   
Sbjct: 70  Q-EVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTER 128

Query: 133 -AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE--PL-VADF 188
            A E+       M+  IG+A  I +LH     +I HRD+K  N+L  S  +   L + DF
Sbjct: 129 EAAEI-------MRD-IGTA--IQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDF 175

Query: 189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           GFAK   +    + T    T  Y+APE     K  +SCD++S G+++  +L G  P
Sbjct: 176 GFAKETTQNA--LQTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 86.4 bits (215), Expect = 2e-19
 Identities = 48/212 (22%), Positives = 97/212 (45%), Gaps = 22/212 (10%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV------EVEVLGRVRHKNL 99
            K+GEG +G+V+  +       +A+K+++ ++   E    V      E+ +L  ++HKN+
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVR-LDDDDE---GVPSSALREICLLKELKHKNI 63

Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           + L        +  +V+++     L  +             K  +   +   +G+ + H 
Sbjct: 64  VRLHDVLHSDKKLTLVFEFCD-QDLKKYFDSCNGDLDPEIVKSFLFQLL---KGLGFCHS 119

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
               +++HRD+K  N+L++ + E  +A+FG A+     V   +  V  TL Y  P+    
Sbjct: 120 R---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVV-TLWYRPPDVLFG 175

Query: 220 GKV-SESCDVYSFGILLLEILTGRKPIEKLPG 250
            K+ S S D++S G +  E+    +P+   PG
Sbjct: 176 AKLYSTSIDMWSAGCIFAELANAGRPL--FPG 205

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 88.4 bits (219), Expect = 3e-19
 Identities = 44/232 (18%), Positives = 92/232 (39%), Gaps = 21/232 (9%)

Query: 23  PNNATWRIFTYKELHTATNGFSD----DNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMN 77
                W+ +  + +    +   D      +LG G FG V+     + G   A K +   +
Sbjct: 135 YVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH 194

Query: 78  SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHL---HGQYAG 134
              +     E++ +  +RH  L+ L       ++ +++Y++M    L   +   H + + 
Sbjct: 195 ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMS- 253

Query: 135 EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV--ADFGFAK 192
             + +    M+      +G+ ++H     + +H D+K  N++  +     +   DFG   
Sbjct: 254 --EDEAVEYMRQVC---KGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTA 305

Query: 193 LIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
            +      +     GT  + APE A    V    D++S G+L   +L+G  P
Sbjct: 306 HLDPK-QSVKVTT-GTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 86.6 bits (215), Expect = 3e-19
 Identities = 62/287 (21%), Positives = 113/287 (39%), Gaps = 67/287 (23%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKL--KAMNSKAEMEFAV----EVEVLGRVRHK--NL 99
           LG GGFGSVY G   SD L +A+K +    ++   E+        EV +L +V      +
Sbjct: 51  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110

Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ--LDWKRRMK----------IA 147
           + L  +    D  +++ +                 ++   +  +  ++          + 
Sbjct: 111 IRLLDWFERPDSFVLILERPEP-----------VQDLFDFITERGALQEELARSFFWQVL 159

Query: 148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTRVK 206
               E + + H+     ++HRDIK  N+L+D +   L + DFG   L+ +     T    
Sbjct: 160 ----EAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFD- 209

Query: 207 GTLGYLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIV 265
           GT  Y  PE+  + +    S  V+S GILL +++ G  P E      +          I+
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFE----HDEE---------II 256

Query: 266 KGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
           +G+       +       ++ +  I     C+   P  RP  +E+ N
Sbjct: 257 RGQVFF---RQ----RVSSECQHLIR---WCLALRPSDRPTFEEIQN 293

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 86.5 bits (215), Expect = 3e-19
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 14/207 (6%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEF-AV-EVEVLGRVRHKNLLGLRG 104
            K+GEG +G VY  + S G  +A+K+++       +   A+ E+ +L  + H N++ L  
Sbjct: 27  EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLID 86

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                    +V+++M    L   L     G      K  +   +    G+ + H      
Sbjct: 87  VIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLL---RGVAHCHQH---R 139

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
           I+HRD+K  N+L++SD    +ADFG A+     V   T  V  TL Y AP+  M  K  S
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV-TLWYRAPDVLMGSKKYS 198

Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPG 250
            S D++S G +  E++T  KP+   PG
Sbjct: 199 TSVDIWSIGCIFAEMIT-GKPL--FPG 222

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 86.4 bits (215), Expect = 3e-19
 Identities = 67/221 (30%), Positives = 97/221 (43%), Gaps = 57/221 (25%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLKAMNSKAEMEFAVEVE-------VLGRVRHKNLL 100
           LG G FG V+  R+    +  A+K LK    K  +    +VE       +L  V H  ++
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLK----KEIVVRLKQVEHTNDERLMLSIVTHPFII 69

Query: 101 GLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAIG 149
            +        Q++ ++ DY+    L S L             YA EV L           
Sbjct: 70  RMW-GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL----------- 117

Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
               + YLH +    II+RD+K  N+LLD +    + DFGFAK +P+    +T  + GT 
Sbjct: 118 ---ALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTP 167

Query: 210 GYLAPE------YAMWGKVSESCDVYSFGILLLEILTGRKP 244
            Y+APE      Y    K   S D +SFGIL+ E+L G  P
Sbjct: 168 DYIAPEVVSTKPY---NK---SIDWWSFGILIYEMLAGYTP 202

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 51/221 (23%), Positives = 91/221 (41%), Gaps = 46/221 (20%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKL--KAMNSKAEMEFAV----EVEVLGRVR----HK 97
           LG+GGFG+V+ G   +D LQ+A+K +    +   + +  +V    EV +L +V     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98

Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ--LDWKRRMK---------- 145
            ++ L  +    +  ++V +               A ++   +  K  +           
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLP-----------AQDLFDYITEKGPLGEGPSRCFFGQ 147

Query: 146 IAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTR 204
           +       I + H      ++HRDIK  N+L+D       + DFG   L+ +     T  
Sbjct: 148 VV----AAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDF 198

Query: 205 VKGTLGYLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKP 244
             GT  Y  PE+    +  +    V+S GILL +++ G  P
Sbjct: 199 D-GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 86.5 bits (215), Expect = 4e-19
 Identities = 64/226 (28%), Positives = 110/226 (48%), Gaps = 39/226 (17%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEME-FAV----EVEVLGRVRHKNLL 100
            K+G+G FG V+  R    G ++A+KK+  M +  E E F +    E+++L  ++H+N++
Sbjct: 23  AKIGQGTFGEVFKARHRKTGQKVALKKVL-MEN--EKEGFPITALREIKILQLLKHENVV 79

Query: 101 GLRGYCAGTDQRL--------IVYDYMPN--LSLLSHLHGQY-AGEVQLDWKRRMKIAIG 149
            L   C               +V+D+  +    LLS++  ++   E+    KR M++ + 
Sbjct: 80  NLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI----KRVMQMLL- 134

Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG----FAKLIPEGVSHMTTRV 205
              G+ Y+H      I+HRD+KA+NVL+  D    +ADFG    F+       +  T RV
Sbjct: 135 --NGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV 189

Query: 206 KGTLGYLAPEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEKLPG 250
             TL Y  PE  +  +      D++  G ++ E+ T R PI  + G
Sbjct: 190 V-TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT-RSPI--MQG 231

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 86.6 bits (215), Expect = 4e-19
 Identities = 54/215 (25%), Positives = 87/215 (40%), Gaps = 45/215 (20%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLKAMNSKAEMEFAVEVE-------VLGRVRHKNLL 100
           LG G FG V   +  +     A+K L     K ++    ++E       +L  V    L+
Sbjct: 49  LGTGSFGRVMLVKHKESGNHYAMKILD----KQKVVKLKQIEHTLNEKRILQAVNFPFLV 104

Query: 101 GLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAIG 149
            L  +    +  L +V +Y+    + SHL             YA ++ L           
Sbjct: 105 KLE-FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL----------- 152

Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTL 209
                 YLH      +I+RD+K  N+L+D      V DFGFAK +       T  + GT 
Sbjct: 153 ---TFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG----RTWTLCGTP 202

Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
             LAPE  +    +++ D ++ G+L+ E+  G  P
Sbjct: 203 EALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 86.1 bits (213), Expect = 5e-19
 Identities = 74/346 (21%), Positives = 114/346 (32%), Gaps = 99/346 (28%)

Query: 46  DNKLGEGGFGSVYWG------RTSDGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRV-RHK 97
              LG G FG V         +T+    +AVK LK             E+++L  +  H 
Sbjct: 27  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86

Query: 98  NLLGLRGYCAGTDQRL-IVYDYMPNLSLLSHL-------------------HGQYAGEVQ 137
           N++ L G C      L ++ ++    +L ++L                      Y G + 
Sbjct: 87  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIP 146

Query: 138 LDWKRRMKIAIGS-------------------------------------------AEGI 154
           +D KRR+     S                                           A+G+
Sbjct: 147 VDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGM 206

Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYL-- 212
            +L        IHRD+ A N+LL       + DFG A+ I +   +    V+     L  
Sbjct: 207 EFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY----VRKGDARLPL 259

Query: 213 ---APEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGK 268
              APE       +   DV+SFG+LL EI + G  P    PG     +    E       
Sbjct: 260 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP---YPG-----VKIDEE------- 304

Query: 269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           F   +    R    +    +     + C   EP +RP   E+V  L
Sbjct: 305 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 350

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 86.3 bits (214), Expect = 7e-19
 Identities = 66/231 (28%), Positives = 92/231 (39%), Gaps = 42/231 (18%)

Query: 36  LHTATNGFSDD-----NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVE 89
           L    N   DD       LG G  G V          + A+K L             EVE
Sbjct: 52  LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML----QDCPKARR-EVE 106

Query: 90  VLGRV-RHKNLLGLRGYC----AGTDQRLIVYDYMPNLSLLSHL----HGQY----AGEV 136
           +  R  +  +++ +        AG    LIV + +    L S +       +    A E+
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 166

Query: 137 QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE--PL-VADFGFAKL 193
                  MK  IG A  I YLH     +I HRD+K  N+L  S      L + DFGFAK 
Sbjct: 167 -------MKS-IGEA--IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213

Query: 194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
                S +TT    T  Y+APE     K  +SCD++S G+++  +L G  P
Sbjct: 214 TTSHNS-LTTPC-YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPP 262

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 85.4 bits (212), Expect = 8e-19
 Identities = 62/213 (29%), Positives = 86/213 (40%), Gaps = 38/213 (17%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLKAMNSKAEMEFA---VEVEVLGRVRHKNLLGLRG 104
           LG+G FG V   R     +  A+K L+     A+ E A    E  VL   RH  L  L+ 
Sbjct: 13  LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71

Query: 105 YCAGTDQRL-IVYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAIGSAEG 153
           Y   T  RL  V +Y     L  HL  +          Y  E+                 
Sbjct: 72  YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS--------------A 117

Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLGY 211
           + YLH      +++RDIK  N++LD D    + DFG  K   EG+S         GT  Y
Sbjct: 118 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEY 171

Query: 212 LAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           LAPE         + D +  G+++ E++ GR P
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 70/345 (20%), Positives = 126/345 (36%), Gaps = 79/345 (22%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKL--KAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           +LG+G F  V      + GL+ A K +  K ++++   +   E  +  +++H N++ L  
Sbjct: 36  ELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD 95

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL--HGQY----AGEVQLDWKRRMKIAIGSAEGILYLH 158
                    +V+D +    L   +     Y    A          ++  +   E I Y H
Sbjct: 96  SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHC-------IQQIL---ESIAYCH 145

Query: 159 HEVTPHIIHRDIKASNVLLDSDFE--PL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPE 215
                 I+HR++K  N+LL S  +   + +ADFG A  + +          GT GYL+PE
Sbjct: 146 SN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-EAWHGFA-GTPGYLSPE 200

Query: 216 YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEP------LIVKGKF 269
                  S+  D+++ G++L  +L G  P              W E        I  G +
Sbjct: 201 VLKKDPYSKPVDIWACGVILYILLVGYPPF-------------WDEDQHRLYAQIKAGAY 247

Query: 270 --------------KELV------DPKLRGDFDENQL--KQAINVAVLCVQSEPEKRPNM 307
                         K L+      +PK R       +   QA+ V  +C +       + 
Sbjct: 248 DYPSPEWDTVTPEAKSLIDSMLTVNPKKR-------ITADQALKVPWICNRERVASAIHR 300

Query: 308 KEVVNTLTGYDPRGK----VMQTRIETLAYKEELLAFDQTTDDDD 348
           ++ V+ L  ++ R K    ++ T I T              +   
Sbjct: 301 QDTVDCLKKFNARRKLKGAILTTMIATRNLSNLGRNLLNKKEQGP 345

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 42/225 (18%), Positives = 86/225 (38%), Gaps = 15/225 (6%)

Query: 27  TWRIFTYKELHTATNGFSD----DNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAE 81
            W+ +  + +        D      +LG G FG V+     + G     K +       +
Sbjct: 33  IWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDK 92

Query: 82  MEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWK 141
                E+ ++ ++ H  L+ L        + +++ +++    L   +  +     + +  
Sbjct: 93  YTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVI 152

Query: 142 RRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV--ADFGFAKLIPEGVS 199
             M+ A    EG+ ++H      I+H DIK  N++ ++     V   DFG A  +     
Sbjct: 153 NYMRQAC---EGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-E 205

Query: 200 HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
            +      T  + APE      V    D+++ G+L   +L+G  P
Sbjct: 206 IVKVTT-ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 44/210 (20%), Positives = 83/210 (39%), Gaps = 42/210 (20%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKL--KAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           +LG+G F  V        G + A   +  K ++++   +   E  +   ++H N++ L  
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD 77

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL--HGQY----AGEVQLDWKRRMKIAIGSAEGILYLH 158
             +      +++D +    L   +     Y    A          ++  +   E +L+ H
Sbjct: 78  SISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHC-------IQQIL---EAVLHCH 127

Query: 159 HEVTPHIIHRDIKASNVLLDSDFE--PL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPE 215
                 ++HR++K  N+LL S  +   + +ADFG A  +            GT GYL+PE
Sbjct: 128 QM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPE 183

Query: 216 ------YAMWGKVSESCDVYSFG----ILL 235
                 Y       +  D+++ G    ILL
Sbjct: 184 VLRKDPY------GKPVDLWACGVILYILL 207

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 84.0 bits (208), Expect = 3e-18
 Identities = 68/360 (18%), Positives = 120/360 (33%), Gaps = 85/360 (23%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVK--------KLKAMNSKAEMEFAVEVEVLGRVRHKNL 99
           LG G FG V+         ++ VK        +   +      +  +E+ +L RV H N+
Sbjct: 32  LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91

Query: 100 LGLRGYCAGTDQRLIVYDYMPN-----LSLLSHLHGQYAGEV--QLDWKRRMKIAIGS-- 150
           + +              D   N     L +  H  G    ++   +D   R+   + S  
Sbjct: 92  IKV-------------LDIFENQGFFQLVMEKHGSG---LDLFAFIDRHPRLDEPLASYI 135

Query: 151 ----AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVK 206
                  + YL  +    IIHRDIK  N+++  DF   + DFG A  +  G     T   
Sbjct: 136 FRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG-KLFYTFC- 190

Query: 207 GTLGYLAPE------YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWA 260
           GT+ Y APE      Y   G      +++S G+ L  ++    P       ++       
Sbjct: 191 GTIEYCAPEVLMGNPYR--GP---ELEMWSLGVTLYTLVFEENPFC----ELEE------ 235

Query: 261 EPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPR 320
               V+        P L      + +   +          PE+R  ++++V      DP 
Sbjct: 236 ---TVEAAIHP---PYLVSKELMSLVSGLLQP-------VPERRTTLEKLVT-----DPW 277

Query: 321 GKVMQTRIETLAYKEELLAFDQTTDDDDRDPGNQELGVFGHTKVQKMRAPYNQFGDQKMH 380
              +   +    Y  E +      +       + E+G    + V + +      G    H
Sbjct: 278 ---VTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVAQAQELCGGEGHHHHH 334

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 85.1 bits (210), Expect = 4e-18
 Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 39/214 (18%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLK--AMNSKAEMEFA-VEVEVLGRV-RHKNLLGLR 103
           LG+G FG V         ++ AVK LK   +    ++E   VE  VL    +   L  L 
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408

Query: 104 GYCAGTDQRL-IVYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAIGSAE 152
             C  T  RL  V +Y+    L+ H+             YA E+ +              
Sbjct: 409 -SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI-------------- 453

Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           G+ +L  +    II+RD+K  NV+LDS+    +ADFG  K   E +     T    GT  
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKTFCGTPD 507

Query: 211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           Y+APE   +    +S D ++FG+LL E+L G+ P
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 83.0 bits (206), Expect = 5e-18
 Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 50/221 (22%)

Query: 49  LGEGGFGSVYWGRTSDGLQI----AVKKLKAMNSKAE-MEFAVEVE-------VLGRVRH 96
           LG+GG+G V+  R   G       A+K LK    KA  +  A +         +L  V+H
Sbjct: 25  LGKGGYGKVFQVRKVTGANTGKIFAMKVLK----KAMIVRNAKDTAHTKAERNILEEVKH 80

Query: 97  KNLLGLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMK 145
             ++ L  Y   T  +L ++ +Y+    L   L  +          Y  E+ +       
Sbjct: 81  PFIVDLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISM------- 132

Query: 146 IAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTT 203
                   + +LH +    II+RD+K  N++L+      + DFG  K   E +    +T 
Sbjct: 133 -------ALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCK---ESIHDGTVTH 179

Query: 204 RVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
              GT+ Y+APE  M    + + D +S G L+ ++LTG  P
Sbjct: 180 TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPP 220

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 82.6 bits (205), Expect = 5e-18
 Identities = 55/209 (26%), Positives = 104/209 (49%), Gaps = 13/209 (6%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEF-AV-EVEVLGRVRHKNLLGLR 103
            KLG G + +VY G   + G+ +A+K++K ++S+      A+ E+ ++  ++H+N++ L 
Sbjct: 11  EKLGNGTYATVYKGLNKTTGVYVALKEVK-LDSEEGTPSTAIREISLMKELKHENIVRLY 69

Query: 104 GYCAGTDQRLIVYDYMPN-LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
                 ++  +V+++M N L               L+            +G+ + H    
Sbjct: 70  DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN-- 127

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
             I+HRD+K  N+L++   +  + DFG A+     V+  ++ V  TL Y AP+  M  + 
Sbjct: 128 -KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVV-TLWYRAPDVLMGSRT 185

Query: 223 -SESCDVYSFGILLLEILTGRKPIEKLPG 250
            S S D++S G +L E++T  KP+   PG
Sbjct: 186 YSTSIDIWSCGCILAEMIT-GKPL--FPG 211

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 81.8 bits (203), Expect = 8e-18
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 14/207 (6%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEF-AV-EVEVLGRVRHKNLLGLRG 104
            K+GEG +G VY  + + G   A+KK++       +    + E+ +L  ++H N++ L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                 + ++V++++    L   L     G   +  K  +   +    GI Y H      
Sbjct: 68  VIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLL---NGIAYCHDR---R 120

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV-S 223
           ++HRD+K  N+L++ + E  +ADFG A+     V   T  +  TL Y AP+  M  K  S
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-TLWYRAPDVLMGSKKYS 179

Query: 224 ESCDVYSFGILLLEILTGRKPIEKLPG 250
            + D++S G +  E++    P+   PG
Sbjct: 180 TTIDIWSVGCIFAEMVN-GTPL--FPG 203

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 83.1 bits (206), Expect = 9e-18
 Identities = 65/214 (30%), Positives = 92/214 (42%), Gaps = 39/214 (18%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLK--AMNSKAEMEFA-VEVEVLGR-VRHKNLLGLR 103
           +G+G FG V   R        AVK L+  A+  K E +    E  VL + V+H  L+GL 
Sbjct: 46  IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 105

Query: 104 GYCAGTDQRL-IVYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAIGSAE 152
            +   T  +L  V DY+    L  HL  +          YA E+                
Sbjct: 106 -FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIAS-------------- 150

Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
            + YLH     +I++RD+K  N+LLDS    ++ DFG  K   E + H   T+   GT  
Sbjct: 151 ALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGTPE 204

Query: 211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           YLAPE         + D +  G +L E+L G  P
Sbjct: 205 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 82.8 bits (205), Expect = 9e-18
 Identities = 56/209 (26%), Positives = 87/209 (41%), Gaps = 31/209 (14%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
           +LG G    VY  +        A+K LK   +  +     E+ VL R+ H N++ L+   
Sbjct: 60  ELGRGATSIVYRCKQKGTQKPYALKVLK--KTVDKKIVRTEIGVLLRLSHPNIIKLKEIF 117

Query: 107 AGTDQRLIVYDYMPNLSLLSHL--HGQY----AGEV--QLDWKRRMKIAIGSAEGILYLH 158
               +  +V + +    L   +   G Y    A +   Q+             E + YLH
Sbjct: 118 ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI------------LEAVAYLH 165

Query: 159 HEVTPHIIHRDIKASNVLLDSDFE--PL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPE 215
                 I+HRD+K  N+L  +     PL +ADFG +K++      M T   GT GY APE
Sbjct: 166 EN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ-VLMKTVC-GTPGYCAPE 220

Query: 216 YAMWGKVSESCDVYSFGILLLEILTGRKP 244
                      D++S GI+   +L G +P
Sbjct: 221 ILRGCAYGPEVDMWSVGIITYILLCGFEP 249

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 51/210 (24%), Positives = 88/210 (41%), Gaps = 24/210 (11%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVK-----KLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +LG G F  V   R  S GL+ A K     + +A       E    EV +L +V H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVI 78

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
            L          +++ + +    L   L      +   + +    +K  +   +G+ YLH
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLS---EEEATSFIKQIL---DGVNYLH 132

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            +    I H D+K  N++L     P+    + DFG A  I +G         GT  ++AP
Sbjct: 133 TK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIF-GTPEFVAP 187

Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           E   +  +    D++S G++   +L+G  P
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASP 217

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 82.3 bits (204), Expect = 1e-17
 Identities = 61/214 (28%), Positives = 95/214 (44%), Gaps = 39/214 (18%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLK--AMNSKAEMEFA-VEVEVLGRV-RHKNLLGLR 103
           +G G +  V   R     +I A+K +K   +N   ++++   E  V  +   H  L+GL 
Sbjct: 17  IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76

Query: 104 GYCAGTDQRL-IVYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAIGSAE 152
             C  T+ RL  V +Y+    L+ H+  Q          Y+ E+ L              
Sbjct: 77  -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL-------------- 121

Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
            + YLH      II+RD+K  NVLLDS+    + D+G  K   EG+     T+   GT  
Sbjct: 122 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPN 175

Query: 211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           Y+APE         S D ++ G+L+ E++ GR P
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 209

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 65/218 (29%), Positives = 93/218 (42%), Gaps = 47/218 (21%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLKAMNSKAEMEFAVEVE-------VLGRV-RHKNL 99
           LG+G FG V+        Q  A+K LK    K  +    +VE       VL     H  L
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALK----KDVVLMDDDVECTMVEKRVLSLAWEHPFL 80

Query: 100 LGLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAI 148
             +      T + L  V +Y+    L+ H+             YA E+ L          
Sbjct: 81  THMF-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL---------- 129

Query: 149 GSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVK 206
               G+ +LH +    I++RD+K  N+LLD D    +ADFG  K   E +     T    
Sbjct: 130 ----GLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCK---ENMLGDAKTNTFC 179

Query: 207 GTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           GT  Y+APE  +  K + S D +SFG+LL E+L G+ P
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 82.4 bits (204), Expect = 2e-17
 Identities = 60/214 (28%), Positives = 95/214 (44%), Gaps = 39/214 (18%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLK--AMNSKAEMEFA-VEVEVLGRV-RHKNLLGLR 103
           +G G +  V   R     +I A++ +K   +N   ++++   E  V  +   H  L+GL 
Sbjct: 60  IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119

Query: 104 GYCAGTDQRL-IVYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAIGSAE 152
             C  T+ RL  V +Y+    L+ H+  Q          Y+ E+ L              
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISL-------------- 164

Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
            + YLH      II+RD+K  NVLLDS+    + D+G  K   EG+     T+   GT  
Sbjct: 165 ALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCK---EGLRPGDTTSTFCGTPN 218

Query: 211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           Y+APE         S D ++ G+L+ E++ GR P
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 81.9 bits (203), Expect = 2e-17
 Identities = 64/214 (29%), Positives = 94/214 (43%), Gaps = 39/214 (18%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLK--AMNSKAEMEFA-VEVEVLGRV-RHKNLLGLR 103
           LG+G FG V         ++ AVK LK   +    ++E   VE  VL    +   L  L 
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87

Query: 104 GYCAGTDQRL-IVYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAIGSAE 152
             C  T  RL  V +Y+    L+ H+             YA E+ +              
Sbjct: 88  -SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAI-------------- 132

Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
           G+ +L  +    II+RD+K  NV+LDS+    +ADFG  K   E +     T    GT  
Sbjct: 133 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCK---ENIWDGVTTKTFCGTPD 186

Query: 211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           Y+APE   +    +S D ++FG+LL E+L G+ P
Sbjct: 187 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 52/244 (21%), Positives = 96/244 (39%), Gaps = 47/244 (19%)

Query: 33  YKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAV------ 86
             ELH   + ++    +  G +G+V  G  S+G+ +A+K++    S       +      
Sbjct: 14  IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLC 73

Query: 87  -----EVEVLGRVRHKNLLGLRG-YCAGTDQRL----IVYDYMP---------NLSLLSH 127
                E+ +L    H N+LGLR  +    +  +    +V + M             ++S 
Sbjct: 74  KRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISP 133

Query: 128 LHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD 187
            H QY     +              G+  LH      ++HRD+   N+LL  + +  + D
Sbjct: 134 QHIQYF-MYHI------------LLGLHVLH---EAGVVHRDLHPGNILLADNNDITICD 177

Query: 188 FGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPIE 246
           F  A+      ++ T  V     Y APE  M +   ++  D++S G ++ E+   RK + 
Sbjct: 178 FNLAREDTAD-ANKTHYV-THRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-NRKAL- 233

Query: 247 KLPG 250
              G
Sbjct: 234 -FRG 236

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 81.2 bits (201), Expect = 2e-17
 Identities = 53/226 (23%), Positives = 87/226 (38%), Gaps = 56/226 (24%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKL--KAMNSKAEMEFAV--EVEVLGRVRHKNLLGLR 103
           LGEG +G V     +    + AVK L  K +      E  V  E+++L R+RHKN++ L 
Sbjct: 13  LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72

Query: 104 G---------------YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAI 148
                           YC    Q +   D +P                    ++R  +  
Sbjct: 73  DVLYNEEKQKMYMVMEYCVCGMQEM--LDSVP--------------------EKRFPVCQ 110

Query: 149 GSA------EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS-HM 201
                    +G+ YLH +    I+H+DIK  N+LL +     ++  G A+ +    +   
Sbjct: 111 AHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDT 167

Query: 202 TTRVKGTLGYLAPEYAMWGKV---SESCDVYSFGILLLEILTGRKP 244
               +G+  +  PE A         +  D++S G+ L  I TG  P
Sbjct: 168 CRTSQGSPAFQPPEIANGLDTFSGFKV-DIWSAGVTLYNITTGLYP 212

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 80.7 bits (200), Expect = 2e-17
 Identities = 49/210 (23%), Positives = 85/210 (40%), Gaps = 24/210 (11%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVK-----KLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +LG G F  V   R    G + A K     +L +       E    EV +L  +RH N++
Sbjct: 12  ELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
            L          +++ + +    L   L          + +  + +K  +   +G+ YLH
Sbjct: 72  TLHDIFENKTDVVLILELVSGGELFDFLAEKESLT---EDEATQFLKQIL---DGVHYLH 125

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            +    I H D+K  N++L     P     + DFG A  I  G +       GT  ++AP
Sbjct: 126 SK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG-NEFKNIF-GTPEFVAP 180

Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           E   +  +    D++S G++   +L+G  P
Sbjct: 181 EIVNYEPLGLEADMWSIGVITYILLSGASP 210

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 81.6 bits (202), Expect = 2e-17
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 40/218 (18%)

Query: 49  LGEGGFGSVYWGR---TSDGLQI-AVKKLK--AMNSKAEMEFAVEVE--VLGRVRHKN-L 99
           LG G +G V+  R     D  ++ A+K LK   +  KA+       E  VL  +R    L
Sbjct: 62  LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121

Query: 100 LGLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAI 148
           + L  Y   T+ +L ++ DY+    L +HL  +          Y GE+ L          
Sbjct: 122 VTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVL---------- 170

Query: 149 GSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGT 208
                + +LH      II+RDIK  N+LLDS+   ++ DFG +K      +       GT
Sbjct: 171 ----ALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGT 223

Query: 209 LGYLAPEYAMWGKV--SESCDVYSFGILLLEILTGRKP 244
           + Y+AP+    G     ++ D +S G+L+ E+LTG  P
Sbjct: 224 IEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 51/219 (23%), Positives = 92/219 (42%), Gaps = 30/219 (13%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEF-------AV-EVEVLGR 93
           +   +KLGEG + +VY G+       +A+K+++       +E        A+ EV +L  
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR-------LEHEEGAPCTAIREVSLLKD 56

Query: 94  VRHKNLLGLRGYCAGTDQRLIVYDYMPN-LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE 152
           ++H N++ L           +V++Y+   L       G       +  K  +   +    
Sbjct: 57  LKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNV--KLFLFQLL---R 111

Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYL 212
           G+ Y H      ++HRD+K  N+L++   E  +ADFG A+            V  TL Y 
Sbjct: 112 GLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV-TLWYR 167

Query: 213 APEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEKLPG 250
            P+  +     S   D++  G +  E+ T  +P+   PG
Sbjct: 168 PPDILLGSTDYSTQIDMWGVGCIFYEMAT-GRPL--FPG 203

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 81.3 bits (201), Expect = 3e-17
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 11/205 (5%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
            S    LG G FG V+    T+ GL++A K +K    K + E   E+ V+ ++ H NL+ 
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
           L       +  ++V +Y+    L   +  +     +LD    MK      EGI ++H   
Sbjct: 151 LYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQIC---EGIRHMHQM- 206

Query: 162 TPHIIHRDIKASNVLLDSDFEPLV--ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
             +I+H D+K  N+L  +     +   DFG A+        +     GT  +LAPE   +
Sbjct: 207 --YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK-LKVNF-GTPEFLAPEVVNY 262

Query: 220 GKVSESCDVYSFGILLLEILTGRKP 244
             VS   D++S G++   +L+G  P
Sbjct: 263 DFVSFPTDMWSVGVIAYMLLSGLSP 287

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 80.4 bits (199), Expect = 4e-17
 Identities = 66/271 (24%), Positives = 118/271 (43%), Gaps = 36/271 (13%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKL--KAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
           +G+G F  V   R    G ++A+K +    +N  +  +   EV ++  + H N++ L   
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82

Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
                   ++ +Y     +  +L     G ++    R     I SA  + Y H +    I
Sbjct: 83  IETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSA--VQYCHQK---RI 135

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE- 224
           +HRD+KA N+LLD+D    +ADFGF+     G   +     G   Y APE    GK  + 
Sbjct: 136 VHRDLKAENLLLDADMNIKIADFGFSNEFTVG-GKLDAFC-GAPPYAAPELFQ-GKKYDG 192

Query: 225 -SCDVYSFGILLLEILTGRKPI--EKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF 281
              DV+S G++L  +++G  P   + L    +R         +++GK++    P      
Sbjct: 193 PEVDVWSLGVILYTLVSGSLPFDGQNLKELRER---------VLRGKYRI---PFYMSTD 240

Query: 282 DENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
            EN LK+ + +        P KR  +++++ 
Sbjct: 241 CENLLKRFLVL-------NPIKRGTLEQIMK 264

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 80.4 bits (199), Expect = 4e-17
 Identities = 53/208 (25%), Positives = 91/208 (43%), Gaps = 16/208 (7%)

Query: 45  DDNKLGEGGFGSVYWGR-TSDGLQIAVK--KLKAMNSKAEMEFAVEVEVLGRVRH-KNLL 100
              +LG G F  V      S G + A K  K +        E   E+ VL   +    ++
Sbjct: 33  TSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVI 92

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV-QLDWKRRMKIAIGSAEGILYLHH 159
            L      T + +++ +Y     + S    + A  V + D  R +K  +   EG+ YLH 
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQIL---EGVYYLHQ 149

Query: 160 EVTPHIIHRDIKASNVLLDSDFE--PL-VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
               +I+H D+K  N+LL S +    + + DFG ++ I      +   + GT  YLAPE 
Sbjct: 150 N---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA-CELREIM-GTPEYLAPEI 204

Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKP 244
             +  ++ + D+++ GI+   +LT   P
Sbjct: 205 LNYDPITTATDMWNIGIIAYMLLTHTSP 232

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 81.0 bits (200), Expect = 5e-17
 Identities = 52/221 (23%), Positives = 102/221 (46%), Gaps = 28/221 (12%)

Query: 48  KLGEGGFGSVYWGRTSD---GLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           K+G G +G VY  +  D       A+K+++       M    E+ +L  ++H N++ L+ 
Sbjct: 28  KVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQK 85

Query: 105 YCAG-TDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS-----AEGILYL 157
                 D+++ +++DY     L   +    A +      +  +  + S      +GI YL
Sbjct: 86  VFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKL--IP-EGVSHMTTRVKGTLG 210
           H      ++HRD+K +N+L+  +        +AD GFA+L   P + ++ +   V  T  
Sbjct: 145 HAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV-TFW 200

Query: 211 YLAPEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEKLPG 250
           Y APE  +  +  +++ D+++ G +  E+LT  +PI     
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLT-SEPI--FHC 238

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 80.4 bits (199), Expect = 5e-17
 Identities = 62/214 (28%), Positives = 91/214 (42%), Gaps = 39/214 (18%)

Query: 49  LGEGGFGSVYWGRTSDGLQI-AVKKLK--AMNSKAEMEFA-VEVEVLGRV-RHKNLLGLR 103
           LG+G FG V   R  +   + AVK LK   +    ++E    E  +L     H  L  L 
Sbjct: 31  LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90

Query: 104 GYCAGTDQRL-IVYDYMPNLSLLSHLHGQ----------YAGEVQLDWKRRMKIAIGSAE 152
             C  T  RL  V +++    L+ H+             YA E+                
Sbjct: 91  -CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIIS-------------- 135

Query: 153 GILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLG 210
            +++LH +    II+RD+K  NVLLD +    +ADFG  K   EG+ +   T    GT  
Sbjct: 136 ALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK---EGICNGVTTATFCGTPD 189

Query: 211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           Y+APE         + D ++ G+LL E+L G  P
Sbjct: 190 YIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 80.0 bits (198), Expect = 5e-17
 Identities = 43/209 (20%), Positives = 83/209 (39%), Gaps = 30/209 (14%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            LG G FG V+    TS       K +K   +   +    E+ +L   RH+N+L L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL-VKKEISILNIARHRNILHLHESF 70

Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGE-----VQLDWKRRMKIAIGSA----EGILYL 157
              ++ +++++++          G    +         ++   +  +       E + +L
Sbjct: 71  ESMEELVMIFEFI---------SG---LDIFERINTSAFELNEREIVSYVHQVCEALQFL 118

Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLV--ADFGFAKLIPEGVSHMTTRVKGTLGYLAPE 215
           H     +I H DI+  N++  +     +   +FG A+ +  G +           Y APE
Sbjct: 119 HSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLF-TAPEYYAPE 173

Query: 216 YAMWGKVSESCDVYSFGILLLEILTGRKP 244
                 VS + D++S G L+  +L+G  P
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 80.1 bits (198), Expect = 7e-17
 Identities = 51/210 (24%), Positives = 88/210 (41%), Gaps = 24/210 (11%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVK-----KLKAMNSKAEME-FAVEVEVLGRVRHKNLL 100
           +LG G F  V   R  S GL+ A K     + +A       E    EV +L +V H N++
Sbjct: 19  ELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNII 78

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
            L          +++ + +    L   L      +   + +    +K  +   +G+ YLH
Sbjct: 79  TLHDVYENRTDVVLILELVSGGELFDFLAQKESLS---EEEATSFIKQIL---DGVNYLH 132

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
            +    I H D+K  N++L     P+    + DFG A  I +G         GT  ++AP
Sbjct: 133 TK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG-VEFKNIF-GTPEFVAP 187

Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           E   +  +    D++S G++   +L+G  P
Sbjct: 188 EIVNYEPLGLEADMWSIGVITYILLSGASP 217

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 79.5 bits (197), Expect = 7e-17
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 35/223 (15%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV------EVEVL---GRVRH 96
            ++G G +G+VY  R    G  +A+K ++ + +       +      EV +L       H
Sbjct: 15  AEIGVGAYGTVYKARDPHSGHFVALKSVR-VPNGGGGGGGLPISTVREVALLRRLEAFEH 73

Query: 97  KNLLGLRGYCAGTDQRL-----IVYDYMPN--LSLLSHLHGQYAGEVQLDWKRRMKIAIG 149
            N++ L   CA +         +V++++     + L            +  K  M+  + 
Sbjct: 74  PNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETI--KDLMRQFL- 130

Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL--IPEGVSHMTTRVKG 207
              G+ +LH      I+HRD+K  N+L+ S     +ADFG A++         +T  V  
Sbjct: 131 --RGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQ---MALTPVVV- 181

Query: 208 TLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPG 250
           TL Y APE  +    +   D++S G +  E+   RKP+    G
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-RKPL--FCG 221

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 56/217 (25%), Positives = 85/217 (39%), Gaps = 37/217 (17%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV----EVEVLGRVRHK 97
           + +   +G G  G V           +A+KKL           A     E+ ++  V HK
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQT--HAKRAYRELVLMKCVNHK 84

Query: 98  NLLGLRG-YCAGTDQRL-----IVYDYMP-NL-----SLLSHLHGQYAGEVQLDWKRRMK 145
           N++GL   +             IV + M  NL       L H    Y             
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSY------------- 131

Query: 146 IAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRV 205
           +      GI +LH   +  IIHRD+K SN+++ SD    + DFG A+        MT  V
Sbjct: 132 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-MMTPYV 187

Query: 206 KGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGR 242
             T  Y APE  +     E+ D++S G ++ E++ G 
Sbjct: 188 -VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 51/210 (24%), Positives = 84/210 (40%), Gaps = 24/210 (11%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVK-----KLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +LG G F  V   R  S GLQ A K     + K+       E    EV +L  ++H N++
Sbjct: 18  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
            L          +++ + +    L   L          + +    +K  +    G+ YLH
Sbjct: 78  TLHEVYENKTDVILILELVAGGELFDFLAEKESLT---EEEATEFLKQIL---NGVYYLH 131

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLAP 214
                 I H D+K  N++L     P     + DFG A  I  G +       GT  ++AP
Sbjct: 132 SL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-NEFKNIF-GTPEFVAP 186

Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           E   +  +    D++S G++   +L+G  P
Sbjct: 187 EIVNYEPLGLEADMWSIGVITYILLSGASP 216

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 57/214 (26%), Positives = 98/214 (45%), Gaps = 27/214 (12%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEF-AV-EVEVLGRVRHKNLLGLR 103
             +GEG +G V   R    G  +A+KK    +    ++  A+ E+++L ++RH+NL+ L 
Sbjct: 31  GLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLL 90

Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
             C    +  +V++++ + ++L  L     G      ++ +   I    GI + H     
Sbjct: 91  EVCKKKKRWYLVFEFV-DHTILDDLELFPNGLDYQVVQKYLFQII---NGIGFCHSH--- 143

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPE-------Y 216
           +IIHRDIK  N+L+       + DFGFA+ +          V  T  Y APE       Y
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVA-TRWYRAPELLVGDVKY 202

Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPIEKLPG 250
                  ++ DV++ G L+ E+  G  P+   PG
Sbjct: 203 ------GKAVDVWAIGCLVTEMFMGE-PL--FPG 227

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 79.3 bits (196), Expect = 1e-16
 Identities = 62/236 (26%), Positives = 94/236 (39%), Gaps = 37/236 (15%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           +G G FG     R       +AVK   +  A++   + E    +     +RH N++  + 
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE----IINHRSLRHPNIVRFKE 83

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                    I+ +Y     L   +    AG    D  R     + S   + Y H      
Sbjct: 84  VILTPTHLAIIMEYASGGELYERI--CNAGRFSEDEARFFFQQLLSG--VSYCHSM---Q 136

Query: 165 IIHRDIKASNVLLDSDFEPL--VADFGFAKLIPEGVSHMTTRVKGTLGYLAPE------Y 216
           I HRD+K  N LLD    P   + DFG++K      S   + V GT  Y+APE      Y
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-SQPKSTV-GTPAYIAPEVLLRQEY 194

Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPIE--KLPGGVKRTITEWAEPLIVKGKFK 270
              GK++   DV+S G+ L  +L G  P E  + P   ++TI       I+  K+ 
Sbjct: 195 D--GKIA---DVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQR-----ILSVKYS 240

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 53/214 (24%), Positives = 94/214 (43%), Gaps = 27/214 (12%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEF-AV-EVEVLGRVRHKNLLGLR 103
            K+GEG +G V+  R    G  +A+KK         ++  A+ E+ +L +++H NL+ L 
Sbjct: 9   GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLL 68

Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                  +  +V++Y  + ++L  L     G  +   K      +   + + + H     
Sbjct: 69  EVFRRKRRLHLVFEYC-DHTVLHELDRYQRGVPEHLVKSITWQTL---QAVNFCHKH--- 121

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPE-------Y 216
           + IHRD+K  N+L+       + DFGFA+L+     +    V  T  Y +PE       Y
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-ATRWYRSPELLVGDTQY 180

Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPIEKLPG 250
                     DV++ G +  E+L+G  P+   PG
Sbjct: 181 ------GPPVDVWAIGCVFAELLSGV-PL--WPG 205

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 79.5 bits (196), Expect = 2e-16
 Identities = 53/217 (24%), Positives = 84/217 (38%), Gaps = 37/217 (17%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV----EVEVLGRVRHK 97
           + +   +G G  G V           +A+KKL           A     E+ ++  V HK
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT--HAKRAYRELVLMKCVNHK 121

Query: 98  NLLGLRG-YCAGTDQRL-----IVYDYMP-NL-----SLLSHLHGQYAGEVQLDWKRRMK 145
           N++ L   +             +V + M  NL       L H    Y             
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSY------------- 168

Query: 146 IAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRV 205
           +      GI +LH   +  IIHRD+K SN+++ SD    + DFG A+        MT  V
Sbjct: 169 LLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-FMMTPYV 224

Query: 206 KGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGR 242
             T  Y APE  +     E+ D++S G ++ E++  +
Sbjct: 225 -VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 78.4 bits (194), Expect = 2e-16
 Identities = 51/220 (23%), Positives = 92/220 (41%), Gaps = 35/220 (15%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEF-AV-EVEVLGRVRHKNLLGLR 103
            KLGEG +G VY    T     +A+K+++  + +  +   A+ EV +L  ++H+N++ L+
Sbjct: 40  TKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELK 99

Query: 104 GYCAGTDQRLIVYDYMPN-L-SLLSHLHGQYAGEV-----QLDWKRRMKIAIGSAEGILY 156
                  +  ++++Y  N L   +          +     QL              G+ +
Sbjct: 100 SVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQL------------INGVNF 147

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPL-----VADFGFAKLIPEGVSHMTTRVKGTLGY 211
            H       +HRD+K  N+LL            + DFG A+     +   T  +  TL Y
Sbjct: 148 CHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII-TLWY 203

Query: 212 LAPEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEKLPG 250
             PE  +  +  S S D++S   +  E+L  + P+   PG
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLM-KTPL--FPG 240

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 78.1 bits (193), Expect = 4e-16
 Identities = 46/219 (21%), Positives = 96/219 (43%), Gaps = 40/219 (18%)

Query: 43  FSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLLG 101
           +++   +G G FG V+  +  +  ++A+KK+       +  F   E++++  V+H N++ 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVD 96

Query: 102 LRGYCAGTDQRL------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE--- 152
           L+ +      +       +V +Y+P       ++ +           ++K  +       
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVP-----ETVY-RA-----SRHYAKLKQTMPMLLIKL 145

Query: 153 -------GILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTR 204
                   + Y+H   +  I HRDIK  N+LLD     L + DFG AK++  G     + 
Sbjct: 146 YMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP-NVSY 201

Query: 205 VKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGR 242
           +  +  Y APE        + + D++S G ++ E++ G+
Sbjct: 202 I-CSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 76.7 bits (189), Expect = 4e-16
 Identities = 24/201 (11%), Positives = 45/201 (22%), Gaps = 41/201 (20%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAE---MEFAVEVEVLGRVRHKNLLGLR 103
             G       +    T+   Q+A+  +       +    E       L R+    +  + 
Sbjct: 38  FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97

Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                    L+V +++   SL                   ++     A      H     
Sbjct: 98  DVVHTRAGGLVVAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA--- 148

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
            +       S V +  D        G   L                  +          +
Sbjct: 149 GVALSIDHPSRVRVSID--------GDVVL-------------AYPATMPD-------AN 180

Query: 224 ESCDVYSFGILLLEILTGRKP 244
              D+   G  L  +L  R P
Sbjct: 181 PQDDIRGIGASLYALLVNRWP 201

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 61/228 (26%), Positives = 101/228 (44%), Gaps = 44/228 (19%)

Query: 43  FSDDNKLGEGGFGSVYWGRTSD-GLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           ++D   +G G FG VY  +  D G  +A+KK+       +  F   E++++ ++ H N++
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIV 110

Query: 101 GLRGYCAGTDQRL------IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAE-- 152
            LR +   + ++       +V DY+P       ++ +           R K  +      
Sbjct: 111 RLRYFFYSSGEKKDEVYLNLVLDYVP-----ETVY-RV-----ARHYSRAKQTLPVIYVK 159

Query: 153 --------GILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTT 203
                    + Y+H   +  I HRDIK  N+LLD D   L + DFG AK +  G     +
Sbjct: 160 LYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-PNVS 215

Query: 204 RVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPIEKLPG 250
            +  +  Y APE        + S DV+S G +L E+L G+ PI   PG
Sbjct: 216 YI-CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ-PI--FPG 259

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 75.0 bits (185), Expect = 2e-15
 Identities = 52/242 (21%), Positives = 93/242 (38%), Gaps = 69/242 (28%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVK---KLKAMNSKAEMEFAV------------------ 86
           +G+G +G V      +D    A+K   K K +                            
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 87  -----EVEVLGRVRHKNLLGLRG-YCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEV-QL 138
                E+ +L ++ H N++ L        +  L +V++ +              G V ++
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ------------GPVMEV 128

Query: 139 DWKRRMKIA--------IGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGF 190
              + +           +    GI YLH++    IIHRDIK SN+L+  D    +ADFG 
Sbjct: 129 PTLKPLSEDQARFYFQDLIK--GIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGV 183

Query: 191 AKLIPEGVSHMTTRVKGTLGYLAPE--------YAMWGKVSESCDVYSFGILLLEILTGR 242
           +       + ++  V GT  ++APE        ++  GK   + DV++ G+ L   + G+
Sbjct: 184 SNEFKGSDALLSNTV-GTPAFMAPESLSETRKIFS--GK---ALDVWAMGVTLYCFVFGQ 237

Query: 243 KP 244
            P
Sbjct: 238 CP 239

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 75.0 bits (185), Expect = 4e-15
 Identities = 57/218 (26%), Positives = 111/218 (50%), Gaps = 35/218 (16%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           +++ + +GEG +G V       + +++A+KK+     +   +  + E+++L R RH+N++
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88

Query: 101 GLRG-YCAGTDQRL----IVYDYMP-NLS------LLSHLHGQYAGEVQLDWKRRMKIAI 148
           G+     A T +++    IV D M  +L        LS+ H  Y    Q+     ++   
Sbjct: 89  GINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYF-LYQI-----LR--- 139

Query: 149 GSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---PEGVSHMTTRV 205
               G+ Y+H   + +++HRD+K SN+LL++  +  + DFG A++     +    +T  V
Sbjct: 140 ----GLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYV 192

Query: 206 KGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGR 242
             T  Y APE  +     ++S D++S G +L E+L+ R
Sbjct: 193 -ATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 73.8 bits (182), Expect = 4e-15
 Identities = 49/206 (23%), Positives = 82/206 (39%), Gaps = 23/206 (11%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKL-KAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
           LGEG +G V           +AVK +              E+ +   + H+N++   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
              + + +  +Y     L   +  +    +     +R    + +   ++YLH      I 
Sbjct: 75  REGNIQYLFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAG--VVYLHGI---GIT 127

Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEG--VSHMTTRVKGTLGYLAPE------YAM 218
           HRDIK  N+LLD      ++DFG A +         +     GTL Y+APE      +  
Sbjct: 128 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREFH- 185

Query: 219 WGKVSESCDVYSFGILLLEILTGRKP 244
             +     DV+S GI+L  +L G  P
Sbjct: 186 -AEPV---DVWSCGIVLTAMLAGELP 207

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 74.6 bits (184), Expect = 5e-15
 Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 40/218 (18%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV----EVEVLGRVRHK 97
           +     +G G +GSV        G ++A+KKL          FA     E+ +L  ++H+
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLLKHMQHE 83

Query: 98  NLLGLR-----GYCAGTDQRL-IVYDYMP-NL-----SLLSHLHGQYAGEVQLDWKRRMK 145
           N++GL                 +V  +M  +L        S    QY    Q+       
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYL-VYQM------- 135

Query: 146 IAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRV 205
                 +G+ Y+H   +  ++HRD+K  N+ ++ D E  + DFG A+        MT  V
Sbjct: 136 -----LKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA---EMTGYV 184

Query: 206 KGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGR 242
             T  Y APE  + W   +++ D++S G ++ E+LTG+
Sbjct: 185 -VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 73.4 bits (181), Expect = 6e-15
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 16/202 (7%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKL-KAMNSKAEMEFAV--EVEVLGRVRHKNLLGLRG 104
           LG G FG V  G     G ++AVK L +      ++   +  E++ L   RH +++ L  
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
             +      +V +Y+    L  ++     G V+    RR+   I SA  + Y H      
Sbjct: 79  VISTPTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSA--VDYCHRH---M 131

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK--V 222
           ++HRD+K  NVLLD+     +ADFG + ++ +G    T+   G+  Y APE    G+   
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS--CGSPNYAAPEVIS-GRLYA 188

Query: 223 SESCDVYSFGILLLEILTGRKP 244
               D++S G++L  +L G  P
Sbjct: 189 GPEVDIWSCGVILYALLCGTLP 210

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 73.8 bits (182), Expect = 8e-15
 Identities = 52/221 (23%), Positives = 96/221 (43%), Gaps = 33/221 (14%)

Query: 47  NKLGEGGFGSVYWGR--TSDGLQIAVKKLKAMNSK------AEMEFAVEVEVLGRVRHKN 98
            ++GEG +G V+  R   + G  +A+K+++    +         E AV    L    H N
Sbjct: 17  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH-LETFEHPN 75

Query: 99  LLGLR----GYCAGTDQRL-IVYDYMPN--LSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
           ++ L           + +L +V++++     + L  +         +  K  M   +   
Sbjct: 76  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI--KDMMFQLL--- 130

Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL--IPEGVSHMTTRVKGTL 209
            G+ +LH      ++HRD+K  N+L+ S  +  +ADFG A++         +T+ V  TL
Sbjct: 131 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVV-TL 183

Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPG 250
            Y APE  +    +   D++S G +  E+   RKP+    G
Sbjct: 184 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL--FRG 221

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 52/219 (23%), Positives = 84/219 (38%), Gaps = 49/219 (22%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKL-KAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
           LGEG +G V           +AVK +              E+ +   + H+N++   G+ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74

Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEV--QLDWKRRMK-----------IAIGSAEG 153
              + + +  +Y               GE+  +++    M            +A     G
Sbjct: 75  REGNIQYLFLEYCSG------------GELFDRIEPDIGMPEPDAQRFFHQLMA-----G 117

Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG--VSHMTTRVKGTLGY 211
           ++YLH      I HRDIK  N+LLD      ++DFG A +         +     GTL Y
Sbjct: 118 VVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPY 173

Query: 212 LAPE------YAMWGKVSESCDVYSFGILLLEILTGRKP 244
           +APE      +    +     DV+S GI+L  +L G  P
Sbjct: 174 VAPELLKRREFH--AEPV---DVWSCGIVLTAMLAGELP 207

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 71.5 bits (176), Expect = 4e-14
 Identities = 62/217 (28%), Positives = 94/217 (43%), Gaps = 47/217 (21%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LGEG FG V          ++A+K   +     S   M    E+  L  +RH +++ L  
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYA-GEV--QLDWKRRMKIA--------IGSAEG 153
                      YD +   + +  +  +YA GE+   +  K+RM           I  A  
Sbjct: 75  -----------YDVITTPTDI-VMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICA-- 120

Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLA 213
           I Y H      I+HRD+K  N+LLD +    +ADFG + ++ +G + + T   G+  Y A
Sbjct: 121 IEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-NFLKTSC-GSPNYAA 175

Query: 214 PE------YAMWGKVSESCDVYSFGILLLEILTGRKP 244
           PE      YA         DV+S GI+L  +L GR P
Sbjct: 176 PEVINGKLYA-----GPEVDVWSCGIVLYVMLVGRLP 207

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 56/208 (26%), Positives = 94/208 (45%), Gaps = 28/208 (13%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVK---KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           LG G FG V  G+    G ++AVK   + K  +     +   E++ L   RH +++ L  
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHL--HGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
             +      +V +Y+    L  ++  +G+    +     RR+   I S   + Y H    
Sbjct: 84  VISTPSDIFMVMEYVSGGELFDYICKNGR----LDEKESRRLFQQILSG--VDYCHRH-- 135

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPE------Y 216
             ++HRD+K  NVLLD+     +ADFG + ++ +G   + T   G+  Y APE      Y
Sbjct: 136 -MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG-EFLRTSC-GSPNYAAPEVISGRLY 192

Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKP 244
           A         D++S G++L  +L G  P
Sbjct: 193 A-----GPEVDIWSSGVILYALLCGTLP 215

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 71.2 bits (175), Expect = 7e-14
 Identities = 55/228 (24%), Positives = 94/228 (41%), Gaps = 40/228 (17%)

Query: 40  TNGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKK--LKAMNSKAEMEFAVEVEVLGRVRH 96
            + F  +   G+G FG+V  G+  S G+ +A+KK          E++    ++ L  + H
Sbjct: 22  MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ---IMQDLAVLHH 78

Query: 97  KNLLGLR------GYCAGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIG 149
            N++ L+      G     D  L +V +Y+P       LH +           R ++A  
Sbjct: 79  PNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLH-RC-----CRNYYRRQVAPP 127

Query: 150 SAE----------GILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGV 198
                         I  LH   + ++ HRDIK  NVL++     L + DFG AK +    
Sbjct: 128 PILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS- 185

Query: 199 SHMTTRVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPI 245
                 +  +  Y APE        + + D++S G +  E++ G +PI
Sbjct: 186 EPNVAYI-CSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-EPI 231

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 71.1 bits (175), Expect = 7e-14
 Identities = 63/236 (26%), Positives = 104/236 (44%), Gaps = 51/236 (21%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV----EVEVLGRVRHK 97
           F   + LGEG +G V        G  +A+KK++  +      FA+    E+++L   +H+
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKP---LFALRTLREIKILKHFKHE 69

Query: 98  NLLGLRG-YCAGTDQRL----IVYDYMP-NLS------LLSHLHGQYAGEVQLDWKRRMK 145
           N++ +       + +      I+ + M  +L       +LS  H QY             
Sbjct: 70  NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQY------------- 116

Query: 146 IAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS------ 199
               +   +  LH     ++IHRD+K SN+L++S+ +  V DFG A++I E  +      
Sbjct: 117 FIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPT 173

Query: 200 ----HMTTRVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPIEKLPG 250
                M   V  T  Y APE  +   K S + DV+S G +L E+   R+PI   PG
Sbjct: 174 GQQSGMVEFV-ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFL-RRPI--FPG 225

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 41/219 (18%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV----EVEVLGRVRHK 97
           + + + +G G +GSV     T  GL++AVKKL           A     E+ +L  ++H+
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII--HAKRTYRELRLLKHMKHE 88

Query: 98  NLLGLR-----GYCAGTDQRL-IVYDYMP-NLS------LLSHLHGQYAGEVQLDWKRRM 144
           N++GL               + +V   M  +L+       L+  H Q+    Q+      
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFL-IYQI------ 141

Query: 145 KIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR 204
                   G+ Y+H   +  IIHRD+K SN+ ++ D E  + DFG A+        MT  
Sbjct: 142 ------LRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT---ADEMTGY 189

Query: 205 VKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGR 242
           V  T  Y APE  + W   +++ D++S G ++ E+LTGR
Sbjct: 190 V-ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 70.0 bits (172), Expect = 1e-13
 Identities = 44/231 (19%), Positives = 92/231 (39%), Gaps = 35/231 (15%)

Query: 28  WRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV 86
           W   ++       + +    KLG G +  V+     ++  ++ VK LK +  K   +   
Sbjct: 23  WDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKR 79

Query: 87  EVEVLGRVR-HKNLLGL----RGYCAGTDQRLIVYDYMPN-----LSLLSHLHGQYAGEV 136
           E+++L  +R   N++ L    +   + T   L+               L+    ++    
Sbjct: 80  EIKILENLRGGPNIITLADIVKDPVSRTPA-LVFEHVNNTDFKQLYQTLTDYDIRFY-MY 137

Query: 137 QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIP 195
           ++             + + Y H   +  I+HRD+K  NV++D +   L + D+G A+   
Sbjct: 138 EI------------LKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182

Query: 196 EGVSHMTTRVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPI 245
            G      RV  +  +  PE  + +     S D++S G +L  ++  ++P 
Sbjct: 183 PG-QEYNVRV-ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 231

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 57/219 (26%), Positives = 97/219 (44%), Gaps = 41/219 (18%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV----EVEVLGRVRHK 97
           + D   +G G +G+V        G ++A+KKL          FA     E+ +L  +RH+
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL--FAKRAYRELRLLKHMRHE 84

Query: 98  NLLGLRG-YCAGTDQRL-----IVYDYMP-NLS------LLSHLHGQYAGEVQLDWKRRM 144
           N++GL   +             +V  +M  +L        L     Q+    Q+      
Sbjct: 85  NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFL-VYQM------ 137

Query: 145 KIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR 204
                  +G+ Y+H      IIHRD+K  N+ ++ D E  + DFG A+      S MT  
Sbjct: 138 ------LKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTGY 185

Query: 205 VKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGR 242
           V  T  Y APE  + W + +++ D++S G ++ E++TG+
Sbjct: 186 V-VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 66.1 bits (162), Expect = 2e-12
 Identities = 47/228 (20%), Positives = 100/228 (43%), Gaps = 46/228 (20%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVRHKNLL 100
           + D   LG GG G V+         ++A+KK+  +     ++ A+ E++++ R+ H N++
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKI-VLTDPQSVKHALREIKIIRRLDHDNIV 71

Query: 101 GLR-------GYCAGTDQRL-------IVYDYMP-NLS------LLSHLHGQYAGEVQLD 139
            +                 L       IV +YM  +L+       L   H +        
Sbjct: 72  KVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHARL------- 124

Query: 140 WKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGV 198
                        G+ Y+H   + +++HRD+K +N+ ++++   L + DFG A+++    
Sbjct: 125 ------FMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175

Query: 199 SH---MTTRVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGR 242
           SH   ++  +  T  Y +P   +     +++ D+++ G +  E+LTG+
Sbjct: 176 SHKGHLSEGL-VTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 65.1 bits (159), Expect = 6e-12
 Identities = 54/252 (21%), Positives = 97/252 (38%), Gaps = 58/252 (23%)

Query: 38  TATNGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV-EVEVLGRVR 95
           T++  +S    LG G FG V        G + A+KK+       +  +   E++++  + 
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ-----DPRYKNRELDIMKVLD 58

Query: 96  HKNLLGLRG--YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGE------------------ 135
           H N++ L    Y  G ++         +  L    +G                       
Sbjct: 59  HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118

Query: 136 -VQLDWKRRMKIAIGSAE----------------GILYLHHEVTPHIIHRDIKASNVLLD 178
            V     + +K  I S                   + ++H   +  I HRDIK  N+L++
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH---SLGICHRDIKPQNLLVN 175

Query: 179 SDFEPL-VADFGFAKLIPEG---VSHMTTRVKGTLGYLAPEYAM-WGKVSESCDVYSFGI 233
           S    L + DFG AK +      V+++ +R      Y APE  +   + + S D++S G 
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEPSVAYICSRF-----YRAPELMLGATEYTPSIDLWSIGC 230

Query: 234 LLLEILTGRKPI 245
           +  E++ G KP+
Sbjct: 231 VFGELILG-KPL 241

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 62.1 bits (151), Expect = 9e-11
 Identities = 52/252 (20%), Positives = 86/252 (34%), Gaps = 60/252 (23%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV----EVEVLGRVRHK 97
           +   + +G G +G VY     +    +A+KK+  M              E+ +L R++  
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLI--DCKRILREITILNRLKSD 85

Query: 98  NLLGLRGYCAGTDQRL-----IVYDYMP-NLS-------LLSHLHGQYAGEVQLDWKRRM 144
            ++ L       D        IV +    +L         L+  H +             
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKT------------ 133

Query: 145 KIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI---------- 194
            I      G  ++H      IIHRD+K +N LL+ D    V DFG A+ I          
Sbjct: 134 -ILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVN 189

Query: 195 ------------PEGVSHMTTRVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTG 241
                             +T+ V  T  Y APE  +     ++S D++S G +  E+L  
Sbjct: 190 DLEENEEPGPHNKNLKKQLTSHV-VTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNM 248

Query: 242 RKPIEKLPGGVK 253
            +     P    
Sbjct: 249 LQSHINDPTNRF 260

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 58.2 bits (141), Expect = 1e-09
 Identities = 62/244 (25%), Positives = 100/244 (40%), Gaps = 57/244 (23%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV----EVEVLGRVR-H 96
           +    KLG+G +G V+       G  +AVKK+      +    A     E+ +L  +  H
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNST--DAQRTFREIMILTELSGH 68

Query: 97  KNLLGLRG-YCAGTDQRL-IVYDYMP-NLS------LLSHLHGQYAGEVQLDWKRRMKIA 147
           +N++ L     A  D+ + +V+DYM  +L       +L  +H QY             + 
Sbjct: 69  ENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEPVHKQY-------------VV 115

Query: 148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG 207
               + I YLH   +  ++HRD+K SN+LL+++    VADFG ++               
Sbjct: 116 YQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLS 172

Query: 208 TLG--------------------YLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPIE 246
                                  Y APE  +   K ++  D++S G +L EIL   KPI 
Sbjct: 173 INENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEIL-CGKPI- 230

Query: 247 KLPG 250
             PG
Sbjct: 231 -FPG 233

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 57.7 bits (140), Expect = 1e-09
 Identities = 55/231 (23%), Positives = 80/231 (34%), Gaps = 63/231 (27%)

Query: 36  LHTATNGFSDD-----NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVE 89
           L    N   DD       LG G  G V          + A+K L+            EVE
Sbjct: 8   LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR-----EVE 62

Query: 90  VLGRV-RHKNLLGLRG-YCAGTDQRLIVYDYMPNLS-------LLSHLHGQY----AGEV 136
           +  R  +  +++ +   Y      R  +   M  L        +       +    A E+
Sbjct: 63  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 122

Query: 137 QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE--PL-VADFGFAKL 193
                  MK  IG A  I YLH     +I HRD+K  N+L  S      L + DFGFAK 
Sbjct: 123 -------MKS-IGEA--IQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 169

Query: 194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
                                +Y       +SCD++S G+++  +L G  P
Sbjct: 170 T-----------------TGEKY------DKSCDMWSLGVIMYILLCGYPP 197

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 52/218 (23%), Positives = 93/218 (42%), Gaps = 34/218 (15%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFA-VEVEVLGRVR---------- 95
           KLG G F +V+  +   +   +A+K ++    K   E A  E+++L RV           
Sbjct: 26  KLGWGHFSTVWLAKDMVNNTHVAMKIVR--GDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 96  -HKNLLGLRGY----CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
              ++L L  +           ++V++ +   +LL+ +       + L + +  +I+   
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVK--QISKQL 140

Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL------VADFGFAKLIPEGVSHMTTR 204
             G+ Y+H      IIH DIK  NVL++    P       +AD G A    E   H T  
Sbjct: 141 LLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---HYTNS 195

Query: 205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGR 242
           ++ T  Y +PE  +        D++S   L+ E++TG 
Sbjct: 196 IQ-TREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 55.6 bits (134), Expect = 9e-09
 Identities = 58/309 (18%), Positives = 101/309 (32%), Gaps = 92/309 (29%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAV----EVEVLGRVRHK 97
           +   + +G G +G V       +   +A+KK+  +              E+ +L R+ H 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLI--DCKRILREIAILNRLNHD 112

Query: 98  NLLGL----RGYCAGTDQRL-IVYDYMP--------NLSLLSHLHGQ---YAGEVQLDWK 141
           +++ +              L +V +               L+ LH +   Y     L   
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLY----NL--- 165

Query: 142 RRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI------- 194
                      G+ Y+H   +  I+HRD+K +N L++ D    V DFG A+ +       
Sbjct: 166 ---------LVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGN 213

Query: 195 --------------------PEGVSHMTTRVKGTLGYLAPEYAM-WGKVSESCDVYSFGI 233
                                     +T  V  T  Y APE  +     +E+ DV+S G 
Sbjct: 214 SQLPISPREDDMNLVTFPHTKNLKRQLTGHV-VTRWYRAPELILLQENYTEAIDVWSIGC 272

Query: 234 LLLEILT----------GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDE 283
           +  E+L            R P+   PG         +    +    K   D K     + 
Sbjct: 273 IFAELLNMIKENVAYHADRGPL--FPG---------SSCFPLSPDQKAGNDFKFHTRGNR 321

Query: 284 NQLKQAINV 292
           +QL    N+
Sbjct: 322 DQLNVIFNI 330

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 52/229 (22%), Positives = 85/229 (37%), Gaps = 40/229 (17%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG-- 104
           K+G G FG +Y G       ++A+K         ++ +  E ++      + L G  G  
Sbjct: 14  KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIY-----RILQGGTGIP 66

Query: 105 --YCAGTDQRLIVYDYM------PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
                G +     Y+ +      P+L  L +   +     +L  K  + +A      + +
Sbjct: 67  NVRWFGVEGD---YNVLVMDLLGPSLEDLFNFCSR-----KLSLKTVLMLADQMINRVEF 118

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEP---LVADFGFAKLI--PEGVSHMTTRVK----G 207
           +H +     +HRDIK  N L+          + DFG AK         H+  R      G
Sbjct: 119 VHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTG 175

Query: 208 TLGYLAPEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRT 255
           T  Y A      G   S   D+ S G +L+  L G  P + L  G K+ 
Sbjct: 176 TARY-ASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ 223

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 54.3 bits (131), Expect = 2e-08
 Identities = 34/173 (19%), Positives = 61/173 (35%), Gaps = 43/173 (24%)

Query: 48  KLGEGGFGSVYWG-RTSDGLQIAVKKLKAMNSKA-----EMEF------AVEVEVLGRVR 95
           K+G GGFG +Y    T+   + A   +K    +      E++F         ++     +
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 96  HKNLLG---LRGY----CAGTDQRLIVYDYM-PNLSLLSHLHGQYAGEVQLDWKRRM--- 144
             + LG     G       G   R +V + +  +L  +                      
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKI------------SGQNGTFKKS 151

Query: 145 ---KIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV--ADFGFAK 192
              ++ I   + + Y+H       +H DIKA+N+LL       V  AD+G + 
Sbjct: 152 TVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSY 201

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 35/169 (20%), Positives = 61/169 (36%), Gaps = 32/169 (18%)

Query: 48  KLGEGGFGSVYWGR------TSDGLQIAVKKLKAMNSKAEMEFAV--------EVEVLGR 93
            +G+GGFG +Y                 VK   + N     E           +++   R
Sbjct: 42  PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101

Query: 94  VRHKNLLG---LRGY----CAGTDQRLIVYDYM-PNLSLLSHLHGQYAGEVQLDWKRRMK 145
            R    LG     G       G   R ++ D    +L  +   + +     +   K  ++
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAK-----RFSRKTVLQ 156

Query: 146 IAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV--ADFGFAK 192
           +++   + + Y+H       +H DIKASN+LL+      V   D+G A 
Sbjct: 157 LSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 53.2 bits (128), Expect = 4e-08
 Identities = 30/170 (17%), Positives = 57/170 (33%), Gaps = 32/170 (18%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVK--------KLKAMNSKAEMEFAV--------EVEV 90
           +       G +Y    +  L             KL A + +   E           +V  
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNK 107

Query: 91  LGRVRHKNLLGL-RGYCAGTDQ---RLIVYDYM-PNL-SLLSHLHGQYAGEVQLDWKRRM 144
             ++    LL +      G  Q   R +V   +  +L S L            L  +  +
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRSLQSALDVSPKH-----VLSERSVL 162

Query: 145 KIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV--ADFGFAK 192
           ++A    + + +LH       +H ++ A N+ +D + +  V  A +GFA 
Sbjct: 163 QVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAF 209

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 52.7 bits (127), Expect = 6e-08
 Identities = 35/163 (21%), Positives = 61/163 (37%), Gaps = 38/163 (23%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVK--KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           ++GEG FG ++ G    +  Q+A+K    ++   +   E+           +K L G  G
Sbjct: 17  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT---------YKLLAGCTG 67

Query: 105 ----YCAGTDQRLIVYDYM------PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
               Y  G +     ++ +      P+L  L  L G+     +   K     A      +
Sbjct: 68  IPNVYYFGQEGL---HNVLVIDLLGPSLEDLLDLCGR-----KFSVKTVAMAAKQMLARV 119

Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEP-----LVADFGFAK 192
             +H +    +++RDIK  N L+            V DFG  K
Sbjct: 120 QSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 53.0 bits (126), Expect = 6e-08
 Identities = 31/201 (15%), Positives = 51/201 (25%), Gaps = 55/201 (27%)

Query: 39  ATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKL-----KAMNSKAEM---EFAVEVEV 90
            T       K+GEG FG V+    +D   +A+K +       +N   +    E   E+ +
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTI-ADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 91  L---------GRVRHKNLLGLRGYC------------------------------AGTDQ 111
                        R +  +GL                                     DQ
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIK 171
             IV ++      L  +  +              I       +      +     HRD+ 
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKL-----SSLATAKSILHQLTASLAVAEASL--RFEHRDLH 189

Query: 172 ASNVLLDSDFEPLVADFGFAK 192
             NVLL       +      K
Sbjct: 190 WGNVLLKKTSLKKLHYTLNGK 210

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 52.4 bits (126), Expect = 8e-08
 Identities = 55/230 (23%), Positives = 87/230 (37%), Gaps = 44/230 (19%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVK--KLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
           K+G G FG +Y G   + G ++A+K   +K  + +  +E  +         +K + G  G
Sbjct: 16  KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI---------YKMMQGGVG 66

Query: 105 ----YCAGTDQRLIVYDYM------PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGI 154
                  G +     Y+ M      P+L  L +   +     +   K  + +A      I
Sbjct: 67  IPTIRWCGAEGD---YNVMVMELLGPSLEDLFNFCSR-----KFSLKTVLLLADQMISRI 118

Query: 155 LYLHHEVTPHIIHRDIKASNVLL---DSDFEPLVADFGFAKLI--PEGVSHMTTRVK--- 206
            Y+H +   + IHRD+K  N L+          + DFG AK         H+  R     
Sbjct: 119 EYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 175

Query: 207 -GTLGYLAPEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKR 254
            GT  Y A      G   S   D+ S G +L+    G  P + L    KR
Sbjct: 176 TGTARY-ASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 224

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 51.2 bits (123), Expect = 2e-07
 Identities = 35/161 (21%), Positives = 61/161 (37%), Gaps = 34/161 (21%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRG-- 104
           K+G G FG +  G+       +A+K     +   ++             +K L    G  
Sbjct: 16  KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRF-------YKQLGSGDGIP 68

Query: 105 --YCAGTDQRLIVYDYM------PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
             Y  G   +   Y+ M      P+L  L  L  +         K  + IAI     + Y
Sbjct: 69  QVYYFGPCGK---YNAMVLELLGPSLEDLFDLCDR-----TFSLKTVLMIAIQLISRMEY 120

Query: 157 LHHEVTPHIIHRDIKASNVLL----DSDFEPL-VADFGFAK 192
           +H +   ++I+RD+K  N L+    +   + + + DF  AK
Sbjct: 121 VHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 48.7 bits (116), Expect = 2e-06
 Identities = 64/362 (17%), Positives = 112/362 (30%), Gaps = 111/362 (30%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKN-------- 98
           KLG G F +V+          +A+K +K+     E     E+ +L  VR+ +        
Sbjct: 44  KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREM 102

Query: 99  ---LLG---LRG-----YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIA 147
              LL    + G      C       +V++ +    LL  +       + L   ++  I 
Sbjct: 103 VVQLLDDFKISGVNGTHIC-------MVFEVL-GHHLLKWIIKSNYQGLPLPCVKK--II 152

Query: 148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD--------------------------- 180
               +G+ YLH +    IIH DIK  N+LL  +                           
Sbjct: 153 QQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAV 210

Query: 181 --------------FEPLVADFGFAKLIPEGVS-----HMTTRVKGTLGYLAPEYAMWGK 221
                          EP  A+    K+   G +     H T  ++ T  Y + E  +   
Sbjct: 211 STAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQ-TRQYRSLEVLIGSG 269

Query: 222 VSESCDVYSFGILLLEILTGRKPIEKLPGGV-------------------KRTITEWAEP 262
            +   D++S   +  E+ TG    E   G                     ++ I      
Sbjct: 270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS 329

Query: 263 LIV---KGKFKELVDPKLRG---------DFDENQLKQAINVAVLCVQSEPEKRPNMKEV 310
                 KG  K +   K  G         ++ + +     +  +  ++  PEKR    E 
Sbjct: 330 KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAEC 389

Query: 311 VN 312
           + 
Sbjct: 390 LR 391

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 47.8 bits (114), Expect = 3e-06
 Identities = 47/214 (21%), Positives = 87/214 (40%), Gaps = 42/214 (19%)

Query: 49  LGEGGFGSVYWGRTSD---GLQIAVKKLKAMNSKAEMEFA-VEVEVLGRVRHK------N 98
           +G+G FG V   +  D      +A+K ++  N K     A  E+ +L  +R +      N
Sbjct: 105 IGKGSFGQVV--KAYDHKVHQHVALKMVR--NEKRFHRQAAEEIRILEHLRKQDKDNTMN 160

Query: 99  LLGLRGY-------CAGTDQRLIVYDYMPNLSLLSHL-HGQYAGEVQLDWKRRMKIAIGS 150
           ++ +          C       + ++ + +++L   +   ++ G          K A   
Sbjct: 161 VIHMLENFTFRNHIC-------MTFELL-SMNLYELIKKNKFQG---FSLPLVRKFAHSI 209

Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL--VADFGFAKLIPEGVSHMTTRVKGT 208
            + +  LH      IIH D+K  N+LL         V DFG +    +    + T ++ +
Sbjct: 210 LQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ---RVYTYIQ-S 262

Query: 209 LGYLAPEYAMWGKVSESCDVYSFGILLLEILTGR 242
             Y APE  +  +     D++S G +L E+LTG 
Sbjct: 263 RFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 44.7 bits (106), Expect = 3e-05
 Identities = 23/91 (25%), Positives = 42/91 (46%), Gaps = 8/91 (8%)

Query: 155 LYLHHEVTPHIIHRDIKASNVLLDSDFEPL--VADFGFAKLIPEGV-SHMTTRVKGTLGY 211
           L         IIH D+K  N+LL +       + DFG +  + + +  ++ +R      Y
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRF-----Y 224

Query: 212 LAPEYAMWGKVSESCDVYSFGILLLEILTGR 242
            +PE  +      + D++S G +L+E+ TG 
Sbjct: 225 RSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 41.9 bits (99), Expect = 2e-04
 Identities = 55/233 (23%), Positives = 86/233 (36%), Gaps = 62/233 (26%)

Query: 48  KLGEGGFGSVY--WGRTSDGLQIAVKKLKAMNSKAEMEFA-VEVEVLGRVRHK------N 98
            LGEG FG V           Q+A+K ++  N     E A +E+ VL +++ K       
Sbjct: 26  NLGEGTFGKVVECLDHARGKSQVALKIIR--NVGKYREAARLEINVLKKIKEKDKENKFL 83

Query: 99  LLGLRGY-------CAGTDQRLIVYDYMPNLSLLSHL-HGQYAGEVQLDWKRRMKIAIGS 150
            + +  +       C       I ++ +   +    L    +     L   R   +A   
Sbjct: 84  CVLMSDWFNFHGHMC-------IAFELL-GKNTFEFLKENNFQP-YPLPHVR--HMAYQL 132

Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLL-DSDFEPL------------------VADFGFA 191
              + +LH      + H D+K  N+L  +S+FE L                  VADFG A
Sbjct: 133 CHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA 189

Query: 192 KLIPEGVSHMT---TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTG 241
               +   H T   TR      Y  PE  +    ++ CDV+S G +L E   G
Sbjct: 190 --TFDHEHHTTIVATRH-----YRPPEVILELGWAQPCDVWSIGCILFEYYRG 235

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.5 bits (99), Expect = 2e-04
 Identities = 36/273 (13%), Positives = 78/273 (28%), Gaps = 76/273 (27%)

Query: 33  YKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLG 92
           +  L      F     +      S+ W                     ++  +  + V+ 
Sbjct: 375 FDRLSV----FPPSAHIPTILL-SLIWF--------------------DVIKSDVMVVVN 409

Query: 93  RVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSH------LH----GQYAGEVQLDWKR 142
           ++   +L+  +       +   +      L L         LH      Y      D   
Sbjct: 410 KLHKYSLVEKQP------KESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDD 463

Query: 143 RMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGF--AKLIPEGVS- 199
            +   +       Y +     HI H      +    + F  +  DF F   K+  +  + 
Sbjct: 464 LIPPYLDQ-----YFYS----HIGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAW 514

Query: 200 HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEW 259
           + +  +  TL  L   Y  +  + ++   Y     L+  +     ++ LP          
Sbjct: 515 NASGSILNTLQQLK-FYKPY--ICDNDPKYE---RLVNAI-----LDFLPK--------- 554

Query: 260 AEPLIVKGKFKELVDPKLRGDFD---ENQLKQA 289
            E  ++  K+ +L+   L  + +   E   KQ 
Sbjct: 555 IEENLICSKYTDLLRIALMAEDEAIFEEAHKQV 587

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	380
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.98
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.77
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.48
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.35
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.22
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.09
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.87
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.72
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.71
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.68
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.53
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.46
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.26
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.22
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.17
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.16
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.94
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.77
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.72
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.62
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.61
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.54
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.54
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.5
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.34
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.29
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.28
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.76
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.48
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.52
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	93.41
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	91.39
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	83.69

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=5.8e-61  Score=441.48  Aligned_cols=254  Identities=23%  Similarity=0.346  Sum_probs=208.5

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ++|++++.||+|+||+||+|++ .+|+.||||++...  .......+.+|+.+|+.++|||||++++++.+++.+|||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            6899999999999999999987 57999999999743  44556688999999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      ||+||+|.+++...  ....+++..++.++.||+.||+|||++   ||+||||||+|||++.+|.+||+|||+++.+...
T Consensus       104 y~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~  178 (350)
T 4b9d_A          104 YCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST  178 (350)
T ss_dssp             CCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHH
T ss_pred             CCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCC
Confidence            99999999999753  234689999999999999999999999   9999999999999999999999999999876432


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                       .......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+....  .....     ...+.         
T Consensus       179 -~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~-----i~~~~---------  241 (350)
T 4b9d_A          179 -VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK--NLVLK-----IISGS---------  241 (350)
T ss_dssp             -HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHH-----HHHTC---------
T ss_pred             -cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHH-----HHcCC---------
Confidence             12334567999999999999999999999999999999999999999753311  11000     01111         


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ....+..++.++.+||.+||+.||++|||+.++++|.+.
T Consensus       242 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~  280 (350)
T 4b9d_A          242 FPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI  280 (350)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred             CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHh
Confidence            112334456789999999999999999999999999653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2e-60  Score=437.19  Aligned_cols=255  Identities=21%  Similarity=0.308  Sum_probs=215.4

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      .+.|++.++||+|+||+||+|++ .+|+.||||++..........+.+|+.+|+.++|||||++++++.+++.+||||||
T Consensus        73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  152 (346)
T 4fih_A           73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  152 (346)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeC
Confidence            35799999999999999999987 57999999999765555556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      |+||+|.+++..     ..+++..+..++.||+.||+|||++   ||+||||||+|||++.+|.+||+|||+++.+....
T Consensus       153 ~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  224 (346)
T 4fih_A          153 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  224 (346)
T ss_dssp             CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS
T ss_pred             CCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCC
Confidence            999999999964     3699999999999999999999999   99999999999999999999999999998875432


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                       ......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+....  .....          +.....+  .
T Consensus       225 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~----------i~~~~~~--~  289 (346)
T 4fih_A          225 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKM----------IRDNLPP--R  289 (346)
T ss_dssp             -CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHH----------HHHSSCC--C
T ss_pred             -CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH--HHHHH----------HHcCCCC--C
Confidence             2345568999999999999999999999999999999999999999753321  00000          0000001  1


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ...+..++.++.+||.+||..||++|||+.|+++|.|..
T Consensus       290 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~  328 (346)
T 4fih_A          290 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA  328 (346)
T ss_dssp             CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhc
Confidence            122334567899999999999999999999999997743

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=4.6e-60  Score=435.05  Aligned_cols=260  Identities=26%  Similarity=0.433  Sum_probs=210.7

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC------CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS------DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  112 (380)
                      ..++|++.++||+|+||+||+|++.      ++..||||+++.........|.+|+.+|++++|||||+++++|.+++.+
T Consensus        39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~  118 (329)
T 4aoj_A           39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL  118 (329)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            3467888899999999999999753      4788999999987777778899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHhhccCCC-----------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC
Q 037869          113 LIVYDYMPNLSLLSHLHGQYA-----------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF  181 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~-----------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~  181 (380)
                      |||||||++|+|.+++.....           ...++++..++.++.|++.||+|||++   +|+||||||+|||++.++
T Consensus       119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCC
Confidence            999999999999999975421           234699999999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhcc
Q 037869          182 EPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEW  259 (380)
Q Consensus       182 ~vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~  259 (380)
                      .+||+|||+++....... .......||+.|+|||++.+..|+.++|||||||++|||+| |..||.......  .    
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~--~----  269 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE--A----  269 (329)
T ss_dssp             EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH--H----
T ss_pred             cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH--H----
Confidence            999999999987644322 23344679999999999999999999999999999999999 899997643210  0    


Q ss_pred             chhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          260 AEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ..          .+....+...+..++.++.+|+.+||+.||++|||+.+|+++|+.+
T Consensus       270 ~~----------~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l  317 (329)
T 4aoj_A          270 ID----------CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQAL  317 (329)
T ss_dssp             HH----------HHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHH
T ss_pred             HH----------HHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            00          0111122234555678899999999999999999999999998754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.9e-60  Score=430.68  Aligned_cols=259  Identities=26%  Similarity=0.449  Sum_probs=215.2

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC------CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS------DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  112 (380)
                      ..++|++.+.||+|+||+||+|++.      ++..||||+++.........|.+|+++|++++|||||++++++.+++.+
T Consensus        11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            4578999999999999999999753      4778999999987777778899999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHhhccCC---------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCce
Q 037869          113 LIVYDYMPNLSLLSHLHGQY---------AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEP  183 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~---------~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~v  183 (380)
                      |||||||++|+|.+++....         .....+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcE
Confidence            99999999999999997542         1235799999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccCCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccch
Q 037869          184 LVADFGFAKLIPEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAE  261 (380)
Q Consensus       184 kl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~  261 (380)
                      ||+|||+++........ ......||+.|+|||++.+..|+.++|||||||++|||+| |..||.......   +   ..
T Consensus       168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~---~---~~  241 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE---V---IE  241 (299)
T ss_dssp             EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH---H---HH
T ss_pred             EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH---H---HH
Confidence            99999999876443222 2233468999999999999999999999999999999998 899997643210   0   00


Q ss_pred             hhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          262 PLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                                .+....+...+..++.++.+|+.+||+.||++|||+.+|+..|+.
T Consensus       242 ----------~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~  286 (299)
T 4asz_A          242 ----------CITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQN  286 (299)
T ss_dssp             ----------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----------HHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence                      011111223455667889999999999999999999999888764

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.1e-60  Score=428.90  Aligned_cols=246  Identities=24%  Similarity=0.342  Sum_probs=208.8

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ++|++.+.||+|+||+||+|++ .+++.||||++...   .......+.+|+++|+.++|||||++++++++++.+||||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm  111 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL  111 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            5699999999999999999987 57999999999742   2233557889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      |||+||+|.+++...    ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.+..
T Consensus       112 Ey~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~  184 (311)
T 4aw0_A          112 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  184 (311)
T ss_dssp             CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             ecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCC
Confidence            999999999999753    5799999999999999999999999   999999999999999999999999999998754


Q ss_pred             CC-ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          197 GV-SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       197 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      .. .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+..  .....     ...+.       
T Consensus       185 ~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~--~~~~~-----i~~~~-------  250 (311)
T 4aw0_A          185 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG--LIFAK-----IIKLE-------  250 (311)
T ss_dssp             TTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH-----HHHTC-------
T ss_pred             CCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH-----HHcCC-------
Confidence            32 23455678999999999999999999999999999999999999999753211  11000     00111       


Q ss_pred             cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHH
Q 037869          276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEV  310 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~l  310 (380)
                         ..++...+.++.+||.+||..||++|||++|+
T Consensus       251 ---~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~  282 (311)
T 4aw0_A          251 ---YDFPEKFFPKARDLVEKLLVLDATKRLGCEEM  282 (311)
T ss_dssp             ---CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGG
T ss_pred             ---CCCCcccCHHHHHHHHHHccCCHhHCcChHHH
Confidence               12334456789999999999999999999885

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.5e-59  Score=439.19  Aligned_cols=254  Identities=21%  Similarity=0.306  Sum_probs=215.3

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      .+.|++.++||+|+||+||+|++ .+|+.||||++..........+.+|+.+|+.++|||||+++++|.+++.+||||||
T Consensus       150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy  229 (423)
T 4fie_A          150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF  229 (423)
T ss_dssp             GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeC
Confidence            46799999999999999999997 57999999999865555556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      |+||+|.+++..     ..+++..+..++.||+.||+|||++   ||+||||||+||||+.+|.+||+|||+++.+....
T Consensus       230 ~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~  301 (423)
T 4fie_A          230 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV  301 (423)
T ss_dssp             CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC
T ss_pred             CCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCC
Confidence            999999999964     3699999999999999999999999   99999999999999999999999999998875432


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                       ......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.....  ....          +.....+  .
T Consensus       302 -~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~--~~~~----------i~~~~~~--~  366 (423)
T 4fie_A          302 -PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK--AMKM----------IRDNLPP--R  366 (423)
T ss_dssp             -CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHHH----------HHHSCCC--C
T ss_pred             -ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHH----------HHcCCCC--C
Confidence             23455689999999999999999999999999999999999999997543210  0000          0000111  1


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ......++.++.+||.+||..||++|||+.|+++|.|.
T Consensus       367 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~  404 (423)
T 4fie_A          367 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL  404 (423)
T ss_dssp             CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGG
T ss_pred             CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHh
Confidence            11223455789999999999999999999999999764

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=6.5e-59  Score=418.97  Aligned_cols=249  Identities=24%  Similarity=0.372  Sum_probs=203.0

Q ss_pred             CCCcceeccCCceEEEEEEe-CCCcEEEEEEecc--cChhhHHHHHHHHHHHhcCCCCcceeEeeEEec----CCeEEEE
Q 037869           43 FSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKA--MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG----TDQRLIV  115 (380)
Q Consensus        43 y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv  115 (380)
                      |++.++||+|+||+||+|.+ .++..||+|++..  ........+.+|+.+|++++|||||+++++|.+    .+.+|||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lv  107 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV  107 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEE
Confidence            36778899999999999987 5689999999964  344456679999999999999999999999865    3558999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCeeeCC-CCceEEeeccCcc
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH--IIHRDIKASNVLLDS-DFEPLVADFGFAK  192 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~--ivHrdlkp~Nill~~-~~~vkl~Dfgl~~  192 (380)
                      ||||+||+|.+++.+.    ..+++..+..++.||+.||+|||++   +  |+||||||+|||++. +|.+||+|||+++
T Consensus       108 mEy~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~---~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~  180 (290)
T 3fpq_A          108 TELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  180 (290)
T ss_dssp             EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence            9999999999999753    5799999999999999999999998   6  999999999999985 7899999999998


Q ss_pred             ccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      ....   ......+||+.|+|||++.+ .|+.++|||||||++|||+||..||.......  .+.   .         .+
T Consensus       181 ~~~~---~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~~~---~---------~i  242 (290)
T 3fpq_A          181 LKRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIY---R---------RV  242 (290)
T ss_dssp             GCCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHH---H---------HH
T ss_pred             eCCC---CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--HHH---H---------HH
Confidence            6433   23445689999999998875 69999999999999999999999996533210  000   0         00


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .........+...++++.+||.+||+.||++|||+.++++|.|.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~  286 (290)
T 3fpq_A          243 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF  286 (290)
T ss_dssp             TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            00000111222334678999999999999999999999999774

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.6e-59  Score=427.62  Aligned_cols=261  Identities=22%  Similarity=0.375  Sum_probs=214.8

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe------CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT------SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQ  111 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  111 (380)
                      ....+++.++||+|+||+||+|..      .+++.||||+++... ......|.+|+.++++++|||||+++|++.+++.
T Consensus        24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~  103 (308)
T 4gt4_A           24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQP  103 (308)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCE
Confidence            345677889999999999999975      246789999997533 3345689999999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHhhccCCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYA------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS  179 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~  179 (380)
                      ++||||||++|+|.+++.....            ....+++..++.++.|++.||+|||++   +|+||||||+||||+.
T Consensus       104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~  180 (308)
T 4gt4_A          104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYD  180 (308)
T ss_dssp             CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECG
T ss_pred             EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECC
Confidence            9999999999999999965321            134689999999999999999999999   9999999999999999


Q ss_pred             CCceEEeeccCccccCCCC-ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchh
Q 037869          180 DFEPLVADFGFAKLIPEGV-SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTIT  257 (380)
Q Consensus       180 ~~~vkl~Dfgl~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~  257 (380)
                      ++.+||+|||+++...... ........||+.|+|||++.+..|+.++|||||||++|||+| |..||.+....   .  
T Consensus       181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~---~--  255 (308)
T 4gt4_A          181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ---D--  255 (308)
T ss_dssp             GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH---H--
T ss_pred             CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH---H--
Confidence            9999999999998764322 222344579999999999999999999999999999999998 89999764321   0  


Q ss_pred             ccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          258 EWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                                 +...+..+.+.+.+..++..+.+|+.+||+.||++|||+.+|+++|+.+.
T Consensus       256 -----------~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          256 -----------VVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             -----------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             -----------HHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence                       00111122223445667788999999999999999999999999998764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-58  Score=420.28  Aligned_cols=261  Identities=30%  Similarity=0.453  Sum_probs=207.2

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecc--cChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKA--MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      ....+++++.++||+|+||+||+|++.+  .||||+++.  ........|.+|+.+|++++|||||++++++.+ +.++|
T Consensus        32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~i  108 (307)
T 3omv_A           32 EIEASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAI  108 (307)
T ss_dssp             BCCTTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEE
T ss_pred             EEcHHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEE
Confidence            3466789999999999999999998753  699999874  334556689999999999999999999998864 56899


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      |||||+||+|.+++...   ...+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       109 VmEy~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~  182 (307)
T 3omv_A          109 VTQWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVK  182 (307)
T ss_dssp             EEECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC-
T ss_pred             EEEcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceec
Confidence            99999999999999754   35799999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCC-ccceeccccccCccCcccccc---CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          195 PEGV-SHMTTRVKGTLGYLAPEYAMW---GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       195 ~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      .... .......+||+.|+|||++.+   ..|+.++|||||||++|||+||..||........  ...    ..     .
T Consensus       183 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~--~~~----~~-----~  251 (307)
T 3omv_A          183 SRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ--IIF----MV-----G  251 (307)
T ss_dssp             -----------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHH----HH-----H
T ss_pred             ccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH--HHH----HH-----h
Confidence            4322 223445679999999999964   4589999999999999999999999976432110  000    00     0


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ...........+.+++..+.+|+.+||+.||++|||+.+|+++|+.+
T Consensus       252 ~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l  298 (307)
T 3omv_A          252 RGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELL  298 (307)
T ss_dssp             TTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHH
T ss_pred             cCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            00111111234455668899999999999999999999999987643

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=7.1e-59  Score=415.18  Aligned_cols=249  Identities=22%  Similarity=0.338  Sum_probs=196.2

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ++|++.+.||+|+||+||+|++ .+|+.||||++....   ......+.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm   92 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI   92 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence            5899999999999999999987 579999999997532   233457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||| +|+|.+++...    ..+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+++....
T Consensus        93 Ey~-~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~  164 (275)
T 3hyh_A           93 EYA-GNELFDYIVQR----DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD  164 (275)
T ss_dssp             ECC-CEEHHHHHHHS----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC-----
T ss_pred             eCC-CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCC
Confidence            999 67999999653    5799999999999999999999999   999999999999999999999999999987644


Q ss_pred             CCccceeccccccCccCccccccCCC-CccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      .  ......+||+.|+|||++.+..| +.++||||+||++|+|++|..||......  .....     ...+        
T Consensus       165 ~--~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~--~~~~~-----i~~~--------  227 (275)
T 3hyh_A          165 G--NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP--VLFKN-----ISNG--------  227 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH-----HHHT--------
T ss_pred             C--CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH--HHHHH-----HHcC--------
Confidence            2  23345689999999999998876 58999999999999999999999753211  00000     0011        


Q ss_pred             cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                        ...++...+.++.+||.+||+.||++|||++|+++|.|.
T Consensus       228 --~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~  266 (275)
T 3hyh_A          228 --VYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWF  266 (275)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHH
T ss_pred             --CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccc
Confidence              012334456789999999999999999999999999763

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=7.7e-59  Score=425.48  Aligned_cols=251  Identities=23%  Similarity=0.256  Sum_probs=206.8

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      .+.|++.++||+|+||+||+|++ .+|+.||||+++....     ..+|+.+|+.++|||||++++++.+++.+||||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy  131 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL  131 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence            35688899999999999999997 5799999999975432     24699999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC-ceEEeeccCccccCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF-EPLVADFGFAKLIPEG  197 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~-~vkl~Dfgl~~~~~~~  197 (380)
                      |+||+|.+++...    ..+++..+..++.|++.||+|||++   +|+||||||+|||++.+| .+||+|||+++.+...
T Consensus       132 ~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~  204 (336)
T 4g3f_A          132 LEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD  204 (336)
T ss_dssp             CTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC---
T ss_pred             cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCC
Confidence            9999999999753    4799999999999999999999999   999999999999999987 6999999999877543


Q ss_pred             Ccc----ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          198 VSH----MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       198 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                      ...    .....+||+.|+|||++.+..|+.++|||||||++|||++|.+||........  ...+     ...      
T Consensus       205 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~i-----~~~------  271 (336)
T 4g3f_A          205 GLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--CLKI-----ASE------  271 (336)
T ss_dssp             ---------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC--HHHH-----HHS------
T ss_pred             CcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH--HHHH-----HcC------
Confidence            211    22345799999999999999999999999999999999999999976433211  1000     000      


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                       +......+..++..+.+||.+||+.||.+|||+.||++++..
T Consensus       272 -~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          272 -PPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             -CCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             -CCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence             001112344566889999999999999999999999998753

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=7.1e-59  Score=420.73  Aligned_cols=251  Identities=24%  Similarity=0.310  Sum_probs=203.2

Q ss_pred             CCCCCcceeccCCceEEEEEEeC----CCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTS----DGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      ++|++.+.||+|+||+||+|++.    +++.||||+++...  ......+.+|+.+|++++|||||++++++.+++.+||
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            57999999999999999999752    47889999997422  2223367889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      |||||+||+|.+++.+.    ..+++..+..++.|++.||+|||++   ||+||||||+|||++.+|.+||+|||+++..
T Consensus       104 vmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~  176 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKES  176 (304)
T ss_dssp             EECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-
T ss_pred             EEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceec
Confidence            99999999999999753    5799999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      .... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..  .....             +..
T Consensus       177 ~~~~-~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~-------------i~~  240 (304)
T 3ubd_A          177 IDHE-KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK--ETMTM-------------ILK  240 (304)
T ss_dssp             -----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH-------------HHH
T ss_pred             cCCC-ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH--HHHHH-------------HHc
Confidence            4322 2344568999999999999999999999999999999999999999754321  00000             000


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHhcC
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPN-----MKEVVNTLTG  316 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps-----~~~ll~~l~~  316 (380)
                      .  ...++...+.++.+||.+||+.||++|||     ++|+++|.|.
T Consensus       241 ~--~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f  285 (304)
T 3ubd_A          241 A--KLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF  285 (304)
T ss_dssp             C--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGG
T ss_pred             C--CCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccc
Confidence            0  11234445678999999999999999998     5899999764

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.5e-57  Score=421.62  Aligned_cols=267  Identities=23%  Similarity=0.330  Sum_probs=218.3

Q ss_pred             cHHHHHHhhCCCCCcceeccCCceEEEEEEeCC------CcEEEEEEecccC-hhhHHHHHHHHHHHhcCCC-CcceeEe
Q 037869           32 TYKELHTATNGFSDDNKLGEGGFGSVYWGRTSD------GLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRH-KNLLGLR  103 (380)
Q Consensus        32 ~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h-~niv~~~  103 (380)
                      ...++....++|++.+.||+|+||+||+|.+..      ++.||||+++... ......+.+|+.+|.+++| ||||+++
T Consensus        55 ~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           55 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            345667788999999999999999999997532      3679999997543 3445678999999999965 8999999


Q ss_pred             eEEecC-CeEEEEEEecCCCCHHHhhccCCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 037869          104 GYCAGT-DQRLIVYDYMPNLSLLSHLHGQYA------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDI  170 (380)
Q Consensus       104 ~~~~~~-~~~~lv~e~~~~g~L~~~i~~~~~------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdl  170 (380)
                      ++|.++ +.++||||||++|+|.++++....            ....+++..+..++.|++.||+|||++   +|+||||
T Consensus       135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDL  211 (353)
T 4ase_A          135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDL  211 (353)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCC
T ss_pred             EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCcc
Confidence            999664 568999999999999999975421            134589999999999999999999999   9999999


Q ss_pred             CCCCeeeCCCCceEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCC
Q 037869          171 KASNVLLDSDFEPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKL  248 (380)
Q Consensus       171 kp~Nill~~~~~vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~  248 (380)
                      ||+|||++.++.+||+|||+++.+..... .......||+.|+|||++.+..|+.++|||||||++|||+| |..||.+.
T Consensus       212 K~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~  291 (353)
T 4ase_A          212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV  291 (353)
T ss_dssp             SGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             CccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999987654322 23445678999999999999999999999999999999998 89999764


Q ss_pred             CCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          249 PGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ....  .             +...+..+.+...+..++.++.+||.+||+.||++|||+.+|++||..
T Consensus       292 ~~~~--~-------------~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~  344 (353)
T 4ase_A          292 KIDE--E-------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  344 (353)
T ss_dssp             CCSH--H-------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CHHH--H-------------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHH
Confidence            3211  0             011111222334455566889999999999999999999999999864

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.7e-56  Score=408.18  Aligned_cols=270  Identities=23%  Similarity=0.295  Sum_probs=202.2

Q ss_pred             hCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC----eEEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD----QRLIV  115 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv  115 (380)
                      .++|.+.++||+|+||+||+|++ +|+.||||+++..... ...+..|+..+..++|||||++++++..++    .+|||
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            35688999999999999999988 5899999999764322 223445777778899999999999997653    58999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhc-----CCCCeEecCCCCCCeeeCCCCceEEeeccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE-----VTPHIIHRDIKASNVLLDSDFEPLVADFGF  190 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~-----~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl  190 (380)
                      ||||++|+|.++++..     .+++..+..++.|++.||+|||++     ..++|+||||||+|||++.++.+||+|||+
T Consensus        80 ~Ey~~~gsL~~~l~~~-----~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl  154 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             ecCCCCCcHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence            9999999999999753     689999999999999999999975     134899999999999999999999999999


Q ss_pred             ccccCCCCcc---ceeccccccCccCccccccC------CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccch
Q 037869          191 AKLIPEGVSH---MTTRVKGTLGYLAPEYAMWG------KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE  261 (380)
Q Consensus       191 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  261 (380)
                      ++........   .....+||+.|+|||++.+.      .|+.++|||||||++|||+||.+||.......... ..+..
T Consensus       155 a~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~-~~~~~  233 (303)
T 3hmm_A          155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLVP  233 (303)
T ss_dssp             CEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TTTSC
T ss_pred             CccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc-hhccc
Confidence            9876543222   22345799999999999764      47889999999999999999988875433211100 00000


Q ss_pred             hh-hhccccccccCCcccCCCC-----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          262 PL-IVKGKFKELVDPKLRGDFD-----ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       262 ~~-~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .. .............++...+     ...+..+.+|+.+||+.||++|||+.+|++.|..+
T Consensus       234 ~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            00 0000000111122222222     34667899999999999999999999999998643

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.6e-56  Score=406.63  Aligned_cols=253  Identities=21%  Similarity=0.327  Sum_probs=192.9

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC---------
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD---------  110 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~---------  110 (380)
                      +|++++.||+|+||+||+|++ .+++.||||+++... ......+.+|+.+|++++|||||++++++.+.+         
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~   85 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSS   85 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC---------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccC
Confidence            589999999999999999987 579999999997533 344567889999999999999999999987544         


Q ss_pred             ---eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEee
Q 037869          111 ---QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD  187 (380)
Q Consensus       111 ---~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~D  187 (380)
                         .+|+|||||+||+|.+++.... .....++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|
T Consensus        86 ~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           86 PKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             -CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC
T ss_pred             CCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEcc
Confidence               3799999999999999997642 223466778899999999999999999   999999999999999999999999


Q ss_pred             ccCccccCCCCcc-----------ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccch
Q 037869          188 FGFAKLIPEGVSH-----------MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI  256 (380)
Q Consensus       188 fgl~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  256 (380)
                      ||+++.+......           .....+||+.|+|||++.+..|+.++|||||||++|||++   ||.....    ..
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~----~~  234 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQME----RV  234 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHH----HH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccH----HH
Confidence            9999876543211           1234579999999999999999999999999999999996   7743110    00


Q ss_pred             hccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          257 TEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                             .   .+....... ........++.+.+||.+||+.||.+|||+.++++|.+.
T Consensus       235 -------~---~~~~~~~~~-~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~  283 (299)
T 4g31_A          235 -------R---TLTDVRNLK-FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF  283 (299)
T ss_dssp             -------H---HHHHHHTTC-CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             -------H---HHHHHhcCC-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhh
Confidence                   0   000000000 011123344567899999999999999999999998653

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.2e-54  Score=405.14  Aligned_cols=265  Identities=21%  Similarity=0.282  Sum_probs=206.8

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEec------CC
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG------TD  110 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~  110 (380)
                      .++|++++.||+|+||+||+|++ .+|+.||||+++..  .......+.+|+++|+.++|||||++++++..      .+
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            36899999999999999999987 57999999999753  33445678899999999999999999998753      36


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccC
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGF  190 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl  190 (380)
                      .+|||||||+ |+|.+++...    ..+++..+..++.||+.||.|||++   ||+||||||+|||++.++.+||+|||+
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~----~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGl  204 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSS----QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGM  204 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSS----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             EEEEEEeCCC-CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecce
Confidence            7899999996 6799999643    5799999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCC---ccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhc
Q 037869          191 AKLIPEGV---SHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVK  266 (380)
Q Consensus       191 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  266 (380)
                      ++.+....   .......+||++|+|||++.+. .|+.++||||+|||+|||++|.+||.+......  +..+..   ..
T Consensus       205 a~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~--l~~I~~---~~  279 (398)
T 4b99_A          205 ARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQ--LQLIMM---VL  279 (398)
T ss_dssp             CBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHH--HHHHHH---HH
T ss_pred             eeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHH--HHHHHH---hc
Confidence            98764321   2234457899999999998875 569999999999999999999999976432110  000000   00


Q ss_pred             cccc-------------c---ccCCccc---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          267 GKFK-------------E---LVDPKLR---GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       267 ~~~~-------------~---~~~~~~~---~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      +...             .   ...+...   ....+..+.++.+||.+||..||.+|||+.|+|+|.+..
T Consensus       280 g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  349 (398)
T 4b99_A          280 GTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA  349 (398)
T ss_dssp             CCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred             CCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence            0000             0   0000000   001122357889999999999999999999999998754

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=5.1e-54  Score=400.39  Aligned_cols=269  Identities=22%  Similarity=0.317  Sum_probs=205.5

Q ss_pred             HHHHhhCCCCCcceeccCCceEEEEEEeC----CCcEEEEEEecccChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecC
Q 037869           35 ELHTATNGFSDDNKLGEGGFGSVYWGRTS----DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGT  109 (380)
Q Consensus        35 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  109 (380)
                      .+....++|++.++||+|+||+||+|+++    +++.||+|++....  ....+.+|+++|+.+ +||||+++++++.+.
T Consensus        15 ~~p~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~   92 (361)
T 4f9c_A           15 AVPQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN   92 (361)
T ss_dssp             HSGGGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred             hcCCccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence            34456789999999999999999999752    47889999987543  334678899999988 699999999999999


Q ss_pred             CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-CceEEeec
Q 037869          110 DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD-FEPLVADF  188 (380)
Q Consensus       110 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~-~~vkl~Df  188 (380)
                      +.+|+|||||+||+|.+++.       .+++..+..++.||+.||+|||++   ||+||||||+|||++.+ +.+||+||
T Consensus        93 ~~~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DF  162 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDF  162 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             CEEEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcC
Confidence            99999999999999999983       489999999999999999999999   99999999999999877 89999999


Q ss_pred             cCccccCCCCc---------------------------cceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHh
Q 037869          189 GFAKLIPEGVS---------------------------HMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILT  240 (380)
Q Consensus       189 gl~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~  240 (380)
                      |+|+.......                           ......+||++|+|||++.+. .|+.++||||+|||+|||++
T Consensus       163 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~  242 (361)
T 4f9c_A          163 GLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLS  242 (361)
T ss_dssp             TTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred             CCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHH
Confidence            99986543211                           112345799999999999875 58999999999999999999


Q ss_pred             CCCCCCCCCCCcccchhccchhh----------h-----------hcccccc---------ccCC---------cccCCC
Q 037869          241 GRKPIEKLPGGVKRTITEWAEPL----------I-----------VKGKFKE---------LVDP---------KLRGDF  281 (380)
Q Consensus       241 g~~p~~~~~~~~~~~~~~~~~~~----------~-----------~~~~~~~---------~~~~---------~~~~~~  281 (380)
                      |..||........ .+..+....          .           .......         ...+         ......
T Consensus       243 G~~Pf~~~~~~~~-~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~  321 (361)
T 4f9c_A          243 GRYPFYKASDDLT-ALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEG  321 (361)
T ss_dssp             TCSSSSCCSSHHH-HHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------
T ss_pred             CCCCCCCCCCHHH-HHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccc
Confidence            9999965432110 000000000          0           0000000         0000         000111


Q ss_pred             CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          282 DENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       282 ~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ....++++.+||.+||..||++|||++|+++|.+.
T Consensus       322 ~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f  356 (361)
T 4f9c_A          322 WNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFF  356 (361)
T ss_dssp             CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred             cccCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence            22345788999999999999999999999999874

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.2e-53  Score=417.69  Aligned_cols=256  Identities=17%  Similarity=0.284  Sum_probs=216.0

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEec
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYM  119 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  119 (380)
                      ++|++.+.||+|+||+||+|.+ .+|+.||+|++......+...+.+|+.+|+.++|||||+++++|.+++.+|||||||
T Consensus       157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~  236 (573)
T 3uto_A          157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  236 (573)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence            5899999999999999999987 579999999998777777778999999999999999999999999999999999999


Q ss_pred             CCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC--CceEEeeccCccccCCC
Q 037869          120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD--FEPLVADFGFAKLIPEG  197 (380)
Q Consensus       120 ~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~--~~vkl~Dfgl~~~~~~~  197 (380)
                      +||+|.+++...   ...+++..+..++.||+.||.|||++   +|+||||||+|||++.+  +.+||+|||+++.+...
T Consensus       237 ~gg~L~~~i~~~---~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~  310 (573)
T 3uto_A          237 SGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  310 (573)
T ss_dssp             CCCBHHHHHTCT---TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT
T ss_pred             CCCcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCC
Confidence            999999999643   35799999999999999999999999   99999999999999864  89999999999987543


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                        ......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.....  ....     .....      ...
T Consensus       311 --~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~--~~~~-----i~~~~------~~~  375 (573)
T 3uto_A          311 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE--TLRN-----VKSCD------WNM  375 (573)
T ss_dssp             --SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHH-----HHTTC------CCC
T ss_pred             --CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH--HHHH-----HHhCC------CCC
Confidence              23445679999999999999999999999999999999999999997543210  0000     00000      011


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ........+.++.+||.+||+.||.+|||+.|+++|.|..
T Consensus       376 ~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~  415 (573)
T 3uto_A          376 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT  415 (573)
T ss_dssp             CSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTS
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcC
Confidence            1122234457899999999999999999999999997754

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8.8e-53  Score=413.03  Aligned_cols=253  Identities=22%  Similarity=0.265  Sum_probs=207.1

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC------hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN------SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ++|++.+.||+|+||+||+|++ .+|+.||||++.+..      .........++.+++.++|||||+++++|.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            5799999999999999999987 579999999996421      111122334577888899999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      ||||||+||+|.+++...    ..+++..+..++.||+.||+|||++   ||+||||||+|||++.+|.+||+|||+++.
T Consensus       269 lVmEy~~GGdL~~~l~~~----~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~  341 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  341 (689)
T ss_dssp             EEECCCCSCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeee
Confidence            999999999999999753    5799999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCccceeccccccCccCccccc-cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      +...   .....+||+.|+|||++. +..|+.++|||||||++|||++|.+||.+........+..   .         .
T Consensus       342 ~~~~---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~---~---------i  406 (689)
T 3v5w_A          342 FSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---M---------T  406 (689)
T ss_dssp             CSSC---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHH---H---------H
T ss_pred             cCCC---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH---h---------h
Confidence            7543   234568999999999997 4679999999999999999999999997533211111000   0         0


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHhcCC
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPN-----MKEVVNTLTGY  317 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps-----~~~ll~~l~~~  317 (380)
                      ..  ....++...+.++.+||.+||+.||.+|++     +++|++|.+..
T Consensus       407 ~~--~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~  454 (689)
T 3v5w_A          407 LT--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR  454 (689)
T ss_dssp             HH--CCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGT
T ss_pred             cC--CCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcccc
Confidence            00  011234455688999999999999999998     79999997643

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=5.5e-52  Score=383.43  Aligned_cols=296  Identities=44%  Similarity=0.787  Sum_probs=248.6

Q ss_pred             CCccceeccHHHHHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChh-hHHHHHHHHHHHhcCCCCcceeE
Q 037869           24 NNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSK-AEMEFAVEVEVLGRVRHKNLLGL  102 (380)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~  102 (380)
                      .....+.|+..++....++|++.+.||+|+||+||+|++.+++.||||++...... ....+.+|+.+++.++||||+++
T Consensus        13 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~   92 (326)
T 3uim_A           13 HLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRL   92 (326)
T ss_dssp             --CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCC
T ss_pred             ccCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccce
Confidence            44557789999999999999999999999999999999878999999999754322 22368899999999999999999


Q ss_pred             eeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc
Q 037869          103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE  182 (380)
Q Consensus       103 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~  182 (380)
                      ++++...+..++||||+++|+|.+++.........+++..++.++.|++.||+|||+.+.+||+||||||+|||++.++.
T Consensus        93 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~  172 (326)
T 3uim_A           93 RGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE  172 (326)
T ss_dssp             CEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCC
T ss_pred             EEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCC
Confidence            99999999999999999999999999876555667999999999999999999999976668999999999999999999


Q ss_pred             eEEeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCC--CCCcccchhccc
Q 037869          183 PLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKL--PGGVKRTITEWA  260 (380)
Q Consensus       183 vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~--~~~~~~~~~~~~  260 (380)
                      +||+|||++...............||+.|+|||++.+..++.++|||||||++|+|++|..||...  ..........|.
T Consensus       173 ~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  252 (326)
T 3uim_A          173 AVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV  252 (326)
T ss_dssp             EEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH
T ss_pred             EEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHH
Confidence            999999999887654444455566999999999999889999999999999999999999999621  111222233333


Q ss_pred             hhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCC
Q 037869          261 EPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP  319 (380)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~  319 (380)
                      .....................+...+..+.+++.+||+.||.+|||+.+++++|+....
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~  311 (326)
T 3uim_A          253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGL  311 (326)
T ss_dssp             TTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSC
T ss_pred             HHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcch
Confidence            33344445556666667777888899999999999999999999999999999986544

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=9.4e-52  Score=381.14  Aligned_cols=285  Identities=37%  Similarity=0.651  Sum_probs=242.7

Q ss_pred             eccHHHHHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecC
Q 037869           30 IFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT  109 (380)
Q Consensus        30 ~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  109 (380)
                      .++..++....++|++.+.||+|+||+||+|.+.+++.||||++..........+.+|+.+++.++||||+++++++...
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  107 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER  107 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC
Confidence            45556666788999999999999999999999888999999999876666677899999999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeecc
Q 037869          110 DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG  189 (380)
Q Consensus       110 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfg  189 (380)
                      +..++||||+++|+|.+++.........+++..++.++.|++.||.|||++   |++||||||+||+++.++.+||+|||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg  184 (321)
T 2qkw_B          108 NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFG  184 (321)
T ss_dssp             TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCT
T ss_pred             CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecc
Confidence            999999999999999999976544455799999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccc
Q 037869          190 FAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGK  268 (380)
Q Consensus       190 l~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (380)
                      ++........ .......||+.|+|||++.+..++.++|||||||++|+|++|..||.............|.......+.
T Consensus       185 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  264 (321)
T 2qkw_B          185 ISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ  264 (321)
T ss_dssp             TCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTC
T ss_pred             cccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcccccc
Confidence            9987543221 223344689999999999989999999999999999999999999986555444444444444444555


Q ss_pred             cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      +....++......+...+..+.+++.+||+.||++|||+.+++++|+..
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          265 LEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             CCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            5666667777778888999999999999999999999999999998743

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6.1e-50  Score=365.01  Aligned_cols=256  Identities=21%  Similarity=0.306  Sum_probs=214.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ..++|++.+.||+|+||+||+|.+ .+++.||+|++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   97 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME   97 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence            457899999999999999999987 5789999999976555556678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+++|+|.+++...     .+++..++.++.|++.||+|||++   ||+||||||+|||++.++.+||+|||++......
T Consensus        98 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  169 (297)
T 3fxz_A           98 YLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (297)
T ss_dssp             CCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             CCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCc
Confidence            99999999999753     589999999999999999999999   9999999999999999999999999999876543


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      .. ......||+.|+|||++.+..++.++|||||||++|+|++|..||........  ..    .....        ...
T Consensus       170 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~----~~~~~--------~~~  234 (297)
T 3fxz_A          170 QS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LY----LIATN--------GTP  234 (297)
T ss_dssp             TC-CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HH----HHHHH--------CSC
T ss_pred             cc-ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HH----HHHhC--------CCC
Confidence            22 23345699999999999999999999999999999999999999965332100  00    00000        000


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ....+...+..+.+||.+||+.||.+|||+.++++|.+..
T Consensus       235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~  274 (297)
T 3fxz_A          235 ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK  274 (297)
T ss_dssp             CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGG
T ss_pred             CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhc
Confidence            1122334557899999999999999999999999997643

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.9e-49  Score=366.36  Aligned_cols=255  Identities=22%  Similarity=0.332  Sum_probs=213.6

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ....++|++.+.||+|+||.||+|.+ .+|+.||||++...  .......+.+|+.+++.++||||+++++++...+..|
T Consensus        11 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~   90 (328)
T 3fe3_A           11 QPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY   90 (328)
T ss_dssp             CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence            34567899999999999999999987 67999999999753  4455667889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||+++|+|.+++...    ..+++..++.++.|++.||+|||++   ||+||||||+||+++.++.+||+|||++..
T Consensus        91 lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  163 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNE  163 (328)
T ss_dssp             EEECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGG
T ss_pred             EEEECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCcee
Confidence            999999999999999653    4699999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCccceeccccccCccCccccccCCCC-ccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVS-ESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      ....  ......+||+.|+|||++.+..++ .++||||+||++|+|++|..||......      ..... ...+.    
T Consensus       164 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~------~~~~~-i~~~~----  230 (328)
T 3fe3_A          164 FTVG--GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLK------ELRER-VLRGK----  230 (328)
T ss_dssp             GSSS--CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHHCC----
T ss_pred             cCCC--CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHH------HHHHH-HHhCC----
Confidence            6543  234456799999999999988765 8999999999999999999999753311      00000 00010    


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                            ...+...+.++.+|+.+||..||.+|||++++++|.+..
T Consensus       231 ------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~  269 (328)
T 3fe3_A          231 ------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWIN  269 (328)
T ss_dssp             ------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTT
T ss_pred             ------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhc
Confidence                  112233457889999999999999999999999997753

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=8.7e-49  Score=359.50  Aligned_cols=258  Identities=26%  Similarity=0.388  Sum_probs=213.7

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      .++|++.+.||+|+||+||+|.+ .+++.||+|++..........+.+|+.+++.++||||+++++++..++..++||||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   88 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEY   88 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEe
Confidence            46899999999999999999987 56899999999877777778899999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++.......
T Consensus        89 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           89 IKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             CTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             cCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            9999999999753   35699999999999999999999999   99999999999999999999999999998764322


Q ss_pred             ccc-------------eeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhh
Q 037869          199 SHM-------------TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIV  265 (380)
Q Consensus       199 ~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  265 (380)
                      ...             .....||+.|+|||++.+..++.++||||||+++|+|++|..||.............       
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~-------  235 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN-------  235 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC-------
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh-------
Confidence            211             114568999999999999999999999999999999999999987543211111000       


Q ss_pred             ccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          266 KGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                         ....    .....+..++..+.+++.+||+.||++|||+.++++.|..+
T Consensus       236 ---~~~~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l  280 (310)
T 3s95_A          236 ---VRGF----LDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETL  280 (310)
T ss_dssp             ---HHHH----HHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---hhcc----ccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence               0000    00112233446788999999999999999999999988755

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.9e-49  Score=362.48  Aligned_cols=267  Identities=29%  Similarity=0.426  Sum_probs=207.3

Q ss_pred             eccHHHHHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEe
Q 037869           30 IFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCA  107 (380)
Q Consensus        30 ~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  107 (380)
                      ......+.....+|++.+.||+|+||+||+|++ ++..||||++....  ......+.+|+.++++++||||+++++++.
T Consensus        26 ~~~~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  104 (309)
T 3p86_A           26 AMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVT  104 (309)
T ss_dssp             ------CBCCGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCCcccccCChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            444555666788999999999999999999987 58899999987533  344567889999999999999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCeeeCCCCceEE
Q 037869          108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH--IIHRDIKASNVLLDSDFEPLV  185 (380)
Q Consensus       108 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~--ivHrdlkp~Nill~~~~~vkl  185 (380)
                      ..+..++||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.   |  |+||||||+||+++.++.+||
T Consensus       105 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL  180 (309)
T 3p86_A          105 QPPNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKV  180 (309)
T ss_dssp             STTCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEE
T ss_pred             ECCceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEE
Confidence            9999999999999999999997541 123499999999999999999999999   8  999999999999999999999


Q ss_pred             eeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhh
Q 037869          186 ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIV  265 (380)
Q Consensus       186 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  265 (380)
                      +|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||........      .     
T Consensus       181 ~Dfg~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~------~-----  248 (309)
T 3p86_A          181 CDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV------V-----  248 (309)
T ss_dssp             CCCC------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH------H-----
T ss_pred             CCCCCCccccccc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------H-----
Confidence            9999998654321 223345689999999999999999999999999999999999999975432100      0     


Q ss_pred             ccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          266 KGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                          ............+...+..+.+||.+||+.||.+|||+.++++.|..+
T Consensus       249 ----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~  296 (309)
T 3p86_A          249 ----AAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL  296 (309)
T ss_dssp             ----HHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----HHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                000001111233445567899999999999999999999999988654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=9.8e-49  Score=365.96  Aligned_cols=257  Identities=23%  Similarity=0.337  Sum_probs=211.6

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChh------hHHHHHHHHHHHhcCCCCcceeEeeEEecCCe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSK------AEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQ  111 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  111 (380)
                      ..++|++.+.||+|+||+||+|.+ .+|+.||+|+++.....      ....+.+|+.+++.++||||+++++++.+.+.
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~   89 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTD   89 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCE
Confidence            567899999999999999999987 46899999999753321      34678899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC----ceEEee
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF----EPLVAD  187 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~----~vkl~D  187 (380)
                      .++||||++||+|.+++...    ..+++..++.++.|++.||.|||+.   ||+||||||+||+++.++    .+||+|
T Consensus        90 ~~lv~e~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~D  162 (361)
T 2yab_A           90 VVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID  162 (361)
T ss_dssp             EEEEEECCCSCBHHHHHTTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence            99999999999999999643    5799999999999999999999999   999999999999998876    799999


Q ss_pred             ccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcc
Q 037869          188 FGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKG  267 (380)
Q Consensus       188 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  267 (380)
                      ||++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ....     ....
T Consensus       163 FG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~--~~~~-----i~~~  233 (361)
T 2yab_A          163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLAN-----ITAV  233 (361)
T ss_dssp             CSSCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHH-----HHTT
T ss_pred             cCCceEcCCCC--ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-----HHhc
Confidence            99998765432  2344579999999999999999999999999999999999999997532110  0000     0000


Q ss_pred             ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .+      ..........+..+.+||.+||..||.+|||+.++++|.+..
T Consensus       234 ~~------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~  277 (361)
T 2yab_A          234 SY------DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT  277 (361)
T ss_dssp             CC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTS
T ss_pred             CC------CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcC
Confidence            00      000011123346889999999999999999999999998754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.6e-48  Score=355.20  Aligned_cols=262  Identities=24%  Similarity=0.368  Sum_probs=208.9

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      ..++|++.+.||+|+||.||+|++ .++..||+|++...   .......+.+|+.+++.++||||+++++++..++..|+
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l   88 (294)
T 4eqm_A            9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYL   88 (294)
T ss_dssp             EETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEE
T ss_pred             hhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEE
Confidence            467999999999999999999987 57899999998642   33445678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ||||++|++|.+++...    ..+++..++.++.|++.||+|||++   ||+||||||+||+++.++.+||+|||++...
T Consensus        89 v~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  161 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL  161 (294)
T ss_dssp             EEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC
T ss_pred             EEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCcccc
Confidence            99999999999999653    4699999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      ............||+.|+|||++.+..++.++||||||+++|+|++|..||.........      .. ....     ..
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~------~~-~~~~-----~~  229 (294)
T 4eqm_A          162 SETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA------IK-HIQD-----SV  229 (294)
T ss_dssp             -------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH------HH-HHSS-----CC
T ss_pred             ccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH------HH-Hhhc-----cC
Confidence            544333444567999999999999999999999999999999999999999764321000      00 0000     00


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHhcCCCC
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRP-NMKEVVNTLTGYDP  319 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp-s~~~ll~~l~~~~~  319 (380)
                      +..........+..+.++|.+||+.||.+|| +++++.+.|.....
T Consensus       230 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~  275 (294)
T 4eqm_A          230 PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLH  275 (294)
T ss_dssp             CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSS
T ss_pred             CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHh
Confidence            1111122334457899999999999999998 88999888876643

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.7e-49  Score=373.50  Aligned_cols=261  Identities=22%  Similarity=0.261  Sum_probs=212.9

Q ss_pred             HHHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecC
Q 037869           34 KELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT  109 (380)
Q Consensus        34 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  109 (380)
                      .++....++|++.+.||+|+||+||+|++ .+++.||+|+++...   ......+.+|+.+++.++||||+++++++.+.
T Consensus        62 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~  141 (410)
T 3v8s_A           62 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  141 (410)
T ss_dssp             HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             HhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC
Confidence            34445668999999999999999999987 468899999987521   11223477899999999999999999999999


Q ss_pred             CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeecc
Q 037869          110 DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG  189 (380)
Q Consensus       110 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfg  189 (380)
                      +.+|+||||++||+|.+++...     .+++..++.++.|++.||+|||++   ||+||||||+|||++.++.+||+|||
T Consensus       142 ~~~~lV~E~~~gg~L~~~l~~~-----~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG  213 (410)
T 3v8s_A          142 RYLYMVMEYMPGGDLVNLMSNY-----DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFG  213 (410)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             CEEEEEEeCCCCCcHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccc
Confidence            9999999999999999999643     589999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCccceeccccccCccCccccccCC----CCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhh
Q 037869          190 FAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK----VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIV  265 (380)
Q Consensus       190 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  265 (380)
                      ++..............+||+.|+|||++.+..    |+.++|||||||++|||++|..||......  ....        
T Consensus       214 ~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~--------  283 (410)
T 3v8s_A          214 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV--GTYS--------  283 (410)
T ss_dssp             TCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHH--------
T ss_pred             eeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh--hHHH--------
Confidence            99887654433445678999999999998655    889999999999999999999999753211  0000        


Q ss_pred             ccccccccCCc--ccCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHHhcCC
Q 037869          266 KGKFKELVDPK--LRGDFDENQLKQAINVAVLCVQSEPEK--RPNMKEVVNTLTGY  317 (380)
Q Consensus       266 ~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~P~~--Rps~~~ll~~l~~~  317 (380)
                           .+....  +..+.....+.++.+||.+||..+|.+  ||++++|++|.+..
T Consensus       284 -----~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~  334 (410)
T 3v8s_A          284 -----KIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFK  334 (410)
T ss_dssp             -----HHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGC
T ss_pred             -----HHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCcccc
Confidence                 011000  001111234578999999999999988  99999999997654

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=8.2e-49  Score=352.07  Aligned_cols=259  Identities=25%  Similarity=0.393  Sum_probs=215.8

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ...++|++.+.||+|+||+||+|.+.++..||+|+++.... ....+.+|+.+++.++||||+++++++......++|||
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSM-SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE   83 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTB-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCC-cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence            35678999999999999999999988888999999986443 34578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+++++|.+++...   ...+++..++.++.|++.||+|||+.   |++||||||+||+++.++.++|+|||++......
T Consensus        84 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           84 YISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             CCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             ccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            99999999999753   34699999999999999999999999   9999999999999999999999999999877554


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      .........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.........      .          .....
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~------~----------~~~~~  221 (268)
T 3sxs_A          158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVV------L----------KVSQG  221 (268)
T ss_dssp             CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH------H----------HHHTT
T ss_pred             hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHH------H----------HHHcC
Confidence            4333344456778999999999899999999999999999999 99999754321000      0          00011


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP  319 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~  319 (380)
                      .....+...+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus       222 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          222 HRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             CCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             CCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            1112223334689999999999999999999999999987754

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.4e-49  Score=376.48  Aligned_cols=268  Identities=22%  Similarity=0.232  Sum_probs=215.2

Q ss_pred             cHHHHHHhhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccCh---hhHHHHHHHHHHHhcCCCCcceeEeeEEe
Q 037869           32 TYKELHTATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNS---KAEMEFAVEVEVLGRVRHKNLLGLRGYCA  107 (380)
Q Consensus        32 ~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~  107 (380)
                      ...++....++|++.+.||+|+||+||+|++. +++.||+|+++....   .....+.+|..++..++||||+++++++.
T Consensus        65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  144 (437)
T 4aw2_A           65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ  144 (437)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            34556667789999999999999999999974 588999999975221   11224788999999999999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEee
Q 037869          108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD  187 (380)
Q Consensus       108 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~D  187 (380)
                      +.+.+|+||||++||+|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus       145 ~~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~D  218 (437)
T 4aw2_A          145 DDNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLAD  218 (437)
T ss_dssp             CSSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             eCCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcc
Confidence            999999999999999999999753   35799999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccCCCCccceeccccccCccCccccc-----cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchh
Q 037869          188 FGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-----WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEP  262 (380)
Q Consensus       188 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  262 (380)
                      ||+++.............+||+.|+|||++.     ...|+.++|||||||++|||++|..||......  .....+.. 
T Consensus       219 FGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~--~~~~~i~~-  295 (437)
T 4aw2_A          219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV--ETYGKIMN-  295 (437)
T ss_dssp             CTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHT-
T ss_pred             hhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh--HHHHhhhh-
Confidence            9999876554444444567999999999987     567999999999999999999999999753311  00000000 


Q ss_pred             hhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCC--CCCHHHHHHHhcCC
Q 037869          263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEK--RPNMKEVVNTLTGY  317 (380)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~--Rps~~~ll~~l~~~  317 (380)
                        ..   .....+    ......+.++.+||.+||..+|++  ||+++++++|.+..
T Consensus       296 --~~---~~~~~p----~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~  343 (437)
T 4aw2_A          296 --HK---ERFQFP----TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFS  343 (437)
T ss_dssp             --HH---HHCCCC----SSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGT
T ss_pred             --cc---ccccCC----cccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccC
Confidence              00   000001    111234578999999999998888  99999999996643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.3e-48  Score=356.03  Aligned_cols=266  Identities=21%  Similarity=0.336  Sum_probs=218.8

Q ss_pred             eeccHHHHHHhhCC----------CCCcceeccCCceEEEEEEeC-CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCC
Q 037869           29 RIFTYKELHTATNG----------FSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHK   97 (380)
Q Consensus        29 ~~~~~~~~~~~~~~----------y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~   97 (380)
                      ..|+.+++..+.+.          |+..+.||+|+||.||+|++. +|+.||||++..........+.+|+.+++.++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            35777777766653          788889999999999999975 7999999999876656667888999999999999


Q ss_pred             cceeEeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 037869           98 NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLL  177 (380)
Q Consensus        98 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill  177 (380)
                      ||+++++++...+..++||||+++++|.+++..     ..+++..++.++.|++.||.|||+.   ||+||||||+||++
T Consensus       103 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll  174 (321)
T 2c30_A          103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILL  174 (321)
T ss_dssp             TBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred             CcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEE
Confidence            999999999999999999999999999999864     3689999999999999999999999   99999999999999


Q ss_pred             CCCCceEEeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchh
Q 037869          178 DSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTIT  257 (380)
Q Consensus       178 ~~~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~  257 (380)
                      +.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||......  ....
T Consensus       175 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~--~~~~  251 (321)
T 2c30_A          175 TLDGRVKLSDFGFCAQISKDVP-KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMK  251 (321)
T ss_dssp             CTTCCEEECCCTTCEECCSSSC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHH
T ss_pred             CCCCcEEEeeeeeeeecccCcc-ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH
Confidence            9999999999999987654322 233456999999999999999999999999999999999999999753211  0000


Q ss_pred             ccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          258 EWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                                .+.....+..  ......+..+.+++.+||+.||.+|||+.++++|.+..
T Consensus       252 ----------~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~  299 (321)
T 2c30_A          252 ----------RLRDSPPPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL  299 (321)
T ss_dssp             ----------HHHHSSCCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGG
T ss_pred             ----------HHhcCCCCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhc
Confidence                      0000000111  11223457889999999999999999999999997754

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.1e-48  Score=351.54  Aligned_cols=256  Identities=24%  Similarity=0.407  Sum_probs=213.4

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ..++|++.+.||+|+||+||+|.+.++..||+|++...... ...+.+|+.++++++||||+++++++.+++..++||||
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEEC
T ss_pred             ChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEe
Confidence            45789999999999999999999988889999999864432 35788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++++|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        87 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           87 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             CTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             CCCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            9999999999654   34689999999999999999999999   99999999999999999999999999998765433


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      ........+++.|+|||++.+..++.++||||||+++|+|++ |..||.......  ..    .          ......
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~--~~----~----------~~~~~~  224 (269)
T 4hcu_A          161 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE--VV----E----------DISTGF  224 (269)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HH----H----------HHHTTC
T ss_pred             cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH--HH----H----------HHhcCc
Confidence            333334456788999999999999999999999999999999 999997533210  00    0          000111


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ....+...+..+.+++.+||+.||.+|||+.+++++|..+
T Consensus       225 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l  264 (269)
T 4hcu_A          225 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  264 (269)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHH
Confidence            1222333457899999999999999999999999998754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-47  Score=361.99  Aligned_cols=258  Identities=17%  Similarity=0.271  Sum_probs=214.4

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      .++|++.+.||+|+||+||+|.+ .+++.||+|++......+...+.+|+.+++.++||||+++++++......++||||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~  129 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF  129 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence            46899999999999999999987 46899999999877666677889999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC--CCceEEeeccCccccCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS--DFEPLVADFGFAKLIPE  196 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~--~~~vkl~Dfgl~~~~~~  196 (380)
                      +++|+|.+++...   ...+++..++.++.|++.||+|||+.   ||+||||||+|||++.  ++.+||+|||++.....
T Consensus       130 ~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~  203 (387)
T 1kob_A          130 LSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP  203 (387)
T ss_dssp             CCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred             CCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCC
Confidence            9999999999643   34699999999999999999999999   9999999999999974  47899999999988754


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      ..  ......||+.|+|||++.+..++.++|||||||++|+|++|..||......  .....     .....      ..
T Consensus       204 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~-----i~~~~------~~  268 (387)
T 1kob_A          204 DE--IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL--ETLQN-----VKRCD------WE  268 (387)
T ss_dssp             TS--CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH--HHHHH-----HHHCC------CC
T ss_pred             Cc--ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHH--HHHHH-----HHhCC------CC
Confidence            32  233446899999999999999999999999999999999999999753211  00000     00000      01


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      .........+.++.+||.+||+.||.+|||+.++++|.+...
T Consensus       269 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (387)
T 1kob_A          269 FDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKG  310 (387)
T ss_dssp             CCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSS
T ss_pred             CCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccC
Confidence            111222345578999999999999999999999999977543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=2.6e-48  Score=359.94  Aligned_cols=253  Identities=26%  Similarity=0.308  Sum_probs=210.8

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      .++|++.+.||+|+||+||+|++ .+++.||+|+++..   .......+.+|+.+++.++||||+++++++...+.+|+|
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv   83 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV   83 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence            46899999999999999999987 46899999999753   223345788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |||++||+|..++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.+|.+||+|||+++...
T Consensus        84 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  156 (337)
T 1o6l_A           84 MEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI  156 (337)
T ss_dssp             EECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcc
Confidence            9999999999998643    4689999999999999999999999   99999999999999999999999999998643


Q ss_pred             CCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      ... ......+||+.|+|||++.+..++.++|||||||++|||++|..||......  ..    ... ....        
T Consensus       157 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~----~~~-i~~~--------  220 (337)
T 1o6l_A          157 SDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--RL----FEL-ILME--------  220 (337)
T ss_dssp             CTT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH--HH----HHH-HHHC--------
T ss_pred             cCC-CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH--HH----HHH-HHcC--------
Confidence            221 2334567999999999999999999999999999999999999999753211  00    000 0000        


Q ss_pred             cccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhcCC
Q 037869          276 KLRGDFDENQLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLTGY  317 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~~~  317 (380)
                        ...++...+.++.+||.+||+.||.+||     ++.++++|.+..
T Consensus       221 --~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~  265 (337)
T 1o6l_A          221 --EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL  265 (337)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             --CCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcC
Confidence              0122334557899999999999999999     999999997643

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.1e-48  Score=355.23  Aligned_cols=270  Identities=23%  Similarity=0.299  Sum_probs=208.7

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ...++|++.+.||+|+||+||+|++.+++.||+|+++...  ......+.+|+.+++.++||||+++++++...+..++|
T Consensus        18 ~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   97 (311)
T 3niz_A           18 GLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV   97 (311)
T ss_dssp             CSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred             chHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence            4668999999999999999999999889999999997532  22345788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |||+++ +|.+.+...   ...+++..++.++.|++.||.|||+.   ||+||||||+|||++.++.+||+|||++....
T Consensus        98 ~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~  170 (311)
T 3niz_A           98 FEFMEK-DLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG  170 (311)
T ss_dssp             EECCSE-EHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETT
T ss_pred             EcCCCC-CHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecC
Confidence            999975 888887643   34699999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh--hccccc--
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI--VKGKFK--  270 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~--  270 (380)
                      .... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........  ..+.....  ....+.  
T Consensus       171 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--~~i~~~~~~~~~~~~~~~  247 (311)
T 3niz_A          171 IPVR-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL--PKIFSILGTPNPREWPQV  247 (311)
T ss_dssp             SCCC----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHH--HHHHHHHCCCCTTTSGGG
T ss_pred             CCcc-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHH--HHHHHHHCCCChHHhhhh
Confidence            3322 2333468999999999876 56899999999999999999999999764432211  00000000  000000  


Q ss_pred             -----------cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          271 -----------ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       271 -----------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                                 ...............+.++.+||.+||+.||.+|||+.++++|.+..
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  305 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK  305 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             hccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccc
Confidence                       00000000011123346889999999999999999999999997643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-48  Score=360.20  Aligned_cols=257  Identities=19%  Similarity=0.299  Sum_probs=211.6

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ..++|++.+.||+|+||+||+|.+ .+++.||+|.+.... .....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus         3 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e   81 (321)
T 1tki_A            3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEE
Confidence            457899999999999999999987 468899999997543 445578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC--CCceEEeeccCccccC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS--DFEPLVADFGFAKLIP  195 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~--~~~vkl~Dfgl~~~~~  195 (380)
                      |++||+|.+++...   ...+++..++.++.|++.||.|||+.   ||+||||||+|||++.  ++.+||+|||++....
T Consensus        82 ~~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~  155 (321)
T 1tki_A           82 FISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             CCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             eCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC
Confidence            99999999999643   34699999999999999999999999   9999999999999987  7899999999998875


Q ss_pred             CCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      ...  ......||+.|+|||++.+..++.++|||||||++|+|++|..||......  .....     .....+      
T Consensus       156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--~~~~~-----i~~~~~------  220 (321)
T 1tki_A          156 PGD--NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIEN-----IMNAEY------  220 (321)
T ss_dssp             TTC--EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHH-----HHHTCC------
T ss_pred             CCC--ccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHH--HHHHH-----HHcCCC------
Confidence            432  233456899999999999988999999999999999999999999753321  00000     000000      


Q ss_pred             cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ..........+.++.+||.+||..||.+|||+.++++|.+..
T Consensus       221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~  262 (321)
T 1tki_A          221 TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLK  262 (321)
T ss_dssp             CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHH
T ss_pred             CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhc
Confidence            000001113357899999999999999999999999997754

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=3.2e-48  Score=364.29  Aligned_cols=259  Identities=28%  Similarity=0.423  Sum_probs=212.4

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC--------CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEec
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS--------DGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAG  108 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  108 (380)
                      ..++|++.+.||+|+||.||+|++.        ++..||||+++.. .......+.+|+.+++.+ +||||+++++++..
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            3468999999999999999999752        3567999999754 334456788999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHhhccCCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCee
Q 037869          109 TDQRLIVYDYMPNLSLLSHLHGQYA------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVL  176 (380)
Q Consensus       109 ~~~~~lv~e~~~~g~L~~~i~~~~~------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nil  176 (380)
                      .+.+|+||||+++|+|.+++.....            ....+++..++.++.|++.||+|||++   ||+||||||+|||
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIl  235 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVL  235 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEE
Confidence            9999999999999999999976421            124589999999999999999999999   9999999999999


Q ss_pred             eCCCCceEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCccc
Q 037869          177 LDSDFEPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKR  254 (380)
Q Consensus       177 l~~~~~vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~  254 (380)
                      ++.++.+||+|||+++....... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.......  
T Consensus       236 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~--  313 (370)
T 2psq_A          236 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE--  313 (370)
T ss_dssp             ECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG--
T ss_pred             ECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH--
Confidence            99999999999999987654322 12233456889999999999999999999999999999999 999997643211  


Q ss_pred             chhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          255 TITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                                    +............+..++..+.++|.+||+.||.+|||+.+++++|..
T Consensus       314 --------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~  361 (370)
T 2psq_A          314 --------------LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  361 (370)
T ss_dssp             --------------HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------------HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence                          000111112223344556789999999999999999999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.4e-48  Score=353.46  Aligned_cols=258  Identities=24%  Similarity=0.424  Sum_probs=211.7

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ....++|++.+.||+|+||+||++.+.++..||+|+++..... ...+.+|+.+++.++||||+++++++...+..++||
T Consensus        20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   98 (283)
T 3gen_A           20 EIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT   98 (283)
T ss_dssp             BCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEE
T ss_pred             cCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEE
Confidence            3467899999999999999999999888889999999864433 357889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++++|.+++...   ...+++..++.++.|++.||.|||++   +|+||||||+||+++.++.++|+|||++.....
T Consensus        99 e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  172 (283)
T 3gen_A           99 EYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD  172 (283)
T ss_dssp             CCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred             eccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccc
Confidence            999999999999753   34699999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      ..........+|+.|+|||++.+..++.++||||||+++|+|++ |..||........  .              .....
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~--~--------------~~~~~  236 (283)
T 3gen_A          173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET--A--------------EHIAQ  236 (283)
T ss_dssp             HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH--H--------------HHHHT
T ss_pred             cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHH--H--------------HHHhc
Confidence            33223333456788999999998999999999999999999998 9999976432100  0              00011


Q ss_pred             cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ......+...+..+.+++.+||+.||.+|||+.+++++|..+
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          237 GLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence            111222333457899999999999999999999999998753

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.4e-48  Score=357.57  Aligned_cols=260  Identities=21%  Similarity=0.314  Sum_probs=210.2

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccCh-hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ..++|++.+.||+|+||+||+|.+. +++.||+|++..... .....+.+|+.+++.++||||+++++++..++..|+||
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            3578999999999999999999874 789999999875332 23356888999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++|+|.+++...    ..+++..++.++.|++.||+|||+.   ||+||||||+|||++.++.+||+|||++..+..
T Consensus        85 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  157 (323)
T 3tki_A           85 EYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (323)
T ss_dssp             ECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceecc
Confidence            999999999999643    4699999999999999999999999   999999999999999999999999999986543


Q ss_pred             CC-ccceeccccccCccCccccccCCC-CccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          197 GV-SHMTTRVKGTLGYLAPEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       197 ~~-~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      .. ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||......... ...             ...
T Consensus       158 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~-~~~-------------~~~  223 (323)
T 3tki_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSD-------------WKE  223 (323)
T ss_dssp             TTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH-HHH-------------HHT
T ss_pred             CCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH-HHH-------------Hhc
Confidence            22 222334579999999999987775 78999999999999999999999764332110 000             000


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCC
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP  319 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~  319 (380)
                      ...........+..+.+||.+||+.||.+|||+.++++|.+....
T Consensus       224 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          224 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             ccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence            111111123345788999999999999999999999999876543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2e-48  Score=369.46  Aligned_cols=266  Identities=21%  Similarity=0.211  Sum_probs=213.0

Q ss_pred             cHHHHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEe
Q 037869           32 TYKELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCA  107 (380)
Q Consensus        32 ~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  107 (380)
                      +.++.....++|++.+.||+|+||+||+|++ .+++.||||+++...   ......+.+|..++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            4556666778999999999999999999987 579999999997522   122235778999999999999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEee
Q 037869          108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD  187 (380)
Q Consensus       108 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~D  187 (380)
                      +.+.+|+||||++||+|.+++...   ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|
T Consensus       132 ~~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~D  205 (412)
T 2vd5_A          132 DENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLAD  205 (412)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECC
T ss_pred             eCCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEee
Confidence            999999999999999999999753   23699999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccCCCCccceeccccccCccCccccc-------cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccc
Q 037869          188 FGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-------WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWA  260 (380)
Q Consensus       188 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~  260 (380)
                      ||++..............+||+.|+|||++.       +..|+.++|||||||++|||++|..||......  .....+.
T Consensus       206 FGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~--~~~~~i~  283 (412)
T 2vd5_A          206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA--ETYGKIV  283 (412)
T ss_dssp             CTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHH
T ss_pred             chhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH--HHHHHHH
Confidence            9999877554333344567999999999987       357899999999999999999999999753321  0000000


Q ss_pred             hhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCC---CCHHHHHHHhcC
Q 037869          261 EPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKR---PNMKEVVNTLTG  316 (380)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~R---ps~~~ll~~l~~  316 (380)
                      ..   .   .....    ...+...+.++.+||.+||. +|.+|   |+++++++|.+.
T Consensus       284 ~~---~---~~~~~----p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff  331 (412)
T 2vd5_A          284 HY---K---EHLSL----PLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFF  331 (412)
T ss_dssp             TH---H---HHCCC----C----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGG
T ss_pred             hc---c---cCcCC----CccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCc
Confidence            00   0   00000    11123345789999999999 99998   699999999664

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.6e-48  Score=363.60  Aligned_cols=254  Identities=22%  Similarity=0.307  Sum_probs=210.1

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      -++|++.+.||+|+||.||+|.+ .+++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv   93 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV   93 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence            46899999999999999999987 468899999987422   23345788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |||+.||+|..++...    ..+++..++.++.|++.||.|||+.   ||+||||||+|||++.++.+||+|||++....
T Consensus        94 ~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~  166 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQN----VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLP  166 (384)
T ss_dssp             ECCCTTEEHHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence            9999999999999753    4699999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCccceeccccccCccCcccccc---CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMW---GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      ..  ......+||+.|+|||++.+   ..|+.++|||||||++|+|++|..||.............   ...        
T Consensus       167 ~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~---~~~--------  233 (384)
T 4fr4_A          167 RE--TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH---TFE--------  233 (384)
T ss_dssp             TT--CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH---HHH--------
T ss_pred             CC--CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH---HHh--------
Confidence            43  23445679999999999974   458999999999999999999999997543321111100   000        


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-HHHHHHHhcC
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPN-MKEVVNTLTG  316 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps-~~~ll~~l~~  316 (380)
                         .....++...+..+.+||.+||+.||.+||+ ++++++|.+.
T Consensus       234 ---~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f  275 (384)
T 4fr4_A          234 ---TTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYM  275 (384)
T ss_dssp             ---HCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGG
T ss_pred             ---hcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhh
Confidence               0011233445578999999999999999998 8999988654

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=8.1e-49  Score=357.12  Aligned_cols=273  Identities=23%  Similarity=0.388  Sum_probs=211.3

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-----CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEec--CCe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-----SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG--TDQ  111 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~  111 (380)
                      ..++|++.+.||+|+||+||+|+.     .+++.||||++..........+.+|+.+++.++||||+++++++..  ...
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   87 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN   87 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence            457899999999999999999973     4688999999987777777789999999999999999999999854  356


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA  191 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~  191 (380)
                      .++||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           88 LKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             CEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             eEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCccc
Confidence            89999999999999999754   34699999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCc--cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccc
Q 037869          192 KLIPEGVS--HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKF  269 (380)
Q Consensus       192 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  269 (380)
                      ........  .......++..|+|||++.+..++.++||||||+++|+|++|..||........................
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence            87644322  1222344778899999999999999999999999999999999998643211000000000000000011


Q ss_pred             ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ............+..++.++.+++.+||+.||.+|||+.++++.|..+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l  289 (295)
T 3ugc_A          242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  289 (295)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            111122223334555668899999999999999999999999998643

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.1e-48  Score=363.05  Aligned_cols=261  Identities=21%  Similarity=0.269  Sum_probs=210.4

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-----hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCe
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-----SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQ  111 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  111 (380)
                      ...++|++.+.||+|+||+||+|.+ .+++.||||++....     ......+.+|+.+++.++||||+++++++..++.
T Consensus        21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  100 (351)
T 3c0i_A           21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGM  100 (351)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            3557899999999999999999987 578999999986421     1235678899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc---eEEeec
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE---PLVADF  188 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~---vkl~Df  188 (380)
                      .|+||||++|++|.+.+.........+++..++.++.|++.||.|||++   +|+||||||+|||++.++.   +||+||
T Consensus       101 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Df  177 (351)
T 3c0i_A          101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGF  177 (351)
T ss_dssp             EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCC
T ss_pred             EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecC
Confidence            9999999999999988865433345689999999999999999999999   9999999999999986654   999999


Q ss_pred             cCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccc
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGK  268 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (380)
                      |++....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....   ...    . ....+.
T Consensus       178 g~a~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~----~-~i~~~~  248 (351)
T 3c0i_A          178 GVAIQLGESG-LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE---RLF----E-GIIKGK  248 (351)
T ss_dssp             TTCEECCTTS-CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH---HHH----H-HHHHTC
T ss_pred             cceeEecCCC-eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH---HHH----H-HHHcCC
Confidence            9998775432 223345699999999999999999999999999999999999999975321   000    0 000000


Q ss_pred             cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      +.      .........+..+.+||.+||+.||.+|||+.++++|.+.
T Consensus       249 ~~------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~  290 (351)
T 3c0i_A          249 YK------MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL  290 (351)
T ss_dssp             CC------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             CC------CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhh
Confidence            00      0000011234788999999999999999999999999664

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=5e-48  Score=356.81  Aligned_cols=257  Identities=26%  Similarity=0.433  Sum_probs=210.0

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC----CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS----DGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ..++|++.+.||+|+||+||+|.+.    .+..||||+++.. .......+.+|+.+++.++||||+++++++...+..+
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  126 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAM  126 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCE
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccE
Confidence            4578999999999999999999873    3456999999864 4445567899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||+++|+|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++..
T Consensus       127 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  200 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRV  200 (325)
T ss_dssp             EEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccc
Confidence            999999999999999643   35799999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcc--ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          194 IPEGVSH--MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       194 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      .......  ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......                ..
T Consensus       201 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----------------~~  264 (325)
T 3kul_A          201 LEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD----------------VI  264 (325)
T ss_dssp             CC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH----------------HH
T ss_pred             cccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH----------------HH
Confidence            6543222  1222345778999999999999999999999999999999 999996543210                00


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ...........+..++..+.+||.+||+.||.+|||+.++++.|..+
T Consensus       265 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l  311 (325)
T 3kul_A          265 SSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL  311 (325)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            01111122233445567899999999999999999999999998754

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.2e-48  Score=357.48  Aligned_cols=258  Identities=21%  Similarity=0.320  Sum_probs=211.0

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh------hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS------KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQ  111 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  111 (380)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++.....      .....+.+|+.+++.++||||+++++++.....
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            456799999999999999999987 4689999999975332      135678899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC----ceEEee
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF----EPLVAD  187 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~----~vkl~D  187 (380)
                      .++||||+++|+|.+++...    ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++    .+||+|
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~D  161 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID  161 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTTS----SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECC
T ss_pred             EEEEEEcCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEE
Confidence            99999999999999999643    5799999999999999999999999   999999999999998887    899999


Q ss_pred             ccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcc
Q 037869          188 FGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKG  267 (380)
Q Consensus       188 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  267 (380)
                      ||++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ....     ....
T Consensus       162 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~-----~~~~  232 (326)
T 2y0a_A          162 FGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLAN-----VSAV  232 (326)
T ss_dssp             CTTCEECCTTS--CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHH-----HHHT
T ss_pred             CCCCeECCCCC--ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH--HHHH-----HHhc
Confidence            99998765332  2334568999999999999999999999999999999999999996532110  0000     0000


Q ss_pred             ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                            ............+..+.+||.+||+.||.+|||+.++++|.+...
T Consensus       233 ------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  277 (326)
T 2y0a_A          233 ------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  277 (326)
T ss_dssp             ------CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSC
T ss_pred             ------CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccC
Confidence                  000000111233467899999999999999999999999987543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8e-48  Score=368.96  Aligned_cols=258  Identities=19%  Similarity=0.255  Sum_probs=210.4

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      ...++|++.+.||+|+||+||+|.+ .+++.||+|++....  ......+.+|+.+++.++||||+++++++.+++..|+
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~l   87 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYL   87 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEE
Confidence            3567899999999999999999987 578999999997533  3445578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC---CCCceEEeeccCc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLD---SDFEPLVADFGFA  191 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~---~~~~vkl~Dfgl~  191 (380)
                      ||||++||+|.+.+...    ..+++..+..++.||+.||.|||+.   ||+||||||+|||++   .++.+||+|||++
T Consensus        88 v~E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a  160 (444)
T 3soa_A           88 IFDLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLA  160 (444)
T ss_dssp             EECCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSC
T ss_pred             EEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCcee
Confidence            99999999999999754    4699999999999999999999999   999999999999998   4678999999999


Q ss_pred             cccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          192 KLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       192 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      ....... .......||+.|+|||++.+..|+.++|||||||++|+|++|.+||.......  ....     ...+.+  
T Consensus       161 ~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~--~~~~-----i~~~~~--  230 (444)
T 3soa_A          161 IEVEGEQ-QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR--LYQQ-----IKAGAY--  230 (444)
T ss_dssp             BCCCTTC-CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-----HHHTCC--
T ss_pred             EEecCCC-ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH--HHHH-----HHhCCC--
Confidence            8765432 22334579999999999999999999999999999999999999996533110  0000     000000  


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                          ..........+.++.+||.+||+.||.+|||+.++++|.+.
T Consensus       231 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~  271 (444)
T 3soa_A          231 ----DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI  271 (444)
T ss_dssp             ----CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTT
T ss_pred             ----CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccc
Confidence                01111122345789999999999999999999999999764

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=4e-48  Score=358.32  Aligned_cols=250  Identities=22%  Similarity=0.305  Sum_probs=208.2

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|++....   ......+.+|+.+++.++||||+++++++...+..++|
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv   87 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV   87 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            46899999999999999999997 678999999987421   11234688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |||+ +|+|.+++...    ..+++..++.++.|++.||.|||+.   ||+||||||+||+++.++.+||+|||++....
T Consensus        88 ~E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~  159 (336)
T 3h4j_B           88 IEYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMT  159 (336)
T ss_dssp             ECCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTT
T ss_pred             EECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceecc
Confidence            9999 78999988643    4699999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCccceeccccccCccCccccccCCC-CccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      ..  ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.........               .... 
T Consensus       160 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~---------------~~i~-  221 (336)
T 3h4j_B          160 DG--NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF---------------KKVN-  221 (336)
T ss_dssp             TS--BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB---------------CCCC-
T ss_pred             CC--cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH---------------HHHH-
Confidence            43  22344579999999999998776 78999999999999999999999753221100               0000 


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                       ......+...+..+.+||.+||+.||.+|||+.++++|.+.
T Consensus       222 -~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~  262 (336)
T 3h4j_B          222 -SCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWF  262 (336)
T ss_dssp             -SSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHH
T ss_pred             -cCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhh
Confidence             00112333455788999999999999999999999999764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.3e-47  Score=361.84  Aligned_cols=261  Identities=21%  Similarity=0.279  Sum_probs=209.3

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  113 (380)
                      ..++|++.+.||+|+||+||+|++ .+++.||+|+++...   ......+.+|..++..+ +||||+++++++.+.+.+|
T Consensus        50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  129 (396)
T 4dc2_A           50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF  129 (396)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEE
Confidence            456899999999999999999987 468899999997532   22233577899998876 8999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||++||+|..++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+++.
T Consensus       130 lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~  202 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKE  202 (396)
T ss_dssp             EEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeee
Confidence            999999999999999753    4699999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccc--hhccchhhhhcccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRT--ITEWAEPLIVKGKFKE  271 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~--~~~~~~~~~~~~~~~~  271 (380)
                      .... .......+||+.|+|||++.+..|+.++|||||||++|||++|..||..........  ...........     
T Consensus       203 ~~~~-~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~-----  276 (396)
T 4dc2_A          203 GLRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE-----  276 (396)
T ss_dssp             CCCT-TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH-----
T ss_pred             cccC-CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc-----
Confidence            3322 223445679999999999999999999999999999999999999996533211100  00000000000     


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHHHhcCC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNM------KEVVNTLTGY  317 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~------~~ll~~l~~~  317 (380)
                         .  ...++...+.++.+||.+||+.||.+||++      .++++|.+..
T Consensus       277 ---~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~  323 (396)
T 4dc2_A          277 ---K--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR  323 (396)
T ss_dssp             ---C--CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTT
T ss_pred             ---c--ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCcccc
Confidence               0  112334456789999999999999999984      8999997653

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-47  Score=350.29  Aligned_cols=272  Identities=20%  Similarity=0.265  Sum_probs=214.0

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC--eEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD--QRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~l  114 (380)
                      ..++|++.+.||+|+||+||+|.+. +++.||||+++... ......+.+|+.+++.++||||+++++++....  ..++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEE
Confidence            4578999999999999999999874 58999999997533 233457788999999999999999999987655  7899


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee----CCCCceEEeeccC
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLL----DSDFEPLVADFGF  190 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill----~~~~~vkl~Dfgl  190 (380)
                      ||||+++++|.+++.... ....+++..++.++.|++.||+|||+.   ||+||||||+||++    +.++.+||+|||+
T Consensus        87 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~  162 (319)
T 4euu_A           87 IMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (319)
T ss_dssp             EEECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTT
T ss_pred             EEeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCC
Confidence            999999999999997642 223499999999999999999999999   99999999999999    7778899999999


Q ss_pred             ccccCCCCccceeccccccCccCccccc--------cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccc--hhccc
Q 037869          191 AKLIPEGVSHMTTRVKGTLGYLAPEYAM--------WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRT--ITEWA  260 (380)
Q Consensus       191 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~--~~~~~  260 (380)
                      +.......  ......||+.|+|||++.        +..++.++|||||||++|+|++|..||..........  ...+.
T Consensus       163 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  240 (319)
T 4euu_A          163 ARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (319)
T ss_dssp             CEECCTTC--CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred             ceecCCCC--ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence            98765432  233456899999999986        5778999999999999999999999997543321110  00000


Q ss_pred             hhhhhcc-----------ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          261 EPLIVKG-----------KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       261 ~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .. ....           .+.-..............+..+.+++.+||+.||++|||+.++++|+.+.
T Consensus       241 ~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          241 TG-KPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HH-CCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             cC-CCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            00 0000           00000011122345678889999999999999999999999999998744

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.5e-46  Score=344.06  Aligned_cols=282  Identities=38%  Similarity=0.652  Sum_probs=227.2

Q ss_pred             cceeccHHHHHHhhCCCCCc------ceeccCCceEEEEEEeCCCcEEEEEEeccc----ChhhHHHHHHHHHHHhcCCC
Q 037869           27 TWRIFTYKELHTATNGFSDD------NKLGEGGFGSVYWGRTSDGLQIAVKKLKAM----NSKAEMEFAVEVEVLGRVRH   96 (380)
Q Consensus        27 ~~~~~~~~~~~~~~~~y~~~------~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h   96 (380)
                      ....|++.++..+++.|...      +.||+|+||.||+|.+ ++..||+|++...    .......+.+|+.+++.++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            46789999999999888877      8999999999999987 5789999998742    23345678899999999999


Q ss_pred             CcceeEeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCee
Q 037869           97 KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVL  176 (380)
Q Consensus        97 ~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nil  176 (380)
                      |||+++++++...+..++||||+++++|.+++... .....+++..++.++.|++.||.|||+.   |++||||||+||+
T Consensus        90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil  165 (307)
T 2nru_A           90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL  165 (307)
T ss_dssp             TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEE
T ss_pred             CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEE
Confidence            99999999999999999999999999999999653 2235699999999999999999999999   9999999999999


Q ss_pred             eCCCCceEEeeccCccccCCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccc
Q 037869          177 LDSDFEPLVADFGFAKLIPEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRT  255 (380)
Q Consensus       177 l~~~~~vkl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~  255 (380)
                      ++.++.++|+|||++......... ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.......  .
T Consensus       166 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~  242 (307)
T 2nru_A          166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--L  242 (307)
T ss_dssp             ECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSS--B
T ss_pred             EcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchH--H
Confidence            999999999999999876443222 2334568999999998875 58999999999999999999999997643321  1


Q ss_pred             hhccchhhh-hccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          256 ITEWAEPLI-VKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       256 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ...+..... ....+.....+. ....+...+..+.+++.+||+.||.+|||+.+++++|..+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l  304 (307)
T 2nru_A          243 LLDIKEEIEDEEKTIEDYIDKK-MNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM  304 (307)
T ss_dssp             TTHHHHHHHTTSCCHHHHSCSS-CSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHhhhhhhhhhhhcccc-ccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            111111111 111122222222 2345677888999999999999999999999999998754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.8e-48  Score=375.80  Aligned_cols=266  Identities=26%  Similarity=0.450  Sum_probs=219.1

Q ss_pred             ccHHHHHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC
Q 037869           31 FTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD  110 (380)
Q Consensus        31 ~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  110 (380)
                      +..+++....++|++.+.||+|+||+||+|.+.++..||||+++... .....+.+|+.+|+.++||||+++++++. .+
T Consensus       178 ~~~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~  255 (454)
T 1qcf_A          178 WEKDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KE  255 (454)
T ss_dssp             CCTTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred             ccccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence            44455666788999999999999999999998888899999998643 34568999999999999999999999986 66


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccC
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGF  190 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl  190 (380)
                      ..++||||+++|+|.+++...  ....+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+
T Consensus       256 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~  330 (454)
T 1qcf_A          256 PIYIITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGL  330 (454)
T ss_dssp             SCEEEECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTG
T ss_pred             ccEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCC
Confidence            799999999999999999743  123688999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhcccc
Q 037869          191 AKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKF  269 (380)
Q Consensus       191 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  269 (380)
                      ++..............++..|+|||++.+..++.++|||||||++|||++ |..||.......   .   .         
T Consensus       331 a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~---~---------  395 (454)
T 1qcf_A          331 ARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---V---I---------  395 (454)
T ss_dssp             GGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---H---H---------
T ss_pred             ceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---H---H---------
Confidence            98765432222233346788999999998999999999999999999999 999997543210   0   0         


Q ss_pred             ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCC
Q 037869          270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP  319 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~  319 (380)
                       ..+....+...+..++..+.+||.+||+.||++|||+.+|++.|..+..
T Consensus       396 -~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          396 -RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             -HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             -HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence             0011112223344566889999999999999999999999999987643

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=5.2e-48  Score=361.74  Aligned_cols=258  Identities=21%  Similarity=0.307  Sum_probs=211.3

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ....++|++.+.||+|+||.||+|.+ .+++.||+|++...  .......+.+|+.+++.++||||+++++++.+.+..|
T Consensus        25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~  104 (362)
T 2bdw_A           25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY  104 (362)
T ss_dssp             CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            34567899999999999999999987 46899999999753  3445567889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC---CceEEeeccC
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD---FEPLVADFGF  190 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~---~~vkl~Dfgl  190 (380)
                      +||||+++|+|.+.+...    ..+++..++.++.|++.||.|||++   ||+||||||+|||++.+   +.+||+|||+
T Consensus       105 lv~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~  177 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGL  177 (362)
T ss_dssp             EEECCCCSCBHHHHHTTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence            999999999999998643    4689999999999999999999999   99999999999999865   4599999999


Q ss_pred             ccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          191 AKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       191 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      +.......  ......||+.|+|||++.+..|+.++|||||||++|+|++|..||......  .....     ...+.+ 
T Consensus       178 a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~--~~~~~-----i~~~~~-  247 (362)
T 2bdw_A          178 AIEVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH--RLYAQ-----IKAGAY-  247 (362)
T ss_dssp             CBCCTTCC--SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH-----HHHTCC-
T ss_pred             ceEecCCc--ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH--HHHHH-----HHhCCC-
Confidence            98765422  233457999999999999999999999999999999999999999753211  00000     000000 


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                           ..........+.++.+||.+||+.||.+|||+.++++|.+.
T Consensus       248 -----~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~  288 (362)
T 2bdw_A          248 -----DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI  288 (362)
T ss_dssp             -----CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHH
T ss_pred             -----CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCccc
Confidence                 00111112345789999999999999999999999999664

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.4e-48  Score=351.77  Aligned_cols=253  Identities=21%  Similarity=0.267  Sum_probs=200.9

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh--------------------------hhHHHHHHHHHHH
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS--------------------------KAEMEFAVEVEVL   91 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------------------------~~~~~~~~E~~~l   91 (380)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||++.....                          .....+.+|+.++
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            347899999999999999999987 5689999999875321                          1124688899999


Q ss_pred             hcCCCCcceeEeeEEec--CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 037869           92 GRVRHKNLLGLRGYCAG--TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRD  169 (380)
Q Consensus        92 ~~l~h~niv~~~~~~~~--~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrd  169 (380)
                      +.++||||+++++++..  ....++||||+++++|.+++.     ...+++..++.++.|++.||+|||+.   +|+|||
T Consensus        91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~D  162 (298)
T 2zv2_A           91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-----LKPLSEDQARFYFQDLIKGIEYLHYQ---KIIHRD  162 (298)
T ss_dssp             HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-----SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCC
T ss_pred             HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccC
Confidence            99999999999999986  568999999999999988654     24799999999999999999999999   999999


Q ss_pred             CCCCCeeeCCCCceEEeeccCccccCCCCccceeccccccCccCccccccCC---CCccchhhhhhHHHHHHHhCCCCCC
Q 037869          170 IKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK---VSESCDVYSFGILLLEILTGRKPIE  246 (380)
Q Consensus       170 lkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~p~~  246 (380)
                      |||+||+++.++.+||+|||++........ ......||+.|+|||++.+..   ++.++|||||||++|+|++|..||.
T Consensus       163 lkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~  241 (298)
T 2zv2_A          163 IKPSNLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM  241 (298)
T ss_dssp             CCGGGEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             CCHHHEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCC
Confidence            999999999999999999999987654322 233456899999999998655   4788999999999999999999996


Q ss_pred             CCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          247 KLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .....      .+... ...        ...........+..+.+||.+||+.||++|||+.++++|.+
T Consensus       242 ~~~~~------~~~~~-~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~  295 (298)
T 2zv2_A          242 DERIM------CLHSK-IKS--------QALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW  295 (298)
T ss_dssp             CSSHH------HHHHH-HHH--------CCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHH
T ss_pred             CccHH------HHHHH-Hhc--------ccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcc
Confidence            53210      00000 000        00111111234478999999999999999999999999865

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2e-48  Score=359.04  Aligned_cols=279  Identities=24%  Similarity=0.276  Sum_probs=212.1

Q ss_pred             cHHHHHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC-
Q 037869           32 TYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD-  110 (380)
Q Consensus        32 ~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-  110 (380)
                      +.+++....++|++.+.||+|+||+||+|++. ++.||||++.... ........|+.+++.++||||+++++++.... 
T Consensus        15 ~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~   92 (322)
T 3soc_A           15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS   92 (322)
T ss_dssp             CCCCEEETTEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS
T ss_pred             CccccccchhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceeccCCC
Confidence            34444556789999999999999999999875 7899999997543 33445667999999999999999999997743 


Q ss_pred             ---eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhc-------CCCCeEecCCCCCCeeeCCC
Q 037869          111 ---QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE-------VTPHIIHRDIKASNVLLDSD  180 (380)
Q Consensus       111 ---~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~-------~~~~ivHrdlkp~Nill~~~  180 (380)
                         .+++||||+++|+|.+++...     .+++..++.++.|++.||+|||+.       ..++|+||||||+|||++.+
T Consensus        93 ~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~  167 (322)
T 3soc_A           93 VDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN  167 (322)
T ss_dssp             SSEEEEEEEECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTT
T ss_pred             CCceEEEEEecCCCCCHHHHHHhc-----CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCC
Confidence               479999999999999999753     599999999999999999999974       12389999999999999999


Q ss_pred             CceEEeeccCccccCCCCcc-ceeccccccCccCcccccc-----CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCccc
Q 037869          181 FEPLVADFGFAKLIPEGVSH-MTTRVKGTLGYLAPEYAMW-----GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKR  254 (380)
Q Consensus       181 ~~vkl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  254 (380)
                      +.+||+|||+++........ ......||+.|+|||++.+     ..++.++|||||||++|||++|..||.........
T Consensus       168 ~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~  247 (322)
T 3soc_A          168 LTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML  247 (322)
T ss_dssp             CCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCC
T ss_pred             CeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhcc
Confidence            99999999999876543222 2333568999999999986     35677899999999999999999999764432211


Q ss_pred             chhccch-----hhhhccccccccCCcccCC-CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          255 TITEWAE-----PLIVKGKFKELVDPKLRGD-FDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       255 ~~~~~~~-----~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .......     .............+.+... .....+..+.+||.+||+.||.+|||+.++++.|..+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l  316 (322)
T 3soc_A          248 PFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQM  316 (322)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             chhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1111000     0000000001111111111 1224567799999999999999999999999998754

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8.9e-48  Score=353.70  Aligned_cols=250  Identities=27%  Similarity=0.334  Sum_probs=210.1

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      .++|++.+.||+|+||+||+|++ .+++.||+|+++...   ......+.+|..+++.++||||+++++++.+.+.+|+|
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv   84 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI   84 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence            36799999999999999999987 478999999997532   22345677899999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |||++||+|.+++...    ..+++..++.++.|++.||.|||++   ||+||||||+|||++.+|.+||+|||++....
T Consensus        85 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~  157 (318)
T 1fot_A           85 MDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP  157 (318)
T ss_dssp             ECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECS
T ss_pred             EeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecC
Confidence            9999999999999753    4689999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      ..    ....+||+.|+|||++.+..++.++|||||||++|+|++|..||......  ...             ..+...
T Consensus       158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~-------------~~i~~~  218 (318)
T 1fot_A          158 DV----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTM--KTY-------------EKILNA  218 (318)
T ss_dssp             SC----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHH-------------HHHHHC
T ss_pred             Cc----cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHH-------------HHHHhC
Confidence            32    33457999999999999999999999999999999999999999653210  000             001101


Q ss_pred             cccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhcCC
Q 037869          276 KLRGDFDENQLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLTGY  317 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~~~  317 (380)
                      .  ..++...+.++.++|.+||..||.+||     +++++++|.+..
T Consensus       219 ~--~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~  263 (318)
T 1fot_A          219 E--LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK  263 (318)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGS
T ss_pred             C--CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCcccc
Confidence            0  112334457899999999999999999     999999997653

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2e-47  Score=346.77  Aligned_cols=266  Identities=22%  Similarity=0.322  Sum_probs=204.6

Q ss_pred             CCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChh--hHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSK--AEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ++|++.+.||+|+||+||+|++.+++.||+|++......  ....+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            579999999999999999999988999999999754322  235788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++ +|.+++...   ...+++..+..++.|++.||+|||++   ||+||||||+||+++.++.+||+|||++.......
T Consensus        82 ~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  154 (288)
T 1ob3_A           82 LDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (288)
T ss_dssp             CSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             cCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccc
Confidence            975 899888653   35689999999999999999999999   99999999999999999999999999998764322


Q ss_pred             ccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh--hcccccc----
Q 037869          199 SHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI--VKGKFKE----  271 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~----  271 (380)
                      . ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......  ..........  ....+..    
T Consensus       155 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T 1ob3_A          155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD--QLMRIFRILGTPNSKNWPNVTEL  231 (288)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGGS
T ss_pred             c-ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHHCCCChhhchhhhcc
Confidence            2 2233468999999999976 458999999999999999999999997543211  0000000000  0000000    


Q ss_pred             --------ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          272 --------LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       272 --------~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                              ...+..........+.++.+||.+||+.||++|||+.++++|.+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  284 (288)
T 1ob3_A          232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF  284 (288)
T ss_dssp             TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence                    000000011223345788999999999999999999999999763

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=5.3e-48  Score=360.09  Aligned_cols=254  Identities=24%  Similarity=0.286  Sum_probs=206.1

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  113 (380)
                      ..++|++.+.||+|+||+||+|++ .+++.||||+++..   .......+.+|..++..+ +||||+++++++...+.+|
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~  100 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF  100 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence            457899999999999999999987 46899999999753   223345677899999988 7999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||++||+|..++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+++.
T Consensus       101 lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~  173 (353)
T 3txo_A          101 FVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKE  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceee
Confidence            999999999999999653    4699999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                      .... .......+||+.|+|||++.+..|+.++|||||||++|||++|..||......  ....             .+.
T Consensus       174 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~~-------------~i~  237 (353)
T 3txo_A          174 GICN-GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED--DLFE-------------AIL  237 (353)
T ss_dssp             SCC----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHH-------------HHH
T ss_pred             cccC-CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH--HHHH-------------HHH
Confidence            4322 22344567999999999999889999999999999999999999999754321  0000             000


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHHHhcCC
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNM------KEVVNTLTGY  317 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~------~~ll~~l~~~  317 (380)
                      ..  ...++...+.++.+||.+||+.||.+||++      .++++|.+..
T Consensus       238 ~~--~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~  285 (353)
T 3txo_A          238 ND--EVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK  285 (353)
T ss_dssp             HC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGT
T ss_pred             cC--CCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCccc
Confidence            00  012233345789999999999999999999      8999997643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.6e-47  Score=356.50  Aligned_cols=249  Identities=25%  Similarity=0.274  Sum_probs=210.0

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ++|++.+.||+|+||.||+|++ .+++.||+|++....   ......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            6899999999999999999987 478999999996532   223457888999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||++||+|.+++...    ..+++..++.++.|++.||.|||++   ||+||||||+|||++.++.+||+|||++.....
T Consensus       121 e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~  193 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             cCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccC
Confidence            999999999999753    4699999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      .    ....+||+.|+|||++.+..++.++|||||||++|+|++|..||......  ...    .. ...+         
T Consensus       194 ~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~----~~-i~~~---------  253 (350)
T 1rdq_E          194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--QIY----EK-IVSG---------  253 (350)
T ss_dssp             C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH----HH-HHHC---------
T ss_pred             C----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHH--HHH----HH-HHcC---------
Confidence            2    23457999999999999999999999999999999999999999753210  000    00 0001         


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHhcCC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPN-----MKEVVNTLTGY  317 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps-----~~~ll~~l~~~  317 (380)
                       ...++...+.++.+||.+||+.||.+||+     +++|++|.+..
T Consensus       254 -~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~  298 (350)
T 1rdq_E          254 -KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA  298 (350)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred             -CCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcC
Confidence             01223345578999999999999999998     99999997643

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=9.1e-48  Score=355.60  Aligned_cols=255  Identities=21%  Similarity=0.289  Sum_probs=203.6

Q ss_pred             hCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC-------
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD-------  110 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-------  110 (380)
                      .++|++.+.||+|+||.||+|++. +++.||||+++... ......+.+|+.+++.++||||+++++++.+..       
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            457999999999999999999984 79999999997533 345567899999999999999999999986543       


Q ss_pred             --------------------------------------------------eEEEEEEecCCCCHHHhhccCCCCCccCCH
Q 037869          111 --------------------------------------------------QRLIVYDYMPNLSLLSHLHGQYAGEVQLDW  140 (380)
Q Consensus       111 --------------------------------------------------~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~  140 (380)
                                                                        ..++|||||++++|.+++.... .....++
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchhh
Confidence                                                              3899999999999999998653 3345677


Q ss_pred             HHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc-----------cceecccccc
Q 037869          141 KRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS-----------HMTTRVKGTL  209 (380)
Q Consensus       141 ~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~-----------~~~~~~~gt~  209 (380)
                      ..++.++.|++.||+|||++   ||+||||||+||+++.++.+||+|||++........           .......||+
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  240 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTK  240 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CG
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCc
Confidence            78999999999999999999   999999999999999999999999999988754321           1223346899


Q ss_pred             CccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHH
Q 037869          210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQA  289 (380)
Q Consensus       210 ~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (380)
                      .|+|||++.+..++.++|||||||++|+|++|..|+....              ...   .... ...........+..+
T Consensus       241 ~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~--------------~~~---~~~~-~~~~~~~~~~~~~~~  302 (332)
T 3qd2_B          241 LYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV--------------RII---TDVR-NLKFPLLFTQKYPQE  302 (332)
T ss_dssp             GGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH--------------HHH---HHHH-TTCCCHHHHHHCHHH
T ss_pred             CccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH--------------HHH---HHhh-ccCCCcccccCChhH
Confidence            9999999999999999999999999999999877653210              000   0000 001111223445678


Q ss_pred             HHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          290 INVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       290 ~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .+||.+||+.||.+|||+.++++|.+.
T Consensus       303 ~~li~~~l~~~p~~Rps~~~~l~~~~f  329 (332)
T 3qd2_B          303 HMMVQDMLSPSPTERPEATDIIENAIF  329 (332)
T ss_dssp             HHHHHHHHCSSGGGSCCHHHHHHSTTC
T ss_pred             HHHHHHHccCCCCcCCCHHHHhhchhh
Confidence            999999999999999999999999763

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.2e-48  Score=364.52  Aligned_cols=261  Identities=26%  Similarity=0.416  Sum_probs=213.8

Q ss_pred             HHHHhhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeE
Q 037869           35 ELHTATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        35 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  112 (380)
                      .+....++|++.+.||+|+||.||+|.+. ++..||||+++... ......+.+|+.+++.++||||+++++++...+..
T Consensus       108 ~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~  187 (377)
T 3cbl_A          108 KWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI  187 (377)
T ss_dssp             TTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred             ccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence            34456678999999999999999999984 78999999997543 33345688899999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      ++||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.+||+|||+++
T Consensus       188 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~  261 (377)
T 3cbl_A          188 YIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSR  261 (377)
T ss_dssp             EEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCE
T ss_pred             EEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCce
Confidence            9999999999999999743   34689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCccce-eccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          193 LIPEGVSHMT-TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       193 ~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      .......... ....+++.|+|||++.+..++.++|||||||++|||++ |..||.......                ..
T Consensus       262 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~----------------~~  325 (377)
T 3cbl_A          262 EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ----------------TR  325 (377)
T ss_dssp             ECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHH----------------HH
T ss_pred             ecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HH
Confidence            7543322111 12235778999999998899999999999999999998 999997643210                00


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .......+...+..++..+.+||.+||+.||.+|||+.+|++.|..+
T Consensus       326 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  372 (377)
T 3cbl_A          326 EFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI  372 (377)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            11111122233444567899999999999999999999999998643

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=7.5e-48  Score=353.63  Aligned_cols=266  Identities=25%  Similarity=0.371  Sum_probs=216.1

Q ss_pred             HHHHHHhhCCCCCcceeccCCceEEEEEEe------CCCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeE
Q 037869           33 YKELHTATNGFSDDNKLGEGGFGSVYWGRT------SDGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGY  105 (380)
Q Consensus        33 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~  105 (380)
                      ..++....++|++.+.||+|+||.||+|.+      .++..||+|+++.. .......+.+|+.+++.++||||++++++
T Consensus        15 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   94 (314)
T 2ivs_A           15 DPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGA   94 (314)
T ss_dssp             CTTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             CcccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence            344455678999999999999999999975      23578999999753 34455678899999999999999999999


Q ss_pred             EecCCeEEEEEEecCCCCHHHhhccCCC--------------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 037869          106 CAGTDQRLIVYDYMPNLSLLSHLHGQYA--------------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI  165 (380)
Q Consensus       106 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~--------------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~i  165 (380)
                      +...+..++||||+++++|.+++.....                    ....+++..++.++.|++.||.|||++   +|
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i  171 (314)
T 2ivs_A           95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KL  171 (314)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CC
Confidence            9999999999999999999999976422                    123589999999999999999999999   99


Q ss_pred             EecCCCCCCeeeCCCCceEEeeccCccccCCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCC
Q 037869          166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRK  243 (380)
Q Consensus       166 vHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~  243 (380)
                      +||||||+||+++.++.++|+|||++......... ......+++.|+|||++.+..++.++|||||||++|+|++ |..
T Consensus       172 vH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~  251 (314)
T 2ivs_A          172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN  251 (314)
T ss_dssp             ECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             cccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCC
Confidence            99999999999999999999999999876443221 2233456888999999999999999999999999999999 999


Q ss_pred             CCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          244 PIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ||........                ............+..++..+.+++.+||+.||.+|||+.+++++|..+
T Consensus       252 p~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~  309 (314)
T 2ivs_A          252 PYPGIPPERL----------------FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKM  309 (314)
T ss_dssp             SSTTCCGGGH----------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCCHHHH----------------HHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            9975432110                001111112233344567899999999999999999999999998654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=9.2e-48  Score=359.99  Aligned_cols=257  Identities=20%  Similarity=0.253  Sum_probs=198.4

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ..++|++.+.||+|+||+||++++. +++.||||++...... ...+.+|+.+++.++||||+++++++...+..++|||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence            4678999999999999999999974 7899999999754332 3468899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc--eEEeeccCccccC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE--PLVADFGFAKLIP  195 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~--vkl~Dfgl~~~~~  195 (380)
                      |+++|+|.+++...    ..+++..++.++.|++.||+|||++   ||+||||||+||+++.++.  +||+|||+++...
T Consensus        97 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           97 YASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             eCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            99999999999643    4699999999999999999999999   9999999999999987765  9999999997543


Q ss_pred             CCCccceeccccccCccCccccccCCCCcc-chhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSES-CDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      ..  .......||+.|+|||++.+..++.+ +|||||||++|+|++|..||.........  ...         +.....
T Consensus       170 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~---------~~~~~~  236 (361)
T 3uc3_A          170 LH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKT---------IQRILS  236 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHH---------HHHHHT
T ss_pred             cc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHH---------HHHHhc
Confidence            22  22334569999999999988877655 89999999999999999999754321110  000         000111


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ...........+..+.+||.+||+.||.+|||+.++++|.+.
T Consensus       237 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f  278 (361)
T 3uc3_A          237 VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWF  278 (361)
T ss_dssp             TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHH
T ss_pred             CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcch
Confidence            111111111234788999999999999999999999999664

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.4e-47  Score=359.99  Aligned_cols=273  Identities=16%  Similarity=0.221  Sum_probs=209.6

Q ss_pred             hhCCCCCcceeccC--CceEEEEEEeC-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           39 ATNGFSDDNKLGEG--GFGSVYWGRTS-DGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G--~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ..++|++.+.||+|  +||+||+|++. +++.||||+++..  .......+.+|+.+++.++||||+++++++..++..+
T Consensus        23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELW  102 (389)
T ss_dssp             CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEE
Confidence            66789999999999  99999999984 7999999999753  2344567888999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||+++|+|.+++....  ...+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||++..
T Consensus       103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~  177 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLS  177 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred             EEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEccccccee
Confidence            9999999999999997542  24599999999999999999999999   999999999999999999999999999865


Q ss_pred             cCCCC------ccceeccccccCccCcccccc--CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh-
Q 037869          194 IPEGV------SHMTTRVKGTLGYLAPEYAMW--GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI-  264 (380)
Q Consensus       194 ~~~~~------~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-  264 (380)
                      .....      ........||+.|+|||++.+  ..++.++|||||||++|+|++|..||.......... ..+..... 
T Consensus       178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~-~~~~~~~~~  256 (389)
T 3gni_B          178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL-EKLNGTVPC  256 (389)
T ss_dssp             CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH-HC-------
T ss_pred             eccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH-HHhcCCCCc
Confidence            42211      111222468999999999987  579999999999999999999999997643321110 00000000 


Q ss_pred             -h------cc-------------ccccc---------cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          265 -V------KG-------------KFKEL---------VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       265 -~------~~-------------~~~~~---------~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                       .      ..             .....         .........+...+..+.+||.+||+.||.+|||+.++++|.+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~  336 (389)
T 3gni_B          257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF  336 (389)
T ss_dssp             -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred             cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence             0      00             00000         0000011123344578999999999999999999999999966


Q ss_pred             CC
Q 037869          316 GY  317 (380)
Q Consensus       316 ~~  317 (380)
                      ..
T Consensus       337 f~  338 (389)
T 3gni_B          337 FK  338 (389)
T ss_dssp             GG
T ss_pred             HH
Confidence            43

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.7e-48  Score=361.22  Aligned_cols=272  Identities=22%  Similarity=0.327  Sum_probs=217.5

Q ss_pred             ceeccHHHHHHhhCCCCCcceeccCCceEEEEEEe------CCCcEEEEEEeccc-ChhhHHHHHHHHHHHhcC-CCCcc
Q 037869           28 WRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRT------SDGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRV-RHKNL   99 (380)
Q Consensus        28 ~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~ni   99 (380)
                      ...+....+....++|++.+.||+|+||.||+|++      .+++.||||+++.. .......+.+|+.++..+ +||||
T Consensus         9 ~~~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpni   88 (359)
T 3vhe_A            9 RLPYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV   88 (359)
T ss_dssp             GSCCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             hCCCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcce
Confidence            34455677778889999999999999999999973      34688999999864 334456788999999999 78999


Q ss_pred             eeEeeEEecCCe-EEEEEEecCCCCHHHhhccCCCC--------------------------------------------
Q 037869          100 LGLRGYCAGTDQ-RLIVYDYMPNLSLLSHLHGQYAG--------------------------------------------  134 (380)
Q Consensus       100 v~~~~~~~~~~~-~~lv~e~~~~g~L~~~i~~~~~~--------------------------------------------  134 (380)
                      +++++++...+. .++||||+++|+|.+++......                                            
T Consensus        89 v~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (359)
T 3vhe_A           89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV  168 (359)
T ss_dssp             CCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------
T ss_pred             eeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccc
Confidence            999999987554 89999999999999999764221                                            


Q ss_pred             ------------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          135 ------------------EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       135 ------------------~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                                        ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||++.....
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  245 (359)
T 3vhe_A          169 EEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYK  245 (359)
T ss_dssp             ---------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTS
T ss_pred             cccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecc
Confidence                              12289999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          197 GVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       197 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      ... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||........  .             .....
T Consensus       246 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~-------------~~~~~  310 (359)
T 3vhe_A          246 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--F-------------CRRLK  310 (359)
T ss_dssp             CTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--H-------------HHHHH
T ss_pred             cccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--H-------------HHHHH
Confidence            222 22334568899999999999999999999999999999998 9999976432110  0             00000


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .......+...+.++.+++.+||+.||.+|||+.+++++|..+
T Consensus       311 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  353 (359)
T 3vhe_A          311 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  353 (359)
T ss_dssp             HTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence            1111222334457899999999999999999999999998743

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.4e-47  Score=353.00  Aligned_cols=262  Identities=22%  Similarity=0.296  Sum_probs=210.0

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  114 (380)
                      .++|++.+.||+|+||.||+|++ .+++.||+|+++..   .......+.+|..++..+ +||||+++++++...+.+|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            36799999999999999999987 46899999999753   334455678899999887 89999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ||||++||+|.+++...    ..+++..++.++.|++.||+|||++   ||+||||||+|||++.++.+||+|||+++..
T Consensus        88 v~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~  160 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEG  160 (345)
T ss_dssp             EECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred             EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccc
Confidence            99999999999999653    4699999999999999999999999   9999999999999999999999999999864


Q ss_pred             CCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      ... .......+||+.|+|||++.+..++.++|||||||++|||++|..||.............  ....    ...+..
T Consensus       161 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~~~----~~~i~~  233 (345)
T 3a8x_A          161 LRP-GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT--EDYL----FQVILE  233 (345)
T ss_dssp             CCT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------C--HHHH----HHHHHH
T ss_pred             cCC-CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccccc--HHHH----HHHHHc
Confidence            322 123445679999999999999999999999999999999999999996532211100000  0000    000000


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH------HHHHHHhcCC
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNM------KEVVNTLTGY  317 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~------~~ll~~l~~~  317 (380)
                      .  ...++...+..+.+||.+||+.||.+||++      .++++|.+..
T Consensus       234 ~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~  280 (345)
T 3a8x_A          234 K--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR  280 (345)
T ss_dssp             C--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGT
T ss_pred             C--CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccC
Confidence            0  112334456789999999999999999995      8999997643

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.9e-47  Score=345.53  Aligned_cols=268  Identities=18%  Similarity=0.249  Sum_probs=205.9

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ++|++.+.||+|+||+||+|.+ .+++.||+|+++..  .......+.+|+.+++.++||||+++++++..++..++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            5799999999999999999987 46899999999743  23334678899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+++ ++.+.+...   ...+++..++.++.|++.||+|||++   ||+||||||+||+++.++.+||+|||++......
T Consensus        82 ~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  154 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSC
T ss_pred             cCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCc
Confidence            9976 666666432   35799999999999999999999999   9999999999999999999999999999876433


Q ss_pred             CccceeccccccCccCccccccCC-CCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh--hcccccc---
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI--VKGKFKE---  271 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~---  271 (380)
                      . .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... ......+.....  ....+..   
T Consensus       155 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~  232 (292)
T 3o0g_A          155 V-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             C-SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSH-HHHHHHHHHHHCCCCTTTCTTGGG
T ss_pred             c-ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCH-HHHHHHHHHHhCCCChhhhhhhcc
Confidence            2 2233456899999999998765 899999999999999999988886432211 111100000000  0000000   


Q ss_pred             ---------ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          272 ---------LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       272 ---------~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                               ..............+..+.+||.+||+.||++|||++++++|.+.-
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  287 (292)
T 3o0g_A          233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS  287 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             cccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccc
Confidence                     0000011112234557889999999999999999999999997643

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.4e-47  Score=349.17  Aligned_cols=251  Identities=20%  Similarity=0.262  Sum_probs=199.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  114 (380)
                      ..++|++.++||+|+||+||+|++. +++.||||++...  ..........|+..+..+ +||||+++++++.+++..++
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            4468999999999999999999985 7999999998643  233344555566655555 89999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ||||+ +++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus       135 v~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~  207 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVEL  207 (311)
T ss_dssp             EEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEEC
T ss_pred             EEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeec
Confidence            99999 66999888653   34699999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      ...  .......||+.|+|||++.+ .++.++|||||||++|||++|..|+.....                  +..+..
T Consensus       208 ~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~------------------~~~~~~  266 (311)
T 3p1a_A          208 GTA--GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG------------------WQQLRQ  266 (311)
T ss_dssp             C--------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH------------------HHHHTT
T ss_pred             ccC--CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH------------------HHHHhc
Confidence            432  22334568999999999876 799999999999999999999776643110                  000111


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .......+...+..+.++|.+||+.||.+|||+.++++|.+..
T Consensus       267 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~  309 (311)
T 3p1a_A          267 GYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR  309 (311)
T ss_dssp             TCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGS
T ss_pred             cCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCcccc
Confidence            1111111223457899999999999999999999999998743

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.8e-48  Score=362.20  Aligned_cols=260  Identities=28%  Similarity=0.402  Sum_probs=210.4

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe------CCCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT------SDGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQ  111 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  111 (380)
                      ..++|++.+.||+|+||+||+|.+      .++..||||+++.. .......+.+|+.+++.++||||+++++++.....
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            457899999999999999999983      24678999999753 34455578899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHhhccCC---CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC---ceEE
Q 037869          112 RLIVYDYMPNLSLLSHLHGQY---AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF---EPLV  185 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~---~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~---~vkl  185 (380)
                      .++||||+++|+|.+++....   .....+++..++.++.|++.||+|||++   ||+||||||+|||++.++   .+||
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEE
Confidence            999999999999999997542   1234699999999999999999999999   999999999999999554   5999


Q ss_pred             eeccCccccCCC-CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhh
Q 037869          186 ADFGFAKLIPEG-VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPL  263 (380)
Q Consensus       186 ~Dfgl~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~  263 (380)
                      +|||+++..... .........||+.|+|||++.+..++.++|||||||++|||++ |..||.......           
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~-----------  294 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE-----------  294 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----------
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-----------
Confidence            999999764221 1122334457899999999999999999999999999999998 999997543210           


Q ss_pred             hhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                           +............+..++..+.+|+.+||+.||.+|||+.+|+++|+..
T Consensus       295 -----~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          295 -----VLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             -----HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                 0001111112223344557899999999999999999999999998754

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.8e-47  Score=359.65  Aligned_cols=262  Identities=30%  Similarity=0.412  Sum_probs=214.2

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEeC--------CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcC-CCCcceeEeeEE
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRTS--------DGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYC  106 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~  106 (380)
                      ....++|++.+.||+|+||+||+|.+.        .+..||||+++.. .......+.+|+.+++.+ +||||+++++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~  144 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGAC  144 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeee
Confidence            446689999999999999999999852        2357999999754 344456788999999999 899999999999


Q ss_pred             ecCCeEEEEEEecCCCCHHHhhccCCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 037869          107 AGTDQRLIVYDYMPNLSLLSHLHGQYA------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASN  174 (380)
Q Consensus       107 ~~~~~~~lv~e~~~~g~L~~~i~~~~~------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~N  174 (380)
                      ..++..++||||+++|+|.+++.....            ....+++..++.++.|++.||+|||+.   +|+||||||+|
T Consensus       145 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  221 (382)
T 3tt0_A          145 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARN  221 (382)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGG
T ss_pred             ccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcce
Confidence            999999999999999999999976431            124699999999999999999999999   99999999999


Q ss_pred             eeeCCCCceEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCc
Q 037869          175 VLLDSDFEPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGV  252 (380)
Q Consensus       175 ill~~~~~vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~  252 (380)
                      ||++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... 
T Consensus       222 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~-  300 (382)
T 3tt0_A          222 VLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE-  300 (382)
T ss_dssp             EEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-
T ss_pred             EEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH-
Confidence            9999999999999999987654322 22333457889999999999999999999999999999999 99999754311 


Q ss_pred             ccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          253 KRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                           .          +...+........+..++.++.+|+.+||+.||.+|||+.+++++|..+
T Consensus       301 -----~----------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  350 (382)
T 3tt0_A          301 -----E----------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  350 (382)
T ss_dssp             -----H----------HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----H----------HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                 0          0011111112223344557899999999999999999999999998654

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.2e-47  Score=356.45  Aligned_cols=255  Identities=27%  Similarity=0.339  Sum_probs=209.3

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCe
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQ  111 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~  111 (380)
                      ....++|++.+.||+|+||.||+|++ .+++.||||+++...   ......+..|..++..+ +||||+++++++.+.+.
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            34568999999999999999999997 468999999997532   22345677889888876 89999999999999999


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA  191 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~  191 (380)
                      +|+||||++||+|.+++...    ..+++..++.++.|++.||+|||++   ||+||||||+|||++.+|.+||+|||++
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a  165 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMC  165 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhh
Confidence            99999999999999999653    4689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          192 KLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       192 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      +...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||......  ...    ... ...    
T Consensus       166 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~--~~~----~~i-~~~----  233 (345)
T 1xjd_A          166 KENMLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELF----HSI-RMD----  233 (345)
T ss_dssp             BCCCCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH----HHH-HHC----
T ss_pred             hhcccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH--HHH----HHH-HhC----
Confidence            8643221 2344567999999999999999999999999999999999999999753311  000    000 000    


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH-HHHHHhcC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMK-EVVNTLTG  316 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~-~ll~~l~~  316 (380)
                            ...++...+.++.+||.+||..||.+||++. ++++|.+.
T Consensus       234 ------~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f  273 (345)
T 1xjd_A          234 ------NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF  273 (345)
T ss_dssp             ------CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred             ------CCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccc
Confidence                  0122334457899999999999999999998 99988664

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.3e-47  Score=356.79  Aligned_cols=270  Identities=21%  Similarity=0.219  Sum_probs=209.7

Q ss_pred             ccHHHHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc-----ChhhHHHHHHHHHHHhcCCCCcceeEee
Q 037869           31 FTYKELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM-----NSKAEMEFAVEVEVLGRVRHKNLLGLRG  104 (380)
Q Consensus        31 ~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~~~~  104 (380)
                      ++-..+....++|++.+.||+|+||+||+|.+ .++..||+|++...     .......+.+|+.+++.++||||+++++
T Consensus        16 ~q~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~   95 (345)
T 3hko_A           16 FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE   95 (345)
T ss_dssp             CCCBCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccCchhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeeh
Confidence            33445566888999999999999999999987 56889999998642     3445568899999999999999999999


Q ss_pred             EEecCCeEEEEEEecCCCCHHHhhccCCC------------------------------------CCccCCHHHHHHHHH
Q 037869          105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYA------------------------------------GEVQLDWKRRMKIAI  148 (380)
Q Consensus       105 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~------------------------------------~~~~~~~~~~~~i~~  148 (380)
                      ++.+.+..++||||+++|+|.+++.....                                    ....+++..++.++.
T Consensus        96 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  175 (345)
T 3hko_A           96 VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR  175 (345)
T ss_dssp             EEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred             hhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence            99999999999999999999999852110                                    122356788899999


Q ss_pred             HHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC--ceEEeeccCccccCCCC---ccceeccccccCccCcccccc--CC
Q 037869          149 GSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF--EPLVADFGFAKLIPEGV---SHMTTRVKGTLGYLAPEYAMW--GK  221 (380)
Q Consensus       149 ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~--~vkl~Dfgl~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~--~~  221 (380)
                      |++.||+|||+.   +|+||||||+||+++.++  .+||+|||++..+....   ........||+.|+|||++.+  ..
T Consensus       176 qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  252 (345)
T 3hko_A          176 QIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNES  252 (345)
T ss_dssp             HHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSC
T ss_pred             HHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCC
Confidence            999999999999   999999999999998776  89999999998653321   112344568999999999975  67


Q ss_pred             CCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCC
Q 037869          222 VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEP  301 (380)
Q Consensus       222 ~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P  301 (380)
                      ++.++|||||||++|+|++|..||.......  ....     .....      ...........+..+.+||.+||+.||
T Consensus       253 ~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~-----~~~~~------~~~~~~~~~~~~~~~~~li~~~l~~~p  319 (345)
T 3hko_A          253 YGPKCDAWSAGVLLHLLLMGAVPFPGVNDAD--TISQ-----VLNKK------LCFENPNYNVLSPLARDLLSNLLNRNV  319 (345)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-----HHHCC------CCTTSGGGGGSCHHHHHHHHHHSCSCT
T ss_pred             CCcHHHHHHHHHHHHHHHHCCCCCCCCChHH--HHHH-----HHhcc------cccCCcccccCCHHHHHHHHHHcCCCh
Confidence            8999999999999999999999997543210  0000     00000      000111112345789999999999999


Q ss_pred             CCCCCHHHHHHHhcC
Q 037869          302 EKRPNMKEVVNTLTG  316 (380)
Q Consensus       302 ~~Rps~~~ll~~l~~  316 (380)
                      .+|||+.++++|.+.
T Consensus       320 ~~Rps~~~~l~hp~~  334 (345)
T 3hko_A          320 DERFDAMRALQHPWI  334 (345)
T ss_dssp             TTSCCHHHHHHSHHH
T ss_pred             hHCCCHHHHhcChhh
Confidence            999999999999663

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.8e-47  Score=342.51  Aligned_cols=251  Identities=27%  Similarity=0.415  Sum_probs=198.3

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccCh----hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNS----KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      ..++|++.+.||+|+||.||+|.+. +..||||+++....    .....+.+|+.+++.++||||+++++++..++..++
T Consensus         5 ~~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (271)
T 3dtc_A            5 DFAELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL   83 (271)
T ss_dssp             CTTSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred             chhheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            3578999999999999999999985 88999999875332    224578889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC---eEecCCCCCCeeeCC--------CCce
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH---IIHRDIKASNVLLDS--------DFEP  183 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~---ivHrdlkp~Nill~~--------~~~v  183 (380)
                      ||||+++++|.+++..     ..+++..++.++.|++.||+|||+.   +   ++||||||+||+++.        ++.+
T Consensus        84 v~e~~~~~~L~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~---~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~  155 (271)
T 3dtc_A           84 VMEFARGGPLNRVLSG-----KRIPPDILVNWAVQIARGMNYLHDE---AIVPIIHRDLKSSNILILQKVENGDLSNKIL  155 (271)
T ss_dssp             EEECCTTEEHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHS---SSSCCCCSCCSGGGEEESSCCSSSCCSSCCE
T ss_pred             EEEcCCCCCHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhC---CCCceeecCCchHHEEEecccccccccCcce
Confidence            9999999999999853     3689999999999999999999998   7   999999999999985        6789


Q ss_pred             EEeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhh
Q 037869          184 LVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL  263 (380)
Q Consensus       184 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  263 (380)
                      +|+|||++.......   .....||+.|+|||++.+..++.++||||||+++|+|++|..||........          
T Consensus       156 kl~Dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~----------  222 (271)
T 3dtc_A          156 KITDFGLAREWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAV----------  222 (271)
T ss_dssp             EECCCCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHH----------
T ss_pred             EEccCCccccccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH----------
Confidence            999999998764322   2234689999999999999999999999999999999999999975432100          


Q ss_pred             hhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                           .............+..++..+.+++.+||+.||.+|||+.+++++|..
T Consensus       223 -----~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~  270 (271)
T 3dtc_A          223 -----AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTT  270 (271)
T ss_dssp             -----HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC
T ss_pred             -----HHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhc
Confidence                 001111122223344556789999999999999999999999999864

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.6e-47  Score=355.35  Aligned_cols=260  Identities=22%  Similarity=0.288  Sum_probs=197.8

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ....++|++.+.||+|+||+||+|.+. +++.||||+++...  ....+.+|+.+++.++||||+++++++...+..++|
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            345678999999999999999999984 68899999998643  344678899999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---CCceEEeeccCcc
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS---DFEPLVADFGFAK  192 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~---~~~vkl~Dfgl~~  192 (380)
                      |||+++|+|.+++...    ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.   ++.+||+|||++.
T Consensus       127 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~  199 (349)
T 2w4o_A          127 LELVTGGELFDRIVEK----GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSK  199 (349)
T ss_dssp             ECCCCSCBHHHHHTTC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC---
T ss_pred             EEeCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCcccc
Confidence            9999999999999643    4689999999999999999999999   9999999999999975   7899999999998


Q ss_pred             ccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      .....  .......||+.|+|||++.+..++.++|||||||++|+|++|..||........ ....     .....    
T Consensus       200 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~-~~~~-----i~~~~----  267 (349)
T 2w4o_A          200 IVEHQ--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF-MFRR-----ILNCE----  267 (349)
T ss_dssp             ---------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH-HHHH-----HHTTC----
T ss_pred             ccCcc--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH-HHHH-----HHhCC----
Confidence            76432  223345689999999999999999999999999999999999999965432110 0000     00000    


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCC
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP  319 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~  319 (380)
                        ...........+..+.+||.+||+.||++|||+.++++|.+....
T Consensus       268 --~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          268 --YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             --CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             --CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence              001112223445789999999999999999999999999876543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.5e-47  Score=358.56  Aligned_cols=257  Identities=27%  Similarity=0.451  Sum_probs=200.3

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC----CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS----DGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ...+|++.+.||+|+||.||+|++.    ++..||||+++.. .......+.+|+.++++++||||+++++++...+..+
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  122 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVM  122 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceE
Confidence            3468999999999999999999864    5778999999754 3445567899999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++.
T Consensus       123 lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  196 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRV  196 (373)
T ss_dssp             EEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----
T ss_pred             EEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccc
Confidence            999999999999999753   34699999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCccc--eeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          194 IPEGVSHM--TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       194 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      ........  .....+++.|+|||++.+..++.++|||||||++|||++ |..||.......                +.
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~----------------~~  260 (373)
T 2qol_A          197 LEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----------------VI  260 (373)
T ss_dssp             -----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH----------------HH
T ss_pred             cccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HH
Confidence            65432211  112235778999999999999999999999999999998 999996543210                00


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ...........+..++..+.+++.+||+.||.+|||+.++++.|..+
T Consensus       261 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          261 KAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             HHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence            01111112223344567899999999999999999999999988755

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.7e-47  Score=349.82  Aligned_cols=271  Identities=21%  Similarity=0.295  Sum_probs=193.9

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ..++|++.+.||+|+||+||+|.+ .+++.||+|+++... ......+.+|+.+++.++||||+++++++..++..++||
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            356899999999999999999987 468999999997543 223357888999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCC--CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          117 DYMPNLSLLSHLHGQYA--GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~--~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ||++ |+|.+++.....  ....+++..+..++.|++.||.|||+.   ||+||||||+||+++.++.+||+|||++...
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9998 599998864321  224589999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhh----------
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL----------  263 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~----------  263 (380)
                      ..... ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......  ....+....          
T Consensus       159 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~~~~~~  235 (317)
T 2pmi_A          159 GIPVN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEE--QLKLIFDIMGTPNESLWPS  235 (317)
T ss_dssp             TSCCC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCCTTTCGG
T ss_pred             CCCcc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHHHHHHHhCCCChhHhhh
Confidence            43222 2234468999999999986 468999999999999999999999997543211  000000000          


Q ss_pred             -hhccccccccCC--------cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          264 -IVKGKFKELVDP--------KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       264 -~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                       .....+......        .+........+.++.+||.+||+.||.+|||+.++++|.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f  297 (317)
T 2pmi_A          236 VTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF  297 (317)
T ss_dssp             GGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred             hhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhh
Confidence             000000000000        00001112234689999999999999999999999999764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=2.9e-47  Score=344.51  Aligned_cols=257  Identities=23%  Similarity=0.358  Sum_probs=199.1

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeCC----CcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTSD----GLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  112 (380)
                      ...++|++.+.||+|+||.||+|.+..    +..||+|.++.. .......+.+|+.+++.++||||+++++++. ++..
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~   90 (281)
T 1mp8_A           12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV   90 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred             EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCcc
Confidence            466899999999999999999998632    456999998753 3444567889999999999999999999985 5678


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      ++||||+++++|.+++...   ...+++..++.++.|++.||.|||+.   |++||||||+||+++.++.+||+|||++.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  164 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSR  164 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-----
T ss_pred             EEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECcccccc
Confidence            9999999999999999753   34689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      ..............+++.|+|||++.+..++.++|||||||++|+|++ |..||........  ..              
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~--~~--------------  228 (281)
T 1mp8_A          165 YMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--IG--------------  228 (281)
T ss_dssp             --------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--HH--------------
T ss_pred             ccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH--HH--------------
Confidence            765433333333456789999999998999999999999999999997 9999975432110  00              


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ..........+..++..+.+++.+||+.||.+|||+.+++++|..+
T Consensus       229 ~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  274 (281)
T 1mp8_A          229 RIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  274 (281)
T ss_dssp             HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            0001111223445567899999999999999999999999998643

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-47  Score=354.62  Aligned_cols=256  Identities=21%  Similarity=0.341  Sum_probs=204.2

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCC--CcceeEeeEEecCCeEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRH--KNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~  113 (380)
                      ...++|++.+.||+|+||.||++.+.+++.||||++...  .......+.+|+.+++.++|  |||+++++++..++..+
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~   85 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY   85 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence            356789999999999999999999888999999998743  33445678899999999976  99999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||| +.+++|.+++...    ..+++..+..++.|++.||.|||+.   +|+||||||+|||++ ++.+||+|||++..
T Consensus        86 lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~  156 (343)
T 3dbq_A           86 MVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQ  156 (343)
T ss_dssp             EEEC-CCSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCC
T ss_pred             EEEe-CCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccc
Confidence            9999 5578999999753    4789999999999999999999999   999999999999997 57899999999987


Q ss_pred             cCCCCcc-ceeccccccCccCcccccc-----------CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccch
Q 037869          194 IPEGVSH-MTTRVKGTLGYLAPEYAMW-----------GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE  261 (380)
Q Consensus       194 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  261 (380)
                      ....... ......||+.|+|||++.+           ..++.++|||||||++|+|++|..||........        
T Consensus       157 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--------  228 (343)
T 3dbq_A          157 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS--------  228 (343)
T ss_dssp             C------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHH--------
T ss_pred             cCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHH--------
Confidence            6543222 2334579999999999865           6789999999999999999999999975322100        


Q ss_pred             hhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          262 PLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                            .+.....+......+...+..+.+||.+||+.||.+|||+.++++|.+.
T Consensus       229 ------~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~  277 (343)
T 3dbq_A          229 ------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV  277 (343)
T ss_dssp             ------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             ------HHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence                  0111122222223333344688999999999999999999999999764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-47  Score=355.41  Aligned_cols=265  Identities=23%  Similarity=0.371  Sum_probs=214.4

Q ss_pred             HHHHhhCCCCCcceeccCCceEEEEEEeC------CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEe
Q 037869           35 ELHTATNGFSDDNKLGEGGFGSVYWGRTS------DGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA  107 (380)
Q Consensus        35 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  107 (380)
                      .+....++|++.+.||+|+||.||+|++.      ++..||+|+++.. .......+.+|+.+++.++||||+++++++.
T Consensus        41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            34456789999999999999999999864      3478999999864 3344567889999999999999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHhhccCCCC--------------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 037869          108 GTDQRLIVYDYMPNLSLLSHLHGQYAG--------------------EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH  167 (380)
Q Consensus       108 ~~~~~~lv~e~~~~g~L~~~i~~~~~~--------------------~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivH  167 (380)
                      ..+..++||||+++|+|.+++......                    ...+++..++.++.|++.||.|||++   +|+|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH  197 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH  197 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---Ceec
Confidence            999999999999999999999764211                    25799999999999999999999999   9999


Q ss_pred             cCCCCCCeeeCCCCceEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCC
Q 037869          168 RDIKASNVLLDSDFEPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPI  245 (380)
Q Consensus       168 rdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~  245 (380)
                      |||||+||+++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            99999999999999999999999987543211 12233457899999999999999999999999999999999 99999


Q ss_pred             CCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          246 EKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      .......   .   .. ....         ......+..++..+.+++.+||+.||.+|||+.+++++|..+.
T Consensus       278 ~~~~~~~---~---~~-~~~~---------~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~  334 (343)
T 1luf_A          278 YGMAHEE---V---IY-YVRD---------GNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  334 (343)
T ss_dssp             TTSCHHH---H---HH-HHHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCChHH---H---HH-HHhC---------CCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence            7533210   0   00 0001         1111233445578999999999999999999999999998664

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.6e-47  Score=343.35  Aligned_cols=256  Identities=24%  Similarity=0.395  Sum_probs=212.2

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ..++|++.+.||+|+||.||+|.+.++..||+|++...... ...+.+|+.+++.++||||+++++++..++..++||||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECC
T ss_pred             chhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeC
Confidence            45789999999999999999999888889999999864432 35788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++++|.+++...   ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.......
T Consensus        85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~  158 (267)
T 3t9t_A           85 MEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  158 (267)
T ss_dssp             CTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             CCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEccccccccccccc
Confidence            9999999999754   34689999999999999999999999   99999999999999999999999999998764432


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                      ........+++.|+|||++.+..++.++||||||+++|+|++ |..||.......      ....          .....
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~~~----------i~~~~  222 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------VVED----------ISTGF  222 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HHHH----------HHTTC
T ss_pred             ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH------HHHH----------HhcCC
Confidence            222233456788999999998899999999999999999999 899997532110      0000          00111


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ....+...+..+.+++.+||+.||.+|||+.+++++|..+
T Consensus       223 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l  262 (267)
T 3t9t_A          223 RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEI  262 (267)
T ss_dssp             CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            1122333457899999999999999999999999998654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.5e-47  Score=354.39  Aligned_cols=253  Identities=26%  Similarity=0.326  Sum_probs=209.3

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  113 (380)
                      ..++|++.+.||+|+||+||+|++. +++.||||+++..   .......+..|..++..+ +||||+++++++...+.+|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            4578999999999999999999975 5889999999753   123345678899999988 7999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||++||+|.+++...    ..+++..++.++.|++.||.|||++   ||+||||||+|||++.+|.+||+|||++..
T Consensus        98 lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~  170 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE  170 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBC
T ss_pred             EEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccc
Confidence            999999999999999653    4699999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                      .... .......+||+.|+|||++.+..++.++|||||||++|||++|..||......  ...    .         .+.
T Consensus       171 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~----~---------~i~  234 (353)
T 2i0e_A          171 NIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELF----Q---------SIM  234 (353)
T ss_dssp             CCCT-TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH----H---------HHH
T ss_pred             cccC-CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH--HHH----H---------HHH
Confidence            4322 12344567999999999999999999999999999999999999999753211  000    0         000


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhcC
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLTG  316 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~~  316 (380)
                      ..  ...++...+.++.+||.+||..||.+||     +++++++|.+.
T Consensus       235 ~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f  280 (353)
T 2i0e_A          235 EH--NVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF  280 (353)
T ss_dssp             HC--CCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGG
T ss_pred             hC--CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccc
Confidence            00  0123344567899999999999999999     47999999664

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.2e-47  Score=350.96  Aligned_cols=254  Identities=22%  Similarity=0.287  Sum_probs=201.6

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe----CCCcEEEEEEecccC----hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT----SDGLQIAVKKLKAMN----SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD  110 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  110 (380)
                      ..++|++.+.||+|+||.||+|++    .+++.||+|+++...    ......+.+|+.+++.++||||+++++++...+
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   94 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGG   94 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCC
Confidence            457899999999999999999986    468999999997532    233446778999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccC
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGF  190 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl  190 (380)
                      ..|+||||+++|+|.+++...    ..+++..++.++.|++.||.|||++   ||+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~  167 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGL  167 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSC
T ss_pred             EEEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCc
Confidence            999999999999999999653    4689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          191 AKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       191 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      +....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||......  ....             
T Consensus       168 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~-------------  231 (327)
T 3a62_A          168 CKESIHDG-TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRK--KTID-------------  231 (327)
T ss_dssp             C-----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHH-------------
T ss_pred             ccccccCC-ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHH--HHHH-------------
Confidence            97643221 2234457999999999999999999999999999999999999999753311  0000             


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhcCC
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLTGY  317 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~~~  317 (380)
                      .+...  ....+...+..+.+||.+||..||.+||     ++.++++|.+..
T Consensus       232 ~i~~~--~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~  281 (327)
T 3a62_A          232 KILKC--KLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR  281 (327)
T ss_dssp             HHHHT--CCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGS
T ss_pred             HHHhC--CCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCccc
Confidence            00000  1122334457899999999999999999     899999997753

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.8e-47  Score=345.63  Aligned_cols=260  Identities=24%  Similarity=0.366  Sum_probs=200.3

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhc--CCCCcceeEeeEEec----CCeE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGR--VRHKNLLGLRGYCAG----TDQR  112 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~----~~~~  112 (380)
                      ..++|++.+.||+|+||+||+|++ +++.||||++....   ...+..|.+++..  ++||||+++++++..    ....
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCcee
Confidence            567899999999999999999988 58899999987542   3344555555555  899999999998644    3458


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEecCCCCCCeeeCCCCceE
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH--------HEVTPHIIHRDIKASNVLLDSDFEPL  184 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH--------~~~~~~ivHrdlkp~Nill~~~~~vk  184 (380)
                      ++||||+++|+|.+++..     ..+++..++.++.|++.||+|||        +.   +|+||||||+|||++.++.+|
T Consensus        82 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~k  153 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYLQL-----TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCC  153 (301)
T ss_dssp             EEEECCCTTCBHHHHHTT-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEE
T ss_pred             EEehhhccCCCHHHHHhh-----cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEE
Confidence            999999999999999954     36999999999999999999999        77   999999999999999999999


Q ss_pred             EeeccCccccCCCCccc---eeccccccCccCccccccC------CCCccchhhhhhHHHHHHHhC----------CCCC
Q 037869          185 VADFGFAKLIPEGVSHM---TTRVKGTLGYLAPEYAMWG------KVSESCDVYSFGILLLEILTG----------RKPI  245 (380)
Q Consensus       185 l~Dfgl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g----------~~p~  245 (380)
                      |+|||++..........   .....||+.|+|||++.+.      .++.++|||||||++|||++|          ..||
T Consensus       154 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf  233 (301)
T 3q4u_A          154 IADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF  233 (301)
T ss_dssp             ECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred             EeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccc
Confidence            99999997764432221   2234689999999999876      556899999999999999999          7777


Q ss_pred             CCCCCCcccchhccchhhhhccccccccCCccc-CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          246 EKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR-GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .......... .........     ....+... .......+..+.+|+.+||+.||.+|||+.++++.|..
T Consensus       234 ~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~  299 (301)
T 3q4u_A          234 YDVVPNDPSF-EDMRKVVCV-----DQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTK  299 (301)
T ss_dssp             TTTSCSSCCH-HHHHHHHTT-----SCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHH
T ss_pred             cccCCCCcch-hhhhHHHhc-----cCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhc
Confidence            5433211110 000000000     00011111 11234567889999999999999999999999999864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=5.6e-47  Score=356.00  Aligned_cols=250  Identities=23%  Similarity=0.298  Sum_probs=202.0

Q ss_pred             cceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCCCCH
Q 037869           46 DNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSL  124 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L  124 (380)
                      .+.||+|+||.||+|.+ .+++.||+|+++.........+.+|+.+++.++||||+++++++...+..++||||+++++|
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L  173 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL  173 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence            56899999999999987 56899999999887666777899999999999999999999999999999999999999999


Q ss_pred             HHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee--CCCCceEEeeccCccccCCCCccce
Q 037869          125 LSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLL--DSDFEPLVADFGFAKLIPEGVSHMT  202 (380)
Q Consensus       125 ~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill--~~~~~vkl~Dfgl~~~~~~~~~~~~  202 (380)
                      .+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||+  +.++.+||+|||++.......  ..
T Consensus       174 ~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~--~~  245 (373)
T 2x4f_A          174 FDRIIDE---SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE--KL  245 (373)
T ss_dssp             HHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC--BC
T ss_pred             HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc--cc
Confidence            9988643   34689999999999999999999999   99999999999999  567899999999998765432  23


Q ss_pred             eccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCC
Q 037869          203 TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD  282 (380)
Q Consensus       203 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                      ....||+.|+|||++.+..++.++|||||||++|+|++|..||......  .....+     ....+      .......
T Consensus       246 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~~i-----~~~~~------~~~~~~~  312 (373)
T 2x4f_A          246 KVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDA--ETLNNI-----LACRW------DLEDEEF  312 (373)
T ss_dssp             CCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHH-----HHTCC------CSCSGGG
T ss_pred             ccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHH-----HhccC------CCChhhh
Confidence            3346899999999999999999999999999999999999999754321  000000     00000      0011111


Q ss_pred             HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          283 ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       283 ~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ...+.++.+||.+||+.||.+|||+.++++|.+.
T Consensus       313 ~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~  346 (373)
T 2x4f_A          313 QDISEEAKEFISKLLIKEKSWRISASEALKHPWL  346 (373)
T ss_dssp             TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCc
Confidence            2345789999999999999999999999999764

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.4e-46  Score=341.02  Aligned_cols=253  Identities=30%  Similarity=0.506  Sum_probs=205.9

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhh-------HHHHHHHHHHHhcCCCCcceeEeeEEecCC
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKA-------EMEFAVEVEVLGRVRHKNLLGLRGYCAGTD  110 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-------~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  110 (380)
                      ..++|++.+.||+|+||+||+|++ .+++.||+|++.......       ...+.+|+.+++.++||||+++++++....
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP   96 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence            457999999999999999999987 578999999986432211       157889999999999999999999997654


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCeeeCCCCc-----e
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH--IIHRDIKASNVLLDSDFE-----P  183 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~--ivHrdlkp~Nill~~~~~-----v  183 (380)
                        ++||||+++|+|.+.+...   ...+++..++.++.|++.||+|||++   +  |+||||||+||+++.++.     +
T Consensus        97 --~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~  168 (287)
T 4f0f_A           97 --RMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCA  168 (287)
T ss_dssp             --EEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred             --eEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeE
Confidence              7999999999999988643   35799999999999999999999999   8  999999999999988776     9


Q ss_pred             EEeeccCccccCCCCccceeccccccCccCccccc--cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccch
Q 037869          184 LVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM--WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE  261 (380)
Q Consensus       184 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  261 (380)
                      ||+|||++.....    ......||+.|+|||++.  ...++.++|||||||++|+|++|..||............    
T Consensus       169 kl~Dfg~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----  240 (287)
T 4f0f_A          169 KVADFGLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN----  240 (287)
T ss_dssp             EECCCTTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH----
T ss_pred             EeCCCCccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH----
Confidence            9999999985433    233456899999999984  456899999999999999999999999754322111000    


Q ss_pred             hhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          262 PLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                               ...........+..++..+.++|.+||+.||.+|||+.++++.|..
T Consensus       241 ---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  286 (287)
T 4f0f_A          241 ---------MIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSE  286 (287)
T ss_dssp             ---------HHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHT
T ss_pred             ---------HHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHh
Confidence                     0111122223444556789999999999999999999999999864

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=9.8e-47  Score=363.82  Aligned_cols=252  Identities=23%  Similarity=0.345  Sum_probs=209.6

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||||++....   ......+.+|+.+++.++||||+++++++...+..|+
T Consensus        14 ~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~l   93 (476)
T 2y94_A           14 KIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFM   93 (476)
T ss_dssp             EETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            347899999999999999999987 479999999997532   1234578899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ||||+++|+|.+++...    ..+++..++.++.|++.||+|||+.   ||+||||||+|||++.++.+||+|||++...
T Consensus        94 v~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~  166 (476)
T 2y94_A           94 VMEYVSGGELFDYICKN----GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM  166 (476)
T ss_dssp             EEECCSSEEHHHHTTSS----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhc
Confidence            99999999999999643    5799999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCccceeccccccCccCccccccCCC-CccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                      ....  .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.......  ...             .+.
T Consensus       167 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~--~~~-------------~i~  229 (476)
T 2y94_A          167 SDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT--LFK-------------KIC  229 (476)
T ss_dssp             CTTC--CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH--HHH-------------HHH
T ss_pred             cccc--cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH--HHH-------------HHh
Confidence            5432  2334579999999999998776 789999999999999999999997533210  000             000


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ...  ...+...+.++.+||.+||+.||.+|||+.++++|.+.
T Consensus       230 ~~~--~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~  270 (476)
T 2y94_A          230 DGI--FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWF  270 (476)
T ss_dssp             TTC--CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHH
T ss_pred             cCC--cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHh
Confidence            000  01223345788999999999999999999999998653

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.6e-47  Score=368.87  Aligned_cols=262  Identities=29%  Similarity=0.462  Sum_probs=210.3

Q ss_pred             HHHHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           34 KELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        34 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      +.+....++|++.+.||+|+||.||+|.+..+..||||+++... .....+.+|+.+|+.++||||+++++++.. +..+
T Consensus       177 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~  254 (452)
T 1fmk_A          177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  254 (452)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence            33445678899999999999999999998877889999998643 234578999999999999999999999875 7789


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||+++|+|.+++...  ....+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       255 iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~  329 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL  329 (452)
T ss_dssp             EEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC-
T ss_pred             EEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCcccee
Confidence            999999999999999642  124589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      .............++..|+|||++.+..++.++|||||||++|||++ |..||.......                +...
T Consensus       330 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~----------------~~~~  393 (452)
T 1fmk_A          330 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLDQ  393 (452)
T ss_dssp             -------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----------------HHHH
T ss_pred             cCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH----------------HHHH
Confidence            65433222333456789999999998999999999999999999999 999997543210                0001


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      +....+...+..++..+.+||.+||+.||++|||+.+|++.|..+.
T Consensus       394 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          394 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            1112222344456678999999999999999999999999998764

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4.5e-47  Score=344.04  Aligned_cols=258  Identities=24%  Similarity=0.347  Sum_probs=203.6

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ..++|++.+.||+|+||+||+|.+ .++..||+|++.... ......+.+|+++++.++||||+++++++......++||
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            446899999999999999999987 568999999987532 334567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee---CCCCceEEeeccCccc
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLL---DSDFEPLVADFGFAKL  193 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill---~~~~~vkl~Dfgl~~~  193 (380)
                      ||+++|+|.+.+.........+++..++.++.|++.||+|||+.   ||+||||||+||++   +.++.++|+|||++..
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            99999999999865433346799999999999999999999999   99999999999999   4568899999999987


Q ss_pred             cCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                      ....  .......||+.|+|||++. ..++.++|||||||++|+|++|..||........      ......    .   
T Consensus       177 ~~~~--~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~------~~~~~~----~---  240 (285)
T 3is5_A          177 FKSD--EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV------QQKATY----K---  240 (285)
T ss_dssp             ------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH------HHHHHH----C---
T ss_pred             cCCc--ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHH------Hhhhcc----C---
Confidence            6432  2233456899999999886 5689999999999999999999999975431100      000000    0   


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .+... ......+..+.+||.+||+.||.+|||+.++++|.+.
T Consensus       241 ~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f  282 (285)
T 3is5_A          241 EPNYA-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF  282 (285)
T ss_dssp             CCCCC-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred             Ccccc-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHh
Confidence            00000 0011134678899999999999999999999998763

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.4e-47  Score=344.59  Aligned_cols=263  Identities=27%  Similarity=0.455  Sum_probs=215.2

Q ss_pred             cHHHHHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCe
Q 037869           32 TYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQ  111 (380)
Q Consensus        32 ~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  111 (380)
                      .-+++....++|++.+.||+|+||.||+|.+.++..||+|.++... .....+.+|+.+++.++||||+++++++. ++.
T Consensus         4 ~~~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~   81 (279)
T 1qpc_A            4 WEDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEP   81 (279)
T ss_dssp             TTCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred             chhhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCC
Confidence            3345566788999999999999999999998888899999997643 23457889999999999999999999986 456


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA  191 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~  191 (380)
                      .++||||+++++|.+++...  ....+++..++.++.|++.||+|||++   |++||||||+||+++.++.++|+|||++
T Consensus        82 ~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  156 (279)
T 1qpc_A           82 IYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLA  156 (279)
T ss_dssp             CEEEEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             cEEEEecCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCccc
Confidence            89999999999999999642  123689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          192 KLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       192 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      ...............++..|+|||++.+..++.++||||||+++|+|++ |..||.......   .   ..         
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~---~~---------  221 (279)
T 1qpc_A          157 RLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---V---IQ---------  221 (279)
T ss_dssp             EECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H---HH---------
T ss_pred             ccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---H---HH---------
Confidence            8875543333334456889999999998899999999999999999999 899997533210   0   00         


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                       ..........+...+..+.+++.+||+.||++|||+.++++.|..+
T Consensus       222 -~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          222 -NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             -HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence             0001111223334557899999999999999999999999987644

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.2e-47  Score=370.58  Aligned_cols=262  Identities=27%  Similarity=0.400  Sum_probs=218.6

Q ss_pred             HHHhhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           36 LHTATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        36 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      +.....+|++.+.||+|+||.||+|.+. ++..||||+++... .....+.+|+.+|+.++||||+++++++......++
T Consensus       215 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l  293 (495)
T 1opk_A          215 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI  293 (495)
T ss_dssp             CBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred             cccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence            3446678999999999999999999875 48899999998643 235678999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ||||+++|+|.+++...  ....+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       294 v~E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  368 (495)
T 1opk_A          294 ITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLM  368 (495)
T ss_dssp             EEECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred             EEEccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceec
Confidence            99999999999999753  234689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                      ............++..|+|||++.+..++.++|||||||++|||++ |..||.......                +...+
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~----------------~~~~~  432 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELL  432 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----------------HHHHH
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHH
Confidence            5433333333446789999999999999999999999999999999 999997643210                01111


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCC
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP  319 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~  319 (380)
                      ....+...+..++..+.+||.+||+.||.+|||+.+|++.|..+..
T Consensus       433 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          433 EKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             HcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence            1222333445566889999999999999999999999999987643

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.2e-47  Score=346.31  Aligned_cols=259  Identities=28%  Similarity=0.415  Sum_probs=217.1

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ....++|++.+.||+|+||+||+|.+. ++..||+|++.... .....+.+|+.+++.++||||+++++++..++..++|
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v   87 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII   87 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEE
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEE
Confidence            346789999999999999999999874 58899999997643 3456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |||+++++|.+++...  ....+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++....
T Consensus        88 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~  162 (288)
T 3kfa_A           88 TEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMT  162 (288)
T ss_dssp             EECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred             EEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence            9999999999999753  235699999999999999999999999   99999999999999999999999999998776


Q ss_pred             CCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      ...........+++.|+|||++.+..++.++||||||+++|+|++ |..||.......                ......
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~----------------~~~~~~  226 (288)
T 3kfa_A          163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLE  226 (288)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----------------HHHHHH
T ss_pred             CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHh
Confidence            544334444557889999999999999999999999999999999 999997543211                001111


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .......+..++..+.+|+.+||+.||.+|||+.++++.|..+
T Consensus       227 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~  269 (288)
T 3kfa_A          227 KDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM  269 (288)
T ss_dssp             TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHH
Confidence            1122233344557899999999999999999999999998654

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3e-47  Score=351.53  Aligned_cols=267  Identities=21%  Similarity=0.290  Sum_probs=199.5

Q ss_pred             CCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccChhh-HHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKA-EMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ++|++.+.||+|+||+||+|.+. +++.||+|+++...... ...+.+|+.+++.++||||+++++++...+..++||||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY   81 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence            57999999999999999999874 78999999997543221 11345699999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      ++ |+|.+++...   ...+++..++.++.|++.||.|||+.   ||+||||||+||+++.++.+||+|||++.......
T Consensus        82 ~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  154 (324)
T 3mtl_A           82 LD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPT  154 (324)
T ss_dssp             CS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC----
T ss_pred             cc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCc
Confidence            97 5899888754   34689999999999999999999999   99999999999999999999999999998654322


Q ss_pred             ccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhh-----------hhc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL-----------IVK  266 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-----------~~~  266 (380)
                       .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........  ...+....           ...
T Consensus       155 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          155 -KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQ--LHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             ---------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCTTTSTTGGGC
T ss_pred             -cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCChHhchhhhcc
Confidence             22333468999999999886 5689999999999999999999999976432110  00000000           000


Q ss_pred             cccccccCCccc----CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          267 GKFKELVDPKLR----GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       267 ~~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ..+.....+...    .......+.++.+||.+||+.||.+|||+.++++|.+..
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  286 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL  286 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGG
T ss_pred             hhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhh
Confidence            000000000000    011123446789999999999999999999999997754

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.6e-47  Score=347.40  Aligned_cols=270  Identities=22%  Similarity=0.268  Sum_probs=204.7

Q ss_pred             hhCCCCCc-ceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEEE
Q 037869           39 ATNGFSDD-NKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        39 ~~~~y~~~-~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ..++|++. +.||+|+||+||+|.+ .+++.||||++..........+.+|+.++.++ +||||+++++++...+..++|
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            45789885 7899999999999986 57899999999876555567888999999885 799999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc---eEEeeccCcc
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE---PLVADFGFAK  192 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~---vkl~Dfgl~~  192 (380)
                      |||+++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.   +||+|||++.
T Consensus        90 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~  162 (316)
T 2ac3_A           90 FEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGS  162 (316)
T ss_dssp             EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC
T ss_pred             EEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCcc
Confidence            9999999999999653    4689999999999999999999999   9999999999999988765   9999999997


Q ss_pred             ccCCCC------ccceeccccccCccCcccccc-----CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccch
Q 037869          193 LIPEGV------SHMTTRVKGTLGYLAPEYAMW-----GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE  261 (380)
Q Consensus       193 ~~~~~~------~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  261 (380)
                      ......      ........||+.|+|||++.+     ..++.++|||||||++|+|++|..||................
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  242 (316)
T 2ac3_A          163 GIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC  242 (316)
T ss_dssp             -------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred             ccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence            653211      111223458999999999875     568999999999999999999999997644321000000000


Q ss_pred             hhhhccccccccCCcccCCCC----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          262 PLIVKGKFKELVDPKLRGDFD----ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      +.........+....  ...+    ...+..+.+||.+||+.||.+|||+.++++|.+..
T Consensus       243 ~~~~~~~~~~i~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~  300 (316)
T 2ac3_A          243 PACQNMLFESIQEGK--YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQ  300 (316)
T ss_dssp             HHHHHHHHHHHHHCC--CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC
T ss_pred             hhHHHHHHHHHhccC--cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhc
Confidence            000000000000000  0111    12346899999999999999999999999997754

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.5e-47  Score=356.14  Aligned_cols=286  Identities=20%  Similarity=0.243  Sum_probs=216.1

Q ss_pred             ccCCCCCccceeccHHHHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCC--
Q 037869           19 TITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR--   95 (380)
Q Consensus        19 ~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--   95 (380)
                      .......+....|+..+.....++|++.++||+|+||+||+|++ .+++.||||+++.. ......+..|+.+++.++  
T Consensus        13 ~~~~~~~~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~   91 (360)
T 3llt_A           13 NLYFQGDDEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQND   91 (360)
T ss_dssp             -------CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCC
T ss_pred             ceeeecCccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhccc
Confidence            33444555666778877788899999999999999999999987 57899999999753 334456777999999886  


Q ss_pred             ---CCcceeEeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCC
Q 037869           96 ---HKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKA  172 (380)
Q Consensus        96 ---h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp  172 (380)
                         ||||+++++++...+..++||||+ +++|.+++....  ...+++..++.++.||+.||+|||+.   ||+||||||
T Consensus        92 ~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp  165 (360)
T 3llt_A           92 DINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKP  165 (360)
T ss_dssp             STTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred             CCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCc
Confidence               999999999999999999999999 899999997642  23589999999999999999999999   999999999


Q ss_pred             CCeeeCC-------------------------CCceEEeeccCccccCCCCccceeccccccCccCccccccCCCCccch
Q 037869          173 SNVLLDS-------------------------DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCD  227 (380)
Q Consensus       173 ~Nill~~-------------------------~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D  227 (380)
                      +|||++.                         ++.+||+|||++......    .....||+.|+|||++.+..++.++|
T Consensus       166 ~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~D  241 (360)
T 3llt_A          166 ENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSD  241 (360)
T ss_dssp             GGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHH
T ss_pred             ccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccc
Confidence            9999975                         789999999999865432    23456899999999999999999999


Q ss_pred             hhhhhHHHHHHHhCCCCCCCCCCCcccchh-ccch--------hhhhccccccccCCcccCCC-----------------
Q 037869          228 VYSFGILLLEILTGRKPIEKLPGGVKRTIT-EWAE--------PLIVKGKFKELVDPKLRGDF-----------------  281 (380)
Q Consensus       228 iwslG~il~ell~g~~p~~~~~~~~~~~~~-~~~~--------~~~~~~~~~~~~~~~~~~~~-----------------  281 (380)
                      ||||||++|+|++|..||............ ....        ....................                 
T Consensus       242 iwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  321 (360)
T 3llt_A          242 MWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCL  321 (360)
T ss_dssp             HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCC
T ss_pred             hHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcc
Confidence            999999999999999999754321100000 0000        00000000000000000000                 


Q ss_pred             ---CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          282 ---DENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       282 ---~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                         .......+.+||.+||+.||.+|||+.++++|.+
T Consensus       322 ~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~  358 (360)
T 3llt_A          322 PLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKF  358 (360)
T ss_dssp             CHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred             cccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcc
Confidence               0011256789999999999999999999999875

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=9.8e-47  Score=345.89  Aligned_cols=270  Identities=20%  Similarity=0.258  Sum_probs=203.7

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      -++|++.+.||+|+||+||+|.+ .+++.||+|++....  ......+.+|+.+++.++||||+++++++...+..++||
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF   81 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence            36899999999999999999998 468999999986533  233456788999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++++|.+++...    ..+++..+..++.|++.||+|||++   ||+||||||+||+++.++.++|+|||++.....
T Consensus        82 e~~~~~~l~~~~~~~----~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  154 (311)
T 4agu_A           82 EYCDHTVLHELDRYQ----RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTG  154 (311)
T ss_dssp             ECCSEEHHHHHHHTS----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EeCCCchHHHHHhhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence            999999999888643    4689999999999999999999999   999999999999999999999999999987653


Q ss_pred             CCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhc---------cchhhhhc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITE---------WAEPLIVK  266 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~---------~~~~~~~~  266 (380)
                      .. .......||+.|+|||++.+ ..++.++||||||+++|+|++|..||.............         ........
T Consensus       155 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (311)
T 4agu_A          155 PS-DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN  233 (311)
T ss_dssp             ------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTC
T ss_pred             cc-cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccc
Confidence            32 22334568999999999976 678999999999999999999999997643211100000         00000000


Q ss_pred             cccccccCCcccC-----CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          267 GKFKELVDPKLRG-----DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       267 ~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ........+....     ......+..+.+||.+||+.||.+|||++++++|.+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  289 (311)
T 4agu_A          234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE  289 (311)
T ss_dssp             GGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGT
T ss_pred             cccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHH
Confidence            0000000000000     00123456789999999999999999999999997754

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-46  Score=356.12  Aligned_cols=268  Identities=23%  Similarity=0.307  Sum_probs=197.3

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecc--cChhhHHHHHHHHHHHhcCC-CCcceeEeeEEecCC--e
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKA--MNSKAEMEFAVEVEVLGRVR-HKNLLGLRGYCAGTD--Q  111 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~--~  111 (380)
                      ...++|++.+.||+|+||.||+|.+ .+++.||||++..  ........+.+|+.+++.+. ||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3568999999999999999999987 5789999999864  33455567888999999997 999999999997544  6


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA  191 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~  191 (380)
                      +|+||||++ ++|..++...     .+++..+..++.|++.||+|||+.   ||+||||||+|||++.++.+||+|||++
T Consensus        86 ~~lv~e~~~-~~L~~~~~~~-----~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a  156 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRAN-----ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLS  156 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHHT-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEecccC-cCHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCccc
Confidence            899999997 5899988643     689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCC--------------------CccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCC
Q 037869          192 KLIPEG--------------------VSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPG  250 (380)
Q Consensus       192 ~~~~~~--------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~  250 (380)
                      +.+...                    ........+||++|+|||++.+ ..|+.++|||||||++|||++|.+||.+...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          157 RSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             EESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            865321                    1112334579999999999986 6799999999999999999999999976432


Q ss_pred             Ccccchhccchhhhhcc--cccccc------------------CCcccCC------------CCHHHHHHHHHHHHhhcC
Q 037869          251 GVKRTITEWAEPLIVKG--KFKELV------------------DPKLRGD------------FDENQLKQAINVAVLCVQ  298 (380)
Q Consensus       251 ~~~~~~~~~~~~~~~~~--~~~~~~------------------~~~~~~~------------~~~~~~~~~~~li~~cl~  298 (380)
                      ..  .+..+........  .+....                  .......            .....+.++.+||.+||+
T Consensus       237 ~~--~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~  314 (388)
T 3oz6_A          237 MN--QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQ  314 (388)
T ss_dssp             HH--HHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCC
T ss_pred             HH--HHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhc
Confidence            11  1100000000000  000000                  0000000            001234689999999999


Q ss_pred             CCCCCCCCHHHHHHHhcC
Q 037869          299 SEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       299 ~~P~~Rps~~~ll~~l~~  316 (380)
                      .||.+|||+.++++|.+.
T Consensus       315 ~dP~~R~t~~e~l~Hp~~  332 (388)
T 3oz6_A          315 FNPNKRISANDALKHPFV  332 (388)
T ss_dssp             SSGGGSCCHHHHTTSTTT
T ss_pred             cCcccCCCHHHHhCCHHH
Confidence            999999999999999764

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2.2e-46  Score=339.08  Aligned_cols=257  Identities=21%  Similarity=0.301  Sum_probs=210.2

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++...  .......+.+|+.+++.++||||+++++++...+..++|
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            468999999999999999999987 46899999998643  344556788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc---eEEeeccCcc
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE---PLVADFGFAK  192 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~---vkl~Dfgl~~  192 (380)
                      |||+++++|.+.+...    ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.   ++|+|||++.
T Consensus        84 ~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~  156 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAI  156 (284)
T ss_dssp             ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeE
Confidence            9999999999888643    4699999999999999999999999   9999999999999986655   9999999998


Q ss_pred             ccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      ......  ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......  ....     ...+..   
T Consensus       157 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~-----~~~~~~---  224 (284)
T 3kk8_A          157 EVNDSE--AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR--LYAQ-----IKAGAY---  224 (284)
T ss_dssp             ECCSSC--BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-----HHHTCC---
T ss_pred             EcccCc--cccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH--HHHH-----HHhccc---
Confidence            765432  2334568999999999999999999999999999999999999996533210  0000     000000   


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                         ..........+..+.+|+.+||+.||.+|||+.++++|.+..
T Consensus       225 ---~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~  266 (284)
T 3kk8_A          225 ---DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWIC  266 (284)
T ss_dssp             ---CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHH
T ss_pred             ---cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCcccc
Confidence               001111123457889999999999999999999999997643

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=9.4e-47  Score=346.93  Aligned_cols=265  Identities=21%  Similarity=0.308  Sum_probs=211.4

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEe----cCCeE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA----GTDQR  112 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----~~~~~  112 (380)
                      ...++|++.+.||+|+||.||++.+ .+++.||||++..........+.+|+.+++.++||||+++++++.    .....
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  105 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEA  105 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCcee
Confidence            4568999999999999999999987 678999999998776677778999999999999999999999986    34578


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      ++||||+++|+|.+++.........+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++.
T Consensus       106 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          106 WLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             EEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            999999999999999976434456799999999999999999999999   99999999999999999999999999987


Q ss_pred             ccCCCCcc--------ceeccccccCccCccccccCC---CCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccch
Q 037869          193 LIPEGVSH--------MTTRVKGTLGYLAPEYAMWGK---VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE  261 (380)
Q Consensus       193 ~~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  261 (380)
                      ........        ......||+.|+|||++.+..   ++.++|||||||++|+|++|..||..........      
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------  256 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSV------  256 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCH------
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchh------
Confidence            65321110        012234799999999987654   6899999999999999999999995321100000      


Q ss_pred             hhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCC
Q 037869          262 PLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP  319 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~  319 (380)
                              ................+..+.++|.+||+.||.+|||+.+++++|..+.+
T Consensus       257 --------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          257 --------ALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             --------HHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             --------hHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence                    00000011112223445789999999999999999999999999987654

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=4e-47  Score=353.82  Aligned_cols=253  Identities=25%  Similarity=0.379  Sum_probs=206.2

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      ..+.|++.+.||+|+||+||+|++ .+++.||||++....   ......+.+|+.+++.++||||+++++++...+..++
T Consensus        52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  131 (348)
T 1u5q_A           52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL  131 (348)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence            346699999999999999999987 578999999997532   2334568899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ||||+. |+|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++...
T Consensus       132 v~e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  204 (348)
T 1u5q_A          132 VMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM  204 (348)
T ss_dssp             EEECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSS
T ss_pred             EEecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceec
Confidence            999997 5888887532   35799999999999999999999999   9999999999999999999999999999875


Q ss_pred             CCCCccceeccccccCccCccccc---cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAM---WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      ..     .....||+.|+|||++.   +..++.++|||||||++|||++|..||.......  ...    .. ..     
T Consensus       205 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~--~~~----~~-~~-----  267 (348)
T 1u5q_A          205 AP-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALY----HI-AQ-----  267 (348)
T ss_dssp             SS-----BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH----HH-HH-----
T ss_pred             CC-----CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH--HHH----HH-Hh-----
Confidence            43     22346899999999985   5678999999999999999999999996533210  000    00 00     


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                         ...........+..+.+||.+||+.||.+|||+.++++|.+...
T Consensus       268 ---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~  311 (348)
T 1u5q_A          268 ---NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  311 (348)
T ss_dssp             ---SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHS
T ss_pred             ---cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhc
Confidence               00011112234577899999999999999999999999977543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.9e-47  Score=350.50  Aligned_cols=265  Identities=24%  Similarity=0.354  Sum_probs=197.1

Q ss_pred             HHHHHhhCCCCCcceeccCCceEEEEEEeCC-C---cEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEe
Q 037869           34 KELHTATNGFSDDNKLGEGGFGSVYWGRTSD-G---LQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA  107 (380)
Q Consensus        34 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  107 (380)
                      +++....++|++.+.||+|+||+||+|.+.. +   ..||||+++..  .......+.+|+.+++.++||||+++++++.
T Consensus        16 ~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   95 (323)
T 3qup_A           16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSL   95 (323)
T ss_dssp             CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred             hhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence            3344567899999999999999999998643 3   27999999753  3445668899999999999999999999998


Q ss_pred             cCCeE------EEEEEecCCCCHHHhhccCCC--CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC
Q 037869          108 GTDQR------LIVYDYMPNLSLLSHLHGQYA--GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS  179 (380)
Q Consensus       108 ~~~~~------~lv~e~~~~g~L~~~i~~~~~--~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~  179 (380)
                      .....      ++||||+.+|+|.+++.....  ....+++..++.++.|++.||+|||+.   ||+||||||+||+++.
T Consensus        96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~  172 (323)
T 3qup_A           96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAE  172 (323)
T ss_dssp             CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECT
T ss_pred             ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcC
Confidence            76655      999999999999999964321  223689999999999999999999999   9999999999999999


Q ss_pred             CCceEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchh
Q 037869          180 DFEPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTIT  257 (380)
Q Consensus       180 ~~~vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~  257 (380)
                      ++.+||+|||++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.........   
T Consensus       173 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~---  249 (323)
T 3qup_A          173 DMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY---  249 (323)
T ss_dssp             TSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---
T ss_pred             CCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH---
Confidence            99999999999987643322 12223446789999999999999999999999999999999 99999764321100   


Q ss_pred             ccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          258 EWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                                   ...........+...+..+.+|+.+||+.||.+|||+.++++.|..+
T Consensus       250 -------------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  296 (323)
T 3qup_A          250 -------------NYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI  296 (323)
T ss_dssp             -------------HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------------HHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                         00001111223344557899999999999999999988888876644

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.4e-47  Score=353.92  Aligned_cols=265  Identities=24%  Similarity=0.371  Sum_probs=212.2

Q ss_pred             HHHhhCCCCCcceeccCCceEEEEEEe------CCCcEEEEEEeccc-ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEe
Q 037869           36 LHTATNGFSDDNKLGEGGFGSVYWGRT------SDGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCA  107 (380)
Q Consensus        36 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  107 (380)
                      +....++|++.+.||+|+||+||+|.+      .++..||+|+++.. .......+.+|+.+++.+ +||||+++++++.
T Consensus        40 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  119 (344)
T 1rjb_A           40 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT  119 (344)
T ss_dssp             GBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            445678999999999999999999985      24568999999753 233345788999999999 8999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHhhccCCCC-------------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEec
Q 037869          108 GTDQRLIVYDYMPNLSLLSHLHGQYAG-------------------EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHR  168 (380)
Q Consensus       108 ~~~~~~lv~e~~~~g~L~~~i~~~~~~-------------------~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHr  168 (380)
                      ..+..++||||+++|+|.+++......                   ...+++..++.++.|++.||+|||++   ||+||
T Consensus       120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~  196 (344)
T 1rjb_A          120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHR  196 (344)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEET
T ss_pred             eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccC
Confidence            999999999999999999999754211                   13489999999999999999999999   99999


Q ss_pred             CCCCCCeeeCCCCceEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCC
Q 037869          169 DIKASNVLLDSDFEPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIE  246 (380)
Q Consensus       169 dlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~  246 (380)
                      ||||+||+++.++.++|+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus       197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~  276 (344)
T 1rjb_A          197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP  276 (344)
T ss_dssp             TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred             CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999987643322 12333457889999999999999999999999999999998 999997


Q ss_pred             CCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          247 KLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      .......  .             ............+...+..+.+|+.+||+.||.+|||+.+++++|....
T Consensus       277 ~~~~~~~--~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~  333 (344)
T 1rjb_A          277 GIPVDAN--F-------------YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQL  333 (344)
T ss_dssp             TCCCSHH--H-------------HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             cCCcHHH--H-------------HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence            6432110  0             0111111222233445578999999999999999999999999987553

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.9e-47  Score=352.25  Aligned_cols=249  Identities=23%  Similarity=0.332  Sum_probs=208.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh--------hhHHHHHHHHHHHhcCCCCcceeEeeEEecC
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS--------KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT  109 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  109 (380)
                      ..++|++.+.||+|+||+||+|.+ .+++.||||+++....        .....+.+|+.+++.++||||+++++++...
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~  101 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ  101 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence            457899999999999999999986 5789999999975421        1223567799999999999999999999999


Q ss_pred             CeEEEEEEecCCC-CHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          110 DQRLIVYDYMPNL-SLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       110 ~~~~lv~e~~~~g-~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                      +..++||||+.+| +|.+++...    ..+++..++.++.|++.||.|||+.   ||+||||||+|||++.++.+||+||
T Consensus       102 ~~~~lv~e~~~~g~~l~~~~~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Df  174 (335)
T 3dls_A          102 GFFQLVMEKHGSGLDLFAFIDRH----PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDF  174 (335)
T ss_dssp             SEEEEEEECCTTSCBHHHHHHTC----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCC
T ss_pred             CEEEEEEEeCCCCccHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeec
Confidence            9999999998766 999999653    4699999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCccceeccccccCccCccccccCCC-CccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcc
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKG  267 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  267 (380)
                      |++.......  ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||......                
T Consensus       175 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------------  236 (335)
T 3dls_A          175 GSAAYLERGK--LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------------  236 (335)
T ss_dssp             TTCEECCTTC--CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------------
T ss_pred             ccceECCCCC--ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------------
Confidence            9998765432  2334568999999999998876 88999999999999999999999652210                


Q ss_pred             ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCC
Q 037869          268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP  319 (380)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~  319 (380)
                           .....  ..+...+.++.+||.+||+.||.+|||+.++++|.+...+
T Consensus       237 -----~~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          237 -----VEAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             -----TTTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             -----Hhhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence                 00000  1111234689999999999999999999999999886543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.1e-47  Score=340.40  Aligned_cols=250  Identities=21%  Similarity=0.302  Sum_probs=208.4

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ..++|++.+.||+|+||+||+|.+ .++..||+|++..........+.+|+.+++.++||||+++++++...+..++|||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   86 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME   86 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence            457899999999999999999987 4578999999987555566789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee---CCCCceEEeeccCcccc
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLL---DSDFEPLVADFGFAKLI  194 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill---~~~~~vkl~Dfgl~~~~  194 (380)
                      |+++++|.+++...    ..+++..++.++.|++.||.|||++   |++||||||+||++   +.++.++|+|||++...
T Consensus        87 ~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~  159 (277)
T 3f3z_A           87 LCTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF  159 (277)
T ss_dssp             CCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             ccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceec
Confidence            99999999988653    4689999999999999999999999   99999999999999   77899999999999876


Q ss_pred             CCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      ....  ......||+.|+|||++.+. ++.++||||||+++|+|++|..||.......  ....     ...+.      
T Consensus       160 ~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~~~-----~~~~~------  223 (277)
T 3f3z_A          160 KPGK--MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE--VMLK-----IREGT------  223 (277)
T ss_dssp             CTTS--CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-----HHHCC------
T ss_pred             cCcc--chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH--HHHH-----HHhCC------
Confidence            5432  23345689999999998754 8999999999999999999999997533210  0000     00000      


Q ss_pred             CcccCCCCH----HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          275 PKLRGDFDE----NQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       275 ~~~~~~~~~----~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                          ...+.    ..+..+.++|.+||+.||.+|||+.++++|.+
T Consensus       224 ----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~  264 (277)
T 3f3z_A          224 ----FTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEW  264 (277)
T ss_dssp             ----CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred             ----CCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHH
Confidence                01111    23478999999999999999999999999865

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=8.2e-47  Score=357.07  Aligned_cols=254  Identities=21%  Similarity=0.340  Sum_probs=203.1

Q ss_pred             hCCCCCcceeccCCceEEEEEEeCCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCC--CCcceeEeeEEecCCeEEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVR--HKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~~~~lv  115 (380)
                      ..+|++.+.||+|+||+||+|.+.+++.||||++...  .......+.+|+.+++.++  ||||+++++++...+.+|+|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            4569999999999999999999877999999998743  3445567889999999996  59999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      || +.+++|.+++...    ..+++..++.++.||+.||.|||+.   +|+||||||+|||++ ++.+||+|||++..+.
T Consensus       135 ~E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~  205 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ  205 (390)
T ss_dssp             EE-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC-
T ss_pred             Ee-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCcccccc
Confidence            99 5688999999754    3788999999999999999999999   999999999999995 5799999999998765


Q ss_pred             CCCcc-ceeccccccCccCcccccc-----------CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhh
Q 037869          196 EGVSH-MTTRVKGTLGYLAPEYAMW-----------GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL  263 (380)
Q Consensus       196 ~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  263 (380)
                      ..... ......||+.|+|||++.+           ..++.++|||||||++|+|++|..||........          
T Consensus       206 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~----------  275 (390)
T 2zmd_A          206 PDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS----------  275 (390)
T ss_dssp             --------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH----------
T ss_pred             CCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHH----------
Confidence            43221 2344579999999999875           3689999999999999999999999975322100          


Q ss_pred             hhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                          .+.....+......+...+..+.+||.+||+.||.+|||+.++++|.+.
T Consensus       276 ----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~  324 (390)
T 2zmd_A          276 ----KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV  324 (390)
T ss_dssp             ----HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             ----HHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence                0111122222222233334688999999999999999999999999764

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=8.2e-47  Score=348.13  Aligned_cols=257  Identities=23%  Similarity=0.328  Sum_probs=210.3

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChh------hHHHHHHHHHHHhcCCCCcceeEeeEEecCCe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSK------AEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQ  111 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  111 (380)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|+++.....      ....+.+|+.+++.++||||+++++++...+.
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   89 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTD   89 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence            456799999999999999999987 46899999999753221      35678899999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC----ceEEee
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF----EPLVAD  187 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~----~vkl~D  187 (380)
                      .++||||+++++|.+++...    ..+++..++.++.|++.||.|||+.   ||+||||||+||+++.++    .++|+|
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~D  162 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQK----ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLID  162 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHTC----SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred             EEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEcc
Confidence            99999999999999999643    4689999999999999999999999   999999999999999887    799999


Q ss_pred             ccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcc
Q 037869          188 FGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKG  267 (380)
Q Consensus       188 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  267 (380)
                      ||++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ....     ....
T Consensus       163 fg~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~-----i~~~  233 (321)
T 2a2a_A          163 FGLAHEIEDGV--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLAN-----ITSV  233 (321)
T ss_dssp             CTTCEECCTTC--CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHH-----HHTT
T ss_pred             CccceecCccc--cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH--HHHH-----HHhc
Confidence            99998765432  2234568999999999999999999999999999999999999996532110  0000     0000


Q ss_pred             ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .      ...........+..+.+||.+||+.||.+|||+.++++|.+..
T Consensus       234 ~------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~  277 (321)
T 2a2a_A          234 S------YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWIT  277 (321)
T ss_dssp             C------CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTS
T ss_pred             c------cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCcccc
Confidence            0      0000011122346789999999999999999999999998754

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2.3e-47  Score=344.56  Aligned_cols=261  Identities=21%  Similarity=0.285  Sum_probs=211.1

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEe--cCCeEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA--GTDQRL  113 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~~~  113 (380)
                      ..++|++.+.||+|+||.||+|.+ .+++.||+|++...  .......+.+|+.+++.++||||+++++++.  .....+
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            357899999999999999999987 47899999999753  3445567889999999999999999999874  467899


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC-----eEecCCCCCCeeeCCCCceEEeec
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH-----IIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~-----ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                      +||||+++++|.+++.........+++..++.++.|++.||+|||+.   +     ++||||||+||+++.++.++|+||
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~df  160 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDF  160 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCC
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecC
Confidence            99999999999999976533445699999999999999999999998   7     999999999999999999999999


Q ss_pred             cCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccc
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGK  268 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (380)
                      |++........ ......|++.|+|||++.+..++.++||||||+++|+|++|..||......   ..   .. ....+ 
T Consensus       161 g~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~---~~-~i~~~-  231 (279)
T 2w5a_A          161 GLARILNHDTS-FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---EL---AG-KIREG-  231 (279)
T ss_dssp             CHHHHC---CH-HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HH---HH-HHHHT-
T ss_pred             chheeeccccc-cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---HH---HH-HHhhc-
Confidence            99987654322 223346899999999999989999999999999999999999999754311   00   00 00011 


Q ss_pred             cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCC
Q 037869          269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP  319 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~  319 (380)
                              .....+...+..+.++|.+||+.||.+|||+.+|+++++...+
T Consensus       232 --------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          232 --------KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             --------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             --------ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence                    1112333455789999999999999999999999999886543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.7e-46  Score=336.90  Aligned_cols=260  Identities=21%  Similarity=0.330  Sum_probs=211.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++... .......+.+|+.+++.++||||+++++++..++..++||
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   84 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence            4468999999999999999999874 7899999998743 2334567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++++|.+++...    ..+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.....
T Consensus        85 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  157 (276)
T 2yex_A           85 EYCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRY  157 (276)
T ss_dssp             ECCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred             EecCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence            999999999998643    4699999999999999999999999   999999999999999999999999999986543


Q ss_pred             CCc-cceeccccccCccCccccccCCC-CccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          197 GVS-HMTTRVKGTLGYLAPEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       197 ~~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      ... .......|++.|+|||++.+..+ +.++||||||+++|+|++|..||........ ....+.             .
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~-------------~  223 (276)
T 2yex_A          158 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWK-------------E  223 (276)
T ss_dssp             TTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHH-------------T
T ss_pred             CcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhh-------------h
Confidence            221 22334568999999999987765 7899999999999999999999976432111 000000             0


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCC
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP  319 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~  319 (380)
                      ...........+..+.+||.+||+.||.+|||+.++++|.+...+
T Consensus       224 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (276)
T 2yex_A          224 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (276)
T ss_dssp             TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             cccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence            000011122345788999999999999999999999999775544

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.2e-46  Score=363.42  Aligned_cols=266  Identities=23%  Similarity=0.251  Sum_probs=201.5

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecC-----
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT-----  109 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----  109 (380)
                      ...++|++.+.||+|+||+||+|.+ .+++.||||++...  .......+.+|+.+++.++||||+++++++...     
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            3468999999999999999999987 56899999999753  444556788999999999999999999999654     


Q ss_pred             -CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          110 -DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       110 -~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                       ...|+||||+++ +|.+.+..      .+++..+..++.|++.||+|||++   ||+||||||+|||++.++.+||+||
T Consensus       139 ~~~~~lv~E~~~~-~l~~~~~~------~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DF  208 (464)
T 3ttj_A          139 FQDVYLVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDF  208 (464)
T ss_dssp             CCEEEEEEECCSE-EHHHHHTS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC
T ss_pred             CCeEEEEEeCCCC-CHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEE
Confidence             457999999976 57766642      488999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchh------
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEP------  262 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~------  262 (380)
                      |+++.....  .......||++|+|||++.+..|+.++|||||||++|+|++|..||.+.....  ....+...      
T Consensus       209 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~--~~~~i~~~lg~p~~  284 (464)
T 3ttj_A          209 GLARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID--QWNKVIEQLGTPCP  284 (464)
T ss_dssp             CCC-----C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCSCCH
T ss_pred             EeeeecCCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCCH
Confidence            999876432  23345679999999999999999999999999999999999999997643210  00000000      


Q ss_pred             ------------hhh------ccccccccCCcccC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          263 ------------LIV------KGKFKELVDPKLRG---DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       263 ------------~~~------~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                                  ...      ...+..........   ......+.++.+||.+||..||.+|||++++++|.+.-
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~  360 (464)
T 3ttj_A          285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN  360 (464)
T ss_dssp             HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTG
T ss_pred             HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhh
Confidence                        000      00000000000000   01112367899999999999999999999999997753

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=4.2e-47  Score=350.60  Aligned_cols=259  Identities=23%  Similarity=0.298  Sum_probs=186.6

Q ss_pred             CCCCc---ceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCC-CCcceeEeeEEecCCeEEEEE
Q 037869           42 GFSDD---NKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR-HKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        42 ~y~~~---~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  116 (380)
                      +|.+.   +.||+|+||+||+|.+ .+++.||||++...   ....+.+|+.+++.+. ||||+++++++.+....|+||
T Consensus         9 ~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~   85 (325)
T 3kn6_A            9 HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM   85 (325)
T ss_dssp             HEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence            45543   7899999999999987 46899999999753   3446778999999997 999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC---ceEEeeccCccc
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF---EPLVADFGFAKL  193 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~---~vkl~Dfgl~~~  193 (380)
                      ||+++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++   .+||+|||++..
T Consensus        86 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~  158 (325)
T 3kn6_A           86 ELLNGGELFERIKKK----KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARL  158 (325)
T ss_dssp             CCCCSCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEE
T ss_pred             EccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEecccccee
Confidence            999999999999754    4799999999999999999999999   999999999999997765   899999999987


Q ss_pred             cCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                      ..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....................+.     
T Consensus       159 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~-----  232 (325)
T 3kn6_A          159 KPPDN-QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD-----  232 (325)
T ss_dssp             CCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTC-----
T ss_pred             cCCCC-CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCC-----
Confidence            64432 223345689999999999999999999999999999999999999976432111000000000000000     


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                       ...........+.++.+||.+||+.||.+|||+.++++|.|..
T Consensus       233 -~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~  275 (325)
T 3kn6_A          233 -FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ  275 (325)
T ss_dssp             -CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGC
T ss_pred             -CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhc
Confidence             0001111123457899999999999999999999999997754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.5e-47  Score=367.09  Aligned_cols=254  Identities=24%  Similarity=0.284  Sum_probs=201.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||+++..   .......+.+|+.+++.++||||+++++++...+.+++
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~l  225 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCF  225 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEE
Confidence            446899999999999999999987 57899999999752   23334567789999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH-EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~-~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      ||||+++|+|.+++...    ..+++..+..++.|++.||+|||+ .   ||+||||||+|||++.++.+||+|||+++.
T Consensus       226 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~  298 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKE  298 (446)
T ss_dssp             EECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCT
T ss_pred             EEeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCcee
Confidence            99999999999999653    478999999999999999999998 7   999999999999999999999999999986


Q ss_pred             cCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                      ..... ......+||+.|+|||++.+..|+.++|||||||++|||++|..||.......  .    ... ...       
T Consensus       299 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~--~----~~~-i~~-------  363 (446)
T 4ejn_A          299 GIKDG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--L----FEL-ILM-------  363 (446)
T ss_dssp             TCC------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H----HHH-HHH-------
T ss_pred             ccCCC-cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH--H----HHH-HHh-------
Confidence            43322 23344679999999999999999999999999999999999999996532110  0    000 000       


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhcCC
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLTGY  317 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~~~  317 (380)
                       .  ...++...+.++.+||.+||+.||.+||     |++++++|.+..
T Consensus       364 -~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~  409 (446)
T 4ejn_A          364 -E--EIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA  409 (446)
T ss_dssp             -C--CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             -C--CCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCcccc
Confidence             0  0112334457899999999999999999     999999997654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=6.3e-47  Score=348.87  Aligned_cols=269  Identities=23%  Similarity=0.367  Sum_probs=217.2

Q ss_pred             eccHHHHHHhhCCCCCcceeccCCceEEEEEEeC------CCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeE
Q 037869           30 IFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTS------DGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGL  102 (380)
Q Consensus        30 ~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~  102 (380)
                      .|..+++....++|++.+.||+|+||.||+|.+.      ++..||+|.+.... ......+.+|+.+++.++||||+++
T Consensus        14 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   93 (322)
T 1p4o_A           14 VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRL   93 (322)
T ss_dssp             CCCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred             ccChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeee
Confidence            4555667778899999999999999999999753      36789999997533 3445578899999999999999999


Q ss_pred             eeEEecCCeEEEEEEecCCCCHHHhhccCC------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCee
Q 037869          103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQY------AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVL  176 (380)
Q Consensus       103 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~------~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nil  176 (380)
                      ++++...+..++||||+++|+|.+++....      .....+++..++.++.|++.||.|||++   ||+||||||+||+
T Consensus        94 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIl  170 (322)
T 1p4o_A           94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCM  170 (322)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEE
T ss_pred             EEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEE
Confidence            999999999999999999999999986431      1124578999999999999999999999   9999999999999


Q ss_pred             eCCCCceEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCccc
Q 037869          177 LDSDFEPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKR  254 (380)
Q Consensus       177 l~~~~~vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~  254 (380)
                      ++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......  
T Consensus       171 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--  248 (322)
T 1p4o_A          171 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ--  248 (322)
T ss_dssp             ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH--
T ss_pred             EcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH--
Confidence            99999999999999986543211 12223356889999999999999999999999999999999 899987543210  


Q ss_pred             chhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          255 TITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                          .... ...         ......+...+..+.++|.+||+.||.+|||+.+++++|...
T Consensus       249 ----~~~~-~~~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~  297 (322)
T 1p4o_A          249 ----VLRF-VME---------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  297 (322)
T ss_dssp             ----HHHH-HHT---------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             ----HHHH-HHc---------CCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHh
Confidence                0000 000         111122334557899999999999999999999999999765

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.8e-46  Score=343.97  Aligned_cols=272  Identities=19%  Similarity=0.293  Sum_probs=205.0

Q ss_pred             eeccHHHHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecc---cChhhHHHHHHHHHHHhcCCCCcceeEee
Q 037869           29 RIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKA---MNSKAEMEFAVEVEVLGRVRHKNLLGLRG  104 (380)
Q Consensus        29 ~~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~~~l~~l~h~niv~~~~  104 (380)
                      +.++.........+|++.+.||+|+||.||+|.+ .+++.||+|+++.   ........+.+|+.+++.++||||+++++
T Consensus        20 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   99 (310)
T 2wqm_A           20 KALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA   99 (310)
T ss_dssp             CCCCGGGTTSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             hcCCCCcccccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            3333333334557899999999999999999987 5789999999974   23445567889999999999999999999


Q ss_pred             EEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceE
Q 037869          105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL  184 (380)
Q Consensus       105 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vk  184 (380)
                      ++..++..++||||+++++|.+++.........+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++
T Consensus       100 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~k  176 (310)
T 2wqm_A          100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVK  176 (310)
T ss_dssp             EEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEE
T ss_pred             EEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEE
Confidence            99999999999999999999999975433345799999999999999999999999   999999999999999999999


Q ss_pred             EeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh
Q 037869          185 VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI  264 (380)
Q Consensus       185 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  264 (380)
                      |+|||++....... .......|++.|+|||++.+..++.++||||||+++|+|++|..||...........    .. .
T Consensus       177 l~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~----~~-~  250 (310)
T 2wqm_A          177 LGDLGLGRFFSSKT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLC----KK-I  250 (310)
T ss_dssp             ECCC-------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHH----HH-H
T ss_pred             EEeccceeeecCCC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHH----HH-h
Confidence            99999998764322 122334689999999999999999999999999999999999999965322110000    00 0


Q ss_pred             hccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          265 VKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ..        ...........+.++.+++.+||+.||.+|||+.++++.|..+
T Consensus       251 ~~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l  295 (310)
T 2wqm_A          251 EQ--------CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM  295 (310)
T ss_dssp             HT--------TCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hc--------ccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            00        0011111133457899999999999999999999999998754

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.1e-46  Score=362.72  Aligned_cols=254  Identities=29%  Similarity=0.400  Sum_probs=209.8

Q ss_pred             HHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC-eEEE
Q 037869           36 LHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD-QRLI  114 (380)
Q Consensus        36 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-~~~l  114 (380)
                      +....++|++.+.||+|+||.||+|.+. ++.||||+++...  ....+.+|+.+|+.++||||+++++++...+ ..++
T Consensus       188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~i  264 (450)
T 1k9a_A          188 WALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI  264 (450)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEE
T ss_pred             cccChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEE
Confidence            3445678999999999999999999885 7799999998643  3457899999999999999999999987655 7999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ||||+++|+|.+++...  ....+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus       265 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~  339 (450)
T 1k9a_A          265 VTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA  339 (450)
T ss_dssp             EEECCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCcccc
Confidence            99999999999999753  223479999999999999999999999   9999999999999999999999999999865


Q ss_pred             CCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                      ...    .....+++.|+|||++.+..++.++|||||||++|||++ |..||........                ...+
T Consensus       340 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~----------------~~~i  399 (450)
T 1k9a_A          340 SST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV----------------VPRV  399 (450)
T ss_dssp             C----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH----------------HHHH
T ss_pred             ccc----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH----------------HHHH
Confidence            332    122356889999999999999999999999999999998 9999976432110                0011


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ....+...+..++..+.+||.+||+.||.+|||+.+|++.|..+
T Consensus       400 ~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i  443 (450)
T 1k9a_A          400 EKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHI  443 (450)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            11222334455668899999999999999999999999988643

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7.3e-47  Score=349.38  Aligned_cols=256  Identities=24%  Similarity=0.406  Sum_probs=202.8

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC-CCc----EEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS-DGL----QIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  112 (380)
                      ..++|++.+.||+|+||+||+|++. +++    +||+|.++.. .......+.+|+.+++.++||||+++++++..+ ..
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~   91 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   91 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-SE
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-Ce
Confidence            3467999999999999999999863 444    4588887642 234456788999999999999999999999865 48


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      ++|++|+.+|+|.+++...   ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus        92 ~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~  165 (327)
T 3poz_A           92 QLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHH
T ss_pred             EEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCccee
Confidence            8999999999999999754   35699999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          193 LIPEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       193 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      ........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......                +.
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----------------~~  229 (327)
T 3poz_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------IS  229 (327)
T ss_dssp             HHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----------------HH
T ss_pred             EccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH----------------HH
Confidence            76543222 2233456889999999999999999999999999999999 999997643211                11


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ...........+..++..+.+++.+||+.||.+|||+.+++++|..+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          230 SILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             HHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence            11111122233344557899999999999999999999999998654

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.5e-46  Score=356.40  Aligned_cols=257  Identities=23%  Similarity=0.275  Sum_probs=196.2

Q ss_pred             CCCCCc-ceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHH-hcCCCCcceeEeeEEec----CCeEE
Q 037869           41 NGFSDD-NKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVL-GRVRHKNLLGLRGYCAG----TDQRL  113 (380)
Q Consensus        41 ~~y~~~-~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~~~~  113 (380)
                      +.|.+. +.||+|+||+||+|.+ .+++.||||++...     ..+.+|+.++ +..+||||+++++++..    ...+|
T Consensus        61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            456665 6899999999999987 46899999999743     2456788876 44589999999999865    56789


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---CCceEEeeccC
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS---DFEPLVADFGF  190 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~---~~~vkl~Dfgl  190 (380)
                      +||||++||+|.+++...  ....+++..++.++.|++.||.|||+.   ||+||||||+|||++.   ++.+||+|||+
T Consensus       136 lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEeccc
Confidence            999999999999999753  234699999999999999999999999   9999999999999987   78999999999


Q ss_pred             ccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          191 AKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       191 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      ++.....  ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||..........  . .......+.+ 
T Consensus       211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~-~~~~i~~~~~-  284 (400)
T 1nxk_A          211 AKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--G-MKTRIRMGQY-  284 (400)
T ss_dssp             CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC--S-HHHHHHHTCC-
T ss_pred             ccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH--H-HHHHHHcCcc-
Confidence            9876432  22345578999999999999999999999999999999999999997543211100  0 0000001110 


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                           .........++.++.+||.+||+.||.+|||+.++++|.+...
T Consensus       285 -----~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  327 (400)
T 1nxk_A          285 -----EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  327 (400)
T ss_dssp             -----CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             -----cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccC
Confidence                 0011111334578999999999999999999999999977543

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.9e-47  Score=351.21  Aligned_cols=273  Identities=25%  Similarity=0.363  Sum_probs=216.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-----CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEe--cCCe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-----SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA--GTDQ  111 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~  111 (380)
                      ..++|++.+.||+|+||.||+|+.     .+++.||||++..........+.+|+.+++.++||||+++++++.  ....
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred             chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence            347899999999999999999982     468899999998877777778999999999999999999999886  4567


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA  191 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~  191 (380)
                      .++||||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             EEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccc
Confidence            89999999999999999753   24699999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc--ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccc
Q 037869          192 KLIPEGVSH--MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKF  269 (380)
Q Consensus       192 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  269 (380)
                      .........  ......||+.|+|||++.+..++.++|||||||++|+|++|..||............ ..........+
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~  253 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMG-CERDVPALSRL  253 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-----CCHHHHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcc-cccccccHHHH
Confidence            876543221  223345788899999999999999999999999999999999998643211000000 00000000111


Q ss_pred             ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      ............+..++..+.+||.+||+.||.+|||+.+++++|....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  302 (327)
T 3lxl_A          254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLW  302 (327)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC-
T ss_pred             HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            1122222333445556688999999999999999999999999987653

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.3e-46  Score=336.92  Aligned_cols=254  Identities=23%  Similarity=0.353  Sum_probs=189.7

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh---hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS---KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      .++|++.+.||+|+||.||+|.+ .+++.||+|++.....   .....+.+|+.+++.++||||+++++++...+..++|
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   89 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV   89 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence            46799999999999999999987 5789999999974321   2235788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |||+++++|.+++...   ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++....
T Consensus        90 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~  163 (278)
T 3cok_A           90 LEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLK  163 (278)
T ss_dssp             EECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeecc
Confidence            9999999999999753   35689999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      .... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.......  ...             .....
T Consensus       164 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~-------------~~~~~  227 (278)
T 3cok_A          164 MPHE-KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN--TLN-------------KVVLA  227 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------------------CCSS
T ss_pred             CCCC-cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH--HHH-------------HHhhc
Confidence            3222 2233568999999999999899999999999999999999999997533210  000             00000


Q ss_pred             cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .  ...+...+.++.++|.+||+.||.+|||+.++++|.+..
T Consensus       228 ~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~  267 (278)
T 3cok_A          228 D--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS  267 (278)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC
T ss_pred             c--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCcccc
Confidence            0  112333457889999999999999999999999997754

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8.6e-47  Score=345.90  Aligned_cols=270  Identities=21%  Similarity=0.281  Sum_probs=202.7

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-----hhhHHHHHHHHHHHhcC---CCCcceeEeeEEec
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-----SKAEMEFAVEVEVLGRV---RHKNLLGLRGYCAG  108 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-----~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~  108 (380)
                      ...++|++.+.||+|+||+||+|++ .+++.||||++....     ......+.+|+.+++.+   +||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            3568999999999999999999997 578999999987422     11123556677777666   49999999999977


Q ss_pred             CC-----eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCce
Q 037869          109 TD-----QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEP  183 (380)
Q Consensus       109 ~~-----~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~v  183 (380)
                      ..     ..++||||+. ++|.+++....  ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.+
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~  159 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTV  159 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCE
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCE
Confidence            55     5899999997 59999997542  23499999999999999999999999   99999999999999999999


Q ss_pred             EEeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhh
Q 037869          184 LVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL  263 (380)
Q Consensus       184 kl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  263 (380)
                      ||+|||++......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ....+....
T Consensus       160 kl~Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~  235 (308)
T 3g33_A          160 KLADFGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD--QLGKIFDLI  235 (308)
T ss_dssp             EECSCSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHH--HHHHHHHHH
T ss_pred             EEeeCccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHh
Confidence            99999999876432  22344578999999999999999999999999999999999999997543211  110000000


Q ss_pred             h--hccccccc-------cC---CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          264 I--VKGKFKEL-------VD---PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       264 ~--~~~~~~~~-------~~---~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .  ....+...       ..   +..........+..+.+||.+||+.||.+|||+.++++|.+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~  301 (308)
T 3g33_A          236 GLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH  301 (308)
T ss_dssp             CCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC-
T ss_pred             CCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcccc
Confidence            0  00000000       00   0000011123457889999999999999999999999997754

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.3e-46  Score=361.69  Aligned_cols=272  Identities=19%  Similarity=0.228  Sum_probs=191.7

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecc--cChhhHHHHHHHHHHHhcCCCCcceeEeeEEec-----CC
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKA--MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG-----TD  110 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~  110 (380)
                      ..++|++.+.||+|+||+||+|.+ .+++.||||++..  ........+.+|+.+|+.++||||+++++++..     ..
T Consensus        51 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           51 IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             SCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            347899999999999999999987 4789999999865  334455678899999999999999999999843     35


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccC
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGF  190 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl  190 (380)
                      .+|+||||+ +++|.+++...    ..+++..++.++.||+.||.|||+.   ||+||||||+|||++.++.+||+|||+
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGl  202 (458)
T 3rp9_A          131 ELYVVLEIA-DSDFKKLFRTP----VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGL  202 (458)
T ss_dssp             CEEEEECCC-SEEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecc-ccchhhhcccC----CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeeccccc
Confidence            789999998 56899998643    5799999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCc--------------------------cceeccccccCccCcccc-ccCCCCccchhhhhhHHHHHHHh---
Q 037869          191 AKLIPEGVS--------------------------HMTTRVKGTLGYLAPEYA-MWGKVSESCDVYSFGILLLEILT---  240 (380)
Q Consensus       191 ~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~---  240 (380)
                      ++.......                          ......+||++|+|||++ .+..|+.++||||||||+|||++   
T Consensus       203 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~  282 (458)
T 3rp9_A          203 ARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIK  282 (458)
T ss_dssp             CBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTST
T ss_pred             chhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhcc
Confidence            987643211                          123345789999999986 46679999999999999999999   


Q ss_pred             --------CCCCCCCCCCCccc---------------chhccchhhhhccc----------------cccccCCc---cc
Q 037869          241 --------GRKPIEKLPGGVKR---------------TITEWAEPLIVKGK----------------FKELVDPK---LR  278 (380)
Q Consensus       241 --------g~~p~~~~~~~~~~---------------~~~~~~~~~~~~~~----------------~~~~~~~~---~~  278 (380)
                              |.++|.+.......               ....+.......+.                +.......   ..
T Consensus       283 ~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  362 (458)
T 3rp9_A          283 ENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDL  362 (458)
T ss_dssp             TTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCG
T ss_pred             ccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCH
Confidence                    55555443210000               00000000000000                00000000   00


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      ....+..+.++.+||.+||..||.+|||++++++|.+.-.
T Consensus       363 ~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~  402 (458)
T 3rp9_A          363 AERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKE  402 (458)
T ss_dssp             GGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             HHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhh
Confidence            1112234578999999999999999999999999977543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=7.2e-47  Score=346.93  Aligned_cols=262  Identities=26%  Similarity=0.424  Sum_probs=213.1

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEe------CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcC-CCCcceeEeeEEec
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRT------SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAG  108 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  108 (380)
                      ....++|++.+.||+|+||.||+|.+      .++..||+|+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   98 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec
Confidence            34668999999999999999999974      346789999998543 34456788999999999 89999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHhhccCCC--------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 037869          109 TDQRLIVYDYMPNLSLLSHLHGQYA--------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASN  174 (380)
Q Consensus       109 ~~~~~lv~e~~~~g~L~~~i~~~~~--------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~N  174 (380)
                      .+..++||||+++|+|.+++.....              ....+++..++.++.|++.||.|||++   |++||||||+|
T Consensus        99 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~N  175 (313)
T 1t46_A           99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN  175 (313)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccce
Confidence            9999999999999999999975421              123589999999999999999999999   99999999999


Q ss_pred             eeeCCCCceEEeeccCccccCCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCc
Q 037869          175 VLLDSDFEPLVADFGFAKLIPEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGV  252 (380)
Q Consensus       175 ill~~~~~vkl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~  252 (380)
                      |+++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......
T Consensus       176 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             EEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            99999999999999999876543222 2223457889999999999999999999999999999999 999997643211


Q ss_pred             ccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          253 KRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .  .             ............+...+..+.+++.+||+.||.+|||+.+++++|..
T Consensus       256 ~--~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  304 (313)
T 1t46_A          256 K--F-------------YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEK  304 (313)
T ss_dssp             H--H-------------HHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             H--H-------------HHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHH
Confidence            0  0             00011111112233445789999999999999999999999999864

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.1e-46  Score=348.51  Aligned_cols=270  Identities=19%  Similarity=0.263  Sum_probs=199.5

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChh--hHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSK--AEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ....++|++.+.||+|+||+||+|.+ .+++.||||+++.....  ....+.+|+.+++.++||||+++++++...+..+
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (329)
T 3gbz_A           30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH  109 (329)
T ss_dssp             --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred             ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence            34567899999999999999999986 57899999999754322  2346778999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC-----CCCceEEeec
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLD-----SDFEPLVADF  188 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~-----~~~~vkl~Df  188 (380)
                      +||||+++ +|.+++...    ..+++..++.++.||+.||.|||+.   +|+||||||+|||++     .++.+||+||
T Consensus       110 lv~e~~~~-~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Df  181 (329)
T 3gbz_A          110 LIFEYAEN-DLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDF  181 (329)
T ss_dssp             EEEECCSE-EHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCT
T ss_pred             EEEecCCC-CHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcC
Confidence            99999974 999999754    4699999999999999999999999   999999999999994     4556999999


Q ss_pred             cCccccCCCCccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh---
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI---  264 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~---  264 (380)
                      |++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.......  ....+.....   
T Consensus       182 g~a~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~  258 (329)
T 3gbz_A          182 GLARAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEID--QLFKIFEVLGLPD  258 (329)
T ss_dssp             THHHHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCC
T ss_pred             CCccccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHH--HHHHHHHHhCCCc
Confidence            99987653322 23344689999999999874 58999999999999999999999997543211  0000000000   


Q ss_pred             --------hcccc----ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          265 --------VKGKF----KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       265 --------~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                              ....+    .......+........+.++.+||.+||+.||.+|||+.++++|.+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  323 (329)
T 3gbz_A          259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS  323 (329)
T ss_dssp             TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccC
Confidence                    00000    000000001111122447889999999999999999999999997743

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.6e-46  Score=340.19  Aligned_cols=253  Identities=20%  Similarity=0.241  Sum_probs=205.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  114 (380)
                      ..++|++.+.||+|+||+||+|.+. +++.||+|+++..  .......+.+|+..+..+ +||||+++++++...+..++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l   88 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI   88 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence            4578999999999999999999874 7999999999753  334456788899999999 89999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC--------------
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD--------------  180 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~--------------  180 (380)
                      ||||+++++|.+++.........+++..++.++.|++.||.|||++   +|+||||||+||+++.+              
T Consensus        89 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           89 QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC----------------
T ss_pred             EEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            9999999999999975433335689999999999999999999999   99999999999999844              


Q ss_pred             -----CceEEeeccCccccCCCCccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCccc
Q 037869          181 -----FEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKR  254 (380)
Q Consensus       181 -----~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  254 (380)
                           ..++|+|||++.......     ...||+.|+|||++.+. .++.++|||||||++|+|++|.+|+.....    
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~----  236 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----  236 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH----
T ss_pred             ccCCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH----
Confidence                 479999999998765422     23589999999999865 667899999999999999999877643210    


Q ss_pred             chhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          255 TITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                       ..     ....         ......+...+..+.++|.+||+.||.+|||+.++++|.+...
T Consensus       237 -~~-----~~~~---------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  285 (289)
T 1x8b_A          237 -WH-----EIRQ---------GRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS  285 (289)
T ss_dssp             -HH-----HHHT---------TCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC--
T ss_pred             -HH-----HHHc---------CCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhh
Confidence             00     0001         1111223344578999999999999999999999999987553

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.9e-46  Score=358.06  Aligned_cols=271  Identities=21%  Similarity=0.253  Sum_probs=202.8

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecC-----C
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT-----D  110 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~  110 (380)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||+++..  .......+.+|+.+|+.++||||+++++++...     .
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            568999999999999999999987 56889999999753  334556788999999999999999999998765     5


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccC
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGF  190 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl  190 (380)
                      ..|+||||+. ++|.+++...    ..+++..++.++.||+.||.|||+.   ||+||||||+|||++.++.+||+|||+
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~----~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGl  175 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTP----IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGL  175 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred             eEEEEEecCC-cCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCC
Confidence            7999999996 5999999643    4699999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCc---------------------cceeccccccCccCcccc-ccCCCCccchhhhhhHHHHHHHhCCCCCCCC
Q 037869          191 AKLIPEGVS---------------------HMTTRVKGTLGYLAPEYA-MWGKVSESCDVYSFGILLLEILTGRKPIEKL  248 (380)
Q Consensus       191 ~~~~~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~ell~g~~p~~~~  248 (380)
                      ++.......                     ......+||++|+|||++ .+..|+.++|||||||++|||++|..||...
T Consensus       176 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~  255 (432)
T 3n9x_A          176 ARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIND  255 (432)
T ss_dssp             CEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSS
T ss_pred             cccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccc
Confidence            987643321                     123456799999999986 4667999999999999999999866655432


Q ss_pred             CCCcccc-----------------------hhccchhhhhccc-------------ccccc-CCcccCC-----CCHHHH
Q 037869          249 PGGVKRT-----------------------ITEWAEPLIVKGK-------------FKELV-DPKLRGD-----FDENQL  286 (380)
Q Consensus       249 ~~~~~~~-----------------------~~~~~~~~~~~~~-------------~~~~~-~~~~~~~-----~~~~~~  286 (380)
                      .......                       ..++.......+.             ..... .......     ..+..+
T Consensus       256 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  335 (432)
T 3n9x_A          256 PTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSIS  335 (432)
T ss_dssp             GGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSC
T ss_pred             cccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCC
Confidence            1110000                       0000000000000             00000 0000000     112345


Q ss_pred             HHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          287 KQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       287 ~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .++.+||.+||+.||.+|||++++++|.+..
T Consensus       336 ~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  366 (432)
T 3n9x_A          336 DDGINLLESMLKFNPNKRITIDQALDHPYLK  366 (432)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTCGGGT
T ss_pred             HHHHHHHHHHhcCCcccCCCHHHHhcChhhh
Confidence            7899999999999999999999999997654

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3.8e-46  Score=338.59  Aligned_cols=260  Identities=30%  Similarity=0.502  Sum_probs=198.3

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ...++|++.++||+|+||+||+|.+..  .||+|+++..  .......+.+|+.+++.++||||++++++. .....++|
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~--~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv   97 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIV   97 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSS--EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcC--ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEE
Confidence            367899999999999999999998743  5999998753  344556788999999999999999999965 45678999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |||+++++|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++....
T Consensus        98 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  171 (289)
T 3og7_A           98 TQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS  171 (289)
T ss_dssp             EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred             EEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccc
Confidence            9999999999999643   35799999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCC-ccceeccccccCccCccccc---cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          196 EGV-SHMTTRVKGTLGYLAPEYAM---WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       196 ~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      ... ........||+.|+|||++.   +..++.++||||||+++|+|++|..||.......  ....    ....+..  
T Consensus       172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~----~~~~~~~--  243 (289)
T 3og7_A          172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIE----MVGRGSL--  243 (289)
T ss_dssp             ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHH----HHHHTSC--
T ss_pred             cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHH----Hhccccc--
Confidence            321 22233456899999999987   6678999999999999999999999997643211  0000    0000000  


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                         ..........++..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus       244 ---~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l  286 (289)
T 3og7_A          244 ---SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL  286 (289)
T ss_dssp             ---CCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             ---CcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHH
Confidence               0111122334557899999999999999999999999998765

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=2e-46  Score=336.64  Aligned_cols=252  Identities=23%  Similarity=0.334  Sum_probs=207.4

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecC--CeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT--DQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~~~l  114 (380)
                      ..++|++.+.||+|+||+||+|.+. +..||+|+++..  .......+.+|+.+++.++||||+++++++...  ...++
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   86 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL   86 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence            3468999999999999999999985 889999999753  344456788999999999999999999999877  77899


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH--IIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~--ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      ||||+++|+|.+++...  ....+++..++.++.|++.||+|||++   +  ++||||||+||+++.++.++|+|||++.
T Consensus        87 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~  161 (271)
T 3kmu_A           87 ITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKF  161 (271)
T ss_dssp             EEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCC
T ss_pred             eecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEecccee
Confidence            99999999999999754  233689999999999999999999998   8  9999999999999999999999998876


Q ss_pred             ccCCCCccceeccccccCccCccccccCCCCc---cchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccc
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE---SCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKF  269 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  269 (380)
                      ....      ....||+.|+|||++.+..++.   ++|||||||++|+|++|..||........               .
T Consensus       162 ~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~---------------~  220 (271)
T 3kmu_A          162 SFQS------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEI---------------G  220 (271)
T ss_dssp             TTSC------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHH---------------H
T ss_pred             eecc------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHH---------------H
Confidence            5322      2235799999999998765544   79999999999999999999975432100               0


Q ss_pred             ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ............+...+..+.+++.+||+.||.+|||+.++++.|..+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l  268 (271)
T 3kmu_A          221 MKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKM  268 (271)
T ss_dssp             HHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHh
Confidence            011111222233445567899999999999999999999999998754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=9.1e-47  Score=347.38  Aligned_cols=270  Identities=27%  Similarity=0.398  Sum_probs=211.7

Q ss_pred             hhCCC-CCcceeccCCceEEEEEEe-----CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEec--C
Q 037869           39 ATNGF-SDDNKLGEGGFGSVYWGRT-----SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG--T  109 (380)
Q Consensus        39 ~~~~y-~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~  109 (380)
                      ..++| ++.+.||+|+||+||++..     .+++.||||+++... ......+.+|+.+++.++||||+++++++..  .
T Consensus        28 ~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  107 (318)
T 3lxp_A           28 FHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA  107 (318)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred             ecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence            34455 9999999999999998853     358899999998643 3445678899999999999999999999987  4


Q ss_pred             CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeecc
Q 037869          110 DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG  189 (380)
Q Consensus       110 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfg  189 (380)
                      ...++||||+++|+|.+++...     .+++..++.++.|++.||+|||+.   ||+||||||+||+++.++.++|+|||
T Consensus       108 ~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg  179 (318)
T 3lxp_A          108 ASLQLVMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFG  179 (318)
T ss_dssp             TEEEEEECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGG
T ss_pred             ceEEEEEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCcc
Confidence            6789999999999999999754     489999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCcc--ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcc
Q 037869          190 FAKLIPEGVSH--MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKG  267 (380)
Q Consensus       190 l~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  267 (380)
                      ++.........  ......++..|+|||++.+..++.++|||||||++|+|++|..||........ ....+........
T Consensus       180 ~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-~~~~~~~~~~~~~  258 (318)
T 3lxp_A          180 LAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-ELIGIAQGQMTVL  258 (318)
T ss_dssp             GCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-HHHCSCCHHHHHH
T ss_pred             ccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhh-hhhcccccchhHH
Confidence            99887543221  22334578889999999999999999999999999999999999864221100 0000000011111


Q ss_pred             ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .+............+..++..+.+||.+||+.||.+|||+.++++.|..+
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  308 (318)
T 3lxp_A          259 RLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV  308 (318)
T ss_dssp             HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            12222223333444556668899999999999999999999999988643

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.3e-46  Score=348.10  Aligned_cols=259  Identities=17%  Similarity=0.195  Sum_probs=207.7

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ..++|++.+.||+|+||+||+|.+ .+++.||||++.....  ...+.+|+.+++.+ +||||+++++++...+..++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~   84 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL   84 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence            457899999999999999999987 6789999999875432  23578899999999 8999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc-----eEEeeccCc
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE-----PLVADFGFA  191 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~-----vkl~Dfgl~  191 (380)
                      ||+ +++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.     +||+|||++
T Consensus        85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a  157 (330)
T 2izr_A           85 ELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA  157 (330)
T ss_dssp             ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTC
T ss_pred             EeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccc
Confidence            999 89999999753   35799999999999999999999999   9999999999999998877     999999999


Q ss_pred             cccCCCCcc------ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhh
Q 037869          192 KLIPEGVSH------MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIV  265 (380)
Q Consensus       192 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  265 (380)
                      ..+......      ......||+.|+|||++.+..++.++|||||||++|||++|..||....................
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~  237 (330)
T 2izr_A          158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR  237 (330)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred             eeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence            876443221      12346799999999999999999999999999999999999999986543211111100000000


Q ss_pred             ccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          266 KGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ....         .......+ ++.+++..||+.||.+||++.+|++.|..
T Consensus       238 ~~~~---------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~  278 (330)
T 2izr_A          238 ATPI---------EVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTD  278 (330)
T ss_dssp             HSCH---------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             cCCH---------HHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHH
Confidence            0000         00111123 89999999999999999999999998753

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.3e-47  Score=368.67  Aligned_cols=255  Identities=22%  Similarity=0.340  Sum_probs=209.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      ..++|++.+.||+|+||+||+|.+ .+++.||||++....   ......+.+|+.+++.++||||+++++++...+..++
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l  103 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYL  103 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            557899999999999999999987 478999999986432   3345678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee---CCCCceEEeeccCc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLL---DSDFEPLVADFGFA  191 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill---~~~~~vkl~Dfgl~  191 (380)
                      ||||+.+|+|.+.+...    ..+++..++.++.|++.||.|||++   ||+||||||+|||+   +.++.+||+|||++
T Consensus       104 v~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a  176 (484)
T 3nyv_A          104 VGEVYTGGELFDEIISR----KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLS  176 (484)
T ss_dssp             EECCCCSCBHHHHHHTC----SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHH
T ss_pred             EEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeee
Confidence            99999999999999653    4699999999999999999999999   99999999999999   46789999999999


Q ss_pred             cccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          192 KLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       192 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      .......  ......||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.......  ....     ...+.+  
T Consensus       177 ~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~-----i~~~~~--  244 (484)
T 3nyv_A          177 THFEASK--KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD--ILKK-----VEKGKY--  244 (484)
T ss_dssp             HHBCCCC--SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-----HHHCCC--
T ss_pred             EEccccc--ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH--HHHH-----HHcCCC--
Confidence            8765432  2334569999999999876 69999999999999999999999997643210  0000     000000  


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                          ....+.....+..+.+||.+||+.||.+|||+.++++|.+.
T Consensus       245 ----~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~  285 (484)
T 3nyv_A          245 ----TFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWI  285 (484)
T ss_dssp             ----CCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHH
T ss_pred             ----CCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhh
Confidence                00111123455789999999999999999999999999663

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.2e-46  Score=349.75  Aligned_cols=258  Identities=24%  Similarity=0.365  Sum_probs=206.7

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ...++|++.+.||+|+||.||+|.+ .+++.||+|++.....    ...+|++++.++ +||||+++++++.+.+..|+|
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv   94 (342)
T 2qr7_A           19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV   94 (342)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred             CccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence            3567899999999999999999987 4689999999976432    234577888777 799999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC----CceEEeeccCc
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD----FEPLVADFGFA  191 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~----~~vkl~Dfgl~  191 (380)
                      |||++||+|.+.+...    ..+++..+..++.|++.||.|||++   ||+||||||+|||+..+    +.+||+|||++
T Consensus        95 ~E~~~gg~L~~~i~~~----~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a  167 (342)
T 2qr7_A           95 TELMKGGELLDKILRQ----KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFA  167 (342)
T ss_dssp             ECCCCSCBHHHHHHTC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTC
T ss_pred             EeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCc
Confidence            9999999999999653    4699999999999999999999999   99999999999998543    35999999999


Q ss_pred             cccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          192 KLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       192 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      ........ .....+||+.|+|||++.+..|+.++|||||||++|+|++|..||..........+   ... ...+.+  
T Consensus       168 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~---~~~-i~~~~~--  240 (342)
T 2qr7_A          168 KQLRAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEI---LAR-IGSGKF--  240 (342)
T ss_dssp             EECBCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHH---HHH-HHHCCC--
T ss_pred             ccCcCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHH---HHH-HccCCc--
Confidence            87654322 23345789999999999988899999999999999999999999975332111111   000 001110  


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                          ..........+.++.+||.+||..||.+|||+.++++|.+..
T Consensus       241 ----~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~  282 (342)
T 2qr7_A          241 ----SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIV  282 (342)
T ss_dssp             ----CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHH
T ss_pred             ----ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeec
Confidence                111122334567899999999999999999999999997753

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.8e-46  Score=346.50  Aligned_cols=261  Identities=28%  Similarity=0.417  Sum_probs=211.2

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeC--------CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEe
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTS--------DGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCA  107 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  107 (380)
                      ...++|++.+.||+|+||.||+|.+.        ++..||+|+++.. .......+.+|+.+++.+ +||||+++++++.
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  111 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  111 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEc
Confidence            45689999999999999999999863        4678999999754 334456788999999999 8999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHhhccCCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCe
Q 037869          108 GTDQRLIVYDYMPNLSLLSHLHGQYA------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNV  175 (380)
Q Consensus       108 ~~~~~~lv~e~~~~g~L~~~i~~~~~------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Ni  175 (380)
                      ..+..++||||+++|+|.+++.....            ....+++..++.++.|++.||+|||+.   ||+||||||+||
T Consensus       112 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NI  188 (334)
T 2pvf_A          112 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNV  188 (334)
T ss_dssp             SSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             cCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceE
Confidence            99999999999999999999976432            123589999999999999999999999   999999999999


Q ss_pred             eeCCCCceEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcc
Q 037869          176 LLDSDFEPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVK  253 (380)
Q Consensus       176 ll~~~~~vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~  253 (380)
                      +++.++.+||+|||++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||....... 
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-  267 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-  267 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH-
Confidence            999999999999999987654322 12223456889999999998899999999999999999999 999997543110 


Q ss_pred             cchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          254 RTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                           ...          ..........+..++..+.++|.+||+.||.+|||+.+++++|..+
T Consensus       268 -----~~~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l  316 (334)
T 2pvf_A          268 -----LFK----------LLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  316 (334)
T ss_dssp             -----HHH----------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----HHH----------HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                 000          0001111223344557899999999999999999999999998754

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.3e-46  Score=338.17  Aligned_cols=251  Identities=29%  Similarity=0.450  Sum_probs=205.4

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      ..++|++.+.||+|+||+||+|.+ .++..||+|++....   ......+.+|+.+++.++||||+++++++......++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL   86 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEE
Confidence            346899999999999999999987 467899999986432   1224568889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ||||+++++|.+++...    ..+++..++.++.|++.||.|||+.   ||+||||||+||+++.++.++|+|||++...
T Consensus        87 v~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~  159 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHA  159 (279)
T ss_dssp             EECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC
T ss_pred             EEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccC
Confidence            99999999999999653    4689999999999999999999998   9999999999999999999999999998654


Q ss_pred             CCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      ...   ......|++.|+|||++.+..++.++||||||+++|+|++|..||.......  ..    ..      +.    
T Consensus       160 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~----~~------~~----  220 (279)
T 3fdn_A          160 PSS---RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE--TY----KR------IS----  220 (279)
T ss_dssp             -----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH----HH------HH----
T ss_pred             Ccc---cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH--HH----HH------HH----
Confidence            332   2234568999999999999999999999999999999999999997532110  00    00      00    


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                       ......+...+..+.+||.+||+.||.+|||+.++++|.+.
T Consensus       221 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~  261 (279)
T 3fdn_A          221 -RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI  261 (279)
T ss_dssp             -HTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHH
T ss_pred             -hCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccc
Confidence             01112233345788999999999999999999999999763

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-46  Score=338.62  Aligned_cols=256  Identities=24%  Similarity=0.374  Sum_probs=209.4

Q ss_pred             hhCCCCCcc-eeccCCceEEEEEEe---CCCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           39 ATNGFSDDN-KLGEGGFGSVYWGRT---SDGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        39 ~~~~y~~~~-~Lg~G~~g~Vy~~~~---~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ..++|.+.+ .||+|+||.||+|.+   .++..||+|+++.. .......+.+|+.+++.++||||+++++++. .+..+
T Consensus         7 ~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   85 (287)
T 1u59_A            7 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALM   85 (287)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEE
T ss_pred             cHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCcE
Confidence            456777776 999999999999975   35788999999864 3445667889999999999999999999994 56799


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||+++++|.+++...   ...+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++..
T Consensus        86 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~  159 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA  159 (287)
T ss_dssp             EEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEeCCCCCHHHHHHhC---CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceee
Confidence            999999999999999643   35699999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCccc--eeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          194 IPEGVSHM--TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       194 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      ........  .....+|+.|+|||++.+..++.++||||||+++|+|++ |..||........      .          
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~------~----------  223 (287)
T 1u59_A          160 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------M----------  223 (287)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH------H----------
T ss_pred             eccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH------H----------
Confidence            75432221  222346889999999998899999999999999999998 9999976432110      0          


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ...........+..++..+.++|.+||+.||.+|||+.+++++|+..
T Consensus       224 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  270 (287)
T 1u59_A          224 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  270 (287)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            00011112233445568899999999999999999999999998754

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.2e-46  Score=366.56  Aligned_cols=260  Identities=27%  Similarity=0.364  Sum_probs=213.8

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ...++|++.+.||+|+||.||+|++ .+++.||+|++....   ......+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~  260 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC  260 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence            3456899999999999999999987 479999999996521   223456788999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||++||+|.+++...  ....+++..++.++.||+.||.|||++   ||+||||||+|||++.+|.+||+|||++..
T Consensus       261 lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~  335 (576)
T 2acx_A          261 LVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVH  335 (576)
T ss_dssp             EEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEeccccee
Confidence            999999999999999754  234599999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                      .....  .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.........  ..+... ..        
T Consensus       336 ~~~~~--~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~--~~i~~~-i~--------  402 (576)
T 2acx_A          336 VPEGQ--TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEVERL-VK--------  402 (576)
T ss_dssp             CCTTC--CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH--HHHHHH-HH--------
T ss_pred             cccCc--cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH--HHHHHH-hh--------
Confidence            65432  233457999999999999999999999999999999999999999764321110  000000 00        


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhcCC
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLTGY  317 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~~~  317 (380)
                        .....++...+.++.+||.+||+.||.+||     ++.++++|.+..
T Consensus       403 --~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~  449 (576)
T 2acx_A          403 --EVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK  449 (576)
T ss_dssp             --HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGT
T ss_pred             --cccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhc
Confidence              001123344557899999999999999999     899999997643

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=2.6e-46  Score=342.04  Aligned_cols=256  Identities=21%  Similarity=0.346  Sum_probs=208.4

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ...++|++.+.||+|+||+||+|++ .+++.||+|+++.........+.+|+.+++.++||||+++++++...+..++||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            3567899999999999999999987 478999999998655555567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee---CCCCceEEeeccCccc
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLL---DSDFEPLVADFGFAKL  193 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill---~~~~~vkl~Dfgl~~~  193 (380)
                      ||+++++|.+++...    ..+++..++.++.|++.||.|||+.   |++||||||+||++   +.++.++|+|||++..
T Consensus        86 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~  158 (304)
T 2jam_A           86 QLVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM  158 (304)
T ss_dssp             CCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCC
T ss_pred             EcCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCccee
Confidence            999999999998643    4689999999999999999999999   99999999999999   7788999999999976


Q ss_pred             cCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                      ....   ......|++.|+|||++.+..++.++|||||||++|+|++|..||.......  ...    . ...+.     
T Consensus       159 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~----~-i~~~~-----  223 (304)
T 2jam_A          159 EQNG---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK--LFE----K-IKEGY-----  223 (304)
T ss_dssp             CCCB---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH----H-HHHCC-----
T ss_pred             cCCC---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH--HHH----H-HHcCC-----
Confidence            4332   2233468999999999999999999999999999999999999997533210  000    0 00000     


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                       ...........+..+.++|.+||..||.+|||+.++++|.+.
T Consensus       224 -~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~  265 (304)
T 2jam_A          224 -YEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI  265 (304)
T ss_dssp             -CCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred             -CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence             001112223445789999999999999999999999999764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.4e-45  Score=335.96  Aligned_cols=262  Identities=16%  Similarity=0.196  Sum_probs=210.4

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ...++|++.+.||+|+||.||+|.+ .+++.||||++....  ....+.+|+.+++.+ +|+|++++++++......++|
T Consensus         7 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   84 (298)
T 1csn_A            7 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV   84 (298)
T ss_dssp             EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred             ccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEE
Confidence            3567899999999999999999987 679999999987543  223577899999999 799999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc-----eEEeeccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE-----PLVADFGF  190 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~-----vkl~Dfgl  190 (380)
                      |||+ +++|.+++...   ...+++..++.++.|++.||+|||++   ||+||||||+||+++.++.     ++|+|||+
T Consensus        85 ~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~  157 (298)
T 1csn_A           85 IDLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGM  157 (298)
T ss_dssp             EECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTT
T ss_pred             EEec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECcc
Confidence            9999 99999999754   34699999999999999999999999   9999999999999987765     99999999


Q ss_pred             ccccCCCCcc------ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh
Q 037869          191 AKLIPEGVSH------MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI  264 (380)
Q Consensus       191 ~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  264 (380)
                      +.........      ......||+.|+|||++.+..++.++|||||||++|+|++|..||...................
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (298)
T 1csn_A          158 VKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  237 (298)
T ss_dssp             CEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             ccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence            9876543221      2334568999999999999999999999999999999999999998654321111110000000


Q ss_pred             hccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          265 VKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .....         ......++..+.+++.+||+.||.+|||+.+|++.|..+
T Consensus       238 ~~~~~---------~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~  281 (298)
T 1csn_A          238 QSTPL---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  281 (298)
T ss_dssp             HHSCH---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             cCccH---------HHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHH
Confidence            00000         011123447899999999999999999999999998754

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.5e-46  Score=364.03  Aligned_cols=255  Identities=23%  Similarity=0.316  Sum_probs=206.8

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ..++|++.+.||+|+||+||+|.+ .+++.||||++...  .......+.+|+.+++.++||||+++++++......|+|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            457899999999999999999987 47899999998642  223456788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC---CCCceEEeeccCcc
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLD---SDFEPLVADFGFAK  192 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~---~~~~vkl~Dfgl~~  192 (380)
                      ||||.+|+|.+.+...    ..+++..++.++.|++.||.|||++   ||+||||||+|||++   .++.+||+|||++.
T Consensus       100 ~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~  172 (486)
T 3mwu_A          100 GELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLST  172 (486)
T ss_dssp             ECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTT
T ss_pred             EEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCe
Confidence            9999999999988653    4699999999999999999999999   999999999999995   45679999999998


Q ss_pred             ccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      .....  .......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.......  ....     ...+.+   
T Consensus       173 ~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~-----i~~~~~---  239 (486)
T 3mwu_A          173 CFQQN--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--ILKR-----VETGKY---  239 (486)
T ss_dssp             TBCCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-----HHHTCC---
T ss_pred             ECCCC--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-----HHhCCC---
Confidence            76543  22344569999999999876 59999999999999999999999997543210  0000     000000   


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                         ....+.....+.++.+||.+||+.||.+|||+.++++|.+.
T Consensus       240 ---~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~  280 (486)
T 3mwu_A          240 ---AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI  280 (486)
T ss_dssp             ---CSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHH
T ss_pred             ---CCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhh
Confidence               00111123445789999999999999999999999999653

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.6e-46  Score=340.21  Aligned_cols=254  Identities=27%  Similarity=0.337  Sum_probs=211.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ..+.|++.+.||+|+||.||+|.+ .+++.||+|++.... ......+.+|+.+++.++||||+++++++..+...++||
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            557899999999999999999987 568999999997533 344567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++++|.+++..     ..+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.....
T Consensus       100 e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~  171 (303)
T 3a7i_A          100 EYLGGGSALDLLEP-----GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD  171 (303)
T ss_dssp             ECCTTEEHHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBT
T ss_pred             EeCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCc
Confidence            99999999999864     3689999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      ... ......|++.|+|||++.+..++.++||||||+++|+|++|..||........      .. ..     ...    
T Consensus       172 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~------~~-~~-----~~~----  234 (303)
T 3a7i_A          172 TQI-KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV------LF-LI-----PKN----  234 (303)
T ss_dssp             TBC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH------HH-HH-----HHS----
T ss_pred             ccc-ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHH------HH-Hh-----hcC----
Confidence            321 23345689999999999999999999999999999999999999975332100      00 00     000    


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .....+...+..+.+||.+||+.||.+|||+.++++|.+..
T Consensus       235 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~  275 (303)
T 3a7i_A          235 NPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL  275 (303)
T ss_dssp             CCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred             CCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhh
Confidence            11122233446799999999999999999999999997643

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=9.8e-47  Score=344.36  Aligned_cols=270  Identities=24%  Similarity=0.378  Sum_probs=209.0

Q ss_pred             hCCCCCcceeccCCceEEEEEE----e-CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecC--Ce
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGR----T-SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT--DQ  111 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~----~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--~~  111 (380)
                      .++|++.+.||+|+||.||+|+    + .+++.||+|++.... ......+.+|+.+++.++||||+++++++...  ..
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   99 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG   99 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence            4568999999999999999998    2 468999999997532 33446788999999999999999999999876  66


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA  191 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~  191 (380)
                      .++||||+++|+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+||+++.++.++|+|||++
T Consensus       100 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~  173 (302)
T 4e5w_A          100 IKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLT  173 (302)
T ss_dssp             EEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             EEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECccccc
Confidence            89999999999999999543   24699999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCc--cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccc
Q 037869          192 KLIPEGVS--HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKF  269 (380)
Q Consensus       192 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  269 (380)
                      ........  .......||..|+|||++.+..++.++||||||+++|+|++|..|+................. .....+
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~  252 (302)
T 4e5w_A          174 KAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQ-MTVTRL  252 (302)
T ss_dssp             EECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGG-GHHHHH
T ss_pred             ccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccc-cCHHHH
Confidence            87754332  223344578889999999999999999999999999999999998643210000000000000 000011


Q ss_pred             ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ............+..++..+.+|+.+||+.||.+|||+.++++.|..
T Consensus       253 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  299 (302)
T 4e5w_A          253 VNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEA  299 (302)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence            11112222333445566889999999999999999999999998863

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.4e-46  Score=345.44  Aligned_cols=269  Identities=23%  Similarity=0.343  Sum_probs=215.2

Q ss_pred             ccHHHHHHhhCCCCCcceeccCCceEEEEEEe------CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcC-CCCcceeE
Q 037869           31 FTYKELHTATNGFSDDNKLGEGGFGSVYWGRT------SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRV-RHKNLLGL  102 (380)
Q Consensus        31 ~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~  102 (380)
                      +...++....++|++.+.||+|+||+||+|.+      .+++.||||+++... ......+.+|+.++..+ +||||+++
T Consensus        17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~   96 (316)
T 2xir_A           17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   96 (316)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence            44566667889999999999999999999974      346889999997643 33455788999999999 78999999


Q ss_pred             eeEEecCC-eEEEEEEecCCCCHHHhhccCCCC------------CccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecC
Q 037869          103 RGYCAGTD-QRLIVYDYMPNLSLLSHLHGQYAG------------EVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRD  169 (380)
Q Consensus       103 ~~~~~~~~-~~~lv~e~~~~g~L~~~i~~~~~~------------~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrd  169 (380)
                      ++++...+ ..++||||+++|+|.+++......            ...+++..++.++.|++.||.|||+.   ||+|||
T Consensus        97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~d  173 (316)
T 2xir_A           97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  173 (316)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence            99987654 589999999999999999765321            12389999999999999999999999   999999


Q ss_pred             CCCCCeeeCCCCceEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCC
Q 037869          170 IKASNVLLDSDFEPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEK  247 (380)
Q Consensus       170 lkp~Nill~~~~~vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~  247 (380)
                      |||+||+++.++.+||+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus       174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~  253 (316)
T 2xir_A          174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  253 (316)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcc
Confidence            999999999999999999999987644322 22334457889999999999999999999999999999998 9999975


Q ss_pred             CCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          248 LPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ......  .   ..          ..........+...+..+.+++.+||+.||.+|||+.+++++|..+
T Consensus       254 ~~~~~~--~---~~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  308 (316)
T 2xir_A          254 VKIDEE--F---CR----------RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  308 (316)
T ss_dssp             CCCSHH--H---HH----------HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhHH--H---HH----------HhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            432110  0   00          0000111122333457899999999999999999999999998643

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1e-45  Score=335.78  Aligned_cols=253  Identities=23%  Similarity=0.346  Sum_probs=204.2

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEec----CCe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG----TDQ  111 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~  111 (380)
                      ....|++.+.||+|+||+||+|.+ .++..||+|.+...  .......+.+|+.+++.++||||+++++++..    ...
T Consensus        24 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~  103 (290)
T 1t4h_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC  103 (290)
T ss_dssp             TSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             CceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence            345688999999999999999987 56889999998743  34556678899999999999999999999865    456


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCeeeC-CCCceEEeec
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH--IIHRDIKASNVLLD-SDFEPLVADF  188 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~--ivHrdlkp~Nill~-~~~~vkl~Df  188 (380)
                      .++||||+++++|.+++...    ..+++..++.++.|++.||.|||+.   +  ++||||||+||+++ .++.++|+||
T Consensus       104 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Df  176 (290)
T 1t4h_A          104 IVLVTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDL  176 (290)
T ss_dssp             EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCT
T ss_pred             EEEEEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeC
Confidence            89999999999999999653    4689999999999999999999998   7  99999999999998 7899999999


Q ss_pred             cCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccc
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGK  268 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (380)
                      |++......   ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.........     ..       
T Consensus       177 g~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-----~~-------  240 (290)
T 1t4h_A          177 GLATLKRAS---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-----YR-------  240 (290)
T ss_dssp             TGGGGCCTT---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH-----HH-------
T ss_pred             CCccccccc---ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH-----HH-------
Confidence            999765432   2334568999999998874 5899999999999999999999999753321100     00       


Q ss_pred             cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                        ...........+...+..+.++|.+||+.||.+|||+.++++|.+.
T Consensus       241 --~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f  286 (290)
T 1t4h_A          241 --RVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF  286 (290)
T ss_dssp             --HHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             --HHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccc
Confidence              0000000111122233678999999999999999999999999764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=6.9e-47  Score=350.43  Aligned_cols=270  Identities=22%  Similarity=0.270  Sum_probs=197.7

Q ss_pred             CCccceeccHHHHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCC-CCccee
Q 037869           24 NNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR-HKNLLG  101 (380)
Q Consensus        24 ~~~~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~  101 (380)
                      +......|....+.....+|++.+.||+|+||.||+|.+ .+++.||||++..........+.+|+.++..+. ||||++
T Consensus        11 ~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~   90 (337)
T 3ll6_A           11 SGRDQSDFVGQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ   90 (337)
T ss_dssp             ----CCSSTTCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCC
T ss_pred             ccchHHHhhcceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhh
Confidence            333444555555566677999999999999999999997 578999999998776677778899999999996 999999


Q ss_pred             EeeEEe--------cCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCC
Q 037869          102 LRGYCA--------GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH--IIHRDIK  171 (380)
Q Consensus       102 ~~~~~~--------~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~--ivHrdlk  171 (380)
                      +++++.        .....++||||+. |+|.+++... .....+++..++.++.|++.||.|||+.   +  |+|||||
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dik  165 (337)
T 3ll6_A           91 FCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKM-ESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLK  165 (337)
T ss_dssp             EEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHH-HTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCC
T ss_pred             ccccccccccccccCCceEEEEEEecC-CCHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCC
Confidence            999983        3445899999996 6999988653 1234699999999999999999999998   8  9999999


Q ss_pred             CCCeeeCCCCceEEeeccCccccCCCCcc-----------ceeccccccCccCcccc---ccCCCCccchhhhhhHHHHH
Q 037869          172 ASNVLLDSDFEPLVADFGFAKLIPEGVSH-----------MTTRVKGTLGYLAPEYA---MWGKVSESCDVYSFGILLLE  237 (380)
Q Consensus       172 p~Nill~~~~~vkl~Dfgl~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~e  237 (380)
                      |+|||++.++.+||+|||++.........           ......||+.|+|||++   .+..++.++|||||||++|+
T Consensus       166 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~e  245 (337)
T 3ll6_A          166 VENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYL  245 (337)
T ss_dssp             GGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHH
T ss_pred             cccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHH
Confidence            99999999999999999999876542211           11134589999999998   56678999999999999999


Q ss_pred             HHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          238 ILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       238 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      |++|..||.......                   ..............+..+.+||.+||+.||.+|||+.+++++|+.+
T Consensus       246 l~~g~~p~~~~~~~~-------------------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~  306 (337)
T 3ll6_A          246 LCFRQHPFEDGAKLR-------------------IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEI  306 (337)
T ss_dssp             HHHSSCCC-------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHhCCCCCcchhHHH-------------------hhcCcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            999999996532210                   0001111111122234578899999999999999999999998755

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5.4e-47  Score=347.77  Aligned_cols=257  Identities=25%  Similarity=0.353  Sum_probs=198.7

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCe---
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQ---  111 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---  111 (380)
                      ..++|++.+.||+|+||.||+|++ .+++.||||+++..   .......+.+|+.+++.++||||+++++++.....   
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~   89 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   89 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence            567999999999999999999997 67899999999753   23334578889999999999999999999876443   


Q ss_pred             -EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccC
Q 037869          112 -RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGF  190 (380)
Q Consensus       112 -~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl  190 (380)
                       .|+||||+++++|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+||+++.++.+||+|||+
T Consensus        90 ~~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~  162 (311)
T 3ork_A           90 LPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGI  162 (311)
T ss_dssp             EEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSC
T ss_pred             ccEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccC
Confidence             49999999999999999643    4699999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCc--cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccc
Q 037869          191 AKLIPEGVS--HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGK  268 (380)
Q Consensus       191 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (380)
                      +........  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ..    ....... 
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~--~~----~~~~~~~-  235 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--VA----YQHVRED-  235 (311)
T ss_dssp             C------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HH----HHHHHCC-
T ss_pred             cccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH--HH----HHHhcCC-
Confidence            987643322  12334568999999999999999999999999999999999999997533210  00    0000000 


Q ss_pred             cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                            ...........+.++.++|.+||+.||.+||++.+++.+.+
T Consensus       236 ------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l  276 (311)
T 3ork_A          236 ------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL  276 (311)
T ss_dssp             ------CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHH
T ss_pred             ------CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHH
Confidence                  00000111224478999999999999999998888887743

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=3.2e-46  Score=363.91  Aligned_cols=254  Identities=23%  Similarity=0.385  Sum_probs=202.7

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ..++|++.+.||+|+||+||+|++ .++..||+|++....  ......+.+|+.+++.++||||+++++++......|+|
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv  114 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLV  114 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            456799999999999999999997 478999999997532  23345788999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC---CceEEeeccCcc
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD---FEPLVADFGFAK  192 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~---~~vkl~Dfgl~~  192 (380)
                      ||||++|+|.+.+...    ..+++..++.++.|++.||.|||++   ||+||||||+|||++..   +.+||+|||++.
T Consensus       115 ~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~  187 (494)
T 3lij_A          115 MECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA  187 (494)
T ss_dssp             EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCe
Confidence            9999999999988643    4699999999999999999999999   99999999999999764   559999999998


Q ss_pred             ccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      .....  .......||+.|+|||++. ..|+.++||||+||++|+|++|..||.......  ....     ...+.+   
T Consensus       188 ~~~~~--~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~~-----i~~~~~---  254 (494)
T 3lij_A          188 VFENQ--KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE--ILRK-----VEKGKY---  254 (494)
T ss_dssp             ECBTT--BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-----HHHTCC---
T ss_pred             ECCCC--ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-----HHhCCC---
Confidence            76543  2234456999999999886 569999999999999999999999997643210  0000     000000   


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                         ..........+..+.+||.+||+.||.+|||+.++++|.+
T Consensus       255 ---~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~  294 (494)
T 3lij_A          255 ---TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPW  294 (494)
T ss_dssp             ---CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHH
T ss_pred             ---CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcc
Confidence               0001111234578999999999999999999999999865

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.4e-46  Score=353.40  Aligned_cols=268  Identities=21%  Similarity=0.240  Sum_probs=203.5

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEec-------
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG-------  108 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-------  108 (380)
                      ....++|++.+.||+|+||+||+|.+ .+++.||||++.....    ...+|+.+++.++||||+++++++..       
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            45678999999999999999999987 6799999999875422    22369999999999999999999843       


Q ss_pred             -------------------------------CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHH
Q 037869          109 -------------------------------TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL  157 (380)
Q Consensus       109 -------------------------------~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~L  157 (380)
                                                     ....++||||++ |+|.+.+.........+++..++.++.|++.||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           334889999998 588877764333456799999999999999999999


Q ss_pred             hhcCCCCeEecCCCCCCeeeC-CCCceEEeeccCccccCCCCccceeccccccCccCccccccC-CCCccchhhhhhHHH
Q 037869          158 HHEVTPHIIHRDIKASNVLLD-SDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILL  235 (380)
Q Consensus       158 H~~~~~~ivHrdlkp~Nill~-~~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il  235 (380)
                      |+.   ||+||||||+||+++ .++.+||+|||++.......  ......||+.|+|||++.+. .++.++||||+||++
T Consensus       158 H~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  232 (383)
T 3eb0_A          158 HSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE--PSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVF  232 (383)
T ss_dssp             HTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS--CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHH
T ss_pred             HHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC--CCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHH
Confidence            999   999999999999997 57899999999998764432  23344689999999998865 589999999999999


Q ss_pred             HHHHhCCCCCCCCCCCcccchhccchhh--------------hhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCC
Q 037869          236 LEILTGRKPIEKLPGGVKRTITEWAEPL--------------IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEP  301 (380)
Q Consensus       236 ~ell~g~~p~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P  301 (380)
                      |+|++|..||.......  .+..+....              .....+.......+....+...+.++.+||.+||+.||
T Consensus       233 ~ell~g~~pf~~~~~~~--~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP  310 (383)
T 3eb0_A          233 GELILGKPLFSGETSID--QLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEP  310 (383)
T ss_dssp             HHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSG
T ss_pred             HHHHhCCCCCCCCChHH--HHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCCh
Confidence            99999999997643211  111100000              00000111111111222334456789999999999999


Q ss_pred             CCCCCHHHHHHHhcC
Q 037869          302 EKRPNMKEVVNTLTG  316 (380)
Q Consensus       302 ~~Rps~~~ll~~l~~  316 (380)
                      .+|||+.++++|.+.
T Consensus       311 ~~R~t~~e~l~hp~f  325 (383)
T 3eb0_A          311 DLRINPYEAMAHPFF  325 (383)
T ss_dssp             GGSCCHHHHHTSGGG
T ss_pred             hhCCCHHHHhcCHHH
Confidence            999999999999764

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.1e-47  Score=342.41  Aligned_cols=252  Identities=20%  Similarity=0.343  Sum_probs=205.3

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC-CC-------cEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS-DG-------LQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD  110 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~-------~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  110 (380)
                      ..++|++.+.||+|+||+||+|.+. ++       ..||+|++..........+.+|+.+++.++||||+++++++..++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGD   85 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence            4578999999999999999999763 33       479999998766666778999999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc--------
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE--------  182 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~--------  182 (380)
                      ..++||||+++|+|.+++...   ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.        
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~  159 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPF  159 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCE
T ss_pred             CCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccce
Confidence            999999999999999999754   34599999999999999999999999   9999999999999988877        


Q ss_pred             eEEeeccCccccCCCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCC-CCCCCCCCcccchhccc
Q 037869          183 PLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRK-PIEKLPGGVKRTITEWA  260 (380)
Q Consensus       183 vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~-p~~~~~~~~~~~~~~~~  260 (380)
                      ++|+|||++.....     .....|++.|+|||++.+ ..++.++|||||||++|+|++|.. ||........      .
T Consensus       160 ~kl~Dfg~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~------~  228 (289)
T 4fvq_A          160 IKLSDPGISITVLP-----KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK------L  228 (289)
T ss_dssp             EEECCCCSCTTTSC-----HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH------H
T ss_pred             eeeccCcccccccC-----ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH------H
Confidence            99999999976532     123457899999999987 679999999999999999999554 4433221000      0


Q ss_pred             hhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCC
Q 037869          261 EPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP  319 (380)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~  319 (380)
                      .....            ....+...+..+.+|+.+||+.||.+|||+.+++++|..+..
T Consensus       229 ~~~~~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~  275 (289)
T 4fvq_A          229 QFYED------------RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFT  275 (289)
T ss_dssp             HHHHT------------TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-
T ss_pred             HHhhc------------cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            00000            011111223568899999999999999999999999987743

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6.9e-46  Score=354.03  Aligned_cols=258  Identities=22%  Similarity=0.364  Sum_probs=197.7

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--------hhhHHHHHHHHHHHhcCCCCcceeEeeEEec
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--------SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG  108 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  108 (380)
                      ...++|++.+.||+|+||+||+|.+ .+++.||||++....        ......+.+|+.+|+.++||||+++++++. 
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-  210 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-  210 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-
Confidence            4578999999999999999999987 568999999987432        111224788999999999999999999986 


Q ss_pred             CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC---CceEE
Q 037869          109 TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD---FEPLV  185 (380)
Q Consensus       109 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~---~~vkl  185 (380)
                      .+..++||||+++|+|.+++...    ..+++..++.++.|++.||+|||++   +|+||||||+|||++.+   +.+||
T Consensus       211 ~~~~~lv~e~~~~g~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl  283 (419)
T 3i6u_A          211 AEDYYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKI  283 (419)
T ss_dssp             SSEEEEEEECCTTCBGGGGTSSS----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEE
T ss_pred             cCceEEEEEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEE
Confidence            45689999999999999988643    5799999999999999999999999   99999999999999754   45999


Q ss_pred             eeccCccccCCCCccceeccccccCccCcccccc---CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchh
Q 037869          186 ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW---GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEP  262 (380)
Q Consensus       186 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  262 (380)
                      +|||+++.....  .......||+.|+|||++.+   ..|+.++|||||||++|+|++|..||........  ..    .
T Consensus       284 ~DFG~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~----~  355 (419)
T 3i6u_A          284 TDFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LK----D  355 (419)
T ss_dssp             CCSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HH----H
T ss_pred             eecccceecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HH----H
Confidence            999999876432  23345679999999999863   6788999999999999999999999975332111  00    0


Q ss_pred             hhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ....+...      .........+..+.+||.+||+.||.+|||+.++++|.+.-
T Consensus       356 ~i~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~  404 (419)
T 3i6u_A          356 QITSGKYN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ  404 (419)
T ss_dssp             HHHTTCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             HHhcCCCC------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccC
Confidence            00000000      00001112347899999999999999999999999998753

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.7e-46  Score=352.20  Aligned_cols=253  Identities=27%  Similarity=0.326  Sum_probs=199.6

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHH-HhcCCCCcceeEeeEEecCCeEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEV-LGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~-l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ..++|++.+.||+|+||.||+|++ .+++.||||+++...   ......+..|..+ ++.++||||+++++++...+.+|
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~  115 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY  115 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence            457899999999999999999987 468899999997532   2233456667776 56789999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||++||+|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.+|.+||+|||+++.
T Consensus       116 lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~  188 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKE  188 (373)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGG
T ss_pred             EEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccc
Confidence            999999999999999653    4689999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                      .... .......+||+.|+|||++.+..|+.++|||||||++|||++|..||......  ...             ..+.
T Consensus       189 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~--~~~-------------~~i~  252 (373)
T 2r5t_A          189 NIEH-NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMY-------------DNIL  252 (373)
T ss_dssp             GBCC-CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH--HHH-------------HHHH
T ss_pred             cccC-CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH--HHH-------------HHHH
Confidence            4322 22344567999999999999999999999999999999999999999653210  000             0001


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH----HHHHHHhcC
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNM----KEVVNTLTG  316 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~----~~ll~~l~~  316 (380)
                      ...  ..++...+..+.+||.+||+.||.+||++    .++++|.+.
T Consensus       253 ~~~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f  297 (373)
T 2r5t_A          253 NKP--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF  297 (373)
T ss_dssp             HSC--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGG
T ss_pred             hcc--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccc
Confidence            010  11223345789999999999999999987    588888653

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=5.4e-46  Score=343.57  Aligned_cols=262  Identities=22%  Similarity=0.295  Sum_probs=209.3

Q ss_pred             HHHhhCCCCCc-ceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCC-CCcceeEeeEEecCC
Q 037869           36 LHTATNGFSDD-NKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVR-HKNLLGLRGYCAGTD  110 (380)
Q Consensus        36 ~~~~~~~y~~~-~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~  110 (380)
                      .....++|.+. +.||+|+||+||+|.+ .+++.||+|+++...  ......+.+|+.++..+. ||||+++++++...+
T Consensus        23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~  102 (327)
T 3lm5_A           23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS  102 (327)
T ss_dssp             HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence            34567789888 8999999999999987 468999999987532  233567889999999994 699999999999999


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---CCceEEee
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS---DFEPLVAD  187 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~---~~~vkl~D  187 (380)
                      ..++||||+++|+|.+++...  ....+++..++.++.|++.||+|||++   ||+||||||+||+++.   ++.+||+|
T Consensus       103 ~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~D  177 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVD  177 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECC
T ss_pred             eEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEee
Confidence            999999999999999998643  235699999999999999999999999   9999999999999987   78999999


Q ss_pred             ccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcc
Q 037869          188 FGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKG  267 (380)
Q Consensus       188 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  267 (380)
                      ||++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||........  ..   ..     
T Consensus       178 fg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~--~~---~i-----  245 (327)
T 3lm5_A          178 FGMSRKIGHAC--ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQET--YL---NI-----  245 (327)
T ss_dssp             GGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HH---HH-----
T ss_pred             CccccccCCcc--ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HH---HH-----
Confidence            99998765322  23345689999999999999999999999999999999999999965332100  00   00     


Q ss_pred             ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                        . ..............+..+.+||.+||+.||.+|||+.++++|.+..
T Consensus       246 --~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~  292 (327)
T 3lm5_A          246 --S-QVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQ  292 (327)
T ss_dssp             --H-HTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGC
T ss_pred             --H-hcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhc
Confidence              0 0011111222234557899999999999999999999999997643

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.9e-46  Score=337.85  Aligned_cols=256  Identities=22%  Similarity=0.325  Sum_probs=204.8

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCC----CcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSD----GLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ..++|++.+.||+|+||+||+|.+..    +..||+|.+... .......+.+|+.+++.++||||+++++++.. +..+
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   88 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTW   88 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCE
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCE
Confidence            56789999999999999999997532    346999999764 34455678899999999999999999999864 5679


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||+++++|.+++...   ...+++..++.++.|++.||.|||++   |++||||||+||+++.++.++|+|||++..
T Consensus        89 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             EEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             EEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            999999999999999653   34689999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      .............+++.|+|||++.+..++.++||||||+++|+|++ |..||.........      ..          
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~------~~----------  226 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVI------GV----------  226 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHH------HH----------
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHH------HH----------
Confidence            65433323334457889999999998999999999999999999998 99999753321100      00          


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .........+...+..+.+++.+||+.||.+|||+.+++++|..+
T Consensus       227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  271 (281)
T 3cc6_A          227 LEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDV  271 (281)
T ss_dssp             HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHH
Confidence            000011122333457899999999999999999999999998643

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4.6e-46  Score=363.28  Aligned_cols=261  Identities=24%  Similarity=0.317  Sum_probs=214.0

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      .++|++.+.||+|+||.||+|++ .+|+.||+|++....   ......+.+|+.+++.++||||+++++++.....+|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            36899999999999999999997 469999999997532   12345788899999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |||++||+|.+++.........+++..++.++.||+.||.|||++   ||+||||||+|||++.+|.+||+|||++..+.
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            999999999999976544456799999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      .... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||........  ...+...         +...
T Consensus       341 ~~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~~~~---------i~~~  408 (543)
T 3c4z_A          341 AGQT-KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKELKQR---------VLEQ  408 (543)
T ss_dssp             TTCC-CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHHHHH---------HHHC
T ss_pred             CCCc-ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHHHHH---------Hhhc
Confidence            4322 23345799999999999999999999999999999999999999976432110  0000000         0000


Q ss_pred             cccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHhcCC
Q 037869          276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPN-----MKEVVNTLTGY  317 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps-----~~~ll~~l~~~  317 (380)
                        ...++...+..+.+||.+||+.||.+||+     +.+|++|.+..
T Consensus       409 --~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~  453 (543)
T 3c4z_A          409 --AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFR  453 (543)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGT
T ss_pred             --ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCcccc
Confidence              11233445678999999999999999996     58999987643

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=347.29  Aligned_cols=273  Identities=23%  Similarity=0.386  Sum_probs=212.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-----CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC--e
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-----SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD--Q  111 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~  111 (380)
                      ..++|++.+.||+|+||.||+|+.     .+++.||+|++..........+.+|+.+++.++||||+++++++...+  .
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  118 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN  118 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence            456799999999999999999983     468899999998776666778999999999999999999999986644  6


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA  191 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~  191 (380)
                      .++||||+++++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+||+++.++.++|+|||++
T Consensus       119 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          119 LKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             CEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             eEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcch
Confidence            89999999999999999754   34689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc--ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccc
Q 037869          192 KLIPEGVSH--MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKF  269 (380)
Q Consensus       192 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  269 (380)
                      .........  ......++..|+|||++.+..++.++|||||||++|+|++|..||.......................+
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            877543221  122334678899999999889999999999999999999999998642110000000000000000011


Q ss_pred             ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ...+........+..++..+.++|.+||+.||.+|||+.++++.|..+
T Consensus       273 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l  320 (326)
T 2w1i_A          273 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI  320 (326)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            111111222233445668899999999999999999999999988643

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=8.1e-47  Score=370.96  Aligned_cols=262  Identities=29%  Similarity=0.465  Sum_probs=215.4

Q ss_pred             HHHHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           34 KELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        34 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      +.+....++|++.+.||+|+||.||+|.+..+..||||+++.... ....+.+|+.+|+.++||||+++++++.. +..+
T Consensus       260 ~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~  337 (535)
T 2h8h_A          260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  337 (535)
T ss_dssp             TCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence            344556788999999999999999999988778899999986432 34578999999999999999999999875 7789


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      |||||+.+|+|.+++...  ....+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       338 lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~  412 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARL  412 (535)
T ss_dssp             EEECCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTT
T ss_pred             EeeehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEccccccee
Confidence            999999999999999642  123589999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      .............++..|+|||++.+..++.++|||||||++|||++ |..||.......   .             ...
T Consensus       413 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~---~-------------~~~  476 (535)
T 2h8h_A          413 IEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---V-------------LDQ  476 (535)
T ss_dssp             CCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH---H-------------HHH
T ss_pred             cCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---H-------------HHH
Confidence            65322222233346788999999998999999999999999999999 999997543210   0             001


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      +....+...+..++..+.+||.+||+.||++|||+.+|++.|..+.
T Consensus       477 i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          477 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            1111222334455678999999999999999999999999998764

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.9e-46  Score=339.39  Aligned_cols=259  Identities=19%  Similarity=0.222  Sum_probs=200.4

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      .-++|++.+.||+|+||.||+|.+ .+++.||+|++....   ......+.+|+.+++.++||||+++++++..++..++
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  111 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV  111 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEE
Confidence            457899999999999999999987 478899999997542   2334678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ||||+++++|.+++...    ..+++..++.++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++...
T Consensus       112 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~  184 (309)
T 2h34_A          112 DMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASAT  184 (309)
T ss_dssp             EEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----
T ss_pred             EEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccc
Confidence            99999999999999753    4689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      ............|++.|+|||++.+..++.++||||||+++|+|++|..||......   ..    .... ....     
T Consensus       185 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~----~~~~-~~~~-----  251 (309)
T 2h34_A          185 TDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VM----GAHI-NQAI-----  251 (309)
T ss_dssp             ------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HH----HHHH-HSCC-----
T ss_pred             cccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HH----HHHh-ccCC-----
Confidence            543333334456899999999999999999999999999999999999999753211   00    0000 0000     


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHhcCCC
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRP-NMKEVVNTLTGYD  318 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp-s~~~ll~~l~~~~  318 (380)
                       ......+...+..+.++|.+||+.||.+|| |++++++.|....
T Consensus       252 -~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l  295 (309)
T 2h34_A          252 -PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAAL  295 (309)
T ss_dssp             -CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTC
T ss_pred             -CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHH
Confidence             001122334456889999999999999999 9999999987653

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.3e-46  Score=347.40  Aligned_cols=256  Identities=26%  Similarity=0.415  Sum_probs=203.6

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcE----EEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQ----IAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~----vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      .++|++.+.||+|+||+||+|.+ .+++.    ||+|.+.... ......+.+|+.+++.++||||+++++++. ++..+
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~   90 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ   90 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence            46899999999999999999986 34544    7888775432 222335678999999999999999999986 56799


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||+.+|+|.+++...   ...+++..++.++.|++.||+|||+.   ||+||||||+|||++.++.+||+|||+++.
T Consensus        91 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             EEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             EEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccc
Confidence            999999999999999753   35789999999999999999999999   999999999999999999999999999988


Q ss_pred             cCCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          194 IPEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       194 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      ....... ......++..|+|||++.+..++.++|||||||++|+|++ |..||.........                .
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~----------------~  228 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVP----------------D  228 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHH----------------H
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHH----------------H
Confidence            7543222 2334557889999999999999999999999999999999 99999764321100                0


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      ..........+..++.++.+++.+||+.||.+|||+.+++++|..+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          229 LLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             HHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             HHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            11111111222334457888999999999999999999999987653

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=4.3e-46  Score=344.17  Aligned_cols=258  Identities=26%  Similarity=0.439  Sum_probs=206.3

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEE--EEEEeccc-ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQI--AVKKLKAM-NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~v--avK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  113 (380)
                      ..++|++.+.||+|+||.||+|++ .++..+  |+|.++.. .......+.+|+.+++.+ +||||+++++++...+..+
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            447899999999999999999986 456644  99988753 233445788899999999 8999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCC------------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC
Q 037869          114 IVYDYMPNLSLLSHLHGQY------------AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF  181 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~------------~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~  181 (380)
                      +||||+++|+|.+++....            .....+++..++.++.|++.||.|||++   ||+||||||+||+++.++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCC
Confidence            9999999999999997642            2234799999999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccc
Q 037869          182 EPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWA  260 (380)
Q Consensus       182 ~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~  260 (380)
                      .+||+|||++.....  ........+++.|+|||++.+..++.++|||||||++|+|++ |..||.......      ..
T Consensus       180 ~~kL~Dfg~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~~  251 (327)
T 1fvr_A          180 VAKIADFGLSRGQEV--YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LY  251 (327)
T ss_dssp             CEEECCTTCEESSCE--ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------HH
T ss_pred             eEEEcccCcCccccc--cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH------HH
Confidence            999999999975322  112223346889999999998899999999999999999998 999997543210      00


Q ss_pred             hhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          261 EPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                                ...........+...+..+.+||.+||+.||.+|||+.+++++|..+
T Consensus       252 ----------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          252 ----------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             ----------HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------HHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                      00111111223334557899999999999999999999999998754

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=7.8e-46  Score=362.02  Aligned_cols=256  Identities=25%  Similarity=0.353  Sum_probs=205.6

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh-------------hhHHHHHHHHHHHhcCCCCcceeEe
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS-------------KAEMEFAVEVEVLGRVRHKNLLGLR  103 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-------------~~~~~~~~E~~~l~~l~h~niv~~~  103 (380)
                      ...++|++.++||+|+||+||+|.+ .++..||+|++.....             .....+.+|+.+++.++||||++++
T Consensus        33 ~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~  112 (504)
T 3q5i_A           33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLF  112 (504)
T ss_dssp             CGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             CcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEE
Confidence            3568999999999999999999987 4688999999975321             2345788999999999999999999


Q ss_pred             eEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC--
Q 037869          104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF--  181 (380)
Q Consensus       104 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~--  181 (380)
                      +++......++|||||++|+|.+.+...    ..+++..++.++.|++.||+|||+.   ||+||||||+|||++.++  
T Consensus       113 ~~~~~~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~  185 (504)
T 3q5i_A          113 DVFEDKKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSL  185 (504)
T ss_dssp             EEEECSSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCC
T ss_pred             EEEEcCCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCC
Confidence            9999999999999999999999998653    4699999999999999999999999   999999999999998775  


Q ss_pred             -ceEEeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccc
Q 037869          182 -EPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWA  260 (380)
Q Consensus       182 -~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~  260 (380)
                       .+||+|||++.......  ......||+.|+|||++. ..|+.++||||+||++|+|++|..||.......  ...   
T Consensus       186 ~~~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--~~~---  257 (504)
T 3q5i_A          186 LNIKIVDFGLSSFFSKDY--KLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD--IIK---  257 (504)
T ss_dssp             SSEEECCCTTCEECCTTS--CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH---
T ss_pred             ccEEEEECCCCEEcCCCC--ccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHH---
Confidence             69999999998765432  233456999999999987 469999999999999999999999997643210  000   


Q ss_pred             hhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          261 EPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                       . ...+.+.      .........+.++.+||.+||+.||.+|||+.++++|.|.
T Consensus       258 -~-i~~~~~~------~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~  305 (504)
T 3q5i_A          258 -K-VEKGKYY------FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI  305 (504)
T ss_dssp             -H-HHHCCCC------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             -H-HHcCCCC------CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhh
Confidence             0 0000000      0000012234789999999999999999999999999664

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.3e-46  Score=347.88  Aligned_cols=264  Identities=22%  Similarity=0.275  Sum_probs=201.9

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC----
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD----  110 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----  110 (380)
                      ...++|++.+.||+|+||.||+|.+ .+|+.||||++...  .......+.+|+.+++.++||||+++++++....    
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  101 (367)
T 1cm8_A           22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDD  101 (367)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTT
T ss_pred             eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCcccc
Confidence            3568999999999999999999987 57999999999642  3344567889999999999999999999997653    


Q ss_pred             --eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          111 --QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       111 --~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                        ..|+||||+ +++|.+++..     ..+++..+..++.|++.||.|||+.   ||+||||||+||+++.++.+||+||
T Consensus       102 ~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Df  172 (367)
T 1cm8_A          102 FTDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDF  172 (367)
T ss_dssp             CCCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCC
T ss_pred             CceEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEee
Confidence              469999999 7899999865     3689999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhh--
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIV--  265 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--  265 (380)
                      |+++.....    .....+|++|+|||++.+ ..++.++||||+||++|+|++|..||.+.....  .+..+......  
T Consensus       173 g~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~~~  246 (367)
T 1cm8_A          173 GLARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD--QLKEIMKVTGTPP  246 (367)
T ss_dssp             TTCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCC
T ss_pred             ecccccccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHhcCCCC
Confidence            999875432    334568999999999887 679999999999999999999999997643211  00000000000  


Q ss_pred             --------c-------cccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          266 --------K-------GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       266 --------~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                              .       ..+...... -........+..+.+|+.+||..||.+|||+.++++|.+..
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~  312 (367)
T 1cm8_A          247 AEFVQRLQSDEAKNYMKGLPELEKK-DFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFE  312 (367)
T ss_dssp             HHHHHTCSCHHHHHHHHHSCCCCCC-CGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGT
T ss_pred             HHHHHHhhhHHHHHHHHhCCCCCCC-CHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHH
Confidence                    0       000000000 01112234457899999999999999999999999997643

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.8e-46  Score=349.12  Aligned_cols=268  Identities=22%  Similarity=0.275  Sum_probs=208.7

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ..++|++.+.||+|+||+||+|.+ .++..||+|++... .......+.+|+.+++.++||||+++++++..++..++||
T Consensus        31 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  110 (360)
T 3eqc_A           31 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM  110 (360)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEE
Confidence            356899999999999999999987 47899999999754 3444567889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH-EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~-~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      ||+++++|.+++...    ..+++..+..++.|++.||.|||+ +   ||+||||||+||+++.++.++|+|||++....
T Consensus       111 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  183 (360)
T 3eqc_A          111 EHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  183 (360)
T ss_dssp             CCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             ECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEcCCccHHHEEECCCCCEEEEECCCCcccc
Confidence            999999999999653    468999999999999999999998 5   79999999999999999999999999997653


Q ss_pred             CCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccc---------------
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWA---------------  260 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~---------------  260 (380)
                      .   .......||+.|+|||++.+..++.++|||||||++|+|++|..||...............               
T Consensus       184 ~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3eqc_A          184 D---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  260 (360)
T ss_dssp             H---HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred             c---ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence            2   2233456899999999999999999999999999999999999999753321100000000               


Q ss_pred             --------hhhhhccc----cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          261 --------EPLIVKGK----FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       261 --------~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                              ........    .................+.++.+||.+||+.||.+|||+.++++|.+.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  328 (360)
T 3eqc_A          261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI  328 (360)
T ss_dssp             -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHH
T ss_pred             CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence                    00000000    000000000111112245689999999999999999999999999763

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.9e-46  Score=342.29  Aligned_cols=266  Identities=25%  Similarity=0.362  Sum_probs=202.6

Q ss_pred             HHHHHHhhCCCCCcceeccCCceEEEEEEeC----CCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEE
Q 037869           33 YKELHTATNGFSDDNKLGEGGFGSVYWGRTS----DGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYC  106 (380)
Q Consensus        33 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  106 (380)
                      ..++....++|++.+.||+|+||.||+|.+.    ++..||+|+++..  .......+.+|+.+++.++||||+++++++
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~  105 (313)
T 3brb_A           26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVC  105 (313)
T ss_dssp             TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEE
Confidence            3444456789999999999999999999753    3558999998753  344456788999999999999999999999


Q ss_pred             ecCC-----eEEEEEEecCCCCHHHhhccCC--CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC
Q 037869          107 AGTD-----QRLIVYDYMPNLSLLSHLHGQY--AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS  179 (380)
Q Consensus       107 ~~~~-----~~~lv~e~~~~g~L~~~i~~~~--~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~  179 (380)
                      ....     ..++||||+++|+|.+++....  .....+++..++.++.|++.||.|||+.   +|+||||||+||+++.
T Consensus       106 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~  182 (313)
T 3brb_A          106 IEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRD  182 (313)
T ss_dssp             EC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECT
T ss_pred             eeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcC
Confidence            7654     3599999999999999985432  2345799999999999999999999999   9999999999999999


Q ss_pred             CCceEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchh
Q 037869          180 DFEPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTIT  257 (380)
Q Consensus       180 ~~~vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~  257 (380)
                      ++.+||+|||++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||........    
T Consensus       183 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~----  258 (313)
T 3brb_A          183 DMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEM----  258 (313)
T ss_dssp             TSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH----
T ss_pred             CCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHH----
Confidence            99999999999987643321 12223456889999999999999999999999999999999 8899875432110    


Q ss_pred             ccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          258 EWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                        ..          ..........+..++..+.++|.+||+.||.+|||+.+++++|..+
T Consensus       259 --~~----------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l  306 (313)
T 3brb_A          259 --YD----------YLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKL  306 (313)
T ss_dssp             --HH----------HHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --HH----------HHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence              00          0001111223334557899999999999999999999999998643

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=5.1e-46  Score=336.46  Aligned_cols=254  Identities=22%  Similarity=0.332  Sum_probs=204.8

Q ss_pred             hCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccCh------hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNS------KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  112 (380)
                      .++|++.+.||+|+||+||+|.+. +++.||+|+++....      .....+.+|+.+++.++||||+++++++......
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV   83 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence            467999999999999999999874 689999999875321      1356788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC----ceEEeec
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF----EPLVADF  188 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~----~vkl~Df  188 (380)
                      ++||||+++++|.+++...    ..+++..++.++.|++.||.|||+.   |++||||||+||+++.++    .++|+||
T Consensus        84 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~df  156 (283)
T 3bhy_A           84 VLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDF  156 (283)
T ss_dssp             EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCC
T ss_pred             EEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEec
Confidence            9999999999999999643    4689999999999999999999999   999999999999998876    8999999


Q ss_pred             cCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccc
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGK  268 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (380)
                      |++.......  ......|++.|+|||++.+..++.++||||||+++|+|++|..||.......  ....     .... 
T Consensus       157 g~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~-----~~~~-  226 (283)
T 3bhy_A          157 GIAHKIEAGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE--TLTN-----ISAV-  226 (283)
T ss_dssp             TTCEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHH-----HHTT-
T ss_pred             ccceeccCCC--cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH--HHHH-----hHhc-
Confidence            9998764422  2234468999999999999999999999999999999999999997533210  0000     0000 


Q ss_pred             cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                           ............+..+.+++.+||..||.+|||+.++++|.+
T Consensus       227 -----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~  268 (283)
T 3bhy_A          227 -----NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSW  268 (283)
T ss_dssp             -----CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHH
T ss_pred             -----ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHH
Confidence                 000000111223467899999999999999999999999865

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-45  Score=344.25  Aligned_cols=272  Identities=22%  Similarity=0.263  Sum_probs=202.0

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhh-----HHHHHHHHHHHhcCCCCcceeEeeEEecCC
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKA-----EMEFAVEVEVLGRVRHKNLLGLRGYCAGTD  110 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  110 (380)
                      ....++|++.+.||+|+||.||+|.+ .+++.||||++.......     ...+.+|+.+++.++||||+++++++...+
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   85 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKS   85 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCC
Confidence            44568999999999999999999997 468999999997532211     236778999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccC
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGF  190 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl  190 (380)
                      ..++||||+++ +|.+++...   ...+++..++.++.|++.||.|||+.   ||+||||||+||+++.++.+||+|||+
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~  158 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKDN---SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGL  158 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTTC---CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGG
T ss_pred             ceEEEEEcCCC-CHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEeccc
Confidence            99999999976 888888643   34688889999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhh--cc
Q 037869          191 AKLIPEGVSHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIV--KG  267 (380)
Q Consensus       191 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~  267 (380)
                      +....... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||......  .....+......  ..
T Consensus       159 a~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~--~~~~~i~~~~~~~~~~  235 (346)
T 1ua2_A          159 AKSFGSPN-RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDL--DQLTRIFETLGTPTEE  235 (346)
T ss_dssp             GSTTTSCC-CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCTT
T ss_pred             ceeccCCc-ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHHcCCCChh
Confidence            98764332 223345689999999999764 5899999999999999999999998754321  111100000000  00


Q ss_pred             cccc------ccCCcccCC-----CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          268 KFKE------LVDPKLRGD-----FDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       268 ~~~~------~~~~~~~~~-----~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      .+..      .........     .....+.++.+||.+||+.||.+|||+.++++|.+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~  297 (346)
T 1ua2_A          236 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  297 (346)
T ss_dssp             TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             hhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhc
Confidence            0000      000000000     11234578999999999999999999999999987543

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-45  Score=341.98  Aligned_cols=257  Identities=26%  Similarity=0.463  Sum_probs=203.3

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCC-----CcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSD-----GLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~-----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  112 (380)
                      ...+|++.+.||+|+||+||+|.+..     +..||+|+++.. .......+.+|+.+++.++||||+++++++...+..
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  121 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM  121 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCc
Confidence            45688889999999999999997532     245999999754 334455788999999999999999999999999999


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      ++||||+++|+|.+++...   ...+++..++.++.|++.||.|||+.   ||+||||||+||+++.++.+||+|||++.
T Consensus       122 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~  195 (333)
T 1mqb_A          122 MIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSR  195 (333)
T ss_dssp             EEEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             EEEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcch
Confidence            9999999999999999753   35699999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcc--ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhcccc
Q 037869          193 LIPEGVSH--MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKF  269 (380)
Q Consensus       193 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  269 (380)
                      ........  ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.......   .   .         
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~---~---~---------  260 (333)
T 1mqb_A          196 VLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE---V---M---------  260 (333)
T ss_dssp             ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---H---H---------
T ss_pred             hhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH---H---H---------
Confidence            76543211  1222345788999999999999999999999999999999 999996533210   0   0         


Q ss_pred             ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                       ...........+..++..+.+++.+||+.||.+||++.+++++|..+
T Consensus       261 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          261 -KAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             -HHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -HHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence             00011111223334567899999999999999999999999998654

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-45  Score=338.37  Aligned_cols=271  Identities=26%  Similarity=0.387  Sum_probs=203.0

Q ss_pred             cHHHHHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhc--CCCCcceeEeeEEecC
Q 037869           32 TYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGR--VRHKNLLGLRGYCAGT  109 (380)
Q Consensus        32 ~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~  109 (380)
                      .........++|++.+.||+|+||.||+|++. ++.||||++....   ......|.+++..  ++||||+++++++...
T Consensus        28 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~  103 (337)
T 3mdy_A           28 PLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKG  103 (337)
T ss_dssp             CHHHHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred             CcccccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence            34444556789999999999999999999885 8999999986543   2244455555555  4899999999999877


Q ss_pred             ----CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEecCCCCCCeeeCCC
Q 037869          110 ----DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV-----TPHIIHRDIKASNVLLDSD  180 (380)
Q Consensus       110 ----~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~-----~~~ivHrdlkp~Nill~~~  180 (380)
                          ...++||||+++|+|.+++...     .+++..++.++.|++.||.|||+..     .++|+||||||+|||++.+
T Consensus       104 ~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~  178 (337)
T 3mdy_A          104 TGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKN  178 (337)
T ss_dssp             CGGGCEEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTT
T ss_pred             CCCCCceEEEEeccCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCC
Confidence                7899999999999999999653     6899999999999999999999741     2279999999999999999


Q ss_pred             CceEEeeccCccccCCCCccc---eeccccccCccCccccccCCCCcc------chhhhhhHHHHHHHhC----------
Q 037869          181 FEPLVADFGFAKLIPEGVSHM---TTRVKGTLGYLAPEYAMWGKVSES------CDVYSFGILLLEILTG----------  241 (380)
Q Consensus       181 ~~vkl~Dfgl~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~il~ell~g----------  241 (380)
                      +.+||+|||++..........   .....||+.|+|||++.+..++..      +|||||||++|||++|          
T Consensus       179 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~  258 (337)
T 3mdy_A          179 GTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEY  258 (337)
T ss_dssp             SCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred             CCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccc
Confidence            999999999997764332221   224568999999999987766655      9999999999999999          


Q ss_pred             CCCCCCCCCCcccchhccchhhhhccccccccCCcccCC-CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          242 RKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGD-FDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       242 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ..||.......... ..... ...    .....+..... ....++..+.+|+.+||+.||.+|||+.+++++|..+
T Consensus       259 ~~p~~~~~~~~~~~-~~~~~-~~~----~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l  329 (337)
T 3mdy_A          259 QLPYHDLVPSDPSY-EDMRE-IVC----IKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKM  329 (337)
T ss_dssp             CCTTTTTSCSSCCH-HHHHH-HHT----TSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccHhhhcCCCCch-hhhHH-HHh----hhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHH
Confidence            55554322111000 00000 000    00011111111 1236778899999999999999999999999998754

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.7e-45  Score=335.01  Aligned_cols=258  Identities=26%  Similarity=0.379  Sum_probs=206.4

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEec
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYM  119 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  119 (380)
                      ..|.....||+|+||.||+|.+ .++..||+|.+..........+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred             cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeC
Confidence            3455566999999999999987 568899999998766666678899999999999999999999999999999999999


Q ss_pred             CCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-CCceEEeeccCccccCCCC
Q 037869          120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS-DFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       120 ~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~-~~~vkl~Dfgl~~~~~~~~  198 (380)
                      ++++|.+++... .....+++..++.++.|++.||.|||+.   |++||||||+||+++. ++.++|+|||++.......
T Consensus       102 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~  177 (295)
T 2clq_A          102 PGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN  177 (295)
T ss_dssp             SEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC--
T ss_pred             CCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCC
Confidence            999999999764 2234577899999999999999999999   9999999999999987 8999999999998764322


Q ss_pred             ccceeccccccCccCccccccCC--CCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGK--VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                       .......|++.|+|||++.+..  ++.++||||||+++|+|++|..||..........        ..      .....
T Consensus       178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~--------~~------~~~~~  242 (295)
T 2clq_A          178 -PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM--------FK------VGMFK  242 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHH--------HH------HHHHC
T ss_pred             -CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHH--------Hh------hcccc
Confidence             2233456899999999997643  8999999999999999999999996432211000        00      00001


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .....+...+..+.++|.+||+.||++|||+.++++|.+..
T Consensus       243 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~  283 (295)
T 2clq_A          243 VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLK  283 (295)
T ss_dssp             CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGC
T ss_pred             ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence            11223344557899999999999999999999999997654

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.1e-46  Score=343.14  Aligned_cols=257  Identities=24%  Similarity=0.402  Sum_probs=202.1

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcE----EEEEEecc-cChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQ----IAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~----vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  112 (380)
                      ..++|++.+.||+|+||+||+|.+ .+++.    |++|.+.. ........+.+|+.+++.++||||+++++++..+ ..
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~   91 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   91 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS-SE
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC-Cc
Confidence            357899999999999999999986 34544    57777753 2334566888999999999999999999999865 48


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      ++|++|+.+|+|.+++...   ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.
T Consensus        92 ~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~  165 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAK  165 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred             eEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence            8999999999999999754   34699999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          193 LIPEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       193 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      ........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......                +.
T Consensus       166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----------------~~  229 (327)
T 3lzb_A          166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------IS  229 (327)
T ss_dssp             --------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----------------HH
T ss_pred             EccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----------------HH
Confidence            76433221 2223346889999999999999999999999999999999 999997643211                01


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      ...........+...+.++.++|.+||+.||.+|||+.++++.|..+.
T Consensus       230 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  277 (327)
T 3lzb_A          230 SILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             HHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            111111222333445578999999999999999999999999987653

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-46  Score=351.19  Aligned_cols=258  Identities=24%  Similarity=0.311  Sum_probs=208.1

Q ss_pred             hCCCCCcceeccCCceEEEEEEe----CCCcEEEEEEecccC----hhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCC
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT----SDGLQIAVKKLKAMN----SKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTD  110 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~  110 (380)
                      .++|++.+.||+|+||+||+|++    .+++.||||+++...    ......+.+|+.+++.+ +||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            46899999999999999999987    368999999987421    12233566799999999 6999999999999999


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccC
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGF  190 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl  190 (380)
                      ..++||||+++|+|.+++...    ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~  205 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGL  205 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSE
T ss_pred             eEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCC
Confidence            999999999999999999653    4689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCccceeccccccCccCcccccc--CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccc
Q 037869          191 AKLIPEGVSHMTTRVKGTLGYLAPEYAMW--GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGK  268 (380)
Q Consensus       191 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (380)
                      ++..............||+.|+|||++.+  ..++.++|||||||++|+|++|..||........  ...+.....    
T Consensus       206 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~~~~----  279 (355)
T 1vzo_A          206 SKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRIL----  279 (355)
T ss_dssp             EEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHHH----
T ss_pred             CeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHHHHh----
Confidence            98765433334445679999999999986  3478999999999999999999999975332111  111000000    


Q ss_pred             cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhcCC
Q 037869          269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLTGY  317 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~~~  317 (380)
                             .....++...+..+.+||.+||..||.+||     |+.++++|++..
T Consensus       280 -------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~  326 (355)
T 1vzo_A          280 -------KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ  326 (355)
T ss_dssp             -------HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred             -------ccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchh
Confidence                   001123344557889999999999999999     999999998754

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-45  Score=350.05  Aligned_cols=274  Identities=20%  Similarity=0.260  Sum_probs=213.3

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC--eEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD--QRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~--~~~l  114 (380)
                      ..++|++.+.||+|+||+||+|++. +++.||||+++... ......+.+|+.+++.++||||+++++++....  ..++
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~l   86 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVL   86 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEE
Confidence            4578999999999999999999974 58999999997533 233456788999999999999999999998655  7899


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee----CCCCceEEeeccC
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLL----DSDFEPLVADFGF  190 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill----~~~~~vkl~Dfgl  190 (380)
                      ||||+++|+|.+++.... ....+++..++.++.|++.||+|||+.   ||+||||||+|||+    +.++.+||+|||+
T Consensus        87 v~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~  162 (396)
T 4eut_A           87 IMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGA  162 (396)
T ss_dssp             EECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGG
T ss_pred             EEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCC
Confidence            999999999999997542 223499999999999999999999999   99999999999999    7778899999999


Q ss_pred             ccccCCCCccceeccccccCccCcccccc--------CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCccc--chhccc
Q 037869          191 AKLIPEGVSHMTTRVKGTLGYLAPEYAMW--------GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKR--TITEWA  260 (380)
Q Consensus       191 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~--~~~~~~  260 (380)
                      ++.....  .......||+.|+|||++.+        ..++.++|||||||++|+|++|..||.........  ....+.
T Consensus       163 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  240 (396)
T 4eut_A          163 ARELEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (396)
T ss_dssp             CEECCCG--GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred             ceEccCC--CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence            9876542  23334568999999999875        56788999999999999999999999754322111  000000


Q ss_pred             hhhh----------hccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          261 EPLI----------VKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       261 ~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      ....          ..+.+.-..............+..+.+++.+||+.||++|||+.++++.+..+.
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il  308 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence            0000          000000000111223455778889999999999999999999999999876553

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.8e-45  Score=337.88  Aligned_cols=258  Identities=24%  Similarity=0.327  Sum_probs=205.6

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ...++|++.+.||+|+||.||+|.+. +++.||+|.+....  ....+.+|+.+++.++||||+++++++...+..++||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  103 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVM  103 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEe
Confidence            46689999999999999999999874 68999999997643  3347888999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++++|.+++...   ...+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.....
T Consensus       104 e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~  177 (314)
T 3com_A          104 EYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTD  177 (314)
T ss_dssp             ECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBT
T ss_pred             ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhh
Confidence            999999999998632   35789999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      ... ......|++.|+|||++.+..++.++||||||+++|+|++|..||........  .      ....    .  ...
T Consensus       178 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~------~~~~----~--~~~  242 (314)
T 3com_A          178 TMA-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA--I------FMIP----T--NPP  242 (314)
T ss_dssp             TBS-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHH--H------HHHH----H--SCC
T ss_pred             hcc-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHH--H------HHHh----c--CCC
Confidence            322 23344689999999999999999999999999999999999999975332100  0      0000    0  000


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      .....+...+..+.+||.+||+.||.+|||+.++++|.+...
T Consensus       243 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~  284 (314)
T 3com_A          243 PTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRS  284 (314)
T ss_dssp             CCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHT
T ss_pred             cccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhc
Confidence            011122334578999999999999999999999999876443

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=9.4e-47  Score=355.41  Aligned_cols=246  Identities=15%  Similarity=0.134  Sum_probs=195.1

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecc---cChhhHHHHHHHH---HHHhcCCCCcceeEe-------eE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKA---MNSKAEMEFAVEV---EVLGRVRHKNLLGLR-------GY  105 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~---~~~~~~~~~~~E~---~~l~~l~h~niv~~~-------~~  105 (380)
                      .++|++.+.||+|+||+||+|.+ .+++.||||++..   ........+.+|+   ++++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46799999999999999999997 5699999999973   3344556788999   556666899999998       66


Q ss_pred             EecCC-----------------eEEEEEEecCCCCHHHhhccCC---CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 037869          106 CAGTD-----------------QRLIVYDYMPNLSLLSHLHGQY---AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI  165 (380)
Q Consensus       106 ~~~~~-----------------~~~lv~e~~~~g~L~~~i~~~~---~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~i  165 (380)
                      +...+                 ..|+||||+ +|+|.+++....   .....+++..++.++.|++.||+|||++   ||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  227 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  227 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---Ce
Confidence            66553                 288999999 679999997531   1123345688889999999999999999   99


Q ss_pred             EecCCCCCCeeeCCCCceEEeeccCccccCCCCccceeccccccCccCccccccC-----------CCCccchhhhhhHH
Q 037869          166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG-----------KVSESCDVYSFGIL  234 (380)
Q Consensus       166 vHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~i  234 (380)
                      +||||||+|||++.++.+||+|||+++....    ......| +.|+|||++.+.           .++.++|||||||+
T Consensus       228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i  302 (377)
T 3byv_A          228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV  302 (377)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred             ecCCCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence            9999999999999999999999999986432    3344567 999999999887           89999999999999


Q ss_pred             HHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 037869          235 LLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL  314 (380)
Q Consensus       235 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l  314 (380)
                      +|||++|..||.........               .....      .....+.++.+||.+||+.||.+|||+.++++|.
T Consensus       303 l~elltg~~Pf~~~~~~~~~---------------~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp  361 (377)
T 3byv_A          303 IYWIWCADLPITKDAALGGS---------------EWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETP  361 (377)
T ss_dssp             HHHHHHSSCCC------CCS---------------GGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSH
T ss_pred             HHHHHHCCCCCcccccccch---------------hhhhh------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhCh
Confidence            99999999999654321100               00000      0122347889999999999999999999999986


Q ss_pred             c
Q 037869          315 T  315 (380)
Q Consensus       315 ~  315 (380)
                      +
T Consensus       362 ~  362 (377)
T 3byv_A          362 E  362 (377)
T ss_dssp             H
T ss_pred             H
Confidence            5

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3e-46  Score=345.86  Aligned_cols=268  Identities=24%  Similarity=0.331  Sum_probs=204.3

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      .-++|++.+.||+|+||.||+|++ .+++.||+|++....  ......+.+|+.+++.++||||+++++++...+..++|
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  102 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLV  102 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEE
Confidence            457899999999999999999987 468999999986533  23345677899999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |||+++++|.+++...    ..+++..++.++.|++.||.|||+.   ||+||||||+||+++.++.++|+|||++....
T Consensus       103 ~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  175 (331)
T 4aaa_A          103 FEFVDHTILDDLELFP----NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA  175 (331)
T ss_dssp             EECCSEEHHHHHHHST----TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC----
T ss_pred             EecCCcchHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeec
Confidence            9999998888876533    4699999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccc-----------hhh
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWA-----------EPL  263 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~-----------~~~  263 (380)
                      ... .......|++.|+|||++.+. .++.++|||||||++|+|++|..||........  ...+.           ...
T Consensus       176 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~  252 (331)
T 4aaa_A          176 APG-EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQ--LYHIMMCLGNLIPRHQELF  252 (331)
T ss_dssp             ---------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCSCCHHHHHHH
T ss_pred             CCc-cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHHHhCCCChhhhhHh
Confidence            322 223345689999999999875 789999999999999999999999976432110  00000           000


Q ss_pred             hhccccccccCCcccCC-----CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          264 IVKGKFKELVDPKLRGD-----FDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       264 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .....+.....+.....     .....+..+.+||.+||+.||.+|||+.++++|.+.
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f  310 (331)
T 4aaa_A          253 NKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF  310 (331)
T ss_dssp             HHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred             hhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchh
Confidence            00000000111111111     112345789999999999999999999999999763

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3e-46  Score=345.19  Aligned_cols=261  Identities=28%  Similarity=0.407  Sum_probs=207.2

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe------CCCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT------SDGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD  110 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  110 (380)
                      ...++|++.+.||+|+||.||+|.+      .++..||||++... .......+.+|+.+++.++||||+++++++....
T Consensus        27 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           27 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             CCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            4668999999999999999999973      35778999999743 3445567889999999999999999999999999


Q ss_pred             eEEEEEEecCCCCHHHhhccCCC---CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---CCceE
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYA---GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS---DFEPL  184 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~---~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~---~~~vk  184 (380)
                      ..++||||+++++|.+++.....   ....+++..++.++.|++.||.|||+.   ||+||||||+||+++.   +..++
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEE
Confidence            99999999999999999976432   224589999999999999999999999   9999999999999984   45699


Q ss_pred             EeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchh
Q 037869          185 VADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP  262 (380)
Q Consensus       185 l~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~  262 (380)
                      |+|||++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.......   .   .. 
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~---~---~~-  256 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE---V---LE-  256 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---H---HH-
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH---H---HH-
Confidence            999999976533221 22233457899999999998999999999999999999998 999996532110   0   00 


Q ss_pred             hhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                               ..........+..++..+.++|.+||+.||.+|||+.+++++|+..
T Consensus       257 ---------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          257 ---------FVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             ---------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------HHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence                     0001111122334557899999999999999999999999998755

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.3e-46  Score=339.66  Aligned_cols=254  Identities=30%  Similarity=0.469  Sum_probs=199.1

Q ss_pred             hCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEec
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYM  119 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  119 (380)
                      .++|++.+.||+|+||+||+|.+. ++.||+|++...  .....+.+|+.++++++||||+++++++.  +..++||||+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~   81 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYA   81 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcC
Confidence            468999999999999999999885 788999999754  34567889999999999999999999876  4589999999


Q ss_pred             CCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc-eEEeeccCccccCCCC
Q 037869          120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE-PLVADFGFAKLIPEGV  198 (380)
Q Consensus       120 ~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~-vkl~Dfgl~~~~~~~~  198 (380)
                      ++|+|.+++.... ....+++..++.++.|++.||+|||+....||+||||||+||+++.++. +||+|||++...... 
T Consensus        82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-  159 (307)
T 2eva_A           82 EGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-  159 (307)
T ss_dssp             TTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-
Confidence            9999999997542 2235789999999999999999999932229999999999999998876 799999999765432 


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                         .....||+.|+|||++.+..++.++||||||+++|+|++|..||............    . ..         ....
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~----~-~~---------~~~~  222 (307)
T 2eva_A          160 ---MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMW----A-VH---------NGTR  222 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHH----H-HH---------TTCC
T ss_pred             ---cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHH----H-Hh---------cCCC
Confidence               22345899999999999999999999999999999999999999754321110000    0 00         0111


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .......+..+.+++.+||+.||.+|||+.+++++|..+
T Consensus       223 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  261 (307)
T 2eva_A          223 PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHL  261 (307)
T ss_dssp             CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            122234457889999999999999999999999998754

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.3e-46  Score=344.63  Aligned_cols=269  Identities=22%  Similarity=0.292  Sum_probs=205.7

Q ss_pred             cceeccHHHHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcC-CCCcceeEee
Q 037869           27 TWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRG  104 (380)
Q Consensus        27 ~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~  104 (380)
                      +...+...++....++|++.+.||+|+||.||+|++ .+++.||||++..... ....+.+|+.+++.+ +||||+++++
T Consensus        10 ~~~~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~   88 (326)
T 2x7f_A           10 SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYG   88 (326)
T ss_dssp             ------CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEE
T ss_pred             cchhccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeee
Confidence            344555566667889999999999999999999987 5789999999975432 345788999999998 7999999999


Q ss_pred             EEec------CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC
Q 037869          105 YCAG------TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLD  178 (380)
Q Consensus       105 ~~~~------~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~  178 (380)
                      ++..      .+..++||||+++|+|.+++....  ...+++..++.++.|++.||.|||+.   |++||||||+||+++
T Consensus        89 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~  163 (326)
T 2x7f_A           89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLT  163 (326)
T ss_dssp             EEEECC--CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEC
T ss_pred             EEeeccCccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEc
Confidence            9976      567999999999999999997542  34689999999999999999999999   999999999999999


Q ss_pred             CCCceEEeeccCccccCCCCccceeccccccCccCccccc-----cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcc
Q 037869          179 SDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM-----WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVK  253 (380)
Q Consensus       179 ~~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  253 (380)
                      .++.++|+|||++....... .......|++.|+|||++.     +..++.++|||||||++|+|++|..||....... 
T Consensus       164 ~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-  241 (326)
T 2x7f_A          164 ENAEVKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR-  241 (326)
T ss_dssp             TTCCEEECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH-
T ss_pred             CCCCEEEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-
Confidence            99999999999998764322 1223446899999999987     5678999999999999999999999996533210 


Q ss_pred             cchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          254 RTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                       ...    . ....        ..........+..+.+||.+||..||.+|||+.++++|.+..
T Consensus       242 -~~~----~-~~~~--------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~  291 (326)
T 2x7f_A          242 -ALF----L-IPRN--------PAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIR  291 (326)
T ss_dssp             -HHH----H-HHHS--------CCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHH
T ss_pred             -HHH----H-hhcC--------ccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHh
Confidence             000    0 0000        001111223347889999999999999999999999986643

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.8e-46  Score=346.19  Aligned_cols=265  Identities=25%  Similarity=0.392  Sum_probs=212.2

Q ss_pred             HHHHhhCCCCCcceeccCCceEEEEEEeC-CC-----cEEEEEEecccC-hhhHHHHHHHHHHHhcC-CCCcceeEeeEE
Q 037869           35 ELHTATNGFSDDNKLGEGGFGSVYWGRTS-DG-----LQIAVKKLKAMN-SKAEMEFAVEVEVLGRV-RHKNLLGLRGYC  106 (380)
Q Consensus        35 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~-----~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~  106 (380)
                      .+....++|++.+.||+|+||+||+|.+. ++     ..||+|.+.... ......+.+|+.+++.+ +||||+++++++
T Consensus        40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            34556789999999999999999999863 23     479999997543 34456788999999999 899999999999


Q ss_pred             ecCCeEEEEEEecCCCCHHHhhccCCC----------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCee
Q 037869          107 AGTDQRLIVYDYMPNLSLLSHLHGQYA----------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVL  176 (380)
Q Consensus       107 ~~~~~~~lv~e~~~~g~L~~~i~~~~~----------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nil  176 (380)
                      ...+..++||||+++|+|.+++.....          ....+++..++.++.|++.||+|||+.   ||+||||||+||+
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl  196 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL  196 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCE
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEE
Confidence            999999999999999999999864311          134689999999999999999999999   9999999999999


Q ss_pred             eCCCCceEEeeccCccccCCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCccc
Q 037869          177 LDSDFEPLVADFGFAKLIPEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKR  254 (380)
Q Consensus       177 l~~~~~vkl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~  254 (380)
                      ++.++.++|+|||++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||........ 
T Consensus       197 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~-  275 (333)
T 2i1m_A          197 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK-  275 (333)
T ss_dssp             EEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH-
T ss_pred             ECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHH-
Confidence            999999999999999865432221 2233456889999999999999999999999999999998 9999975432110 


Q ss_pred             chhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          255 TITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                       .             ............+...+..+.+++.+||+.||.+|||+.+++++|...
T Consensus       276 -~-------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  324 (333)
T 2i1m_A          276 -F-------------YKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQ  324 (333)
T ss_dssp             -H-------------HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -H-------------HHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHH
Confidence             0             001111111122333457899999999999999999999999998643

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.2e-45  Score=334.36  Aligned_cols=251  Identities=25%  Similarity=0.392  Sum_probs=208.7

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|++....   ......+.+|+.+++.++||||+++++++...+..++
T Consensus        12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   91 (284)
T 2vgo_A           12 TIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYL   91 (284)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEE
Confidence            3468999999999999999999874 68889999986432   1224578889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ||||+++++|.+++...    ..+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++...
T Consensus        92 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~  164 (284)
T 2vgo_A           92 MLEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHA  164 (284)
T ss_dssp             EECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccC
Confidence            99999999999999653    4689999999999999999999999   9999999999999999999999999999765


Q ss_pred             CCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      ...   ......|++.|+|||++.+..++.++||||||+++|+|++|..||.......  ..    .         .+..
T Consensus       165 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~----~---------~~~~  226 (284)
T 2vgo_A          165 PSL---RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE--TH----R---------RIVN  226 (284)
T ss_dssp             SSS---CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH----H---------HHHT
T ss_pred             ccc---ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH--HH----H---------HHhc
Confidence            432   2234568999999999999999999999999999999999999997532110  00    0         0000


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .  ...++...+..+.++|.+||+.||.+|||+.++++|.+.
T Consensus       227 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~  266 (284)
T 2vgo_A          227 V--DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWV  266 (284)
T ss_dssp             T--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHH
T ss_pred             c--ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHH
Confidence            0  112233445788999999999999999999999998664

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=3.2e-46  Score=337.06  Aligned_cols=259  Identities=29%  Similarity=0.394  Sum_probs=202.4

Q ss_pred             ccHHHHHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecC-
Q 037869           31 FTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT-  109 (380)
Q Consensus        31 ~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-  109 (380)
                      |....+....++|++.+.||+|+||+||++.+. ++.||+|+++...  ....+.+|+.+++.++||||+++++++... 
T Consensus        11 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   87 (278)
T 1byg_A           11 FYRSGWALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEK   87 (278)
T ss_dssp             ----CCBCCGGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC-
T ss_pred             hhhccccCChhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            333333446689999999999999999999874 8899999997643  445788999999999999999999997554 


Q ss_pred             CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeecc
Q 037869          110 DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG  189 (380)
Q Consensus       110 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfg  189 (380)
                      +..++||||+++++|.+++...  ....+++..++.++.|++.||+|||++   +++||||||+||+++.++.++|+|||
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg  162 (278)
T 1byg_A           88 GGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFG  162 (278)
T ss_dssp             -CCEEEECCCTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred             CceEEEEecCCCCCHHHHHHhc--ccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecc
Confidence            4789999999999999999653  122488999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccc
Q 037869          190 FAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGK  268 (380)
Q Consensus       190 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (380)
                      ++......    .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.......  .             
T Consensus       163 ~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~-------------  223 (278)
T 1byg_A          163 LTKEASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--V-------------  223 (278)
T ss_dssp             C----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG--H-------------
T ss_pred             cccccccc----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH--H-------------
Confidence            99865432    122357889999999999999999999999999999998 999997543210  0             


Q ss_pred             cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                       ............+...+..+.++|.+||+.||.+|||+.++++.|..+
T Consensus       224 -~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i  271 (278)
T 1byg_A          224 -VPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI  271 (278)
T ss_dssp             -HHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -HHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHH
Confidence             001111112233445567899999999999999999999999988643

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5e-46  Score=339.65  Aligned_cols=260  Identities=22%  Similarity=0.286  Sum_probs=206.4

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ...++|++.+.||+|+||.||+|.+. ++..||+|++..........+.+|+.+++.++||||+++++++..++..++||
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   95 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMI   95 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEE
Confidence            46789999999999999999999984 68999999998766666678899999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++++|.+++...   ...+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++.....
T Consensus        96 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  169 (302)
T 2j7t_A           96 EFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK  169 (302)
T ss_dssp             ECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH
T ss_pred             EeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccc
Confidence            999999999988642   24689999999999999999999999   999999999999999999999999998764321


Q ss_pred             CCccceeccccccCccCcccc-----ccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYA-----MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      . ........|++.|+|||++     .+..++.++||||||+++|+|++|..||.......  ...    . .....   
T Consensus       170 ~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~----~-~~~~~---  238 (302)
T 2j7t_A          170 T-LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLL----K-IAKSD---  238 (302)
T ss_dssp             H-HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH--HHH----H-HHHSC---
T ss_pred             c-ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH--HHH----H-HhccC---
Confidence            1 1112334689999999998     36678999999999999999999999997543210  000    0 00000   


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                          ......+...+..+.++|.+||+.||.+|||+.++++|.+...
T Consensus       239 ----~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  281 (302)
T 2j7t_A          239 ----PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS  281 (302)
T ss_dssp             ----CCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTT
T ss_pred             ----CcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhh
Confidence                0011122344578999999999999999999999999976543

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.1e-45  Score=346.22  Aligned_cols=276  Identities=18%  Similarity=0.247  Sum_probs=205.5

Q ss_pred             ccHHHHHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccC-----------hhhHHHHHHHHHHHhcCCCCcc
Q 037869           31 FTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMN-----------SKAEMEFAVEVEVLGRVRHKNL   99 (380)
Q Consensus        31 ~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~-----------~~~~~~~~~E~~~l~~l~h~ni   99 (380)
                      ....++....++|++.+.||+|+||.||+|.+.++..||||++....           ......+.+|+.+++.++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            34678889999999999999999999999998889999999986422           1223678899999999999999


Q ss_pred             eeEeeEEec-----CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 037869          100 LGLRGYCAG-----TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASN  174 (380)
Q Consensus       100 v~~~~~~~~-----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~N  174 (380)
                      +++++++..     ....|+||||+. |+|.+.+...   ...+++..++.++.|++.||.|||+.   ||+||||||+|
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~N  164 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ---RIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGN  164 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGG
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHH
Confidence            999999843     346899999997 5888888643   35799999999999999999999999   99999999999


Q ss_pred             eeeCCCCceEEeeccCccccCCCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcc
Q 037869          175 VLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVK  253 (380)
Q Consensus       175 ill~~~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  253 (380)
                      |+++.++.+||+|||++......  .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||....... 
T Consensus       165 Il~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-  241 (362)
T 3pg1_A          165 ILLADNNDITICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN-  241 (362)
T ss_dssp             EEECTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-
T ss_pred             EEEcCCCCEEEEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHH-
Confidence            99999999999999999765432  22334568999999999886 679999999999999999999999997543110 


Q ss_pred             cchhccchhhh----------hccccccccCC-------cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          254 RTITEWAEPLI----------VKGKFKELVDP-------KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       254 ~~~~~~~~~~~----------~~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                       ....+.....          ...........       ..........+..+.+||.+||+.||.+|||+.++++|.+.
T Consensus       242 -~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f  320 (362)
T 3pg1_A          242 -QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYF  320 (362)
T ss_dssp             -HHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             -HHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchh
Confidence             0000000000          00000000000       00011122335678999999999999999999999999774


Q ss_pred             C
Q 037869          317 Y  317 (380)
Q Consensus       317 ~  317 (380)
                      -
T Consensus       321 ~  321 (362)
T 3pg1_A          321 E  321 (362)
T ss_dssp             T
T ss_pred             h
Confidence            3

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.1e-45  Score=344.67  Aligned_cols=271  Identities=21%  Similarity=0.322  Sum_probs=203.3

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEec--------
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG--------  108 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------  108 (380)
                      .++|++.+.||+|+||+||+|++ .+++.||+|++....  ......+.+|+.+++.++||||+++++++..        
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            46899999999999999999997 578999999986432  2223467789999999999999999999876        


Q ss_pred             CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          109 TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       109 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                      .+..++||||+++ +|.+.+...   ...+++..++.++.|++.||+|||+.   ||+||||||+|||++.++.+||+||
T Consensus        96 ~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Df  168 (351)
T 3mi9_A           96 KGSIYLVFDFCEH-DLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  168 (351)
T ss_dssp             -CEEEEEEECCSE-EHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCC-CHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccc
Confidence            3468999999975 777777543   24699999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCC---ccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhc-cc---
Q 037869          189 GFAKLIPEGV---SHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITE-WA---  260 (380)
Q Consensus       189 gl~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~-~~---  260 (380)
                      |++..+....   ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||............. ..   
T Consensus       169 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~  248 (351)
T 3mi9_A          169 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI  248 (351)
T ss_dssp             TTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             hhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9998764322   122334568999999999876 568999999999999999999999997643211000000 00   


Q ss_pred             ----hhhhhccccccccC--CcccCCCCHH-----HHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          261 ----EPLIVKGKFKELVD--PKLRGDFDEN-----QLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       261 ----~~~~~~~~~~~~~~--~~~~~~~~~~-----~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                          .+............  ..........     .+..+.+||.+||+.||.+|||+.++++|.+..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  316 (351)
T 3mi9_A          249 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW  316 (351)
T ss_dssp             CTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred             ChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcC
Confidence                00000000000000  0000000000     135688999999999999999999999998754

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.8e-45  Score=334.78  Aligned_cols=253  Identities=23%  Similarity=0.325  Sum_probs=210.0

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++...   .......+.+|+.+++.++||||+++++++...+..++
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l   92 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV   92 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence            4568999999999999999999974 6889999998643   33455678889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ||||+++++|.+++...    ..+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++...
T Consensus        93 v~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  165 (294)
T 2rku_A           93 VLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV  165 (294)
T ss_dssp             EEECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceec
Confidence            99999999999988643    4689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      ..... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.......  ..             .....
T Consensus       166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~-------------~~~~~  229 (294)
T 2rku_A          166 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--TY-------------LRIKK  229 (294)
T ss_dssp             CSTTC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH-------------HHHHT
T ss_pred             ccCcc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HH-------------HHHhh
Confidence            43222 2333568999999999999899999999999999999999999997532110  00             00000


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .  ....+...+..+.+++.+||+.||++|||+.++++|.+.
T Consensus       230 ~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~  269 (294)
T 2rku_A          230 N--EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF  269 (294)
T ss_dssp             T--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred             c--cCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChhe
Confidence            0  011223345688999999999999999999999998653

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=8.7e-46  Score=336.49  Aligned_cols=260  Identities=25%  Similarity=0.391  Sum_probs=207.9

Q ss_pred             HHHHHhhCCCCCcc-eeccCCceEEEEEEe---CCCcEEEEEEecccC--hhhHHHHHHHHHHHhcCCCCcceeEeeEEe
Q 037869           34 KELHTATNGFSDDN-KLGEGGFGSVYWGRT---SDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGRVRHKNLLGLRGYCA  107 (380)
Q Consensus        34 ~~~~~~~~~y~~~~-~Lg~G~~g~Vy~~~~---~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  107 (380)
                      .++....++|++.+ .||+|+||+||+|.+   .+++.||||+++...  ......+.+|+.+++.++||||+++++++ 
T Consensus         9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-   87 (291)
T 1xbb_A            9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-   87 (291)
T ss_dssp             --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred             ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence            34445567899888 999999999999953   347889999997532  23356788999999999999999999999 


Q ss_pred             cCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEee
Q 037869          108 GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD  187 (380)
Q Consensus       108 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~D  187 (380)
                      ..+..++||||+++++|.+++...    ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.++|+|
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~D  160 (291)
T 1xbb_A           88 EAESWMLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISD  160 (291)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECC
T ss_pred             CCCCcEEEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEcc
Confidence            567789999999999999999753    4689999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccCCCCccc--eeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhh
Q 037869          188 FGFAKLIPEGVSHM--TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLI  264 (380)
Q Consensus       188 fgl~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~  264 (380)
                      ||++..........  .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.......   .        
T Consensus       161 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~--------  229 (291)
T 1xbb_A          161 FGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---V--------  229 (291)
T ss_dssp             CTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---H--------
T ss_pred             CCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---H--------
Confidence            99998765433221  222346788999999998889999999999999999999 999997643210   0        


Q ss_pred             hccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          265 VKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                           ............+..++..+.++|.+||+.||.+|||+.++++.|..+
T Consensus       230 -----~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  277 (291)
T 1xbb_A          230 -----TAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY  277 (291)
T ss_dssp             -----HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -----HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                 000111112223445567899999999999999999999999998654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=9.2e-46  Score=347.04  Aligned_cols=266  Identities=18%  Similarity=0.192  Sum_probs=202.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCC------CcEEEEEEecccChhhH-----------HHHHHHHHHHhcCCCCccee
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSD------GLQIAVKKLKAMNSKAE-----------MEFAVEVEVLGRVRHKNLLG  101 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~-----------~~~~~E~~~l~~l~h~niv~  101 (380)
                      ..++|++.+.||+|+||+||+|.+..      ++.||||++........           .....|+..++.++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            55699999999999999999998743      47899999876432211           12344666788889999999


Q ss_pred             EeeEEecC----CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 037869          102 LRGYCAGT----DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLL  177 (380)
Q Consensus       102 ~~~~~~~~----~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill  177 (380)
                      +++++...    ...++||||+ +++|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||+
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill  185 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLL  185 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEE
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEE
Confidence            99998764    4589999999 99999999753   35799999999999999999999999   99999999999999


Q ss_pred             C--CCCceEEeeccCccccCCCCcc------ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCC
Q 037869          178 D--SDFEPLVADFGFAKLIPEGVSH------MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLP  249 (380)
Q Consensus       178 ~--~~~~vkl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~  249 (380)
                      +  .++.+||+|||+++.+......      ......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus       186 ~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~  265 (364)
T 3op5_A          186 NYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL  265 (364)
T ss_dssp             ESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             ecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence            8  8899999999999876432111      1123459999999999999999999999999999999999999997533


Q ss_pred             CCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          250 GGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ......  ..... .....+..+..+.+.   ....+.++.+++..||+.||.+||++.+|++.|...
T Consensus       266 ~~~~~~--~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~  327 (364)
T 3op5_A          266 KDPKYV--RDSKI-RYRENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQG  327 (364)
T ss_dssp             TCHHHH--HHHHH-HHHHCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cCHHHH--HHHHH-HhhhhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHH
Confidence            221110  00000 000111111111110   122347899999999999999999999999987643

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5e-46  Score=346.34  Aligned_cols=266  Identities=18%  Similarity=0.190  Sum_probs=199.9

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC----CCcEEEEEEecccChhh-----------HHHHHHHHHHHhcCCCCcceeEe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS----DGLQIAVKKLKAMNSKA-----------EMEFAVEVEVLGRVRHKNLLGLR  103 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~-----------~~~~~~E~~~l~~l~h~niv~~~  103 (380)
                      ..++|++.+.||+|+||+||+|.+.    ++..||+|++.......           ...+.+|+..++.++||||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            3468999999999999999999874    57889999987543211           12356788899999999999999


Q ss_pred             eEEec----CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC
Q 037869          104 GYCAG----TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS  179 (380)
Q Consensus       104 ~~~~~----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~  179 (380)
                      +++..    ....|+||||+ +++|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+|||++.
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~  186 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGY  186 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEES
T ss_pred             cccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEcc
Confidence            99987    67899999999 99999999754    3799999999999999999999999   9999999999999988


Q ss_pred             CC--ceEEeeccCccccCCCCc------cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCC
Q 037869          180 DF--EPLVADFGFAKLIPEGVS------HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGG  251 (380)
Q Consensus       180 ~~--~vkl~Dfgl~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  251 (380)
                      ++  .+||+|||+++.+.....      .......||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus       187 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~  266 (345)
T 2v62_A          187 KNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKD  266 (345)
T ss_dssp             SSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTC
T ss_pred             CCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccc
Confidence            77  999999999987643211      1123456899999999999999999999999999999999999999643221


Q ss_pred             cccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          252 VKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      ....... ....  ...+.......   ......+..+.++|.+||+.||.+|||+.+|++.|....
T Consensus       267 ~~~~~~~-~~~~--~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          267 PVAVQTA-KTNL--LDELPQSVLKW---APSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHHHHHH-HHHH--HHTTTHHHHHH---SCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             cHHHHHH-HHhh--cccccHHHHhh---ccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            1110000 0000  00000000000   000134468999999999999999999999999998654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=2.5e-45  Score=344.11  Aligned_cols=259  Identities=22%  Similarity=0.358  Sum_probs=208.1

Q ss_pred             HHHhhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccCh--------hhHHHHHHHHHHHhcC-CCCcceeEeeE
Q 037869           36 LHTATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNS--------KAEMEFAVEVEVLGRV-RHKNLLGLRGY  105 (380)
Q Consensus        36 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l-~h~niv~~~~~  105 (380)
                      .....++|++.+.||+|+||.||+|.+. +|+.||||+++....        .....+.+|+.+++.+ +||||++++++
T Consensus        89 ~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  168 (365)
T 2y7j_A           89 AKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDS  168 (365)
T ss_dssp             HHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred             hhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            3445678999999999999999999984 799999999875321        1234677899999998 79999999999


Q ss_pred             EecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEE
Q 037869          106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV  185 (380)
Q Consensus       106 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl  185 (380)
                      +......++||||++|++|.+++...    ..+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|
T Consensus       169 ~~~~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl  241 (365)
T 2y7j_A          169 YESSSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRL  241 (365)
T ss_dssp             EEBSSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEE
T ss_pred             EeeCCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEE
Confidence            99999999999999999999999643    4699999999999999999999999   9999999999999999999999


Q ss_pred             eeccCccccCCCCccceeccccccCccCcccccc------CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhcc
Q 037869          186 ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW------GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEW  259 (380)
Q Consensus       186 ~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~  259 (380)
                      +|||++..+....  ......||+.|+|||++.+      ..++.++|||||||++|+|++|..||.......  ...  
T Consensus       242 ~DfG~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~--~~~--  315 (365)
T 2y7j_A          242 SDFGFSCHLEPGE--KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL--MLR--  315 (365)
T ss_dssp             CCCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH--
T ss_pred             EecCcccccCCCc--ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH--HHH--
Confidence            9999998765432  2334578999999999863      358999999999999999999999996532100  000  


Q ss_pred             chhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          260 AEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                         ....+...      .........+..+.++|.+||+.||.+|||+.++++|.+.
T Consensus       316 ---~i~~~~~~------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f  363 (365)
T 2y7j_A          316 ---MIMEGQYQ------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFF  363 (365)
T ss_dssp             ---HHHHTCCC------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             ---HHHhCCCC------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccc
Confidence               00000000      0000001234678999999999999999999999999763

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.7e-45  Score=343.02  Aligned_cols=264  Identities=24%  Similarity=0.270  Sum_probs=197.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC-----
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD-----  110 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----  110 (380)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||++...  .......+.+|+.+++.++||||+++++++...+     
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~  102 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  102 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTC
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccc
Confidence            457899999999999999999987 46899999999752  3344567889999999999999999999997654     


Q ss_pred             -eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeecc
Q 037869          111 -QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG  189 (380)
Q Consensus       111 -~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfg  189 (380)
                       ..|+||||+++ +|.+.+..      .+++..+..++.|++.||.|||+.   ||+||||||+|||++.++.+||+|||
T Consensus       103 ~~~~lv~e~~~~-~l~~~~~~------~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg  172 (371)
T 2xrw_A          103 QDVYIVMELMDA-NLCQVIQM------ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  172 (371)
T ss_dssp             CEEEEEEECCSE-EHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred             cceEEEEEcCCC-CHHHHHhh------ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEee
Confidence             78999999975 78888852      488999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccch--------
Q 037869          190 FAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE--------  261 (380)
Q Consensus       190 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~--------  261 (380)
                      ++......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+......  ...+..        
T Consensus       173 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~i~~~~~~~~~~  248 (371)
T 2xrw_A          173 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ--WNKVIEQLGTPCPE  248 (371)
T ss_dssp             C------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHC-CCCCCHH
T ss_pred             cccccccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHHhCCCCHH
Confidence            99875432  223345689999999999999999999999999999999999999976432100  000000        


Q ss_pred             ----------hhhhc------cccccccCCccc---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          262 ----------PLIVK------GKFKELVDPKLR---GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       262 ----------~~~~~------~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                                .....      ..+.........   .......+.++.+||.+||..||.+|||++++++|.+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~  322 (371)
T 2xrw_A          249 FMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYI  322 (371)
T ss_dssp             HHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred             HHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcch
Confidence                      00000      000000000000   01112346789999999999999999999999999764

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=8.8e-46  Score=335.99  Aligned_cols=259  Identities=21%  Similarity=0.260  Sum_probs=193.2

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhh-HHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKA-EMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ..++|++.+.||+|+||+||+|.+ .+++.||+|+++... ... ...+..+...++.++||||+++++++...+..++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv   84 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWIC   84 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEE
Confidence            567899999999999999999997 578999999997542 222 22344455568888999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |||++ |+|.+++.........+++..++.++.|++.||+|||+..  |++||||||+||+++.++.+||+|||++....
T Consensus        85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~  161 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV  161 (290)
T ss_dssp             EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred             Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence            99997 4888877653334567999999999999999999999842  89999999999999999999999999998764


Q ss_pred             CCCccceeccccccCccCcccc----ccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYA----MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      ...  ......||+.|+|||++    .+..++.++|||||||++|+|++|..||........ ..             ..
T Consensus       162 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~-------------~~  225 (290)
T 3fme_A          162 DDV--AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQ-QL-------------KQ  225 (290)
T ss_dssp             ----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHH-HH-------------HH
T ss_pred             ccc--cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHH-HH-------------HH
Confidence            432  22334689999999996    466789999999999999999999999965322110 00             00


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ..............+.++.+++.+||+.||.+|||+.++++|.+.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f  270 (290)
T 3fme_A          226 VVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFF  270 (290)
T ss_dssp             HHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred             HhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCccc
Confidence            001111111122345789999999999999999999999998663

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=7.9e-45  Score=337.57  Aligned_cols=268  Identities=24%  Similarity=0.348  Sum_probs=208.5

Q ss_pred             cHHHHHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhc--CCCCcceeEeeEEecC
Q 037869           32 TYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGR--VRHKNLLGLRGYCAGT  109 (380)
Q Consensus        32 ~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~~~~~~~~~  109 (380)
                      +........++|++.+.||+|+||.||+|.+ +++.||||++...   ....+.+|.+++..  ++||||+++++++...
T Consensus        33 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~  108 (342)
T 1b6c_B           33 PLLVQRTIARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKD  108 (342)
T ss_dssp             CHHHHHHHHHHCEEEEEEEEETTEEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECC
T ss_pred             ceeecccccccEEEEeeecCCCCcEEEEEEE-cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeeccc
Confidence            3433455678999999999999999999988 4899999999753   23466778888876  7899999999999877


Q ss_pred             C----eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHh--------hcCCCCeEecCCCCCCeee
Q 037869          110 D----QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH--------HEVTPHIIHRDIKASNVLL  177 (380)
Q Consensus       110 ~----~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH--------~~~~~~ivHrdlkp~Nill  177 (380)
                      .    ..++||||+++|+|.+++...     .+++..++.++.|++.||+|||        +.   +|+||||||+||++
T Consensus       109 ~~~~~~~~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll  180 (342)
T 1b6c_B          109 NGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILV  180 (342)
T ss_dssp             CSSCCCEEEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEE
T ss_pred             CCccceeEEEEeecCCCcHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEE
Confidence            6    799999999999999999653     6899999999999999999999        77   99999999999999


Q ss_pred             CCCCceEEeeccCccccCCCCcc---ceeccccccCccCccccccC------CCCccchhhhhhHHHHHHHhC-------
Q 037869          178 DSDFEPLVADFGFAKLIPEGVSH---MTTRVKGTLGYLAPEYAMWG------KVSESCDVYSFGILLLEILTG-------  241 (380)
Q Consensus       178 ~~~~~vkl~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~ell~g-------  241 (380)
                      +.++.+||+|||++.........   ......||+.|+|||++.+.      .++.++|||||||++|+|++|       
T Consensus       181 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~  260 (342)
T 1b6c_B          181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH  260 (342)
T ss_dssp             CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC
T ss_pred             CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc
Confidence            99999999999999876543322   22345689999999999865      344789999999999999999       


Q ss_pred             ---CCCCCCCCCCcccchhccchhhhhccccccccCCcccCC-CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          242 ---RKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGD-FDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       242 ---~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                         ..||......... ...+... ..    .....+..... .....+..+.+|+.+||+.||.+|||+.+++++|..+
T Consensus       261 ~~~~~p~~~~~~~~~~-~~~~~~~-~~----~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i  334 (342)
T 1b6c_B          261 EDYQLPYYDLVPSDPS-VEEMRKV-VC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  334 (342)
T ss_dssp             CCCCCTTTTTSCSSCC-HHHHHHH-HT----TSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cccccCccccCcCccc-HHHHHHH-HH----HHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence               6677543221110 0000000 00    00111111111 1236678899999999999999999999999998754

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4.8e-45  Score=337.41  Aligned_cols=263  Identities=17%  Similarity=0.254  Sum_probs=206.0

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCC-CCcceeEeeEEec--CCeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR-HKNLLGLRGYCAG--TDQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~l  114 (380)
                      ..++|++.+.||+|+||+||+|.+ .+++.||||+++...   ...+.+|+.+++.++ ||||+++++++..  ....++
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l  110 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  110 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence            347899999999999999999987 578999999997543   347889999999997 9999999999987  667899


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC-ceEEeeccCccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF-EPLVADFGFAKL  193 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~-~vkl~Dfgl~~~  193 (380)
                      ||||+++++|.+++.       .+++..++.++.|++.||+|||++   ||+||||||+|||++.++ .+||+|||++..
T Consensus       111 v~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~  180 (330)
T 3nsz_A          111 VFEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF  180 (330)
T ss_dssp             EEECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceE
Confidence            999999999999984       488999999999999999999999   999999999999999776 899999999987


Q ss_pred             cCCCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh--------
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI--------  264 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~--------  264 (380)
                      .....  ......|++.|+|||++.+ ..++.++|||||||++|+|++|..||......... +..+.....        
T Consensus       181 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~-l~~~~~~~~~~~~~~~~  257 (330)
T 3nsz_A          181 YHPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ-LVRIAKVLGTEDLYDYI  257 (330)
T ss_dssp             CCTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH-HHHHHHHHCHHHHHHHH
T ss_pred             cCCCC--ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHH-HHHHHHhcCCchhhhHH
Confidence            65432  2334468999999999987 67999999999999999999999999543221100 000000000        


Q ss_pred             h------cccc--------ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          265 V------KGKF--------KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       265 ~------~~~~--------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .      ...+        ................+.++.+||.+||+.||.+|||++++++|.+..
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~  324 (330)
T 3nsz_A          258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY  324 (330)
T ss_dssp             HHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHh
Confidence            0      0000        000000111112223467899999999999999999999999997754

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.7e-46  Score=350.29  Aligned_cols=267  Identities=20%  Similarity=0.268  Sum_probs=200.0

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC------eE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD------QR  112 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~  112 (380)
                      ...+|++.+.||+|+||+||+|++..+..||+|++.....    ...+|+.+++.++||||+++++++....      .+
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~  113 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL  113 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEE
Confidence            3467999999999999999999987777799998865322    2236999999999999999999985433      37


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC-CCCceEEeeccCc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLD-SDFEPLVADFGFA  191 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~-~~~~vkl~Dfgl~  191 (380)
                      ++||||++++ +...+.........+++..++.++.|++.||+|||++   ||+||||||+|||++ .++.+||+|||++
T Consensus       114 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a  189 (394)
T 4e7w_A          114 NLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSA  189 (394)
T ss_dssp             EEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             EEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCc
Confidence            8999999864 4444432212345799999999999999999999999   999999999999998 7899999999999


Q ss_pred             cccCCCCccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccch---------
Q 037869          192 KLIPEGVSHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE---------  261 (380)
Q Consensus       192 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~---------  261 (380)
                      +......  ......||+.|+|||++.+. .|+.++|||||||++|+|++|..||.+.....  .+..+..         
T Consensus       190 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~~~~  265 (394)
T 4e7w_A          190 KILIAGE--PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGID--QLVEIIKVLGTPSREQ  265 (394)
T ss_dssp             EECCTTC--CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCHHH
T ss_pred             ccccCCC--CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCHHH
Confidence            8764432  23345689999999998765 59999999999999999999999997643211  1100000         


Q ss_pred             -----hhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          262 -----PLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       262 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                           +......+.......+...++...+.++.+||.+||+.||.+|||+.++++|.+.-
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  326 (394)
T 4e7w_A          266 IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD  326 (394)
T ss_dssp             HHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGS
T ss_pred             HHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhh
Confidence                 00000000000111111112233557899999999999999999999999996643

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=8.7e-45  Score=330.31  Aligned_cols=262  Identities=19%  Similarity=0.275  Sum_probs=202.1

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEE-ecCCeEEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC-AGTDQRLIV  115 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv  115 (380)
                      ...++|++.+.||+|+||+||+|.+ .+++.||||++......  ..+.+|+.+++.++|++++..+..+ ...+..++|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            3568999999999999999999987 67899999987653322  2577899999999988777766655 667888999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee---CCCCceEEeeccCcc
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLL---DSDFEPLVADFGFAK  192 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill---~~~~~vkl~Dfgl~~  192 (380)
                      |||+ +++|.+++...   ...+++..++.++.|++.||.|||++   +|+||||||+||++   +.++.+||+|||++.
T Consensus        84 ~e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~  156 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK  156 (296)
T ss_dssp             EECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCE
T ss_pred             EEcc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccce
Confidence            9999 89999999743   34699999999999999999999999   99999999999999   788999999999998


Q ss_pred             ccCCCCc------cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhc
Q 037869          193 LIPEGVS------HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVK  266 (380)
Q Consensus       193 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~  266 (380)
                      .......      .......||+.|+|||++.+..++.++|||||||++|+|++|..||.....................
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  236 (296)
T 4hgt_A          157 KYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS  236 (296)
T ss_dssp             ECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred             eccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence            7654322      1223456899999999999999999999999999999999999999865432221111100000000


Q ss_pred             cccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ...         .......+..+.+++.+||+.||++|||+.++++.|..+
T Consensus       237 ~~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~  278 (296)
T 4hgt_A          237 TPI---------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             SCH---------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             chh---------hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHH
Confidence            000         001122347899999999999999999999999988654

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-45  Score=332.40  Aligned_cols=255  Identities=25%  Similarity=0.366  Sum_probs=202.2

Q ss_pred             CCCCcceeccCCceEEEEEEeC-C---CcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeE-EEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRTS-D---GLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQR-LIV  115 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~~-~---~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-~lv  115 (380)
                      .|++.+.||+|+||+||+|.+. +   +..||+|.+.... ......+.+|+.+++.++||||+++++++...+.. ++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            5666799999999999999752 2   3379999997533 34456788999999999999999999999776655 999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |||+.+|+|.+++...   ...+++..++.++.|++.||+|||+.   |++||||||+||+++.++.+||+|||++....
T Consensus       102 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  175 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDIL  175 (298)
T ss_dssp             ECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTT
T ss_pred             EecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCccccc
Confidence            9999999999999753   35689999999999999999999999   99999999999999999999999999998654


Q ss_pred             CCCc---cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          196 EGVS---HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       196 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      ....   .......+++.|+|||.+.+..++.++|||||||++|+|++|..|+.......  ..             ...
T Consensus       176 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~--~~-------------~~~  240 (298)
T 3pls_A          176 DREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPF--DL-------------THF  240 (298)
T ss_dssp             TGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGG--GH-------------HHH
T ss_pred             CCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHH--HH-------------HHH
Confidence            3211   12233457899999999999999999999999999999999555543221110  00             001


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .........+...+..+.+++.+||+.||.+|||+.++++.|..+
T Consensus       241 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~  285 (298)
T 3pls_A          241 LAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI  285 (298)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            111111222334457899999999999999999999999998644

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.6e-45  Score=338.44  Aligned_cols=253  Identities=23%  Similarity=0.328  Sum_probs=210.1

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      ...+|++.+.||+|+||.||++.+ .+++.||+|++...   .......+.+|+.+++.++||||+++++++...+..++
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l  118 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV  118 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            457899999999999999999987 46889999998643   33455678889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ||||+++++|.+++...    ..+++..++.++.|++.||.|||++   ||+||||||+||+++.++.++|+|||++...
T Consensus       119 v~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  191 (335)
T 2owb_A          119 VLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV  191 (335)
T ss_dssp             EECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceec
Confidence            99999999999988643    4689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                      ..... ......|++.|+|||++.+..++.++||||||+++|+|++|..||.......  ..    .. ....       
T Consensus       192 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~----~~-~~~~-------  256 (335)
T 2owb_A          192 EYDGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE--TY----LR-IKKN-------  256 (335)
T ss_dssp             CSTTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH----HH-HHHT-------
T ss_pred             ccCcc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH--HH----HH-HhcC-------
Confidence            43222 2334568999999999999899999999999999999999999996532110  00    00 0000       


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                         ....+...+..+.+||.+||+.||.+|||+.++++|.+.
T Consensus       257 ---~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~  295 (335)
T 2owb_A          257 ---EYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFF  295 (335)
T ss_dssp             ---CCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHH
T ss_pred             ---CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence               011223344678999999999999999999999998653

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.9e-45  Score=334.08  Aligned_cols=257  Identities=27%  Similarity=0.395  Sum_probs=202.9

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCC----CcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEe-cCCeE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSD----GLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA-GTDQR  112 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-~~~~~  112 (380)
                      ...+|++.+.||+|+||+||+|.+.+    ...||+|.+... .......+.+|+.++++++||||+++++++. .++..
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence            34578999999999999999998532    335899998753 3344567889999999999999999999864 45678


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      ++||||+++|+|.+++...   ...+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+|||++.
T Consensus       103 ~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~  176 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLAR  176 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCT---TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGC
T ss_pred             EEEEeCCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccc
Confidence            9999999999999999753   35689999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCc---cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccc
Q 037869          193 LIPEGVS---HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGK  268 (380)
Q Consensus       193 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (380)
                      .......   .......+|+.|+|||++.+..++.++||||||+++|+|++ +.+||..........             
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~-------------  243 (298)
T 3f66_A          177 DMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-------------  243 (298)
T ss_dssp             CCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHH-------------
T ss_pred             cccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHH-------------
Confidence            7643221   11233457889999999999999999999999999999999 566665432211000             


Q ss_pred             cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                         ..........+...+..+.+++.+||+.||.+|||+.++++.|..+
T Consensus       244 ---~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~  289 (298)
T 3f66_A          244 ---YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  289 (298)
T ss_dssp             ---HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---HHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence               0000111122233457899999999999999999999999998643

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=5.2e-45  Score=366.50  Aligned_cols=253  Identities=26%  Similarity=0.336  Sum_probs=210.4

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~  113 (380)
                      ..++|++.+.||+|+||.||+|++ .+++.||||+++..   .......+..|..++..+ +||+|+++++++.+.+.+|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            346899999999999999999987 46889999999742   223345677899999988 7999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      |||||++||+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus       419 lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~  491 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKE  491 (674)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEE
T ss_pred             EEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeec
Confidence            999999999999999753    4699999999999999999999999   999999999999999999999999999986


Q ss_pred             cCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                      .... .......+||+.|+|||++.+..|+.++|||||||++|||++|..||......  ..             +..+.
T Consensus       492 ~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~--~~-------------~~~i~  555 (674)
T 3pfq_A          492 NIWD-GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--EL-------------FQSIM  555 (674)
T ss_dssp             CCCT-TCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HH-------------HHHHH
T ss_pred             cccC-CcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH--HH-------------HHHHH
Confidence            4322 22344567999999999999999999999999999999999999999763321  00             01111


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCH-----HHHHHHhcC
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNM-----KEVVNTLTG  316 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~-----~~ll~~l~~  316 (380)
                      ...  ..++...+.++.+||.+||+.||.+||++     ++|++|.+.
T Consensus       556 ~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff  601 (674)
T 3pfq_A          556 EHN--VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFF  601 (674)
T ss_dssp             SSC--CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGG
T ss_pred             hCC--CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccc
Confidence            111  12344556889999999999999999997     999998654

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=6.9e-46  Score=338.70  Aligned_cols=272  Identities=23%  Similarity=0.311  Sum_probs=192.9

Q ss_pred             HHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           36 LHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        36 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      +....++|++.+.||+|+||.||+|.+ .+++.||||++.... ......+.+|+.+++.++||||+++++++...+..+
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            344678999999999999999999987 468999999987532 233456888999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccC----CCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeecc
Q 037869          114 IVYDYMPNLSLLSHLHGQ----YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG  189 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~----~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfg  189 (380)
                      +||||+++++|.+++...    ......+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEecc
Confidence            999999999999998631    11235689999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCc----cceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh
Q 037869          190 FAKLIPEGVS----HMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI  264 (380)
Q Consensus       190 l~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  264 (380)
                      ++........    .......||+.|+|||++.+ ..++.++|||||||++|+|++|..||...........       .
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-------~  239 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML-------T  239 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH-------H
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH-------H
Confidence            9987643211    11233568999999999875 5689999999999999999999999976432111000       0


Q ss_pred             hccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          265 VKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .....................+..+.++|.+||+.||.+|||+.++++|.+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  292 (303)
T 2vwi_A          240 LQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ  292 (303)
T ss_dssp             HTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-
T ss_pred             hccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhh
Confidence            00000000000001112223446889999999999999999999999997643

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.5e-45  Score=345.59  Aligned_cols=265  Identities=21%  Similarity=0.275  Sum_probs=189.6

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecC-----
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT-----  109 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----  109 (380)
                      ...++|++.+.||+|+||.||+|.+ .+|+.||||++...  .......+.+|+.+++.++||||+++++++...     
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~  105 (367)
T 2fst_X           26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE  105 (367)
T ss_dssp             EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGG
T ss_pred             CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCcccc
Confidence            4568999999999999999999987 57899999999752  334456788999999999999999999998654     


Q ss_pred             -CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          110 -DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       110 -~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                       ...|+|+|++ +++|.+++..     ..+++..++.++.||+.||.|||+.   ||+||||||+||+++.++.+||+||
T Consensus       106 ~~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DF  176 (367)
T 2fst_X          106 FNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDF  176 (367)
T ss_dssp             CCCCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC-
T ss_pred             CCeEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeec
Confidence             5679999999 6899888864     3699999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh---
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI---  264 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~---  264 (380)
                      |+++.....    .....||++|+|||++.+ ..++.++|||||||++|+|++|..||.+.....  .+..+.....   
T Consensus       177 G~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~l~~i~~~~g~p~  250 (367)
T 2fst_X          177 GLARHTADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID--QLKLILRLVGTPG  250 (367)
T ss_dssp             ------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCSCC
T ss_pred             ccccccccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCC
Confidence            999875432    334568999999999987 679999999999999999999999997643211  0000000000   


Q ss_pred             -------hcc---ccccccCCccc---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          265 -------VKG---KFKELVDPKLR---GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       265 -------~~~---~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                             ...   .+...+.....   .......+..+.+||.+||..||.+|||+.++++|.+.-
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~  316 (367)
T 2fst_X          251 AELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFA  316 (367)
T ss_dssp             HHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhh
Confidence                   000   00000000000   001112346789999999999999999999999997643

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-45  Score=345.89  Aligned_cols=254  Identities=27%  Similarity=0.397  Sum_probs=194.5

Q ss_pred             CCCCcceeccCCceEEEEEEeC--C--CcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEec-CCeEEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRTS--D--GLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG-TDQRLIV  115 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv  115 (380)
                      .|++.+.||+|+||+||+|.+.  +  ...||+|.++.. .......+.+|+.+++.++||||+++++++.. ++..++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4677899999999999999752  2  246899998753 33455688999999999999999999998754 5678999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |||+++|+|.+++...   ...+++..++.++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       170 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~  243 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMY  243 (373)
T ss_dssp             EECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             EECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeecccccccc
Confidence            9999999999999753   34688999999999999999999999   99999999999999999999999999998664


Q ss_pred             CCCcc---ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          196 EGVSH---MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       196 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      .....   ......+++.|+|||++.+..++.++|||||||++|||++ |.+||..........       ....     
T Consensus       244 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~-------~~~~-----  311 (373)
T 3c1x_A          244 DKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV-------YLLQ-----  311 (373)
T ss_dssp             --------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHH-------HHHT-----
T ss_pred             ccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHH-------HHHc-----
Confidence            32211   1223456789999999999999999999999999999999 677776543211000       0000     


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                          ......+..++..+.+++.+||+.||.+|||+.+++++|..+
T Consensus       312 ----~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i  353 (373)
T 3c1x_A          312 ----GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  353 (373)
T ss_dssp             ----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                111122334457899999999999999999999999998644

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=5e-46  Score=336.49  Aligned_cols=249  Identities=26%  Similarity=0.425  Sum_probs=206.1

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEec---------
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG---------  108 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---------  108 (380)
                      ...+|++.+.||+|+||.||+|.+. +++.||+|+++....    .+.+|+.+++.++||||+++++++..         
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG----GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH----HHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            5678999999999999999999984 799999999976432    46689999999999999999998854         


Q ss_pred             -------CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC
Q 037869          109 -------TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF  181 (380)
Q Consensus       109 -------~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~  181 (380)
                             ....++||||+++++|.+++....  ...+++..++.++.|++.||.|||+.   ||+||||||+||+++.++
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~  159 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTK  159 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETT
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCC
Confidence                   345899999999999999997532  34689999999999999999999999   999999999999999999


Q ss_pred             ceEEeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccch
Q 037869          182 EPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE  261 (380)
Q Consensus       182 ~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  261 (380)
                      .++|+|||++.......  ......|++.|+|||++.+..++.++||||||+++|+|++|..|+....        ..  
T Consensus       160 ~~kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------~~--  227 (284)
T 2a19_B          160 QVKIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------KF--  227 (284)
T ss_dssp             EEEECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------HH--
T ss_pred             CEEECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------HH--
Confidence            99999999998765432  2233468999999999999999999999999999999999998874210        00  


Q ss_pred             hhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCC
Q 037869          262 PLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP  319 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~  319 (380)
                             ...+...    ..+...+..+.++|.+||+.||.+|||+.+++++|+.+..
T Consensus       228 -------~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          228 -------FTDLRDG----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             -------HHHHHTT----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             -------HHHhhcc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence                   0001111    1122234678899999999999999999999999886643

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.3e-45  Score=336.15  Aligned_cols=257  Identities=23%  Similarity=0.370  Sum_probs=201.9

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh--------hhHHHHHHHHHHHhcCCCCcceeEeeEEecC
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS--------KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT  109 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  109 (380)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||++.....        .....+.+|+.+++.++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            457899999999999999999987 4689999999864321        1223578899999999999999999998765


Q ss_pred             CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc---eEEe
Q 037869          110 DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE---PLVA  186 (380)
Q Consensus       110 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~---vkl~  186 (380)
                      . .++||||+++++|.+++...    ..+++..++.++.|++.||.|||++   ||+||||||+||+++.++.   +||+
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~  159 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGN----KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKIT  159 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTT----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEEC
T ss_pred             c-eEEEEecCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEc
Confidence            4 89999999999999998643    5799999999999999999999999   9999999999999987654   9999


Q ss_pred             eccCccccCCCCccceeccccccCccCccccc---cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhh
Q 037869          187 DFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM---WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL  263 (380)
Q Consensus       187 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~  263 (380)
                      |||++......  .......||+.|+|||++.   ...++.++|||||||++|+|++|..||........  ...    .
T Consensus       160 Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~----~  231 (322)
T 2ycf_A          160 DFGHSKILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD----Q  231 (322)
T ss_dssp             CCTTCEECCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHH----H
T ss_pred             cCccceecccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHH----H
Confidence            99999876542  2223456899999999974   56789999999999999999999999975432111  000    0


Q ss_pred             hhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ...+...      .........+..+.+||.+||+.||.+|||+.++++|.+..
T Consensus       232 ~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~  279 (322)
T 2ycf_A          232 ITSGKYN------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ  279 (322)
T ss_dssp             HHHTCCC------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGC
T ss_pred             HHhCccc------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcC
Confidence            0000000      00001112347889999999999999999999999997754

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.6e-45  Score=341.77  Aligned_cols=269  Identities=20%  Similarity=0.258  Sum_probs=209.1

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhh-----------------HHHHHHHHHHHhcCCCCccee
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKA-----------------EMEFAVEVEVLGRVRHKNLLG  101 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------~~~~~~E~~~l~~l~h~niv~  101 (380)
                      ..++|++.+.||+|+||.||+|.+ +++.||+|++.......                 ...+.+|+.+++.++||||++
T Consensus        29 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           29 YINDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             EETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             ccCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            457999999999999999999999 89999999987432111                 168889999999999999999


Q ss_pred             EeeEEecCCeEEEEEEecCCCCHHHh------hccCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCC
Q 037869          102 LRGYCAGTDQRLIVYDYMPNLSLLSH------LHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH-EVTPHIIHRDIKASN  174 (380)
Q Consensus       102 ~~~~~~~~~~~~lv~e~~~~g~L~~~------i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~-~~~~~ivHrdlkp~N  174 (380)
                      +++++...+..++||||+++|+|.++      +...  ....+++..++.++.|++.||.|||+ .   |++||||||+|
T Consensus       108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~N  182 (348)
T 2pml_X          108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKN--YTCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSN  182 (348)
T ss_dssp             CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSS--SCCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGG
T ss_pred             EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhc--cccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHh
Confidence            99999999999999999999999998      4331  24679999999999999999999998 8   99999999999


Q ss_pred             eeeCCCCceEEeeccCccccCCCCccceeccccccCccCccccccC-CCCc-cchhhhhhHHHHHHHhCCCCCCCCCCCc
Q 037869          175 VLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG-KVSE-SCDVYSFGILLLEILTGRKPIEKLPGGV  252 (380)
Q Consensus       175 ill~~~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~il~ell~g~~p~~~~~~~~  252 (380)
                      |+++.++.++|+|||++......   ......|++.|+|||++.+. .++. ++|||||||++|+|++|..||.......
T Consensus       183 il~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          183 ILMDKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             EEECTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             EEEcCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            99999999999999999876443   33445689999999999877 6766 9999999999999999999997643310


Q ss_pred             ccchhccchhh-hhcc---ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          253 KRTITEWAEPL-IVKG---KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       253 ~~~~~~~~~~~-~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      . ....+.... ....   .+................+..+.+||.+||+.||.+|||+.++++|.+..
T Consensus       260 ~-~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~  327 (348)
T 2pml_X          260 E-LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA  327 (348)
T ss_dssp             H-HHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGT
T ss_pred             H-HHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence            0 000000000 0000   00000000000011134457899999999999999999999999997754

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.2e-45  Score=349.35  Aligned_cols=275  Identities=21%  Similarity=0.320  Sum_probs=189.5

Q ss_pred             HhhCCCCC-cceeccCCceEEEEEEeC---CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEe--cCCe
Q 037869           38 TATNGFSD-DNKLGEGGFGSVYWGRTS---DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA--GTDQ  111 (380)
Q Consensus        38 ~~~~~y~~-~~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~  111 (380)
                      ...+.|++ .++||+|+||+||+|++.   +++.||||++.....  ...+.+|+.+|+.++||||+++++++.  .+..
T Consensus        17 ~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (405)
T 3rgf_A           17 RVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRK   94 (405)
T ss_dssp             CHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC--CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred             hhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC--CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence            34456776 458999999999999854   578999999975432  236778999999999999999999994  4678


Q ss_pred             EEEEEEecCCCCHHHhhccCC-----CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee----CCCCc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQY-----AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLL----DSDFE  182 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~-----~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill----~~~~~  182 (380)
                      .++||||+. |+|.+++....     .....+++..++.++.||+.||+|||+.   +|+||||||+|||+    +.++.
T Consensus        95 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~  170 (405)
T 3rgf_A           95 VWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGR  170 (405)
T ss_dssp             EEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTC
T ss_pred             EEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCc
Confidence            999999996 48888775321     1223599999999999999999999999   99999999999999    67789


Q ss_pred             eEEeeccCccccCCCCc--cceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccch---
Q 037869          183 PLVADFGFAKLIPEGVS--HMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI---  256 (380)
Q Consensus       183 vkl~Dfgl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~---  256 (380)
                      +||+|||+++.......  .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||...........   
T Consensus       171 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~  250 (405)
T 3rgf_A          171 VKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH  250 (405)
T ss_dssp             EEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCC
T ss_pred             EEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccch
Confidence            99999999987653221  22344678999999999987 4599999999999999999999999975443211000   


Q ss_pred             -hccchhhhhcc-----ccccc------------cCCcccCCC---------CHHHHHHHHHHHHhhcCCCCCCCCCHHH
Q 037869          257 -TEWAEPLIVKG-----KFKEL------------VDPKLRGDF---------DENQLKQAINVAVLCVQSEPEKRPNMKE  309 (380)
Q Consensus       257 -~~~~~~~~~~~-----~~~~~------------~~~~~~~~~---------~~~~~~~~~~li~~cl~~~P~~Rps~~~  309 (380)
                       ..+.......+     .+..+            .........         ....+..+.+||.+||..||.+|||+.+
T Consensus       251 ~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e  330 (405)
T 3rgf_A          251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQ  330 (405)
T ss_dssp             HHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHH
Confidence             00000000000     00000            000000000         0011457889999999999999999999


Q ss_pred             HHHHhcCCC
Q 037869          310 VVNTLTGYD  318 (380)
Q Consensus       310 ll~~l~~~~  318 (380)
                      +++|.+...
T Consensus       331 ~L~hp~f~~  339 (405)
T 3rgf_A          331 AMQDPYFLE  339 (405)
T ss_dssp             HHTSGGGTS
T ss_pred             HhcChhhcc
Confidence            999988654

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.7e-45  Score=344.76  Aligned_cols=256  Identities=10%  Similarity=0.030  Sum_probs=187.0

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh---hhHHHHHHH---HHHHhcCCCCcceeEe-------eE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS---KAEMEFAVE---VEVLGRVRHKNLLGLR-------GY  105 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E---~~~l~~l~h~niv~~~-------~~  105 (380)
                      ...|++.+.||+|+||+||+|.+ .+++.||||++.....   .....+.+|   +.+|+. +||||++++       ++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~  139 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDA  139 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehh
Confidence            34599999999999999999997 4789999999986432   334456777   455666 799988755       45


Q ss_pred             EecC-----------------CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHH------HHHHHHHHHHHHHHhhcCC
Q 037869          106 CAGT-----------------DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRR------MKIAIGSAEGILYLHHEVT  162 (380)
Q Consensus       106 ~~~~-----------------~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~------~~i~~ql~~al~~LH~~~~  162 (380)
                      +...                 ...|+||||++ |+|.+++...   ...+.+..+      +.++.|++.||+|||++  
T Consensus       140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~--  213 (371)
T 3q60_A          140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL---DFVYVFRGDEGILALHILTAQLIRLAANLQSK--  213 (371)
T ss_dssp             EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH---HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh---ccccchhhhhhhhhHHHHHHHHHHHHHHHHHC--
Confidence            4433                 34899999998 8999999753   123444455      67779999999999999  


Q ss_pred             CCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccceeccccccCccCcccccc--CCCCccchhhhhhHHHHHHHh
Q 037869          163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW--GKVSESCDVYSFGILLLEILT  240 (380)
Q Consensus       163 ~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~  240 (380)
                       ||+||||||+|||++.++.+||+|||+++.....    .....+|+.|+|||++.+  ..++.++|||||||++|+|++
T Consensus       214 -~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~ellt  288 (371)
T 3q60_A          214 -GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWC  288 (371)
T ss_dssp             -TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHH
T ss_pred             -CCccCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHh
Confidence             9999999999999999999999999999876431    213456799999999987  679999999999999999999


Q ss_pred             CCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          241 GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       241 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      |..||...............        .................+..+.+||.+||+.||++|||+.++++|.+
T Consensus       289 g~~Pf~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  355 (371)
T 3q60_A          289 LFLPFGLVTPGIKGSWKRPS--------LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPE  355 (371)
T ss_dssp             SSCSTTBCCTTCTTCCCBCC--------TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHH
T ss_pred             CCCCCCCcCcccccchhhhh--------hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHH
Confidence            99999865432211111000        00001111111222345678999999999999999999999999865

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2e-44  Score=328.05  Aligned_cols=261  Identities=20%  Similarity=0.283  Sum_probs=206.2

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEE-ecCCeEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC-AGTDQRLIVY  116 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-~~~~~~~lv~  116 (380)
                      ..++|++.+.||+|+||.||+|++ .+++.||||++......  ..+.+|+.+++.++|++++..+..+ ......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence            568999999999999999999997 67999999998754322  3678899999999988876666554 6677889999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC---CCCceEEeeccCccc
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLD---SDFEPLVADFGFAKL  193 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~---~~~~vkl~Dfgl~~~  193 (380)
                      ||+ +++|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+||+++   .++.+||+|||++..
T Consensus        85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  157 (296)
T 3uzp_A           85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK  157 (296)
T ss_dssp             ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             Eec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence            999 89999999743   34699999999999999999999999   999999999999994   788999999999987


Q ss_pred             cCCCCcc------ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcc
Q 037869          194 IPEGVSH------MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKG  267 (380)
Q Consensus       194 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  267 (380)
                      .......      ......||+.|+|||++.+..++.++|||||||++|+|++|..||......................
T Consensus       158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 3uzp_A          158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             ccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence            6543221      1234568999999999999999999999999999999999999998644322111111000000000


Q ss_pred             ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ..         ......++..+.+++.+||+.||.+|||+.++++.|..+
T Consensus       238 ~~---------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  278 (296)
T 3uzp_A          238 PI---------EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL  278 (296)
T ss_dssp             CH---------HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHH
T ss_pred             ch---------HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHH
Confidence            00         001122347899999999999999999999999998754

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.2e-45  Score=343.38  Aligned_cols=273  Identities=22%  Similarity=0.312  Sum_probs=208.7

Q ss_pred             HHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecC---
Q 037869           35 ELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT---  109 (380)
Q Consensus        35 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---  109 (380)
                      ++....++|++.+.||+|+||.||+|.+ .++..||||++.... ......+.+|+.+++.++||||+++++++...   
T Consensus        21 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  100 (364)
T 3qyz_A           21 QVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE  100 (364)
T ss_dssp             CBCCCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTT
T ss_pred             EeccccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcc
Confidence            3444568999999999999999999987 478899999997533 33446788999999999999999999998654   


Q ss_pred             --CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEee
Q 037869          110 --DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD  187 (380)
Q Consensus       110 --~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~D  187 (380)
                        ...|+||||+. |+|.+++...     .+++..++.++.|++.||+|||+.   ||+||||||+||+++.++.+||+|
T Consensus       101 ~~~~~~iv~e~~~-~~L~~~l~~~-----~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~D  171 (364)
T 3qyz_A          101 QMKDVYIVQDLME-TDLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICD  171 (364)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECC
T ss_pred             ccceEEEEEcccC-cCHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEe
Confidence              46899999997 5999988643     699999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccCCCCcc--ceeccccccCccCccccc-cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh
Q 037869          188 FGFAKLIPEGVSH--MTTRVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI  264 (380)
Q Consensus       188 fgl~~~~~~~~~~--~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  264 (380)
                      ||++.........  ......||+.|+|||++. +..++.++|||||||++|+|++|..||........  ...+.....
T Consensus       172 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~  249 (364)
T 3qyz_A          172 FGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ--LNHILGILG  249 (364)
T ss_dssp             CTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH--HHHHHHHHC
T ss_pred             CcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH--HHHHHHHhC
Confidence            9999876432211  123457899999999875 45689999999999999999999999976432111  110000000


Q ss_pred             hc-------------ccc-ccccCCc--ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          265 VK-------------GKF-KELVDPK--LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       265 ~~-------------~~~-~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      ..             ..+ .......  .........+.++.+||.+||+.||.+|||+.++++|.+...
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  319 (364)
T 3qyz_A          250 SPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ  319 (364)
T ss_dssp             SCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTT
T ss_pred             CCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhh
Confidence            00             000 0000000  000111233568899999999999999999999999977543

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=9e-45  Score=330.72  Aligned_cols=258  Identities=24%  Similarity=0.330  Sum_probs=208.9

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---------hhhHHHHHHHHHHHhcCC-CCcceeEeeEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---------SKAEMEFAVEVEVLGRVR-HKNLLGLRGYC  106 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---------~~~~~~~~~E~~~l~~l~-h~niv~~~~~~  106 (380)
                      ...++|++.+.||+|+||.||+|.+ .+++.||||++....         ......+.+|+.+++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            4568999999999999999999987 468999999997532         122346778999999995 99999999999


Q ss_pred             ecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEe
Q 037869          107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVA  186 (380)
Q Consensus       107 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~  186 (380)
                      ...+..++||||+++++|.+++...    ..+++..++.++.|++.||.|||+.   |++||||+|+||+++.++.++|+
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~  166 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLT  166 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEEC
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEe
Confidence            9999999999999999999999653    4689999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccCCCCccceeccccccCccCccccc------cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccc
Q 037869          187 DFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM------WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWA  260 (380)
Q Consensus       187 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~  260 (380)
                      |||++.......  ......|++.|+|||++.      ...++.++||||||+++|+|++|..||.......  ..    
T Consensus       167 dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~~----  238 (298)
T 1phk_A          167 DFGFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--ML----  238 (298)
T ss_dssp             CCTTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----
T ss_pred             cccchhhcCCCc--ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH--HH----
Confidence            999998765432  233456899999999985      4568999999999999999999999996532110  00    


Q ss_pred             hhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          261 EPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      . ....+..      ..........+..+.++|.+||+.||.+|||+.++++|.+..
T Consensus       239 ~-~~~~~~~------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (298)
T 1phk_A          239 R-MIMSGNY------QFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ  288 (298)
T ss_dssp             H-HHHHTCC------CCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             H-HHhcCCc------ccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhh
Confidence            0 0000000      001111234457899999999999999999999999987643

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=5.6e-45  Score=328.41  Aligned_cols=252  Identities=22%  Similarity=0.336  Sum_probs=200.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++....   ......+.+|+.+++.++||||+++++++...+..++
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   88 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFM   88 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEE
Confidence            4578999999999999999999874 79999999987532   2234578889999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ||||+++++|.+++...    ..+++..++.++.|++.||.|||+.   |++||||||+||+++.++.++|+|||++...
T Consensus        89 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~  161 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMM  161 (276)
T ss_dssp             EEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCC
T ss_pred             EEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeeccccccc
Confidence            99999999999999653    4689999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCccceeccccccCccCccccccCCC-CccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                      ....  ......|++.|+|||++.+..+ +.++||||||+++|+|++|..||......      ..... ...+      
T Consensus       162 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~------~~~~~-~~~~------  226 (276)
T 2h6d_A          162 SDGE--FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP------TLFKK-IRGG------  226 (276)
T ss_dssp             CC---------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH------HHHHH-HHHC------
T ss_pred             CCCc--ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH------HHHHH-hhcC------
Confidence            5422  2234468999999999987765 68999999999999999999999653210      00000 0000      


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                          ....+...+..+.++|.+||+.||.+|||+.++++|.+.
T Consensus       227 ----~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~  265 (276)
T 2h6d_A          227 ----VFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWF  265 (276)
T ss_dssp             ----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHH
T ss_pred             ----cccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhh
Confidence                011223344788999999999999999999999999653

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.1e-45  Score=363.94  Aligned_cols=252  Identities=24%  Similarity=0.376  Sum_probs=202.0

Q ss_pred             CCCCcc-eeccCCceEEEEEEeC---CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           42 GFSDDN-KLGEGGFGSVYWGRTS---DGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        42 ~y~~~~-~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ++.+.+ .||+|+||.||+|.+.   ++..||||+++.. .......+.+|+.+|+.++||||+++++++.. +..++||
T Consensus       336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~  414 (613)
T 2ozo_A          336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM  414 (613)
T ss_dssp             SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred             ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence            334444 7999999999999753   4667999999864 23456689999999999999999999999976 6699999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+++|+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus       415 E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~  488 (613)
T 2ozo_A          415 EMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGA  488 (613)
T ss_dssp             ECCTTCBHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-
T ss_pred             EeCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccC
Confidence            999999999999643   35699999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCccc--eeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          197 GVSHM--TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       197 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                      .....  .....+++.|+|||++.+..++.++|||||||++|||++ |..||.......                +...+
T Consensus       489 ~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----------------~~~~i  552 (613)
T 2ozo_A          489 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----------------VMAFI  552 (613)
T ss_dssp             -------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH----------------HHHHH
T ss_pred             CCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----------------HHHHH
Confidence            32211  122235689999999999999999999999999999998 999997644211                00111


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ....+...+..++..+.+||.+||+.||.+|||+.+|++.|..
T Consensus       553 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  595 (613)
T 2ozo_A          553 EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRA  595 (613)
T ss_dssp             HTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHH
T ss_pred             HcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            1122233445566899999999999999999999999998764

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.7e-45  Score=351.35  Aligned_cols=264  Identities=24%  Similarity=0.308  Sum_probs=199.5

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecC------CeEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT------DQRL  113 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~------~~~~  113 (380)
                      .+|++.+.||+|+||.||+|.+ .+++.||||++.....    ...+|+++|+.++||||+++++++...      ..++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            4799999999999999999998 4689999999875321    234699999999999999999988431      2367


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-CceEEeeccCcc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD-FEPLVADFGFAK  192 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~-~~vkl~Dfgl~~  192 (380)
                      +||||+++ +|.+.+.........+++..++.++.||+.||+|||++   ||+||||||+|||++.+ +.+||+|||+++
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~  205 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAK  205 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhh
Confidence            99999975 67666653323346799999999999999999999999   99999999999999965 678999999998


Q ss_pred             ccCCCCccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhh--------
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL--------  263 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~--------  263 (380)
                      .......  .....||+.|+|||++.+. .|+.++|||||||++|||++|..||.+....  ..+..+....        
T Consensus       206 ~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~--~~l~~i~~~lg~p~~~~~  281 (420)
T 1j1b_A          206 QLVRGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV--DQLVEIIKVLGTPTREQI  281 (420)
T ss_dssp             ECCTTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCSCCHHHH
T ss_pred             hcccCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHHHhCCCCHHHH
Confidence            7644322  2345689999999999765 7999999999999999999999999764321  1111110000        


Q ss_pred             -hhccccccccCCcc-----cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          264 -IVKGKFKELVDPKL-----RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       264 -~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                       .....+.....+..     ...++...+.++.+||.+||..||.+|||+.++++|.+.
T Consensus       282 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f  340 (420)
T 1j1b_A          282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF  340 (420)
T ss_dssp             HHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhh
Confidence             00000111111111     111223345789999999999999999999999999764

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.4e-45  Score=338.62  Aligned_cols=265  Identities=20%  Similarity=0.331  Sum_probs=206.5

Q ss_pred             eeccHHHHHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCC--CCcceeEee
Q 037869           29 RIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVR--HKNLLGLRG  104 (380)
Q Consensus        29 ~~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~--h~niv~~~~  104 (380)
                      ..+.+..+....++|++.+.||+|+||.||++.+.+++.||+|++...  .......+.+|+.+++.++  ||||+++++
T Consensus        16 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~   95 (313)
T 3cek_A           16 ENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD   95 (313)
T ss_dssp             ----CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEE
T ss_pred             CCCCeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEE
Confidence            345555566678899999999999999999999888999999999743  3445567889999999997  599999999


Q ss_pred             EEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceE
Q 037869          105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL  184 (380)
Q Consensus       105 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vk  184 (380)
                      ++..++..++||| +.+++|.+++...    ..+++..++.++.|++.||.|||+.   +|+||||||+||+++. +.+|
T Consensus        96 ~~~~~~~~~lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~k  166 (313)
T 3cek_A           96 YEITDQYIYMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLK  166 (313)
T ss_dssp             EEECSSEEEEEEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEE
T ss_pred             EeecCCEEEEEEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEE
Confidence            9999999999999 5588999999754    4789999999999999999999999   9999999999999964 7999


Q ss_pred             EeeccCccccCCCCcc-ceeccccccCccCcccccc-----------CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCc
Q 037869          185 VADFGFAKLIPEGVSH-MTTRVKGTLGYLAPEYAMW-----------GKVSESCDVYSFGILLLEILTGRKPIEKLPGGV  252 (380)
Q Consensus       185 l~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  252 (380)
                      |+|||++......... ......|++.|+|||++.+           ..++.++|||||||++|+|++|..||.......
T Consensus       167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  246 (313)
T 3cek_A          167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI  246 (313)
T ss_dssp             ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH
T ss_pred             EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH
Confidence            9999999876433221 2234468999999999875           468899999999999999999999996543211


Q ss_pred             ccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          253 KRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .              .+.....+......+...+..+.++|.+||+.||.+|||+.++++|.+.
T Consensus       247 ~--------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~  296 (313)
T 3cek_A          247 S--------------KLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV  296 (313)
T ss_dssp             H--------------HHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred             H--------------HHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence            0              0111112222222333335788999999999999999999999999764

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.9e-45  Score=348.03  Aligned_cols=268  Identities=18%  Similarity=0.214  Sum_probs=205.3

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcC------CCCcceeEeeEEecCC
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV------RHKNLLGLRGYCAGTD  110 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~~~~~~~~~~  110 (380)
                      ....+|++.+.||+|+||+||+|.+ .+++.||||+++... .....+.+|+.+++.+      .|+||+++++++...+
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            3457899999999999999999987 468999999997642 3344667787777766      5789999999999999


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc--eEEeec
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE--PLVADF  188 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~--vkl~Df  188 (380)
                      ..++||||+. ++|.+++....  ...+++..++.++.||+.||+|||+.   +|+||||||+|||++.++.  +||+||
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DF  246 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDF  246 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCC
T ss_pred             eEEEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeec
Confidence            9999999996 59999987542  23589999999999999999999999   9999999999999999887  999999


Q ss_pred             cCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhh-----
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL-----  263 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~-----  263 (380)
                      |++......    .....||+.|+|||++.+..++.++|||||||++|||++|.+||.......  .+..+....     
T Consensus       247 G~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~--~l~~i~~~~~~p~~  320 (429)
T 3kvw_A          247 GSSCYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD--QLACMIELLGMPSQ  320 (429)
T ss_dssp             TTCEETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCH
T ss_pred             ccceecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHcCCCCH
Confidence            999765432    234568999999999999999999999999999999999999997643211  000000000     


Q ss_pred             --h-hccccccc--------------------------------cCCccc----CCCCHHHHHHHHHHHHhhcCCCCCCC
Q 037869          264 --I-VKGKFKEL--------------------------------VDPKLR----GDFDENQLKQAINVAVLCVQSEPEKR  304 (380)
Q Consensus       264 --~-~~~~~~~~--------------------------------~~~~~~----~~~~~~~~~~~~~li~~cl~~~P~~R  304 (380)
                        . ........                                ..+...    .......+..+.+||.+||+.||.+|
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~R  400 (429)
T 3kvw_A          321 KLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVR  400 (429)
T ss_dssp             HHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhC
Confidence              0 00000000                                000000    00111224678999999999999999


Q ss_pred             CCHHHHHHHhcCCC
Q 037869          305 PNMKEVVNTLTGYD  318 (380)
Q Consensus       305 ps~~~ll~~l~~~~  318 (380)
                      ||+.++++|.|...
T Consensus       401 pta~e~L~Hpw~~~  414 (429)
T 3kvw_A          401 MTPGQALRHPWLRR  414 (429)
T ss_dssp             CCHHHHHTSTTTC-
T ss_pred             CCHHHHhCChhhcc
Confidence            99999999988653

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.3e-44  Score=330.11  Aligned_cols=257  Identities=25%  Similarity=0.387  Sum_probs=199.8

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEec---------
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG---------  108 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~---------  108 (380)
                      ..++|++.+.||+|+||.||+|++ .+++.||||++... ......+.+|+.+++.++||||+++++++..         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            456899999999999999999997 57899999999753 3445678899999999999999999998854         


Q ss_pred             ----CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceE
Q 037869          109 ----TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL  184 (380)
Q Consensus       109 ----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vk  184 (380)
                          ....++||||+++|+|.+++...   ...+++..++.++.|++.||+|||++   |++||||||+||+++.++.++
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~k  156 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVK  156 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEE
Confidence                35689999999999999999753   35688899999999999999999999   999999999999999999999


Q ss_pred             EeeccCccccCCCC-------------ccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCC
Q 037869          185 VADFGFAKLIPEGV-------------SHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPG  250 (380)
Q Consensus       185 l~Dfgl~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~  250 (380)
                      |+|||++.......             ........|++.|+|||++.+. .++.++|||||||++|+|++   ||.....
T Consensus       157 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~  233 (303)
T 1zy4_A          157 IGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGME  233 (303)
T ss_dssp             ECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHH
T ss_pred             EeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchh
Confidence            99999998764321             1122345689999999999865 68999999999999999998   5532110


Q ss_pred             CcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          251 GVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                           ......      .+. .........++...+..+.++|.+||+.||.+|||+.++++|.+..
T Consensus       234 -----~~~~~~------~~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (303)
T 1zy4_A          234 -----RVNILK------KLR-SVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP  288 (303)
T ss_dssp             -----HHHHHH------HHH-STTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSC
T ss_pred             -----HHHHHH------hcc-ccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcC
Confidence                 000000      000 0111222334445567789999999999999999999999998753

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=339.93  Aligned_cols=256  Identities=18%  Similarity=0.157  Sum_probs=204.1

Q ss_pred             HHHHhhCCCCCcceeccCCceEEEEEE------eCCCcEEEEEEecccChhhHHHHHHHHHHHhcCC---CCcceeEeeE
Q 037869           35 ELHTATNGFSDDNKLGEGGFGSVYWGR------TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR---HKNLLGLRGY  105 (380)
Q Consensus        35 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~------~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~  105 (380)
                      ++....++|++.+.||+|+||+||+|.      ..+++.||||+++.....   .+..|+.++..++   |+||++++++
T Consensus        59 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~---~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           59 EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW---EFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             EEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHH---HHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             eEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChh---HHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            334467889999999999999999993      356889999999865433   5667777777776   9999999999


Q ss_pred             EecCCeEEEEEEecCCCCHHHhhccCCC-CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-----
Q 037869          106 CAGTDQRLIVYDYMPNLSLLSHLHGQYA-GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS-----  179 (380)
Q Consensus       106 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~-~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~-----  179 (380)
                      +...+..++||||+++|+|.+++..... ....+++..++.++.|++.||+|||++   +|+||||||+|||++.     
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~  212 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQ  212 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCc
Confidence            9999999999999999999999964321 245799999999999999999999999   9999999999999988     


Q ss_pred             ------CCceEEeeccCccccCC-CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCc
Q 037869          180 ------DFEPLVADFGFAKLIPE-GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGV  252 (380)
Q Consensus       180 ------~~~vkl~Dfgl~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  252 (380)
                            ++.+||+|||+++.+.. .........+||+.|+|||++.+..++.++|||||||++|||++|..||.......
T Consensus       213 ~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~  292 (365)
T 3e7e_A          213 DDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE  292 (365)
T ss_dssp             ------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE
T ss_pred             cccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc
Confidence                  89999999999976532 12233445679999999999999999999999999999999999999986432210


Q ss_pred             ccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCC-CCHHHHHHHhcCC
Q 037869          253 KRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKR-PNMKEVVNTLTGY  317 (380)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~R-ps~~~ll~~l~~~  317 (380)
                      ..                  ....+...   .....+.+++..||+.+|.+| |++.++.+.|..+
T Consensus       293 ~~------------------~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~  337 (365)
T 3e7e_A          293 CK------------------PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKV  337 (365)
T ss_dssp             EE------------------ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHH
T ss_pred             ee------------------echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHH
Confidence            00                  00001111   124677889999999999999 6777777666543

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=8.6e-46  Score=340.76  Aligned_cols=281  Identities=24%  Similarity=0.368  Sum_probs=207.1

Q ss_pred             cccccCCCCCccceeccHHHHHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccC--hhhHHHHHHHHHHHhc
Q 037869           16 GLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMN--SKAEMEFAVEVEVLGR   93 (380)
Q Consensus        16 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~   93 (380)
                      .++..+.++..+.......++....++|++.+.||+|+||.||+|.+..  .||+|+++...  ......+.+|+.+++.
T Consensus         8 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~   85 (319)
T 2y4i_B            8 LLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQ   85 (319)
T ss_dssp             --------------CCCGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTT
T ss_pred             ccccCccCccccccccccccccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhc
Confidence            3344445555555566667777788999999999999999999998853  49999987432  2223457789999999


Q ss_pred             CCCCcceeEeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCC
Q 037869           94 VRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKAS  173 (380)
Q Consensus        94 l~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~  173 (380)
                      ++||||+++++++...+..++||||+++++|.+++...   ...+++..++.++.|++.||+|||+.   |++||||||+
T Consensus        86 l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~  159 (319)
T 2y4i_B           86 TRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSK  159 (319)
T ss_dssp             CCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCST
T ss_pred             CCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChh
Confidence            99999999999999999999999999999999999653   34689999999999999999999999   9999999999


Q ss_pred             CeeeCCCCceEEeeccCccccCCCC----ccceeccccccCccCcccccc---------CCCCccchhhhhhHHHHHHHh
Q 037869          174 NVLLDSDFEPLVADFGFAKLIPEGV----SHMTTRVKGTLGYLAPEYAMW---------GKVSESCDVYSFGILLLEILT  240 (380)
Q Consensus       174 Nill~~~~~vkl~Dfgl~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~il~ell~  240 (380)
                      ||+++ ++.++|+|||++.......    ........|++.|+|||++.+         ..++.++|||||||++|+|++
T Consensus       160 NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~  238 (319)
T 2y4i_B          160 NVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHA  238 (319)
T ss_dssp             TEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHH
T ss_pred             hEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHh
Confidence            99998 6799999999987643211    112223458999999999874         357899999999999999999


Q ss_pred             CCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCCC
Q 037869          241 GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDPR  320 (380)
Q Consensus       241 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~~  320 (380)
                      |..||.......  ..    .. ...+     ..+..   .....+..+.+++.+||..||.+|||+.++++.|..+..+
T Consensus       239 g~~p~~~~~~~~--~~----~~-~~~~-----~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          239 REWPFKTQPAEA--II----WQ-MGTG-----MKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             SSCSSSSCCHHH--HH----HH-HHTT-----CCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             CCCCCCCCCHHH--HH----HH-hccC-----CCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            999997533210  00    00 0000     00111   1112345788999999999999999999999999987654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=328.76  Aligned_cols=255  Identities=23%  Similarity=0.249  Sum_probs=202.2

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC----hhhHHHHHHHHHHHhcCCCCcceeEeeEEe--cCCe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN----SKAEMEFAVEVEVLGRVRHKNLLGLRGYCA--GTDQ  111 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~----~~~~~~~~~E~~~l~~l~h~niv~~~~~~~--~~~~  111 (380)
                      ..++|++.+.||+|+||.||+|.+ .++..||+|+++...    ......+.+|+.+++.++||||+++++++.  ....
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            357899999999999999999997 568999999997532    234567889999999999999999999984  4567


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA  191 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~  191 (380)
                      .++||||+.++ |.+++...  ....+++..++.++.|++.||.|||++   |++||||||+||+++.++.++|+|||++
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~  156 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVA  156 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccc
Confidence            89999999876 77777543  235799999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCC-ccceeccccccCccCccccccCC--CCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccc
Q 037869          192 KLIPEGV-SHMTTRVKGTLGYLAPEYAMWGK--VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGK  268 (380)
Q Consensus       192 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (380)
                      ....... ........|++.|+|||++.+..  ++.++||||||+++|+|++|..||......      ..... ...+ 
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~------~~~~~-i~~~-  228 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY------KLFEN-IGKG-  228 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHHHH-HHHC-
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH------HHHHH-HhcC-
Confidence            8764322 22233456899999999998644  478999999999999999999999753210      00000 0000 


Q ss_pred             cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                               ....+..++..+.++|.+||+.||.+|||+.++++|.+.
T Consensus       229 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~  267 (305)
T 2wtk_C          229 ---------SYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWF  267 (305)
T ss_dssp             ---------CCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHH
T ss_pred             ---------CCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccc
Confidence                     011223345788999999999999999999999999664

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=2e-45  Score=333.74  Aligned_cols=259  Identities=29%  Similarity=0.420  Sum_probs=199.7

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe--CCCc--EEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT--SDGL--QIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQ  111 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~--~~~~--~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  111 (380)
                      ..++|++.+.||+|+||+||+|.+  .++.  .||+|+++..   .......+.+|+.+++.++||||+++++++.... 
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            457899999999999999999974  2333  6899998753   2344567889999999999999999999998654 


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA  191 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~  191 (380)
                      .++||||+++++|.+++...   ...+++..++.++.|++.||.|||++   +++||||||+||+++.++.++|+|||++
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~  168 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLM  168 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEcccccc
Confidence            89999999999999999753   34689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc--ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccc
Q 037869          192 KLIPEGVSH--MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGK  268 (380)
Q Consensus       192 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (380)
                      .........  ......++..|+|||++.+..++.++||||||+++|+|++ |..||.......  .             
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~-------------  233 (291)
T 1u46_A          169 RALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ--I-------------  233 (291)
T ss_dssp             EECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--H-------------
T ss_pred             ccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH--H-------------
Confidence            876543222  1223457888999999998889999999999999999999 999997543210  0             


Q ss_pred             cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCC
Q 037869          269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP  319 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~  319 (380)
                      .............+..++..+.+++.+||+.||.+|||+.+++++|....+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          234 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             HHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             HHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            001111111122333456789999999999999999999999999876543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=335.58  Aligned_cols=271  Identities=21%  Similarity=0.314  Sum_probs=196.7

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEec-----CCeEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG-----TDQRL  113 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~~~~  113 (380)
                      ..++|++.+.||+|+||+||+|+. +++.||||++...... ......|+..+..++||||+++++.+..     ....+
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~-~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~   88 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ-NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL   88 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchh-hHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence            457999999999999999999977 5889999999754322 1122334444556899999999986532     23578


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcC------CCCeEecCCCCCCeeeCCCCceEEee
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV------TPHIIHRDIKASNVLLDSDFEPLVAD  187 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~------~~~ivHrdlkp~Nill~~~~~vkl~D  187 (380)
                      +||||+++|+|.+++...     ..++..++.++.|++.||+|||+..      .++|+||||||+|||++.++.+||+|
T Consensus        89 lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~D  163 (336)
T 3g2f_A           89 LVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD  163 (336)
T ss_dssp             EEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECC
T ss_pred             EEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEee
Confidence            999999999999999654     4588999999999999999999752      22899999999999999999999999


Q ss_pred             ccCccccCCCC-------ccceeccccccCccCcccccc-------CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcc
Q 037869          188 FGFAKLIPEGV-------SHMTTRVKGTLGYLAPEYAMW-------GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVK  253 (380)
Q Consensus       188 fgl~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  253 (380)
                      ||++..+....       ........||+.|+|||++.+       ..++.++|||||||++|||++|..||........
T Consensus       164 FG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~  243 (336)
T 3g2f_A          164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE  243 (336)
T ss_dssp             CTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCC
T ss_pred             ccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhH
Confidence            99998764321       112234468999999999987       4567899999999999999999777654322111


Q ss_pred             cchhccchhhhhcc--------ccccccCCcccCC--CCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          254 RTITEWAEPLIVKG--------KFKELVDPKLRGD--FDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       254 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .... +........        .......+.+...  .....+..+.+||.+||+.||++|||+.++++.|..+
T Consensus       244 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~l  316 (336)
T 3g2f_A          244 YQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAEL  316 (336)
T ss_dssp             CCCT-THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHh-hhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHH
Confidence            1000 000000000        0000111111111  1234677899999999999999999999999987654

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.9e-45  Score=336.21  Aligned_cols=266  Identities=19%  Similarity=0.277  Sum_probs=199.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEe----------
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA----------  107 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~----------  107 (380)
                      ..++|++.+.||+|+||.||+|.+. +++.||+|++..........+.+|+.+++.++||||+++++++.          
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   88 (320)
T 2i6l_A            9 LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV   88 (320)
T ss_dssp             ETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred             cCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence            4679999999999999999999974 58999999998777777778999999999999999999999873          


Q ss_pred             ----cCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC-CCCc
Q 037869          108 ----GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLD-SDFE  182 (380)
Q Consensus       108 ----~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~-~~~~  182 (380)
                          .....++||||++ |+|.+++..     ..+++..++.++.|++.||+|||++   ||+||||||+||+++ .++.
T Consensus        89 ~~~~~~~~~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~  159 (320)
T 2i6l_A           89 GSLTELNSVYIVQEYME-TDLANVLEQ-----GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLV  159 (320)
T ss_dssp             --CCSCSEEEEEEECCS-EEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTE
T ss_pred             ccccccCceeEEeeccC-CCHHHHhhc-----CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCe
Confidence                3467899999997 599999864     3689999999999999999999999   999999999999997 5679


Q ss_pred             eEEeeccCccccCCCCc--cceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhcc
Q 037869          183 PLVADFGFAKLIPEGVS--HMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEW  259 (380)
Q Consensus       183 vkl~Dfgl~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~  259 (380)
                      +||+|||++........  .......++..|+|||++.+ ..++.++|||||||++|+|++|..||........  ...+
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~  237 (320)
T 2i6l_A          160 LKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ--MQLI  237 (320)
T ss_dssp             EEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHH
T ss_pred             EEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHH--HHHH
Confidence            99999999987643211  12233457999999998875 6789999999999999999999999976432110  0000


Q ss_pred             chhhh---------hccccc----cccC-C-cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          260 AEPLI---------VKGKFK----ELVD-P-KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       260 ~~~~~---------~~~~~~----~~~~-~-~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .....         ....+.    .... + ..........+.++.+||.+||+.||.+|||+.++++|.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~  308 (320)
T 2i6l_A          238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPY  308 (320)
T ss_dssp             HHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHH
T ss_pred             HHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcc
Confidence            00000         000000    0000 0 0000111234578999999999999999999999999865

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=2.7e-44  Score=337.91  Aligned_cols=264  Identities=20%  Similarity=0.275  Sum_probs=202.4

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeE--
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQR--  112 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--  112 (380)
                      ...++|++.+.||+|+||+||+|.+ .+++.||||++...  .......+.+|+.+++.++||||+++++++...+..  
T Consensus        39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~  118 (371)
T 4exu_A           39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRN  118 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTT
T ss_pred             cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccc
Confidence            3568999999999999999999987 56899999999753  333456788999999999999999999999877655  


Q ss_pred             ----EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          113 ----LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       113 ----~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                          ++||||+. ++|.+.+.      ..+++..++.++.|++.||+|||+.   ||+||||||+||+++.++.+||+||
T Consensus       119 ~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Df  188 (371)
T 4exu_A          119 FYDFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDF  188 (371)
T ss_dssp             CCCCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECST
T ss_pred             ceeEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEec
Confidence                99999997 58888874      3489999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhc-
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVK-  266 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~-  266 (380)
                      |++.....    ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||......  .....+....... 
T Consensus       189 g~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~~~~~~~~  262 (371)
T 4exu_A          189 GLARHADA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYL--DQLTQILKVTGVPG  262 (371)
T ss_dssp             TCC------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHHHHHHCCCC
T ss_pred             Cccccccc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCc
Confidence            99986543    2334568999999999987 67999999999999999999999999754311  0000000000000 


Q ss_pred             ------------cccccccCCccc---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          267 ------------GKFKELVDPKLR---GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       267 ------------~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                                  ..+.........   .......+..+.+||.+||+.||.+|||+.++++|.+.-
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~  328 (371)
T 4exu_A          263 TEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE  328 (371)
T ss_dssp             HHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGT
T ss_pred             HHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccc
Confidence                        000000000000   011123457899999999999999999999999997753

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.9e-44  Score=332.80  Aligned_cols=269  Identities=20%  Similarity=0.300  Sum_probs=204.4

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe--CCCcEEEEEEecccCh--hhHHHHHHHHHHHhcC---CCCcceeEeeEEe----
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT--SDGLQIAVKKLKAMNS--KAEMEFAVEVEVLGRV---RHKNLLGLRGYCA----  107 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l---~h~niv~~~~~~~----  107 (380)
                      ..++|++.+.||+|+||.||+|++  .+++.||+|+++....  .....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            568999999999999999999987  4578999999874321  1122455677666655   8999999999987    


Q ss_pred             -cCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEe
Q 037869          108 -GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVA  186 (380)
Q Consensus       108 -~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~  186 (380)
                       .....++||||+. |+|.+++....  ...+++..++.++.|++.||.|||+.   ||+||||||+||+++.++.++|+
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~  162 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLA  162 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEEC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEe
Confidence             5567899999997 59999987542  23589999999999999999999999   99999999999999999999999


Q ss_pred             eccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhh-
Q 037869          187 DFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIV-  265 (380)
Q Consensus       187 Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-  265 (380)
                      |||++......  .......|++.|+|||++.+..++.++|||||||++|+|++|..||.......  ....+...... 
T Consensus       163 Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~i~~~~~~~  238 (326)
T 1blx_A          163 DFGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGLP  238 (326)
T ss_dssp             SCCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCC
T ss_pred             cCcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHHHcCCC
Confidence            99999875432  22334568999999999999999999999999999999999999997543211  00000000000 


Q ss_pred             -ccccc----------cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          266 -KGKFK----------ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       266 -~~~~~----------~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                       ...+.          ...............+..+.+||.+||+.||.+|||+.++++|.+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  301 (326)
T 1blx_A          239 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ  301 (326)
T ss_dssp             CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGT
T ss_pred             CcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCcccc
Confidence             00000          00000011122234557889999999999999999999999996643

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=6.8e-45  Score=340.47  Aligned_cols=274  Identities=22%  Similarity=0.258  Sum_probs=195.4

Q ss_pred             HHHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCe-
Q 037869           34 KELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQ-  111 (380)
Q Consensus        34 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-  111 (380)
                      .+.....++|++.+.||+|+||+||+|.+ .+++.||||++.... .......++++.++.++||||+++++++..... 
T Consensus        16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~   94 (360)
T 3e3p_A           16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER   94 (360)
T ss_dssp             HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred             hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence            44556778999999999999999999987 568999999986532 222356678888888999999999999865333 


Q ss_pred             ------EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHh--hcCCCCeEecCCCCCCeeeCC-CCc
Q 037869          112 ------RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH--HEVTPHIIHRDIKASNVLLDS-DFE  182 (380)
Q Consensus       112 ------~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH--~~~~~~ivHrdlkp~Nill~~-~~~  182 (380)
                            .++||||+++ +|...+.........+++..++.++.|++.||.|||  +.   ||+||||||+|||++. ++.
T Consensus        95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~  170 (360)
T 3e3p_A           95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGT  170 (360)
T ss_dssp             CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTE
T ss_pred             cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCc
Confidence                  7899999986 555555433234567899999999999999999999  77   9999999999999996 899


Q ss_pred             eEEeeccCccccCCCCccceeccccccCccCccccccCC-CCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccch
Q 037869          183 PLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE  261 (380)
Q Consensus       183 vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  261 (380)
                      +||+|||++.......  ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||......  .....+..
T Consensus       171 ~kl~Dfg~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~--~~~~~~~~  246 (360)
T 3e3p_A          171 LKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA--GQLHEIVR  246 (360)
T ss_dssp             EEECCCTTCBCCCTTS--CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH
T ss_pred             EEEeeCCCceecCCCC--CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH--HHHHHHHH
Confidence            9999999998765432  233456899999999987654 899999999999999999999999764321  11111000


Q ss_pred             hhhh-----------c-ccccc-----ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          262 PLIV-----------K-GKFKE-----LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       262 ~~~~-----------~-~~~~~-----~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ....           . .....     ..............+.++.+||.+||+.||.+|||+.++++|.+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f  318 (360)
T 3e3p_A          247 VLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYF  318 (360)
T ss_dssp             HHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGG
T ss_pred             HcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccc
Confidence            0000           0 00000     000001111222356789999999999999999999999999764

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.2e-44  Score=328.22  Aligned_cols=256  Identities=23%  Similarity=0.317  Sum_probs=206.5

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ....++|++.+.||+|+||.||+|.+. +++.||+|++...  .......+.+|+.++++++||||+++++++...+..+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   97 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFY   97 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEE
Confidence            345679999999999999999999874 7899999998643  2334567889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC---CceEEeeccC
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD---FEPLVADFGF  190 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~---~~vkl~Dfgl  190 (380)
                      +||||+++++|.+.+...    ..+++..++.++.|++.||.|||+.   |++||||||+||+++.+   +.+||+|||+
T Consensus        98 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            999999999999988643    4689999999999999999999999   99999999999999764   4799999999


Q ss_pred             ccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          191 AKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       191 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      +.......  ......|++.|+|||++.+ .++.++||||||+++|+|++|..||.......  .    ... ...+...
T Consensus       171 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~--~----~~~-~~~~~~~  240 (287)
T 2wei_A          171 STCFQQNT--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD--I----LKR-VETGKYA  240 (287)
T ss_dssp             GGTBCCCS--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--H----HHH-HHHCCCC
T ss_pred             ceeecCCC--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH--H----HHH-HHcCCCC
Confidence            98765432  2233458999999999876 48999999999999999999999997543210  0    000 0001000


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                            .........+..+.++|.+||+.||.+|||+.++++|.+
T Consensus       241 ------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~  279 (287)
T 2wei_A          241 ------FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPW  279 (287)
T ss_dssp             ------CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHH
T ss_pred             ------CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHH
Confidence                  000111234578899999999999999999999999865

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=341.72  Aligned_cols=261  Identities=16%  Similarity=0.181  Sum_probs=203.6

Q ss_pred             hCCCCCcceeccCCceEEEEEEeCC---------CcEEEEEEecccChhhHHHHHHHHHHHhcCCCCccee---------
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTSD---------GLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG---------  101 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~---------  101 (380)
                      .++|++.+.||+|+||.||+|.+..         ++.||+|++...     ..+.+|+.+++.++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            5799999999999999999998753         789999999754     26778999999999999987         


Q ss_pred             ------EeeEEec-CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 037869          102 ------LRGYCAG-TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASN  174 (380)
Q Consensus       102 ------~~~~~~~-~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~N  174 (380)
                            +++++.. ++..++||||+ +++|.+++...  ....+++..++.++.|++.||.|||++   +|+||||||+|
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~N  189 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAEN  189 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGG
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHH
Confidence                  6677765 78899999999 99999999754  135799999999999999999999999   99999999999


Q ss_pred             eeeCCCC--ceEEeeccCccccCCCCcc------ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCC
Q 037869          175 VLLDSDF--EPLVADFGFAKLIPEGVSH------MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIE  246 (380)
Q Consensus       175 ill~~~~--~vkl~Dfgl~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~  246 (380)
                      |+++.++  .++|+|||++..+......      ......||+.|+|||++.+..++.++|||||||++|+|++|..||.
T Consensus       190 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~  269 (352)
T 2jii_A          190 IFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT  269 (352)
T ss_dssp             EEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999998  8999999999876432111      1233468999999999999999999999999999999999999997


Q ss_pred             CCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          247 KLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ............ ....  ......+....   ......+..+.+|+.+||+.||.+|||+.+|++.|..+
T Consensus       270 ~~~~~~~~~~~~-~~~~--~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~  334 (352)
T 2jii_A          270 NCLPNTEDIMKQ-KQKF--VDKPGPFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEAL  334 (352)
T ss_dssp             GGTTCHHHHHHH-HHHH--HHSCCCEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cCCcCHHHHHHH-HHhc--cCChhhhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHH
Confidence            643221111100 0000  00001111000   00112347899999999999999999999999998654

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.5e-44  Score=340.79  Aligned_cols=267  Identities=22%  Similarity=0.243  Sum_probs=206.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCC--------CCcceeEeeEEe--
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR--------HKNLLGLRGYCA--  107 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~~~~~~~--  107 (380)
                      ..++|++.+.||+|+||+||+|++ .+++.||||+++.. ......+.+|+.+++.++        |+||+++++++.  
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            468999999999999999999987 56889999999754 344557888999999885        788999999987  


Q ss_pred             --cCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC----
Q 037869          108 --GTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF----  181 (380)
Q Consensus       108 --~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~----  181 (380)
                        .....++||||+ +++|.+.+...  ....+++..++.++.||+.||.|||+++  ||+||||||+|||++.++    
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhh
Confidence              556799999999 56777666543  2246999999999999999999999852  799999999999998775    


Q ss_pred             ---------------------------------------------ceEEeeccCccccCCCCccceeccccccCccCccc
Q 037869          182 ---------------------------------------------EPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY  216 (380)
Q Consensus       182 ---------------------------------------------~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~  216 (380)
                                                                   .+||+|||++......    .....||+.|+|||+
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence                                                         7999999999876432    233468999999999


Q ss_pred             cccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccc-hhccchhhh----------hccc-----------cccccC
Q 037869          217 AMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRT-ITEWAEPLI----------VKGK-----------FKELVD  274 (380)
Q Consensus       217 ~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~-~~~~~~~~~----------~~~~-----------~~~~~~  274 (380)
                      +.+..++.++|||||||++|+|++|..||.......... .........          ..+.           +.....
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            999999999999999999999999999997654322110 000000000          0000           000000


Q ss_pred             Cc---------ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          275 PK---------LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       275 ~~---------~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ..         .....+...+..+.+||.+||+.||.+|||+.++++|.+
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~  394 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPW  394 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGG
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcc
Confidence            00         011345677889999999999999999999999999976

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.4e-44  Score=360.96  Aligned_cols=246  Identities=25%  Similarity=0.400  Sum_probs=199.4

Q ss_pred             ceeccCCceEEEEEEe---CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCC
Q 037869           47 NKLGEGGFGSVYWGRT---SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPN  121 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~---~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  121 (380)
                      +.||+|+||+||+|.+   ..+..||||+++..  .......+.+|+.+|+.++||||+++++++. .+..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence            4799999999999954   34688999999753  2334568999999999999999999999997 4568999999999


Q ss_pred             CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc--
Q 037869          122 LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS--  199 (380)
Q Consensus       122 g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~--  199 (380)
                      |+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.+.....  
T Consensus       454 g~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~  526 (635)
T 4fl3_A          454 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  526 (635)
T ss_dssp             EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----
T ss_pred             CCHHHHHhhC----CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccc
Confidence            9999999643    4689999999999999999999999   999999999999999999999999999987654322  


Q ss_pred             cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          200 HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       200 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.......                +...+.....
T Consensus       527 ~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----------------~~~~i~~~~~  590 (635)
T 4fl3_A          527 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------VTAMLEKGER  590 (635)
T ss_dssp             --------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----------------HHHHHHTTCC
T ss_pred             ccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHcCCC
Confidence            12223346789999999999999999999999999999998 999997643210                1111112222


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ...+..++.++.+||.+||+.||++|||+.+|++.|..
T Consensus       591 ~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~  628 (635)
T 4fl3_A          591 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  628 (635)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            33445566889999999999999999999999998864

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.3e-44  Score=332.53  Aligned_cols=267  Identities=21%  Similarity=0.295  Sum_probs=206.7

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe--CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCC------cceeEeeEEecCC
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT--SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHK------NLLGLRGYCAGTD  110 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~~~~~~~~~~  110 (380)
                      ..++|++.+.||+|+||+||+|.+  .+++.||||+++.. ......+.+|+.+++.++|+      +++++++++...+
T Consensus        12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~   90 (339)
T 1z57_A           12 LSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG   90 (339)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred             ccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence            567999999999999999999986  36889999999754 33445778899988887654      5999999999999


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-----------
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS-----------  179 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~-----------  179 (380)
                      ..++||||+ +++|.+++...  ....+++..++.++.|++.||+|||++   ||+||||||+||+++.           
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred             cEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCcc
Confidence            999999999 88999999754  224689999999999999999999999   9999999999999987           


Q ss_pred             --------CCceEEeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCC
Q 037869          180 --------DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGG  251 (380)
Q Consensus       180 --------~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  251 (380)
                              ++.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             ccccccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                    668999999999875432    23446899999999999999999999999999999999999999754321


Q ss_pred             cccchh-ccch----hhhhc---c--------cc----------ccccCC-cccCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 037869          252 VKRTIT-EWAE----PLIVK---G--------KF----------KELVDP-KLRGDFDENQLKQAINVAVLCVQSEPEKR  304 (380)
Q Consensus       252 ~~~~~~-~~~~----~~~~~---~--------~~----------~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~P~~R  304 (380)
                      ...... ....    .....   .        .+          .....+ ..........+..+.+||.+||+.||.+|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            100000 0000    00000   0        00          000000 00112234567889999999999999999


Q ss_pred             CCHHHHHHHhcC
Q 037869          305 PNMKEVVNTLTG  316 (380)
Q Consensus       305 ps~~~ll~~l~~  316 (380)
                      ||+.++++|.+.
T Consensus       321 pt~~ell~hp~f  332 (339)
T 1z57_A          321 ITLREALKHPFF  332 (339)
T ss_dssp             CCHHHHTTSGGG
T ss_pred             cCHHHHhcCHHH
Confidence            999999999663

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.4e-44  Score=334.05  Aligned_cols=268  Identities=22%  Similarity=0.277  Sum_probs=204.1

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecC-----Ce
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGT-----DQ  111 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~  111 (380)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||++... .......+.+|+.+++.++||||+++++++..+     ..
T Consensus         9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   88 (353)
T 2b9h_A            9 ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE   88 (353)
T ss_dssp             SCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred             cccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence            567999999999999999999987 46899999999753 334455788899999999999999999987654     67


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA  191 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~  191 (380)
                      .++||||+. ++|.+++..     ..+++..++.++.|++.||+|||++   ||+||||||+||+++.++.+||+|||++
T Consensus        89 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  159 (353)
T 2b9h_A           89 VYIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLA  159 (353)
T ss_dssp             EEEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTC
T ss_pred             EEEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccc
Confidence            899999997 589998864     3689999999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCcc---------ceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccch
Q 037869          192 KLIPEGVSH---------MTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE  261 (380)
Q Consensus       192 ~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  261 (380)
                      .........         ......||+.|+|||++.+ ..++.++|||||||++|+|++|..||........  ...+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~  237 (353)
T 2b9h_A          160 RIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ--LLLIFG  237 (353)
T ss_dssp             EECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHH
T ss_pred             cccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH--HHHHHH
Confidence            876432211         1223468999999998764 7789999999999999999999999976432100  000000


Q ss_pred             hh---------------hhccccccccC--CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          262 PL---------------IVKGKFKELVD--PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       262 ~~---------------~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ..               ........+..  ...........+.++.+||.+||+.||.+|||+.++++|.+..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~  310 (353)
T 2b9h_A          238 IIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQ  310 (353)
T ss_dssp             HHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             HhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCcccc
Confidence            00               00000000000  0000011123457889999999999999999999999997643

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2e-43  Score=341.26  Aligned_cols=261  Identities=20%  Similarity=0.296  Sum_probs=205.7

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCC-CcceeEeeEEecCCeEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRH-KNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~  116 (380)
                      ..++|++.++||+|+||.||+|.+ .+++.||||++......  ..+..|+++++.++| ++|..+..++...+..++||
T Consensus         5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm   82 (483)
T 3sv0_A            5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM   82 (483)
T ss_dssp             ETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence            457999999999999999999987 57899999998754322  257789999999987 55666666677788899999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee---CCCCceEEeeccCccc
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLL---DSDFEPLVADFGFAKL  193 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill---~~~~~vkl~Dfgl~~~  193 (380)
                      ||+ +++|.+++...   ...+++..++.++.||+.||.|||++   +|+||||||+||||   +.++.+||+|||+++.
T Consensus        83 e~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~  155 (483)
T 3sv0_A           83 DLL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK  155 (483)
T ss_dssp             ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred             ECC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCccee
Confidence            999 89999999743   34699999999999999999999999   99999999999999   5789999999999987


Q ss_pred             cCCCCcc------ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcc
Q 037869          194 IPEGVSH------MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKG  267 (380)
Q Consensus       194 ~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  267 (380)
                      +......      ......||+.|+|||++.+..++.++|||||||++|||++|..||......................
T Consensus       156 ~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~  235 (483)
T 3sv0_A          156 YRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT  235 (483)
T ss_dssp             CBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred             ccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence            6543221      1224579999999999999999999999999999999999999998654322111111110000000


Q ss_pred             ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .+.         .....++.++.+||..||+.+|.+||++.+|++.|..+
T Consensus       236 ~~~---------~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          236 SIE---------ALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             CHH---------HHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cHH---------HHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            000         11112346899999999999999999999999876544

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=4.1e-44  Score=332.13  Aligned_cols=257  Identities=23%  Similarity=0.246  Sum_probs=178.9

Q ss_pred             hhCCCCCcc-eeccCCceEEEEEEeC-CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEec----CCeE
Q 037869           39 ATNGFSDDN-KLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG----TDQR  112 (380)
Q Consensus        39 ~~~~y~~~~-~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~  112 (380)
                      ..++|.+.+ .||+|+||+||+|.+. +++.||||++.... .   ........++.++||||+++++++..    ....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            567899865 6999999999999874 79999999997532 2   11222334566799999999999875    4558


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---CCceEEeecc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS---DFEPLVADFG  189 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~---~~~vkl~Dfg  189 (380)
                      ++||||+++|+|.+++...  ....+++..++.++.|++.||.|||+.   ||+||||||+||+++.   ++.+||+|||
T Consensus       102 ~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccc
Confidence            9999999999999999754  234699999999999999999999999   9999999999999976   4559999999


Q ss_pred             CccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccc
Q 037869          190 FAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKF  269 (380)
Q Consensus       190 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  269 (380)
                      ++......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||...........  ... ...    
T Consensus       177 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~-~~~----  246 (336)
T 3fhr_A          177 FAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPG--MKR-RIR----  246 (336)
T ss_dssp             TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------------------------
T ss_pred             cceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhh--HHH-hhh----
Confidence            99875432   23344689999999999988999999999999999999999999965432111000  000 000    


Q ss_pred             ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                        ..............+..+.+||.+||+.||.+|||+.++++|.+.
T Consensus       247 --~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~  291 (336)
T 3fhr_A          247 --LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWI  291 (336)
T ss_dssp             ------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHH
T ss_pred             --ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccc
Confidence              000011111123445789999999999999999999999999764

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.7e-44  Score=343.56  Aligned_cols=261  Identities=23%  Similarity=0.333  Sum_probs=195.8

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ..+.|.+.+.||+|+||+||.+...+|+.||||++....   ...+.+|+.+++.+ +||||+++++++...+..|+|||
T Consensus        13 l~~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           13 LKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             CSSCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             hhheeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            345666778999999999988777789999999987532   33677899999876 89999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCcc---CCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-------------C
Q 037869          118 YMPNLSLLSHLHGQYAGEVQ---LDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD-------------F  181 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~---~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~-------------~  181 (380)
                      ||. |+|.+++.........   .++..++.++.|++.||+|||++   ||+||||||+|||++.+             +
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~  165 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENL  165 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCce
Confidence            996 6999999754221111   13335678999999999999999   99999999999999754             4


Q ss_pred             ceEEeeccCccccCCCCcc---ceeccccccCccCcccccc-------CCCCccchhhhhhHHHHHHHh-CCCCCCCCCC
Q 037869          182 EPLVADFGFAKLIPEGVSH---MTTRVKGTLGYLAPEYAMW-------GKVSESCDVYSFGILLLEILT-GRKPIEKLPG  250 (380)
Q Consensus       182 ~vkl~Dfgl~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~ell~-g~~p~~~~~~  250 (380)
                      .+||+|||++.........   ......||+.|+|||++.+       ..++.++|||||||++|||++ |..||.....
T Consensus       166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~  245 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS  245 (434)
T ss_dssp             EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred             EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence            8999999999887543221   1234569999999999976       568999999999999999999 9999965322


Q ss_pred             CcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          251 GVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      ...         ....+..   ..+..........+.++.+||.+||+.||.+|||+.++++|.+...
T Consensus       246 ~~~---------~i~~~~~---~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          246 RES---------NIIRGIF---SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HHH---------HHHHTCC---CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             hHH---------HHhcCCC---CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            110         0001100   0111122234567789999999999999999999999999987643

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=2.5e-44  Score=332.27  Aligned_cols=262  Identities=25%  Similarity=0.357  Sum_probs=185.4

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHH-HHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVE-VLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~-~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ..++|++.+.||+|+||.||+|.+ .+++.||||+++... ......+..|+. +++.++||||+++++++...+..++|
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv   99 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWIC   99 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEE
Confidence            568999999999999999999987 478999999997643 333445566666 77888999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCC-CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          116 YDYMPNLSLLSHLHGQY-AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~-~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      |||+++ +|.+++.... .....+++..++.++.|++.||.|||+..  |++||||||+||+++.++.+||+|||++...
T Consensus       100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~--~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~  176 (327)
T 3aln_A          100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGISGQL  176 (327)
T ss_dssp             ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHH--SCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred             EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccC--CEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence            999975 8877775311 12357899999999999999999999842  7999999999999999999999999999876


Q ss_pred             CCCCccceeccccccCccCcccc----ccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYA----MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      ....  ......||+.|+|||++    .+..++.++|||||||++|+|++|..||........ ....          ..
T Consensus       177 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~~~----------~~  243 (327)
T 3aln_A          177 VDSI--AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD-QLTQ----------VV  243 (327)
T ss_dssp             -------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------CC----------CC
T ss_pred             cccc--ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH-HHHH----------Hh
Confidence            4322  22333689999999998    456789999999999999999999999975322100 0000          00


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ....+.+........+..+.+||.+||+.||.+|||+.++++|.+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~  289 (327)
T 3aln_A          244 KGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFI  289 (327)
T ss_dssp             CSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHH
T ss_pred             cCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHH
Confidence            0011111111222345789999999999999999999999998664

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5.6e-45  Score=335.72  Aligned_cols=264  Identities=25%  Similarity=0.375  Sum_probs=204.7

Q ss_pred             CCCCCccceeccHHHHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChh------hHHHHHHHHHHHhc
Q 037869           21 TTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSK------AEMEFAVEVEVLGR   93 (380)
Q Consensus        21 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~   93 (380)
                      +++...+.+.....+.....++|++.+.||+|+||.||+|.+ .+++.||||++......      ....+.+|+.+++.
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~  102 (320)
T 3a99_A           23 PCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK  102 (320)
T ss_dssp             -----------------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHH
T ss_pred             hHHHhhhhccCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHh
Confidence            344444455566677777889999999999999999999987 57899999998753211      12356678999999


Q ss_pred             CC--CCcceeEeeEEecCCeEEEEEEecCC-CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 037869           94 VR--HKNLLGLRGYCAGTDQRLIVYDYMPN-LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDI  170 (380)
Q Consensus        94 l~--h~niv~~~~~~~~~~~~~lv~e~~~~-g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdl  170 (380)
                      ++  |+||+++++++...+..++|||++.+ ++|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||
T Consensus       103 l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dl  175 (320)
T 3a99_A          103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDI  175 (320)
T ss_dssp             HCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCC
T ss_pred             hccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCC
Confidence            86  59999999999999999999999976 8999998653    4689999999999999999999999   9999999


Q ss_pred             CCCCeeeC-CCCceEEeeccCccccCCCCccceeccccccCccCccccccCCC-CccchhhhhhHHHHHHHhCCCCCCCC
Q 037869          171 KASNVLLD-SDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEKL  248 (380)
Q Consensus       171 kp~Nill~-~~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~  248 (380)
                      ||+||+++ .++.+||+|||++......   ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||...
T Consensus       176 kp~NIll~~~~~~~kL~Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  252 (320)
T 3a99_A          176 KDENILIDLNRGELKLIDFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD  252 (320)
T ss_dssp             SGGGEEEETTTTEEEECCCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred             CHHHEEEeCCCCCEEEeeCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence            99999999 7789999999999876542   2233468999999999987665 78899999999999999999999642


Q ss_pred             CCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          249 PGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ..             .....          ...+...+..+.+||.+||+.||.+|||+.++++|.+..
T Consensus       253 ~~-------------~~~~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~  298 (320)
T 3a99_A          253 EE-------------IIRGQ----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ  298 (320)
T ss_dssp             HH-------------HHHCC----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             hh-------------hhccc----------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhc
Confidence            10             00000          011223346889999999999999999999999997643

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.2e-44  Score=360.84  Aligned_cols=259  Identities=23%  Similarity=0.360  Sum_probs=206.9

Q ss_pred             HHHhhCCCCCcceeccCCceEEEEEEeC----CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC
Q 037869           36 LHTATNGFSDDNKLGEGGFGSVYWGRTS----DGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD  110 (380)
Q Consensus        36 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~----~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~  110 (380)
                      .....++|++.+.||+|+||.||+|.+.    .+..||+|.++.. .......+.+|+.+++.++||||+++++++. ++
T Consensus       385 ~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~  463 (656)
T 2j0j_A          385 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN  463 (656)
T ss_dssp             TBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             cccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence            3345678999999999999999999863    2467999998753 3344567889999999999999999999985 56


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccC
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGF  190 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl  190 (380)
                      ..++||||+++|+|.+++...   ...+++..++.++.|++.||.|||++   ||+||||||+|||++.++.+||+|||+
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~  537 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGL  537 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCC
Confidence            789999999999999999753   34689999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhcccc
Q 037869          191 AKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKF  269 (380)
Q Consensus       191 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  269 (380)
                      +...............+++.|+|||++.+..++.++|||||||++|||++ |..||.......  ..    .      .+
T Consensus       538 a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~----~------~i  605 (656)
T 2j0j_A          538 SRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND--VI----G------RI  605 (656)
T ss_dssp             CCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH--HH----H------HH
T ss_pred             CeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH--HH----H------HH
Confidence            98775443333334457889999999998999999999999999999997 999997543210  00    0      00


Q ss_pred             ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                          ........+..++..+.+||.+||+.||.+|||+.++++.|..+
T Consensus       606 ----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~i  649 (656)
T 2j0j_A          606 ----ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI  649 (656)
T ss_dssp             ----HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----HcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                01111223445567899999999999999999999999988643

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-44  Score=332.13  Aligned_cols=254  Identities=24%  Similarity=0.371  Sum_probs=196.6

Q ss_pred             HHHHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChh------hHHHHHHHHHHHhcC----CCCccee
Q 037869           33 YKELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSK------AEMEFAVEVEVLGRV----RHKNLLG  101 (380)
Q Consensus        33 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~E~~~l~~l----~h~niv~  101 (380)
                      ..+.....++|++.+.||+|+||.||+|++ .+++.||||++......      ....+.+|+.++..+    +||||++
T Consensus        23 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~  102 (312)
T 2iwi_A           23 GKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIR  102 (312)
T ss_dssp             ----------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCC
T ss_pred             ccchhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeee
Confidence            344556778999999999999999999987 57889999999754321      222455688888888    8999999


Q ss_pred             EeeEEecCCeEEEEEEe-cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC-C
Q 037869          102 LRGYCAGTDQRLIVYDY-MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLD-S  179 (380)
Q Consensus       102 ~~~~~~~~~~~~lv~e~-~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~-~  179 (380)
                      +++++...+..++|||+ +.+++|.+++...    ..+++..++.++.|++.||.|||+.   ||+||||||+||+++ .
T Consensus       103 ~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~  175 (312)
T 2iwi_A          103 LLDWFETQEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLR  175 (312)
T ss_dssp             EEEEC-----CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETT
T ss_pred             EEEEEecCCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCC
Confidence            99999988999999999 7899999999653    4699999999999999999999999   999999999999999 7


Q ss_pred             CCceEEeeccCccccCCCCccceeccccccCccCccccccCCC-CccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhc
Q 037869          180 DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITE  258 (380)
Q Consensus       180 ~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~  258 (380)
                      ++.++|+|||++......   ......|+..|+|||++.+..+ +.++|||||||++|+|++|..||.....        
T Consensus       176 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--------  244 (312)
T 2iwi_A          176 RGCAKLIDFGSGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE--------  244 (312)
T ss_dssp             TTEEEECCCSSCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH--------
T ss_pred             CCeEEEEEcchhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH--------
Confidence            899999999999876542   2234568999999999987665 4589999999999999999999964210        


Q ss_pred             cchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCCC
Q 037869          259 WAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYDP  319 (380)
Q Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~~  319 (380)
                           ....          ....+...+..+.++|.+||+.||++|||+.++++|.+....
T Consensus       245 -----~~~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~  290 (312)
T 2iwi_A          245 -----ILEA----------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP  290 (312)
T ss_dssp             -----HHHT----------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred             -----Hhhh----------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence                 0000          011223345788999999999999999999999999775443

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7.7e-44  Score=332.60  Aligned_cols=261  Identities=20%  Similarity=0.268  Sum_probs=201.7

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCe----
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQ----  111 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~----  111 (380)
                      ..++|++.+.||+|+||.||+|.+ .+|+.||||++...  .......+.+|+.+++.++||||+++++++.....    
T Consensus        22 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           22 LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             cCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            357899999999999999999987 57999999999753  33345578899999999999999999999987654    


Q ss_pred             --EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeecc
Q 037869          112 --RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG  189 (380)
Q Consensus       112 --~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfg  189 (380)
                        .++||||+. ++|.+++.      ..+++..++.++.|++.||.|||++   ||+||||||+||+++.++.+||+|||
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg  171 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFG  171 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTT
T ss_pred             eeEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecc
Confidence              499999997 58888774      2489999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhh---
Q 037869          190 FAKLIPEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIV---  265 (380)
Q Consensus       190 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~---  265 (380)
                      ++......    .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.......  ....+......   
T Consensus       172 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~--~~~~i~~~~~~~~~  245 (353)
T 3coi_A          172 LARHADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD--QLTQILKVTGVPGT  245 (353)
T ss_dssp             CTTC------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHH--HHHHHHHHHCBCCH
T ss_pred             cccCCCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHHHhCCCCH
Confidence            99865332    234468999999999886 678999999999999999999999997643210  00000000000   


Q ss_pred             -------c-------cccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          266 -------K-------GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       266 -------~-------~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                             .       ..+....... ........+..+.+||.+||+.||.+|||+.++++|.+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f  309 (353)
T 3coi_A          246 EFVQKLNDKAAKSYIQSLPQTPRKD-FTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF  309 (353)
T ss_dssp             HHHTTCSCHHHHHHHHTSCBCSSCC-TTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGG
T ss_pred             HHHHHHhhHHHHHHHHhCcCCCCcc-HHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcch
Confidence                   0       0000000000 112223456789999999999999999999999999774

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.5e-43  Score=334.17  Aligned_cols=276  Identities=18%  Similarity=0.211  Sum_probs=207.8

Q ss_pred             ccHHHHHHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCC-CC-----cceeEe
Q 037869           31 FTYKELHTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR-HK-----NLLGLR  103 (380)
Q Consensus        31 ~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~~~  103 (380)
                      |.........++|++.+.||+|+||+||+|.+ .+++.||||+++.. ......+..|+.+++.++ |+     +|++++
T Consensus        44 ~~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~  122 (382)
T 2vx3_A           44 YIVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLK  122 (382)
T ss_dssp             BCCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEE
T ss_pred             EEeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEee
Confidence            34444455678999999999999999999987 46889999999753 233456777888887774 44     599999


Q ss_pred             eEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC--CCC
Q 037869          104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLD--SDF  181 (380)
Q Consensus       104 ~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~--~~~  181 (380)
                      +++...+..++||||+. |+|.+++....  ...+++..++.++.|++.||.|||++ ..||+||||||+|||++  .++
T Consensus       123 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~  198 (382)
T 2vx3_A          123 RHFMFRNHLCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRS  198 (382)
T ss_dssp             EEEEETTEEEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSC
T ss_pred             eeeccCCceEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCC
Confidence            99999999999999996 59999997542  24589999999999999999999953 22899999999999995  468


Q ss_pred             ceEEeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccch
Q 037869          182 EPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE  261 (380)
Q Consensus       182 ~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  261 (380)
                      .+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......  ....+..
T Consensus       199 ~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~--~~~~i~~  272 (382)
T 2vx3_A          199 AIKIVDFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD--QMNKIVE  272 (382)
T ss_dssp             CEEECCCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHH
T ss_pred             cEEEEeccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHH
Confidence            8999999999876432    234568999999999999999999999999999999999999997643211  0000000


Q ss_pred             hh------h--------------hccccc--------------------cccC---------CcccCCCCHHHHHHHHHH
Q 037869          262 PL------I--------------VKGKFK--------------------ELVD---------PKLRGDFDENQLKQAINV  292 (380)
Q Consensus       262 ~~------~--------------~~~~~~--------------------~~~~---------~~~~~~~~~~~~~~~~~l  292 (380)
                      ..      .              ..+.+.                    ..+.         ..............+.+|
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl  352 (382)
T 2vx3_A          273 VLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDL  352 (382)
T ss_dssp             HHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHH
T ss_pred             HhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHH
Confidence            00      0              000000                    0000         000001122344689999


Q ss_pred             HHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          293 AVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       293 i~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      |.+||+.||++|||+.++++|.+..
T Consensus       353 i~~mL~~dP~~Rpta~e~L~hp~f~  377 (382)
T 2vx3_A          353 ILRMLDYDPKTRIQPYYALQHSFFK  377 (382)
T ss_dssp             HHHHTCSCTTTSCCHHHHTTSGGGC
T ss_pred             HHHhcCCChhhCCCHHHHhcCcccc
Confidence            9999999999999999999997743

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.4e-43  Score=331.45  Aligned_cols=269  Identities=22%  Similarity=0.261  Sum_probs=204.7

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCC-----------CCcceeEeeEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR-----------HKNLLGLRGYC  106 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~  106 (380)
                      ..++|++.+.||+|+||+||+|.+ .+++.||||++... ......+.+|+.+++.++           ||||+++++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~   95 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF   95 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence            357899999999999999999987 57899999999753 334457788999988876           89999999998


Q ss_pred             ecCC----eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC----
Q 037869          107 AGTD----QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLD----  178 (380)
Q Consensus       107 ~~~~----~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~----  178 (380)
                      ...+    ..++||||+ +++|.+++....  ...+++..++.++.|++.||+|||++.  ||+||||||+|||++    
T Consensus        96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           96 NHKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             EEEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEET
T ss_pred             hccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCC
Confidence            7644    789999999 889999997542  345899999999999999999999842  899999999999994    


Q ss_pred             --CCCceEEeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccch
Q 037869          179 --SDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI  256 (380)
Q Consensus       179 --~~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  256 (380)
                        ..+.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|+|++|..||...........
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  246 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD  246 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred             CcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCCh
Confidence              4458999999999876432    2334689999999999999999999999999999999999999975442211100


Q ss_pred             h-ccchhhhhcc---------------------ccccccCC---------cccCCCCHHHHHHHHHHHHhhcCCCCCCCC
Q 037869          257 T-EWAEPLIVKG---------------------KFKELVDP---------KLRGDFDENQLKQAINVAVLCVQSEPEKRP  305 (380)
Q Consensus       257 ~-~~~~~~~~~~---------------------~~~~~~~~---------~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp  305 (380)
                      . .........+                     .+......         ......+...+.++.+||.+||+.||.+||
T Consensus       247 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  326 (373)
T 1q8y_A          247 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA  326 (373)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred             HHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccC
Confidence            0 0000000000                     00000000         011235567888999999999999999999


Q ss_pred             CHHHHHHHhcCC
Q 037869          306 NMKEVVNTLTGY  317 (380)
Q Consensus       306 s~~~ll~~l~~~  317 (380)
                      |+.++++|.+..
T Consensus       327 t~~ell~hp~f~  338 (373)
T 1q8y_A          327 DAGGLVNHPWLK  338 (373)
T ss_dssp             CHHHHHTCGGGT
T ss_pred             CHHHHhhChhhh
Confidence            999999997754

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.2e-43  Score=328.12  Aligned_cols=267  Identities=21%  Similarity=0.264  Sum_probs=203.7

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC-CC-cEEEEEEecccChhhHHHHHHHHHHHhcCCCCc------ceeEeeEEecCC
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS-DG-LQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKN------LLGLRGYCAGTD  110 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~-~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~~~~~~~~~~  110 (380)
                      ..++|++.+.||+|+||+||+|.+. ++ ..||+|+++.. ......+.+|+.+++.++|++      ++.+++++...+
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~   95 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG   95 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence            5689999999999999999999873 44 68999999753 344557788999998887655      899999999999


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee-------------
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLL-------------  177 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill-------------  177 (380)
                      ..++||||+ +++|.+.+...  ....+++..++.++.||+.||+|||++   ||+||||||+|||+             
T Consensus        96 ~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           96 HMCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             eEEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccc
Confidence            999999999 56777777543  224689999999999999999999999   99999999999999             


Q ss_pred             ------CCCCceEEeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCC
Q 037869          178 ------DSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGG  251 (380)
Q Consensus       178 ------~~~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  251 (380)
                            +.++.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHEH----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTSC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccCCCcEEEeecCcccccccc----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                  56789999999999865432    23456899999999999999999999999999999999999999754321


Q ss_pred             cccchh-ccc----hhhhhccc---------------------cccccC-CcccCCCCHHHHHHHHHHHHhhcCCCCCCC
Q 037869          252 VKRTIT-EWA----EPLIVKGK---------------------FKELVD-PKLRGDFDENQLKQAINVAVLCVQSEPEKR  304 (380)
Q Consensus       252 ~~~~~~-~~~----~~~~~~~~---------------------~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~P~~R  304 (380)
                      ...... ...    ........                     ...... ...........+.++.+||.+||+.||.+|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            100000 000    00000000                     000000 000011223456789999999999999999


Q ss_pred             CCHHHHHHHhcC
Q 037869          305 PNMKEVVNTLTG  316 (380)
Q Consensus       305 ps~~~ll~~l~~  316 (380)
                      ||+.++++|.+.
T Consensus       326 pt~~e~l~hp~f  337 (355)
T 2eu9_A          326 ITLAEALLHPFF  337 (355)
T ss_dssp             CCHHHHTTSGGG
T ss_pred             cCHHHHhcChhh
Confidence            999999999764

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.7e-44  Score=339.97  Aligned_cols=257  Identities=20%  Similarity=0.287  Sum_probs=194.0

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ....+|.+.+.||+|+||+||.....+++.||||++......   .+.+|+.+|+.+ +||||+++++++......|+||
T Consensus        21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~   97 (432)
T 3p23_A           21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI   97 (432)
T ss_dssp             ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence            345679999999999999977665667999999999754322   356799999998 7999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-----CCceEEeeccCc
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS-----DFEPLVADFGFA  191 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~-----~~~vkl~Dfgl~  191 (380)
                      |||. |+|.+++....   ....+..++.++.|++.||.|||++   +|+||||||+|||++.     ...++|+|||++
T Consensus        98 E~~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           98 ELCA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             ECCS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             ECCC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            9996 59999997542   2344445678999999999999999   9999999999999953     235889999999


Q ss_pred             cccCCCCc--cceeccccccCccCccccc---cCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhh
Q 037869          192 KLIPEGVS--HMTTRVKGTLGYLAPEYAM---WGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIV  265 (380)
Q Consensus       192 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~  265 (380)
                      ........  .......||+.|+|||++.   ...++.++|||||||++|+|++ |..||..........         .
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~---------~  241 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI---------L  241 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH---------H
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH---------H
Confidence            87653321  2234457999999999998   4567889999999999999999 999985432110000         0


Q ss_pred             ccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          266 KGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      ...   .  ...........+..+.+||.+||+.||.+|||+.++++|.+...
T Consensus       242 ~~~---~--~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          242 LGA---C--SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             TTC---C--CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             hcc---C--CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            000   0  00001112344567899999999999999999999999987653

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=325.22  Aligned_cols=257  Identities=21%  Similarity=0.295  Sum_probs=184.7

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChh-hH-HHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSK-AE-MEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ....++|++.+.||+|+||.||+|.+ .+++.||||++...... .. ..+..+..+++.++||||+++++++...+..+
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~  100 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF  100 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence            34567899999999999999999987 47899999999754322 22 23444556788889999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH-EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~-~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      +||||+ ++.+..+....   ...+++..++.++.|++.||.|||+ +   |++||||||+||+++.++.+||+|||++.
T Consensus       101 lv~e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~  173 (318)
T 2dyl_A          101 IAMELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISG  173 (318)
T ss_dssp             EEECCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC-
T ss_pred             EEEecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCch
Confidence            999999 55555555422   3468999999999999999999998 6   89999999999999999999999999997


Q ss_pred             ccCCCCccceeccccccCccCccccc-----cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcc
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAM-----WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKG  267 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  267 (380)
                      ......  ......|++.|+|||++.     +..++.++|||||||++|+|++|..||........ ..    .... ..
T Consensus       174 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-~~----~~~~-~~  245 (318)
T 2dyl_A          174 RLVDDK--AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFE-VL----TKVL-QE  245 (318)
T ss_dssp             ---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHH-HH----HHHH-HS
T ss_pred             hccCCc--cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHH-HH----HHHh-cc
Confidence            764322  223446899999999985     45689999999999999999999999975322100 00    0000 00


Q ss_pred             ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .     .+..  ......+..+.++|.+||+.||.+|||+.++++|.+
T Consensus       246 ~-----~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~  286 (318)
T 2dyl_A          246 E-----PPLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSF  286 (318)
T ss_dssp             C-----CCCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHH
T ss_pred             C-----CCCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHH
Confidence            0     0000  111124478899999999999999999999999865

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.1e-43  Score=350.92  Aligned_cols=269  Identities=23%  Similarity=0.294  Sum_probs=204.1

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEec------CCe
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG------TDQ  111 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~  111 (380)
                      .++|++.+.||+|+||+||+|.+ .+++.||||+++.. .......+.+|+.+++.++||||+++++++..      .+.
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            37899999999999999999987 56899999998753 44556678899999999999999999998765      667


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc---eEEeec
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE---PLVADF  188 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~---vkl~Df  188 (380)
                      .++||||++||+|.+++... .....+++..++.++.|++.||+|||+.   ||+||||||+||+++.++.   ++|+||
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~-~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQF-ENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSS-SCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             EEEEEEeCCCCCHHHHHHhc-ccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEccc
Confidence            89999999999999999764 2234688999999999999999999999   9999999999999987665   899999


Q ss_pred             cCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCccc-------chhccch
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKR-------TITEWAE  261 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~-------~~~~~~~  261 (380)
                      |++.......  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........       .......
T Consensus       169 G~a~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          169 GYAKELDQGE--LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             CCCCBTTSCC--CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred             cccccccccc--ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence            9998765432  234457899999999999999999999999999999999999999653211000       0000000


Q ss_pred             hhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHh
Q 037869          262 PLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL  314 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l  314 (380)
                      .....+.+................+..+.++|.+||..||.+|||+.++++|.
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp  299 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVG  299 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCT
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCH
Confidence            00000111100111112334556788999999999999999999998876653

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=7.3e-42  Score=345.33  Aligned_cols=237  Identities=19%  Similarity=0.271  Sum_probs=191.9

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeC--CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCe---
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTS--DGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQ---  111 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~--~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---  111 (380)
                      ...++|++.+.||+|+||+||+|.+.  +++.||||++... .......+.+|+.+++.++||||+++++++...+.   
T Consensus        77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~  156 (681)
T 2pzi_A           77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGD  156 (681)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSC
T ss_pred             EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCC
Confidence            34589999999999999999999874  6899999998753 33445578899999999999999999999987655   


Q ss_pred             --EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeecc
Q 037869          112 --RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG  189 (380)
Q Consensus       112 --~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfg  189 (380)
                        .|+||||++|++|.+++..      .+++..++.++.||+.||.|||++   ||+||||||+|||++.+ .+||+|||
T Consensus       157 ~~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG  226 (681)
T 2pzi_A          157 PVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLG  226 (681)
T ss_dssp             EEEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCT
T ss_pred             ceeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecc
Confidence              7999999999999887742      689999999999999999999999   99999999999999886 99999999


Q ss_pred             CccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccc
Q 037869          190 FAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKF  269 (380)
Q Consensus       190 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  269 (380)
                      ++......     ....||+.|+|||++.+.. +.++|||||||++|+|++|.+||.......                 
T Consensus       227 ~a~~~~~~-----~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------------  283 (681)
T 2pzi_A          227 AVSRINSF-----GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------------  283 (681)
T ss_dssp             TCEETTCC-----SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------------
T ss_pred             cchhcccC-----CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCccccccc-----------------
Confidence            99876542     3456899999999987654 899999999999999999998876421100                 


Q ss_pred             ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHH
Q 037869          270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT  313 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~  313 (380)
                        +.    ........+..+.+||.+||+.||.+||+..+.+.+
T Consensus       284 --~~----~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~  321 (681)
T 2pzi_A          284 --LP----EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSA  321 (681)
T ss_dssp             --CC----TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             --cc----ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHH
Confidence              00    000111234678999999999999999965554443

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.8e-41  Score=309.21  Aligned_cols=233  Identities=23%  Similarity=0.296  Sum_probs=183.5

Q ss_pred             hhCCCCCc-ceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHH-hcCCCCcceeEeeEEec----CCe
Q 037869           39 ATNGFSDD-NKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVL-GRVRHKNLLGLRGYCAG----TDQ  111 (380)
Q Consensus        39 ~~~~y~~~-~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~~~~~~~~----~~~  111 (380)
                      ..++|.+. +.||+|+||.||+|.+ .+++.||+|+++..     ..+.+|+.++ +.++||||+++++++..    ...
T Consensus        15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            34567776 7899999999999987 57899999999753     2566788887 56689999999999876    677


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---CCceEEeec
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS---DFEPLVADF  188 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~---~~~vkl~Df  188 (380)
                      .++||||+++|+|.+++...  ....+++..++.++.|++.||.|||+.   +|+||||||+||+++.   ++.++|+||
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Df  164 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDF  164 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCC
T ss_pred             EEEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEecc
Confidence            89999999999999999764  234699999999999999999999999   9999999999999998   789999999


Q ss_pred             cCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccc
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGK  268 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (380)
                      |++....                       +..++.++|||||||++|+|++|..||..........           ..
T Consensus       165 g~a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~-----------~~  210 (299)
T 3m2w_A          165 GFAKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP-----------GM  210 (299)
T ss_dssp             TTCEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------C-----------CS
T ss_pred             ccccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhH-----------HH
Confidence            9986532                       2456889999999999999999999996543211000           00


Q ss_pred             cccccCCcccCCCC----HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          269 FKELVDPKLRGDFD----ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       269 ~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .......  ....+    ...+.++.+||.+||+.||.+|||+.++++|.+..
T Consensus       211 ~~~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~  261 (299)
T 3m2w_A          211 KTRIRMG--QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM  261 (299)
T ss_dssp             CCSSCTT--CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHH
T ss_pred             HHHHhhc--cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhc
Confidence            0000000  00111    23457899999999999999999999999997644

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.8e-40  Score=300.67  Aligned_cols=231  Identities=15%  Similarity=0.070  Sum_probs=184.0

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeC-CCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      ..++|++.+.||+|+||.||+|.+. +++.||||++....   ......+.+|+.++..++||||+++++++...+..|+
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            4578999999999999999999984 58999999997543   3334678899999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ||||++|++|.+++...      .....+..++.|++.||+|||++   ||+||||||+|||++.++.++|+++|     
T Consensus       109 v~e~~~g~~L~~~l~~~------~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~-----  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADTS------PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPA-----  174 (286)
T ss_dssp             EEECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred             EEEecCCCCHHHHHhcC------CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEecc-----
Confidence            99999999999999532      35557888999999999999999   99999999999999999999998443     


Q ss_pred             CCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccC
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD  274 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (380)
                                      |++       .++.++|||||||++|+|++|..||.............  ..  ..+.      
T Consensus       175 ----------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~--~~--~~~~------  221 (286)
T 3uqc_A          175 ----------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--RD--TAGQ------  221 (286)
T ss_dssp             ----------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC--BC--TTSC------
T ss_pred             ----------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH--HH--hccC------
Confidence                            233       36899999999999999999999997644321100000  00  0000      


Q ss_pred             CcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       275 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ...........+..+.++|.+||+.||.+| |+.++++.|...
T Consensus       222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~  263 (286)
T 3uqc_A          222 PIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQA  263 (286)
T ss_dssp             BCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHH
T ss_pred             CCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHH
Confidence            000001122345789999999999999999 999999998754

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.3e-42  Score=320.40  Aligned_cols=246  Identities=16%  Similarity=0.165  Sum_probs=189.2

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccC--------hhhHHHHHHHHHHHhcCC---------CCccee
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMN--------SKAEMEFAVEVEVLGRVR---------HKNLLG  101 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--------~~~~~~~~~E~~~l~~l~---------h~niv~  101 (380)
                      ..++|++.+.||+|+||+||+|++ +++.||||+++...        ......+.+|+.+++.++         ||||++
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             CHHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             ccccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            457899999999999999999998 68999999997542        223357788888888775         677766


Q ss_pred             EeeEE-----------------ec-------------CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHH
Q 037869          102 LRGYC-----------------AG-------------TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA  151 (380)
Q Consensus       102 ~~~~~-----------------~~-------------~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~  151 (380)
                      +.+++                 ..             .+..|+||||+++|++.+.+.+     ..+++..++.++.||+
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHH
Confidence            66653                 22             6789999999999987777743     3689999999999999


Q ss_pred             HHHHHHh-hcCCCCeEecCCCCCCeeeCCCC--------------------ceEEeeccCccccCCCCccceeccccccC
Q 037869          152 EGILYLH-HEVTPHIIHRDIKASNVLLDSDF--------------------EPLVADFGFAKLIPEGVSHMTTRVKGTLG  210 (380)
Q Consensus       152 ~al~~LH-~~~~~~ivHrdlkp~Nill~~~~--------------------~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~  210 (380)
                      .||+||| ++   +|+||||||+|||++.++                    .+||+|||+++.....      ...||+.
T Consensus       172 ~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~  242 (336)
T 2vuw_A          172 ASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDV  242 (336)
T ss_dssp             HHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCC
T ss_pred             HHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeec
Confidence            9999999 88   999999999999999887                    8999999999876432      2368999


Q ss_pred             ccCccccccCCCCccchhhhhhHH-HHHHHhCCCCCCCCCCCcccchhccchhhhhcccccc-ccCCcccCCCCHHHHHH
Q 037869          211 YLAPEYAMWGKVSESCDVYSFGIL-LLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE-LVDPKLRGDFDENQLKQ  288 (380)
Q Consensus       211 y~aPE~~~~~~~~~~~DiwslG~i-l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  288 (380)
                      |+|||++.+.. +.++||||++++ .+++++|..||....         |.... ....... ..............+.+
T Consensus       243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~---------~~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~  311 (336)
T 2vuw_A          243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL---------WLHYL-TDKMLKQMTFKTKCNTPAMKQIKRK  311 (336)
T ss_dssp             TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH---------HHHHH-HHHHHHTCCCSSCCCSHHHHHHHHH
T ss_pred             ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchh---------hhhHH-HHhhhhhhccCcccchhhhhhcCHH
Confidence            99999998766 899999998777 777888999984310         00000 0000000 01111112234567889


Q ss_pred             HHHHHHhhcCCCCCCCCCHHHHH-HHhc
Q 037869          289 AINVAVLCVQSEPEKRPNMKEVV-NTLT  315 (380)
Q Consensus       289 ~~~li~~cl~~~P~~Rps~~~ll-~~l~  315 (380)
                      +.+||.+||+.|     |+.+++ +|.+
T Consensus       312 ~~dli~~~L~~d-----sa~e~l~~Hp~  334 (336)
T 2vuw_A          312 IQEFHRTMLNFS-----SATDLLCQHSL  334 (336)
T ss_dssp             HHHHHHHGGGSS-----SHHHHHHHCGG
T ss_pred             HHHHHHHHhccC-----CHHHHHhcCCC
Confidence            999999999977     999999 8865

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.6e-41  Score=321.84  Aligned_cols=246  Identities=15%  Similarity=0.092  Sum_probs=185.0

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh---hhHHHHHHHHHHHhcCCC-Cccee-------------
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS---KAEMEFAVEVEVLGRVRH-KNLLG-------------  101 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h-~niv~-------------  101 (380)
                      ...|++.+.||+|+||+||+|.+ .+|+.||||+++....   .....+.+|+.+++.++| +|...             
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            34588889999999999999996 5799999999884222   224578899999999977 22111             


Q ss_pred             --------EeeEEec-----CCeEEEEEEecCCCCHHHhhccC---CCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCe
Q 037869          102 --------LRGYCAG-----TDQRLIVYDYMPNLSLLSHLHGQ---YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI  165 (380)
Q Consensus       102 --------~~~~~~~-----~~~~~lv~e~~~~g~L~~~i~~~---~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~i  165 (380)
                              +..++..     ....+++|+++ +++|.+++...   ......+++..++.++.|++.||+|||++   +|
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~i  232 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GL  232 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---Cc
Confidence                    1111111     22457777776 57999888421   12345688899999999999999999999   99


Q ss_pred             EecCCCCCCeeeCCCCceEEeeccCccccCCCCccceeccccccCccCcccc----------ccCCCCccchhhhhhHHH
Q 037869          166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA----------MWGKVSESCDVYSFGILL  235 (380)
Q Consensus       166 vHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwslG~il  235 (380)
                      +||||||+|||++.++.+||+|||+++.....    ....+| +.|+|||++          .+..++.++|||||||++
T Consensus       233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil  307 (413)
T 3dzo_A          233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAI  307 (413)
T ss_dssp             ECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHH
T ss_pred             ccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHH
Confidence            99999999999999999999999998865332    344567 999999999          555689999999999999


Q ss_pred             HHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          236 LEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       236 ~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      |+|++|..||........               ......      .....+..+.+||.+||+.||.+|||+.++++|.+
T Consensus       308 ~elltg~~Pf~~~~~~~~---------------~~~~~~------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~  366 (413)
T 3dzo_A          308 YWIWCADLPNTDDAALGG---------------SEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPE  366 (413)
T ss_dssp             HHHHHSSCCCCTTGGGSC---------------SGGGGS------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred             HHHHHCCCCCCCcchhhh---------------HHHHHh------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHH
Confidence            999999999975321100               000110      00123478999999999999999999999988754

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.98  E-value=1.1e-33  Score=278.57  Aligned_cols=186  Identities=15%  Similarity=0.079  Sum_probs=131.7

Q ss_pred             eeccCCceEEEEEE-eCCCcEEEEEEeccc----------ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEEE
Q 037869           48 KLGEGGFGSVYWGR-TSDGLQIAVKKLKAM----------NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        48 ~Lg~G~~g~Vy~~~-~~~~~~vavK~~~~~----------~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~lv  115 (380)
                      .++.|+.|.+..++ ...|+.|++|++...          ......++.+|+++|+++ .|+||+++++++++++..|||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV  320 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV  320 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence            46677777776664 346889999998642          123345788999999999 699999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |||++|++|.++|...    .++++.   .|+.||+.||+|||++   |||||||||+|||++.+|++||+|||+++...
T Consensus       321 MEyv~G~~L~d~i~~~----~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          321 MEKLPGRLLSDMLAAG----EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             EECCCSEEHHHHHHTT----CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred             EecCCCCcHHHHHHhC----CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence            9999999999999754    456654   4789999999999999   99999999999999999999999999998765


Q ss_pred             CCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPI  245 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~  245 (380)
                      ... ......+||+.|+|||++.+ .+..++|+||+|++++++.++..|+
T Consensus       391 ~~~-~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          391 QDC-SWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             ----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred             CCC-ccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            432 23345679999999999875 4677899999999988876655443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.6e-29  Score=247.57  Aligned_cols=184  Identities=17%  Similarity=0.177  Sum_probs=145.2

Q ss_pred             CCcceeccCCceEEEEEEeCCCcEEEEEEecccCh--------hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           44 SDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNS--------KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        44 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ...+.||+|+||+||++.. .+..+++|+......        .....+.+|++++++++||||+++..++...+..|+|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            4567999999999999954 578899998653211        1134578999999999999999665565567778999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |||++|++|.+++..            +..++.|++.||.|||++   +|+||||||+|||++.  .+||+|||+++...
T Consensus       418 mE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~  480 (540)
T 3en9_A          418 MSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISN  480 (540)
T ss_dssp             EECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECC
T ss_pred             EECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECC
Confidence            999999999999964            457999999999999999   9999999999999998  99999999999875


Q ss_pred             CCCccc------eeccccccCccCcccccc--CCCCccchhhhhhHHHHHHHhCCCCC
Q 037869          196 EGVSHM------TTRVKGTLGYLAPEYAMW--GKVSESCDVYSFGILLLEILTGRKPI  245 (380)
Q Consensus       196 ~~~~~~------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~p~  245 (380)
                      ......      .....||+.|+|||++.+  ..|+..+|+||..+-..+.+.++.+|
T Consensus       481 ~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          481 LDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            432211      235679999999999986  67889999999999988888877766

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=6.6e-26  Score=204.12  Aligned_cols=162  Identities=17%  Similarity=0.078  Sum_probs=127.0

Q ss_pred             HHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccCh------------------hhHHHHHHHHHHHhcCCCC
Q 037869           36 LHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNS------------------KAEMEFAVEVEVLGRVRHK   97 (380)
Q Consensus        36 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~   97 (380)
                      +......|.+.+.||+|+||.||+|.+.+|+.||+|+++....                  .....+.+|+.+++.++  
T Consensus        85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--  162 (282)
T 1zar_A           85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--  162 (282)
T ss_dssp             HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred             HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence            3344567778899999999999999997799999999964321                  13456889999999998  


Q ss_pred             cceeEeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeee
Q 037869           98 NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLL  177 (380)
Q Consensus        98 niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill  177 (380)
                      | +++.+++.. +..|+||||++|++|.+ +..          .....++.|++.||.|||+.   ||+||||||+|||+
T Consensus       163 ~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl  226 (282)
T 1zar_A          163 G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLV  226 (282)
T ss_dssp             T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEE
T ss_pred             C-CCcCeEEec-cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEE
Confidence            4 666665543 56799999999999998 421          12346999999999999999   99999999999999


Q ss_pred             CCCCceEEeeccCccccCCCCccceeccccccCccCcccccc----------CCCCccchhhh
Q 037869          178 DSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW----------GKVSESCDVYS  230 (380)
Q Consensus       178 ~~~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~Diws  230 (380)
                      + ++.++|+|||+++.              +..+.|||.+..          ..|...+|+|.
T Consensus       227 ~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~  274 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVE--------------VGEEGWREILERDVRNIITYFSRTYRTEKDINS  274 (282)
T ss_dssp             E-TTEEEECCCTTCEE--------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred             E-CCcEEEEECCCCeE--------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence            9 99999999999864              344678887653          33455566654

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=9.9e-22  Score=174.66  Aligned_cols=138  Identities=17%  Similarity=0.182  Sum_probs=107.1

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcE--EEEEEecccChh------------------------hHHHHHHHHHHHhc
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQ--IAVKKLKAMNSK------------------------AEMEFAVEVEVLGR   93 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~--vavK~~~~~~~~------------------------~~~~~~~E~~~l~~   93 (380)
                      .-|.+.+.||+|+||.||+|.+ .+|+.  ||||+++.....                        ....+.+|+.+|..
T Consensus        47 ~~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~  126 (258)
T 1zth_A           47 YITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER  126 (258)
T ss_dssp             SEEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH
T ss_pred             CchhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH
Confidence            3477899999999999999988 67888  999997542111                        12357789999999


Q ss_pred             CCCCcc--eeEeeEEecCCeEEEEEEecCC-C----CHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHh-hcCCCCe
Q 037869           94 VRHKNL--LGLRGYCAGTDQRLIVYDYMPN-L----SLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH-HEVTPHI  165 (380)
Q Consensus        94 l~h~ni--v~~~~~~~~~~~~~lv~e~~~~-g----~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH-~~~~~~i  165 (380)
                      +.|+++  ..+++.    ...++||||+.+ |    +|.+....       .++..+..++.|++.||.||| +.   ||
T Consensus       127 l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~---gi  192 (258)
T 1zth_A          127 AKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEA---EL  192 (258)
T ss_dssp             HHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTS---CE
T ss_pred             HHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHC---CE
Confidence            987754  334432    356899999942 3    66665432       223456789999999999999 88   99


Q ss_pred             EecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          166 IHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       166 vHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      +||||||+|||++.  .++|+|||++...
T Consensus       193 vHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          193 VHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             ECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             EeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999999998  9999999999765

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.77  E-value=1.1e-19  Score=168.05  Aligned_cols=137  Identities=15%  Similarity=0.167  Sum_probs=100.2

Q ss_pred             CCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccCh--------------hhH--------HHHHHHHHHHhcCCCCc
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNS--------------KAE--------MEFAVEVEVLGRVRHKN   98 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--------------~~~--------~~~~~E~~~l~~l~h~n   98 (380)
                      .-|.+..+||.|++|.||+|.+.+|+.||||+++....              ...        .....|...|.++.+.+
T Consensus        95 ~iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           95 DVYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             SCSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             CEEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            45999999999999999999998899999998753100              000        11234666666664433


Q ss_pred             c--eeEeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCee
Q 037869           99 L--LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVL  176 (380)
Q Consensus        99 i--v~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nil  176 (380)
                      +  ...++.    ...+|||||++|++|..+...          .....++.|++.+|.+||+.   |||||||||.|||
T Consensus       175 v~vp~p~~~----~~~~LVME~i~G~~L~~l~~~----------~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NIL  237 (397)
T 4gyi_A          175 FPVPEPIAQ----SRHTIVMSLVDALPMRQVSSV----------PDPASLYADLIALILRLAKH---GLIHGDFNEFNIL  237 (397)
T ss_dssp             CSCCCEEEE----ETTEEEEECCSCEEGGGCCCC----------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEE
T ss_pred             CCCCeeeec----cCceEEEEecCCccHhhhccc----------HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEE
Confidence            3  222222    224799999999888665421          12356889999999999999   9999999999999


Q ss_pred             eCCCC----------ceEEeeccCcccc
Q 037869          177 LDSDF----------EPLVADFGFAKLI  194 (380)
Q Consensus       177 l~~~~----------~vkl~Dfgl~~~~  194 (380)
                      ++.++          .+.|+||+-+-..
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             EeCCCCcccccccccceEEEEeCCcccC
Confidence            98776          3899999977543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.48  E-value=1.3e-13  Score=122.44  Aligned_cols=145  Identities=11%  Similarity=-0.001  Sum_probs=112.6

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCC-CCcceeEeeEEecCCeEEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR-HKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      .-..|++...++.|+.+.||++... +..+++|+...........+.+|+.+++.+. +..+.++++++...+..|+|||
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e   90 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMS   90 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEE
Confidence            3457999999999999999999764 6789999987522122335778999998884 6678889999888889999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV------------------------------------  161 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~------------------------------------  161 (380)
                      |++|.+|.+.+..         ......++.+++.+|+.||+..                                    
T Consensus        91 ~i~G~~l~~~~~~---------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           91 EADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             CCSSEEHHHHCCT---------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             ecCCeehhhccCC---------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            9999998876421         1122367889999999999820                                    


Q ss_pred             --------------------CCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          162 --------------------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       162 --------------------~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                                          ...++|||++|.||+++.++.+.|+||+.+..
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                03589999999999998765567999987753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.35  E-value=1.6e-12  Score=114.91  Aligned_cols=138  Identities=14%  Similarity=0.057  Sum_probs=100.3

Q ss_pred             CCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCc--ceeEeeEEecCCeEEEEEEe
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKN--LLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~~~~~~~~~~~~~lv~e~  118 (380)
                      ..|.+....+.|..+.||++...+|..+++|......   ...+..|+.+++.+.+.+  +.+++++...++..++||||
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~---~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~   96 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGE   96 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEEC
T ss_pred             CCCceEecccCCCCceEEEEecCCCCeEEEEeCCccc---chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEe
Confidence            3455544444666799999987778889999976542   235677888888885434  55688888877889999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------------
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV-------------------------------------  161 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~-------------------------------------  161 (380)
                      ++|.+|.  ...       .+   ...++.+++..|+.||+..                                     
T Consensus        97 i~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (264)
T 1nd4_A           97 VPGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG  164 (264)
T ss_dssp             CSSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred             cCCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence            9998874  211       11   1246777888888888752                                     


Q ss_pred             ------------------CCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          162 ------------------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       162 ------------------~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                                        ...++|||++|.||+++.++.+.|+||+.+..
T Consensus       165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                              01299999999999998776667999998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.22  E-value=5.3e-11  Score=110.51  Aligned_cols=145  Identities=13%  Similarity=0.162  Sum_probs=107.4

Q ss_pred             CCCCcceeccCCceEEEEEEeCCCcEEEEEEec--ccC-hhhHHHHHHHHHHHhcCC--CCcceeEeeEEecC---CeEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLK--AMN-SKAEMEFAVEVEVLGRVR--HKNLLGLRGYCAGT---DQRL  113 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~--~~~-~~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~---~~~~  113 (380)
                      .....+.|+.|.++.||++... +..+++|+..  ... ......+.+|+.+++.+.  +..+.+++.++.+.   +..|
T Consensus        39 ~~~~~~~l~~G~sn~~y~v~~~-~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~  117 (359)
T 3dxp_A           39 GPLSVEQFKGGQSNPTFKLVTP-GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAF  117 (359)
T ss_dssp             CCCEEEECCC-CCSCEEEEECS-SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCE
T ss_pred             CCceEEEcCCcccceEEEEEEC-CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeE
Confidence            3445778999999999999875 4678888876  321 122346778999998886  45578888888765   4489


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV--------------------------------  161 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~--------------------------------  161 (380)
                      +||||++|..+.+...      ..++......++.+++.+|+.||+..                                
T Consensus       118 ~vme~v~G~~l~~~~~------~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (359)
T 3dxp_A          118 YIMEFVSGRVLWDQSL------PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSET  191 (359)
T ss_dssp             EEEECCCCBCCCCTTC------TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCC
T ss_pred             EEEEecCCeecCCCcc------ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCC
Confidence            9999999977754221      24677788889999999999999831                                


Q ss_pred             -----------------------CCCeEecCCCCCCeeeCCCCc--eEEeeccCccc
Q 037869          162 -----------------------TPHIIHRDIKASNVLLDSDFE--PLVADFGFAKL  193 (380)
Q Consensus       162 -----------------------~~~ivHrdlkp~Nill~~~~~--vkl~Dfgl~~~  193 (380)
                                             ...++|||++|.||+++.++.  +.|+||+.+..
T Consensus       192 ~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          192 ESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             SCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             cCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                   147999999999999997753  68999998865

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.09  E-value=5.6e-11  Score=107.72  Aligned_cols=184  Identities=17%  Similarity=0.134  Sum_probs=121.3

Q ss_pred             cceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCC-CCc--ceeEeeEEecCC---eEEEEEEec
Q 037869           46 DNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR-HKN--LLGLRGYCAGTD---QRLIVYDYM  119 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~~~~~~~~~~---~~~lv~e~~  119 (380)
                      .+.++.|.+..||++.    ..+++|.....  .....+.+|..+|+.+. +..  +.+++.......   ..|+||+++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            5679999999999873    46889986532  34457888999998773 322  334444433332   348999999


Q ss_pred             CCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcC--------------------------------------
Q 037869          120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV--------------------------------------  161 (380)
Q Consensus       120 ~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~--------------------------------------  161 (380)
                      +|.++.....      ..++......++.+++..|+.||+..                                      
T Consensus        99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            9988865432      24667777788888888888888621                                      


Q ss_pred             -----------------CCCeEecCCCCCCeeeCC--CCceEEeeccCccccCCCCccceeccccccCc---cCcccccc
Q 037869          162 -----------------TPHIIHRDIKASNVLLDS--DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGY---LAPEYAMW  219 (380)
Q Consensus       162 -----------------~~~ivHrdlkp~Nill~~--~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y---~aPE~~~~  219 (380)
                                       ...++|+|++|.||+++.  +..+.|+||+.+..-... .....    ...+   ..|+....
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~-~Dl~~----~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD-NDFIS----LMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT-HHHHT----TCCTTTSCCHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH-HHHHH----HHhhccccCHHHHHH
Confidence                             135899999999999998  456789999998653221 11000    0011   12221110


Q ss_pred             ------C--------CCCccchhhhhhHHHHHHHhCCCCCC
Q 037869          220 ------G--------KVSESCDVYSFGILLLEILTGRKPIE  246 (380)
Q Consensus       220 ------~--------~~~~~~DiwslG~il~ell~g~~p~~  246 (380)
                            .        ......+.|+++.++|.+.+|..+|.
T Consensus       248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence                  0        01123689999999999999998763

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.72  E-value=7.7e-08  Score=85.25  Aligned_cols=136  Identities=15%  Similarity=0.135  Sum_probs=96.8

Q ss_pred             ceeccCCce-EEEEEEeC-CCcEEEEEEecccChhhHHHHHHHHHHHhcCC-CCcceeEeeEEecCCeEEEEEEecCCCC
Q 037869           47 NKLGEGGFG-SVYWGRTS-DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR-HKNLLGLRGYCAGTDQRLIVYDYMPNLS  123 (380)
Q Consensus        47 ~~Lg~G~~g-~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~~~g~  123 (380)
                      +.+..|..+ .||+.... ++..+++|+-...   ....+.+|...|+.+. +--+.+++.++..++..++|||+++|.+
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence            355566655 68988764 5678999986542   3446778999888774 3236678888888899999999999988


Q ss_pred             HHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcC------------------------------------------
Q 037869          124 LLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV------------------------------------------  161 (380)
Q Consensus       124 L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~------------------------------------------  161 (380)
                      +.+.....        ......+..++...|+.||+..                                          
T Consensus       107 ~~~~~~~~--------~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          107 AFQVLEEY--------PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             HHHHHHHC--------GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             ccccccCC--------HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            87665321        1122345566667777777530                                          


Q ss_pred             -------------CCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          162 -------------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       162 -------------~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                                   ...++|+|+.+.||+++.++.+-|+||+.+..
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                         11379999999999999877777999988764

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.71  E-value=1.4e-07  Score=85.23  Aligned_cols=137  Identities=19%  Similarity=0.129  Sum_probs=94.2

Q ss_pred             CcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCC---cceeEeeEEe-cCCeEEEEEEecC
Q 037869           45 DDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHK---NLLGLRGYCA-GTDQRLIVYDYMP  120 (380)
Q Consensus        45 ~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~~~~~~~-~~~~~~lv~e~~~  120 (380)
                      -.+.++.|....||+.    +..+++|+-.  .......+..|..+|+.+.+.   .+.+++.+.. ..+..++|||+++
T Consensus        23 ~v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~   96 (306)
T 3tdw_A           23 SVESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ   96 (306)
T ss_dssp             CEEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred             eeeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence            3567899999999998    5678888843  233455788899999998642   3555666663 4556789999999


Q ss_pred             CCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhc----------------------------------------
Q 037869          121 NLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE----------------------------------------  160 (380)
Q Consensus       121 ~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~----------------------------------------  160 (380)
                      |.++......      .++......++.++...|+.||+.                                        
T Consensus        97 G~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~  170 (306)
T 3tdw_A           97 GQILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRD  170 (306)
T ss_dssp             SEECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHH
T ss_pred             CeECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHH
Confidence            9887663211      233444444555555555555542                                        


Q ss_pred             -----------------CCCCeEecCCCCCCeeeCC---CCce-EEeeccCccc
Q 037869          161 -----------------VTPHIIHRDIKASNVLLDS---DFEP-LVADFGFAKL  193 (380)
Q Consensus       161 -----------------~~~~ivHrdlkp~Nill~~---~~~v-kl~Dfgl~~~  193 (380)
                                       ....++|+|++|.||+++.   ++.+ .|+||+.+..
T Consensus       171 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          171 YLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                             1225799999999999987   4554 7999998765

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.46  E-value=2.2e-07  Score=85.85  Aligned_cols=81  Identities=10%  Similarity=0.048  Sum_probs=54.4

Q ss_pred             ccee-ccCCceEEEEEEeC-------CCcEEEEEEecccC---hhhHHHHHHHHHHHhcCC-C--CcceeEeeEEecC--
Q 037869           46 DNKL-GEGGFGSVYWGRTS-------DGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVR-H--KNLLGLRGYCAGT--  109 (380)
Q Consensus        46 ~~~L-g~G~~g~Vy~~~~~-------~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~-h--~niv~~~~~~~~~--  109 (380)
                      .+.| +.|....+|+....       ++..+++|......   ......+..|+.+++.+. +  -.+.+++.++...  
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            4677 88999999998653       26688998865422   001135667888887773 2  3466677776554  


Q ss_pred             -CeEEEEEEecCCCCHHH
Q 037869          110 -DQRLIVYDYMPNLSLLS  126 (380)
Q Consensus       110 -~~~~lv~e~~~~g~L~~  126 (380)
                       +..++|||+++|.++.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             35689999999876543

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.26  E-value=9.8e-06  Score=74.00  Aligned_cols=142  Identities=15%  Similarity=0.232  Sum_probs=78.4

Q ss_pred             ceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcC-----CCCcceeEe-e--EEecCCeEEEEEEe
Q 037869           47 NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-----RHKNLLGLR-G--YCAGTDQRLIVYDY  118 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~~~-~--~~~~~~~~~lv~e~  118 (380)
                      +.|+.|..+.||++...++ .+++|+.... .   ..+..|..+++.|     ..|.++... +  +....+..++||+|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            4566678899999987544 5899998752 2   2233444444443     234444311 1  12335678999999


Q ss_pred             cCCCCHH--------------HhhccC---C--CCC-----ccCCHHH-------------------------------H
Q 037869          119 MPNLSLL--------------SHLHGQ---Y--AGE-----VQLDWKR-------------------------------R  143 (380)
Q Consensus       119 ~~~g~L~--------------~~i~~~---~--~~~-----~~~~~~~-------------------------------~  143 (380)
                      ++|.++.              ..++..   .  ...     ..-.+..                               +
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              111110   0  000     0011111                               0


Q ss_pred             HHHHHHHHHHHHHHhh----------cCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          144 MKIAIGSAEGILYLHH----------EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       144 ~~i~~ql~~al~~LH~----------~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      ..+...+..++.+|+.          .....++|||+++.||+++.++.+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            1111223345666653          0134899999999999998888999999997753

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.22  E-value=3.3e-06  Score=79.13  Aligned_cols=75  Identities=13%  Similarity=0.142  Sum_probs=48.5

Q ss_pred             cceeccCCceEEEEEEeC-CCcEEEEEEecccCh-------hhHHHHHHHHHHHhcCCC--Cc-ceeEeeEEecCCeEEE
Q 037869           46 DNKLGEGGFGSVYWGRTS-DGLQIAVKKLKAMNS-------KAEMEFAVEVEVLGRVRH--KN-LLGLRGYCAGTDQRLI  114 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-------~~~~~~~~E~~~l~~l~h--~n-iv~~~~~~~~~~~~~l  114 (380)
                      .+.||.|.++.||++... ++..|++|.......       .....+..|..+++.+..  +. +.+++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            568999999999999753 467899998653211       112345678888876632  33 3455543  3445689


Q ss_pred             EEEecCCC
Q 037869          115 VYDYMPNL  122 (380)
Q Consensus       115 v~e~~~~g  122 (380)
                      |||++++.
T Consensus       113 vmE~l~g~  120 (397)
T 2olc_A          113 VMEDLSHL  120 (397)
T ss_dssp             EECCCTTS
T ss_pred             EEEeCCCc
Confidence            99999764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.17  E-value=1.5e-05  Score=71.90  Aligned_cols=77  Identities=13%  Similarity=0.137  Sum_probs=60.4

Q ss_pred             CCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCC---CCcceeEeeEEecCCeEEEEEEecC
Q 037869           44 SDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR---HKNLLGLRGYCAGTDQRLIVYDYMP  120 (380)
Q Consensus        44 ~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~~~~~~~~~~~~~lv~e~~~  120 (380)
                      .-.+.|+.|....+|+... ++..+++|+....   ....+..|...|+.|.   ...+.+++.+....+..++|||+++
T Consensus        39 ~~~~~l~gG~~n~~y~v~~-~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~  114 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND-EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALN  114 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES-SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCC
T ss_pred             eeeEEeCCccceeeeEEEE-CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEecc
Confidence            3456899999999999986 4678999987643   3456788988888773   3567888888877788999999999


Q ss_pred             CCCH
Q 037869          121 NLSL  124 (380)
Q Consensus       121 ~g~L  124 (380)
                      |..+
T Consensus       115 G~~~  118 (312)
T 3jr1_A          115 KSKN  118 (312)
T ss_dssp             CCCC
T ss_pred             CCCC
Confidence            8765

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.16  E-value=6.4e-06  Score=73.55  Aligned_cols=82  Identities=15%  Similarity=0.151  Sum_probs=58.8

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCC---CcceeEeeEEecCCeEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRH---KNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~~~~~~~~~~~~~lv  115 (380)
                      ......-.+.+|.|..+.||+++..+|+.|++|+-..........+..|...|+.|..   --+.+++.+.    .-++|
T Consensus        13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv   88 (288)
T 3f7w_A           13 TGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLA   88 (288)
T ss_dssp             HCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEE
T ss_pred             cCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEE
Confidence            3456667889999999999999998899999998765443333467789888887742   1244455442    24789


Q ss_pred             EEecCCCCH
Q 037869          116 YDYMPNLSL  124 (380)
Q Consensus       116 ~e~~~~g~L  124 (380)
                      |||+.++..
T Consensus        89 ~e~l~~~~~   97 (288)
T 3f7w_A           89 MEWVDERPP   97 (288)
T ss_dssp             EECCCCCCC
T ss_pred             EEeecccCC
Confidence            999877643

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.94  E-value=3.6e-05  Score=72.58  Aligned_cols=77  Identities=16%  Similarity=0.155  Sum_probs=45.4

Q ss_pred             CCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccceecc-ccccCccCccccccC---CCCccchhhhhhHHHHHH
Q 037869          163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRV-KGTLGYLAPEYAMWG---KVSESCDVYSFGILLLEI  238 (380)
Q Consensus       163 ~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~el  238 (380)
                      ..++|||++|.|||++.++ +.|+||+.+..-.... ...... .-...|.+|+.....   .-....++.++...+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~-Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGF-DIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHH-HHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHH-HHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            3899999999999998876 9999999887532110 000000 012345555544311   112234555777777776


Q ss_pred             HhC
Q 037869          239 LTG  241 (380)
Q Consensus       239 l~g  241 (380)
                      ..+
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.77  E-value=8e-05  Score=66.79  Aligned_cols=71  Identities=8%  Similarity=0.011  Sum_probs=44.0

Q ss_pred             cceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcc-eeEeeEEecCCeEEEEEEec-CCCC
Q 037869           46 DNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL-LGLRGYCAGTDQRLIVYDYM-PNLS  123 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~-~~g~  123 (380)
                      .+.|+.|....+|++     ..+++|+....... .....+|+.+++.+....+ .+++..  ..+..++|+||+ +|-+
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence            788999999999999     56888887643211 1123457777666632222 344443  334457899999 6644


Q ss_pred             H
Q 037869          124 L  124 (380)
Q Consensus       124 L  124 (380)
                      +
T Consensus        95 l   95 (301)
T 3dxq_A           95 M   95 (301)
T ss_dssp             C
T ss_pred             C
Confidence            4

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.72  E-value=0.00034  Score=63.18  Aligned_cols=160  Identities=17%  Similarity=0.180  Sum_probs=85.5

Q ss_pred             ccHHHHHHhhCCCCC-----cceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCC-----CCcce
Q 037869           31 FTYKELHTATNGFSD-----DNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR-----HKNLL  100 (380)
Q Consensus        31 ~~~~~~~~~~~~y~~-----~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv  100 (380)
                      .+.+++...-.+|.+     .+.|+.|....+|++...++ .+++|......  ....+..|+.++..+.     -|.++
T Consensus         7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~~   83 (322)
T 2ppq_A            7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL   83 (322)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCccc
Confidence            344555555555655     34577788899999987655 68899887521  1124445666666553     23333


Q ss_pred             eEe-e--EEecCCeEEEEEEecCCCCHHH--------------hhcc---CCCCC--ccC---CHHHHHH----------
Q 037869          101 GLR-G--YCAGTDQRLIVYDYMPNLSLLS--------------HLHG---QYAGE--VQL---DWKRRMK----------  145 (380)
Q Consensus       101 ~~~-~--~~~~~~~~~lv~e~~~~g~L~~--------------~i~~---~~~~~--~~~---~~~~~~~----------  145 (380)
                      ... +  +....+..++++++++|..+..              .++.   .....  ...   .|...+.          
T Consensus        84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~  163 (322)
T 2ppq_A           84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  163 (322)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence            211 1  1122456799999998865321              1111   00000  000   1111000          


Q ss_pred             --HHHHHHHHHHHHhhc----CCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          146 --IAIGSAEGILYLHHE----VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       146 --i~~ql~~al~~LH~~----~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                        +...+...+..+...    ...+++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence              001133445555432    123799999999999998876568999987753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.62  E-value=0.0004  Score=63.12  Aligned_cols=144  Identities=15%  Similarity=0.061  Sum_probs=71.8

Q ss_pred             cceeccCCceE-EEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCC--CcceeEeeEEecCCeEEEEEEecCCC
Q 037869           46 DNKLGEGGFGS-VYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRH--KNLLGLRGYCAGTDQRLIVYDYMPNL  122 (380)
Q Consensus        46 ~~~Lg~G~~g~-Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g  122 (380)
                      .+.|+.|.... +|+....++..+++|.......   ..+..|+.+++.+..  -.+.+++.+....  .+++||++.+.
T Consensus        23 ~~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~---~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~   97 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG---GDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDA   97 (333)
T ss_dssp             ECC--------CCEEEECTTCCEEEEEECCTTTT---CCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSC
T ss_pred             eeECCCCCCCceEEEEEcCCCCeEEEEECCCCCC---ccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCc
Confidence            34676665555 6677654467788876543221   133345666655532  2345556553333  37899999776


Q ss_pred             CHHHhhccCC---------------------CC-CccCCHHHHH-------HHH-------------HHHHHHHHHHhh-
Q 037869          123 SLLSHLHGQY---------------------AG-EVQLDWKRRM-------KIA-------------IGSAEGILYLHH-  159 (380)
Q Consensus       123 ~L~~~i~~~~---------------------~~-~~~~~~~~~~-------~i~-------------~ql~~al~~LH~-  159 (380)
                      ++.+.+....                     .. -..++.....       .+.             ..+...+..+.. 
T Consensus        98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~  177 (333)
T 3csv_A           98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA  177 (333)
T ss_dssp             BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence            6654332110                     00 0112221110       000             011112222211 


Q ss_pred             --cCCCCeEecCCCCCCeeeCCC----CceEEeeccCcccc
Q 037869          160 --EVTPHIIHRDIKASNVLLDSD----FEPLVADFGFAKLI  194 (380)
Q Consensus       160 --~~~~~ivHrdlkp~Nill~~~----~~vkl~Dfgl~~~~  194 (380)
                        .....++|||+.+.||+++.+    +.+.|+||+.+..-
T Consensus       178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence              113379999999999999874    67999999988753

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.61  E-value=0.00027  Score=59.21  Aligned_cols=143  Identities=12%  Similarity=0.049  Sum_probs=92.3

Q ss_pred             CHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCccce
Q 037869          123 SLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMT  202 (380)
Q Consensus       123 ~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~~~  202 (380)
                      +|.+.+...   +.+++++++|.++.|.+.+|.-+-...  .-..+=+.|..|++..+|.|.+.+ +.+.          
T Consensus        34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~--~~~~~i~~~~~i~l~~dG~V~f~~-~~s~----------   97 (229)
T 2yle_A           34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRR--QPRHRVRSAAQIRVWRDGAVTLAP-AADD----------   97 (229)
T ss_dssp             EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT--CCCCCCCSGGGEEEETTSCEEECC-C-------------
T ss_pred             cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcc--cCCceecCCcceEEecCCceeccc-cccc----------
Confidence            788888754   579999999999999999987762210  111333456889999999888864 1110          


Q ss_pred             eccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcccCCCC
Q 037869          203 TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD  282 (380)
Q Consensus       203 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (380)
                         .....+.|||... ...+.+.=|||||+++|..+--..|-..                                  .
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e~e----------------------------------E  139 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKENE----------------------------------E  139 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCTTE----------------------------------E
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCccc----------------------------------c
Confidence               1133456888653 4557888999999999999874444211                                  0


Q ss_pred             HHHHHHHHHHHHhhcCC-------------------------CCCCCCCHHHHHHHhcCCCC
Q 037869          283 ENQLKQAINVAVLCVQS-------------------------EPEKRPNMKEVVNTLTGYDP  319 (380)
Q Consensus       283 ~~~~~~~~~li~~cl~~-------------------------~P~~Rps~~~ll~~l~~~~~  319 (380)
                      ...+..+.+||..|...                         .+..|+++++|++.......
T Consensus       140 ~eLS~~LE~LL~~Mt~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~hl~  201 (229)
T 2yle_A          140 RELSPPLEQLIDHMANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAAHLP  201 (229)
T ss_dssp             ECCCHHHHHHHHHHTTCCC--------------------CCSCCCCCCSHHHHHHHHHTTSS
T ss_pred             hhhCHHHHHHHHHHHhcccccccccccccccccccccccccccccCcCCHHHHHHHHHhhcc
Confidence            11125677777777655                         35688999999998765543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.54  E-value=0.00025  Score=65.63  Aligned_cols=143  Identities=14%  Similarity=0.152  Sum_probs=81.6

Q ss_pred             cceeccCCceEEEEEEeC--------CCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCc-ceeEeeEEecCCeEEEEE
Q 037869           46 DNKLGEGGFGSVYWGRTS--------DGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKN-LLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~  116 (380)
                      .+.|..|-...+|++...        ++..|++++.-.. ......+.+|..+++.+...+ ..++++.+..    .+||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~  129 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-LQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLE  129 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-cchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEE
Confidence            467888989999999764        2478999986332 123445668988888774222 3556666543    2999


Q ss_pred             EecCCCCHHHh-----------------hccCCC-CCccC--CHHHHHHHHHHHHH-------------------HHHHH
Q 037869          117 DYMPNLSLLSH-----------------LHGQYA-GEVQL--DWKRRMKIAIGSAE-------------------GILYL  157 (380)
Q Consensus       117 e~~~~g~L~~~-----------------i~~~~~-~~~~~--~~~~~~~i~~ql~~-------------------al~~L  157 (380)
                      ||++|.+|...                 ++.... .....  -+..+.++..++-.                   .+..|
T Consensus       130 e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L  209 (379)
T 3feg_A          130 QYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNL  209 (379)
T ss_dssp             ECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHH
T ss_pred             EEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHH
Confidence            99987655311                 111100 01111  23444445443321                   12233


Q ss_pred             h----hc-CCCCeEecCCCCCCeeeCCC----CceEEeeccCccc
Q 037869          158 H----HE-VTPHIIHRDIKASNVLLDSD----FEPLVADFGFAKL  193 (380)
Q Consensus       158 H----~~-~~~~ivHrdlkp~Nill~~~----~~vkl~Dfgl~~~  193 (380)
                      .    .. ....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       210 ~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          210 RKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            2    21 12368999999999999876    7899999988753

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.54  E-value=0.00022  Score=67.32  Aligned_cols=74  Identities=16%  Similarity=0.249  Sum_probs=49.6

Q ss_pred             CcceeccCCceEEEEEEeCC--------CcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcc-eeEeeEEecCCeEEEE
Q 037869           45 DDNKLGEGGFGSVYWGRTSD--------GLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL-LGLRGYCAGTDQRLIV  115 (380)
Q Consensus        45 ~~~~Lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv  115 (380)
                      -.+.|+.|....||++...+        +..|++|+......  ...+..|..+++.+...++ .++++.+..    .+|
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v  150 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  150 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEE
Confidence            35678899999999998642        57899998844211  1345578888887743333 556665532    389


Q ss_pred             EEecCCCCH
Q 037869          116 YDYMPNLSL  124 (380)
Q Consensus       116 ~e~~~~g~L  124 (380)
                      +||++|-+|
T Consensus       151 ~e~l~G~~l  159 (429)
T 1nw1_A          151 EEYIPSRPL  159 (429)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeCCccc
Confidence            999986443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.50  E-value=0.00081  Score=60.81  Aligned_cols=143  Identities=14%  Similarity=0.116  Sum_probs=80.0

Q ss_pred             ceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCC--cceeEeeE-----EecCCeEEEEEEec
Q 037869           47 NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHK--NLLGLRGY-----CAGTDQRLIVYDYM  119 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~~~~~-----~~~~~~~~lv~e~~  119 (380)
                      ..|+ |....||++...+|+.+++|...... .....+..|..+++.+...  .+.+++..     ....+..++||+++
T Consensus        32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcCCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4577 88889999887667789999987432 1233556677777666321  13333332     12245678999999


Q ss_pred             CCCCHHH--------------hhccC---C--CCCccCCHHHH----------------------HHHHHHHHHHHHHHh
Q 037869          120 PNLSLLS--------------HLHGQ---Y--AGEVQLDWKRR----------------------MKIAIGSAEGILYLH  158 (380)
Q Consensus       120 ~~g~L~~--------------~i~~~---~--~~~~~~~~~~~----------------------~~i~~ql~~al~~LH  158 (380)
                      +|.++..              .++..   .  .....++....                      ...+..++..+.-+-
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            8754320              01110   0  00111221111                      111112222222221


Q ss_pred             h-cCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          159 H-EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       159 ~-~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      . .....++|||+++.||+++ + .+.|+||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            1 0123689999999999999 4 899999987754

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.34  E-value=0.00035  Score=64.53  Aligned_cols=74  Identities=8%  Similarity=-0.019  Sum_probs=43.5

Q ss_pred             cceeccCCceEEEEEEeCC---------CcEEEEEEecccChhhHHHHHHHHHHHhcCCCCc-ceeEeeEEecCCeEEEE
Q 037869           46 DNKLGEGGFGSVYWGRTSD---------GLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKN-LLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~~---------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv  115 (380)
                      .+.|+.|....+|++...+         +..|++|+...... .......|..+++.+...+ +.++++..  .  -++|
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v  112 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRI  112 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEE
Confidence            4678889899999997643         26888888754221 1112356777777664323 34555544  2  3789


Q ss_pred             EEecCCCCH
Q 037869          116 YDYMPNLSL  124 (380)
Q Consensus       116 ~e~~~~g~L  124 (380)
                      |||++|.++
T Consensus       113 ~e~i~G~~l  121 (369)
T 3c5i_A          113 EEWLYGDPL  121 (369)
T ss_dssp             EECCCSEEC
T ss_pred             EEEecCCcC
Confidence            999987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.29  E-value=0.0017  Score=59.14  Aligned_cols=30  Identities=30%  Similarity=0.420  Sum_probs=27.1

Q ss_pred             CeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          164 HIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       164 ~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      .++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            699999999999999888899999987764

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.28  E-value=0.0011  Score=62.89  Aligned_cols=74  Identities=8%  Similarity=0.050  Sum_probs=47.1

Q ss_pred             cceeccCCceEEEEEEeCC-CcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcc-eeEeeEEecCCeEEEEEEecCCCC
Q 037869           46 DNKLGEGGFGSVYWGRTSD-GLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL-LGLRGYCAGTDQRLIVYDYMPNLS  123 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv~e~~~~g~  123 (380)
                      .+.|+.|-...+|++...+ +..|++|+....... .....+|..+++.|...++ .++++.+.  +  .+||||++|-+
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~  187 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYA  187 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCcc
Confidence            4578889999999998754 478889887432211 1122468888888864444 45666663  2  35999998754


Q ss_pred             H
Q 037869          124 L  124 (380)
Q Consensus       124 L  124 (380)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.48  E-value=0.0057  Score=57.34  Aligned_cols=74  Identities=9%  Similarity=0.039  Sum_probs=47.3

Q ss_pred             cceeccCCceEEEEEEeCC--------CcEEEEEEecccChhhHHHHHHHHHHHhcCCCCc-ceeEeeEEecCCeEEEEE
Q 037869           46 DNKLGEGGFGSVYWGRTSD--------GLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKN-LLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~~~~~~~~~~~~~lv~  116 (380)
                      .+.|..|-...+|+....+        +..|++++..... .......+|..+++.+...+ ..++++.+.    -+.||
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~I~  149 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGRIE  149 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCEEE
Confidence            5678889999999998642        5789998865422 11113346777777764222 344554332    27899


Q ss_pred             EecCCCCH
Q 037869          117 DYMPNLSL  124 (380)
Q Consensus       117 e~~~~g~L  124 (380)
                      +|++|.+|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.52  E-value=0.19  Score=46.57  Aligned_cols=30  Identities=23%  Similarity=0.480  Sum_probs=24.9

Q ss_pred             CeEecCCCCCCeee------CCCCceEEeeccCccc
Q 037869          164 HIIHRDIKASNVLL------DSDFEPLVADFGFAKL  193 (380)
Q Consensus       164 ~ivHrdlkp~Nill------~~~~~vkl~Dfgl~~~  193 (380)
                      .++|+|+.+.||++      +.+..+.++||..+..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            36799999999999      4457899999988753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=93.41  E-value=0.26  Score=41.08  Aligned_cols=117  Identities=11%  Similarity=0.150  Sum_probs=81.1

Q ss_pred             CCCcceeEeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 037869           95 RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASN  174 (380)
Q Consensus        95 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~N  174 (380)
                      .||+++.. .+-.+++.+.|.++.-..+.=+..+       ...+....++++.+|+....+++++     +|--|.|+|
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i-------k~~~~~eKlr~l~ni~~l~~~~~~r-----~tf~L~P~N  109 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI-------KSFTKNEKLRYLLNIKNLEEVNRTR-----YTFVLAPDE  109 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG-------GGSCHHHHHHHHHHGGGGGGGGGSS-----EECCCSGGG
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH-------HhcCHHHHHHHHHHHHHHHHHhcCc-----eEEEEecce
Confidence            68888876 4555566666666655433223334       2578889999999999888666644     888999999


Q ss_pred             eeeCCCCceEEeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCC
Q 037869          175 VLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEK  247 (380)
Q Consensus       175 ill~~~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  247 (380)
                      |+++.++.+++.=.|+-..+.                  |.     ..+...=+-.+-|++..++++...|+.
T Consensus       110 L~f~~~~~p~i~~RGik~~l~------------------P~-----~~~ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          110 LFFTRDGLPIAKTRGLQNVVD------------------PL-----PVSEAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             EEECTTSCEEESCCEETTTBS------------------CC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             EEEcCCCCEEEEEccCccCCC------------------CC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            999999999998666543321                  11     112223344678888999999888864

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=91.39  E-value=0.63  Score=38.94  Aligned_cols=116  Identities=11%  Similarity=0.154  Sum_probs=78.5

Q ss_pred             CCCcceeEeeEEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHH-HHhhcCCCCeEecCCCCC
Q 037869           95 RHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGIL-YLHHEVTPHIIHRDIKAS  173 (380)
Q Consensus        95 ~h~niv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~-~LH~~~~~~ivHrdlkp~  173 (380)
                      .||++ . ..+-.+++.+.|.++.-+++.-+..+.       .++....++++.+|+.... ++++     -+|--|.|+
T Consensus        48 ~~~~f-~-~~I~~~eD~~~i~y~~~~~~~~f~~i~-------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~  113 (219)
T 4ano_A           48 VDPCI-V-RDIDVSEDEVKVVIKPPSSFLTFAAIR-------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPE  113 (219)
T ss_dssp             SCSSS-E-EEEEECSSEEEEEEECCTTCEEHHHHH-------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGG
T ss_pred             cCCCC-C-eEEEEeCCEEEEEEEcCcccCcHHHHH-------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCc
Confidence            57888 2 333366677777777664544444553       5788889999999888776 5654     488899999


Q ss_pred             CeeeCCCCceEEeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCC
Q 037869          174 NVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEK  247 (380)
Q Consensus       174 Nill~~~~~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  247 (380)
                      ||+++.++.+++.=.|+-..+                  +|.-     .+..-=+-++-|++..++.+...|+.
T Consensus       114 NL~f~~~~~p~i~hRGi~~~l------------------pP~e-----~~ee~fl~qyKali~all~~K~~Fe~  164 (219)
T 4ano_A          114 NLMFNRALEPFFLHVGVKESL------------------PPDE-----WDDERLLREVKATVLALTEGEYRFDE  164 (219)
T ss_dssp             GEEECTTCCEEESCCEETTTB------------------SSCS-----CCHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred             eEEEeCCCcEEEEEcCCcccC------------------CCCC-----CCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            999999999999876664433                  2211     11122233677788888888777743

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=83.69  E-value=0.12  Score=49.10  Aligned_cols=61  Identities=3%  Similarity=0.014  Sum_probs=19.1

Q ss_pred             CCcceeccCCceEEEEEEeCC-CcEEEE------EEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEe
Q 037869           44 SDDNKLGEGGFGSVYWGRTSD-GLQIAV------KKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA  107 (380)
Q Consensus        44 ~~~~~Lg~G~~g~Vy~~~~~~-~~~vav------K~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  107 (380)
                      .+.+.||   ||.||++.... ..+||+      |..+..  .......+.+|..+++.++|||+++.+++..
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~  214 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV  214 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence            4567887   99999998643 467888      766542  2222345777888888999999999988754

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	380
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	3e-71
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	7e-65
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	6e-64
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-64
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-63
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-62
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-62
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-62
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-62
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-61
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-60
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-60
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-59
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-59
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	9e-59
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-58
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-58
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-58
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	8e-58
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-57
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-56
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-55
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-55
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-55
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-54
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-54
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-54
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-52
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-52
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	4e-50
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-49
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-48
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-48
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-47
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	8e-47
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-45
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	3e-45
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-43
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-43
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-43
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-43
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	4e-43
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-42
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-42
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-42
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-41
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	1e-40
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-40
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	3e-39
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-39
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-37
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	4e-37
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-33
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-32
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-31
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	3e-29
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-27
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-19

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (566), Expect = 3e-71
 Identities = 72/272 (26%), Positives = 125/272 (45%), Gaps = 22/272 (8%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            ++G G FG+VY G+    + + +  + A   +    F  EV VL + RH N+L   GY 
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73

Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
               Q  IV  +    SL  HLH     E + +  + + IA  +A+G+ YLH      II
Sbjct: 74  TA-PQLAIVTQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHA---KSII 126

Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEG-VSHMTTRVKGTLGYLAPEYAM---WGKV 222
           HRD+K++N+ L  D    + DFG A +      SH   ++ G++ ++APE          
Sbjct: 127 HRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPY 186

Query: 223 SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
           S   DVY+FGI+L E++TG+ P   +               +V   +      K+R +  
Sbjct: 187 SFQSDVYAFGIVLYELMTGQLPYSNIN-------NRDQIIFMVGRGYLSPDLSKVRSNCP 239

Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           +        +   C++ + ++RP   +++ ++
Sbjct: 240 K----AMKRLMAECLKKKRDERPLFPQILASI 267

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 7e-65
 Identities = 70/272 (25%), Positives = 123/272 (45%), Gaps = 22/272 (8%)

Query: 43  FSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
                +LG G FG V+ G  +   ++AVK LK   S +   F  E  ++ +++H+ L+ L
Sbjct: 15  LKLVERLGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
                  +   I+ +YM N SL+  L       ++L   + + +A   AEG+ ++     
Sbjct: 74  YAVVT-QEPIYIITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEE--- 127

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
            + IHRD++A+N+L+       +ADFG A+LI +         K  + + APE   +G  
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187

Query: 223 SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
           +   DV+SFGILL EI+T  +                  P +++      ++   R    
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRIPY----------PGMTNPEVIQ-----NLERGYRMVRP 232

Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           +N  ++   +  LC +  PE RP    + + L
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVL 264

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  204 bits (519), Expect = 6e-64
 Identities = 70/303 (23%), Positives = 129/303 (42%), Gaps = 41/303 (13%)

Query: 31  FTYKELHTATNGFSD---------DNKLGEGGFGSVYWGR----TSDGLQIAVKKLK-AM 76
           FT+++ + A   F+          +  +G G FG V  G         + +A+K LK   
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66

Query: 77  NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEV 136
             K   +F  E  ++G+  H N++ L G    +   +I+ ++M N SL S L        
Sbjct: 67  TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--- 123

Query: 137 QLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE 196
           Q    + + +  G A G+ YL      + +HRD+ A N+L++S+    V+DFG ++ + +
Sbjct: 124 QFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180

Query: 197 GVSHMTTR----VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGG 251
             S  T       K  + + APE   + K + + DV+S+GI++ E+++ G +P   +   
Sbjct: 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN- 239

Query: 252 VKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVV 311
                                ++   R     +       + + C Q +   RP   ++V
Sbjct: 240 ---------------QDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIV 284

Query: 312 NTL 314
           NTL
Sbjct: 285 NTL 287

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 7e-64
 Identities = 63/269 (23%), Positives = 119/269 (44%), Gaps = 24/269 (8%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            +LG G FG V +G+      +A+K +K   S +E EF  E +V+  + H+ L+ L G C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIK-EGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
                  I+ +YM N  LL++L        +   ++ +++     E + YL        +
Sbjct: 69  TKQRPIFIITEYMANGCLLNYLREMRH---RFQTQQLLEMCKDVCEAMEYLES---KQFL 122

Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD+ A N L++      V+DFG ++ + +     +   K  + +  PE  M+ K S   
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182

Query: 227 DVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
           D+++FG+L+ EI + G+ P E+                    +  E +   LR       
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFT----------------NSETAEHIAQGLRLYRPHLA 226

Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            ++   +   C   + ++RP  K +++ +
Sbjct: 227 SEKVYTIMYSCWHEKADERPTFKILLSNI 255

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (516), Expect = 1e-63
 Identities = 76/275 (27%), Positives = 131/275 (47%), Gaps = 22/275 (8%)

Query: 43  FSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
              + KLG+G FG V+ G  +   ++A+K LK   + +   F  E +V+ ++RH+ L+ L
Sbjct: 19  LRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQL 77

Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
               +  +   IV +YM   SLL  L G+    ++    + + +A   A G+ Y+     
Sbjct: 78  YAVVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLR--LPQLVDMAAQIASGMAYVER--- 131

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
            + +HRD++A+N+L+  +    VADFG A+LI +         K  + + APE A++G+ 
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF 191

Query: 223 SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
           +   DV+SFGILL E+ T  +     PG V R + +              V+   R    
Sbjct: 192 TIKSDVWSFGILLTELTTKGRVPY--PGMVNREVLDQ-------------VERGYRMPCP 236

Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY 317
               +   ++   C + EPE+RP  + +   L  Y
Sbjct: 237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 1e-62
 Identities = 63/268 (23%), Positives = 118/268 (44%), Gaps = 22/268 (8%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            ++G G FG V+ G   +  ++A+K ++   + +E +F  E EV+ ++ H  L+ L G C
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
                  +V+++M +  L  +L  Q         +  + + +   EG   + +     +I
Sbjct: 70  LEQAPICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEG---MAYLEEACVI 123

Query: 167 HRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESC 226
           HRD+ A N L+  +    V+DFG  + + +     +T  K  + + +PE   + + S   
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183

Query: 227 DVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQL 286
           DV+SFG+L+ E+ +  K   +      R+ +E  E  I  G    L  P+L         
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYE-----NRSNSEVVE-DISTG--FRLYKPRLAST------ 229

Query: 287 KQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                +   C +  PE RP    ++  L
Sbjct: 230 -HVYQIMNHCWKERPEDRPAFSRLLRQL 256

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  199 bits (508), Expect = 2e-62
 Identities = 72/273 (26%), Positives = 115/273 (42%), Gaps = 22/273 (8%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLG 101
            +  +KLG G +G VY G      L +AVK LK  ++    EF  E  V+  ++H NL+ 
Sbjct: 19  ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLK-EDTMEVEEFLKEAAVMKEIKHPNLVQ 77

Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
           L G C       I+ ++M   +LL +L        ++     + +A   +  + YL    
Sbjct: 78  LLGVCTREPPFYIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEK-- 133

Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK 221
             + IHRD+ A N L+  +    VADFG ++L+           K  + + APE   + K
Sbjct: 134 -KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192

Query: 222 VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF 281
            S   DV++FG+LL EI T                     P I   +  EL++   R + 
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSP---------------YPGIDLSQVYELLEKDYRMER 237

Query: 282 DENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            E   ++   +   C Q  P  RP+  E+    
Sbjct: 238 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAF 270

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 4e-62
 Identities = 60/291 (20%), Positives = 114/291 (39%), Gaps = 30/291 (10%)

Query: 48  KLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCA 107
            +G+G FG V+ G+   G ++AVK       +       E+     +RH+N+LG      
Sbjct: 10  SIGKGRFGEVWRGK-WRGEEVAVKIFS-SREERSWFREAEIYQTVMLRHENILGFIAADN 67

Query: 108 GTD----QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV-- 161
             +    Q  +V DY  + SL  +L+        +  +  +K+A+ +A G+ +LH E+  
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVG 122

Query: 162 ---TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG---VSHMTTRVKGTLGYLAPE 215
               P I HRD+K+ N+L+  +    +AD G A         +        GT  Y+APE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182

Query: 216 Y------AMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGG----VKRTITEWAEPLIV 265
                      +  +  D+Y+ G++  EI                      ++ +   + 
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242

Query: 266 KGKFKELVDPKLRGDFDENQ-LKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
           K   ++ + P +   +   + L+    +   C  +    R     +  TL+
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 9e-62
 Identities = 68/289 (23%), Positives = 122/289 (42%), Gaps = 31/289 (10%)

Query: 34  KELHTATNGFS-DDNKLGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEME-FAVEV 88
           K+L    +     D +LG G FGSV  G        + +A+K LK    KA+ E    E 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 89  EVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAI 148
           +++ ++ +  ++ L G C   +  ++V +      L   L G+     ++      ++  
Sbjct: 61  QIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGK---REEIPVSNVAELLH 116

Query: 149 GSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR--VK 206
             + G+ YL      + +HRD+ A NVLL +     ++DFG +K +    S+ T R   K
Sbjct: 117 QVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 207 GTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIV 265
             L + APE   + K S   DV+S+G+ + E L+ G+KP +K+ G               
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG--------------- 218

Query: 266 KGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
             +    ++   R +       +   +   C   + E RP+   V   +
Sbjct: 219 -PEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 266

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 5e-61
 Identities = 63/306 (20%), Positives = 117/306 (38%), Gaps = 38/306 (12%)

Query: 36  LHTATNGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKL-KAMNSKAEMEFAVEVEVLGR 93
           +    + F   ++LG G  G V+       GL +A K +   +      +   E++VL  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 94  VRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEG 153
                ++G  G      +  I  ++M   SL   L        ++  +   K++I   +G
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKG 116

Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLA 213
           + YL  +    I+HRD+K SN+L++S  E  + DFG +  + +    M     GT  Y++
Sbjct: 117 LTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---SMANSFVGTRSYMS 171

Query: 214 PEYAMWGKVSESCDVYSFGILLLEILTGRKPIE-----------------------KLPG 250
           PE       S   D++S G+ L+E+  GR PI                          P 
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231

Query: 251 GVKRTITEWAEPLIVKGKFKELVDPKLRGDF----DENQLKQAINVAVLCVQSEPEKRPN 306
              R ++ +           EL+D  +              +  +    C+   P +R +
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291

Query: 307 MKEVVN 312
           +K+++ 
Sbjct: 292 LKQLMV 297

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 5e-60
 Identities = 63/278 (22%), Positives = 116/278 (41%), Gaps = 32/278 (11%)

Query: 45  DDNKLGEGGFGSVYWGR---TSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNL 99
           +D +LG G FG+V  G          +AVK LK  A +   + E   E  V+ ++ +  +
Sbjct: 11  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70

Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           + + G C   +  ++V +      L  +L         +  K  +++    + G+ YL  
Sbjct: 71  VRMIGICE-AESWMLVMEMAELGPLNKYLQQNR----HVKDKNIIELVHQVSMGMKYLEE 125

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR--VKGTLGYLAPEYA 217
               + +HRD+ A NVLL +     ++DFG +K +    ++   +   K  + + APE  
Sbjct: 126 S---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECI 182

Query: 218 MWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
            + K S   DV+SFG+L+ E  + G+KP   + G                 +   +++  
Sbjct: 183 NYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG----------------SEVTAMLEKG 226

Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            R        ++  ++  LC   + E RP    V   L
Sbjct: 227 ERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRL 264

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 8e-60
 Identities = 75/269 (27%), Positives = 110/269 (40%), Gaps = 28/269 (10%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
             +G+G FG V  G    G ++AVK +K  N      F  E  V+ ++RH NL+ L G  
Sbjct: 13  QTIGKGEFGDVMLGD-YRGNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 107 AGTDQRL-IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
                 L IV +YM   SL+ +L  +  G   L     +K ++   E + YL      + 
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEG---NNF 124

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSES 225
           +HRD+ A NVL+  D    V+DFG  K      S      K  + + APE     K S  
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKEA----SSTQDTGKLPVKWTAPEALREKKFSTK 180

Query: 226 CDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
            DV+SFGILL EI +  +          R   +   P + KG          + D  +  
Sbjct: 181 SDVWSFGILLWEIYSFGRVPY------PRIPLKDVVPRVEKGY---------KMDAPDGC 225

Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                 V   C   +   RP+  ++   L
Sbjct: 226 PPAVYEVMKNCWHLDAAMRPSFLQLREQL 254

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 1e-59
 Identities = 63/275 (22%), Positives = 118/275 (42%), Gaps = 31/275 (11%)

Query: 46  DNKLGEGGFGSVYWGR-TSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
           D ++G G F +VY G  T   +++A  +L+   +       F  E E+L  ++H N++  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 103 RGYCAGTDQR----LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
                 T +     ++V + M + +L ++L         +  K          +G+ +LH
Sbjct: 74  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK----VMKIKVLRSWCRQILKGLQFLH 129

Query: 159 HEVTPHIIHRDIKASNVLLDS-DFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
              TP IIHRD+K  N+ +        + D G A L     +     V GT  ++APE  
Sbjct: 130 TR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR---ASFAKAVIGTPEFMAPEMY 185

Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL 277
              K  ES DVY+FG+ +LE+ T   P              ++E       ++ +     
Sbjct: 186 E-EKYDESVDVYAFGMCMLEMATSEYP--------------YSECQNAAQIYRRVTSGVK 230

Query: 278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
              FD+  + +   +   C++   ++R ++K+++N
Sbjct: 231 PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 1e-59
 Identities = 65/280 (23%), Positives = 128/280 (45%), Gaps = 29/280 (10%)

Query: 43  FSDDNKLGEGGFGSVYWGRTSDG-----LQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRH 96
            +    +G G FG VY G          + +A+K LKA    K  ++F  E  ++G+  H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
            N++ L G  +     +I+ +YM N +L   L  +   + +    + + +  G A G+ Y
Sbjct: 69  HNIIRLEGVISKYKPMMIITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKY 125

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG--VSHMTTRVKGTLGYLAP 214
           L +    + +HRD+ A N+L++S+    V+DFG ++++ +    ++ T+  K  + + AP
Sbjct: 126 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAP 182

Query: 215 EYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD 274
           E   + K + + DV+SFGI++ E++T  +               W        +  + ++
Sbjct: 183 EAISYRKFTSASDVWSFGIVMWEVMTYGERP------------YWELS---NHEVMKAIN 227

Query: 275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
              R     +       + + C Q E  +RP   ++V+ L
Sbjct: 228 DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSIL 267

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 9e-59
 Identities = 58/273 (21%), Positives = 104/273 (38%), Gaps = 24/273 (8%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
             +G G +G     R  SDG  +  K+L   +M    +     EV +L  ++H N++   
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 104 GYCAGTDQRL--IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH--H 159
                       IV +Y     L S +         LD +  +++       +   H   
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 129

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
           +    ++HRD+K +NV LD      + DFG A+++    S       GT  Y++PE    
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA-FVGTPYYMSPEQMNR 188

Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
              +E  D++S G LL E+     P          +  E A   I +GKF+ +       
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPFT------AFSQKELAG-KIREGKFRRI------- 234

Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
                   +   +    +  +   RP+++E++ 
Sbjct: 235 --PYRYSDELNEIITRMLNLKDYHRPSVEEILE 265

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 1e-58
 Identities = 65/291 (22%), Positives = 118/291 (40%), Gaps = 40/291 (13%)

Query: 47  NKLGEGGFGSVYWGR------TSDGLQIAVKKLK-AMNSKAEMEFAVEVEVLGRV-RHKN 98
             LG G FG V          +   + +AVK LK + +         E++VL  +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQ--------------YAGEVQLDWKRRM 144
           ++ L G C      L++ +Y     LL+ L  +                 E+ LD +  +
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 145 KIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM-TT 203
             +   A+G+ +L  +   + IHRD+ A N+LL       + DFG A+ I    +++   
Sbjct: 149 SFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 204 RVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL 263
             +  + ++APE       +   DV+S+GI L E+ +                      +
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS--------------PYPGM 251

Query: 264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            V  KF +++    R    E+   +  ++   C  ++P KRP  K++V  +
Sbjct: 252 PVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 2e-58
 Identities = 69/279 (24%), Positives = 115/279 (41%), Gaps = 30/279 (10%)

Query: 46  DNKLGEGGFGSVYWGR----TSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLL 100
           +  +G G FG VY G         +  AVK L  +    E+  F  E  ++    H N+L
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 101 GLRGYCAGTDQR-LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
            L G C  ++   L+V  YM +  L + +  +         K  +   +  A+G   +  
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKG---MKF 145

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG---VSHMTTRVKGTLGYLAPEY 216
             +   +HRD+ A N +LD  F   VADFG A+ + +      H  T  K  + ++A E 
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205

Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
               K +   DV+SFG+LL E++T   P             +    L+   + + L+ P 
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP-----DVNTFDITVYLL---QGRRLLQP- 256

Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
                 E        V + C   + E RP+  E+V+ ++
Sbjct: 257 ------EYCPDPLYEVMLKCWHPKAEMRPSFSELVSRIS 289

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (485), Expect = 2e-58
 Identities = 67/296 (22%), Positives = 121/296 (40%), Gaps = 47/296 (15%)

Query: 48  KLGEGGFGSVY------WGRTSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRV-RHKNL 99
            LG G FG V         +T   +Q+AVK LK     +E E    E++++ ++  H+N+
Sbjct: 44  VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103

Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQ-------------------YAGEVQLDW 140
           + L G C  +    ++++Y     LL++L  +                         L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163

Query: 141 KRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH 200
           +  +  A   A+G+ +L        +HRD+ A NVL+       + DFG A+ I    ++
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 220

Query: 201 MT-TRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITE 258
           +     +  + ++APE    G  +   DV+S+GILL EI + G  P   +P         
Sbjct: 221 VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP--------- 271

Query: 259 WAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                 V   F +L+    + D      ++   +   C   +  KRP+   + + L
Sbjct: 272 ------VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  188 bits (478), Expect = 8e-58
 Identities = 61/310 (19%), Positives = 107/310 (34%), Gaps = 46/310 (14%)

Query: 33  YKELHTATNGFSDDNKLGEGGFGSVYWGR------TSDGLQIAVKKLK-AMNSKAEMEFA 85
              L    N       +GEG FG V+  R            +AVK LK   ++  + +F 
Sbjct: 5   LLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ 64

Query: 86  VEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQ-------------- 131
            E  ++    + N++ L G CA      ++++YM    L   L                 
Sbjct: 65  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLS 124

Query: 132 ------YAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV 185
                   G   L    ++ IA   A G+ YL        +HRD+   N L+  +    +
Sbjct: 125 TRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKI 181

Query: 186 ADFGFAKLIPEG-VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
           ADFG ++ I               + ++ PE   + + +   DV+++G++L EI +    
Sbjct: 182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ 241

Query: 245 IEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKR 304
                             +  +     + D  +     EN   +  N+  LC    P  R
Sbjct: 242 --------------PYYGMAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADR 286

Query: 305 PNMKEVVNTL 314
           P+   +   L
Sbjct: 287 PSFCSIHRIL 296

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (475), Expect = 3e-57
 Identities = 73/312 (23%), Positives = 128/312 (41%), Gaps = 39/312 (12%)

Query: 41  NGFSDDNKLGEGGFGSVYWGR---TSDGLQIAVKKLKAMNSKAEM-EFAVEVEVLGRV-R 95
           N     + +GEG FG V   R       +  A+K++K   SK +  +FA E+EVL ++  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 96  HKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQ------------LDWKRR 143
           H N++ L G C       +  +Y P+ +LL  L      E              L  ++ 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT 203
           +  A   A G+ YL        IHRD+ A N+L+  ++   +ADFG ++     V     
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 186

Query: 204 RVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL 263
           R    + ++A E   +   + + DV+S+G+LL EI++              T  E     
Sbjct: 187 R--LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC-----GMTCAELY--- 236

Query: 264 IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY--DPRG 321
                  E +    R +   N   +  ++   C + +P +RP+  +++ +L     + + 
Sbjct: 237 -------EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKT 289

Query: 322 KVMQTRIETLAY 333
            V  T  E   Y
Sbjct: 290 YVNTTLYEKFTY 301

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 7e-56
 Identities = 76/270 (28%), Positives = 118/270 (43%), Gaps = 31/270 (11%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLK---AMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
             LG+G FG+VY  R       +A+K L       +  E +   EVE+   +RH N+L L
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
            GY     +  ++ +Y P  ++   L        + D +R        A  + Y H +  
Sbjct: 72  YGYFHDATRVYLILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK-- 125

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
             +IHRDIK  N+LL S  E  +ADFG++   P   S   T + GTL YL PE       
Sbjct: 126 -RVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGRMH 181

Query: 223 SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
            E  D++S G+L  E L G+ P E        T  E  +  I + +F           F 
Sbjct: 182 DEKVDLWSLGVLCYEFLVGKPPFE------ANTYQETYK-RISRVEF----------TFP 224

Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
           +   + A ++    ++  P +RP ++EV+ 
Sbjct: 225 DFVTEGARDLISRLLKHNPSQRPMLREVLE 254

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 1e-55
 Identities = 64/280 (22%), Positives = 117/280 (41%), Gaps = 31/280 (11%)

Query: 43  FSDDNKLGEGGFGSVYWGR-----TSDGLQIAVKKLK-AMNSKAEMEFAVEVEVLGRVRH 96
           F     LG G FG+VY G          + +A+K+L+ A + KA  E   E  V+  V +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
            ++  L G C  T    ++   MP   LL ++      +  +  +  +   +  A+G+ Y
Sbjct: 71  PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNY 126

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPE 215
           L       ++HRD+ A NVL+ +     + DFG AKL+  E   +     K  + ++A E
Sbjct: 127 LED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183

Query: 216 YAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD 274
             +    +   DV+S+G+ + E++T G KP + +P                  +   +++
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----------------ASEISSILE 227

Query: 275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
              R             + V C   + + RP  +E++   
Sbjct: 228 KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF 267

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  182 bits (464), Expect = 1e-55
 Identities = 69/304 (22%), Positives = 119/304 (39%), Gaps = 36/304 (11%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLK---AMNSKAEMEFAVEVEVLGRVRHKN 98
           FSD  ++G G FG+VY+ R   +   +A+KK+      +++   +   EV  L ++RH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
            +  RG         +V +Y    +       +      L       +  G+ +G+ YLH
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLH 132

Query: 159 HEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAM 218
                ++IHRD+KA N+LL       + DFG A ++            GT  ++APE  +
Sbjct: 133 SH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----ANSFVGTPYWMAPEVIL 184

Query: 219 W---GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP 275
               G+     DV+S GI  +E+   + P+  +           A   I + +   L   
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN-------AMSALYHIAQNESPALQSG 237

Query: 276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNT--LTGYDPRGKVMQTRIETLAY 333
                      +   N    C+Q  P+ RP  + ++    +    P   +M     T   
Sbjct: 238 HWS--------EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDA 289

Query: 334 KEEL 337
             EL
Sbjct: 290 VREL 293

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (459), Expect = 4e-55
 Identities = 57/272 (20%), Positives = 108/272 (39%), Gaps = 27/272 (9%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
            +LG+G FG VY  +     +  A K +   + +   ++ VE+++L    H N++ L   
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               +   I+ ++    ++ + +      E  L   +   +   + + + YLH      I
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KI 131

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW-----G 220
           IHRD+KA N+L   D +  +ADFG +      +    + + GT  ++APE  M       
Sbjct: 132 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-GTPYWMAPEVVMCETSKDR 190

Query: 221 KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGD 280
                 DV+S GI L+E+     P  +L     R + +     I K +   L  P     
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELN--PMRVLLK-----IAKSEPPTLAQP----- 238

Query: 281 FDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
                     +    C++   + R    +++ 
Sbjct: 239 --SRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 3e-54
 Identities = 75/279 (26%), Positives = 112/279 (40%), Gaps = 32/279 (11%)

Query: 47  NKLGEGGFGSVYWGR----TSDGLQIAVKKLK---AMNSKAEMEFAVEVEVLGRVRHKNL 99
            KLG+G FG V  G     +   + +AVK LK       +A  +F  EV  +  + H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           + L G    T    +V +  P  SLL  L      +         + A+  AEG+ YL  
Sbjct: 74  IRLYGVVL-TPPMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLES 129

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH--MTTRVKGTLGYLAPEYA 217
                 IHRD+ A N+LL +     + DFG  + +P+   H  M    K    + APE  
Sbjct: 130 ---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESL 186

Query: 218 MWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
                S + D + FG+ L E+ T G++P   L G                    ++    
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG---------------SQILHKIDKEG 231

Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
            R    E+  +   NV V C   +PE RP    + + L 
Sbjct: 232 ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 3e-54
 Identities = 57/278 (20%), Positives = 103/278 (37%), Gaps = 29/278 (10%)

Query: 43  FSDD----NKLGEGGFGSVYWGR-TSDGLQIAVKKL-KAMNSKAEMEFAVEVEVLGRVRH 96
           F +D      LGEG +G V           +AVK +              E+ +   + H
Sbjct: 3   FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNH 62

Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
           +N++   G+    + + +  +Y     L   +         +      +       G++Y
Sbjct: 63  ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI----GMPEPDAQRFFHQLMAGVVY 118

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPE 215
           LH      I HRDIK  N+LLD      ++DFG A +        +  ++ GTL Y+APE
Sbjct: 119 LHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175

Query: 216 YAMWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVD 274
                +  +E  DV+S GI+L  +L G  P              W +P     ++ +  +
Sbjct: 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELP--------------WDQPSDSCQEYSDWKE 221

Query: 275 PKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
            K   +  +      + +    +   P  R  + ++  
Sbjct: 222 KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK 259

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 6e-54
 Identities = 57/267 (21%), Positives = 109/267 (40%), Gaps = 24/267 (8%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGY 105
            K+G+G  G+VY     + G ++A++++       +     E+ V+   ++ N++     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 106 CAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHI 165
               D+  +V +Y+   SL   +      E  +D  +   +     + + +LH      +
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN---QV 137

Query: 166 IHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSES 225
           IHRDIK+ N+LL  D    + DFGF   I    S  +T V GT  ++APE          
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-GTPYWMAPEVVTRKAYGPK 196

Query: 226 CDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQ 285
            D++S GI+ +E++ G  P              +     ++  +    +        E  
Sbjct: 197 VDIWSLGIMAIEMIEGEPP--------------YLNENPLRALYLIATNGTPELQNPEKL 242

Query: 286 LKQAINVAVLCVQSEPEKRPNMKEVVN 312
                +    C+  + EKR + KE++ 
Sbjct: 243 SAIFRDFLNRCLDMDVEKRGSAKELLQ 269

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (438), Expect = 3e-52
 Identities = 58/273 (21%), Positives = 109/273 (39%), Gaps = 27/273 (9%)

Query: 48  KLGEGGFGSVYWGR----TSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHKNLLGL 102
            +GEG FG V+ G      +  L +A+K  K   S +  E F  E   + +  H +++ L
Sbjct: 14  CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73

Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
            G     +   I+ +      L S L  +      LD    +  A   +  + YL     
Sbjct: 74  IGVITE-NPVWIIMELCTLGELRSFLQVRKYS---LDLASLILYAYQLSTALAYLES--- 126

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
              +HRDI A NVL+ S+    + DFG ++ + +   +  ++ K  + ++APE   + + 
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186

Query: 223 SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
           + + DV+ FG+ + EIL                  +  +   V G+ +      +  +  
Sbjct: 187 TSASDVWMFGVCMWEILMHGVK-----------PFQGVKNNDVIGRIENGERLPMPPNCP 235

Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT 315
                   ++   C   +P +RP   E+   L+
Sbjct: 236 P----TLYSLMTKCWAYDPSRRPRFTELKAQLS 264

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 6e-52
 Identities = 61/288 (21%), Positives = 119/288 (41%), Gaps = 32/288 (11%)

Query: 43  FSDDNKLGEGGFGSVYWG------RTSDGLQIAVKKL-KAMNSKAEMEFAVEVEVLGRVR 95
            +   +LG+G FG VY G      +     ++A+K + +A + +  +EF  E  V+    
Sbjct: 22  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 96  HKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGE------VQLDWKRRMKIAIG 149
             +++ L G  +     L++ + M    L S+L                   + +++A  
Sbjct: 82  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGE 141

Query: 150 SAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG-VSHMTTRVKGT 208
            A+G+ YL+       +HRD+ A N ++  DF   + DFG  + I E        +    
Sbjct: 142 IADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 209 LGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGK 268
           + +++PE    G  +   DV+SFG++L EI T  +         +    E     +++G 
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY------QGLSNEQVLRFVMEGG 252

Query: 269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG 316
                      D  +N       +  +C Q  P+ RP+  E+++++  
Sbjct: 253 ---------LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 291

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (426), Expect = 4e-50
 Identities = 78/292 (26%), Positives = 119/292 (40%), Gaps = 43/292 (14%)

Query: 47  NKLGEGGFGSVYWGR--------TSDGLQIAVKKLKA-MNSKAEMEFAVEVEVLGRV-RH 96
             LGEG FG V             +   ++AVK LK+    K   +   E+E++  + +H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQ------------YAGEVQLDWKRRM 144
           KN++ L G C       ++ +Y    +L  +L  +            +  E QL  K  +
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 145 KIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTR 204
             A   A G+ YL        IHRD+ A NVL+  D    +ADFG A+ I     +  T 
Sbjct: 139 SCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195

Query: 205 VK-GTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEP 262
                + ++APE       +   DV+SFG+LL EI T G  P   +P        E    
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP-------VEELFK 248

Query: 263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
           L+ +G          R D   N   +   +   C  + P +RP  K++V  L
Sbjct: 249 LLKEGH---------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDL 291

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  168 bits (427), Expect = 1e-49
 Identities = 45/269 (16%), Positives = 100/269 (37%), Gaps = 26/269 (9%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
           +LG G FG V+     + G   A K +   +   +     E++ +  +RH  L+ L    
Sbjct: 33  ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92

Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
              ++ +++Y++M    L   +  ++    ++     ++      +G+ ++H     + +
Sbjct: 93  EDDNEMVMIYEFMSGGELFEKVADEHN---KMSEDEAVEYMRQVCKGLCHMHEN---NYV 146

Query: 167 HRDIKASNVLLDSDFEPLV--ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
           H D+K  N++  +     +   DFG    +    S   T   GT  + APE A    V  
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPEVAEGKPVGY 204

Query: 225 SCDVYSFGILLLEILTGRKPIE-KLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDE 283
             D++S G+L   +L+G  P   +      R +              +     +      
Sbjct: 205 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC------DWNMDDSAFSGIS----- 253

Query: 284 NQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
              +   +     + ++P  R  + + + 
Sbjct: 254 ---EDGKDFIRKLLLADPNTRMTIHQALE 279

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 1e-48
 Identities = 64/290 (22%), Positives = 106/290 (36%), Gaps = 39/290 (13%)

Query: 47  NKLGEGGFGSVYWGR------TSDGLQIAVKKLK-AMNSKAEMEFAVEVEVLGR-VRHKN 98
             LG G FG V          T+    +AVK LK             E+++L     H N
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 99  LLGLRGYCAGTDQRL-IVYDYMPNLSLLSHLHGQ------------YAGEVQLDWKRRMK 145
           ++ L G C      L ++ ++    +L ++L  +               +  L  +  + 
Sbjct: 79  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 146 IAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH-MTTR 204
            +   A+G+ +L        IHRD+ A N+LL       + DFG A+ I +   +     
Sbjct: 139 YSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195

Query: 205 VKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI 264
            +  L ++APE       +   DV+SFG+LL EI +               I E     +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP-----GVKIDEEFCRRL 250

Query: 265 VKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
            +G          R    +    +     + C   EP +RP   E+V  L
Sbjct: 251 KEGT---------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHL 291

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 1e-48
 Identities = 61/271 (22%), Positives = 105/271 (38%), Gaps = 29/271 (10%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLK---AMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
             LGEG F +V   R  +   + A+K L+    +          E +V+ R+ H   + L
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73

Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
                  ++      Y  N  LL ++          D              + YLH    
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHG--- 126

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLI-PEGVSHMTTRVKGTLGYLAPEYAMWGK 221
             IIHRD+K  N+LL+ D    + DFG AK++ PE          GT  Y++PE      
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 186

Query: 222 VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF 281
             +S D+++ G ++ +++ G  P      G +  I +     I+K ++          DF
Sbjct: 187 ACKSSDLWALGCIIYQLVAGLPP---FRAGNEYLIFQ----KIIKLEY----------DF 229

Query: 282 DENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
            E    +A ++    +  +  KR   +E+  
Sbjct: 230 PEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  163 bits (413), Expect = 1e-47
 Identities = 49/292 (16%), Positives = 106/292 (36%), Gaps = 28/292 (9%)

Query: 28  WRIFTYKELHTATNGFSDD----NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEM 82
           W+ +  + +        D      +LG G FG V+     + G     K +       + 
Sbjct: 12  WKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY 71

Query: 83  EFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKR 142
               E+ ++ ++ H  L+ L        + +++ +++    L   +  +   + ++    
Sbjct: 72  TVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAE---DYKMSEAE 128

Query: 143 RMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV--ADFGFAKLIPEGVSH 200
            +     + EG+ ++H      I+H DIK  N++ ++     V   DFG A  +      
Sbjct: 129 VINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD--E 183

Query: 201 MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWA 260
           +      T  + APE      V    D+++ G+L   +L+G  P     G       +  
Sbjct: 184 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP---FAGEDDLETLQ-- 238

Query: 261 EPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
              + +       D +   D   +   +A +     +Q EP KR  + + + 
Sbjct: 239 --NVKRC------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 8e-47
 Identities = 52/268 (19%), Positives = 107/268 (39%), Gaps = 25/268 (9%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
            LG G FG V+    TS       K +K +    ++    E+ +L   RH+N+L L    
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFVK-VKGTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
              ++ +++++++  L +   ++       +L+ +  +       E + +LH     +I 
Sbjct: 71  ESMEELVMIFEFISGLDIFERIN---TSAFELNEREIVSYVHQVCEALQFLHS---HNIG 124

Query: 167 HRDIKASNVLLDSDFEPLV--ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
           H DI+  N++  +     +   +FG A+ +  G +           Y APE      VS 
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF--TAPEYYAPEVHQHDVVST 182

Query: 225 SCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDEN 284
           + D++S G L+  +L+G  P         + I E     I+  ++    D +   +    
Sbjct: 183 ATDMWSLGTLVYVLLSGINP---FLAETNQQIIE----NIMNAEYT--FDEEAFKEISI- 232

Query: 285 QLKQAINVAVLCVQSEPEKRPNMKEVVN 312
              +A++     +  E + R    E + 
Sbjct: 233 ---EAMDFVDRLLVKERKSRMTASEALQ 257

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (394), Expect = 3e-45
 Identities = 53/282 (18%), Positives = 106/282 (37%), Gaps = 21/282 (7%)

Query: 33  YKELHTATNGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKL-KAMNSKAEMEFAVEVEV 90
           +K+     + +   + LG G F  V           +A+K + K      E     E+ V
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 91  LGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGS 150
           L +++H N++ L           ++   +    L   +  +         +   ++    
Sbjct: 61  LHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG----FYTERDASRLIFQV 116

Query: 151 AEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLG 210
            + + YLH     H   +        LD D + +++DFG +K+   G   + +   GT G
Sbjct: 117 LDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG--SVLSTACGTPG 174

Query: 211 YLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFK 270
           Y+APE       S++ D +S G++   +L G  P             +  E  I+K +++
Sbjct: 175 YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFY------DENDAKLFE-QILKAEYE 227

Query: 271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
              D     D  +     A +     ++ +PEKR   ++ + 
Sbjct: 228 --FDSPYWDDISD----SAKDFIRHLMEKDPEKRFTCEQALQ 263

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 3e-45
 Identities = 69/315 (21%), Positives = 114/315 (36%), Gaps = 37/315 (11%)

Query: 18  TTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAM 76
           T + TP     R             ++D   +G G FG VY  +    G  +A+KK+   
Sbjct: 5   TVVATPGQGPDRPQEVS--------YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-- 54

Query: 77  NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQR------LIVYDYMPNLSLLSHLHG 130
             + +     E++++ ++ H N++ LR +   + ++       +V DY+P        H 
Sbjct: 55  --QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHY 112

Query: 131 QYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFG 189
             A +  L               + Y+H      I HRDIK  N+LLD D   L + DFG
Sbjct: 113 SRAKQ-TLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFG 168

Query: 190 FAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP----- 244
            AK +  G     + +                 + S DV+S G +L E+L G+       
Sbjct: 169 SAKQLVRG-EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227

Query: 245 -------IEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCV 297
                  I K+ G   R       P   + KF ++        F      +AI +    +
Sbjct: 228 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL 287

Query: 298 QSEPEKRPNMKEVVN 312
           +  P  R    E   
Sbjct: 288 EYTPTARLTPLEACA 302

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 2e-43
 Identities = 62/285 (21%), Positives = 102/285 (35%), Gaps = 28/285 (9%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLK-----AMNSKAEMEFAVEVEVLGRVRHKNLL 100
           + LGEG F +VY  R  +    +A+KK+K                 E+++L  + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
           GL           +V+D+M     +            L         + + +G+ YLH  
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSL----VLTPSHIKAYMLMTLQGLEYLHQ- 118

Query: 161 VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG 220
               I+HRD+K +N+LLD +    +ADFG AK         T +V  T  Y APE     
Sbjct: 119 --HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV-VTRWYRAPELLFGA 175

Query: 221 KV-SESCDVYSFGILLLEILTGRKP------------IEKLPGGVKRTITEWAEPLIVKG 267
           ++     D+++ G +L E+L                 I +  G            L    
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
            FK      L   F        +++        P  R    + + 
Sbjct: 236 TFKSFPGIPLHHIFS-AAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  149 bits (378), Expect = 2e-43
 Identities = 67/286 (23%), Positives = 112/286 (39%), Gaps = 31/286 (10%)

Query: 40  TNGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLK---AMNSKAEMEFAVEVEVLGRVR 95
           ++ +     LG GG   V+  R       +AVK L+   A +    + F  E +    + 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 96  HKNLLGLRGYCAGTDQRL----IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSA 151
           H  ++ +               IV +Y+  ++L   +H +      +  KR +++   + 
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG----PMTPKRAIEVIADAC 121

Query: 152 EGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHM--TTRVKGTL 209
           + + + H      IIHRD+K +N+++ +     V DFG A+ I +  + +  T  V GT 
Sbjct: 122 QALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 178

Query: 210 GYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKF 269
            YL+PE A    V    DVYS G +L E+LTG  P          +    A    V+   
Sbjct: 179 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT------GDSPVSVAY-QHVRE-- 229

Query: 270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRP-NMKEVVNTL 314
               DP       E        V +  +   PE R     E+   L
Sbjct: 230 ----DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADL 271

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 3e-43
 Identities = 54/285 (18%), Positives = 109/285 (38%), Gaps = 24/285 (8%)

Query: 47  NKLGEGGFGSVYWGR--TSDGLQIAVKKLKAMNSKAEMEFAVEVEV-----LGRVRHKNL 99
            ++GEG +G V+  R   + G  +A+K+++    +  M  +   EV     L    H N+
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 100 LGLRGYC--AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
           + L   C  + TD+   +     ++      +     E  +  +    +      G+ +L
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           H      ++HRD+K  N+L+ S  +  +ADFG A++         T V  TL Y APE  
Sbjct: 133 HSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEVL 187

Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPIEK----------LPGGVKRTITEWAEPLIVKG 267
           +    +   D++S G +  E+   +               L         +W   + +  
Sbjct: 188 LQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 247

Query: 268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
           +       +    F  +  +   ++ + C+   P KR +    ++
Sbjct: 248 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 292

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  150 bits (380), Expect = 4e-43
 Identities = 64/267 (23%), Positives = 106/267 (39%), Gaps = 32/267 (11%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLK---AMNSKAEMEFAVEVEVLGRVRHKNLLGL 102
             LG G FG V+  R   +G   A+K LK    +  K       E  +L  V H  ++ +
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 103 RGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
            G      Q  ++ DY+    L S L         +      ++        L L +  +
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVC-------LALEYLHS 122

Query: 163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV 222
             II+RD+K  N+LLD +    + DFGFAK +P+    +T  + GT  Y+APE       
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTKPY 178

Query: 223 SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFD 282
           ++S D +SFGIL+ E+L G  P             +  E  I+  + +          F 
Sbjct: 179 NKSIDWWSFGILIYEMLAGYTPFY------DSNTMKTYE-KILNAELR----------FP 221

Query: 283 ENQLKQAINVAVLCVQSEPEKRPNMKE 309
               +   ++    +  +  +R    +
Sbjct: 222 PFFNEDVKDLLSRLITRDLSQRLGNLQ 248

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (378), Expect = 4e-43
 Identities = 50/286 (17%), Positives = 99/286 (34%), Gaps = 23/286 (8%)

Query: 43  FSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNL 99
           F    K+GEG +G VY  R    G  +A+KK++              E+ +L  + H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 100 LGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH 159
           + L       ++  +V++++ +  L   +         +             +G+ + H 
Sbjct: 64  VKLLDVIHTENKLYLVFEFL-HQDLKKFMDASALTG--IPLPLIKSYLFQLLQGLAFCHS 120

Query: 160 EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
                ++HRD+K  N+L++++    +ADFG A+     V   T  V              
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGC 177

Query: 220 GKVSESCDVYSFGILLLEILTGRKP-------------IEKLPGGVKRTITEWAEPLIVK 266
              S + D++S G +  E++T R                  L    +            K
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

Query: 267 GKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
             F +               +   ++    +  +P KR + K  + 
Sbjct: 238 PSFPKWARQDFSKVVP-PLDEDGRSLLSQMLHYDPNKRISAKAALA 282

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  148 bits (374), Expect = 1e-42
 Identities = 66/291 (22%), Positives = 108/291 (37%), Gaps = 43/291 (14%)

Query: 43  FSDD----NKLGEGGFGSVYWGR-TSDGLQIAVKKLK---------AMNSKAEMEFAVEV 88
           F ++      LG G    V          + AVK +              +       EV
Sbjct: 1   FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60

Query: 89  EVLGRVR-HKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIA 147
           ++L +V  H N++ L+          +V+D M    L  +L  +    V L  K   KI 
Sbjct: 61  DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIM 116

Query: 148 IGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKG 207
               E I  LH     +I+HRD+K  N+LLD D    + DFGF+  +  G       V G
Sbjct: 117 RALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--EKLREVCG 171

Query: 208 TLGYLAPEYAMWG------KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE 261
           T  YLAPE              +  D++S G+++  +L G  P         R       
Sbjct: 172 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW------HRKQMLMLR 225

Query: 262 PLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
            +I+ G ++         D+ +       ++    +  +P+KR   +E + 
Sbjct: 226 -MIMSGNYQ--FGSPEWDDYSD----TVKDLVSRFLVVQPQKRYTAEEALA 269

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  148 bits (373), Expect = 2e-42
 Identities = 52/280 (18%), Positives = 106/280 (37%), Gaps = 21/280 (7%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
            K+GEG +G VY  + + G   A+KK++    +         E+ +L  ++H N++ L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                 + ++V++++           +      L+        +    GI Y H      
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEG----GLESVTAKSFLLQLLNGIAYCHD---RR 120

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
           ++HRD+K  N+L++ + E  +ADFG A+     V   T  +               K S 
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 225 SCDVYSFGILLLEILTGRKP------------IEKLPGGVKRTITEWAEPLIVKGKFKEL 272
           + D++S G +  E++ G               I ++ G            L        +
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
            +P     F +   +  I++    ++ +P +R   K+ + 
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 3e-42
 Identities = 59/292 (20%), Positives = 121/292 (41%), Gaps = 23/292 (7%)

Query: 40  TNGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEME-FAVEVEVLGRVRHK 97
              +++ + +GEG +G V       + +++A+KK+     +   +    E+++L R RH+
Sbjct: 7   GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66

Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
           N++G+           +   Y+    L+     +      L              G+ Y+
Sbjct: 67  NIIGINDIIRAPTIEQMKDVYLVT-HLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125

Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMT--TRVKGTLGYLAPE 215
           H     +++HRD+K SN+LL++  +  + DFG A++      H    T    T  Y APE
Sbjct: 126 HSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 216 YAMWGKV-SESCDVYSFGILLLEILTGRKP---------IEKLPGGVKRTITEWAEPLIV 265
             +  K  ++S D++S G +L E+L+ R           +  + G +     E    +I 
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 266 KGKFKELVDPKLRGDFDENQL-----KQAINVAVLCVQSEPEKRPNMKEVVN 312
                 L+    +     N+L      +A+++    +   P KR  +++ + 
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA 294

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  147 bits (371), Expect = 2e-41
 Identities = 56/275 (20%), Positives = 99/275 (36%), Gaps = 32/275 (11%)

Query: 41  NGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAE------MEFAVEVEVLGR 93
           N FS    +G GGFG VY  R    G   A+K L     K +      +   + + ++  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 94  VRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEG 153
                ++ +       D+   + D M    L  HL                  A     G
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYAAEIILG 119

Query: 154 ILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLA 213
           + ++H+     +++RD+K +N+LLD      ++D G A    +   H +    GT GY+A
Sbjct: 120 LEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMA 173

Query: 214 PEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL 272
           PE    G     S D +S G +L ++L G  P  +     K  I                
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM------------- 220

Query: 273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNM 307
               +  +  ++   +  ++    +Q +  +R   
Sbjct: 221 -TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGC 254

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (361), Expect = 1e-40
 Identities = 47/277 (16%), Positives = 92/277 (33%), Gaps = 27/277 (9%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
           K+G G FG +Y G   + G ++A+K           +  +E ++   ++    +    +C
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIKLEC--VKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
                  ++   +   SL    +       +   K  + +A      I Y+H +   + I
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFI 125

Query: 167 HRDIKASNVL---LDSDFEPLVADFGFAKLIPEGVSH------MTTRVKGTLGYLAPEYA 217
           HRD+K  N L           + DFG AK   +  +H          + GT  Y +    
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185

Query: 218 MWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL 277
           +  + S   D+ S G +L+    G  P + L                 +   K++  P  
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA-------ATKRQKYERISEKKMSTP-- 236

Query: 278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
                +    +       C     + +P+   +    
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLF 273

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (362), Expect = 2e-40
 Identities = 70/268 (26%), Positives = 105/268 (39%), Gaps = 30/268 (11%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLK---AMNSKAEMEFAVEVEVLGRV-RHKNLLG 101
             LG+G FG V+           A+K LK    +         VE  VL     H  L  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 102 LRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV 161
           +       +    V +Y+    L+ H+   +    + D  R    A     G+ +LH   
Sbjct: 68  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCH----KFDLSRATFYAAEIILGLQFLHS-- 121

Query: 162 TPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK 221
              I++RD+K  N+LLD D    +ADFG  K    G +   T   GT  Y+APE  +  K
Sbjct: 122 -KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFC-GTPDYIAPEILLGQK 179

Query: 222 VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDF 281
            + S D +SFG+LL E+L G+ P     G  +  +       I                +
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSP---FHGQDEEELFHS----IRMDNP----------FY 222

Query: 282 DENQLKQAINVAVLCVQSEPEKRPNMKE 309
                K+A ++ V     EPEKR  ++ 
Sbjct: 223 PRWLEKEAKDLLVKLFVREPEKRLGVRG 250

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (351), Expect = 2e-39
 Identities = 46/282 (16%), Positives = 101/282 (35%), Gaps = 23/282 (8%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
            K+GEG +G+V+  +       +A+K+++    +         E+ +L  ++HKN++ L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 104 GYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTP 163
                  +  +V+++              +    LD +          +G+ + H     
Sbjct: 68  DVLHSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS---R 120

Query: 164 HIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVS 223
           +++HRD+K  N+L++ + E  +A+FG A+     V   +  V                 S
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 224 ESCDVYSFGILLLEILTGRKP-------------IEKLPGGVKRTITEWAEPLIVKGKFK 270
            S D++S G +  E+    +P             I +L G            L     + 
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
                    +          ++    ++  P +R + +E + 
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 3e-39
 Identities = 64/276 (23%), Positives = 111/276 (40%), Gaps = 43/276 (15%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEME------FAVEVEVLGRVR--HKN 98
            LG GGFGSVY G   SD L +A+K ++        E        +EV +L +V      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 99  LLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLH 158
           ++ L  +    D  +++ +    +  L     +      L  +          E + + H
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCH 127

Query: 159 HEVTPHIIHRDIKASNVLLDSD-FEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
           +     ++HRDIK  N+L+D +  E  + DFG   L+ +    + T   GT  Y  PE+ 
Sbjct: 128 NC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPPEWI 181

Query: 218 MWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
            + +    S  V+S GILL +++ G  P E              +  I++G+        
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGDIPFE-------------HDEEIIRGQV------- 221

Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
               F +    +  ++   C+   P  RP  +E+ N
Sbjct: 222 ---FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (354), Expect = 3e-39
 Identities = 64/273 (23%), Positives = 105/273 (38%), Gaps = 30/273 (10%)

Query: 49  LGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRV-RHKNLLGLRGYC 106
           LG G  G V          + A+K L+            EVE+  R  +  +++ +    
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKMLQ----DCPK-ARREVELHWRASQCPHIVRIVDVY 74

Query: 107 ----AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVT 162
               AG    LIV + +    L S +  +  G+     +   +I     E I YLH    
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI-- 130

Query: 163 PHIIHRDIKASNVLLDSDFEPLV---ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW 219
            +I HRD+K  N+L  S     +    DFGFAK      S  T     T  Y+APE    
Sbjct: 131 -NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--TPYYVAPEVLGP 187

Query: 220 GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRG 279
            K  +SCD++S G+++  +L G  P               +  +  + +  +   P    
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFY------SNHGLAISPGMKTRIRMGQYEFPNPEW 241

Query: 280 DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
                ++K  I      +++EP +R  + E +N
Sbjct: 242 SEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 6e-39
 Identities = 55/276 (19%), Positives = 104/276 (37%), Gaps = 33/276 (11%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEM------EFAVEVEVLGRVRHKNLL 100
           +LG G F  V   R  S GLQ A K +K   +K+        +   EV +L  ++H N++
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 101 GLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE 160
            L          +++ + +        L    A +  L  +   +       G   +++ 
Sbjct: 77  TLHEVYENKTDVILILELVAG----GELFDFLAEKESLTEEEATEFLKQILNG---VYYL 129

Query: 161 VTPHIIHRDIKASNVLLDSDFEPL----VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
            +  I H D+K  N++L     P     + DFG A  I  G  +    + GT  ++APE 
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG--NEFKNIFGTPEFVAPEI 187

Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
             +  +    D++S G++   +L+G  P               A    V  +F++     
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLG-----DTKQETLANVSAVNYEFEDEYFSN 242

Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
                       A +     +  +P+KR  +++ + 
Sbjct: 243 TS--------ALAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 3e-38
 Identities = 62/303 (20%), Positives = 115/303 (37%), Gaps = 27/303 (8%)

Query: 31  FTYKELHTATNGFSDD----NKLGEGGFGSVYWGR-TSDGLQIAVKKLK--AMNSKAEME 83
           F  +E+                +G G +G+V        G ++A+KKL     +      
Sbjct: 4   FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63

Query: 84  FAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRR 143
              E+ +L  +RH+N++GL       +      D+   +  +    G+     +L   R 
Sbjct: 64  AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI 123

Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT 203
             +     +G+ Y+H      IIHRD+K  N+ ++ D E  + DFG A+      S MT 
Sbjct: 124 QFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQAD---SEMTG 177

Query: 204 RVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP------------IEKLPGG 251
            V             W + +++ D++S G ++ E++TG+              I K+ G 
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGT 237

Query: 252 VKRTITEWAEPLIVKGKFKEL--VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKE 309
                 +  +    K   K L  ++ K       N    A+N+    +  + E+R    E
Sbjct: 238 PPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGE 297

Query: 310 VVN 312
            + 
Sbjct: 298 ALA 300

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (339), Expect = 3e-37
 Identities = 57/296 (19%), Positives = 116/296 (39%), Gaps = 37/296 (12%)

Query: 47  NKLGEGGFGSVYWGR-TSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLR 103
            K+G+G FG V+  R    G ++A+KK+          +    E+++L  ++H+N++ L 
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 104 GYCAGTDQR--------LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGIL 155
             C               +V+D+  +      L      +  L   +R+   +     + 
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLA--GLLSNVLVKFTLSEIKRVMQML-----LN 128

Query: 156 YLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS---HMTTRVKGTLGYL 212
            L++     I+HRD+KA+NVL+  D    +ADFG A+      +   +  T    TL Y 
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

Query: 213 APEYAMWGK-VSESCDVYSFGILLLEILTGRKP------------IEKLPGGVKRTITEW 259
            PE  +  +      D++  G ++ E+ T                I +L G +   +   
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248

Query: 260 AEPLIVKGKFKELVDPKLRGDFDENQL---KQAINVAVLCVQSEPEKRPNMKEVVN 312
            +   +  K + +   K +             A+++    +  +P +R +  + +N
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  133 bits (336), Expect = 4e-37
 Identities = 43/279 (15%), Positives = 83/279 (29%), Gaps = 29/279 (10%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
           ++GEG FG ++ G    +  Q+A+K     +   +     E      +     +    Y 
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ--LRDEYRTYKLLAGCTGIPNVYYF 69

Query: 107 AGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHII 166
                  ++   +   SL   L        +   K     A      +  +H      ++
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHE---KSLV 123

Query: 167 HRDIKASNVLLDSDFEPL-----VADFGFAKLIPEGVS------HMTTRVKGTLGYLAPE 215
           +RDIK  N L+            V DFG  K   + V+           + GT  Y++  
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183

Query: 216 YAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP 275
             +  + S   D+ + G + +  L G  P     G    T  +  E      +  E    
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLP---WQGLKAATNKQKYE------RIGEKKQS 234

Query: 276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTL 314
               +      ++             +  P+   +    
Sbjct: 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLF 273

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 1e-36
 Identities = 64/273 (23%), Positives = 103/273 (37%), Gaps = 29/273 (10%)

Query: 41  NGFSDDNKLGEGGFGSVYWGR-TSDGLQIAVKKLK---AMNSKAEMEFAVEVEVLGRVRH 96
           N F     LG+G FG V   R  + G   A+K L+    +          E  VL   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64

Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
             L  L+      D+   V +Y     L  HL  +         +R        AE +  
Sbjct: 65  PFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYG---AEIVSA 117

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEY 216
           L +  +  +++RDIK  N++LD D    + DFG  K      + M T   GT  YLAPE 
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC-GTPEYLAPEV 176

Query: 217 AMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK 276
                   + D +  G+++ E++ GR P         +      E LI+  + +      
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFY------NQDHERLFE-LILMEEIR------ 223

Query: 277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKE 309
               F      +A ++    ++ +P++R     
Sbjct: 224 ----FPRTLSPEAKSLLAGLLKKDPKQRLGGGP 252

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  125 bits (315), Expect = 2e-33
 Identities = 58/239 (24%), Positives = 92/239 (38%), Gaps = 25/239 (10%)

Query: 10  SEKVEEGLTTITTPNNATWRIFTYKELHTATNGFSDDNKLGEGGFGSVYWGR-TSDGLQI 68
           ++  E+ L    TP+  T ++  +  +            LG G FG V   +    G   
Sbjct: 20  AKAKEDFLKKWETPSQNTAQLDQFDRI----------KTLGTGSFGRVMLVKHKESGNHY 69

Query: 69  AVKKL---KAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLL 125
           A+K L   K +  K       E  +L  V    L+ L           +V +Y+    + 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129

Query: 126 SHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLV 185
           SHL        +         A        YLH      +I+RD+K  N+L+D      V
Sbjct: 130 SHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQV 182

Query: 186 ADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP 244
            DFGFAK +       T  + GT   LAPE  +    +++ D ++ G+L+ E+  G  P
Sbjct: 183 TDFGFAKRVK----GRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  122 bits (307), Expect = 1e-32
 Identities = 55/310 (17%), Positives = 112/310 (36%), Gaps = 46/310 (14%)

Query: 34  KELHTATNGFSDD----NKLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEV 88
            E H    G  DD     KLG G +  V+     ++  ++ VK LK +  K   +   E+
Sbjct: 24  YESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREI 80

Query: 89  EVLGRVR-HKNLLGLRGYCAGTDQRLI--VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMK 145
           ++L  +R   N++ L         R    V++++ N                L       
Sbjct: 81  KILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ-------TLTDYDIRF 133

Query: 146 IAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL-VADFGFAKLIPEGVSHMTTR 204
                 + + Y H      I+HRD+K  NV++D +   L + D+G A+    G       
Sbjct: 134 YMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG--QEYNV 188

Query: 205 VKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKP-------------IEKLPG 250
              +  +  PE  + +     S D++S G +L  ++  ++P             I K+ G
Sbjct: 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248

Query: 251 GVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLK--------QAINVAVLCVQSEPE 302
                       + +  +F +++    R  ++             +A++     ++ + +
Sbjct: 249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308

Query: 303 KRPNMKEVVN 312
            R   +E + 
Sbjct: 309 SRLTAREAME 318

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 4e-31
 Identities = 67/270 (24%), Positives = 107/270 (39%), Gaps = 31/270 (11%)

Query: 47  NKLGEGGFGSVYWGR----TSDGLQIAVKKLK----AMNSKAEMEFAVEVEVLGRVRHK- 97
             LG G +G V+  R       G   A+K LK       +K       E +VL  +R   
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 98  NLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYL 157
            L+ L        +  ++ DY+    L +HL  +     +              E +L L
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRE----RFTEHEVQIYV---GEIVLAL 142

Query: 158 HHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYA 217
            H     II+RDIK  N+LLDS+   ++ DFG +K      +       GT+ Y+AP+  
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 202

Query: 218 MWGK--VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP 275
             G     ++ D +S G+L+ E+LTG  P      G K +  E     I +   K   +P
Sbjct: 203 RGGDSGHDKAVDWWSLGVLMYELLTGASPFT--VDGEKNSQAE-----ISRRILKS--EP 253

Query: 276 KLRGDFDENQLKQAINVAVLCVQSEPEKRP 305
               +        A ++    +  +P+KR 
Sbjct: 254 PYPQEMSA----LAKDLIQRLLMKDPKKRL 279

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 6e-31
 Identities = 61/303 (20%), Positives = 111/303 (36%), Gaps = 27/303 (8%)

Query: 31  FTYKELHTATNGFSDD----NKLGEGGFGSVYWGR-TSDGLQIAVKKLK--AMNSKAEME 83
           F  +EL+       +     + +G G +GSV     T  GL++AVKKL     +      
Sbjct: 4   FYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR 63

Query: 84  FAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRR 143
              E+ +L  ++H+N++GL              D      L+           +L     
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV 123

Query: 144 MKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTT 203
             +      G+ Y+H      IIHRD+K SN+ ++ D E  + DFG A+   +    MT 
Sbjct: 124 QFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD---EMTG 177

Query: 204 RVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKP------------IEKLPGG 251
            V             W   +++ D++S G ++ E+LTGR              I +L G 
Sbjct: 178 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 237

Query: 252 VKRTITEWAEPLIVKGKFKELVDPKLRG--DFDENQLKQAINVAVLCVQSEPEKRPNMKE 309
               + +       +   + L         +        A+++    +  + +KR    +
Sbjct: 238 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQ 297

Query: 310 VVN 312
            + 
Sbjct: 298 ALA 300

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 3e-29
 Identities = 65/293 (22%), Positives = 112/293 (38%), Gaps = 34/293 (11%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLK--AMNSKAEMEFAVEVEVLGRVRHKNLLGLRG 104
            +G G  G V           +A+KKL     N         E+ ++  V HKN++ L  
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83

Query: 105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH 164
                       D    + L+     Q   +++LD +R   +      GI +LH      
Sbjct: 84  VFTPQKTLEEFQDVYLVMELMDANLCQVI-QMELDHERMSYLLYQMLCGIKHLHS---AG 139

Query: 165 IIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSE 224
           IIHRD+K SN+++ SD    + DFG A+      S M T    T  Y APE  +     E
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT--SFMMTPYVVTRYYRAPEVILGMGYKE 197

Query: 225 SCDVYSFGILLLEILTGRKP-----------------IEKLPGGVKRTITEWAEPLIVKG 267
           + D++S G ++ E++  +                       P  +K+        +  + 
Sbjct: 198 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 257

Query: 268 KFKELVDPKLRGD--------FDENQLKQAINVAVLCVQSEPEKRPNMKEVVN 312
           K+  L  PKL  D         ++ +  QA ++    +  +P KR ++ + + 
Sbjct: 258 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  108 bits (269), Expect = 4e-27
 Identities = 58/311 (18%), Positives = 108/311 (34%), Gaps = 49/311 (15%)

Query: 48  KLGEGGFGSVYWGR-TSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYC 106
           KLG G F +V+  +   +   +A+K ++      E     E+++L RV   +        
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADNTKEDSMG 78

Query: 107 AGTDQRLI-VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMK-----------IAIGSAEGI 154
           A    +L+  +++     +   +  +  GE  L   ++ +           I+     G+
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 155 LYLHHEVTPHIIHRDIKASNVLLDS-DFEPLVADFGFAKLIPEGVSHMTTR-VKGTLGYL 212
            Y+H      IIH DIK  NVL++  D    +     A L               T  Y 
Sbjct: 139 DYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 213 APEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGG-----------VKRTITEWAE 261
           +PE  +        D++S   L+ E++TG    E   G            +   + E   
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256

Query: 262 PLIVKGKFKELVDPKL--------------------RGDFDENQLKQAINVAVLCVQSEP 301
            L+  GK+                            +  F +++ K+  +     +Q +P
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316

Query: 302 EKRPNMKEVVN 312
            KR +   +VN
Sbjct: 317 RKRADAGGLVN 327

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 82.9 bits (204), Expect = 2e-19
 Identities = 33/203 (16%), Positives = 69/203 (33%), Gaps = 29/203 (14%)

Query: 47  NKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNS----------KAEMEFAVEVEVLGRVRH 96
             +GEG   +V+   +    +  VK  K  ++            ++ F+V      R   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 97  KNLLGLRGYCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILY 156
           + L  L+G           Y +  N  L+  +  +    V+++      +     E +  
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPDE--VLDMILEEVAK 118

Query: 157 LHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI--PEGVSHMTTRVKGTLGYLAP 214
            +H     I+H D+   NVL+  +    + DF  +  +        +   V+  + Y + 
Sbjct: 119 FYH---RGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSR 174

Query: 215 EYAMWGKVSESCDVYSFGILLLE 237
            Y          D+ S    +L+
Sbjct: 175 TY------RTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	380
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.87
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.39
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.83
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.23
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.2
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.94

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-59  Score=417.81  Aligned_cols=254  Identities=21%  Similarity=0.316  Sum_probs=214.7

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      .++|++.+.||+|+||+||+|++ .+|+.||||+++.........+.+|+.+++.++||||+++++++.+++.+|+||||
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy   98 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY   98 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEe
Confidence            45899999999999999999987 57999999999865555566889999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      |+||+|.+++...     .+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+++.+....
T Consensus        99 ~~gg~L~~~~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~  170 (293)
T d1yhwa1          99 LAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (293)
T ss_dssp             CTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             cCCCcHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeecccc
Confidence            9999999988643     699999999999999999999999   99999999999999999999999999998875432


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                       ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+....  .....    ....        ....
T Consensus       171 -~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~----~~~~--------~~~~  235 (293)
T d1yhwa1         171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPL--RALYL----IATN--------GTPE  235 (293)
T ss_dssp             -CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHHH----HHHH--------CSCC
T ss_pred             -ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHH--HHHHH----HHhC--------CCCC
Confidence             2334557999999999999999999999999999999999999999753321  00000    0000        0111


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ...+...+.++.+||.+||+.||++|||+.|+++|.+.
T Consensus       236 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~  273 (293)
T d1yhwa1         236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL  273 (293)
T ss_dssp             CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGG
T ss_pred             CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence            12334556889999999999999999999999999764

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-58  Score=413.35  Aligned_cols=257  Identities=21%  Similarity=0.302  Sum_probs=210.4

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh-hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS-KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      .++|++.+.||+|+||+||+|++ .+|+.||||++..... .....+.+|+.+|+.++||||+++++++.+++..|+|||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE   83 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   83 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence            46799999999999999999987 5789999999975432 234568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      ||+||+|.+++...    ..+++..++.++.|++.||+|||++   ||+||||||+|||++.++.+||+|||+++.....
T Consensus        84 y~~gg~L~~~l~~~----~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~  156 (271)
T d1nvra_          84 YCSGGELFDRIEPD----IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYN  156 (271)
T ss_dssp             CCTTEEGGGGSBTT----TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEET
T ss_pred             ccCCCcHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccC
Confidence            99999999999643    5799999999999999999999999   9999999999999999999999999999876433


Q ss_pred             Cc-cceeccccccCccCccccccCCC-CccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          198 VS-HMTTRVKGTLGYLAPEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       198 ~~-~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      .. ......+||+.|+|||++.+..+ +.++|||||||++|||++|..||...........              .....
T Consensus       157 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~--------------~~~~~  222 (271)
T d1nvra_         157 NRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS--------------DWKEK  222 (271)
T ss_dssp             TEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHH--------------HHHTT
T ss_pred             CccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHH--------------HHhcC
Confidence            22 23445679999999999988776 6789999999999999999999975432211100              00111


Q ss_pred             cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ..........+.++.+||.+||+.||++|||++++++|.|.-
T Consensus       223 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~  264 (271)
T d1nvra_         223 KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYN  264 (271)
T ss_dssp             CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTT
T ss_pred             CCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhC
Confidence            111112234457889999999999999999999999998754

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-59  Score=414.77  Aligned_cols=259  Identities=20%  Similarity=0.287  Sum_probs=201.0

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEec--CCeEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG--TDQRLI  114 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--~~~~~l  114 (380)
                      .++|++.+.||+|+||+||+|++ .+|+.||||++...  .......+.+|+++|++++|||||++++++.+  ++.+|+
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            35799999999999999999987 57899999998753  34455678899999999999999999999864  466899


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcC--CCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV--TPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~--~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      |||||++|+|.+++.........+++..++.++.|++.||.|||+..  ..+|+||||||+|||++.++.+||+|||+++
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            99999999999999754334567999999999999999999999871  1139999999999999999999999999998


Q ss_pred             ccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      .+.... .......||+.|+|||++.+..|+.++|||||||++|||++|..||...+..  .....     ...+.    
T Consensus       163 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--~~~~~-----i~~~~----  230 (269)
T d2java1         163 ILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGK-----IREGK----  230 (269)
T ss_dssp             HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHH-----HHHTC----
T ss_pred             ecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH--HHHHH-----HHcCC----
Confidence            875432 2334567999999999999999999999999999999999999999754321  00000     01111    


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                           ....+...+.++.+||.+||+.||.+|||+.|+++|.+
T Consensus       231 -----~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~  268 (269)
T d2java1         231 -----FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPL  268 (269)
T ss_dssp             -----CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTT
T ss_pred             -----CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCc
Confidence                 11233445678999999999999999999999999875

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-58  Score=408.13  Aligned_cols=248  Identities=29%  Similarity=0.455  Sum_probs=210.3

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ++|++.+.||+|+||+||+|++ .+++.||+|++...   .......+.+|+.+++.++||||+++++++.+++..|+||
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm   85 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL   85 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence            4699999999999999999998 46899999998642   2233457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      |||++|+|.+++...    ..+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||++.....
T Consensus        86 Ey~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~  158 (263)
T d2j4za1          86 EYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  158 (263)
T ss_dssp             ECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC
T ss_pred             eecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCC
Confidence            999999999999653    4799999999999999999999999   999999999999999999999999999987654


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      .   ......||+.|+|||++.+..|+.++|||||||++|+|++|..||......  ....             .+... 
T Consensus       159 ~---~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~-------------~i~~~-  219 (263)
T d2j4za1         159 S---RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETYK-------------RISRV-  219 (263)
T ss_dssp             C---CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHH-------------HHHTT-
T ss_pred             C---cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH--HHHH-------------HHHcC-
Confidence            2   234457999999999999999999999999999999999999999753311  0000             00011 


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                       ....+...+.++.+||.+||+.||++|||++|+++|.+
T Consensus       220 -~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~  257 (263)
T d2j4za1         220 -EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPW  257 (263)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHH
T ss_pred             -CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcC
Confidence             11233445678999999999999999999999999865

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-58  Score=412.32  Aligned_cols=257  Identities=21%  Similarity=0.274  Sum_probs=213.7

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      +.+.|++.+.||+|+||+||+|++ .+++.||||+++.........+.+|+++|++++|||||++++++.+++..|+|||
T Consensus        10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            345799999999999999999997 5789999999987666666789999999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      ||++|+|.+++...   ...+++..+..++.||+.||.|||++   ||+||||||+|||++.++.+||+|||++......
T Consensus        90 y~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~  163 (288)
T d2jfla1          90 FCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT  163 (288)
T ss_dssp             CCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHH
T ss_pred             cCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCC
Confidence            99999999987643   34699999999999999999999999   9999999999999999999999999999765322


Q ss_pred             CccceeccccccCccCccccc-----cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAM-----WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                       ........||+.|+|||++.     +..|+.++|||||||++|||++|..||.+.....  ....     ...+     
T Consensus       164 -~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~--~~~~-----i~~~-----  230 (288)
T d2jfla1         164 -IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR--VLLK-----IAKS-----  230 (288)
T ss_dssp             -HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG--HHHH-----HHHS-----
T ss_pred             -cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH--HHHH-----HHcC-----
Confidence             12233457999999999984     4568999999999999999999999997643211  1100     0000     


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                        .......+...+.++.+||.+||+.||.+|||++|+++|.+.
T Consensus       231 --~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~  272 (288)
T d2jfla1         231 --EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV  272 (288)
T ss_dssp             --CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGG
T ss_pred             --CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence              001112234556889999999999999999999999999764

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1e-56  Score=414.89  Aligned_cols=256  Identities=18%  Similarity=0.279  Sum_probs=216.0

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEec
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYM  119 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  119 (380)
                      +.|++.+.||+|+||+||+|++ .+|+.||||+++.....+...+.+|+.+|++++|||||++++++.+++.+|+|||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  108 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL  108 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5799999999999999999987 579999999998776666778889999999999999999999999999999999999


Q ss_pred             CCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC--CCCceEEeeccCccccCCC
Q 037869          120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLD--SDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       120 ~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~--~~~~vkl~Dfgl~~~~~~~  197 (380)
                      +||+|.+.+...   ...+++..++.++.||+.||+|||++   ||+||||||+|||++  .++.+||+|||++..+...
T Consensus       109 ~gg~L~~~~~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~  182 (352)
T d1koba_         109 SGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  182 (352)
T ss_dssp             CCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             CCChHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCC
Confidence            999999988643   35699999999999999999999999   999999999999997  5689999999999987653


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                        .......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.....  ....     ....      ....
T Consensus       183 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~~-----i~~~------~~~~  247 (352)
T d1koba_         183 --EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE--TLQN-----VKRC------DWEF  247 (352)
T ss_dssp             --SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH--HHHH-----HHHC------CCCC
T ss_pred             --CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-----HHhC------CCCC
Confidence              23444578999999999999999999999999999999999999997543210  0000     0000      1111


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ........+.++.+||.+||+.||.+|||+.|+++|.+.-
T Consensus       248 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~  287 (352)
T d1koba_         248 DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLK  287 (352)
T ss_dssp             CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTS
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhC
Confidence            2223345567899999999999999999999999997643

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-57  Score=405.52  Aligned_cols=254  Identities=24%  Similarity=0.404  Sum_probs=201.5

Q ss_pred             hCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEec
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYM  119 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  119 (380)
                      ..+|++.+.||+|+||+||+|++.++..||||+++... .....+.+|+++++.++||||+++++++..++..++||||+
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEec
Confidence            46899999999999999999999888899999998643 33457999999999999999999999999999999999999


Q ss_pred             CCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc
Q 037869          120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS  199 (380)
Q Consensus       120 ~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~  199 (380)
                      ++|+|.+++...   ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.......
T Consensus        83 ~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~  156 (263)
T d1sm2a_          83 EHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY  156 (263)
T ss_dssp             TTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred             CCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCc
Confidence            999999998654   35689999999999999999999999   999999999999999999999999999987755444


Q ss_pred             cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhC-CCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          200 HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTG-RKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       200 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      .......||+.|+|||++.+..|+.++|||||||++|||+|+ .+||.....      .....          ......+
T Consensus       157 ~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~------~~~~~----------~i~~~~~  220 (263)
T d1sm2a_         157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN------SEVVE----------DISTGFR  220 (263)
T ss_dssp             --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH------HHHHH----------HHHHTCC
T ss_pred             eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH------HHHHH----------HHHhcCC
Confidence            444445789999999999999999999999999999999995 555543221      00000          0111122


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ...+..++.++.+||.+||+.||++|||+++|+++|+.
T Consensus       221 ~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~  258 (263)
T d1sm2a_         221 LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAE  258 (263)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            23344456789999999999999999999999999864

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-57  Score=399.33  Aligned_cols=254  Identities=25%  Similarity=0.438  Sum_probs=216.5

Q ss_pred             hCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEec
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYM  119 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  119 (380)
                      .++|++.++||+|+||+||+|++++++.||||+++.... ....+.+|+.++++++||||+++++++.+++.+++||||+
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred             hHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEcc
Confidence            468999999999999999999998888999999986443 3458999999999999999999999999999999999999


Q ss_pred             CCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc
Q 037869          120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS  199 (380)
Q Consensus       120 ~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~  199 (380)
                      ++|+|..++...   ...+++..+++++.|+++||+|||+.   ||+||||||+||+++.++.+||+|||+++.......
T Consensus        82 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~  155 (258)
T d1k2pa_          82 ANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY  155 (258)
T ss_dssp             TTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred             CCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCc
Confidence            999999997643   45789999999999999999999999   999999999999999999999999999987765444


Q ss_pred             cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          200 HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       200 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      .......||+.|+|||++.+..|+.++|||||||++|||+| |..||.......   .   .          ..+....+
T Consensus       156 ~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~---~----------~~i~~~~~  219 (258)
T d1k2pa_         156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---T---A----------EHIAQGLR  219 (258)
T ss_dssp             CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---H---H----------HHHHTTCC
T ss_pred             eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---H---H----------HHHHhCCC
Confidence            44445668999999999999999999999999999999998 899997643210   0   0          01111222


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ...+...+..+.+||.+||+.||++|||+++|+++|.+
T Consensus       220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence            33445556789999999999999999999999999854

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.1e-58  Score=412.40  Aligned_cols=260  Identities=27%  Similarity=0.368  Sum_probs=217.8

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ...++|++.+.||+|+||+||+|.+ .+++.||||+++... ...+.+.+|+.+|+.++|||||++++++.+++..++||
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~   92 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT   92 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence            4567899999999999999999987 468899999997543 34557999999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      |||++|+|.+++...  ....+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++....
T Consensus        93 E~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~  167 (287)
T d1opja_          93 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTG  167 (287)
T ss_dssp             ECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCS
T ss_pred             ecccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCC
Confidence            999999999998653  235799999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      ..........|++.|+|||++.+..|+.++|||||||++|||++|..||......  ..             +...+...
T Consensus       168 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~-------------~~~~i~~~  232 (287)
T d1opja_         168 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQ-------------VYELLEKD  232 (287)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HH-------------HHHHHHTT
T ss_pred             CCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HH-------------HHHHHhcC
Confidence            4444444456899999999999999999999999999999999977666432210  00             11112222


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      .+...+..++.++.+||.+||+.||++|||+.+|++.|..+.
T Consensus       233 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         233 YRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence            333445566788999999999999999999999999887553

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-57  Score=404.65  Aligned_cols=260  Identities=28%  Similarity=0.456  Sum_probs=206.0

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecc--cChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKA--MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ...++|++.+.||+|+||+||+|+..  ..||||+++.  ........+.+|+.+|++++|||||++++++. ++.+++|
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv   81 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIV   81 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEE
Confidence            45689999999999999999999864  3599999874  34455678999999999999999999999875 4568999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      ||||++|+|.+++...   +..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        82 ~Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~  155 (276)
T d1uwha_          82 TQWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKS  155 (276)
T ss_dssp             EECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC--
T ss_pred             EecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeecc
Confidence            9999999999999643   35699999999999999999999999   99999999999999999999999999998765


Q ss_pred             CCCc-cceeccccccCccCcccccc---CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          196 EGVS-HMTTRVKGTLGYLAPEYAMW---GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       196 ~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      .... .......||+.|+|||++.+   ..|+.++|||||||++|||+||..||.+......  ...    ....     
T Consensus       156 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~--~~~----~~~~-----  224 (276)
T d1uwha_         156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIF----MVGR-----  224 (276)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHH----HHHH-----
T ss_pred             ccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH--HHH----HHhc-----
Confidence            4322 23445679999999999874   3589999999999999999999999976432110  000    0000     


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ..........+..++.++.+||.+||+.||++|||+.+|+++|+.+
T Consensus       225 ~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l  270 (276)
T d1uwha_         225 GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELL  270 (276)
T ss_dssp             TSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            0111111223445567899999999999999999999999998643

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-56  Score=399.66  Aligned_cols=248  Identities=23%  Similarity=0.371  Sum_probs=201.4

Q ss_pred             CCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEec----CCeEEEE
Q 037869           43 FSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG----TDQRLIV  115 (380)
Q Consensus        43 y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----~~~~~lv  115 (380)
                      |++.++||+|+||+||+|.+ .++..||+|++...  .......+.+|+++|++++|||||++++++..    ...+|+|
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~iv   90 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLV   90 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEE
Confidence            36778999999999999987 56889999998753  34455678899999999999999999999865    3568999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCC--eEecCCCCCCeeeC-CCCceEEeeccCcc
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPH--IIHRDIKASNVLLD-SDFEPLVADFGFAK  192 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~--ivHrdlkp~Nill~-~~~~vkl~Dfgl~~  192 (380)
                      ||||++|+|.+++...    ..+++..++.++.||+.||+|||++   +  |+||||||+|||++ .++.+||+|||+++
T Consensus        91 mE~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~---~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~  163 (270)
T d1t4ha_          91 TELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT  163 (270)
T ss_dssp             EECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred             EeCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHC---CCCEEeCCcChhhceeeCCCCCEEEeecCcce
Confidence            9999999999999653    4799999999999999999999998   7  99999999999997 47899999999998


Q ss_pred             ccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          193 LIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       193 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      ....   ......+||+.|+|||++.+ .|+.++|||||||++|||++|..||........ ...             .+
T Consensus       164 ~~~~---~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~-~~~-------------~i  225 (270)
T d1t4ha_         164 LKRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ-IYR-------------RV  225 (270)
T ss_dssp             GCCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH-HHH-------------HH
T ss_pred             eccC---CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH-HHH-------------HH
Confidence            6543   23345679999999999875 599999999999999999999999975332110 000             00


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .........+...++++.+||.+||+.||++|||+.|+++|.+
T Consensus       226 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~  268 (270)
T d1t4ha_         226 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAF  268 (270)
T ss_dssp             TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcc
Confidence            0000111122233467899999999999999999999999975

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-57  Score=416.13  Aligned_cols=266  Identities=22%  Similarity=0.296  Sum_probs=209.7

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ..++|++.++||+|+||+||+|++ .+|+.||+|+++.. .......+.+|+.+|+.++|||||+++++|.+.+.+|+||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm   83 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM   83 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            457899999999999999999997 57899999999753 3444567899999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH-EVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~-~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      |||+||+|.+++.+.    ..+++..+..++.|++.||.|||+ +   ||+||||||+|||++.++.+||+|||+|+...
T Consensus        84 Ey~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~  156 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI  156 (322)
T ss_dssp             ECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHH
T ss_pred             EcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccC
Confidence            999999999999653    469999999999999999999996 5   89999999999999999999999999998764


Q ss_pred             CCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhh---------hh-
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPL---------IV-  265 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~---------~~-  265 (380)
                      .   ......+||+.|+|||++.+..|+.++||||+||++|||++|..||..................         .. 
T Consensus       157 ~---~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (322)
T d1s9ja_         157 D---SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  233 (322)
T ss_dssp             H---HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred             C---CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccc
Confidence            2   2334568999999999999999999999999999999999999999764322110000000000         00 


Q ss_pred             -------------ccc----cccccCCcccCCCC-HHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          266 -------------KGK----FKELVDPKLRGDFD-ENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       266 -------------~~~----~~~~~~~~~~~~~~-~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                                   ...    ........ ....+ ...+.++.+||.+||+.||.+|||++|+++|.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf  300 (322)
T d1s9ja_         234 GRPLSSYGMDSRPPMAIFELLDYIVNEP-PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF  300 (322)
T ss_dssp             ------------CCCCHHHHHHHHHTSC-CCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             cccccccccccccchhHHHHHhhhhccC-CccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHh
Confidence                         000    00000000 00011 123468999999999999999999999999965

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-57  Score=405.50  Aligned_cols=259  Identities=26%  Similarity=0.411  Sum_probs=213.3

Q ss_pred             HHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           36 LHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        36 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      +....++|++.+.||+|+||+||+|+++++..||||+++... .....+.+|+.++++++|||||++++++. ++..++|
T Consensus         8 wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv   85 (272)
T d1qpca_           8 WEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYII   85 (272)
T ss_dssp             TBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEE
T ss_pred             eecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEE
Confidence            344668899999999999999999999888899999997643 33457999999999999999999999876 4668999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      ||||++|+|.+++...  ....+++..++.++.|++.||.|||++   +|+||||||+||||+.++.+||+|||+++...
T Consensus        86 ~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~  160 (272)
T d1qpca_          86 TEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE  160 (272)
T ss_dssp             EECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEcc
Confidence            9999999999988643  234689999999999999999999999   99999999999999999999999999999876


Q ss_pred             CCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      ...........||+.|+|||++.+..|+.++|||||||++|||+||..|+.......  .             +...+..
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~--~-------------~~~~i~~  225 (272)
T d1qpca_         161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP--E-------------VIQNLER  225 (272)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--H-------------HHHHHHT
T ss_pred             CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH--H-------------HHHHHHh
Confidence            554444455678999999999999999999999999999999999665553322100  0             0011111


Q ss_pred             cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ..+...+..++.++.+|+.+||+.||++|||+.+|++.|..
T Consensus       226 ~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         226 GYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence            22333445566789999999999999999999999998753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2.1e-56  Score=412.57  Aligned_cols=256  Identities=17%  Similarity=0.279  Sum_probs=214.8

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEec
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYM  119 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~  119 (380)
                      ++|++.+.||+|+||+||+|++ .+|+.||||++..........+.+|+.+|+.++|||||++++++.+++.+|+|||||
T Consensus        26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~  105 (350)
T d1koaa2          26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM  105 (350)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            5899999999999999999987 579999999998777777778999999999999999999999999999999999999


Q ss_pred             CCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC--CCceEEeeccCccccCCC
Q 037869          120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS--DFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       120 ~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~--~~~vkl~Dfgl~~~~~~~  197 (380)
                      +||+|.+++...   ...+++..+..++.||+.||.|||++   ||+||||||+|||++.  ++.+||+|||+++.+...
T Consensus       106 ~gg~L~~~l~~~---~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~  179 (350)
T d1koaa2         106 SGGELFEKVADE---HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK  179 (350)
T ss_dssp             CSCBHHHHHTCT---TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred             CCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccc
Confidence            999999998643   34699999999999999999999999   9999999999999964  578999999999887543


Q ss_pred             CccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                        .......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+....  .....+     ....      ...
T Consensus       180 --~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i-----~~~~------~~~  244 (350)
T d1koaa2         180 --QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRNV-----KSCD------WNM  244 (350)
T ss_dssp             --SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH-----HHTC------CCS
T ss_pred             --cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH--HHHHHH-----HhCC------CCC
Confidence              2344567999999999999999999999999999999999999999753211  111000     0000      001


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ........+.++.+||.+||+.||++|||+.|+++|.+..
T Consensus       245 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~  284 (350)
T d1koaa2         245 DDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLT  284 (350)
T ss_dssp             CCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTS
T ss_pred             CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence            1122234457899999999999999999999999996643

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.2e-57  Score=408.42  Aligned_cols=257  Identities=20%  Similarity=0.328  Sum_probs=197.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ..+.|++.+.||+|+||+||+|++ .+++.||||++.... ......+.+|+.+|+.++||||+++++++.+++.+|+||
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm   86 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM   86 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            467899999999999999999987 468999999997533 223346788999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeC---CCCceEEeeccCccc
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLD---SDFEPLVADFGFAKL  193 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~---~~~~vkl~Dfgl~~~  193 (380)
                      |||+||+|.+++...    ..+++..+..++.||+.||+|||++   ||+||||||+||++.   .++.+||+|||+++.
T Consensus        87 E~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~  159 (307)
T d1a06a_          87 QLVSGGELFDRIVEK----GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM  159 (307)
T ss_dssp             CCCCSCBHHHHHHTC----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC-----
T ss_pred             eccCCCcHHHhhhcc----cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEE
Confidence            999999999999643    5799999999999999999999999   999999999999995   478999999999987


Q ss_pred             cCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELV  273 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (380)
                      ....  ......+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.....  ....     ....      
T Consensus       160 ~~~~--~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~~-----i~~~------  224 (307)
T d1a06a_         160 EDPG--SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--LFEQ-----ILKA------  224 (307)
T ss_dssp             ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHH-----HHTT------
T ss_pred             ccCC--CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH--HHHH-----Hhcc------
Confidence            6432  23344679999999999999999999999999999999999999997532110  0000     0000      


Q ss_pred             CCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          274 DPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ............+.++.+||.+||+.||++|||++|+++|.+..
T Consensus       225 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~  268 (307)
T d1a06a_         225 EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIA  268 (307)
T ss_dssp             CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTT
T ss_pred             CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhC
Confidence            01111223345567899999999999999999999999997653

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.9e-57  Score=408.02  Aligned_cols=250  Identities=24%  Similarity=0.371  Sum_probs=206.2

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      .+.|++++.||+|+||+||+|++ .+++.||||+++...   ......+.+|+.+|++++|||||++++++.+++..|+|
T Consensus        14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv   93 (309)
T d1u5ra_          14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV   93 (309)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence            34699999999999999999987 578999999997533   23345688999999999999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      ||||.+|+|..++..    ...+++..++.++.||+.||.|||++   ||+||||||+|||++.++.+||+|||++....
T Consensus        94 ~E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~  166 (309)
T d1u5ra_          94 MEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMA  166 (309)
T ss_dssp             EECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSS
T ss_pred             EEecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccC
Confidence            999999998776643    25799999999999999999999999   99999999999999999999999999998754


Q ss_pred             CCCccceeccccccCccCcccccc---CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMW---GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      .     .....||+.|+|||++.+   ..|+.++|||||||++|||++|..||.+....  ....             ..
T Consensus       167 ~-----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~--~~~~-------------~i  226 (309)
T d1u5ra_         167 P-----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAM--SALY-------------HI  226 (309)
T ss_dssp             S-----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHH--HHHH-------------HH
T ss_pred             C-----CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHH--HHHH-------------HH
Confidence            3     234579999999999864   45899999999999999999999999753321  0000             00


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .........+...+..+.+||.+||+.||.+|||++++++|.+.
T Consensus       227 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~  270 (309)
T d1u5ra_         227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV  270 (309)
T ss_dssp             HHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHH
T ss_pred             HhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHh
Confidence            00111111223345789999999999999999999999998654

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-56  Score=403.84  Aligned_cols=248  Identities=23%  Similarity=0.321  Sum_probs=204.8

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ++|++.+.||+|+||+||+|++ .+++.||||+++..   .......+.+|+++|++++||||+++++++.+++.+|+||
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm   87 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL   87 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence            5699999999999999999987 57999999998742   2233457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      |||+||+|.+++...    ..+++..++.++.|++.||+|||+.   ||+||||||+|||++.++.+||+|||+++.+..
T Consensus        88 Ey~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~  160 (288)
T d1uu3a_          88 SYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSP  160 (288)
T ss_dssp             CCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             EccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceeccc
Confidence            999999999998643    5799999999999999999999999   999999999999999999999999999988754


Q ss_pred             CC-ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          197 GV-SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       197 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      .. .......+||+.|+|||++.+..|+.++|||||||++|+|++|..||......  ...             ..+...
T Consensus       161 ~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~-------------~~i~~~  225 (288)
T d1uu3a_         161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY--LIF-------------QKIIKL  225 (288)
T ss_dssp             ---------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHH-------------HHHHTT
T ss_pred             CCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHH--HHH-------------HHHHcC
Confidence            32 22344567999999999999999999999999999999999999999753211  000             000110


Q ss_pred             cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHH
Q 037869          276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVN  312 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~  312 (380)
                        ...++...+.++.+||.+||+.||++|||++|+++
T Consensus       226 --~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         226 --EYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             --CCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             --CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence              11233445678999999999999999999998643

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.3e-56  Score=402.01  Aligned_cols=256  Identities=26%  Similarity=0.443  Sum_probs=201.0

Q ss_pred             hCCCCCcceeccCCceEEEEEEeC-CC---cEEEEEEecc-cChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTS-DG---LQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~---~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      ..+|++.+.||+|+||+||+|++. ++   ..||||.+.. ........+.+|+.+|++++|||||++++++..++..++
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            467889999999999999999864 33   3588998865 344455679999999999999999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      |||||++|+|.+++...   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.+
T Consensus       105 v~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~  178 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFL  178 (299)
T ss_dssp             EEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             EEEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEc
Confidence            99999999999988753   35699999999999999999999999   9999999999999999999999999999876


Q ss_pred             CCCCccc----eeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhcccc
Q 037869          195 PEGVSHM----TTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKF  269 (380)
Q Consensus       195 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  269 (380)
                      .......    .....||+.|+|||++.+..|+.++|||||||++|||+| |..||.......                +
T Consensus       179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~----------------~  242 (299)
T d1jpaa_         179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD----------------V  242 (299)
T ss_dssp             -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----------------H
T ss_pred             cCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH----------------H
Confidence            5432211    122457899999999999999999999999999999998 899997643210                0


Q ss_pred             ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ...+....+.+.+..++..+.+||.+||+.||++|||+.+|++.|..+
T Consensus       243 ~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         243 INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             HHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            011111222334455678899999999999999999999999998643

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=399.00  Aligned_cols=256  Identities=21%  Similarity=0.323  Sum_probs=211.2

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC------hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN------SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQ  111 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  111 (380)
                      ..++|++.+.||+|+||+||+|++ .+|+.||||+++...      ......+.+|+.+|++++|||||++++++.+.+.
T Consensus         8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~   87 (293)
T d1jksa_           8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   87 (293)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            457899999999999999999997 579999999986422      2235678999999999999999999999999999


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC----ceEEee
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF----EPLVAD  187 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~----~vkl~D  187 (380)
                      +|+|||||+||+|.+++...    ..+++..++.++.|++.||+|||+.   +|+||||||+||+++.++    .+||+|
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~D  160 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIID  160 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECC
T ss_pred             EEEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecc
Confidence            99999999999999999653    4799999999999999999999999   999999999999998776    599999


Q ss_pred             ccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcc
Q 037869          188 FGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKG  267 (380)
Q Consensus       188 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  267 (380)
                      ||++.......  ......||+.|+|||++.+..|+.++||||+||++|||++|..||.+.....  ....     ....
T Consensus       161 fG~a~~~~~~~--~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~~-----i~~~  231 (293)
T d1jksa_         161 FGLAHKIDFGN--EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLAN-----VSAV  231 (293)
T ss_dssp             CTTCEECTTSC--BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH-----HHTT
T ss_pred             hhhhhhcCCCc--cccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH--HHHH-----HHhc
Confidence            99998875432  2344568999999999999999999999999999999999999997543210  0000     0000


Q ss_pred             ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .      .......+...+..+.+||.+||+.||++|||++++++|.+.
T Consensus       232 ~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~  274 (293)
T d1jksa_         232 N------YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI  274 (293)
T ss_dssp             C------CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTT
T ss_pred             C------CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCccc
Confidence            0      000111122345788999999999999999999999999764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-56  Score=407.39  Aligned_cols=260  Identities=25%  Similarity=0.397  Sum_probs=210.6

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeCC-C-----cEEEEEEeccc-ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecC
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTSD-G-----LQIAVKKLKAM-NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGT  109 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~  109 (380)
                      ...++|++.+.||+|+||+||+|++.. +     ..||+|.+... .......+.+|+.+|+++ +|||||++++++.+.
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~  113 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS  113 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC
Confidence            356789999999999999999998632 2     36899998643 333445788999999998 899999999999999


Q ss_pred             CeEEEEEEecCCCCHHHhhccCCC-------------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCC
Q 037869          110 DQRLIVYDYMPNLSLLSHLHGQYA-------------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDI  170 (380)
Q Consensus       110 ~~~~lv~e~~~~g~L~~~i~~~~~-------------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdl  170 (380)
                      +.+|+|||||++|+|.+++.....                   ....+++..++.++.|++.||+|||++   +|+||||
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDl  190 (325)
T d1rjba_         114 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDL  190 (325)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTC
T ss_pred             CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccC
Confidence            999999999999999999975421                   123589999999999999999999999   9999999


Q ss_pred             CCCCeeeCCCCceEEeeccCccccCCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCC
Q 037869          171 KASNVLLDSDFEPLVADFGFAKLIPEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKL  248 (380)
Q Consensus       171 kp~Nill~~~~~vkl~Dfgl~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~  248 (380)
                      ||+|||++.++.+||+|||+++........ ......||+.|+|||++.+..|+.++|||||||++|||+| |..||.+.
T Consensus       191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence            999999999999999999999876543322 2334568999999999999999999999999999999998 89999764


Q ss_pred             CCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          249 PGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      +...  .             +...+....+.+.+..++.++.+||.+||+.||++|||+++|+++|.
T Consensus       271 ~~~~--~-------------~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         271 PVDA--N-------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCSH--H-------------HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CHHH--H-------------HHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            4311  0             11112222333445566789999999999999999999999999984

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-55  Score=395.16  Aligned_cols=254  Identities=24%  Similarity=0.381  Sum_probs=209.2

Q ss_pred             hhCCCCCcc-eeccCCceEEEEEEeC---CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           39 ATNGFSDDN-KLGEGGFGSVYWGRTS---DGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        39 ~~~~y~~~~-~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ..++|.+.+ +||+|+||+||+|.+.   ++..||||+++.. .......+.+|+++|++++|||||++++++.. +.+|
T Consensus         6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~   84 (285)
T d1u59a_           6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM   84 (285)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred             cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEE
Confidence            346677777 4999999999999753   3557999999753 34456689999999999999999999999874 5689


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +|||||++|+|.+++...   +..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++.
T Consensus        85 lvmE~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~  158 (285)
T d1u59a_          85 LVMEMAGGGPLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKA  158 (285)
T ss_dssp             EEEECCTTEEHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             EEEEeCCCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhc
Confidence            999999999999998543   35799999999999999999999999   999999999999999999999999999988


Q ss_pred             cCCCCcc--ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccc
Q 037869          194 IPEGVSH--MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFK  270 (380)
Q Consensus       194 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (380)
                      +......  ......||+.|+|||++.+..++.++|||||||++|||+| |..||.......   .             .
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~-------------~  222 (285)
T d1u59a_         159 LGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---V-------------M  222 (285)
T ss_dssp             CTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---H-------------H
T ss_pred             ccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---H-------------H
Confidence            7543322  2233468999999999999999999999999999999998 899997643210   0             0


Q ss_pred             cccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          271 ELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ..+..+.+...+..++.++.+||.+||+.||++|||+.+|++.|+
T Consensus       223 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~  267 (285)
T d1u59a_         223 AFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  267 (285)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHH
Confidence            111122233445566789999999999999999999999988775

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-55  Score=399.76  Aligned_cols=251  Identities=25%  Similarity=0.304  Sum_probs=212.5

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ++|++++.||+|+||+||+|++ .+|+.||||+++..   .......+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~   84 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence            5799999999999999999997 57999999999742   2233557889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      |||+||+|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.+|.+||+|||+++....
T Consensus        85 ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~  157 (337)
T d1o6la_          85 EYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS  157 (337)
T ss_dssp             ECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred             eccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeeccccccccc
Confidence            999999999999753    5799999999999999999999999   999999999999999999999999999987643


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      .. ......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.....  ..    .. ...+         
T Consensus       158 ~~-~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~----~~-i~~~---------  220 (337)
T d1o6la_         158 DG-ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LF----EL-ILME---------  220 (337)
T ss_dssp             TT-CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH----HH-HHHC---------
T ss_pred             CC-cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH--HH----HH-HhcC---------
Confidence            22 23445679999999999999999999999999999999999999997643210  00    00 0000         


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHhcC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPN-----MKEVVNTLTG  316 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps-----~~~ll~~l~~  316 (380)
                       ...++...+.++.+||.+||++||.+||+     ++++++|.+.
T Consensus       221 -~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f  264 (337)
T d1o6la_         221 -EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF  264 (337)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred             -CCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccc
Confidence             11234455678999999999999999994     9999999764

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=9.5e-55  Score=396.39  Aligned_cols=248  Identities=27%  Similarity=0.339  Sum_probs=209.6

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ++|++.+.||+|+||+||+|++ .+|+.||||+++..   .......+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   83 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   83 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence            4699999999999999999997 56999999999742   2233557889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      |||+||+|..++...    ..+++..+..++.||+.||+|||++   ||+||||||+|||++.+|.+||+|||+++....
T Consensus        84 E~~~gg~l~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~  156 (316)
T d1fota_          84 DYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD  156 (316)
T ss_dssp             CCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred             eecCCcccccccccc----ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEecc
Confidence            999999999998654    5688999999999999999999999   999999999999999999999999999988654


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      .    ....+||+.|+|||++.+..|+.++|||||||++|+|++|..||.......  ..             ..+... 
T Consensus       157 ~----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~-------------~~i~~~-  216 (316)
T d1fota_         157 V----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--TY-------------EKILNA-  216 (316)
T ss_dssp             C----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HH-------------HHHHHC-
T ss_pred             c----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH--HH-------------HHHHcC-
Confidence            2    334679999999999999999999999999999999999999997533210  00             000000 


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhcC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLTG  316 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~~  316 (380)
                       ....+...+.++.+++.+||..||.+|+     |++++++|.+.
T Consensus       217 -~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f  260 (316)
T d1fota_         217 -ELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF  260 (316)
T ss_dssp             -CCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGG
T ss_pred             -CCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccc
Confidence             1123344557899999999999999996     99999999664

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-55  Score=390.22  Aligned_cols=245  Identities=25%  Similarity=0.400  Sum_probs=200.1

Q ss_pred             ceeccCCceEEEEEEeC---CCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEecCC
Q 037869           47 NKLGEGGFGSVYWGRTS---DGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDYMPN  121 (380)
Q Consensus        47 ~~Lg~G~~g~Vy~~~~~---~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~  121 (380)
                      ++||+|+||+||+|.+.   .++.||||+++..  .+.....+.+|+.+|++++|||||++++++.. +..++|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            46999999999999753   3578999999742  33345679999999999999999999999964 567999999999


Q ss_pred             CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCcc-
Q 037869          122 LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVSH-  200 (380)
Q Consensus       122 g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~~-  200 (380)
                      |+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++.+...... 
T Consensus        92 g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~  164 (277)
T d1xbba_          92 GPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  164 (277)
T ss_dssp             EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhcccccccc
Confidence            9999999753    4699999999999999999999999   9999999999999999999999999999876543322 


Q ss_pred             -ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          201 -MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       201 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                       ......||+.|+|||++.+..++.++|||||||++|||+| |..||.+....   .             +...+....+
T Consensus       165 ~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~-------------~~~~i~~~~~  228 (277)
T d1xbba_         165 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---E-------------VTAMLEKGER  228 (277)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---H-------------HHHHHHTTCC
T ss_pred             ccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---H-------------HHHHHHcCCC
Confidence             2233568999999999999999999999999999999998 89999764321   0             0011112223


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ...+..++.++.+||.+||+.||++|||+.+|++.|.
T Consensus       229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~  265 (277)
T d1xbba_         229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLR  265 (277)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHH
T ss_pred             CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhh
Confidence            3445566788999999999999999999999987765

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-55  Score=392.72  Aligned_cols=258  Identities=28%  Similarity=0.435  Sum_probs=206.1

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ..++|++.+.||+|+||+||+|++.++..||||+++... .....+.+|+.++++++|||||++++++. ++..++||||
T Consensus        15 ~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey   92 (285)
T d1fmka3          15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEY   92 (285)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECC
T ss_pred             CHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECccc-CCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEe
Confidence            346899999999999999999999888889999997543 33457999999999999999999999985 4668999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++|+|..++...  ....+++..++.++.|++.||+|||+.   +|+||||||+||||+.++.+||+|||+++......
T Consensus        93 ~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~  167 (285)
T d1fmka3          93 MSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  167 (285)
T ss_dssp             CTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             cCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence            9999999988653  234699999999999999999999999   99999999999999999999999999998775444


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCccc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKLR  278 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (380)
                      ........||+.|+|||++.+..++.++|||||||++|||++|..|+...... ...              ...+....+
T Consensus       168 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~-~~~--------------~~~i~~~~~  232 (285)
T d1fmka3         168 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN-REV--------------LDQVERGYR  232 (285)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHH--------------HHHHHTTCC
T ss_pred             ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH-HHH--------------HHHHHhcCC
Confidence            34444456899999999999999999999999999999999976665432211 000              001111223


Q ss_pred             CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCCC
Q 037869          279 GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGYD  318 (380)
Q Consensus       279 ~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~~  318 (380)
                      .+.+..++.++.+||.+||+.||++|||+++|++.|..+.
T Consensus       233 ~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         233 MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             CCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence            3445556688999999999999999999999999887654

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=389.45  Aligned_cols=256  Identities=25%  Similarity=0.420  Sum_probs=202.7

Q ss_pred             hCCCCCcceeccCCceEEEEEEeCC-C----cEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTSD-G----LQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~~-~----~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ...|++.+.||+|+||+||+|.+.. +    ..||||+++.. .......+.+|+.++++++|||||++++++.+.+..+
T Consensus         6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence            4578999999999999999997532 2    46999999753 3444557889999999999999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +|||||.+|++.+.+...   ...+++..+..++.|++.||+|||++   +|+||||||+||||+.++.+||+|||+++.
T Consensus        86 ~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~  159 (283)
T d1mqba_          86 IITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRV  159 (283)
T ss_dssp             EEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             EEEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhc
Confidence            999999999999988644   35799999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCcc--ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccccc
Q 037869          194 IPEGVSH--MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKE  271 (380)
Q Consensus       194 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (380)
                      +......  ......||+.|+|||++.+..++.++|||||||++|||+++..|+......  ..             +..
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~-------------~~~  224 (283)
T d1mqba_         160 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HE-------------VMK  224 (283)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HH-------------HHH
T ss_pred             ccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HH-------------HHH
Confidence            6443221  223345899999999999999999999999999999999966665432211  00             111


Q ss_pred             ccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          272 LVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .+..+.+.+.+..++..+.+||.+||+.||++|||+.+|++.|..
T Consensus       225 ~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~  269 (283)
T d1mqba_         225 AINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDK  269 (283)
T ss_dssp             HHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             HHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHH
Confidence            112223334555566889999999999999999999999998864

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-55  Score=391.71  Aligned_cols=255  Identities=24%  Similarity=0.363  Sum_probs=199.9

Q ss_pred             hhCCCCCcceeccCCceEEEEEEeCC----CcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRTSD----GLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ..++|++.+.||+|+||+||+|.+..    +..||||.++.. .......+.+|+.+|++++||||+++++++. ++.+|
T Consensus         5 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~   83 (273)
T d1mp8a_           5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVW   83 (273)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCE
T ss_pred             CHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEE
Confidence            56789999999999999999998632    356899998753 3444567899999999999999999999996 56789


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +||||+++|+|.+++...   ...+++..++.++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++.
T Consensus        84 iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~  157 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRY  157 (273)
T ss_dssp             EEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC------
T ss_pred             EEEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhhee
Confidence            999999999999987643   35789999999999999999999999   999999999999999999999999999988


Q ss_pred             cCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      .............||+.|+|||++.+..|+.++|||||||++|||++ |.+||........  .              ..
T Consensus       158 ~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~--~--------------~~  221 (273)
T d1mp8a_         158 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV--I--------------GR  221 (273)
T ss_dssp             -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH--H--------------HH
T ss_pred             ccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH--H--------------HH
Confidence            76544444455668999999999999999999999999999999998 8999876432110  0              00


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      +....+.+.+..++..+.+||.+||+.||++|||+.+|+++|..
T Consensus       222 i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~  265 (273)
T d1mp8a_         222 IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLST  265 (273)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            11112223455667889999999999999999999999999864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.4e-54  Score=396.62  Aligned_cols=249  Identities=24%  Similarity=0.276  Sum_probs=210.1

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  116 (380)
                      ++|++++.||+|+||+||+|++ .+|+.||||++...   .......+.+|+.+|+.++||||+++++++......++||
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~  120 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence            4799999999999999999987 57999999998642   2233457889999999999999999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCC
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPE  196 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~  196 (380)
                      ||+.+|+|..++...    ..+++..++.++.||+.||.|||++   +|+||||||+|||++.+|.+||+|||+++.+..
T Consensus       121 e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~  193 (350)
T d1rdqe_         121 EYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG  193 (350)
T ss_dssp             ECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred             ccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeeccc
Confidence            999999999999653    4799999999999999999999999   999999999999999999999999999998753


Q ss_pred             CCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          197 GVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       197 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      .    .....||+.|+|||++.+..|+.++|||||||++|+|++|..||.+....  .....     ...+         
T Consensus       194 ~----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~-----i~~~---------  253 (350)
T d1rdqe_         194 R----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--QIYEK-----IVSG---------  253 (350)
T ss_dssp             C----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH-----HHHC---------
T ss_pred             c----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHH--HHHHH-----HhcC---------
Confidence            2    33457999999999999999999999999999999999999999753210  00000     0000         


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCC-----CCHHHHHHHhcCC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKR-----PNMKEVVNTLTGY  317 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~R-----ps~~~ll~~l~~~  317 (380)
                       ....+...+.++.+||.+||+.||.+|     ||+++|++|.+..
T Consensus       254 -~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~  298 (350)
T d1rdqe_         254 -KVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA  298 (350)
T ss_dssp             -CCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGT
T ss_pred             -CCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCcccc
Confidence             012233455789999999999999999     4999999997643

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-54  Score=393.04  Aligned_cols=256  Identities=19%  Similarity=0.306  Sum_probs=210.2

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      .-++|++.+.||+|+||+||+|.+ .+++.||||+++... .+...+.+|+++|+.++||||+++++++.+++.+|+|||
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            347899999999999999999987 478999999998654 334568899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC--CceEEeeccCccccC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD--FEPLVADFGFAKLIP  195 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~--~~vkl~Dfgl~~~~~  195 (380)
                      ||+||+|.+++...   ...+++..++.++.||+.||+|||++   ||+||||||+|||++.+  +.+||+|||+++...
T Consensus        82 ~~~gg~L~~~i~~~---~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~  155 (321)
T d1tkia_          82 FISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK  155 (321)
T ss_dssp             CCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECC
T ss_pred             cCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccc
Confidence            99999999999643   34699999999999999999999999   99999999999999854  589999999998765


Q ss_pred             CCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      ..  .......+|+.|+|||.+.+..|+.++|||||||++|+|++|..||......  .....     .....+      
T Consensus       156 ~~--~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~--~~~~~-----i~~~~~------  220 (321)
T d1tkia_         156 PG--DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ--QIIEN-----IMNAEY------  220 (321)
T ss_dssp             TT--CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHH-----HHHTCC------
T ss_pred             cC--CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH--HHHHH-----HHhCCC------
Confidence            43  2334456899999999999999999999999999999999999999754321  00000     000000      


Q ss_pred             cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ..........+.++.+||.+||..||.+|||+.|+++|.+.
T Consensus       221 ~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~  261 (321)
T d1tkia_         221 TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL  261 (321)
T ss_dssp             CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHH
T ss_pred             CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence            00001111235678999999999999999999999999653

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.2e-53  Score=396.39  Aligned_cols=253  Identities=22%  Similarity=0.264  Sum_probs=206.4

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC---hhhHHHH---HHHHHHHhcCCCCcceeEeeEEecCCeEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN---SKAEMEF---AVEVEVLGRVRHKNLLGLRGYCAGTDQRL  113 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~---~~E~~~l~~l~h~niv~~~~~~~~~~~~~  113 (380)
                      ++|++.+.||+|+||+||+|++ .+|+.||||++....   ......+   ..++.+++.++|||||++++++.+++.+|
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~   83 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS   83 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence            5799999999999999999997 479999999986421   1111223   34578888899999999999999999999


Q ss_pred             EEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          114 IVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       114 lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      +|||||+||+|.+++...    ..+++..++.++.||+.||.|||++   ||+||||||+|||++.+|.+||+|||+++.
T Consensus        84 ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~  156 (364)
T d1omwa3          84 FILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACD  156 (364)
T ss_dssp             EEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred             EEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeee
Confidence            999999999999999653    5789999999999999999999999   999999999999999999999999999987


Q ss_pred             cCCCCccceeccccccCccCccccc-cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      +...   ......||+.|+|||++. +..|+.++|||||||++|||++|..||..........+..            . 
T Consensus       157 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~------------~-  220 (364)
T d1omwa3         157 FSKK---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR------------M-  220 (364)
T ss_dssp             CSSS---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH------------H-
T ss_pred             cCCC---cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------h-
Confidence            6543   234457999999999997 4578999999999999999999999997644321111100            0 


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCC-----HHHHHHHhcCC
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPN-----MKEVVNTLTGY  317 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps-----~~~ll~~l~~~  317 (380)
                       ........+...+.++.+||.+||+.||++|||     ++++++|.+..
T Consensus       221 -~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~  269 (364)
T d1omwa3         221 -TLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR  269 (364)
T ss_dssp             -SSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGT
T ss_pred             -cccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCcccc
Confidence             001111233345678999999999999999999     79999997643

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1e-53  Score=382.34  Aligned_cols=254  Identities=25%  Similarity=0.337  Sum_probs=209.6

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh---------hhHHHHHHHHHHHhcCC-CCcceeEeeEEec
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS---------KAEMEFAVEVEVLGRVR-HKNLLGLRGYCAG  108 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---------~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~  108 (380)
                      .++|++.+.||+|+||+||+|++ .+++.||||+++....         .....+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            47899999999999999999997 5789999999875321         12235778999999997 9999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          109 TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       109 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                      ++..|||||||++|+|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+||+||
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DF  154 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDF  154 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCC
T ss_pred             CcceEEEEEcCCCchHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccc
Confidence            99999999999999999999643    5799999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCccceeccccccCccCcccccc------CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchh
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMW------GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEP  262 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  262 (380)
                      |++..+....  ......||+.|+|||.+.+      ..++.++||||+||++|+|++|..||.+.....  ..     .
T Consensus       155 G~a~~~~~~~--~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~--~~-----~  225 (277)
T d1phka_         155 GFSCQLDPGE--KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML--ML-----R  225 (277)
T ss_dssp             TTCEECCTTC--CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HH-----H
T ss_pred             hheeEccCCC--ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH--HH-----H
Confidence            9999875532  2344579999999999863      357899999999999999999999997643210  00     0


Q ss_pred             hhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          263 LIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ....+.      ...........++++.+|+.+||+.||++|||+.++++|.+
T Consensus       226 ~i~~~~------~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~  272 (277)
T d1phka_         226 MIMSGN------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPF  272 (277)
T ss_dssp             HHHHTC------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGG
T ss_pred             HHHhCC------CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHH
Confidence            001111      11122233456688999999999999999999999999965

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=392.56  Aligned_cols=254  Identities=23%  Similarity=0.249  Sum_probs=202.8

Q ss_pred             hCCCCCcc-eeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhc-CCCCcceeEeeEEec----CCeE
Q 037869           40 TNGFSDDN-KLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGR-VRHKNLLGLRGYCAG----TDQR  112 (380)
Q Consensus        40 ~~~y~~~~-~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~~~~~~~~----~~~~  112 (380)
                      -++|.+.. .||+|+||+||+|++ .+++.||||+++..     ..+.+|+.++.+ .+|||||+++++|++    +..+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            46788875 599999999999987 57899999999753     256679988654 589999999999865    4668


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---CCceEEeecc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS---DFEPLVADFG  189 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~---~~~vkl~Dfg  189 (380)
                      |+|||||+||+|.+++...  ....+++..++.++.||+.||+|||++   ||+||||||+|||++.   ++.+||+|||
T Consensus        85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG  159 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFG  159 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             EEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccc
Confidence            9999999999999999753  234699999999999999999999999   9999999999999985   4679999999


Q ss_pred             CccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccc
Q 037869          190 FAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKF  269 (380)
Q Consensus       190 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  269 (380)
                      +++......  ......||+.|+|||++.+..|+.++|||||||++|+|+||..||.+........  .         ..
T Consensus       160 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~--~---------~~  226 (335)
T d2ozaa1         160 FAKETTSHN--SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP--G---------MK  226 (335)
T ss_dssp             TCEECCCCC--CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC------------------
T ss_pred             eeeeccCCC--ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH--H---------HH
Confidence            998765432  3345579999999999999999999999999999999999999997543211000  0         00


Q ss_pred             ccccCCc--ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          270 KELVDPK--LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       270 ~~~~~~~--~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .......  .........+.++.+||.+||+.||++|||+.++++|.+.
T Consensus       227 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~  275 (335)
T d2ozaa1         227 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI  275 (335)
T ss_dssp             -CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHH
T ss_pred             HHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHh
Confidence            0000011  1111123456789999999999999999999999999654

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-54  Score=392.10  Aligned_cols=251  Identities=28%  Similarity=0.343  Sum_probs=207.2

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHh-cCCCCcceeEeeEEecCCeEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLG-RVRHKNLLGLRGYCAGTDQRLIV  115 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv  115 (380)
                      ++|++.+.||+|+||+||+|.+ .+++.||||+++..   .......+..|..++. .++||||+++++++.+++.+|+|
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            5799999999999999999987 57999999999742   1223345666666654 68999999999999999999999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIP  195 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~  195 (380)
                      ||||++|+|.+++...    ..+++..++.++.||+.||+|||++   +|+||||||+|||++.++.+||+|||+++...
T Consensus        82 mEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~  154 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENM  154 (320)
T ss_dssp             EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcc
Confidence            9999999999999653    4789999999999999999999999   99999999999999999999999999998764


Q ss_pred             CCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCC
Q 037869          196 EGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDP  275 (380)
Q Consensus       196 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (380)
                      ... .......||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.....  ...    . ...+        
T Consensus       155 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~--~~~----~-i~~~--------  218 (320)
T d1xjda_         155 LGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE--LFH----S-IRMD--------  218 (320)
T ss_dssp             CTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHH----H-HHHC--------
T ss_pred             ccc-ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH--HHH----H-HHcC--------
Confidence            432 23344579999999999999999999999999999999999999997533210  000    0 0000        


Q ss_pred             cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH-HHHHHhcC
Q 037869          276 KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMK-EVVNTLTG  316 (380)
Q Consensus       276 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~-~ll~~l~~  316 (380)
                        ...++...+.++.+||.+||..||.+|||+. ++++|.+.
T Consensus       219 --~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff  258 (320)
T d1xjda_         219 --NPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF  258 (320)
T ss_dssp             --CCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGG
T ss_pred             --CCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchh
Confidence              1123344567899999999999999999996 89988664

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=389.13  Aligned_cols=254  Identities=24%  Similarity=0.408  Sum_probs=204.4

Q ss_pred             CCCCCcceeccCCceEEEEEEeC-CCc----EEEEEEecc-cChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTS-DGL----QIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~-~~~----~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  114 (380)
                      .+|++.+.||+|+||+||+|.+. +|+    +||+|.++. ........+.+|+.++++++|||||++++++.+ +..++
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~   87 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQL   87 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeeE
Confidence            46999999999999999999863 444    689998864 333456689999999999999999999999986 56788


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLI  194 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~  194 (380)
                      ++||+.+|+|.+.+...   ...+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|||+++..
T Consensus        88 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~  161 (317)
T d1xkka_          88 ITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLL  161 (317)
T ss_dssp             EEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred             EEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceec
Confidence            89999999999988754   45799999999999999999999999   9999999999999999999999999999887


Q ss_pred             CCCCcc-ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccc
Q 037869          195 PEGVSH-MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKEL  272 (380)
Q Consensus       195 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (380)
                      ...... ......||+.|+|||++.+..|+.++|||||||++|||+| |.+||...+...                +...
T Consensus       162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~----------------~~~~  225 (317)
T d1xkka_         162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSI  225 (317)
T ss_dssp             TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG----------------HHHH
T ss_pred             ccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH----------------HHHH
Confidence            543322 2334468999999999999999999999999999999998 788887643211                1111


Q ss_pred             cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          273 VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      +..+.+...+..++..+.+|+.+||+.||++|||+.+|+++|..+
T Consensus       226 i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         226 LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             HHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence            112223344555668899999999999999999999999997643

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.2e-53  Score=380.42  Aligned_cols=257  Identities=25%  Similarity=0.356  Sum_probs=201.5

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC----
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD----  110 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----  110 (380)
                      ..++|++.+.||+|+||+||+|++ .+|+.||||+++..   .......+.+|+.+++.++||||+++++++...+    
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~   84 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP   84 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSE
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCc
Confidence            457899999999999999999987 57999999999753   2334557889999999999999999999987643    


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccC
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGF  190 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl  190 (380)
                      ..|+|||||+|++|.+++...    ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.++|+|||.
T Consensus        85 ~~~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~  157 (277)
T d1o6ya_          85 LPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGI  157 (277)
T ss_dssp             EEEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTT
T ss_pred             eEEEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhh
Confidence            389999999999999988653    4799999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCc--cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccc
Q 037869          191 AKLIPEGVS--HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGK  268 (380)
Q Consensus       191 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (380)
                      +........  .......||+.|+|||++.+..|+.++|||||||++|+|+||..||.......  ...    ...... 
T Consensus       158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~--~~~----~~~~~~-  230 (277)
T d1o6ya_         158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS--VAY----QHVRED-  230 (277)
T ss_dssp             CEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHH----HHHHCC-
T ss_pred             hhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH--HHH----HHHhcC-
Confidence            876543222  23444679999999999999999999999999999999999999997543210  000    000000 


Q ss_pred             cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC-CHHHHHHHhc
Q 037869          269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRP-NMKEVVNTLT  315 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp-s~~~ll~~l~  315 (380)
                            +..........+.++.++|.+||+.||.+|| |++++++.|.
T Consensus       231 ------~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         231 ------PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             ------CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             ------CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence                  0011122234457899999999999999999 8999987764

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-53  Score=387.02  Aligned_cols=264  Identities=23%  Similarity=0.374  Sum_probs=212.9

Q ss_pred             HHHHhhCCCCCcceeccCCceEEEEEEeC------CCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEe
Q 037869           35 ELHTATNGFSDDNKLGEGGFGSVYWGRTS------DGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCA  107 (380)
Q Consensus        35 ~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~  107 (380)
                      ++..+.++|++.+.||+|+||+||+|+..      +++.||||+++... ......+.+|+.+|+.++||||+++++++.
T Consensus         7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~   86 (301)
T d1lufa_           7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA   86 (301)
T ss_dssp             HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence            44557789999999999999999999853      35789999997543 334567999999999999999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHhhccCC--------------------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEe
Q 037869          108 GTDQRLIVYDYMPNLSLLSHLHGQY--------------------AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIH  167 (380)
Q Consensus       108 ~~~~~~lv~e~~~~g~L~~~i~~~~--------------------~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivH  167 (380)
                      ..+..++||||+++|+|.+++....                    .....+++..++.++.|++.||+|||+.   +++|
T Consensus        87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivH  163 (301)
T d1lufa_          87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVH  163 (301)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEe
Confidence            9999999999999999999985421                    1223589999999999999999999999   9999


Q ss_pred             cCCCCCCeeeCCCCceEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCC-CCC
Q 037869          168 RDIKASNVLLDSDFEPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGR-KPI  245 (380)
Q Consensus       168 rdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~p~  245 (380)
                      |||||+|||++.++.+||+|||+++....... .......|++.|+|||.+.+..|+.++|||||||++|||++|. +||
T Consensus       164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCC
Confidence            99999999999999999999999987643322 2233456899999999999999999999999999999999985 567


Q ss_pred             CCCCCCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          246 EKLPGGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .......   .   .          ..+........+..++.++.+||.+||+.||++|||+.+|++.|+.+
T Consensus       244 ~~~~~~e---~---~----------~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i  299 (301)
T d1lufa_         244 YGMAHEE---V---I----------YYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRM  299 (301)
T ss_dssp             TTSCHHH---H---H----------HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHT
T ss_pred             CCCCHHH---H---H----------HHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            6533210   0   0          01111122234455667899999999999999999999999988754

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=377.90  Aligned_cols=249  Identities=29%  Similarity=0.412  Sum_probs=200.5

Q ss_pred             hCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEec-CCeEEEEEEe
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG-TDQRLIVYDY  118 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~  118 (380)
                      .++|++.+.||+|+||.||+|+++ |..||||+++...  ..+.+.+|++++++++||||+++++++.+ .+.+|+||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEec
Confidence            457889999999999999999984 7899999997643  34578999999999999999999999865 4568999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +++|+|.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++..... 
T Consensus        83 ~~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-  156 (262)
T d1byga_          83 MAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  156 (262)
T ss_dssp             CTTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             cCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC-
Confidence            9999999999643  123589999999999999999999999   9999999999999999999999999999875432 


Q ss_pred             ccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhccccccccCCcc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPKL  277 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (380)
                         .....++..|+|||++.+..++.++|||||||++|||+| |.+||.......                +...+....
T Consensus       157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~----------------~~~~i~~~~  217 (262)
T d1byga_         157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----------------VVPRVEKGY  217 (262)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG----------------HHHHHTTTC
T ss_pred             ---CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH----------------HHHHHHcCC
Confidence               223457899999999999999999999999999999998 688776533210                111112233


Q ss_pred             cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          278 RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       278 ~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      +...+...+.++.+||.+||+.||.+|||+.+|+++|..
T Consensus       218 ~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~  256 (262)
T d1byga_         218 KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEH  256 (262)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHH
Confidence            344555666889999999999999999999999999864

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-53  Score=385.75  Aligned_cols=266  Identities=23%  Similarity=0.321  Sum_probs=202.9

Q ss_pred             HHHHHHhhCCCCCcceeccCCceEEEEEEeC------CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcC-CCCcceeEee
Q 037869           33 YKELHTATNGFSDDNKLGEGGFGSVYWGRTS------DGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRV-RHKNLLGLRG  104 (380)
Q Consensus        33 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~  104 (380)
                      ..++....++|++.++||+|+||.||+|++.      +++.||||+++.. .......+.+|..++.++ +|+||+.+++
T Consensus         5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~   84 (299)
T d1ywna1           5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLG   84 (299)
T ss_dssp             HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeee
Confidence            3445566789999999999999999999752      2468999999753 334455677888888776 6899999999


Q ss_pred             EEecC-CeEEEEEEecCCCCHHHhhccCCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCC
Q 037869          105 YCAGT-DQRLIVYDYMPNLSLLSHLHGQYA------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIK  171 (380)
Q Consensus       105 ~~~~~-~~~~lv~e~~~~g~L~~~i~~~~~------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlk  171 (380)
                      ++..+ ..+++|||||++|+|.+++.....            ....+++..+..++.|++.||+|||++   +|+|||||
T Consensus        85 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlK  161 (299)
T d1ywna1          85 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLA  161 (299)
T ss_dssp             EECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCC
T ss_pred             eeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCC
Confidence            98654 468999999999999999965421            234589999999999999999999999   99999999


Q ss_pred             CCCeeeCCCCceEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhC-CCCCCCCC
Q 037869          172 ASNVLLDSDFEPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTG-RKPIEKLP  249 (380)
Q Consensus       172 p~Nill~~~~~vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g-~~p~~~~~  249 (380)
                      |+|||++.++.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||++| .+||....
T Consensus       162 p~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         162 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             GGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987644322 223345799999999999999999999999999999999986 46776533


Q ss_pred             CCcccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          250 GGVKRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ...  .             +...+....+...+...++++.+||.+||+.||++|||+.+|++||..
T Consensus       242 ~~~--~-------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~  293 (299)
T d1ywna1         242 IDE--E-------------FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGN  293 (299)
T ss_dssp             CSH--H-------------HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHH--H-------------HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence            211  0             001111122223444556789999999999999999999999999864

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-53  Score=380.60  Aligned_cols=254  Identities=29%  Similarity=0.413  Sum_probs=199.8

Q ss_pred             hCCCCCcceeccCCceEEEEEEeC--C--CcEEEEEEeccc---ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTS--D--GLQIAVKKLKAM---NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~--~--~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~  112 (380)
                      .++|++.+.||+|+||+||+|+..  +  ...||||+++..   .......+.+|+.+|++++||||+++++++.+ +..
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~   85 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM   85 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cch
Confidence            467999999999999999999742  2  246899998742   33445678999999999999999999999975 577


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      ++|||||++|++.+.+...   ...+++..++.++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++
T Consensus        86 ~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~  159 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR  159 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred             heeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhh
Confidence            9999999999999988653   35699999999999999999999999   99999999999999999999999999999


Q ss_pred             ccCCCCcc--ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcccchhccchhhhhcccc
Q 037869          193 LIPEGVSH--MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVKRTITEWAEPLIVKGKF  269 (380)
Q Consensus       193 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  269 (380)
                      .+......  ......|+..|+|||++.+..++.++|||||||++|||+| |..||.+.....               ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~---------------~~  224 (273)
T d1u46a_         160 ALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ---------------IL  224 (273)
T ss_dssp             ECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---------------HH
T ss_pred             hcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH---------------HH
Confidence            87544322  2233457889999999999999999999999999999998 899997543210               01


Q ss_pred             ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      ..+.....+.+.+..++..+.+||.+||+.||++|||+.+|++.|+
T Consensus       225 ~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~  270 (273)
T d1u46a_         225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL  270 (273)
T ss_dssp             HHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence            1122223333445556688999999999999999999999998875

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-52  Score=379.07  Aligned_cols=267  Identities=21%  Similarity=0.275  Sum_probs=202.9

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh--hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS--KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ++|+++++||+|+||+||+|.+ .+++.||||+++....  .....+.+|+++|++++||||+++++++.+.+.+|+|||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            5799999999999999999997 5789999999964322  224578899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      |+.++ +..++...  ....+++..++.++.|++.||+|||+.   ||+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~~~-~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~  155 (298)
T d1gz8a_          82 FLHQD-LKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP  155 (298)
T ss_dssp             CCSEE-HHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred             ecCCc-hhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCC
Confidence            99764 44444322  235699999999999999999999999   9999999999999999999999999999877543


Q ss_pred             CccceeccccccCccCccccccCC-CCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccch-----------hhhh
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE-----------PLIV  265 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~-----------~~~~  265 (380)
                      .. ......||+.|+|||++.... ++.++||||+||++|+|++|..||.......  .......           ....
T Consensus       156 ~~-~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~  232 (298)
T d1gz8a_         156 VR-TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTLGTPDEVVWPGVTS  232 (298)
T ss_dssp             SB-CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCCTTTSTTGGG
T ss_pred             cc-cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHH--HHHHHHHhcCCCchhhcccccc
Confidence            32 333456999999999987665 5899999999999999999999997543211  0000000           0000


Q ss_pred             ccccccccCCcccC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          266 KGKFKELVDPKLRG---DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       266 ~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ..............   ......+.++.+|+.+||..||.+|||++|+++|.+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff  286 (298)
T d1gz8a_         233 MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF  286 (298)
T ss_dssp             STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGG
T ss_pred             ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhh
Confidence            00000000000000   0112334688999999999999999999999999664

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-53  Score=382.23  Aligned_cols=262  Identities=23%  Similarity=0.247  Sum_probs=198.8

Q ss_pred             CcceeccCCceEEEEEEe-CCCcEEEEEEecccChhh-----HHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           45 DDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKA-----EMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        45 ~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      .+++||+|+||+||+|++ .+|+.||||+++......     ...+.+|+.+|+.++|||||++++++..++.+|+||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~   81 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF   81 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence            357899999999999997 569999999997532211     23688899999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +.++++......    ...+++..+..++.||+.||+|||++   ||+||||||+|||++.++.+||+|||+++......
T Consensus        82 ~~~~~~~~~~~~----~~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          82 METDLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             CSEEHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             hcchHHhhhhhc----ccCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCc
Confidence            998877766643    35788999999999999999999999   99999999999999999999999999998765432


Q ss_pred             ccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhh--ccccc---cc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIV--KGKFK---EL  272 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~---~~  272 (380)
                      . .....+||+.|+|||++.+ ..|+.++||||+||++|||++|.+||.......  .+..+......  ...+.   ..
T Consensus       155 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~--~l~~i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         155 R-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD--QLTRIFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             C-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             c-cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHH--HHHHHHHhcCCCChhhccchhcc
Confidence            2 2334578999999999875 468999999999999999999999997543211  00000000000  00000   00


Q ss_pred             ---cC-Ccc----cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          273 ---VD-PKL----RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       273 ---~~-~~~----~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                         .. ...    ........+.++.+||.+||+.||++|||++|+++|.+.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f  283 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF  283 (299)
T ss_dssp             TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGG
T ss_pred             chhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhh
Confidence               00 000    000112335789999999999999999999999999764

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=381.61  Aligned_cols=257  Identities=26%  Similarity=0.426  Sum_probs=205.8

Q ss_pred             hCCCCCcceeccCCceEEEEEEeC-CCc--EEEEEEeccc-ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEecCCeEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTS-DGL--QIAVKKLKAM-NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~~~~~~l  114 (380)
                      .++|++.++||+|+||+||+|.+. ++.  .||||+++.. .......+.+|+++|.++ +|||||++++++.+.+.+++
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            368899999999999999999863 444  4788887643 334455789999999998 79999999999999999999


Q ss_pred             EEEecCCCCHHHhhccCC------------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc
Q 037869          115 VYDYMPNLSLLSHLHGQY------------AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE  182 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~------------~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~  182 (380)
                      ||||+++|+|.+++....            .....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGC
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCc
Confidence            999999999999996541            2345799999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCC-CCCCCCCCCcccchhccch
Q 037869          183 PLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGR-KPIEKLPGGVKRTITEWAE  261 (380)
Q Consensus       183 vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~p~~~~~~~~~~~~~~~~~  261 (380)
                      +||+|||+++.....  .......||..|+|||.+.+..|+.++|||||||++|||++|. +||......   .+     
T Consensus       166 ~kl~DfG~a~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~---~~-----  235 (309)
T d1fvra_         166 AKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---EL-----  235 (309)
T ss_dssp             EEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HH-----
T ss_pred             eEEcccccccccccc--ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHH---HH-----
Confidence            999999999865332  2223446899999999999999999999999999999999965 566543210   00     


Q ss_pred             hhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          262 PLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                              ...+....+...+..+++++.+||.+||+.||++|||+.+|+++|..+
T Consensus       236 --------~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i  283 (309)
T d1fvra_         236 --------YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  283 (309)
T ss_dssp             --------HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             --------HHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                    011111223344455668999999999999999999999999998654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=6.5e-52  Score=373.74  Aligned_cols=267  Identities=21%  Similarity=0.303  Sum_probs=205.0

Q ss_pred             CCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccCh--hhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEEe
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNS--KAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYDY  118 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~  118 (380)
                      ++|++.++||+|+||+||+|++.+|+.||||+++....  .....+.+|+.+|++++||||+++++++..++..+++||+
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            58999999999999999999998899999999975432  2245788999999999999999999999999999999999


Q ss_pred             cCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCC
Q 037869          119 MPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGV  198 (380)
Q Consensus       119 ~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~  198 (380)
                      +.++.+..+...    ...+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus        82 ~~~~~~~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~  154 (286)
T d1ob3a_          82 LDQDLKKLLDVC----EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV  154 (286)
T ss_dssp             CSEEHHHHHHTS----TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--
T ss_pred             ehhhhHHHHHhh----cCCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCc
Confidence            988766666543    35799999999999999999999999   99999999999999999999999999998765432


Q ss_pred             ccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccc----------hhccchhhhhcc
Q 037869          199 SHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRT----------ITEWAEPLIVKG  267 (380)
Q Consensus       199 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~----------~~~~~~~~~~~~  267 (380)
                      . ......+++.|+|||.+.+. .++.++|||||||++|||++|..||..........          ...|........
T Consensus       155 ~-~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  233 (286)
T d1ob3a_         155 R-KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPK  233 (286)
T ss_dssp             --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTT
T ss_pred             c-ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhh
Confidence            2 23344689999999998754 56999999999999999999999997543211000          000000000000


Q ss_pred             c--cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          268 K--FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       268 ~--~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                      .  ......+..........+.++.+||.+||+.||++|||++|+++|.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~  283 (286)
T d1ob3a_         234 YDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY  283 (286)
T ss_dssp             CCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGG
T ss_pred             cccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence            0  00000011111222334578899999999999999999999999865

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-52  Score=375.45  Aligned_cols=271  Identities=23%  Similarity=0.293  Sum_probs=201.8

Q ss_pred             hCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC----eEEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD----QRLIV  115 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~~lv  115 (380)
                      ..+|++.++||+|+||+||+|+. +|+.||||+++..... ......|+..+..++||||+++++++...+    .+++|
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv   79 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEE
Confidence            45788999999999999999987 5889999999754322 223444666667889999999999997643    58999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcC-----CCCeEecCCCCCCeeeCCCCceEEeeccC
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV-----TPHIIHRDIKASNVLLDSDFEPLVADFGF  190 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~-----~~~ivHrdlkp~Nill~~~~~vkl~Dfgl  190 (380)
                      ||||++|+|.+++++.     .+++..++.++.|++.||+|||+..     .+||+||||||+||||+.++.+||+|||+
T Consensus        80 ~Ey~~~g~L~~~l~~~-----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          80 SDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EECCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EecccCCCHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence            9999999999999753     6899999999999999999999731     23899999999999999999999999999


Q ss_pred             ccccCCCCcc---ceeccccccCccCccccccCC------CCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccch
Q 037869          191 AKLIPEGVSH---MTTRVKGTLGYLAPEYAMWGK------VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE  261 (380)
Q Consensus       191 ~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~  261 (380)
                      ++........   ......||+.|+|||++.+..      ++.++|||||||++|||+||..||................
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~  234 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence            9877543222   233467999999999987643      6789999999999999999998886433221111110000


Q ss_pred             hhhhccccccccCCcccCCC-----CHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          262 PLIVKGKFKELVDPKLRGDF-----DENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       262 ~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ...............++...     .......+.+|+.+||+.||++|||+.||+++|..+
T Consensus       235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i  295 (303)
T d1vjya_         235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence            00000000111112222222     234557799999999999999999999999998644

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-53  Score=378.81  Aligned_cols=244  Identities=26%  Similarity=0.410  Sum_probs=201.1

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccCh------hhHHHHHHHHHHHhcCC--CCcceeEeeEEecCC
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNS------KAEMEFAVEVEVLGRVR--HKNLLGLRGYCAGTD  110 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~------~~~~~~~~E~~~l~~l~--h~niv~~~~~~~~~~  110 (380)
                      .++|++.+.||+|+||+||+|++ .+|+.||||+++....      .....+.+|+.+|+.++  ||||+++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            57899999999999999999997 5799999999864211      11224667999999886  899999999999999


Q ss_pred             eEEEEEEecCC-CCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCC-CceEEeec
Q 037869          111 QRLIVYDYMPN-LSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSD-FEPLVADF  188 (380)
Q Consensus       111 ~~~lv~e~~~~-g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~-~~vkl~Df  188 (380)
                      ..|+||||+.+ +++.+++...    ..+++..++.++.|++.||+|||++   ||+||||||+|||++.+ +.+||+||
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~----~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DF  155 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITER----GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDF  155 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eEEEEEEeccCcchHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECcc
Confidence            99999999976 5777777543    5799999999999999999999999   99999999999999854 79999999


Q ss_pred             cCccccCCCCccceeccccccCccCccccccCCC-CccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcc
Q 037869          189 GFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKV-SESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKG  267 (380)
Q Consensus       189 gl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~  267 (380)
                      |++......   ......||+.|+|||++.+..+ +.++||||+||++|+|++|..||.....             ...+
T Consensus       156 G~a~~~~~~---~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------i~~~  219 (273)
T d1xwsa_         156 GSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------IIRG  219 (273)
T ss_dssp             TTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------HHHC
T ss_pred             ccceecccc---cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------------Hhhc
Confidence            999875432   2345679999999999987665 6789999999999999999999964210             0011


Q ss_pred             ccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          268 KFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      .          ..++...+.++.+||.+||+.||++|||++|+++|.+.
T Consensus       220 ~----------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~  258 (273)
T d1xwsa_         220 Q----------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM  258 (273)
T ss_dssp             C----------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGG
T ss_pred             c----------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhh
Confidence            0          01222345789999999999999999999999999764

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-52  Score=379.88  Aligned_cols=261  Identities=26%  Similarity=0.436  Sum_probs=213.3

Q ss_pred             HHhhCCCCCcceeccCCceEEEEEEe------CCCcEEEEEEeccc-ChhhHHHHHHHHHHHhcC-CCCcceeEeeEEec
Q 037869           37 HTATNGFSDDNKLGEGGFGSVYWGRT------SDGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRV-RHKNLLGLRGYCAG  108 (380)
Q Consensus        37 ~~~~~~y~~~~~Lg~G~~g~Vy~~~~------~~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~~  108 (380)
                      ....++|++.++||+|+||.||+|+.      .++..||||+++.. .......+.+|+.+++.+ +|||||++++++.+
T Consensus        19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~   98 (311)
T d1t46a_          19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI   98 (311)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee
Confidence            34668999999999999999999974      34678999999753 344556788999999999 69999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHhhccCCC--------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCC
Q 037869          109 TDQRLIVYDYMPNLSLLSHLHGQYA--------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASN  174 (380)
Q Consensus       109 ~~~~~lv~e~~~~g~L~~~i~~~~~--------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~N  174 (380)
                      .+..++|||||++|+|.+++.....              ....+++..+..++.||+.||+|||++   +++||||||+|
T Consensus        99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~N  175 (311)
T d1t46a_          99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARN  175 (311)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGG
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceeeccccccc
Confidence            9999999999999999999975421              234689999999999999999999999   99999999999


Q ss_pred             eeeCCCCceEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCc
Q 037869          175 VLLDSDFEPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGV  252 (380)
Q Consensus       175 ill~~~~~vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~  252 (380)
                      |+++.++.++++|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+| |.+||.......
T Consensus       176 Il~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~  255 (311)
T d1t46a_         176 ILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (311)
T ss_dssp             EEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             ccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH
Confidence            9999999999999999987754332 23344678999999999999999999999999999999999 555554432211


Q ss_pred             ccchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          253 KRTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                                     .+...+....+...+...+..+.+||.+||+.||++|||+.+|++.|.
T Consensus       256 ---------------~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~  303 (311)
T d1t46a_         256 ---------------KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIE  303 (311)
T ss_dssp             ---------------HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ---------------HHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHH
Confidence                           011122222333444455688999999999999999999999999875

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-52  Score=377.94  Aligned_cols=267  Identities=19%  Similarity=0.267  Sum_probs=201.4

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CC-CcEEEEEEecccC--hhhHHHHHHHHHHHhcC---CCCcceeEeeEEec----
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SD-GLQIAVKKLKAMN--SKAEMEFAVEVEVLGRV---RHKNLLGLRGYCAG----  108 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~-~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l---~h~niv~~~~~~~~----  108 (380)
                      .++|+++++||+|+||+||+|++ .+ ++.||||+++...  ......+.+|+.+|+.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            47999999999999999999987 44 5679999986422  12222455677766655   79999999999853    


Q ss_pred             -CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEee
Q 037869          109 -TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVAD  187 (380)
Q Consensus       109 -~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~D  187 (380)
                       ....+++|||+.++.+......   ....+++..++.++.|++.||+|||++   +|+||||||+|||++.++.+||+|
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~d  159 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLAD  159 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecc
Confidence             3468999999998776655433   245789999999999999999999999   999999999999999999999999


Q ss_pred             ccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccc-------
Q 037869          188 FGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWA-------  260 (380)
Q Consensus       188 fgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~-------  260 (380)
                      ||++.....  ........||+.|+|||++.+..|+.++||||+||++|||++|.+||.......  .+..+.       
T Consensus       160 fg~~~~~~~--~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~--~~~~i~~~~~~~~  235 (305)
T d1blxa_         160 FGLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD--QLGKILDVIGLPG  235 (305)
T ss_dssp             CCSCCCCCG--GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHHHHHCCCC
T ss_pred             hhhhhhhcc--cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHH--HHHHHHHhhCCCc
Confidence            999886533  233455679999999999999999999999999999999999999997543211  000000       


Q ss_pred             -----hhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          261 -----EPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       261 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                           .........................+..+.+||.+||+.||++|||+.|+++|.+.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff  296 (305)
T d1blxa_         236 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  296 (305)
T ss_dssp             GGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGG
T ss_pred             hhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence                 00000000000000111112233455788999999999999999999999999763

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-52  Score=378.00  Aligned_cols=260  Identities=30%  Similarity=0.408  Sum_probs=208.2

Q ss_pred             HhhCCCCCcceeccCCceEEEEEEeCC--------CcEEEEEEecccC-hhhHHHHHHHHHHHhcC-CCCcceeEeeEEe
Q 037869           38 TATNGFSDDNKLGEGGFGSVYWGRTSD--------GLQIAVKKLKAMN-SKAEMEFAVEVEVLGRV-RHKNLLGLRGYCA  107 (380)
Q Consensus        38 ~~~~~y~~~~~Lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l-~h~niv~~~~~~~  107 (380)
                      ...++|++.+.||+|+||.||+|+...        +..||||+++... ......+.+|...+.++ +|||||++++++.
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~   89 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT   89 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence            466899999999999999999997522        2469999997643 34456788899988888 7999999999999


Q ss_pred             cCCeEEEEEEecCCCCHHHhhccCCC------------CCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCe
Q 037869          108 GTDQRLIVYDYMPNLSLLSHLHGQYA------------GEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNV  175 (380)
Q Consensus       108 ~~~~~~lv~e~~~~g~L~~~i~~~~~------------~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Ni  175 (380)
                      +++..++|||||++|+|.+++.....            ....+++..++.++.|++.||+|||+.   +|+||||||+||
T Consensus        90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~Ni  166 (299)
T d1fgka_          90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNV  166 (299)
T ss_dssp             SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccce
Confidence            99999999999999999999965421            234689999999999999999999999   999999999999


Q ss_pred             eeCCCCceEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHh-CCCCCCCCCCCcc
Q 037869          176 LLDSDFEPLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILT-GRKPIEKLPGGVK  253 (380)
Q Consensus       176 ll~~~~~vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~-g~~p~~~~~~~~~  253 (380)
                      |++.++.+||+|||+++....... .......|++.|+|||.+.+..|+.++|||||||++|||++ |.+||....... 
T Consensus       167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~-  245 (299)
T d1fgka_         167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE-  245 (299)
T ss_dssp             EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-
T ss_pred             eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHH-
Confidence            999999999999999987654322 23344568999999999999999999999999999999998 788886543210 


Q ss_pred             cchhccchhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          254 RTITEWAEPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                                     +...+....+...+..++.++.+||.+||+.||++|||+.+|++.|..
T Consensus       246 ---------------~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~  293 (299)
T d1fgka_         246 ---------------LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  293 (299)
T ss_dssp             ---------------HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---------------HHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence                           001111222334445566789999999999999999999999998853

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-51  Score=372.97  Aligned_cols=251  Identities=27%  Similarity=0.382  Sum_probs=202.1

Q ss_pred             cceeccCCceEEEEEEeCC----CcEEEEEEecc-cChhhHHHHHHHHHHHhcCCCCcceeEeeEEec-CCeEEEEEEec
Q 037869           46 DNKLGEGGFGSVYWGRTSD----GLQIAVKKLKA-MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG-TDQRLIVYDYM  119 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~~----~~~vavK~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~  119 (380)
                      .++||+|+||+||+|++..    ...||||+++. ........+.+|+++|++++||||+++++++.. +...++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            5789999999999998633    23589999974 445556789999999999999999999999865 56899999999


Q ss_pred             CCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCCCc
Q 037869          120 PNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEGVS  199 (380)
Q Consensus       120 ~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~~~  199 (380)
                      ++|+|.+++...   ...+++..++.++.|++.||.|||+.   +|+||||||+|||+++++.+||+|||+++.......
T Consensus       112 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         112 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             ecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            999999998754   34678889999999999999999999   999999999999999999999999999987654322


Q ss_pred             c---ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccccccccCCc
Q 037869          200 H---MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKFKELVDPK  276 (380)
Q Consensus       200 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (380)
                      .   ......||+.|+|||.+.+..++.++||||||+++|||++|..||.......     .+...          +...
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~-----~~~~~----------i~~g  250 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF-----DITVY----------LLQG  250 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-----------CHHH----------HHTT
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHH-----HHHHH----------HHcC
Confidence            1   2223468999999999999999999999999999999999888875432111     00000          0111


Q ss_pred             ccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          277 LRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       277 ~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      .+...+..++..+.+||.+||+.||++|||+.||+++|+.+
T Consensus       251 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i  291 (311)
T d1r0pa_         251 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI  291 (311)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            12233444567899999999999999999999999998644

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-52  Score=376.47  Aligned_cols=263  Identities=24%  Similarity=0.364  Sum_probs=213.4

Q ss_pred             HHHhhCCCCCcceeccCCceEEEEEEeC------CCcEEEEEEeccc-ChhhHHHHHHHHHHHhcCCCCcceeEeeEEec
Q 037869           36 LHTATNGFSDDNKLGEGGFGSVYWGRTS------DGLQIAVKKLKAM-NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG  108 (380)
Q Consensus        36 ~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~------~~~~vavK~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~  108 (380)
                      +....++|++.++||+|+||+||+|.+.      ++..||||+++.. .......+.+|+.++++++||||+++++++..
T Consensus        15 ~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          15 WEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             eeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            4456689999999999999999999752      2578999999753 33444578899999999999999999999999


Q ss_pred             CCeEEEEEEecCCCCHHHhhccCC------CCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCc
Q 037869          109 TDQRLIVYDYMPNLSLLSHLHGQY------AGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFE  182 (380)
Q Consensus       109 ~~~~~lv~e~~~~g~L~~~i~~~~------~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~  182 (380)
                      .+..++||||+++|+|.+++....      .....+++..+..++.|++.||.|||++   +|+||||||+|||++.+++
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~  171 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFT  171 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCC
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCce
Confidence            999999999999999999886431      1223578999999999999999999999   9999999999999999999


Q ss_pred             eEEeeccCccccCCCCc-cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCC-CCCCCCCCCcccchhccc
Q 037869          183 PLVADFGFAKLIPEGVS-HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGR-KPIEKLPGGVKRTITEWA  260 (380)
Q Consensus       183 vkl~Dfgl~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~-~p~~~~~~~~~~~~~~~~  260 (380)
                      +||+|||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+||. +||......      ++.
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~------~~~  245 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE------QVL  245 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH------HHH
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH------HHH
Confidence            99999999987643222 2233346899999999999999999999999999999999984 777543211      000


Q ss_pred             hhhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          261 EPLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                               . .+....+...+..++..+.+||.+||+.||++|||+.+|+++|+..
T Consensus       246 ---------~-~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~  292 (308)
T d1p4oa_         246 ---------R-FVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE  292 (308)
T ss_dssp             ---------H-HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGG
T ss_pred             ---------H-HHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence                     0 0111122334445567899999999999999999999999998754

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-50  Score=373.25  Aligned_cols=263  Identities=24%  Similarity=0.288  Sum_probs=198.4

Q ss_pred             CCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcceeEeeEEec------CCeEEE
Q 037869           42 GFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG------TDQRLI  114 (380)
Q Consensus        42 ~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~~~~~l  114 (380)
                      +|+..++||+|+||+||+|++ .+|+.||||+++....    ...+|+.+|++++||||++++++|..      ..++++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            688899999999999999998 5799999999975432    23469999999999999999999854      235789


Q ss_pred             EEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC-ceEEeeccCccc
Q 037869          115 VYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF-EPLVADFGFAKL  193 (380)
Q Consensus       115 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~-~vkl~Dfgl~~~  193 (380)
                      |||||+++ +...+.........+++..++.++.||+.||+|||++   ||+||||||+|||++.++ .+||+|||++..
T Consensus        97 v~Ey~~~~-~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~  172 (350)
T d1q5ka_          97 VLDYVPET-VYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ  172 (350)
T ss_dssp             EEECCSEE-HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred             EEeccCCc-cHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhh
Confidence            99999765 4433332222345799999999999999999999999   999999999999999775 899999999987


Q ss_pred             cCCCCccceeccccccCccCcccccc-CCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccch-----------
Q 037869          194 IPEGVSHMTTRVKGTLGYLAPEYAMW-GKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAE-----------  261 (380)
Q Consensus       194 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~-----------  261 (380)
                      .....  ......||+.|+|||.+.+ ..|+.++||||+||++|||++|..||.......  .+..+..           
T Consensus       173 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~--~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         173 LVRGE--PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             CCTTS--CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH--HHHHHHHHHCCCCHHHHH
T ss_pred             ccCCc--ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHH--HHHHHHHHhCCChHHhhh
Confidence            65432  2334578999999998875 568999999999999999999999997543211  1100000           


Q ss_pred             ---hhhhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          262 ---PLIVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       262 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                         .......+................++++.+||.+||..||++|||+.|+++|.+.
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f  306 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF  306 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhh
Confidence               0000000111111111112233455789999999999999999999999999653

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-50  Score=367.82  Aligned_cols=269  Identities=20%  Similarity=0.272  Sum_probs=199.1

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEec--------
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG--------  108 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~--------  108 (380)
                      .++|+++++||+|+||+||+|++ .+|+.||||++...  .......+.+|+++|+.++||||+++++++..        
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            47899999999999999999997 57999999998643  23334578899999999999999999999855        


Q ss_pred             CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeec
Q 037869          109 TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADF  188 (380)
Q Consensus       109 ~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Df  188 (380)
                      ....|+||||+.++.+......    ...+++..++.++.|++.||.|||+.   ||+||||||+|||++.++.+||+||
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~----~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~df  161 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNV----LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADF  161 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCT----TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCC
T ss_pred             CceEEEEEeccCCCccchhhhc----ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeec
Confidence            3458999999987666554432    35789999999999999999999999   9999999999999999999999999


Q ss_pred             cCccccCCCCc---cceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh
Q 037869          189 GFAKLIPEGVS---HMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI  264 (380)
Q Consensus       189 gl~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  264 (380)
                      |++..+.....   ......+||+.|+|||++.+. .|+.++||||+||++|||++|..||.+.......  ........
T Consensus       162 g~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~--~~i~~~~~  239 (318)
T d3blha1         162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL--ALISQLCG  239 (318)
T ss_dssp             TTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHHHHHHC
T ss_pred             ceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHH--HHHHHhcC
Confidence            99987653221   123335689999999998865 6899999999999999999999999753321100  00000000


Q ss_pred             --hcccc--------ccccC-C-cccCCCCH-----HHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          265 --VKGKF--------KELVD-P-KLRGDFDE-----NQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       265 --~~~~~--------~~~~~-~-~~~~~~~~-----~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                        .....        ..... . ........     ..+.++.+||.+||+.||++|||++|+++|.+..
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~  309 (318)
T d3blha1         240 SITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW  309 (318)
T ss_dssp             CCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGS
T ss_pred             CCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhc
Confidence              00000        00000 0 00000000     1135678999999999999999999999998743

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1e-49  Score=366.30  Aligned_cols=263  Identities=17%  Similarity=0.264  Sum_probs=203.3

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCC-CCcceeEeeEEec--CCeEEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR-HKNLLGLRGYCAG--TDQRLIV  115 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--~~~~~lv  115 (380)
                      .++|+++++||+|+||+||+|++ .+|+.||||+++...   ...+.+|+.+|+.++ ||||+++++++..  ...+++|
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v  110 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  110 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEE
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEE
Confidence            36799999999999999999998 579999999997643   347888999999995 9999999999974  4569999


Q ss_pred             EEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCC-ceEEeeccCcccc
Q 037869          116 YDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDF-EPLVADFGFAKLI  194 (380)
Q Consensus       116 ~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~-~vkl~Dfgl~~~~  194 (380)
                      ||||.+++|....       ..+++..+..++.||+.||.|||++   ||+||||||+|||++.++ .++|+|||+++..
T Consensus       111 ~e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~  180 (328)
T d3bqca1         111 FEHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY  180 (328)
T ss_dssp             EECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEEC
T ss_pred             EeecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceec
Confidence            9999999987764       2589999999999999999999999   999999999999998755 6999999999876


Q ss_pred             CCCCccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchh--c---------cchh
Q 037869          195 PEGVSHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTIT--E---------WAEP  262 (380)
Q Consensus       195 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~--~---------~~~~  262 (380)
                      ....  ......+|+.|+|||++.+. .++.++||||+||++|+|++|..||............  .         +...
T Consensus       181 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~  258 (328)
T d3bqca1         181 HPGQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDK  258 (328)
T ss_dssp             CTTC--CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHH
T ss_pred             cCCC--cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhh
Confidence            5432  23445689999999998865 5799999999999999999999999754332110000  0         0000


Q ss_pred             hhh--ccccccc--------cCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcCC
Q 037869          263 LIV--KGKFKEL--------VDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTGY  317 (380)
Q Consensus       263 ~~~--~~~~~~~--------~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~~  317 (380)
                      ...  ...+...        .............+.++.+||.+||..||++|||++|+|+|.+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~  323 (328)
T d3bqca1         259 YNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY  323 (328)
T ss_dssp             TTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGT
T ss_pred             cccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence            000  0000000        000111112234457899999999999999999999999998753

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-50  Score=369.87  Aligned_cols=264  Identities=22%  Similarity=0.272  Sum_probs=199.6

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecc--cChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC-----
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKA--MNSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD-----  110 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~-----  110 (380)
                      ..++|+++++||+|+||+||+|.+ .+|+.||||+++.  ........+.+|+++|+.++|||||+++++|...+     
T Consensus        16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            467999999999999999999997 5699999999975  33344567889999999999999999999997654     


Q ss_pred             -eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeecc
Q 037869          111 -QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG  189 (380)
Q Consensus       111 -~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfg  189 (380)
                       .+|+||||| +.+|...+..     ..+++..++.++.||+.||.|||++   ||+||||||+|||++.++.+|++|||
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg  166 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFG  166 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCT
T ss_pred             ceEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccccccccccc
Confidence             579999999 5678777754     3699999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCccceeccccccCccCccccccC-CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchh-----------
Q 037869          190 FAKLIPEGVSHMTTRVKGTLGYLAPEYAMWG-KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTIT-----------  257 (380)
Q Consensus       190 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~-----------  257 (380)
                      +++.....    .....||+.|+|||++.+. .++.++||||+||++|+|++|..||............           
T Consensus       167 ~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  242 (346)
T d1cm8a_         167 LARQADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF  242 (346)
T ss_dssp             TCEECCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ceeccCCc----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHH
Confidence            99876432    3345689999999998764 5799999999999999999999999764321100000           


Q ss_pred             --ccchhh--hhccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          258 --EWAEPL--IVKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       258 --~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                        .+....  ............. ........+.++.+||.+||..||.+|||+.|+|+|.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f  304 (346)
T d1cm8a_         243 VQRLQSDEAKNYMKGLPELEKKD-FASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF  304 (346)
T ss_dssp             HHTCSCHHHHHHHHHSCCCCCCC-GGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGG
T ss_pred             HhhhcchhhhhhhccCCcccccc-hHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhh
Confidence              000000  0000000000000 111223345788999999999999999999999999664

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-49  Score=358.41  Aligned_cols=267  Identities=17%  Similarity=0.209  Sum_probs=208.8

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEecCCeEEEEEE
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  117 (380)
                      ++|+++++||+|+||+||+|++ .+++.||||+++..  .......+.+|+.+|+.++||||+++++++......++|++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            5899999999999999999997 57899999999643  33445688899999999999999999999999999999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCccccCCC
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAKLIPEG  197 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~~~~~  197 (380)
                      ++.+++|..++...    ..+++..++.++.|++.||+|||++   ||+||||||+|||++.++.+||+|||.+......
T Consensus        82 ~~~~~~l~~~~~~~----~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~  154 (292)
T d1unla_          82 FCDQDLKKYFDSCN----GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP  154 (292)
T ss_dssp             CCSEEHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred             eccccccccccccc----cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCC
Confidence            99999888877543    5789999999999999999999999   9999999999999999999999999999887543


Q ss_pred             CccceeccccccCccCccccccCC-CCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchh------------hh
Q 037869          198 VSHMTTRVKGTLGYLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEP------------LI  264 (380)
Q Consensus       198 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~------------~~  264 (380)
                      .. ......+++.|.|||++.+.. ++.++||||+||++|||++|..||........ ........            ..
T Consensus       155 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  232 (292)
T d1unla_         155 VR-CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD-QLKRIFRLLGTPTEEQWPSMTK  232 (292)
T ss_dssp             CS-CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH-HHHHHHHHHCCCCTTTCTTGGG
T ss_pred             Cc-cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH-HHHHHHhhcCCCChhhhhhhhh
Confidence            32 233345788999999988655 69999999999999999999999754322110 00000000            00


Q ss_pred             --hccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          265 --VKGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       265 --~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                        .....................+..+.+|+.+||+.||.+|||++|+++|.+.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f  286 (292)
T d1unla_         233 LPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF  286 (292)
T ss_dssp             STTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGG
T ss_pred             cccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhh
Confidence              0000000000111112233445788999999999999999999999999753

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-49  Score=367.91  Aligned_cols=269  Identities=20%  Similarity=0.292  Sum_probs=200.1

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccC-hhhHHHHHHHHHHHhcCCCCcceeEeeEEecCC----eE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMN-SKAEMEFAVEVEVLGRVRHKNLLGLRGYCAGTD----QR  112 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~----~~  112 (380)
                      .+.+|++++.||+|+||+||+|.+ .+|+.||||+++... ......+.+|+.+|+.++||||+++++++....    ..
T Consensus         6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            457899999999999999999987 689999999997543 344567889999999999999999999986543    23


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCcc
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFAK  192 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~  192 (380)
                      +++++++.+|+|.+++...     .+++..++.++.|++.||+|||++   ||+||||||+|||++.++.+||+|||++.
T Consensus        86 ~~l~~~~~~g~L~~~l~~~-----~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~  157 (345)
T d1pmea_          86 VYLVTHLMGADLYKLLKTQ-----HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLAR  157 (345)
T ss_dssp             EEEEEECCCEEHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             EEEEEeecCCchhhhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCcee
Confidence            4555666799999999643     699999999999999999999999   99999999999999999999999999998


Q ss_pred             ccCCCCc--cceeccccccCccCccccc-cCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhcc--chh--hhh
Q 037869          193 LIPEGVS--HMTTRVKGTLGYLAPEYAM-WGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEW--AEP--LIV  265 (380)
Q Consensus       193 ~~~~~~~--~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~--~~~--~~~  265 (380)
                      .......  .......||+.|+|||++. +..++.++||||+||++|+|++|..||..............  ..+  ...
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  237 (345)
T d1pmea_         158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL  237 (345)
T ss_dssp             ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHH
T ss_pred             eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhh
Confidence            7643221  1234456899999999985 55689999999999999999999999975432110000000  000  000


Q ss_pred             -------ccccccccCCccc---CCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          266 -------KGKFKELVDPKLR---GDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       266 -------~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                             .............   .......+.++.+|+.+||..||.+|||++++++|.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf  297 (345)
T d1pmea_         238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY  297 (345)
T ss_dssp             HTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGG
T ss_pred             hhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHh
Confidence                   0000000000000   0111233467899999999999999999999999965

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-50  Score=366.50  Aligned_cols=256  Identities=25%  Similarity=0.330  Sum_probs=208.0

Q ss_pred             CCCCCcceeccCCceEEEEEEe----CCCcEEEEEEeccc----ChhhHHHHHHHHHHHhcCCC-CcceeEeeEEecCCe
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT----SDGLQIAVKKLKAM----NSKAEMEFAVEVEVLGRVRH-KNLLGLRGYCAGTDQ  111 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~----~~~~~vavK~~~~~----~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~  111 (380)
                      ++|++.+.||+|+||+||+|++    .+|+.||||+++..    .......+.+|++++++++| |||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            5699999999999999999975    24789999998642    12234467789999999976 899999999999999


Q ss_pred             EEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccCc
Q 037869          112 RLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGFA  191 (380)
Q Consensus       112 ~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~  191 (380)
                      .+++|||+.+|+|.+++...    ..+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.+||+|||++
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a  176 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLS  176 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred             eeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccch
Confidence            99999999999999999654    4678899999999999999999999   9999999999999999999999999999


Q ss_pred             cccCCCCccceeccccccCccCccccccC--CCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhcccc
Q 037869          192 KLIPEGVSHMTTRVKGTLGYLAPEYAMWG--KVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGKF  269 (380)
Q Consensus       192 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  269 (380)
                      +.+............|++.|+|||.+.+.  .++.++|||||||+||+|++|..||........  ........     .
T Consensus       177 ~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~--~~~i~~~~-----~  249 (322)
T d1vzoa_         177 KEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISRRI-----L  249 (322)
T ss_dssp             EECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHHHH-----H
T ss_pred             hhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHHhc-----c
Confidence            88755444445566799999999999754  478899999999999999999999976433211  11000000     0


Q ss_pred             ccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCC-----CHHHHHHHhcC
Q 037869          270 KELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRP-----NMKEVVNTLTG  316 (380)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp-----s~~~ll~~l~~  316 (380)
                            ......+...+.++.+||.+||..||.+||     |++|+++|.+.
T Consensus       250 ------~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff  295 (322)
T d1vzoa_         250 ------KSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF  295 (322)
T ss_dssp             ------HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred             ------cCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhh
Confidence                  001123445668999999999999999999     58999999764

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-49  Score=365.71  Aligned_cols=266  Identities=22%  Similarity=0.250  Sum_probs=195.9

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEec------C
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG------T  109 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~------~  109 (380)
                      ..++|+++++||+|+||+||+|++ .+|+.||||+++..  .......+.+|+.+|+.++||||++++++|..      .
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~   94 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF   94 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTC
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccC
Confidence            347899999999999999999998 47999999999743  34445578899999999999999999999953      4


Q ss_pred             CeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeecc
Q 037869          110 DQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFG  189 (380)
Q Consensus       110 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfg  189 (380)
                      ..+|+|||||.++ +...+.      ..+++..++.++.|++.||.|||++   ||+||||||+|||++.++.++++|||
T Consensus        95 ~~~~iv~Ey~~~~-l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~  164 (355)
T d2b1pa1          95 QDVYLVMELMDAN-LCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFG  164 (355)
T ss_dssp             CEEEEEEECCSEE-HHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             ceeEEEEeccchH-HHHhhh------cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechh
Confidence            6889999999765 444553      3589999999999999999999999   99999999999999999999999999


Q ss_pred             CccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccch----------hcc
Q 037869          190 FAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI----------TEW  259 (380)
Q Consensus       190 l~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~----------~~~  259 (380)
                      +++.....  .......+|+.|+|||++.+..++.++||||+||++|+|++|.+||.+.+.......          ..|
T Consensus       165 ~~~~~~~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~  242 (355)
T d2b1pa1         165 LARTAGTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM  242 (355)
T ss_dssp             C-----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             hhhccccc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHH
Confidence            98876442  234445689999999999999999999999999999999999999975432110000          000


Q ss_pred             ch---h---hhhc------cccccccCCcc---cCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          260 AE---P---LIVK------GKFKELVDPKL---RGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       260 ~~---~---~~~~------~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ..   .   ....      ...........   ........+.++.+||.+||..||++|||++|+|+|.+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~  314 (355)
T d2b1pa1         243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI  314 (355)
T ss_dssp             TTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTT
T ss_pred             HHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCccc
Confidence            00   0   0000      00000010111   111223457889999999999999999999999999764

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.9e-48  Score=350.48  Aligned_cols=258  Identities=20%  Similarity=0.259  Sum_probs=196.8

Q ss_pred             hCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcce-eEeeEEecCCeEEEEEE
Q 037869           40 TNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNLL-GLRGYCAGTDQRLIVYD  117 (380)
Q Consensus        40 ~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~~~~~~~~~~~~~lv~e  117 (380)
                      .++|++.+.||+|+||+||+|++ .+|+.||||++.....  ...+..|+++++.++|+|++ .+..++...+..++|||
T Consensus         6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme   83 (299)
T d1ckia_           6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   83 (299)
T ss_dssp             TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEE
Confidence            46899999999999999999987 5689999999875432  23577899999999877655 45556677888999999


Q ss_pred             ecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC---CCceEEeeccCcccc
Q 037869          118 YMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS---DFEPLVADFGFAKLI  194 (380)
Q Consensus       118 ~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~---~~~vkl~Dfgl~~~~  194 (380)
                      |+ +++|...+...   ...+++..+..++.|++.||+|||++   ||+||||||+|||++.   +..++|+|||+++.+
T Consensus        84 ~~-~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          84 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             Ec-CCchhhhhhhc---cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            99 45676666532   35799999999999999999999999   9999999999999864   457999999999887


Q ss_pred             CCCCc------cceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhhccc
Q 037869          195 PEGVS------HMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIVKGK  268 (380)
Q Consensus       195 ~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  268 (380)
                      .....      .......||+.|+|||++.+..++.++|||||||++|||++|..||.......................
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~  236 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  236 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSC
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCC
Confidence            54321      123345799999999999999999999999999999999999999976443221111100000000000


Q ss_pred             cccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhc
Q 037869          269 FKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLT  315 (380)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~  315 (380)
                               .......++.++.+++.+||+.+|++||++.+|.+.|+
T Consensus       237 ---------~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~  274 (299)
T d1ckia_         237 ---------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFR  274 (299)
T ss_dssp             ---------HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHH
T ss_pred             ---------hhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHH
Confidence                     00112234578999999999999999999998876554

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=8.1e-48  Score=347.53  Aligned_cols=260  Identities=16%  Similarity=0.198  Sum_probs=205.9

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCCC-CcceeEeeEEecCCeEEEEE
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRH-KNLLGLRGYCAGTDQRLIVY  116 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~~~~~~~~~~~~~lv~  116 (380)
                      ..++|++.+.||+|+||+||+|++ .+|+.||||++.....  ...+.+|++.+..++| +|++.+++++..+...++||
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm   80 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   80 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence            357999999999999999999997 4689999999865432  2356788899998865 89999999999999999999


Q ss_pred             EecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCC-----CCceEEeeccCc
Q 037869          117 DYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDS-----DFEPLVADFGFA  191 (380)
Q Consensus       117 e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~-----~~~vkl~Dfgl~  191 (380)
                      ||+ +++|.+++...   ...+++..+..++.|++.||+|||+.   ||+||||||+|||++.     ++.+||+|||++
T Consensus        81 e~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a  153 (293)
T d1csna_          81 DLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  153 (293)
T ss_dssp             ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             Eec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEccccee
Confidence            999 67999988653   34799999999999999999999999   9999999999999964     578999999999


Q ss_pred             cccCCCCcc------ceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhhh
Q 037869          192 KLIPEGVSH------MTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLIV  265 (380)
Q Consensus       192 ~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~  265 (380)
                      +.+......      ......||+.|+|||++.+..++.++|||||||++|||++|..||....................
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~  233 (293)
T d1csna_         154 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  233 (293)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             EEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC
Confidence            876533211      23345799999999999999999999999999999999999999976543222111110000000


Q ss_pred             ccccccccCCcccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          266 KGKFKELVDPKLRGDFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                      ....         ......+++++.+++..|++.+|++||+++.+.+.+..
T Consensus       234 ~~~~---------~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~  275 (293)
T d1csna_         234 STPL---------RELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSK  275 (293)
T ss_dssp             HSCH---------HHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHH
T ss_pred             CCCh---------HHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHH
Confidence            0000         11122344689999999999999999999988776643

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-48  Score=359.31  Aligned_cols=264  Identities=21%  Similarity=0.258  Sum_probs=199.7

Q ss_pred             hhCCCCCcceeccCCceEEEEEEe-CCCcEEEEEEeccc--ChhhHHHHHHHHHHHhcCCCCcceeEeeEEec-----CC
Q 037869           39 ATNGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAM--NSKAEMEFAVEVEVLGRVRHKNLLGLRGYCAG-----TD  110 (380)
Q Consensus        39 ~~~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~~  110 (380)
                      ..++|+++++||+|+||+||+|++ .+|+.||||+++..  .......+.+|+.+|+.++||||+++++++..     +.
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~   95 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF   95 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence            467899999999999999999997 57999999999753  33445578899999999999999999999864     33


Q ss_pred             eEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceEEeeccC
Q 037869          111 QRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPLVADFGF  190 (380)
Q Consensus       111 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl  190 (380)
                      ..+++++|+.+|+|.+++..     ..+++..++.++.||+.||+|||++   ||+||||||+|||++.++.+|++|||+
T Consensus        96 ~~~~i~~~~~gg~L~~~~~~-----~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~  167 (348)
T d2gfsa1          96 NDVYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGL  167 (348)
T ss_dssp             CCCEEEEECCSEEHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC--
T ss_pred             ceEEEEEeecCCchhhhccc-----ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccch
Confidence            45667778889999999854     3699999999999999999999999   999999999999999999999999999


Q ss_pred             ccccCCCCccceeccccccCccCccccccCC-CCccchhhhhhHHHHHHHhCCCCCCCCCCCcccchhccchhhh-----
Q 037869          191 AKLIPEGVSHMTTRVKGTLGYLAPEYAMWGK-VSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTITEWAEPLI-----  264 (380)
Q Consensus       191 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~-----  264 (380)
                      +.....    ......|++.|+|||++.+.. ++.++|||||||++|+|++|..||.+......  ...+.....     
T Consensus       168 a~~~~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~--~~~i~~~~~~~~~~  241 (348)
T d2gfsa1         168 ARHTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ--LKLILRLVGTPGAE  241 (348)
T ss_dssp             --CCTG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHHHHHCCCCHH
T ss_pred             hcccCc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHH--HHHHHHhcCCCChH
Confidence            976532    334456899999999877654 68999999999999999999999975432110  000000000     


Q ss_pred             -hc-------cccccccCCcccC---CCCHHHHHHHHHHHHhhcCCCCCCCCCHHHHHHHhcC
Q 037869          265 -VK-------GKFKELVDPKLRG---DFDENQLKQAINVAVLCVQSEPEKRPNMKEVVNTLTG  316 (380)
Q Consensus       265 -~~-------~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~P~~Rps~~~ll~~l~~  316 (380)
                       ..       .............   ......+.++.+||.+||..||.+|||+.|+++|.+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f  304 (348)
T d2gfsa1         242 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF  304 (348)
T ss_dssp             HHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGG
T ss_pred             HhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhh
Confidence             00       0000000000000   0012334678999999999999999999999999764

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.5e-43  Score=327.05  Aligned_cols=268  Identities=22%  Similarity=0.213  Sum_probs=195.0

Q ss_pred             CCCCCcceeccCCceEEEEEEe-CCCcEEEEEEecccChhhHHHHHHHHHHHhcCC-----------CCcceeEeeEEec
Q 037869           41 NGFSDDNKLGEGGFGSVYWGRT-SDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR-----------HKNLLGLRGYCAG  108 (380)
Q Consensus        41 ~~y~~~~~Lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~~~~~~~~  108 (380)
                      ++|+++++||+|+||+||+|++ .+|+.||||+++... .....+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            4699999999999999999997 579999999998643 23446778888887764           5789999998754


Q ss_pred             --CCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhh-cCCCCeEecCCCCCCeeeCCCC----
Q 037869          109 --TDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHH-EVTPHIIHRDIKASNVLLDSDF----  181 (380)
Q Consensus       109 --~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~-~~~~~ivHrdlkp~Nill~~~~----  181 (380)
                        ....+++++++..+......... .....+++..+..++.|++.||+|||+ .   ||+||||||+|||++.++    
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~  167 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPEN  167 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTT
T ss_pred             ccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccc
Confidence              45667777776554433322221 234578999999999999999999998 6   999999999999997654    


Q ss_pred             --ceEEeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHHHHHHhCCCCCCCCCCCcccch-hc
Q 037869          182 --EPLVADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILLLEILTGRKPIEKLPGGVKRTI-TE  258 (380)
Q Consensus       182 --~vkl~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~-~~  258 (380)
                        .++++|||.+.....    ......||+.|+|||++.+..|+.++||||+||++++|++|..||........... ..
T Consensus       168 ~~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~  243 (362)
T d1q8ya_         168 LIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  243 (362)
T ss_dssp             EEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             cceeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHH
Confidence              399999999986543    23345689999999999999999999999999999999999999975433211100 00


Q ss_pred             cchhhhhccc--------------------cccccCC----------cccCCCCHHHHHHHHHHHHhhcCCCCCCCCCHH
Q 037869          259 WAEPLIVKGK--------------------FKELVDP----------KLRGDFDENQLKQAINVAVLCVQSEPEKRPNMK  308 (380)
Q Consensus       259 ~~~~~~~~~~--------------------~~~~~~~----------~~~~~~~~~~~~~~~~li~~cl~~~P~~Rps~~  308 (380)
                      ........+.                    .......          ..........+..+.+||.+||..||.+|||++
T Consensus       244 ~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~  323 (362)
T d1q8ya_         244 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG  323 (362)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHH
T ss_pred             HHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHH
Confidence            0000000000                    0000000          012234567788999999999999999999999


Q ss_pred             HHHHHhcCC
Q 037869          309 EVVNTLTGY  317 (380)
Q Consensus       309 ~ll~~l~~~  317 (380)
                      |+|+|.+..
T Consensus       324 e~L~Hp~f~  332 (362)
T d1q8ya_         324 GLVNHPWLK  332 (362)
T ss_dssp             HHHTCGGGT
T ss_pred             HHhcCcccC
Confidence            999997643

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=3.7e-26  Score=191.91  Aligned_cols=170  Identities=14%  Similarity=0.060  Sum_probs=121.5

Q ss_pred             CCCcceeccCCceEEEEEEeCCCcEEEEEEecccCh------------------hhHHHHHHHHHHHhcCCCCcceeEee
Q 037869           43 FSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNS------------------KAEMEFAVEVEVLGRVRHKNLLGLRG  104 (380)
Q Consensus        43 y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~------------------~~~~~~~~E~~~l~~l~h~niv~~~~  104 (380)
                      +.+.++||+|+||+||+|.+.+|+.||||+++....                  ........|...+.++.|.+++..++
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~   81 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA   81 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred             chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence            456789999999999999988899999998753110                  11223456888999999999998876


Q ss_pred             EEecCCeEEEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcCCCCeEecCCCCCCeeeCCCCceE
Q 037869          105 YCAGTDQRLIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEVTPHIIHRDIKASNVLLDSDFEPL  184 (380)
Q Consensus       105 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~~~~ivHrdlkp~Nill~~~~~vk  184 (380)
                      +..    .+++|||+++..+..           ++...+..++.|++.+|+|||++   ||+||||||+|||++++ .++
T Consensus        82 ~~~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~-~~~  142 (191)
T d1zara2          82 WEG----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEE-GIW  142 (191)
T ss_dssp             EET----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETT-EEE
T ss_pred             ecC----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCC-CEE
Confidence            532    379999998765432           23334567899999999999999   99999999999999865 589


Q ss_pred             EeeccCccccCCCCccceeccccccCccCccccccCCCCccchhhhhhHHH
Q 037869          185 VADFGFAKLIPEGVSHMTTRVKGTLGYLAPEYAMWGKVSESCDVYSFGILL  235 (380)
Q Consensus       185 l~Dfgl~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il  235 (380)
                      |+|||++.....+.......  ..... -.+ +..+.|+.++|+||+.--+
T Consensus       143 liDFG~a~~~~~~~~~~~l~--rd~~~-~~~-~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         143 IIDFPQSVEVGEEGWREILE--RDVRN-IIT-YFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             ECCCTTCEETTSTTHHHHHH--HHHHH-HHH-HHHHHHCCCCCHHHHHHHH
T ss_pred             EEECCCcccCCCCCcHHHHH--HHHHH-HHH-HHcCCCCCcccHHHHHHHH
Confidence            99999997764322111000  00000 001 1236788999999986443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.87  E-value=4.6e-09  Score=90.61  Aligned_cols=150  Identities=12%  Similarity=0.030  Sum_probs=104.8

Q ss_pred             HHHHHhhCCCCCcceeccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCC-CCcceeEeeEEecCCeE
Q 037869           34 KELHTATNGFSDDNKLGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR-HKNLLGLRGYCAGTDQR  112 (380)
Q Consensus        34 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  112 (380)
                      +++...-+.|++.+..+.++.+.||+... ++..+++|+...........+.+|...++.+. +--+.+++.+...++..
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~   85 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS   85 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence            56777778898888766666789999865 46678889886544333445667888777663 33356677777888899


Q ss_pred             EEEEEecCCCCHHHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhcC-------------------------------
Q 037869          113 LIVYDYMPNLSLLSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHEV-------------------------------  161 (380)
Q Consensus       113 ~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~~-------------------------------  161 (380)
                      ++||++++|.++.+.....      ..   ...++.+++..++.||+..                               
T Consensus        86 ~lv~~~l~G~~~~~~~~~~------~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYEDE------QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEECCSSEEHHHHTTTC------SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred             EEEEEeccccccccccccc------cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence            9999999998876654221      11   1224455555666666420                               


Q ss_pred             -------------------------CCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          162 -------------------------TPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       162 -------------------------~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                                               ...++|+|+.|.||++++++.+-|+||+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                     11479999999999999876667999988764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.39  E-value=1.1e-06  Score=74.75  Aligned_cols=131  Identities=15%  Similarity=0.076  Sum_probs=85.9

Q ss_pred             eeccCCc-eEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCC--CcceeEeeEEecCCeEEEEEEecCCCCH
Q 037869           48 KLGEGGF-GSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRH--KNLLGLRGYCAGTDQRLIVYDYMPNLSL  124 (380)
Q Consensus        48 ~Lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~~~~~~~~~~~~~lv~e~~~~g~L  124 (380)
                      .+..|.. +.||+....++..+++|........   .+..|...++.+..  -.+.+++.+..+++..++||++++|-++
T Consensus        17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred             EcCCcccCCeEEEEEeCCCCEEEEEeCCccCHh---HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence            4555554 6899998877888999987654322   45667777766632  2356677777888889999999988665


Q ss_pred             HHhhccCCCCCccCCHHHHHHHHHHHHHHHHHHhhc--------------------------------------------
Q 037869          125 LSHLHGQYAGEVQLDWKRRMKIAIGSAEGILYLHHE--------------------------------------------  160 (380)
Q Consensus       125 ~~~i~~~~~~~~~~~~~~~~~i~~ql~~al~~LH~~--------------------------------------------  160 (380)
                      .+..         ....   .++.++...|+-||+.                                            
T Consensus        94 ~~~~---------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (255)
T d1nd4a_          94 LSSH---------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  161 (255)
T ss_dssp             TTSC---------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             cccc---------ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence            3311         1111   1122333344444431                                            


Q ss_pred             -----------CCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          161 -----------VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       161 -----------~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                                 ....++|+|+.|.||+++++..+-|+||+.+..
T Consensus       162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                       012489999999999999876678999987754

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.83  E-value=2.6e-05  Score=70.56  Aligned_cols=77  Identities=13%  Similarity=0.117  Sum_probs=47.7

Q ss_pred             cceeccCCceEEEEEEeC-CCcEEEEEEecc----c---ChhhHHHHHHHHHHHhcCC--CC-cceeEeeEEecCCeEEE
Q 037869           46 DNKLGEGGFGSVYWGRTS-DGLQIAVKKLKA----M---NSKAEMEFAVEVEVLGRVR--HK-NLLGLRGYCAGTDQRLI  114 (380)
Q Consensus        46 ~~~Lg~G~~g~Vy~~~~~-~~~~vavK~~~~----~---~~~~~~~~~~E~~~l~~l~--h~-niv~~~~~~~~~~~~~l  114 (380)
                      .+.||.|....||++.+. +++.|+||.-..    .   .+....+...|...|+.+.  .| .+.+++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            457999999999999874 467899997432    1   1112223455777776552  23 45555544  3456689


Q ss_pred             EEEecCCCCH
Q 037869          115 VYDYMPNLSL  124 (380)
Q Consensus       115 v~e~~~~g~L  124 (380)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999976543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.23  E-value=0.00074  Score=59.02  Aligned_cols=139  Identities=14%  Similarity=0.114  Sum_probs=78.1

Q ss_pred             CCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCCC-----CcceeEe--eEEecCCeEEEEEEecCCCCH
Q 037869           52 GGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRH-----KNLLGLR--GYCAGTDQRLIVYDYMPNLSL  124 (380)
Q Consensus        52 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h-----~niv~~~--~~~~~~~~~~lv~e~~~~g~L  124 (380)
                      +.--.||++...+|..|++|+.+... ....++..|...+..|..     +..+..-  ..+......+.++++++|..+
T Consensus        33 s~EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~  111 (325)
T d1zyla1          33 SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF  111 (325)
T ss_dssp             CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred             cccceeEEEEcCCCCEEEEEEeCCCC-CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence            33458999998889999999987643 234467778887776632     1111111  123446778899999876433


Q ss_pred             HH--------------hhcc----C-CCCCccCCHH----------------------HHHHHHHHHHHHHHHHh-hcCC
Q 037869          125 LS--------------HLHG----Q-YAGEVQLDWK----------------------RRMKIAIGSAEGILYLH-HEVT  162 (380)
Q Consensus       125 ~~--------------~i~~----~-~~~~~~~~~~----------------------~~~~i~~ql~~al~~LH-~~~~  162 (380)
                      ..              .++.    . .......+..                      .....+..+...+.-+- +...
T Consensus       112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p  191 (325)
T d1zyla1         112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT  191 (325)
T ss_dssp             CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred             CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence            10              0000    0 0011111111                      11222333333332221 1113


Q ss_pred             CCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          163 PHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       163 ~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      .+++|+|+.+.|||++++  ..++||+-+..
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            479999999999999743  45899988764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.20  E-value=0.0006  Score=61.35  Aligned_cols=74  Identities=16%  Similarity=0.247  Sum_probs=49.2

Q ss_pred             CcceeccCCceEEEEEEeCC--------CcEEEEEEecccChhhHHHHHHHHHHHhcCCCCcc-eeEeeEEecCCeEEEE
Q 037869           45 DDNKLGEGGFGSVYWGRTSD--------GLQIAVKKLKAMNSKAEMEFAVEVEVLGRVRHKNL-LGLRGYCAGTDQRLIV  115 (380)
Q Consensus        45 ~~~~Lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~~~~~~~~~~~~~lv  115 (380)
                      .++.|+.|-.-.+|++...+        .+.|++++.-..  .......+|..+++.+.-.++ .++++++..    .+|
T Consensus        46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I  119 (395)
T d1nw1a_          46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRL  119 (395)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEE
T ss_pred             EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceE
Confidence            35689999999999997543        345666665422  223356678888888743344 467777642    689


Q ss_pred             EEecCCCCH
Q 037869          116 YDYMPNLSL  124 (380)
Q Consensus       116 ~e~~~~g~L  124 (380)
                      +||++|-++
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeccccC
Confidence            999987544

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.94  E-value=0.0081  Score=51.68  Aligned_cols=158  Identities=13%  Similarity=0.095  Sum_probs=81.3

Q ss_pred             HHHHHHhhCCCCCcce-----eccCCceEEEEEEeCCCcEEEEEEecccChhhHHHHHHHHHHHhcCC-----CCcceeE
Q 037869           33 YKELHTATNGFSDDNK-----LGEGGFGSVYWGRTSDGLQIAVKKLKAMNSKAEMEFAVEVEVLGRVR-----HKNLLGL  102 (380)
Q Consensus        33 ~~~~~~~~~~y~~~~~-----Lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~~  102 (380)
                      -+|+...-.+|.+.+.     |..|---+.|+..+.+| .+++|++.....  ...+..|++++..|.     .|..+..
T Consensus         5 ~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g-~yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi~~   81 (316)
T d2ppqa1           5 EDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPLPR   81 (316)
T ss_dssp             HHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCB
T ss_pred             HHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCC-cEEEEEcCCCCC--HHHHHHHHHHHHhhhhcccccccccee
Confidence            3566666677877543     34666678899988655 589999865322  223444565665553     2332221


Q ss_pred             ee---EEecCCeEEEEEEecCCCCHHHh--------------hc---cCCC--CCccC------------------CHHH
Q 037869          103 RG---YCAGTDQRLIVYDYMPNLSLLSH--------------LH---GQYA--GEVQL------------------DWKR  142 (380)
Q Consensus       103 ~~---~~~~~~~~~lv~e~~~~g~L~~~--------------i~---~~~~--~~~~~------------------~~~~  142 (380)
                      .+   +.........++.+..+......              ++   ....  .....                  ....
T Consensus        82 ~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (316)
T d2ppqa1          82 KDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG  161 (316)
T ss_dssp             TTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT
T ss_pred             cCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchh
Confidence            11   12224556677777665433210              00   0000  00000                  0001


Q ss_pred             HHHHHHHHHHHHHHHhhc-CCCCeEecCCCCCCeeeCCCCceEEeeccCccc
Q 037869          143 RMKIAIGSAEGILYLHHE-VTPHIIHRDIKASNVLLDSDFEPLVADFGFAKL  193 (380)
Q Consensus       143 ~~~i~~ql~~al~~LH~~-~~~~ivHrdlkp~Nill~~~~~vkl~Dfgl~~~  193 (380)
                      ....+......+...+.. ...|++|+|+.+.||+++.+...-|.||+.+..
T Consensus       162 ~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         162 LREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             HHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence            111222222223332221 134899999999999999887778999998753